PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, Q; Sun, Z; Yang, HS				Wang, Q.; Sun, Z.; Yang, H-S			Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells	ONCOGENE			English	Article						Pdcd4; invasion; beta-catenin; AP-1; E-cadherin; stably knockdown	E-CADHERIN EXPRESSION; INITIATION-FACTOR 4A; RECEPTOR U-PAR; NF-KAPPA-B; TRANSFORMATION SUPPRESSOR; AP-1 TRANSACTIVATION; CANCER; CARCINOGENESIS; TUMORIGENESIS; TRANSLATION	Programmed cell death 4 (Pdcd4) is a tumor suppressor that inhibits neoplastic transformation and tumor invasion. Tissue microarray analysis showed that Pdcd4 expression is downregulated in colon adenocarcinoma and carcinoma relative to adjacent normal tissues. To address the issue of whether reduced Pdcd4 expression is sufficient to promote tumor progression, we knocked down Pdcd4 expression in colon tumor HT29 cells using pdcd4 short hairpin RNA (shRNA). Pdcd4 knockdown results in a. broblast-like transition, while the control cells (expressing LacZ shRNA) remain as clumped similar to the parental cells. In addition, expression of pdcd4 shRNA in HT29 cells promotes invasion. In an effort to characterize the molecular mechanism underlying these observations, we discovered that knockdown of Pdcd4 results in reduction of E-cadherin expression, and accumulation of active beta-catenin in the nucleus. The active beta-catenin binds with T-cell factor 4 (Tcf4) and activates beta-catenin/Tcf-dependent transcription. Furthermore, Pdcd4 knockdown dramatically increases AP-1-dependent transcription. Thus, the mechanism by which reduced Pdcd4 expression promotes invasion appears to involve the activation of beta-catenin/Tcf and AP-1-dependent transcription.	[Wang, Q.; Sun, Z.; Yang, H-S] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Yang, H-S] Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Yang, HS (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	hyang3@uky.edu	Yang, Hsin-Sheng/AAF-6793-2020; Yang, Hsin-Sheng/A-6419-2008	Yang, Hsin-Sheng/0000-0002-0566-3036; Yang, Hsin-Sheng/0000-0002-0566-3036				Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gao F, 2007, ONCOL REP, V17, P123; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Kemler R, 1992, Semin Cell Biol, V3, P149; KINSELLA AR, 1994, CLIN EXP METASTAS, V12, P335, DOI 10.1007/BF01753841; Lamb RF, 1997, MOL CELL BIOL, V17, P963, DOI 10.1128/MCB.17.2.963; Laufs S, 2006, CELL CYCLE, V5, P1760; Lee S, 2006, ONCOL REP, V16, P747; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li JJ, 1998, ONCOGENE, V16, P2711, DOI 10.1038/sj.onc.1201798; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Matsuhashi S, 2007, EXP DERMATOL, V16, P179, DOI 10.1111/j.1600-0625.2006.00531.x; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; VANAKEN J, 1993, PATHOL RES PRACT, V189, P975; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634	33	132	138	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1527	1535		10.1038/sj.onc.1210793	http://dx.doi.org/10.1038/sj.onc.1210793			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17828298				2022-12-25	WOS:000253815800004
J	Vempati, P; Karagiannis, ED; Popel, AS				Vempati, Prakash; Karagiannis, Emmanouil D.; Popel, Aleksander S.			A biochemical model of matrix metalloproteinase 9 activation and inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; TISSUE INHIBITOR; IV COLLAGENASE; GELATINASE-A; MATRIX METALLOPROTEINASE-9; KINETIC-ANALYSIS; PROGELATINASE-B; 4-AMINOPHENYLMERCURIC ACETATE; ENZYMATIC-PROPERTIES; 92-KDA GELATINASE	Matrix metalloproteinases (MMPs) are a class of extracellular and membrane-bound proteases involved in an array of physiological processes, including angiogenesis. We present a detailed computational model of MMP9 activation and inhibition. Our model is validated to existing biochemical experimental data. We determine kinetic rate constants for the processes of MMP9 activation by MMP3, MMP10, MMP13, and trypsin; inhibition by the tissue inhibitors of metalloproteinases (TIMPs) 1 and 2; and MMP9 deactivation. This computational approach allows us to investigate discrepancies in our understanding of the interaction of MMP9 with TIMP1. Specifically, we find that inhibition due to a single binding event cannot describe MMP9 inhibition by TIMP1. Temporally accurate biphasic inhibition requires either an additional isomerization step or a second lower affinity isoform of MMP9. We also theoretically characterize the MMP3/ TIMP2/ pro-MMP9 and MMP3/ TIMP1/ pro-MMP9 systems. We speculate that these systems differ significantly in their time scales of activation and inhibition such that MMP9 is able to temporarily overshoot its final equilibrium value in the latter. Our numerical simulations suggest that the ability of pro-MMP9 to complex TIMP1 increases this overshoot. In all, our analysis serves as a summary of existing kinetic data for MMP9 and a foundation for future models utilizing MMP9 or other MMPs under physiologically well defined microenvironments.	[Vempati, Prakash; Karagiannis, Emmanouil D.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Vempati, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 613 Taylor Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	prakashvempati1@jhu.edu	Popel, Aleksander S/A-6724-2009; Karagiannis, Emmanouil D./CAA-0759-2022	Karagiannis, Emmanouil/0000-0003-0131-6552; Popel, Aleksander/0000-0002-6706-9235	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079653, R33HL087351] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079653, R33 HL087351] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bannikov GA, 2002, J BIOL CHEM, V277, P16022, DOI 10.1074/jbc.M110931200; BARAGI VM, 1994, J BIOL CHEM, V269, P12692; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; FRIDMAN R, 1995, CANCER RES, V55, P2548; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Hahn-Dantona E, 1999, ANN NY ACAD SCI, V878, P372, DOI 10.1111/j.1749-6632.1999.tb07696.x; Hutton M, 1998, BIOCHEMISTRY-US, V37, P10094, DOI 10.1021/bi980616p; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; KOLKENBROCK H, 1995, BIOL CHEM H-S, V376, P495, DOI 10.1515/bchm3.1995.376.8.495; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Patterson BC, 1997, J BIOL CHEM, V272, P28823, DOI 10.1074/jbc.272.46.28823; SANG QX, 1995, BBA-PROTEIN STRUCT M, V1251, P99, DOI 10.1016/0167-4838(95)00086-A; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; Taylor KB, 1996, J BIOL CHEM, V271, P23938, DOI 10.1074/jbc.271.39.23938; Troeberg L, 2002, BIOCHEMISTRY-US, V41, P15025, DOI 10.1021/bi026454l; WATANABE H, 1993, J CELL SCI, V104, P991; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023	34	73	76	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37585	37596		10.1074/jbc.M611500200	http://dx.doi.org/10.1074/jbc.M611500200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17848556	hybrid			2022-12-25	WOS:000251833600034
J	Webb, MR; Plank, JL; Long, DT; Hsieh, TS; Kreuzer, KN				Webb, Michael R.; Plank, Jody L.; Long, David T.; Hsieh, Tao-Shih; Kreuzer, Kenneth N.			The phage T4 protein UvsW drives Holliday Junction branch migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-III-ALPHA; DNA-REPLICATION; ESCHERICHIA-COLI; STRAND EXCHANGE; RECG HELICASE; FORK REVERSAL; BACTERIOPHAGE-T4; RECOMBINATION; REPAIR; MECHANISMS	The phage T4 UvsW protein has been shown to play a crucial role in the switch from origin-dependent to recombination-dependent replication in T4 infections through the unwinding of origin R-loop initiation intermediates. UvsW also functions with UvsX and UvsY to repair damaged DNA through homologous recombination, and, based on genetic evidence, has been proposed to act as a Holliday junction branch migration enzyme. Here we report the purification and characterization of UvsW. Using oligonucleotide-based substrates, we confirm that UvsW unwinds branched DNA substrates, including X and Y structures, but shows little activity in unwinding linear duplex substrates with blunt or single-strand ends. Using a novel Holliday junction-containing substrate, we also demonstrate that UvsW promotes the branch migration of Holliday junctions efficiently through more than 1000 bp of DNA. The ATP hydrolysis-deficient mutant protein, UvsW-K141R, is unable to promote Holliday junction branch migration. However, both UvsW and UvsW-K141R are capable of stabilizing Holliday junctions against spontaneous branch migration when ATP is not present. Using two-dimensional agarose gel electrophoresis we also show that UvsW acts on T4-generated replication intermediates, including Holliday junction-containing X-shaped intermediates and replication fork-shaped intermediates. Taken together, these results strongly support a role for UvsW in the branch migration of Holliday junctions that form during T4 recombination, replication, and repair.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Kreuzer, KN (corresponding author), Duke Univ, Med Ctr, Dept Biochem, BOx 3711, Durham, NC 27710 USA.	kenneth.kreuzer@duke.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012; Plank, Jody/B-4827-2009	Long, David/0000-0001-9232-0316	NATIONAL CANCER INSTITUTE [T32CA009111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934, R01GM029006] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA 009111-30, T32 CA009111] Funding Source: Medline; NIGMS NIH HHS [R01 GM 066934, R01 GM029006, R01 GM 29006, R01 GM066934, R01 GM029006-26] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; BERNSTEIN H, 1989, J BACTERIOL, V171, P2265, DOI 10.1128/jb.171.5.2265-2270.1989; Bregeon D, 2004, BIOTECHNIQUES, V37, P760, DOI 10.2144/04375ST01; Briggs GS, 2004, PHILOS T R SOC B, V359, P49, DOI 10.1098/rstb.2003.1364; Brosh RM, 2006, METHOD ENZYMOL, V409, P52, DOI 10.1016/S0076-6879(05)09004-X; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; Constantinou Angelos, 2004, Methods Mol Biol, V262, P239; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; DERR LK, 1990, MOL GEN GENET, V222, P257, DOI 10.1007/BF00633826; DERR LK, 1990, J MOL BIOL, V214, P643, DOI 10.1016/0022-2836(90)90283-R; Dudas KC, 2001, MOL CELL BIOL, V21, P2706, DOI 10.1128/MCB.21.8.2706-2715.2001; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; George JW, 2001, P NATL ACAD SCI USA, V98, P8290, DOI 10.1073/pnas.131007598; Grigoriev M, 1998, MOL CELL, V2, P373, DOI 10.1016/S1097-2765(00)80281-6; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Kadyrov FA, 2004, J BIOL CHEM, V279, P35735, DOI 10.1074/jbc.M403942200; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kerr ID, 2007, J BIOL CHEM, V282, P34392, DOI 10.1074/jbc.M705900200; KODADEK T, 1987, NATURE, V326, P312, DOI 10.1038/326312a0; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Marians KJ, 2004, PHILOS T ROY SOC B, V359, P71, DOI 10.1098/rstb.2003.1366; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; SALINAS F, 1995, CELL, V82, P111, DOI 10.1016/0092-8674(95)90057-8; Sickmier EA, 2004, STRUCTURE, V12, P583, DOI 10.1016/j.str.2004.02.016; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; SPICER EK, 1988, J BIOL CHEM, V263, P7478; Thain A, 1996, TRENDS GENET, V12, P209, DOI 10.1016/S0168-9525(96)90022-0; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; ZHOU MY, 1994, BIOTECHNIQUES, V16, P58	45	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34401	34411		10.1074/jbc.M705913200	http://dx.doi.org/10.1074/jbc.M705913200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17823128	Green Accepted, hybrid			2022-12-25	WOS:000251145700056
J	Claret, L; Miquel, S; Vieille, N; Ryjenkov, DA; Gomelsky, M; Darfeuille-Michaud, A				Claret, Laurent; Miquel, Sylvie; Vieille, Natacha; Ryjenkov, Dmitri A.; Gomelsky, Mark; Darfeuille-Michaud, Arlette			The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; EAL DOMAIN PROTEIN; C-DI-GMP; YERSINIA-ENTEROCOLITICA; LEGIONELLA-PNEUMOPHILA; GENE-EXPRESSION; ILEAL MUCOSA; TYPE-1 PILI; CAMPYLOBACTER-JEJUNI; VIBRIO-CHOLERAE	The invasion of intestinal epithelial cells by the Crohn disease-associated adherent-invasive Escherichia coli (AIEC) strain LF82 depends on surface appendages, such as type 1 pili and flagella. The absence of flagella in the AIEC strain LF82 results in a concomitant loss of type 1 pili. Here, we show that flagellar regulators, transcriptional activator FlhD(2)C(2), and sigma factor FliA are involved in the coordination of flagellar and type 1 pili synthesis. In the deletion mutants lacking these regulators, type 1 pili synthesis, adhesion, and invasion were severely decreased. FliA expressed alone in trans was sufficient to restore these defects in both the LF82-Delta flhD and LF82-Delta fliA mutants. We related the loss of type 1 pili to the decreased expression of the FliA-dependent yhjH gene in the LF82-Delta fliA mutant. YhjH is an EAL domain phosphodiesterase involved in degradation of the bacterial second messenger cyclic dimeric GMP (c-di-GMP). Increased expression of either yhjH or an alternative c-di-GMP phosphodiesterase, yahA, partially restored type 1 pili synthesis, adhesion, and invasion in the LF82-Delta fliA mutant. Deletion of the GGDEF domain diguanylate cyclase gene, yaiC, involved in c-di-GMP synthesis in the LF82-Delta fliA mutant also partially restored these defects, whereas overexpression of the c-di-GMP receptor YcgR had the opposite effect. These findings show that in the AIEC strain LF82, FliA is a key regulatory component linking flagellar and type 1 pili synthesis and that its effect on type 1 pili is mediated, at least in part, via a c-di-GMP-dependent pathway.	Univ Clermont Ferrand 1, Bacteriol Lab, Inst Natl Rech Agronom, Unite Sous Contrat 2018,USC INRA 2018, F-63001 Clermont Ferrand, France; Inst Univ Technol & Genie Biol, F-63172 Aubiere, France; Univ Wyoming, Dept Biol Mol, Laramie, WY 82071 USA	INRAE; Universite Clermont Auvergne (UCA); University of Wyoming	Claret, L (corresponding author), Univ Clermont Ferrand 1, Bacteriol Lab, Inst Natl Rech Agronom, Unite Sous Contrat 2018,USC INRA 2018, 28 Pl Henri Dunant, F-63001 Clermont Ferrand, France.	laurent.claret@u-clermont1.fr	gomelsky, mark/F-6209-2010	Miquel, Sylvie/0000-0001-8405-5073; Gomelsky, Mark/0000-0003-4077-3932				Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; ARNOSTI DN, 1989, P NATL ACAD SCI USA, V86, P830, DOI 10.1073/pnas.86.3.830; Barnich N, 2004, INFECT IMMUN, V72, P2484, DOI 10.1128/IAI.72.5.2484-2493.2004; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Bleves S, 2002, J BACTERIOL, V184, P3214, DOI 10.1128/JB.184.12.3214-3223.2002; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Chadsey MS, 1998, GENE DEV, V12, P3123, DOI 10.1101/gad.12.19.3123; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001; Fraser GM, 2002, MICROBIOL-SGM, V148, P2191, DOI 10.1099/00221287-148-7-2191; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Goon S, 2006, INFECT IMMUN, V74, P769, DOI 10.1128/IAI.74.1.769-772.2006; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heuner K, 2002, INFECT IMMUN, V70, P1604, DOI 10.1128/IAI.70.3.1604-1608.2002; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Horne SM, 2006, ARCH MICROBIOL, V185, P115, DOI 10.1007/s00203-005-0077-1; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kapatral V, 2004, MICROBIOL-SGM, V150, P2289, DOI 10.1099/mic.0.26814-0; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Krakowka S, 1996, VET IMMUNOL IMMUNOP, V52, P159, DOI 10.1016/0165-2427(95)05547-9; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; LEVINE MM, 1984, INFECT IMMUN, V44, P409, DOI 10.1128/IAI.44.2.409-420.1984; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; ORNDORFF PE, 1984, J BACTERIOL, V159, P736, DOI 10.1128/JB.159.2.736-744.1984; Park D, 2006, MOL MICROBIOL, V61, P1397, DOI 10.1111/j.1365-2958.2006.05320.x; Pruss BM, 2003, J BACTERIOL, V185, P534, DOI 10.1128/JB.185.2.534-543.2003; Rabaan AA, 2001, INFECT IMMUN, V69, P4257, DOI 10.1128/IAI.69.7.4257-4267.2001; RICHARDSON K, 1991, INFECT IMMUN, V59, P2727, DOI 10.1128/IAI.59.8.2727-2736.1991; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schmiel DH, 2000, J BACTERIOL, V182, P2314, DOI 10.1128/JB.182.8.2314-2320.2000; SCHWAN WR, 1992, J BACTERIOL, V174, P2367, DOI 10.1128/JB.174.7.2367-2375.1992; Shen L, 2006, J BACTERIOL, V188, P7364, DOI 10.1128/JB.01014-06; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999; Yu HHY, 2006, J BACTERIOL, V188, P8206, DOI 10.1128/JB.01082-06	57	71	72	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33275	33283		10.1074/jbc.M702800200	http://dx.doi.org/10.1074/jbc.M702800200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827157	hybrid, Green Published			2022-12-25	WOS:000250840200007
J	Pollak, N; Niere, M; Ziegler, M				Pollak, Nadine; Niere, Marc; Ziegler, Mathias			NAD kinase levels control the NADPH concentration in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; GENE; EXPRESSION; PEROXIREDOXIN; TRANSCRIPTION; PROTEINS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; IDENTIFICATION; ACTIVATION; RESPONSES	NAD kinases (NADKs) are vital, as they generate the cellular NADP pool. As opposed to three compartment-specific isoforms in plants and yeast, only a single NADK has been identified in mammals whose cytoplasmic localization we established by immunocytochemistry. To understand the physiological roles of the human enzyme, we generated and analyzed cell lines stably deficient in or overexpressing NADK. Short hairpin RNA mediated down-regulation led to similar ( about 70%) decrease of both NADK expression, activity, and the NADPH concentration and was accompanied by increased sensitivity toward H2O2. Overexpression of NADK resulted in a 4-5-fold increase in the NADPH, but not NADP(+), concentration, although the recombinant enzyme phosphorylated preferentially NAD(+). Surprisingly, NADK overexpression and the ensuing increase of the NADPH level only moderately enhanced protection against oxidant treatment. Apparently, to maintain the NADPH level for the regeneration of oxidative defense systems human cells depend primarily on NADP-dependent dehydrogenases ( which re-reduce NADP(+)), rather than on a net increase of NADP. The stable shifts of the NADPH level in the generated cell lines were also accompanied by alterations in the expression of peroxiredoxin 5 and Nrf2. Because the basal oxygen radical level in the cell lines was only slightly changed, the redox state of NADP may be a major transmitter of oxidative stress.	Univ Bergen, Dept Mol Biol, N-5008 Bergen, Norway	University of Bergen	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	Mathias.Ziegler@mbi.uib.no		Ziegler, Mathias/0000-0001-6961-2396				Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berrin JG, 2005, MOL GENET GENOMICS, V273, P10, DOI 10.1007/s00438-005-1113-1; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BURCH HB, 1967, J BIOL CHEM, V242, P4546; Bykova NV, 2001, PHYSIOL PLANTARUM, V111, P448, DOI 10.1034/j.1399-3054.2001.1110404.x; Chai MF, 2006, PLANT J, V47, P665, DOI 10.1111/j.1365-313X.2006.02816.x; Chai MF, 2005, PLANT MOL BIOL, V59, P553, DOI 10.1007/s11103-005-6802-y; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Kropotov A, 1999, EUR J BIOCHEM, V260, P336, DOI 10.1046/j.1432-1327.1999.00162.x; Kropotov A, 2006, FEBS J, V273, P2607, DOI 10.1111/j.1742-4658.2006.05265.x; Lee SH, 2004, INT J RADIAT BIOL, V80, P635, DOI 10.1080/09553000400007680; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeng O, 2004, BIOCHEM BIOPH RES CO, V317, P558, DOI 10.1016/j.bbrc.2004.03.075; Magni G, 2006, MINI-REV MED CHEM, V6, P739, DOI 10.2174/138955706777698688; MCGUINNESS ET, 1985, INT J BIOCHEM, V17, P1, DOI 10.1016/0020-711X(85)90079-5; Mori S, 2005, J BIOL CHEM, V280, P24104, DOI 10.1074/jbc.M502518200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Takahashi H, 2006, PLANT CELL PHYSIOL, V47, P1678, DOI 10.1093/pcp/pcl029; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner WL, 2005, BIOCHEM J, V385, P217, DOI 10.1042/BJ20040292; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; WILLIAMS MB, 1985, ARCH BIOCHEM BIOPHYS, V237, P80, DOI 10.1016/0003-9861(85)90256-5; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	43	138	144	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33562	33571		10.1074/jbc.M704442200	http://dx.doi.org/10.1074/jbc.M704442200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855339	hybrid, Green Submitted			2022-12-25	WOS:000250840200037
J	Vielreicher, M; Harms, G; Butt, E; Walter, U; Obergfell, A				Vielreicher, Martin; Harms, Gregory; Butt, Elke; Walter, Ulrich; Obergfell, Achim			Dynamic interaction between Src and C-terminal Src kinase in integrin alpha(IIb)beta(3)-mediated signaling to the cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SINGLE-MOLECULE RESEARCH; TYROSINE KINASES; FLUORESCENT PROTEIN; IN-VIVO; ACTIN; CSK; TRANSDUCTION; ACTIVATION; PHOSPHORYLATION	Integrin-bound Src tyrosine kinase mediates alpha(IIb)beta(3)outside-in signaling to the cytoskeleton required for platelet adhesion and thrombus formation. Src activation ( signal initiation) by phosphorylation of Tyr-418 occurs at lamellipodia leading edges. However, little is known about Src inactivation mediated by C-terminal Src kinase (Csk) Tyr-529 phosphorylation. In an established platelet model cell line (A5-Chinese hamster ovary), we studied the inactivation of Src during alpha(IIb)beta(3) mediated adhesion to fibrinogen with live cell fluorescence resonance energy transfer ( FRET) microscopy. Imaging revealed highly dynamic Src-Csk interactions at the leading edges of active lamellipodia. The Src-Csk interaction followed a highly dynamic pattern. Every 2-3 min, Src-Csk complexes moved inward in the cell, reorganized, and formed stable focal adhesions. These accumulations were primarily seen during retraction of lamellipodia, whereas no interaction was observed during protrusions. Western blot analysis during the run time of FRET signaling revealed an increase in Csk-mediated SrcTyr-529 phosphorylation with a parallel decline of tyrosine 418 phosphorylation. Mutation analysis provided additional insights into the role of Src. Although inactivation of Csk (CskK222R) had no effect on cell adhesion and spreading efficiency, cells with constitutively active expressed Src (SrcY529F) exhibited hardly any adhesion and no spreading. The few adherent cells showed weak focal adhesions that were disorganized and oversized. The data clearly demonstrate the important role of tight Src control by Csk for functional cell adhesion and spreading. The novel experimental FRET approach reported here for the inactivation of Src can be readily applied to other integrin and signaling pathways, including closely related Src family kinase members.	Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; Univ Wurzburg, Mol Microscopy Grp, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Walter, U (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Rudolf Virchow Ctr, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	uwalter@klin-biochem.uni-wuerzburg.de	Vielreicher, Martin/L-1768-2013; Walter, ulrich/W-2478-2017	Vielreicher, Martin/0000-0002-7515-1431; Walter, ulrich/0000-0001-6784-2307				Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; FROJMOVIC MM, 1991, BLOOD, V78, P369; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Harms GS, 2001, BIOPHYS J, V80, P2396, DOI 10.1016/S0006-3495(01)76209-1; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lieser SA, 2005, J BIOL CHEM, V280, P7769, DOI 10.1074/jbc.M411736200; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa T, 2000, INT J CANCER, V88, P384, DOI 10.1002/1097-0215(20001101)88:3<384::AID-IJC10>3.3.CO;2-2; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Steinmeyer R, 2005, J FLUORESC, V15, P707, DOI 10.1007/s10895-005-2978-4; THOMAS JE, 1991, SCIENCE, V254, P568, DOI 10.1126/science.1719633; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	33	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33623	10.1074/jbc.M704107200	http://dx.doi.org/10.1074/jbc.M704107200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855352	hybrid			2022-12-25	WOS:000250840200043
J	Carlson, BA; Moustafa, ME; Sengupta, A; Schweizer, U; Shrimali, R; Rao, M; Zhong, N; Wang, S; Feigenbaum, L; Lee, BJ; Gladyshev, VN; Hatfield, DL				Carlson, Bradley A.; Moustafa, Mohamed E.; Sengupta, Aniruddha; Schweizer, Ulrich; Shrimali, Rajeev; Rao, Mahadev; Zhong, Nianxin; Wang, Shulin; Feigenbaum, Lionel; Lee, Byeong Jae; Gladyshev, Vadim N.; Hatfield, Dolph L.			Selective restoration of the selenoprotein population in a mouse hepatocyte selenoproteinless background with different mutant selenocysteine tRNAs lacking Um34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-PEROXIDASE; THIOREDOXIN REDUCTASE; TARGETED DISRUPTION; SELENIUM DEFICIENCY; MESSENGER-RNA; MICE LACKING; GENE; EXPRESSION; MECHANISM; LIVER	Novel mouse models were developed in which the hepatic selenoprotein population was targeted for removal by disrupting the selenocysteine (Sec) tRNA([Ser]Sec) gene (trsp), and selenoprotein expression was then restored by introducing wild type or mutant trsp transgenes. The selenoprotein population was partially replaced in liver with mutant transgenes encoding mutations at either position 34(34T -> A) or 37 ( 37A -> G) in tRNA[ Ser] Sec. The A34 transgene product lacked the highly modified 5- methoxy-carbonylmethyl-2' -O-methyluridine, and its mutant base A was converted to I34. The G37 transgene product lacked the highly modified N-6-isopentenyladenosine. Both mutant tRNAs lacked the 2'-methylribose at position 34 ( Um34), and both supported expression of housekeeping selenoproteins ( e. g. thioredoxin reductase 1) in liver but not stress- related proteins ( e. g. glutathione peroxidase 1). Thus, Um34 is responsible for synthesis of a select group of selenoproteins rather than the entire selenoprotein population. The ICA anticodon in the A34 mutant tRNA decoded Cys codons, UGU and UGC, as well as the Sec codon, UGA. However, metabolic labeling of A34 transgenic mice with Se-75 revealed that selenoproteins incorporated the label from the A34 mutant tRNA, whereas other proteins did not. These results suggest that the A34 mutant tRNA did not randomly insert Sec in place of Cys, but specifically targeted selected selenoproteins. High copy numbers of A34 transgene, but not G37 transgene, were not tolerated in the absence of wild type trsp, further suggesting insertion of Sec in place of Cys in selenoproteins.	NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Canc Res Ctr,Natl Inst Hlth, Bethesda, MD 20892 USA; Charite Univ Med Berlin, Inst Expt Endocrinol, Ctr Res Neurosci, D-10117 Berlin, Germany; NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Frederick, MD 21702 USA; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Seoul National University (SNU); Seoul National University (SNU); University of Nebraska System; University of Nebraska Lincoln	Hatfield, DL (corresponding author), NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Canc Res Ctr,Natl Inst Hlth, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov	Gladyshev, Vadim N/A-9894-2013; Moustafa, Mohamed E/E-9002-2018; Schweizer, Ulrich/E-8105-2013; Moustafa, Mohamed/AAM-2211-2021; Gladyshev, Vadim N/J-6187-2013	Schweizer, Ulrich/0000-0003-1380-4780; Moustafa, Mohamed/0000-0003-1308-6221; Sengupta, Aniruddha/0000-0001-5560-0837; Gladyshev, Vadim/0000-0002-0372-7016	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BURK RF, 1980, BIOCHEM PHARMACOL, V29, P39, DOI 10.1016/0006-2952(80)90241-5; Carlson BA, 2005, TOP CURR GENET, V12, P431, DOI 10.1007/b106652; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Chittum HS, 1997, BBA-MOL CELL RES, V1359, P25, DOI 10.1016/S0167-4889(97)00092-X; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; Diwadkar-Navsariwala V, 2006, P NATL ACAD SCI USA, V103, P8179, DOI 10.1073/pnas.0508218103; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; HATFIELD D, 1979, BIOCHIM BIOPHYS ACTA, V564, P414, DOI 10.1016/0005-2787(79)90032-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HATFIELD DL, 2006, SELENIUM ITS MOL BIO, V2; HATFIELD DL, 2007, CCR FRONTIERS SCI, V6, P8; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hornberger TA, 2003, J NUTR, V133, P3091, DOI 10.1093/jn/133.10.3091; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; KELMERS AD, 1971, ANAL BIOCHEM, V44, P486, DOI 10.1016/0003-2697(71)90236-3; Kim LK, 2000, RNA, V6, P1306, DOI 10.1017/S1355838200000388; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Martin GW, 1996, RNA, V2, P171; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; NIRENBERG MW, 1964, SCIENCE, V145, P1399, DOI 10.1126/science.145.3639.1399; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rao M, 2003, RNA, V9, P923, DOI 10.1261/rna.5510503; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SCHOMBURG L, 2007, IN PRESS BIOL CHEM; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Sheridan PA, 2007, J NUTR, V137, P1466, DOI 10.1093/jn/137.6.1466; Shrimali RK, 2007, NEUROMUSCULAR DISORD, V17, P135, DOI 10.1016/j.nmd.2006.10.006; Tajsharghi H, 2005, NEUROMUSCULAR DISORD, V15, P299, DOI 10.1016/j.nmd.2004.11.004; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Weiss SL, 1998, RNA, V4, P816, DOI 10.1017/S1355838298971990; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	52	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32591	32602		10.1074/jbc.M707036200	http://dx.doi.org/10.1074/jbc.M707036200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848557	hybrid			2022-12-25	WOS:000250625400008
J	Kim, PY; Nesheim, ME				Kim, Paul Y.; Nesheim, Michael E.			Further evidence for two functional forms of prothrombinase each specific for either of the two prothrombin activation cleavages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TICK ANTICOAGULANT PEPTIDE; COAGULATION FACTOR-XA; BOVINE FACTOR-V; BLOOD-COAGULATION; PHOSPHOLIPID-VESICLES; BINDING-SITE; HEAVY-CHAIN; COMPLEX; SUBSTRATE; THROMBIN	Previous work showed that prothrombin derivatives cleavable only at Arg- 320 ( rMZ) or Arg- 271 ( rP2) are partial, rather than competitive, inhibitors of prothrombin activation by prothrombinase. A " ping- pong"- like model, which posits two equilibrating forms of prothrombinase, explained the inhibition pattern. The present studies were undertaken to further investigate this putative mechanism. Two models were developed, one allowing for one form of the enzyme and the other allowing for two forms. Both models also allowed channeling and ratcheting. The models were fit to full time courses of prothrombin, meizothrombin, prethrombin- 2, and the B- chain. In the absence of ratcheting and channeling, neither model fits the data. In their presence, however, both models fit very well, and thus they could not be distinguished. Therefore, inhibition of rMZ activation by rP2 was studied. Inhibition was partial and the two- form model fit the data with randomly distributed residuals, whereas the one-form model did not. Initial rates of fluorescein- labeled prothrombin cleavage in the presence of various prothrombin derivatives reported by Brufatto and Nesheim ( Brufatto, N., and Nesheim, M. E. ( 2003) J. Biol. Chem. 278, 6755 - 6764) were also analyzed using the two models. The two- form model fit the partial inhibition data well, whereas the one- form model did not. In addition, prothrombin at varying concentrations was activated, and subsequently, the initial rates were plotted with respect to the initial prothrombin concentration. When compared with the expected initial rates as determined by the simulation of the models, the two- form model fit the observed rates better than the one- form model. The results obtained here further support the existence of two functional forms of prothrombinase.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	nesheimm@post.queensu.ca	Kim, Paul/GYV-3258-2022	Kim, Paul/0000-0003-0943-4924	NHLBI NIH HHS [5P01 HL 046703] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; BAJZAR L, 1990, J BIOL CHEM, V265, P16948; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; Boskovic DS, 2004, J BIOL CHEM, V279, P20786, DOI 10.1074/jbc.M400469200; Boskovic DS, 2001, J BIOL CHEM, V276, P28686, DOI 10.1074/jbc.M101813200; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; CHURCH WR, 1991, J BIOL CHEM, V266, P8384; ESMON CT, 1975, J BIOL CHEM, V250, P4095; ESMON CT, 1974, J BIOL CHEM, V249, P7791; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HIBBARD LS, 1982, BIOCHEMISTRY-US, V21, P2285, DOI 10.1021/bi00539a003; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KOTKOW KJ, 1995, J BIOL CHEM, V270, P4551, DOI 10.1074/jbc.270.9.4551; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; MANN KG, 1991, ANN NY ACAD SCI, V614, P63; MANN KG, 1980, METHOD ENZYMOL, V23, P286; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1981, J BIOL CHEM, V256, P6537; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; PRYZDIAL ELG, 1991, J BIOL CHEM, V266, P8969; ROSING J, 1986, J BIOL CHEM, V261, P4224; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; SEGEL IH, 1975, ENZYME KINETICS, P606; Steen M, 2002, SCAND J CLIN LAB INV, V62, P5, DOI 10.1080/003655102762377439; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; VANDEWAART P, 1984, BIOCHEMISTRY-US, V23, P2838, DOI 10.1021/bi00307a047; VANRIJN JLML, 1984, BIOCHEMISTRY-US, V23, P4557, DOI 10.1021/bi00315a008; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	44	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32568	32581		10.1074/jbc.M701781200	http://dx.doi.org/10.1074/jbc.M701781200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17726029	hybrid			2022-12-25	WOS:000250625400006
J	Nilsson, P; Henriksson, N; Niedzwiecka, A; Balatsos, NAA; Kokkoris, K; Eriksson, J; Virtanen, A				Nilsson, Per; Henriksson, Niklas; Niedzwiecka, Anna; Balatsos, Nikolaos A. A.; Kokkoris, Kyriakos; Eriksson, Jens; Virtanen, Anders			A multifunctional RNA recognition motif in poly(A)-specific ribonuclease with cap and poly(A) binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; POLY(A)-BINDING PROTEIN; IN-VITRO; STRUCTURAL BASIS; 3' EXONUCLEASE; ACTIVE-SITE; COMPLEX; DEADENYLATION; TRANSLATION; PARN	Poly(A)-specific ribonuclease (PARN) is an oligomeric, processive and cap-interacting 3' exoribonuclease that efficiently degrades mRNA poly(A) tails. Here we show that the RNA recognition motif (RRM) of PARN harbors both poly(A) and cap binding properties, suggesting that the RRM plays an important role for the two critical and unique properties that are tightly associated with PARN activity, i.e. recognition and dependence on both the cap structure and poly(A) tail during poly(A) hydrolysis. We show that PARN and its RRM have micromolar affinity to the cap structure by using fluorescence spectroscopy and nanomolar affinity for poly(A) by using filter binding assay. We have identified one tryptophan residue within the RRM that is essential for cap binding but not required for poly(A) binding, suggesting that the cap-and poly(A)-binding sites associated with the RRM are both structurally and functionally separate from each other. RRM is one of the most commonly occurring RNA-binding domains identified so far, suggesting that other RRMs may have both cap and RNA binding properties just as the RRM of PARN.	Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; Polish Acad Sci, Inst Phys, Biol Phys Grp, PL-02668 Warsaw, Poland; Univ Warsaw, Inst Expt Phys, Dept Biophys, PL-02089 Warsaw, Poland	Uppsala University; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; University of Warsaw	Virtanen, A (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.	Anders.Virtanen@icm.uu.se	Henriksson, Niklas/A-5898-2013; Niedzwiecka, Anna/E-8940-2010	Niedzwiecka, Anna/0000-0001-5208-0733; Eriksson, Jens/0000-0002-8945-2665; Balatsos, Nikolaos/0000-0002-1146-1174				ASTROM J, 1991, EMBO J, V10, P3067, DOI 10.1002/j.1460-2075.1991.tb07858.x; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Boeck R, 1996, J BIOL CHEM, V271, P432, DOI 10.1074/jbc.271.1.432; Cai A, 1999, BIOCHEMISTRY-US, V38, P8538, DOI 10.1021/bi9830213; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Gu MG, 2004, MOL CELL, V14, P67, DOI 10.1016/S1097-2765(04)00180-7; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Nilsson P, 2006, INT J BIOL MACROMOL, V39, P95, DOI 10.1016/j.ijbiomac.2006.02.025; Opyrchal M, 2005, INSECT BIOCHEM MOLEC, V35, P1321, DOI 10.1016/j.ibmb.2005.08.004; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Ren YG, 2004, J BIOL CHEM, V279, P48702, DOI 10.1074/jbc.M403858200; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; Reverdatto SV, 2004, RNA, V10, P1200, DOI 10.1261/rna.7540204; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Worch R, 2005, RNA, V11, P1355, DOI 10.1261/rna.2850705; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869	51	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32902	32911		10.1074/jbc.M702375200	http://dx.doi.org/10.1074/jbc.M702375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17785461	hybrid			2022-12-25	WOS:000250625400039
J	Salzman, DW; Shubert-Coleman, J; Furneaux, H				Salzman, David W.; Shubert-Coleman, Jonathan; Furneaux, Henry			P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; HUMAN-CELLS; DROSHA-DGCR8 COMPLEX; PASSENGER-STRAND; DISTINCT ROLES; HUMAN RISC; PROTEIN; DICER; SIRNA; CLEAVAGE	MicroRNAs are short, single- stranded RNAs that arise from a transient precursor duplex. We have identified a novel activity in HeLa cell extracts that can unwind the let- 7 microRNA duplex. Using partially purified material, we have shown that microRNA helicase activity requires ATP and has a native molecular mass of similar to 68 kDa. Affinity purification of the unwinding activity revealed co- purification of P68 RNA helicase. Importantly, recombinant P68 RNA helicase was sufficient to unwind the let- 7 duplex. Moreover, like its native homolog, P68 RNA helicase did not unwind an analogous small interfering RNA duplex. We further showed that knockdown of P68 inhibited let- 7 microRNA function. From our data, we conclude that P68 RNA helicase is an essential component of the let- 7 microRNA pathway, and in conjunction with other factors, it may play a role in the loading of let- 7 microRNA into the silencing complex.	Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut	Furneaux, H (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 235 Farmington Ave, Farmington, CT 06030 USA.	furneaux@nso.uchc.edu		furneaux, henry/0000-0003-2212-1017	NHLBI NIH HHS [P01 HL 70694] Funding Source: Medline; NIDA NIH HHS [R03 DA 022226] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA022226] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; LANE D, 1988, NATURE, V334, P478, DOI 10.1038/334478a0; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; RAY BK, 1985, J BIOL CHEM, V260, P7651; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	48	78	81	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32773	32779		10.1074/jbc.M705054200	http://dx.doi.org/10.1074/jbc.M705054200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17724023	hybrid			2022-12-25	WOS:000250625400026
J	Wawrzynow, B; Zylicz, A; Wallace, M; Hupp, T; Zylicz, M				Wawrzynow, Bartosz; Zylicz, Alicja; Wallace, Maura; Hupp, Ted; Zylicz, Maciej			MDM2 chaperones the p53 tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITINATION IN-VITRO; HEAT-SHOCK PROTEIN; WILD-TYPE P53; MOLECULAR CHAPERONES; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; MESSENGER-RNAS; CANCER MUTANTS; BINDING-SITE; CELL-GROWTH	The murine double minute ( mdm2) gene encodes an E3 ubiquitin ligase that plays a key role in the degradation of p53 tumor suppressor protein. Nevertheless recent data highlight other p53- independent functions of MDM2. Given that MDM2 protein binds ATP, can interact with the Hsp90 chaperone, plays a role in the modulation of transcription factors and protection and activation of DNA polymerases, and is involved in ribosome assembly and nascent p53 protein biosynthesis, we have evaluated and found MDM2 protein to possess an intrinsic molecular chaperone activity. MDM2 can substitute for the Hsp90 molecular chaperone in promoting binding of p53 to the p21- derived promoter sequence. This reaction is driven by recycling of MDM2 from the p53 complex, triggered by binding of ATP to MDM2. The ATP binding mutant MDM2 protein ( K454A) lacks the chaperone activity both in vivo and in vitro. Mdm2 cotransfected in the H1299 cell line with wild- type p53 stimulates efficient p53 folding in vivo but at the same time accelerates the degradation of p53. MDM2 in which one of the Zn2+ coordinating residues is mutated ( C478S or C464A) blocks degradation but enhances folding of p53. This is the first demonstration that MDM2 possesses an intrinsic molecular chaperone activity, indicating that the ATP binding function of MDM2 can mediate its chaperone function toward the p53 tumor suppressor.	Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; Univ Edinburgh, Div Oncol, Canc Res UK, Cell Signalling Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Cancer Research UK; University of Edinburgh	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol, 4 Trojdena St, PL-02109 Warsaw, Poland.	mzylicz@iimcb.gov.pl		Zylicz, Alicja/0000-0003-4174-3073				Asahara H, 2003, NUCLEIC ACIDS RES, V31, P2451, DOI 10.1093/nar/gkg342; Bartel F, 2004, MOL CANCER RES, V2, P29; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; Calabro V, 2002, J BIOL CHEM, V277, P2674, DOI 10.1074/jbc.M107173200; CORDONCARDO C, 1994, CANCER RES, V54, P794; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Ellis R. J., 1993, P1; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Ganguli G, 2003, MOL CANCER RES, V1, P1027; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hirano Y, 2006, CELL, V127, P675, DOI 10.1016/j.cell.2006.11.003; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Liang HL, 2004, GENE, V338, P217, DOI 10.1016/j.gene.2004.05.015; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; MILNER J, 1990, J MOL BIOL, V216, P481, DOI 10.1016/0022-2836(90)90371-R; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Ongkeko WM, 1999, CURR BIOL, V9, P829, DOI 10.1016/S0960-9822(99)80367-4; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Shimizu H, 2003, TRENDS BIOCHEM SCI, V28, P346, DOI 10.1016/S0968-0004(03)00140-3; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shimizu H, 2006, BIOCHEM J, V397, P355, DOI 10.1042/BJ20051521; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Vargas DA, 2003, ADV CANCER RES, V89, P1, DOI 10.1016/S0065-230X(03)01001-7; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	65	46	47	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32603	32612		10.1074/jbc.M702767200	http://dx.doi.org/10.1074/jbc.M702767200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848574	hybrid			2022-12-25	WOS:000250625400009
J	Saravanan, M; Vasu, K; Ghosh, S; Nagaraja, V				Saravanan, Matheshwaran; Vasu, Kommireddy; Ghosh, Soumitra; Nagaraja, Valakunja			Dual role for Zn2+ in maintaining structural integrity and inducing DNA sequence specificity in a promiscuous endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; ZINC-FINGER; RESTRICTION-ENDONUCLEASE; BINDING; ENZYMES; NUCLEASE; DOMAIN; DISCRIMINATION; CLEAVAGE; COMPLEX	We describe two uncommon roles for Zn2+ in enzyme KpnI restriction endonuclease (REase). Among all of the REases studied, KpnI REase is unique in its DNA binding and cleavage characteristics. The enzyme is a poor discriminator of DNA sequences, cleaving DNA in a promiscuous manner in the presence of Mg2+. Unlike most Type II REases, the active site of the enzyme comprises an HNH motif, which can accommodate Mg2+, Mn2+, or Ca2+. Among these metal ions, Mg2+ and Mn2+ induce promiscuous cleavage by the enzyme, whereas Ca2+ bound enzyme exhibits site-specific cleavage. Examination of the sequence of the protein revealed the presence of a zinc finger CCCH motif rarely found in proteins of prokaryotic origin. The zinc binding motif tightly coordinates zinc to provide a rigid structural framework for the enzyme needed for its function. In addition to this structural scaffold, another atom of zinc binds to the active site to induce high fidelity cleavage and suppress the Mg2+- and Mn2+-mediated promiscuous behavior of the enzyme. This is the first demonstration of distinct structural and catalytic roles for zinc in an enzyme, suggesting the distinct origin of KpnI REase.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in	Matheshwaran, Saravanan/E-9461-2010; Kommireddy, Vasu/C-3928-2018; Matheshwaran, Saravanan/CAG-9469-2022	Kommireddy, Vasu/0000-0002-7608-7566; Ghosh, Soumitra/0000-0002-8376-8677; MATHESHWARAN, SARAVANAN/0000-0001-6762-9928				Amann BT, 2003, BIOCHEMISTRY-US, V42, P217, DOI 10.1021/bi026988m; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Berg JM, 1997, ANNU REV BIOPH BIOM, V26, P357, DOI 10.1146/annurev.biophys.26.1.357; Boysen RI, 2001, J PEPT RES, V57, P19, DOI 10.1034/j.1399-3011.2001.00752.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bujnicki JM, 2000, MOL MICROBIOL, V37, P1280, DOI 10.1046/j.1365-2958.2000.02010.x; Bujnicki JM, 2001, TRENDS BIOCHEM SCI, V26, P9, DOI 10.1016/S0968-0004(00)01690-X; Chandrashekaran S, 2004, J BIOL CHEM, V279, P49736, DOI 10.1074/jbc.M409483200; Chandrashekaran S, 1999, J BIOSCIENCE, V24, P269, DOI 10.1007/BF02941240; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; GITE S, 1992, EUR J BIOCHEM, V210, P437, DOI 10.1111/j.1432-1033.1992.tb17439.x; HANAS JS, 1983, J BIOL CHEM, V258, P4120; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; Keilin D, 1940, BIOCHEM J, V34, P1163, DOI 10.1042/bj0341163; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Ko TP, 1999, STRUCT FOLD DES, V7, P91, DOI 10.1016/S0969-2126(99)80012-4; Komori K, 2001, J BIOL CHEM, V276, P25654, DOI 10.1074/jbc.M102423200; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lin YY, 2005, J BACTERIOL, V187, P7881, DOI 10.1128/JB.187.23.7881-7889.2005; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Sapranauskas R, 2000, J BIOL CHEM, V275, P30878, DOI 10.1074/jbc.M003350200; Saravanan M, 2004, NUCLEIC ACIDS RES, V32, P6129, DOI 10.1093/nar/gkh951; Saravanan M, 2007, NUCLEIC ACIDS RES, V35, P2777, DOI 10.1093/nar/gkm114; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Van Roey P, 2001, EMBO J, V20, P3631, DOI 10.1093/emboj/20.14.3631; Vanamee ES, 2003, J MOL BIOL, V334, P595, DOI 10.1016/j.jmb.2003.09.043	33	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32320	32326		10.1074/jbc.M705927200	http://dx.doi.org/10.1074/jbc.M705927200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785455	hybrid			2022-12-25	WOS:000250480300055
J	Feng, H; Ren, M; Chen, L; Rubin, CS				Feng, Hui; Ren, Min; Chen, Lu; Rubin, Charles S.			Properties, regulation, and in vivo functions of a novel protein kinase D - Caenorhabditis elegans DKF-2 links diacylglycerol second messenger to the regulation of stress responses and life span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; CYSTEINE-RICH MOTIFS; D ACTIVATION; C-ELEGANS; EXPRESSION; GENE; DOMAINS; PATHWAY; DAF-16; FAMILY	Protein kinase D (PKD) isoforms are protein kinase C effectors in signaling cascades controlled by diacylglycerol (DAG). All PKDs are regulated by DAG/phorbol 12-myristate 13-acetate-binding C1 domains and an activation loop (A-loop). To understand how PKD isoforms diversify DAG signaling networks, it is essential to determine redundant and novel properties of their regulatory domains, characterize factors controlling PKD gene expression, and discover their in vivo physiological roles. Studies on a novel PKD, Caenorhabditis elegans DKF-2 (D kinase family-2), addressed these topics. The C1b domain mediates phorbol 12-myristate 13-acetate-induced translocation and activation of DKF-2. However, when DAG is elevated, C1a and C1b contribute equally to targeting/activation of DKF-2. DKF-2 C1 domains do not inhibit catalytic activity; they mediate delivery of DKF-2 to a membrane where protein kinase C phosphorylates Ser(925) and Ser(929) in the A-loop. This potently stimulates DKF-2 catalytic activity. Phosphorylation of Ser(925) alone switches on 70% of maximal kinase activity. Persistent phosphorylation of Ser (929) tags DKF-2 for proteasomal degradation; Ser(P)(925) plays a minor role in DKF-2 degradation. GATA enhancer sequences govern DKF-2 expression in intestine in vivo. Adult life span increases 40% in animals lacking DKF-2. In thermally stressed wild type animals, the DAF-16 transcription factor is segregated from the nuclei of adult intestinal cells. In contrast, DAF-16 enters adult intestinal nuclei of DKF-2-deficient, thermally stressed animals, where it can trigger gene transcription that protects against various insults. The results suggest a mechanism for increased longevity and show that a PKD links DAG signals to regulation of stress responses and life span.				rubin@aecom.yu.edu						Anderson G, 2005, CELL SIGNAL, V17, P1397, DOI 10.1016/j.cellsig.2005.02.007; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Dieterich S, 1996, FEBS LETT, V381, P183, DOI 10.1016/0014-5793(96)00116-0; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; EGAN CR, 1995, DEV BIOL, V170, P397, DOI 10.1006/dbio.1995.1225; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; Huang P, 2005, CYTOKINE GROWTH F R, V16, P151, DOI 10.1016/j.cytogfr.2005.03.002; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Iglesias T, 1998, FEBS LETT, V437, P19, DOI 10.1016/S0014-5793(98)01189-2; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; IslasTrejo A, 1997, J BIOL CHEM, V272, P6629, DOI 10.1074/jbc.272.10.6629; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kazanietz MG, 2005, BBA-PROTEINS PROTEOM, V1754, P296, DOI 10.1016/j.bbapap.2005.07.034; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; LAND M, 1994, J BIOL CHEM, V269, P9234; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohki-Hamazaki H, 2005, INT J DEV BIOL, V49, P293, DOI 10.1387/ijdb.041954ho; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Rennecke J, 1996, EUR J BIOCHEM, V242, P428, DOI 10.1111/j.1432-1033.1996.0428r.x; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sturany S, 2002, J BIOL CHEM, V277, P29431, DOI 10.1074/jbc.M200934200; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tobin DM, 2004, J NEUROBIOL, V61, P161, DOI 10.1002/neu.20082; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wu SL, 1998, J BIOL CHEM, V273, P1130, DOI 10.1074/jbc.273.2.1130; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	57	35	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31273	31288		10.1074/jbc.M701532200	http://dx.doi.org/10.1074/jbc.M701532200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728253	hybrid			2022-12-25	WOS:000250309200017
J	Hubbard, PA; Padovani, D; Labunska, T; Mahlstedt, SA; Banerjee, R; Drennan, CL				Hubbard, Paul A.; Padovani, Dominique; Labunska, Tetyana; Mahlstedt, Sarah A.; Banerjee, Ruma; Drennan, Catherine L.			Crystal structure and mutagenesis of the metallochaperone MeaB - Insight into the causes of methylmalonic aciduria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA MUTASE; MAXIMUM-LIKELIHOOD; ACCESSORY PROTEINS; ESCHERICHIA-COLI; DIOL DEHYDRATASE; METAL-BINDING; NICKEL; HYPB; VITAMIN-B-12; COEFFICIENTS	MeaB is an auxiliary protein that plays a crucial role in the protection and assembly of the B-12-dependent enzyme methyl-malonyl-CoA mutase. Impairments in the human homologue of MeaB, MMAA, lead to methylmalonic aciduria, an inborn error of metabolism. To explore the role of this metallochaperone, its structure was solved in the nucleotide-free form, as well as in the presence of product, GDP. MeaB is a homodimer, with each subunit containing a central alpha/beta-core G domain that is typical of the GTPase family, as well as alpha-helical extensions at the N and C termini that are not found in other metalloenzyme chaperone GTPases. The C-terminal extension appears to be essential for nucleotide-independent dimerization, and the N-terminal region is implicated in protein-protein interaction with its partner protein, methylmalonyl-CoA mutase. The structure of MeaB confirms that it is a member of the G3E family of P-loop GTPases, which contains other putative metallochaperones HypB, CooC, and UreG. Interestingly, the so-called switch regions, responsible for signal transduction following GTP hydrolysis, are found at the dimer interface of MeaB instead of being positioned at the surface of the protein where its partner protein methylmalonyl-CoA mutase should bind. This observation suggests a large conformation change of MeaB must occur between the GDP- and GTP-bound forms of this protein. Because of their high sequence homology, the missense mutations in MMAA that result in methylmalonic aciduria have been mapped onto MeaB and, in conjunction with mutagenesis data, provide possible explanations for the pathology of this disease.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Nebraska System; University of Nebraska Lincoln	Drennan, CL (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065337] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK45776] Funding Source: Medline; NIEHS NIH HHS [P30 ES002109] Funding Source: Medline; NIGMS NIH HHS [GM65337] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee R., 1999, Chemistry and biochemistry of B12., P707; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HOWELL PL, 1992, J APPL CRYSTALLOGR, V25, P81, DOI 10.1107/S0021889891010385; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Khil PP, 2004, PROTEINS, V54, P371, DOI 10.1002/prot.10430; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mori K, 1997, BIOSCI BIOTECH BIOCH, V61, P1729, DOI 10.1271/bbb.61.1729; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; MULROONEY SB, 1990, J BACTERIOL, V172, P5837, DOI 10.1128/jb.172.10.5837-5843.1990; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; TAOKA S, 1994, J BIOL CHEM, V269, P31630; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Toraya T, 1999, J BIOL CHEM, V274, P3372, DOI 10.1074/jbc.274.6.3372; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; 1997, ACTA CRYSTALLOGR D B, V276, P307	35	35	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31308	31316		10.1074/jbc.M704850200	http://dx.doi.org/10.1074/jbc.M704850200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728257	hybrid			2022-12-25	WOS:000250309200020
J	Muddasani, P; Norman, JC; Ellman, M; van Wijnen, AJ; Im, HJ				Muddasani, Prasuna; Norman, Jim C.; Ellman, Michael; van Wijnen, Andre J.; Im, Hee-Jeong			Basic fibroblast growth factor activates the MAPK and NF kappa B pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FACTOR-I; ALPHA-5-BETA-1 INTEGRINS; FIBRONECTIN FRAGMENTS; OSTEOGENIC PROTEIN-1; PLATE CHONDROCYTES; MMP-13 EXPRESSION; RESPONSE ELEMENT; COLLAGENASE-3; CARTILAGE	The pathology of joint destruction is associated with elevated production of basic fibroblast growth factor (bFGF) and matrix metalloproteinase-13 (MMP-13). In osteoarthritic joint disease, expression of bFGF and MMP-13 in chondrocytes and their release into the synovial fluid are significantly increased. We have previously found that the capacity for cartilage repair in human adult articular chondrocytes is severely compromised by minimal exposure to bFGF because bFGF reduces responsiveness to bone morphogenetic protein-7 and insulin-like growth factor-1 and induces MMP-13 through protein kinase C delta-dependent activation of multiple mitogen-activated protein kinase (MAPK) signaling pathways. Here we show using biochemical and molecular approaches that transcription factor Elk-1, a direct downstream target of MAPK, is a critical transcriptional activator of of MMP-13 by bFGF in human articular chondrocytes. We also provide evidence that Elk-1 is a direct target of NF kappa B and induces MMP-13 expression upon activation of the NF kappa B signaling pathway. Taken together, our results suggest that elevated expression of MMP-13 occurs through Elk-1 activation of both MAPK and NF kappa B signaling pathways, thus revealing a two-pronged biological mechanism by which bFGF controls the production of catabolic enzymes that are associated with excessive degradation of the cartilage matrix in degenerative joint diseases such as osteoarthritis.	Rush Univ, Ctr Med, Dept Biochem, Chicago, IL 60612 USA; Rush Univ, Dept Biochem, Chicago, IL 60612 USA; Rush Univ, Dept Internal Med, Chicago, IL 60612 USA; Rush Univ, Rheumatol Sect, Chicago, IL 60612 USA; Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA	Rush University; Rush University; Rush University; Rush University; Rush University; Beatson Institute; University of Massachusetts System; University of Massachusetts Worcester	Im, HJ (corresponding author), Rush Univ, Ctr Med, Dept Biochem, Cohn Res BD 516,1735 W Harrison, Chicago, IL 60612 USA.	Jeong_Sampen@rush.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; NORMAN, Jim/0000-0002-0098-3014	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR053220] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR049069, R01 AR053220] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Carreras I, 2001, AM J PHYSIOL-LUNG C, V281, pL766, DOI 10.1152/ajplung.2001.281.4.L766; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Fernandes JC, 1998, J RHEUMATOL, V25, P1585; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Fosang AJ, 1996, J CLIN INVEST, V98, P2292, DOI 10.1172/JCI119040; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Im HJ, 2003, J BIOL CHEM, V278, P25386, DOI 10.1074/jbc.M302048200; Im HJ, 1999, BRAIN RES, V829, P174, DOI 10.1016/S0006-8993(99)01364-5; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Loeser RF, 2005, ARTHRITIS RHEUM-US, V52, P3910, DOI 10.1002/art.21472; Loeser RF, 2003, J BIOL CHEM, V278, P24577, DOI 10.1074/jbc.M304530200; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Miwa HE, 2006, BBA-GEN SUBJECTS, V1760, P472, DOI 10.1016/j.bbagen.2005.12.003; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; OKEEFE RJ, 1994, J ORTHOPAED RES, V12, P299, DOI 10.1002/jor.1100120302; OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106; Papachristou DJ, 2005, HISTOCHEM CELL BIOL, V124, P215, DOI 10.1007/s00418-005-0026-8; PELLETIER JP, 2001, ARTHRITIS ALLIED CON, P2195; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; ROSSELOT G, 1994, J BONE MINER RES, V9, P431; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Varghese S, 2000, ENDOCRINOLOGY, V141, P2185, DOI 10.1210/en.141.6.2185; Vincent T, 2002, P NATL ACAD SCI USA, V99, P8259, DOI 10.1073/pnas.122033199; Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X	40	80	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31409	31421		10.1074/jbc.M706508200	http://dx.doi.org/10.1074/jbc.M706508200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724016	hybrid			2022-12-25	WOS:000250309200031
J	St-Jean, M; Sygusch, J				St-Jean, Miguel; Sygusch, Jurgen			Stereospecific proton transfer by a mobile catalyst in mammalian fructose-1,6-bisphosphate aldolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE-BISPHOSPHATE ALDOLASE; DIHYDROXYACETONE PHOSPHATE; RABBIT MUSCLE; DIPHOSPHATE ALDOLASE; TERMINAL REGION; MECHANISM; CARBOXYPEPTIDASE; CRYSTALLOGRAPHY; COMPLEXES; CLEAVAGE	Class I fructose-1,6-bisphosphate aldolases catalyze the interconversion between the enamine and iminium covalent enzymatic intermediates by stereospecific exchange of the pro( S) proton of the dihydroxyacetone-phosphate C3 carbon, an obligatory reaction step during substrate cleavage. To investigate the mechanism of stereospecific proton exchange, high resolution crystal structures of native and a mutant Lys(146)-> Met aldolase were solved in complex with dihydroxyacetone phosphate. The structural analysis revealed trapping of the enamine intermediate at Lys(229) in native aldolase. Mutation of conserved active site residue Lys(146) to Met drastically decreased activity and enabled trapping of the putative iminium intermediate in the crystal structure showing active site attachment by C-terminal residues 360-363. Attachment positions the conserved C-terminal Tyr(363) hydroxyl within 2.9 angstrom of the C3 carbon in the iminium in an orientation consistent with incipient re face proton transfer. We propose a catalytic mechanism by which the mobile C-terminal Tyr(363) is activated by the iminium phosphate via a structurally conserved water molecule to yield a transient phenate, whose developing negative charge is stabilized by a Lys(146) positive charge, and which abstracts the C3 pro( S) proton forming the enamine. An identical C-terminal binding mode observed in the presence of phosphate in the native structure corroborates Tyr(363) interaction with Lys(146) and is consistent with transient C terminus binding in the enamine. The absence of charge stabilization and of a mobile C-terminal catalyst explains the extraordinary stability of enamine intermediates in transaldolases.	Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@UMontreal.CA		Sygusch, Jurgen/0000-0002-6629-2128				ADELMAN RC, 1968, ARCH BIOCHEM BIOPHYS, V126, P343, DOI 10.1016/0003-9861(68)90590-0; BARANOWSKI T, 1949, J BIOL CHEM, V180, P543; BERTHIAUME L, 1993, J BIOL CHEM, V268, P10826; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; DeLano WL, 2004, PYMOL MOL GRAPHICS S; DRECHSLER ER, 1959, J BIOL CHEM, V234, P2627; GINSBURG A, 1966, BIOCHEMISTRY-US, V5, P2623, DOI 10.1021/bi00872a021; GRAZI E, 1974, BIOCHIM BIOPHYS ACTA, V364, P120, DOI 10.1016/0005-2744(74)90139-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V7, P250, DOI 10.1016/0006-291X(62)90184-5; GRAZI E, 1973, BIOCHEMISTRY-US, V12, P2583, DOI 10.1021/bi00738a006; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; IYENGAR R, 1981, BIOCHEMISTRY-US, V20, P1223, DOI 10.1021/bi00508a026; JAI J, 1997, PROTEIN SCI, V6, P119; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P120; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorentzen E, 2003, J BIOL CHEM, V278, P47253, DOI 10.1074/jbc.M305922200; Maurady A, 2002, J BIOL CHEM, V277, P9474, DOI 10.1074/jbc.M107600200; MORRIS AJ, 1994, BIOCHEMISTRY-US, V33, P12291, DOI 10.1021/bi00206a036; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; MUNGER C, 2002, ENZYMATIC MECH FRUCT; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENHOET EE, 1971, J BIOL CHEM, V246, P318; PERIANA RA, 1980, J AM CHEM SOC, V102, P3923, DOI 10.1021/ja00531a040; RACKER E, 1947, J BIOL CHEM, V167, P843; RAY BD, 1983, J AM CHEM SOC, V105, P3731, DOI 10.1021/ja00349a075; Richard JP, 2001, CURR OPIN CHEM BIOL, V5, P626, DOI 10.1016/S1367-5931(01)00258-7; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; Rios A, 2001, J AM CHEM SOC, V123, P7949, DOI 10.1021/ja016250c; Rios A, 2000, J AM CHEM SOC, V122, P9373, DOI 10.1021/ja001749c; ROSE IA, 1958, J AM CHEM SOC, V80, P5835, DOI 10.1021/ja01554a063; ROSE IA, 1965, J BIOL CHEM, V240, P1758; ROSE IA, 1958, J BIOL CHEM, V231, P315; ROSE IA, 1969, J BIOL CHEM, V244, P126; ROSE IA, 1985, BIOCHEMISTRY-US, V24, P3952, DOI 10.1021/bi00336a023; ROSE IA, 1987, J BIOL CHEM, V262, P692; RUTTER WJ, 1961, J BIOL CHEM, V236, P3193; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; SYGUSCH J, 1990, ARCH BIOCHEM BIOPHYS, V283, P227, DOI 10.1016/0003-9861(90)90636-D; VENKATARAMAN R, 1961, J BIOL CHEM, V236, P1883	47	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31028	31037		10.1074/jbc.M704968200	http://dx.doi.org/10.1074/jbc.M704968200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728250	hybrid			2022-12-25	WOS:000250136300070
J	Eickholt, BJ; Ahmed, AI; Davies, M; Papakonstanti, EA; Pearce, W; Starkey, ML; Bilando, A; Need, AC; Smith, AJH; Hall, SM; Hamers, FP; Giese, KP; Bradbury, EJ; Vanhaesebroeck, B				Eickholt, Britta J.; Ahmed, Aminul I.; Davies, Meirion; Papakonstanti, Evangelia A.; Pearce, Wayne; Starkey, Michelle L.; Bilando, Antonio; Need, Anna C.; Smith, Andrew J. H.; Hall, Susan M.; Hamers, Frank P.; Giese, Karl P.; Bradbury, Elizabeth J.; Vanhaesebroeck, Bart			Control of Axonal Growth and Regeneration of Sensory Neurons by the p110 delta PI 3-Kinase	PLOS ONE			English	Article								The expression and function of the 8 distinct catalytic isoforms of PI 3-kinase (P13K) in the nervous system are unknown. Whereas most P13Ks have a broad tissue distribution, the tyrosine kinase-linked p110 delta isoform has previously been shown to be enriched in leukocytes. Here we report that p110 delta is also highly expressed in the nervous system. Inactivation of p110 delta in mice did not affect gross neuronal development but led to an increased vulnerability of dorsal root ganglia neurons to exhibit growth cone collapse and decreases in axonal extension. Loss of p110 delta activity also dampened axonal regeneration following peripheral nerve injury in adult mice and impaired functional recovery of locomotion. p110 delta inactivation resulted in reduced neuronal signaling through the Akt protein kinase, and increased activity of the small GTPase RhoA. Pharmacological inhibition of ROCK, a downstream effector of RhoA, restored axonal extension defects in neurons with inactive p110 delta, suggesting a key role of RhoA in p110 delta signaling in neurons. Our data identify p110 delta as an important signaling component for efficient axonal elongation in the developing and regenerating nervous system.	[Eickholt, Britta J.; Ahmed, Aminul I.] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Davies, Meirion; Starkey, Michelle L.; Hall, Susan M.; Bradbury, Elizabeth J.] Kings Coll London, Neurorestorat Grp, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Papakonstanti, Evangelia A.; Pearce, Wayne; Bilando, Antonio; Vanhaesebroeck, Bart] Ludwig Inst Canc Res, London W1P 8BT, England; [Need, Anna C.; Giese, Karl P.] Kings Coll London, Ctr Cellular Basis Behav, Inst Psychiat, London WC2R 2LS, England; [Smith, Andrew J. H.] Univ Edinburgh, Gene Targeting Lab, Inst Stem Cell Res, Edinburgh, Midlothian, Scotland; [Hamers, Frank P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Vanhaesebroeck, Bart] UCL, Dept Biochem & Mol Biol, London, England	University of London; King's College London; University of London; King's College London; Ludwig Institute for Cancer Research; University of London; King's College London; University of Edinburgh; Utrecht University; Utrecht University Medical Center; University of London; University College London	Eickholt, BJ (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England.	Britta.J.Eickholt@kcl.ac.uk	Eickholt, Britta/C-5337-2009; Giese, Karl P/A-3112-2011	Giese, Karl P/0000-0003-4503-7344; Ahmed, Aminul/0000-0001-6670-0438; Need, Anna/0000-0003-3955-8207; Bradbury, Elizabeth/0000-0003-4252-0234; BILANCIO, Antonio/0000-0002-5118-3359; Eickholt, Britta/0000-0001-7873-8687; Papakonstanti, Evangelia/0000-0002-7119-6026; Pearce, Wayne/0000-0001-5407-4767	MRC [G9900989, G0400983, G120/818] Funding Source: UKRI; Medical Research Council [G0300058B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/C505659/1, BB/C505659/2] Funding Source: Medline; Medical Research Council [G0400983, G9900989, G120/818] Funding Source: Medline; Wellcome Trust [GR067121] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; BI L, 2002, EARLY EMBRYONIC LETH, V13, P169; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mills J, 2003, J NEUROSCI, V23, P1638; Need AC, 2003, GENES BRAIN BEHAV, V2, P132, DOI 10.1034/j.1601-183X.2003.00020.x; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Okkenhaug K, 2002, SCIENCE, V297, P1031; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sawyer C, 2003, CANCER RES, V63, P1667; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vogelaar CF, 2004, BRAIN RES, V1027, P67, DOI 10.1016/j.brainres.2004.08.036; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	40	86	89	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e869	10.1371/journal.pone.0000869	http://dx.doi.org/10.1371/journal.pone.0000869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17846664	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000207455600016
J	Rolland, M; Nickle, DC; Deng, W; Frahm, N; Brander, C; Learn, GH; Heckerman, D; Jojic, N; Jojic, V; Walker, BD; Mullins, JI				Rolland, Morgane; Nickle, David C.; Deng, Wenjie; Frahm, Nicole; Brander, Christian; Learn, Gerald H.; Heckerman, David; Jojic, Nebosja; Jojic, Vladimir; Walker, Bruce D.; Mullins, James I.			Recognition of HIV-1 Peptides by Host CTL Is Related to HIV-1 Similarity to Human Proteins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-LYMPHOCYTE RESPONSES; CELL RESPONSES; IMMUNODOMINANT REGIONS; EPITOPE; INFECTION; AUTOANTIBODIES; PATHOGENESIS; ANTIBODIES; HOMOLOGY	Background. While human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes preferentially target specific regions of the viral proteome, HIV-1 features that contribute to immune recognition are not well understood. One hypothesis is that similarities between HIV and human proteins influence the host immune response, i.e., resemblance between viral and host peptides could preclude reactivity against certain HIV epitopes. Methodology/Principal Findings. We analyzed the extent of similarity between HIV-1 and the human proteome. Proteins from the HIV-1 B consensus sequence from 2001 were dissected into overlapping k-mers, which were then probed against a non-redundant database of the human proteome in order to identify segments of high similarity. We tested the relationship between HIV-1 similarity to host encoded peptides and immune recognition in HIV-infected individuals, and found that HIV immunogenicity could be partially modulated by the sequence similarity to the host proteome. ELISpot responses to peptides spanning the entire viral proteome evaluated in 314 individuals showed a trend indicating an inverse relationship between the similarity to the host proteome and the frequency of recognition. In addition, analysis of responses by a group of 30 HIV-infected individuals against 944 overlapping peptides representing a broad range of individual HIV-1B Nef variants, affirmed that the degree of similarity to the host was significantly lower for peptides with reactive epitopes than for those that were not recognized. Conclusions/Significance. Our results suggest that antigenic motifs that are scarcely represented in human proteins might represent more immunogenic CTL targets not selected against in the host. This observation could provide guidance in the design of more effective HIV immunogens, as sequences devoid of host-like features might afford superior immune reactivity.	[Rolland, Morgane; Nickle, David C.; Deng, Wenjie; Learn, Gerald H.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Frahm, Nicole; Brander, Christian; Walker, Bruce D.] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Harvard Med Sch, Charlestown, MA USA; [Heckerman, David; Jojic, Nebosja; Jojic, Vladimir] Microsoft Res, Machine Learning & Appl Stat Grp, Redmond, WA USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Microsoft	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@u.washington.edu	Nickle, David/ABF-2727-2020; Learn, Gerald H/B-6934-2011; Learn, Jerry/E-3356-2012	Learn, Gerald H/0000-0003-0434-7733; Brander, Christian/0000-0002-0548-5778	Boeing Corporation; NIH [AI57005]; University of Washington Center for AIDS Research [AI27757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757] Funding Source: NIH RePORTER	Boeing Corporation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a gift from the Boeing Corporation, and by grants from the NIH to JIM (AI57005) and from the University of Washington Center for AIDS Research (AI27757). The funding agencies had no role in the study.	Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BERZOFSKY JA, 1987, IMMUNOL REV, V98, P9, DOI 10.1111/j.1600-065X.1987.tb00518.x; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Bonnet F, 2003, J RHEUMATOL, V30, P2005; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Chretien P, 2003, CLIN EXP RHEUMATOL, V21, P210; CORDIALI P, 1992, AIDS RES HUM RETROV, V8, P1561, DOI 10.1089/aid.1992.8.1561; DEKEYSER F, 1992, CLIN IMMUNOL IMMUNOP, V62, P285, DOI 10.1016/0090-1229(92)90104-V; DENG W, VIROBLAST BLAS UNPUB; DOHLMAN JG, 1993, BIOCHEM BIOPH RES CO, V195, P686, DOI 10.1006/bbrc.1993.2100; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; GOLDING H, 1989, J CLIN INVEST, V83, P1430, DOI 10.1172/JCI114034; GOLDING H, 1988, J EXP MED, V167, P914, DOI 10.1084/jem.167.3.914; GonzalezConejero R, 1996, BRIT J HAEMATOL, V93, P464, DOI 10.1046/j.1365-2141.1996.00502.x; Goulder PJR, 2000, J VIROL, V74, P5679, DOI 10.1128/JVI.74.12.5679-5690.2000; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; HABESHAW J, 1992, IMMUNOL TODAY, V13, P207, DOI 10.1016/0167-5699(92)90155-Z; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Jiang X, 2006, SCAND J IMMUNOL, V63, P338, DOI 10.1111/j.1365-3083.2006.01748.x; Jin YM, 2005, PROTEINS, V61, P167, DOI 10.1002/prot.20734; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANZAVECCHIA A, 1995, J EXP MED, V181, P1945, DOI 10.1084/jem.181.6.1945; Letvin NL, 1999, IMMUNOL REV, V170, P127, DOI 10.1111/j.1600-065X.1999.tb01334.x; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; LOPALCO L, 1993, EUR J IMMUNOL, V23, P2016, DOI 10.1002/eji.1830230844; Lucchiari-Hartz M, 2003, P NATL ACAD SCI USA, V100, P7755, DOI 10.1073/pnas.1232228100; Maksyutov AZ, 2004, J CLIN VIROL, V31, pS26, DOI 10.1016/j.jcv.2004.09.007; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McClure MA, 2005, GENOMICS, V85, P512, DOI 10.1016/j.ygeno.2004.12.006; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Moudgil KD, 2005, TRENDS IMMUNOL, V26, P355, DOI 10.1016/j.it.2005.05.007; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; Quan V, 1999, IMMUNOGENETICS, V49, P957, DOI 10.1007/s002510050579; Rakowicz-Szulczynska EM, 1998, CANCER LETT, V124, P213, DOI 10.1016/S0304-3835(97)00483-7; REIHER WE, 1986, P NATL ACAD SCI USA, V83, P9188, DOI 10.1073/pnas.83.23.9188; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; TALAL N, 1990, ARTHRITIS RHEUM, V33, P774, DOI 10.1002/art.1780330603; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	58	22	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e823	10.1371/journal.pone.0000823	http://dx.doi.org/10.1371/journal.pone.0000823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786195	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500007
J	Ku, YX; Ohara, S; Wang, LP; Lenz, FA; Hsiao, SS; Bodner, M; Hong, B; Zhou, YD				Ku, Yixuan; Ohara, Shinji; Wang, Liping; Lenz, Fred A.; Hsiao, Steven S.; Bodner, Mark; Hong, Bo; Zhou, Yong-Di			Prefrontal Cortex and Somatosensory Cortex in Tactile Crossmodal Association: An Independent Component Analysis of ERP Recordings	PLOS ONE			English	Article								Our previous studies on scalp-recorded event-related potentials (ERPs) showed that somatosensory N140 evoked by a tactile vibration in working memory tasks was enhanced when human subjects expected a coming visual stimulus that had been paired with the tactile stimulus. The results suggested that such enhancement represented the cortical activities involved in tactile-visual crossmodal association. In the present study, we further hypothesized that the enhancement represented the neural activities in somatosensory and frontal cortices in the crossmodal association. By applying independent component analysis (ICA) to the ERP data, we found independent components (ICs) located in the medial prefrontal cortex (around the anterior cingulate cortex, ACC) and the primary somatosensory cortex (SI). The activity represented by the IC in SI cortex showed enhancement in expectation of the visual stimulus. Such differential activity thus suggested the participation of SI cortex in the task-related crossmodal association. Further, the coherence analysis and the Granger causality spectral analysis of the ICs showed that SI cortex appeared to cooperate with ACC in attention and perception of the tactile stimulus in crossmodal association. The results of our study support with new evidence an important idea in cortical neurophysiology: higher cognitive operations develop from the modality-specific sensory cortices (in the present study, SI cortex) that are involved in sensation and perception of various stimuli.	[Ku, Yixuan; Ohara, Shinji; Wang, Liping; Lenz, Fred A.; Bodner, Mark; Zhou, Yong-Di] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21218 USA; [Hsiao, Steven S.; Zhou, Yong-Di] Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD USA; [Hsiao, Steven S.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Hong, Bo] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Wang, Liping] E China Normal Univ, Inst Cognit Neurosci, Shanghai 200062, Peoples R China; [Bodner, Mark] Mus Intelligence Neural Dev Inst, Costa Mesa, CA USA; [Ku, Yixuan; Hong, Bo] Tsinghua Univ, Beijing 100084, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; East China Normal University; Tsinghua University	Zhou, YD (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21218 USA.	yzhou12@jhmi.edu	Zhou, Yongdi/GOH-3291-2022; Ku, Yixuan/D-4063-2018	Ku, Yixuan/0000-0003-2804-5123	NINDS [NS-38493, NS-40059]; Johns Hopkins Institution Fund; MIND Institute; East China Normal University; National Science Foundation of China [30630022]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040059, R56NS038493, R01NS038493] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Johns Hopkins Institution Fund; MIND Institute; East China Normal University; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS Grants NS-38493 and NS-40059 to FA Lenz, and by a Johns Hopkins Institution Fund to Y-D Zhou. This work was also supported by a research fund from MIND Institute, and a research fund from East China Normal University to Y-D Zhou. Y Ku and B Hong were partially supported by the National Science Foundation of China 30630022.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLISON T, 1992, ELECTROEN CLIN NEURO, V84, P301, DOI 10.1016/0168-5597(92)90082-M; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bodner M, 1997, J NEUROPHYSIOL, V77, P2219, DOI 10.1152/jn.1997.77.4.2219; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Druschky K, 2003, EXP BRAIN RES, V148, P186, DOI 10.1007/s00221-002-1293-4; Eimer M, 2001, NEUROSCI BIOBEHAV R, V25, P497, DOI 10.1016/S0149-7634(01)00029-X; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Eimer M, 2003, CLIN NEUROPHYSIOL, V114, P1298, DOI 10.1016/S1388-2457(03)00107-X; Eimer M, 2003, EXP BRAIN RES, V151, P24, DOI 10.1007/s00221-003-1437-1; Falchier A, 2002, J NEUROSCI, V22, P5749; Forster B, 2005, PSYCHOPHYSIOLOGY, V42, P171, DOI 10.1111/j.1469-8986.2005.00268.x; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; Frot M, 2001, PAIN, V94, P65, DOI 10.1016/S0304-3959(01)00342-6; Fu KMG, 2003, J NEUROSCI, V23, P7510; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GARCIALARREA L, 1995, PSYCHOPHYSIOLOGY, V32, P526, DOI 10.1111/j.1469-8986.1995.tb01229.x; GEWEKE J, 1982, J AM STAT ASSOC, V77, P323, DOI 10.2307/2287243; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; HAMALAINEN H, 1990, ELECTROEN CLIN NEURO, V75, P13, DOI 10.1016/0013-4694(90)90148-D; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Harris JA, 2002, J NEUROSCI, V22, P8720; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kekoni J, 1997, BIOL PSYCHOL, V46, P125, DOI 10.1016/S0301-0511(97)05249-6; Kekoni J, 1996, EVOKED POTENTIAL, V100, P115, DOI 10.1016/0013-4694(95)00231-6; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P871, DOI 10.1016/j.clinph.2003.11.037; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Le Pera D, 2005, NEUROSCI RES, V52, P379, DOI 10.1016/j.neures.2005.05.001; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Lutkenhoner B, 2002, NEUROIMAGE, V15, P509, DOI 10.1006/nimg.2001.0991; Luu P, 2003, BRAIN, V126, P2119, DOI 10.1093/brain/awg257; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 1999, J NEUROSCI, V19, P2665; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, PSYCHOPHYSIOLOGY, V33, pS58; Meftah EM, 2002, J NEUROPHYSIOL, V88, P3133, DOI 10.1152/jn.00121.2002; Michelson A., 1887, PHILOS MAG, V24, P463, DOI [10.1080/14786448708628131, DOI 10.1080/14786448708628131]; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Ohara S, 2006, NEUROSCIENCE, V139, P299, DOI 10.1016/j.neuroscience.2005.05.058; Ohara S, 2006, NEUROSCIENCE, V138, P1387, DOI 10.1016/j.neuroscience.2005.12.005; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Restuccia D, 2001, BRAIN, V124, P757, DOI 10.1093/brain/124.4.757; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schaefer M, 2006, NEUROIMAGE, V29, P587, DOI 10.1016/j.neuroimage.2005.07.016; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Talairach J., 1988, COPLANAR STEREOTAXIC, P122; Tarkka IM, 1996, NEUROSCIENCE, V75, P275, DOI 10.1016/0306-4522(96)00287-4; Taylor-Clarke M, 2004, NEUROSCI LETT, V354, P22, DOI 10.1016/j.neulet.2003.09.068; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; Valeriani M, 2001, MUSCLE NERVE, V24, P1677, DOI 10.1002/mus.1203; Waberski TD, 2002, NEUROIMAGE, V17, P1347, DOI 10.1006/nimg.2002.1222; Zhou YD, 1997, EXP BRAIN RES, V116, P551, DOI 10.1007/PL00005783; Zhou YD, 2000, P NATL ACAD SCI USA, V97, P9777, DOI 10.1073/pnas.97.17.9777; Zhou YD, 2004, BEHAV BRAIN RES, V153, P573, DOI 10.1016/j.bbr.2003.12.024; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P10533, DOI 10.1073/pnas.93.19.10533; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	78	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e771	10.1371/journal.pone.0000771	http://dx.doi.org/10.1371/journal.pone.0000771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712419	Green Published, gold			2022-12-25	WOS:000207455300019
J	Yeo, ZX; Wong, ST; Arjunan, SNV; Piras, V; Tomita, M; Selvarajoo, K; Giuliani, A; Tsuchiya, M				Yeo, Zhen Xuan; Wong, Sum Thai; Arjunan, Satya Nanda Vel; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar; Giuliani, Alessandro; Tsuchiya, Masa			Sequential Logic Model Deciphers Dynamic Transcriptional Control of Gene Expressions	PLOS ONE			English	Article							CIS-REGULATORY LOGIC; NETWORK MOTIFS; ENDO16 GENE; ORGANIZATION; HYSTERESIS; NUMBERS	Background. Cellular signaling involves a sequence of events from ligand binding to membrane receptors through transcription factors activation and the induction of mRNA expression. The transcriptional-regulatory system plays a pivotal role in the control of gene expression. A novel computational approach to the study of gene regulation circuits is presented here. Methodology. Based on the concept of finite state machine, which provides a discrete view of gene regulation, a novel sequential logic model (SLM) is developed to decipher control mechanisms of dynamic transcriptional regulation of gene expressions. The SLM technique is also used to systematically analyze the dynamic function of transcriptional inputs, the dependency and cooperativity, such as synergy effect, among the binding sites with respect to when, how much and how fast the gene of interest is expressed. Principal Findings. SLM is verified by a set of well studied expression data on endo16 of Strongylocentrotus purpuratus ( sea urchin) during the embryonic midgut development. A dynamic regulatory mechanism for endo16 expression controlled by three binding sites, UI, R and Otx is identified and demonstrated to be consistent with experimental findings. Furthermore, we show that during transition from specification to differentiation in wild type endo16 expression profile, SLM reveals three binary activities are not sufficient to explain the transcriptional regulation of endo16 expression and additional activities of binding sites are required. Further analyses suggest detailed mechanism of R switch activity where indirect dependency occurs in between UI activity and R switch during specification to differentiation stage. Conclusions/Significance. The sequential logic formalism allows for a simplification of regulation network dynamics going from a continuous to a discrete representation of gene activation in time. In effect our SLM is non-parametric and model-independent, yet providing rich biological insight. The demonstration of the efficacy of this approach in endo16 is a promising step for further application of the proposed method.	[Arjunan, Satya Nanda Vel; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar; Tsuchiya, Masa] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Yeo, Zhen Xuan] Genome Inst Singapore, Singapore, Singapore; [Wong, Sum Thai] Bioinformat Inst, Singapore, Singapore; [Giuliani, Alessandro] Inst Super Sanita, Dept Environm & Hlth, Rome, Italy	Keio University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Istituto Superiore di Sanita (ISS)	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp	Arjunan, Satya/AAL-2433-2020; Arjunan, Satya N. V./B-3441-2008; Giuliani, Alessandro/AAF-1740-2020; Giuliani, Alessandro/K-7589-2016; Piras, Vincent/K-3203-2012	Arjunan, Satya/0000-0002-2913-3347; Arjunan, Satya N. V./0000-0002-2913-3347; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Piras, Vincent/0000-0002-3427-0995; Selvarajoo, Kumar/0000-0002-0314-9666	Agency for Science, Technology and Research of Singapore (A* STAR); Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Yamagata Prefecture and Tsuruoka City, Japan	Agency for Science, Technology and Research of Singapore (A* STAR)(Agency for Science Technology & Research (A*STAR)); Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamagata Prefecture and Tsuruoka City, Japan	This work was supported by the Agency for Science, Technology and Research of Singapore (A* STAR), Japan Science and Technology Agency/ Core Research for Evolutional Science and Technology (JST CREST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and Research fund by Yamagata Prefecture and Tsuruoka City, Japan.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Barrett CL, 2005, P NATL ACAD SCI USA, V102, P19103, DOI 10.1073/pnas.0505231102; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Blasi MF, 2005, PHYSICA A, V348, P349, DOI 10.1016/j.physa.2004.09.005; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DICAMILLO B, 2005, BMC BIOINFORMATIC S4, V1, pS44; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Giuliani A, 1996, BIOL CYBERN, V74, P181, DOI 10.1007/BF00204206; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; MANO MM, 2001, DIGITAL DESIGN, P516; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Ruklisa Dace, 2005, Genome Inform, V16, P225; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Soinov LA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r6; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Wolf DM, 1998, J THEOR BIOL, V195, P167, DOI 10.1006/jtbi.1998.0790; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Yuh CH, 1996, DEVELOPMENT, V122, P1069; Yuh CH, 2004, DEV BIOL, V269, P536, DOI 10.1016/j.ydbio.2004.02.025; Yuh CH, 2005, DEV BIOL, V281, P286, DOI 10.1016/j.ydbio.2005.02.034; Yuh CH, 2001, DEVELOPMENT, V128, P617; Yuh CH, 1996, DEVELOPMENT, V122, P4045	40	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e776	10.1371/journal.pone.0000776	http://dx.doi.org/10.1371/journal.pone.0000776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712424	Green Published, gold			2022-12-25	WOS:000207455300024
J	Kindt, N; Menzebach, A; Van de Wouwer, MV; Betz, I; De Vriese, A; Conway, EM				Kindt, Nele; Menzebach, Axel; Van de Wouwer, Marlies; Betz, Inge; De Vriese, Astrid; Conway, Edward M.			Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure	FASEB JOURNAL			English	Article						caspase; cisplatin; kidney; transgenic mice; p53; hydrodynamic gene therapy	TUBULAR EPITHELIAL-CELLS; ISCHEMIA-REPERFUSION INJURY; HEPATOCYTE GROWTH-FACTOR; MOLECULAR-MECHANISMS; TRANSGENIC MICE; UP-REGULATION; DEATH; EXPRESSION; KIDNEY; P53	Acute renal failure (ARF) is a major worldwide cause of morbidity and mortality, lacking specific targeted, effective therapies. Renal tubular cell apoptosis has been recognized to play a critical role in the pathogenesis of ARF, yet few studies have evaluated whether intervention in apoptotic pathways can ameliorate the deterioration in renal function associated with ARF. Using transgenic mice with diminished levels of the inhibitor of apoptosis protein, survivin, we show that survivin is required to protect the kidney from apoptosis, to suppress renal expression of p53, and to ameliorate renal dysfunction in two models of ARF. Gene delivery of survivin to wild-type mice and mice with 50% levels of survivin, prior to or at the time of induction of ARF, interferes with the deterioration of renal function and preserves the integrity of the kidneys and the renal tubular cells by inhibiting activation of apoptotic pathways in the kidneys and suppressing expression of p53. These results encourage further evaluation of survivin, its active structural domains, and other inhibitors of apoptosis proteins, for preventing and/or treating acute renal failure.	[Kindt, Nele; Menzebach, Axel; Van de Wouwer, Marlies; Betz, Inge; De Vriese, Astrid; Conway, Edward M.] Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Conway, EM (corresponding author), Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, Ctr Transgene Technol & Gene Therapy, Herestr 49, B-3000 Louvain, Belgium.	ed.conway@med.kuleuven.be		Conway, Edward/0000-0003-0081-0305				Alino SF, 2003, GENE THER, V10, P1672, DOI 10.1038/sj.gt.3302065; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; Beltrami E, 2004, J BIOL CHEM, V279, P2077, DOI 10.1074/jbc.M309479200; Bonegio R, 2002, CURR OPIN NEPHROL HY, V11, P301, DOI 10.1097/00041552-200205000-00006; Chen J, 2000, NEOPLASIA, V2, P235, DOI 10.1038/sj.neo.7900091; Conway EM, 2000, BLOOD, V95, P1435, DOI 10.1182/blood.V95.4.1435.004k01_1435_1442; Conway EM, 2003, AM J PATHOL, V163, P935, DOI 10.1016/S0002-9440(10)63453-0; Conway EM, 2002, GASTROENTEROLOGY, V123, P619, DOI 10.1053/gast.2002.34753; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; de Vries B, 2003, AM J PATHOL, V163, P47, DOI 10.1016/S0002-9440(10)63629-2; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Devarajan P, 2003, MOL GENET METAB, V80, P365, DOI 10.1016/j.ymgme.2003.09.012; Dohi T, 2006, EMBO REP, V7, P438, DOI 10.1038/sj.embor.7400640; Dohi T, 2005, CELL CYCLE, V4, P21, DOI 10.4161/cc.4.1.1367; Evenepoel Pieter, 2004, Best Pract Res Clin Anaesthesiol, V18, P37, DOI 10.1016/j.bpa.2003.09.007; Faubel S, 2004, KIDNEY INT, V66, P2202, DOI 10.1111/j.1523-1755.2004.66010.x; Fiaschi-Taesch NM, 2004, J AM SOC NEPHROL, V15, P112, DOI 10.1097/01.ASN.0000102470.12285.C6; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Ito T, 2000, HEPATOLOGY, V31, P1080, DOI 10.1053/he.2000.6496; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Justo P, 2003, KIDNEY INT, V64, pS52, DOI 10.1046/j.1523-1755.64.s86.10.x; Kaushal GP, 2003, SEMIN NEPHROL, V23, P425, DOI 10.1016/S0270-9295(03)00086-X; Kawai H, 2004, AM J PATHOL, V165, P1603, DOI 10.1016/S0002-9440(10)63417-7; Kelly KJ, 2004, AM J PHYSIOL-RENAL, V287, pF760, DOI 10.1152/ajprenal.00050.2004; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P128, DOI 10.1097/01.ASN.0000040596.23073.01; Kelly KJ, 2001, J CLIN INVEST, V108, P1291, DOI 10.1172/JCI13018; KLINGLER EL, 1980, ARCH PATHOL LAB MED, V104, P87; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li SY, 2005, AM J PHYSIOL-RENAL, V289, pF469, DOI 10.1152/ajprenal.00038.2005; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu KD, 2003, CRIT CARE MED, V31, pS572, DOI 10.1097/01.CCM.0000081592.36382.BC; Liu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102; Nogae S, 1998, J AM SOC NEPHROL, V9, P620; Oberbauer R, 1999, J AM SOC NEPHROL, V10, P2006; Olie RA, 2000, CANCER RES, V60, P2805; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Ortiz A., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P181; Padanilam BJ, 2003, AM J PHYSIOL-RENAL, V284, pF608, DOI 10.1152/ajprenal.00284.2002; Perco P, 2006, EUR J CLIN INVEST, V36, P753, DOI 10.1111/j.1365-2362.2006.01729.x; Sabbatini M, 2004, J AM SOC NEPHROL, V15, P901, DOI 10.1097/01.ASN.0000119573.01290.AE; Santos NAG, 2008, CANCER CHEMOTH PHARM, V61, P145, DOI 10.1007/s00280-007-0459-y; Schwarz C, 2002, LAB INVEST, V82, P941, DOI 10.1097/01.LAB.0000021174.66841.4C; Sheikh-Hamad D, 2004, ARCH TOXICOL, V78, P147, DOI 10.1007/s00204-003-0521-4; Silvester W, 2001, CRIT CARE MED, V29, P1910, DOI 10.1097/00003246-200110000-00010; Tamm I, 1998, CANCER RES, V58, P5315; Tsuruya K, 2003, AM J PHYSIOL-RENAL, V285, pF208, DOI 10.1152/ajprenal.00311.2002; Tsuruya K, 2003, KIDNEY INT, V63, P72, DOI 10.1046/j.1523-1755.2003.00709.x; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wan B, 2006, EXP MOL PATHOL, V81, P211, DOI 10.1016/j.yexmp.2006.02.005; Wan Li, 2003, Curr Opin Crit Care, V9, P496, DOI 10.1097/00075198-200312000-00006; Wei QQ, 2006, AM J PHYSIOL-RENAL, V290, pF35, DOI 10.1152/ajprenal.00184.2005; Xia CY, 2002, MOL CANCER THER, V1, P687; Xie J, 2007, AM J PHYSIOL-RENAL, V292, pF107, DOI 10.1152/ajprenal.00083.2006	60	36	40	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					510	521		10.1096/fj.07-8882com	http://dx.doi.org/10.1096/fj.07-8882com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17804696				2022-12-25	WOS:000252822600021
J	Tanaka, K; Sata, M; Natori, T; Kim-Kaneyama, J; Nose, K; Shibanuma, M; Hirata, Y; Nagai, R				Tanaka, Kimie; Sata, Masataka; Natori, Takeshi; Kim-Kaneyama, Joo-ri; Nose, Kiyoshi; Shibanuma, Motoko; Hirata, Yasunobu; Nagai, Ryozo			Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice	FASEB JOURNAL			English	Article						smooth muscle cell; irradiation; stem cells; vascular repair; parabiosis	HEMATOPOIETIC STEM-CELLS; BONE-MARROW-CELLS; SMOOTH-MUSCLE-CELLS; X-RAY-IRRADIATION; VASCULAR INJURY; POTENTIAL CONTRIBUTION; VESSEL WALL; ATHEROSCLEROSIS; RESTENOSIS; DISEASE	Recent evidence suggests that bone marrow-derived cells may contribute to repair and lesion formation following vascular injury. In most studies, bone marrow- derived cells were tracked by transplanting exogenous cells into bone marrow that had been compromised by irradiation. It remains to be determined whether endogenous circulating progenitors actually contribute to arterial remodeling under physiological conditions. Here, we established a parabiotic model in which two mice were conjoined subcutaneously without any vascular anastomosis. When wild-type mice were joined with transgenic mice that expressed green fluorescent protein (GFP) in all tissues, GFP-positive cells were detected not only in the peripheral blood but also in the bone marrow of the wild-type mice. The femoral arteries of the wild-type mice were mechanically injured by insertion of a large wire. At 4 wk, there was neointima hyperplasia that mainly consisted of alpha-smooth muscle actin-positive cells. GFP-positive cells were readily detected in the neointima (14.8 +/- 4.5%) and media (31.1 +/- 8.8%) of the injured artery. Some GFP-positive cells expressed alpha-smooth muscle actin or an endothelial cell marker. These results indicate that circulating progenitors contribute to re-endothelialization and neointimal formation after mechanical vascular injury even in nonirradiated mice.	[Tanaka, Kimie; Sata, Masataka; Hirata, Yasunobu; Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Tokyo 1138655, Japan; [Sata, Masataka; Natori, Takeshi] Univ Tokyo, Grad Sch Med, Dept Surg, Tokyo 1138655, Japan; [Kim-Kaneyama, Joo-ri; Nose, Kiyoshi; Shibanuma, Motoko] Showa Univ, Sch Pharmaceut Sci, Dept Microbiol, Tokyo 142, Japan; [Tanaka, Kimie] Japan Hlth Sci Fdn, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Showa University	Sata, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	msata-circ@umin.net						Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; BILLINGHAM ME, 1987, TRANSPLANT P, V19, P19; Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100; Cheng SWK, 1999, AM J SURG, V178, P323, DOI 10.1016/S0002-9610(99)00184-1; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Frickhofen N, 1996, BONE MARROW TRANSPL, V17, P131; Fukuda D, 2005, CIRCULATION, V111, P926, DOI 10.1161/01.CIR.0000155612.47040.17; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Han CL, 2001, J VASC RES, V38, P113, DOI 10.1159/000051038; Harris RBS, 1997, AM J PHYSIOL-REG I, V272, pR1809; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Hoofnagle MH, 2004, J CLIN INVEST, V113, P1249, DOI 10.1172/JCI200421761; Iwata H, 2007, FRONT BIOSCI, V12, P4157, DOI 10.2741/2377; Jabs A, 2005, J VASC RES, V42, P174, DOI 10.1159/000084406; Kearney M, 1997, CIRCULATION, V95, P1998, DOI 10.1161/01.CIR.95.8.1998; KONEFF AA, 1952, ENDOCRINOLOGY, V51, P249, DOI 10.1210/endo-51-3-249; KOSTANECKI W, 1976, ARCH DERMATOL RES, V256, P297, DOI 10.1007/BF00572496; Liu X, 2005, J TRAUMA, V59, P682, DOI 10.1097/01.ta.0000177674.55388.40; McKinney-Freeman S, 2004, EXP HEMATOL, V32, P868, DOI 10.1016/j.exphem.2004.06.010; Mert M, 2003, Z KARDIOL, V92, P682, DOI 10.1007/s00392-003-0943-2; NIH, 1985, NIH PUBL; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; Ohtani K, 2004, CIRCULATION, V110, P2444, DOI 10.1161/01.CIR.0000145123.85083.66; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okada S, 2000, INT IMMUNOL, V12, P861, DOI 10.1093/intimm/12.6.861; ORZAN F, 1993, BRIT HEART J, V69, P496; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sahara M, 2005, STEM CELLS, V23, P874, DOI 10.1634/stemcells.2005-0012; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Sarjeant JM, 2002, CARDIOVASC PATHOL, V11, P263, DOI 10.1016/S1054-8807(02)00125-4; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Sata M, 2006, ARTERIOSCL THROM VAS, V26, P1008, DOI 10.1161/01.ATV.0000206123.94140.f3; Sata M, 2003, CIRC J, V67, P983, DOI 10.1253/circj.67.983; Sata M, 2003, TRENDS CARDIOVAS MED, V13, P249, DOI 10.1016/S1050-1738(03)00106-3; Sata M, 2003, CIRCULATION, V107, pE106, DOI 10.1161/01.CIR.0000067691.89615.F9; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Sata M, 1998, P NATL ACAD SCI USA, V95, P1213, DOI 10.1073/pnas.95.3.1213; Schafer K, 2006, ARTERIOSCL THROM VAS, V26, P1254, DOI 10.1161/01.ATV.0000215982.14003.b7; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121; Shoji M, 2004, CARDIOVASC PATHOL, V13, P306, DOI 10.1016/j.carpath.2004.08.004; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Tanaka K, 2005, J AM COLL CARDIOL, V46, P134, DOI 10.1016/j.jacc.2005.03.058; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Togni M, 2004, CIRCULATION, V110, P135, DOI 10.1161/01.CIR.0000134956.96543.4F; Veinot JP, 1996, HUM PATHOL, V27, P766, DOI 10.1016/S0046-8177(96)90447-5; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013	53	53	54	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					428	436		10.1096/fj.06-6884com	http://dx.doi.org/10.1096/fj.06-6884com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17848623				2022-12-25	WOS:000252822600013
J	Huang, Y; Qiu, JH; Dong, S; Redell, MS; Poli, V; Mancini, MA; Tweardy, DJ				Huang, Ying; Qiu, Jihui; Dong, Shuo; Redell, Michele S.; Poli, Valeria; Mancini, Michael A.; Tweardy, David J.			Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of stat3 beta mapping to its unique C-terminal end	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; EPIDERMAL-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVATION; INTERFERON-GAMMA; FACTOR-RECEPTOR; CANCER-THERAPY; GENE; ELEMENTS; CELLS	Two isoforms of Stat3 ( signal transducer and activator of transcription 3) are expressed in cells, alpha(p92) and beta (p83), both derived from a single gene by alternative mRNA splicing. The 55-residue C-terminal transactivation domain of Stat3 alpha is deleted in Stat3 beta and replaced by seven unique C-terminal residues (CT7) whose function remains uncertain. We subcloned the open reading frames of Stat3 alpha and Stat3 beta into the C terminus of green fluorescent protein (GFP). Fluorescent microscopic analysis of HEK293T cells transiently transfected with GFP-Stat3 alpha or GFP-Stat3 beta revealed similar kinetics and cytokine concentration dependence of nuclear accumulation; these findings were confirmed by high throughput microscope analysis of murine embryonic fibroblasts that lacked endogenous Stat3 but stably expressed either GFP-Stat3 alpha or GFP-Stat3 beta. However, although time to half-maximal cytoplasmic reaccumulation after cytokine withdrawal was 15 min for GFP-Stat3 alpha, it was > 180 min for GFP-Stat3 beta. Furthermore, although the intranuclear mobility of GFP-Stat3 alpha was rapid and increased with cytokine stimulation, the intranuclear mobility of GFP-Stat3 beta in unstimulated cells was slower than that of GFP-Stat3 alpha in unstimulated cells and was slowed further following cytokine stimulation. Deletion of the unique CT7 domain from Stat3 beta eliminated prolonged nuclear retention but did not alter its intranuclear mobility. Thus, Stat3 alpha and Stat3 beta have distinct intracellular dynamics, with Stat3 beta exhibiting prolonged nuclear retention and reduced intranuclear mobility especially following ligand stimulation. Prolonged nuclear retention, but not reduced intranuclear mobility, mapped to the CT7 domain of Stat3 beta.	Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Shanghai Jiao Tong Univ, Chinese Minist Educ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China; Univ Turin, Dept Genet, I-10126 Turin, Italy; Univ Turin, Dept Biol, I-10126 Turin, Italy; Univ Turin, Dept Biochem, I-10126 Turin, Italy	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Shanghai Jiao Tong University; University of Turin; University of Turin; University of Turin	Tweardy, DJ (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, 1 Baylor Plaza,BCM 286,Rm N1319, Houston, TX 77030 USA.	dtweardy@bcm.edu	Tweardy, David/L-3929-2019; Poli, Valeria/A-9215-2012	Poli, Valeria/0000-0002-3739-3966; Redell, Michele/0000-0002-2515-3703	NCI NIH HHS [CA72261] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072261] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Berno V, 2006, METHOD ENZYMOL, V414, P188, DOI 10.1016/s0076-6879(06)14011-2; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Caldenhoven E, 1999, Mol Cell Biol Res Commun, V1, P95, DOI 10.1006/mcbr.1999.0114; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chakraborty A, 1998, J LEUKOCYTE BIOL, V64, P675, DOI 10.1002/jlb.64.5.675; Chakraborty A, 1996, BLOOD, V88, P2442, DOI 10.1182/blood.V88.7.2442.bloodjournal8872442; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Dong S, 2002, BLOOD, V99, P2637, DOI 10.1182/blood.V99.8.2637; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Herrmann A, 2004, J CELL SCI, V117, P339, DOI 10.1242/jcs.00833; Hoey T, 2003, EMBO J, V22, P4237, DOI 10.1093/emboj/cdg393; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; LIPPINCOTTSCHWA.J, 2003, NAT CELL BIOL S, V17, P7; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Lokuta MA, 1998, J IMMUNOL, V161, P1594; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Meyer T, 2002, EXP CELL RES, V272, P45, DOI 10.1006/excr.2001.5405; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Patel BKR, 1998, P NATL ACAD SCI USA, V95, P172, DOI 10.1073/pnas.95.1.172; Piazza F, 2000, BLOOD, V96, P1358, DOI 10.1182/blood.V96.4.1358.h8001358_1358_1365; Pranada AL, 2004, J BIOL CHEM, V279, P15114, DOI 10.1074/jbc.M312530200; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Sato N, 2005, BIOCHEM BIOPH RES CO, V336, P617, DOI 10.1016/j.bbrc.2005.08.145; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Shao H, 2006, J IMMUNOL, V176, P2933, DOI 10.4049/jimmunol.176.5.2933; Sherman MA, 1999, J IMMUNOL, V162, P2703; Sherman MA, 2002, J IMMUNOL, V169, P3811, DOI 10.4049/jimmunol.169.7.3811; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	59	45	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34958	34967		10.1074/jbc.M704548200	http://dx.doi.org/10.1074/jbc.M704548200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855361	hybrid			2022-12-25	WOS:000251155200040
J	Busse, M; Feta, A; Presto, J; Wilen, M; Gronning, M; Kjellen, L; Kusche-Gullberg, M				Busse, Marta; Feta, Almir; Presto, Jenny; Wilen, Maria; Gronning, Mona; Kjellen, Lena; Kusche-Gullberg, Marion			Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY MULTIPLE EXOSTOSES; TUMOR SUPPRESSORS; BIOSYNTHESIS; POLYMERIZATION; EXPRESSION; PROTEINS; DEFICIENT; DIVERSITY; DISTINCT; DOMAIN	The exostosin (EXT) family of genes encodes glycosyltransferases involved in heparan sulfate biosynthesis. Five human members of this family have been cloned to date: EXT1, EXT2, EXTL1, EXTL2, and EXTL3. EXT1 and EXT2 are believed to form a Golgi-located hetero-oligomeric complex that catalyzes the chain elongation step in heparan sulfate biosynthesis, whereas the EXTL proteins exhibit overlapping glycosyltransferase activities in vitro, so that it is not apparent what reactions they catalyze in vivo. We used gene-silencing strategies to investigate the roles of EXT1, EXT2, and EXTL3 in heparan sulfate chain elongation. Small interfering RNAs (siRNAs) directed against the human EXT1, EXT2, or EXTL3 mRNAs were introduced into human embryonic kidney 293 cells. Compared with cells transfected with control siRNA, those transfected with EXT1 or EXT2 siRNA synthesized shorter heparan sulfate chains, and those transfected with EXTL3 siRNA synthesized longer chains. We also generated human cell lines overexpressing the EXT proteins. Overexpression of EXT1 resulted in increased HS chain length, which was even more pronounced in cells coexpressing EXT2, whereas overexpression of EXT2 alone had no detectable effect on heparan sulfate chain elongation. Mutations in either EXT1 or EXT2 are associated with hereditary multiple exostoses, a human disorder characterized by the formation of cartilage-capped bony outgrowths at the epiphyseal growth plates. To further investigate the role of EXT2, we generated human cell lines overexpressing mutant EXT2. One of the mutations, EXT2-Y419X, resulted in a truncated protein. Interestingly, the capacity of wild type EXT2 to enhance HS chain length together with EXT1 was not shared by the EXT2Y419X mutant.	Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Bergen; Uppsala University	Kusche-Gullberg, M (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	Marion.Kusche@biomed.uib.no	Kusche-Gullberg, Marion/P-4466-2016; Kjellen, Lena/F-1362-2011	Kusche-Gullberg, Marion/0000-0002-5636-1695; Presto, Jenny/0000-0001-5102-6815				Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Francannet C, 2001, J MED GENET, V38, P430, DOI 10.1136/jmg.38.7.430; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hecht JT, 2005, DIFFERENTIATION, V73, P212, DOI 10.1111/j.1432-0436.2005.00025.x; Hecht JT, 2002, BONE, V31, P199, DOI 10.1016/S8756-3282(02)00796-2; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Rong JH, 2000, BIOCHEM J, V346, P463, DOI 10.1042/0264-6021:3460463; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wei G, 2000, J BIOL CHEM, V275, P27733; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6; ZHANG L, 1995, J BIOL CHEM, V270, P12557, DOI 10.1074/jbc.270.21.12557	37	138	145	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32802	32810		10.1074/jbc.M703560200	http://dx.doi.org/10.1074/jbc.M703560200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17761672	hybrid			2022-12-25	WOS:000250625400029
J	Sun, JM; Chen, HY; Davie, JR				Sun, Jian-Min; Chen, Hou Yu; Davie, James R.			Differential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; CORE HISTONE ACETYLATION; NUCLEAR-MATRIX; TRANSCRIPTION FACTORS; CHICKEN ERYTHROCYTES; CROSS-LINKING; IN-SITU; PROTEIN; DNA; IMMUNOPRECIPITATION	Histone deacetylase 2 ( HDAC2) is one of the histone-modifying enzymes that regulate gene expression by remodeling chromatin structure. Along with HDAC1, HDAC2 is found in the Sin3 and NuRD multiprotein complexes, which are recruited to promoters by DNA-binding proteins. In this study, we show that the majority of HDAC2 in human breast cancer cells is not phosphorylated. However, the minor population of HDAC2, preferentially cross-linked to DNA by cisplatin, is mono-, di-, or tri-phosphorylated. Furthermore, HDAC2 phosphorylation is required for formation of Sin3 and NuRD complexes and recruitment to promoters by transcription factors including p53, Rb, YY1, NF-kappa B, Sp1, and Sp3. Unmodified HDAC2 requires linker DNA to associate with chromatin but is not cross-linked to DNA by formaldehyde. We provide evidence that unmodified HDAC2 is associated with the coding region of transcribed genes, whereas phosphorylated HDAC2 is primarily recruited to promoters.	Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	Davie, JR (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	davie@cc.umanitoba.ca		Davie, James/0000-0002-0420-6888				Ahmad A, 1999, J BIOL CHEM, V274, P16646, DOI 10.1074/jbc.274.23.16646; Brehm A, 1999, TRENDS BIOCHEM SCI, V24, P142, DOI 10.1016/S0968-0004(99)01368-7; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen HY, 1996, BIOCHEM J, V320, P257, DOI 10.1042/bj3200257; Ciccone DN, 2004, METHOD ENZYMOL, V376, P334; Clem BF, 2006, MOL ENDOCRINOL, V20, P100, DOI 10.1210/me.2004-0495; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DELCUVE GP, 1989, BIOCHEM J, V263, P179, DOI 10.1042/bj2630179; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HENDZEL MJ, 1991, J BIOL CHEM, V266, P21936; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; RIDSDALE JA, 1988, NUCLEIC ACIDS RES, V16, P5915, DOI 10.1093/nar/16.13.5915; Samuel SK, 1998, CANCER RES, V58, P3004; Samuel SK, 1997, CANCER RES, V57, P147; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Spencer VA, 2000, CANCER RES, V60, P288; Spencer VA, 2001, J BIOL CHEM, V276, P34810, DOI 10.1074/jbc.M104886200; Spencer VA, 2002, PROTEIN PROTOCOLS HD, P753; SPENCER VA, 2002, PROTEIN PROTOCOLS HD, P747; Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Sun JM, 2001, J BIOL CHEM, V276, P49435, DOI 10.1074/jbc.M108364200; Sun JM, 1996, J CELL BIOCHEM, V62, P454, DOI 10.1002/(SICI)1097-4644(19960915)62:4<454::AID-JCB3>3.0.CO;2-L; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Wang XY, 2001, J BIOL CHEM, V276, P12764, DOI 10.1074/jbc.M100501200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	34	39	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33227	33236		10.1074/jbc.M703549200	http://dx.doi.org/10.1074/jbc.M703549200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827154	hybrid			2022-12-25	WOS:000250625400070
J	Bee, MS; Hulme, EC				Bee, Mark S.; Hulme, Edward C.			Functional analysis of transmembrane domain 2 of the M-1 muscarinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; SCANNING MUTAGENESIS; 7-TRANSMEMBRANE RECEPTORS; CONSTITUTIVE ACTIVATION; RHODOPSIN FAMILY; AMINO-ACIDS; BINDING; IDENTIFICATION; ASPARTATE; RESIDUES	Ala substitution scanning mutagenesis has been used to probe the functional role of amino acids in transmembrane (TM) domain 2 of the M-1 muscarinic acetylcholine receptor, and of the highly conserved Asn(43) in TM1. The mutation of Asn(43), Asn(61), and Leu(64) caused an enhanced ACh affinity phenotype. Interpreted using a rhodopsin-based homology model, these results suggest the presence of a network of specific contacts between this group of residues and Pro(415) and Tyr(418) in the highly conserved NPXXY motif in TM7 that exhibit a similar mutagenic phenotype. These contacts may be rearranged or broken when ACh binds. D71A, like N414A, was devoid of signaling activity. We suggest that formation of a direct hydrogen bond between the highly conserved side chains of Asp(71) and Asn(414) may be a critical feature stabilizing the activated state of the M-1 receptor. Mutation of Leu(67), Ala(70), and Ile(74) also reduced the signaling efficacy of the ACh-receptor complex. The side chains of these residues are modeled as an extended surface that may help to orient and insulate the proposed hydrogen bond between Asp(71) and Asn(414). Mutation of Leu(72), Gly(75), and Met(79) in the outer half of TM2 primarily reduced the expression of functional receptor binding sites. These residues may mediate contacts with TM1 and TM7 that are preserved throughout the receptor activation cycle. Thermal inactivation measurements confirmed that a reduction in structural stability followed the mutation of Met(79) as well as Asp(71).	Natl Inst Med Res, MRC, Ridgeway, Div Phys Biochem, London NW7 1AA, England	MRC National Institute for Medical Research	Hulme, EC (corresponding author), Natl Inst Med Res, MRC, Ridgeway, Div Phys Biochem, Mill Hill, London NW7 1AA, England.	ehulme@nimr.mrc.ac.uk			MRC [MC_U117532184] Funding Source: UKRI; Medical Research Council [MC_U117532184] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allman K, 2000, MOL PHARMACOL, V58, P175, DOI 10.1124/mol.58.1.175; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Donnelly D, 1999, BIOCHEM J, V339, P55, DOI 10.1042/0264-6021:3390055; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Geva A, 2000, J BIOL CHEM, V275, P35393, DOI 10.1074/jbc.M005602200; Hamilton SE, 2001, J BIOL CHEM, V276, P15850, DOI 10.1074/jbc.M011563200; Han SJ, 2005, J BIOL CHEM, V280, P24870, DOI 10.1074/jbc.M500379200; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; Hulme EC, 1999, EUR J PHARMACOL, V375, P247, DOI 10.1016/S0014-2999(99)00297-6; Hulme EC, 1998, J PHYSIOLOGY-PARIS, V92, P269, DOI 10.1016/S0928-4257(98)80031-4; Hulme EC, 2003, RECEPTOR CHANNEL, V9, P215, DOI 10.1080/10606820308261; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Hulme Edward C., 2006, P137; Javitch JA, 1999, BIOCHEMISTRY-US, V38, P7961, DOI 10.1021/bi9905314; JONES PG, 1995, EUR J PHARM-MOLEC PH, V288, P251, DOI 10.1016/0922-4106(95)90036-5; Lee YS, 2002, J PEDIATR ENDOCR MET, V15, P211; Li B, 2005, J BIOL CHEM, V280, P5664, DOI 10.1074/jbc.M411623200; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Lu ZL, 1997, MOL PHARMACOL, V51, P234, DOI 10.1124/mol.51.2.234; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perlman JH, 1997, J BIOL CHEM, V272, P11937, DOI 10.1074/jbc.272.18.11937; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; SPALDING TA, 1994, J BIOL CHEM, V269, P4092; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Vogel WK, 1999, ARCH BIOCHEM BIOPHYS, V361, P283, DOI 10.1006/abbi.1998.0985; WARD WHJ, 1990, TRENDS PHARMACOL SCI, V11, P280, DOI 10.1016/0165-6147(90)90009-W; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Xu W, 1999, FEBS LETT, V447, P318, DOI 10.1016/S0014-5793(99)00316-6	44	12	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32471	32479		10.1074/jbc.M703909200	http://dx.doi.org/10.1074/jbc.M703909200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823120	hybrid			2022-12-25	WOS:000250480300070
J	Vishnivetskiy, SA; Raman, D; Wei, J; Kennedy, MJ; Hurley, JB; Gurevich, VV				Vishnivetskiy, Sergey A.; Raman, Dayanidhi; Wei, Junhua; Kennedy, Matthew J.; Hurley, James B.; Gurevich, Vsevolod V.			Regulation of arrestin binding by rhodopsin phosphorylation level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGHT-DEPENDENT PHOSPHORYLATION; SINGLE-PHOTON RESPONSES; VISUAL ARRESTIN; MULTIPLE PHOSPHORYLATION; BETA-ARRESTIN; PHOTORECEPTOR-MEMBRANES; CRYSTAL-STRUCTURE; IN-VIVO; CONSTITUTIVE ACTIVATION	Arrestins ensure the timely termination of receptor signaling. The role of rhodopsin phosphorylation in visual arrestin binding was established more than 20 years ago, but the effects of the number of receptor-attached phosphates on this interaction remain controversial. Here we use purified rhodopsin fractions with carefully quantified content of individual phosphorylated rhodopsin species to elucidate the impact of phosphorylation level on arrestin interaction with three biologically relevant functional forms of rhodopsin: light-activated and dark phosphorhodopsin and phospho-opsin. We found that a single receptor-attached phosphate does not facilitate arrestin binding, two are necessary to induce high affinity interaction, and three phosphates fully activate arrestin. Higher phosphorylation levels do not increase the stability of arrestin complex with light-activated rhodopsin but enhance its binding to the dark phosphorhodopsin and phospho-opsin. The complex of arrestin with hyperphosphorylated light-activated rhodopsin is less sensitive to high salt and appears to release retinal faster. These data suggest that arrestin likely quenches rhodopsin signaling after the third phosphate is added by rhodopsin kinase. The complex of arrestin with heavily phosphorylated rhodopsin, which appears to form in certain disease states, has distinct characteristics that may contribute to the phenotype of these visual disorders.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Vanderbilt University; University of Washington; University of Washington Seattle	Hurley, JB (corresponding author), Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,PRB 418, Nashville, TN 37232 USA.	jbhhh@u.washington.edu; vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NEI NIH HHS [EY11500, EY06641, R01 EY011500-12, R01 EY006641, F32 EY006641, R01 EY011500, R01 EY006641-22] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006641, F32EY006641, R01EY011500] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ablonczy Z, 2005, PHOTOCHEM PHOTOBIOL, V81, P541, DOI 10.1562/2004-08-27-RA-294.1; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; BINDER BM, 1990, J BIOL CHEM, V265, P15333; Binder BM, 1996, J BIOL CHEM, V271, P19826, DOI 10.1074/jbc.271.33.19826; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chen JY, 2006, J NEUROSCI, V26, P11929, DOI 10.1523/JNEUROSCI.3212-06.2006; Chuang JZ, 2004, J CLIN INVEST, V114, P131, DOI 10.1172/JCI200421136; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; GUREVICH VV, 2004, TIPS, V25, P59; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KIRKWOOD A, 1994, J GEN PHYSIOL, V103, P679, DOI 10.1085/jgp.103.4.679; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Lee KA, 2002, PROTEIN SCI, V11, P862, DOI 10.1110/ps.3870102; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; McDowell J. H., 1993, PHOTORECEPTOR CELLS, V15, P123; MCDOWELL JH, 1977, BIOCHEMISTRY-US, V16, P4054, DOI 10.1021/bi00637a018; MCDOWELL JH, 2000, METHODS ENZYMOL, V315; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Niu L, 2002, P NATL ACAD SCI USA, V99, P13409, DOI 10.1073/pnas.212518899; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OHGURO H, 1994, BIOCHEMISTRY-US, V33, P1023, DOI 10.1021/bi00170a022; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032	78	109	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32075	32083		10.1074/jbc.M706057200	http://dx.doi.org/10.1074/jbc.M706057200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848565	Green Accepted, hybrid			2022-12-25	WOS:000250480300028
J	Franco, R; Panayiotidis, MI; Cidlowski, JA				Franco, Rodrigo; Panayiotidis, Mihalis I.; Cidlowski, John A.			Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-MEDIATED APOPTOSIS; MITOCHONDRIAL PERMEABILITY TRANSITION; JURKAT T-CELLS; INTRACELLULAR GLUTATHIONE; OXIDATIVE STRESS; REDUCED GLUTATHIONE; HYDROGEN-PEROXIDE; NITRIC-OXIDE; MEMBRANE-TRANSPORT; GSH EXTRUSION	Changes in the intracellular redox environment of cells have been reported to be critical for the activation of apoptotic enzymes and the progression of programmed cell death. Glutathione (GSH) depletion is an early hallmark observed in apoptosis, and we have demonstrated that GSH efflux during death receptor-mediated apoptosis occurs via a GSH transporter. We now evaluate the relationship between GSH depletion, the generation of reactive oxygen species (ROS), and the progression of apoptosis. Simultaneous single cell analysis of changes in GSH content and ROS formation by multiparametric FACS revealed that loss of intracellular GSH was paralleled by the generation of different ROS including hydrogen peroxide, superoxide anion, hydroxyl radical, and lipid peroxides. However, inhibition of ROS formation by a variety of antioxidants showed that GSH loss was independent from the generation of ROS. Furthermore, GSH depletion was observed to be necessary for ROS generation. Interestingly, high extracellular thiol concentration (GSH and N-acetyl-cysteine) inhibited apoptosis, whereas, inhibition of ROS generation by other non-thiol antioxidants was ineffective in preventing cell death. Finally, GSH depletion was shown to be a necessary for the progression of apoptosis activated by both extrinsic and intrinsic signaling pathways. These results document a necessary and critical role for GSH loss in apoptosis and clearly uncouple for the first time GSH depletion from ROS formation.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlows1@mail.nih.gov	Franco, Rodrigo/D-9470-2013; Panagiotidis, Mihalis/AAG-6274-2020; Cidlowski, John A/G-2548-2019	Franco, Rodrigo/0000-0003-3241-8615; Panagiotidis, Mihalis/0000-0002-1450-3552; Cidlowski, John A/0000-0003-1420-0516; Panagiotidis, Mihalis/0000-0002-1130-5972	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090079, ZIAES090079] Funding Source: NIH RePORTER; Intramural NIH HHS [NIH0011756287] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Aronis A, 2003, CELL DEATH DIFFER, V10, P335, DOI 10.1038/sj.cdd.4401150; Bajt ML, 2002, ANTIOXID REDOX SIGN, V4, P733, DOI 10.1089/152308602760598873; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Banki K, 1999, J IMMUNOL, V162, P1466; BEAVER JP, 1995, EUR J CELL BIOL, V68, P47; Beltran B, 2002, P NATL ACAD SCI USA, V99, P8892, DOI 10.1073/pnas.092259799; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Bernassola F, 2001, J CELL BIOCHEM, V82, P123, DOI 10.1002/jcb.1143; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Briz O, 2006, J BIOL CHEM, V281, P30326, DOI 10.1074/jbc.M602048200; Brunner T, 2003, SEMIN IMMUNOL, V15, P167, DOI 10.1016/S1044-5323(03)00035-6; Cable H, 1999, J PHARM PHARMACOL, V51, P131, DOI 10.1211/0022357991772231; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Carmody RJ, 2001, REDOX REP, V6, P77, DOI 10.1179/135100001101536085; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chiba T, 1996, EUR J IMMUNOL, V26, P1164, DOI 10.1002/eji.1830260530; Clement MV, 2003, CELL DEATH DIFFER, V10, P1273, DOI 10.1038/sj.cdd.4401302; Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x; Coppola S, 2000, BIOCHEM SOC T, V28, P56, DOI 10.1042/bst0280056; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Deas O, 1997, INT IMMUNOL, V9, P117, DOI 10.1093/intimm/9.1.117; Devadas S, 2003, FREE RADICAL BIO MED, V35, P648, DOI 10.1016/S0891-5849(03)00391-5; DOBBELSTEEN DJ, 1996, J BIOL CHEM, V271, P15420; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Furuke K, 1998, INT IMMUNOL, V10, P1261, DOI 10.1093/intimm/10.9.1261; GARCIARUIZ C, 1992, J BIOL CHEM, V267, P22256; Ghelli A, 1997, J BIOCHEM, V121, P746; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; Girotti AW, 1998, J LIPID RES, V39, P1529; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gouaze V, 2002, J BIOL CHEM, V277, P42867, DOI 10.1074/jbc.M203067200; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Gulbins E, 1996, IMMUNOLOGY, V89, P205, DOI 10.1046/j.1365-2567.1996.d01-743.x; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hall AG, 1999, ADV EXP MED BIOL, V457, P199; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Hammond CL, 2001, J HEPATOL, V34, P946, DOI 10.1016/S0168-8278(01)00037-X; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; He YY, 2003, J BIOL CHEM, V278, P8058, DOI 10.1074/jbc.M207781200; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; HUG H, 1994, FEBS LETT, V351, P311, DOI 10.1016/0014-5793(94)00852-3; Iantomasi T, 1997, BBA-BIOMEMBRANES, V1330, P274; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Jayanthi S, 1999, MOL BRAIN RES, V72, P158, DOI 10.1016/S0169-328X(99)00216-8; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kim H, 2005, ONCOGENE, V24, P1252, DOI 10.1038/sj.onc.1208282; Kohno T, 1996, J IMMUNOL, V156, P4722; LAUB R, 1985, BIOCHEM PHARMACOL, V34, P1175, DOI 10.1016/0006-2952(85)90492-7; Lee TK, 2001, TOXICOL APPL PHARM, V174, P207, DOI 10.1006/taap.2001.9208; Lewandowska H, 2007, J BIOL INORG CHEM, V12, P345, DOI 10.1007/s00775-006-0192-8; Li LQ, 2000, MOL PHARMACOL, V58, P335, DOI 10.1124/mol.58.2.335; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; MAHAGITA C, 2007, AM J PHYSIOL, V293, pE271; Makrigiorgos GM, 1997, J BIOCHEM BIOPH METH, V35, P23, DOI 10.1016/S0165-022X(97)00020-1; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Medan D, 2005, J CELL PHYSIOL, V203, P78, DOI 10.1002/jcp.20201; Nakamichi N, 2005, J NEUROCHEM, V93, P84, DOI 10.1111/j.1471-4159.2005.02999.x; Ng KH, 2003, KIDNEY INT, V63, P976, DOI 10.1046/j.1523-1755.2003.00818.x; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Pardo M, 2006, FREE RADICAL BIO MED, V41, P1795, DOI 10.1016/j.freeradbiomed.2006.08.027; Perez-Cruz I, 2003, BLOOD, V102, P336, DOI 10.1182/blood-2002-11-3559; Perl A, 2002, ANTIOXID REDOX SIGN, V4, P427, DOI 10.1089/15230860260196227; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Ramakrishnan N, 1998, FREE RADICAL RES, V29, P283, DOI 10.1080/10715769800300321; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; ROEDERER M, 1993, ANN NY ACAD SCI, V677, P113, DOI 10.1111/j.1749-6632.1993.tb38770.x; Russel FGM, 2002, ANNU REV PHYSIOL, V64, P563, DOI 10.1146/annurev.physiol.64.081501.155913; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Serinkan BF, 2004, ANTIOXID REDOX SIGN, V6, P227, DOI 10.1089/152308604322899297; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shang F, 2003, FREE RADICAL BIO MED, V34, P521, DOI 10.1016/S0891-5849(02)01304-7; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; SZE G, 1993, AM J PHYSIOL, V265, pG1128, DOI 10.1152/ajpgi.1993.265.6.G1128; Tirosh O, 2003, BIOCHEM PHARMACOL, V66, P1331, DOI 10.1016/S0006-2952(03)00481-7; Ueda S, 1998, J IMMUNOL, V161, P6689; Um HD, 1996, J IMMUNOL, V156, P3469; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	98	210	214	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30452	30465		10.1074/jbc.M703091200	http://dx.doi.org/10.1074/jbc.M703091200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724027	hybrid, Green Accepted			2022-12-25	WOS:000250136300013
J	Gong, Y; Ishida-Takahashi, R; Villanueva, EC; Fingar, DC; Muenzberg, H; Myers, MG				Gong, Yusong; Ishida-Takahashi, Ryoko; Villanueva, Eneida C.; Fingar, Diane C.; Muenzberg, Heike; Myers, Martin G., Jr.			The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; UNITED-STATES; FOOD-INTAKE; FEEDBACK INHIBITION; SIGNALING PROTEINS; GROWTH-FACTOR; BODY-WEIGHT; OB-R; MICE; ACTIVATION	The action of leptin via the long form of its receptor (LepRb) is central to the control of body energy homeostasis and neuroendocrine function, but the mechanisms by which LepRb regulates intracellular signaling have remained incompletely understood. Here we demonstrate that leptin stimulates the phosphorylation of STAT5 and ribosomal protein S6 in the hypothalamic arcuate nucleus in mice. In cultured cells, we investigate the mechanisms by which leptin regulates each of these pathways. Our analysis reveals a dominant role for LepRb Tyr(1077) ( which we demonstrate to be phosphorylated during receptor activation) and a secondary role for LepRb Tyr(1138) in the acute phosphorylation of STAT5a and STAT5b. Tyr(1138) and STAT3 attenuate STAT5-dependent transcription over the long-term, however. In contrast, Tyr(985) ( the LepRb phosphorylation site required for ERK activation) mediates the phosphorylation of the ribosomal S6 kinase (RSK) and S6, as well as cap-dependent translation. Thus, these data demonstrate the phosphorylation of Tyr(1077) on LepRb during receptor activation, substantiate the hypothalamic regulation of STAT5 and S6 by leptin, and define the alternate LepRb signaling pathways that mediate each of these signals and their effects in cultured cells. Dissecting the contributions of these individual pathways to leptin action will be important for our ultimate understanding of the processes that regulate energy balance in vivo.	Univ Michigan, Dept Internal Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Myers, MG (corresponding author), 5560 MSRB 2-0678,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mgmyers@umich.edu	Muenzberg-Gruening, Heike/N-1978-2017		NCI NIH HHS [P30CA046592] Funding Source: Medline; NIDDK NIH HHS [R01 DK56731, R01 DK57768, R01 DK78135, DK20572] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078135, P60DK020572, R01DK056731, R01DK057768] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banks WA, 2004, PEPTIDES, V25, P331, DOI 10.1016/j.peptides.2004.02.014; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; BERGAD PL, 1995, J BIOL CHEM, V270, P24903, DOI 10.1074/jbc.270.42.24903; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dunn SL, 2005, MOL ENDOCRINOL, V19, P925, DOI 10.1210/me.2004-0353; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Farooqi IS, 2004, RECENT PROG HORM RES, V59, P409, DOI 10.1210/rp.59.1.409; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Hekerman P, 2005, FEBS J, V272, P109, DOI 10.1111/j.1432-1033.2004.04391.x; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Leshan RL, 2006, OBESITY, V14, P208, DOI 10.1038/oby.2006.310; Mantzoros CS, 2000, J CLIN ENDOCR METAB, V85, P4000, DOI 10.1210/jc.85.11.4000; Marx J, 2003, SCIENCE, V299, P846, DOI 10.1126/science.299.5608.846; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyoshi K, 2001, GENOMICS, V71, P150, DOI 10.1006/geno.2000.6433; MONTOYE T, 2006, GROWTH REGULAT, V580, P3301; Munzberg H, 2005, CELL MOL LIFE SCI, V62, P642, DOI 10.1007/s00018-004-4432-1; MUNZBERG H, 2004, ENDOCRINOLOGY, V145, P11797; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Rizk NM, 2001, ENDOCRINOLOGY, V142, P3027, DOI 10.1210/en.142.7.3027; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tierney EF, 2006, JAMA-J AM MED ASSOC, V295, P383, DOI 10.1001/jama.295.4.383-a; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	60	133	136	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31019	31027		10.1074/jbc.M702838200	http://dx.doi.org/10.1074/jbc.M702838200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726024	hybrid			2022-12-25	WOS:000250136300069
J	Kelleher, ZT; Matsumoto, A; Stamler, JS; Marshall, HE				Kelleher, Zachary T.; Matsumoto, Akio; Stamler, Jonathan S.; Marshall, Harvey E.			NOS2 regulation of NF-kappa B by S-nitrosylation of p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; DNA-BINDING; INHIBITION; TRANSCRIPTION; GENE; NITROSATION; KINASE; INDUCTION; DISEASE; TRANSACTIVATION	Signal transduction in the NF-kappa B transcription factor pathway is inhibited by inducible nitric oxide synthase ( NOS2) activity, although the molecular mechanism( s) are incompletely understood. We have previously shown that nitric oxide ( NO), derived from NOS2 consequent upon cytokine stimulation, attenuates NF-kappa B p50-p65 heterodimer DNA binding and have identified the p50 monomer as a locus for inhibitory S-nitrosylation. We now show that the binding partner of p50, NF-kappa B p65, is also targeted by NO following cytokine stimulation of respiratory epithelial cells and macrophages and identify a conserved cysteine within the Rel homology domain that is the site for S-nitrosylation. S-Nitrosylation of p65 inhibits NF-kappa B-dependent gene transcription, and nuclear levels of S-nitrosylated p65 correlate with decreased DNA binding of the p50-p65 heterodimer. NOS2 regulates cytokine-induced S-nitrosylation of p65, resulting in decreased NF-kappa B binding to the NOS2 promoter, thereby inhibiting further NOS2 expression. Collectively, these findings delineate a mechanism by which NOS2 modulates NF-kappa B activity and regulates gene expression in inflammation.	Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA	Duke University	Marshall, HE (corresponding author), Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Box 2613,MSRB 201, Durham, NC 27710 USA.	marsh015@mc.duke.edu		Stamler, Jonathan/0000-0002-6866-1572; Matsumoto, Akio/0000-0002-3402-6992	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES012496] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08HL004287] Funding Source: Medline; NIEHS NIH HHS [U19 ES012496] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Cieslik KA, 2006, MOL PHARMACOL, V70, P2004, DOI 10.1124/mol.106.026054; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Cruz MT, 2001, IMMUNOL CELL BIOL, V79, P590, DOI 10.1046/j.1440-1711.2001.01041.x; Darieva Z, 2004, J LEUKOCYTE BIOL, V75, P689, DOI 10.1189/jlb.0603280; Dikopoulos N, 2001, EUR J CLIN INVEST, V31, P234, DOI 10.1046/j.1365-2362.2001.00802.x; Du C, 2007, AM J TRANSPLANT, V7, P17, DOI 10.1111/j.1600-6143.2006.01558.x; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hongo F, 2005, BIOCHEM BIOPH RES CO, V336, P692, DOI 10.1016/j.bbrc.2005.08.150; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Marshall HE, 2002, J BIOL CHEM, V277, P34223, DOI 10.1074/jbc.M201638200; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; McCartney-Francis NL, 2001, J IMMUNOL, V166, P2734, DOI 10.4049/jimmunol.166.4.2734; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Peng HB, 1998, J IMMUNOL, V161, P1970; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Walley KR, 1999, AM J RESP CRIT CARE, V160, P698, DOI 10.1164/ajrccm.160.2.9809081; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200; Zeidler PC, 2004, TOXICOL APPL PHARM, V195, P45, DOI 10.1016/j.taap.2003.10.005	41	164	168	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30667	30672		10.1074/jbc.M705929200	http://dx.doi.org/10.1074/jbc.M705929200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720813	hybrid			2022-12-25	WOS:000250136300034
J	Paranjape, SM; Harris, E				Paranjape, Suman Marie; Harris, Eva			Y box-binding protein-1 binds to the dengue virus 3 '-untranslated region and mediates antiviral effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE EMBRYONIC-DEVELOPMENT; 3' UNTRANSLATED REGION; COLD SHOCK DOMAIN; RNA-SYNTHESIS; CELLULAR-PROTEINS; MESSENGER-RNA; BREAST-CANCER; 3'-TERMINAL REGIONS; GENE-EXPRESSION; GENOMIC RNA	Dengue virus, a member of the family Flaviviridae, poses a serious public health threat worldwide. Dengue virus is a positive-sense RNA virus that harbors a genome of similar to 10.7 kb. Replication of dengue virus is mediated coordinately by cis-acting genomic sequences, viral proteins, and host cell factors. We have isolated and identified several host cell factors from baby hamster kidney cell extracts that bind with high specificity and high affinity to sequences within the untranslated regions of the dengue virus genome. Among the factors identified, Ybox-binding protein-1 (YB-1) and the heterogeneous nuclear ribonucleoproteins (hnRNPs), hnRNP A1, hnRNP A2/B1, and hnRNP Q, bind to the dengue virus 3'-untranslated region. Further analysis indicated that YB-1 binds to the dengue virus 3' stem loop, a conserved structural feature located at the 3' terminus of the 3'-untranslated region of many flaviviruses. Analysis of the impact of YB-1 on replication of dengue virus in YB-1(+/+) and YB-1(-/-) mouse embryo fibroblasts indicated that host YB-1 mediates an antiviral effect. Further studies demonstrated that this antiviral impact is due, at least in part, to a repressive role of YB-1 on dengue virus translation via a mechanism that requires viral genomic sequences. These results suggest a novel role for YB-1 as an antiviral host cell factor.	Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, 50 Univ Hall, Berkeley, CA 94720 USA.	eharris@berkeley.edu						Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Asai K, 2003, VIROLOGY, V314, P229, DOI 10.1016/S0042-6822(03)00400-8; Bader AG, 2004, ONCOGENE, V23, P3145, DOI 10.1038/sj.onc.1207550; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Bieler A, 2006, HUM GENE THER, V17, P55, DOI 10.1089/hum.2006.17.55; Bienvenut WV, 2002, PROTEOMICS, V2, P868, DOI 10.1002/1615-9861(200207)2:7<868::AID-PROT868>3.0.CO;2-D; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CHEN NN, 1995, P NATL ACAD SCI USA, V92, P1087, DOI 10.1073/pnas.92.4.1087; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Dooley S, 2006, J BIOL CHEM, V281, P1784, DOI 10.1074/jbc.M510215200; Edgil D, 2003, VIROLOGY, V317, P275, DOI 10.1016/j.virol.2003.08.012; Edgil D, 2006, VIRUS RES, V119, P43, DOI 10.1016/j.virusres.2005.10.012; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024; Gessner C, 2004, EUR RESPIR J, V23, P14, DOI 10.1183/09031936.03.00033203; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004; Huang JX, 2005, INT J ONCOL, V26, P607; Ito Y, 2003, PATHOL INT, V53, P429, DOI 10.1046/j.1440-1827.2003.01494.x; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; JIMINEZ A, 1998, CURRENT PROTOCOLS PR; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kinney RM, 2005, J VIROL, V79, P5116, DOI 10.1128/JVI.79.8.5116-5128.2005; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kuwano M, 2003, CANCER SCI, V94, P9, DOI 10.1111/j.1349-7006.2003.tb01344.x; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Lu ZH, 2006, MOL CELL BIOL, V26, P8410, DOI 10.1128/MCB.01196-06; Miwa A, 2006, BBA-GEN SUBJECTS, V1760, P1675, DOI 10.1016/j.bbagen.2006.08.027; Olsthoorn RCL, 2001, RNA, V7, P1370; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Princler GL, 2003, VIROLOGY, V317, P136, DOI 10.1016/j.virol.2003.09.010; Raj GV, 1996, J VIROL, V70, P5944, DOI 10.1128/JVI.70.9.5944-5953.1996; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sawaya BE, 1998, J GEN VIROL, V79, P239, DOI 10.1099/0022-1317-79-2-239; Shi ST, 2005, CURR TOP MICROBIOL, V287, P95, DOI 10.1007/3-540-26765-4_4; Shibahara K, 2001, CLIN CANCER RES, V7, P3151; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; UCHIDA T, 1967, J BIOCHEM-TOKYO, V61, P44, DOI 10.1093/oxfordjournals.jbchem.a128519; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; Yano T, 2003, KIDNEY INT, V64, P2052, DOI 10.1046/j.1523-1755.2003.00335.x; Yasen M, 2005, CLIN CANCER RES, V11, P7354, DOI 10.1158/1078-0432.CCR-05-1027; Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042; Yocupicio-Monroy RME, 2003, J VIROL, V77, P3067, DOI 10.1128/JVI.77.5.3067-3076.2003; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005	63	116	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30497	30508		10.1074/jbc.M705755200	http://dx.doi.org/10.1074/jbc.M705755200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726010	hybrid			2022-12-25	WOS:000250136300017
J	Zhang, MM; Green, BR; Catlin, P; Fiedler, B; Azam, L; Chadwick, A; Terlau, H; McArthur, JR; French, RJ; Gulyas, J; Rivier, JE; Smith, BJ; Norton, RS; Olivera, BM; Yoshikami, D; Bulaj, G				Zhang, Min-Min; Green, Brad R.; Catlin, Philip; Fiedler, Brian; Azam, Layla; Chadwick, Ashley; Terlau, Heinrich; McArthur, Jeff R.; French, Robert J.; Gulyas, Josef; Rivier, Jean E.; Smith, Brian J.; Norton, Raymond S.; Olivera, Baldomero M.; Yoshikami, Doju; Bulaj, Grzegorz			Structure/Function characterization of mu-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY NEURONS; ACETYLCHOLINE-RECEPTORS; CHEMICAL-SYNTHESIS; POTENT INHIBITOR; CONUS-STRIATUS; TTX; PAIN; PEPTIDE; GIIIA; RAT	Peptide neurotoxins from one snails continue to supply compounds with therapeutic potential. Although several analgesic conotoxins have already reached human clinical trials, a continuing need exists for the discovery and development of novel nonopioid analgesics, such as subtype-selective sodium channel blockers. mu-Conotoxin KIIIA is representative of mu-conopeptides previously characterized as inhibitors of tetrodotoxin (TTX)-resistant sodium channels in amphibian dorsal root ganglion neurons. Here, we show that KIIIA has potent analgesin activity in the mouse pain model. Surprisingly, KIIIA was found to block most (>80%) of the TTX-sensitive, but only similar to 20% of the TTX-resistant, sodium current in mouse dorsal root ganglion neurons. KIIIA was tested on cloned mammalian channels expressed in Xenopus oocytes. Both Na(nu)1.2 and Na(nu)1.6 were strongly blocked; within experimental wash times of 40-60 min, block was reversed very little for Na(nu)1.2 and only partially for Na(nu)1.6. Other isoforms were blocked reversibly: Na(nu)1.3 (IC50 8 mu M), Na(nu)1.5 (IC50 284 mu M), and Na(nu)1.4 (IC50 80 nM). "Alanine-walk" and related analogs were snythesized and tested against both Na(nu)1.2 and Na(nu)1.4; replacement of Trp-8 resulted in reversible block of Na(nu)1.2, whereas replacement of Lys-7, Trp-8, or Asp-11 yielded a more profound effect on the block of Na(nu)1.4 than of Na(nu)1.2. Taken together, these data suggest that KIIIA is an effective tool to study structure and function of Na(nu)1.2 and that further engineering of mu-conopeptides belonging to the KIIIA group may provide subtype-selective pharmacological compounds for mammalian neuronal sodium channels and potential therapeutics for the treatment of pain.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Klinikum Schleswig Holstein, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany; Univ Calgary, Dept Phys & Biophys, Calgary, AB T2N 4N1, Canada; Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Utah, Coll Pharm, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; University of Kiel; Schleswig Holstein University Hospital; University of Calgary; Salk Institute; Walter & Eliza Hall Institute; Utah System of Higher Education; University of Utah	Smith, BJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	bulaj@pharm.utah.edu	McArthur, Jeffrey/T-8018-2019; McArthur, Jeffrey R/E-7869-2014; Smith, Brian J/F-8282-2011	McArthur, Jeffrey/0000-0002-2546-7913; Smith, Brian J/0000-0003-0498-1910; Norton, Raymond/0000-0001-8893-0584	NIGMS NIH HHS [GM 48677] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAM SE, 1994, ANESTHESIOLOGY, V80, P383, DOI 10.1097/00000542-199402000-00018; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Blackburn-Munro G, 2002, EUR J PHARMACOL, V445, P231, DOI 10.1016/S0014-2999(02)01765-X; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; CRUZ LJ, 1989, BIOCHEMISTRY-US, V28, P3437, DOI 10.1021/bi00434a043; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; FAINZILBER M, 1995, J BIOL CHEM, V270, P1123, DOI 10.1074/jbc.270.3.1123; FAINZILBER M, 1995, BIOCHEMISTRY-US, V34, P5364, DOI 10.1021/bi00016a007; French R J, 1999, Methods Enzymol, V294, P575; French RJ, 2004, CURR MED CHEM, V11, P3053, DOI 10.2174/0929867043363866; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; Green BR, 2007, CHEM BIOL, V14, P399, DOI 10.1016/j.chembiol.2007.02.009; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; KRUEGER BK, 1986, ANN NY ACAD SCI, V479, P257, DOI 10.1111/j.1749-6632.1986.tb15574.x; Lewis RJ, 2007, MOL PHARMACOL, V71, P676, DOI 10.1124/mol.106.028225; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Livett BG, 2004, CURR MED CHEM, V11, P1715, DOI 10.2174/0929867043364928; Marcil J, 2006, BRIT J ANAESTH, V96, P761, DOI 10.1093/bja/ael096; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Priest BT, 2007, P NATL ACAD SCI USA, V104, P8205, DOI 10.1073/pnas.0703091104; Safo P, 2000, J NEUROSCI, V20, P76, DOI 10.1523/JNEUROSCI.20-01-00076.2000; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; Shon KJ, 1998, J NEUROSCI, V18, P4473; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; Weiser T, 2006, NEUROSCI LETT, V395, P179, DOI 10.1016/j.neulet.2005.10.058; West PJ, 2005, J NEUROPHYSIOL, V94, P3916, DOI 10.1152/jn.01304.2004; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	44	113	128	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30699	30706		10.1074/jbc.M704616200	http://dx.doi.org/10.1074/jbc.M704616200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724025	hybrid			2022-12-25	WOS:000250136300038
J	Jo, S; Kim, T; Im, W				Jo, Sunhwan; Kim, Taehoon; Im, Wonpil			Automated Builder and Database of Protein/Membrane Complexes for Molecular Dynamics Simulations	PLOS ONE			English	Article							ENERGY TRANSDUCTION; POTASSIUM CHANNELS; ESCHERICHIA-COLI; WATER PERMEATION; OMPF PORIN; MEMBRANE; MECHANISM; ENERGETICS; GRAMICIDIN; TRANSPORT	Molecular dynamics simulations of membrane proteins have provided deeper insights into their functions and interactions with surrounding environments at the atomic level. However, compared to solvation of globular proteins, building a realistic protein/membrane complex is still challenging and requires considerable experience with simulation software. Membrane Builder in the CHARMM-GUI website (http://www.charmm-gui.org) helps users to build such a complex system using a web browser with a graphical user interface. Through a generalized and automated building process including system size determination as well as generation of lipid bilayer, pore water, bulk water, and ions, a realistic membrane system with virtually any kinds and shapes of membrane proteins can be generated in 5 minutes to 2 hours depending on the system size. Default values that were elaborated and tested extensively are given in each step to provide reasonable options and starting points for both non-expert and expert users. The efficacy of Membrane Builder is illustrated by its applications to 12 transmembrane and 3 interfacial membrane proteins, whose fully equilibrated systems with three different types of lipid molecules (DMPC, DPPC, and POPC) and two types of system shapes (rectangular and hexagonal) are freely available on the CHARMM-GUI website. One of the most significant advantages of using the web environment is that, if a problem is found, users can go back and re-generate the whole system again before quitting the browser. Therefore, Membrane Builder provides the intuitive and easy way to build and simulate the biologically important membrane system.	[Kim, Taehoon; Im, Wonpil] Univ Kansas, Ctr Bioinformat, Dept Mol Biosci, Lawrence, KS 66045 USA; [Jo, Sunhwan] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Im, W (corresponding author), Univ Kansas, Ctr Bioinformat, Dept Mol Biosci, Lawrence, KS 66045 USA.	wonpil@ku.edu		Jo, Sunhwan/0000-0002-4104-6473	The University of Kansas	The University of Kansas	Funding: This work was supported by institutional funding from The University of Kansas.	ALBERTS B, 2002, MOL BIOL CELL, pR34; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Dolan EA, 2002, BIOPHYS J, V82, P2317, DOI 10.1016/S0006-3495(02)75577-X; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Faraldo-Gomez JD, 2002, EUR BIOPHYS J BIOPHY, V31, P217, DOI 10.1007/s00249-002-0207-5; FELLER SE, 1995, J CHEM PHYS, V103, P10267, DOI 10.1063/1.469928; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Petrache HI, 2000, J MOL BIOL, V302, P727, DOI 10.1006/jmbi.2000.4072; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roux B, 2004, STRUCTURE, V12, P1343, DOI 10.1016/j.str.2004.06.013; Shen LY, 1997, BIOPHYS J, V73, P3, DOI 10.1016/S0006-3495(97)78042-1; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; White S.H., MEMBRANE PROTEINS KN; WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631; Woolf TB, 1996, PROTEINS, V24, P92; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	36	647	651	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e880	10.1371/journal.pone.0000880	http://dx.doi.org/10.1371/journal.pone.0000880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849009	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600026
J	Moroni, F; Nobili, L; Curcio, G; De Carli, F; Fratello, F; Marzano, C; De Gennaro, L; Ferrillo, F; Cossu, M; Francione, S; Lo Russo, G; Bertini, M; Ferrara, M				Moroni, Fabio; Nobili, Lino; Curcio, Giuseppe; De Carli, Fabrizio; Fratello, Fabiana; Marzano, Cristina; De Gennaro, Luigi; Ferrillo, Franco; Cossu, Massimo; Francione, Stefano; Lo Russo, Giorgio; Bertini, Mario; Ferrara, Michele			Sleep in the Human Hippocampus: A Stereo-EEG Study	PLOS ONE			English	Article								Background. There is compelling evidence indicating that sleep plays a crucial role in the consolidation of new declarative, hippocampus-dependent memories. Given the increasing interest in the spatiotemporal relationships between cortical and hippocampal activity during sleep, this study aimed to shed more light on the basic features of human sleep in the hippocampus. Methodology/Principal Findings. We recorded intracerebral stereo-EEG directly from the hippocampus and neocortical sites in five epileptic patients undergoing presurgical evaluations. The time course of classical EEG frequency bands during the first three NREM-REM sleep cycles of the night was evaluated. We found that delta power shows, also in the hippocampus, the progressive decrease across sleep cycles, indicating that a form of homeostatic regulation of delta activity is present also in this subcortical structure. Hippocampal sleep was also characterized by: i) a lower relative power in the slow oscillation range during NREM sleep compared to the scalp EEG; ii) a flattening of the time course of the very low frequencies (up to 1 Hz) across sleep cycles, with relatively high levels of power even during REM sleep; iii) a decrease of power in the beta band during REM sleep, at odds with the typical increase of power in the cortical recordings. Conclusions/Significance. Our data imply that cortical slow oscillation is attenuated in the hippocampal structures during NREM sleep. The most peculiar feature of hippocampal sleep is the increased synchronization of the EEG rhythms during REM periods. This state of resonance may have a supportive role for the processing/consolidation of memory.	[Ferrara, Michele] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy; [Moroni, Fabio; Curcio, Giuseppe; Fratello, Fabiana; Marzano, Cristina; De Gennaro, Luigi; Bertini, Mario] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Nobili, Lino; Cossu, Massimo; Francione, Stefano; Lo Russo, Giorgio] Osped Niguarda Ca Granda, Ctr Epilepsy Surg C Munari, Ctr Sleep Med, Milan, Italy; [De Carli, Fabrizio] CNR, Inst Bioimaging & Mol Physiol, Sect Genova, Genoa, Italy; [Ferrillo, Franco] Univ Genoa, Sleep Disorders Ctr, Genoa, Italy	University of L'Aquila; Sapienza University Rome; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Consiglio Nazionale delle Ricerche (CNR); University of Genoa	Ferrara, M (corresponding author), Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy.	michele.ferrara@cc.univaq.it	Cossu, Massimo/K-2133-2018; Francione, Stefano/AAC-7574-2022; Curcio, Giuseppe/M-1635-2014; De Carli, Fabrizio/F-8208-2013; Russo, Giorgio Lo/AAC-5261-2022; Cossu, Massimo/HHM-9543-2022; De Gennaro, Luigi/L-8711-2015; Ferrara, Michele/AAB-7574-2022; Nobili, Lino/AAB-6398-2020; Francione, Stefano/K-2615-2018	Cossu, Massimo/0000-0002-1891-7648; Francione, Stefano/0000-0002-0577-5193; De Carli, Fabrizio/0000-0002-1841-5146; De Gennaro, Luigi/0000-0003-3613-6631; Ferrara, Michele/0000-0003-2304-7576; Nobili, Lino/0000-0001-9317-5405; Moroni, Fabio/0000-0003-0587-0614; Curcio, Giuseppe/0000-0003-2248-781X				Bodizs R, 2005, BRAIN RES BULL, V65, P169, DOI 10.1016/j.brainresbull.2005.01.002; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; Borbely A A, 1982, Hum Neurobiol, V1, P195; Bragin A, 2002, ANN NEUROL, V52, P407, DOI 10.1002/ana.10291; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Cantero JL, 2003, J NEUROSCI, V23, P10897; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Cossu M, 2005, J NEUROSURG, V103, P333, DOI 10.3171/ped.2005.103.4.0333; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Dang-Vu TT, 2005, NEUROIMAGE, V28, P14, DOI 10.1016/j.neuroimage.2005.05.028; De Gennaro L, 2002, CLIN NEUROPHYSIOL, V113, P561, DOI 10.1016/S1388-2457(02)00045-7; DIJK DJ, 1990, SLEEP 90, P3; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; FREEMON FR, 1970, COMPR PSYCHIAT, V2, P544, DOI 10.1016/0010-440X(70)90017-9; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; LANCEL M, 1992, SLEEP, V15, P102, DOI 10.1093/sleep/15.2.102; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 1997, MOL PSYCHIATR, V2, P195, DOI 10.1038/sj.mp.4000239; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nishida M, 2004, NEUROSCI RES, V50, P331, DOI 10.1016/j.neures.2004.08.004; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; RECHTSCHAFFEN A, 1986, NIH PUBLICATION, V204; ROBINSON TE, 1980, BRAIN RES REV, V2, P69, DOI 10.1016/0165-0173(80)90004-1; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Staba RJ, 2004, ANN NEUROL, V56, P108, DOI 10.1002/ana.20164; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Uchida S, 2001, BRAIN RES, V891, P7, DOI 10.1016/S0006-8993(00)03154-1; Wehrle R, 2007, EUR J NEUROSCI, V25, P863, DOI 10.1111/j.1460-9568.2007.05314.x; Winson J, 1993, Curr Opin Neurobiol, V3, P243, DOI 10.1016/0959-4388(93)90217-M; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0	46	43	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e867	10.1371/journal.pone.0000867	http://dx.doi.org/10.1371/journal.pone.0000867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848998	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600014
J	Bergeron, A; Belcaid, M; Steward, GF; Poisson, G				Bergeron, Anne; Belcaid, Mahdi; Steward, Grieg F.; Poisson, Guylaine			Divide and Conquer: Enriching Environmental Sequencing Data	PLOS ONE			English	Article								Background. In environmental sequencing projects, a mix of DNA from a whole microbial community is fragmented and sequenced, with one of the possible goals being to reconstruct partial or complete genomes of members of the community. In communities with high diversity of species, a significant proportion of the sequences do not overlap any other fragment in the sample. This problem will arise not only in situations with a relatively even distribution of many species, but also when the community in a particular environment is routinely dominated by the same few species. In the former case, no genomes may be assembled at all, while in the latter case a few dominant species in an environment will always be sequenced at high coverage to the detriment of coverage of the greater number of sparse species. Methods and Results. Here we show that, with the same global sequencing effort, separating the species into two or more sub-communities prior to sequencing can yield a much higher proportion of sequences that can be assembled. We first use the Lander-Waterman model to show that, if the expected percentage of singleton sequences is higher than 25%, then, under the uniform distribution hypothesis, splitting the community is always a wise choice. We then construct simulated microbial communities to show that the results hold for highly non-uniform distributions. We also show that, for the distributions considered in the experiments, it is possible to estimate quite accurately the relative diversity of the two sub-communities. Conclusion. Given the fact that several methods exist to split microbial communities based on physical properties such as size, density, surface biochemistry, or optical properties, we strongly suggest that groups involved in environmental sequencing, and expecting high diversity, consider splitting their communities in order to maximize the information content of their sequencing effort.	[Bergeron, Anne] Univ Quebec, Montreal, PQ H3C 3P8, Canada; [Belcaid, Mahdi; Poisson, Guylaine] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Steward, Grieg F.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	University of Quebec; University of Quebec Montreal; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Bergeron, A (corresponding author), Univ Quebec, Montreal, PQ H3C 3P8, Canada.	bergeron.anne@uqam.ca	Steward, Grieg F./D-9768-2011; Bergeron, Anne/B-9861-2012	Steward, Grieg F./0000-0001-5988-0522; 	NSERC; National Science Foundation [OCE 04-42664, EF 04-24599]; National Center for Research Resources [P20 RR-16467]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	AB was partly supported by NSERC. GFS was partly supported by a grant from the National Science Foundation (OCE 04-42664 and EF 04-24599). GP was partly supported by the NIH Grant number P20 RR-16467 from the National Center for Research Resources, and, as appropriate, its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; LANDER E S, 1988, Genomics, V2, P231; OLLIVON M, 1986, ANAL BIOCHEM, V152, P262, DOI 10.1016/0003-2697(86)90408-2; RICE RH, 1972, VIROLOGY, V49, P602, DOI 10.1016/0042-6822(72)90512-0; RICKWOOD D, CENTRIFUGATION PRACT; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; SMITH TJ, 1987, J VIROL METHODS, V16, P263, DOI 10.1016/0166-0934(87)90011-5; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Steward GF, 2007, ISME J, V1, P100, DOI 10.1038/ismej.2007.25; [No title captured]	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e830	10.1371/journal.pone.0000830	http://dx.doi.org/10.1371/journal.pone.0000830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786202	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500014
J	Diks, SH; Parikh, K; van der Sijde, M; Joore, J; Ritsema, T; Peppelenbosch, MP				Diks, Sander H.; Parikh, Kaushal; van der Sijde, Marijke; Joore, Jos; Ritsema, Tita; Peppelenbosch, Maikel P.			Evidence for a Minimal Eukaryotic Phosphoproteome?	PLOS ONE			English	Article								Background. Reversible phosphorylation catalysed by kinases is probably the most important regulatory mechanism in eukaryotes. Methodology/Principal Findings. We studied the in vitro phosphorylation of peptide arrays exhibiting the majority of PhosphoBase-deposited protein sequences, by factors in cell lysates from representatives of various branches of the eukaryotic species. We derived a set of substrates from the PhosphoBase whose phosphorylation by cellular extracts is common to the divergent members of different kingdoms and thus may be considered a minimal eukaryotic phosphoproteome. The protein kinases ( or kinome) responsible for phosphorylation of these substrates are involved in a variety of processes such as transcription, translation, and cytoskeletal reorganisation. Conclusions/Significance. These results indicate that the divergence in eukaryotic kinases is not reflected at the level of substrate phosphorylation, revealing the presence of a limited common substrate space for kinases in eukaryotes and suggests the presence of a set of kinase substrates and regulatory mechanisms in an ancestral eukaryote that has since remained constant in eukaryotic life.	[Diks, Sander H.; Parikh, Kaushal; van der Sijde, Marijke; Peppelenbosch, Maikel P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Kinome Profiling Unit, Groningen, Netherlands; [Joore, Jos] Pepscan Presto, Lelystad, Flevoland, Netherlands; [Ritsema, Tita] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	University of Groningen; Utrecht University	Diks, SH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Kinome Profiling Unit, Groningen, Netherlands.	m.p.peppelenbosch@med.umcg.nl		Parikh, Kaushal/0000-0002-3247-3676; Peppelenbosch, Maikel/0000-0001-9112-6028; Joore, Jos/0000-0002-2744-4862	the regional programme of innovative actions in Groningen (IAG); Top Institute Pharma (TI Pharma); Netherlands Organisation for Scientific Research (NWO)	the regional programme of innovative actions in Groningen (IAG); Top Institute Pharma (TI Pharma); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by grants from the regional programme of innovative actions in Groningen (IAG) and Top Institute Pharma (TI Pharma). SHD is supported by a Casimir fellowship funded by the Netherlands Organisation for Scientific Research (NWO).	Alexopoulos C. J., 1996; Besant PG, 2003, INT J BIOCHEM CELL B, V35, P297, DOI 10.1016/S1357-2725(02)00257-1; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; DOUVILLE E, 1994, CANCER METAST REV, V13, P1, DOI 10.1007/BF00690414; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Krupa A, 2002, GENOME BIOL, V3; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Malathi K, 1999, GENETICS, V153, P1145; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; MIRANDASAAVEDRA D, 2007, PROTEINS; Modesti A, 2001, ELECTROPHORESIS, V22, P576, DOI 10.1002/1522-2683(200102)22:3<576::AID-ELPS576>3.0.CO;2-P; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Rudrabhatla P, 2004, BIOCHEMISTRY-US, V43, P12123, DOI 10.1021/bi0497042; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; STERN DF, 1991, MOL CELL BIOL, V11, P987, DOI 10.1128/MCB.11.2.987; VARELA F G, 1974, Biosystems, V5, P187, DOI 10.1016/0303-2647(74)90031-8; Vieth M, 2005, DRUG DISCOV TODAY, V10, P839, DOI 10.1016/S1359-6446(05)03477-X; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wolanin PM, 2002, GENOME BIOL, V3; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	41	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e777	10.1371/journal.pone.0000777	http://dx.doi.org/10.1371/journal.pone.0000777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712425	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455300025
J	Averous, J; Fonseca, BD; Proud, CG				Averous, J.; Fonseca, B. D.; Proud, C. G.			Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1	ONCOGENE			English	Article						rapamycin; translation initiation; 4E-BP1; cell cycle; cancer	CAP-BINDING PROTEIN; MESSENGER-RNA; TRANSLATION INITIATION; MAMMALIAN TARGET; AMINO-ACIDS; C-MYC; RAPAMYCIN; PHOSPHORYLATION; MEDIATE; EIF-4E	There is currently substantial interest in the regulation of cell function by mammalian target of rapamycin ( mTOR), especially effects linked to the rapamycin-sensitive mTOR complex 1 ( mTORC1). Rapamycin induces G(1) arrest and blocks proliferation of many tumor cells, suggesting that the inhibition of mTORC1 signaling may be useful in cancer therapy. In MCF7 breast adenocarcinoma cells, rapamycin decreases levels of cyclin D1, without affecting cytoplasmic levels of its mRNA. In some cell - types, rapamycin does not affect cyclin D1 levels, whereas the starvation for leucine ( which impairs mTORC1 signaling more profoundly than rapamycin) does. This pattern correlates with the behavior of eukaryotic initiation factor 4E-binding protein 1 ( 4E-BP1, an mTORC1 target that regulates translation initiation). siRNA-mediated knockdown of 4E-BP1 abrogates the effect of rapamycin on cyclin D1 expression and increases the polysomal association of the cyclin D1 mRNA. Our data identify 4E-BP1 as a key regulator of cyclin D1 expression, indicate that this effect is not mediated through the changes in cytoplasmic levels of cyclin D1 mRNA and suggest that, in some cell types, interfering with the amino acid input to mTORC1, rather than using rapamycin, may inhibit proliferation.	[Averous, J.; Fonseca, B. D.; Proud, C. G.] Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Proud, CG (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cgpr@interchange.ubc.ca		Proud, Christopher/0000-0003-0704-6442				ALBERS MW, 1993, J BIOL CHEM, V268, P22825; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Averous J, 2005, FEBS LETT, V579, P2609, DOI 10.1016/j.febslet.2005.03.077; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gingras AC, 2001, GENE DEV, V15, P2852; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Koziczak M, 2004, J BIOL CHEM, V279, P50004, DOI 10.1074/jbc.M404252200; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	30	141	142	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2008	27	8					1106	1113		10.1038/sj.onc.1210715	http://dx.doi.org/10.1038/sj.onc.1210715			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	262GJ	17724476				2022-12-25	WOS:000253136700010
J	Li, YF; He, W; Jha, KN; Klotz, K; Kim, YH; Mandal, A; Pulido, S; Digilio, L; Flickinger, CJ; Herr, JC				Li, Yan-Feng; He, Wei; Jha, Kula N.; Klotz, Ken; Kim, Young-Hwan; Mandal, Arabinda; Pulido, Silvia; Digilio, Laura; Flickinger, Charles J.; Herr, John C.			FSCB, a novel protein kinase a-phosphorylated calcium-binding protein, is a CABYR-binding partner involved in late steps of fibrous sheath biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; HUMAN SPERM; ACROSOME REACTION; HAMSTER SPERMATOZOA; MAMMALIAN SPERM; CAPACITATION; MOUSE; HYPERACTIVATION; IDENTIFICATION; PENTOXIFYLLINE	We report characterization of a novel testis- and sperm-specific protein, FSCB ((f) under bar ibrous (s) under bar heath (C) under bar ABYR (b) under bar inding), that is expressed post- meiotically and localized in mouse sperm flagella. FSCB was identified as a binding partner of CABYR, a calcium-binding protein that is tyrosine-phosphorylated during capacitation. Orthologous genes of FSCB are present in other mammals, including rat and human, and conserved motifs in FSCB include PXXP, proline-rich and extensin-like regions. FSCB is phosphorylated by protein kinase A as shown by in vitro phosphorylation assay and also by determining phosphorylation sites in native FSCB from mouse sperm. Calcium overlay assay showed that FSCB is a calcium-binding protein from sperm. FSCB is a post meiotic protein first expressed at step 11 of mouse spermatogenesis in the elongating spermatids, and it subsequently incorporates into the flagellar principal piece of the sperm. Ultrastructurally, FSCB localized to a cortical layer of intermediate electron density at the surface of the ribs and longitudinal columns of the fibrous sheath. Due to its temporal appearance during spermiogenesis and location at the cortex of the fibrous sheath, FSCB is postulated to be involved in the later stages of fibrous sheath assembly.	Univ Virginia, Dept Cell Biol, Ctr Res Contracept & Reprod Hlth, Charlottesville, VA 22908 USA; Third Mil Med Univ, Daping Hosp, Dept Urol, Chongqing 400042, Peoples R China; Third Mil Med Univ, SW Hosp, Dept Obstet & Gynecol, Chongqing 400038, Peoples R China	University of Virginia; Army Medical University; Army Medical University	Herr, JC (corresponding author), Univ Virginia, Dept Cell Biol, Ctr Res Contracept & Reprod Hlth, POB 800732, Charlottesville, VA 22908 USA.	jch7k@virginia.edu	li, yan/GTI-4638-2022		NICHD NIH HHS [D43 TW/HD 000654] Funding Source: Medline; PHS HHS [U54 29099] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Brown PR, 2003, BIOL REPROD, V68, P2241, DOI 10.1095/biolreprod.102.013466; Carrera A, 1996, DEV BIOL, V180, P284, DOI 10.1006/dbio.1996.0301; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; CLERMONT Y, 1969, FERTIL STERIL, V20, P805; CLERMONT Y, 1990, ANAT RECORD, V227, P447, DOI 10.1002/ar.1092270408; Ecroyd H, 2003, BIOL REPROD, V69, P1801, DOI 10.1095/biolreprod.103.017350; EDDY EM, 1991, ANN NY ACAD SCI, V637, P224, DOI 10.1111/j.1749-6632.1991.tb27312.x; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; El-Alfy M, 1999, J ANDROL, V20, P307; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Fujita A, 2000, J CELL SCI, V113, P103; FULCHER KD, 1995, BIOL REPROD, V52, P41, DOI 10.1095/biolreprod52.1.41; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Hsu HC, 2005, BIOCHEM BIOPH RES CO, V329, P1108, DOI 10.1016/j.bbrc.2005.02.089; IRONS MJ, 1982, AM J ANAT, V165, P121, DOI 10.1002/aja.1001650204; Jha KN, 2002, MOL REPROD DEV, V61, P258, DOI 10.1002/mrd.1155; Johnson LR, 1997, DEV BIOL, V192, P340, DOI 10.1006/dbio.1997.8767; Kim YH, 2005, DEV BIOL, V286, P46, DOI 10.1016/j.ydbio.2005.07.005; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Mandal A, 1999, BIOL REPROD, V61, P1184, DOI 10.1095/biolreprod61.5.1184; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Moseley FLC, 2005, MOL HUM REPROD, V11, P523, DOI 10.1093/molehr/gah188; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; Nassar A, 1999, FERTIL STERIL, V71, P919, DOI 10.1016/S0015-0282(99)00013-8; Nauc V, 2004, J ANDROL, V25, P573; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; O'Flaherty C, 2005, BIOL REPROD, V73, P94, DOI 10.1095/biolreprod.104.038794; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oko R, 1998, ANDROLOGIA, V30, P193; OKO R, 1989, ANAT REC, V225, P46, DOI 10.1002/ar.1092250108; OKUNO M, 1981, CELL MOTIL CYTOSKEL, V1, P349, DOI 10.1002/cm.970010306; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; SAKAI Y, 1986, ANAT REC, V215, P119, DOI 10.1002/ar.1092150205; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; Sen B, 2003, GENE, V310, P67, DOI 10.1016/S0378-1119(03)00495-5; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; Turner RMO, 1999, MOL HUM REPROD, V5, P816, DOI 10.1093/molehr/5.9.816; Turner RMO, 1998, J BIOL CHEM, V273, P32135, DOI 10.1074/jbc.273.48.32135; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; VISCONTI PE, 1989, BIOL REPROD, V40, P223, DOI 10.1095/biolreprod40.2.223; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Yeung CH, 1999, MOL REPROD DEV, V54, P194, DOI 10.1002/(SICI)1098-2795(199910)54:2<194::AID-MRD12>3.3.CO;2-3; YOVICH JM, 1990, FERTIL STERIL, V53, P715	54	34	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34104	34119		10.1074/jbc.M702238200	http://dx.doi.org/10.1074/jbc.M702238200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855365	hybrid			2022-12-25	WOS:000251145700025
J	Huang, J; Liang, Z; Yang, B; Tian, H; Ma, J; Zhang, H				Huang, Jialing; Liang, Zhihui; Yang, Bin; Tian, Heng; Ma, Jin; Zhang, Hui			Derepression of MicroRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN-CELLS; P-BODIES; ENDOGENOUS RETROVIRUSES; ALU RETROTRANSPOSITION; LTR-RETROTRANSPOSON; HUMAN HEPATOCYTES; HIV-1 INFECTION; STRESS GRANULES; VIF PROTEIN	The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G or A3G) and its fellow cytidine deaminase family members are potent restrictive factors for human immunodeficiency virus type 1 (HIV-1) and many other retroviruses. A3G interacts with a vast spectrum of RNA-binding proteins and is located in processing bodies and stress granules. However, its cellular function remains to be further clarified. Using a luciferase reporter gene and green fluorescent protein reporter gene, we demonstrate that A3G and other APOBEC family members can counteract the inhibition of protein synthesis by various microRNAs ( miRNAs) such as mir-10b, mir-16, mir-25, and let-7a. A3G could also enhance the expression level of miRNA-targeted mRNA. Further, A3G facilitated the association of microRNA-targeted mRNA with polysomes rather than with processing bodies. Intriguingly, experiments with a C288A/C291A A3G mutant indicated that this function of A3G is separable from its cytidine deaminase activity. Our findings suggest that the major cellular function of A3G, in addition to inhibiting the mobility of retrotransposons and replication of endogenous retroviruses, is most likely to prevent the decay of miRNA-targeted mRNA in processing bodies.	Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, Philadelphia, PA 19107 USA	Jefferson University	Zhang, H (corresponding author), Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, JAH334, Philadelphia, PA 19107 USA.	hui.zhang@jefferson.edu	Yang, Bin/J-4044-2015; Yang, Bin/W-7014-2019	Yang, Bin/0000-0003-4110-1513; Yang, Bin/0000-0003-1180-6184	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052732, R01AI058798] Funding Source: NIH RePORTER; NIAID NIH HHS [AI052732, AI058798] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; ARGYRIS EG, 2007, IN PRESS VIROLOGY; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bruno I, 2006, CELL, V125, P1036, DOI 10.1016/j.cell.2006.06.003; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yang SC, 2001, J BIOL CHEM, V276, P4889, DOI 10.1074/jbc.M004895200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	54	97	98	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33632	10.1074/jbc.M705116200	http://dx.doi.org/10.1074/jbc.M705116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848567	hybrid			2022-12-25	WOS:000250840200044
J	Kim, SH; Hisano, T; Takeda, K; Iwasaki, W; Ebihara, A; Miki, K				Kim, Seong-Hoon; Hisano, Tamao; Takeda, Kazuki; Iwasaki, Wakana; Ebihara, Akio; Miki, Kunio			Crystal Structure of the oxygenase component (HpaB) of the 4-hydroxyphenylacetate 3-Monooxygenase from Thermus thermophilus HB8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-HYDROXYBENZOATE HYDROXYLASE; P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; ESCHERICHIA-COLI W; MOLECULAR CHARACTERIZATION; 2-COMPONENT MONOOXYGENASE; ACINETOBACTER-BAUMANNII; FUNCTIONAL-ANALYSIS; PHENOL HYDROXYLASE; CATABOLIC PATHWAY; MECHANISM	The 4-hydroxyphenylacetate ( 4HPA) 3-monooxygenase is involved in the initial step of the 4HPA degradation pathway and catalyzes 4HPA hydroxylation to 3,4-dihydroxyphenylacetate. This enzyme consists of two components, an oxygenase ( HpaB) and a reductase ( HpaC). To understand the structural basis of the catalytic mechanism of HpaB, crystal structures of HpaB from Thermus thermophilus HB8 were determined in three states: a ligand-free form, a binary complex with FAD, and a ternary complex with FAD and 4HPA. Structural analysis revealed that the binding and dissociation of flavin are accompanied by conformational changes of the loop between beta 5 and beta 6 and of the loop between beta 8 and beta 9, leading to preformation of part of the substrate-binding site ( Ser-197 and Thr-198). The latter loop further changes its conformation upon binding of 4HPA and obstructs the active site from the bulk solvent. Arg-100 is located adjacent to the putative oxygen-binding site and may be involved in the formation and stabilization of the C4-ahydroperoxyflavin intermediate.	Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; RIKEN Harima Inst, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Kyoto University; RIKEN	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp	Ebihara, Akio/AAI-6155-2020; Iwasaki, Wakana/C-4258-2017; Takeda, Kazuki/AAQ-9238-2021	Ebihara, Akio/0000-0002-1763-9084; Iwasaki, Wakana/0000-0002-0161-777X; Takeda, Kazuki/0000-0002-4094-6816				Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Arias-Barrau E, 2005, J BIOL CHEM, V280, P26435, DOI 10.1074/jbc.M501988200; BACH RD, 1994, J AM CHEM SOC, V116, P5392, DOI 10.1021/ja00091a050; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; COOPER RA, 1980, J BACTERIOL, V143, P302, DOI 10.1128/JB.143.1.302-306.1980; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Duffner FM, 1998, FEMS MICROBIOL LETT, V161, P37, DOI 10.1016/S0378-1097(98)00047-0; Enroth C, 1998, STRUCTURE, V6, P605, DOI 10.1016/S0969-2126(98)00062-8; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Fernandez-Medarde A, 1997, FEMS MICROBIOL LETT, V157, P47, DOI 10.1016/S0378-1097(97)00452-7; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Galan B, 2001, J BIOL CHEM, V276, P37060, DOI 10.1074/jbc.M103033200; Gibello A, 1997, ARCH MICROBIOL, V167, P160, DOI 10.1007/s002030050429; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kim SH, 2007, ACTA CRYSTALLOGR F, V63, P556, DOI 10.1107/S174430910702492X; KIM SH, 2007, IN PRESS PROTEINS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martins BM, 2004, P NATL ACAD SCI USA, V101, P15645, DOI 10.1073/pnas.0403952101; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Nagpal A, 2006, BIOCHEMISTRY-US, V45, P1138, DOI 10.1021/bi051966w; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; PRIETO MA, 1994, J BIOL CHEM, V269, P22823; SCHREUDER HA, 1988, J MOL BIOL, V199, P637, DOI 10.1016/0022-2836(88)90307-5; SHOUN H, 1979, J BIOL CHEM, V254, P944; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; TAKIZAWA N, 1995, J FERMENT BIOENG, V80, P318, DOI 10.1016/0922-338X(95)94198-Z; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; UETZ T, 1992, J BACTERIOL, V174, P1179, DOI 10.1128/jb.174.4.1179-1188.1992; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; van der Ploeg JR, 1998, MICROBIOL-SGM, V144, P2555, DOI 10.1099/00221287-144-9-2555; Velasco A, 1998, J BACTERIOL, V180, P1063, DOI 10.1128/JB.180.5.1063-1071.1998; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213	49	48	54	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33107	33117		10.1074/jbc.M703440200	http://dx.doi.org/10.1074/jbc.M703440200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804419	hybrid			2022-12-25	WOS:000250625400059
J	Kolachala, VL; Bajaj, R; Wang, L; Yan, Y; Ritzenthaler, JD; Gewirtz, AT; Roman, J; Merlin, D; Sitaraman, SV				Kolachala, Vasantha L.; Bajaj, Rahul; Wang, Lixin; Yan, Yutao; Ritzenthaler, Jeff D.; Gewirtz, Andrew T.; Roman, Jesse; Merlin, Didier; Sitaraman, Shanthi V.			Epithelial-derived fibronectin expression, signaling, and function in intestinal inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PLASMA FIBRONECTIN; CROHNS-DISEASE; CELL-ADHESION; EXPERIMENTAL COLITIS; IN-VITRO; INTEGRIN; RATS; FIBROBLASTS; ACTIVATION	Fibronectin (FN) is a multifunctional extracellular matrix protein that plays an important role in cell proliferation, adhesion, and migration. FN expression or its role in colitis is not known. The goal of this study is to characterize FN expression, regulation, and role during intestinal inflammation. Wild-type and transgenic mice expressing luciferase under the control of the human FN promoter, given water or 3% dextran sodium sulfate, were used as animal models of colitis. The Caco2-BBE model intestinal epithelial cell line was used for in vitro studies. FN protein is abundantly expressed by surface epithelial cells in the normal colon. Immunohistochemistry and luciferase assay in mice expressing the FN promoter linked to luciferase demonstrated that FN synthesis was up-regulated during colitis, during both the acute phase and the healing phase. In vitro experiments demonstrated that FN increased the expression of the FN integrin receptor alpha 5 beta 1 in a dose-and time-dependent manner. FN also induced the expression and activation of NF-kappa B. Further, FN potentiated Caco2-BBE cell attachment and wound healing, which was inhibited by RGD peptide as well as NF-kappa B inhibitors MG-132 and 1-pyrrolidinecarbodithioic acid, ammonium salt. In conclusion, FN is abundantly expressed and synthesized by colonic epithelial cells. FN is transcriptionally up-regulated in epithelial cells during both the dextran sodium sulfate-induced colitic and the recovery phase. FN enhances cell attachment and wound healing, which is dependent on binding to the integrin receptor and the NF-kappa B signaling. Together our data show that epithelial-derived FN potentiates cell attachment and wound healing through epithelial-matrix interactions and that FN expression may have important implications for maintaining normal epithelial integrity as well as regulating epithelial response to injury during colitis.	Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; Emory Univ, Div Pulm & Crit Care Med, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Sitaraman, SV (corresponding author), Emory Univ, Div Digest Dis, Rm 201-F,615 Michael St,Whitehead Res Bldg, Atlanta, GA 30322 USA.	ssitar2@emory.edu			NIDDK NIH HHS [DK 02831, 5R24 DK 064399-02, DK 06411] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, K01DK002831] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama S K, 1996, Hum Cell, V9, P181; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ALLAN A, 1989, GUT, V30, P627, DOI 10.1136/gut.30.5.627; BASSON CT, 1990, J CELL BIOL, V110, P789, DOI 10.1083/jcb.110.3.789; Basson MD, 2001, LIFE SCI, V69, P3005, DOI 10.1016/S0024-3205(01)01408-4; Brenmoehl J, 2007, INT J COLORECTAL DIS, V22, P611, DOI 10.1007/s00384-006-0188-4; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Charrier L, 2005, AM J PHYSIOL-GASTR L, V288, pG346, DOI 10.1152/ajpgi.00262.2004; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; COOPER HS, 1993, LAB INVEST, V69, P238; Courtois G, 2005, CELL MOL LIFE SCI, V62, P1682, DOI 10.1007/s00018-005-5031-5; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dorsey CW, 2005, MOL MICROBIOL, V57, P196, DOI 10.1111/j.1365-2958.2005.04666.x; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gewirtz AT, 2002, BEST PRACT RES CL GA, V16, P851, DOI 10.1053/bega.2002.0339; Goke M, 1996, AM J PHYSIOL-GASTR L, V271, pG729, DOI 10.1152/ajpgi.1996.271.5.G729; Jobin C, 2000, INFLAMM BOWEL DIS, V6, P206, DOI 10.1097/00054725-200008000-00007; Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z; Kaspar M, 2006, INT J CANCER, V118, P1331, DOI 10.1002/IJC.21677; Kwon AH, 2007, SURGERY, V141, P254, DOI 10.1016/j.surg.2006.06.036; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Loeser RF, 2002, BIORHEOLOGY, V39, P119; MCNEIL PL, 1990, J CELL SCI, V96, P549; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x; Nakajima K, 2006, NEUROSCI LETT, V401, P199, DOI 10.1016/j.neulet.2006.03.014; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Qiu ZY, 2007, J SURG RES, V138, P64, DOI 10.1016/j.jss.2006.06.034; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Ritchie CK, 2000, J CELL PHYSIOL, V184, P214, DOI 10.1002/1097-4652(200008)184:2<214::AID-JCP9>3.3.CO;2-Q; Roman J, 2004, FASEB J, V18, P1436, DOI 10.1096/fj.03-0826fje; Strauch ED, 2003, ANN SURG, V237, P494, DOI 10.1097/00000658-200304000-00010; Tomic R, 2005, CHEST, V127, P257, DOI 10.1378/chest.127.1.257; VERSPAGET HW, 1991, HEPATO-GASTROENTEROL, V38, P231; Walia B, 2004, BIOCHEM J, V382, P589, DOI 10.1042/BJ20040021; Wang JH, 2003, J IMMUNOL, V170, P795, DOI 10.4049/jimmunol.170.2.795; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Watanabe K, 2006, PEPTIDES, V27, P1538, DOI 10.1016/j.peptides.2005.11.005; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; Wu WT, 2004, BIOCHEM J, V379, P587, DOI 10.1042/BJ20031579; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x; Zhang JH, 2006, GASTROENTEROLOGY, V131, P1179, DOI 10.1053/j.gastro.2006.08.007	46	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32965	32973		10.1074/jbc.M704388200	http://dx.doi.org/10.1074/jbc.M704388200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855340	hybrid			2022-12-25	WOS:000250625400045
J	Zhai, PY; Gao, SM; Holle, E; Yu, XZ; Yatani, A; Wagner, T; Sadoshima, J				Zhai, Peiyong; Gao, Shumin; Holle, Eric; Yu, Xianzhong; Yatani, Atsuko; Wagner, Thomas; Sadoshima, Junichi			Glycogen synthase kinase-3 alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; TUBEROUS SCLEROSIS; ACTIVATION; PHOSPHORYLATION; DYSFUNCTION; OVEREXPRESSION; REQUIREMENT; PROTECTION; SURVIVAL; AGONISTS	Glycogen synthase kinase-3 ( GSK-3) is a serine/threonine kinase having multiple functions and consisting of two isoforms, GSK-3 alpha and GSK-3 beta. Pressure overload increases expression of GSK-3 alpha but not GSK-3 beta. Despite our wealth of knowledge about GSK-3 beta, the function of GSK-3 alpha in the heart is not well understood. To address this issue, we made cardiac-specific GSK-3 alpha transgenic mice ( Tg). Left ventricular weight and cardiac myocyte size were significantly smaller in Tg than in non-Tg ( NTg) mice, indicating that GSK-3 alpha inhibits cardiac growth. After 4 weeks of aortic banding ( transverse aortic constriction ( TAC)), increases in left ventricular weight and myocyte size were significantly smaller in Tg than in NTg, indicating that GSK-3 alpha inhibits cardiac hypertrophy. More severe cardiac dysfunction developed in Tg after TAC. Increases in fibrosis and apoptosis were greater in Tg than in NTg after TAC. Among signaling molecules screened, ERK phosphorylation was decreased in Tg. Adenovirus-mediated overexpression of GSK-3 alpha, but not GSK-3 beta, inhibited ERK in cultured cardiac myocytes. Knockdown of GSK-3 alpha increased ERK phosphorylation, an effect that was inhibited by PD98059, rottlerin, and protein kinase C epsilon ( PKC epsilon) inhibitor peptide, suggesting that GSK-3 alpha inhibits ERK through PKC-MEK-dependent mechanisms. Knockdown of GSK-3 alpha increased protein content and reduced apoptosis, effects that were abolished by PD98059, indicating that inhibition of ERK plays a major role in the modulation of cardiac growth and apoptosis by GSK-3 alpha. In conclusion, up-regulation of GSK-3 alpha inhibits cardiac growth and pressure overload-induced cardiac hypertrophy but increases fibrosis and apoptosis in the heart. The anti-hypertrophic and pro-apoptotic effect of GSK-3 alpha is mediated through inhibition of ERK.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Inst Cardiovasc Res, Newark, NJ 07103 USA; Oncol Res Inst, Greenville, SC USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), 185 S Orange Ave,MSB G609, Newark, NJ 07103 USA.	sadoshju@umdnj.edu		Sadoshima, Junichi/0000-0003-3724-4132	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069020, F32HL080861, R01HL067727, P01HL059139, R01HL067724] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 69020, HL 67727, HL 73048, 1F32 HL 080861, HL 67724, HL 59139] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Esposito G, 2001, CIRCULATION, V103, P1453, DOI 10.1161/01.CIR.103.10.1453; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; GOODE N, 1992, J BIOL CHEM, V267, P16878; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Inagaki K, 2005, J MOL CELL CARDIOL, V39, P203, DOI 10.1016/j.yjmcc.2005.05.014; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Klein G, 2005, CIRC RES, V96, P748, DOI 10.1161/01.RES.0000161999.86198.1e; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Morgan HE, 1997, MOL CELL BIOCHEM, V176, P145, DOI 10.1023/A:1006855818855; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; OLIVETTI G, 1992, AM J PATHOL, V141, P227; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Ping PP, 1999, AM J PHYSIOL-HEART C, V277, pH1771, DOI 10.1152/ajpheart.1999.277.5.H1771; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; WATSON PA, 1989, AM J PHYSIOL, V256, pC1257, DOI 10.1152/ajpcell.1989.256.6.C1257; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 2001, SCI STKE, pRE12; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zhai PY, 2006, CIRC RES, V99, P528, DOI 10.1161/01.RES.0000240147.49390.61; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330	41	56	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33181	33191		10.1074/jbc.M705133200	http://dx.doi.org/10.1074/jbc.M705133200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855351	hybrid			2022-12-25	WOS:000250625400065
J	Shimamoto, S; Yoshida, T; Inui, T; Gohda, K; Kobayashi, Y; Fujimori, K; Tsurumura, T; Aritake, K; Urade, Y; Ohkubo, T				Shimamoto, Shigeru; Yoshida, Takuya; Inui, Takashi; Gohda, Keigo; Kobayashi, Yuji; Fujimori, Ko; Tsurumura, Toshiharu; Aritake, Kosuke; Urade, Yoshihiro; Ohkubo, Tadayasu			NMR solution structure of lipocalin-type prostaglandin D synthase - Evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TRACE; CEREBROSPINAL-FLUID; PROTEIN; IDENTIFICATION; PURIFICATION; SYSTEM; FIELD	Lipocalin-type prostaglandin (PG) D synthase (L-PGDS) catalyzes the isomerization of PGH(2), a common precursor of various prostanoids, to produce PGD(2), an endogenous somnogen and nociceptive modulator, in the brain. L-PGDS is a member of the lipocalin superfamily and binds lipophilic substances, such as retinoids and bile pigments, suggesting that L-PGDS is a dual functional protein acting as a PGD(2)-synthesizing enzyme and a transporter for lipophilic ligands. In this study we determined by NMR the three-dimensional structure of recombinant mouse L-PGDS with the catalytic residue Cys-65. The structure of L-PGDS exhibited the typical lipocalin fold, consisting of an eight-stranded, antiparallel beta-barrel and a long alpha-helix associated with the outer surface of the barrel. The interior of the barrel formed a hydrophobic cavity opening to the upper end of the barrel, the size of which was larger than those of other lipocalins, and the cavity contained two pockets. Molecular docking studies, based on the result of NMR titration experiments with retinoic acid and PGH2 analog, revealed that PGH(2) almost fully occupied the hydrophilic pocket 1, in which Cys-65 was located and all-trans-retinoic acid occupied the hydrophobic pocket 2, in which amino acid residues important for retinoid binding in other lipocalins were well conserved. Mutational and kinetic studies provide the direct evidence for the PGH(2) binding mode. These results indicated that the two binding sites for PGH2 and retinoic acid in the large cavity of L-PGDS were responsible for the broad ligand specificity of L-PGDS and the non-competitive inhibition of L-PGDS activity by retinoic acid.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5998531, Japan; Osaka Biosci Inst, Dept Biol Behav Mol, Suita, Osaka 5650874, Japan; Comp Aided Mol Modeling Res Ctr, Higashinada Ku, Kobe, Hyogo 6580012, Japan; Osaka Univ Pharmaceut Sci, Osaka 580, Japan	Osaka University; Osaka Metropolitan University; Osaka University of Pharmaceutical Sciences	Ohkubo, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	ohkubo@phs.osaka-u.ac.jp	Fujimori, Ko/AAD-5428-2021; Inui, Takashi/G-1069-2011	Fujimori, Ko/0000-0002-2506-0769; Yoshida, Takuya/0000-0002-3491-9344; Gohda, Keigo/0000-0002-9345-2377				BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Bertinia I, 2003, J BIOMOL NMR, V26, P355, DOI 10.1023/A:1024092421649; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Beynon RJ, 2004, PEPTIDES, V25, P1553, DOI 10.1016/j.peptides.2003.12.025; Breustedt DA, 2005, J BIOL CHEM, V280, P484, DOI 10.1074/jbc.M410466200; Briand L, 2004, PEPTIDES, V25, P1545, DOI 10.1016/j.peptides.2003.10.026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN LX, 1995, J BIOL CHEM, V270, P4518, DOI 10.1074/jbc.270.9.4518; CLAUSEN J, 1961, P SOC EXP BIOL MED, V107, P170; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craik D J, 1997, Methods Mol Biol, V60, P195; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujimori K, 2006, GENE, V375, P14, DOI 10.1016/j.gene.2006.01.037; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Irikura D, 2007, J BIOCHEM, V141, P173, DOI 10.1093/jb/mvm016; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; MARSILI M, 1980, CROAT CHEM ACTA, V53, P601; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pattanayek R, 1999, PROTEIN SCI, V8, P2027, DOI 10.1110/ps.8.10.2027; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; So SP, 2000, J BIOL CHEM, V275, P40679, DOI 10.1074/jbc.M005752200; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Toh H, 1996, PROTEIN ENG, V9, P1067, DOI 10.1093/protein/9.12.1067; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Urade Y, 2006, LIPOCALINS, P99; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRCH K, 1986, NMR PROTEINS NUCL AC	40	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31373	31379		10.1074/jbc.M700123200	http://dx.doi.org/10.1074/jbc.M700123200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715133	hybrid			2022-12-25	WOS:000250309200027
J	Strahl, T; Huttner, IG; Lusin, JD; Osawa, M; King, D; Thorner, J; Ames, JB				Strahl, Thomas; Huttner, Inken G.; Lusin, Jacqueline D.; Osawa, Masanori; King, David; Thorner, Jeremy; Ames, James B.			Structural insights into activation of phosphatidylinositol 4-kinase (Pik1) by yeast frequenin (Frq1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR-1; PROTEIN-KINASE-C; KV4 K+ CHANNELS; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BINDING PROTEINS; MYRISTOYLATED RECOVERIN; SECONDARY STRUCTURE; GUANYLYL CYCLASE	Yeast frequenin (Frq1), a small N-myristoylated EF-hand protein, activates phosphatidylinositol 4-kinase Pik1. The NMR structure of Ca2+-bound Frq1 complexed to an N-terminal Pik1 fragment (residues 121-174) was determined. The Frq1 main chain is similar to that in free Frq1 and related proteins in the same branch of the calmodulin superfamily. The myristoyl group and first eight residues of Frq1 are solvent-exposed, and Ca2+ binds the second, third, and fourth EF-hands, which associate to create a groove with two pockets. The Pik1 peptide forms two helices (125-135 and 156-169) connected by a 20-residue loop. Side chains in the Pik1 N-terminal helix (Val-127, Ala-128, Val-131, Leu-132, and Leu135) interact with solvent-exposed residues in the Frq1 C-terminal pocket (Leu-101, Trp-103, Val-125, Leu-138, Ile-152, and Leu-155); side chains in the Pik1 C-terminal helix (Ala-157, Ala-159, Leu-160, Val-161, Met-165, and Met-167) contact solvent-exposed residues in the Frq1 N-terminal pocket (Trp-30, Phe-34, Phe-48, Ile-51, Tyr-52, Phe-55, Phe-85, and Leu- 89). This defined complex confirms that residues in Pik1 pinpointed as necessary for Frq1 binding by site-directed mutagenesis are indeed sufficient for binding. Removal of the Pik1 N-terminal region (residues 8-760) from its catalytic domain (residues 792-1066) abolishes lipid kinase activity, inconsistent with Frq1 binding simply relieving an autoinhibitory constraint. Deletion of the lipid kinase unique motif (residues 35-110) also eliminates Pik1 activity. In the complex, binding of Ca2+- bound Frq1 forces the Pik1 chain into a U-turn. Frq1 may activate Pik1 by facilitating membrane targeting via the exposed N-myristoyl group and by imposing a structural transition that promotes association of the lipid kinase unique motif with the kinase domain.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu	Osawa, Masanori/GRS-5726-2022; Strahl, Thomas/E-4315-2010; THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X; Martin, Inken/0000-0002-8790-092X; Osawa, Masanori/0000-0002-1285-4316	NCRR NIH HHS [RR11973] Funding Source: Medline; NEI NIH HHS [EY012347] Funding Source: Medline; NIGMS NIH HHS [GM21841] Funding Source: Medline; NINDS NIH HHS [NS045909] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841, R37GM021841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045909] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Gromada J, 2005, P NATL ACAD SCI USA, V102, P10303, DOI 10.1073/pnas.0504487102; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; HENDRICKS KB, 1999, FRQU GENE PRODUCT PO; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Huttner IG, 2003, J BIOL CHEM, V278, P4862, DOI 10.1074/jbc.M207920200; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MCINTOSH LP, 1990, Q REV BIOPHYS, V23, P1, DOI 10.1017/S0033583500005400; Meyers R E, 1998, Methods Mol Biol, V105, P99; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; O'Callaghan DW, 2004, J BIOL CHEM, V279, P14347, DOI 10.1074/jbc.M310152200; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Simonsen A, 2001, NAT CELL BIOL, V3, pE179, DOI 10.1038/35087112; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tachibanaki S, 2000, J BIOL CHEM, V275, P3313, DOI 10.1074/jbc.275.5.3313; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tanaka T, 1998, J BIOMOL NMR, V11, P135, DOI 10.1023/A:1008212316986; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zhang XL, 1998, SEMIN CELL DEV BIOL, V9, P153, DOI 10.1006/scdb.1997.0220; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	76	51	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30949	30959		10.1074/jbc.M705499200	http://dx.doi.org/10.1074/jbc.M705499200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720810	hybrid			2022-12-25	WOS:000250136300063
J	Dori, D; Choder, M				Dori, Dov; Choder, Mordechai			Conceptual Modeling in Systems Biology Fosters Empirical Findings: The mRNA Lifecycle	PLOS ONE			English	Article							P-BODIES; TRANSLATION TERMINATION; STRESS GRANULES; CELL SIMULATION; FACTOR ERF3; DECAY; PROTEINS; RELEASE; REPRESENTATION; RECRUITMENT	One of the main obstacles to understanding complex biological systems is the extent and rapid evolution of information, way beyond the capacity individuals to manage and comprehend. Current modeling approaches and tools lack adequate capacity to model concurrently structure and behavior of biological systems. Here we propose Object-Process Methodology (OPM), a holistic conceptual modeling paradigm, as a means to model both diagrammatically and textually biological systems formally and intuitively at any desired number of levels of detail. OPM combines objects, e.g., proteins, and processes, e.g., transcription, in a way that is simple and easily comprehensible to researchers and scholars. As a case in point, we modeled the yeast mRNA lifecycle. The mRNA lifecycle involves mRNA synthesis in the nucleus, mRNA transport to the cytoplasm, and its subsequent translation and degradation therein. Recent studies have identified specific cytoplasmic foci, termed processing bodies that contain large complexes of mRNAs and decay factors. Our OPM model of this cellular subsystem, presented here, led to the discovery of a new constituent of these complexes, the translation termination factor eRF3. Association of eRF3 with processing bodies is observed after a long-term starvation period. We suggest that OPM can eventually serve as a comprehensive evolvable model of the entire living cell system. The model would serve as a research and communication platform, highlighting unknown and uncertain aspects that can be addressed empirically and updated consequently while maintaining consistency.	[Dori, Dov] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel; [Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Biotechnol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Dori, D (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel.	dori@ie.technion.ac.il		Dori, Dov/0000-0002-2393-3124				Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; [Anonymous], 2011, ENCY KNOWLEDGE MANAG; Aragon AD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r9; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; *BIOUML, BIOUML FRAM SYST BIO; Blinov ML, 2006, NAT BIOTECHNOL, V24, P137, DOI 10.1038/nbt0206-137; BOOCH C, 1999, UML USER GUIDE; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dori D, 2003, LECT NOTES COMPUT SC, V2813, P570; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Fillman C, 2005, CURR OPIN CELL BIOL, V17, P326, DOI 10.1016/j.ceb.2005.04.002; FUNAHAHSI A, 2007, CELLDESIGNER SYSTEMS; Harel D, 2005, NAT BIOTECHNOL, V23, P495, DOI 10.1038/nbt0405-495; HAREL D, 2003, LNCS, V2623, P2; Hedley WJ, 2001, PHILOS T ROY SOC A, V359, P1073, DOI 10.1098/rsta.2001.0817; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; KAM N, 2004, MODELLING MOL BIOL; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; KEET C, 2006, KNOWL WEB PHD S KWEP; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kofuji S, 2006, BIOCHEM BIOPH RES CO, V344, P547, DOI 10.1016/j.bbrc.2006.03.174; Kohn KW, 2001, CHAOS, V11, P84, DOI 10.1063/1.1338126; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; KRITIKOU E, 2006, NATURE REV MOL CELL; LANGE C, 2003, CONS PROBL UML BAS S; LONGABAUGH WJR, 2007, BIOTAPESTRY; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lovrics A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-494; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Maciag K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100045; Marx J, 2005, SCIENCE, V310, P764, DOI 10.1126/science.310.5749.764; Mayer R. E., 2001, MULTIMEDIA LEARNING; *OBJ MAN GROUP, INTR OMGS UN MOD LAN; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Peleg M, 2000, IEEE T SOFTWARE ENG, V26, P742, DOI 10.1109/32.879812; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Siau K., 2001, Journal of Database Management, V12, P26, DOI 10.4018/jdm.2001010103; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; *SYSML, 2007, SYSML OP SOURC SPEC; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; TEIXEIRA D, 2005, RNA; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; *UML 2, UN MOD LANG UML VERS; van der Kuyl AC, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-21; Watson JD, 2004, MOL BIOL GENE; WEBB K, 2004, P 3 INT JOINT C AUT; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011	63	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e872	10.1371/journal.pone.0000872	http://dx.doi.org/10.1371/journal.pone.0000872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849002	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600019
J	Lewis, MS; Pikaard, DJ; Nasrallah, M; Doelling, JH; Pikaard, CS				Lewis, Michelle S.; Pikaard, Diane J.; Nasrallah, Mikhail; Doelling, Jed H.; Pikaard, Craig S.			Locus-Specific Ribosomal RNA Gene Silencing in Nucleolar Dominance	PLOS ONE			English	Article								The silencing of one parental set of rRNA genes in a genetic hybrid is an epigenetic phenomenon known as nucleolar dominance. We showed previously that silencing is restricted to the nucleolus organizer regions (NORs), the loci where rRNA genes are tandemly arrayed, and does not spread to or from neighboring protein-coding genes. One hypothesis is that nucleolar dominance is the net result of hundreds of silencing events acting one rRNA gene at a time. A prediction of this hypothesis is that rRNA gene silencing should occur independent of chromosomal location. An alternative hypothesis is that the regulatory unit in nucleolar dominance is the NOR, rather than each individual rRNA gene, in which case NOR localization may be essential for rRNA gene silencing. To test these alternative hypotheses, we examined the fates of rRNA transgenes integrated at ectopic locations. The transgenes were accurately transcribed in all independent transgenic Arabidopsis thaliana lines tested, indicating that NOR localization is not required for rRNA gene expression. Upon crossing the transgenic A. thaliana lines as ovule parents with A. lyrata to form F1 hybrids, a new system for the study of nucleolar dominance, the endogenous rRNA genes located within the A. thaliana NORs are silenced. However, rRNA transgenes escaped silencing in multiple independent hybrids. Collectively, our data suggest that rRNA gene activation can occur in a gene-autonomous fashion, independent of chromosomal location, whereas rRNA gene silencing in nucleolar dominance is locus-dependent.	[Doelling, Jed H.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV USA; [Lewis, Michelle S.; Pikaard, Diane J.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Nasrallah, Mikhail] Cornell Univ, Dept Plant Biol, Ithaca, NY USA	West Virginia University; Washington University (WUSTL); Cornell University	Doelling, JH (corresponding author), W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV USA.	Jed.Doelling@mail.wvu.edu; pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	National Institutes of Health [R01GM60380]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grant R01GM60380 to CSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions expressed in this paper are those of the authors and do not necessarily reflect the views of the NIH.	BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; COPENHAVER GP, 1995, PLANT J, V7, P273, DOI 10.1046/j.1365-313X.1995.7020273.x; Copenhaver GP, 1996, PLANT J, V9, P259, DOI 10.1046/j.1365-313X.1996.09020259.x; DOELLING JH, 1995, PLANT J, V8, P683, DOI 10.1046/j.1365-313X.1995.08050683.x; DOELLING JH, 1993, P NATL ACAD SCI USA, V90, P7528, DOI 10.1073/pnas.90.16.7528; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; FLAVELL RB, 1986, OXF SURV PLANT MOL C, V3, P252; Frieman M, 1999, GENETICS, V152, P451; Gerbi S. A., 1985, MOL EVOLUTIONARY GEN, P419, DOI DOI 10.1007/978-1-4684-4988-4_7; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; HONJO T, 1973, J MOL BIOL, V80, P217, DOI 10.1016/0022-2836(73)90168-X; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; KARPEN GH, 1988, GENE DEV, V2, P1745, DOI 10.1101/gad.2.12b.1745; Kononov ME, 1997, PLANT J, V11, P945, DOI 10.1046/j.1365-313X.1997.11050945.x; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lewis MS, 2004, GENETICS, V167, P931, DOI 10.1534/genetics.103.026203; Lewis MS, 2001, P NATL ACAD SCI USA, V98, P14536, DOI 10.1073/pnas.251424098; McCLINTOCK BARBARA, 1934, ZEITSCHR ZELLJORSCH U MIKROSK ANAT, V21, P294, DOI 10.1007/BF00374060; MUSCARELLA DE, 1990, MOL CELL BIOL, V10, P3386, DOI 10.1128/MCB.10.7.3386; Nasrallah ME, 2000, PLANT PHYSIOL, V124, P1605, DOI 10.1104/pp.124.4.1605; Neves N, 2005, ANNU PLANT REV, V19, P201, DOI 10.1002/9780470988626.ch7; PHILLIPS RL, 1971, CHROMOSOMA, V36, P79, DOI 10.1007/BF00326423; Pikaard CS, 2000, PLANT MOL BIOL, V43, P163, DOI 10.1023/A:1006471009225; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; PREUSS S, 2007, BIOCH BIOPHYS ACTA; REEDER RH, 1985, J CELL BIOL, V101, P2013, DOI 10.1083/jcb.101.5.2013; REEDER RH, 1974, RIBOSOMES, P489; RITOSSA FM, 1965, P NATL ACAD SCI USA, V53, P737, DOI 10.1073/pnas.53.4.737; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237; VIERA A, 1990, GENOME, V33, P707; WALLACE H, 1966, BIOCHIM BIOPHYS ACTA, V114, P296, DOI 10.1016/0005-2787(66)90311-X; Wanzenbock EM, 1997, PLANT J, V11, P1007, DOI 10.1046/j.1365-313X.1997.11051007.x	36	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e815	10.1371/journal.pone.0000815	http://dx.doi.org/10.1371/journal.pone.0000815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726545	Green Published, gold			2022-12-25	WOS:000207455400032
J	Lieberman, BS; Melott, AL				Lieberman, Bruce S.; Melott, Adrian L.			Considering the Case for Biodiversity Cycles: Re-Examining the Evidence for Periodicity in the Fossil Record	PLOS ONE			English	Article								We re-examine the evidence for a 62 million year (Myr) periodicity in biodiversity throughout the Phanerozoic history of animal life reported by [1], as well as related questions of periodicity in origination and extinction. We find that the signal is robust against variations in methods of analysis, and is based on fluctuations in the Paleozoic and a substantial part of the Mesozoic. Examination of origination and extinction is somewhat ambiguous, with results depending upon procedure. Origination and extinction intensity as defined by [1] may be affected by an artifact at 27 Myr in the duration of stratigraphic intervals. Nevertheless, when a procedure free of this artifact is implemented, the 27 Myr periodicity appears in origination, suggesting that the artifact may ultimately be based on a signal in the data. A 62 Myr feature appears in extinction, when this same procedure is used. We conclude that evidence for a periodicity at 62 Myr is robust, and evidence for periodicity at approximately 27 Myr is also present, albeit more ambiguous.	[Lieberman, Bruce S.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; [Lieberman, Bruce S.] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Melott, Adrian L.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas	Lieberman, BS (corresponding author), Univ Kansas, Dept Geol, Lawrence, KS 66045 USA.	blieber@ku.edu			NASA Astrobiology: Exobiology and Evolutionary Biology [NNG04GM14G]	NASA Astrobiology: Exobiology and Evolutionary Biology(National Aeronautics & Space Administration (NASA))	This research was supported by NASA Astrobiology: Exobiology and Evolutionary Biology grant NNG04GM14G to ALM and BSL and a Madison and Lila Self Faculty Fellowship to BSL; funding organizations did not have any role and were not involved in the design and conduct of the study, the collection, analysis, and interpretation of the data, and the preparation, review, or approval of the manuscript.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BRIGHAM FO, 1988, FAST FOURIER TRANSFO, P448; CAMP CHARLES L., 1952, JOUR PALEONTOL, V26, P353; Cornette JL, 2007, COMPUT SCI ENG, V9, P61, DOI 10.1109/MCSE.2007.76; Cornette JL, 2004, P NATL ACAD SCI USA, V101, P187, DOI 10.1073/pnas.2637009100; Ding GH, 2006, PLOS COMPUT BIOL, V2, P918, DOI 10.1371/journal.pcbi.0020102; Droser ML, 2000, GEOLOGY, V28, P675, DOI 10.1130/0091-7613(2000)028<0675:DOTAES>2.3.CO;2; ELDREDGE N, 1998, PATTERN EVOLUTION, P219; Fischer A.G., 1977, SOC EC PALEONTOLOGIS, V25, P19; FISCHER AG, 1982, STUDIES GEOPHYS, P97; Foote M, 2005, PALEOBIOLOGY, V31, P6, DOI 10.1666/0094-8373(2005)031<0006:POAEIT>2.0.CO;2; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; GILINSKY NL, 1991, PALEOBIOLOGY, V17, P145, DOI 10.1017/S0094837300010460; GRABAU AW, 1937, PALAEOZOIC FORMATI 2, V3, P850; HENBEST LLOYD G., 1952, JOUR PALEONTOL, V26, P299; Kirchner JW, 2000, P ROY SOC B-BIOL SCI, V267, P1301, DOI 10.1098/rspb.2000.1142; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kirchner JW, 2002, NATURE, V415, P65, DOI 10.1038/415065a; Laguna P, 1998, IEEE T BIO-MED ENG, V45, P698, DOI 10.1109/10.678605; Lu PJ, 2006, P NATL ACAD SCI USA, V103, P2736, DOI 10.1073/pnas.0511083103; Medvedev MV, 2007, ASTROPHYS J, V664, P879, DOI 10.1086/518757; Miller AI, 2003, SCIENCE, V302, P1030, DOI 10.1126/science.1089719; MULLER RA, 2002, ICE AGES ASTRONOMICA, P337; NEWELL ND, 1949, GEOL SOC AM BULL, V60, P1911; NEWELL NORMAN D., 1952, JOUR PALEONTOL, V26, P371; OGG JG, 2005, GEOLOGIC TIME SCALE, P610; Omerbashich M, 2006, COMPUT SCI ENG, V8, P26, DOI 10.1109/MCSE.2006.68; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Plotnick RE, 2001, PALEOBIOLOGY, V27, P126, DOI 10.1666/0094-8373(2001)027<0126:AMMMFO>2.0.CO;2; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; RAUP DM, 1984, P NATL ACAD SCI-BIOL, V81, P801, DOI 10.1073/pnas.81.3.801; Rohde R.A., 2006, GEOL SOC AM M PROGR, P63; Rohde RA, 2005, NATURE, V434, P208, DOI 10.1038/nature03339; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Sepkoski J. J., 2002, B AM PALEONTOL, V363, P560; Sepkoski J.J. Jr, 1986, P3; SIMPSON GEORGE GAYLORD, 1952, JOUR PALEONTOL, V26, P359; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; VRBA ES, 1980, S AFR J SCI, V76, P61	43	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e759	10.1371/journal.pone.0000759	http://dx.doi.org/10.1371/journal.pone.0000759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712407	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455300007
J	Breit, JF; Ault-Ziel, K; Al-Mehdi, AB; Gillespie, MN				Breit, Jeffrey F.; Ault-Ziel, Katheryn; Al-Mehdi, Abu-Bakr; Gillespie, Mark N.			Nuclear protein-induced bending and flexing of the hypoxic response element of the rat vascular endothelial growth factor promoter	FASEB JOURNAL			English	Article						DNA topography; VEGF expression	RESONANCE ENERGY-TRANSFER; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; PULMONARY-HYPERTENSION; INDUCIBLE FACTOR-1; VEGF GENE; DNA; TRANSCRIPTION; ENDONUCLEASE; FLEXIBILITY	Bending and flexing of DNA may contribute to transcriptional regulation. Because hypoxia and other physiological signals induce formation of an abasic site at a key base within the hypoxic response element (HRE) of the vascular endothelial growth factor (VEGF) gene (FASEB J. 19, 387-394, 2005) and because abasic sites can introduce flexibility in model DNA sequences, in the present study we used a fluorescence resonance energy transfer-based reporter system to assess topological changes in a wild-type (WT) sequence of the HRE of the rat VEGF gene and in a sequence harboring a single abasic site mimicking the effect of hypoxia. Binding of the hypoxia-inducible transcriptional complex present in hypoxic pulmonary artery endothelial cell nuclear extract to the WT sequence failed to alter sequence topology whereas nuclear protein binding to the modified HRE engendered considerable sequence flexibility. Topological effects of nuclear proteins on the modified VEGF HRE were dependent on the transcription factor hypoxia- inducible factor-1 and on formation of a single-strand break at the abasic site mediated by the coactivator, Ref-1/Ape1. These observations suggest that oxidative base modifications in the VEGF HRE evoked by physiological signals could be a precursor to single-strand break formation that has an impact on gene expression by modulating sequence flexibility.-Breit, J. F., Ault-Ziel, K., Al-Mehdi, A.-B., Gillespie, M. N. Nuclear protein-induced bending and flexing of the hypoxic response element of the rat vascular endothelial growth factor promoter.	[Breit, Jeffrey F.; Ault-Ziel, Katheryn; Al-Mehdi, Abu-Bakr; Gillespie, Mark N.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Breit, Jeffrey F.; Ault-Ziel, Katheryn; Al-Mehdi, Abu-Bakr; Gillespie, Mark N.] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Breit, JF (corresponding author), Univ S Alabama, Coll Med, Dept Pharmacol, MSB 3366, Mobile, AL 36688 USA.	mgillesp@jaguar1.usouthal.edu	Al-Mehdi, Abu-Bakr/A-8636-2009		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299, R01HL058234, R01HL073244] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL084521, P01 HL066299, R01 HL073244, R01 HL058234] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayadi L, 2000, J BIOMOL STRUCT DYN, V17, P645, DOI 10.1080/07391102.2000.10506555; Barsky D, 2000, NUCLEIC ACIDS RES, V28, P2613, DOI 10.1093/nar/28.13.2613; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Cheng XL, 2005, J AM CHEM SOC, V127, P13906, DOI 10.1021/ja052542s; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Gillespie MN, 2007, AM J PHYSIOL-LUNG C, V292, pL1, DOI 10.1152/ajplung.00275.2006; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grishko V, 2001, FASEB J, V15, P1267, DOI 10.1096/fj.00-0755fje; HAGERMAN PJ, 1990, J MOL BIOL, V212, P351, DOI 10.1016/0022-2836(90)90130-E; Haince JF, 2006, SCIENCE, V312, P1752, DOI 10.1126/science.1129808; Hardwidge PR, 2003, BIOPOLYMERS, V69, P110, DOI 10.1002/bip.10321; HAYS JB, 1970, J MOL BIOL, V48, P297, DOI 10.1016/0022-2836(70)90162-2; Hu B, 1997, MOL CELL BIOL, V17, P851, DOI 10.1128/MCB.17.2.851; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Killilea DW, 2000, AM J PHYSIOL-LUNG C, V279, pL408, DOI 10.1152/ajplung.2000.279.2.L408; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Liu JQ, 2003, AM J PHYSIOL-LUNG C, V285, pL322, DOI 10.1152/ajplung.00337.2002; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Parkhurst LJ, 2004, METHOD ENZYMOL, V379, P235; Parkhurst LJ, 2001, BIOPOLYMERS, V61, P180; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Robinson JM, 2003, J MOL BIOL, V329, P371, DOI 10.1016/S0022-2836(03)00424-8; Ruchko M, 2005, AM J PHYSIOL-LUNG C, V288, pL530, DOI 10.1152/ajplung.00255.2004; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; She MD, 1998, EUR J BIOCHEM, V252, P600, DOI 10.1046/j.1432-1327.1998.2520600.x; Vologodskaia M, 2002, J MOL BIOL, V317, P205, DOI 10.1006/jmbi.2001.5366; Williams SL, 2006, NUCLEIC ACIDS RES, V34, P1028, DOI 10.1093/nar/gkj498; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Yang DI, 2004, BRIT J PHARMACOL, V141, P988, DOI 10.1038/sj.bjp.0705687; Zhang YL, 2003, BIOPHYS J, V84, P136, DOI 10.1016/S0006-3495(03)74838-3; Ziel KA, 2005, FASEB J, V19, P387, DOI 10.1096/fj.04-2805com; Ziel KA, 2004, FASEB J, V18, P986, DOI 10.1096/fj.03-1160fje	38	17	20	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					19	29		10.1096/fj.07-8102com	http://dx.doi.org/10.1096/fj.07-8102com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17766324				2022-12-25	WOS:000252309900005
J	Zhao, WQ; De Felice, FG; Fernandez, S; Chen, H; Lambert, MP; Quon, MJ; Krafft, GA; Klein, WL				Zhao, Wei-Qin; De Felice, Fernanda G.; Fernandez, Sara; Chen, Hui; Lambert, Mary P.; Quon, Michael J.; Krafft, Grant A.; Klein, William L.			Amyloid beta oligomers induce impairment of neuronal insulin receptors	FASEB JOURNAL			English	Review						insulin resistance; calcium; NMDA receptor; receptor loss; Akt serine(473); tyrosine phosphorylation	PROTEIN-KINASE-C; HIPPOCAMPAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; DIABETES-MELLITUS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; SECRETED OLIGOMERS; GABA(A) RECEPTORS	Recent studies have indicated an association between Alzheimer's disease (AD) and central nervous system (CNS) insulin resistance. However, the cellular mechanisms underlying the link between these two pathologies have not been elucidated. Here we show that signal transduction by neuronal insulin receptors (IR) is strikingly sensitive to disruption by soluble A beta oligomers (also known as ADDLs). ADDLs are known to accumulate in AD brain and have recently been implicated as primary candidates for initiating deterioration of synapse function, composition, and structure. Using mature cultures of hippocampal neurons, a preferred model for studies of synaptic cell biology, we found that ADDLs caused a rapid and substantial loss of neuronal surface IRs specifically on dendrites bound by ADDLs. Removal of dendritic IRs was associated with increased receptor immunoreactivity in the cell body, indicating redistribution of the receptors. The neuronal response to insulin, measured by evoked IR tyrosine autophosphorylation, was greatly inhibited by ADDLs. Inhibition also was seen with added glutamate or potassium-induced depolarization. The effects on IR function were completely blocked by NMDA receptor antagonists, tetrodotoxin, and calcium chelator BAPTA-AM. Downstream from the IR, ADDLs induced a phosphorylation of Akt at serine(473), a modification associated with neurodegenerative and insulin resistance diseases. These results identify novel factors that affect neuronal IR signaling and suggest that insulin resistance in AD brain is a response to ADDLs, which disrupt insulin signaling and may cause a brain-specific form of diabetes as part of an overall pathogenic impact on CNS synapses.	[Zhao, Wei-Qin; De Felice, Fernanda G.; Fernandez, Sara; Lambert, Mary P.; Klein, William L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Zhao, Wei-Qin; Quon, Michael J.] Blanchette Rockefeller Neurosci Inst, Rockville, MD USA; [Zhao, Wei-Qin] Acumen Pharmaceut, San Francisco, CA USA; [De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil; [Chen, Hui] NIH, NCCAM, Bethesda, MD 20892 USA	Northwestern University; Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Zhao, WQ (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2205 Tech Dr,Hogan 5-110, Evanston, IL 60208 USA.	w-zhao@northwestern.edu	De Felice, Fernanda G/M-1074-2017; Quon, Michael/B-1970-2008	Quon, Michael/0000-0002-9601-9915; QUON, MICHAEL/0000-0002-5289-3707	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z01AT000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018877] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIA NIH HHS [R01-AG18877] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Anderson E.W., 1998, J SERV RES-US, V1, P5, DOI DOI 10.1177/109467059800100102; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Assini A, 2004, NEUROLOGY, V63, P828, DOI 10.1212/01.WNL.0000137040.64252.ED; Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Bi XN, 2005, AM J PATHOL, V167, P1081, DOI 10.1016/S0002-9440(10)61197-2; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6; Bossenmaier B, 1997, DIABETOLOGIA, V40, P863, DOI 10.1007/s001250050761; Boutaud O, 2006, J NEUROCHEM, V96, P917, DOI 10.1111/j.1471-4159.2005.03586.x; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001; CRAFT S, 1993, BEHAV NEUROSCI, V107, P926; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Craft S, 2006, ALZ DIS ASSOC DIS, V20, P298, DOI 10.1097/01.wad.0000213866.86934.7e; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; DEFELICE FG, 2007, NEUROBIOL AGING; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005; DRAZNIN B, 1989, ENDOCRINOLOGY, V125, P2341, DOI 10.1210/endo-125-5-2341; FROGUEL P, 1993, DIABETES METAB, V19, P1; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Gambassi G, 1998, NEUROLOGY, V51, P925, DOI 10.1212/WNL.51.3.925-b; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Grimble RF, 2002, CURR OPIN CLIN NUTR, V5, P551, DOI 10.1097/00075197-200209000-00015; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Haring HU, 1996, DIABETES, V45, pS115, DOI 10.2337/diab.45.1.S115; HEIDENREICH KA, 1983, J BIOL CHEM, V258, P8527; HEIDENREICH KA, 1988, MOL CELL ENDOCRINOL, V56, P255, DOI 10.1016/0303-7207(88)90068-8; HENDRICKS SA, 1984, J NEUROCHEM, V43, P1302, DOI 10.1111/j.1471-4159.1984.tb05387.x; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Hoyer S, 2000, EXP GERONTOL, V35, P1363, DOI 10.1016/S0531-5565(00)00156-X; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; KATO H, 1993, J BIOL CHEM, V268, P2655; KELLERER M, 1990, BIOCHEM BIOPH RES CO, V172, P446, DOI 10.1016/0006-291X(90)90693-H; Kelly BL, 2005, J BIOL CHEM, V280, P31746, DOI 10.1074/jbc.M503259200; Kim D, 2002, J BIOCHEM MOL BIOL, V35, P106; Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; KLEIN WL, 2007, MEMORIES MIL CIRCUIT; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LACOR PN, 2007, J NEUROSCI; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Launer Lenore J, 2005, Curr Diab Rep, V5, P59, DOI 10.1007/s11892-005-0069-1; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Lee YH, 2004, ARCH PHARM RES, V27, P361, DOI 10.1007/BF02980074; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; LOWE W, 1986, ENDOCRINOLOGY, V118, P1669, DOI 10.1210/endo-118-4-1669; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; MATSUMOTO H, 1990, J NEUROCHEM, V54, P347, DOI 10.1111/j.1471-4159.1990.tb13321.x; Mattson MP, 2002, J NEUROVIROL, V8, P539, DOI 10.1080/13550280290100978; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MENEILLY GS, 1993, J AM GERIATR SOC, V41, P710, DOI 10.1111/j.1532-5415.1993.tb07458.x; Messier C, 2003, EXP GERONTOL, V38, P941, DOI 10.1016/S0531-5565(03)00153-0; Mielke JG, 2005, J NEUROCHEM, V92, P103, DOI 10.1111/j.1471-4159.2004.02841.x; Morisco C, 2005, CIRC RES, V96, P180, DOI 10.1161/01.RES.0000152968.71868.c3; Nakai M, 2001, NEUROCHEM INT, V38, P593, DOI 10.1016/S0197-0186(00)00126-1; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Odetti P, 2005, J ALZHEIMERS DIS, V8, P243; OLEFSKY JM, 1995, AM J CLIN NUTR, V61, p980S, DOI 10.1093/ajcn/61.4.980S; Park CR, 2001, NEUROSCI BIOBEHAV R, V25, P311, DOI 10.1016/S0149-7634(01)00016-1; Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Qiao LY, 1999, J BIOL CHEM, V274, P10625, DOI 10.1074/jbc.274.15.10625; QUON MJ, 1992, BIOCHEMISTRY-US, V31, P9947, DOI 10.1021/bi00156a013; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rickle A, 2004, NEUROREPORT, V15, P955, DOI 10.1097/00001756-200404290-00005; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; STEVENS GR, 1998, THESIS NW U, P101; Syed NA, 2002, J CELL BIOCHEM, V86, P118, DOI 10.1002/jcb.10189; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanimukai S, 2002, NEUROREPORT, V13, P549, DOI 10.1097/00001756-200203250-00037; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Tian R, 2005, CIRC RES, V96, P139, DOI 10.1161/01.RES.0000156076.17807.1F; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zhao WQ, 2004, J NEUROCHEM, V90, P609, DOI 10.1111/j.1471-4159.2004.02509.x; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	110	441	466	1	51	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					246	260		10.1096/fj.06-7703com	http://dx.doi.org/10.1096/fj.06-7703com			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17720802				2022-12-25	WOS:000252309900027
J	O'Keefe, SJ; Mudgett, JS; Cupo, S; Parsons, JN; Chartrain, NA; Fitzgerald, C; Chen, SL; Lowitz, K; Rasa, C; Visco, D; Luell, S; Carballo-Jane, E; Owens, K; Zaller, DM				O'Keefe, Stephen J.; Mudgett, John S.; Cupo, Susan; Parsons, Janey N.; Chartrain, Nicole A.; Fitzgerald, Catherine; Chen, Shiow-Ling; Lowitz, Karen; Rasa, Cordelia; Visco, Denise; Luell, Silvi; Carballo-Jane, Ester; Owens, Karen; Zaller, Dennis M.			Chemical genetics define the roles of p38 alpha and p38 beta in acute and chronic inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; MONOCLONAL-ANTIBODIES; INHIBITORS; STRESS; SPECIFICITY; EXPRESSION; INDUCTION; REGULATOR; MOLECULES	The p38 MAP kinase signal transduction pathway is an important regulator of proinflammatory cytokine production and inflammation. Defining the roles of the various p38 family members, specifically p38 alpha and p38 beta, in these processes has been difficult. Here we use a chemical genetics approach using knock-in mice in which either p38 alpha or p38 beta kinase has been rendered resistant to the effects of specific inhibitors along with p38 beta knock-out mice to dissect the biological function of these specific kinase isoforms. Mice harboring a T106M mutation in p38 alpha are resistant to pharmacological inhibition of LPS-induced TNF production and collagen antibody-induced arthritis, indicating that p38 beta activity is not required for acute or chronic inflammatory responses. LPS-induced TNF production, however, is still completely sensitive to p38 inhibitors in mice with a T106M point mutation in p38 beta. Similarly, p38 beta knock-out mice respond normally to inflammatory stimuli. These results demonstrate conclusively that specific inhibition of the p38 alpha isoform is necessary and sufficient for anti-inflammatory efficacy in vivo.	Merck Res Labs, Ctr Genet Engn Models, Dept Immunol, Rahway, NJ 07065 USA; Merck Res Labs, Dept Lab Anim Res, Rahway, NJ 07065 USA; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA; Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	O'Keefe, SJ (corresponding author), Merck Res Labs, Ctr Genet Engn Models, Dept Immunol, Rahway, NJ 07065 USA.	stephen_okeefe@merck.com						Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bao JM, 2006, BIOORG MED CHEM LETT, V16, P64, DOI 10.1016/j.bmcl.2005.09.065; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Crews CM, 1999, TRENDS BIOCHEM SCI, V24, P317, DOI 10.1016/S0968-0004(99)01425-5; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Fijen JW, 2001, CLIN EXP IMMUNOL, V124, P16, DOI 10.1046/j.1365-2249.2001.01485.x; Fischer PM, 2004, CURR MED CHEM, V11, P1563, DOI 10.2174/0929867043365062; Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hynes J, 2005, CURR TOP MED CHEM, V5, P967, DOI 10.2174/1568026054985920; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kagari T, 2002, J IMMUNOL, V169, P1459, DOI 10.4049/jimmunol.169.3.1459; KEREN A, 2006, IMMUNOLOGY, V252, P224; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lisnock JM, 1998, BIOCHEMISTRY-US, V37, P16573, DOI 10.1021/bi981591x; Liverton NJ, 1999, J MED CHEM, V42, P2180, DOI 10.1021/jm9805236; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Natarajan SR, 2006, BIOORG MED CHEM LETT, V16, P5468, DOI 10.1016/j.bmcl.2006.06.084; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanaka D, 2006, IMMUNOLOGY, V119, P195, DOI 10.1111/j.1365-2567.2006.02424.x; TERATO K, 1992, J IMMUNOL, V148, P2103; Terato K, 1995, AUTOIMMUNITY, V22, P137, DOI 10.3109/08916939508995311; Vieth M, 2005, DRUG DISCOV TODAY, V10, P839, DOI 10.1016/S1359-6446(05)03477-X; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0	48	64	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34663	34671		10.1074/jbc.M704236200	http://dx.doi.org/10.1074/jbc.M704236200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855341	hybrid			2022-12-25	WOS:000251155200008
J	Thomas, C; Moreau, F; Dieterle, M; Hoffmann, C; Gatti, S; Hofmann, C; Van Troys, M; Ampe, C; Steinmetz, A				Thomas, Clement; Moreau, Flora; Dieterle, Monika; Hoffmann, Celine; Gatti, Sabrina; Hofmann, Christina; Van Troys, Marleen; Ampe, Christophe; Steinmetz, Andre			The LIM domains of WLIM1 define a new class of actin bundling modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH-PROTEIN; POLLEN-TUBE GROWTH; ROOT HAIR-CELLS; MUSCLE DIFFERENTIATION; BINDING PROTEINS; CROSS-LINKING; GENE-EXPRESSION; ALPHA-ACTININ; PLANT VILLIN; ORGANIZATION	Actin filament bundling, i.e. the formation of actin cables, is an important process that relies on proteins able to directly bind and cross-link subunits of adjacent actin filaments. Animal cysteine-rich proteins and their plant counterparts are two LIM domain-containing proteins that were recently suggested to define a new family of actin cytoskeleton regulators involved in actin filament bundling. We here identified the LIM domains as responsible for F-actin binding and bundling activities of the tobacco WLIM1. The deletion of one of the two LIM domains reduced significantly, but did not entirely abolish, the ability of WLIM1 to bind actin filaments. Individual LIM domains were found to interact directly with actin filaments, although with a reduced affinity compared with the native protein. Variants lacking the C-terminal or the inter-LIM domain were only weakly affected in their F-actin stabilizing and bundling activities and trigger the formation of thick cables containing tightly packed actin filaments as does the native protein. In contrast, the deletion of one of the two LIM domains negatively impacted both activities and resulted in the formation of thinner and wavier cables. In conclusion, we demonstrate that the LIM domains of WLIM1 are new autonomous actin binding and bundling modules that cooperate to confer WLIM1 high actin binding and bundling activities.	Ctr Rech Publ Sante, L-1526 Luxembourg, Luxembourg; CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Gent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium; Fac Med & Hlth Sci, Dept Biochem, B-9052 Ghent, Belgium	Luxembourg Institute of Health; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Thomas, C (corresponding author), Ctr Rech Publ Sante, L-1526 Luxembourg, Luxembourg.	clement.thomas@crp-sante.lu	Thomas, Clément/AAK-4501-2020; Ampe, Christophe/B-5534-2012	Thomas, Clement/0000-0001-6720-5615; Van Troys, Marleen/0000-0003-4283-8103; Dieterle, Monika/0000-0002-9918-6022				Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Baluska F, 2001, DEV BIOL, V236, P478, DOI 10.1006/dbio.2001.0333; BANJOKO A, 1995, PLANT PHYSIOL, V107, P1201, DOI 10.1104/pp.107.4.1201; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen CY, 2002, PLANT CELL, V14, P2175, DOI 10.1105/tpc.003038; Cheung AY, 2004, PLANT CELL, V16, P257, DOI 10.1105/tpc.016550; El-Assall SE, 2004, PLANT J, V38, P526, DOI 10.1111/j.1365-313X.2004.02065.x; Eliasson A, 2000, MOL GEN GENET, V264, P257, DOI 10.1007/s004380000312; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Furukawa R, 1997, INT REV CYTOL, V175, P29, DOI 10.1016/S0074-7696(08)62125-7; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Grubinger M, 2004, FEBS LETT, V557, P88, DOI 10.1016/S0014-5793(03)01451-0; HUNOLD R, 1995, PLANT SCI, V105, P95, DOI 10.1016/0168-9452(94)04038-I; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kawaoka A, 2000, PLANT J, V22, P289, DOI 10.1046/j.1365-313x.2000.00737.x; Klahre U, 2000, PLANT PHYSIOL, V122, P35, DOI 10.1104/pp.122.1.35; Konrat R, 1998, J BIOL CHEM, V273, P23233, DOI 10.1074/jbc.273.36.23233; Kovar DR, 2001, PLANTA, V213, P390, DOI 10.1007/s004250000494; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Le J, 2003, CURR BIOL, V13, P1341, DOI 10.1016/S0960-9822(03)00493-7; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; MASCARENHAS JP, 1993, PLANT CELL, V5, P1303, DOI 10.1105/tpc.5.10.1303; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Pomies P, 1997, J CELL BIOL, V139, P157, DOI 10.1083/jcb.139.1.157; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; SHIMMEN T, 1995, PROTOPLASMA, V185, P188, DOI 10.1007/BF01272859; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; STAIGER CJ, 1994, CURR BIOL, V4, P215, DOI 10.1016/S0960-9822(00)00050-6; Sweetman J, 2000, SEX PLANT REPROD, V12, P339, DOI 10.1007/PL00009836; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Thomas C, 2007, PLANT SIGNAL BEHAV, V2, P99, DOI 10.4161/psb.2.2.3614; Tominaga M, 2000, PLANTA, V210, P836, DOI 10.1007/s004250050687; Tran TC, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-45; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Van Troys M, 1999, BBA-MOL CELL RES, V1448, P323, DOI 10.1016/S0167-4889(98)00152-9; Vidali L, 2001, PROTOPLASMA, V215, P64, DOI 10.1007/BF01280304; Vidali L, 1999, PROTOPLASMA, V209, P283, DOI 10.1007/BF01453456; Weiskirchen R, 2003, BIOESSAYS, V25, P152, DOI 10.1002/bies.10226; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Yao X, 1999, BIOCHEMISTRY-US, V38, P5701, DOI 10.1021/bi982036y; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132	48	35	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33599	10.1074/jbc.M703691200	http://dx.doi.org/10.1074/jbc.M703691200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827159	hybrid			2022-12-25	WOS:000250840200041
J	Hofer, A; Bussiere, C; Johnson, AW				Hofer, Anne; Bussiere, Cyril; Johnson, Arlen W.			Mutational analysis of the ribosomal protein Rpl10 from yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; NUCLEAR EXPORT; ANGSTROM RESOLUTION; INITIATION COMPLEX; SUBUNIT; NMD3P; ADAPTER; EVOLUTION; CYTOPLASM	Yeast Rpl10 belongs to the L10e family of ribosomal proteins. In the large ( 60 S) subunit, Rpl10 is positioned in a cleft between the central protuberance and the GTPase- activating center. It is loaded into the 60 S subunit at a late step in maturation. We have shown previously that Rpl10 is required for the release of the Crm1- dependent nuclear export adapter Nmd3, an event that also requires the cytoplasmic GTPase Lsg1. Here we have carried out an extensive mutational analysis of Rpl10 to identify mutations that would allow us to map activities to distinct domains of the protein to begin to understand the molecular interaction between Rpl10 and Nmd3. We found that mutations in a central loop ( amino acids 102 - 112) had a significant impact on the release of Nmd3. This loop is unstructured in the crystal and solution structures of prokaryotic Rpl10 orthologs. Thus, the loop is not necessary for stable interaction of Rpl10 with the ribosome, suggesting that it plays a dynamic role in ribosome function or regulating the association of other factors. We also found that mutant Rpl10 proteins were engineered to be unable to bind to the ribosome accumulated in the nucleus. This was unexpected and may suggest a nuclear role for Rpl10.	Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Johnson, AW (corresponding author), Univ Texas, Sect Mol Genet & Microbiol, 1 Univ Stn,A5000, Austin, TX 78712 USA.	arlen@mail.utexas.edu		Johnson, Arlen/0000-0002-4742-085X	NIGMS NIH HHS [R01 GM 53655] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053655] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hedges J, 2006, J BIOL CHEM, V281, P36579, DOI 10.1074/jbc.M606798200; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Kaiser C., 1994, METHODS YEAST GENETI; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Karl T, 1999, CURR GENET, V34, P419, DOI 10.1007/s002940050416; KAZEMIE M, 1975, EUR J BIOCHEM, V58, P501, DOI 10.1111/j.1432-1033.1975.tb02398.x; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MOORE VG, 1975, P NATL ACAD SCI USA, V72, P844, DOI 10.1073/pnas.72.3.844; Nishimura M, 2004, J MOL BIOL, V344, P1369, DOI 10.1016/j.jmb.2004.10.011; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; TERAOKA H, 1978, FEBS LETT, V88, P223, DOI 10.1016/0014-5793(78)80179-3; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; ZINKER S, 1976, J BIOL CHEM, V251, P1799	27	30	32	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32630	32639		10.1074/jbc.M705057200	http://dx.doi.org/10.1074/jbc.M705057200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17761675	hybrid			2022-12-25	WOS:000250625400012
J	Meissner, B; Schleicher, E; Weber, S; Essen, LO				Meissner, Britta; Schleicher, Erik; Weber, Stefan; Essen, Lars-Oliver			The dodecin from Thermus thermophilus, a bifunctional cofactor storage protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; CRYSTAL-STRUCTURE; LIGHT; PHOTOLYASE; ENDOR; FAD	Dodecins are so far the smallest known flavoproteins ( 68 - 71 amino acids) and are most likely involved in prokaryotic flavin storage. The dodecin monomers adopt a simple beta alpha beta beta-fold and assemble to hollow sphere-like dodecameric complexes. Flavin binding by the dodecin from Thermus thermophilus showed a 1: 1 stoichiometry and apparent dissociation constants in the submicromolar to nanomolar range as characterized by isothermal titration calorimetry and fluorescence titrations. The x-ray structures of the flavin-prebound and FMN-reconstituted state of the T. thermophilus dodecin revealed binding of FMN dimers in a novel si-si-rather than the re-re-orientation of their isoalloxazine moieties as found before in an archaeal dodecin. Electron paramagnetic resonance studies demonstrated that upon reduction the excess electron is localized only on one flavin, thus making dodecin-bound flavins highly refractory to redox chemistry. Besides FMN dimers, trimers of coenzyme A are additionally bound to this eubacterial dodecin along the 3-fold symmetry face II of the dodecin complex. Therefore, dodecins can act as bifunctional cofactor storage proteins that sequester catalytic cofactors in prokaryotes very efficiently in an aggregated and unreactive state.	Univ Marburg, Dept Chem, D-35032 Marburg, Germany; Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany	Philipps University Marburg; Free University of Berlin	Essen, LO (corresponding author), Univ Marburg, Dept Chem, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de	Schleicher, Erik/C-9951-2010; Essen, Lars-Oliver/L-3862-2016; Weber, Stefan/G-6164-2010	Essen, Lars-Oliver/0000-0003-4272-4026; Schleicher, Erik/0000-0003-2953-050X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Cuello AO, 2000, J AM CHEM SOC, V122, P3517, DOI 10.1021/ja994204v; DAVIES ER, 1974, PHYS LETT A, VA 47, P1, DOI 10.1016/0375-9601(74)90078-4; DeLano W, 2002, PYMOL 0 99; EDMONDSON DE, 1983, TOP CURR CHEM, V108, P109; EDMONDSON DE, 1985, BIOCHEM SOC T, V13, P593, DOI 10.1042/bst0130593; Edwards AM, 2001, J PHOTOCH PHOTOBIO B, V63, P126, DOI 10.1016/S1011-1344(01)00209-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; Grininger M, 2006, J MOL BIOL, V357, P842, DOI 10.1016/j.jmb.2005.12.072; Grininger M, 2006, J MOL BIOL, V364, P561, DOI 10.1016/j.jmb.2006.08.083; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; KAUFMANN U, 1975, J PHYS C SOLID STATE, V8, P381; Kay CWM, 1999, BIOCHEMISTRY-US, V38, P16740, DOI 10.1021/bi991442u; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; LUDWIG ML, 1992, CHEM BIOCH FLAVOENZY, V3, P389; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Medina M, 1999, BIOPHYS J, V77, P1712, DOI 10.1016/S0006-3495(99)77017-7; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORRIS JR, 1971, P NATL ACAD SCI USA, V68, P625, DOI 10.1073/pnas.68.3.625; Schnegg A, 2006, APPL MAGN RESON, V30, P345, DOI 10.1007/BF03166205; Schnegg A, 2006, MOL PHYS, V104, P1627, DOI 10.1080/00268970600593108; Srivatsan N, 2003, J PHYS CHEM B, V107, P2127, DOI 10.1021/jp0255233; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433	35	23	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33142	33154		10.1074/jbc.M704951200	http://dx.doi.org/10.1074/jbc.M704951200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855371	hybrid			2022-12-25	WOS:000250625400062
J	Shi, B; Sepp-Lorenzino, L; Prisco, M; Linsley, P; DeAngelis, T; Baserga, R				Shi, Bin; Sepp-Lorenzino, Laura; Prisco, Marco; Linsley, Peter; DeAngelis, Tiziana; Baserga, Renato			Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MICRO-RNA; FACTOR-I; INSULIN-RECEPTOR-SUBSTRATE-1 IRS-1; DIFFERENTIATION; TRANSFORMATION; SIZE; PRINCIPLES	The insulin receptor substrate- 1 ( IRS- 1), a docking protein for both the type 1 insulin- like growth factor receptor ( IGF- IR) and the insulin receptor, is known to send a mitogenic, anti- apoptotic, and anti- differentiation signal. Several micro RNAs ( miRs) are suggested by the data base as possible candidates for targeting IRS- 1. We show here that one of the miRs predicted by the data base, miR145, whether transfected as a synthetic oligonucleotide or expressed from a plasmid, causes down- regulation of IRS- 1 in human colon cancer cells. IRS- 1 mRNA is not decreased by miR145, while it is down- regulated by an siRNA targeting IRS- 1. Targeting of the IRS- 1 3'-untranslated region (UTR) by miR145 was confirmed using a reporter gene ( luciferase) expressing the miR145 binding sites of the IRS- 1 3'-UTR. In agreement with the role of IRS- 1 in cell proliferation, we show that treatment of human colon cancer cells with miR145 causes growth arrest comparable to the use of an siRNA against IRS- 1. Taken together, these results identify miR145 as a micro RNA that down- regulates the IRS- 1 protein, and inhibits the growth of human cancer cells.	Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; Merck & Co Inc, West Point, PA 19486 USA	Jefferson University; Merck & Company	Shi, B (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA.	b_lupo@mail.jci.tju.edu			NCI NIH HHS [CA 089640, CA 78890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089640, P01CA078890] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akao Y, 2006, ONCOL REP, V16, P845; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Baserga Renato, 2004, VVolume 42, P235; Belletti B, 2001, J BIOL CHEM, V276, P13867, DOI 10.1074/jbc.M010509200; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cesarone G, 2006, J CELL BIOCHEM, V98, P440, DOI 10.1002/jcb.20817; Chang Q, 2002, CANCER RES, V62, P6035; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cristofanelli B, 2000, ONCOGENE, V19, P3245, DOI 10.1038/sj.onc.1203664; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; DAMBROSIO C, 1995, CELL GROWTH DIFFER, V6, P557; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Michael MZ, 2003, MOL CANCER RES, V1, P882; Pete G, 1999, ENDOCRINOLOGY, V140, P5478, DOI 10.1210/en.140.12.5478; Prisco M, 2001, MOL CELL BIOL, V21, P5447, DOI 10.1128/MCB.21.16.5447-5458.2001; Reiss K, 1998, EXP CELL RES, V242, P361, DOI 10.1006/excr.1998.4113; Shi B, 2006, J CELL PHYSIOL, V207, P706, DOI 10.1002/jcp.20613; Sun HZ, 2006, CANCER RES, V66, P11106, DOI 10.1158/0008-5472.CAN-06-2641; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; Valentinis B, 2000, J BIOL CHEM, V275, P25451, DOI 10.1074/jbc.M002271200; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908	47	290	319	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32582	32590		10.1074/jbc.M702806200	http://dx.doi.org/10.1074/jbc.M702806200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827156	Green Submitted, hybrid			2022-12-25	WOS:000250625400007
J	Henry, BL; Monien, BH; Bock, PE; Desai, UR				Henry, Brian L.; Monien, Bernhard H.; Bock, Paul E.; Desai, Umesh R.			A novel allosteric pathway of thrombin inhibition - Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING EXOSITE; HEPARIN; ANTITHROMBIN; PROTEINASES; SUBSTRATE; RESIDUES; SITE	Thrombin and factor Xa, two important pro-coagulant proteinases, can be regulated through direct and indirect inhibition mechanisms. Recently, we designed sulfated dehydropolymers (DHPs) of 4-hydroxycinnamic acids that displayed interesting anticoagulant properties (Monien, B. H., Henry, B. L., Raghuraman, A., Hindle, M., and Desai, U. R. (2006) Bioorg. Med. Chem. 14, 7988 -7998). To better understand their mechanism of action, we studied the direct inhibition of thrombin, factor Xa, factor IXa, and factor VIIa by CDSO3, FDSO3, and SDSO3, three analogs of sulfated DHPs. All three sulfated DHPs displayed a 2 -3-fold preference for direct inhibition of thrombin over factor Xa, whereas this preference for inhibiting thrombin over factor IXa and factor VIIa increased to 17-300-fold, suggesting a high level of selectivity. Competitive binding studies with a thrombin-specific chromogenic substrate, a fluorescein-labeled hirudin peptide, bovine heparin, enoxaparin, and a heparin octasaccharide suggest that CDSO3 preferentially binds in or near anion-binding exosite II of thrombin. Studies of the hydrolysis of H-D-hexahydrotyrosol-Ala-Arg-p-nitroanilide indicate that CDSO3 inhibits thrombin through allosteric disruption of the catalytic apparatus, specifically through the catalytic step. Overall, designed sulfated DHPs appear to be the first molecules that bind primarily in the region defined by exosite II and allosterically induce thrombin inhibition. The molecules are radically different in structure from all the current clinically used anticoagulants and thus represent a novel class of potent dual thrombin and factor Xa inhibitors.	Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Virginia Commonwealth University; Virginia Commonwealth University; Vanderbilt University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, 410 N 12th St,POB 980540, Richmond, VA 23298 USA.	urdesai@vcu.edu	Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038779, R01HL038779, R41HL081972, R01HL069975] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL038779, R01 HL038779, R01 HL038779-20, R01 HL069975, R41 HL081972] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bauersachs RM, 2005, EUR J CLIN INVEST, V35, P27, DOI 10.1111/j.0960-135X.2005.01454.x; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; BERLINER LJ, 1977, BIOCHEMISTRY-US, V16, P4622, DOI 10.1021/bi00640a015; Bianchini EP, 2004, J BIOL CHEM, V279, P3671, DOI 10.1074/jbc.M309691200; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011; Desai UR, 2004, MED RES REV, V24, P151, DOI 10.1002/med.10058; Desai UR, 2005, CHEM BIOL HEPARIN HE, P483; Gerotziafas GT, 2005, CURR PHARM DESIGN, V11, P3855, DOI 10.2174/138161205774580552; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENNY NS, 2003, THROMBOSIS HEMORRHAG, P1; Kikelj D, 2003, PATHOPHYSIOL HAEMO T, V33, P487, DOI 10.1159/000083850; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LINHARDT RJ, 1990, J MED CHEM, V33, P1639, DOI 10.1021/jm00168a017; LIU LW, 1991, J BIOL CHEM, V266, P16977; MENAJOVSKY JB, 2005, AM J MED S8A, V118, P21; Monien BH, 2006, BIOORGAN MED CHEM, V14, P7988, DOI 10.1016/j.bmc.2006.07.066; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; Nutescu EA, 2006, CLIN GERIATR MED, V22, P33, DOI 10.1016/j.cger.2005.09.009; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Reale S, 2004, MASS SPECTROM REV, V23, P87, DOI 10.1002/mas.10072; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Richardson JL, 2002, BIOCHEMISTRY-US, V41, P2535, DOI 10.1021/bi011605q; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SONDER SA, 1986, CLIN CHEM, V32, P934; Turpie Alexander G G, 2005, Expert Opin Drug Saf, V4, P707, DOI 10.1517/14740338.4.4.707; van Dongen CJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001100.PUB2; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; YE J, 1992, J BIOL CHEM, V267, P11023	40	68	69	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31891	31899		10.1074/jbc.M704257200	http://dx.doi.org/10.1074/jbc.M704257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804413	Green Accepted, hybrid			2022-12-25	WOS:000250480300009
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Suppressor mutations in the transmembrane segments of P-glycoprotein promote maturation of processing mutants and disrupt a subset of drug-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONDUCTANCE REGULATOR; PHARMACOLOGICAL CHAPERONES; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; CELL-SURFACE; ATP-BINDING; RESISTANCE; PROTEIN; DOMAIN; POCKET	Defective folding of cystic fibrosis transmembrane conductance regulator protein missing Phe(508) (Delta F508) is the major cause of cystic fibrosis. The folding defect in Delta F508 cystic fibrosis transmembrane conductance regulator might be correctable because misfolding of a P-glycoprotein (P-gp; ABCB1) mutant lacking the equivalent residue (Delta Y490) could be corrected with drug substrates or by introduction of an arginine residue into transmembrane (TM) segments 5 (I306R) or 6 (F343R). Possible mechanisms of arginine rescue were that they mimicked some of the effects of drug substrate interactions with P-gp or that they affected global folding such that all drug substrate/ modulator interactions with P-gp were altered. To distinguish between these mechanisms, we tested whether arginines introduced into other TMs predicted to line the drug-binding pocket (TM1 or TM3) would affect folding. It was found that mutation of L65R(TM1) or T199R(TM3) promoted maturation of processing mutants. Wethen tested whether arginine suppressor mutations had local or global effects on P-gp interactions with drug substrates and modulators. The L65R(TM1), T199R(TM3), I306R(TM5), or F343R(TM6) mutations were introduced into the P-gp mutant L339C(TM6)/F728C(TM7), and thiol crosslinking was carried out in the presence of various concentrations of vinblastine, cyclosporin A, or rhodamine B. The presence of arginine residues reduced the apparent affinity of P-gp for vinblastine (L65R, T199R, and I306R), cyclosporin (I306R and F343R), or rhodamine B (F343R) by 4 -60-fold. These results show that the arginine mutations affect a subset of drug-binding sites and suggest that they rescue processing mutants by mimicking drug substrate interactions with P-gp.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, Rm 7342,Med Sci Bld,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188				Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Hennessy M, 2007, PHARMACOL RES, V55, P1, DOI 10.1016/j.phrs.2006.10.007; HOOF T, 1994, J BIOL CHEM, V269, P20575; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 1998, J BIOL CHEM, V273, P32373, DOI 10.1074/jbc.273.49.32373; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; Loo TW, 1996, J BIOL CHEM, V271, P15414, DOI 10.1074/jbc.271.26.15414; LOO TW, 1994, J BIOL CHEM, V269, P28683; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Pleban K, 2005, MOL PHARMACOL, V67, P365, DOI 10.1124/mol.104.006973; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Song JM, 2001, MOL PHARMACOL, V60, P254, DOI 10.1124/mol.60.2.254; Taguchi Y, 1997, FEBS LETT, V413, P142, DOI 10.1016/S0014-5793(97)00899-5; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; WARD CL, 1994, J BIOL CHEM, V269, P25710; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200	45	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32043	32052		10.1074/jbc.M706175200	http://dx.doi.org/10.1074/jbc.M706175200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848563	hybrid			2022-12-25	WOS:000250480300025
J	Akerstrom, B; Maghzal, GJ; Winterbourn, CC; Kettle, AJ				Akerstrom, Bo; Maghzal, Ghassan J.; Winterbourn, Christine C.; Kettle, Anthony J.			The lipocalin alpha(1)-microglobulin has radical scavenging activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; LIPID-PEROXIDATION; PROTEIN FAMILY; ALPHA-1-MICROGLOBULIN; CHROMOPHORE; HEMOGLOBIN; ACID); HEME; HC; REDUCTION	The lipocalin alpha(1)-microglobulin (alpha(1)m) is a 26-kDa glycoprotein present in plasma and in interstitial fluids of all tissues. The protein was recently shown to have reductase properties, reducing heme-proteins and other substrates, and was also reported to be involved in binding and scavenging of heme and tryptophan metabolites. To investigate its possible role as a reductant of organic radicals, we have studied the interaction of alpha(1)m with the synthetic radical, 2,2(')-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS radical). The lipocalin readily reacted with the ABTS radical forming reduced ABTS. The apparent rate constant for this reaction was 6.3 +/- 2.5 x 10(3) m(-1) s(-1). A second reaction product with an intense purple color and an absorbance maximum at 550 nm was formed at a similar rate. This was shown by liquid chromatography/mass spectrometry to be derived from covalent attachment of a portion of ABTS radical to tyrosine residues on alpha(1)m. The relative yields of reduced ABTS and the purple ABTS derivative bound to alpha(1)m were similar to 2:1. Both reactions were dependent on the thiolate group of the cysteine residue in position 34 of the alpha(1)m polypeptide. Our results indicate that alpha(1)m is involved in a sequential reduction of ABTS radicals followed by trapping of these radicals by covalent attachment. In combination with the reported physiological properties of the protein, our results suggest that alpha(1)m may be a radical reductant and scavenger in vivo.	Lund Univ, Dept Clin Sci, Lund 22184, Sweden; Univ Sydney, Ctr Vasc Res, Fac Med, Dept Pathol, Sydney, NSW 2006, Australia; Christchurch Sch Med & Hlth Sci, Free Rad Res Grp, Dept Pathol, Christchurch 8140, New Zealand	Lund University; University of Sydney; University of Otago	Akerstrom, B (corresponding author), Lund Univ, Dept Clin Sci, Lund 22184, Sweden.	bo.akerstrom@med.lu.se	maghzal, ghassan/A-9692-2015; Kettle, Anthony J/A-8520-2008	Kettle, Anthony J/0000-0002-8218-7766				Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; AKERSTROM B, 1995, FEBS LETT, V362, P50, DOI 10.1016/0014-5793(95)00206-O; AKERSTROM B, 1990, TRENDS BIOCHEM SCI, V15, P240, DOI 10.1016/0968-0004(90)90037-C; Akerstrom Bo, 2006, P1; Aliaga C, 2000, CAN J CHEM, V78, P1052, DOI 10.1139/cjc-78-8-1052; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2003, J INVEST DERMATOL, V121, P640, DOI 10.1046/j.1523-1747.2003.12409.x; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; ARNAO MB, 1990, ANAL BIOCHEM, V185, P335, DOI 10.1016/0003-2697(90)90304-R; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Berggard T, 1998, J HISTOCHEM CYTOCHEM, V46, P887, DOI 10.1177/002215549804600803; Berggard T, 1999, AM J REPROD IMMUNOL, V41, P52; Berggard T, 1999, PROTEIN SCI, V8, P2611; BERGGARD T, 1987, EUR J BIOCHEM, V245, P676; BOUIC P, 1984, HISTOCHEM J, V16, P1311, DOI 10.1007/BF01003728; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; DAVIES MJ, 1997, RADICAL MEDIATED PRO, P95; DEMARS DD, 1989, CLIN CHEM, V35, P766; EKSTROM B, 1975, BIOCHEM BIOPH RES CO, V65, P1427, DOI 10.1016/S0006-291X(75)80388-3; EKSTROM B, 1977, J BIOL CHEM, V252, P8048; ESCRIBANO J, 1991, J BIOL CHEM, V266, P15758; Flower DR, 1996, BIOCHEM J, V318, P1; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; ISHII T, 1992, ARCH BIOCHEM BIOPHYS, V294, P616, DOI 10.1016/0003-9861(92)90733-D; KAUMEYER JF, 1986, NUCLEIC ACIDS RES, V14, P7839, DOI 10.1093/nar/14.20.7839; Kwasek A, 2007, PROTEIN EXPRES PURIF, V53, P145, DOI 10.1016/j.pep.2006.10.023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson J, 2004, ARCH BIOCHEM BIOPHYS, V432, P196, DOI 10.1016/j.abb.2004.09.021; Larsson J, 2001, J LAB CLIN MED, V137, P165, DOI 10.1067/mlc.2001.112957; LOGDBERG L, 1981, SCAND J IMMUNOL, V13, P383, DOI 10.1111/j.1365-3083.1981.tb00148.x; Logdberg LE, 2000, J HISTOCHEM CYTOCHEM, V48, P1545, DOI 10.1177/002215540004801111; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MENDEZ E, 1986, P NATL ACAD SCI USA, V83, P1472, DOI 10.1073/pnas.83.5.1472; Miller NJ, 1997, FREE RADICAL RES, V26, P195, DOI 10.3109/10715769709097799; ODUM L, 1994, HISTOCHEM J, V26, P799; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Olsson MG, 2007, FREE RADICAL BIO MED, V42, P842, DOI 10.1016/j.freeradbiomed.2006.12.017; Pattison DI, 2002, TOXICOLOGY, V177, P23, DOI 10.1016/S0300-483X(02)00193-2; Pawlak D., 2001, International Urology and Nephrology, V33, P399, DOI 10.1023/A:1015238418500; PE R, 1999, FREE RADIC BIOL MED, V26, P1231; PERVAIZ S, 1985, SCIENCE, V228, P335, DOI 10.1126/science.2580349; Prutz W A, 1986, Free Radic Res Commun, V2, P69, DOI 10.3109/10715768609088056; Sala A, 2004, J BIOL CHEM, V279, P51033, DOI 10.1074/jbc.M408242200; Sanchez D, 2002, MECH DEVELOP, V117, P293, DOI 10.1016/S0925-4773(02)00202-2; Santin M, 1999, SCAND J IMMUNOL, V50, P289; SHIN T, 1987, ANAL BIOCHEM, V166, P380, DOI 10.1016/0003-2697(87)90588-4; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; TEJLER L, 1976, BIOCHIM BIOPHYS ACTA, V439, P82, DOI 10.1016/0005-2795(76)90164-1; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Vazquez S, 2000, FREE RADICAL RES, V32, P11, DOI 10.1080/10715760000300021; Villoutreix BO, 2000, BLOOD COAGUL FIBRIN, V11, P261; Wester L, 1998, SCAND J IMMUNOL, V48, P1; Wester L, 1997, PROTEIN EXPRES PURIF, V11, P95, DOI 10.1006/prep.1997.0760	55	86	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31493	31503		10.1074/jbc.M702624200	http://dx.doi.org/10.1074/jbc.M702624200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766242	hybrid			2022-12-25	WOS:000250309200041
J	Fort, J; de la Ballina, LR; Burghardt, HE; Ferrer-Costa, C; Turnay, J; Ferrer-Orta, C; Uson, I; Zorzano, A; Fernandez-Recio, J; Orozco, M; Lizarbe, MA; Fita, I; Palacin, M				Fort, Joana; de la Ballina, Laura R.; Burghardt, Hans E.; Ferrer-Costa, Carles; Turnay, Javier; Ferrer-Orta, Cristina; Uson, Isabel; Zorzano, Antonio; Fernandez-Recio, Juan; Orozco, Modesto; Lizarbe, Maria Antonia; Fita, Ignacio; Palacin, Manuel			The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ALPHA-AMYLASE; PROTEIN; CD98; ASSOCIATION; IDENTIFICATION; EXPRESSION; COMPLEX	4F2hc ( CD98hc) is a multifunctional type II membrane glycoprotein involved in amino acid transport and cell fusion, adhesion, and transformation. The structure of the ectodomain of human 4F2hc has been solved using monoclinic ( Protein Data Bank code 2DH2) and orthorhombic ( Protein Data Bank code 2DH3) crystal forms at 2.1 and 2.8 angstrom, respectively. It is composed of a (beta alpha)(8) barrel and an antiparallel beta(8) sandwich related to bacterial alpha- glycosidases, although lacking key catalytic residues and consequently catalytic activity. 2DH3 is a dimer with Zn2+ coordination at the interface. Human 4F2hc expressed in several cell types resulted in cell surface and Cys(109) disulfide bridge- linked homodimers with major architectural features of the crystal dimer, as demonstrated by cross- linking experiments. 4F2hc has no significant hydrophobic patches at the surface. Monomer and homodimer have a polarized charged surface. The N terminus of the solved structure, including the position of Cys(109) residue located four residues apart from the transmembrane domain, is adjacent to the positive face of the ectodomain. This location of the N terminus and the Cys(109)-intervening disulfide bridge imposes space restrictions sufficient to support a model for electrostatic interaction of the 4F2hc ectodomain with membrane phospholipids. These results provide the first crystal structure of heteromeric amino acid transporters and suggest a dynamic interaction of the 4F2hc ectodomain with the plasma membrane.	Univ Barcelona, Ctr Invest Biomed Red Enfermedades Raras, Inst Res Biomed, Fac Biol,Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain; Inst Mol Biol, ICREA, E-08028 Barcelona, Spain; Supercomp Ctr, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Palacin, M (corresponding author), Univ Barcelona, Ctr Invest Biomed Red Enfermedades Raras, Inst Res Biomed, Fac Biol,Dept Biochem & Mol Biol, E-08028 Barcelona, Spain.	mpalacin@pcb.ub.es; ifrcri@ibmb.csic.es; mpalacin@pcb.ub.es	Fita, Ignasi/R-4515-2019; Fort, Joana/H-7018-2015; Calderon, Caterina/I-8471-2018; Lizarbe, M Antonia/K-5219-2014; Zorzano, Antonio/R-5479-2018; Turnay, Javier/AAB-1497-2022; Turnay, Javier/K-4551-2014	Fita, Ignasi/0000-0002-7521-2679; Fort, Joana/0000-0003-0399-2116; Calderon, Caterina/0000-0002-6956-9321; Lizarbe, M Antonia/0000-0003-1722-1240; Turnay, Javier/0000-0002-6135-2179; Turnay, Javier/0000-0002-6135-2179; Palacin, Manuel/0000-0002-8670-293X; Fernandez-Recio, Juan/0000-0002-3986-7686; Orozco Lopez, Modesto/0000-0002-8608-3278; Rodriguez de la Ballina, Laura/0000-0001-5363-7433; Ferrer Orta, Cristina/0000-0002-1072-8463	ICREA Funding Source: Custom	ICREA(ICREA)		BELLONE G, 1989, EUR J IMMUNOL, V19, P1, DOI 10.1002/eji.1830190102; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Broer A, 2001, BIOCHEM J, V355, P725, DOI 10.1042/bj3550725; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dalton P, 2007, FEBS J, V274, P2715, DOI 10.1111/j.1742-4658.2007.05806.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong S, 1997, GLYCOCONJUGATE J, V14, P267, DOI 10.1023/A:1018554124545; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Hara K, 2000, ONCOGENE, V19, P6209, DOI 10.1038/sj.onc.1204019; HEMLER ME, 1982, J IMMUNOL, V129, P623; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Janecek S, 1997, PROG BIOPHYS MOL BIO, V67, P67, DOI 10.1016/S0079-6107(97)00015-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kakugawa K, 2003, FEBS LETT, V552, P184, DOI 10.1016/S0014-5793(03)00924-4; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Pfeiffer R, 1998, FEBS LETT, V439, P157, DOI 10.1016/S0014-5793(98)01359-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Shishido T, 2000, INT J CANCER, V87, P311, DOI 10.1002/1097-0215(20000801)87:3<311::AID-IJC1>3.0.CO;2-W; Sundstrom M, 1996, J BIOL CHEM, V271, P32212, DOI 10.1074/jbc.271.50.32212; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Tsai ML, 2004, J STRUCT BIOL, V148, P290, DOI 10.1016/j.jsb.2004.07.002; Tsurudome M, 2000, CRIT REV IMMUNOL, V20, P167; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WIEGAND G, 1995, J MOL BIOL, V247, P99, DOI 10.1006/jmbi.1994.0125; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yoon JH, 2003, ANTICANCER RES, V23, P3877	54	84	89	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31444	31452		10.1074/jbc.M704524200	http://dx.doi.org/10.1074/jbc.M704524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724034	hybrid			2022-12-25	WOS:000250309200035
J	Fu, YC; Luo, LH; Luo, NL; Zhu, XL; Garvey, T				Fu, Yuchang; Luo, Liehong; Luo, Nanlan; Zhu, Xiaolin; Garvey, Timothy			NR4A orphan nuclear receptors modulate insulin action and the glucose transport system - Potential role in insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NGFI-B; DIFFERENT MECHANISMS; GROWTH-FACTORS; EXPRESSION; NOR-1; HETERODIMERIZATION; HYPERTENSION; ENDOCRINE; GENES	After observing that expression of two NR4A orphan nuclear receptors, NR4A3 and NR4A1, was altered by insulin in cDNA microarray analyses of human skeletal muscle, we studied whether these receptors could modulate insulin sensitivity. We found that both NR4A3 and NR4A1 were induced by insulin and by thiazolidinedione drugs (pioglitazone and troglitazone) in 3T3-L1 adipocytes. Furthermore, gene expression of NR4A3 and NR4A1 was reduced in skeletal muscles and adipose tissues from multiple rodent models of insulin resistance. To determine whether NR4A3 could modulate insulin sensitivity, 3T3-L1 adipocytes were stably transduced with NR4A3 or LacZ (control) lentiviral vectors. Compared with LacZ expressing cells, hyperexpression of NR4A3 increased the ability of insulin to augment glucose transport activity, and the mechanism involved increased recruitment of GLUT4 glucose transporters to the plasma membrane. NR4A3 hyperexpression also led to an increase in insulin-mediated tyrosine phosphorylation of insulin receptor substrate-1 as well as Akt phosphorylation. Suppression of NR4A3 using lentiviral short hairpin RNA constructs reduced the ability of insulin to stimulate glucose transport and phosphorylate Insulin receptor substrate-1 and Akt. Thus, NR4A3 and NR4A1 are attractive novel therapeutic targets for potential amelioration of insulin resistance, and treatment and prevention of type 2 diabetes and the metabolic syndrome.	Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Fu, YC (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, 1675 Univ Blvd, Birmingham, AL 35294 USA.	yfu@uab.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038765, P30DK056336, R01DK038765] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK-56336, DK-38765] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; FINGAR DC, 1993, J BIOL CHEM, V268, P3005; FROST SC, 1985, J BIOL CHEM, V260, P2646; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HEDVAT CV, 1995, MOL ENDOCRINOL, V9, P1692, DOI 10.1210/me.9.12.1692; Hunter SJ, 1998, AM J MED, V105, P331, DOI 10.1016/S0002-9343(98)00300-3; Laflamme C, 2003, CANCER RES, V63, P449; Maltais A, 2000, DNA CELL BIOL, V19, P121, DOI 10.1089/104454900314636; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Maruyama K, 1997, NEUROENDOCRINOLOGY, V65, P2, DOI 10.1159/000127158; MAYOR P, 1992, DIABETES, V41, P274, DOI 10.2337/diabetes.41.3.274; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; OCURRA T, 1994, BIOCHEM BIOPH RES CO, V205, P1959; Ohkura N, 2001, DEV NEUROSCI-BASEL, V23, P17, DOI 10.1159/000048692; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Ponnio T, 2002, MOL CELL BIOL, V22, P935, DOI 10.1128/MCB.22.3.935-945.2002; REAVEN GM, 1991, DIABETES CARE, V14, P195, DOI 10.2337/diacare.14.3.195; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; SCEARCE LM, 1993, J BIOL CHEM, V268, P8855; Tofovic SP, 2003, METH MOLEC MED, V86, P29; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656	32	93	97	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31525	31533		10.1074/jbc.M701132200	http://dx.doi.org/10.1074/jbc.M701132200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785466	hybrid			2022-12-25	WOS:000250309200044
J	Gatot, JS; Gioia, R; Chau, TL; Patrascu, F; Warnier, M; Close, P; Chapelle, JP; Muraille, E; Brown, K; Siebenlist, U; Piette, J; Dejardin, E; Chariot, A				Gatot, Jean-Stephane; Gioia, Romain; Chau, Tieu-Lan; Patrascu, Felicia; Warnier, Michael; Close, Pierre; Chapelle, Jean-Paul; Muraille, Eric; Brown, Keith; Siebenlist, Ulrich; Piette, Jacques; Dejardin, Emmanuel; Chariot, Alain			Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKK epsilon-dependent lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; UBIQUITIN-CONJUGATING ENZYME; KINASE-RELATED KINASES; IKK-EPSILON; ANTIVIRAL RESPONSE; NEMO/IKK-GAMMA; RIG-I; PATHWAY; TBK1	Type I interferon gene induction relies on IKK-related kinase TBK1 and IKK epsilon-mediated phosphorylations of IRF3/7 through the Toll-like receptor-dependent signaling pathways. The scaffold proteins that assemble these kinase complexes are poorly characterized. We show here that TANK/ITRAF is required for the TBK1- and IKK epsilon-mediated IRF3/7 phosphorylations through some Toll-like receptor-dependent pathways and is part of a TRAF3-containing complex. Moreover, TANK is dispensable for the early phase of double-stranded RNA-mediated IRF3 phosphorylation. Interestingly, TANK is heavily phosphorylated by TBK1-IKK epsilon upon lipopolysaccharide stimulation and is also subject to lipopolysaccharide- and TBK1-IKK epsilon-mediated Lys(63)-linked polyubiquitination, a mechanism that does not require TBK1-IKK epsilon kinase activity. Thus, we have identified TANK as a scaffold protein that assembles some but not all IRF3/7-phosphorylating TBK1-IKK epsilon complexes and demonstrated that these kinases possess two functions, namely the phosphorylation of both IRF3/7 and TANK as well as the recruitment of an E3 ligase for Lys63-linked polyubiquitination of their scaffold protein, TANK.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms ENS 3LD, Herts, England; Univ Liege, GIGA Res, Med Chem Unit, B-4000 Liege, Belgium; Univ Liege, Interdisciplinary Cluster Appl Genoproteom, B-4000 Liege, Belgium; Univ Liege, Virol Immunol Units, B-4000 Liege, Belgium; Free Univ Brussels, Parasitol Lab, B-1070 Brussels, Belgium; NIH, NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA	Cancer Research UK; University of Liege; University of Liege; University of Liege; Universite Libre de Bruxelles; Vrije Universiteit Brussel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chariot, A (corresponding author), Free Univ Brussels, Inst Mol Biol & Med, Dept Appl Genet, B-6041 Gossellies, Belgium.	Alain.chariot@ulg.ac.be	Mrl, Eric/ABC-5458-2021; Dejardin, Emmanuel/AAE-9076-2021	CLOSE, PIERRE/0000-0002-8844-9616; Chariot, Alain/0000-0002-1691-4347; Muraille, Eric/0000-0003-1250-5228				Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bonif M, 2006, BIOCHEM J, V394, P593, DOI 10.1042/BJ20051659; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Israel A, 2006, TRENDS IMMUNOL, V27, P395, DOI 10.1016/j.it.2006.07.003; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kaye KM, 1996, P NATL ACAD SCI USA, V93, P11085, DOI 10.1073/pnas.93.20.11085; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Nomura F, 2000, GENES CELLS, V5, P191; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; ZHAO T, 2007, IN PRESS NAT IMMUNOL; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	57	68	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31131	31146		10.1074/jbc.M701690200	http://dx.doi.org/10.1074/jbc.M701690200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17823124	hybrid, Green Submitted			2022-12-25	WOS:000250309200003
J	Liu, L; He, B; Liu, WM; Zhou, DM; Cox, JV; Zhang, XA				Liu, Li; He, Bo; Liu, Wei M.; Zhou, Dongming; Cox, John V.; Zhang, Xin A.			Tetraspanin CD151 promotes cell migration by regulating integrin trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE 4 SUPERFAMILY; PLASMA-MEMBRANE; DEPENDENT INTERNALIZATION; ALPHA-3-BETA-1 INTEGRIN; PROTEIN CD151; IN-VIVO; ADHESION; MEMBER; ASSOCIATION; ENDOCYTOSIS	Regulation of cell migration is an important feature of tetraspanin CD151. Although it is well established that CD151 physically associates with integrins, the mechanism by which CD151 regulates integrin-dependent cell migration is basically unknown. Given the fact that CD151 is localized in both the plasma membrane and intracellular vesicles, we found that CD151 and its associated alpha 3 beta 1, alpha 5 beta 1, and alpha 6 beta 1 integrins undergo endocytosis and accumulate in the same intracellular vesicular compartments. CD151 contains a YRSL sequence, a YXX phi type of endocytosis/sorting motif, in its C-terminal cytoplasmic domain. Mutation of this motif markedly attenuated CD151 internalization. The loss of CD151 trafficking completely abrogated CD151-promoted cell migration on extracellular matrices such as laminin and diminished the internalization of its associated integrins, indicating a critical role for integrin trafficking in regulating cell motility. In conclusion, the YXX phi motif-mediated internalization of CD151 promotes integrin-dependent cell migration by modulating the endocytosis and/or vesicular trafficking of its associated integrins.	Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Inst Canc,Dept Med, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Zhang, XA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Inst Canc,Dept Med, Memphis, TN 38163 USA.	xazhang@utmem.edu		Zhou, Dongming/0000-0002-5989-7591	NCI NIH HHS [CA96991] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096991] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Bonifacino J. S., 1998, CURRENT PROTOCOLS CE; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; BRETSCHER MS, 1984, SCIENCE, V224, P681, DOI 10.1126/science.6719108; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hasegawa H, 1998, J IMMUNOL, V161, P3087; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; MCGRAW TE, CURRENT PROTOCOLS CE; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Pierini LM, 2000, BLOOD, V95, P2471; REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Sawada S, 2003, J BIOL CHEM, V278, P26323, DOI 10.1074/jbc.C300210200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shigeta M, 2003, J CELL BIOL, V163, P165, DOI 10.1083/jcb.200301075; Sincock PM, 1999, J CELL SCI, V112, P833; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Sterk LMT, 2002, J CELL SCI, V115, P1161; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2000, J CELL SCI, V113, P1871; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Testa JE, 1999, CANCER RES, V59, P3812; Thompson CRL, 2002, DEVELOPMENT, V129, P4185; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481	64	108	117	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31631	31642		10.1074/jbc.M701165200	http://dx.doi.org/10.1074/jbc.M701165200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716972	hybrid			2022-12-25	WOS:000250309200055
J	Nishiyama, Y; Mitsuda, Y; Taguchi, H; Planque, S; Salas, M; Hanson, CV; Paul, S				Nishiyama, Yasuhiro; Mitsuda, Yukie; Taguchi, Hiroaki; Planque, Stephanie; Salas, Maria; Hanson, Carl V.; Paul, Sudhir			Towards covalent vaccination - Improved polyclonal hiv neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEOLYTIC ANTIBODY; LIGHT-CHAIN; ENVELOPE GLYCOPROTEINS; CATALYTIC ANTIBODIES; CHEMOKINE RECEPTOR; CRYSTAL-STRUCTURE; BINDING ACTIVITY; VARIABLE DOMAIN; TYPE-1	Rare monoclonal antibodies (Abs) can form irreversible complexes with antigens by enzyme-like covalent nucleophile-electrophile pairing. To determine the feasibility of applying irreversible antigen inactivation by Abs as the basis of vaccination against microbes, we studied the polyclonal nucleophilic Ab response induced by the electrophilic analog of a synthetic peptide corresponding to the principal neutralizing determinant (PND) of human immunodeficiency virus type-1 (HIV) gp120 located in the V3 domain. Abs from mice immunized with the PND analog containing electrophilic phosphonates (E-PND) neutralized a homologous HIV strain (MN) similar to 50-fold more potently than control Abs from mice immunized with PND. The IgG fractions displayed binding to intact HIV particles. HIV complexes formed by anti-E-PND IgG dissociated noticeably more slowly than the complexes formed by anti-PND IgG. The slower dissociation kinetics are predicted to maintain long-lasting blockade of host cell receptor recognition by gp120. Pretreatment of the anti-PND IgG with a haptenic electrophilic phosphonate compound resulted in more rapid dissociation of the HIV-IgG complexes, consistent with the hypothesis that enhanced Ab nucleophilic reactivity induced by electrophilic immunization imparts irreversible character to the complexes. These results suggest that electrophilic immunization induces a sufficiently robust nucleophilic Ab response to enhance the anti-microbial efficacy of candidate polypeptide vaccines.	Univ Texas, Sch Med, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA 94804 USA	University of Texas System; California Department of Public Health	Nishiyama, Y (corresponding author), Univ Texas, Sch Med, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA.	Yasuhiro.Nishiyama@uth.tmc.edu; Sudhir.Paul@uth.tmc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071951, R01AI067020, R21AI062455, R01AI058865] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI058865, R01AI067020, R21AI062455, R21AI071951] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOUDET F, 1992, INT IMMUNOL, V4, P283, DOI 10.1093/intimm/4.2.283; BROLIDEN PA, 1992, P NATL ACAD SCI USA, V89, P461, DOI 10.1073/pnas.89.2.461; ESTAQUIER J, 1994, EUR J IMMUNOL, V24, P2789, DOI 10.1002/eji.1830241132; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; HANSON CV, 1990, J CLIN MICROBIOL, V28, P2030, DOI 10.1128/JCM.28.9.2030-2034.1990; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hill CM, 1997, J VIROL, V71, P6296, DOI 10.1128/JVI.71.9.6296-6304.1997; Hu QX, 2000, J MOL BIOL, V302, P359, DOI 10.1006/jmbi.2000.4076; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; KALAGA R, 1995, J IMMUNOL, V155, P2695; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Lefevre S, 2001, FEBS LETT, V489, P25, DOI 10.1016/S0014-5793(01)02075-0; NEURATH AR, 1990, MOL IMMUNOL, V27, P539, DOI 10.1016/0161-5890(90)90073-9; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Paul S, 1996, MOL BIOTECHNOL, V5, P197, DOI 10.1007/BF02900358; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Sun M, 1997, J MOL BIOL, V271, P374, DOI 10.1006/jmbi.1997.1196; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; VANCOTT TC, 1994, J IMMUNOL, V153, P449; WANG CY, 1991, SCIENCE, V254, P285, DOI 10.1126/science.1925584; WARREN RQ, 1992, J VIROL, V66, P5210, DOI 10.1128/JVI.66.9.5210-5215.1992; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254	39	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31250	31256		10.1074/jbc.M706471200	http://dx.doi.org/10.1074/jbc.M706471200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728243	hybrid			2022-12-25	WOS:000250309200014
J	Busuttil, RA; Garcia, AM; Reddick, RL; Dolle, MET; Calder, RB; Nelson, JF; Vijg, J				Busuttil, Rita A.; Garcia, Ana Maria; Reddick, Robert L.; Dolle, Martijn E. T.; Calder, Robert B.; Nelson, James F.; Vijg, Jan			Intra-Organ Variation in Age-Related Mutation Accumulation in the Mouse	PLOS ONE			English	Article								Using a transgenic mouse model harboring chromosomally integrated lacZ mutational target genes, we previously demonstrated that mutations accumulate with age much more rapidly in the small intestine than in the brain. Here it is shown that in the small intestine point mutations preferentially accumulate in epithelial cells of the mucosa scraped off the underlying serosa. The mucosal cells are the differentiated villus cells that have undergone multiple cell divisions. A smaller age-related increase, also involving genome rearrangements, was observed in the serosa, which consists mainly of the remaining crypts and non-dividing smooth muscle cells. In the brain we observed an accumulation of only point mutations in no other areas than hypothalamus and hippocampus. To directly test for cell division as the determining factor in the generation of point mutations we compared mutation induction between mitotically active and quiescent embryonic fibroblasts from the same lacZ mice, treated with either UV (a point mutagen) or hydrogen peroxide (a clastogen). The results indicate that while point mutations are highly replication-dependent, genome rearrangements are as easily induced in nondividing cells as in mitotically active ones. This strongly suggests that the point mutations found to have accumulated in the mucosal part of the small intestine are the consequence of replication errors. The same is likely true for point mutations accumulating in hippocampus and hypothalamus of the brain since neurogenesis in these two areas continues throughout life. The observed intra-organ variation in mutation susceptibility as well as the variation in replication dependency of different types of mutations indicates the need to not only extend observations made on whole organs to their sub-structures but also take the type of mutations and mitotic activity of the cells into consideration. This should help elucidating the impact of genome instability and its consequences on aging and disease.	[Busuttil, Rita A.; Calder, Robert B.; Vijg, Jan] Buck Inst Age Res, Novato, CA USA; [Garcia, Ana Maria] Univ Texas San Antonio, San Antonio, TX USA; [Reddick, Robert L.; Nelson, James F.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Dolle, Martijn E. T.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Buck Institute for Research on Aging; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Netherlands National Institute for Public Health & the Environment	Vijg, J (corresponding author), Buck Inst Age Res, Novato, CA USA.	jvijg@buckinstitute.org			NIA NIH HHS [R01 AG020438, P01 AG017242, AG20438, AG17242] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017242, R01AG020438] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beck-Peccoz P, 2006, BEST PRACT RES CL EN, V20, P529, DOI 10.1016/j.beem.2006.11.001; Busuttil R, 2007, NEUROSCIENCE, V145, P1341, DOI 10.1016/j.neuroscience.2006.09.060; Busuttil RA, 2006, DNA REPAIR, V5, P52, DOI 10.1016/j.dnarep.2005.07.006; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Chambers JM., 1992, STAT MODELS S; CRAVEN PA, 1986, J CLIN INVEST, V77, P850, DOI 10.1172/JCI112382; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Dolle MET, 1999, ENVIRON MOL MUTAGEN, V34, P112, DOI 10.1002/(SICI)1098-2280(1999)34:2/3&lt;112::AID-EM9&gt;3.0.CO;2-W; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Drake JW, 1998, GENETICS, V148, P1667; FEIG DI, 1994, CANCER RES, V54, pS1890; Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; HINRICHS HR, 1964, ARCH PATHOL, V78, P245; Loeb LA, 1998, ADV CANCER RES, V72, P25, DOI 10.1016/S0065-230X(08)60699-5; MULLAART E, 1989, CARCINOGENESIS, V10, P393, DOI 10.1093/carcin/10.2.393; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Ono T, 2004, CANCER RES, V64, P6919, DOI 10.1158/0008-5472.CAN-04-1476; *R DCT, 2006, R LANG ENV STAT COMP; Siqueira IR, 2005, INT J DEV NEUROSCI, V23, P663, DOI 10.1016/j.ijdevneu.2005.03.001; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Vijg J., 2007, AGING GENOME; Vogel F., 1997, HUMAN GENETICS PROBL; Yandell BS, 1997, PRACTICAL DATA ANAL	26	47	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e876	10.1371/journal.pone.0000876	http://dx.doi.org/10.1371/journal.pone.0000876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849005	Green Published, gold			2022-12-25	WOS:000207455600022
J	Lundstedt, AC; McCarthy, S; Gustafsson, MCU; Godaly, G; Jodal, U; Karpman, D; Leijonhufvud, I; Linden, C; Martinell, J; Ragnarsdottir, B; Samuelsson, M; Truedsson, L; Andersson, B; Svanborg, C				Lundstedt, Ann-Charlotte; McCarthy, Shane; Gustafsson, Mattias C. U.; Godaly, Gabriela; Jodal, Ulf; Karpman, Diana; Leijonhufvud, Irene; Linden, Carin; Martinell, Jeanette; Ragnarsdottir, Bryndis; Samuelsson, Martin; Truedsson, Lennart; Andersson, Bjorn; Svanborg, Catharina			A Genetic Basis of Susceptibility to Acute Pyelonephritis	PLOS ONE			English	Article								Background. For unknown reasons, urinary tract infections (UTIs) are clustered in certain individuals. Here we propose a novel, genetically determined cause of susceptibility to acute pyelonephritis, which is the most severe form of UTI. The IL-8 receptor, CXCR1, was identified as a candidate gene when mIL-8Rh mutant mice developed acute pyelonephritis (APN) with severe tissue damage. Methods and Findings. We have obtained CXCR1 sequences from two, highly selected APN prone patient groups, and detected three unique mutations and two known polymorphisms with a genotype frequency of 23% and 25% compared to 7% in controls (p<0.001 and p<0.0001, respectively). When reflux was excluded, 54% of the patients had CXCR1 sequence variants. The UTI prone children expressed less CXCR1 protein than the pediatric controls (p<0.0001) and two sequence variants were shown to impair transcription. Conclusions. The results identify a genetic innate immune deficiency, with a strong link to APN and renal scarring.	[Lundstedt, Ann-Charlotte; Gustafsson, Mattias C. U.; Godaly, Gabriela; Leijonhufvud, Irene; Ragnarsdottir, Bryndis; Samuelsson, Martin; Truedsson, Lennart; Svanborg, Catharina] Lund Univ, Dept Microbiol Immunol & Glycobiol, Inst Lab Med, Lund, Sweden; [McCarthy, Shane; Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Jodal, Ulf; Martinell, Jeanette] Gothenburg Univ, Dept Pediat, Queen Silvia Childrens Hosp, S-41124 Gothenburg, Sweden; [Karpman, Diana] Lund Univ, Dept Pediat, Lund, Sweden; [Linden, Carin] Gothenburg Univ, Dept Infect Dis, Gothenburg, Sweden	Lund University; Karolinska Institutet; Queen Silvia Children's Hospital; University of Gothenburg; Lund University; University of Gothenburg	Svanborg, C (corresponding author), Lund Univ, Dept Microbiol Immunol & Glycobiol, Inst Lab Med, Lund, Sweden.	Catharina.Svanborg@med.lu.se	Andersson, Bjorn/G-9832-2013; Godaly, Gabriela/AAD-7545-2019; Gustafsson, Mattias C. U./A-7451-2010; Godaly, Gabriela/C-8786-2014	Andersson, Bjorn/0000-0002-4624-0259; Godaly, Gabriela/0000-0002-3467-1350; Gustafsson, Mattias C. U./0000-0003-3260-0724; Godaly, Gabriela/0000-0002-3467-1350; Karpman, Diana/0000-0001-7220-7658; Aradottir, Sigridur Sunna/0000-0002-6898-3256	Swedish Medical Research Council [-07934, 14577, 14578]; The Royal Physiographic Society; The Medical Faculty, Lund University; Foundation for Strategic Research; Beijer Foundation; Bristol-Myers Squibb; Swedish Medical Research Council	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); The Royal Physiographic Society; The Medical Faculty, Lund University; Foundation for Strategic Research; Beijer Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This study was supported by grants from the Swedish Medical Research Council (grants no. -07934, 14577, 14578); The Royal Physiographic Society and The Medical Faculty, Lund University. The sequencing efforts were supported by the Genome Project of the Foundation for Strategic Research and the Beijer Foundation. Catharina Svanborg was a recipient of the Bristol-Myers Squibb, unrestricted grant and Gabriela Godaly is the recipient of Junior Research Scientist Grant from the Swedish Medical Research Council.	AGACE WW, 1995, INFECT IMMUN, V63, P4054, DOI 10.1128/IAI.63.10.4054-4062.1995; AHUJA SK, 1992, NAT GENET, V2, P31, DOI 10.1038/ng0992-31; AHUJA SK, 1994, J BIOL CHEM, V269, P26381; ANDERSEN HJ, 1966, J PEDIATR-US, V68, P542, DOI 10.1016/S0022-3476(66)80391-8; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; BAILEY RR, 1978, BRIT MED J, V1, P48, DOI 10.1136/bmj.1.6104.48-e; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; DECKER CJ, 1995, CURR OPIN CELL BIOL, V7, P386, DOI 10.1016/0955-0674(95)80094-8; EDEN CS, 1984, INFECTION, V12, P118, DOI 10.1007/BF01641692; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Frendeus B, 2001, J INFECT DIS, V183, pS56, DOI 10.1086/318848; Gbadegesin RA, 2006, INT J IMMUNOGENET, V33, P49, DOI 10.1111/j.1744-313X.2006.00565.x; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; HAGBERG L, 1985, J IMMUNOL, V134, P4118; Hang L, 2000, J INFECT DIS, V182, P1738, DOI 10.1086/317599; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hodson C J, 1975, Br J Radiol, VSuppl 13, P1; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Jakobsson B, 1999, PEDIATRICS, V104, P222, DOI 10.1542/peds.104.2.222; Kunin CM, 1997, URINARY TRACT INFECT; Lennartsson A, 2003, BIOCHEM BIOPH RES CO, V311, P853, DOI 10.1016/j.bbrc.2003.10.067; LLOYD A, 1993, CYTOGENET CELL GENET, V63, P238, DOI 10.1159/000133541; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Mao SF, 1999, MOL CELL BIOL, V19, P3635; MARTINELL J, 1995, PEDIATR NEPHROL, V9, P131, DOI 10.1007/BF00860724; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; RANSLEY PG, 1978, BRIT J RADIOL      S, V14, P1; Sherry ST, 1999, GENOME RES, V9, P677; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; SORENSEN UB, 1988, INFECT IMMUN; SPRENGER H, 1994, J IMMUNOL, V153, P2524; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAMM WE, 1991, REV INFECT DIS, V13, P77; Sun W, 2006, WORLD J GASTROENTERO, V12, P5005, DOI 10.3748/wjg.v12.i31.5005; Svanborg C, 2001, ANN MED, V33, P563, DOI 10.3109/07853890109002101; Svensson M, 2005, KIDNEY INT, V67, P103, DOI 10.1111/j.1523-1755.2005.00060.x; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wilkinson NC, 1999, J BIOL CHEM, V274, P438, DOI 10.1074/jbc.274.1.438; Wolf M, 1998, EUR J IMMUNOL, V28, P164, DOI 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S; Yamada R, 2004, J MOL MED-JMM, V82, P558, DOI 10.1007/s00109-004-0547-y	52	64	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e825	10.1371/journal.pone.0000825	http://dx.doi.org/10.1371/journal.pone.0000825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786197	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500009
J	McGurk, L; Morrison, H; Keegan, LP; Sharpe, J; O'Connell, MA				McGurk, Leeanne; Morrison, Harris; Keegan, Liam P.; Sharpe, James; O'Connell, Mary A.			Three-Dimensional Imaging of Drosophila melanogaster	PLOS ONE			English	Article								Background. The major hindrance to imaging the intact adult Drosophila is that the dark exoskeleton makes it impossible to image through the cuticle. We have overcome this obstacle and describe a method whereby the internal organs of adult Drosophila can be imaged in 3D by bleaching and clearing the adult and then imaging using a technique called optical projection tomography (OPT). The data is displayed as 2D optical sections and also in 3D to provide detail on the shape and structure of the adult anatomy. Methodology. We have used OPT to visualize in 2D and 3D the detailed internal anatomy of the intact adult Drosophila. In addition this clearing method used for OPT was tested for imaging with confocal microscopy. Using OPT we have visualized the size and shape of neurodegenerative vacuoles from within the head capsule of flies that suffer from age-related neurodegeneration due to a lack of ADAR mediated RNA-editing. In addition we have visualized tau-lacZ expression in 2D and 3D. This shows that the wholemount adult can be stained without any manipulation and that this stain penetrates well as we have mapped the localization pattern with respect to the internal anatomy. Conclusion. We show for the first time that the intact adult Drosophila can be imaged in 3D using OPT, also we show that this method of clearing is also suitable for confocal microscopy to image the brain from within the intact head. The major advantage of this is that organs can be represented in 3D in their natural surroundings. Furthermore optical sections are generated in each of the three planes and are not prone to the technical limitations that are associated with manual sectioning. OPT can be used to dissect mutant phenotypes and to globally map gene expression in both 2D and 3D.	[McGurk, Leeanne; Morrison, Harris; Keegan, Liam P.; O'Connell, Mary A.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Sharpe, James] Ctr Regulacio Genom, Syst Biol Program, Barcelona, Spain	University of Edinburgh; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	O'Connell, MA (corresponding author), MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland.	Mary.O'Connell@hgu.mrc.ac.uk	Keegan, Liam P./AAL-3753-2021; Sharpe, James/AAB-7948-2019; O'Connell, Mary Anne/U-7693-2019; Keegan, Liam P/F-1106-2017; Sharpe, James/L-1150-2014; McGurk, Leeanne/L-6734-2019; OConnell, Mary Anne/G-4740-2015	Keegan, Liam P./0000-0001-7915-5790; O'Connell, Mary Anne/0000-0003-3844-6174; Keegan, Liam P/0000-0001-7915-5790; Sharpe, James/0000-0002-1434-9743; McGurk, Leeanne/0000-0002-6493-6751; OConnell, Mary Anne/0000-0003-3844-6174	Medical Research Council [U.1275.01.005.00001.01]; Medical Research Council [MC_U127574434, MC_U127584490] Funding Source: researchfish; MRC [MC_U127584490, MC_U127574434] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LM was funded by a MRC Capacity Building Area Research Studentship and this work was funded by the Medical Research Council U.1275.01.005.00001.01.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; ASHBURNER M, 1990, DROSOPHILA LAB HDB; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; BALLINGER DG, 1989, P NATL ACAD SCI USA, V86, P9402, DOI 10.1073/pnas.86.23.9402; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Christiansen JH, 2006, NUCLEIC ACIDS RES, V34, pD637, DOI 10.1093/nar/gkj006; Crowther DC, 2004, CURR OPIN PHARMACOL, V4, P513, DOI 10.1016/j.coph.2004.07.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferber D, 2001, SCIENCE, V292, P1983; *FLYBRAIN, ONL ATL DAT DROS NER; Gates J, 2000, GENETICS, V156, P1765; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Jenett A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-544; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kerwin J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-27; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LUDWIG MZ, 1993, P NATL ACAD SCI USA, V90, P6233, DOI 10.1073/pnas.90.13.6233; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Sarma S, 2005, BRAIN RES BULL, V66, P449, DOI 10.1016/j.brainresbull.2005.05.022; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Spradling AC, 1999, GENETICS, V153, P135; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382	36	52	52	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e834	10.1371/journal.pone.0000834	http://dx.doi.org/10.1371/journal.pone.0000834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786206	Green Published, gold			2022-12-25	WOS:000207455500018
J	Thiel, M; Caldwell, CC; Kreth, S; Kuboki, S; Chen, P; Smith, P; Ohta, A; Lentsch, AB; Lukashev, D; Sitkovsky, MV				Thiel, Manfred; Caldwell, Charles C.; Kreth, Simone; Kuboki, Satoshi; Chen, P.; Smith, Patrick; Ohta, Akio; Lentsch, Alex B.; Lukashev, Dmitry; Sitkovsky, Michail V.			Targeted Deletion of HIF-1 alpha Gene in T Cells Prevents their Inhibition in Hypoxic Inflamed Tissues and Improves Septic Mice Survival	PLOS ONE			English	Article							NF-KAPPA-B; LYMPHOCYTE DEVELOPMENT; ADENOSINE RECEPTORS; ACTIVATION; EXPRESSION; REPRESSION; REVEALS; P50	Background. Sepsis patients may die either from an overwhelming systemic immune response and/or from an immunoparalysis-associated lack of anti-bacterial immune defence. We hypothesized that bacterial superantigen-activated T cells may be prevented from contribution into anti-bacterial response due to the inhibition of their effector functions by the hypoxia inducible transcription factor (HIF-1 alpha) in inflamed and hypoxic areas. Methodology/ Principal Findings. Using the Cre-lox-P-system we generated mice with a T-cell targeted deletion of the HIF-1 alpha gene and analysed them in an in vivo model of bacterial sepsis. We show that deletion of the HIF-1 alpha gene leads to higher levels of pro-inflammatory cytokines, stronger anti-bacterial effects and much better survival of mice. These effects can be at least partially explained by significantly increased NF-kappa B activation in TCR activated HIF-1 alpha deficient T cells. Conclusions/Significance. T cells can be recruited to powerfully contribute to anti-bacterial response if they are relieved from inhibition by HIF-1 alpha in inflamed and hypoxic areas. Our experiments uncovered the before unappreciated reserve of anti-bacterial capacity of T cells and suggest novel therapeutic anti-pathogen strategies based on targeted deletion or inhibition of HIF-1 alpha in T cells.	[Thiel, Manfred; Caldwell, Charles C.; Chen, P.; Smith, Patrick; Ohta, Akio; Lukashev, Dmitry; Sitkovsky, Michail V.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Thiel, Manfred; Kreth, Simone] Univ Munich, Klinikum Grosshadern, Dept Anaesthesiol, D-8000 Munich, Germany; [Caldwell, Charles C.; Kuboki, Satoshi; Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Trauma Sepsis & Inflammat Res Grp, Cincinnati, OH 45267 USA; [Caldwell, Charles C.] Shriners Hosp Children, Dept Res, Cincinnati, OH USA; [Ohta, Akio; Lukashev, Dmitry; Sitkovsky, Michail V.] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Munich; University System of Ohio; University of Cincinnati; Northeastern University	Sitkovsky, MV (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	m.sitkovsky@neu.edu	Lukashev, Dmitriy/F-8133-2010	Caldwell, Charles/0000-0003-1692-4550; Kreth, Simone/0000-0002-0073-2098	New England Inflammation and Tissue Protection Institute at Northeastern University, Boston [1R21 AT002788-01]; National Institutes of Health; Shriner's Hospital for Children [8560]; German National Research Foundation [TH733/2-1]; National Institute of Allergy and Infectious Diseases Intramural program; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT002788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072760] Funding Source: NIH RePORTER	New England Inflammation and Tissue Protection Institute at Northeastern University, Boston; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriner's Hospital for Children; German National Research Foundation(German Research Foundation (DFG)); National Institute of Allergy and Infectious Diseases Intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by New England Inflammation and Tissue Protection Institute at Northeastern University, Boston, 1R21 AT002788-01(MS), National Institutes of Health grants, and Shriner's Hospital for Children Project 8560 (CCC) as well as by the German National Research Foundation Grant TH733/2-1 and National Institute of Allergy and Infectious Diseases Intramural program.	Andreakos E, 2006, P NATL ACAD SCI USA, V103, P14459, DOI 10.1073/pnas.0603493103; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Ebong S, 1999, INFECT IMMUN, V67, P6603; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Kojima H, 2002, P NATL ACAD SCI USA, V99, P2170, DOI 10.1073/pnas.052706699; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006; Laughlin KM, 1996, J PHARMACOL EXP THER, V277, P1049; Lukac R, 2006, J VIS COMMUN IMAGE R, V17, P1, DOI 10.1016/j.jvcir.2005.08.007; Lukashev DE, 2003, BIOCHEM PHARMACOL, V65, P2081, DOI 10.1016/S0006-2952(03)00158-8; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	26	131	136	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e853	10.1371/journal.pone.0000853	http://dx.doi.org/10.1371/journal.pone.0000853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786224	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500036
J	Fraser, C				Fraser, Christophe			Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic	PLOS ONE			English	Article								Reproduction numbers, defined as averages of the number of people infected by a typical case, play a central role in tracking infectious disease outbreaks. The aim of this paper is to develop methods for estimating reproduction numbers which are simple enough that they could be applied with limited data or in real time during an outbreak. I present a new estimator for the individual reproduction number, which describes the state of the epidemic at a point in time rather than tracking individuals over time, and discuss some potential benefits. Then, to capture more of the detail that micro-simulations have shown is important in outbreak dynamics, I analyse a model of transmission within and between households, and develop a method to estimate the household reproduction number, defined as the number of households infected by each infected household. This method is validated by numerical simulations of the spread of influenza and measles using historical data, and estimates are obtained for would-be emerging epidemics of these viruses. I argue that the household reproduction number is useful in assessing the impact of measures that target the household for isolation, quarantine, vaccination or prophylactic treatment, and measures such as social distancing and school or workplace closures which limit between-household transmission, all of which play a key role in current thinking on future infectious disease mitigation.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London, England	Imperial College London	Fraser, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London, England.	c.fraser@imperial.ac.uk	Fraser, Christophe/A-8109-2008	Fraser, Christophe/0000-0003-2399-9657	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	The work was funded by a Royal Society University Research Fellowship. The sponsors played no role in the study.	Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; BAILEY NTJ, 1957, MATHE THEORY EPIDEMI; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Ball F, 2006, STAT METHODS MED RES, V15, P481, DOI 10.1177/0962280206071643; Ball F, 1997, ANN APPL PROBAB, V7, P46; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Hall R, 1996, EPIDEMIOL INFECT, V117, P443, DOI 10.1017/S0950268800059100; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klinkenberg D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000012; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; LUDWIG D, 1975, Mathematical Biosciences, V23, P33, DOI 10.1016/0025-5564(75)90119-4; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; O'Neill PD, 2000, J ROY STAT SOC C-APP, V49, P517, DOI 10.1111/1467-9876.00210; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; SIMPSON REH, 1952, LANCET, V263, P549; SVENSSON A, 2006, MATH BIOSCI IN PRESS, DOI DOI 10.1016/J.MBS.2006.1.0.010; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; White PJ, 2006, AIDS, V20, P1898, DOI 10.1097/01.aids.0000244213.23574.fa; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	38	192	193	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e758	10.1371/journal.pone.0000758	http://dx.doi.org/10.1371/journal.pone.0000758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712406	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455300006
J	Heldermon, CD; Hennig, AK; Ohlemiller, KK; Ogilvie, JM; Herzog, ED; Breidenbach, A; Vogler, C; Wozniak, DF; Sands, MS				Heldermon, Coy D.; Hennig, Anne K.; Ohlemiller, Kevin K.; Ogilvie, Judith M.; Herzog, Erik D.; Breidenbach, Annalisa; Vogler, Carole; Wozniak, David F.; Sands, Mark S.			Development of Sensory, Motor and Behavioral Deficits in the Murine Model of Sanfilippo Syndrome Type B	PLOS ONE			English	Article								Background. Mucopolysaccharidosis (MPS) IIIB (Sanfilippo Syndrome type B) is caused by a deficiency in the lysosomal enzyme N-acetyl-glucosaminidase (Naglu). Children with MPS IIIB develop disturbances of sleep, activity levels, coordination, vision, hearing, and mental functioning culminating in early death. The murine model of MPS IIIB demonstrates lysosomal distention in multiple tissues, a shortened life span, and behavioral changes. Principal Findings. To more thoroughly assess MPS IIIB in mice, alterations in circadian rhythm, activity level, motor function, vision, and hearing were tested. The suprachiasmatic nucleus (SCN) developed pathologic changes and locomotor analysis showed that MPS IIIB mice start their daily activity later and have a lower proportion of activity during the night than wild-type controls. Rotarod assessment of motor function revealed a progressive inability to coordinate movement in a rocking paradigm. Purkinje cell counts were significantly reduced in the MPS IIIB animals compared to age matched controls. By electroretinography (ERG), MPS IIIB mice had a progressive decrease in the amplitude of the dark-adapted b-wave response. Corresponding pathology revealed shortening of the outer segments, thinning of the outer nuclear layer, and inclusions in the retinal pigmented epithelium. Auditory-evoked brainstem responses (ABR) demonstrated progressive hearing deficits consistent with the observed loss of hair cells in the inner ear and histologic abnormalities in the middle ear. Conclusions/Significance. The mouse model of MPS IIIB has several quantifiable phenotypic alterations and is similar to the human disease. These physiologic and histologic changes provide insights into the progression of this disease and will serve as important parameters when evaluating various therapies.	[Heldermon, Coy D.; Hennig, Anne K.; Ohlemiller, Kevin K.; Sands, Mark S.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Ogilvie, Judith M.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Herzog, Erik D.; Breidenbach, Annalisa] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Vogler, Carole] St Louis Univ, Sch Med, St Louis, MO USA; [Wozniak, David F.] Washington Univ, Dept Psychiat, St Louis, MO USA	Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	Sands, MS (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	msands@im.wustl.edu		Sands, Mark/0000-0002-5559-0832; Ogilvie, Judith/0000-0001-9499-9975; Heldermon, Coy/0000-0002-2148-2868; Herzog, Erik/0000-0001-7209-5174	National MPS Society; NIH [HL007088, DK57586, DC04946, MH63104, P30 DC004665, P30 NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004665, R03DC004946] Funding Source: NIH RePORTER	National MPS Society; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from the National MPS Society (JMO) and NIH grants: HL007088 (CDH), DK57586 (MSS), DC04946 (AKH), MH63104 (EDH), P30 DC004665 (D. D. Simmons), P30 NS057105 (DFW). The funders had no role in any aspect of design, data collection, or manuscript preparation.	ANDRIA G, 1979, CLIN GENET, V15, P500; Barone R, 1999, NEUROPEDIATRICS, V30, P270, DOI 10.1055/s-2007-973503; BAX MCO, 1995, ARCH DIS CHILD, V73, P77, DOI 10.1136/adc.73.1.77; BREDENKAMP JK, 1992, ANN OTO RHINOL LARYN, V101, P472, DOI 10.1177/000348949210100605; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; Colville GA, 1996, DEV MED CHILD NEUROL, V38, P538; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Daly TM, 1999, P NATL ACAD SCI USA, V96, P2296, DOI 10.1073/pnas.96.5.2296; DELMONTE MA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1255; Ellinwood NM, 2003, J INHERIT METAB DIS, V26, P489, DOI 10.1023/A:1025177411938; FERRER I, 1988, NEUROPATH APPL NEURO, V14, P315, DOI 10.1111/j.1365-2990.1988.tb00891.x; Fraser J, 2005, ARCH DIS CHILD, V90, P1239, DOI 10.1136/adc.2004.065482; Fraser J, 2002, CLIN GENET, V62, P418, DOI 10.1034/j.1399-0004.2002.620512.x; Gorlin R., 1995, OXFORD MONOGRAPHS ME, V28, P318; HADFIELD MG, 1980, ARCH NEUROL-CHICAGO, V37, P645, DOI 10.1001/archneur.1980.00500590069012; Hennig AK, 2004, MOL THER, V10, P106, DOI 10.1016/j.ymthe.2004.03.018; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; Johnson KR, 2006, BRAIN RES, V1091, P79, DOI 10.1016/j.brainres.2006.02.021; KREISEL B, 1978, BRAIN RES BULL, V3, P707, DOI 10.1016/0361-9230(78)90022-9; Kriegsfeld LJ, 2004, J NEUROSCI, V24, P2449, DOI 10.1523/JNEUROSCI.5323-03.2004; LAVERY MA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1263; Leung L S, 1971, Birth Defects Orig Artic Ser, V7, P32; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Mariotti R, 2003, CLIN ELECTROENCEPHAL, V34, P18, DOI 10.1177/155005940303400108; MARSH J, 1985, CLIN GENET, V27, P258; Monroy MA, 2002, BONE, V30, P352, DOI 10.1016/S8756-3282(01)00679-2; NIDIFFER FD, 1983, J MENT DEFIC RES, V27, P185; Ohlemiller KK, 2000, EXP EYE RES, V71, P469, DOI 10.1006/exer.2000.0897; Ohlemiller KK, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P581; Ohlemiller KK, 2002, HEARING RES, V169, P69, DOI 10.1016/S0378-5955(02)00341-6; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Papsin BC, 1998, OTOLARYNG HEAD NECK, V118, P30, DOI 10.1016/S0194-5998(98)70371-7; VANDEKAMP JJP, 1981, CLIN GENET, V20, P152; VANSCHROJENSTEINDEVALK HMJ, 1987, AM J MED GENET, V28, P125; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Yogalingam G, 2000, BBA-MOL BASIS DIS, V1502, P415, DOI 10.1016/S0925-4439(00)00066-1; Zafeiriou DI, 2001, BRAIN DEV-JPN, V23, P385, DOI 10.1016/S0387-7604(01)00242-X	39	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e772	10.1371/journal.pone.0000772	http://dx.doi.org/10.1371/journal.pone.0000772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712420	Green Published, gold			2022-12-25	WOS:000207455300020
J	Kao, CJ; Chiang, YJ; Chen, PH; Lin, KR; Hwang, PI; Yang-Yen, HF; Yen, JJY				Kao, C-J; Chiang, Y-J; Chen, P-H; Lin, K-R; Hwang, P-I; Yang-Yen, H-F; Yen, J. J-Y			CBAP interacts with the un-liganded common beta-subunit of the GM-CSF/IL-3/IL-5 receptor and induces apoptosis via mitochondrial dysfunction	ONCOGENE			English	Article						apoptosis; cytokine deprivation; mitochondrial dysfunction; cytokine receptor	COLONY-STIMULATING FACTOR; GM-CSF; SIGNAL-TRANSDUCTION; EXPRESSION CLONING; JAK2; CHAIN; ERYTHROPOIETIN; PROLIFERATION; REQUIRES; REGION	The cytoplasmic domain of the common beta-chain (beta c) of the granulocyte-macrophage-colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3)/IL-5 receptor contains a membrane proximal region that is sufficient to mediate ligand-dependent mitogenic activity. Within this region two motifs, designated as box 1 and box 2, are highly conserved among members of the cytokine receptor superfamily. Whereas box 1 is required for the recruitment and phosphorylation of Janus kinase-2, the function of box 2 remains largely unknown. Here, we report the identification of a novel transmembrane protein (common beta-chain associated protein (CBAP)) which directly associated with beta c via the box 2 motif. Interestingly, such an association only occurred in the absence of GM-CSF in vivo. Ectopic overexpression of CBAP triggered apoptosis of factor-dependent cells via mitochondrial dysfunction, which could be inhibited by Bcl-2 overexpression. Reduced expression of endogenous CBAP by small interfering RNA did not interfere GM-CSF-activated signaling molecules, but such treatment significantly inhibited apoptosis induced by GM-CSF deprivation, but not other death stimuli. Domain mapping studies indicated that one apoptogenic domain of CBAP correlated with its ability to interact with beta c. Taken together, these results suggest that CBAP modulates GM-CSF-deprivation-induced apoptosis possibly via a novel mechanism involving interaction with an un-liganded beta c molecule.	[Kao, C-J; Chiang, Y-J; Chen, P-H; Lin, K-R; Yen, J. J-Y] Acad Sinica, Inst Biomed Sci, Agr Biotechnol Res Ctr, Taipei 11529, Taiwan; [Kao, C-J; Yen, J. J-Y] Natl Taiwan Univ, Sch Med, Inst Mol Med, Taipei 10764, Taiwan; [Hwang, P-I] Acad Sinica, Bioinformat Core Lab, Agr Biotechnol Res Ctr, Taipei 11529, Taiwan; [Yang-Yen, H-F] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Yen, JJY (corresponding author), Acad Sinica, Inst Biomed Sci, Agr Biotechnol Res Ctr, 128 Sec 2,Yen Jiou Yuan Rd, Taipei 11529, Taiwan.	bmjyen@ibms.sinica.edu.tw	Yen, Jeffrey Jong-Young/Q-5134-2018; Chen, Ping-Hung/AAN-6443-2020; Lin, Kuo-Ray/V-6333-2019; Yang-Yen, Hsin-Fang/ABA-5808-2021	Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Chen, Ping-Hung/0000-0002-7156-0510; Yang-Yen, Hsin-Fang/0000-0001-9048-4800				ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Drachman JG, 2002, J BIOL CHEM, V277, P23544, DOI 10.1074/jbc.M201120200; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; Huang HM, 1999, BLOOD, V93, P2569, DOI 10.1182/blood.V93.8.2569.408k08_2569_2577; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Lee SF, 1999, MOL CELL BIOL, V19, P7399; MIURA O, 1993, BLOOD, V81, P1739; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L	15	7	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 28	2008	27	10					1397	1403		10.1038/sj.onc.1210778	http://dx.doi.org/10.1038/sj.onc.1210778			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	267ZR	17828305				2022-12-25	WOS:000253548200006
J	Kajiya, K; Huggenberger, R; Drinnenberg, I; Ma, BJ; Detmar, M				Kajiya, Kentaro; Huggenberger, Reto; Drinnenberg, Ines; Ma, Beijia; Detmar, Michael			Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha 1 beta 1-impact on inflammation	FASEB JOURNAL			English	Article						lymphangiogenesis; vascular endothelial growth factor-A; UVB; endothelium; angiogenesis	ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL EXPRESSION; LYMPHANGIOGENESIS; ANGIOGENESIS; GLYCOPROTEIN; PURIFICATION; PHYSIOLOGY; SYNTHASE	The lymphatic vascular system regulates tissue fluid homeostasis and the afferent phase of the immune response, and it is also involved in tumor metastasis. There is increasing evidence that lymphatic vessels also mediate acute and chronic inflammation. However, the mechanisms and functional consequences of lymphangiogenesis under inflammatory conditions are largely unknown. Here, we show that lymphatic endothelial cells (LECs) specifically express the alpha 1 beta 1 isoform of soluble guanylate cyclase (sGC), that vascular endothelial growth factor-A potently induces sGC alpha 1 beta 1, and that nitric oxide (NO)-induced LEC proliferation, migration, and cGMP production in LECs are specifically dependent on sGC alpha 1 beta 1. Moreover, the specific sGC inhibitor NS-2028 completely prevents ultraviolet B-irradiation-induced lymphatic vessel enlargement, edema formation, and skin inflammation in vivo. These findings identify a crucial role of the NO/sGC alpha 1 beta 1/cGMP pathway in modulating lymphatic vessel function. The blockade of sGC alpha 1 beta 1 signaling might serve as a novel therapeutic strategy for inhibiting lymphangiogenesis and inflammation, in addition to its effects on the blood vasculature.	[Kajiya, Kentaro; Huggenberger, Reto; Drinnenberg, Ines; Ma, Beijia; Detmar, Michael] ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Kajiya, Kentaro] Shiseido Life Sci Res Ctr, Yokohama, Kanagawa, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; Shiseido Company, Limited	Detmar, M (corresponding author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Wolfgang Pauli Str 10,HCI H303, CH-8093 Zurich, Switzerland.	michael.detmar@pharma.ethz.ch		Kajiya, Kentaro/0000-0002-5224-7051	NCI NIH HHS [CA69184, CA92644] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069184, P01CA092644] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Cudmore M, 2006, BIOCHEM BIOPH RES CO, V345, P1275, DOI 10.1016/j.bbrc.2006.04.031; Cueni LN, 2006, J INVEST DERMATOL, V126, P2167, DOI 10.1038/sj.jid.5700464; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Franchi A, 2006, J PATHOL, V208, P439, DOI 10.1002/path.1892; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; HIRAKAWA S, 2006, BLOOD, V126, P919; Jadeski LC, 2000, INT J CANCER, V86, P30, DOI 10.1002/(SICI)1097-0215(20000401)86:1<30::AID-IJC5>3.0.CO;2-I; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Kajiya K, 2006, J INVEST DERMATOL, V126, P919, DOI 10.1038/sj.jid.5700126; Kajiya K, 2006, AM J PATHOL, V169, P1496, DOI 10.2353/ajpath.2006.060197; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kosarikov DN, 2001, ARCH BIOCHEM BIOPHYS, V388, P185, DOI 10.1006/abbi.2001.2284; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Morbidelli L, 2003, CURR PHARM DESIGN, V9, P521, DOI 10.2174/1381612033391405; Ohhashi T, 2005, PHARMACOL THERAPEUT, V105, P165, DOI 10.1016/j.pharmthera.2004.10.009; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; SATO Y, 1986, AM J PATHOL, V125, P431; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Shirasawa Y, 2000, AM J PHYSIOL-GASTR L, V278, pG551, DOI 10.1152/ajpgi.2000.278.4.G551; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Yano K, 2004, J INVEST DERMATOL, V122, P201, DOI 10.1046/j.0022-202X.2003.22101.x; YUEN PST, 1990, BIOCHEMISTRY-US, V29, P10872, DOI 10.1021/bi00501a002; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051	35	28	29	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					530	537		10.1096/fj.07-8873com	http://dx.doi.org/10.1096/fj.07-8873com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17855621				2022-12-25	WOS:000252822600023
J	McDunn, JE; Muenzer, JT; Rachdi, L; Chang, KC; Davis, CG; Dunne, WM; Piwnica-Worms, D; Bernal-Mizrachi, E; Hotchkiss, RS				McDunn, Jonathan E.; Muenzer, Jared T.; Rachdi, Latif; Chang, Katherine C.; Davis, Chris G.; Dunne, W. Michael; Piwnica-Worms, David; Bernal-Mizrachi, Ernesto; Hotchkiss, Richard S.			Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis	FASEB JOURNAL			English	Article							IMPROVES SURVIVAL; CECAL LIGATION; TCL1 FAMILY; SEPSIS; PROTEIN; IDENTIFICATION; DEATH; BCL-2; MICE	Lymphocyte apoptosis is a hallmark of sepsis and contributes to disease mortality. In other acute injuries, such as myocardial and cerebral ischemia/reperfusion, apoptosis plays a significant role in disease-associated morbidity and mortality. We previously showed that constitutive activation of the potent antiapoptotic Akt/protein kinase B signaling pathway in lymphocytes both reduces sepsis-induced lymphocyte apoptosis and confers a significant survival advantage compared to wild-type littermates. Here, we demonstrate a therapeutic approach to acutely augment Akt activity in a wild-type animal. A cell-permeable peptide conjugated to the Akt-binding domain of the endogenous Akt coactivator, Tcl-1, prolongs Akt activity, activates extracellular regulated kinase (ERK) signaling and protects lymphocytes from numerous apoptotic stimuli both in vitro and in vivo. Molecular approaches to activate the antiapoptotic Akt and ERK signaling pathways may provide a novel tool to study these signaling pathways, as well as a new antiapoptotic strategy for the treatment of sepsis and other acute injuries.	[McDunn, Jonathan E.; Chang, Katherine C.; Davis, Chris G.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [McDunn, Jonathan E.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Muenzer, Jared T.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rachdi, Latif; Bernal-Mizrachi, Ernesto; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Dunne, W. Michael] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Piwnica-Worms, David; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, Mol Imaging Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	McDunn, JE (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Campus Box 8054,660 S Euclid Ave, St Louis, MO 63110 USA.	mcdunnj@wustl.edu	Rachdi, Latif/I-1988-2017; McDunn, Jonathan/A-6816-2009	Rachdi, Latif/0000-0002-1089-2837; McDunn, Jonathan/0000-0001-8792-828X	NCI NIH HHS [CA-82841, P50 CA094056-019003, P50 CA094056, CA-94056, R01 CA082841] Funding Source: Medline; NEI NIH HHS [R01 EY019587, R01 EY019587-11] Funding Source: Medline; NIGMS NIH HHS [R01 GM044118, GM-044188, R01 GM055194, R01 GM044118-10, GM-055194, R01 GM055194-12] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082841, P50CA094056] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055194, R01GM044118] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Auguin D, 2004, J BIOL CHEM, V279, P35890, DOI 10.1074/jbc.M400364200; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; BAKER CC, 1983, SURGERY, V94, P331; Bommhardt U, 2004, J IMMUNOL, V172, P7583, DOI 10.4049/jimmunol.172.12.7583; Chung TP, 2006, J AM COLL SURGEONS, V203, P585, DOI 10.1016/j.jamcollsurg.2006.06.028; Gammon ST, 2003, BIOCONJUGATE CHEM, V14, P368, DOI 10.1021/bc0256291; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hiromura M, 2004, J BIOL CHEM, V279, P53407, DOI 10.1074/jbc.M403775200; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hoyer KK, 2005, J IMMUNOL, V175, P864, DOI 10.4049/jimmunol.175.2.864; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Li B, 2002, GENE THER, V9, P233, DOI 10.1038/sj.gt.3301641; Matsui T, 2001, CIRCULATION, V104, P330; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Parrillo J E, 1993, N Engl J Med, V328, P1471; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sampson WR, 1999, J PEPT SCI, V5, P403, DOI 10.1002/(SICI)1099-1387(199909)5:9<403::AID-PSC213>3.0.CO;2-S; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530	30	17	19	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					561	568		10.1096/fj.07-8283com	http://dx.doi.org/10.1096/fj.07-8283com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17855622	Green Accepted			2022-12-25	WOS:000252822600026
J	Paugh, BS; Paugh, SW; Bryan, L; Kapitonov, D; Wilczynska, KM; Gopalan, SM; Rokita, H; Milstien, S; Spiegel, S; Kordula, T				Paugh, Barbara S.; Paugh, Steven W.; Bryan, Lauren; Kapitonov, Dmitri; Wilczynska, Katarzyna M.; Gopalan, Sunita M.; Rokita, Hanna; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz			EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKC delta, and sphingosine kinase 1 in glioblastoma cells	FASEB JOURNAL			English	Article						glioma; invasiveness	EPIDERMAL-GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; FACTOR RECEPTOR GENE; HUMAN-BRAIN-TUMORS; UROKINASE-TYPE; ONCOSTATIN-M; KAPPA-B; EXPRESSION; INVASION; SYSTEM	Patients with gliomas expressing high levels of epidermal growth factor receptor ( EGFR) and plasminogen activator inhibitor-1 (PAI-1) have a shorter overall survival prognosis. Moreover, EGF enhances PAI-1 expression in glioma cells. Although multiple known signaling cascades are activated by EGF in glioma cells, we show for the first time that EGF enhances expression of PAI-1 via sequential activation of c-Src, protein kinase C delta (PKC delta), and sphingosine kinase 1 (SphK1), the enzyme that produces sphingosine-1-phosphate. EGF induced rapid phosphorylation of c-Src and PKC delta and concomitant translocation of PKC delta as well as SphK1 to the plasma membrane. Down-regulation of PKC delta abolished EGF-induced SphK1 translocation and up-regulation of PAI-1 by EGF; whereas, down-regulation of PKC alpha had no effect on the EGF-induced PAI-1 activation but enhanced its basal expression. Similarly, inhibition of c-Src activity by PP2 blocked both EGF-induced translocation of SphK1 and PKC delta to the plasma membrane and up-regulation of PAI-1 expression. Furthermore, SphK1 was indispensable for both EGF-induced c-Jun phosphorylation and PAI-1 expression. Collectively, our results provide a functional link between three critical downstream targets of EGF, c-Src, PKC delta, and SphK1 that have all been implicated in regulating motility and invasion of glioma cells.	[Paugh, Barbara S.; Paugh, Steven W.; Bryan, Lauren; Kapitonov, Dmitri; Wilczynska, Katarzyna M.; Gopalan, Sunita M.; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Rokita, Hanna] Jagiellonian Univ, Fac Biotechnol, Krakow, Poland; [Milstien, Sheldon] NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	Virginia Commonwealth University; Jagiellonian University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Kordula, T (corresponding author), Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tkordula@vcu.edu	Paugh, Barbara/B-3625-2009; Paugh, Steven/A-7739-2008	Paugh, Steven/0000-0001-5697-9228; Rokita, Hanna/0000-0003-2675-2393; Kapitonov, Dmitri/0000-0001-9177-5239	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [P30 CA016059, R01 CA061774-14, P30 CA16059, R01 CA61774, R01 CA061774, R01 CA061774-15] Funding Source: Medline; NINDS NIH HHS [R01 NS044118-04, R01 NS044118-02, R01 NS044118-03, R01 NS044118] Funding Source: Medline; PHS HHS [NSO44118, NSO46280] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044118] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; Anteby EY, 2004, MOL HUM REPROD, V10, P229, DOI 10.1093/molehr/gah031; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Czekay RP, 2004, EXP BIOL MED, V229, P1090, DOI 10.1177/153537020422901102; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Foekens JA, 2000, CANCER RES, V60, P636; Frederick L, 2000, CANCER RES, V60, P1383; Gopalan S, 2005, J NEUROCHEM, V94, P763, DOI 10.1111/j.1471-4159.2005.03204.x; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Hjortland GO, 2004, EXP CELL RES, V294, P130, DOI 10.1016/j.yexcr.2003.10.013; HOPKINS WE, 1991, NUCLEIC ACIDS RES, V19, P163, DOI 10.1093/nar/19.1.163; Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200; JANICKE F, 1991, SEMIN THROMB HEMOST, V17, P303, DOI 10.1055/s-2007-1002624; Kasza A, 2001, CYTOKINE, V16, P187, DOI 10.1006/cyto.2001.0957; Kasza A, 2002, J NEUROCHEM, V83, P696, DOI 10.1046/j.1471-4159.2002.01163.x; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; LANDAU BJ, 1994, CANCER RES, V54, P1105; Levicar N, 2003, ACTA NEUROCHIR, V145, P825, DOI 10.1007/s00701-003-0097-z; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; MAWATARI M, 1991, EXP CELL RES, V192, P574, DOI 10.1016/0014-4827(91)90078-9; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; MIZUNO K, 1991, EUR J BIOCHEM, V202, P931, DOI 10.1111/j.1432-1033.1991.tb16453.x; Mueller MM, 2003, ACTA NEUROCHIR, V145, P999, DOI 10.1007/s00701-003-0132-0; Muracciole X, 2002, INT J RADIAT ONCOL, V52, P592, DOI 10.1016/S0360-3016(01)02699-2; Nagamine Y, 2005, THROMB HAEMOSTASIS, V93, P661, DOI 10.1160/TH04-12-0814; Nakada M, 2003, FRONT BIOSCI, V8, pE261, DOI 10.2741/1016; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; PLATASALAMAN CR, 1991, PEPTIDES, V12, P653, DOI 10.1016/0196-9781(91)90115-6; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Quan AL, 2005, INT J RADIAT ONCOL, V63, P695, DOI 10.1016/j.ijrobp.2005.03.051; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Rooprai HK, 1997, ANTICANCER RES, V17, P4151; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SEEBACHER T, 1992, EXP CELL RES, V203, P504, DOI 10.1016/0014-4827(92)90029-8; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Valter MM, 1999, INT J DEV NEUROSCI, V17, P565, DOI 10.1016/S0736-5748(99)00048-9; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; VONDEIMLING A, 1992, J NEUROSURG, V77, P295, DOI 10.3171/jns.1992.77.2.0295; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Yamaguchi K, 2005, CANCER CHEMOTH PHARM, V56, P585, DOI 10.1007/s00280-005-1030-3	50	65	70	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					455	465		10.1096/fj.07-8276com	http://dx.doi.org/10.1096/fj.07-8276com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17855624	Green Accepted			2022-12-25	WOS:000252822600016
J	Schildknecht, S; Daiber, A; Ghisla, S; Cohen, RA; Bachschmid, MM				Schildknecht, Stefan; Daiber, Andreas; Ghisla, Sandro; Cohen, Richard A.; Bachschmid, Markus M.			Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite	FASEB JOURNAL			English	Article						endothelium; cyclooxygenase; superoxide; nitric oxide; peroxide tone	PROSTAGLANDIN-H SYNTHASE; N-ACYLPHENOLAMINE AM404; PROSTACYCLIN SYNTHESIS; NITRIC-OXIDE; CYCLOOXYGENASE; MECHANISM; MACROPHAGES; NITRATION; CELLS; PARACETAMOL	The primary pharmacological target of acetaminophen is prostaglandin endoperoxide H-2 synthase (PGHS). The enzymatic catalytic mechanism is radical-based, initiated, and maintained by the persistent presence of peroxides, particularly peroxynitrite, which is termed "peroxide tone". Whereas the prevailing concept assumes a direct reduction of the active, oxidized enzyme by acetaminophen, here we show that acetaminophen is a potent scavenger of peroxynitrite (peroxynitrite- mediated phenol nitration, IC50 approximate to 72 mu M; Sin-1-mediated DHR123 oxidation, IC50 approximate to 11 mu M) and thus inhibits PGHS by eliminating the peroxide tone. Nanomolar concentrations of peroxynitrite increased the activity of isolated PGHS and prostacyclin formation by aortic endothelial cells. This elevated activity was efficiently inhibited by pharmacologically relevant concentrations of acetaminophen ( IC50 approximate to 10 mu M for 6-keto-PGF(1 alpha)) and other free radical scavengers. However, when the peroxide tone was provided by H2O2 or tert-butyl-OOH, acetaminophen had only negligible inhibitory effects. Our concept could help to explain the efficacy of acetaminophen to inhibit PGHS in cell types with moderate oxidant formation. However, high levels of peroxynitrite or other peroxides such as lipid peroxides formed at inflammatory sites might overwhelm the ability of acetaminophen to decrease PGHS activation. The concept presented herein provides a molecular basis to explain the excellent analgesic and antipyretic properties of acetaminophen together with its minimal anti-inflammatory effects.-Schildknecht, S., Daiber, A., Ghisla, S., Cohen, R. A., Bachschmid, M. M. Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite.	[Schildknecht, Stefan; Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Sch Med, Dept Med, Vasc Biol Unit, Boston, MA 02118 USA; [Daiber, Andreas] Johannes Gutenberg Univ Mainz, Dept Cardiol, Mainz, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biochem, Constance, Germany	Boston University; Johannes Gutenberg University of Mainz; University of Konstanz	Bachschmid, MM (corresponding author), Boston Univ, Sch Med, Dept Med, Vasc Biol Unit, 650 Albany St X720, Boston, MA 02118 USA.	bach@bu.edu		/0000-0002-1070-6408; Bachschmid, Markus Michael/0000-0002-0748-5528	NCRR NIH HHS [P41RR10888-6] Funding Source: Medline; NHLBI NIH HHS [P01 HL 68758, N01-HV-28178, P01 HL081738] Funding Source: Medline; NIA NIH HHS [R01 AG027080] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027080] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Aronoff DM, 2003, J PHARMACOL EXP THER, V304, P589, DOI 10.1124/jpet.102.042853; Bachschmid M, 2003, FASEB J, V17, P914, DOI 10.1096/fj.02-0530fje; Bakovic M, 1996, J BIOL CHEM, V271, P2048, DOI 10.1074/jbc.271.4.2048; Bambai B, 2000, J BIOL CHEM, V275, P27608; Caballero FJ, 2007, BIOCHEM PHARMACOL, V73, P1013, DOI 10.1016/j.bcp.2006.12.001; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; CUSHMAN DW, 1976, BIOCHIM BIOPHYS ACTA, V424, P449, DOI 10.1016/0005-2760(76)90034-5; Daiber A, 1998, NITRIC OXIDE-BIOL CH, V2, P259, DOI 10.1006/niox.1998.0186; DEWHIRST FE, 1980, PROSTAGLANDINS, V20, P209, DOI 10.1016/S0090-6980(80)80040-2; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; FELDBERG W, 1973, J PHYSIOL-LONDON, V228, P41, DOI 10.1113/jphysiol.1973.sp010071; FELDBERG W, 1973, J PHYSIOL-LONDON, V234, P279, DOI 10.1113/jphysiol.1973.sp010346; Greco A, 2003, J NEUROSCI RES, V71, P844, DOI 10.1002/jnr.10543; GREEN K, 1989, PROSTAG OTH LIPID M, V37, P311, DOI 10.1016/0090-6980(89)90001-4; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; HANEL AM, 1982, BIOCHEM PHARMACOL, V31, P3307, DOI 10.1016/0006-2952(82)90565-2; Harvison P J, 1986, Adv Exp Med Biol, V197, P739; HARVISON PJ, 1988, CHEM-BIOL INTERACT, V64, P251, DOI 10.1016/0009-2797(88)90101-9; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kis B, 2005, AM J PHYSIOL-REG I, V288, pR897, DOI 10.1152/ajpregu.00613.2004; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Lakshmi VM, 2000, CHEM RES TOXICOL, V13, P891, DOI 10.1021/tx000115g; Lucas R, 2005, FASEB J, V19, P635, DOI 10.1096/fj.04-2437fje; Merrill GF, 2001, BASIC RES CARDIOL, V96, P423, DOI 10.1007/s003950170023; Moldeus P, 1981, Adv Exp Med Biol, V136 Pt B, P1099; Ouellet M, 2001, ARCH BIOCHEM BIOPHYS, V387, P273, DOI 10.1006/abbi.2000.2232; POTTER DW, 1987, J BIOL CHEM, V262, P974; ROBAK J, 1978, BIOCHEM PHARMACOL, V27, P393, DOI 10.1016/0006-2952(78)90367-2; ROBERTS DW, 1987, J PHARMACOL EXP THER, V241, P527; Schildknecht S, 2006, BIOCHEM BIOPH RES CO, V340, P318, DOI 10.1016/j.bbrc.2005.12.009; Schildknecht S, 2005, FASEB J, V19, P1169, DOI 10.1096/fj.04-3465fje; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; THOMAS DJ, 1990, MOL PHARMACOL, V37, P255; Trostchansky A, 2007, FREE RADICAL BIO MED, V42, P1029, DOI 10.1016/j.freeradbiomed.2007.01.009; van Dalen CJ, 2000, J BIOL CHEM, V275, P11638, DOI 10.1074/jbc.275.16.11638; Van Dyke K, 1998, J BIOLUM CHEMILUM, V13, P339; WELLER PE, 1985, ARCH BIOCHEM BIOPHYS, V243, P633, DOI 10.1016/0003-9861(85)90541-7; ZENSER TV, 1978, METABOLISM, V27, P227, DOI 10.1016/0026-0495(78)90168-3	41	40	41	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					215	224		10.1096/fj.06-8015com	http://dx.doi.org/10.1096/fj.06-8015com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17724253	Green Submitted			2022-12-25	WOS:000252309900024
J	Rak, M; Tetaud, E; Duvezin-Caubet, S; Ezkurdia, N; Bietenhader, M; Rytka, J; di Rago, JP				Rak, Malgorzata; Tetaud, Emmanuel; Duvezin-Caubet, Stephane; Ezkurdia, Nahia; Bietenhader, Maielis; Rytka, Joanna; di Rago, Jean-Paul			A yeast model of the neurogenic ataxia retinitis pigmentosa (NARP) T8993G mutation in the mitochondrial ATP synthase-6 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C SUBUNIT OLIGOMER; SACCHAROMYCES-CEREVISIAE; LEIGH-SYNDROME; OXIDATIVE-PHOSPHORYLATION; F1F0-ATP SYNTHASE; ESCHERICHIA-COLI; PROTON TRANSPORT; DNA MUTATION; MTDNA; F-1-ATPASE	NARP (neuropathy, ataxia, and retinitis pigmentosa) and MILS (maternally inherited Leigh syndrome) are mitochondrial disorders associated with point mutations of the mitochondrial DNA (mtDNA) in the gene encoding the Atp6p subunit of the ATP synthase. The most common and studied of these mutations is T8993G converting the highly conserved leucine 156 into arginine. We have introduced this mutation at the corresponding position (183) of yeast Saccharomyces cerevisiae mitochondrially encoded Atp6p. The "yeast NARP mutant" grew very slowly on respiratory substrates, possibly because mitochondrial ATP synthesis was only 10% of the wild type level. The mutated ATP synthase was found to be correctly assembled and present at nearly normal levels (80% of the wild type). Contrary to what has been reported for human NARP cells, the reverse functioning of the ATP synthase, i.e. ATP hydrolysis in the F-1 coupled to F-0-mediated proton translocation out of the mitochondrial matrix, was significantly compromised in the yeast NARP mutant. Interestingly, the oxygen consumption rate in the yeast NARP mutant was decreased by about 80% compared with the wild type, due to a selective lowering in cytochrome c oxidase (complex IV) content. This finding suggests a possible regulatory mechanism between ATP synthase activity and complex IV expression in yeast mitochondria. The availability of a yeast NARP model could ease the search for rescuing mechanisms against this mitochondrial disease.	Univ Bordeaux 2, Inst Biochim & Genet Cellulaires, CNRS, F-33077 Bordeaux, France; Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	di Rago, JP (corresponding author), Univ Bordeaux 2, Inst Biochim & Genet Cellulaires, CNRS, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	jp.dirago@ibgc.u-bordeaux2.fr		Duvezin-Caubet, Stephane/0000-0002-0243-2697				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729; Carrozzo R, 2000, FEBS LETT, V486, P297, DOI 10.1016/S0014-5793(00)02244-4; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Cortes-Hernandez P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fillingame RH, 2000, NAT STRUCT BIOL, V7, P1002, DOI 10.1038/80902; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Guerin B, 1979, Methods Enzymol, V55, P149; HARTZOG PE, 1993, J BIOL CHEM, V268, P12250; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Hosokawa H, 2005, J BIOL CHEM, V280, P23797, DOI 10.1074/jbc.M502650200; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386; Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103; Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200; ONISHI T, 1967, EUR J BIOCHEM, V1, P301, DOI 10.1111/j.1432-1033.1967.tb00074.x; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; REAUME SE, 1949, ARCH BIOCHEM, V22, P331; RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Schwimmer Christine, 2006, Biotechnology Journal, V1, P270, DOI 10.1002/biot.200500053; Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748; SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t	49	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34039	34047		10.1074/jbc.M703053200	http://dx.doi.org/10.1074/jbc.M703053200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855363	hybrid			2022-12-25	WOS:000251145700018
J	Rusinova, R; Mirshahi, T; Logothetis, DE				Rusinova, Radda; Mirshahi, Tooraj; Logothetis, Diomedes E.			Specificity of g beta gamma signaling to kir3 channels depends on the helical domain of pertussis toxin-sensitive g alpha Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+-CHANNEL; HETEROTRIMERIC G-PROTEINS; POTASSIUM CHANNEL; INTERDOMAIN INTERACTIONS; MUSCARINIC RECEPTOR; INDUCED INHIBITION; ADENYLYL-CYCLASE; PHOSPHOLIPASE-C; I-KACH; ACTIVATION	Acetylcholine signaling through muscarinic type 2 receptors activates atrial G protein-gated inwardly rectifying K+ (Kir3) channels via the beta gamma subunits of G proteins (G beta gamma). Different combinations of recombinant G beta gamma subunits have been shown to activate Kir3 channels in a similar manner. In native systems, however, only G beta gamma subunits associated with the pertussis toxin-sensitive G alpha(i/o) subunits signal to K+ channels. Additionally, in vitro binding experiments supported the notion that the C terminus of Kir3 channels interacts preferentially with G alpha(i) over G alpha(q). In this study we confirmed in two heterologous expression systems a preference of G alpha(i) over G alpha(q) in the activation of K+ currents. To identify determinants of G beta gamma signaling specificity, we first exchanged domains of G alpha(i) and G alpha(q) subunits responsible for receptor coupling selectivity and swapped their receptor coupling partners. Our results established that the G proteins, regardless of the receptor type to which they coupled, conferred specificity to Kir3 activation. We next tested signaling through chimeras between the G alpha(i) and G alpha(q) subunits in which the N terminus, the helical, or the GTPase domains of theG alpha subunits were exchanged. Our results revealed that the helical domain of G alpha(i) (residues 63-175) in the background of G alpha(q) could support Kir3 activation, whereas the reverse chimera could not. Moreover, the helical domain of theG alpha(i) subunit conferred "G alpha(i)-like" binding of the Kir3 C terminus to the G alpha(q) subunits that contained it. These results implicate the helical domain of G alpha(i) proteins as a critical determinant of G beta gamma signaling specificity.	Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Logothetis, DE (corresponding author), Icahn Med Inst, Rm 16-20B,1 Gustave L Levy Pl,Box 1677, New York, NY 10029 USA.	Diomedes.Logothetis@mssm.edu			NHLBI NIH HHS [HL 54185, T32 HL 07824] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054185, T32HL007824] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Bahia DS, 1998, BIOCHEMISTRY-US, V37, P11555, DOI 10.1021/bi980284o; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cohen NA, 1996, J BIOL CHEM, V271, P32301, DOI 10.1074/jbc.271.50.32301; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; FUNG BKK, 1983, J BIOL CHEM, V258, P503; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; HUNT TW, 1994, J BIOL CHEM, V269, P29565; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Kawano T, 2007, MOL PHARMACOL, V71, P1179, DOI 10.1124/mol.106.032508; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kozasa Tohru, 2003, V237, P21; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu W, 1998, P NATL ACAD SCI USA, V95, P12878, DOI 10.1073/pnas.95.22.12878; Lober RM, 2006, J NEUROSCI, V26, P12602, DOI 10.1523/JNEUROSCI.4020-06.2006; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Marin EP, 2001, J BIOL CHEM, V276, P23873, DOI 10.1074/jbc.M101197200; Medina R, 1996, J BIOL CHEM, V271, P24720, DOI 10.1074/jbc.271.40.24720; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; NOMA A, 1978, PFLUG ARCH EUR J PHY, V377, pR4; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Remmers AE, 1999, BIOCHEMISTRY-US, V38, P13795, DOI 10.1021/bi990887f; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; STEHNOBITTEL L, 1995, J BIOL CHEM, V270, P30068; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; WILSON PT, 1995, J BIOL CHEM, V270, P9667, DOI 10.1074/jbc.270.16.9667	68	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34019	34030		10.1074/jbc.M704928200	http://dx.doi.org/10.1074/jbc.M704928200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17872944	hybrid			2022-12-25	WOS:000251145700016
J	Xie, Y; Kerscher, O; Kroetz, MB; McConchie, HF; Sung, P; Hochstrasser, M				Xie, Yang; Kerscher, Oliver; Kroetz, Mary B.; McConchie, Heather F.; Sung, Patrick; Hochstrasser, Mark			The yeast Hex3.Slx8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; RING-RING COMPLEX; SACCHAROMYCES-CEREVISIAE; SUMO MODIFICATION; MAT-ALPHA-2 REPRESSOR; RAD51 RECOMBINASE; DNA-REPLICATION; DEGRADATION; BINDING; GENE	Hex3 and Slx8 are Saccharomyces cerevisiae proteins with important functions in DNA damage control and maintenance of genomic stability. Both proteins have RING domains at their C termini. Such domains are common in ubiquitin and ubiquitin-like protein ligases (E3s), but little was known about the molecular functions of either protein. In this study we identified HEX3 as a high-copy suppressor of a temperature-sensitive small ubiquitin-related modifier (SUMO) protease mutant, ulp1ts, suggesting that it may affect cellular SUMO dynamics. Remarkably, even a complete deletion of ULP1 is strongly suppressed. Hex3 forms a heterodimer with Slx8. We found that the Hex3 center dot Slx8 complex has a robust substrate-specific E3 ubiquitin ligase activity. In this E3 complex, Slx8 appears to bear the core ligase function, with Hex3 strongly enhancing its activity. Notably, SUMO attachment to a substrate stimulates its Hex3 center dot Slx8 dependent ubiquitination, primarily through direct noncovalent interactions between SUMO and Hex3. Our data reveal a novel mechanism of substrate targeting in which sumoylation of a protein can help trigger its subsequent ubiquitination by recruiting a SUMO-binding ubiquitin ligase.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA	Yale University; Yale University; William & Mary	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053756, R01GM046904, R37GM046904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 053756, GM 046904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Boulton SJ, 2006, CELL CYCLE, V5, P1481, DOI 10.4161/cc.5.14.2930; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Dobson MJ, 2005, MOL CELL BIOL, V25, P4299, DOI 10.1128/MCB.25.10.4299-4310.2005; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GUTHRIE C, 1991, GUIDE YEAST GENETIC; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Mullen JR, 2001, GENETICS, V157, P103; NASMYTH KA, 1980, CELL, V19, P753, DOI 10.1016/S0092-8674(80)80051-1; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010	50	185	189	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34176	34184		10.1074/jbc.M706025200	http://dx.doi.org/10.1074/jbc.M706025200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17848550	hybrid			2022-12-25	WOS:000251145700032
J	Chemin, J; Mezghrani, A; Bidaud, I; Dupasquier, S; Marger, F; Barrere, C; Nargeot, J; Lory, P				Chemin, Jean; Mezghrani, Alexandre; Bidaud, Isabelle; Dupasquier, Sebastien; Marger, Fabrice; Barrere, Christian; Nargeot, Joel; Lory, Philippe			Temperature-dependent modulation of Ca(V)3 T-type calcium channels by protein kinases C and A in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; MOLECULAR-BASIS; INHIBITION; CURRENTS; MECHANISMS; ALPHA(1G); NEURONS; PHOSPHORYLATION; DETERMINANTS; SUBUNIT	Modulation of low voltage- activated Ca(V)3 T- type calcium channels remains poorly characterized compared with high voltage- activated Ca(V)1 and Ca(V)2 calcium channels. Notably, it is yet unresolved whether Ca(V)3 channels are modulated by protein kinases in mammalian cells. In this study, we demonstrate that protein kinase A ( PKA) and PKC ( but not PKG) activation induces a potent increase in Ca(V)3.1, Ca(V)3.2, and Ca(V)3.3 currents in various mammalian cell lines. Notably, we show that protein kinase effects occur at physiological temperature( similar to 30 - 37 degrees C) but not at room temperature ( similar to 22 - 27 C). This temperature dependence could involve kinase translocation, which is impaired at room temperature. A similar temperature dependence was observed for PKC- mediated increase in high voltage- activated Ca(V)2.3 currents. We also report that neither CaV3 surface expression nor T- current macroscopic properties are modified upon kinase activation. In addition, we provide evidence for the direct phosphorylation of Ca(V)3.2 channels by PKA in in vitro assays. Overall, our results clearly establish the role of PKA and PKC in the modulation of Ca(V)3 T- channels and further highlight the key role of the physiological temperature in the effects described.	Univ Montpellier I, Inst Federatif Rech 3, Inst Genom Fonct,U661, Dept Oncol Mol & Cellulaire,CNRS UMR 2503,INSERM, F-34094 Montpellier, France; Univ Montpellier 2, Inst Federatif Rech 3, Inst Genom Fonct,U661, Dept Oncol Mol & Cellulaire,CNRS UMR 2503,INSERM, F-34094 Montpellier, France; Univ Montpellier 2, Inst Federatif Rech 3, Dept Physiol, F-34094 Montpellier, France; Univ Montpellier I, Inst Federatif Rech 3, Dept Physiol, F-34094 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Chemin, J (corresponding author), Inst Genom Fonct, Dept Physiol, 141 Rue Cardonille, F-34094 Montpellier, France.	jean.chemin@igf.cnrs.fr		BIDAUD, Isabelle/0000-0002-1812-1447; Barrere, Christian/0000-0001-8710-0976; Nargeot, Joel/0000-0003-2893-5636; chemin, jean/0000-0002-6089-5964; LORY, philippe/0000-0002-1638-7604				ALVAREZ JL, 1992, J GEN PHYSIOL, V100, P519, DOI 10.1085/jgp.100.3.519; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2001, EUR J NEUROSCI, V14, P1678, DOI 10.1046/j.0953-816x.2001.01796.x; Chemin J, 2001, BIOPHYS J, V80, P1238, DOI 10.1016/S0006-3495(01)76100-0; Chemin J, 2007, J BIOL CHEM, V282, P2314, DOI 10.1074/jbc.M610033200; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; Lehel C, 1996, BIOCHEM BIOPH RES CO, V223, P98, DOI 10.1006/bbrc.1996.0852; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Mullner C, 2004, J BIOL CHEM, V279, P51844, DOI 10.1074/jbc.M408756200; Noma A, 1996, JPN HEART J, V37, P673; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Park JY, 2003, FEBS LETT, V547, P37, DOI 10.1016/S0014-5793(03)00665-3; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; SMITH BL, 1992, BIOCHEM BIOPH RES CO, V188, P1235, DOI 10.1016/0006-291X(92)91363-U; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; VASSORT G, 1969, PFLUG ARCH EUR J PHY, V309, P70, DOI 10.1007/BF00592283; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Wolfe JT, 2002, J PHYSIOL-LONDON, V538, P343, DOI 10.1113/jphysiol.2001.012839; Yao JL, 2006, J CLIN INVEST, V116, P2403, DOI 10.1172/JCI27918; Zhang Y, 2000, AM J PHYSIOL-HEART C, V278, pH184, DOI 10.1152/ajpheart.2000.278.1.H184; Zhong XL, 2006, HUM MOL GENET, V15, P1497, DOI 10.1093/hmg/ddl068	54	64	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32710	32718		10.1074/jbc.M702746200	http://dx.doi.org/10.1074/jbc.M702746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855364	hybrid			2022-12-25	WOS:000250625400019
J	Kang, NJ; Lee, KW; Rogozin, EA; Cho, YY; Heo, YS; Bode, AM; Lee, HJ; Dong, Z				Kang, Nam Joo; Lee, Ki Won; Rogozin, Evgeny A.; Cho, Yong-Yeon; Heo, Yong-Seok; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR PROTEIN-1; TEA POLYPHENOLS; GREEN TEA; AP-1 TRANSACTIVATION; KINASE KINASE; GROWTH; FLAVONOIDS; GENISTEIN; DAMAGE; DNA	Daidzein and genistein are isoflavones found in soybean. Genistein is known to exhibit anticarcinogenic activities and inhibit tyrosine kinase activity. However, the underlying molecular mechanisms of the chemopreventive activities of daidzein and its metabolite, equol, are not understood. Here we report that equol inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced neoplastic transformation of JB6 P+ mouse epidermal cells by targeting the MEK/ERK/p90RSK/activator protein-1 signaling pathway. TPA-induced neoplastic cell transformation was inhibited by equol, but not daidzein, at noncytotoxic concentrations in a dose-dependent manner. Equol dose-dependently attenuated TPA-induced activation of activator protein-1 and c-fos, whereas daidzein did not exert any effect when tested at the same concentrations. The TPA-induced phosphorylation of ERK1/2, p90RSK, and Elk, but not MEK or c-Jun N-terminal kinase, was inhibited by equol but not by daidzein. In vitro kinase assays revealed that equol greatly inhibited MEK1, but not Raf1, kinase activity, and an ex vivo kinase assay also demonstrated that equol suppressed TPA-induced MEK1 kinase activity in JB6 P+ cell lysates. Equol dose-dependently inhibited neoplastic transformation of JB6 P+ cells induced by epidermal growth factor or H-Ras. Both in vitro and ex vivo pull-down assays revealed that equol directly bound with glutathione S-transferase-MEK1 to inhibit MEK1 activity without competing with ATP. These results suggested that the antitumor-promoting effect of equol is due to the inhibition of cell transformation mainly by targeting a MEK signaling pathway. These findings are the first to reveal a molecular basis for the anticancer action of equol and may partially account for the reported chemopreventive effects of soybean.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea; Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; Konkuk Univ, Dept Chem, Seoul 143701, South Korea	University of Minnesota System; Seoul National University (SNU); Konkuk University; Konkuk University	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Lee, Ki Won/M-4114-2018; Heo, Yong-Seok/D-8244-2011; Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651	NCI NIH HHS [CA 88961, CA 120388, CA 81064, CA 111536] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, P01CA088961, R01CA081064, R37CA081064] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams SI, 1996, SEMIN ONCOL, V23, P118; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Arora A, 1998, ARCH BIOCHEM BIOPHYS, V356, P133, DOI 10.1006/abbi.1998.0783; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Chang YC, 1995, J NAT PROD, V58, P1901, DOI 10.1021/np50126a016; Chung JY, 1999, CANCER RES, V59, P4610; Chung JY, 2001, FASEB J, V15, P2022, DOI 10.1096/fj.01-0031fje; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DONG Z, 2002, SCI STKE 2002, pP67; Dong ZG, 1997, J BIOL CHEM, V272, P9962; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Dong ZG, 1997, CANCER RES, V57, P4414; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; ELDRIDGE AC, 1983, J AGR FOOD CHEM, V31, P394, DOI 10.1021/jf00116a052; Galati G, 2004, FREE RADICAL BIO MED, V37, P287, DOI 10.1016/j.freeradbiomed.2004.04.034; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Iwashita K, 2000, BIOSCI BIOTECH BIOCH, V64, P1813, DOI 10.1271/bbb.64.1813; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KELLY GE, 1995, P SOC EXP BIOL MED, V208, P40, DOI 10.3181/00379727-208-43829; Kim H, 1998, AM J CLIN NUTR, V68, p1418S, DOI 10.1093/ajcn/68.6.1418S; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee KW, 2006, BIOFACTORS, V26, P105, DOI 10.1002/biof.5520260202; Lee KW, 2006, MECH AGEING DEV, V127, P424, DOI 10.1016/j.mad.2006.01.021; Lee KW, 2005, J AGR FOOD CHEM, V53, P1990, DOI 10.1021/jf0486040; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Oikawa S, 2003, FREE RADICAL RES, V37, P881, DOI 10.1080/1071576031000150751; PETERSON G, 1995, J NUTR, V125, pS784, DOI 10.1093/jn/125.suppl_3.784S; Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601_5; Sang SM, 2005, ANTIOXID REDOX SIGN, V7, P1704, DOI 10.1089/ars.2005.7.1704; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; Sierens J, 2001, MUTAT RES-DNA REPAIR, V485, P169, DOI 10.1016/S0921-8777(00)00069-0; SPINOZZI F, 1994, LEUKEMIA RES, V18, P431, DOI 10.1016/0145-2126(94)90079-5; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Verma SP, 1998, NUTR CANCER, V30, P232, DOI 10.1080/01635589809514669; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; Widyarini S, 2005, PHOTOCHEM PHOTOBIOL, V81, P32, DOI 10.1562/2004-06-02-RA-183.1; Widyarini S, 2006, J VET SCI, V7, P217, DOI 10.4142/jvs.2006.7.3.217; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307; Zachos G, 1997, CRIT REV ONCOL HEMAT, V26, P65, DOI 10.1016/S1040-8428(97)00013-9; Zhong SP, 2001, CANCER RES, V61, P4084	50	60	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32856	32866		10.1074/jbc.M701459200	http://dx.doi.org/10.1074/jbc.M701459200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17724030	hybrid			2022-12-25	WOS:000250625400035
J	Schmidt, V; Sporbert, A; Rohe, M; Reimer, T; Rehm, A; Andersen, OM; Willnow, TE				Schmidt, Vanessa; Sporbert, Anje; Rohe, Michael; Reimer, Tatjana; Rehm, Armin; Andersen, Olav M.; Willnow, Thomas E.			SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; TRANS-GOLGI NETWORK; ALZHEIMER-DISEASE; CYTOPLASMIC DOMAIN; SORTING RECEPTOR; BETA-PEPTIDE; TRAFFICKING; GENERATION; CELLS; PATHOGENESIS	SorLA has been recognized as a novel sorting receptor that regulates trafficking and processing of the amyloid precursor protein (APP) and that represents a significant risk factor for sporadic Alzheimer disease. Here, we investigated the cellular mechanisms that control intracellular trafficking of sorLA and their relevance for APP processing. We demonstrate that sorLA acts as a retention factor for APP in trans-Golgi compartments/trans-Golgi network, preventing release of the precursor into regular processing pathways. Proper localization and activity of sorLA are dependent on functional interaction with GGA and PACS-1, adaptor proteins involved in protein transport to and from the trans-Golgi network. Aberrant targeting of sorLA to the recycling compartment or the plasma membrane causes faulty APP trafficking and imbalance in non-amyloidogenic and amyloidogenic processing fates. Thus, our findings identified altered routing of sorLA as a major cellular mechanism contributing to abnormal APP processing and enhanced amyloid alpha-peptide formation.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Willnow, TE (corresponding author), Max Delbruck Ctr Mol Med, Robert Roessle Str 10, D-13125 Berlin, Germany.	willnow@mdc-berlin.de	Andersen, Olav/N-2777-2017	Andersen, Olav/0000-0003-4226-3354; Willnow, Thomas/0000-0001-9515-7921				Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; De Strooper B, 2000, J CELL SCI, V113, P1857; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Doray B, 2002, J BIOL CHEM, V277, P18477, DOI 10.1074/jbc.M201879200; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; Ghosh P, 2004, EUR J CELL BIOL, V83, P257, DOI 10.1078/0171-9335-00374; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hampe W, 2000, J CELL SCI, V113, P4475; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Khvotchev M, 2004, J BIOL CHEM, V279, P47101, DOI 10.1074/jbc.M408474200; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Peraus GC, 1997, J NEUROSCI, V17, P7714; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Sudoh S, 2000, EUR J BIOCHEM, V267, P2036, DOI 10.1046/j.1432-1327.2000.01206.x; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; von Arnim CAF, 2006, J NEUROSCI, V26, P9913, DOI 10.1523/JNEUROSCI.2290-06.2006; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431	34	136	140	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32956	32964		10.1074/jbc.M705073200	http://dx.doi.org/10.1074/jbc.M705073200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855360	hybrid			2022-12-25	WOS:000250625400044
J	Bahari, L; Parlitz, R; Eitan, A; Stjepanovic, G; Bochkareva, ES; Sinning, I; Bibi, E				Bahari, Liat; Parlitz, Richard; Eitan, Asa; Stjepanovic, Goran; Bochkareva, Elena S.; Sinning, Irmgard; Bibi, Eitan			Membrane targeting of Ribosomes and their release require distinct and separable functions of ftsy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; SRP RECEPTOR FTSY; ESCHERICHIA-COLI; INNER MEMBRANE; ACIDIC PHOSPHOLIPIDS; CRYSTAL-STRUCTURE; GTPASE DOMAIN; NG DOMAIN; PROTEIN; BINDING	The mechanism underlying the interaction of the Escherichia coli signal recognition particle ( SRP) receptor FtsY with the cytoplasmic membrane is not fully understood. We investigated this issue by utilizing active ( NG + 1) and inactive ( NG) mutants of FtsY. In solution, the mutants comparably bind and hydrolyze nucleotides and associate with SRP. In contrast, a major difference was observed in the cellular distribution of NG and NG + 1. Unlike NG + 1, which distributes almost as the wild-type receptor, the inactive NG mutant accumulates on the membrane, together with ribosomes and SRP. The results suggest that NG function is compromised only at a later stage of the targeting pathway and that despite their identical behavior in solution, the membrane-bound NG-SRP complex is less active than NG + 1-SRP. This notion is strongly supported by the observation that lipids stimulate the GTPase activity of NG + 1-SRP, whereas no stimulation is observed with NG-SRP. In conclusion, we propose that the SRP receptor has two distinct and separable roles in ( i) mediating membrane targeting and docking of ribosomes and ( ii) promoting their productive release from the docking site.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Univ Heidelberg, Biochemiezentrum, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Ruprecht Karls University Heidelberg	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Stjepanovic, Goran/A-7902-2010; Sinning, Irmgard/A-2982-2010	Stjepanovic, Goran/0000-0002-4841-9949; Bibi, Eitan/0000-0003-3700-2707				Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; Bibi E, 2001, TRENDS BIOCHEM SCI, V26, P15, DOI 10.1016/S0968-0004(00)01711-4; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; deLeeuw E, 1997, FEBS LETT, V416, P225, DOI 10.1016/S0014-5793(97)01238-6; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gariani T, 2006, J STRUCT BIOL, V153, P85, DOI 10.1016/j.jsb.2005.10.003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; KUSTERS R, 1995, FEBS LETT, V372, P253, DOI 10.1016/0014-5793(95)00997-N; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; Millman JS, 1999, J BIOL CHEM, V274, P33227, DOI 10.1074/jbc.274.47.33227; Millman JS, 2001, J BIOL CHEM, V276, P25982, DOI 10.1074/jbc.M011331200; Montoya G, 2000, STRUCTURE, V8, P515, DOI 10.1016/S0969-2126(00)00131-3; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Shepotinovskaya IV, 2002, BBA-PROTEIN STRUCT M, V1597, P107, DOI 10.1016/S0167-4838(02)00287-X; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	37	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32168	32175		10.1074/jbc.M705429200	http://dx.doi.org/10.1074/jbc.M705429200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726013	hybrid			2022-12-25	WOS:000250480300039
J	Beyer, KS; Beauchamp, RL; Lee, MF; Gusella, JF; Naar, AM; Ramesh, V				Beyer, Kim S.; Beauchamp, Roberta L.; Lee, Ming-Fen; Gusella, James F.; Naar, Anders M.; Ramesh, Vijaya			Mediator subunit MED28 (magicin) is a repressor of smooth muscle cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE EG-1; COMPLEX; TRANSCRIPTION; PROTEIN; IDENTIFICATION; COACTIVATORS; ACTIVATION; EXPRESSION; FAMILY	Magicin, a protein that we isolated earlier as an interactor of the neurofibromatosis 2 protein merlin, was independently identified as MED28, a subunit of the mammalian Mediator complex. Mediator complex is an evolutionarily conserved transcriptional cofactor, which plays an essential role in positive and negative gene regulation. Distinct Mediator subunit composition is thought to contribute to gene regulation specificity based on the interaction of specific subunits with subsets of transcription factors. Here we report that down-regulation of Med28 expression in NIH3T3 cells results in a significant induction of several genes associated with smooth muscle cell ( SMC) differentiation. Conversely, overexpression of MED28 represses expression of SMC genes, in concordance with our knockdown data. More importantly, multipotent mesenchymal-derived murine precursors can transdifferentiate into SMCs when Med28 is down-regulated. Our data also show that Med28 functions as a negative regulator of SMC differentiation in concert with other Mediator subunits including Med6, Med8, and Med18 within the Mediator head module. Our results provide strong evidence that MED28 may function as a scaffolding protein by maintaining the stability of a submodule within the head module and that components of this submodule act together in a gene regulatory program to suppress SMC differentiation. The results presented here demonstrate for the first time that the mammalian Mediator subunit MED28 functions as a repressor of SMC differentiation, which could have implications for disorders associated with abnormalities in SMC growth and differentiation, including atherosclerosis, asthma, hypertension, and smooth muscle tumors.	Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Cell Biol, Massachusetts Gen Hosp,Canc Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ramesh, V (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Simches Res Bldg,185 Cambridge ST, Boston, MA 02114 USA.	ramesh@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279, P30NS045776] Funding Source: NIH RePORTER; NINDS NIH HHS [NS45776, NS24279] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Gu JY, 2002, J BIOL CHEM, V277, P27154, DOI 10.1074/jbc.M204144200; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee MF, 2006, BIOCHEM BIOPH RES CO, V348, P826, DOI 10.1016/j.bbrc.2006.07.126; Liu CH, 2002, BIOCHEM BIOPH RES CO, V290, P602, DOI 10.1006/bbrc.2001.6119; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lu M, 2005, CANCER RES, V65, P6159, DOI 10.1158/0008-5472.CAN-04-4016; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang S, 2004, J BIOL CHEM, V279, P13593, DOI 10.1074/jbc.M312274200; Wiederhold T, 2004, ONCOGENE, V23, P8815, DOI 10.1038/sj.onc.1208110; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zhang LP, 2004, CLIN CANCER RES, V10, P3504, DOI 10.1158/1078-0432.CCR-03-0467	28	20	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32152	32157		10.1074/jbc.M706592200	http://dx.doi.org/10.1074/jbc.M706592200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848560	hybrid			2022-12-25	WOS:000250480300037
J	Doppler, H; Storz, P				Doeppler, Heike; Storz, Peter			A novel tyrosine phosphorylation site in protein kinase D contributes to oxidative stress-mediated activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; NF-KAPPA-B; D-DEPENDENT ACTIVATION; MU PKC-MU; C-DELTA; LYSOPHOSPHATIDIC ACID; LOOP PHOSPHORYLATION; DOWNSTREAM TARGET; CELLS; BINDING	Protein kinase D1 (PKD1) is a mediator of oxidative stress signaling where it regulates cellular detoxification and survival. Critical for the regulation of PKD1 activity in response to oxidative stress are Src- and Abl- mediated tyrosine phosphorylations that eventually lead to protein kinase C delta(PKC delta)- mediated activation of PKD1. Here we identify Tyr95 in PKD1 as a previously undescribed phosphorylation site that is regulated by oxidative stress. Our data suggest that PKD1 phosphorylation at Tyr95 generates a binding motif for PKC delta, and that oxidative stress-mediated PKC delta/PKD interaction results in PKD1 activation loop phosphorylation and activation. We further analyzed all PKD isoforms for this mechanism and show that PKD enzymes PKD1 and PKD2 are targets for PKC delta in response to oxidative stress, and that PKD3 is not a target because it lacks the relevant tyrosine residue that generates a PKC delta interaction motif.	Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Griffin Rm 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu						Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Dekker LV, 1997, J BIOL CHEM, V272, P12747, DOI 10.1074/jbc.272.19.12747; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hu YY, 2007, CELL SIGNAL, V19, P410, DOI 10.1016/j.cellsig.2006.07.017; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; LI WQ, 1994, J BIOL CHEM, V269, P2349; Lopez-Lluch G, 2001, BIOCHEM J, V357, P39, DOI 10.1042/0264-6021:3570039; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Storz P, 2005, BIOCHEM J, V387, P47, DOI 10.1042/BJ20041443; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan MQ, 2004, ARTERIOSCL THROM VAS, V24, P2271, DOI 10.1161/01.ATV.0000148449.92035.3a; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; ZANG Q, 1995, CELL GROWTH DIFFER, V6, P1367	49	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31873	31881		10.1074/jbc.M703584200	http://dx.doi.org/10.1074/jbc.M703584200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804414	hybrid			2022-12-25	WOS:000250480300007
J	Gust, AA; Biswas, R; Lenz, HD; Rauhut, T; Ranf, S; Kemmerling, B; Gotz, F; Glawischnig, E; Lee, J; Felix, G; Nurnberger, T				Gust, Andrea A.; Biswas, Raja; Lenz, Heike D.; Rauhut, Thomas; Ranf, Stefanie; Kemmerling, Birgit; Goetz, Friedrich; Glawischnig, Erich; Lee, Justin; Felix, Georg; Nuernberger, Thorsten			Bacteria-derived peptidoglycans constitute pathogen-associated molecular patterns triggering innate immunity in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-SYRINGAE; PROTEIN-KINASES; SALICYLIC-ACID; COLD-SHOCK; RECOGNITION; PLANTS; FLAGELLIN; THALIANA; CALCIUM; PERCEPTION	Pathogen-associated molecular pattern (PAMP)-triggered immunity constitutes the primary plant immune response that has evolved to recognize invariant structures of microbial surfaces. Here we show that Gram-positive bacteria-derived peptidoglycan (PGN) constitutes a novel PAMP of immune responses in Arabidopsis thaliana. Treatment with PGN from Staphylococcus aureus results in the activation of plant responses, such as medium alkalinization, elevation of cytoplasmic calcium concentrations, nitric oxide, and camalexin production and the post-translational induction of MAPK activities. Microarray analysis performed with RNA prepared from PGN-treated Arabidopsis leaves revealed enhanced transcript levels for 236 genes, many of which are also altered upon administration of flagellin. Comparison of cellular responses after treatment with bacteria-derived PGN and structurally related fungal chitin indicated that both PAMPs are perceived via different perception systems. PGN-mediated immune stimulation in Arabidopsis is based upon recognition of the PGN sugar backbone, while muramyldipeptide, which is inactive in this plant, triggers immunity-associated responses in animals. PGN adds to the list of PAMPs that induce innate immune programs in both plants and animals. However, we propose that PGN perception systems arose independently in both lineages and are the result of convergent evolution.	Univ Tubingen, Ctr Plant Mol Biol Plant Biochem, D-72076 Tubingen, Germany; Tech Univ Munich, Dept Genet, D-85350 Freising Weihenstephan, Germany; Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle, Germany	Eberhard Karls University of Tubingen; Technical University of Munich; Leibniz Institut fur Pflanzenbiochemie	Gust, AA (corresponding author), Univ Tubingen, Ctr Plant Mol Biol Plant Biochem, Morgenstelle 5, D-72076 Tubingen, Germany.	andrea.gust@zmbp.uni-tuebingen.de	poinssot, benoit/B-2569-2009; Ranf, Stefanie/J-2474-2016; Lee, Justin/B-6096-2012	poinssot, benoit/0000-0001-5890-4318; Ranf, Stefanie/0000-0003-2262-2938; Lee, Justin/0000-0001-8269-7494; Glawischnig, Erich/0000-0001-9280-5065				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; ATKINSON MM, 1985, PLANT PHYSIOL, V79, P843, DOI 10.1104/pp.79.3.843; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Filipe SR, 2005, EMBO REP, V6, P327, DOI 10.1038/sj.embor.7400371; Fuerst RAUA, 1996, PLANT PHYSIOL, V112, P1023, DOI 10.1104/pp.112.3.1023; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Hagemeier J, 2001, P NATL ACAD SCI USA, V98, P753, DOI 10.1073/pnas.021551098; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi M, 2007, MOL PLANT MICROBE IN, V20, P599, DOI 10.1094/MPMI-20-6-0599; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KNIGHT MR, 1992, P NATL ACAD SCI USA, V89, P4967, DOI 10.1073/pnas.89.11.4967; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Laird J, 2004, PLANTA, V219, P1089, DOI 10.1007/s00425-004-1355-x; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Loria R, 2006, ANNU REV PHYTOPATHOL, V44, P469, DOI 10.1146/annurev.phyto.44.032905.091147; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Qutob D, 2006, PLANT CELL, V18, P3721, DOI 10.1105/tpc.106.044180; Raacke IC, 2006, MOL PLANT MICROBE IN, V19, P1138, DOI 10.1094/MPMI-19-1138; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Ramonell KM, 2002, MOL PLANT PATHOL, V3, P301, DOI 10.1046/j.1364-3703.2002.00123.x; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Reutter F, 2005, J PEPT RES, V65, P375, DOI 10.1111/j.1399-3011.2005.00242.X; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shapiro AD, 2001, PLANT PHYSIOL, V127, P1089, DOI 10.1104/pp.010096; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; STEWARTTULL DES, 1980, ANNU REV MICROBIOL, V34, P311, DOI 10.1146/annurev.mi.34.100180.001523; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Traub S, 2006, J ENDOTOXIN RES, V12, P69, DOI 10.1179/096805106X89044; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	77	217	228	3	58	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32338	32348		10.1074/jbc.M704886200	http://dx.doi.org/10.1074/jbc.M704886200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761682	hybrid			2022-12-25	WOS:000250480300057
J	Heyes, DJ; Sakuma, M; Scrutton, NS				Heyes, Derren J.; Sakuma, Michiyo; Scrutton, Nigel S.			Laser excitation studies of the product release steps in the catalytic cycle of the light-driven enzyme, protochlorophyllide oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLVENT VISCOSITY; DYNAMICS; NADPH; IDENTIFICATION; ENZYMOLOGY; REDUCTION; INSIGHTS	The latter stages of the catalytic cycle of the light- driven enzyme, protochlorophyllide oxidoreductase, have been investigated using novel laser photoexcitation methods. The formation of the ternary product complex was initiated with a 6- ns laser pulse, which allowed the product release steps to be kinetically accessed for the first time. Subsequent absorbance changes associated with the release of the NADP(+) and chlorophyllide products from the enzyme could be followed on a millisecond timescale. This has facilitated a detailed kinetic and thermodynamic characterization for the interconversion of all the various bound and unbound product species. Initially, NADP(+) is released from the enzyme in a biphasic process with rate constants of 1210 and 237 s(-1). The rates of both phases show a significant dependence on the viscosity of the solvent and become considerably slower at higher glycerol concentrations. The fast phase of this process exhibits no dependence on NADP(+) concentration, suggesting that conformational changes are required prior to NADP(+) release. Following NADP(+) release, the NADPH rebinds to the enzyme with a maximum rate constant of similar to 72 s(-1). At elevated temperatures (> 298 K) chlorophyllide is released from the enzyme to yield the free product with a maximum rate constant of 20 s(-1). The temperature dependencies of the rates of each of these steps were measured, and enthalpies and entropies of activation were calculated using the Eyring equation. A comprehensive kinetic and thermodynamic scheme for these final stages of the reaction mechanism is presented.	Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	derren.heyes@manchester.ac.uk		Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: Medline; BBSRC [BB/D01963X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Dirama TE, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1938191; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2000, FEBS LETT, V483, P47, DOI 10.1016/S0014-5793(00)02081-0; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Lebedev N, 1999, P NATL ACAD SCI USA, V96, P9954, DOI 10.1073/pnas.96.17.9954; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Schoefs B, 2003, PHOTOCHEM PHOTOBIOL, V78, P543, DOI 10.1562/0031-8655(2003)078&lt;0543:PRMAE&gt;2.0.CO;2; Sierks MR, 1997, BIOTECHNOL PROGR, V13, P601, DOI 10.1021/bp9700824; VALERA V, 1987, BIOCHEM BIOPH RES CO, V148, P515, DOI 10.1016/0006-291X(87)91141-7; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724	21	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32015	32020		10.1074/jbc.M706098200	http://dx.doi.org/10.1074/jbc.M706098200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848549	hybrid			2022-12-25	WOS:000250480300022
J	Lubyova, B; Kellum, MJ; Frisancho, JA; Pitha, PM				Lubyova, Barbora; Kellum, Merrill J.; Frisancho, Jose A.; Pitha, Paula M.			Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY EFFUSION LYMPHOMA; INTERFERON REGULATORY FACTORS; EPSTEIN-BARR-VIRUS; CELL-CYCLE; B-CELL; TUMOR-SUPPRESSOR; BINDING PROTEIN; EXPRESSED GENES; LANA PROTEIN; KAPPA-B	Kaposi sarcoma-associated herpesvirus is associated with two lymphoproliferative disorders, primary effusion lymphoma ( PEL) and Castleman disease. In PEL, Kaposi sarcoma-associated herpesvirus is present in a latent form expressing only few viral genes. Among them is a viral homologue of cellular interferon regulatory factors, vIRF-3. To study the role of vIRF-3 in PEL lymphomagenesis, we analyzed the interaction of vIRF-3 with cellular proteins. Using yeast two-hybrid screen, we detected the association between vIRF-3 and c-Myc suppressor, MM-1 alpha. The vIRF-3 and MM-1 alpha interaction was also demonstrated by glutathione S-transferase pulldown assay and coimmunoprecipitation of endogenous vIRF-3 and MM-1 alpha in PEL-derived cell lines. Overexpression of vIRF-3 enhanced the c-Myc-dependent transcription of the gene cdk4. Addressing the molecular mechanism of the vIRF-3-mediated stimulation, we demonstrated that the association between MM-1 alpha and c-Myc was inhibited by vIRF-3. Furthermore, the recruitment of vIRF-3 to the cdk4 promoter and the elevated levels of the histone H3 acetylation suggest the direct involvement of vIRF-3 in the activation of c-Myc-mediated transcription. These findings indicate that vIRF-3 can effectively stimulate c-Myc function in PEL cells and consequently contribute to de-regulation of B-cell growth and differentiation.	Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague 12800, Czech Republic; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Charles University Prague; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Lubyova, B (corresponding author), Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Studnickova 7, Prague 12800, Czech Republic.	bluby@lf1.cuni.cz	Lubyova, Barbora/G-5921-2014	Lubyova, Barbora/0000-0002-8714-0414	NATIONAL CANCER INSTITUTE [R01CA076946] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA76946] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; Borah S, 2004, J VIROL, V78, P10336, DOI 10.1128/JVI.78.19.10336-10347.2004; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bubman D, 2007, ONCOGENE, V26, P4979, DOI 10.1038/sj.onc.1210299; Burysek L, 1999, J HUMAN VIROL, V2, P19; Carbone A, 1998, BRIT J HAEMATOL, V102, P1081, DOI 10.1046/j.1365-2141.1998.00877.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Dittmer DP, 2003, CANCER RES, V63, P2010; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; DUYAO MP, 1992, J BIOL CHEM, V267, P16288; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Fulmer-Smentek SB, 2001, HUM MOL GENET, V10, P645, DOI 10.1093/hmg/10.6.645; Gaidano G, 1996, ACTA HAEMATOL-BASEL, V95, P193; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Guo HG, 2003, J VIROL, V77, P2631, DOI 10.1128/JVI.77.4.2631-2639.2003; Hagio Y, 2006, J CELL BIOCHEM, V97, P145, DOI 10.1002/jcb.20619; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HERMEKING H, 1995, ONCOGENE, V11, P1409; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Jones KD, 1999, BLOOD, V94, P2871; Kaiser C, 1999, J VIROL, V73, P4481, DOI 10.1128/JVI.73.5.4481-4484.1999; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Li MT, 1997, J VIROL, V71, P1984, DOI 10.1128/JVI.71.3.1984-1991.1997; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; Lubyova B, 2000, J VIROL, V74, P8194, DOI 10.1128/JVI.74.17.8194-8201.2000; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Munoz-Fontela C, 2007, J VIROL, V81, P1511, DOI 10.1128/JVI.01816-06; Muralidhar S, 1998, J VIROL, V72, P4980, DOI 10.1128/JVI.72.6.4980-4988.1998; Offermann MK, 2007, CURR TOP MICROBIOL, V312, P185; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Rodriguez-Puebla ML, 2002, AM J PATHOL, V161, P405, DOI 10.1016/S0002-9440(10)64196-X; Rui LX, 2006, CURR MOL MED, V6, P291, DOI 10.2174/156652406776894563; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Seo T, 2004, ONCOGENE, V23, P6146, DOI 10.1038/sj.onc.1207807; Talbot SJ, 1999, VIROLOGY, V257, P84, DOI 10.1006/viro.1999.9672; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	66	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31944	31953		10.1074/jbc.M706430200	http://dx.doi.org/10.1074/jbc.M706430200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728244	hybrid			2022-12-25	WOS:000250480300015
J	Muramatsu, S; Wakabayashi, M; Ohno, T; Amano, K; Ooishi, R; Sugahara, T; Shiojiri, S; Tashiro, K; Suzuki, Y; Nishimura, R; Kuhara, S; Sugano, S; Yoneda, T; Matsuda, A				Muramatsu, Shuji; Wakabayashi, Makoto; Ohno, Takeshi; Amano, Katsuhiko; Ooishi, Rika; Sugahara, Toshinori; Shiojiri, Satoshi; Tashiro, Kosuke; Suzuki, Yutaka; Nishimura, Riko; Kuhara, Satoru; Sugano, Sumio; Yoneda, Toshiyuki; Matsuda, Akio			Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; PRO-ALPHA-1(II) COLLAGEN GENE; HEAT-EVOKED ACTIVATION; CELL-LINE; CONSTITUTIVE ACTIVATION; CARTILAGE FORMATION; SIGNALING PATHWAY; MAMMALIAN-CELLS; II COLLAGEN; SOX9	Sox9 is a transcription factor that is essential for chondrocyte differentiation and chondrocyte-specific gene expression. However, the precise mechanism of Sox9 activation during chondrogenesis is not fully understood. To investigate this mechanism, we performed functional gene screening to identify genes that activate SOX9-dependent transcription, using full-length cDNA libraries generated from a murine chondrogenic cell line, ATDC5. Screening revealed that TRPV4 ( (t) under bar ransient (r) under bar eceptor (p) under bar otential (v) under bar anilloid 4), a cation channel molecule, significantly elevates SOX9-dependent reporter activity. Microarray and quantitative real time PCR analyses demonstrated that during chondrogenesis in ATDC5 and C3H10T1/2 ( murine mesenchymal stem cell line), the expression pattern of TRPV4 was similar to the expression patterns of chondrogenic marker genes, such as type II collagen and aggrecan. Activation of TRPV4 by a pharmacological activator induced SOX9-dependent reporter activity, and this effect was abolished by the addition of the TRPV antagonist ruthenium red or by using a small interfering RNA for TRPV4. The SOX9-dependent reporter activity due to TRPV4 activation was abrogated by both EGTA and a calmodulin inhibitor, suggesting that the Ca2+/calmodulin signal is essential in this process. Furthermore, activation of TRPV4 in concert with insulin activity in ATDC5 cells or in concert with bone morphogenetic protein-2 in C3H10T1/2 cells promoted synthesis of sulfated glycosaminoglycan, but activation of TRPV4 had no effect alone. We showed that activation of TRPV4 increased the steady-state levels of SOX9 mRNA and protein and SOX6 mRNA. Taken together, our results suggest that TRPV4 regulates the SOX9 pathway and contributes to the process of chondrogenesis.	Asahi Kasei Pharma Corp, Lab Drug Discovery, Res Ctr, Shizuoka 4168501, Japan; Kyushu Univ, Fac Agr, Dept Genet Resources Technol, Higashi Ku, Fukuoka 8128581, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan	Asahi Kasei Pharma Corporation; Kyushu University; University of Tokyo; Osaka University	Muramatsu, S (corresponding author), Asahi Kasei Pharma Corp, Lab Drug Discovery, Res Ctr, 2-1 Samejima, Shizuoka 4168501, Japan.	muramatsu.sb@om.asahi-kasei.co.jp		Nishimura, Riko/0000-0001-7279-8363				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Giordano J, 2001, AM J MED GENET, V98, P176, DOI 10.1002/1096-8628(20010115)98:2<176::AID-AJMG1027>3.0.CO;2-Q; Guler AD, 2002, J NEUROSCI, V22, P6408; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jin EJ, 2006, MOL CELLS, V22, P353; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; MARUYAMA K, 1994, GENE, V138, P171; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Takahashi I, 1998, J CELL SCI, V111, P2067; Valhmu WB, 2002, BIOCHEM J, V361, P689, DOI 10.1042/0264-6021:3610689; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zhang P, 2003, J BIOL CHEM, V278, P117, DOI 10.1074/jbc.M208049200; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103	40	153	163	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32158	32167		10.1074/jbc.M706158200	http://dx.doi.org/10.1074/jbc.M706158200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804410	hybrid			2022-12-25	WOS:000250480300038
J	Wu, PY; Frit, P; Malivert, L; Revy, P; Biard, D; Salles, B; Calsou, P				Wu, Pei-Yu; Frit, Philippe; Malivert, Laurent; Revy, Patrick; Biard, Denis; Salles, Bernard; Calsou, Patrick			Interplay between Cernunnos-XLF and nonhomologous end-joining proteins at DNA ends in the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CLASS SWITCH RECOMBINATION; LIGASE-IV; V(D)J RECOMBINATION; PHOSPHORYLATION SITES; CATALYTIC SUBUNIT; KINASE; COMPLEX; PK; AUTOPHOSPHORYLATION	Cernunnos-XLF is the most recently identified core component in the nonhomologous end-joining (NHEJ) pathway for the repair of DNA double strand breaks (DSBs) in mammals. It associates with the XRCC4/ligase IV ligation complex and stimulates its activity in a still unknown manner. NHEJ also requires the DNA-dependent protein kinase that contains a Ku70/Ku80 heterodimer and the DNA-dependent protein kinase catalytic subunit. To understand the interplay between Cernunnos-XLF and the other proteins implicated in the NHEJ process, we have analyzed the interactions of Cernunnos-XLF and NHEJ proteins in cells after treatment with DNA double strand-breaking agents by means of a detergent-based cellular fractionation protocol. We report that Cernunnos-XLF is corecruited with the core NHEJ components on chromatin damaged with DSBs in human cells and is phosphorylated by the DNA-dependent protein kinase catalytic subunit. Our data show a pivotal role for DNA ligase IV in the NHEJ ligation complex assembly and recruitment to DSBs because the association of Cernunnos-XLF with the XRCC4/ligase IV complex relies primarily on the DNA ligase IV component, and an intact XRCC4/ligase IV complex is necessary for Cernunnos-XLF mobilization to damaged chromatin. Conversely, a Cernunnos-XLF defect has no apparent impact on the XRCC4/ligase IV association and recruitment to the DSBs or on the stimulation of the DNA-dependent protein kinase on DNA ends.	Univ Toulouse 2, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse 4, France; Hop Necker Enfants Malad, INSERM, Unite Dev Normal & Pathol Syst Immunitaire, U768, F-75015 Paris, France; Univ Paris 05, Fac Med Rene Descartes, F-75005 Paris, France; Direct Sci Vivant, Inst Radiol Cellulaire & Mol, Lab Genet Radiosenibilite, Commissariat Energie Atom, F-92265 Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Salles, B (corresponding author), Univ Toulouse 2, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse 4, France.	bernard.salles@ipbs.fr	salles, bernard/B-8531-2008; Revy, Patrick/H-8137-2017; calsou, patrick/AAB-5123-2020	Calsou, Patrick/0000-0001-7951-9806; BIARD, Denis Serge Francois/0000-0001-9697-4392; Revy, Patrick/0000-0003-0758-8022; Malivert, Laurent/0000-0002-0944-6573				Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Ahnesorg P, 2007, DNA REPAIR, V6, P190, DOI 10.1016/j.dnarep.2006.09.010; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Bryans M, 1999, MUTAT RES-DNA REPAIR, V433, P53, DOI 10.1016/S0921-8777(98)00063-9; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Callebaut I, 2006, J BIOL CHEM, V281, P13857, DOI 10.1074/jbc.C500473200; Cantagrel V, 2007, HUM MUTAT, V28, P356, DOI 10.1002/humu.20450; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8; Despras E, 2007, CANCER RES, V67, P2526, DOI 10.1158/0008-5472.CAN-06-3371; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Drouet J, 2006, J BIOL CHEM, V281, P27784, DOI 10.1074/jbc.M603047200; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Hoppe BS, 2000, RADIAT RES, V153, P125, DOI 10.1667/0033-7587(2000)153[0125:COTRMC]2.0.CO;2; Hsu HL, 2002, DNA REPAIR, V1, P225, DOI 10.1016/S1568-7864(01)00018-0; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee KJ, 2004, DNA REPAIR, V3, P267, DOI 10.1016/j.dnarep.2003.11.005; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Revy P, 2006, CURR OPIN ALLERGY CL, V6, P416, DOI 10.1097/01.all.0000246623.72365.43; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Salles B, 2006, PATHOL BIOL, V54, P185, DOI 10.1016/j.patbio.2006.01.012; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104	43	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31937	31943		10.1074/jbc.M704554200	http://dx.doi.org/10.1074/jbc.M704554200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17720816	hybrid			2022-12-25	WOS:000250480300014
J	Yoon, H; Laxmikanthan, G; Lee, J; Blaber, SI; Rodriguez, A; Kogot, JM; Scarisbrick, IA; Blaber, M				Yoon, Hyesook; Laxmikanthan, Gurunathan; Lee, Jihun; Blaber, Sachiko I.; Rodriguez, Aaron; Kogot, Joshua M.; Scarisbrick, Isobel A.; Blaber, Michael			Activation profiles and regulatory cascades of the human kallikrein-related peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN GLANDULAR KALLIKREIN; MYELENCEPHALON-SPECIFIC PROTEASE; CORNEUM CHYMOTRYPTIC ENZYME; NUCLEAR-MAGNETIC-RESONANCE; FIBROBLAST-GROWTH-FACTOR; SERINE-PROTEASE; GENE FAMILY; TISSUE KALLIKREIN; STRATUM-CORNEUM	The human kallikrein (KLK)-related peptidases are the largest family of serine peptidases, comprising 15 members (KLK1-15) and with the majority (KLK4-15) being identified only within the last decade. Members of this family are associated with important diseased states (including cancer, inflammation, and neurodegeneration) and have been utilized or proposed as clinically important biomarkers or therapeutic targets of interest. All human KLKs are synthesized as prepro-forms that are proteolytically processed to secreted pro-forms via the removal of an amino-terminal secretion signal peptide. The secreted inactive pro-KLKs are then activated extracellularly to mature peptidases by specific proteolytic release of their amino-terminal propeptide. Although a key step in the regulation of KLK function, details regarding the activation of the human pro-KLKs (i. e. the KLK " activome") are unknown, to a significant extent, but have been postulated to involve "activation cascades" with other KLKs and endopeptidases. To characterize more completely the KLK activome, we have expressed from Escherichia coli individual KLK propeptides fused to the amino terminus of a soluble carrier protein. The ability of 12 different mature KLKs to process the 15 different pro-KLK peptide sequences has been determined. Various autolytic and cross-activation relationships identified using this system have subsequently been characterized using recombinant pro-KLK proteins. The results demonstrate the potential for extensive KLK activation cascades and, when combined with available data for the tissue-specific expression of the KLK family, permit the construction of specific regulatory cascades. One such tissue-specific cascade is proposed for the central nervous system.	Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; Mayo Clin & Mayo Grad Sch Med, Program Mol Neurosci, Rochester, MN 55905 USA; Mayo Clin & Mayo Grad Sch Med, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin & Mayo Grad Sch Med, Dept Phys Med & Rehabil, Rochester, MN 55905 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Blaber, M (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 3350G Biomed Sci Bldg, Tallahassee, FL 32306 USA.	michael.blaber@med.fsu.edu	Blaber, Michael/N-1083-2019; Blaber, Michael/ABA-5031-2021; Laxmikanthan, Gurunathan/D-1049-2012; Blaber, Michael/E-7478-2011	Blaber, Michael/0000-0002-6856-1643; Lee, Jihun/0000-0002-8803-7689				Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; BACK T, 1994, STROKE, V25, P494, DOI 10.1161/01.STR.25.2.494; Barrett AJ, 2003, BIOL CHEM, V384, P873, DOI 10.1515/BC.2003.098; Bayes A, 2004, BIOL CHEM, V385, P517, DOI 10.1515/BC.2004.061; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Blaber SI, 2007, BIOCHEMISTRY-US, V46, P5209, DOI 10.1021/bi6025006; Blaber SI, 2004, FASEB J, V18, P920, DOI 10.1096/fj.03-1212fje; Blaber SI, 2002, BIOCHEMISTRY-US, V41, P1165, DOI 10.1021/bi015781a; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Breitenbach U, 2001, J INVEST DERMATOL, V117, P634, DOI 10.1046/j.0022-202x.2001.01437.x; Brych SR, 2004, J MOL BIOL, V344, P769, DOI 10.1016/j.jmb.2004.09.060; Brych SR, 2001, PROTEIN SCI, V10, P2587, DOI 10.1110/ps.ps.34701; Catalona WJ, 1997, J UROLOGY, V158, P2162, DOI 10.1016/S0022-5347(01)68187-4; CHAGAS JR, 1995, BIOCHEM J, V306, P63, DOI 10.1042/bj3060063; CHEN ZL, 1995, J NEUROSCI, V15, P5088; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; CLEMENTS JA, 1989, ENDOCR REV, V10, P393, DOI 10.1210/edrv-10-4-393; Darson MF, 1999, UROLOGY, V53, P939, DOI 10.1016/S0090-4295(98)00637-2; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; DESHPANDE MS, 1992, J MED CHEM, V35, P3094, DOI 10.1021/jm00095a002; Diamandis E P, 2001, Expert Rev Mol Diagn, V1, P182, DOI 10.1586/14737159.1.2.182; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Fiedler F, 1979, Adv Exp Med Biol, V120A, P261; Fuessel S, 2003, INT J ONCOL, V23, P221; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Hooper JD, 2001, GENOMICS, V73, P117, DOI 10.1006/geno.2000.6490; Iwadate H, 2002, CAN J PHYSIOL PHARM, V80, P245, DOI 10.1139/Y02-026; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; KIRSHNAWAMI S, 2004, J THROMB HAEMOST, V3, P54; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Little SP, 1997, J BIOL CHEM, V272, P25135, DOI 10.1074/jbc.272.40.25135; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lovgren J, 1999, EUR J BIOCHEM, V266, P1050, DOI 10.1046/j.1432-1327.1999.00946.x; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; Lozano RM, 2000, BIOCHEMISTRY-US, V39, P4982, DOI 10.1021/bi992544n; LUDERER AA, 1995, UROLOGY, V46, P187, DOI 10.1016/S0090-4295(99)80192-7; LUNDSTROM A, 1991, ACTA DERM-VENEREOL, V71, P471; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; LUO LY, 2006, HUM CANC BIOL, V12, P742; Memari N, 2007, BIOL CHEM, V388, P427, DOI 10.1515/BC.2007.049; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Mikolajczyk SD, 1997, EUR J BIOCHEM, V246, P440, DOI 10.1111/j.1432-1033.1997.00440.x; Mitsui S, 2000, BIOCHEM BIOPH RES CO, V272, P205, DOI 10.1006/bbrc.2000.2761; NAKAYAMA A, 1992, J BIOTECHNOL, V23, P55, DOI 10.1016/0168-1656(92)90099-U; Okui A, 2001, NEUROREPORT, V12, P1345, DOI 10.1097/00001756-200105250-00011; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x; Recker F, 2000, UROLOGY, V55, P481, DOI 10.1016/S0090-4295(99)00611-1; Scarisbrick IA, 2006, J NEUROIMMUNOL, V178, P167, DOI 10.1016/j.jneuroim.2006.05.022; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Scarisbrick IA, 1997, J NEUROSCI, V17, P8156; Schechter I, 1967, BIOCHEM BIOPH RES CO, V27, P156; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Silva JA, 2000, FASEB J, V14, P1858; SKYTT A, 1995, BIOCHEM BIOPH RES CO, V211, P586, DOI 10.1006/bbrc.1995.1853; Sotiropoulou G, 2003, ONCOL RES, V13, P381; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Takayama TK, 1997, J BIOL CHEM, V272, P21582, DOI 10.1074/jbc.272.34.21582; Tomasselli AG, 1997, BIOTECHNOL APPL BIOC, V26, P39; Uchida A, 2004, MOL BRAIN RES, V126, P129, DOI 10.1016/j.molbrainres.2004.04.009; Vaisanen V, 1999, PROSTATE CANCER P D, V2, P91, DOI 10.1038/sj.pcan.4500289; Yamanaka H, 1999, MOL BRAIN RES, V71, P217, DOI 10.1016/S0169-328X(99)00187-4; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; YOUNG CYF, 1995, J ANDROL, V16, P97; Yousef GM, 2000, GENOMICS, V69, P331, DOI 10.1006/geno.2000.6346; Yousef GM, 2001, CANCER RES, V61, P3425; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	75	131	133	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31852	31864		10.1074/jbc.M705190200	http://dx.doi.org/10.1074/jbc.M705190200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823117	Green Submitted, hybrid			2022-12-25	WOS:000250480300005
J	Gaskell, AA; Crack, JC; Kelemen, GH; Hutchings, MI; Le Brun, NE				Gaskell, Alisa A.; Crack, Jason C.; Kelemen, Gabriella H.; Hutchings, Matthew I.; Le Brun, Nick E.			RsmA is an anti-sigma factor that modulates its activity through a [2Fe-2S] cluster cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI SOXR PROTEIN; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; STRESS-RESPONSE; RNA-POLYMERASE; AZOTOBACTER-VINELANDII; FACTOR SPOIIAB; IN-VITRO	The rsmA gene of Streptomyces coelicolor lies directly upstream of the gene encoding the group 3 sigma factor sigma(M). The RsmA protein is a putative member of the HATPase_c family of anti-sigma factors but is unusual in that it contains seven cysteine residues. Bacterial two-hybrid studies demonstrate that it interacts specifically with sigma(M), and in vitro studies of the purified proteins by native PAGE and transcription assays confirmed that they form a complex. Characterization of RsmA revealed that it binds ATP and that, as isolated, it contains significant quantities of iron and inorganic sulfide, in equal proportion, with spectroscopic properties characteristic of a [2Fe-2S] cluster-containing protein. Importantly, the interaction between RsmA and sigma(M) is dependent on the presence of the iron-sulfur cluster. We propose a model in which RsmA regulates the activity of sigma(M). Loss of the cluster, in response to an as yet unidentified signal, activates sigma(M) by abolishing its interaction with the anti-sigma factor. This represents a major extension of the functional diversity of iron-sulfur cluster proteins.	Univ E Anglia, Sch Chem Sci, Ctr Metalloprotein Spectroscopy & Biol, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Med Hlth Policy & Pract, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia; University of East Anglia	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem Sci, Ctr Metalloprotein Spectroscopy & Biol, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk	Hutchings, Matt/D-1923-2009; Kelemen, Gabriella/G-8486-2011	Hutchings, Matt/0000-0001-6628-5940; Le Brun, Nick/0000-0001-9780-4061; Crack, Jason C./0000-0002-4979-1910				Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BERTRAND P, 1979, BIOCHIM BIOPHYS ACTA, V579, P107, DOI 10.1016/0005-2795(79)90091-6; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; BUTTNER MJ, 1985, J MOL BIOL, V185, P177, DOI 10.1016/0022-2836(85)90189-5; Caldeira J, 2000, BIOCHEMISTRY-US, V39, P2700, DOI 10.1021/bi9921485; Campbell EA, 2000, J MOL BIOL, V300, P17, DOI 10.1006/jmbi.2000.3838; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; CHENG H, 1994, BIOCHEMISTRY-US, V33, P3155, DOI 10.1021/bi00177a003; Choulet F, 2006, J BACTERIOL, V188, P6599, DOI 10.1128/JB.00734-06; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Crack JC, 2006, J BIOL CHEM, V281, P18909, DOI 10.1074/jbc.C600042200; Dautin N, 2000, J BACTERIOL, V182, P7060, DOI 10.1128/JB.182.24.7060-7066.2000; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; FEE JA, 1984, J BIOL CHEM, V259, P124; GIBSON JF, 1966, P NATL ACAD SCI USA, V56, P987, DOI 10.1073/pnas.56.3.987; GREEN J, 1993, FEMS MICROBIOL LETT, V113, P219, DOI 10.1111/j.1574-6968.1993.tb06517.x; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Hiratsuka T, 2003, EUR J BIOCHEM, V270, P3479, DOI 10.1046/j.1432-1033.2003.03748.x; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Hugo N, 1998, J BIOL CHEM, V273, P9622, DOI 10.1074/jbc.273.16.9622; IGO MM, 1986, J MOL BIOL, V191, P615, DOI 10.1016/0022-2836(86)90449-3; Jervis AJ, 2007, J BACTERIOL, V189, P2930, DOI 10.1128/JB.01921-06; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Lee EJ, 2004, J BACTERIOL, V186, P8490, DOI 10.1128/JB.186.24.8490-8498.2004; Li W, 2003, J MOL BIOL, V333, P461, DOI 10.1016/j.jmb.2003.08.038; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sevcikova B, 2002, FEMS MICROBIOL LETT, V209, P229, DOI 10.1016/S0378-1097(02)00513-X; SHAW DJ, 1983, J MOL BIOL, V166, P241, DOI 10.1016/S0022-2836(83)80011-4; STEPHENS PJ, 1991, BIOCHEMISTRY-US, V30, P3200, DOI 10.1021/bi00227a007; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TA DT, 1992, J BIOL CHEM, V267, P11120; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; Xia B, 1996, BIOCHEMISTRY-US, V35, P9488, DOI 10.1021/bi960467f; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	55	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31812	31820		10.1074/jbc.M705160200	http://dx.doi.org/10.1074/jbc.M705160200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766240	hybrid			2022-12-25	WOS:000250309200071
J	Mazzulli, JR; Armakola, M; Dumoulin, M; Parastatidis, I; Ischiropoulos, H				Mazzulli, Joseph R.; Armakola, Maria; Dumoulin, Michelle; Parastatidis, Ioannis; Ischiropoulos, Harry			Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a c-terminal sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; PARKINSONS-DISEASE; MUTATION; AGGREGATION; DOPAMINE; MICE; NEUROTOXICITY; PROTEIN; STABILIZATION; PROTEASOME	The mechanisms that govern the formation of alpha-synuclein (alpha-syn) aggregates are not well understood but are considered a central event in the pathogenesis of Parkinson's disease (PD). A critically important modulator of alpha-syn aggregation in vitro is dopamine and other catechols, which can prevent the formation of alpha-syn aggregates in cell-free and cellular model systems. Despite the profound importance of this interaction for the pathogenesis of PD, the processes by which catechols alter alpha-syn aggregation are unclear. Molecular and biochemical approaches were employed to evaluate the mechanism of catechol-alpha-syn interactions and the effect on inclusion formation. The data show that the intracellular inhibition of alpha-syn aggregation requires the oxidation of catechols and the specific noncovalent interaction of the oxidized catechols with residues (YEMPS129)-Y-125 in the C-terminal region of the protein. Cell-free studies using novel near infrared fluorescence methodology for the detection of covalent protein-ortho-quinone adducts showed that although covalent modification of alpha-syn occurs, this does not affect alpha-syn fibril formation. In addition, oxidized catechols are unable to prevent both thermal and acid- induced protein aggregation as well as fibrils formed from a protein that lacks a YEMPS amino acid sequence, suggesting a specific effect for alpha-syn. These results suggest that inappropriate C-terminal cleavage of alpha-syn, which is known to occur in vivo in PD brain or a decline of intracellular catechol levels might affect disease progression, resulting in accelerated alpha-syn inclusion formation and dopaminergic neurodegeneration.	Univ Penn, Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat & Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ischiropoulos, H (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu		Bridi, Michelle/0000-0001-5533-5092	NIA NIH HHS [AG13966] Funding Source: Medline; NIEHS NIH HHS [ES013508] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013966] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nakashima A, 2002, J NEUROCHEM, V82, P202, DOI 10.1046/j.1471-4159.2002.00921.x; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Norris EH, 2003, J BIOL CHEM, V278, P27230, DOI 10.1074/jbc.M212436200; PAZ MA, 1991, J BIOL CHEM, V266, P689; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROSENBERG PA, 1988, J NEUROSCI, V8, P2887, DOI 10.1523/jneurosci.08-08-02887.1988; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	41	65	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31621	31630		10.1074/jbc.M704737200	http://dx.doi.org/10.1074/jbc.M704737200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785456	hybrid			2022-12-25	WOS:000250309200054
J	McGugan, GC; Joshi, MB; Dwyer, DM				McGugan, Glen C., Jr.; Joshi, Manju B.; Dwyer, Dennis M.			Identification and biochemical characterization of unique secretory nucleases of the human enteric pathogen, Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RIBONUCLEASE; EXPRESSION; GENE; PURIFICATION; TROPHOZOITES; SEQUENCE; TRANSFECTION	The ancient eukaryotic human pathogen, Entamoeba histolytica, is a nucleo-base auxotroph (i.e. lacks the ability to synthesize purines or pyrimidines de novo) and therefore is totally dependent upon its host for the supply of these essential nutrients. In this study, we identified two unique 28- kDa, dithiothreitolsensitive nucleases and showed that they are constitutively released/secreted by parasites during axenic culture. Using several different molecular approaches, we identified and characterized the structure of EhNucI and EhNucII, genes that encode ribonuclease T2 family proteins. Homologous episomal expression of epitope-tagged EhNucI and EhNucII chimeric constructs was used to define the functional and biochemical properties of these released/secreted enzymes. Results of coupled immuno-precipitation-enzyme activity analyses demonstrated that these "secretory" enzymes could hydrolyze a variety of synthetic polynucleotides, as well as the natural nucleic acid substrate RNA. Furthermore, our results demonstrated that sera from acutely infected amebiasis patients recognized and immunoprecipitated these parasite secretory enzymes. Based on these observations, we hypothesize that within its host, these secretory nucleases could function, at a distance away from the parasite, to harness (i.e. hydrolyze/access) host-derived nucleic acids to satisfy the essential purine and pyrimidine requirements of these organisms. Thus, these enzymes might play an important role in facilitating the survival, growth, and development of this important human pathogen.	NIAID, Div Intramural Res, Parasit Dis Lab, Cell Biol Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dwyer, DM (corresponding author), NIAID, Div Intramural Res, Parasit Dis Lab, Cell Biol Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ddwyer@niaid.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000745, Z01AI000745, Z01AI000162] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali IKM, 2005, J CLIN MICROBIOL, V43, P5842, DOI 10.1128/JCM.43.12.5842-5847.2005; Anderson IJ, 2005, EXP PARASITOL, V110, P173, DOI 10.1016/j.exppara.2005.03.010; Banuelos C, 2005, EXP PARASITOL, V110, P292, DOI 10.1016/j.exppara.2005.03.005; BATES PA, 1993, FEMS MICROBIOL LETT, V107, P53, DOI 10.1111/j.1574-6968.1993.tb06003.x; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BOODEN T, 1978, ARCH INVEST MED, V9, P133; BOODEN T, 1976, J PARASITOL, V62, P641, DOI 10.2307/3279435; BOONLAYANGOOR P, 1980, ARCH INVEST MED, V11, P83; BOONLAYANGOOR P, 1978, EXP PARASITOL, V45, P225, DOI 10.1016/0014-4894(78)90063-2; Bruchhaus I, 1996, MOL MICROBIOL, V22, P255, DOI 10.1046/j.1365-2958.1996.00111.x; Chacko R, 1998, BBA-GEN SUBJECTS, V1379, P264, DOI 10.1016/S0304-4165(97)00103-7; CLARK CG, 1991, MOL BIOCHEM PARASIT, V46, P11, DOI 10.1016/0166-6851(91)90194-B; Das P, 1997, PARASITOL RES, V83, P364, DOI 10.1007/s004360050263; DEBRABANT A, 1995, MOL BIOCHEM PARASIT, V71, P51, DOI 10.1016/0166-6851(95)00035-Y; Debrabant A, 2000, J BIOL CHEM, V275, P16366, DOI 10.1074/jbc.M908725199; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Esteban R., 1999, Plant Physiology, V119, P1149; Field J, 2000, J EUKARYOT MICROBIOL, V47, P511, DOI 10.1111/j.1550-7408.2000.tb00083.x; Fitzsimmons CM, 2005, MOL BIOCHEM PARASIT, V144, P123, DOI 10.1016/j.molbiopara.2005.08.003; Frisardi M, 2000, INFECT IMMUN, V68, P4217, DOI 10.1128/IAI.68.7.4217-4224.2000; GERBER LD, 1992, J BIOL CHEM, V267, P12168; Ghosh SK, 1999, INFECT IMMUN, V67, P3073, DOI 10.1128/IAI.67.6.3073-3081.1999; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Gonzalez E, 2002, AM J TROP MED HYG, V67, P636, DOI 10.4269/ajtmh.2002.67.636; GUYTON AC, 1996, TXB MED PHYSL, P793; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; HAMES BD., 1981, GEL ELECTROPHORESIS, P1; HORITSU H, 1980, CAN J BIOCHEM CELL B, V58, P489, DOI 10.1139/o80-065; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; Inokuchi N, 1998, J BIOCHEM, V124, P848, DOI 10.1093/oxfordjournals.jbchem.a022189; INOKUCHI N, 1993, J BIOCHEM-TOKYO, V113, P425, DOI 10.1093/oxfordjournals.jbchem.a124062; Joshi MB, 2007, J BIOL CHEM, V282, P10079, DOI 10.1074/jbc.M610770200; KAWATA Y, 1990, EUR J BIOCHEM, V187, P255, DOI 10.1111/j.1432-1033.1990.tb15303.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leippe M, 1997, PARASITOL TODAY, V13, P178, DOI 10.1016/S0169-4758(97)01038-7; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MANN BJ, 1991, P NATL ACAD SCI USA, V88, P3248, DOI 10.1073/pnas.88.8.3248; MAOURI A, 1987, EUR J BIOCHEM, V168, P523, DOI 10.1111/j.1432-1033.1987.tb13449.x; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McCombie W R, 1992, DNA Seq, V2, P289, DOI 10.3109/10425179209030961; MCKEON TA, 1991, ARCH BIOCHEM BIOPHYS, V290, P303, DOI 10.1016/0003-9861(91)90545-T; MCLAUGHLIN J, 1985, J PROTOZOOL, V32, P221; NICKEL R, 1994, P NATL ACAD SCI USA, V91, P7095, DOI 10.1073/pnas.91.15.7095; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ramos MA, 2000, ARCH MED RES, V31, pS173, DOI 10.1016/S0188-4409(00)00113-2; REED S, 1993, J CLIN INVEST, V91, P1532, DOI 10.1172/JCI116359; REED SL, 1990, J CLIN INVEST, V86, P1815, DOI 10.1172/JCI114911; REED SL, 1995, J IMMUNOL, V155, P266; ROJO MA, 1994, PLANTA, V194, P328, DOI 10.1007/BF00197532; ROSENBAUM RM, 1970, J CELL BIOL, V45, P367, DOI 10.1083/jcb.45.2.367; RUSHIZKY GW, 1963, J BIOL CHEM, V238, P371; Sanchez-Lopez R, 1998, MOL BIOCHEM PARASIT, V92, P355, DOI 10.1016/S0166-6851(98)00017-6; Sato D, 2006, FEBS LETT, V580, P5306, DOI 10.1016/j.febslet.2006.08.081; Shimizu T, 2001, GENE, V274, P227, DOI 10.1016/S0378-1119(01)00601-1; Tanaka N, 2000, J MOL BIOL, V298, P859, DOI 10.1006/jmbi.2000.3707; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALSH JA, 1986, REV INFECT DIS, V8, P228; WHO, 1997, WKLY EPIDEMIOL REC R, V72, P97	62	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31789	31802		10.1074/jbc.M705975200	http://dx.doi.org/10.1074/jbc.M705975200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766245	hybrid			2022-12-25	WOS:000250309200069
J	Kommagani, R; Payal, V; Kadakia, MP				Kommagani, Ramakrishna; Payal, Vandana; Kadakia, Madhavi P.			Differential regulation of vitamin D receptor (VDR) by the p53 family - p73-dependent induction of VDR upon DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HUMAN CANCERS; TARGET GENES; P73 FUNCTION; MUTANT P53; CELL-DEATH; IN-VIVO; P63; APOPTOSIS; ACTIVATION	p63 and p73, members of the p53 family, have been shown to be functionally distinct from p53. VitaminD receptor ( VDR) is a ligand ( vitamin D3)- dependent transcription factor, which is shown to play a major role in calcium homeostasis and keratinocyte differentiation. VitaminD and its analogues in combination with DNA- damaging agents are extensively used for cancer chemotherapy. In this report, we examined whether p53 affects p63- mediated induction of VDR and studied the effect of DNA damage on VDR induction in p53 null cell lines. Our results demonstrate that p53 itself does not induce VDR expression, nor does it affect p63- mediated VDR induction in the cell lines tested in this study. Furthermore, we observed p53- independent activation of VDR upon DNA damage and associated the induction of VDR to p73. We have demonstrated that ectopic expression of various p73 isoforms can induce VDR expression. Inhibition of p73 in cells treated with DNA- damaging agents exhibited decreased VDR expression. Finally, we show that upon DNA damage, induction of VDR sensitizes the cells to vitaminD treatment. In conclusion, our results indicate that VDR is regulated by p63 and p73 and that the induction of VDR expression upon DNA damage is p73- dependent.	Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; Wright State Univ, Ctr Genom Res, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Kadakia, MP (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, 3640 Col Glenn Hwy, Dayton, OH 45435 USA.	madhavi.kadakia@wright.edu		Kommagani, Ramakrishna/0000-0003-0403-0971	NCI NIH HHS [R21 CA118315-01A1, R21 CA118315, CA118315-2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA118315] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Banwell CM, 2003, RECENT RESULTS CANC, V164, P83; Campbell MJ, 2000, ONCOGENE, V19, P5091, DOI 10.1038/sj.onc.1203888; Campbell MJ, 2006, EXPERT OPIN THER TAR, V10, P735, DOI 10.1517/14728222.10.5.735; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Demay MB, 2006, ANN NY ACAD SCI, V1068, P204, DOI 10.1196/annals.1346.026; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dietz S, 2002, FEBS LETT, V525, P93, DOI 10.1016/S0014-5793(02)03093-4; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gombart AF, 2006, ANTICANCER RES, V26, P2531; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hawker NP, 2007, J INVEST DERMATOL, V127, P874, DOI 10.1038/sj.jid.5700624; Hershberger PA, 2002, MOL CANCER THER, V1, P821; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kang KH, 2002, FEBS LETT, V522, P161, DOI 10.1016/S0014-5793(02)02921-6; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Nezbedova P, 2004, Endocr Regul, V38, P29; Ordonez-Moran P, 2005, FRONT BIOSCI-LANDMRK, V10, P2723, DOI 10.2741/1731; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Prabhu NS, 1998, INT J ONCOL, V13, P5; Rashid SF, 2001, STEROIDS, V66, P433, DOI 10.1016/S0039-128X(00)00203-8; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Scoumanne A, 2005, CANCER BIOL THER, V4, P1178, DOI 10.4161/cbt.4.11.2254; Senoo M, 2002, ONCOGENE, V21, P2455, DOI 10.1038/sj.onc.1205330; Sniezek JC, 2004, LARYNGOSCOPE, V114, P2063, DOI 10.1097/01.mlg.0000149437.35855.4b; Torres R, 2000, MOL CELL BIOCHEM, V208, P157, DOI 10.1023/A:1007089632152; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vikhanskaya F, 2007, NUCLEIC ACIDS RES, V35, P2093, DOI 10.1093/nar/gkm099; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	48	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29847	29854		10.1074/jbc.M703641200	http://dx.doi.org/10.1074/jbc.M703641200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716971	Green Accepted, hybrid			2022-12-25	WOS:000249981200013
J	Fontaine, KM; Cooley, JR; Simon, C				Fontaine, Kathryn M.; Cooley, John R.; Simon, Chris			Evidence for Paternal Leakage in Hybrid Periodical Cicadas (Hemiptera: Magicicada spp.)	PLOS ONE			English	Article								Mitochondrial inheritance is generally assumed to be maternal. However, there is increasing evidence of exceptions to this rule, especially in hybrid crosses. In these cases, mitochondria are also inherited paternally, so "paternal leakage'' of mitochondria occurs. It is important to understand these exceptions better, since they potentially complicate or invalidate studies that make use of mitochondrial markers. We surveyed F-1 offspring of experimental hybrid crosses of the 17-year periodical cicadas Magicicada septendecim, M. septendecula, and M. cassini for the presence of paternal mitochondrial markers at various times during development (1-day eggs; 3-,6-, 9-week eggs; 16-month old 1(st) and 2(nd) instar nymphs). We found evidence of paternal leakage in both reciprocal hybrid crosses in all of these samples. The relative difficulty of detecting paternal mtDNA in the youngest eggs and ease of detecting leakage in older eggs and in nymphs suggests that paternal mitochondria proliferate as the eggs develop. Our data support recent theoretical predictions that paternal leakage may be more common than previously estimated.	[Fontaine, Kathryn M.; Cooley, John R.; Simon, Chris] Univ Connecticut, Dept Ecol & Evolut Biol, Storrs, CT 06269 USA	University of Connecticut	Cooley, JR (corresponding author), Univ Connecticut, Dept Ecol & Evolut Biol, Storrs, CT 06269 USA.	john.cooley@uconn.edu			National Science Foundation [DEB 99-74369, DEB 04-22386, DEB 05-29679, DEB 06-19012]; University of Connecticut Research Foundation	National Science Foundation(National Science Foundation (NSF)); University of Connecticut Research Foundation	Funding: This material is based upon work partially supported by the National Science Foundation under Grant No. DEB 99-74369, DEB 04-22386, DEB 05-29679, and DEB 06-19012 (REU), and from a University of Connecticut Research Foundation grant to CS. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF or other granting agencies.	Alexander R. D., 1962, Miscellaneous Publications Museum of Zoology University of Michigan, Vno. 121, P1; Andolfatto P, 2003, EVOLUTION, V57, P305, DOI 10.1111/j.0014-3820.2003.tb00265.x; Arunkumar KP, 2006, MOL PHYLOGENET EVOL, V40, P419, DOI 10.1016/j.ympev.2006.02.023; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Budowle B, 2003, ANNU REV GENOM HUM G, V4, P119, DOI 10.1146/annurev.genom.4.070802.110352; Chesser RK, 1998, GENETICS, V150, P1309; Cooley JR, 2003, BIOSCIENCE, V53, P151, DOI 10.1641/0006-3568(2003)053[0151:TSASIP]2.0.CO;2; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; COOLEY JR, 1999, SEXUAL BEHAV N AM CI, P326; COX RT, 1991, AM MIDL NAT, V125, P63, DOI 10.2307/2426370; Cox RT, 2003, EVOLUTION, V57, P428; Cox RT, 1998, AM NAT, V152, P162, DOI 10.1086/286158; DUNNING DC, 1979, ANIM BEHAV, V27, P1073, DOI 10.1016/0003-3472(79)90056-3; DYBAS HS, 1974, ECOL MONOGR, V44, P279, DOI 10.2307/2937032; DYBAS HS, 1962, ECOLOGY, V43, P444, DOI 10.2307/1933373; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Gillham N.W., 1994, ORGANELLE GENES GENO; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; KARBAN R, 1981, OECOLOGIA, V51, P260, DOI 10.1007/BF00540611; KONDO R, 1992, GENET RES, V59, P81, DOI 10.1017/S0016672300030287; KONDO R, 1990, GENETICS, V126, P657; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; LANSMAN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1969, DOI 10.1073/pnas.80.7.1969; LLOYD M, 1966, EVOLUTION, V20, P466, DOI 10.1111/j.1558-5646.1966.tb03381.x; LLOYD M, 1966, EVOLUTION, V20, P133, DOI 10.1111/j.1558-5646.1966.tb03350.x; MAGOULAS A, 1993, MOL BIOL EVOL, V10, P319; MAIER CT, 1982, ANN ENTOMOL SOC AM, V75, P14, DOI 10.1093/aesa/75.1.14; MARLATT C, 1923, USDA BUREAU ENTOMOLO, V71; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; MEUSEL MS, 1993, CURR GENET, V24, P539, DOI 10.1007/BF00351719; Osborn H., 1902, OHIO NAT, V3, P323; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; ROKAS A, 2003, TRENDS ECOLOGY EVOLU, V18; Sackton TB, 2003, EVOLUTION, V57, P2315; SATTA Y, 1988, GENET RES, V52, P1, DOI 10.1017/S0016672300027245; SATTA Y, 1990, GENETICS, V126, P657; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sherengul W, 2006, GENES GENET SYST, V81, P399, DOI 10.1266/ggs.81.399; Shitara H, 1998, GENETICS, V148, P851; Simon C, 2000, EVOLUTION, V54, P1326; Simon C., 1988, Bulletin of the Entomological Society of America, V34, P163; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; St John JC, 2002, THERIOGENOLOGY, V57, P109, DOI 10.1016/S0093-691X(01)00661-6; Steinborn R, 1998, FEBS LETT, V426, P352, DOI 10.1016/S0014-5793(98)00350-0; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 2003, BIOL REPROD, V68, P1793, DOI 10.1095/biolreprod.102.012799; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Ujvari B, 2007, BIOL LETTERS, V3, P189, DOI 10.1098/rsbl.2006.0587; WHITE JA, 1973, ECOLOGY, V54, P573, DOI 10.2307/1935342; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; Xu JP, 2005, GENOME, V48, P951, DOI [10.1139/g05-082, 10.1139/G05-082]; YOUNG D, 1983, J COMP PHYSIOL, V152, P197, DOI 10.1007/BF00611184; Zhao X, 2004, HEREDITY, V93, P399, DOI 10.1038/sj.hdy.6800516	60	49	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e892	10.1371/journal.pone.0000892	http://dx.doi.org/10.1371/journal.pone.0000892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849021	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455600038
J	Pattaradilokrat, S; Cheesman, SJ; Carter, R				Pattaradilokrat, Sittiporn; Cheesman, Sandra J.; Carter, Richard			Linkage Group Selection: Towards Identifying Genes Controlling Strain Specific Protective Immunity in Malaria	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-CHABAUDI-CHABAUDI; HETEROLOGOUS STRAINS; ENZYME VARIATION; FALCIPARUM; INFECTIONS; PARASITES; SEQUENCE; ANTIGEN; ANTIBODIES	Protective immunity against blood infections of malaria is partly specific to the genotype, or strain, of the parasites. The target antigens of Strain Specific Protective Immunity are expected, therefore, to be antigenically and genetically distinct in different lines of parasite. Here we describe the use of a genetic approach, Linkage Group Selection, to locate the target(s) of Strain Specific Protective Immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi. In a previous such analysis using the progeny of a genetic cross between P. c. chabaudi lines AS-pyr1 and CB, a location on P. c. chabaudi chromosome 8 containing the gene for merozoite surface protein-1, a known candidate antigen for Strain Specific Protective Immunity, was strongly selected. P. c. chabaudi apical membrane antigen-1, another candidate for Strain Specific Protective Immunity, could not have been evaluated in this cross as AS-pyr1 and CB are identical within the cell surface domain of this protein. Here we use Linkage Group Selection analysis of Strain Specific Protective Immunity in a cross between P. c. chabaudi lines CB-pyr10 and AJ, in which merozoite surface protein-1 and apical membrane antigen-1 are both genetically distinct. In this analysis strain specific immune selection acted strongly on the region of P. c. chabaudi chromosome 8 encoding merozoite surface protein-1 and, less strongly, on the P. c. chabaudi chromosome 9 region encoding apical membrane antigen-1. The evidence from these two independent studies indicates that Strain Specific Protective Immunity in P. c. chabaudi in mice is mainly determined by a narrow region of the P. c. chabaudi genome containing the gene for the P. c. chabaudi merozoite surface protein-1 protein. Other regions, including that containing the gene for P. c. chabaudi apical membrane antigen-1, may be more weakly associated with Strain Specific Protective Immunity in these parasites.	[Pattaradilokrat, Sittiporn; Cheesman, Sandra J.; Carter, Richard] Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	University of Edinburgh	Carter, R (corresponding author), Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	r.carter@ed.ac.uk		Pattaradilokrat, Sittiporn/0000-0002-1516-1961	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Babiker HA, 1999, T ROY SOC TROP MED H, V93, pS11, DOI 10.1016/S0035-9203(99)90321-8; Beale G.H., 1978, P213; BOYLE DB, 1982, INFECT IMMUN, V38, P94, DOI 10.1128/IAI.38.1.94-102.1982; BROWN KN, 1985, ANN INST PASTEUR IMM, VC136, P11, DOI 10.1016/S0769-2625(85)80036-2; CARDIGAN FC, 1969, MIL MED, V134, P1135; CARTER R, 1978, PARASITOLOGY, V76, P241, DOI 10.1017/S0031182000048137; CARTER R, 1975, ANN TROP MED PARASIT, V69, P187, DOI 10.1080/00034983.1975.11687000; CARTER R, 1973, T ROY SOC TROP MED H, V67, P830, DOI 10.1016/0035-9203(73)90011-4; Carter R, 2007, INT J PARASITOL, V37, P285, DOI 10.1016/j.ijpara.2006.11.013; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Cheesman S, 2006, INFECT IMMUN, V74, P2996, DOI 10.1128/IAI.74.5.2996-3001.2006; Cheesman SJ, 2003, MOL BIOCHEM PARASIT, V131, P83, DOI 10.1016/S0166-6851(03)00195-6; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; CONWAY DJ, 1991, PARASITOLOGY, V103, P7, DOI 10.1017/S0031182000059229; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Culleton R, 2005, GENOME RES, V15, P92, DOI 10.1101/gr.2866205; DAY K P, 1991, Immunology Today, V12, pA68; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; Ferguson HM, 2002, P ROY SOC B-BIOL SCI, V269, P1217, DOI 10.1098/rspb.2002.2023; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Grech K, 2002, MOL BIOCHEM PARASIT, V123, P95, DOI 10.1016/S0166-6851(02)00142-1; Hunt P, 2004, MOL BIOCHEM PARASIT, V136, P157, DOI 10.1016/j.molbiopara.2004.03.008; JARRA W, 1985, PARASITE IMMUNOL, V7, P595, DOI 10.1111/j.1365-3024.1985.tb00103.x; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Jones TR, 2000, AM J TROP MED HYG, V62, P675, DOI 10.4269/ajtmh.2000.62.675; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Magesa SM, 2002, ACTA TROP, V84, P83, DOI 10.1016/S0001-706X(02)00179-1; Marshall VM, 1996, MOL BIOCHEM PARASIT, V77, P109, DOI 10.1016/0166-6851(96)02583-2; Martinelli A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-11; Martinelli A, 2005, P NATL ACAD SCI USA, V102, P814, DOI 10.1073/pnas.0405097102; Martinelli A, 2004, MOL BIOCHEM PARASIT, V136, P117, DOI 10.1016/j.molbiopara.2004.02.011; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; MCGREGOR IA, 1974, B WORLD HEALTH ORGAN, V50, P259; MCKEAN PG, 1993, MOL BIOCHEM PARASIT, V62, P199, DOI 10.1016/0166-6851(93)90109-B; MCKEAN PG, 1993, MOL BIOCHEM PARASIT, V62, P211, DOI 10.1016/0166-6851(93)90110-J; MENDIS KN, 1991, IMMUNOPARASITOL TOD, pA34, DOI 10.1016/S0167-5699(05)80010-6; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; Polley SD, 2001, GENETICS, V158, P1505; POWELL RD, 1972, P HELM SOC WASH, V39, P51; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; WALLIKER D, 1975, PARASITOLOGY, V70, P19, DOI 10.1017/S0031182000048824	46	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e857	10.1371/journal.pone.0000857	http://dx.doi.org/10.1371/journal.pone.0000857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848988	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455600004
J	Seamari, Y; Narvaez, JA; Vico, FJ; Lobo, D; Sanchez-Vives, MV				Seamari, Yamina; Narvaez, Jose A.; Vico, Francisco J.; Lobo, Daniel; Sanchez-Vives, Maria V.			Robust Off- and Online Separation of Intracellularly Recorded Up and Down Cortical States	PLOS ONE			English	Article							MEMBRANE-POTENTIAL FLUCTUATIONS; STRIATAL NEURONS; NEOCORTICAL NEURONS; NETWORK ACTIVITY; FIRING PATTERNS; IN-VIVO; SLOW; OSCILLATION; SYNCHRONIZATION; MECHANISMS	Background. The neuronal cortical network generates slow (<1 Hz) spontaneous rhythmic activity that emerges from the recurrent connectivity. This activity occurs during slow wave sleep or anesthesia and also in cortical slices, consisting of alternating up (active, depolarized) and down (silent, hyperpolarized) states. The search for the underlying mechanisms and the possibility of analyzing network dynamics in vitro has been subject of numerous studies. This exposes the need for a detailed quantitative analysis of the membrane fluctuating behavior and computerized tools to automatically characterize the occurrence of up and down states. Methodology/Principal Findings. Intracellular recordings from different areas of the cerebral cortex were obtained from both in vitro and in vivo preparations during slow oscillations. A method that separates up and down states recorded intracellularly is defined and analyzed here. The method exploits the crossover of moving averages, such that transitions between up and down membrane regimes can be anticipated based on recent and past voltage dynamics. We demonstrate experimentally the utility and performance of this method both offline and online, the online use allowing to trigger stimulation or other events in the desired period of the rhythm. This technique is compared with a histogram-based approach that separates the states by establishing one or two discriminating membrane potential levels. The robustness of the method presented here is tested on data that departs from highly regular alternating up and down states. Conclusions/Significance. We define a simple method to detect cortical states that can be applied in real time for offline processing of large amounts of recorded data on conventional computers. Also, the online detection of up and down states will facilitate the study of cortical dynamics. An open-source MATLAB (R) toolbox, and Spike 2 (R)-compatible version are made freely available.	[Vico, Francisco J.; Lobo, Daniel] Univ Malaga, Dept Lenguajes & Ciencias Computac, Escuela Tecn Super Ingn Informat, E-29071 Malaga, Spain; [Seamari, Yamina; Narvaez, Jose A.] Univ Malaga, Dept Fisiol Gen, Fac Med, E-29071 Malaga, Spain; [Sanchez-Vives, Maria V.] Univ Miguel Hernandez, Consejo Super Invest Cient, Alicante, San Juan Alican, Spain	Universidad de Malaga; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Vico, FJ (corresponding author), Univ Malaga, Dept Lenguajes & Ciencias Computac, Escuela Tecn Super Ingn Informat, E-29071 Malaga, Spain.	fjv@geb.uma.es	Sanchez-Vives, Maria/J-8526-2014	Sanchez-Vives, Maria/0000-0002-8437-9083; Seamari, Yamina/0000-0002-6411-6120; Narvaez, Jose A./0000-0002-3575-6903; Lobo, Daniel/0000-0003-4666-6118	Programa de Perfeccionamiento de Doctores of the Junta de Andalucia; Ministerio de Educacion y Ciencia (Spain)	Programa de Perfeccionamiento de Doctores of the Junta de Andalucia; Ministerio de Educacion y Ciencia (Spain)(Spanish Government)	Funding: This work has been funded in part by Programa de Perfeccionamiento de Doctores of the Junta de Andalucia and grants for short stays of Universidad de Malaga to YS. MVSV was funded by Ministerio de Educacion y Ciencia (Spain). The sponsors played no role in the study.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Azouz R, 1999, J NEUROSCI, V19, P2209; Benucci A, 2004, NEURAL COMPUT, V16, P2351, DOI 10.1162/0899766041941871; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Crochet S, 2005, EUR J NEUROSCI, V21, P1030, DOI 10.1111/j.1460-9568.2005.03932.x; Crochet S, 2004, CEREB CORTEX, V14, P1110, DOI 10.1093/cercor/bhh071; ELLINGER AG, 1971, ART INVESTMENT; FUENTEALBA P, 2005, THAL REL SY IN PRESS; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Mahon S, 2003, J PHYSIOL-PARIS, V97, P557, DOI 10.1016/j.jphysparis.2004.01.013; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; Peters Y, 2004, SYNAPSE, V52, P143, DOI 10.1002/syn.20015; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Timofeev I, 1996, J PHYSIOL-LONDON, V494, P265, DOI 10.1113/jphysiol.1996.sp021489; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wilson CJ, 1996, J NEUROSCI, V16, P2397	38	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e888	10.1371/journal.pone.0000888	http://dx.doi.org/10.1371/journal.pone.0000888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849017	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455600034
J	Wong, H; Victor, JM; Mozziconacci, J				Wong, Hua; Victor, Jean-Marc; Mozziconacci, Julien			An All-Atom Model of the Chromatin Fiber Containing Linker Histones Reveals a Versatile Structure Tuned by the Nucleosomal Repeat Length	PLOS ONE			English	Article								In the nucleus of eukaryotic cells, histone proteins organize the linear genome into a functional and hierarchical architecture. In this paper, we use the crystal structures of the nucleosome core particle, B-DNA and the globular domain of H5 linker histone to build the first all-atom model of compact chromatin fibers. In this 3D jigsaw puzzle, DNA bending is achieved by solving an inverse kinematics problem. Our model is based on recent electron microscopy measurements of reconstituted fiber dimensions. Strikingly, we find that the chromatin fiber containing linker histones is a polymorphic structure. We show that different fiber conformations are obtained by tuning the linker histone orientation at the nucleosomes entry/exit according to the nucleosomal repeat length. We propose that the observed in vivo quantization of nucleosomal repeat length could reflect nature's ability to use the DNA molecule's helical geometry in order to give chromatin versatile topological and mechanical properties.	[Wong, Hua; Victor, Jean-Marc; Mozziconacci, Julien] Univ Paris 06, Lab Phys Theor Mat Condensee, Paris, France; [Mozziconacci, Julien] European Mol Biol Lab, Heidelberg, Germany	UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL)	Mozziconacci, J (corresponding author), Univ Paris 06, Lab Phys Theor Mat Condensee, Paris, France.	pipo@lptmc.jussieu.fr	Victor, Jean-Marc/AAB-1362-2020; Mozziconacci, Julien/M-4731-2019					ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Arya G, 2006, P NATL ACAD SCI USA, V103, P16236, DOI 10.1073/pnas.0604817103; Barbi M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031910; BARTOLOME S, 1994, J CELL SCI, V107, P2983; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; Ben-Haim E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051921; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boomsma W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-159; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Buss S. R., 2005, Journal of Graphics Tools, V10, P37; Daban JR, 1998, BIOCHEMISTRY-US, V37, P4299, DOI 10.1021/bi973117h; Daban JR, 2000, BIOCHEMISTRY-US, V39, P3861, DOI 10.1021/bi992628w; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; DUBOCHET J, 1978, SCIENCE, V202, P280, DOI 10.1126/science.694532; Duggan MM, 2000, J MOL BIOL, V304, P21, DOI 10.1006/jmbi.2000.4205; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; LAVERY R, 1995, COMPUT PHYS COMMUN, V91, P135, DOI 10.1016/0010-4655(95)00046-I; Lee KC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.128101; LEFORESTIER A, 1993, BIOPHYS J, V65, P56, DOI 10.1016/S0006-3495(93)81063-4; MAKAROV V, 1985, FEBS LETT, V181, P357, DOI 10.1016/0014-5793(85)80292-1; Mangenot S, 2003, J MOL BIOL, V333, P907, DOI 10.1016/j.jmb.2003.09.015; MIRZABEKOV AD, 1990, J MOL BIOL, V211, P479, DOI 10.1016/0022-2836(90)90366-T; Mozziconacci J, 2003, J STRUCT BIOL, V143, P72, DOI 10.1016/S1047-8477(03)00102-3; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Sivolob A, 2003, J MOL BIOL, V331, P1025, DOI 10.1016/S0022-2836(03)00831-3; TATCHELL K, 1978, P NATL ACAD SCI USA, V75, P3583, DOI 10.1073/pnas.75.8.3583; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; VANHOLDE K, 1995, J BIOL CHEM, V270, P8373, DOI 10.1074/jbc.270.15.8373; VANHOLDE KE, SPRINGER SERIES MOL; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; WORCEL A, 1981, P NATL ACAD SCI-BIOL, V78, P1461, DOI 10.1073/pnas.78.3.1461; YAO J, 1993, P NATL ACAD SCI USA, V90, P9364, DOI 10.1073/pnas.90.20.9364	41	110	110	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e877	10.1371/journal.pone.0000877	http://dx.doi.org/10.1371/journal.pone.0000877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849006	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455600023
J	Glas, J; Seiderer, J; Wetzke, M; Konrad, A; Torok, HP; Schmechel, S; Tonenchi, L; Grassl, C; Dambacher, J; Pfennig, S; Maier, K; Griga, T; Klein, W; Epplen, JT; Schiemann, U; Folwaczny, C; Lohse, P; Goke, B; Ochsenkuhn, T; Muller-Myhsok, B; Folwaczny, M; Mussack, T; Brand, S				Glas, Juergen; Seiderer, Julia; Wetzke, Martin; Konrad, Astrid; Toeroek, Helga-Paula; Schmechel, Silke; Tonenchi, Laurian; Grassl, Christine; Dambacher, Julia; Pfennig, Simone; Maier, Kerstin; Griga, Thomas; Klein, Wolfram; Epplen, Joerg T.; Schiemann, Uwe; Folwaczny, Christian; Lohse, Peter; Goeke, Burkhard; Ochsenkuehn, Thomas; Mueller-Myhsok, Bertram; Folwaczny, Matthias; Mussack, Thomas; Brand, Stephan			rs1004819 Is the Main Disease-Associated IL23R Variant in German Crohn's Disease Patients: Combined Analysis of IL23R, CARD15, and OCTN1/2 Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CATION TRANSPORTER GENES; T-CELL; EXPERIMENTAL COLITIS; DENDRITIC CELLS; PROMOTER POLYMORPHISM; FRAMESHIFT MUTATION; MONOCLONAL-ANTIBODY	Background. The IL23R gene has been identified as a susceptibility gene for inflammatory bowel disease (IBD) in the North American population. The aim of our study was to test this association in a large German IBD cohort and to elucidate potential interactions with other IBD genes as well as phenotypic consequences of IL23R variants. Methods. Genomic DNA from 2670 Caucasian individuals including 833 patients with Crohn's disease (CD), 456 patients with ulcerative colitis (UC), and 1381 healthy unrelated controls was analyzed for 10 IL23R SNPs. Genotyping included the NOD2 variants p.Arg702Trp, p.Gly908Arg, and p.Leu1007fsX1008 and polymorphisms in SLC22A4/OCTN1 (1672 C -> T) and SLC22A5/OCTN2 (-207 G -> C). Results. All IL23R gene variants analyzed displayed highly significant associations with CD. The strongest association was found for the SNP rs1004819 [P = 1.92x10(-11); OR 1.56; 95 % CI (1.37-1.78)]. 93.2% of the rs1004819 TT homozygous carriers as compared to 78% of CC wildtype carriers had ileal involvement [P = 0.004; OR 4.24; CI (1.46-12.34)]. The coding SNP rs11209026 (p.Arg381Gln) was protective for CD [P = 8.04x10(-8); OR 0.43; CI (0.31-0.59)]. Similar, but weaker associations were found in UC. There was no evidence for epistasis between the IL23R gene and the CD susceptibility genes CARD15 and SLC22A4/5. Conclusion. IL23R is an IBD susceptibility gene, but has no epistatic interaction with CARD15 and SLC22A4/5. rs1004819 is the major IL23R variant associated with CD in the German population, while the p. Arg381Gln IL23R variant is a protective marker for CD and UC.	[Glas, Juergen; Seiderer, Julia; Wetzke, Martin; Konrad, Astrid; Toeroek, Helga-Paula; Schmechel, Silke; Dambacher, Julia; Pfennig, Simone; Goeke, Burkhard; Ochsenkuehn, Thomas; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Wetzke, Martin; Tonenchi, Laurian; Grassl, Christine; Maier, Kerstin; Folwaczny, Matthias] Univ Munich, Clin Prevent Dent & Parodontol, Munich, Germany; [Folwaczny, Christian; Mussack, Thomas] Univ Munich, Dept Surg, Munich, Germany; [Griga, Thomas] Knappschaftskrankenhaus Dortmund, Dept Internal Med, Dortmund, Germany; [Klein, Wolfram; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Schiemann, Uwe] Inselspital Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Lohse, Peter] Univ Munich, Inst Clin Chem Grosshadern, Munich, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; University of Munich; Ruhr University Bochum; University of Bern; University Hospital of Bern; University of Munich; Max Planck Society	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013; Wetzke, Martin/HDM-2614-2022	Epplen, Joerg T./0000-0002-6087-3327	University of Munich; Deutsche Forschungsgemeinschaft (DFG) [KO 2228/4-1, BR 1912/5-1]; Broad Medical Foundation [IBD-0126R2]; Else-Kroner-Fresenius-Stiftung [P50/05/EKMS05/62]; DCCV e. V	University of Munich; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Broad Medical Foundation; Else-Kroner-Fresenius-Stiftung; DCCV e. V	J. Seiderer and J. Dambacher were supported by grants from the University of Munich (FoFoLe Nr. 422; Habilitationsstipendium to J. S. and Promotionsstipendium to J. D.). A. Konrad was supported by grants of the Deutsche Forschungsgemeinschaft (DFG; KO 2228/4-1). J. Glas and H.-P. Torok were supported by a grant from the Broad Medical Foundation (IBD-0126R2). S. Brand was supported by grants from the DFG (BR 1912/5-1) and the Else-Kroner-Fresenius-Stiftung (P50/05/EKMS05/62) and by the Ludwig-Demling Grant 2007 from DCCV e. V. This work contains parts of the unpublished degree theses of M. Wetzke and J. Dambacher. We thank B. Salil for excellent technical support. Design and conduct of the study, collection, analysis, interpretation of the data, preparation, review and approval of the manuscript were completely independent of the sponsors of this study.	Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Brandt F, 2007, INT J MOD PHYS A, V22, P1, DOI 10.1142/S0217751X0703501X; Cardon LR, 2006, SCIENCE, V314, P1403, DOI 10.1126/science.1136668; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Dambacher J, 2007, INFLAMM BOWEL DIS, V13, P71, DOI 10.1002/ibd.20008; Dubinsky MC, 2007, INFLAMM BOWEL DIS, V13, P511, DOI 10.1002/ibd.20126; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Glas J, 2006, INFLAMM BOWEL DIS, V12, P606, DOI 10.1097/01.ibd.0000225346.23765.6b; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hao JS, 2006, CANCER IMMUNOL IMMUN, V55, P1426, DOI 10.1007/s00262-006-0171-5; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mizoguchi A, 2007, J CLIN INVEST, V117, P605, DOI 10.1172/JCI30150; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Noble CL, 2005, GASTROENTEROLOGY, V129, P1854, DOI 10.1053/j.gastro.2005.09.025; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Vaknin-Dembinsky A, 2006, J IMMUNOL, V176, P7768, DOI 10.4049/jimmunol.176.12.7768; Limbergen J, 2007, GUT, V56, P1173, DOI 10.1136/gut.2007.122069; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Waibler Z, 2007, MOL IMMUNOL, V44, P1483, DOI 10.1016/j.molimm.2006.09.001; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang ZL, 2007, INT IMMUNOPHARMACOL, V7, P409, DOI 10.1016/j.intimp.2006.09.024; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; ZHOU L, 2007, NAT IMMUNOL     0620	53	115	118	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e819	10.1371/journal.pone.0000819	http://dx.doi.org/10.1371/journal.pone.0000819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786191	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455500003
J	Moffett, A; Shackelford, N; Sarkar, S				Moffett, Alexander; Shackelford, Nancy; Sarkar, Sahotra			Malaria in Africa: Vector Species' Niche Models and Relative Risk Maps	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; CHROMOSOMAL INVERSION POLYMORPHISM; PERMETHRIN-IMPREGNATED BEDNETS; CHAIN-REACTION METHOD; HUMAN-BLOOD INDEX; PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; FUNESTUS DIPTERA; GILES COMPLEX; KISUMU AREA	A central theoretical goal of epidemiology is the construction of spatial models of disease prevalence and risk, including maps for the potential spread of infectious disease. We provide three continent-wide maps representing the relative risk of malaria in Africa based on ecological niche models of vector species and risk analysis at a spatial resolution of 1 arc-minute (9 185 275 cells of approximately 4 sq km). Using a maximum entropy method we construct niche models for 10 malaria vector species based on species occurrence records since 1980, 19 climatic variables, altitude, and land cover data (in 14 classes). For seven vectors (Anopheles coustani, A. funestus, A. melas, A. merus, A. moucheti, A. nili, and A. paludis) these are the first published niche models. We predict that Central Africa has poor habitat for both A. arabiensis and A. gambiae, and that A. quadriannulatus and A. arabiensis have restricted habitats in Southern Africa as claimed by field experts in criticism of previous models. The results of the niche models are incorporated into three relative risk models which assume different ecological interactions between vector species. The "additive'' model assumes no interaction; the "minimax'' model assumes maximum relative risk due to any vector in a cell; and the "competitive exclusion'' model assumes the relative risk that arises from the most suitable vector for a cell. All models include variable anthrophilicity of vectors and spatial variation in human population density. Relative risk maps are produced from these models. All models predict that human population density is the critical factor determining malaria risk. Our method of constructing relative risk maps is equally general. We discuss the limits of the relative risk maps reported here, and the additional data that are required for their improvement. The protocol developed here can be used for any other vector-borne disease.	[Moffett, Alexander; Shackelford, Nancy; Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Sarkar, S (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	sarkar@mail.utexas.edu						Adugna N, 1996, ETHIOPIAN MED J, V34, P1; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Akogbeto M., 1988, Parassitologia (Rome), V30, P7; Ameneshewa B, 1996, ANN TROP MED PARASIT, V90, P515, DOI 10.1080/00034983.1996.11813077; Antonio-Nkondjio C, 2005, T ROY SOC TROP MED H, V99, P347, DOI 10.1016/j.trstmh.2004.07.003; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; APPAWU MA, 1994, ACTA TROP, V56, P15, DOI 10.1016/0001-706X(94)90036-1; Aranda C, 2005, J MED ENTOMOL, V42, P180, DOI 10.1603/0022-2585(2005)042[0180:ECOMTI]2.0.CO;2; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P75, DOI 10.1179/000349802125000538; Awono-Ambene HP, 2004, J MED ENTOMOL, V41, P561, DOI 10.1603/0022-2585-41.4.561; Ayala D, 2006, ACTA TROP, V97, P292, DOI 10.1016/j.actatropica.2005.12.002; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; BLACK WC, 2005, BIOL DIS VECTORS; BOCKARIE MJ, 1994, ANN TROP MED PARASIT, V88, P251, DOI 10.1080/00034983.1994.11812865; Bogh C, 1998, MED VET ENTOMOL, V12, P52, DOI 10.1046/j.1365-2915.1998.00091.x; Bogh C, 2001, J MED ENTOMOL, V38, P822, DOI 10.1603/0022-2585-38.6.822; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bryan J.H., 1987, Parassitologia (Rome), V29, P221; BRYAN JH, 1982, GENETICA, V59, P167, DOI 10.1007/BF00056539; CAMBOURNAC F J C, 1982, Parassitologia (Rome), V24, P265; Cano J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-21; Carnahan J, 2002, J HERED, V93, P249, DOI 10.1093/jhered/93.4.249; CHANDLER JA, 1975, T ROY SOC TROP MED H, V69, P415, DOI 10.1016/0035-9203(75)90200-X; Charalambous M, 1999, B ENTOMOL RES, V89, P111, DOI 10.1017/S0007485399000188; Charlwood JD, 1996, J MED ENTOMOL, V33, P202, DOI 10.1093/jmedent/33.2.202; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-9; Charlwood JD, 2001, ACTA TROP, V80, P1, DOI 10.1016/S0001-706X(01)00152-8; Chen H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-17; Clarke D, 1996, T ROY SOC TROP MED H, V90, P302, DOI 10.1016/S0035-9203(96)90262-X; COENE J, 1993, MED VET ENTOMOL, V7, P127, DOI 10.1111/j.1365-2915.1993.tb00665.x; COETZEE M, 1989, Mosquito Systematics, V21, P100; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; COETZEE M, 1993, S AFR J SCI, V89, P227; Coetzee Maureen, 1994, Mosquito Systematics, V26, P125; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Cohuet A, 2004, INSECT MOL BIOL, V13, P251, DOI 10.1111/j.0962-1075.2004.00482.x; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; COLLINS FH, 1995, ANNU REV ENTOMOL, V40, P195, DOI 10.1146/annurev.en.40.010195.001211; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; CONSTANTINI C, 1998, AM J TROP MED HYG, V58, P56; COOSEMANS M, 1989, Parassitologia (Rome), V31, P113; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; *CTR INT EARTH SCI, 2004, GRIDD POP WORLD GPW; Cuamba N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-2; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Dia I, 2005, J MED ENTOMOL, V42, P104, DOI 10.1603/0022-2585(2005)042[0104:COHCAO]2.0.CO;2; Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; DossouYovo J, 1995, TROP MED PARASITOL, V46, P263; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Duchemin JB, 2001, MED VET ENTOMOL, V15, P50, DOI 10.1046/j.1365-2915.2001.00276.x; Elissa N, 1999, J AM MOSQUITO CONTR, V15, P15; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ELSAID S, 1986, J AM MOSQUITO CONTR, V2, P158; *ESRI, 2004, ARCGIS 9 1; FAYE O, 1994, B SOC PATHOL EXOT, V87, P157; Faye O, 1997, J MED ENTOMOL, V34, P285, DOI 10.1093/jmedent/34.3.285; Fettene M, 2002, MED VET ENTOMOL, V16, P214, DOI 10.1046/j.1365-2915.2002.00354.x; Fettene M, 2004, AFR ENTOMOL, V12, P83; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; FONTENILLE D, 1992, J MED ENTOMOL, V29, P197, DOI 10.1093/jmedent/29.2.197; FONTENILLE D, 1993, ANN PARASIT HUM COMP, V68, P239; Fuller T, 2007, BIOL CONSERV, V134, P593, DOI 10.1016/j.biocon.2006.08.028; Fuller T, 2006, BIOL CONSERV, V133, P131, DOI 10.1016/j.biocon.2006.04.040; GAD A M, 1987, Journal of the Egyptian Society of Parasitology, V17, P207; GARRETTJONES C, 1980, B ENTOMOL RES, V70, P165, DOI 10.1017/S0007485300007422; GARRETTJONES C, 1963, WHOMAL391; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gillies M, 1987, ANOPHELINAE AFRICA S; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; GITHEKO AK, 1994, ACTA TROP, V58, P307, DOI 10.1016/0001-706X(94)90024-8; GITHEKO AK, 1993, MED VET ENTOMOL, V7, P373, DOI 10.1111/j.1365-2915.1993.tb00708.x; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; GREEN C A, 1982, Journal of Heredity, V73, P3; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Habtewold T, 2004, MED VET ENTOMOL, V18, P408, DOI 10.1111/j.0269-283X.2004.00525.x; Habtewold T, 2001, T ROY SOC TROP MED H, V95, P584, DOI 10.1016/S0035-9203(01)90086-0; Hadis M, 1997, T ROY SOC TROP MED H, V91, P376, DOI 10.1016/S0035-9203(97)90245-5; Haji H, 1996, T ROY SOC TROP MED H, V90, P494, DOI 10.1016/S0035-9203(96)90292-8; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Haworth J., 1988, P1379; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; HIGHTON RB, 1979, B ENTOMOL RES, V69, P43, DOI 10.1017/S0007485300017879; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hogg JC, 1996, MED VET ENTOMOL, V10, P385, DOI 10.1111/j.1365-2915.1996.tb00761.x; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; IJUMBA JN, 1990, MED VET ENTOMOL, V4, P425, DOI 10.1111/j.1365-2915.1990.tb00461.x; Illoldi-Rangel P, 2004, J MAMMAL, V85, P658, DOI 10.1644/BER-024; JAENSON TGT, 1994, T ROY SOC TROP MED H, V88, P620, DOI 10.1016/0035-9203(94)90197-X; JOSHI GP, 1975, ANN TROP MED PARASIT, V69, P91, DOI 10.1080/00034983.1975.11686988; Kamau L, 2003, J MED ENTOMOL, V40, P664, DOI 10.1603/0022-2585-40.5.664; Kamau L, 2002, J MED ENTOMOL, V39, P78, DOI 10.1603/0022-2585-39.1.78; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Klinkenberg E, 2003, ACTA TROP, V85, P71, DOI 10.1016/S0001-706X(02)00254-1; Kuhn KG, 2002, J MED ENTOMOL, V39, P621, DOI 10.1603/0022-2585-39.4.621; laGrange JJP, 1995, AFR ENTOMOL, V3, P217; LAMBERT DM, 1983, EVOLUTION, V37, P484, DOI [10.2307/2408262, 10.1111/j.1558-5646.1983.tb05565.x]; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; Levine RS, 2004, J MED ENTOMOL, V41, P607, DOI 10.1603/0022-2585-41.4.607; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; LOGAN TM, 1991, J AM MOSQUITO CONTR, V7, P395; MacNab YC, 2001, BIOMETRICS, V57, P949, DOI 10.1111/j.0006-341X.2001.00949.x; MATOLA YG, 1987, J TROP MED HYG, V90, P127; Mboera LEG, 1999, ENTOMOL EXP APPL, V92, P83, DOI 10.1023/A:1003780811793; Mbogo CNM, 1996, MED VET ENTOMOL, V10, P251, DOI 10.1111/j.1365-2915.1996.tb00739.x; MBOGO CNM, 1993, J AM MOSQUITO CONTR, V9, P225; MEKURIA Y, 1982, Parassitologia (Rome), V24, P237; Mendis C, 2000, MED VET ENTOMOL, V14, P171, DOI 10.1046/j.1365-2915.2000.00228.x; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MNZAVA AEP, 1986, ACTA TROP, V43, P277; MNZAVA AEP, 1995, MED VET ENTOMOL, V9, P316, DOI 10.1111/j.1365-2915.1995.tb00140.x; MNZAVA AEP, 1994, J AM MOSQUITO CONTR, V10, P507; MNZAVA AEP, 1989, ACTA TROP, V46, P323, DOI 10.1016/0001-706X(89)90045-4; MOSHA FW, 1983, T ROY SOC TROP MED H, V77, P344, DOI 10.1016/0035-9203(83)90161-X; MOSHA FW, 1982, WHOVBC82867; MPOFU SM, 1985, T ROY SOC TROP MED H, V79, P169, DOI 10.1016/0035-9203(85)90327-X; Mukabayire O, 1999, MOL ECOL, V8, P289, DOI 10.1046/j.1365-294X.1999.00567.x; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Muturi EJ, 2006, J VECTOR ECOL, V31, P129, DOI 10.3376/1081-1710(2006)31[129:MSDAAI]2.0.CO;2; Mwangangi JM, 2003, J AM MOSQUITO CONTR, V19, P371; NIGATU W, 1995, J AM MOSQUITO CONTR, V11, P238; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Ortega-Huerta MA, 2004, DIVERS DISTRIB, V10, P39, DOI 10.1111/j.1472-4642.2004.00051.x; PASKEWITZ SM, 1993, J MED ENTOMOL, V30, P953, DOI 10.1093/jmedent/30.5.953; PAWAR SS, 2007, BIOL CONSER IN PRESS; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; PETRARCA V, 1987, MED VET ENTOMOL, V1, P303, DOI 10.1111/j.1365-2915.1987.tb00359.x; PETRARCA V, 1991, J MED ENTOMOL, V28, P307, DOI 10.1093/jmedent/28.3.307; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; Petrarca V, 1998, J MED ENTOMOL, V35, P16, DOI 10.1093/jmedent/35.1.16; Petrarca V., 1984, Parassitologia (Rome), V26, P247; PETRARCA V, 1990, Parassitologia (Rome), V32, P371; PETRARCA V, 1983, Parassitologia (Rome), V25, P29; PETROVICHEV N, 1986, SOV EDUC, V28, P41, DOI 10.2753/RES1060-9393280341; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Quakyi IA, 2000, AM J TROP MED HYG, V63, P222; ROBERT V, 1991, B WORLD HEALTH ORGAN, V69, P735; ROBERT V, 1993, TROP MED PARASITOL, V44, P14; Robert V, 1998, J MED ENTOMOL, V35, P948, DOI 10.1093/jmedent/35.6.948; ROBERT V, 1989, ANN PARASIT HUM COMP, V64, P290, DOI 10.1051/parasite/1989644290; ROBERT V, 1990, T ROY SOC TROP MED H, V84, P346, DOI 10.1016/0035-9203(90)90309-3; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Schneider P, 2000, MED VET ENTOMOL, V14, P165, DOI 10.1046/j.1365-2915.2000.00204.x; SERVICE MW, 1978, ANN TROP MED PARASIT, V72, P377, DOI 10.1080/00034983.1978.11719332; SHARP BL, 1991, B ENTOMOL RES, V81, P107, DOI 10.1017/S000748530005330X; SHARP BL, 1983, J ENTOMOL SOC S AFR, V46, P367; SHARP BL, 1984, J ENTOMOL SOC S AFR, V47, P251; SHARP BL, 1993, J AM MOSQUITO CONTR, V9, P414; Simard F, 2000, INSECT MOL BIOL, V9, P467, DOI 10.1046/j.1365-2583.2000.00210.x; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Smits A, 1996, J MED ENTOMOL, V33, P545, DOI 10.1093/jmedent/33.4.545; Smits A, 1995, B ENTOMOL RES, V85, P541, DOI 10.1017/S0007485300033046; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sousa CA, 2001, J MED ENTOMOL, V38, P122, DOI 10.1603/0022-2585-38.1.122; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sylla EHK, 2000, T ROY SOC TROP MED H, V94, P652, DOI 10.1016/S0035-9203(00)90219-0; Taye A, 2006, ACTA TROP, V97, P50, DOI 10.1016/j.actatropica.2005.08.002; TAYLOR CE, 1993, MED VET ENTOMOL, V7, P351, DOI 10.1111/j.1365-2915.1993.tb00704.x; THOMSON MC, 1995, MED VET ENTOMOL, V9, P413, DOI 10.1111/j.1365-2915.1995.tb00015.x; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Toure YT, 1996, MED VET ENTOMOL, V10, P197, DOI 10.1111/j.1365-2915.1996.tb00731.x; TOURE YT, 1983, PARASSITOLOGIA, V25, P367; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Tsy JMLP, 2003, MALARIA J, V2; *UN, 2002, WORLD URB PROSP 2001; United Nations, 2004, WORLD URB PROSP 2003; VanRensburg AJ, 1996, J AM MOSQUITO CONTR, V12, P271; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; Walker TW, 1996, J AM MOSQUITO CONTR, V12, P172; Waller LA, 1997, J AM STAT ASSOC, V92, P607, DOI 10.2307/2965708; White G B, 1971, East Afr Med J, V48, P120; WHITE GB, 1973, B ENTOMOL RES, V62, P613, DOI 10.1017/S0007485300005502; WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738; White GB., 1989, MALARIA GEOGRAPHICAL, P7; *WHO, 2003, INT TRAV HLTH SIT 1; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; WOYESSA A, 2004, ETHIOP J HEALTH DEV, V18, P2; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001	199	110	121	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e824	10.1371/journal.pone.0000824	http://dx.doi.org/10.1371/journal.pone.0000824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786196	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500008
J	Tamm, E; Kivisild, T; Reidla, M; Metspalu, M; Smith, DG; Mulligan, CJ; Bravi, CM; Rickards, O; Martinez-Labarga, C; Khusnutdinova, EK; Fedorova, SA; Golubenko, MV; Stepanov, VA; Gubina, MA; Zhadanov, SI; Ossipova, LP; Damba, L; Voevoda, MI; Dipierri, JE; Villems, R; Malhi, RS				Tamm, Erika; Kivisild, Toomas; Reidla, Maere; Metspalu, Mait; Smith, David Glenn; Mulligan, Connie J.; Bravi, Claudio M.; Rickards, Olga; Martinez-Labarga, Cristina; Khusnutdinova, Elsa K.; Fedorova, Sardana A.; Golubenko, Maria V.; Stepanov, Vadim A.; Gubina, Marina A.; Zhadanov, Sergey I.; Ossipova, Ludmila P.; Damba, Larisa; Voevoda, Mikhail I.; Dipierri, Jose E.; Villems, Richard; Malhi, Ripan S.			Beringian Standstill and Spread of Native American Founders	PLOS ONE			English	Article							MITOCHONDRIAL GENOME VARIATION; MTDNA VARIATION; DNA DIVERSITY; NEW-WORLD; POPULATION; HAPLOTYPES; PREHISTORY; MIGRATION; SEQUENCES; LINEAGES	Native Americans derive from a small number of Asian founders who likely arrived to the Americas via Beringia. However, additional details about the intial colonization of the Americas remain unclear. To investigate the pioneering phase in the Americas we analyzed a total of 623 complete mtDNAs from the Americas and Asia, including 20 new complete mtDNAs from the Americas and seven from Asia. This sequence data was used to direct high-resolution genotyping from 20 American and 26 Asian populations. Here we describe more genetic diversity within the founder population than was previously reported. The newly resolved phylogenetic structure suggests that ancestors of Native Americans paused when they reached Beringia, during which time New World founder lineages differentiated from their Asian sister-clades. This pause in movement was followed by a swift migration southward that distributed the founder types all the way to South America. The data also suggest more recent bi-directional gene flow between Siberia and the North American Arctic.	[Malhi, Ripan S.] Univ Illinois, Inst Genom Biol, Dept Anthropol, Champaign, IL USA; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Mulligan, Connie J.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Bravi, Claudio M.] Inst Multidisciplinario Biol Celular, La Plata, Buenos Aires, Argentina; [Rickards, Olga; Martinez-Labarga, Cristina] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Khusnutdinova, Elsa K.] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Fedorova, Sardana A.] Russian Acad Med Sci, Yakut Res Ctr, Dept Mol Genet, Yakutia, Russia; [Golubenko, Maria V.; Stepanov, Vadim A.] Russian Acad Med Sci, Tomsk Res Ctr, Inst Med Genet, Tomsk, Russia; [Gubina, Marina A.; Zhadanov, Sergey I.; Ossipova, Ludmila P.; Damba, Larisa; Voevoda, Mikhail I.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Zhadanov, Sergey I.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Dipierri, Jose E.] Univ Nacl Jujuy, Inst Biol Altura, San Salvador De Jujuy, Argentina; [Tamm, Erika; Kivisild, Toomas; Reidla, Maere; Metspalu, Mait; Fedorova, Sardana A.; Golubenko, Maria V.; Zhadanov, Sergey I.; Damba, Larisa; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, Estonian Bioctr, EE-50090 Tartu, Estonia	University of Illinois System; University of Illinois Urbana-Champaign; University of Cambridge; University of California System; University of California Davis; State University System of Florida; University of Florida; University of Rome Tor Vergata; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Russian Academy of Medical Sciences; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Pennsylvania; Estonian Biocentre; University of Tartu	Malhi, RS (corresponding author), Univ Illinois, Inst Genom Biol, Dept Anthropol, Champaign, IL USA.	malhi@uiuc.edu	Kivisild, Toomas/P-5889-2017; Metspalu, Mait/G-8671-2015; Tamm, Erika/G-2818-2017; Golubenko, Maria V/A-8107-2014; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Voevoda, Mikhail/N-6713-2015; Gubina, Marina/AAD-9163-2019; Stepanov, Vadim A./N-7657-2014; Khusnutdinova, Elza Kamilevna/A-4810-2013; Stepanov, Vadim/G-4320-2013; Osipova, Ludmila P/O-6480-2014; Fedorova, Sardana/K-5445-2017; Rickards, Olga/L-7878-2015	Kivisild, Toomas/0000-0002-6297-7808; Metspalu, Mait/0000-0003-3099-9161; Tamm, Erika/0000-0003-0694-3598; Golubenko, Maria V/0000-0002-7692-9954; MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Voevoda, Mikhail/0000-0001-9425-413X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Stepanov, Vadim/0000-0002-5166-331X; Osipova, Ludmila P/0000-0001-7602-1156; Rickards, Olga/0000-0003-2880-7466; Dipierri, Jose Edgardo/0000-0002-1679-0727; Fedorova, Sardana/0000-0002-6952-3868; Malhi, Ripan/0000-0002-1484-0292	NSF BCS [0422144]; University of Tartu [PBGMR06901]	NSF BCS(National Science Foundation (NSF)); University of Tartu	Funding for this work is from NSF BCS#0422144 to RSM and from the University of Tartu #PBGMR06901 to TK.	BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bermisheva MA, 2005, RUSS J GENET+, V41, P66, DOI 10.1007/s11177-005-0069-x; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CRAWFORD MH, 1998, ORIGINS NATIVE AM EV; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Eshleman JA, 2003, EVOL ANTHROPOL, V12, P7, DOI 10.1002/evan.10048; Fedorova SA, 2003, MOL BIOL+, V37, P544, DOI 10.1023/A:1025135326954; Forster P, 1996, AM J HUM GENET, V59, P935; Goltsova T V, 2005, Genetika, V41, P954; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HORAI S, 1993, MOL BIOL EVOL, V47, P10; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1997, GENETICS, V147, P1289; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Lorenz JG, 1996, AM J PHYS ANTHROPOL, V101, P307, DOI 10.1002/(SICI)1096-8644(199611)101:3<307::AID-AJPA1>3.0.CO;2-W; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Malyarchuk BA, 2004, ANN HUM GENET, V68, P324, DOI 10.1046/j.1529-8817.2004.00099.x; MELTON PE, 2007, AM J PHYS ANTHR 0305; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; NON AL, 2006, MOL PHYLOGENET EVOL; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; SCHROEDER KB, 2007, BIOL LETT; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; TORRONI A, 1993, AM J HUM GENET, V53, P563; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663	50	380	398	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e829	10.1371/journal.pone.0000829	http://dx.doi.org/10.1371/journal.pone.0000829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786201	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500013
J	Comeau, AM; Tetart, F; Trojet, SN; Prere, MF; Krisch, HM				Comeau, Andre M.; Tetart, Francoise; Trojet, Sabrina N.; Prere, Marie-Francoise; Krisch, H. M.			Phage-Antibiotic Synergy (PAS): beta-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth	PLOS ONE			English	Article								Although the multiplication of bacteriophages (phages) has a substantial impact on the biosphere, comparatively little is known about how the external environment affects phage production. Here we report that sub-lethal concentrations of certain antibiotics can substantially stimulate the host bacterial cell's production of some virulent phage. For example, a low dosage of cefotaxime, a cephalosporin, increased an uropathogenic Escherichia coli strain's production of the phage phi MFP by more than 7-fold. We name this phenomenon Phage-Antibiotic Synergy (PAS). A related effect was observed in diverse host-phage systems, including the T4-like phages, with beta-lactam and quinolone antibiotics, as well as mitomycin C. A common characteristic of these antibiotics is that they inhibit bacterial cell division and trigger the SOS system. We therefore examined the PAS effect within the context of the bacterial SOS and filamentation responses. We found that the PAS effect appears SOS-independent and is primarily a consequence of cellular filamentation; it is mimicked by cells that constitutively filament. The fact that completely unrelated phages manifest this phenomenon suggests that it confers an important and general advantage to the phages.	[Comeau, Andre M.; Tetart, Francoise; Trojet, Sabrina N.; Prere, Marie-Francoise; Krisch, H. M.] Univ Toulouse 3, CNRS, Lab Microbiol & Genet Mol, F-31062 Toulouse, France; [Prere, Marie-Francoise] Ctr Hosp Univ Toulouse, Inst Fed Biol, Bacteriol Lab, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse	Krisch, HM (corresponding author), Univ Toulouse 3, CNRS, Lab Microbiol & Genet Mol, F-31062 Toulouse, France.	krisch@ibcg.biotoul.fr	Comeau, André/E-7461-2012		CNRS; Ministere de la Recherche (ACI-Microbiology Biodefense Initiative)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche (ACI-Microbiology Biodefense Initiative)(Ministry of Research, France)	This work was supported by the CNRS and by a grant from the Ministere de la Recherche (ACI-Microbiology Biodefense Initiative).	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Andersson MI, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg212; BURTON P, 1983, MOL GEN GENET, V190, P309, DOI 10.1007/BF00330656; Dressman HK, 1999, J BACTERIOL, V181, P4391, DOI 10.1128/JB.181.14.4391-4396.1999; Goerke C, 2006, ANTIMICROB AGENTS CH, V50, P171, DOI 10.1128/AAC.50.1.171-177.2006; Gottfredsson M, 1998, ANTIMICROB AGENTS CH, V42, P1005, DOI 10.1128/AAC.42.5.1005; JOSHI A, 1982, J VIROL, V41, P1038, DOI 10.1128/JVI.41.3.1038-1043.1982; KARAM J, 1994, MOL BIOL BACTERIOPHA, P633; Liu GW, 2001, MOL MICROBIOL, V40, P909, DOI 10.1046/j.1365-2958.2001.02434.x; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Paddison P, 1998, GENETICS, V148, P1539; PIDDOCK LJV, 1990, ANTIMICROB AGENTS CH, V34, P2331, DOI 10.1128/AAC.34.12.2331; SEKIGUCHI M, 1967, P NATL ACAD SCI USA, V58, P2315, DOI 10.1073/pnas.58.6.2315; SUZUKI H, 1967, J BACTERIOL, V93, P675, DOI 10.1128/JB.93.2.675-682.1967; YAMAGAMI H, 1969, J VIROL, V3, P343, DOI 10.1128/JVI.3.3.343-349.1969	17	218	221	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e799	10.1371/journal.pone.0000799	http://dx.doi.org/10.1371/journal.pone.0000799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726529	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455400016
J	Wood, RJ; Maynard-Smith, MD; Robinson, VL; Oyston, PCF; Titball, RW; Roach, PL				Wood, Robert J.; Maynard-Smith, Michael D.; Robinson, Victoria L.; Oyston, Petra C. F.; Titball, Rick W.; Roach, Peter L.			Kinetic Analysis of Yersinia pestis DNA Adenine Methyltransferase Activity Using a Hemimethylated Molecular Break Light Oligonucleotide	PLOS ONE			English	Article							DAM METHYLASE; RECOGNITION SEQUENCE; CLEAVAGE; PSEUDOTUBERCULOSIS; REPLICATION; MECHANISM; PLASMID; MUTANT; ASSAY	Background. DNA adenine methylation plays an important role in several critical bacterial processes including mismatch repair, the timing of DNA replication and the transcriptional control of gene expression. The dependence of bacterial virulence on DNA adenine methyltransferase (Dam) has led to the proposal that selective Dam inhibitors might function as broad spectrum antibiotics. Methodology/Principal Findings. Herein we report the expression and purification of Yersinia pestis Dam and the development of a continuous fluorescence based assay for DNA adenine methyltransferase activity that is suitable for determining the kinetic parameters of the enzyme and for high throughput screening against potential Dam inhibitors. The assay utilised a hemimethylated break light oligonucleotide substrate containing a GATC methylation site. When this substrate was fully methylated by Dam, it became a substrate for the restriction enzyme DpnI, resulting in separation of fluorophore (fluorescein) and quencher (dabcyl) and therefore an increase in fluorescence. The assays were monitored in real time using a fluorescence microplate reader in 96 well format and were used for the kinetic characterisation of Yersinia pestis Dam, its substrates and the known Dam inhibitor, S-adenosylhomocysteine. The assay has been validated for high throughput screening, giving a Z-factor of 0.71 +/- 0.07 indicating that it is a sensitive assay for the identification of inhibitors. Conclusions/Significance. The assay is therefore suitable for high throughput screening for inhibitors of DNA adenine methyltransferases and the kinetic characterisation of the inhibition.	[Wood, Robert J.; Maynard-Smith, Michael D.; Roach, Peter L.] Univ Southampton, Sch Chem, Southampton, Hants, England; [Robinson, Victoria L.; Oyston, Petra C. F.; Titball, Rick W.] Def Sci & Technol Lab, Salisbury, Wilts, England	University of Southampton; Defence Science & Technology Laboratory	Wood, RJ (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.	rjw4@soton.ac.uk; plr2@soton.ac.uk	Roach, Peter/AAW-7071-2021; Roach, Peter/C-6248-2013	Roach, Peter/0000-0001-9880-2877	Defence Science and Technology Laboratory; Engineering and Physical Sciences Research Council; Royal Society via a University Research Fellowship	Defence Science and Technology Laboratory; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society via a University Research Fellowship	RJW was supported by the Defence Science and Technology Laboratory, MDMS was supported by the Engineering and Physical Sciences Research Council and PLR was supported by the Royal Society via a University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRAJ JA, 1983, J BACTERIOL, V153, P562, DOI 10.1128/JB.153.1.562-565.1983; Berdis AJ, 1998, P NATL ACAD SCI USA, V95, P2874, DOI 10.1073/pnas.95.6.2874; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Bheemanaik S, 2006, BIOL CHEM, V387, P515, DOI 10.1515/BC.2006.067; Biggins JB, 2000, P NATL ACAD SCI USA, V97, P13537, DOI 10.1073/pnas.240460997; Dryden D. S, 1999, BACTERIAL DNA METHYL, P283; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GEIER GE, 1979, CLIN RES, V27, pA604; HANISH J, 1991, NUCLEIC ACIDS RES, V19, P829, DOI 10.1093/nar/19.4.829; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; KOSSYKH VG, 1995, J BIOL CHEM, V270, P14389, DOI 10.1074/jbc.270.24.14389; Kossykh VG, 1997, J BACTERIOL, V179, P3239, DOI 10.1128/jb.179.10.3239-3243.1997; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Li J, 2007, ANAL CHEM, V79, P1050, DOI 10.1021/ac061694i; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Mashhoon N, 2004, J BIOL CHEM, V279, P52075, DOI 10.1074/jbc.M408182200; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Ranasinghe RT, 2005, CHEM COMMUN, P5487, DOI 10.1039/b509522k; REICH NO, 1990, J BIOL CHEM, V265, P8966; Rizzo J, 2002, MOL CELL PROBE, V16, P277, DOI 10.1006/mcpr.2002.0423; Robinson VL, 2005, FEMS MICROBIOL LETT, V252, P251, DOI 10.1016/j.femsle.2005.09.001; Sambrook J, 2001, MOL CLONING LAB MANU; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Taylor VL, 2005, MICROBIOL-SGM, V151, P1919, DOI 10.1099/mic.0.27959-0; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zinoviev VV, 2003, J BIOL CHEM, V278, P7829, DOI 10.1074/jbc.M210769200	33	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e801	10.1371/journal.pone.0000801	http://dx.doi.org/10.1371/journal.pone.0000801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726531	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455400018
J	Auerbach, RK; Tuanyok, A; Probert, WS; Kenefic, L; Vogler, AJ; Bruce, DC; Munk, C; Brettin, TS; Eppinger, M; Ravel, J; Wagner, DM; Keim, P				Auerbach, Raymond K.; Tuanyok, Apichai; Probert, William S.; Kenefic, Leo; Vogler, Amy J.; Bruce, David C.; Munk, Christine; Brettin, Thomas S.; Eppinger, Mark; Ravel, Jacques; Wagner, David M.; Keim, Paul			Yersinia pestis Evolution on a Small Timescale: Comparison of Whole Genome Sequences from North America	PLOS ONE			English	Article								Background. Yersinia pestis, the etiologic agent of plague, was responsible for several devastating epidemics throughout history and is currently of global importance to current public heath and biodefense efforts. Y. pestis is widespread in the Western United States. Because Y. pestis was first introduced to this region just over 100 years ago, there has been little time for genetic diversity to accumulate. Recent studies based upon single nucleotide polymorphisms have begun to quantify the genetic diversity of Y. pestis in North America. Methodology/Principal Findings. To examine the evolution of Y. pestis in North America, a gapped genome sequence of CA88-4125 was generated. Sequence comparison with another North American Y. pestis strain, CO92, identified seven regions of difference (six inversions, one rearrangement), differing IS element copy numbers, and several SNPs. Conclusions/Significance. The relatively large number of inverted/rearranged segments suggests that North American Y. pestis strains may be undergoing inversion fixation at high rates over a short time span, contributing to higher-than-expected diversity in this region. These findings will hopefully encourage the scientific community to sequence additional Y. pestis strains from North America and abroad, leading to a greater understanding of the evolutionary history of this pathogen.	[Auerbach, Raymond K.; Tuanyok, Apichai; Kenefic, Leo; Vogler, Amy J.; Wagner, David M.; Keim, Paul] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Bruce, David C.; Munk, Christine; Brettin, Thomas S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Probert, William S.] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Eppinger, Mark; Ravel, Jacques] Inst Genom Res, J Craig Venter Inst, Rockville, MD USA	Northern Arizona University; United States Department of Energy (DOE); Los Alamos National Laboratory; California Department of Public Health; Translational Genomics Research Institute; J. Craig Venter Institute	Keim, P (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu	Ravel, Jacques/D-2530-2009; Keim, Paul S/A-2269-2010; Wagner, David M/A-5125-2010	Wagner, David/0000-0003-2684-6007; Ravel, Jacques/0000-0002-0851-2233	Intelligence Technology Innovation Center [CA88-4125]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [NO1-AI-30071]	Intelligence Technology Innovation Center; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for Y. pestis CA88-4125 sequencing was provided by the Intelligence Technology Innovation Center. JR and ME were supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under NIAID contract NO1-AI-30071.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; ACHTMAN M, 2004, YERSINIA MOL CELLULA, P432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DEVIGNAT R, 1951, Bull World Health Organ, V4, P247; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Jackson PJ, 1997, APPL ENVIRON MICROB, V63, P1400, DOI 10.1128/AEM.63.4.1400-1405.1997; Keim P, 1997, J BACTERIOL, V179, P818, DOI 10.1128/jb.179.3.818-824.1997; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LINK V B, 1955, Public Health Monogr, V26, P1; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Touchman JW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000220; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309	22	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e770	10.1371/journal.pone.0000770	http://dx.doi.org/10.1371/journal.pone.0000770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712418	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455300018
J	Ponseti, J; Siebner, HR; Kloppel, S; Wolff, S; Granert, O; Jansen, O; Mehdorn, HM; Bosinski, HA				Ponseti, Jorge; Siebner, Hartwig R.; Kloeppel, Stefan; Wolff, Stephan; Granert, Oliver; Jansen, Olav; Mehdorn, Hubertus M.; Bosinski, Hartmut A.			Homosexual Women Have Less Grey Matter in Perirhinal Cortex than Heterosexual Women	PLOS ONE			English	Article								Is sexual orientation associated with structural differences in the brain? To address this question, 80 homosexual and heterosexual men and women ( 16 homosexual men and 15 homosexual women) underwent structural MRI. We used voxel-based morphometry to test for differences in grey matter concentration associated with gender and sexual orientation. Compared with heterosexual women, homosexual women displayed less grey matter bilaterally in the temporo-basal cortex, ventral cerebellum, and left ventral premotor cortex. The relative decrease in grey matter was most prominent in the left perirhinal cortex. The left perirhinal area also showed less grey matter in heterosexual men than in heterosexual women. Thus, in homosexual women, the perirhinal cortex grey matter displayed a more male-like structural pattern. This is in accordance with previous research that revealed signs of sex-atypical prenatal androgenization in homosexual women, but not in homosexual men. The relevance of the perirhinal area for high order multimodal ( olfactory and visual) object, social, and sexual processing is discussed.	[Ponseti, Jorge; Bosinski, Hartmut A.] Univ Kiel, Sect Sexual Med, Kiel, Germany; [Siebner, Hartwig R.; Granert, Oliver] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Siebner, Hartwig R.; Granert, Oliver] NeuroImage Nord, Hamburg, Germany; [Kloeppel, Stefan] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Kloeppel, Stefan] Univ Freiburg, Dept Neurol, D-7800 Freiburg, Germany; [Wolff, Stephan; Jansen, Olav] Univ Kiel, Dept Neurosurg, Neuroradiol Sect, Kiel, Germany	University of Kiel; University of Kiel; University of London; University College London; University of Freiburg; University of Kiel	Ponseti, J (corresponding author), Univ Kiel, Sect Sexual Med, Kiel, Germany.	ponseti@sexmed.uni-kiel.de	Jansen, Olav/D-2547-2010; Siebner, Hartwig R/G-4052-2016; Mehdorn, Maximilian/D-2495-2010	Granert, Oliver/0000-0002-0656-1023; Kloppel, Stefan/0000-0001-6452-9964	Federal Ministry of Education and Research [01 GO 0511]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Structural MRI was performed in the MRI unit sponsored by the Federal Ministry of Education and Research. HS (grant 01 GO 0511) is supported by a structural grant sponsored by the Federal Ministry of Education and Research to NeuroImageNord.	Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; ALLEN LS, 1992, P NATL ACAD SCI USA, V89, P7199, DOI 10.1073/pnas.89.15.7199; [Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Byne W, 2001, HORM BEHAV, V40, P86, DOI 10.1006/hbeh.2001.1680; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; ENGEN T, 1987, AM SCI, V75, P497; FRANKE G, 1996, SYMPTOM CHECKLISTE D; Garcia-Falgueras A, 2006, BRAIN RES, V1116, P103, DOI 10.1016/j.brainres.2006.07.115; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; GRAMMER K, 1993, ETHOL SOCIOBIOL, V14, P201, DOI 10.1016/0162-3095(93)90006-4; HUMMEL T, 1991, EXPERIENTIA, V47, P712, DOI 10.1007/BF01958823; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Kirk KM, 2000, BEHAV GENET, V30, P345, DOI 10.1023/A:1026557719181; Lasco MS, 2002, BRAIN RES, V936, P95, DOI 10.1016/S0006-8993(02)02590-8; Lee ACH, 2006, NEUROIMAGE, V33, P362, DOI 10.1016/j.neuroimage.2006.06.021; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Mayeaux DJ, 2004, PHYSIOL BEHAV, V82, P653, DOI 10.1016/j.physbeh.2004.06.002; Mustanski BS, 2002, ANN REV SEX RES, V13, P89; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passe TJ, 1997, PROG NEURO-PSYCHOPH, V21, P1231, DOI 10.1016/S0278-5846(97)00160-7; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; PETERS M, 1991, CAN J PSYCHOL, V45, P507, DOI 10.1037/h0084307; Petrulis A, 2003, NEUROSCIENCE, V122, P599, DOI 10.1016/j.neuroscience.2003.08.009; Ponseti J, 2006, NEUROIMAGE, V33, P825, DOI 10.1016/j.neuroimage.2006.08.002; Rahman Q, 2005, NEUROSCI BIOBEHAV R, V29, P1057, DOI 10.1016/j.neubiorev.2005.03.002; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; SCHIFFER B, 2006, J PSYCHIAT RES; Sowell E, 2006, CEREB CORTEX; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; van Anders SM, 2005, HORM BEHAV, V47, P92, DOI 10.1016/j.yhbeh.2004.09.003; VERCHISNKI B, 2000, NEUROIMAGE, V11, P228	40	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e762	10.1371/journal.pone.0000762	http://dx.doi.org/10.1371/journal.pone.0000762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712410	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455300010
J	Mahanivong, C; Chen, HM; Yee, SW; Pan, ZK; Dong, Z; Huang, S				Mahanivong, C.; Chen, H. M.; Yee, S. W.; Pan, Z. K.; Dong, Z.; Huang, S.			Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells	ONCOGENE			English	Article						ovarian cancer; LPA; uPA; NF-kappa B	GROWTH-FACTOR EXPRESSION; EPITHELIAL-CELLS; RECEPTOR; TUMOR; BCL10; LYSOPHOSPHOLIPIDS; PHOSPHORYLATION; PROGRESSION; INDUCTION; SECRETION	We reported previously that a signaling pathway consisting of G(i)-Ras-NF-kappa B mediates lysophosphatidic acid (LPA)-induced urokinase plasminogen activator (uPA) upregulation in ovarian cancer cells. However, it is not clear what signaling components link Ras to nuclear factor (NF)-kappa B for this LPA-induced event. In the present study, we found that treatment of protein kinase C (PKC) inhibitors including conventional PKC (cPKC) inhibitor Go6976 abolished LPA-induced uPA upregulation in ovarian cancer cell lines tested, indicating the importance of cPKC activity in this LPA-induced event. Indeed, LPA stimulation led to the activation of PKC alpha and Ras-PKC alpha interaction. Although constitutively active mutants of PKC alpha (a cPKC), PKC theta (a novel PKC (nPKC)) and PKC zeta (an atypical PKC (aPKC)) were all able to activate NF-kappa B and upregulate uPA expression, only dominant-negative PKCa mutant attenuated LPA-induced NF-kappa B activation and uPA upregulation. These results suggest that PKCa, rather than PKC isoforms in other PKC classes, participates in LPA-induced NF-kappa B activation and uPA upregulation in ovarian cancer cells. To determine the signaling components downstream of PKC alpha mediating LPA-induced uPA upregulation, we showed that forced expression of dominant-negative CARMA3 or silencing CARMA3, Bcl10 and MALT1 with specific siRNAs diminished these LPA-induced events. Furthermore, we demonstrated that PKC alpha/CARMA3 signaling axis is important in LPA-induced ovarian cancer cell in vitro invasion.	[Mahanivong, C.; Chen, H. M.; Yee, S. W.; Huang, S.] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Pan, Z. K.] Med Univ Ohio, Dept Med Microbiol & Immunol, Toledo, OH USA; [Dong, Z.] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Huang, S (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	shuang@mcg.edu		Yee, Sook Wah/0000-0001-8121-8746	NATIONAL CANCER INSTITUTE [R01CA093926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043524] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA093926, R01 CA93926] Funding Source: Medline; NIAID NIH HHS [R01 AI043524, R01 AI043524-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; DLUGOSZ AA, 1994, CANCER RES, V54, P6413; Do TV, 2007, MOL CANCER RES, V5, P121, DOI 10.1158/1541-7786.MCR-06-0319; Eder AM, 2000, CLIN CANCER RES, V6, P2482; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Fischer K, 1998, FEBS LETT, V438, P101, DOI 10.1016/S0014-5793(98)01279-4; Fishman DA, 2001, CANCER RES, V61, P3194; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Hu YL, 2001, J NATL CANCER I, V93, P762, DOI 10.1093/jnci/93.10.762; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Konecny G, 2001, CLIN CANCER RES, V7, P1743; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Li HB, 2005, J BIOL CHEM, V280, P10564, DOI 10.1074/jbc.M412152200; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Murthi P, 2004, GYNECOL ONCOL, V92, P80, DOI 10.1016/j.ygyno.2003.09.016; Pal S, 2001, J BIOL CHEM, V276, P2395, DOI 10.1074/jbc.M007818200; Perletti GP, 1996, ONCOGENE, V12, P847; Pustilnik TB, 1999, CLIN CANCER RES, V5, P3704; SCHMALFELDT B, 1995, CANCER RES, V55, P3958; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Tanyi JL, 2003, CANCER RES, V63, P1073; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wang P, 2007, GYNECOL ONCOL, V104, P714, DOI 10.1016/j.ygyno.2006.10.016; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719	33	63	69	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 21	2008	27	9					1273	1280		10.1038/sj.onc.1210746	http://dx.doi.org/10.1038/sj.onc.1210746			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17724468	Green Accepted			2022-12-25	WOS:000253407000009
J	Basile, JR; Gavard, J; Gutkind, JS				Basile, John R.; Gavard, Julie; Gutkind, J. Silvio			Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; FOCAL ADHESION KINASE; PDZ-RHOGEF; RECEPTOR PLEXIN-B1; AXON GUIDANCE; R-RAS; SEMAPHORIN; MECHANISM	The semaphorins are a family of proteins originally identified as axon-guiding molecules in the developing nervous system that have been recently shown to regulate many cellular functions, including motility, in a variety of cell types. We have previously shown that in endothelial cells Semaphorin 4D acts through its receptor, Plexin-B1, to elicit a pro-angiogenic phenotype that involves the activation of the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. Here we show through the use of a receptor chimeric approach, Plexin-B1 mutants, and dominant negative and pharmacological inhibitors that this response is dependent upon the activation of RhoA and its downstream target, Rho kinase (ROK). Indeed, we demonstrate that in endothelial cells, Semaphorin 4D promotes the formation of focal adhesion complexes, stress fibers, and the phosphorylation of myosin light chain, a response that was abolished by the use of ROK inhibitors and absent from cells expressing Plexin-B1 mutant constructs incapable of signaling to RhoA. Stress fiber polymerization and contraction are in turn necessary for RhoA-dependent pro-angiogenic signaling through Plexin-B1. Furthermore, we observed that in endothelial cells Plexin-B1 promotes the integrin-mediated activation of Pyk2, resulting in the stimulation of PI3K, Akt, and ERK. These findings provide evidence that Plexin-B1 promotes endothelial cell motility through RhoA and ROK by regulating the integrin-dependent signaling networks that result in the activation of PI3K and Akt.	NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gavard, Julie/I-5487-2012; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Gutkind, J. Silvio/0000-0002-5150-4482; Gavard, Julie/0000-0003-3107-2026	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALBINI A, 1987, J CELL BIOL, V105, P1867, DOI 10.1083/jcb.105.4.1867; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Aurandt J, 2006, BIOCHEM J, V394, P459, DOI 10.1042/BJ20051123; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; BISMUTH G, 2002, SCI STKE, pRE4; BRETTI S, 1989, INT J CANCER, V43, P102, DOI 10.1002/ijc.2910430120; Brown CB, 2001, DEVELOPMENT, V128, P3071; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Christensen CRL, 1998, CANCER RES, V58, P1238; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Ito T, 2000, MECH DEVELOP, V97, P35, DOI 10.1016/S0925-4773(00)00401-9; Katz BZ, 2002, BBA-MOL CELL RES, V1592, P141, DOI 10.1016/S0167-4889(02)00308-7; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kreuter M, 2002, ANN HEMATOL, V81, pS74; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; OINUMA I, 2006, J CELL BIOL; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Spriggs MK, 1999, CURR OPIN IMMUNOL, V11, P387, DOI 10.1016/S0952-7915(99)80065-X; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2	54	94	108	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34888	34895		10.1074/jbc.M705467200	http://dx.doi.org/10.1074/jbc.M705467200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855350	hybrid			2022-12-25	WOS:000251155200031
J	Chen, BB; Mallampalli, RK				Chen, Bill. B.; Mallampalli, Rama K.			Calmodulin binds and stabilizes the regulatory enzyme, CTP : Phosphocholine cytidylyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT PHOSPHATIDYLCHOLINE SYNTHESIS; KAPPA-B-ALPHA; CALPAIN PROTEOLYSIS; PEST SEQUENCES; MU-CALPAIN; II CELLS; IN-VIVO; PROTEIN; MEMBRANE; GENE	CTP: phosphocholine cytidylyltransferase (CCT alpha) is a proteolytically sensitive enzyme essential for production of phosphatidylcholine, the major phospholipid of animal cell membranes. The molecular signals that govern CCT alpha protein stability are unknown. An NH2-terminal PEST sequence within CCT alpha did not serve as a degradation signal for the proteinase, calpain. Calmodulin (CaM) stabilized CCT alpha from calpain proteolysis. Adenoviral gene transfer of CaM in cells protected CCT alpha, whereas CaM small interfering RNA accentuated CCT alpha degradation by calpains. CaM bound CCT alpha as revealed by fluorescence resonance energy transfer and two-hybrid analysis. Mapping and site-directed mutagenesis of CCT alpha uncovered a motif (LQERVDKVK) harboring a vital recognition site, Gln(243), whereby CaM directly binds to the enzyme. Mutagenesis of CCT alpha Gln(243) not only resulted in loss of CaM binding but also led to complete calpain resistance in vitro and in vivo. Thus, calpains and CaM both access CCT alpha using a structurally similar molecular signature that profoundly affects CCT alpha levels. These data suggest that CaM, by antagonizing calpain, serves as a novel binding partner for CCT alpha that stabilizes the enzyme under proinflammatory stress.	Univ Iowa, Div Pulm & Crit Care, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Vet Affairs Med Ctr, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Mallampalli, RK (corresponding author), Univ Iowa, Div Pulm & Crit Care, Dept Internal Med, Roy J & Lucille A Carver Coll Med, C-33K,GH, Iowa City, IA 52242 USA.	ramamallampalli@uiowa.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080229, R01HL071040, R01HL068135, R01HL081784] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL071040, HL068135, HL081784, HL080229] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; BEYNON RJ, 1986, AM J PHYSIOL, V251, pC141, DOI 10.1152/ajpcell.1986.251.2.C141; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BOTBOL V, 1983, J BIOL CHEM, V258, P1942; BRANDT NR, 1992, J MEMBRANE BIOL, V127, P35; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Choi I, 2005, J BIOTECHNOL, V120, P251, DOI 10.1016/j.jbiotec.2005.06.014; Croall DE, 1996, BBA-PROTEIN STRUCT M, V1298, P276, DOI 10.1016/S0167-4838(96)00138-0; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Erdman DD, 2002, EMERG INFECT DIS, V8, P269, DOI 10.3201/eid0803.010190; Ferrington DA, 1997, BIOCHEM BIOPH RES CO, V237, P163, DOI 10.1006/bbrc.1997.7105; GROBLEWSKI GE, 1995, J BIOL CHEM, V270, P1437, DOI 10.1074/jbc.270.3.1437; Gul A, 2006, NEUROGENETICS, V7, P105, DOI 10.1007/s10048-006-0042-4; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Henderson FC, 2006, J LIPID RES, V47, P2314, DOI 10.1194/jlr.M600284-JLR200; Ishii M, 2005, BIOCHEM BIOPH RES CO, V338, P839, DOI 10.1016/j.bbrc.2005.10.026; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; Lagace TA, 2005, BIOCHEM J, V392, P449, DOI 10.1042/BJ20051021; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; MOLINARI M, 1995, J BIOL CHEM, V270, P14576, DOI 10.1074/jbc.270.24.14576; OFULUE AF, 1993, PEDIATR PULM, V15, P145, DOI 10.1002/ppul.1950150304; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P441, DOI 10.1016/0005-2760(84)90170-X; POST M, 1984, BIOCHIM BIOPHYS ACTA, V795, P552, DOI 10.1016/0005-2760(84)90185-1; Rasouli M, 2004, BBA-MOL CELL BIOL L, V1682, P92, DOI 10.1016/j.bbalip.2004.02.002; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Sugimoto H, 2005, J BIOL CHEM, V280, P40857, DOI 10.1074/jbc.M503578200; Sun H, 2001, BIOCHEMISTRY-US, V40, P9605, DOI 10.1021/bi0104266; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Walker G, 2001, BBA-GEN SUBJECTS, V1568, P216, DOI 10.1016/S0304-4165(01)00223-9; Wang JH, 1996, AM J PHYSIOL-LUNG C, V271, pL245, DOI 10.1152/ajplung.1996.271.2.L245; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; Zhou JM, 2003, J BIOL CHEM, V278, P37032, DOI 10.1074/jbc.M304316200	45	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33494	10.1074/jbc.M706472200	http://dx.doi.org/10.1074/jbc.M706472200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17804406	hybrid			2022-12-25	WOS:000250840200030
J	Kanayasu-Toyoda, T; Ishii-Watabe, A; Suzuki, T; Oshizawa, T; Yamaguchi, T				Kanayasu-Toyoda, Toshie; Ishii-Watabe, Akiko; Suzuki, Takayoshi; Oshizawa, Tadashi; Yamaguchi, Teruhide			A new role of thrombopoietin enhancing ex vivo expansion of endothelial precursor cells derived from AC133-positive cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; PROGENITOR CELLS; C-MPL; NEUTROPHILIC DIFFERENTIATION; 3-KINASE ACTIVATION; PERIPHERAL-BLOOD; HL-60 CELLS; PROLIFERATION; TRANSPLANTATION; ERYTHROPOIETIN	We previously reported that CD31(bright) cells, which were sorted from cultured AC133(+) cells of adult peripheral blood cells, differentiated more efficiently into endothelial cells than CD31(+) cells or CD31(-) cells, suggesting that CD31(bright) cells may be endothelial precursor cells. In this study, we found that CD31bright cells have a strong ability to release cytokines. The mixture of vascular endothelial growth factor ( VEGF), thrombopoietin (TPO), and stem cell factor stimulated ex vivo expansion of the total cell number from cultured AC133(+) cells of adult peripheral blood cells and cord blood cells, resulting in incrementation of the adhesion cells, in which endothelial nitric oxide synthase and kinase insert domain-containing receptor were positive. Moreover, the mixture of VEGF and TPO increased the CD31bright cell population when compared with VEGF alone or the mixture of VEGF and stem cell factor. These data suggest that TPO is an important growth factor that can promote endothelial precursor cells expansion ex vivo.	Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan	Yamaguchi, T (corresponding author), Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	yamaguch@nihs.go.jp	SUZUKI, TAKAYOSHI/ABA-2386-2020	SUZUKI, TAKAYOSHI/0000-0002-2261-5263				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x; Brizzi MF, 1999, CIRC RES, V84, P785; BROUDY VC, 1995, BLOOD, V85, P1719, DOI 10.1182/blood.V85.7.1719.bloodjournal8571719; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; George J, 2005, ARTERIOSCL THROM VAS, V25, P2636, DOI 10.1161/01.ATV.0000188554.49745.9e; Gill M, 2001, CIRC RES, V88, P167; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kanayasu-Toyoda T, 2003, J CELL PHYSIOL, V195, P119, DOI 10.1002/jcp.10229; Kanayasu-Toyoda T, 1999, J BIOL CHEM, V274, P25471, DOI 10.1074/jbc.274.36.25471; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KAUSHANSKY K, 1995, J CLIN INVEST, V96, P1683, DOI 10.1172/JCI118210; Kaushansky K, 1996, EXP HEMATOL, V24, P265; Kawamoto A, 2001, CIRCULATION, V103, P634; KELEMEN E., 1958, ACTA HAEMATOL, V20, P350; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; KOBAYASHI M, 1995, BLOOD, V86, P2494; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Miyamoto K, 2006, CIRCULATION, V114, P2679, DOI 10.1161/CIRCULATIONAHA.106.644203; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Nieda M, 1997, BRIT J HAEMATOL, V98, P775, DOI 10.1046/j.1365-2141.1997.2583074.x; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Yamaguchi T, 1999, J BIOL CHEM, V274, P15575, DOI 10.1074/jbc.274.22.15575; YAMAMOTO S, 1957, ACTA HAEMATOL JPN, V20, P163; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433	44	7	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33507	10.1074/jbc.M703919200	http://dx.doi.org/10.1074/jbc.M703919200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827152	hybrid			2022-12-25	WOS:000250840200031
J	Kashiwayama, Y; Asahina, K; Morita, M; Imanaka, T				Kashiwayama, Yoshinori; Asahina, Kota; Morita, Masashi; Imanaka, Tsuneo			Hydrophobic regions adjacent to transmembrane domains 1 and 5 are important for the targeting of the 70-kDa peroxisomal membrane protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADRENOLEUKODYSTROPHY PROTEIN; RAT-LIVER PEROXISOMES; ZELLWEGER-SYNDROME; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; BIOGENESIS DISORDERS; ABC TRANSPORTERS; INTERNAL REGION; POTENTIAL ROLE; HUMAN PEX19P	The 70-kDa peroxisomal membrane protein (PMP70) is a major component of peroxisomal membranes. Human PMP70 consists of 659 amino acid residues and has six putative transmembrane domains (TMDs). PMP70 is synthesized on cytoplasmic ribosomes and targeted posttranslationally to peroxisomes by an unidentified peroxisomal membrane protein targeting signal (mPTS). In this study, to examine the mPTS within PMP70 precisely, we expressed various COOH-terminally or NH2-terminally deleted constructs of PMP70 fused with green fluorescent protein (GFP) in Chinese hamster ovary cells and determined their intracellular localization by immunofluorescence. In the COOH-terminally truncated PMP70, PMP70(AA.1-144)-GFP, including TMD1 and TMD2 of PMP70, was still localized to peroxisomes. However, by further removal of TMD2, PMP70(AA.1-124)-GFP lost the targeting ability, and PMP70( TMD2)-GFP did not target to peroxisomes by itself. The substitution of TMD2 in PMP70( AA.1-144)-GFP for TMD4 or TMD6 did not affect the peroxisomal localization, suggesting that PMP70(AA.1-124) contains the mPTS and an additional TMD is required for the insertion into the peroxisomal membrane. In the NH2-terminal 124-amino acid region, PMP70 possesses hydrophobic segments in the region adjacent to TMD1. By the disruption of these hydrophobic motifs by the mutation of L21Q/L22Q/L23QorI70N/L71Q, PMP70( AA.1-144)-GFP lost targeting efficiency. The NH2-terminally truncated PMP70, GFP-PMP70(AA.263-375), including TMD5 and TMD6, exhibited the peroxisomal localization. PMP70( AA.263-375) also possesses hydrophobic residues (Ile(307)/Leu(308)) in the region adjacent to TMD5, which were important for targeting. These results suggest that PMP70 possesses two distinct targeting signals, and hydrophobic regions adjacent to the first TMD of each region are important for targeting.	Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, Toyama 9300194, Japan	University of Toyama	Imanaka, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, 2630 Sugitani, Toyama 9300194, Japan.	imanaka@pha.u-toyama.ac.jp						Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Biermanns M, 2001, BIOCHEM BIOPH RES CO, V285, P649, DOI 10.1006/bbrc.2001.5220; Brosius U, 2002, J BIOL CHEM, V277, P774, DOI 10.1074/jbc.M108155200; Brosius U, 2002, CELL MOL LIFE SCI, V59, P1058, DOI 10.1007/s00018-002-8486-7; Chang CC, 1999, J CELL SCI, V112, P1579; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Fransen M, 2004, J BIOL CHEM, V279, P12615, DOI 10.1074/jbc.M304941200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Girzalsky W, 2006, J BIOL CHEM, V281, P19417, DOI 10.1074/jbc.M603344200; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Graf SA, 2004, J BIOL CHEM, V279, P42954, DOI 10.1074/jbc.M405040200; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; HARTL FU, 1987, ARCH BIOCHEM BIOPHYS, V255, P109, DOI 10.1016/0003-9861(87)90300-6; HASHIMOTO T, 1986, J BIOCHEM-TOKYO, V100, P301, DOI 10.1093/oxfordjournals.jbchem.a121716; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Honsho M, 2001, J BIOL CHEM, V276, P9375, DOI 10.1074/jbc.M003304200; Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Imanaka T, 1996, J BIOL CHEM, V271, P3706; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Jones JM, 2001, J CELL BIOL, V153, P1141, DOI 10.1083/jcb.153.6.1141; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Landgraf P, 2003, EUR J CELL BIOL, V82, P401, DOI 10.1078/0171-9335-00331; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LAZAROW PB, 1994, METABOLIC BASIS INHE, P2287; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; MCCAMMON MT, 1994, J CELL BIOL, V124, P915, DOI 10.1083/jcb.124.6.915; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; Muntau AC, 2000, AM J HUM GENET, V67, P967, DOI 10.1086/303071; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Pause B, 2000, FEBS LETT, V471, P23, DOI 10.1016/S0014-5793(00)01332-6; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Shani N, 1998, METHOD ENZYMOL, V292, P753; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Van Ael E, 2006, BBA-MOL CELL RES, V1763, P1629, DOI 10.1016/j.bbamcr.2006.08.020; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Vizeacoumar FJ, 2006, J BIOL CHEM, V281, P14805, DOI 10.1074/jbc.M601808200; Wang XD, 2004, MOL BIOL CELL, V15, P1702, DOI 10.1091/mbc.E03-11-0810; Wang XD, 2001, J BIOL CHEM, V276, P10897, DOI 10.1074/jbc.M010883200; YOKOTA S, 1982, J HISTOCHEM CYTOCHEM, V29, P805	58	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33831	33844		10.1074/jbc.M703369200	http://dx.doi.org/10.1074/jbc.M703369200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17761678	hybrid			2022-12-25	WOS:000250840200065
J	Zhang, XM; Ling, MT; Wang, Q; Lau, CK; Leung, SCL; Lee, TK; Cheung, ALM; Wong, YC; Wang, XH				Zhang, Xiaomeng; Ling, Ming-Tat; Wang, Qi; Lau, Chi-Keung; Leung, Steve C. L.; Lee, Terence K.; Cheung, Annie L. M.; Wong, Yong-Chuan; Wang, Xianghong			Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; E-CADHERIN EXPRESSION; BREAST-CANCER; CELLULAR SENESCENCE; TUMOR PROGRESSION; MOLECULAR TARGET; DNA-BINDING; PATHWAY; ACTIVATION; OVEREXPRESSION	Recently, ID-1 (inhibitor of differentiation/DNA binding) is suggested as an oncogene and is reported to promote cell proliferation, invasion, and survival in several types of human cancer cells through multiple signaling pathways. However, how Id-1 interacts with these pathways and the immediate downstream effectors of the Id-1 protein are not known. In this study, using a yeast two-hybrid screening technique, we identified a novel Id-1-interacting protein, caveolin-1 (Cav-1), a cell membrane protein, and a positive regulator of cell survival and metastasis in prostate cancer. Using an immunoprecipitation method, we found that the helix-loop-helix domain of the Id-1 protein was essential for the physical interaction between Id-1 and Cav-1. In addition, we also demonstrated that the physical interaction between Id-1 and Cav-1 played a key role in the epithelial-mesenchymal transition and increased cell migration rate as well as resistance to taxol-induced apoptosis in prostate cancer cells. Furthermore, our results revealed that this effect was regulated by Id-1-induced Akt activation through promoting the binding activity between Cav-1 and protein phosphatase 2A. Our study demonstrates a novel Id-1 binding partner and suggests a molecular mechanism that mediates the function of Id-1 in promoting prostate cancer progression through activation of the Akt pathway leading to cancer cell invasion and resistance to anticancer drug-induced apoptosis.	Univ Hong Kong, Fac Med Bldg, Dept Anat, Canc Biol Grp, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Fac Med, Dept Surg, Canc Biol Grp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, YC (corresponding author), Univ Hong Kong, Fac Med Bldg, Dept Anat, Canc Biol Grp, 1-F,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	ycwong@hkucc.hku.hk; xhwang@hkucc.hku.hk	; /C-4230-2009	Lee, Kin Wah/0000-0003-0682-322X; /0000-0003-3217-1456				Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Aldred MA, 2003, CANCER RES, V63, P2864; Bagnoli M, 2000, ONCOGENE, V19, P4754, DOI 10.1038/sj.onc.1203839; Bender FC, 2000, CANCER RES, V60, P5870; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cheung HW, 2004, CARCINOGENESIS, V25, P881, DOI 10.1093/carcin/bgh087; Choo CK, 1999, PROSTATE, V40, P150, DOI 10.1002/(SICI)1097-0045(19990801)40:3<150::AID-PROS2>3.0.CO;2-7; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Lin CQ, 2000, CANCER RES, V60, P1332; Lin JC, 2005, J UROLOGY, V174, P2022, DOI 10.1097/01.ju.0000176476.14572.39; Ling MT, 2006, CARCINOGENESIS, V27, P205, DOI 10.1093/carcin/bgi217; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Maruyama H, 1999, AM J PATHOL, V155, P815, DOI 10.1016/S0002-9440(10)65180-2; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Norton JD, 2000, J CELL SCI, V113, P3897; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Schindl M, 2003, CLIN CANCER RES, V9, P779; Schindl M, 2001, CANCER RES, V61, P5703; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Singh J, 2002, ONCOGENE, V21, P1812, DOI 10.1038/sj.onc.1205252; Skjoth IHE, 2006, INT J ONCOL, V28, P217; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson TC, 1999, APOPTOSIS, V4, P233, DOI 10.1023/A:1009612708099; Tsuchiya T, 2005, CANCER SCI, V96, P784, DOI 10.1111/j.1349-7006.2005.00113.x; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wong YC, 2004, APOPTOSIS, V9, P279, DOI 10.1023/B:APPT.0000025804.25396.79; Yang G, 1999, CANCER RES, V59, P5719; Yuen HF, 2006, MODERN PATHOL, V19, P931, DOI 10.1038/modpathol.3800602; Zhang XM, 2007, CANCER SCI, V98, P308, DOI 10.1111/j.1349-7006.2007.00400.x; Zhang XM, 2006, INT J CANCER, V118, P2072, DOI 10.1002/ijc.21592; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	65	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33284	33294		10.1074/jbc.M705089200	http://dx.doi.org/10.1074/jbc.M705089200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855368	hybrid, Green Published			2022-12-25	WOS:000250840200008
J	Takeda, N; Maemura, K; Horie, S; Oishi, K; Imai, Y; Harada, T; Saito, T; Shiga, T; Amiya, E; Manabe, I; Ishida, N; Nagai, R				Takeda, Norihiko; Maemura, Koji; Horie, Shuichi; Oishi, Katsutaka; Imai, Yasushi; Harada, Tomohiro; Saito, Tetsuya; Shiga, Taro; Amiya, Eisuke; Manabe, Ichiro; Ishida, Norio; Nagai, Ryozo			Thrombomodulin is a clock-controlled gene in vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CIRCADIAN CLOCK; MOLECULAR-MECHANISMS; GROWTH-FACTOR; PAS DOMAIN; EXPRESSION; MUTANT; HEART; ONSET; TRANSACTIVATION	Cardiovascular diseases are closely related to circadian rhythm, which is under the control of an internal biological clock mechanism. Although a biological clock exists not only in the hypothalamus but also in each peripheral tissue, the biological relevance of the peripheral clock remains to be elucidated. In this study we searched for clock- controlled genes in vascular endothelial cells using microarray technology. The expression of a total of 229 genes was up- regulated by CLOCK/ BMAL2. Among the genes that we identified, we examined the thrombomodulin ( TM) gene further, because TM is an integral membrane glycoprotein that is expressed primarily in vascular endothelial cells and plays a major role in the regulation of intravascular coagulation. TM mRNA and protein expression showed a clear circadian oscillation in the mouse lung and heart. Reporter analyses, gel shift assays, and chromatin immunoprecipitation analyses using the TM promoter revealed that a heterodimer of CLOCK and BMAL2 binds directly to the E- box of the TM promoter, resulting in TM promoter transactivation. Indeed, the oscillation of TM gene expression was abolished in clock mutant mice, suggesting that TM expression is regulated by the clock gene in vivo. Finally, the phase of circadian oscillation of TM mRNA expression was altered by temporal feeding restriction, suggesting TM gene expression is regulated by the peripheral clock system. In conclusion, these data suggest that the peripheral clock in vascular endothelial cells regulates TM gene expression and that the oscillation of TM expression may contribute to the circadian variation of cardiovascular events.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Kagawa Nutr Univ, Saitama 3500288, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	University of Tokyo; Kagawa Nutrition University; National Institute of Advanced Industrial Science & Technology (AIST)	Maemura, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kmae-tky@umin.ac.jp	Amiya, Eisuke/O-4981-2019; Manabe, Ichiro/AAE-5105-2021; Manabe, Ichiro/E-1529-2014; Oishi, Katsutaka/L-6906-2018	Amiya, Eisuke/0000-0003-2810-8040; Oishi, Katsutaka/0000-0002-4870-0837				ANDREOTTI F, 1991, CHRONOBIOL INT, V8, P336, DOI 10.3109/07420529109059170; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BRAUNWALD E, 1995, CIRCULATION, V91, P1604, DOI 10.1161/01.CIR.91.5.1604; COLANTONIO D, 1989, AM J CARDIOL, V64, P403, DOI 10.1016/0002-9149(89)90548-1; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DeRisi J, 1996, NAT GENET, V14, P457; Doggen CJM, 1998, THROMB HAEMOSTASIS, V80, P743; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Horie S, 2001, J BIOL CHEM, V276, P2440, DOI 10.1074/jbc.M004942200; Ishii H, 2003, BLOOD, V101, P4765, DOI 10.1182/blood-2002-08-2428; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Koyanagi S, 2003, CANCER RES, V63, P7277; LENTZ SR, 1991, BLOOD, V77, P542; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Maemura K, 2001, ANN NY ACAD SCI, V947, P398; Manabe I, 2001, J CLIN INVEST, V107, P823, DOI 10.1172/JCI11385; MARLER JR, 1989, STROKE, V20, P473, DOI 10.1161/01.STR.20.4.473; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Mutch NJ, 2007, J THROMB HAEMOST, V5, P812, DOI 10.1111/j.1538-7836.2007.02430.x; Nonaka H, 2001, CIRCULATION, V104, P1746, DOI 10.1161/hc4001.098048; Ohlin AK, 1999, THROMB HAEMOSTASIS, V81, P338; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Oishi K, 1998, NEUROSCI LETT, V256, P117, DOI 10.1016/S0304-3940(98)00765-4; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Otto ME, 2004, CIRCULATION, V109, P2507, DOI 10.1161/01.CIR.0000128207.26863.C4; Portman MA, 2001, CIRC RES, V89, P1084, DOI 10.1161/res.89.12.1084; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; Sassone-Corsi P, 1998, NATURE, V392, P871, DOI 10.1038/31821; Schibler U, 2000, NATURE, V404, P25, DOI 10.1038/35003674; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yamamoto K, 1998, INT J HEMATOL, V68, P371; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Young ME, 2001, CIRC RES, V88, P1142, DOI 10.1161/hh1101.091190	46	87	91	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32561	32567		10.1074/jbc.M705692200	http://dx.doi.org/10.1074/jbc.M705692200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848551	hybrid			2022-12-25	WOS:000250625400005
J	Vandeput, F; Wolda, SL; Krall, J; Hambleton, R; Uher, L; Mccaw, KN; Radwanski, PB; Florio, V; Movsesian, MA				Vandeput, Fabrice; Wolda, Sharon L.; Krall, Judith; Hambleton, Ryan; Uher, Lothar; Mccaw, Kim N.; Radwanski, Przemyslaw B.; Florio, Vincent; Movsesian, Matthew A.			Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-I; NITRIC-OXIDE; NATRIURETIC-PEPTIDE; CA2+ CURRENT; SARCOPLASMIC-RETICULUM; VENTRICULAR MYOCYTES; ADENYLYL-CYCLASE; CALCIUM CURRENT; G(I) PROTEINS; RAT-HEART	Isoforms in the PDE1 family of cyclic nucleotide phosphodiesterases were recently found to comprise a significant portion of the cGMP- inhibited cAMP hydrolytic activity in human hearts. We examined the expression of PDE1 isoforms in human myocardium, characterized their catalytic activity, and quantified their contribution to cAMP hydrolytic and cGMP hydrolytic activity in subcellular fractions of this tissue. Western blotting with isoform- selective anti- PDE1 monoclonal antibodies showed PDE1C1 to be the principal isoform expressed in human myocardium. Immunohistochemical analysis showed that PDE1C1 is distributed along the Z- lines and M- lines of cardiac myocytes in a striated pattern that differs from that of the other major dual- specificity cyclic nucleotide phosphodiesterase in human myocardium, PDE3A. Most of the PDE1C1 activity was recovered in soluble fractions of human myocardium. It binds both cAMP and cGMP with Km values of similar to 1 mu M and hydrolyzes both substrates with similar catalytic rates. PDE1C1 activity in subcellular fractions was quantified using a new PDE1- selective inhibitor, IC295. At substrate concentrations of 0.1 mu M, PDE1C1 constitutes the great majority of cAMP hydrolytic and cGMP hydrolytic activity in soluble fractions and the majority of cGMP hydrolytic activity in microsomal fractions, whereas PDE3 constitutes the majority of cAMP hydrolytic activity in microsomal fractions. These results indicate that PDE1C1 is expressed at high levels in human cardiac myocytes with an intracellular distribution distinct from that of PDE3A and that it may have a role in the integration of cGMP-, cAMP- and Ca2+-mediated signaling in these cells.	Vet Affairs Salt Lake City Hlth Care Syst, Cardiol Sect, Salt Lake City, UT 84148 USA; Univ Utah, Sch Med, Dept Internal Med Cardiol, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Pharmacotherapy, Salt Lake City, UT 84132 USA; ICOS Corp, Bothell, WA 98021 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Icos Corporation	Movsesian, MA (corresponding author), Vet Affairs Salt Lake City Hlth Care Syst, Cardiol Sect, 500 Foothill Blvd, Salt Lake City, UT 84148 USA.	matthew.movsesian@hsc.utah.edu		Radwanski, Przemyslaw/0000-0002-0750-2308				Armoundas AA, 2003, CIRC RES, V93, P46, DOI 10.1161/01.RES.0000080932.98903.D8; BEAULIEU P, 1997, AM J PHYSIOL-HEART C, V273, pH1933; BENDER AT, 2007, CYCLIC NUCLEOTIDE PH, P35; BODE DC, 1991, CIRC RES, V68, P1070, DOI 10.1161/01.RES.68.4.1070; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; EPSTEIN PM, 1987, BIOCHEM J, V243, P525, DOI 10.1042/bj2430525; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; FRACE AM, 1993, J GEN PHYSIOL, V101, P337, DOI 10.1085/jgp.101.3.337; GALAEV IY, 1994, J CHROMATOGR A, V662, P27, DOI 10.1016/0021-9673(94)85292-8; Georget M, 2002, FASEB J, V16, P1636, DOI 10.1096/fj.02-0292fje; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; HAN X, 1995, J GEN PHYSIOL, V106, P45, DOI 10.1085/jgp.106.1.45; Han X, 1996, CIRC RES, V78, P998, DOI 10.1161/01.RES.78.6.998; HANSEN RS, 1982, P NATL ACAD SCI-BIOL, V79, P2788, DOI 10.1073/pnas.79.9.2788; Harlow E., 1988, ANTIBODIES LAB MANUA; Hassan Madiha A. H., 2005, BMC Pharmacology, V5, P10, DOI 10.1186/1471-2210-5-10; Hirose M, 1998, J PHARMACOL EXP THER, V286, P70; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Kambayashi J, 2007, CYCLIC NUCLEOTIDE PH, P627; KINCAID RL, 1988, METHOD ENZYMOL, V159, P457; Kishimoto I, 2001, P NATL ACAD SCI USA, V98, P2703, DOI 10.1073/pnas.051625598; Knowles JW, 2001, J CLIN INVEST, V107, P975, DOI 10.1172/JCI11273; Kuschel M, 1999, J BIOL CHEM, V274, P22048, DOI 10.1074/jbc.274.31.22048; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Lee R, 2002, CELL SIGNAL, V14, P277, DOI 10.1016/S0898-6568(01)00250-9; LEIBOWITZ MD, 1995, DIABETES, V44, P67, DOI 10.2337/diabetes.44.1.67; Loughney K, 1996, J BIOL CHEM, V271, P796, DOI 10.1074/jbc.271.2.796; MACPHEE CH, 1988, J BIOL CHEM, V263, P10353; MERY PF, 1993, J BIOL CHEM, V268, P26286; MOHINDRU A, 1982, BIOCHEM J, V205, P427, DOI 10.1042/bj2050427; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; MOVSESIAN MA, 1991, J CLIN INVEST, V88, P15, DOI 10.1172/JCI115272; MOVSESIAN MA, 1989, CIRC RES, V65, P1141, DOI 10.1161/01.RES.65.4.1141; MOVSESIAN MA, 2007, CYCLIC NUCLEOTIDE PH, P485; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; RivetBastide M, 1997, J CLIN INVEST, V99, P2710, DOI 10.1172/JCI119460; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shimizu K, 2002, BRIT J PHARMACOL, V137, P127, DOI 10.1038/sj.bjp.0704843; Stehlik Josef, 2006, Expert Opin Investig Drugs, V15, P733, DOI 10.1517/13543784.15.7.733; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tkachuk V A, 1982, Adv Myocardiol, V3, P541; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; Wallis RM, 1999, AM J CARDIOL, V83, p3C; Wechsler J, 2002, J BIOL CHEM, V277, P38072, DOI 10.1074/jbc.M203647200; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; WEISHAAR RE, 1986, BIOCHEM PHARMACOL, V35, P787, DOI 10.1016/0006-2952(86)90247-9; Wollert KC, 2003, BRIT J PHARMACOL, V140, P1227, DOI 10.1038/sj.bjp.0705567; Wollert KC, 2002, HYPERTENSION, V39, P87, DOI 10.1161/hy1201.097292; Xiao RP, 2000, CIRC RES, V87, P635, DOI 10.1161/01.RES.87.8.635; XIAO RP, 1994, J BIOL CHEM, V269, P19151; Xiao RP, 1999, CIRC RES, V84, P43; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zahabi A, 2003, J BIOL CHEM, V278, P47694, DOI 10.1074/jbc.M309661200	58	83	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32749	32757		10.1074/jbc.M703173200	http://dx.doi.org/10.1074/jbc.M703173200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17726023	hybrid			2022-12-25	WOS:000250625400023
J	Kim, WJ; Rajasekaran, B; Brown, KD				Kim, Wan-Ju; Rajasekaran, Baskaran; Brown, Kevin D.			MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-Methyl-N '-nitro-N '-nitrosoguanidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR SYSTEM; JUN NH2-TERMINAL KINASE; DNA-DAMAGING AGENTS; CELL-CYCLE ARREST; PROTEIN-KINASE; TYROSINE KINASE; IONIZING-RADIATION; TRANSCRIPTIONAL ACTIVATION; INDUCED APOPTOSIS; GENOTOXIC STRESS	N-Methyl-N'-nitro-N'-nitrosoguanidine (MNNG) is a DNA-methylating agent, and deficiency in mismatch repair (MMR) results in lack of sensitivity to this genotoxin (termed alkylation tolerance). A number of DNA damage response pathways are activated in a MMR-dependent manner following MNNG, and several also require ATM kinase activity. Here we show that activation of the transcription factor c-Jun is dependent upon both the MMR component MLH1 and ATM, but not ATR, in response to MNNG. In addition to c-Jun, the upstream MAPKs JNK and MKK4 are also activated in a MLH1-and ATM-dependent manner. Wedocument that c-Jun activation is dependent on the MAPK kinase kinase MEKK1. Additionally, the tyrosine kinase c-Abl is required to activate this signaling cascade and forms a complex with MEKK1 and MLH1. This study indicates that an arm of DNA damage-activated MAPK signaling is activated in an MLH1- and ATM-dependent manner in response to MNNG and perhaps suggests that dysregulation of this signaling is responsible, in part, for alkylation tolerance.	Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Univ Florida Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Pittsburgh, Med Ctr, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brown, KD (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, 1600 SW Archer Rd,Box 100245, Gainesville, FL 32610 USA.	kdbrown1@ufl.edu			NATIONAL CANCER INSTITUTE [R01CA102289] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA102289] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Adamson AW, 2002, J BIOL CHEM, V277, P38222, DOI 10.1074/jbc.M204409200; Aebi S, 1996, CANCER RES, V56, P3087; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Beardsley DI, 2005, MOL PHARMACOL, V68, P1049, DOI 10.1124/mol.105.013888; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Caporali S, 2004, MOL PHARMACOL, V66, P478; Catani MV, 2002, BIOCHEM J, V364, P441, DOI 10.1042/BJ20011713; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Cong F, 1999, P NATL ACAD SCI USA, V96, P13819, DOI 10.1073/pnas.96.24.13819; Cuenda A, 1998, BIOCHEM J, V333, P11, DOI 10.1042/bj3330011; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Dunkern T, 2003, MUTAT RES-REV MUTAT, V544, P167, DOI 10.1016/j.mrrev.2003.06.005; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; Gong JG, 1999, NATURE, V399, P806; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; HARTWELL L, 1994, COLD SPRING HARB SYM, V59, P259, DOI 10.1101/SQB.1994.059.01.030; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Ho ELY, 2007, J BIOL CHEM, V282, P21913, DOI 10.1074/jbc.M610651200; KALAMEGHAM R, 1988, CARCINOGENESIS, V9, P1749, DOI 10.1093/carcin/9.10.1749; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kim WJ, 2005, TOXICOL APPL PHARM, V202, P84, DOI 10.1016/j.taap.2004.06.009; KOI M, 1994, CANCER RES, V54, P4308; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; Nehme A, 1997, CANCER RES, V57, P3253; Ochs K, 2000, CANCER RES, V60, P5815; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SHAFMAN TD, 1995, CANCER RES, V55, P3242; Shangary S, 2000, J BIOL CHEM, V275, P30163, DOI 10.1074/jbc.M004302200; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Umar A, 1997, CANCER RES, V57, P3949; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAN MH, 1994, NATURE, V372, P798; Yin F, 2004, ONCOGENE, V23, P4614, DOI 10.1038/sj.onc.1207598; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	86	28	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32021	32031		10.1074/jbc.M701451200	http://dx.doi.org/10.1074/jbc.M701451200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804421	hybrid			2022-12-25	WOS:000250480300023
J	Woodbury, EL; Morgan, DO				Woodbury, Erika L.; Morgan, David O.			The role of self-association in Fin1 function on the mitotic spindle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MICROTUBULE DYNAMICS; ANAPHASE-B; CHROMOSOME SEGREGATION; YEAST; SWITCH; PHOSPHORYLATION; EXPRESSION; FILAMENTS; PROTEINS	Stabilization of spindle microtubules during anaphase is essential for proper chromosome segregation. Fin1 is a budding yeast protein that localizes to the poles and microtubules of the spindle during anaphase and contributes to spindle stability. The N-terminal half of Fin1 is phosphorylated at multiple sites by the cyclin-dependent kinase Clb5-Cdk1, and dephosphorylation in anaphase triggers its localization to the spindle. The C-terminal half of Fin1 contains coiled-coil motifs that are required for its self-association. Here we investigated the functional importance of the two regions of Fin1. Fin1 mutants lacking the C-terminal coiled-coil domains localized to spindle pole bodies but not along spindle microtubules. These mutants failed to self-associate and displayed reduced binding to microtubules in vitro but were functional in vivo and stabilized anaphase spindles when dephosphorylated. Deletion of the Fin1 C terminus suppressed the lethal phenotypes of the phospho-mutant Fin1(5A). Our findings suggest that the N-terminal region of Fin1 is sufficient for its regulated function as a spindle-stabilizing factor and that this function involves association with the spindle pole body. The ability of the C-terminal region to promote Fin1 self-association and microtubule binding may underlie lethal effects of the deregulated Fin1(5A) mutant.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, Genetech Hall,Rm N312B,600 16th St, San Francisco, CA 94158 USA.	David.Morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416	NIGMS NIH HHS [GM069901, R01 GM069901] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayscough KR, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P477; Bloom K, 2002, P NATL ACAD SCI USA, V99, P4757, DOI 10.1073/pnas.092136999; Brust-Mascher I, 2004, P NATL ACAD SCI USA, V101, P15938, DOI 10.1073/pnas.0407044101; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Cheerambathur DK, 2007, J CELL BIOL, V177, P995, DOI 10.1083/jcb.200611113; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Guacci V, 1997, MOL BIOL CELL, V8, P957, DOI 10.1091/mbc.8.6.957; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Johansen KM, 2002, CELL CYCLE, V1, P312, DOI 10.4161/cc.1.5.144; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Marino-Ramirez L, 2002, YEAST, V19, P641, DOI 10.1002/yea.867; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Hemert MJ, 2003, J BIOL CHEM, V278, P15049, DOI 10.1074/jbc.M212495200; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	29	8	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32138	32143		10.1074/jbc.M705344200	http://dx.doi.org/10.1074/jbc.M705344200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804403	hybrid			2022-12-25	WOS:000250480300035
J	Boassa, D; Ambrosi, C; Qiu, F; Dahl, G; Gaietta, G; Sosinsky, G				Boassa, Daniela; Ambrosi, Cinzia; Qiu, Feng; Dahl, Gerhard; Gaietta, Guido; Sosinsky, Gina			Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; INTERLEUKIN-1-BETA RELEASE; P2X(7) RECEPTOR; XENOPUS OOCYTES; EXPRESSION; FAMILY; ATP; BIOSYNTHESIS; LOCALIZATION; TRAFFICKING	Pannexins are newly discovered channel proteins expressed in many different tissues and abundantly in the vertebrate central nervous system. Based on membrane topology, folding and secondary structure prediction, pannexins are proposed to form gap junction-like structures. We show here that Pannexin1 forms a hexameric channel and reaches the cell surface but, unlike connexins, is N-glycosylated. Using site-directed mutagenesis we analyzed three putative N-linked glycosylation sites and examined the effects of each mutation on channel expression. Weshow for the first time that Pannexin1 is glycosylated at Asn-254 and that this residue is important for plasma membrane targeting. The glycosylation of Pannexin1 at its extracellular surface makes it unlikely that two oligomers could dock to form an intercellular channel. Ultrastructural analysis by electron microscopy confirmed that Pannexin1 junctional areas do not appear as canonical gap junctions. Rather, Pannexin1 channels are distributed throughout the plasma membrane. We propose that N-glycosylation of Pannexin1 could be a significant mechanism for regulating the trafficking of these membrane proteins to the cell surface in different tissues.	Univ Calif San Diego, Biol Res Ctr, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Miami	Boassa, D (corresponding author), BSB 1000,9500 Gilman Dr MC 0608, La Jolla, CA 92093 USA.	dboassa@gmail.com; gina@ncmir.ucsd.edu	Qiu, Feng/D-8223-2011		NCRR NIH HHS [P41 RR004050, P41 RR002250, RR04050] Funding Source: Medline; NIGMS NIH HHS [R01 GM048610, GM065937, R01 GM048610-14, GM48610, R01 GM072881, GM072881] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050, P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065937, R01GM072881, R01GM048610] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; GOLDBERGER G, 1984, J BIOL CHEM, V259, P6492; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Litvin O, 2006, J CELL MOL MED, V10, P613, DOI 10.1111/j.1582-4934.2006.tb00424.x; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; MOUS JM, 1982, J BIOL CHEM, V257, P1822; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; THORNHILL WB, 1987, BIOCHEMISTRY-US, V26, P4381, DOI 10.1021/bi00388a029; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Verselis VK, 2000, BRAZ J MED BIOL RES, V33, P379, DOI 10.1590/S0100-879X2000000400003; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061; [No title captured]	29	216	221	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31733	31743		10.1074/jbc.M702422200	http://dx.doi.org/10.1074/jbc.M702422200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715132	hybrid			2022-12-25	WOS:000250309200064
J	Gharavi, NM; Alva, JA; Mouillesseaux, KP; Lai, C; Yeh, M; Yeung, W; Johnson, J; Szeto, WL; Hong, LS; Fishbein, M; Wei, L; Pfeffer, LM; Berliner, JA				Gharavi, Nima M.; Alva, Jackelyn A.; Mouillesseaux, Kevin P.; Lai, Chi; Yeh, Michael; Yeung, Winnie; Johnson, Jaclyn; Szeto, Wan Lam; Hong, Longsheng; Fishbein, Michael; Wei, Lai; Pfeffer, Lawrence M.; Berliner, Judith A.			Role of the JAK/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; DEPENDENT MECHANISM; SIGNALING PATHWAYS; INTERFERON-GAMMA; GENE-EXPRESSION; SRC ACTIVATION; STAT3; KINASES; IL-8; INDUCTION	Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (Ox-PAPC) and its component phospholipid, 1-palmitoyl-2- epoxyisoprostane-sn-glycero-3-phosphorylcholine, induce endothelial cells (EC) to synthesize chemotactic factors, such as interleukin 8 (IL-8). Previously, we demonstrated a role for c-Src kinase activation in Ox-PAPC-induced IL-8 transcription. In this study, we have examined the mechanism regulating IL-8 transcription by Ox-PAPC downstream of c-Src. Our findings demonstrate an important role for JAK2 in the regulation of IL-8 transcription by Ox-PAPC. Treatment of human aortic EC with Ox-PAPC and 1-palmitoyl-2-epoxyisoprostane-sn-glycero-3- phosphorylcholine induced a rapid yet sustained activation of JAK2; activation of JAK2 by Ox-PAPC was dependent on c-Src kinase activity. Furthermore, pretreatment with selective JAK2 inhibitors significantly reduced Ox-PAPC-induced IL-8 transcription. In previous studies, we also demonstrated activation of STAT3 by Ox-PAPC. Here we provide evidence that STAT3 activation by Ox-PAPC is dependent on JAK2 activation and that STAT3 activation regulates IL-8 transcription by Ox-PAPC in human EC. Transfection with small interfering RNA against STAT3 significantly reduced Ox-PAPC-induced IL-8 transcription. Using chromatin immunoprecipitation assays, we demonstrated binding of activated STAT3 to the sequence flanking the consensus gamma-interferon activation sequence (GAS) in the IL-8 promoter; site-directed mutagenesis of GAS inhibited IL-8 transcription by Ox-PAPC. Finally, these studies demonstrate a role for STAT3 activation in atherosclerosis in vivo. We found increased staining for activated STAT3 in the inflammatory regions of human atherosclerotic lesions and reduced fatty streak formation in EC-specific STAT3 knock-out mice on the atherogenic diet. Taken together, these data demonstrate an important role for the JAK2/STAT3 pathway in Ox-PAPC-induced IL-8 transcription in vitro and in atherosclerosis in vivo.	Univ Calif Los Angeles, Sch Med, Div Cardiol, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90024 USA; Univ Tennessee, Ctr Hlth Sci, Inst Canc, Dept Pathol & Lab Med, Memphis, TN 38163 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tennessee System; University of Tennessee Health Science Center	Berliner, JA (corresponding author), 13-239 CHS-Pathol,650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	jberliner@mednet.ucla.edu	Wei, Lai/D-1088-2014; Gharavi, Nima/AAN-7890-2020	Pfeffer, Lawrence/0000-0003-2809-1234	NCI NIH HHS [R01 CA073753, CA73753, R01 CA133322] Funding Source: Medline; NHLBI NIH HHS [HL30568, HL064731] Funding Source: Medline; NIGMS NIH HHS [GM008042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073753, R01CA133322] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL064731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharya S, 2006, BIOCHEM J, V397, P437, DOI 10.1042/BJ20060256; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Chatti K, 2004, BIOCHEMISTRY-US, V43, P4272, DOI 10.1021/bi036109b; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Gharavi NM, 2006, CIRC RES, V98, P768, DOI 10.1161/01.RES.0000215343.89308.93; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Ingley E, 2006, GROWTH FACTORS, V24, P89, DOI 10.1080/08977190500368031; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kotanides H, 1996, J BIOL CHEM, V271, P25555, DOI 10.1074/jbc.271.41.25555; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; Masamune A, 2005, WORLD J GASTROENTERO, V11, P3385, DOI 10.3748/wjg.v11.i22.3385; Maziere C, 2001, FREE RADICAL BIO MED, V31, P1334, DOI 10.1016/S0891-5849(01)00649-9; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Pramanik R, 2004, J BIOL CHEM, V279, P16121, DOI 10.1074/jbc.M313140200; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; Qiao JH, 2003, HUM PATHOL, V34, P402, DOI 10.1053/hupa.2003.72; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Srivastava S, 2003, J BIOL CHEM, V278, P46171, DOI 10.1074/jbc.M308545200; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Trevino Jose G., 2006, Angiogenesis, V9, P101, DOI 10.1007/s10456-006-9038-9; Verma A, 2003, CANCER METAST REV, V22, P423, DOI 10.1023/A:1023805715476; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; WONG P, 1994, MOL CELL BIOL, V14, P914, DOI 10.1128/MCB.14.2.914; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Yeh M, 2001, ARTERIOSCL THROM VAS, V21, P1585, DOI 10.1161/hq1001.097027; YUAN JP, 1994, MOL CELL BIOL, V14, P1657, DOI 10.1128/MCB.14.3.1657	44	115	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31460	31468		10.1074/jbc.M704267200	http://dx.doi.org/10.1074/jbc.M704267200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726017	hybrid			2022-12-25	WOS:000250309200037
J	La, P; Yang, YQ; Karnik, SK; Silva, AC; Schnepp, RW; Kim, SK; Hua, XX				La, Ping; Yang, Yuqing; Karnik, Satyajit K.; Silva, Albert C.; Schnepp, Robert W.; Kim, Seung K.; Hua, Xianxin			Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; JUND-ACTIVATED TRANSCRIPTION; HOX GENE-EXPRESSION; TUMOR-SUPPRESSOR; CHILDHOOD NEUROBLASTOMAS; INDUCED APOPTOSIS; DNA-DAMAGE; PROTEIN; CELLS; DEACETYLASE	Multiple endocrine neoplasia type 1 (MEN1) is a familial tumor syndrome linked to mutation of the MEN1 gene, which encodes a tumor suppressor, menin. We previously reported that menin up-regulates the caspase 8 expression and promotes TNF-alpha-induced apoptosis. However, it remains unclear how menin up-regulates caspase 8 expression and whether menin-mediated caspase 8 expression plays a role in repressing MEN1 development. Here we show that menin binds the 5(')-untranslated region (5(')-UTR) of the Caspase 8 locus in vivo and activates transcription of a reporter gene through the 5(')-UTR. Menin directly binds the 5(')-UTR in a sequence-independent manner in vitro. Moreover, Men1 ablation in cells reduces acetylation of histones H3 and H4 at the 5(')-UTR of the caspase 8 locus bound by menin in vivo. Notably, the MEN1-derived menin point mutants lose their ability to bind the caspase 8 locus and fail to induce caspase 8 expression and TNF-alpha-mediated apoptosis. Consistent with these observations, the expression level of caspase 8 is markedly reduced in insulinomas from Men1(+/-) mice. Together, our results indicate that menin enhances the caspase 8 expression by binding the caspase 8 locus, and suggest that menin suppresses MEN1 tumorigenesis, at least in part, by up-regulating caspase 8 expression.	Univ Penn, Abramson Canc Ctr, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University	Hua, XX (corresponding author), Univ Penn, Abramson Canc Ctr, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu		Kim, Seung/0000-0001-6135-7810	NCI NIH HHS [R01 CA113962-04, R01 CA113962, R01 CA100912-04, R01 CA100912] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113962, R01CA100912] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Bertolino P, 2003, CANCER RES, V63, P4836; Biondi CA, 2004, MOL CELL BIOL, V24, P3125, DOI 10.1128/MCB.24.8.3125-3131.2004; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Farley SM, 2006, J SURG RES, V133, P29, DOI 10.1016/j.jss.2006.02.021; Gobl AE, 1999, BBA-GENE STRUCT EXPR, V1447, P51, DOI 10.1016/S0167-4781(99)00132-3; Grignani F, 1998, CANCER RES, V58, P14; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Hopkins-Donaldson S, 2000, MED PEDIATR ONCOL, V35, P608; Hopkins-Donaldson S, 2000, CANCER RES, V60, P4315; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hussein N, 2007, EUR J CANCER, V43, P402, DOI 10.1016/j.ejca.2006.08.038; Jin SH, 2003, CANCER RES, V63, P4204; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim H, 2003, CANCER RES, V63, P6135; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; La P, 2006, ONCOGENE, V25, P3537, DOI 10.1038/sj.onc.1209400; La P, 2004, J BIOL CHEM, V279, P49045, DOI 10.1074/jbc.M409358200; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Marx SJ, 2005, J INTERN MED, V257, P2, DOI 10.1111/j.1365-2796.2004.01419.x; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; OUELLETTE MM, 1992, ONCOGENE, V7, P1075; Pannett AAJ, 1999, ENDOCR-RELAT CANCER, V6, P449, DOI 10.1677/erc.0.0060449; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sayo Y, 2002, ENDOCRINOLOGY, V143, P2437, DOI 10.1210/en.143.6.2437; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schnepp RW, 2004, CANCER RES, V64, P6791, DOI 10.1158/0008-5472.CAN-04-0724; Schnepp RW, 2004, J BIOL CHEM, V279, P10685, DOI 10.1074/jbc.M308073200; Takita J, 2000, MED PEDIATR ONCOL, V35, P541, DOI 10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	51	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31332	31340		10.1074/jbc.M609555200	http://dx.doi.org/10.1074/jbc.M609555200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766243	hybrid, Green Accepted			2022-12-25	WOS:000250309200022
J	Nelson, TJ; Alkon, DL				Nelson, Thomas J.; Alkon, Daniel L.			Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							C-REACTIVE PROTEIN; IN-GEL DIGESTION; ALZHEIMERS-DISEASE; PRECURSOR-PROTEIN; A-BETA; ENDOPLASMIC-RETICULUM; INTRACEREBROVENTRICULAR INFUSION; NEUROFIBRILLARY TANGLES; COGNITIVE DEFICITS; DOWN-REGULATION	beta-Amyloid peptide produces apoptosis in neurons at micromolar concentrations, but the mechanism by which beta-amyloid exerts its toxic effect is unknown. The normal biological function of beta-amyloid is also unknown. We used phage display, coprecipitation, and mass spectrometry to examine the proteinprotein interactions of beta-amyloid in normal rabbit brain in order to identify the biochemical receptors for beta-amyloid. beta-Amyloid was found to bind primarily to proteins involved in low density lipoprotein and cholesterol transport and metabolism, including sortilin, endoplasmic reticulum-Golgi intermediate compartment 2 (ERGIC2), ERGIC-53, steroid 5 alpha-reductase, and apolipoprotein B. beta-Amyloid also bound to the C-reactive protein precursor, a protein involved in inflammation, and to 14-3-3, a protein that regulates glycogen synthase kinase-3 beta, the kinase involved in tau phosphorylation. Of eight synthetic peptides identified as targets of beta-amyloid, three were found to be effective blockers of the toxic effect of beta-amyloid on cultured neuronal cells. These peptides bound to the hydrophobic region (residues 17-21) or to the nearby protein kinase C pseudo-phosphorylation site (residues 26-30) of beta-amyloid, suggesting that these may be the most critical regions for beta-amyloid effector action and for aggregation. Peptides or other small molecules that bind to this region may protect against beta-amyloid toxic effect by competitively blocking its ability to bind beta-amyloid effector proteins such as sortilin and 14-3-3.	Blanchette Rockefeller Neurosci Inst, Rockville, MD 20850 USA; Blanchette Rockefeller Neurosci Inst, Rockville, MD 20850 USA		Nelson, TJ (corresponding author), Blanchette Rockefeller Neurosci Inst, 317 Acad & Res Bldg,9601 Med Ctr Dr, Rockville, MD 20850 USA.	tjnelson@brni-jhu.org						ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; ALVAREZ R, 1992, ANAL BIOCHEM, V203, P76, DOI 10.1016/0003-2697(92)90045-9; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Bae J, 2001, APOPTOSIS, V6, P319, DOI 10.1023/A:1011319901057; Barbato C, 2005, NEUROBIOL DIS, V18, P399, DOI 10.1016/j.nbd.2004.10.011; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Bezdek J. C., 1973, Journal of Cybernetics, V3, P58, DOI 10.1080/01969727308546047; Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Bjelik A, 2006, NEUROCHEM INT, V49, P393, DOI 10.1016/j.neuint.2006.01.026; Blanchard Barbara J., 2000, Journal of Alzheimer's Disease, V2, P137; Blanchard BJ, 1997, BRAIN RES, V776, P40, DOI 10.1016/S0006-8993(97)01003-2; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Boyd-Kimball D, 2005, NEUROSCIENCE, V132, P313, DOI 10.1016/j.neuroscience.2004.12.022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Chen C, 2006, FEBS LETT, V580, P813, DOI 10.1016/j.febslet.2005.12.097; Chen Xi, 2006, Current Alzheimer Research, V3, P515, DOI 10.2174/156720506779025215; Chen X, 2006, IUBMB LIFE, V58, P686, DOI 10.1080/15216540601047767; Cruz M, 2004, J PEPT RES, V63, P324, DOI 10.1111/j.1399-3011.2004.00156.x; Culvenor JG, 1997, J NEUROSCI RES, V49, P719, DOI 10.1002/(SICI)1097-4547(19970915)49:6<719::AID-JNR6>3.0.CO;2-A; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ETCHEBERRIGARAY R, 1994, SCIENCE, V264, P276, DOI 10.1126/science.8146663; EVES EM, 1992, P NATL ACAD SCI USA, V89, P4373, DOI 10.1073/pnas.89.10.4373; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; Fountoulakis M, 1999, J NEURAL TRANSM-SUPP, P323; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gomez-Ramos P, 2007, J ALZHEIMERS DIS, V11, P53; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Grilli M, 2003, FUNCT NEUROL, V18, P145; HAAN MN, 2007, IN PRESS NEUROBIOL; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Higgins GA, 2003, BEHAV PHARMACOL, V14, P419, DOI 10.1097/01.fbp.0000088420.18414.ff; Holscher C, 2005, REV NEUROSCIENCE, V16, P181; Hughes SR, 1996, P NATL ACAD SCI USA, V93, P2065, DOI 10.1073/pnas.93.5.2065; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Islam K, 1997, AM J PATHOL, V151, P265; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; Jellinger Kurt A., 2006, Current Alzheimer Research, V3, P377, DOI 10.2174/156720506778249434; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaufman L, 1990, FINDING GROUP DATA I; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Kwok SCM, 2001, DNA CELL BIOL, V20, P349, DOI 10.1089/10445490152122460; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Lee W, 2004, MOL CELL NEUROSCI, V26, P222, DOI 10.1016/j.mcn.2003.10.020; Li T, 2007, NEUROSCI LETT, V414, P203, DOI 10.1016/j.neulet.2006.11.073; Luo Y, 1996, NEUROSCI LETT, V217, P125, DOI 10.1016/S0304-3940(96)13087-1; Malissein E, 2006, APOPTOSIS, V11, P1003, DOI 10.1007/s10495-006-6713-7; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Masters SC, 2002, BIOCHEM SOC T, V30, P360, DOI 10.1042/bst0300360; Matsunaga W, 2003, NEUROSCI LETT, V342, P129, DOI 10.1016/S0304-3940(03)00240-4; McGeer EG, 2001, NEUROBIOL AGING, V22, P843, DOI 10.1016/S0197-4580(01)00288-3; Mileusnic R, 2000, EUR J NEUROSCI, V12, P4487, DOI 10.1046/j.1460-9568.2000.01344.x; Morais VA, 2006, BBA-MOL BASIS DIS, V1762, P802, DOI 10.1016/j.bbadis.2006.06.018; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; MUJUMDAR A, 2007, IN PRESS NEUROBIOL A; Nakamura S, 2001, BRAIN RES, V912, P128, DOI 10.1016/S0006-8993(01)02704-4; NAMBA Y, 1992, NEUROSCI LETT, V134, P264, DOI 10.1016/0304-3940(92)90531-B; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohi N, 2006, AM J PATHOL, V168, P1097, DOI 10.2353/ajpath.2006.050462; Olariu A, 2002, BRAIN RES, V957, P278, DOI 10.1016/S0006-8993(02)03608-9; Orner BP, 2006, J AM CHEM SOC, V128, P11882, DOI 10.1021/ja0619861; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Plant LD, 2003, J NEUROSCI, V23, P5531; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rossner S, 2005, J NEUROCHEM, V92, P226, DOI 10.1111/j.1471-4159.2004.02857.x; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Small D H, 1999, J Alzheimers Dis, V1, P275; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Stepanichev MY, 2003, J NEUROSCI RES, V71, P110, DOI 10.1002/jnr.10469; Suram A, 2007, ARCH BIOCHEM BIOPHYS, V463, P245, DOI 10.1016/j.abb.2007.03.015; Verdier Y, 2005, J NEUROCHEM, V94, P617, DOI 10.1111/j.1471-4159.2005.03158.x; WEISSBARTH S, 1981, J NEUROCHEM, V37, P677; White AR, 1999, J NEUROSCI, V19, P9170; White AR, 2001, NEUROBIOL DIS, V8, P299, DOI 10.1006/nbdi.2001.0386; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Wilson CA, 2003, J NEUROSCI RES, V74, P361, DOI 10.1002/jnr.10776; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X; YOUSSEF I, 2007, IN PRESS NEUROBIOL A; Yu JM, 1998, GENOMICS, V53, P90, DOI 10.1006/geno.1998.5500; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200; Zheng L, 2006, ANN NY ACAD SCI, V1067, P248, DOI 10.1196/annals.1354.032	122	36	41	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31238	31249		10.1074/jbc.M705558200	http://dx.doi.org/10.1074/jbc.M705558200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761669	hybrid			2022-12-25	WOS:000250309200013
J	Watanabe, K; Bianco, C; Strizzi, L; Hamada, S; Mancino, M; Bailly, V; Mo, W; Wen, D; Miatkowski, K; Gonzales, M; Sanicola, M; Seno, M; Salomon, DS				Watanabe, Kazuhide; Bianco, Caterina; Strizzi, Luigi; Hamada, Shin; Mancino, Mario; Bailly, Veronique; Mo, Wenjun; Wen, Dingyi; Miatkowski, Konrad; Gonzales, Monica; Sanicola, Michele; Seno, Masaharu; Salomon, David S.			Growth factor induction of cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-CFC FAMILY; MAMMARY-GLAND; ANCHORED PROTEINS; TGF-BETA; RELEASE; CLEAVAGE; OVEREXPRESSION; MEMBRANES; PATHWAYS; BLOCKADE	Cripto-1 (CR-1) is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein that has been shown to play an important role in embryogenesis and cellular transformation. CR-1 is reported to function as a membrane-bound co-receptor and as a soluble ligand. Although a number of studies implicate the role of CR-1 as a soluble ligand in tumor progression, it is unclear how transition from the membrane-bound to the soluble form is physiologically regulated and whether differences in biological activity exist between these forms. Here, we demonstrate that CR-1 protein is secreted from tumor cells into the conditioned medium after treatment with serum, epidermal growth factor, or lysophosphatidic acid, and this soluble form of CR-1 exhibits the ability to promote endothelial cell migration as a paracrine chemoattractant. On the other hand, membranebound CR-1 can stimulate endothelial cell sprouting through direct cell-cell interaction. Shedding of CR-1 occurs at the GPI-anchorage site by the activity of GPI-phospholipase D (GPIPLD), because CR-1 shedding was suppressed by siRNA knockdown of GPI-PLD and enhanced by overexpression of GPI-PLD. These findings describe a novel molecular mechanism of CR-1 shedding, which may contribute to endothelial cell migration and possibly tumor angiogenesis.	NIH, NCI, Canc Res Ctr, Mammary Biol & Tumorgenesis Lab,Tumor Growth FS, Bethesda, MD 20892 USA; Biogen Inc, Cambridge, MA 02142 USA; Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med & Bioengn Sci, Okayama 7008530, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Biogen; Okayama University	Salomon, DS (corresponding author), NIH, NCI, Canc Res Ctr, Mammary Biol & Tumorgenesis Lab,Tumor Growth FS, Bethesda, MD 20892 USA.	salomond@mail.nih.gov	Watanabe, Kazuhide/C-9667-2017; SENO, Masaharu/B-2092-2011; Hamada, Shin/Z-3023-2019	Watanabe, Kazuhide/0000-0002-5331-0593; SENO, Masaharu/0000-0001-8547-6259; Mancino, Mario/0000-0003-1957-3119	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bianco C, 2005, CURR TOP DEV BIOL, V67, P85, DOI 10.1016/S0070-2153(05)67003-2; Bianco C, 2005, J NATL CANCER I, V97, P132, DOI 10.1093/jnci/dji011; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Bianco C, 2006, CLIN CANCER RES, V12, P5158, DOI 10.1158/1078-0432.CCR-06-0274; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; De Luca A, 2000, ONCOGENE, V19, P5863, DOI 10.1038/sj.onc.1203979; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kung M, 1997, BBA-MOL CELL RES, V1357, P329, DOI 10.1016/S0167-4889(97)00044-X; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Lee JY, 1998, NEUROCHEM RES, V23, P899, DOI 10.1023/A:1022419314330; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; METZ CN, 1994, EMBO J, V13, P1741, DOI 10.1002/j.1460-2075.1994.tb06438.x; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Naghibalhossaini F, 2006, CANCER LETT, V234, P158, DOI 10.1016/j.canlet.2005.03.028; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Normanno N, 2001, FRONT BIOSCI-LANDMRK, V6, pD685, DOI 10.2741/Normano; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; ROBERTS JM, 1990, FEBS LETT, V267, P213, DOI 10.1016/0014-5793(90)80927-B; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; Sun Y, 2005, AM J PATHOL, V167, P585, DOI 10.1016/S0002-9440(10)63000-3; van Cruijsen H, 2005, INT J CANCER, V117, P883, DOI 10.1002/ijc.21479; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Wechselberger C, 2005, ONCOGENE, V24, P4094, DOI 10.1038/sj.onc.1208417; Xing PX, 2004, CANCER RES, V64, P4018, DOI 10.1158/0008-5472.CAN-03-3888; Yamamoto Y, 2005, BIOCHEM BIOPH RES CO, V333, P223, DOI 10.1016/j.bbrc.2005.05.084; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	44	52	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31643	31655		10.1074/jbc.M702713200	http://dx.doi.org/10.1074/jbc.M702713200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17720976	hybrid			2022-12-25	WOS:000250309200056
J	Cumming, RC; Dargusch, R; Fischer, WH; Schubert, D				Cumming, Robert C.; Dargusch, Richard; Fischer, Wolfgang H.; Schubert, David			Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ALZHEIMERS-DISEASE BRAIN; ACTIVE-SITE CYSTEINE; PROTEOMIC ANALYSIS; THIOREDOXIN REDUCTASE; GEL-ELECTROPHORESIS; HIPPOCAMPAL-NEURONS; GLUCOSE-METABOLISM; HYDROGEN-PEROXIDE; IN-VIVO	Peroxiredoxins (Prxs) are a ubiquitously expressed family of thiol peroxidases that reduce hydrogen peroxide, peroxynitrite, and hydroperoxides using a highly conserved cysteine. There is substantial evidence that oxidative stress elicited by amyloid beta (A beta) accumulation is a causative factor in the pathogenesis of Alzheimer disease (AD). Here we show that A beta-resistant PC12 cell lines exhibit increased expression of multiple Prx isoforms with reduced cysteine oxidation. A beta-resistant PC12 cells also display higher levels of thioredoxin and thioredoxin reductase, two enzymes critical for maintaining Prx activity. PC12 cells and rat primary hippocampal neurons transfected with wild type Prx1 exhibit increased A beta resistance, whereas mutant Prx1, lacking a catalytic cysteine, confers no protection. Using an antibody that specifically recognizes sulfinylated and sulfonylated Prxs, it is demonstrated that primary rat cortical nerve cells exposed to A beta display a time-dependent increase in cysteine oxidation of the catalytic site of Prxs that can be blocked by the addition of the thiol-antioxidant N-acetylcysteine. In support of previous findings, expression of Prx1 is higher in post-mortem human AD cortex tissues than in age-matched controls. In addition, two-dimensional gel electrophoresis and mass spectrometry analysis revealed that Prx2 exists in a more oxidized state in AD brains than in control brains. These findings suggest that increased Prx expression and resistance to sulfhydryl oxidation in A beta-resistant nerve cells is a compensatory response to the oxidative stress initiated by chronic pro-oxidant A beta exposure.	Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA; Peptide Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Schubert, D (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schubert@salk.edu	Cumming, Robert/G-2185-2010		NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER; NIA NIH HHS [AG5142] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aksenov MY, 1998, J MOL NEUROSCI, V10, P181, DOI 10.1007/BF02761773; Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Ichimiya S, 1997, DNA CELL BIOL, V16, P311, DOI 10.1089/dna.1997.16.311; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Krapfenbauer K, 2002, ELECTROPHORESIS, V23, P2541, DOI 10.1002/1522-2683(200208)23:15<2541::AID-ELPS2541>3.0.CO;2-1; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Ohki EC, 2001, J NEUROSCI METH, V112, P95, DOI 10.1016/S0165-0270(01)00441-1; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Sagara Y, 1996, J NEUROSCI, V16, P497; Sarafian TA, 1999, J NEUROSCI RES, V56, P206, DOI 10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR1>3.0.CO;2-X; Schonberger SJ, 2001, PROTEOMICS, V1, P1519, DOI 10.1002/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; WILLIAMS JF, 1980, TRENDS BIOCHEM SCI, V5, P315, DOI 10.1016/0968-0004(80)90139-5; Wilson KE, 2005, PROTEOMICS, V5, P3851, DOI 10.1002/pmic.200401255; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077; Zitzler J, 2004, MOL CELL PROTEOMICS, V3, P834, DOI 10.1074/mcp.M400054-MCP200	46	45	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30523	30534		10.1074/jbc.M700869200	http://dx.doi.org/10.1074/jbc.M700869200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17761673	hybrid			2022-12-25	WOS:000250136300020
J	Harikumar, KG; Pinon, DI; Miller, LJ				Harikumar, Kaleeckal G.; Pinon, Delia I.; Miller, Laurence J.			Transmembrane segment IV contributes a functionally important interface for oligomerization of the class II G protein-coupled secretin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; RESONANCE ENERGY-TRANSFER; CHOLECYSTOKININ RECEPTORS; SPATIAL APPROXIMATION; CRYSTAL-STRUCTURE; AGONIST BINDING; AMINO-TERMINUS; DIMERIZATION; LIGAND; ACTIVATION	Oligomerization of the Class II G protein-coupled secretin receptor has been reported, but the molecular basis for this and its functional significance have not been determined. In the current work, we have examined the possible contribution of each of the transmembrane (TM) segments of this receptor to its homo-oligomerization, using the method of competitive disruption screening for inhibition of receptor bioluminescence resonance energy transfer signal. TM IV was the only segment that was found to disrupt receptor bioluminescence resonance energy transfer. Evaluation of predicted interhelical and lipid-exposed faces of this TM segment demonstrated that its lipid-exposed face represented the determinant for oligomerization. This was further confirmed by mutagenesis of the intact secretin receptor. Morphological FRET was utilized to demonstrate that secretin receptor oligomerization occurred at the cell surface and that this oligomerization was disrupted by mutating Gly(243) and Ile(247), key residues within the lipid-exposed face of TM IV. Although disruption of the receptor oligomerization interface had no effect on secretin binding parameters, it reduced the ability of secretin to stimulate intracellular cAMP. This supports a clear functional effect of oligomerization of this receptor. Such an effect might be particularly relevant to clinical situations in which this receptor is overexpressed, such as in certain neoplasms.	Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu		Harikumar, Kaleeckal/0000-0003-0411-5334	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46577] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Ding WQ, 2002, CANCER RES, V62, P5223; Dong MQ, 2005, MOL ENDOCRINOL, V19, P1821, DOI 10.1210/me.2004-0421; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Donnelly D, 1997, FEBS LETT, V409, P431, DOI 10.1016/S0014-5793(97)00546-2; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frimurer TM, 1999, PROTEINS, V35, P375, DOI 10.1002/(SICI)1097-0134(19990601)35:4<375::AID-PROT1>3.0.CO;2-2; GOSSEN D, 1990, EUR J BIOCHEM, V193, P149, DOI 10.1111/j.1432-1033.1990.tb19316.x; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2006, BIOCHEMISTRY-US, V45, P14706, DOI 10.1021/bi061107n; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Langer I, 2006, BRIT J PHARMACOL, V148, P1051, DOI 10.1038/sj.bjp.0706816; Latif R, 2002, J BIOL CHEM, V277, P45059, DOI 10.1074/jbc.M206693200; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Lohse MJ, 2006, NAT METHODS, V3, P972, DOI 10.1038/nmeth1206-972; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	32	78	78	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30363	30372		10.1074/jbc.M702325200	http://dx.doi.org/10.1074/jbc.M702325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726027	hybrid			2022-12-25	WOS:000250136300004
J	Nara, N; Nakayama, Y; Okamoto, S; Tamura, H; Kiyono, M; Muraoka, M; Tanaka, K; Taya, C; Shitara, H; Ishii, R; Yonekawa, H; Minokoshi, Y; Hara, T				Nara, Noriko; Nakayama, Yuki; Okamoto, Shiki; Tamura, Hiroshi; Kiyono, Mari; Muraoka, Masatoshi; Tanaka, Kiyoko; Taya, Choji; Shitara, Hiroshi; Ishii, Rie; Yonekawa, Hiromichi; Minokoshi, Yasuhiko; Hara, Takahiko			Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; DENDRITIC CELLS; ADIPOSE-TISSUE; IKK-BETA; IN-VIVO; EXPRESSION; CLONING; BRAK; OVEREXPRESSION; LOCALIZATION	In obese individuals, white adipose tissue (WAT) is infiltrated by large numbers of macrophages, resulting in enhanced inflammatory responses that contribute to insulin resistance. Here we show that expression of the CXC motif chemokine ligand-14 (CXCL14), which targets tissue macrophages, is elevated in WAT of obese mice fed a high fat diet (HFD) compared with lean mice fed a regular diet. We found that HFD-fed CXCL14-deficient mice have impaired WAT macrophage mobilization and improved insulin responsiveness. Insulin-stimulated phosphorylation of Akt kinase in skeletal muscle was severely attenuated in HFD-fed CXCL14(+/-) mice but not in HFD-fed CXCL14(-/-) mice. The insulin-sensitive phenotype of CXCL14(-/-) mice after HFD feeding was prominent in female mice but not in male mice. HFD-fed CXCL14(+/-) mice were protected from hyperglycemia, hyperinsulinemia, and hypoadiponectinemia and did not exhibit increased levels of circulating retinol-binding protein-4 and increased expression of interleukin-6 in WAT. Transgenic overexpression of CXCL14 in skeletal muscle restored obesity-induced insulin resistance in CXCL14(+/-) mice. CXCL14 attenuated insulin-stimulated glucose uptake in cultured myocytes and to a lesser extent in cultured adipocytes. These results demonstrate that CXCL14 is a critical chemoattractant of WAT macrophages and a novel regulator of glucose metabolism that functions mainly in skeletal muscle.	Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Lab Mouse Model Human Heritable Dis, Bunkyo Ku, Tokyo 1138613, Japan; Natl Inst Physiol Sci, Div Endocrinol & Metab, Aichi 4448585, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Hara, T (corresponding author), Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	thara@rinshoken.or.jp	Okamoto, Shiki/X-7274-2018	Okamoto, Shiki/0000-0002-2802-0527; Minokoshi, Yasuhiko/0000-0002-7119-4805				Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao XT, 2000, J IMMUNOL, V165, P2588, DOI 10.4049/jimmunol.165.5.2588; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Sleeman MA, 2000, INT IMMUNOL, V12, P677, DOI 10.1093/intimm/12.5.677; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	33	128	136	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30794	30803		10.1074/jbc.M700412200	http://dx.doi.org/10.1074/jbc.M700412200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724031	hybrid			2022-12-25	WOS:000250136300048
J	Rider, L; Shatrova, A; Feener, EP; Webb, L; Diakonova, M				Rider, Leah; Shatrova, Alla; Feener, Edward P.; Webb, Leslie; Diakonova, Maria			JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; NF-KAPPA-B; P21-ACTIVATED KINASE-1-INTERACTING SUBSTRATE; GROWTH-FACTOR RECEPTOR; CONSTITUTIVE ACTIVATION; ADAPTER PROTEIN; P35/CDK5 KINASE; SH2-B-BETA; ACTIN; APOPTOSIS	The serine-threonine kinase PAK1 is activated by small GTPase-dependent and -independent mechanisms and promotes cell survival. However, the role of tyrosyl phosphorylation in the regulation of PAK1 function is poorly understood. In this study, we have shown that the prolactin-activated tyrosine kinase JAK2 phosphorylates PAK1 in vivo. Wild type, but not kinase-dead, JAK2 directly phosphorylates PAK1 in cells and in an in vitro kinase assay. PAK1 tyrosines 153, 201, and 285 were identified as sites of JAK2 tyrosyl phosphorylation by mass spectrometry and two-dimensional peptide mapping. Mutation of PAK1 tyrosines 153, 201, and 285 to phenylalanines individually or in combination implicated these PAK1 tyrosines in the regulation of PAK1 kinase activity. Tyrosyl phosphorylation by JAK2 significantly increases PAK1 kinase activity, whereas similar phosphorylation of the PAK1 Y153F, Y201F, Y285F mutant has no effect on PAK1 activity. Tyrosyl phosphorylation of wild type PAK1 decreases apoptosis induced by serum deprivation and staurosporine treatment and increases cell motility. In contrast, these parameters are unaltered in the PAK1 Y153F, Y201F, Y285F mutant. Our findings indicate that JAK2 phosphorylates PAK1 at these specific tyrosines and that this phosphorylation plays an important role in cell survival and motility.	Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; Univ Michigan, Sch Med, Dept Mol Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Integrat Physiol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Diakonova, M (corresponding author), 2801 W Bancroft St, Toledo, OH 43606 USA.	mdiakon@utnet.utoledo.edu	Shatrova, Alla/R-8042-2016	Diakonova, Maria/0000-0002-4554-2730	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074689, P60DK020572, R01DK060165] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK074689, P60 DK20572, R01 DK60165, P60 DK020572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Argente J, 1996, HORM RES, V45, P1, DOI 10.1159/000184814; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Banerjee M, 2002, CURR BIOL, V12, P1233, DOI 10.1016/S0960-9822(02)00956-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Diakonova M, 2002, J BIOL CHEM, V277, P10669, DOI 10.1074/jbc.M111138200; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Faruqi TR, 2001, P NATL ACAD SCI USA, V98, P9014, DOI 10.1073/pnas.161281298; FIORUCCI G, 1995, J VIROL, V69, P5833, DOI 10.1128/JVI.69.9.5833-5837.1995; Foryst-Ludwig A, 2000, J BIOL CHEM, V275, P39779, DOI 10.1074/jbc.M007617200; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; GOUT PW, 1987, CANCER RES, V47, P1751; Humphreys RC, 2000, ONCOGENE, V19, P1085, DOI 10.1038/sj.onc.1203278; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Johnson K, 2005, J NEUROSCI RES, V79, P809, DOI 10.1002/jnr.20415; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; McManus MJ, 2000, J BIOL CHEM, V275, P35328, DOI 10.1074/jbc.M005399200; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Murata T, 1995, J BIOL CHEM, V270, P30829, DOI 10.1074/jbc.270.51.30829; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; O'Brien KB, 2003, J BIOL CHEM, V278, P11970, DOI 10.1074/jbc.M210765200; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Renkema GH, 2002, MOL CELL BIOL, V22, P6719, DOI 10.1128/MCB.22.19.6719-6725.2002; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Ruchatz H, 2003, EXP HEMATOL, V31, P309, DOI 10.1016/S0301-472X(03)00007-9; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; Rui LY, 2000, MOL CELL BIOL, V20, P3168, DOI 10.1128/MCB.20.9.3168-3177.2000; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	75	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30985	30996		10.1074/jbc.M701794200	http://dx.doi.org/10.1074/jbc.M701794200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726028	hybrid			2022-12-25	WOS:000250136300066
J	Kass, EM; Ahn, J; Tanaka, T; Freed-Pastor, WA; Keezer, S; Prives, C				Kass, Elizabeth M.; Ahn, Jinwoo; Tanaka, Tomoaki; Freed-Pastor, William A.; Keezer, Susan; Prives, Carol			Stability of checkpoint kinase 2 is regulated via phosphorylation at serine 456	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHK2 PROTEIN-KINASE; DNA-DAMAGE RESPONSE; LI-FRAUMENI-SYNDROME; TUMOR-SUPPRESSOR; IN-VIVO; CHK2-DEPENDENT PHOSPHORYLATION; THREONINE-68 PHOSPHORYLATION; IONIZING-RADIATION; PROTEASOME PATHWAY; BREAST-CANCER	Checkpoint kinase 2 (Chk2), a DNA damage-activated protein kinase, is phosphorylated at Thr-68 by ataxia telangiectasia mutated leading to its activation by phosphorylation at several additional sites. Using mass spectrometry we identified a new Chk2 phosphorylation site at Ser-456. We show that phosphorylation of Ser-456 plays a role in the regulation of Chk2 stability particularly after DNA damage. Mutation of Ser-456 to alanine results in hyperubiquitination of Chk2 and dramatically reduced Chk2 stability. Furthermore, cells expressing S456A Chk2 show a reduction in the apoptotic response to DNA damage. These findings suggest a mechanism for stabilization of Chk2 in response to DNA damage via phosphorylation at Ser-456 and proteasome-dependent turnover of Chk2 protein via dephosphorylation of the same residue.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Cell Signaling Technol Inc, Danvers, MA 01923 USA	Columbia University	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	clp3@columbia.edu		FREED-PASTOR, WILLIAM/0000-0002-7377-2111				Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2001, ONCOGENE, V20, P5897, DOI 10.1038/sj.onc.1204746; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Craig A, 2003, EMBO REP, V4, P787, DOI 10.1038/sj.embor.embor901; Craig Ashley L, 2003, Methods Mol Biol, V234, P171; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gibson SL, 2006, RADIAT RES, V166, P646, DOI 10.1667/RR0660.1; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; Haruki N, 2000, CANCER RES, V60, P4689; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2001, CANCER RES, V61, P5362; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Shieh SY, 2000, GENE DEV, V14, P289; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Tort F, 2002, BLOOD, V100, P4602, DOI 10.1182/blood-2002-04-1078; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhang PL, 2005, BIOCHEM BIOPH RES CO, V328, P567, DOI 10.1016/j.bbrc.2005.01.007; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278	50	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30311	30321		10.1074/jbc.M704642200	http://dx.doi.org/10.1074/jbc.M704642200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715138	hybrid			2022-12-25	WOS:000249981200062
J	Aldridge, JE; Horibe, T; Hoogenraad, NJ				Aldridge, Jonathan E.; Horibe, Tomohisa; Hoogenraad, Nicholas J.			Discovery of Genes Activated by the Mitochondrial Unfolded Protein Response (mtUPR) and Cognate Promoter Elements	PLOS ONE			English	Article								In an accompanying paper, we show that the mitochondrial Unfolded Protein Response or mtUPR is initiated by the activation of transcription of chop through an AP-1 element in the chop promoter. Further, we show that the c/ebp beta gene is similarly activated and CHOP and C/EBP beta subsequently hetero-dimerise to activate transcription of mtUPR responsive genes. Here, we report the discovery of six additional mtUPR responsive genes. We found that these genes encoding mitochondrial proteases YME1L1 and MPP beta, import component Tim17A and enzymes NDUFB2, endonuclease G and thioredoxin 2, all contain a CHOP element in their promoters. In contrast, genes encoding mitochondrial proteins Afg3L2, Paraplegin, Lon and SAM 50, which do not have a CHOP element, were not up-regulated. Conversely, genes with CHOP elements encoding cytosolic proteins were not induced by the accumulation of unfolded proteins in mitochondria. These results indicate that mtUPR responsive genes appear to share a requirement for a CHOP element, but that this is not sufficient for the regulation of the mtUPR. A more detailed analysis of promoters of mtUPR responsive genes revealed at least two additional highly conserved, putative regulatory sites either side of the CHOP element, one a motif of 12 bp which lies 14 bp upstream of the CHOP site and another 9 bp element, 2 bp downstream of the CHOP site. Both of these additional elements are conserved in the promoters of 9 of the ten mtUPR responsive genes we have identified so far, the exception being the Cpn60/10 bidirectional promoter. Mutation of each of these elements substantially reduced the mtUPR responsiveness of the promoters suggesting that these elements coordinately regulate mtUPR.	[Aldridge, Jonathan E.; Horibe, Tomohisa; Hoogenraad, Nicholas J.] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia	La Trobe University	Hoogenraad, NJ (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia.	n.hoogenraad@latrobe.edu.au	Hoogenraad, Nicholas J/C-7505-2011					Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HORIBE T, 2007, PLOSONE IN PRESS; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Langer T, 1996, EXPERIENTIA, V52, P1069, DOI 10.1007/BF01952104; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Ohsato T, 2002, EUR J BIOCHEM, V269, P5765, DOI 10.1046/j.1432-1033.2002.03238.x; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2006, MOL BIOTECHNOL, V34, P279, DOI 10.1385/MB:34:2:279; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	26	209	212	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e874	10.1371/journal.pone.0000874	http://dx.doi.org/10.1371/journal.pone.0000874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849004	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455600021
J	MacDonald, SM; Song, G; Poon, CS				MacDonald, Shawna M.; Song, Gang; Poon, Chi-Sang			Nonassociative Learning Promotes Respiratory Entrainment to Mechanical Ventilation	PLOS ONE			English	Article								(B)ackground. Patient-ventilator synchrony is a major concern in critical care and is influenced by phasic lung-volume feedback control of the respiratory rhythm. Routine clinical application of positive end-expiratory pressure (PEEP) introduces a tonic input which, if unopposed, might disrupt respiratory-ventilator entrainment through sustained activation of the vagally-mediated Hering-Breuer reflex. We suggest that this potential adverse effect may be averted by two differentiator forms of nonassociative learning (habituation and desensitization) of the Hering-Breuer reflex via pontomedullary pathways. Methodology/Principal Findings. We tested these hypotheses in 17 urethane-anesthetized adult Sprague-Dawley rats under controlled mechanical ventilation. Without PEEP, phrenic discharge was entrained 1:1 to the ventilator rhythm. Application of PEEP momentarily dampened the entrainment to higher ratios but this effect was gradually adapted by nonassociative learning. Bilateral electrolytic lesions of the pneumotaxic center weakened the adaptation to PEEP, whereas sustained stimulation of the pneumotaxic center weakened the entrainment independent of PEEP. In all cases, entrainment was abolished after vagotomy. Conclusions/Significance. Our results demonstrate an important functional role for pneumotaxic desensitization and extra-pontine habituation of the Hering-Breuer reflex elicited by lung inflation: acting as buffers or high-pass filters against tonic vagal volume input, these differentiator forms of nonassociative learning help to restore respiratory-ventilator entrainment in the face of PEEP. Such central sites-specific habituation and desensitization of the Hering-Breuer reflex provide a useful experimental model of nonassociative learning in mammals that is of particular significance in understanding respiratory rhythmogenesis and coupled-oscillator entrainment mechanisms, and in the clinical management of mechanical ventilation in respiratory failure.	[MacDonald, Shawna M.; Song, Gang; Poon, Chi-Sang] MIT, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Poon, CS (corresponding author), MIT, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cpoon@mit.edu			NHLBI NIH HHS [R01 HL079503, HL072849, HL079503, R01 HL072849, R01 HL067966, HL067966] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079503, R01HL072849, R01HL067966] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allo JC, 2006, CRIT CARE MED, V34, P2997, DOI 10.1097/01.CCM.0000242520.50665.9F; BACONNIER PF, 1993, J THEOR BIOL, V164, P149, DOI 10.1006/jtbi.1993.1145; Baumer JH, 2000, ARCH DIS CHILD-FETAL, V82, pF5, DOI 10.1136/fn.82.1.F5; Beresford MW, 2000, ARCH DIS CHILD-FETAL, V82, pF14, DOI 10.1136/fn.82.1.F14; Breuer J., 1970, BREATHING, P365; Brochard L, 2002, INTENS CARE MED, V28, P1376, DOI 10.1007/s00134-002-1438-8; Chao DC, 1997, CHEST, V112, P1592, DOI 10.1378/chest.112.6.1592; Dick CR, 1996, CLIN CHEST MED, V17, P423, DOI 10.1016/S0272-5231(05)70325-7; GAUTIER H, 1981, J APPL PHYSIOL, V51, P1162, DOI 10.1152/jappl.1981.51.5.1162; GRAVES C, 1986, AM J PHYSIOL, V250, pR902, DOI 10.1152/ajpregu.1986.250.5.R902; GRIPPI MA, 1985, J APPL PHYSIOL, V58, P1360, DOI 10.1152/jappl.1985.58.4.1360; GUZ A, 1971, J PHYSIOL-LONDON, V213, P329, DOI 10.1113/jphysiol.1971.sp009385; GUZ A, 1964, CLIN SCI, V27, P293; Haberthur C, 2005, CRIT CARE, V9, pR407, DOI 10.1186/cc3735; HAMILTON RD, 1988, RESP PHYSIOL, V73, P145, DOI 10.1016/0034-5687(88)90062-X; HAMILTON RD, 1990, RESP PHYSIOL, V81, P87, DOI 10.1016/0034-5687(90)90072-7; Hering E., 1970, BREATHING, P359; Imanaka H, 2000, CRIT CARE MED, V28, P402, DOI 10.1097/00003246-200002000-00019; Kondili E, 2003, BRIT J ANAESTH, V91, P106, DOI 10.1093/bja/aeg129; Lumsden T, 1923, J PHYSIOL-LONDON, V57, P153; MADOR MJ, 1990, CHEST, V97, P877, DOI 10.1378/chest.97.4.877; Matsugu M, 1998, J COMPUT NEUROSCI, V5, P35, DOI 10.1023/A:1008826326829; McGuire M, 2007, RESP PHYSIOL NEUROBI, V158, P107, DOI 10.1016/j.resp.2007.01.017; MUZZIN S, 1992, AM J PHYSIOL, V263, pR292, DOI 10.1152/ajpregu.1992.263.2.R292; MUZZIN S, 1989, RESP PHYSIOL, V75, P157, DOI 10.1016/0034-5687(89)90060-1; Oddo M, 2006, INTENS CARE MED, V32, P501, DOI 10.1007/s00134-005-0045-x; PEPE PE, 1982, AM REV RESPIR DIS, V126, P166; PETRILLO GA, 1983, CAN J PHYSIOL PHARM, V61, P599, DOI 10.1139/y83-092; PETRILLO GA, 1984, AM J PHYSIOL, V246, pR311, DOI 10.1152/ajpregu.1984.246.3.R311; Poon Chi-Sang, 2006, Behav Brain Funct, V2, P29, DOI 10.1186/1744-9081-2-29; Poon CS, 2000, RESP PHYSIOL, V122, P83, DOI 10.1016/S0034-5687(00)00152-3; Poon CS, 2004, ADV EXP MED BIOL, V551, P95; Poon CS, 2000, NEUROSCI LETT, V284, P5, DOI 10.1016/S0304-3940(00)00993-9; Poon CS, 1997, RESP PHYSIOL, V108, P117, DOI 10.1016/S0034-5687(97)00014-5; Saito Y, 1999, DEV MED CHILD NEUROL, V41, P560, DOI 10.1017/S0012162299001188; Sharshar T, 2003, AM J RESP CRIT CARE, V168, P760, DOI 10.1164/rccm.200203-241OC; Simon PM, 1999, AM J RESP CRIT CARE, V160, P950, DOI 10.1164/ajrccm.160.3.9712057; Simon PM, 2000, J APPL PHYSIOL, V89, P760, DOI 10.1152/jappl.2000.89.2.760; Sinderby C, 1999, NAT MED, V5, P1433, DOI 10.1038/71012; Siniaia MS, 2000, J PHYSIOL-LONDON, V523, P479, DOI 10.1111/j.1469-7793.2000.t01-1-00479.x; Song G, 2006, J NEUROSCI, V26, P300, DOI 10.1523/JNEUROSCI.3029-05.2006; Song G, 2004, RESP PHYSIOL NEUROBI, V143, P281, DOI 10.1016/j.resp.2004.05.009; STANLEY NN, 1975, J APPL PHYSIOL, V38, P474, DOI 10.1152/jappl.1975.38.3.474; Thille AW, 2006, INTENS CARE MED, V32, P1515, DOI 10.1007/s00134-006-0301-8; Tobin M. J., 2006, PRINCIPLES PRACTICE, P1121; Tobin MJ, 2001, NEW ENGL J MED, V344, P1986, DOI 10.1056/NEJM200106283442606; Tobin MJ, 2001, AM J RESP CRIT CARE, V163, P1059, DOI 10.1164/ajrccm.163.5.2005125; Tryfon S, 2001, RESPIRATION, V68, P140, DOI 10.1159/000050483; VIBERT JF, 1981, BIOL CYBERN, V41, P119, DOI 10.1007/BF00335366; WIDDICOMBE J, 1961, CLIN SCI, V21, P163; YOUNES M, 1985, J APPL PHYSIOL, V59, P1072, DOI 10.1152/jappl.1985.59.4.1072; YOUNES M, 1987, J APPL PHYSIOL, V62, P1502, DOI 10.1152/jappl.1987.62.4.1502; Young DL, 2003, J APPL PHYSIOL, V94, P1213, DOI 10.1152/japplphysiol.00639.2002	53	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e865	10.1371/journal.pone.0000865	http://dx.doi.org/10.1371/journal.pone.0000865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848996	Green Published, gold			2022-12-25	WOS:000207455600012
J	Moura, G; Pinheiro, M; Arrais, J; Gomes, AC; Carreto, L; Freitas, A; Oliveira, JL; Santos, MAS				Moura, Gabriela; Pinheiro, Miguel; Arrais, Joel; Gomes, Ana Cristina; Carreto, Laura; Freitas, Adelaide; Oliveira, Jose L.; Santos, Manuel A. S.			Large Scale Comparative Codon-Pair Context Analysis Unveils General Rules that Fine-Tune Evolution of mRNA Primary Structure	PLOS ONE			English	Article								Background. Codon usage and codon-pair context are important gene primary structure features that influence mRNA decoding fidelity. In order to identify general rules that shape codon-pair context and minimize mRNA decoding error, we have carried out a large scale comparative codon-pair context analysis of 119 fully sequenced genomes. Methodologies/Principal Findings. We have developed mathematical and software tools for large scale comparative codon-pair context analysis. These methodologies unveiled general and species specific codon-pair context rules that govern evolution of mRNAs in the 3 domains of life. We show that evolution of bacterial and archeal mRNA primary structure is mainly dependent on constraints imposed by the translational machinery, while in eukaryotes DNA methylation and tri-nucleotide repeats impose strong biases on codon-pair context. Conclusions. The data highlight fundamental differences between prokaryotic and eukaryotic mRNA decoding rules, which are partially independent of codon usage.	[Moura, Gabriela; Gomes, Ana Cristina; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal; [Pinheiro, Miguel; Arrais, Joel; Oliveira, Jose L.] Univ Aveiro, Inst Elect & Telemat Engn, P-3800 Aveiro, Portugal; [Freitas, Adelaide] Univ Aveiro, Dept Math, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Santos, MAS (corresponding author), Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal.	msantos@bio.ua.pt	Pinheiro, Miguel/K-6572-2017; Freitas, Adelaide/H-8880-2012; Oliveira, José Luis/A-2223-2012; Moura, Gabriela/GPF-9079-2022; Santos, Manuel/E-6704-2010; Moura, Gabriela R/E-6717-2010	Pinheiro, Miguel/0000-0002-6601-7513; Freitas, Adelaide/0000-0002-4685-1615; Oliveira, José Luis/0000-0002-6672-6176; Moura, Gabriela/0000-0003-2243-6123; Santos, Manuel/0000-0002-0437-1146; Moura, Gabriela R/0000-0003-2243-6123; Arrais, Joel/0000-0003-4937-2334	FEDER/FCT [POCTI/BME/39030, SAU-MMO/55476, BIA-PRO/55472, BIA-MIC/55466, PTDC/MAT/72974/2006]; Human Frontier Science Programme [RGP45/2005]; Fundação para a Ciência e a Tecnologia [POCI/BIA-PRO/55472/2004, POCI/BIA-MIC/55466/2004, POCTI/BME/39030/2001, POCI/SAU-MMO/55476/2004, PTDC/MAT/72974/2006] Funding Source: FCT	FEDER/FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Human Frontier Science Programme(Human Frontier Science Program); Fundação para a Ciência e a Tecnologia	This study was supported by FEDER/FCT projects POCTI/BME/39030; SAU-MMO/55476; BIA-PRO/55472; BIA-MIC/55466; PTDC/MAT/72974/2006 and Human Frontier Science Programme project RGP45/2005.	AKASHI H, 1994, GENETICS, V136, P927; ATKINS JF, 1991, ANNU REV GENET, V25, P201; Berg OG, 1997, NUCLEIC ACIDS RES, V25, P1397, DOI 10.1093/nar/25.7.1397; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; Borstnik B, 2002, GENOME RES, V12, P909, DOI 10.1101/gr.138802; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; BUCKINGHAM RH, 1990, EXPERIENTIA, V46, P1126, DOI 10.1007/BF01936922; BUCKINGHAM RH, 1986, ACCURACY MOL PROCESS, P83; Caburet S, 2004, GENETICS, V167, P1813, DOI 10.1534/genetics.104.029082; Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Cliften PF, 2006, GENETICS, V172, P863, DOI 10.1534/genetics.105.048900; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; CURRAN JF, 1995, NUCLEIC ACIDS RES, V23, P4104, DOI 10.1093/nar/23.20.4104; DIX DB, 1989, P NATL ACAD SCI USA, V86, P6888, DOI 10.1073/pnas.86.18.6888; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Fedorov A, 2002, NUCLEIC ACIDS RES, V30, P1192, DOI 10.1093/nar/30.5.1192; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Hooper SD, 2000, NUCLEIC ACIDS RES, V28, P3517, DOI 10.1093/nar/28.18.3517; Hooper SD, 2002, J MOL EVOL, V54, P365, DOI 10.1007/s00239-001-0051-8; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lao PJ, 2000, GENOME RES, V10, P228, DOI 10.1101/gr.10.2.228; Lin YW, 2005, GENOMICS, V86, P431, DOI 10.1016/j.ygeno.2005.07.003; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; McVean GAT, 2000, J MOL EVOL, V50, P264, DOI 10.1007/s002399910031; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; MURGOLA EJ, 1984, J MOL BIOL, V175, P19, DOI 10.1016/0022-2836(84)90442-X; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; Nakashima H, 1997, DNA Res, V4, P185, DOI 10.1093/dnares/4.3.185; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Percudani R, 1999, MOL BIOL EVOL, V16, P1752, DOI 10.1093/oxfordjournals.molbev.a026087; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rocha EPC, 1999, MOL MICROBIOL, V32, P11, DOI 10.1046/j.1365-2958.1999.01334.x; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Shah AA, 2002, BIOINFORMATICS, V18, P1046, DOI 10.1093/bioinformatics/18.8.1046; SIMENOFF JS, 2003, ANAL CATEGORICAL DAT; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Tate WP, 1996, PROG NUCLEIC ACID RE, V52, P293, DOI 10.1016/S0079-6603(08)60970-8; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Tork S, 2004, NUCLEIC ACIDS RES, V32, P415, DOI 10.1093/nar/gkh201; van de Lagemaat LN, 2005, GENOME RES, V15, P1243, DOI 10.1101/gr.3910705	53	71	85	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e847	10.1371/journal.pone.0000847	http://dx.doi.org/10.1371/journal.pone.0000847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786218	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500030
J	Asai, A; Sahani, N; Kaneki, M; Ouchi, Y; Martyn, JAJ; Yasuhara, SE				Asai, Akihiro; Sahani, Nita; Kaneki, Masao; Ouchi, Yasuyoshi; Martyn, J. A. Jeevendra; Yasuhara, Shingo Egusa			Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy	PLOS ONE			English	Article								Background. Duchenne Muscular Dystrophy (DMD) is characterized by increased muscle damage and an abnormal blood flow after muscle contraction: the state of functional ischemia. Until now, however, the cause-effect relationship between the pathogenesis of DMD and functional ischemia was unclear. We examined (i) whether functional ischemia is necessary to cause contraction-induced myofiber damage and (ii) whether functional ischemia alone is sufficient to induce the damage. Methodology/Principal Findings. In vivo microscopy was used to document assays developed to measure intramuscular red blood cell flux, to quantify the amount of vasodilatory molecules produced from myofibers, and to determine the extent of myofiber damage. Reversal of functional ischemia via pharmacological manipulation prevented contraction-induced myofiber damage in mdx mice, the murine equivalent of DMD. This result indicates that functional ischemia is required for, and thus an essential cause of, muscle damage in mdx mice. Next, to determine whether functional ischemia alone is enough to explain the disease, the extent of ischemia and the amount of myofiber damage were compared both in control and mdx mice. In control mice, functional ischemia alone was found insufficient to cause a similar degree of myofiber damage observed in mdx mice. Additional mechanisms are likely contributing to cause more severe myofiber damage in mdx mice, suggestive of the existence of a "two-hit'' mechanism in the pathogenesis of this disease. Conclusions/Significance. Evidence was provided supporting the essential role of functional ischemia in contraction-induced myofiber damage in mdx mice. Furthermore, the first quantitative evidence for the "two-hit'' mechanism in this disease was documented. Significantly, the vasoactive drug tadalafil, a phosphodiesterase 5 inhibitor, administered to mdx mice ameliorated muscle damage.	[Asai, Akihiro; Sahani, Nita; Kaneki, Masao; Martyn, J. A. Jeevendra; Yasuhara, Shingo Egusa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Anesthesiol & Crit Ca, Boston, MA 02115 USA; [Asai, Akihiro; Ouchi, Yasuyoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Tokyo	Yasuhara, SE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Anesthesiol & Crit Ca, Boston, MA 02115 USA.	shingo_yasuhara@yahoo.com	Asai, Akihiro/AAH-3162-2021	Asai, Akihiro/0000-0003-3029-5754	Shriners Philanthropy Grant [8830]; NIH [GM31569, GM55082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055082, R23GM031569, R01GM031569] Funding Source: NIH RePORTER	Shriners Philanthropy Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This works was made possible through a Shriners Philanthropy Grant (# 8830 to SEY). Additional financial support was provided by NIH (# GM31569, GM55082 to JAJ).	AUWERX JH, 1989, BLOOD, V74, P1807; Berg BR, 1996, AM J PHYSIOL-HEART C, V271, pH2263, DOI 10.1152/ajpheart.1996.271.6.H2263; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bloom TJ, 2002, CAN J PHYSIOL PHARM, V80, P1132, DOI 10.1139/Y02-149; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BURBACH JA, 1987, AM J ANAT, V179, P291, DOI 10.1002/aja.1001790311; Carter AB, 2004, AM J RESP CELL MOL, V31, P43, DOI 10.1165/rcmb.2003-0377OC; Chao DS, 1998, J NEUROCHEM, V71, P784; Chiba S, 2001, J AUTON PHARMACOL, V21, P7, DOI 10.1046/j.1365-2680.2001.00199.x; CORCONDILAS A, 1964, J APPL PHYSIOL, V19, P142, DOI 10.1152/jappl.1964.19.1.142; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Doughty JM, 1999, AM J PHYSIOL-HEART C, V276, pH1107, DOI 10.1152/ajpheart.1999.276.3.H1107; EDWARDS RJ, 1984, PRENATAL DIAG, V4, P267, DOI 10.1002/pd.1970040406; *EL LIL CO DRUG IN, EL LIL RAT STUD SHOW; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; EMERY AEH, 1977, NATURE, V266, P472, DOI 10.1038/266472a0; ENGEL WK, 1971, REV NEUROL, V124, P291; Ferreira LF, 2006, J PHYSIOL-LONDON, V573, P787, DOI 10.1113/jphysiol.2006.104802; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRIFFITH TM, 1985, EUR J PHARMACOL, V112, P195, DOI 10.1016/0014-2999(85)90496-0; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HUNTER EG, 1983, CAN J PHYSIOL PHARM, V61, P182, DOI 10.1139/y83-028; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Ito K, 2006, HUM MOL GENET, V15, P2266, DOI 10.1093/hmg/ddl151; JERUSALEM F, 1974, BRAIN, V97, P115, DOI 10.1093/brain/97.1.115; Kim MB, 2003, MICROCIRCULATION, V10, P167, DOI 10.1038/sj.mn.7800182; KOBAYASHI Y, 1983, TOHOKU J EXP MED, V140, P381, DOI 10.1620/tjem.140.381; KOMORI K, 1990, BLOOD VESSELS, V27, P238; Lau KS, 1998, FEBS LETT, V431, P71, DOI 10.1016/S0014-5793(98)00728-5; Lau KS, 2000, PHYSIOL GENOMICS, V2, P21, DOI 10.1152/physiolgenomics.2000.2.1.21; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lopes-Ferreira M, 2001, INT J EXP PATHOL, V82, P55, DOI 10.1046/j.1365-2613.2001.00181.x; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; MACLEOD KM, 1987, MOL PHARMACOL, V32, P59; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; Mavrogeni S, 2005, CHEST, V127, P143, DOI 10.1378/chest.127.1.143; MENDELL JR, 1971, SCIENCE, V172, P1143, DOI 10.1126/science.172.3988.1143; MIIKE T, 1987, J NEUROL SCI, V82, P67, DOI 10.1016/0022-510X(87)90007-4; MIYATAKE M, 1989, J NEUROL SCI, V93, P11, DOI 10.1016/0022-510X(89)90157-3; MOHR T, 1987, PHYS THER, V67, P526, DOI 10.1093/ptj/67.4.526; Morikawa K, 2003, J CLIN INVEST, V112, P1871, DOI 10.1172/JCI200319351; MUSCH BC, 1975, J NEUROL SCI, V26, P221, DOI 10.1016/0022-510X(75)90034-9; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Rando TA, 2001, MICROSC RES TECHNIQ, V55, P223, DOI 10.1002/jemt.1172; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Strahler AN., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI DOI 10.1029/TR038I006P00913; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Tidball JG, 2004, MOL GENET METAB, V82, P312, DOI 10.1016/j.ymgme.2004.06.006; TIDBALL JG, 1995, J CELL SCI, V108, P2197; Toda N, 2005, PHARMACOL THERAPEUT, V106, P233, DOI 10.1016/j.pharmthera.2004.11.011; TOMODA T, 1991, ACTA HAEMATOL-BASEL, V86, P183; TSAI AG, 1989, MICROVASC RES, V37, P308, DOI 10.1016/0026-2862(89)90049-6; TSAI AG, 1991, INT J MICROCIRC, V10, P317; Uruno A, 2005, CIRCULATION, V112, P727, DOI 10.1161/CIRCULATIONAHA.104.500959; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; WELLER B, 1990, J NEUROL SCI, V100, P9, DOI 10.1016/0022-510X(90)90005-8; White R, 1997, EUR J PHARMACOL, V339, P157, DOI 10.1016/S0014-2999(97)01397-6; Winston BW, 1999, CLIN INVEST MED, V22, P236	61	98	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e806	10.1371/journal.pone.0000806	http://dx.doi.org/10.1371/journal.pone.0000806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726536	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455400023
J	Banjac, A; Perisic, T; Sato, H; Seiler, A; Bannai, S; Weiss, N; Kolle, P; Tschoep, K; Issels, RD; Daniel, PT; Conrad, M; Bornkamm, GW				Banjac, A.; Perisic, T.; Sato, H.; Seiler, A.; Bannai, S.; Weiss, N.; Koelle, P.; Tschoep, K.; Issels, R. D.; Daniel, P. T.; Conrad, M.; Bornkamm, G. W.			The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death	ONCOGENE			English	Article						cystine-glutamate exchange; glutathione metabolism; lipid peroxidation; redox regulation; system x(c)(-)	CYSTINE TRANSPORT ACTIVITY; BURKITT-LYMPHOMA CELLS; THIOREDOXIN REDUCTASE; GLUTATHIONE SYNTHESIS; GLUTAMATE TOXICITY; APOPTOSIS; INDUCTION; FIBROBLASTS; METABOLISM; INHIBITION	The glutathione-dependent system is one of the key systems regulating cellular redox balance, and thus cell fate. Cysteine, typically present in its oxidized form cystine in the extracellular space, is regarded as the rate-limiting substrate for glutathione (GSH) synthesis. Cystine is transported into cells by the highly specific amino-acid antiporter system x(c)(-). Since Burkitt's Lymphoma (BL) cells display limited uptake capacity for cystine, and are thus prone to oxidative stress-induced cell death, we stably expressed the substrate-specific subunit of system x(c)(-), xCT, in HH514 BL cells. xCT-overexpressing cells became highly resistant to oxidative stress, particularly upon GSH depletion. Contrary to previous predictions, the increase of intracellular cysteine did not affect the cellular GSH pool, but concomitantly boosted extracellular cysteine concentrations. Even though cells were depleted of bulk GSH, xCT overexpression maintained cellular integrity by protecting against lipid peroxidation, a very early event in cell death progression. Our results show that system x(c)(-) protects against oxidative stress not by elevating intracellular GSH levels, but rather creates a reducing extracellular environment by driving a highly efficient cystine/cysteine redox cycle. Our findings show that the cystine/cysteine redox cycle by itself must be viewed as a discrete major regulator of cell survival.	[Banjac, A.; Seiler, A.; Conrad, M.; Bornkamm, G. W.] GSF Forschungszentrum Umwelt & Gesundheit, Inst Klin Mol Biol & Tumor Genet, Munich, Germany; [Perisic, T.; Seiler, A.] Univ Tsukuba, Inst Basic Med Sci, Dept Biochem, Tsukuba, Ibaraki 305, Japan; [Weiss, N.; Koelle, P.] Univ Munich, Med Poliklin Innnenstadt, D-8000 Munich, Germany; [Tschoep, K.; Issels, R. D.] Univ Munich, GSF, Klin Kooperat Grp Hyperthermie, Med Clin 3, Munich, Germany; [Daniel, P. T.] Humboldt Univ, Med Klin Schwerpunkt Hamatol & Onkol, Berlin, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Tsukuba; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Humboldt University of Berlin	Conrad, M (corresponding author), GSF, Res Ctr, Inst Clin Mol Biol & Tumor Genet, Marchioninistr 25, D-81377 Munich, Germany.	marcus.conrad@gsf.de	Conrad, Marcus/E-8792-2015	Conrad, Marcus/0000-0003-1140-5612; Issels, Rolf/0000-0002-3494-6561				Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BANNAI S, 1982, J CELL PHYSIOL, V112, P265, DOI 10.1002/jcp.1041120216; Brielmeier M, 1998, NUCLEIC ACIDS RES, V26, P2082, DOI 10.1093/nar/26.9.2082; BROOME JD, 1973, J EXP MED, V138, P574, DOI 10.1084/jem.138.3.574; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; DROGE W, 1991, AM J MED, V91, P140; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; FALK MH, 1993, INT J CANCER, V55, P485, DOI 10.1002/ijc.2910550327; FalK MH, 1998, INT J CANCER, V75, P620, DOI 10.1002/(SICI)1097-0215(19980209)75:4<620::AID-IJC21>3.0.CO;2-B; Feussner A, 1997, EUR J CLIN CHEM CLIN, V35, P687; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Hattori H, 2005, BIOCHEM BIOPH RES CO, V337, P464, DOI 10.1016/j.bbrc.2005.09.076; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Jonas CR, 2002, FREE RADICAL BIO MED, V33, P1499, DOI 10.1016/S0891-5849(02)01081-X; Kuppner MC, 2003, BLOOD, V102, P3668, DOI 10.1182/blood-2003-05-1408; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Melino G, 2005, CELL DEATH DIFFER, V12, P1155, DOI 10.1038/sj.cdd.4401740; METCALF D, 1976, J IMMUNOL, V116, P635; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; NOVOGRODSKY A, 1979, P NATL ACAD SCI USA, V76, P4932, DOI 10.1073/pnas.76.10.4932; Okita C, 2004, BIOTECHNIQUES, V36, P418, DOI 10.2144/04363ST01; Okuno S, 2003, BRIT J CANCER, V88, P951, DOI 10.1038/sj.bjc.6600786; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shi ZZ, 2000, P NATL ACAD SCI USA, V97, P5101, DOI 10.1073/pnas.97.10.5101; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Sonoda Y, 2004, BBA-MOL CELL BIOL L, V1683, P22, DOI 10.1016/j.bbalip.2004.04.002; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Ye ZC, 1999, CANCER RES, V59, P4383	42	193	201	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1618	1628		10.1038/sj.onc.1210796	http://dx.doi.org/10.1038/sj.onc.1210796			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17828297	Bronze			2022-12-25	WOS:000253815800014
J	Kouloumenta, A; Mavroidis, M; Capetanaki, Y				Kouloumenta, Asimina; Mavroidis, Manolis; Capetanaki, Yassemi			Proper perinuclear localization of the TRIM-like protein myospryn requires its binding partner desmin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT CYTOSKELETON; HERMANSKY-PUDLAK-SYNDROME; MICE LACKING DESMIN; SKELETAL-MUSCLE; HEPATOCYTIC AUTOPHAGY; NULL MUTATION; OKADAIC ACID; KINASE-A; VIMENTIN; COMPLEX	Desmin, the muscle-specific intermediate filament protein, surrounds the Z disks and links the entire contractile apparatus to the sarcolemmal cytoskeleton, cytoplasmic organelles, and the nucleus. In an attempt to explore the molecular mechanisms of these associations, we performed a yeast two-hybrid screening of a cardiac cDNA library. We showed that the desmin amino-terminal domain (N-(1-103)) binds to a 413-kDa TRIM-like protein, myospryn, originally identified as the muscle-specific partner of dysbindin, a component of the (b)under bar>iogenesis of (l) under bar ysosome-(r) under bar elated (o) under bar rganelles (c) under bar omplex 1 (BLOC-1). Binding of desmin with myospryn was confirmed with glutathione S-transferase pulldown assays and coimmunoprecipitation experiments. Western blot analysis revealed that the complex immunoprecipitated by desmin antibodies, in addition to myospryn, contained the BLOC-1 components dysbindin and pallidin. Deletion analysis revealed that only the ( N-(1-103)) fragment of desmin binds to myospryn carboxyl terminus and that this association takes place through the 24-amino acid-long carboxyl-terminal end of the SPRY domain of myospryn. Using an antibody against the COOH terminus of myospryn, we demonstrated that myospryn colocalizes with desmin at the periphery of the nucleus, in close proximity to the endoplasmic reticulum, of mouse neonatal cardiomyocytes. In adult heart muscle, the two proteins colocalize, predominantly at intercalated disks and costameres. We also showed that myospryn colocalizes with lysosomes. Using desmin null hearts, we determined that desmin is required for both the proper perinuclear localization of myospryn, as well as the proper positioning of lysosomes, thus suggesting a potential role of desmin intermediate filaments in lysosomes and lysosome-related organelle biogenesis and/or positioning.	Acad Athens, Div Cell Biol, Ctr Basic Res, Biomed Res Fdn, Athens 11527, Greece	Academy of Athens	Capetanaki, Y (corresponding author), Acad Athens, Div Cell Biol, Ctr Basic Res, Biomed Res Fdn, Soranou Efesiou 4, Athens 11527, Greece.	ycapetanaki@bioacademy.gr		Mavroidis, Manolis/0000-0002-3870-3954				ALLEN RE, 1991, J CELL PHYSIOL, V149, P525, DOI 10.1002/jcp.1041490323; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Benson MA, 2004, J BIOL CHEM, V279, P10450, DOI 10.1074/jbc.M312664200; BLANKSON H, 1995, EXP CELL RES, V218, P522, DOI 10.1006/excr.1995.1187; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008; Gao YS, 2002, EUR J CELL BIOL, V81, P391, DOI 10.1078/0171-9335-00260; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gillard BK, 1998, EXP CELL RES, V242, P561, DOI 10.1006/excr.1998.4126; GILLARD BK, 1994, J CELL SCI, V107, P3545; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; HERRMANN H, 1989, DEVELOPMENT, V105, P279; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; Huizing M, 2000, TRAFFIC, V1, P823, DOI 10.1034/j.1600-0854.2000.011103.x; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606; Kuisk IR, 1996, DEV BIOL, V174, P1, DOI 10.1006/dbio.1996.0046; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LI H, 1994, J CELL BIOL, V124, P827, DOI 10.1083/jcb.124.5.827; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Milner DJ, 1999, J MOL CELL CARDIOL, V31, P2063, DOI 10.1006/jmcc.1999.1037; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; O'Neill A, 2002, MOL BIOL CELL, V13, P2347, DOI 10.1091/mbc.01-12-0576; Ralston E, 2006, J CELL PHYSIOL, V209, P874, DOI 10.1002/jcp.20780; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0; Styers ML, 2005, TRAFFIC, V6, P359, DOI 10.1111/j.1600-0854.2005.00286.x; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Swank RT, 2000, PIGM CELL RES, V13, P59, DOI 10.1034/j.1600-0749.13.s8.12.x; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Weitzer G, 1995, DEV BIOL, V172, P422, DOI 10.1006/dbio.1995.8070	48	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35211	35221		10.1074/jbc.M704733200	http://dx.doi.org/10.1074/jbc.M704733200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17872945	hybrid			2022-12-25	WOS:000251155200066
J	Brock, M; Fan, F; Mei, FC; Li, S; Gessner, C; Woods, VL; Cheng, X				Brock, Melissa; Fan, Fenghui; Mei, Fang C.; Li, Sheng; Gessner, Christopher; Woods, Virgil L., Jr.; Cheng, Xiaodong			Conformational analysis of Epac activation using amide hydrogen/deuterium exchange mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-DEUTERIUM EXCHANGE; DEPENDENT PROTEIN-KINASE; CAMP-BINDING DOMAINS; TERMINAL SRC KINASE; CYCLIC-AMP; REGULATORY SUBUNIT; II-BETA; STRUCTURAL DETERMINANTS; CELL-ADHESION; RI-ALPHA	Exchange proteins directly activated by cAMP ( Epac) play important roles in mediating the effects of cAMP through the activation of downstream small GTPases, Rap. To delineate the mechanism of Epac activation, we probed the conformation and structural dynamics of Epac using amide hydrogen/deuterium exchange and structural modeling. Our studies show that cAMP induces significant conformational changes that lead to a spatial rearrangement of the regulatory components of Epac and allows the exposure of the catalytic core for effector binding without imposing significant conformational change on the catalytic core. Homology modeling and comparative structural analyses of the cAMP binding domains of Epac and cAMP-dependent protein kinase ( PKA) lead to a model of Epac activation, in which Epac and PKA activation by cAMP employs the same underlying principle, although the detailed structural and conformational changes associated with Epac and PKA activation are significantly different.	Univ Calif San Diego, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA; Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brock, M (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Fan, Fenghui/A-2404-2011; Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	NCI NIH HHS [CA099835, CA118595] Funding Source: Medline; NIAID NIH HHS [AI022160, AI0220221] Funding Source: Medline; NIGMS NIH HHS [GM066170, GM037684] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA099835, R33CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R01GM037684] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Davidson W, 2004, BIOCHEMISTRY-US, V43, P11658, DOI 10.1021/bi0495073; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Derunes C, 2006, FEBS LETT, V580, P175, DOI 10.1016/j.febslet.2005.11.070; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Engen JR, 2001, ANAL CHEM, V73, p256A, DOI 10.1021/ac012452f; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Garcia RA, 2005, MOL PHARMACOL, V67, P1128, DOI 10.1124/mol.104.006346; Golynskiy M, 2007, J BIOL INORG CHEM, V12, P699, DOI 10.1007/s00775-007-0216-z; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; JOHNSON RS, 1994, PROTEIN SCI, V3, P2411, DOI 10.1002/pro.5560031224; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; Yu SN, 2004, BIOCHEMISTRY-US, V43, P1908, DOI 10.1021/bi0354435; Zawadzki KM, 2003, PROTEIN SCI, V12, P1980, DOI 10.1110/ps.03166903; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	59	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32256	32263		10.1074/jbc.M706231200	http://dx.doi.org/10.1074/jbc.M706231200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785454	hybrid			2022-12-25	WOS:000250480300048
J	Deshmukh, L; Tyukhtenko, S; Liu, JM; Fox, JEB; Qin, J; Vinogradova, O				Deshmukh, Lalit; Tyukhtenko, Sergiy; Liu, Jianmin; Fox, Joan E. B.; Qin, Jun; Vinogradova, Olga			Structural insight into the interaction between platelet integrin alpha(IIb)beta(3) and cytoskeletal protein skelemin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION; SEQUENCE; TITIN; REFINEMENT; MODULATION; ACTIVATION; EXPRESSION; COMPLEXES; MECHANISM; MOTIFS	Skelemin is a large cytoskeletal protein critical for cell morphology. Previous studies have suggested that its two-tandem immunoglobulin C2-like repeats (SkIgC4 and SkIgC5) are involved in binding to integrin beta(3) cytoplasmic tail (CT), providing a mechanism for skelemin to regulate integrin-mediated signaling and cell spreading. Using NMR spectroscopy, we have studied the molecular details of the skelemin IgC45 interaction with the cytoplasmic face of integrin alpha(IIb)beta(3). Here, we show that skelemin IgC45 domains form a complex not only with integrin beta(3) CT but also, surprisingly, with the integrin alpha(IIb) CT. Chemical shift mapping experiments demonstrate that both membrane-proximal regions of alpha(IIb) and beta(3) CTs are involved in binding to skelemin. NMR structural determinations, combined with homology modeling, revealed that SkIgC4 and SkIgC5 both exhibited a conserved Ig-fold and both repeats were required for effective binding to and attenuation of alpha(IIb)beta(3) cytoplasmic complex. These data provide the first molecular insight into how skelemin may interact with integrins and regulate integrin-mediated signaling and cell spreading.	Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, Storrs, CT 06269 USA; Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA	University of Connecticut; Cleveland Clinic Foundation	Vinogradova, O (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	olga.vinogradova@uconn.edu	Qin, Jun/D-5559-2009; Deshmukh, Lalit/C-5073-2015; Vinogradova, Olga/ABE-8367-2020	Vinogradova, Olga/0000-0001-5101-7361; Qin, Jun/0000-0002-2647-9270; TYUKHTENKO, SERGIY/0000-0002-0446-9979				AYMESOUTHGATE A, 1991, P NATL ACAD SCI USA, V88, P7973, DOI 10.1073/pnas.88.18.7973; Bates PA, 2001, PROTEINS, P39; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jung JW, 2005, J BIOCHEM MOL BIOL, V38, P550; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; NOGUCHI J, 1992, J BIOL CHEM, V267, P20302; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; PRICE MG, 1993, J BIOL CHEM, V268, P21800; Reddy KB, 1998, J BIOL CHEM, V273, P35039, DOI 10.1074/jbc.273.52.35039; Reddy KB, 2001, J BIOL CHEM, V276, P28300, DOI 10.1074/jbc.M102794200; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Steiner F, 1999, GENOMICS, V56, P78, DOI 10.1006/geno.1998.5682; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343	32	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32349	32356		10.1074/jbc.M704666200	http://dx.doi.org/10.1074/jbc.M704666200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804417	hybrid			2022-12-25	WOS:000250480300058
J	Hardman, RM; Stansfeld, PJ; Dalibalta, S; Sutcliffe, MJ; Mitcheson, JS				Hardman, Rachael M.; Stansfeld, Phillip J.; Dalibalta, Sarah; Sutcliffe, Michael J.; Mitcheson, John S.			Activation Gating of hERG potassium channels - S6 glycines are not required as gating hinges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S4-S5 LINKER; K+ CHANNEL; CRYSTAL-STRUCTURE; CONFORMATIONAL DYNAMICS; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; VOLTAGE SENSOR; GATE; PORE; HELICES	The opening of ion channels is proposed to arise from bending of the pore inner helices that enables them to pivot away from the central axis creating a cytosolic opening for ion diffusion. The flexibility of the inner helices is suggested to occur either at a conserved glycine located adjacent to the selectivity filter (glycine gating hinge) and/or at a second site occupied by glycine or proline containing motifs. Sequence alignment with other K+ channels shows that hERG possesses glycine residues (Gly(648) and Gly(657)) at each of these putative hinge sites. In apparent contrast to the hinge hypotheses, substitution of both glycine residues for alanine causes little effect on either the voltage-dependence or kinetics of channel activation, and open state block by intracellular blockers. Substitution of the glycines with larger hydrophobic residues causes a greater propensity for the channel to open. We propose that in contrast to Shaker the pore of hERG is intrinsically more stable in the open than the closed conformation and that substitution at Gly648 or Gly657 further shifts the gating equilibrium to favor the open state. Molecular dynamics simulations indicate the S6 helices of hERG are inherently flexible, even in the absence of the glycine residues. Thus hERG activation gating exhibits important differences to other K-V channels. Our findings indicate that the hERG inner helix glycine residues are required for the tight packing of the channel helices and that the flexibility afforded by glycine or proline residues is not universally required for activation gating.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Oxford, Dept Biochem, Struct Bioinformat & Computat Biochem Unit, Oxford OX1 3QU, England; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7ND, Lancs, England	University of Leicester; University of Oxford; University of Manchester	Mitcheson, JS (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.	jm109@le.ac.uk	Dalibalta, Sarah/AAJ-7479-2021; Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011	Dalibalta, Sarah/0000-0003-2288-9210; Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Mitcheson, John/0000-0002-2683-2839; Sutcliffe, Mike/0000-0003-0414-1700	MRC [G0001361] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C511305/1] Funding Source: Medline; Medical Research Council [G0001361] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Arcangeli Annarosa, 2005, V266, P225; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Claydon TW, 2003, J BIOL CHEM, V278, P50654, DOI 10.1074/jbc.M308183200; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faraldo-Gomez JD, 2002, EUR BIOPHYS J BIOPHY, V31, P217, DOI 10.1007/s00249-002-0207-5; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Grottesi A, 2005, BIOCHEMISTRY-US, V44, P14586, DOI 10.1021/bi0510429; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Perry M, 2006, MOL PHARMACOL, V69, P509, DOI 10.1124/mol.105.016741; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Recanatini M, 2005, MED RES REV, V25, P133, DOI 10.1002/med.20019; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Shrivastava IH, 2000, BIOPHYS J, V78, P79, DOI 10.1016/S0006-3495(00)76574-X; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	56	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31972	31981		10.1074/jbc.M705835200	http://dx.doi.org/10.1074/jbc.M705835200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823114	hybrid			2022-12-25	WOS:000250480300018
J	Saijou, E; Itoh, T; Kim, KW; Iemura, SI; Natsume, T; Miyajima, A				Saijou, Eiko; Itoh, Tohru; Kim, Kyung-Woon; Iemura, Shun-Ichiro; Natsume, Tohru; Miyajima, Atsushi			Nucleocytoplasmic shuttling of the zinc finger protein EZI is mediated by importin-7-dependent nuclear import and CRM1-independent export mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LOCALIZATION SIGNAL; TRANSPORT RECEPTORS; BINDING-PROTEINS; CYTOPLASM; PATHWAY; BETA; IDENTIFICATION; DOMAIN; CRM1	Nucleocytoplasmic translocation constitutes a foundation for nuclear proteins to exert their proper functions and hence for various biological reactions to occur normally in eukaryotic cells. We reported previously that EZI/Zfp467, a 12 zinc finger motif-containing protein, localizes predominantly in the nucleus, yet the underlying mechanism still remains elusive. Here we constructed a series of mutant forms of EZI and examined their subcellular localization. The results delineated a non-canonical nuclear localization signal in the region covering the 9th to the 12th zinc fingers, which was necessary for nuclear accumulation of EZI as well as sufficient to confer nuclear localizing ability to a heterologous protein. We also found that the N-terminal domain of EZI is necessary for its nuclear export, the process of which was not sensitive to the CRM1 inhibitor leptomycin B. An interaction proteomics approach and the following co-immunoprecipitation experiments identified the nuclear import receptor importin-7 as a molecule that associated with EZI and, importantly, short interfering RNA-mediated knockdown of importin-7 expression completely abrogated nuclear accumulation of EZI. Taken together, these results identify EZI as a novel cargo protein for importin-7 and demonstrate a nucleocytoplasmic shuttling mechanism that is mediated by importin-7-dependent nuclear localization and CRM1-independent nuclear export.	Univ Tokyo, Lab Cell Growth & Differentiat, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Kohtoh Ku, Tokyo 1350064, Japan; Japan Sci & Technol Agcy, Kawaguchi Shi, Saitama 3320012, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Itoh, T (corresponding author), Univ Tokyo, Lab Cell Growth & Differentiat, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	itohru@iam.u-tokyo.ac.jp	Itoh, Tohru/GYQ-8698-2022; Kim, Kyung-Woon/F-7287-2018; Natsume, Tohru/M-7627-2018	Itoh, Tohru/0000-0002-6579-1638; Kim, Kyung-Woon/0000-0003-0225-9684; Natsume, Tohru/0000-0002-1510-2582				Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Bruening W, 1996, FEBS LETT, V393, P41, DOI 10.1016/0014-5793(96)00853-8; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Nakayama K, 2002, EMBO J, V21, P6174, DOI 10.1093/emboj/cdf596; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; NISHI K, 1994, J BIOL CHEM, V269, P6320; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Yu Z, 1998, J ENDOCRINOL, V159, P53, DOI 10.1677/joe.0.1590053; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	36	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32327	32337		10.1074/jbc.M706793200	http://dx.doi.org/10.1074/jbc.M706793200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848547	hybrid			2022-12-25	WOS:000250480300056
J	Wiertz, FGM; Richter, OMH; Ludwig, B; de Vries, S				Wiertz, Frank G. M.; Richter, Oliver-Matthias H.; Ludwig, Bernd; de Vries, Simon			Kinetic resolution of a tryptophan-radical intermediate in the reaction cycle of Paracoccus denitrificans cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN CHARACTERIZATION; FREEZE-HYPERQUENCHING MHQ; HIGH-FIELD EPR; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; RHODOBACTER-SPHAEROIDES; RIBONUCLEOTIDE REDUCTASE; OXYGEN ACTIVATION; CATALYTIC CYCLE; PROTON PUMP	The catalytic mechanism, electron transfer coupled to proton pumping, of heme-copper oxidases is not yet fully understood. Microsecond freeze-hyperquenching single turnover experiments were carried out with fully reduced cytochrome aa(3) reacting with O-2 between 83 mu s and 6 ms. Trapped intermediates were analyzed by low temperature UV-visible, X-band, and Q-band EPR spectroscopy, enabling determination of the oxidation-reduction kinetics of Cu-A, heme a, heme a(3), and of a recently detected tryptophan radical (Wiertz, F. G. M., Richter, O. M. H., Cherepanov, A. V., MacMillan, F., Ludwig, B., and de Vries, S. (2004) FEBS Lett. 575, 127-130). Cu-B and heme a3 were EPR silent during all stages of the reaction. Cu-A and heme a are in electronic equilibrium acting as a redox pair. The reduction potential of Cu-A is 4.5 mV lower than that of heme a. Both redox groups are oxidized in two phases with apparent half-lives of 57 mu s and 1.2 ms together donating a single electron to the binuclear center in each phase. The formation of the heme a3 oxoferryl species PR (maxima at 430 nm and 606 nm) was completed in similar to 130 mu s, similar to the first oxidation phase of Cu-A and heme a. The intermediate F (absorbance maximum at 571 nm) is formed from PR and decays to a hitherto undetected intermediate named F-W*. F-W* harbors a tryptophan radical, identified by Q-band EPR spectroscopy as the tryptophan neutral radical of the strictly conserved Trp-272 (Trp-272*). The Trp-272* populates to 4-5% due to its relatively low rate of formation (t(1/2) = 1.2 ms) and rapid rate of breakdown (t(1/2) = 60 mu s), which represents electron transfer from Cu-A/ heme a to Trp-272*. The formation of the Trp-272* constitutes the major rate-determining step of the catalytic cycle. Our findings show that Trp-272 is a redox-active residue and is in this respect on an equal par to the metallo-centers of the cytochrome c oxidase. Trp-272 is the direct reductant either to the heme a3 oxoferryl species or to Cu-B(2+). The potential role of Trp-272 in proton pumping is discussed.	Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; JW Goethe Univ, Inst Biochem & Cluster Excellence Macromol Comple, D-60438 Frankfurt, Germany	Delft University of Technology; Goethe University Frankfurt	de Vries, S (corresponding author), Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands.	s.devries@tudelft.nl						Adelroth P, 1997, BIOCHEMISTRY-US, V36, P13824, DOI 10.1021/bi9629079; ADELROTH P, 1995, BIOCHEMISTRY-US, V34, P2844; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Baldwin J, 2000, J AM CHEM SOC, V122, P12195, DOI 10.1021/ja001278u; Ballou D P, 1978, Methods Enzymol, V54, P85; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; BLACKBURN NJ, 1994, BIOCHEMISTRY-US, V33, P10401, DOI 10.1021/bi00200a022; BLAIR DF, 1985, J AM CHEM SOC, V107, P7389, DOI 10.1021/ja00311a029; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Brzezinski P, 2004, TRENDS BIOCHEM SCI, V29, P380, DOI 10.1016/j.tibs.2004.05.008; Budiman K, 2004, BIOCHEMISTRY-US, V43, P11709, DOI 10.1021/bi048898i; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; Einarsdottir O, 2004, BBA-BIOENERGETICS, V1655, P263, DOI 10.1016/j.bbabio.2003.07.011; ESPE MP, 1995, BIOCHEMISTRY-US, V34, P7593, DOI 10.1021/bi00023a005; FABIAN M, 1995, BIOCHEMISTRY-US, V34, P13802, DOI 10.1021/bi00042a011; Farver O, 2006, BIOPHYS J, V90, P2131, DOI 10.1529/biophysj.105.075440; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Florens L, 2001, BIOCHEMISTRY-US, V40, P7491, DOI 10.1021/bi0101188; HAN S, 1990, P NATL ACAD SCI USA, V87, P2491, DOI 10.1073/pnas.87.7.2491; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; HANSSON O, 1982, EMBO J, V1, P1295, DOI 10.1002/j.1460-2075.1982.tb01313.x; HENDLER RW, 1991, BIOPHYS J, V60, P415, DOI 10.1016/S0006-3495(91)82067-7; Hendriks J, 2000, BBA-BIOENERGETICS, V1459, P266, DOI 10.1016/S0005-2728(00)00161-4; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kass H, 2000, J PHYS CHEM B, V104, P5362, DOI 10.1021/jp993133j; Kitagawa T, 2000, J INORG BIOCHEM, V82, P9, DOI 10.1016/S0162-0134(00)00155-0; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Lu S, 2005, J RAMAN SPECTROSC, V36, P359, DOI 10.1002/jrs.1314; LUDWIG B, 1986, METHOD ENZYMOL, V126, P153; MacMillan F, 2006, FEBS LETT, V580, P1345, DOI 10.1016/j.febslet.2006.01.054; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Nyquist RM, 2003, P NATL ACAD SCI USA, V100, P8715, DOI 10.1073/pnas.1530408100; Ogura T, 2004, BBA-BIOENERGETICS, V1655, P290, DOI 10.1016/j.bbabio.2003.10.013; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pecoraro C, 2001, BIOCHEMISTRY-US, V40, P9695, DOI 10.1021/bi010115v; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pilet E, 2004, P NATL ACAD SCI USA, V101, P16198, DOI 10.1073/pnas.0405032101; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; PROSHLYAKOV DA, 1994, J BIOL CHEM, V269, P29385; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Ribacka C, 2005, BIOCHEMISTRY-US, V44, P16502, DOI 10.1021/bi0511336; Rich PR, 2002, BBA-BIOENERGETICS, V1554, P137, DOI 10.1016/S0005-2728(02)00228-1; Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0; Rigby SEJ, 2000, BIOCHEMISTRY-US, V39, P5921, DOI 10.1021/bi992614q; Ruitenberg M, 2002, NATURE, V417, P99, DOI 10.1038/417099a; Salomonsson L, 2005, P NATL ACAD SCI USA, V102, P17624, DOI 10.1073/pnas.0505431102; Schmidt B, 2004, BBA-BIOENERGETICS, V1655, P248, DOI 10.1016/j.bbabio.2003.11.008; Schmidt B, 2003, P NATL ACAD SCI USA, V100, P15539, DOI 10.1073/pnas.2633243100; Siletsky SA, 2006, BBA-BIOENERGETICS, V1757, P1122, DOI 10.1016/j.bbabio.2006.07.003; Sucheta A, 1997, BIOCHEMISTRY-US, V36, P554, DOI 10.1021/bi962422k; Sucheta A, 1998, BIOCHEMISTRY-US, V37, P17905, DOI 10.1021/bi981092w; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Svistunenko DA, 2004, BBA-BIOENERGETICS, V1655, P372, DOI 10.1016/j.bbabio.2003.06.006; Szundi I, 2004, BIOCHEMISTRY-US, V43, P15746, DOI 10.1021/bi049408p; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; Verkhovsky MI, 2006, BBA-BIOENERGETICS, V1757, P401, DOI 10.1016/j.bbabio.2006.05.026; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Wiertz FGM, 2004, FEBS LETT, V575, P127, DOI 10.1016/j.febslet.2004.08.048; Wiertz FGM, 2006, BIOCHEM SOC T, V34, P136, DOI 10.1042/BST0340136; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; WIKSTROM M, 2003, BIOCHIM BIOPHYS ACTA, V1757, P1047; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P1110, DOI 10.1016/j.bbabio.2006.06.004; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028; Zaslavsky D, 1999, BIOCHEMISTRY-US, V38, P2307, DOI 10.1021/bi9822832	76	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31580	31591		10.1074/jbc.M705520200	http://dx.doi.org/10.1074/jbc.M705520200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761680	hybrid			2022-12-25	WOS:000250309200050
J	Matouk, IJ; DeGroot, N; Mezan, S; Ayesh, S; Abu-Iail, R; Hochberg, A; Galun, E				Matouk, Imad J.; DeGroot, Nathan; Mezan, Shaul; Ayesh, Suhail; Abu-Iail, Rasha; Hochberg, Abraham; Galun, Eithan			The H19 Non-Coding RNA Is Essential for Human Tumor Growth	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; IMPRINTED H19; HEPATOCELLULAR-CARCINOMA; BIALLELIC EXPRESSION; CELL-PROLIFERATION; CANCER; KINASE; MARKER; IDENTIFICATION	Background. Mutations and epigenetic aberrant signaling of growth factors pathways contribute to carcinogenesis. Recent studies reveal that non-coding RNAs are controllers of gene expression. H19 is an imprinted gene that demonstrates maternal monoallelic expression without a protein product; although its expression is shut off in most tissues postnatally, it is reactivated during adult tissue regeneration and tumorigenesis. Moreover, H19 is highly expressed in liver metastasis derived from a range of carcinomas. The objective of this study is to explore the role of H19 in carcinogenesis, and to determine its identification as an anti-tumor target. Methodology/Principle Findings. By controlling oxygen pressure during tumor cell growth and H19 expression levels, we investigated the role of H19 expression in vitro and in vivo in hepatocellular (HCC) and bladder carcinoma. Hypoxia upregulates the level of H19 RNA. Ablations of tumorigenicity of HCC and bladder carcinomas in vivo are seen by H19 knockdown which also significantly abrogates anchorage-independent growth after hypoxia recovery, while ectopic H19 expression enhances tumorigenic potential of carcinoma cells in vivo. Knocking-down H19 message in hypoxic stress severely diminishes p57(kip2) induction. We identified a number of potential downstream targets of H19 RNA, including angiogenin and FGF18. Conclusions. H19 RNA harbors pro-tumorigenic properties, thus the H19 gene behaves as an oncogene and may serve as a potential new target for anti-tumor therapy.	[Galun, Eithan] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Matouk, Imad J.; DeGroot, Nathan; Mezan, Shaul; Ayesh, Suhail; Abu-Iail, Rasha; Hochberg, Abraham] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Galun, E (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	eithang@hadassah.org.il	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702	Israeli Science Foundation; Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center; Blum; Harold Grinspoon; Horowitz; Wolfson Foundation;  [LSHB-CT-2004-512034];  [LSHB-CT-2005-018961]	Israeli Science Foundation(Israel Science Foundation); Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center; Blum; Harold Grinspoon; Horowitz; Wolfson Foundation; ; 	This work is supported by the Israeli Science Foundation, the Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center and through grants LSHB-CT-2004-512034 (MOLEDA) and LSHB-CT-2005-018961 (INTHER). Additional support was provided through grants from the Blum, the Harold Grinspoon, the Horowitz and the Wolfson Foundations.	Adriaenssens E, 2002, EXP CELL RES, V275, P215, DOI 10.1006/excr.2002.5500; Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; Ariel I, 1998, J CLIN PATHOL-MOL PA, V51, P21, DOI 10.1136/mp.51.1.21; Ariel L, 2004, MOL CARCINOGEN, V41, P69, DOI 10.1002/mc.20046; Ayesh S, 2002, MOL CARCINOGEN, V35, P63, DOI 10.1002/mc.10075; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Coulouarn C, 2006, HEPATOLOGY, V44, P1003, DOI 10.1002/hep.21293; Datta K, 2004, CANCER RES, V64, P456, DOI 10.1158/0008-5472.CAN-03-2706; Dugimont T, 1998, ONCOGENE, V16, P2395, DOI 10.1038/sj.onc.1201742; Dugimont T, 1995, BIOL CELL, V85, P117, DOI 10.1016/0248-4900(96)85272-5; Elkin M, 1998, CARCINOGENESIS, V19, P2095, DOI 10.1093/carcin/19.12.2095; ELKIN M, 1995, FEBS LETT, V374, P57, DOI 10.1016/0014-5793(95)01074-O; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fellig Y, 2004, BIOCHEM BIOPH RES CO, V321, P269, DOI 10.1016/j.bbrc.2004.06.148; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Graveel CR, 2001, ONCOGENE, V20, P2704, DOI 10.1038/sj.onc.1204391; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iizuka N, 2002, CANCER RES, V62, P3939; Ito Y, 2003, CANCER RES, V63, P6651; Ito Y, 2001, ONCOLOGY-BASEL, V61, P221, DOI 10.1159/000055378; Jiang Z, 2004, AM J CLIN PATHOL, V122, P275, DOI 10.1309/EJUYUQPEX1MG68MK; Kaplan JL, 2003, J RECONSTR MICROSURG, V19, P63, DOI 10.1055/s-2003-37807; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; LIU Z, 2006, DEV BIOL; Lottin S, 2002, ONCOGENE, V21, P1625, DOI 10.1038/sj.onc.1205233; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Manoharan H, 2003, MOL CARCINOGEN, V38, P40, DOI 10.1002/mc.10144; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Matouk I, 2005, CANC THER, V3, P249; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Meyer AM, 2004, CARCINOGENESIS, V25, P1517, DOI 10.1093/carcin/bgh150; MOLL R, 1995, AM J PATHOL, V147, P1383; Moreno MJ, 2006, GLIA, V53, P845, DOI 10.1002/glia.20345; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ogushi T, 2005, CANCER RES, V65, P3700, DOI 10.1158/0008-5472.CAN-04-3497; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Poon TCW, 2006, GASTROENTEROLOGY, V131, P1262, DOI 10.1053/j.gastro.2006.08.014; PUISIEUX A, 1991, CANCER RES, V51, P6185; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Scott RE, 2005, DIFFERENTIATION, V73, P294; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Smith P, 2006, CELL CYCLE, V5, P1262, DOI 10.4161/cc.5.12.2813; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Triest BV, 2000, CLIN CANCER RES, V6, P1063; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Wald O, 2006, J IMMUNOL, V177, P6983, DOI 10.4049/jimmunol.177.10.6983; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	79	530	565	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e845	10.1371/journal.pone.0000845	http://dx.doi.org/10.1371/journal.pone.0000845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786216	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500028
J	Dawson-Scully, K; Armstrong, GAB; Kent, C; Robertson, RM; Sokolowski, MB				Dawson-Scully, Ken; Armstrong, Gary A. B.; Kent, Clement; Robertson, R. Meldrum; Sokolowski, Marla B.			Natural Variation in the Thermotolerance of Neural Function and Behavior due to a cGMP-Dependent Protein Kinase	PLOS ONE			English	Article							HEAT-SHOCK; SMOOTH-MUSCLE; TEMPERATURE; CANTHARIDIN; ADAPTATION; CURRENTS; LOCUST; GENE	Although it is acknowledged that genetic variation contributes to individual differences in thermotolerance, the specific genes and pathways involved and how they are modulated by the environment remain poorly understood. We link natural variation in the thermotolerance of neural function and behavior in Drosophila melanogaster to the foraging gene (for, which encodes a cGMP-dependent protein kinase (PKG)) as well as to its downstream target, protein phosphatase 2A (PP2A). Genetic and pharmacological manipulations revealed that reduced PKG (or PP2A) activity caused increased thermotolerance of synaptic transmission at the larval neuromuscular junction. Like synaptic transmission, feeding movements were preserved at higher temperatures in larvae with lower PKG levels. In a comparative assay, pharmacological manipulations altering thermotolerance in a central circuit of Locusta migratoria demonstrated conservation of this neuroprotective pathway. In this circuit, either the inhibition of PKG or PP2A induced robust thermotolerance of neural function. We suggest that PKG and therefore the polymorphism associated with the allelic variation in for may provide populations with natural variation in heat stress tolerance. for's function in behavior is conserved across most organisms, including ants, bees, nematodes, and mammals. PKG's role in thermotolerance may also apply to these and other species. Natural variation in thermotolerance arising from genes involved in the PKG pathway could impact the evolution of thermotolerance in natural populations.	[Dawson-Scully, Ken; Kent, Clement; Sokolowski, Marla B.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Armstrong, Gary A. B.; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	University of Toronto; University Toronto Mississauga; Queens University - Canada	Sokolowski, MB (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	msokolow@utm.utoronto.ca	Robertson, Robert M/B-2482-2009; Kent, Clement F./B-9982-2008	Robertson, Robert M/0000-0002-2666-7861; Kent, Clement F./0000-0003-4994-0098; Sokolowski, Marla/0000-0002-7462-8007; Armstrong, Gary/0000-0003-4613-8817	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research; National Science and Engineering Council	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from The Heart and Stroke Foundation of Canada for KD-S, The Canadian Institutes of Health Research for KD-S, MBS and CK, and by the National Science and Engineering Council for RMR and GABA.	Armstrong GAB, 2006, J NEUROSCI, V26, P12118, DOI 10.1523/JNEUROSCI.3347-06.2006; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bressin S, 2000, J EXP BIOL, V203, P2511; CAIRNS J, 1994, J BIOL CHEM, V269, P9176; Dawson-Scully K, 1998, NEUROREPORT, V9, P2589, DOI 10.1097/00001756-199808030-00030; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; DEBELLE JS, 1989, GENETICS, V123, P157; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Glazer JL, 2005, AM FAM PHYSICIAN, V71, P2133; GRAZIANO MJ, 1988, MOL PHARMACOL, V33, P706; GRIDER JR, 1993, AM J PHYSIOL, V264, pG334, DOI 10.1152/ajpgi.1993.264.2.G334; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Karunanithi S, 1999, J NEUROSCI, V19, P4360; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Newman AEM, 2003, J INSECT PHYSIOL, V49, P1039, DOI 10.1016/j.jinsphys.2003.08.001; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Ramirez JM, 1999, J NEUROPHYSIOL, V81, P795, DOI 10.1152/jn.1999.81.2.795; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SOKOLOWSKI MB, 1982, ANIM BEHAV, V30, P1252, DOI 10.1016/S0003-3472(82)80218-2; SOKOLOWSKI MB, 1989, J INSECT BEHAV, V2, P829, DOI 10.1007/BF01049403; Spiewok S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P188, DOI 10.1086/498181; Tryba AK, 2004, J NEUROPHYSIOL, V92, P2844, DOI 10.1152/jn.00752.2003; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; White RE, 2002, CARDIOVASC RES, V53, P650, DOI 10.1016/S0008-6363(01)00428-X; WHYARD S, 1986, J COMP PHYSIOL B, V156, P813, DOI 10.1007/BF00694255; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760	33	49	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e773	10.1371/journal.pone.0000773	http://dx.doi.org/10.1371/journal.pone.0000773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712421	Green Published, gold			2022-12-25	WOS:000207455300021
J	Campanero, MR; Herrero, A; Calvo, V				Campanero, M. R.; Herrero, A.; Calvo, V.			The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites	ONCOGENE			English	Article						GADD45 gamma; HDAC inhibitor; TSA; Oct; NF-Y	TRANSCRIPTION FACTORS OCT-1; GROWTH-ARREST; CELL-GROWTH; P53-INDEPENDENT INDUCTION; GENOTOXIC STRESS; CANCER CELLS; GENE GADD45; DNA-DAMAGE; PROMOTER; RECRUITMENT	The GADD45 gamma protein is a potential tumor suppressor whose expression is reduced in several tumors. However, very little is known about the regulation of its expression. We have determined that the most relevant region of its promoter lies between nucleotides -112 and -54, relative to the transcription start site. Putative Oct and NF-Y elements were found in this region and factors belonging to these families interacted with these elements in vitro and with the promoter in vivo. Mutation of these elements reduced the basal activity of the promoter, suggesting that both sites are essential for basal expression. These factors interact with chromatin modifying proteins and we found that histone deacetylase 1 or silencing mediator for retinoid and thyroid hormone receptor overexpression reduced the basal activity of the promoter. In contrast, forced expression of the histone acetylase protein PCAF or cell treatment with the HDAC inhibitor trichostatin A increased GADD45 gamma mRNA levels and induced GADD45 gamma promoter activity through its Oct and NF-Y elements. Moreover, ectopic expression of a dominant-negative version of NF-YA strongly inhibited trichostatin A-induced activation of the promoter. Our data strongly suggest that inhibition of deacetylase activity could potentially be used for treatment of tumors where GADD45 gamma expression is reduced.	[Herrero, A.; Calvo, V.] Univ Autonoma Madrid, Fac Med, CSIC, E-28029 Madrid, Spain; [Campanero, M. R.] Univ Autonoma Madrid, Inst Invest Biomed, CSIC, Madrid, Spain; [Herrero, A.; Calvo, V.] Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Calvo, V (corresponding author), Univ Autonoma Madrid, Fac Med, CSIC, Arzobiospo Morcillo 4, E-28029 Madrid, Spain.	vcalvo@iib.uam.es	HERRERO, ANA/GOV-3351-2022; Campanero, Miguel R/A-4052-2013; Calvo, Victor/L-5024-2014	HERRERO, ANA/0000-0001-8065-2225; Campanero, Miguel R/0000-0003-1410-8621; Calvo, Victor/0000-0002-5913-7058				Balliet AG, 2003, DNA CELL BIOL, V22, P457, DOI 10.1089/104454903322247334; BEADLING C, 1993, P NATL ACAD SCI USA, V90, P2719, DOI 10.1073/pnas.90.7.2719; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Campanero MR, 1999, MOL CELL BIOL, V19, P8442; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Chung HK, 2003, J CLIN ENDOCR METAB, V88, P3913, DOI 10.1210/jc.2002-022031; Constance CM, 1996, MOL CELL BIOL, V16, P3878; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Della Ragione F, 2001, FEBS LETT, V499, P199, DOI 10.1016/S0014-5793(01)02539-X; Fan W, 1999, ONCOGENE, V18, P6573, DOI 10.1038/sj.onc.1203054; HINKLEY C, 1992, MOL CELL BIOL, V12, P4400, DOI 10.1128/MCB.12.10.4400; Hirose T, 2003, ONCOGENE, V22, P7762, DOI 10.1038/sj.onc.1207091; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Jiang F, 2004, MOL CELL ENDOCRINOL, V213, P121, DOI 10.1016/j.mce.2003.10.050; Jin SQ, 2001, ONCOGENE, V20, P2683, DOI 10.1038/sj.onc.1204390; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jung N, 2000, EUR J BIOCHEM, V267, P6180, DOI 10.1046/j.1432-1327.2000.01692.x; Kakizawa T, 2001, J BIOL CHEM, V276, P9720, DOI 10.1074/jbc.M008531200; Kojima S, 1999, FEBS LETT, V446, P313, DOI 10.1016/S0014-5793(99)00234-3; Liebermann DA, 2003, BLOOD CELL MOL DIS, V31, P213, DOI 10.1016/S1079-9796(03)00160-8; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; Mariadason JM, 2000, CANCER RES, V60, P4561; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nakayama K, 1999, J BIOL CHEM, V274, P24766, DOI 10.1074/jbc.274.35.24766; Osborne A, 2001, MOL CELL BIOL, V21, P6495, DOI 10.1128/MCB.21.19.6495-6506.2001; Park SH, 2002, J BIOL CHEM, V277, P5168, DOI 10.1074/jbc.M106451200; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Sun LH, 2003, MOL BIOL REP, V30, P249, DOI 10.1023/A:1026370726763; Takahashi S, 2001, CANCER RES, V61, P1187; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; ZHAN QM, 1994, CANCER RES, V54, P2755; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885; Zhang W, 2001, INT J ONCOL, V18, P749; Zhang X, 2002, J CLIN ENDOCR METAB, V87, P1262, DOI 10.1210/jc.87.3.1262	50	22	23	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2008	27	9					1263	1272		10.1038/sj.onc.1210735	http://dx.doi.org/10.1038/sj.onc.1210735			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17724474				2022-12-25	WOS:000253407000008
J	Ogata, N; Kawaguchi, H; Chung, U; Roth, SI; Segre, GV				Ogata, Naoshi; Kawaguchi, Hiroshi; Chung, Ung-il; Roth, Sanford I.; Segre, Gino V.			Continuous activation of G alpha(q) in osteoblasts results in osteopenia through impaired osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY G-PROTEIN; PARATHYROID-HORMONE; BONE-FORMATION; PHOSPHOLIPASE-C; TRANSGENIC MICE; ALPHA-SUBUNITS; GROWTH-PLATE; CELLS; EXPRESSION; RECEPTOR	We explored the role of G alpha(q)- mediated signaling on skeletal homeostasis by selectively expressing a constitutively active G alpha(q) ( mutation of Q209L) in osteoblasts. Continuous signaling via G alpha(q) in mouse osteoblastic MC3T3- E1 cells impaired differentiation. Mice that expressed the constitutively active G alpha(q) transgene in cells of the osteoblast lineage exhibited severe osteopenia in cortical and trabecular bones. Osteoblast number, bone volume, and trabecular thickness were reduced in transgenic mice, but the osteoclasts were unaffected. Osteoblasts from transgenic mice showed impaired differentiation and matrix formation. In the presence of a protein kinase C inhibitor GF109203X, this impairment was not seen, indicating mediation by the protein kinase C pathway. We propose that continuous activation of the G alpha(q) signal in osteoblasts plays a crucial, previously unrecognized role in bone formation.	Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA	University of Tokyo; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp			NIDDK NIH HHS [DK47034, DK11794] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOWLER WB, 1999, FRONT BIOSCI, V3, P769; BREUR GJ, 1991, J ORTHOPAED RES, V9, P348, DOI 10.1002/jor.1100090306; BREUR GJ, 1994, ANAT RECORD, V239, P255, DOI 10.1002/ar.1092390304; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458; KEMBER NF, 1979, J THEOR BIOL, V78, P365, DOI 10.1016/0022-5193(79)90336-9; KEMBER NF, 1978, CELL TISSUE KINET, V11, P477, DOI 10.1111/j.1365-2184.1978.tb00820.x; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P283; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; MONIERFAUGERE MC, 1998, METABOLIC BONE DIS, P230; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Pantschenko AG, 2005, J BONE MINER RES, V20, P1414, DOI 10.1359/JBMR.050315; PARTRIDGE NC, 1989, MOL ENDOCRINOL, V3, P232, DOI 10.1210/mend-3-2-232; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Quarles LD, 1996, J BONE MINER RES, V11, P1375; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; SPIEGEL AM, 1993, J CLIN INVEST, V92, P1119, DOI 10.1172/JCI116680; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Swarthout JT, 2001, J BIOL CHEM, V276, P7586, DOI 10.1074/jbc.M007400200; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WEINSTEIN LS, PRINCIPLES BONE BIOL, P877; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; WU DQ, 1992, J BIOL CHEM, V267, P1811	34	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35757	35764		10.1074/jbc.M611902200	http://dx.doi.org/10.1074/jbc.M611902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17823129	hybrid			2022-12-25	WOS:000251458100037
J	Hanoulle, X; Melchior, A; Sibille, N; Parent, B; Denys, A; Wieruszeski, JM; Horvath, D; Allain, F; Lippens, G; Landrieu, I				Hanoulle, Xavier; Melchior, Aurelie; Sibille, Nathalie; Parent, Benjamin; Denys, Agnes; Wieruszeski, Jean-Michel; Horvath, Dragos; Allain, Fabrice; Lippens, Guy; Landrieu, Isabelle			Structural and functional characterization of the interaction between cyclophilin B and a heparin-derived oligosaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD T-LYMPHOCYTES; MOLECULAR-STRUCTURE DETERMINATION; RESIDUAL DIPOLAR COUPLINGS; X-RAY-STRUCTURE; DYNAMIC PROPERTIES; BINDING-SITES; CELL-SURFACE; XPLOR-NIH; PROTEIN; CD147	The chemotaxis and integrin-mediated adhesion of T lymphocytes triggered by secreted cyclophilin B (CypB) depend on interactions with both cell surface heparan sulfate proteoglycans (HSPG) and the extracellular domain of the CD147 membrane receptor. Here, we use NMR spectroscopy to characterize the interaction of CypB with heparin-derived oligosaccharides. Chemical shift perturbation experiments allowed the precise definition of the heparan sulfate (HS) binding site of CypB. The N-terminal extremity of CypB, which contains a consensus sequence for heparin-binding proteins was modeled on the basis of our experimental NMR data. Because the HS binding site extends toward the CypB catalytic pocket, we measured its peptidylprolyl cis-trans isomerase (PPIase) activity in the absence or presence of a HS oligosaccharide toward a CD147-derived peptide. We report the first direct evidence that CypB is enzymatically active on CD147, as it is able to accelerate the cis/trans isomerization of the Asp(179)-Pro(180) bond in a CD147-derived peptide. However, HS binding has no significant influence on this PPIase activity. We thus conclude that the glycanic moiety of HSPG serves as anchor for CypB at the cell surface, and that the signal could be transduced by CypB via its PPIase activity toward CD147.	Univ Sci & Technol Lille, CNRS, UMR 8576, IFR 147,Unite Glycobiol Struct & Fonctionnelle, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Landrieu, I (corresponding author), Univ Sci & Technol Lille, CNRS, UMR 8576, IFR 147,Unite Glycobiol Struct & Fonctionnelle, F-59655 Villeneuve Dascq, France.	isabelle.landrieu@univ-lille1.fr	Horvath, Dragos/W-9789-2018; Landrieu, Isabelle/AAF-8495-2019; Sibille, Nathalie/K-2905-2015; HANOULLE, Xavier/HHN-4815-2022; Hanoulle, Xavier/AAK-7236-2021	Horvath, Dragos/0000-0003-0173-5714; Landrieu, Isabelle/0000-0002-4883-2637; Sibille, Nathalie/0000-0001-8145-6795; Hanoulle, Xavier/0000-0002-3755-2680; Allain, Fabrice/0000-0002-4484-6302				Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Allain F, 1996, BIOCHEM J, V317, P565, DOI 10.1042/bj3170565; ALLAIN F, 1994, J BIOL CHEM, V269, P16537; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Angulo J, 2004, CHEMBIOCHEM, V5, P55, DOI 10.1002/cbic.200300696; Angulo J, 2005, GLYCOBIOLOGY, V15, P1008, DOI 10.1093/glycob/cwi091; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carpentier M, 1999, J BIOL CHEM, V274, P10990, DOI 10.1074/jbc.274.16.10990; Carpentier M, 2002, BIOCHEMISTRY-US, V41, P5222, DOI 10.1021/bi015951j; Conrad H. E., 1998, HEPARIN BINDING PROT; Delehedde M., 2002, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V1, P89, DOI 10.2174/1568014023355935; Denys A, 1998, BIOCHEM J, V336, P689, DOI 10.1042/bj3360689; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Galat A, 1999, ARCH BIOCHEM BIOPHYS, V371, P149, DOI 10.1006/abbi.1999.1434; Gama CI, 2005, CURR OPIN CHEM BIOL, V9, P609, DOI 10.1016/j.cbpa.2005.10.003; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hakansson S, 2003, BIOCHEMISTRY-US, V42, P8999, DOI 10.1021/bi020715+; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Kaplan J.I., 1980, NMR CHEM EXCHANGING; KE HM, 1992, J MOL BIOL, V228, P539, DOI 10.1016/0022-2836(92)90841-7; Koharudin LMI, 2003, J MAGN RESON, V163, P228, DOI 10.1016/S1090-7807(03)00149-6; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Otting G, 2000, J BIOMOL NMR, V16, P343, DOI 10.1023/A:1008372630606; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sokolskaja E, 2006, CURR OPIN MICROBIOL, V9, P404, DOI 10.1016/j.mib.2006.06.011; SPIK G, 1991, J BIOL CHEM, V266, P10735; SPITZFADEN C, 1994, J BIOMOL NMR, V4, P463, DOI 10.1007/BF00156614; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; Vanpouille C, 2004, BIOCHEM J, V382, P733, DOI 10.1042/BJ20031453; VANPOUILLE C, 2007, J BIOL CHEM; WISHART DS, 1994, J BIOMOL NMR, V4, P171; XU Q, 1992, J BIOL CHEM, V267, P11968; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Yurchenko V, 2001, BIOCHEM BIOPH RES CO, V288, P786, DOI 10.1006/bbrc.2001.5847	51	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34148	34158		10.1074/jbc.M706353200	http://dx.doi.org/10.1074/jbc.M706353200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855358	hybrid			2022-12-25	WOS:000251145700029
J	Hessel, S; Eichinger, A; Isken, A; Amengual, J; Hunzelmann, S; Hoeller, U; Elste, V; Hunziker, W; Goralczyk, R; Oberhauser, V; von Lintig, J; Wyss, A				Hessel, Susanne; Eichinger, Anne; Isken, Andrea; Amengual, Jaume; Hunzelmann, Silke; Hoeller, Ulrich; Elste, Volker; Hunziker, Willi; Goralczyk, Regina; Oberhauser, Vitus; von Lintig, Johannes; Wyss, Adrian			CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; RETINOIC-ACID-RECEPTOR; DIET-INDUCED OBESITY; PEROXISOME PROLIFERATOR; INSULIN-RESISTANCE; PPAR-GAMMA; ENZYMATIC CLEAVAGE; NUCLEAR RECEPTORS; BETA,BETA-CAROTENE 15,15'-DIOXYGENASE; PROVITAMIN-A	Carotenoids are currently investigated regarding their potential to lower the risk of chronic disease and to combat vitamin A deficiency in humans. These plant-derived compounds must be cleaved and metabolically converted by intrinsic carotenoid oxygenases to support the panoply of vitamin A-dependent physiological processes. Two different carotenoid-cleaving enzymes were identified in mammals, the classical carotenoid-15,15' -oxygenase (CMO1) and a putative carotenoid-9',10'-oxygenase (CMO2). To analyze the role of CMO1 in mammalian physiology, here we disrupted the corresponding gene by targeted homologous recombination in mice. On a diet providing beta-carotene as major vitamin A precursor, vitamin A levels fell dramatically in several tissues examined. Instead, this mouse mutant accumulated the provitamin in large quantities ( e. g. as seen by an orange coloring of adipose tissues). Besides impairments in beta-carotene metabolism, CMO1 deficiency more generally interfered with lipid homeostasis. Even on a vitamin A-sufficient chow, CMO1(-/-) mice developed a fatty liver and displayed altered serum lipid levels with elevated serum unesterified fatty acids. Additionally, this mouse mutant was more susceptible to high fat diet-induced impairments in fatty acid metabolism. Quantitative reverse transcription-PCR analysis revealed that the expression of peroxisome proliferator-activated receptor gamma-regulated marker genes related to adipogenesis was elevated in visceral adipose tissues. Thus, our study identifies CMO1 as the key enzyme for vitamin A production and provides evidence for a role of carotenoids as more general regulators of lipid metabolism.	Univ Freiburg, Dept Neurobiol & Anim Physiol, Inst Biol 1, D-79104 Freiburg, Germany; DSM Nutr Prod Ltd, R&D Human Nutr & Hlth, CH-4002 Basel, Switzerland; Chemin Musee, Frimorfo SA, CH-1700 Fribourg, Switzerland	University of Freiburg; DSM NV	von Lintig, J (corresponding author), Univ Freiburg, Dept Neurobiol & Anim Physiol, Inst Biol 1, Hauptstr 1, D-79104 Freiburg, Germany.	lintig@biologie.uni-freiburg.de; adrian.wyss@dsm.com		von Lintig, Johannes/0000-0002-2079-2143	NEI NIH HHS [R01 EY020551] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY020551] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Blaner WS, 2001, J AM ACAD DERMATOL, V45, pS129, DOI 10.1067/mjd.2001.113714; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Krinsky N, 2001, NUTR REV, V59, P309; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Lee MY, 2002, DIABETES, V51, P3400; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; LILLIE RD, 1977, CONNS BIOL STAINS, P66; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PARKER RS, 1989, J NUTR, V119, P101, DOI 10.1093/jn/119.1.101; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Shin DJ, 2002, MOL CELL ENDOCRINOL, V195, P39, DOI 10.1016/S0303-7207(02)00215-0; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Simoni D, 2001, CURR PHARM DESIGN, V7, P1823, DOI 10.2174/1381612013397168; SU NY, 1991, SOCIOBIOLOGY, V19, P349; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; WOLF G, 1995, NUTR REV, V53, P134, DOI 10.1111/j.1753-4887.1995.tb01537.x; Wolf G, 2001, NUTR REV, V59, P116; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zaripheh S, 2006, J NUTR, V136, P932, DOI 10.1093/jn/136.4.932; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	55	193	202	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33553	10.1074/jbc.M706763200	http://dx.doi.org/10.1074/jbc.M706763200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855355	hybrid			2022-12-25	WOS:000250840200036
J	Mueller, GM; Kashlan, OB; Bruns, JB; Maarouf, AB; Aridor, M; Kleyman, TR; Hughey, RP				Mueller, Gunhild M.; Kashlan, Ossama B.; Bruns, James B.; Maarouf, Ahmad B.; Aridor, Meir; Kleyman, Thomas R.; Hughey, Rebecca P.			Epithelial sodium channel exit from the endoplasmic reticulum is regulated by a signal within the carboxyl cytoplasmic domain of the alpha subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CELL-SURFACE EXPRESSION; NA+ SELF-INHIBITION; N-LINKED GLYCANS; LIDDLES-SYNDROME; A6 CELLS; FUNCTIONAL EXPRESSION; MEMBRANE TOPOLOGY; APICAL MEMBRANE; GAMMA-SUBUNIT	Epithelial sodium channels ( ENaCs) are assembled in the endoplasmic reticulum ( ER) from alpha, beta, and gamma subunits, each with two transmembrane domains, a large extracellular loop, and cytoplasmic amino and carboxyl termini. ENaC maturation involves transit through the Golgi complex where Asn-linked glycans are processed to complex type and the channel is activated by furin-dependent cleavage of the alpha and gamma subunits. To identify signals in ENaC for ER retention/retrieval or ER exit/ release, chimera were prepared with the interleukin alpha subunit (Tac) and each of the three cytoplasmic carboxyl termini of mouse ENaC (Tac- Ct) or with gamma-glutamyltranspeptidase and each of the three cytoplasmic amino termini (Nt-GGT). By monitoring acquisition of endoglycosidase H resistance after metabolic labeling, we found no evidence of ER retention of any chimera when compared with control Tac or GGT, but we did observe enhanced exit of Tac-alpha Ct when compared with Tac. ER exit of ENaC was assayed after metabolic labeling by following the appearance of cleaved alpha as cleaved alpha subunit, but not non-cleaved alpha, is endoglycosidase H-resistant. Interestingly ER exit of epitope-tagged and truncated alpha(alpha Delta 624-699-V5) with full-length beta gamma was similar to wild type alpha(+beta gamma), whereas ER exit of ENaC lacking the entire cytoplasmic carboxyl tail of alpha (alpha Delta 613-699- V5+beta gamma) was significantly reduced. Subsequent analysis of ER exit for ENaCs with mutations within the intervening sequence (613)HRFRSRYWSPG(623) within the context of the full-length alpha revealed that mutation alpha RSRYW620 to AAAAA significantly reduced ER exit. These data indicate that ER exit of ENaC is regulated by a signal within the alpha subunit carboxyl cytoplasmic tail.	Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			NIDDK NIH HHS [F32 DK066883, R01 DK062318, DK65161] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062318, R01DK065161, F32DK066883, R56DK065161] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bruns JB, 2003, AM J PHYSIOL-RENAL, V285, pF600, DOI 10.1152/ajprenal.00095.2003; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Cormier JH, 2005, MOL CELL, V19, P717, DOI 10.1016/j.molcel.2005.08.029; de la Rosa DA, 2004, J GEN PHYSIOL, V124, P395, DOI 10.1085/jgp.200409120; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Eaton Douglas C, 2004, Proc Am Thorac Soc, V1, P10, DOI 10.1513/pats.2306008; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; Joyce-Brady M, 2001, J BIOL CHEM, V276, P9468, DOI 10.1074/jbc.M004352200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; May A, 1997, J AM SOC NEPHROL, V8, P1813; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; Poland PA, 1997, GLYCOCONJUGATE J, V14, P89, DOI 10.1023/A:1018569100438; Prince LS, 1998, BIOCHEM J, V336, P705, DOI 10.1042/bj3360705; RENARD S, 1994, J BIOL CHEM, V269, P12981; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Volk KA, 2001, J BIOL CHEM, V276, P43887, DOI 10.1074/jbc.M108714200; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200	72	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33475	10.1074/jbc.M707339200	http://dx.doi.org/10.1074/jbc.M707339200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855354	hybrid			2022-12-25	WOS:000250840200028
J	Zavros, Y; Waghray, M; Tessier, A; Bai, LC; Todisco, A; Gumucio, DL; Samuelson, LC; Dlugosz, A; Merchant, JL				Zavros, Yana; Waghray, Meghna; Tessier, Arthur; Bai, Longchuan; Todisco, Andrea; Gumucio, Deborah L.; Samuelson, Linda C.; Dlugosz, Andrzej; Merchant, Juanita L.			Reduced pepsin a processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-EXTENDED GASTRIN; TRANSGENIC MICE; ACID-SECRETION; DEFICIENT MICE; COLONIC PROLIFERATION; HELICOBACTER-PYLORI; CANCER-EPIDEMIOLOGY; OXYNTIC ATROPHY; ALPHA-SUBUNIT; LONG	Sonic hedgehog (Shh) is not only essential to the development of the gastrointestinal tract, but is also necessary to maintain the characteristic acid-secreting phenotype of the adult stomach. Gastrin is the only hormone capable of stimulating gastric acid and is thus required to maintain functional parietal cells. We have shown previously that gastrin-null mice display gastric atrophy and metaplasia prior to progression to distal, intestinal-type gastric cancer. Because reduced levels of Shh peptide correlate with gastric atrophy, we examined whether gastrin regulates Shh expression in parietal cells. We show here that gastrin stimulates Shh gene expression and acid-dependent processing of the 45-kDa Shh precursor to the 19-kDa secreted peptide in primary parietal cell cultures. This cleavage was blocked by the proton pump inhibitor omeprazole and mediated by the acid-activated protease pepsin A. Pepsin A was also the protease responsible for processing Shh in tissue extracts from human stomach. By contrast, extracts prepared from neoplastic gastric mucosa had reduced levels of pepsin A and did not process Shh. Therefore processing of Shh in the normal stomach is hormonally regulated, acid-dependent, and mediated by the aspartic protease pepsin A. Moreover parietal cell atrophy, a known preneoplastic lesion, correlates with loss of Shh processing.	Univ Michigan, Dept Internal Med Gastroenterol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Merchant, JL (corresponding author), BSRB, 109 Zina Pitcher Pl,BSRB Rm 2051, Ann Arbor, MI 48109 USA.	merchanj@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184	NIDDK NIH HHS [P01 DK062041-05S1, P30 DK034933-219001, P30-DK32533, R01 DK061410-04, R01 DK061410, R01 DK056882, P30-DK34933, P30 DK034933, R01-DK61410, P01-DK62041, P01 DK062041] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056882, P01DK062041, R01DK061410, P30DK034933] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Canfield V, 1996, P NATL ACAD SCI USA, V93, P2431, DOI 10.1073/pnas.93.6.2431; Chen D, 2000, GASTROENTEROLOGY, V119, P756, DOI 10.1053/gast.2000.16480; CORREA P, 1975, LANCET, V2, P58; CORREA P, 1992, CANCER RES, V52, P6735; Dimmler A, 2003, LAB INVEST, V83, P1829, DOI 10.1097/01.LAB.0000101729.25140.0C; El-Zimaity HMT, 2002, CANCER-AM CANCER SOC, V94, P1428, DOI 10.1002/cncr.10375; Friis-Hansen L, 1998, AM J PHYSIOL-GASTR L, V274, pG561, DOI 10.1152/ajpgi.1998.274.3.G561; Fruton JS, 2002, Q REV BIOL, V77, P127, DOI 10.1086/340729; Goetz JA, 2002, BIOESSAYS, V24, P157, DOI 10.1002/bies.10056; Goldenring JR, 2000, GASTROENTEROLOGY, V118, P1080, DOI 10.1016/S0016-5085(00)70361-1; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; JOHNSON RL, 1995, CELL, V81, P313, DOI 10.1016/0092-8674(95)90381-X; Judd LM, 2005, J GASTROEN HEPATOL, V20, P1266, DOI 10.1111/j.1440-1746.2005.03867.x; KAISE M, 1995, J BIOL CHEM, V270, P18637, DOI 10.1074/jbc.270.31.18637; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; Koh TJ, 1999, J CLIN INVEST, V103, P1119, DOI 10.1172/JCI4910; Koh TJ, 1997, GASTROENTEROLOGY, V113, P1015, DOI 10.1016/S0016-5085(97)70199-9; Kokkola A, 2005, WORLD J GASTROENTERO, V11, P1032, DOI 10.3748/wjg.v11.i7.1032; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; LIN XL, 1989, J BIOL CHEM, V264, P4482; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Nomura AMY, 2005, J INFECT DIS, V191, P2075, DOI 10.1086/430353; Nomura S, 2005, AM J PHYSIOL-GASTR L, V288, pG362, DOI 10.1152/ajpgi.00160.2004; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rembiasz K, 2005, DIGEST DIS SCI, V50, P474, DOI 10.1007/s10620-005-2461-8; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Shao JS, 1998, AM J PHYSIOL-GASTR L, V274, pG62, DOI 10.1152/ajpgi.1998.274.1.G62; Shiotani A, 2005, AM J GASTROENTEROL, V100, P581, DOI 10.1111/j.1572-0241.2005.41001.x; Shiotani A, 2005, INT J CANCER, V115, P463, DOI 10.1002/ijc.20852; SOLL AH, 1985, AM J PHYSIOL, V248, pG569, DOI 10.1152/ajpgi.1985.248.5.G569; SOLL AH, 1978, J CLIN INVEST, V61, P370, DOI 10.1172/JCI108947; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Stepan V, 2005, J BIOL CHEM, V280, P15700, DOI 10.1074/jbc.M413037200; Suzuki H, 2005, J PATHOL, V206, P186, DOI 10.1002/path.1763; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van den Brink GR, 2002, GUT, V51, P628, DOI 10.1136/gut.51.5.628; WALSH JH, 1990, DIGESTION, V47, P11, DOI 10.1159/000200509; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 2002, GASTROENTEROLOGY, V122, P119, DOI 10.1053/gast.2002.30298; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	50	53	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33265	33274		10.1074/jbc.M707090200	http://dx.doi.org/10.1074/jbc.M707090200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17872943	hybrid			2022-12-25	WOS:000250840200006
J	Browning, C; Martin, E; Loch, C; Wurtz, JM; Moras, D; Stote, RH; Dejaegere, AP; Billas, IML				Browning, Christopher; Martin, Elyette; Loch, Caroline; Wurtz, Jean-Marie; Moras, Dino; Stote, Roland H.; Dejaegere, Annick P.; Billas, Isabelle M. L.			Critical role of desolvation in the binding of 20-hydroxyecdysone to the ecdysone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GAS-PHASE; HETERODIMERIC COMPLEX; MOLECULAR REPLACEMENT; AQUEOUS-SOLUTION; MANDUCA-SEXTA; FREE-ENERGIES; ULTRASPIRACLE; PROTEINS; METAMORPHOSIS	The insect steroid hormone 20-hydroxyecdysone (20E) binds to its cognate nuclear receptor composed of the ecdysone receptor (EcR) and Ultraspiracle (USP) and triggers the main developmental transitions, in particular molting and metamorphosis. We present the crystal structure of the ligand-binding domains of EcR/USP in complex with 20E at 2.4 A resolution and compare it with published structures of EcR/USP bound to ponasterone A (ponA). ponA is essentially identical to 20E but lacks the 25-OH group of 20E. The structure of 20E-bound EcR indicates that an additional hydrogen bond is formed compared with the ponA-bound receptor, yet, paradoxically, ponA has a significantly higher affinity for EcR than 20E. Theoretical studies based on docking and free energy methods lead to a rationale for understanding the difference in binding affinities between 20E and ponA. Results of the calculations indicate that the favorable contribution from the extra H-bond made by 25-OH of 20E is counterbalanced by its larger desolvation cost compared with that of ponA. The contribution of 25-OH to the binding affinity is further compared with those of 20- and 22-OH groups. Ligands that lack the 20- or 22-OH group are indeed known to bind less favorably to EcR than 20E, an effect opposite to that observed for ponA. The results indicate that their respective contributions to receptor-ligand complex stability reside mostly in their different contributions to solvation/desolvation. Together, the data demonstrate the critical role of ligand desolvation in determining binding affinity, with general implications for the binding of hormones to their cognate nuclear receptors.	IGBMC, Dept Biol & Genom Struct, F-67400 Illkirch Graffenstaden, France; INSERM, U596, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg 1, Fac Sci Vie, F-67000 Strasbourg, France; Univ Strasbourg 1, Inst Chim Strasbourg, Mol Biophys Lab, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dejaegere, AP (corresponding author), IGBMC, Dept Biol & Genom Struct, 1 Rue Laurent Fries, F-67400 Illkirch Graffenstaden, France.	annick@igbmc.u-strasbg.fr	Billas, Isabelle M.L./I-2790-2016; Wurtz, Jean-Marie/P-4652-2016	Billas, Isabelle M.L./0000-0003-2323-4208; Wurtz, Jean-Marie/0000-0003-2963-8617				Billas IML, 2005, VITAM HORM, V73, P101, DOI 10.1016/S0083-6729(05)73004-1; Billas IML, 2003, NATURE, V426, P91, DOI 10.1038/nature02112; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carmichael JA, 2005, J BIOL CHEM, V280, P22258, DOI 10.1074/jbc.M500661200; Champlin DT, 1998, DEVELOPMENT, V125, P269; Champlin DT, 1998, DEVELOPMENT, V125, P2009; CRAMER CJ, 1994, J AM CHEM SOC, V116, P3892, DOI 10.1021/ja00088a027; Crittenden DL, 2005, J PHYS CHEM A, V109, P2971, DOI 10.1021/jp045233h; DAVIS ME, 1991, COMPUT PHYS COMMUN, V62, P187, DOI 10.1016/0010-4655(91)90094-2; DEJAEGERE A, 1994, J CHEM SOC FARADAY T, V90, P1763, DOI 10.1039/ft9949001763; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Dinan L, 1999, J COMPUT AID MOL DES, V13, P185, DOI 10.1023/A:1008052320014; Fabian L, 2002, ACTA CRYSTALLOGR B, V58, P710, DOI 10.1107/S0108768102005608; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Hakansson K, 1996, INT J BIOL MACROMOL, V18, P189, DOI 10.1016/0141-8130(95)01068-8; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; LAPENNA S, 2007, J INSECT SCI, V57, P32; Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riddiford LM, 2001, VITAM HORM, V60, P1; Rizzo RC, 2006, J CHEM THEORY COMPUT, V2, P128, DOI 10.1021/ct050097l; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Trindle C, 2003, J PHYS CHEM A, V107, P6236, DOI 10.1021/jp034598j; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200	53	54	56	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32924	32934		10.1074/jbc.M705559200	http://dx.doi.org/10.1074/jbc.M705559200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848566	Green Published, hybrid			2022-12-25	WOS:000250625400041
J	Chen, YR; Chen, CL; Pfeiffer, DR; Zweier, JL				Chen, Yeong-Renn; Chen, Chwen-Lih; Pfeiffer, Douglas R.; Zweier, Jay L.			Mitochondrial complex II in the post-ischemic heart - Oxidative injury and the role of protein S-glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-REDUCTASE; REDOX SIGNAL-TRANSDUCTION; OXYGEN-FREE RADICALS; SUCCINATE-DEHYDROGENASE; NITRIC-OXIDE; RHODOBACTER-SPHAEROIDES; ELECTRON-TRANSPORT; HYDROGEN-PEROXIDE; SUBUNIT-IV; QUINONE OXIDOREDUCTASES	Mitochondrial superoxide (O-2(radical-anion)) is an important mediator of ischemia/ reperfusion ( I/ R) injury. The O-2(radical-anion) generated in mitochondria also acts as a redox signal triggering cellular apoptosis. The enzyme succinate ubiquinone reductase ( SQR or complex II) is one of the major mitochondrial components hosting regulatory thiols. Here the intrinsic protein S- glutathionylation ( PrSSG) at the 70- kDa FAD- binding subunit of SQR was detected in rat heart and in isolated SQR using an anti- GSH monoclonal antibody. When rats were subjected to 30 min of coronary ligation followed by 24 h of reperfusion, the electron transfer activity ( ETA) of SQR in post- ischemic myocardium was significantly decreased by 41.5 +/- 2.9%. The PrSSGs of SQR- 70 kDa were partially or completely eliminated in post- ischemic myocardium obtained from in vivo regional I/ R hearts or isolated global I/ R hearts, respectively. These results were further confirmed by using isolated succinate cytochrome c reductase ( complex II + complex III). In the presence of succinate, O-2(radical-anion) was generated and oxidized the SQR portion of SCR, leading to a 60 - 70% decrease in its ETA. The gel band of the S- glutathionylated SQR 70- kDa polypeptide was cut out and digested with trypsin, and the digests were subjected to liquid chromatography/ tandem mass spectrometry analysis. One cysteine residue, Cys(90), was involved in S- glutathionylation. These results indicate that the glutathione-binding domain, (77)AAFGLSEAGFNTACVTK(93) ( where underline indicates Cys90), is susceptible to redox change induced by oxidative stress. Furthermore, in vitro S- glutathionylation of purified SQR resulted in enhanced SQR- derived electron transfer efficiency and decreased formation of the 70- kDa- derived protein thiyl radical induced by O-2(radical-anion).Thus, the decreasing S- glutathionylation and ETA in mitochondrial complex II are marked during myocardial ischemia/ reperfusion. This redox- triggered impairment of complex II occurs in the post- ischemic heart and should be useful to identify disease pathogenesis related to reactive oxygen species- induced mitochondrial dysfunction.	Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Mol & Cellular Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, YR (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 607, 473 W 12th Ave, Columbus, OH 43210 USA.	yeong-renn.chen@osumc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL083237] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Altschuld R A, 1996, EXS, V76, P87; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; BIRCHMACHIN MA, 1992, J BIOL CHEM, V267, P11553; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; CHEN YR, 1994, BIOCHEMISTRY-US, V33, P10207, DOI 10.1021/bi00199a050; CHEN YR, 1995, J BIOL CHEM, V270, P11496, DOI 10.1074/jbc.270.19.11496; Chen YR, 2006, J BIOL CHEM, V281, P13159, DOI 10.1074/jbc.M513627200; Chen YR, 2004, FREE RADICAL BIO MED, V37, P1591, DOI 10.1016/j.freeradbiomed.2004.07.013; Chen YR, 1996, J BIOL CHEM, V271, P2057, DOI 10.1074/jbc.271.4.2057; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Detweiler CD, 2002, FREE RADICAL BIO MED, V33, P364, DOI 10.1016/S0891-5849(02)00895-X; Di Lisa F, 1998, BBA-BIOENERGETICS, V1366, P69, DOI 10.1016/S0005-2728(98)00121-2; Doliba NM, 1999, J MOL CELL CARDIOL, V31, P543, DOI 10.1006/jmcc.1998.0890; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Ferrari C, 1996, ANNU REV FLUID MECH, V28, P1; FERRARI R, 1995, AM J CARDIOL, V76, pB17; Ferrari R, 1998, AM J CARDIOL, V82, p2K, DOI 10.1016/S0002-9149(98)00531-1; FERRARI R, 1994, ADV EXP MED BIOL, V366, P99; Ferrari R, 1992, Am J Cardiovasc Pathol, V4, P103; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hatefi Y, 1978, Methods Enzymol, V53, P11; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; KENNEY WC, 1975, J BIOL CHEM, V250, P3089; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; LEE GY, 1995, J BIOL CHEM, V270, P6193, DOI 10.1074/jbc.270.11.6193; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shiva S, 2004, BIOCHEM J, V379, P359, DOI 10.1042/BJ20031758; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; VERCESI A, 1978, J BIOL CHEM, V253, P6379; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1; Welter R, 1996, ARCH BIOCHEM BIOPHYS, V331, P9, DOI 10.1006/abbi.1996.0276; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; YU L, 1982, J BIOL CHEM, V257, P2016; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; ZWEIER JL, 1991, J BIOL CHEM, V266, P20296; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	67	192	195	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32640	32654		10.1074/jbc.M702294200	http://dx.doi.org/10.1074/jbc.M702294200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848555	hybrid			2022-12-25	WOS:000250625400013
J	Kou, RQ; Michel, T				Kou, Ruqin; Michel, Thomas			Epinephrine regulation of the endothelial nitric-oxide synthase - Roles of RAC1 and beta(3)-adrenergic receptors in endothelial no signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; ADRENERGIC-RECEPTORS; CELL MIGRATION; HEART-FAILURE; IN-VITRO; ACTIVATION; PHOSPHORYLATION; AKT; STIMULATION; PATHWAYS	beta- Adrenergic receptors ( beta AR) play an important role in vasodilation, but the mechanisms whereby adrenergic pathways regulate the endothelial isoform of nitric- oxide synthase ( eNOS) are incompletely understood. We found that epinephrine significantly increases eNOS activity in cultured bovine aortic endothelial cells ( BAEC). Epinephrine- dependent eNOS activation was accompanied by an increase in phosphorylation of eNOS at Ser(1179) and with decreased eNOS phosphorylation at the inhibitory phosphoresidues Ser(116) and Thr(497). Epinephrine promoted activation of the small G protein Rac1 and also led to the activation of protein kinase A. All of these responses to epinephrine in BAEC were blocked by the beta(3)AR blocker SR59230A. We transfected and validated duplex small interfering RNA ( siRNA) constructs to selectively " knock down" specific signaling proteins in BAEC. siRNA- mediated knockdown of Rac1 completely blocked all beta(3)AR signaling to eNOS and also abrogated epinephrine- dependent cAMP- dependent protein kinase ( PKA) and Akt activation. However, siRNA- mediated knockdown of PKA did not affect Rac1 activation by epinephrine but did attenuate Akt activation by epinephrine. These findings indicate that Rac1 is an upstream regulator of beta(3)AR signaling to PKA and to eNOS and identify a novel beta(3)AR -> Rac1 -> PKA -> Akt pathway in endothelium. We exploited the p21- activated kinase pulldown assay to identify proteins associated with activated Rac1 and found that epinephrine stimulated the association of eNOS with Rac1; epinephrine- stimulated eNOS- Rac1 interactions were blocked by the beta(3)AR antagonist SR59230A. Co- transfection of eNOS cDNA with constitutively active Rac1 enhanced beta(3)AR- promoted eNOS- Rac1 association; co- transfection of eNOS with dominant negative Rac1 completely blocked the eNOS- Rac1 association. We also found that epinephrine-induced Rac1 -> PKA -> Akt pathway mediates beta(3)AR-mediated endothelial cell migration. Taken together, our data establish that the small G protein Rac1 is a key regulator of beta(3)AR signaling in cultured aortic endothelial cells with potentially important implications for the pathways involved in adrenergic modulation of eNOS pathways in the vascular wall.	Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Michel, T (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Thorn Bldg,Rm 1210A,75 Francis ST, Boston, MA 02115 USA.	tmichel@research.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 48743, HL 46457] Funding Source: Medline; NIGMS NIH HHS [GM 36259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACIC F, 1992, METAB BRAIN DIS, V7, P125, DOI 10.1007/BF01000158; Balligand JL, 2000, ACTA CLIN BELG, V55, P209, DOI 10.1080/17843286.2000.11754298; Balligand JL, 1997, ARTERIOSCL THROM VAS, V17, P1846, DOI 10.1161/01.ATV.17.10.1846; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; Brum PC, 2006, AN ACAD BRAS CIENC, V78, P485, DOI 10.1590/S0001-37652006000300009; BRYAN RM, 1995, AM J PHYSIOL-HEART C, V269, pH1171, DOI 10.1152/ajpheart.1995.269.3.H1171; BUSCONI L, 1994, J BIOL CHEM, V269, P25016; Chen XH, 2007, CIRC J, V71, P574, DOI 10.1253/circj.71.574; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Dessy C, 2005, CIRCULATION, V112, P1198, DOI 10.1161/CIRCULATIONAHA.104.532960; Dessy C, 2004, CIRCULATION, V110, P948, DOI 10.1161/01.CIR.0000139331.85766.AF; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eckhart AD, 2001, J PHARMACOL EXP THER, V299, P1; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Ferro A, 2004, BRIT J PHARMACOL, V143, P397, DOI 10.1038/sj.bjp.0705933; Ferro A, 1999, BRIT J PHARMACOL, V126, P1872, DOI 10.1038/sj.bjp.0702512; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; Gurdal HG, 2005, BRIT J PHARMACOL, V145, P203, DOI 10.1038/sj.bjp.0706177; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; JONES CJH, 1993, CIRCULATION, V87, P1264, DOI 10.1161/01.CIR.87.4.1264; KENDALL MJ, 1989, J CARDIOVASC PHARM, V14, pS4, DOI 10.1097/00005344-198906147-00003; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087; LIAO JK, 1992, CIRC RES, V70, P1018, DOI 10.1161/01.RES.70.5.1018; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Pott C, 2006, PHARMAZIE, V61, P255; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Saucerman JJ, 2006, ANN NY ACAD SCI, V1080, P348, DOI 10.1196/annals.1380.026; Steinle JJ, 2003, J BIOL CHEM, V278, P20681, DOI 10.1074/jbc.M300368200; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH704, DOI 10.1152/ajpheart.01076.2003	41	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32719	32729		10.1074/jbc.M706815200	http://dx.doi.org/10.1074/jbc.M706815200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855349	hybrid			2022-12-25	WOS:000250625400020
J	Meyer, V; Damveld, RA; Arentshorst, M; Stahl, U; van den Hondel, CAMJJ; Ram, AFJ				Meyer, Vera; Damveld, Robbert A.; Arentshorst, Mark; Stahl, Ulf; van den Hondel, Cees A. M. J. J.; Ram, Arthur F. J.			Survival in the presence of antifungals - Genome-wide expression profiling of aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; MAP-KINASE; TRANSCRIPTIONAL RESPONSE; CHITIN SYNTHASES; PLASMA-MEMBRANE; STRESS-RESPONSE; DOWN-REGULATION; ENCODING GENES	How yeast cells respond to cell wall stress is relatively well however, how filamentous fungi cope with cell wall is largely unexplored. Here we report the first transcriptome analysis of Aspergillus niger exposed to the antifungal caspofungin, an inhibitor of beta-1,3-glucan synthesis, fenpropimorph, which inhibits ergosterol synthesis. The of sublethal drug concentrations allowed A. niger to to the stress conditions and to continue growth by the of new polarity axes and formation of new germ By comparing the expression profile between caspofungin-exposed and nonexposed A. niger germlings, we identified a of 172 responsive genes out of 14,509 open reading frames on the Affymetrix microarray chips. Among 165 up-regulated genes, mainly genes predicted to function in (i) cell wall and remodeling, (ii) cytoskeletal organization, (iii) signaling, and (iv) oxidative stress response were affected. Fenpropimorph modulated expression of 43 genes, of which 41 enhanced expression. Here, genes predicted to function (i) membrane reconstruction, (ii) lipid signaling, (iii) cell wall and (iv) oxidative stress response were identified. analyses of selected genes were used to confirm the analyses. The results further show that expression of agsA gene encoding an alpha-1,3-glucan synthase is up-regulated by both compounds. Using two PagsA-GFP reporter of A. niger and subjecting them to 16 different antifungal including caspofungin and fenpropimorph, we show that agsA is specifically activated by compounds directly or indirectly with cell wall biosynthesis.	Berlin Univ Technol, Inst Biotechnol, Dept Genet & Microbiol, D-13355 Berlin, Germany; Leiden Univ, Inst Biol, Dept Biol Mol, NL-2333 AL Leiden, Netherlands	Technical University of Berlin; Leiden University; Leiden University - Excl LUMC	Meyer, V (corresponding author), Berlin Univ Technol, Inst Biotechnol, Dept Genet & Microbiol, Gustav Meyer Allee 25, D-13355 Berlin, Germany.	v.meyer@lb.tu-berlin.de	Ram, Arthur FJ/S-4648-2017	Ram, Arthur FJ/0000-0002-2487-8016; Van den Hondel, Kees/0000-0003-4782-2725; Meyer, Vera/0000-0002-2298-2258				Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Alonso-Monge R, 2001, MOL MICROBIOL, V41, P717, DOI 10.1046/j.1365-2958.2001.02549.x; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Baudry K, 2001, J BIOL CHEM, V276, P12702, DOI 10.1074/jbc.M100274200; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Bennett JW, 1991, MORE GENE MANIPULATI; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Borgia PT, 1996, FUNGAL GENET BIOL, V20, P193, DOI 10.1006/fgbi.1996.0035; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; CABIB E, 1991, ANTIMICROB AGENTS CH, V35, P170, DOI 10.1128/AAC.35.1.170; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Chen CB, 2006, EUKARYOT CELL, V5, P155, DOI 10.1128/EC.5.1.155-166.2006; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; DAMVELD RA, 2005, THESIS U LEIDEN; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Ferreyra RG, 2006, ARCH BIOCHEM BIOPHYS, V453, P197, DOI 10.1016/j.abb.2006.06.024; Fisher N, 2004, EUR J BIOCHEM, V271, P2264, DOI 10.1111/j.1432-1033.2004.04169.x; Fontaine T, 2000, J BIOL CHEM, V275, P27594; FOURIE PJ, 2001, PFLANZENSCHUTZ NACHR, V3, P399; Franzot SP, 1997, ANTIMICROB AGENTS CH, V41, P331, DOI 10.1128/AAC.41.2.331; Fritz R, 1997, PESTIC SCI, V49, P40, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;40::AID-PS470&gt;3.0.CO;2-Y; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gorovits R, 2003, EUKARYOT CELL, V2, P699, DOI 10.1128/EC.2.4.699-707.2003; Hagen S, 2007, APPL ENVIRON MICROB, V73, P2128, DOI 10.1128/AEM.02497-06; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Henry KW, 2000, ANTIMICROB AGENTS CH, V44, P2693, DOI 10.1128/AAC.44.10.2693-2700.2000; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacoby JJ, 1997, FEBS LETT, V417, P219, DOI 10.1016/S0014-5793(97)01287-8; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kale TA, 2003, CURR TOP MED CHEM, V3, P1043, DOI 10.2174/1568026033452087; Khalaj V, 2001, FUNGAL GENET BIOL, V32, P55, DOI 10.1006/fgbi.2000.1245; Kiso T, 2004, ANTIMICROB AGENTS CH, V48, P1739, DOI 10.1128/AAC.48.5.1739-1748.2004; Klahre U, 2006, PLANT CELL, V18, P3033, DOI 10.1105/tpc.106.045336; Klis F., 2007, BIOL FUNGAL CELL, P97; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; KLIS FM, 1998, METABOLISM MOL PHYSL, P117; Kojima K, 2004, MOL MICROBIOL, V53, P1785, DOI 10.1111/j.1365-2958.2004.04244.x; KOLAR M, 1988, GENE, V62, P127, DOI 10.1016/0378-1119(88)90586-0; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; KURTZ MB, 1994, ANTIMICROB AGENTS CH, V38, P1480, DOI 10.1128/AAC.38.7.1480; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; Leber R, 2003, ANTIMICROB AGENTS CH, V47, P3890, DOI 10.1128/AAC.47.12.3890-3900.2003; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li RK, 1999, ANTIMICROB AGENTS CH, V43, P1401, DOI 10.1128/AAC.43.6.1401; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Lin WW, 2000, CELL SIGNAL, V12, P457, DOI 10.1016/S0898-6568(00)00090-5; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Michell RH, 2003, BIOCHEM SOC T, V31, P11, DOI 10.1042/bst0310011; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mizutani O, 2004, EUKARYOT CELL, V3, P1036, DOI 10.1128/EC.3.4.1036-1048.2004; Muller C, 2002, MICROBIOL-SGM, V148, P4025, DOI 10.1099/00221287-148-12-4025; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; NIKI T, 1994, YEAST, V10, P1467, DOI 10.1002/yea.320101110; Oestreich A, 1997, ARCH ENVIRON CON TOX, V33, P329, DOI 10.1007/s002449900261; OFFRINGA R, 1990, EMBO J, V9, P3077, DOI 10.1002/j.1460-2075.1990.tb07504.x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Punt PJ, 2001, MOL MICROBIOL, V41, P513, DOI 10.1046/j.1365-2958.2001.02541.x; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; RONCERO C, 1988, J BACTERIOL, V170, P1945, DOI 10.1128/jb.170.4.1945-1949.1988; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Schmidt A, 2002, MOL MICROBIOL, V45, P1433, DOI 10.1046/j.1365-2958.2002.03110.x; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Staudohar M, 2002, MICROBIOL-SGM, V148, P2635, DOI 10.1099/00221287-148-8-2635; Swain E, 2002, J BIOL CHEM, V277, P26177, DOI 10.1074/jbc.M204115200; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Terashima H, 2000, MOL GEN GENET, V264, P64, DOI 10.1007/s004380000285; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; Uhrig JF, 2006, CURR BIOL, V16, pR211, DOI 10.1016/j.cub.2006.02.028; Utsugi T, 2002, GENES CELLS, V7, P1, DOI 10.1046/j.1356-9597.2001.00495.x; Viaud M, 2003, MOL MICROBIOL, V50, P1451, DOI 10.1046/j.1365-2958.2003.03798.x; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Zhao W, 2006, INFECT IMMUN, V74, P4865, DOI 10.1128/IAI.00565-06	106	68	127	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32935	32948		10.1074/jbc.M705856200	http://dx.doi.org/10.1074/jbc.M705856200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804411	hybrid, Green Published			2022-12-25	WOS:000250625400042
J	Singh, AB; Sugimoto, K; Harris, RC				Singh, Amar B.; Sugimoto, Keisuke; Harris, Raymond C.			Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-RENAL-FAILURE; BCL-X-L; UP-REGULATION; INTEGRIN ALPHA-3-BETA-1; MOLECULAR-MECHANISMS; CLUSTERIN PROTECTS; MEDIATED APOPTOSIS; PREVENT ANOIKIS; CARCINOMA-CELLS; DOWN-REGULATION	Loss of cell-matrix adhesion is often associated with acute epithelial injury, suggesting that "anoikis" may be an important contributor to cell death. Resistance against anoikis is a key characteristic of transformed cells. When nontransformed epithelia are injured, activation of the epidermal growth factor (EGF) receptor (EGFR) by paracrine/autocrine release of soluble ligands can induce a prosurvival program, but there is generally evidence for concomitant dedifferentiation. The EGFR ligand, heparin-binding EGF-like growth factor (HB-EGF), is synthesized as a membrane-anchored precursor that can activate the EGFR via juxtacrine signaling or can be released and act as a soluble growth factor. In Madin-Darby canine kidney cells, expression of membrane-anchored HB-EGF increases cell-cell and cell-matrix adhesion. Therefore, these studies were designed to test the effects of juxtacrine HB-EGF signaling upon cell survival and epithelial integrity when cells are denied proper cell-matrix interactions. Cells expressing a noncleavable mutated form of membrane-anchored HB-EGF demonstrated increased survival from anoikis, formed larger cell aggregates, and maintained epithelial characteristics even following prolonged detachment from the substratum. Physical association between membrane-anchored HB-EGF and EGFR was observed. Signaling studies indicated synergistic effects of EGFR activation and phosphatidylinositol 3-kinase signaling to regulate apoptotic and survival pathways. In contrast, although administration of exogenous EGF partially suppressed anoikis in wild type cells, it also led to an increased expression of mesenchymal markers, suggesting dedifferentiation. Taken together, we propose a novel role for membrane-anchored HB-EGF in the cytoprotection of epithelial cells.	Vanderbilt Univ, Dept Med, Med Ctr N, Nashville, TN 37232 USA	Vanderbilt University	Harris, RC (corresponding author), Vanderbilt Univ, Dept Med, Med Ctr N, C-3121, Nashville, TN 37232 USA.	ray.harris@vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051265] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 51265] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AMSLER K, 1982, AM J PHYSIOL, V242, pC94, DOI 10.1152/ajpcell.1982.242.1.C94; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Chen JC, 2007, MOL CELL BIOL, V27, P3023, DOI 10.1128/MCB.01482-06; Devarajan P, 2005, CURR OPIN PEDIATR, V17, P193, DOI 10.1097/01.mop.0000152620.59425.eb; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Girton RA, 2002, AM J PHYSIOL-RENAL, V282, pF703, DOI 10.1152/ajprenal.00060.2001; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hacker G, 2006, INT IMMUNOL, V18, P1749, DOI 10.1093/intimm/dxl109; Hammerman MR, 1998, CURR OPIN NEPHROL HY, V7, P419, DOI 10.1097/00041552-199807000-00012; Harris R C, 1997, Adv Ren Replace Ther, V4, P43; Hasuwa H, 2001, BIOCHEM BIOPH RES CO, V289, P782, DOI 10.1006/bbrc.2001.6053; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hise MK, 2000, RENAL FAILURE, V22, P423, DOI 10.1081/JDI-100100884; Hise MK, 2001, NEPHRON, V88, P71, DOI 10.1159/000045962; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Idogawa M, 2003, INT J CANCER, V107, P215, DOI 10.1002/ijc.11399; Iglesias-Serret D, 2007, LEUKEMIA, V21, P281, DOI 10.1038/sj.leu.2404483; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jin YS, 2006, MOL CANCER THER, V5, P1754, DOI 10.1158/1535-7163.MCT-06-0043; Jost M, 1999, J INVEST DERMATOL, V112, P443, DOI 10.1046/j.1523-1747.1999.00543.x; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Khwaja A, 1997, J CELL BIOL, V139, P1017, DOI 10.1083/jcb.139.4.1017; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; MOLITORIS BA, 1992, AM J PHYSIOL, V263, pF488, DOI 10.1152/ajprenal.1992.263.3.F488; Molitoris BA, 1997, PEDIATR NEPHROL, V11, P761, DOI 10.1007/s004670050385; Nakamura K, 2000, J BIOL CHEM, V275, P18284, DOI 10.1074/jbc.M907971199; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; Nakamura Y, 2001, J HISTOCHEM CYTOCHEM, V49, P439, DOI 10.1177/002215540104900403; Nony PA, 2003, J PHARMACOL EXP THER, V304, P905, DOI 10.1124/jpet.102.035022; NOUWEN EJ, 1994, RENAL FAILURE, V16, P49, DOI 10.3109/08860229409044847; PERANTONI A, 1979, IN VITRO CELL DEV B, V15, P446; Piechocki MP, 2006, INT J CANCER, V119, P441, DOI 10.1002/ijc.21837; Pullan S, 1996, J CELL SCI, V109, P631; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Quadros MR, 2006, CANCER BIOL THER, V5, P498, DOI 10.4161/cbt.5.5.2567; RAAB G, 1997, BIOCHIM BIOPHYS ACTA, V1333, P179; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Ramljak D, 2003, EXP CELL RES, V287, P397, DOI 10.1016/S0014-4827(03)00135-6; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Safirstein R, 1998, SEMIN NEPHROL, V18, P519; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; Schwochau GB, 1998, KIDNEY INT, V53, P1647, DOI 10.1046/j.1523-1755.1998.00902.x; SHEIKHHAMAD D, 2000, AM J PHYSIOL, V279, pR136; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Silkensen JR, 1995, J CLIN INVEST, V96, P2646, DOI 10.1172/JCI118330; Singh AB, 2004, J CELL SCI, V117, P1365, DOI 10.1242/jcs.01037; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Takemura T, 1997, J BIOL CHEM, V272, P31036, DOI 10.1074/jbc.272.49.31036; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Valentinis B, 1998, J CELL PHYSIOL, V176, P648, DOI 10.1002/(SICI)1097-4652(199809)176:3<648::AID-JCP22>3.3.CO;2-6; Versteilen AMG, 2004, INT J ARTIF ORGANS, V27, P1019, DOI 10.1177/039139880402701203; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zhuang SG, 2005, J BIOL CHEM, V280, P21036, DOI 10.1074/jbc.M413300200; Zuk A, 1998, AM J PHYSIOL-CELL PH, V275, pC711, DOI 10.1152/ajpcell.1998.275.3.C711	72	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32890	32901		10.1074/jbc.M702677200	http://dx.doi.org/10.1074/jbc.M702677200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848576	hybrid			2022-12-25	WOS:000250625400038
J	Tews, BA; Meyers, G				Tews, Birke Andrea; Meyers, Gregor			The pestivirus glycoprotein E-rns is anchored in plane in the membrane via an amphipathic helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DIARRHEA-VIRUS; SWINE-FEVER VIRUS; INTERFERON REGULATORY FACTOR-3; PROTEIN E-RNS; NEUTRALIZING MONOCLONAL-ANTIBODIES; DOUBLE-STRANDED-RNA; HOG-CHOLERA VIRUS; N-PRO; PROTEASOMAL DEGRADATION; ENVELOPE GLYCOPROTEINS	E-rns is a structural glycoprotein of pestiviruses found to be attached to the virion and to membranes within infected cells via its COOH terminus, although it lacks a hydrophobic anchor sequence. The COOH- terminal sequence was hypothesized to fold into an amphipathic alpha-helix. Alanine insertion scanning revealed that the ability of the Erns COOH terminus to bind membranes is considerably reduced by the insertion of a single amino acid at a wide variety of positions. Mutations decreasing the hydrophobicity of the apolar face of the putative helix led to reduction of membrane association. Proteinase K protection assays showed that Erns translated in vitro in the presence of microsomal membranes was protected, whereas a mutant with an artificial transmembrane region and a short cytosolic tag was shortened by the protease treatment. A tag fused to the COOH terminus of wild type Erns was not accessible for antibodies within digitonin- permeabilized cells, but the variant with the tag located downstream of the artificial transmembrane region was detected under the same conditions. These results are in accordance with the model that the COOH- terminal membrane anchor of Erns represents an amphipathic helix embedded in plane into the membrane. The integrity of the membrane important for recovery of infectious virus.	Friedrich Loeffler Inst, Inst Immunol, D-72001 Tubingen, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, D-72001 Tubingen, Germany.	gregor.meyers@fli.bund.de		Tews, Birke Andrea/0000-0002-8647-0497				Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; BOLIN S, 1988, ARCH VIROL, V99, P117, DOI 10.1007/BF01311029; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cocquerel L, 2002, EMBO J, V21, P2893, DOI 10.1093/emboj/cdf295; COLLETT MS, 1991, ARCH VIROL, P19; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONIS RO, 1988, J GEN VIROL, V69, P77, DOI 10.1099/0022-1317-69-1-77; Echeverri A, 1998, VIRUS RES, V54, P217, DOI 10.1016/S0168-1702(98)00016-1; Elbers K, 1996, J VIROL, V70, P4131, DOI 10.1128/JVI.70.6.4131-4135.1996; Fetzer C, 2005, J VIROL, V79, P11901, DOI 10.1128/JVI.79.18.11901-11913.2005; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006; Harada T, 2000, J VIROL, V74, P9498, DOI 10.1128/JVI.74.20.9498-9506.2000; Hausmann Y, 2004, J VIROL, V78, P5507, DOI 10.1128/JVI.78.10.5507-5512.2004; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HEINZ FX, 2000, VIRUS TAXONOMY 7 REP; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; Hulst MM, 2000, J VIROL, V74, P9553, DOI 10.1128/JVI.74.20.9553-9561.2000; HULST MM, 1994, VIROLOGY, V200, P558, DOI 10.1006/viro.1994.1218; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; Hulst MM, 2001, METHOD ENZYMOL, V342, P431, DOI 10.1016/S0076-6879(01)42564-X; Iqbal M, 2000, J GEN VIROL, V81, P451, DOI 10.1099/0022-1317-81-2-451; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Iqbal M, 2002, J GEN VIROL, V83, P2153, DOI 10.1099/0022-1317-83-9-2153; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kessler S W, 1981, Methods Enzymol, V73, P442; KONIG M, 1995, J VIROL, V69, P6479; Kusov YY, 1998, ARCH VIROL, V143, P931, DOI 10.1007/s007050050343; La Rocca SA, 2005, J VIROL, V79, P7239, DOI 10.1128/JVI.79.11.7239-7247.2005; Lackner T, 2004, J VIROL, V78, P10765, DOI 10.1128/JVI.78.19.10765-10775.2004; Lampio A, 2000, J BIOL CHEM, V275, P37853, DOI 10.1074/jbc.M004865200; LANGE Y, 1991, J LIPID RES, V32, P329; Langedijk JPM, 2002, J BIOL CHEM, V277, P5308, DOI 10.1074/jbc.M104147200; Langedijk JPM, 2002, J VIROL, V76, P10383, DOI 10.1128/JVI.76.20.10383-10392.2002; Langedijk JPM, 2001, J CLIN MICROBIOL, V39, P906, DOI 10.1128/JCM.39.3.906-912.2001; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meyer C, 2002, J VIROL, V76, P8494, DOI 10.1128/JVI.76.16.8494-8503.2002; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Meyers G, 1996, J VIROL, V70, P1588, DOI 10.1128/JVI.70.3.1588-1595.1996; Meyers G, 2007, J VIROL, V81, P3327, DOI 10.1128/JVI.02372-06; Nina M, 2000, EUR BIOPHYS J BIOPHY, V29, P439, DOI 10.1007/PL00006649; PAUL AV, 1994, VIROLOGY, V199, P188, DOI 10.1006/viro.1994.1111; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ruggli N, 2005, VIROLOGY, V340, P265, DOI 10.1016/j.virol.2005.06.033; Ruggli N, 2003, J VIROL, V77, P7645, DOI 10.1128/JVI.77.13.7645-7654.2003; RUMENAPF T, 1993, J VIROL, V67, P3288; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; SCHNEIDER R, 1993, SCIENCE, V261, P1169, DOI 10.1126/science.8356450; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; STARK R, 1993, J VIROL, V67, P7088, DOI 10.1128/JVI.67.12.7088-7095.1993; Tautz N, 1999, J VIROL, V73, P9422, DOI 10.1128/JVI.73.11.9422-9432.1999; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; van Gennip HGP, 2000, VACCINE, V19, P447, DOI 10.1016/S0264-410X(00)00198-5; WEILAND E, 1990, J VIROL, V64, P3563, DOI 10.1128/JVI.64.8.3563-3569.1990; WEILAND E, 1992, J VIROL, V66, P3677, DOI 10.1128/JVI.66.6.3677-3682.1992; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Windisch JM, 1996, J VIROL, V70, P352, DOI 10.1128/JVI.70.1.352-358.1996; WISKERCHEN M, 1991, J VIROL, V65, P4508, DOI 10.1128/JVI.65.8.4508-4514.1991; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997	68	40	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32730	32741		10.1074/jbc.M706803200	http://dx.doi.org/10.1074/jbc.M706803200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848558	hybrid			2022-12-25	WOS:000250625400021
J	Read, JT; Rahmani, M; Boroomand, S; Allahverdian, S; McManus, BM; Rennie, PS				Read, Jason T.; Rahmani, Maziar; Boroomand, Seti; Allahverdian, Sima; McManus, Bruce M.; Rennie, Paul S.			Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE MOTIFS; T-CELL FACTOR; BETA-CATENIN; PROSTATE-CANCER; EXTRACELLULAR-MATRIX; SQUAMOUS TRANSDIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; BREAST-CANCER; TUMOR-CELLS; DNA-BINDING	Versican, one of the key components of prostatic stroma, plays a central role in tumor initiation and progression. Here, we investigated promoter elements and mechanisms of androgen receptor (AR)-mediated regulation of the versican gene in prostate cancer cells. Using transient transfection assays in prostate cancer LNCaP and cervical cancer HeLa cells engineered to express the AR, we demonstrate that the synthetic androgen R1881 and dihydrotestosterone stimulate expression of a versican promoter-driven luciferase reporter vector (versican-Luc). Further, both basal and androgen-stimulated versican-Luc activities were significantly diminished in LNCaP cells, when AR gene expression was knocked down using a short hairpin RNA. Methylation-protection foot-printing analysis revealed an AR-protected element between positions +75 and +102 of the proximal versican promoter, which strongly resembled a consensus steroid receptor element. Electrophoretic mobility shift and supershift assays revealed strong and specific binding of the recombinant AR DNA binding domain to oligonucleotides corresponding to this protected DNA sequence. Site-directed mutagenesis of the steroid receptor element site markedly diminished R1881-stimulated versican-Luc activity. In contrast to the response seen using LNCaP cells, R1881 did not significantly induce versican promoter activity and mRNA levels in AR-positive prostate stromal fibroblasts. Interestingly, overexpression of beta catenin in the presence of androgen augmented versican promoter activity 10-and 30-fold and enhanced versican mRNA levels 2.8-fold in fibroblasts. In conclusion, we demonstrate that AR transactivates versican expression, which may augment tumor-stromal interactions and may contribute to prostate cancer progression.	Univ British Columbia, Prostate Ctr, Vancouver Gen Hosp, Dept Urol Sci, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Pathol & Lab Med, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Providence Res Inst, Vancouver, BC V6Z 1Y6, Canada	University of British Columbia; University of British Columbia	Rennie, PS (corresponding author), Univ British Columbia, Prostate Ctr, Vancouver Gen Hosp, Dept Urol Sci, Vancouver, BC V6T 2B5, Canada.	prennie@interchange.ubc.ca						Ang LC, 1999, J NEUROPATH EXP NEUR, V58, P597, DOI 10.1097/00005072-199906000-00004; BERCHEM GJ, 1995, CANCER RES, V55, P735; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0; Condon MS, 2005, SEMIN CANCER BIOL, V15, P132, DOI 10.1016/j.semcancer.2004.08.002; Cross NA, 2005, PROSTATE, V63, P269, DOI 10.1002/pros.20182; CUNHA GR, 1980, ENDOCRINOLOGY, V107, P1767, DOI 10.1210/endo-107-6-1767; CUNHA GR, 1991, ENDOCRINOLOGY, V128, P3293, DOI 10.1210/endo-128-6-3293; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Haelens A, 2001, BIOCHEM J, V353, P611, DOI 10.1042/0264-6021:3530611; Hamdy NAT, 2001, SEMIN NUCL MED, V31, P62, DOI 10.1053/snuc.2001.18767; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Kojima S, 2004, J UROLOGY, V171, P679, DOI 10.1097/01.ju.0000106190.32540.6c; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; McAlhany SJ, 2003, CANCER RES, V63, P5859; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Mulholland DJ, 2003, ONCOGENE, V22, P5602, DOI 10.1038/sj.onc.1206802; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; NASO MF, 1994, J BIOL CHEM, V269, P32999; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rahmani M, 2004, CAN J CARDIOL, V20, p58B; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539; Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048; Russell DL, 2003, ENDOCRINOLOGY, V144, P1020, DOI 10.1210/en.2002-220434; Sakko AJ, 2003, CANCER RES, V63, P4786; Sakko AJ, 2001, CANCER RES, V61, P926; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schwartz NB, 2004, GLYCOCONJUGATE J, V21, P329, DOI 10.1023/B:GLYC.0000046278.34016.36; Shan JD, 2003, BIOCHEM BIOPH RES CO, V311, P864, DOI 10.1016/j.bbrc.2003.10.071; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Truica CI, 2000, CANCER RES, V60, P4709; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yeung LHY, 2003, BIOCHEM J, V371, P843, DOI 10.1042/BJ20021816; Zhang Y, 1998, J BIOL CHEM, V273, P33054, DOI 10.1074/jbc.273.49.33054; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	57	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31954	31963		10.1074/jbc.M702099200	http://dx.doi.org/10.1074/jbc.M702099200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728259	hybrid			2022-12-25	WOS:000250480300016
J	Yin, HY; Brooks, JD; Gao, L; Porter, NA; Morrow, JD				Yin, Huiyong; Brooks, Joshua D.; Gao, Ling; Porter, Ned A.; Morrow, Jason D.			Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL; DOCOSAHEXAENOIC ACID; OXIDATION-PRODUCTS; MASS-SPECTROMETRY; OXIDIZED OMEGA-3-FATTY-ACIDS; ARACHIDONIC-ACID; OXIDANT STRESS; PPAR-ALPHA; N-3	Increased intake of fish oil rich in the omega- 3 fatty acids eicosapentaenoic acid (EPA, C22:6 omega- 3) and docosahexaenoic acid (DHA, C22: 6 omega- 3) reduces the incidence of human disorders such as atherosclerotic cardiovascular disease. However, mechanisms that contribute to the beneficial effects of fish oil consumption are poorly understood. Mounting evidence suggests that oxidation products of EPA andDHAmay be responsible, at least in part, for these benefits. Previously, we have defined the free radical- induced oxidation of arachidonic acid in vitro and in vivo and have proposed a unified mechanism for its peroxidation. Wehypothesize that the oxidation of EPA can be rationally defined but would be predicted to be significantly more complex than arachidonate because of the fact that EPA contains an addition carbon- carbon double bond. Herein, we present, for the first time, a unified mechanism for the peroxidation of EPA. Novel oxidation products were identified employing state- oftheart mass spectrometric techniques including Ag (+) coordination ionspray and atmospheric pressure chemical ionization mass spectrometry. Predicted compounds detected both in vitro and in vivo included monocylic peroxides, serial cyclic peroxides, bicyclic endoperoxides, and dioxolane- endoperoxides. Systematic study of the peroxidation of EPA provides the basis to examine the role of specific oxidation products as mediators of the biological effects of fish oil.	Vanderbilt Univ, Dept Med & Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Morrow, JD (corresponding author), Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Sch Med, 532 RRB,23rd & Pierce Ave, Nashville, TN 37232 USA.	Jason.morrow@vanderbilt.edu		yin, hui yong/0000-0001-7049-1560	NCI NIH HHS [CA77839.] Funding Source: Medline; NCRR NIH HHS [RR00096] Funding Source: Medline; NIDDK NIH HHS [DK48831] Funding Source: Medline; NIEHS NIH HHS [ES31125, ES13125, ES000267] Funding Source: Medline; NIGMS NIH HHS [GM15431] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achard F, 1997, BIOCHEM BIOPH RES CO, V241, P513, DOI 10.1006/bbrc.1997.7848; Arita K, 2003, FREE RADICAL BIO MED, V35, P189, DOI 10.1016/S0891-5849(03)00310-1; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Brouwer IA, 2006, PROG LIPID RES, V45, P357, DOI 10.1016/j.plipres.2006.02.004; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Connor SL, 1997, AM J CLIN NUTR, V66, P1020; Davis TA, 2006, J AM CHEM SOC, V128, P14897, DOI 10.1021/ja064399o; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; Harmon SD, 2006, PROSTAG LEUKOTR ESS, V75, P169, DOI 10.1016/j.plefa.2006.05.005; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Punta C, 2005, CHEM RES TOXICOL, V18, P349, DOI 10.1021/tx049685x; Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S; Seal JR, 2003, J AM SOC MASS SPECTR, V14, P872, DOI 10.1016/S1044-0305(03)00339-8; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sethi S, 2002, REDOX REP, V7, P369, DOI 10.1179/135100002125001144; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Takahashi M, 2002, AM J PHYSIOL-GASTR L, V282, pG338, DOI 10.1152/ajpgi.00376.2001; Vallve JC, 2002, ATHEROSCLEROSIS, V164, P45, DOI 10.1016/S0021-9150(02)00046-1; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wong KW, 2005, J AM DIET ASSOC, V105, P98, DOI 10.1016/j.jada.2004.10.009; Yang PY, 2004, J LIPID RES, V45, P1030, DOI 10.1194/jlr.M300455-JLR200; Yin HY, 2005, J BIOL CHEM, V280, P26600, DOI 10.1074/jbc.M503088200; Yin HY, 2005, ANTIOXID REDOX SIGN, V7, P170, DOI 10.1089/ars.2005.7.170; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200; Yin HY, 2003, J BIOL CHEM, V278, P16720, DOI 10.1074/jbc.M300604200; Yin HY, 2002, J AM CHEM SOC, V124, P7745, DOI 10.1021/ja0201092; Yin HY, 2001, J AM SOC MASS SPECTR, V12, P449, DOI 10.1016/S1044-0305(01)00205-7; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	46	44	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29890	29901		10.1074/jbc.M703108200	http://dx.doi.org/10.1074/jbc.M703108200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711863	hybrid			2022-12-25	WOS:000249981200018
J	Shimeld, SM; van den Heuvel, M; Dawber, R; Briscoe, J				Shimeld, Sebastian M.; van den Heuvel, Marcel; Dawber, Rebecca; Briscoe, James			An Amphioxus Gli Gene Reveals Conservation of Midline Patterning and the Evolution of Hedgehog Signalling Diversity in Chordates	PLOS ONE			English	Article								Background. Hedgehog signalling, interpreted in receiving cells by Gli transcription factors, plays a central role in the development of vertebrate and Drosophila embryos. Many aspects of the signalling pathway are conserved between these lineages, however vertebrates have diverged in at least one key aspect: they have evolved multiple Gli genes encoding functionally-distinct proteins, increasing the complexity of the hedgehog-dependent transcriptional response. Amphioxus is one of the closest living relatives of the vertebrates, having split from the vertebrate lineage prior to the widespread gene duplication prominent in early vertebrate evolution. Principal Findings. We show that amphioxus has a single Gli gene, which is deployed in tissues adjacent to sources of hedgehog signalling derived from the midline and anterior endoderm. This shows the duplication and divergence of the Gli gene family, and hence the origin of vertebrate Gli functional diversity, was specific to the vertebrate lineage. However we also show that the single amphioxus Gli gene produces two distinct transcripts encoding different proteins. We utilise three tests of Gli function to examine the transcription regulatory capacities of these different proteins, demonstrating one has activating activity similar to Gli2, while the other acts as a weak repressor, similar to Gli3. Conclusions. These data show that vertebrates and amphioxus have evolved functionally-similar repertoires of Gli proteins using parallel molecular routes; vertebrates via gene duplication and divergence, and amphioxus via alternate splicing of a single gene. Our results demonstrate that similar functional complexity of intercellular signalling can be achieved via different evolutionary pathways.	[Shimeld, Sebastian M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [van den Heuvel, Marcel; Dawber, Rebecca] Univ Oxford, MRC, Funct Genet Unit, Dept Human Anat & Genet, Oxford OX1 3PS, England; [Briscoe, James] Natl Inst Med Res, London NW7 1AA, England	University of Oxford; University of Oxford; MRC National Institute for Medical Research	Shimeld, SM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sebastian.shimeld@zoo.ox.ac.uk		Shimeld, Sebastian/0000-0003-0195-7536; Briscoe, James/0000-0002-1020-5240	MRC; BBSRC; Royal Society; Medical Research Council [MC_U117560541, MC_U137761451] Funding Source: researchfish; MRC [MC_U137761451, MC_U117560541] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank The MRC, BBSRC and Royal Society for support and Michael Schubert for critical comments on the manuscript.	Altaba ARI, 1999, NAT CELL BIOL, V1, pE147, DOI 10.1038/14099; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Boorman CJ, 2002, EVOL DEV, V4, P354, DOI 10.1046/j.1525-142X.2002.02021.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Candiani S, 1998, J COMP NEUROL, V392, P343; Cheng L, 2004, DEV BIOL, V274, P348, DOI 10.1016/j.ydbio.2004.07.020; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ferrier DEK, 2001, DEV BIOL, V237, P270, DOI 10.1006/dbio.2001.0375; Ferrier DEK, 2001, DEV GENES EVOL, V211, P103, DOI 10.1007/s004270000124; Gorbman A, 1999, GEN COMP ENDOCR, V113, P251, DOI 10.1006/gcen.1998.7193; Gostling NJ, 2003, EVOL DEV, V5, P136, DOI 10.1046/j.1525-142X.2003.03020.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; HOLLAND LZ, 1995, DEV BIOL, V171, P665, DOI 10.1006/dbio.1995.1313; Holland LZ, 1999, EVOL DEV, V1, P153, DOI 10.1046/j.1525-142x.1999.99019.x; HOLLAND PWH, 1991, FEBS LETT, V291, P211, DOI 10.1016/0014-5793(91)81286-H; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jackman WR, 2000, DEV BIOL, V220, P16, DOI 10.1006/dbio.2000.9630; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Lee J, 1997, DEVELOPMENT, V124, P2537; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lewis KE, 2001, DEVELOPMENT, V128, P3485; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Materna SC, 2006, DEV BIOL, V300, P108, DOI 10.1016/j.ydbio.2006.08.032; Mazet F, 2006, CURR BIOL, V16, pR314, DOI 10.1016/j.cub.2006.03.088; Methot N, 2001, DEVELOPMENT, V128, P733; Miwata K, 2006, DEV BIOL, V292, P546, DOI 10.1016/j.ydbio.2006.01.024; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Mullor JL, 2000, DEV BIOL, V228, P211, DOI 10.1006/dbio.2000.9862; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Norris W, 2000, J CELL SCI, V113, P2695; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Sbrogna JL, 2003, DEV BIOL, V254, P19, DOI 10.1016/S0012-1606(02)00027-1; Sharman AC, 1999, DEV GENES EVOL, V209, P260, DOI 10.1007/s004270050251; Shimeld SM, 1999, DEV GENES EVOL, V209, P40, DOI 10.1007/s004270050225; Speek M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-13; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Tanimura A, 1998, J VIROL, V72, P3958, DOI 10.1128/JVI.72.5.3958-3964.1998; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Venkatesh TV, 1999, DEV GENES EVOL, V209, P254; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Walton KD, 2006, DEV BIOL, V300, P153, DOI 10.1016/j.ydbio.2006.08.064; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang Y, 2002, MECH DEVELOP, V117, P315, DOI 10.1016/S0925-4773(02)00197-1; Yamada L, 2003, DEV GENES EVOL, V213, P245, DOI 10.1007/s00427-003-0316-x; Yasui K, 2000, DEVELOPMENT, V127, P187; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	75	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e864	10.1371/journal.pone.0000864	http://dx.doi.org/10.1371/journal.pone.0000864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848995	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600011
J	de Boer, OJ; van der Meer, JJ; Teeling, P; van der Loos, CM; van der Wal, AC				de Boer, Onno J.; van der Meer, Jelger J.; Teeling, Peter; van der Loos, Chris M.; van der Wal, Allard C.			Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions	PLOS ONE			English	Article								Background. T cell mediated inflammation contributes to atherogenesis and the onset of acute cardiovascular disease. Effector T cell functions are under a tight control of a specialized T cell subset, regulatory T cells (Treg). At present, nothing is known about the in situ presence of Treg in human atherosclerotic tissue. In the present study we investigated the frequency of naturally occurring Treg cells in all developmental stages of human atherosclerotic lesions including complicated thrombosed plaques. Methodology. Normal arteries, early lesions (American Heart Association classification types I, II, and III), fibrosclerotic plaques (types Vb and Vc) and 'high risk' plaques (types IV, Va and VI) were obtained at surgery and autopsy. Serial sections were immunostained for markers specific for regulatory T cells (FOXP3 and GITR) and the frequency of these cells was expressed as a percentage of the total numbers of CD3(+) T cells. Results were compared with Treg counts in biopsies of normal and inflammatory skin lesions (psoriasis, spongiotic dermatitis and lichen planus). Principle findings. In normal vessel fragments T cells were virtually absent. Treg were present in the intima during all stages of plaque development (0.5-5%). Also in the adventitia of atherosclerotic vessels Treg were encountered, in similar low amounts. High risk lesions contained significantly increased numbers of Treg compared to early lesions (mean: 3.9 and 1.2%, respectively). The frequency of FOXP3(+) cells in high risk lesions was also higher compared to stable lesions (1.7%), but this difference was not significant. The mean numbers of intimal FOXP3 positive cells in atherosclerotic lesions (2.4%) was much lower than those in normal (24.3%) or inflammatory skin lesions (28%). Conclusion. Low frequencies of Treg in all developmental stages of human plaque formation could explain the smoldering chronic inflammatory process that takes place throughout the longstanding course of atherosclerosis.	[de Boer, Onno J.; van der Meer, Jelger J.; Teeling, Peter; van der Loos, Chris M.; van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	de Boer, OJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	o.j.deboer@amc.uva.nl		van der Wal, Allard/0000-0001-5590-3758; de Boer, Onno/0000-0001-8844-1326	Academic Medical Center, University of Amsterdam	Academic Medical Center, University of Amsterdam	Academic Medical Center, University of Amsterdam (no external funding)	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bacchetta R, 2005, AUTOIMMUN REV, V4, P491, DOI 10.1016/j.autrev.2005.04.005; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; de Boer OJ, 2007, J HISTOCHEM CYTOCHEM, V55, P891, DOI 10.1369/jhc.6A7119.2007; De Palma R, 2006, CIRCULATION, V113, P640, DOI 10.1161/CIRCULATIONAHA.105.537712; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Engelse MA, 1999, CIRC RES, V85, P931; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hosono M, 2003, ATHEROSCLEROSIS, V168, P73, DOI 10.1016/S0021-9150(03)00024-8; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Maggi E, 2005, AUTOIMMUN REV, V4, P579, DOI 10.1016/j.autrev.2005.04.010; Mallat Z, 2003, CIRCULATION, V108, P1232, DOI 10.1161/01.CIR.0000089083.61317.A1; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Palinski W, 2000, J INTERN MED, V247, P371, DOI 10.1046/j.1365-2796.2000.00656.x; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sardella G, 2007, THROMB RES, V120, P631, DOI 10.1016/j.thromres.2006.12.005; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Sommeijer DW, 2004, J HISTOCHEM CYTOCHEM, V52, P1141, DOI 10.1369/jhc.3A6207.2004; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; van der Wal AC, 1998, HEART, V80, P14, DOI 10.1136/hrt.80.1.14; VANDERWAL AC, 1989, LAB INVEST, V61, P166; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Zhou XH, 2000, CIRCULATION, V102, P2919	32	186	190	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e779	10.1371/journal.pone.0000779	http://dx.doi.org/10.1371/journal.pone.0000779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712427	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455300027
J	Wang, P; Lushnikova, T; Odvody, J; Greiner, TC; Jones, SN; Eischen, CM				Wang, P.; Lushnikova, T.; Odvody, J.; Greiner, T. C.; Jones, S. N.; Eischen, C. M.			Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells	ONCOGENE			English	Article						Mdm2; Myc; p53; ARF; lymphoma chromosome	MYC-INDUCED LYMPHOMAGENESIS; BURKITTS-LYMPHOMA; DNA-DAMAGE; C-MYC; P53; ONCOGENE; OVEREXPRESSION; APOPTOSIS; PATHWAY; ARF	Mdm2, a regulator of the p53 tumor suppressor, is frequently overexpressed in lymphomas, including lymphomas that have inactivated p53. However, the biological consequences of Mdm2 overexpression in lymphocytes are not fully resolved. Here, we report that increased expression of Mdm2 in B cells augmented proliferation and reduced susceptibility to p53-dependent apoptosis, which was due to inhibition of p53 and suppression of p21 expression. Notably, developing and mature B cells from Mdm2 transgenic mice had an increased frequency of chromosomal/chromatid breaks and/or aneuploidy. This Mdm2-mediated genome instability occurred at a similar frequency as that in B cells overexpressing the oncogene c-Myc, but the chromosomal instability was not further enhanced when Mdm2 and c-Myc were overexpressed together. Elevated Mdm2 expression alone increased the occurrence of B-cell transformation in vivo and cooperated with c-Myc overexpression, resulting in an acceleration of B-cell lymphomagenesis. In addition, the frequency of p53 mutations was reduced, but not eliminated, in lymphomas arising in Mdm2/E mu-myc double transgenic mice. Therefore, increased Mdm2 expression facilitated B-cell lymphomagenesis, in part, through regulation of p53 by altering B-cell proliferation and susceptibility to apoptosis, and by inducing chromosomal instability.	[Wang, P.; Lushnikova, T.; Odvody, J.; Eischen, C. M.] Vanderbilt Univ, Ctr Med, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Greiner, T. C.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA; [Jones, S. N.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA	Vanderbilt University; University of Nebraska System; University of Nebraska Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Eischen, CM (corresponding author), Vanderbilt Univ, Ctr Med, Dept Pathol, Sch Med, MCN C3321,1161 21st Ave S, Nashville, TN 37232 USA.	eischen@vanderbilt.edu			NCI NIH HHS [CA098139, CA117935] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098139, R01CA117935] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Capoulade C, 1998, ONCOGENE, V16, P1603, DOI 10.1038/sj.onc.1201702; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Eischen CM, 2004, ONCOGENE, V23, P8931, DOI 10.1038/sj.onc.1208052; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; Gumy-Pause F, 2004, LEUKEMIA, V18, P238, DOI 10.1038/sj.leu.2403221; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; STRASSER A, 1993, ONCOGENE, V8, P1; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Watanabe T, 1996, LEUKEMIA LYMPHOMA, V21, P391, DOI 10.3109/10428199609093436; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	29	59	61	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1590	1598		10.1038/sj.onc.1210788	http://dx.doi.org/10.1038/sj.onc.1210788			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17828300				2022-12-25	WOS:000253815800011
J	Sedding, DG; Homann, M; Seay, U; Tillmanns, H; Preissner, KT; Braun-Dullaeus, RC				Sedding, Daniel G.; Homann, Matthias; Seay, Ulrike; Tillmanns, Harald; Preissner, Klaus T.; Braun-Dullaeus, Ruediger C.			Calpain counteracts mechanosensitive apoptosis of vascular smooth muscle cells in vitro and in vivo	FASEB JOURNAL			English	Article						signal transduction; remodeling; p53; restenosis	P53-DEPENDENT APOPTOSIS; HUMAN ATHEROSCLEROSIS; BALLOON ANGIOPLASTY; PROTEASE CALPAIN; PROLIFERATION; P53; EXPRESSION; CELLULARITY; RESTENOSIS; INHIBITOR	Mechanical forces contribute to vascular remodeling processes. Elevated mechanical stress causes apoptosis of vascular smooth muscle cells (VSMCs) within the media. This study examined the role of the cystein protease calpain in force-induced vascular cell apoptosis and its effect on injury-induced vascular remodeling processes. VSMCs were exposed to cyclic tensile force in vitro, which resulted in increased p53 protein expression and transcriptional activity as well as a significant increase of apoptotic VSMCs. Apoptosis was prevented by the p53 inhibitor pifithrin and by p53 antisense oligonucleotides, indicating dependency of force-induced apoptosis on p53. Simultaneously, calpain activity increased by mechanical stress. Prevention of calpain activation by calpeptin or antisense oligonucleotides augmented strain-induced p53 expression and transcriptional activity, resulting in a further increase of apoptotic rate. p53 protein was directly disintegrated by activated calpain. The in vivo relevance of the findings was tested: pharmacologic inhibition of initial calpain activation augmented early apoptosis of medial VSMCs 24 h after balloon injury in a p53-dependent manner but resulted in a marked increase in late neointima formation. We conclude that calpain counteracts mechanically induced excessive VSMC apoptosis through its p53-degrading properties, which identifies calpain as a key regulator of mechanosensitive remodeling processes of the vascular wall.	[Braun-Dullaeus, Ruediger C.] Tech Univ Dresden, Dept Internal Med Cardiol, D-01307 Dresden, Germany; [Homann, Matthias; Preissner, Klaus T.] Univ Giessen, Dept Biochem, Giessen, Germany; [Sedding, Daniel G.; Seay, Ulrike; Tillmanns, Harald] Univ Giessen, Dept Internal Med Cardiol, Giessen, Germany	Technische Universitat Dresden; Justus Liebig University Giessen; Justus Liebig University Giessen	Braun-Dullaeus, RC (corresponding author), Tech Univ Dresden, Dept Internal Med Cardiol, Fetscherstr 76, D-01307 Dresden, Germany.	r.braun-dullaeus@mailbox.tu-dresden.de	Braun-Dullaeus, Ruediger C/G-1844-2013	Braun-Dullaeus, Ruediger C/0000-0003-3888-6532				Ariyoshi H, 1998, ARTERIOSCL THROM VAS, V18, P493, DOI 10.1161/01.ATV.18.3.493; Atencio IA, 2000, CELL GROWTH DIFFER, V11, P247; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Beohar N, 2004, CIRCULATION, V109, P108, DOI 10.1161/01.CIR.0000105724.30980.CD; Best PJM, 1999, ARTERIOSCL THROM VAS, V19, P14, DOI 10.1161/01.ATV.19.1.14; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Braun-Dullaeus RC, 1999, J CLIN INVEST, V104, P815, DOI 10.1172/JCI5339; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Durand E, 2002, J AM COLL CARDIOL, V39, P1680, DOI 10.1016/S0735-1097(02)01831-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonen H, 1997, FEBS LETT, V406, P17, DOI 10.1016/S0014-5793(97)00225-1; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; HAN DKM, 1995, AM J PATHOL, V147, P267; HANKE H, 1990, CIRC RES, V67, P651, DOI 10.1161/01.RES.67.3.651; Ihling C, 1998, J PATHOL, V185, P303; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; Kamenz J, 2000, CARDIOVASC RES, V45, P766, DOI 10.1016/S0008-6363(99)00355-7; Kollum M, 1997, ARTERIOSCL THROM VAS, V17, P2383, DOI 10.1161/01.ATV.17.11.2383; Lauth M, 2000, HYPERTENSION, V35, P648, DOI 10.1161/01.HYP.35.2.648; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; Mayr M, 2000, FASEB J, V14, P261, DOI 10.1096/fasebj.14.2.261; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; Mnjoyan ZH, 2003, CIRCULATION, V108, P464, DOI 10.1161/01.CIR.0000080339.49212.49; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343; Pariat M, 1997, MOL CELL BIOL, V17, P2806, DOI 10.1128/MCB.17.5.2806; Perlman H, 1997, CIRCULATION, V95, P981; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Sotoudeh M, 2002, AM J PHYSIOL-HEART C, V282, pH1709, DOI 10.1152/ajpheart.00744.2001; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88; Yonemitsu Y, 1998, CIRC RES, V82, P147	41	13	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					579	589		10.1096/fj.07-8853com	http://dx.doi.org/10.1096/fj.07-8853com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17846083				2022-12-25	WOS:000252822600028
J	Band, M; Shams, I; Joel, A; Avivi, A				Band, Mark; Shams, Imad; Joel, Alma; Avivi, Aaron			Cloning and in vivo expression of vascular endothelial growth factor receptor 2 (Flk1) in the naturally hypoxia-tolerant subterranean mole rat	FASEB JOURNAL			English	Article						Spalax ehrenbergi; VEGF-R2	ENDOTHELIAL GROWTH-FACTOR; SPALAX-EHRENBERGI; FACTOR RECEPTOR-2; UP-REGULATION; BLOOD-FLOW; GLUCOSE-TRANSPORTER; MESSENGER-RNA; RESPONSES; VEGF; ERYTHROPOIETIN	Vascular endothelial growth factor receptor (VEGF) plays a critical role in blood vessel formation and affects nerve growth and survival. VEGF receptor 2 (Flk1) functions as the major signal transducer of angiogenesis, mediating VEGF induction of endothelial tubulogenesis. We have cloned and analyzed expression of Flk1 in the blind subterranean mole rat Spalax ehrenbergi. Spalax experience abrupt and sharp changes in oxygen supply in their sealed underground niche and, hence, are genetically adapted to hypoxia and serve as a unique, natural mammalian model organism for hypoxia tolerance. Spalax Flk1 is relatively conserved at the nucleic acid and amino acid level compared to human, mouse, and rat orthologs. Reverse transcription-quantitative polymerase chain reaction was used to analyze Flk1 expression in muscle and brain of animals exposed to ambient or variant hypoxic oxygen levels at multiple stages of development. Transcript levels were compared with those obtained from Rattus, a primary model for human physiology. Our findings demonstrate that under normoxic conditions Flk1 patterns of expression correlate well with our previous investigations of VEGF expression. Exposure to hypoxic conditions resulted in divergent patterns of Flk1 expression between Spalax and Rattus and between muscle and brain. It appears that the regulatory mechanisms differentiating expression between the species and between tissues are most likely unique, suggesting that Flk1 expression may be regulated by multiple processes, including both angiogenesis and neurogenesis.-Band, M., Shams, I., Joel, A., Avivi, A. Cloning and in vivo expression of vascular endothelial growth factor receptor 2 (Flk1) in the naturally hypoxia-tolerant subterranean mole rat.	[Shams, Imad; Joel, Alma; Avivi, Aaron] Univ Haifa, Inst Evolut, Lab Anim Mol Evolut, IL-31905 Haifa, Israel; [Band, Mark] Univ Illinois, W M Keck Ctr Comparat & Fuct Genom, Urbana, IL 61801 USA	University of Haifa; University of Illinois System; University of Illinois Urbana-Champaign	Avivi, A (corresponding author), Univ Haifa, Inst Evolut, Lab Anim Mol Evolut, Mt Carmel, IL-31905 Haifa, Israel.	aaron@research.haifa.ac.il		Shams, Imad/0000-0001-6496-2928				Andresen J, 2006, J APPL PHYSIOL, V100, P318, DOI 10.1152/japplphysiol.00937.2005; AR A, 1977, RESP PHYSIOL, V30, P201, DOI 10.1016/0034-5687(77)90031-7; ARIELI R, 1991, COMP BIOCHEM PHYS A, V100, P543, DOI 10.1016/0300-9629(91)90367-L; ARIELI R, 1984, EXPERIENTIA, V40, P512, DOI 10.1007/BF01952413; ARIELI R, 1986, EXPERIENTIA, V42, P441, DOI 10.1007/BF02118650; ARIELI R, 1986, EXPERIENTIA, V42, P131, DOI 10.1007/BF01952430; ARIELI R, 1977, PHYSIOL ZOOL, V50, P61, DOI 10.1086/physzool.50.1.30155716; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Avivi A, 2007, ONCOGENE, V26, P2507, DOI 10.1038/sj.onc.1210045; Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje; Avivi A, 1999, FEBS LETT, V452, P133, DOI 10.1016/S0014-5793(99)00584-0; Avivi A, 2006, PHYSIOL GENOMICS, V27, P54, DOI 10.1152/physiolgenomics.00001.2006; BURLINGTON RF, 1968, NATURE, V219, P1370, DOI 10.1038/2191370a0; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Gilbert RD, 2003, HIGH ALT MED BIOL, V4, P203, DOI 10.1089/152702903322022802; GURNETT AM, 1984, J PROTEIN CHEM, V3, P445, DOI 10.1007/BF01025063; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hare Gregory M T, 2004, Curr Opin Anaesthesiol, V17, P363, DOI 10.1097/00001503-200410000-00003; Harik N, 1996, BRAIN RES, V737, P335, DOI 10.1016/0006-8993(96)00965-1; Jensen A, 1999, EUR J OBSTET GYN R B, V84, P155, DOI 10.1016/S0301-2115(98)00325-X; Kappel A, 2000, BLOOD, V96, P3078; KEREM D, 1973, COMP BIOCHEM PHYSIOL, V45, P731, DOI 10.1016/0300-9629(73)90076-5; KLEINSCHMIDT T, 1984, H-S Z PHYSIOL CHEM, V365, P531, DOI 10.1515/bchm2.1984.365.1.531; Kremer C, 1997, CANCER RES, V57, P3852; Laudenbach V, 2007, NEUROBIOL DIS, V26, P243, DOI 10.1016/j.nbd.2006.12.020; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; LOU HC, 1987, ANN NEUROL, V22, P289, DOI 10.1002/ana.410220302; Nevo, 1999, MOSAIC EVOLUTION SUB; NEVO E, 1989, HEREDITY, V62, P85, DOI 10.1038/hdy.1989.11; Nevo E., 1961, Mammalia Paris, V25, P127, DOI 10.1515/mamm.1961.25.2.127; Nevo E., 2001, ADAPTIVE RAD BLIND S; Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shams I, 2005, FASEB J, V19, P1749, DOI 10.1096/fj.05-3975fje; Shams I, 2005, COMP BIOCHEM PHYS A, V142, P376, DOI 10.1016/j.cbpa.2005.09.003; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; Shams Imad, 2005, FASEB J, V19, P307; Shen BQ, 1998, J BIOL CHEM, V273, P29979, DOI 10.1074/jbc.273.45.29979; Shiote M, 2005, NEUROSCIENCE, V132, P175, DOI 10.1016/j.neuroscience.2004.12.031; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Soderstrom V, 1999, J EXP BIOL, V202, P829; Soderstrom V, 1999, NEUROSCI LETT, V267, P1, DOI 10.1016/S0304-3940(99)00269-4; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Widmer HR, 1997, P NATL ACAD SCI USA, V94, P2062, DOI 10.1073/pnas.94.5.2062; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Yang SY, 2001, ARTERIOSCL THROM VAS, V21, P1934, DOI 10.1161/hq1201.099432; Zeller K, 1996, DEV BRAIN RES, V91, P200, DOI 10.1016/0165-3806(95)00177-8	52	10	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					105	112		10.1096/fj.07-8892com	http://dx.doi.org/10.1096/fj.07-8892com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17726089				2022-12-25	WOS:000252309900014
J	Deb, R; Shakib, F; Reid, K; Clark, H				Deb, Roona; Shakib, Farouk; Reid, Kenneth; Clark, Howard			Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVITY; BRONCHOALVEOLAR LAVAGE; ASPERGILLUS-FUMIGATUS; HISTAMINE-RELEASE; CRYSTAL-STRUCTURE; P-I; DER-P-1; INFLAMMATION; COLLECTINS; BINDING	Lung surfactant proteins (SP) A and D are calcium-dependent carbohydrate-binding proteins. In addition to playing multiple roles in innate immune defense such as bacterial aggregation and modulation of leukocyte function, SP-A and SP-D have also been implicated in the allergic response. They interact with a wide range of inhaled allergens, competing with their binding to cell-sequestered IgE resulting in inhibition of mast cell degranulation, and exogenous administration of SP-A and SP-D diminishes allergic hypersensitivity in vivo. House dust mite allergens are a major cause of allergic asthma in the western world, and here we confirm the interaction of SP-A and SP-D with two major mite allergens, Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1, and show that the cysteine protease activity of these allergens results in the degradation of SP-A and SP-D under physiological conditions, with multiple sites of cleavage. A recombinant fragment of SP-D that is effective in diminishing allergic hypersensitivity in mouse models of dust mite allergy was more susceptible to degradation than the native full-length protein. Degradation was enhanced in the absence of calcium, with different sites of cleavage, indicating that the calcium associated with SP-A and SP-D influences accessibility to the allergens. Degradation of SP-A and SP-D was associated with diminished binding to carbohydrates and to D. pteronyssinus 1 itself and diminished capacity to agglutinate bacteria. Thus, the degradation and consequent inactivation of SP-A and SP-D may be a novel mechanism to account for the potent allergenicity of these common dust mite allergens.	[Clark, Howard] Univ Southampton, Southampton Gen Hosp, Sch Med, Dept Child Hlth,Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; [Deb, Roona; Reid, Kenneth] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; [Shakib, Farouk] Univ Nottingham, Inst Infect Immun & Inflammat, Queens Med Ctr, Nottingham NG7 2RD, England	University of Southampton; University of Oxford; University of Nottingham	Clark, H (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Med, Dept Child Hlth,Div Infect Inflammat & Repair, MP 803 Level F,South Block, Southampton SO16 6YD, Hants, England.	h.w.clark@soton.ac.uk		Clark, Howard/0000-0001-7354-2028				CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Carlstedt F, 2001, CRIT CARE CLIN, V17, P139, DOI 10.1016/S0749-0704(05)70156-1; Cheng G, 2000, EUR RESPIR J, V16, P831, DOI 10.1183/09031936.00.16583100; Clark H, 2002, J IMMUNOL, V169, P2892, DOI 10.4049/jimmunol.169.6.2892; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Erpenbeck VJ, 2006, ALLERGY, V61, P598, DOI 10.1111/j.1398-9995.2006.01062.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FERGUSON P, 1995, AM J RESP CRIT CARE, V151, P71, DOI 10.1164/ajrccm.151.1.7812575; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Ghaemmaghami AM, 2001, EUR J IMMUNOL, V31, P1211, DOI 10.1002/1521-4141(200104)31:4&lt;1211::AID-IMMU1211&gt;3.0.CO;2-R; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; HAAGSMAN HP, 1989, AM J PHYSIOL, V257, pL421, DOI 10.1152/ajplung.1989.257.6.L421; HAAGSMAN HP, 1990, BIOCHEMISTRY-US, V29, P8894, DOI 10.1021/bi00490a003; Haczku A, 2001, AM J RESP CELL MOL, V25, P45, DOI 10.1165/ajrcmb.25.1.4391; Haczku A, 2006, J IMMUNOL, V176, P3557, DOI 10.4049/jimmunol.176.6.3557; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; Haley KJ, 2002, AM J PHYSIOL-LUNG C, V282, pL573, DOI 10.1152/ajplung.00117.2001; Hansen S, 2002, IMMUNOBIOLOGY, V205, P498, DOI 10.1078/0171-2985-00150; HAWGOOD S, 1989, AM J PHYSIOL, V257, pL13, DOI 10.1152/ajplung.1989.257.2.L13; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; KUROKI Y, 1991, J BIOL CHEM, V266, P3068; Liu CF, 2005, CLIN EXP ALLERGY, V35, P515, DOI 10.1111/j.1365-2222.2005.02205.x; Madan T, 1997, CLIN EXP IMMUNOL, V110, P241; Madan T, 2001, J CLIN INVEST, V107, P467, DOI 10.1172/JCI10124; Masuda K, 1999, VET IMMUNOL IMMUNOP, V72, P303, DOI 10.1016/S0165-2427(99)00142-7; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Nadesalingam J, 2003, J BIOL CHEM, V278, P25678, DOI 10.1074/jbc.M210186200; Nakamura T, 2006, J INVEST DERMATOL, V126, P2719, DOI 10.1038/sj.jid.5700584; Ohtani K, 1999, J BIOL CHEM, V274, P13681, DOI 10.1074/jbc.274.19.13681; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Palaniyar N, 1998, J STRUCT BIOL, V122, P297, DOI 10.1006/jsbi.1998.4004; PERSSON AV, 1992, BIOCHEMISTRY-US, V31, P12183, DOI 10.1021/bi00163a030; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SCHULZ O, 1995, EUR J IMMUNOL, V25, P3191, DOI 10.1002/eji.1830251131; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Schulz O, 1998, J CLIN PATHOL-MOL PA, V51, P222, DOI 10.1136/mp.51.4.222; Shakib F, 1998, IMMUNOL TODAY, V19, P313, DOI 10.1016/S0167-5699(98)01284-5; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Sidobre S, 2000, J BIOL CHEM, V275, P2415, DOI 10.1074/jbc.275.4.2415; Strong P, 2003, CLIN EXP IMMUNOL, V134, P181, DOI 10.1046/j.1365-2249.2003.02281.x; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Strong P, 2002, CLIN EXP IMMUNOL, V130, P19, DOI 10.1046/j.1365-2249.2002.01968.x; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Suwabe A, 1996, ARCH BIOCHEM BIOPHYS, V327, P285, DOI 10.1006/abbi.1996.0123; Takai T, 2005, INT ARCH ALLERGY IMM, V137, P194, DOI 10.1159/000086331; Taneva S, 1997, BIOCHEMISTRY-US, V36, P8173, DOI 10.1021/bi963040h; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wang JY, 1996, CLIN EXP IMMUNOL, V106, P367, DOI 10.1046/j.1365-2249.1996.d01-838.x; Wang JY, 1998, AM J RESP CRIT CARE, V158, P510, DOI 10.1164/ajrccm.158.2.9709111; Wang JY, 2001, CLIN EXP ALLERGY, V31, P652, DOI 10.1046/j.1365-2222.2001.01031.x; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	60	75	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36808	36819		10.1074/jbc.M702336200	http://dx.doi.org/10.1074/jbc.M702336200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17848554	hybrid			2022-12-25	WOS:000251646000005
J	Matsuda, Y; Osaki, T; Hashii, T; Koshiba, T; Kawabata, SI				Matsuda, Yasuyuki; Osaki, Tsukasa; Hashii, Tomoyuki; Koshiba, Takumi; Kawabata, Shun-Ichiro			A cysteine-rich protein from an arthropod stabilizes clotting mesh and immobilizes bacteria at injury sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSESHOE-CRAB HEMOCYTES; AMINO-ACID-SEQUENCE; TACHYPLEUS-TRIDENTATUS HEMOCYTES; CORNIFIED CELL-ENVELOPE; LIMULUS BLOOD-CLOT; ANTIBACTERIAL ACTIVITY; CLOTTABLE PROTEIN; MOLECULAR-BASIS; GRAINY-HEAD; HEMOLYMPH	Hemolymph coagulation in arthropods plays key roles in host defense, including sealing wounds to staunch bleeding and immobilizing invading microorganisms. We have previously reported that horseshoe crab transglutaminase ( TGase) promotes cross-linking of a clotting protein ( coagulin) with hemocyte-derived proteins (proxins), resulting in the formation of stable coagulin fibrils. Here we show that TGase also cross-links proxins to another hemocyte-derived protein named stablin. Stablin is a cysteine-rich protein of 131 residues. Surface plasmon resonance analysis revealed the specific interaction of stablin with proxin-1 at K-d = 4.0 X 10(-9) M. Stablin was predominantly localized in the large granules of hemocytes and secreted by lipopolysaccharide-induced exocytosis. Interestingly, stablin bound to chitin at K-d = 1.5 x 10(-8) M, as determined by using a quartz-crystal microbalance. Stablin also interacted with lipopolysaccharides and lipoteichoic acids and exhibited bacterial agglutinating activity against Gram-positive and -negative bacteria. Immunostaining showed that stablin is co-localized with coagulin in the clotting fibrils that effectively trap bacteria. Moreover, an anti-stablin antibody strongly inhibited the proper formation of the clotting fibrils. These data suggest that stablin promotes the formation of the clotting mesh and the immobilization of invading microbes at injury sites. In arthropods, the TGase-mediated cross-linking may play an important role in the initial stage of host defense, wound closure, and healing, as in the case of mammals.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Kawabata, SI (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	skawascb@mbox.nc.kyushu-u.ac.jp	Koshiba, Takumi/A-3996-2013	Osaki, Tsukasa/0000-0002-9487-3253; Koshiba, Takumi/0000-0001-8535-5043				Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Armstrong PB, 2003, BIOL BULL-US, V205, P201, DOI 10.2307/1543252; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; DONOVAN MA, 1991, J BIOL CHEM, V266, P2121; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; HAINE ER, 2007, COMP IMMUNOL, V31, P456; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; Harlow E., 1989, ANTIBODIES LAB MANUA; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Isakova V, 2003, BIOL BULL-US, V205, P203, DOI 10.2307/1543253; Iwanaga S, 1998, J BIOCHEM, V123, P1; Kalinin A, 2001, J CELL SCI, V114, P3069; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kawabata S, 2002, BBA-GEN SUBJECTS, V1572, P414, DOI 10.1016/S0304-4165(02)00322-7; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; MANAB AR, 1989, J INVEST DERMATOL, V92, P263; Mastroberardino PG, 2006, BBA-BIOENERGETICS, V1757, P1357, DOI 10.1016/j.bbabio.2006.07.007; NAKAMURA T, 1987, J BIOCHEM, V101, P1297, DOI 10.1093/oxfordjournals.jbchem.a121994; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; Osaki T, 1999, J BIOL CHEM, V274, P26172, DOI 10.1074/jbc.274.37.26172; Powell B C, 1997, EXS, V78, P59; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SATO T, 1994, BIOCHEM BIOPH RES CO, V204, P551, DOI 10.1006/bbrc.1994.2494; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Shibuya K, 2004, GENOMICS, V83, P679, DOI 10.1016/j.ygeno.2003.09.024; SHIGENAGA T, 1993, J BIOCHEM-TOKYO, V114, P307, DOI 10.1093/oxfordjournals.jbchem.a124173; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Theopold U, 2002, CELL MOL LIFE SCI, V59, P363, DOI 10.1007/s00018-002-8428-4; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; TOKUNAGA F, 1993, J BIOL CHEM, V268, P252; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262	44	23	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33545	10.1074/jbc.M705854200	http://dx.doi.org/10.1074/jbc.M705854200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855345	hybrid			2022-12-25	WOS:000250840200035
J	Toth, J; Varga, B; Kovacs, M; Malnasi-Csizmadia, A; Vertessy, BG				Toth, Judit; Varga, Balazs; Kovacs, Mihaly; Malnasi-Csizmadia, Andras; Vertessy, Beata G.			Kinetic mechanism of human dUTPase, an essential nucleotide pyrophosphatase enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; DEOXYURIDINE TRIPHOSPHATASE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; EXPRESSION; PHOSPHATE; BINDING; MYOSIN; NUCLEOTIDOHYDROLASE	Human dUTPase is essential in controlling relative cellular levels of dTTP/ dUTP, both of which can be incorporated into DNA. The nuclear isoform of the enzyme has been proposed as a promising novel target for anticancer chemotherapeutic strategies. The recently determined three-dimensional structure of this protein in complex with an isosteric substrate analogue allowed in-depth structural characterization of the active site. However, fundamental steps of the dUTPase enzymatic cycle have not yet been revealed. This knowledge is indispensable for a functional understanding of the molecular mechanism and can also contribute to the design of potential antagonists. Here we present detailed pre-steady-state and steady-state kinetic investigations using a single tryptophan fluorophore engineered into the active site of human dUTPase. This sensor allowed distinction of the apoenzyme, enzyme-substrate, and enzyme product complexes. We show that the dUTP hydrolysis cycle consists of at least four distinct enzymatic steps: (i) fast substrate binding, (ii) isomerization of the enzyme-substrate complex into the catalytically competent conformation, (iii) a hydrolysis (chemical) step, and (iv) rapid, nonordered release of the products. Independent quenched-flow experiments indicate that the chemical step is the rate-limiting step of the enzymatic cycle. To follow the reaction in the quenched-flow, we devised a novel method to synthesize gamma-(32) P-labeled dUTP. We also determined by indicator-based rapid kinetic assays that proton release is concomitant with the rate-limiting hydrolysis step. Our results led to a quantitative kinetic model of the human dUTPase catalytic cycle and to direct assessment of relative flexibilities of the C-terminal arm, critical for enzyme activity, in the enzyme-ligand complexes along the reaction pathway.	Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary; Eotvos Lorand Univ, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University	Toth, J (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Karolina Ut 29, H-1113 Budapest, Hungary.	tothj@enzim.hu; vertessy@enzim.hu	Kovacs, Mihaly/A-6841-2011; Csizmadia, András Málnási/K-7632-2018; Vertessy, Beata G/H-6202-2012	Csizmadia, András Málnási/0000-0002-2430-8398; Vertessy, Beata G./0000-0002-1288-2982; Kovacs, Mihaly/0000-0002-1200-4741	FIC NIH HHS [D43 TW006230, R01 TW007241-01] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW006230, R01TW007241] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bekesi A, 2004, J BIOL CHEM, V279, P22362, DOI 10.1074/jbc.M313647200; Chano T, 2004, ONCOL REP, V11, P1257; Dauter Z, 1999, J MOL BIOL, V285, P655, DOI 10.1006/jmbi.1998.2332; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Kovacs M, 2002, J BIOL CHEM, V277, P28459, DOI 10.1074/jbc.M202180200; KOVARI J, 2007, IN PRESS PROTEINS; Ladner RD, 2000, CANCER RES, V60, P3493; Lakowicz JR, 1999, PRINCIPLES FLUORESCE, P291, DOI 10.1007/978-1-4757-3061-6; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Larsson G, 1996, NAT STRUCT BIOL, V3, P532, DOI 10.1038/nsb0696-532; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; MOLNAR J, 1961, ARCH BIOCHEM BIOPHYS, V93, P353, DOI 10.1016/0003-9861(61)90278-8; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2707; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Pearl LH, 1996, NAT STRUCT BIOL, V3, P485, DOI 10.1038/nsb0696-485; Prasad GS, 2000, ACTA CRYSTALLOGR D, V56, P1100, DOI 10.1107/S0907444900009197; Pugacheva EN, 2002, ONCOGENE, V21, P4595, DOI 10.1038/sj.onc.1205704; Romeike BFM, 2005, PATHOL RES PRACT, V201, P727, DOI 10.1016/j.prp.2005.08.005; Sambrook J, 2001, MOL CLONING A LAB MA, V3rd; SHLOMAI J, 1978, J BIOL CHEM, V253, P3305; STRAHLER JR, 1993, P NATL ACAD SCI USA, V90, P4991, DOI 10.1073/pnas.90.11.4991; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vertessy BG, 1998, FEBS LETT, V421, P83, DOI 10.1016/S0014-5793(97)01545-7; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h	33	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33572	10.1074/jbc.M706230200	http://dx.doi.org/10.1074/jbc.M706230200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848562	hybrid			2022-12-25	WOS:000250840200038
J	Hrizo, SL; Gusarova, V; Habiel, DM; Goeckeler, JL; Fisher, EA; Brodsky, JL				Hrizo, Stacy L.; Gusarova, Viktoria; Habiel, David M.; Goeckeler, Jennifer L.; Fisher, Edward A.; Brodsky, Jeffrey L.			The Hsp110 molecular chaperone stabilizes apolipoprotein B from endoplasmic reticulum-associated degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN-PROTEASOME PATHWAY; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; APO-B; HSP90 COCHAPERONE; CYSTIC-FIBROSIS; HEPG2 CELLS; MECHANISTICALLY DISTINCT	Apolipoprotein B ( apoB) is the most abundant protein in low density lipoproteins and plays key roles in cholesterol homeostasis. The co- translational degradation of apoB is controlled by fatty acid levels in the endoplasmic reticulum ( ER) and is mediated by the proteasome. To define the mechanism of apoB degradation, we employed a cell- free system in which proteasome-dependent degradation is recapitulated with yeast cytosol, and we developed an apoB yeast expression system. We discovered that a yeast Hsp110, Sse1p, associates with and stabilizes apoB, which contrasts with data indicating that select Hsp70s and Hsp90s facilitate apoB degradation. However, the Ssb Hsp70 chaperones have no effect on apoB turnover. To determine whether our results are relevant in mammalian cells, Hsp110 was overexpressed in hepatocytes, and enhanced apoB secretion was observed. This study indicates that chaperones within distinct complexes can play unique roles during ER- associated degradation ( ERAD), establishes a role for Sse1/ Hsp110 in ERAD, and identifies Hsp110 as a target to lower cholesterol.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; NYU, Sch Med, Dept Med Cardiol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; New York University	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, 274 Crawford Hall, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Fisher, Edward/ABE-7469-2020	Hrizo, Stacy/0000-0003-1723-720X; Goeckeler-Fried, Jennifer/0000-0001-5940-9917; Fisher, Edward/0000-0001-9802-143X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL058541, HL 058541] Funding Source: Medline; NIGMS NIH HHS [R01 GM075061, R01 GM075061-02, GM 75061] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adeli K, 1997, J BIOL CHEM, V272, P22489, DOI 10.1074/jbc.272.36.22489; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Du EZ, 1999, J BIOL CHEM, V274, P1856, DOI 10.1074/jbc.274.3.1856; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JONES EW, 1982, GENETICS, V102, P665; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Qiu W, 2005, ARTERIOSCL THROM VAS, V25, P571, DOI 10.1161/01.ATV.0000154142.61859.94; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rashid KA, 2002, J BIOL CHEM, V277, P22010, DOI 10.1074/jbc.M112448200; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Segrest JP, 2001, J LIPID RES, V42, P1346; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; SHIRAYAMA M, 1993, MOL GEN GENET, V240, P323, DOI 10.1007/BF00280382; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tietge UJF, 1999, J LIPID RES, V40, P2134; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Whitfield AJ, 2004, CLIN CHEM, V50, P1725, DOI 10.1373/clinchem.2004.038026; WU AL, 1981, J BIOL CHEM, V256, P3615; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; ZHANG HY, 1994, J BIOL CHEM, V269, P27799; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	65	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32665	32675		10.1074/jbc.M705216200	http://dx.doi.org/10.1074/jbc.M705216200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17823116	hybrid, Green Accepted			2022-12-25	WOS:000250625400015
J	Meslin, F; Thiery, J; Richon, C; Jalil, A; Chouaib, S				Meslin, Franck; Thiery, Jerome; Richon, Catherine; Jalil, Abdelali; Chouaib, Salem			Granzyme B-induced cell death involves induction of p53 tumor suppressor gene and its activation in tumor target cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA FRAGMENTATION; APOPTOSIS; MITOCHONDRIA; LYMPHOCYTES; PERFORIN; PROTEIN; PUMA; CTL; BAX	In this study we investigated the involvement of p53 in cytotoxic T-lymphocyte (CTL)-induced tumor target cell killing mediated by the perforin/granzymes pathway. For this purpose we used a human CTL clone (LT12) that kills its autologous melanoma target cells (T1), harboring a wild type p53. We demonstrated initially that LT12 kills its T1 target in a perforin/granzymes-dependent manner. Confocal microscopy and Western blot analysis indicated that conjugate formed between LT12 and T1 resulted in rapid cytoplasmic accumulation of p53 and its activation in T1 target cells. Cytotoxic assay using recombinant granzyme B (GrB) showed that this serine protease is the predominant factor inducing such accumulation. Furthermore, RNA interference-mediated lowering of the p53 protein in T1 cells or pifithrin-alpha-induced p53-specific inhibition activity significantly decreased CTL-induced target killing mediated by CTL or recombinant GrB. This emphasizes that p53 is an important determinant in granzyme B-induced apoptosis. Our data show furthermore that when T1 cells were treated with streptolysin-O/granzyme B, specific phosphorylation of p53 at Ser-15 and Ser-37 residues was observed subsequent to the activation of the stress kinases ataxia telangiectasia mutated (ATM) and p38K. Treatment of T1 cells with pifithrin-alpha resulted in inhibition of p53 phosphorylation at these residues and in a significant decrease in GrB-induced apoptotic T1 cell death. Furthermore, small interference RNAs targeting p53 was also accompanied by an inhibition of streptolysin-O/granzyme B-induced apoptotic T1 cell death. The present study supports p53 induction after CTL-induced stress in target cells. These findings provide new insight into a potential role of p53 as a component involved in the dynamic regulation of the major pathway of CTL-mediated cell death and may have therapeutic implications.	Inst Gustave Roussy, INSERM, Lab Immunol Tumeurs Humaines Interact Effecteurs, U753,PR1,IFR 54, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Chouaib, S (corresponding author), Inst Gustave Roussy, INSERM, Lab Immunol Tumeurs Humaines Interact Effecteurs, U753,PR1,IFR 54, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	chouaib@igr.fr	Chouaib, Salem/F-7939-2016; THIERY, Jerome/N-2469-2018	THIERY, Jerome/0000-0002-0998-3627; RICHON, Catherine/0000-0002-3556-3941; JALIL, Abdelali/0000-0003-2710-8735				Abouzahr S, 2006, P NATL ACAD SCI USA, V103, P1428, DOI 10.1073/pnas.0510454103; Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Anichini A, 1999, J EXP MED, V190, P651, DOI 10.1084/jem.190.5.651; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brown JM, 1999, CANCER RES, V59, P1391; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dufour E, 1997, J IMMUNOL, V158, P3787; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Faour WH, 2006, J BIOL CHEM, V281, P19849, DOI 10.1074/jbc.M601293200; Gorgoulis VG, 2003, EMBO J, V22, P1567, DOI 10.1093/emboj/cdg157; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Karawajew L, 2005, BLOOD, V105, P4767, DOI 10.1182/blood-2004-09-3428; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; PROSS HF, 1981, J CLIN IMMUNOL, V1, P51, DOI 10.1007/BF00915477; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Thiery J, 2005, J IMMUNOL, V174, P871, DOI 10.4049/jimmunol.174.2.871; Thiery J, 2003, J IMMUNOL, V170, P5919, DOI 10.4049/jimmunol.170.12.5919; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Trapani JA, 1998, J BIOL CHEM, V273, P27934, DOI 10.1074/jbc.273.43.27934; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Webster GA, 1999, MOL CELL BIOL, V19, P3485	43	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32991	32999		10.1074/jbc.M705290200	http://dx.doi.org/10.1074/jbc.M705290200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855337	hybrid			2022-12-25	WOS:000250625400048
J	Birrell, MA; Catley, MC; Hardaker, E; Wong, S; Willson, TM; McCluskie, K; Leonard, T; Farrow, SN; Collins, JL; Haj-Yahia, S; Belvisi, MG				Birrell, Mark A.; Catley, Matthew C.; Hardaker, Elizabeth; Wong, Sissie; Willson, Timothy M.; McCluskie, Kerryn; Leonard, Thomas; Farrow, Stuart N.; Collins, Jon L.; Haj-Yahia, Saleem; Belvisi, Maria G.			Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; LXR-ALPHA; KAPPA-B; CHOLESTEROL EFFLUX; NITRIC-OXIDE; MACROPHAGES; EXPRESSION; NEUTROPHILIA; INHIBITION; PATHWAY	The liver X receptors (LXR alpha/beta) are part of the nuclear receptor family and are believed to regulate cholesterol and lipid homeostasis. It has also been suggested that LXR agonists possess anti-inflammatory properties. The aim of this work was to determine the effect of LXR agonists on the innate immune response in human primary lung macrophages and a pre-clinical rodent model of lung inflammation. Before profiling the impact of the agonist, we established that both the human macrophages and the rodent lungs expressed LXR alpha/beta. We then used two structurally distinct LXR agonists to demonstrate that activation of this transcription factor reduces cytokine production in THP-1 cells and lung macrophages. Then, using the expression profile of ATP binding cassettes A1 (ABCA-1; a gene directly linked to LXR activation) as a biomarker for lung exposure of the compound, we demonstrated an LXR-dependent reduction in lung neutrophilia rodents in vivo. This inhibition was not associated with a suppression of c-Fos/c-Jun mRNA expression or NF-kappa B/AP-1 DNA binding, suggesting that any anti-inflammatory activity of LXR agonists is not via inhibition of NF-kappa B/AP-1 transcriptional activity. These data do not completely rule out an impact of these agonists on these two prominent transcription factors. In summary, this study is the first to demonstrate anti-inflammatory actions of LXRs in the lung. Chronic innate inflammatory responses observed in some airway diseases is thought to be central to disease pathogenesis. Therefore, data suggest that LXR ligands have utility in the treatment of lung diseases that involves chronic inflammation mediated by macrophages and neutrophils.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Airway Dis Dept,Resp Pharmacol Grp, London SW3 6LY, England; GlaxoSmithKline Inc, Discovery Res, High Throughput Chem, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline Inc, Ctr Excellence Drug Discovery, King Of Prussia, PA 19406 USA; GlaxoSmithKline Inc, Resp & Inflammat CEDD, Stevenage SG1 2NY, Herts, England; Royal Brompton & Harefield Hosp, London, England	Imperial College London; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital	Belvisi, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Airway Dis Dept,Resp Pharmacol Grp, Dovehouse St, London SW3 6LY, England.	m.belvisi@imperial.ac.uk	feinstein, doug/M-9414-2019; Belvisi, Maria G/A-3055-2009		Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: Medline; BBSRC [BB/E52708X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Birrell MA, 2006, J PHARMACOL EXP THER, V316, P1318, DOI 10.1124/jpet.105.093310; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Cao GQ, 2004, DRUG NEWS PERSPECT, V17, P35, DOI 10.1358/dnp.2004.17.1.829024; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Collins JL, 2004, CURR OPIN DRUG DISC, V7, P692; Costet P, 2000, J BIOL CHEM, V275, P28240; Englund MCO, 2001, ATHEROSCLEROSIS, V158, P61, DOI 10.1016/S0021-9150(01)00407-5; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liu SX, 1998, ATHEROSCLEROSIS, V136, P43, DOI 10.1016/S0021-9150(97)00185-8; McCluskie K, 2004, J PHARMACOL EXP THER, V311, P625, DOI 10.1124/jpet.104.068890; Michael LF, 2005, MINI-REV MED CHEM, V5, P729, DOI 10.2174/1389557054553767; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wagsater D, 2003, INT J MOL MED, V11, P419	26	47	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31882	31890		10.1074/jbc.M703278200	http://dx.doi.org/10.1074/jbc.M703278200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17766241	hybrid			2022-12-25	WOS:000250480300008
J	Gibb, SL; Boston-Howes, W; Lavina, ZS; Gustincich, S; Brown, RH; Pasinelli, P; Trotti, D				Gibb, Stuart L.; Boston-Howes, William; Lavina, Zeno S.; Gustincich, Stefano; Brown, Robert H., Jr.; Pasinelli, Piera; Trotti, Davide			A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DISEASE; SUMO-1 MODIFICATION; PROTEIN SUMOYLATION; 2-HYBRID SYSTEM; SPINAL-CORD; DNA-DAMAGE; PML BODIES; ALS; MICE; ACTIVATION	EAAT2 (excitatory amino acid transporter 2) is a high affinity, Na+-dependent glutamate transporter of glial origin that is essential for the clearance of synaptically released glutamate and prevention of excitotoxicity. During the course of human amyotrophic lateral sclerosis (ALS) and in a transgenic mutant SOD1 mouse model of the disease, expression and activity of EAAT2 is remarkably reduced. We previously showed that some of the mutant SOD1 proteins exposed to oxidative stress inhibit EAAT2 by triggering caspase-3 cleavage of EAAT2 at a single defined locus. This gives rise to two fragments that we termed truncated EAAT2 and COOH terminus of EAAT2 (CTE). In this study, we report that analysis of spinal cord homogenates prepared from mutant G93A-SOD1 mice reveals CTE to be of a higher molecular weight than expected because it is conjugated with SUMO-1. The sumoylated CTE fragment (CTE-SUMO-1) accumulates in the spinal cord of these mice as early as presymptomatic stage(70 days of age) andnot in other central nervous system areas unaffected by the disease. The presence and accumulation of CTE-SUMO-1 is specific to ALS mice, since it does not occur in the R6/2 mouse model for Huntington disease. Furthermore, using an astroglial cell line, primary culture of astrocytes, and tissue samples from G93A-SOD1 mice, we show that CTE-SUMO-1 is targeted to promyelocytic leukemia nuclear bodies. Since one of the proposed functions of promyelocytic leukemia nuclear bodies is regulation of gene transcription, we suggest a possible novel mechanism by which the glial glutamate transporter EAAT2 could contribute to the pathology of ALS.	Thomas Jefferson Univ, Weinberg Unit ALS Res, Farber Inst Neurosci, Philadelphia, PA 19107 USA; Massachusetts Gen Hosp, Cecil B Day Lab Neuromuscular Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Giovanni Armenise Harvard Fdn Lab, Sector Neurobiol, Scuola Int Super Studi Avanzati, I-34012 Basovizza, Italy	Jefferson University; Harvard University; Massachusetts General Hospital; Harvard University	Trotti, D (corresponding author), Thomas Jefferson Univ, Weinberg Unit ALS Res, Farber Inst Neurosci, 900 Walnut St, Philadelphia, PA 19107 USA.	davide.trotti@jefferson.edu	Longo, Kenneth A/A-5631-2010	Pasinelli, Piera/0000-0002-3385-2707; Gustincich, Stefano/0000-0002-2749-2514; Trotti, Davide/0000-0001-6338-6404	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044292] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS44292] Funding Source: Medline; Telethon [GGP06268] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Bendotti C, 2001, J NEUROCHEM, V79, P737, DOI 10.1046/j.1471-4159.2001.00572.x; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Chung TL, 2004, J BIOL CHEM, V279, P39653, DOI 10.1074/jbc.M405637200; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Danbolt NC, 1998, METHOD ENZYMOL, V296, P388; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Fei EK, 2006, BIOCHEM BIOPH RES CO, V347, P406, DOI 10.1016/j.bbrc.2006.06.092; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holmseth S, 2006, ANAT EMBRYOL, V211, P257, DOI 10.1007/s00429-005-0077-6; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Janssen K, 2007, ONCOGENE, V26, P1557, DOI 10.1038/sj.onc.1209923; Johansson A, 2007, J NEUROL SCI, V255, P17, DOI 10.1016/j.jns.2007.01.057; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Pardo AC, 2006, EXP NEUROL, V201, P120, DOI 10.1016/j.expneurol.2006.03.028; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pederzoli M, 2005, J IMMUNOL, V174, P6381, DOI 10.4049/jimmunol.174.10.6381; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sun YJ, 2003, GENOMICS, V82, P250, DOI 10.1016/S0888-7543(03)00075-2; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Taylor AR, 2007, J NEUROSCI, V27, P634, DOI 10.1523/JNEUROSCI.4947-06.2007; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	63	65	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32480	32490		10.1074/jbc.M704314200	http://dx.doi.org/10.1074/jbc.M704314200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823119	hybrid			2022-12-25	WOS:000250480300071
J	Savinov, AY; Rozanov, DV; Strongin, AY				Savinov, Alexei Y.; Rozanov, Dmitri V.; Strongin, Alex Y.			Specific inhibition of autoimmune T cell transmigration contributes to beta cell functionality and insulin synthesis in non-obese diabetic (NOD) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; LOW-DOSE STREPTOZOTOCIN; TISSUE INHIBITOR; MMP INHIBITOR; REGENERATION; CD44; EXPRESSION; MIGRATION; PANCREAS; MODEL	Human diabetes mellitus ( IDDM; type I diabetes) is a T cell-mediated disease that is closely modeled in non-obese diabetic ( NOD) mice. The pathogenesis of IDDM involves the transmigration of autoimmune T cells into the pancreatic islets and the subsequent destruction of insulin-producing beta cells. Therapeutic interventions leading to beta cell regeneration and the reversal of established IDDM are exceedingly limited. We report here that specific inhibition of T cell intra-islet transmigration by using a small molecule proteinase inhibitor restores beta cell functionality, increases insulin-producing beta cell mass, and alleviates the severity of IDDM in acutely diabetic NOD mice. As a result, acutely diabetic NOD mice do not require insulin injections for survival for a significant time period, thus providing a promising clue to effect IDDM reversal in humans. The extensive morphometric analyses and the measurements of both the C-peptide blood levels and the proinsulin mRNA levels in the islets support our conclusions. Diabetes transfer experiments suggest that the inhibitor specifically represses the T cell transmigration and homing processes as opposed to causing immunosuppression. Overall, our data provide a rationale for the pharmacological control of the T cell transmigration step in human IDDM.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NCRR NIH HHS [RR020843] Funding Source: Medline; NIAID NIH HHS [AI061139, AI056385] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056385, U01AI061139] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Annabi B, 2002, BBA-MOL CELL RES, V1542, P209, DOI 10.1016/S0167-4889(01)00187-2; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Bresson D, 2007, AUTOIMMUN REV, V6, P315, DOI 10.1016/j.autrev.2006.09.013; Cappuzzo Federico, 2003, Expert Opin Emerg Drugs, V8, P179, DOI 10.1517/14728214.8.1.179; Chiang WC, 2006, ORAL DIS, V12, P27, DOI 10.1111/j.1601-0825.2005.01151.x; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Bedoui J, 2005, CARDIOVASC RES, V67, P317, DOI 10.1016/j.cardiores.2005.03.017; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Gallegos AM, 2004, CELL, V117, P149, DOI 10.1016/S0092-8674(04)00340-X; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Ikejiri M, 2005, J ORG CHEM, V70, P5709, DOI 10.1021/jo050339+; Jiang HW, 2007, DIABETES, V56, P49, DOI 10.2337/db06-0710; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kohnert KD, 1997, ACTA DIABETOL, V34, P301, DOI 10.1007/s005920050092; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Liu MJ, 2007, MOL THER, V15, P86, DOI 10.1038/sj.mt.6300005; Marhaba R, 2006, EUR J IMMUNOL, V36, P3017, DOI 10.1002/eji.200636158; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Pelegri C, 2001, MOL MED, V7, P311, DOI 10.1007/BF03402214; Rood PPM, 2006, PHARM RES-DORDR, V23, P227, DOI 10.1007/s11095-005-9095-6; Savinov AY, 2007, IUBMB LIFE, V59, P6, DOI 10.1080/15216540601187795; Savinov AY, 2006, FASEB J, V20, P1793, DOI 10.1096/fj.06-6207com; Savinov AY, 2005, J BIOL CHEM, V280, P27755, DOI 10.1074/jbc.M506016200; Savinov AY, 2001, J IMMUNOL, V167, P6637, DOI 10.4049/jimmunol.167.11.6637; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Shalinsky DR, 1999, ANN NY ACAD SCI, V878, P236, DOI 10.1111/j.1749-6632.1999.tb07689.x; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Trucco M, 2006, CELL TRANSPLANT, V15, pS75; Weiss L, 2000, P NATL ACAD SCI USA, V97, P285, DOI 10.1073/pnas.97.1.285; Wong FS, 1999, J AUTOIMMUN, V13, P290, DOI 10.1006/jaut.1999.0322; Woods CC, 2006, J AUTOIMMUN, V27, P28, DOI 10.1016/j.jaut.2006.04.004; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	43	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32106	32111		10.1074/jbc.M705348200	http://dx.doi.org/10.1074/jbc.M705348200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761671	hybrid			2022-12-25	WOS:000250480300031
J	Zhang, L; Wang, Y; Olive, AJ; Smith, ND; Picking, WD; De Guzman, RN; Picking, WL				Zhang, Lingling; Wang, Yu; Olive, Andrew J.; Smith, Nathan D.; Picking, William D.; De Guzman, Roberto N.; Picking, Wendy L.			Identification of the MxiH needle protein residues responsible for anchoring invasion plasmid antigen D to the type III secretion needle tip	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHIGELLA-FLEXNERI; SYSTEM NEEDLE; BURKHOLDERIA-PSEUDOMALLEI; STRUCTURAL-ANALYSIS; EPITHELIAL-CELLS; IPAD; BIPD; SALMONELLA; MECHANISM; PATHOGENS	The pathogenesis of Shigella flexneri requires a functional type III secretion apparatus to serve as a conduit for injecting host-altering effector proteins into the membrane and cytoplasm of the targeted cell. The type III secretion apparatus is composed of a basal body and an exposed needle that is an extended polymer of MxiH with a 2.0-nm inner channel. Invasion plasmid antigen D ( IpaD) resides at the tip of the needle to control type III secretion. The atomic structures of MxiH and IpaD have been solved. MxiH ( 8.3 kDa) is a helix-turn-helix, whereas IpaD ( 36.6 kDa) has a dumbbell shape with two globular domains flanking a central coiled-coil that stabilizes the protein. These structures alone, however, have not been sufficient to produce a workable in silico model by which IpaD docks at the needle tip. Thus, the work presented here provides an initial step in understanding this important protein-protein interaction. We have identified key MxiH residues located in its PSNP loop and the contiguous surface that uniquely contribute to the formation of the IpaD-needle interface as determined by NMR chemical shift mapping. Mutation of Asn-43, Leu-47, and Tyr-50 residues severely affects the stable maintenance of IpaD at the Shigella surface and thus compromises the invasive phenotype of S. flexneri. Other residues could be mutated to give rise to intermediate phenotypes, suggesting they have a role in tip complex stabilization while not being essential for tip complex formation. Initial in vitro fluorescence polarization studies confirmed that specific amino acid changes adversely affect the MxiH-IpaD interaction. Meanwhile, none of the mutations appeared to have a negative effect on the MxiH-MxiH interactions required for efficient needle assembly.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Picking, WL (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	pickingw@ku.edu	Zhang, Lingling/A-1100-2015; wang, yu/A-3473-2011	Olive, Andrew/0000-0003-3441-3113	NCRR NIH HHS [RR017708] Funding Source: Medline; NIAID NIH HHS [AI057927, AI067858, AI034428] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034428, R01AI057927, R29AI034428, R01AI067858] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Darboe N, 2006, PROTEIN SCI, V15, P543, DOI 10.1110/ps.051733506; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Deane JE, 2006, ACTA CRYSTALLOGR F, V62, P302, DOI 10.1107/S1744309106006555; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutta S, 2003, J CLIN MICROBIOL, V41, P5833, DOI 10.1128/JCM.41.12.5833-5834.2003; Erskine PT, 2006, J MOL BIOL, V363, P125, DOI 10.1016/j.jmb.2006.07.069; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Harrington AT, 2003, INFECT IMMUN, V71, P1255, DOI 10.1128/IAI.71.3.1255-1264.2003; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MARQUART ME, 1995, BIOCHEM BIOPH RES CO, V214, P963, DOI 10.1006/bbrc.1995.2380; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; MOHLEBOETANI JC, 1995, AM J PUBLIC HEALTH, V85, P812, DOI 10.2105/AJPH.85.6.812; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06; Parsot C, 1996, CURR TOP MICROBIOL, V209, P25; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Picking WL, 2001, MOL MICROBIOL, V39, P100, DOI 10.1046/j.1365-2958.2001.02210.x; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Zhang LL, 2006, J MOL BIOL, V359, P322, DOI 10.1016/j.jmb.2006.03.028; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	32	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32144	32151		10.1074/jbc.M703403200	http://dx.doi.org/10.1074/jbc.M703403200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827155	hybrid, Green Published			2022-12-25	WOS:000250480300036
J	Bakre, MM; Hoi, A; Mong, JCY; Koh, YY; Wong, KY; Stanton, LW				Bakre, Manjiri Manohar; Hoi, Aina; Mong, Jamie Chen Yee; Koh, Yvonne Yiling; Wong, Kee Yew; Stanton, Lawrence W.			Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; TYROSINE KINASE; DIVERGING POINT; AXIS FORMATION; GERM LAYER; CATENIN; MESODERM; LINEAGES; CULTURE; FATE	Pluripotent embryonic stem cells (ESCs) are capable of differentiating into cell types belonging to all three germ layers within the body, which makes them an interesting and intense field of research. Inefficient specific differentiation and contamination with unwanted cell types are the major issues in the use of ESCs in regenerative medicine. Lineage-specific progenitors generated from ESCs could be utilized to circumvent the issue. We demonstrate here that sustained activation of the Wnt pathway ( using Wnt3A or an inhibitor of glycogen synthase kinase 3 beta) in multiple mouse and human ESCs results in meso/endodermspecific differentiation. Using monolayer culture conditions, we have generated multipotential "mesendodermal progenitor clones" (MPC) from mouse ESCs by sustained Wnt pathway activation. MPCs express increased levels of meso/endodermal and mesendodermal markers and exhibit a stable phenotype in culture over a year. The MPCs have enhanced potential to differentiate along endothelial, cardiac, vascular smooth muscle, and skeletal lineages than undifferentiated ESCs. In conclusion, we demonstrate that the Wnt pathway activation can be utilized to generate lineage-specific progenitors from ESCs, which can be further differentiated into desired organ-specific cells.	Gen Inst Singapore, Stem Cell & Dev Biol, Singapore, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Bakre, MM (corresponding author), Gen Inst Singapore, Stem Cell & Dev Biol, 60,Biopolis St gen 02-01, Singapore, Singapore.	bakre@gis.a-star.edu.sg	Mong, Jamie/AFU-5649-2022	Mong, Jamie/0000-0003-0312-4482				ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Choi K, 1998, DEVELOPMENT, V125, P725; Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152; DADUE P, 2006, P NATL ACAD SCI USA, V103, P16806; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Li F, 2006, HISTOL HISTOPATHOL, V21, P103, DOI 10.14670/HH-21.103; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shibamoto S, 1998, GENES CELLS, V3, P659; SHIBUYA M, 1990, ONCOGENE, V5, P519; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	51	98	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31703	31712		10.1074/jbc.M704287200	http://dx.doi.org/10.1074/jbc.M704287200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17711862	hybrid			2022-12-25	WOS:000250309200061
J	Johnson, CM; Tapping, RI				Johnson, Christopher M.; Tapping, Richard I.			Microbial products stimulate human toll-like receptor 2 expression through histone modification surrounding a proximal NF-kappa b-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-2; DIFFERENTIAL EXPRESSION; GENE; LEUKOCYTES; MONOCYTES; ACTIVATION; LIPOPOLYSACCHARIDE; TRANSCRIPTION; INFLAMMATION; MACROPHAGES	Previous studies have yielded conflicting results regarding the ability of microbial products to activate TLR2 gene expression in human monocytes. In this study, we found that TLR2 mRNA was rapidly up-regulated in human monocytes treated with TLR2 and TLR4 agonists, and this corresponded to an increase in cell surface receptor levels. This induction was abrogated by actinomycin D as well as a pharmacologic inhibitor of NF-kappa B, suggesting that the TLR2 gene is transcriptionally activated via NF-kappa B. Microbial agonists were found to shift the transcription initiation site of the TLR2 gene, and sequence examination revealed a near-consensus NF-kappa B-binding element immediately upstream of this site. Electromobility shift assays confirmed that NF-kappa B bound to this putative site in vitro. However, luciferase reporter plasmids driven by the TLR2 promoter were not responsive to TLR2 agonists. Overexpression of the NF-kappa B p65 subunit was sufficient to induce expression of the endogenous TLR2 mRNA, and co-transfection of the CREB-binding protein and p300 co-activators further increased TLR2 mRNA levels. Chromatin immunoprecipitation analysis revealed that p65, CREB-binding protein, and p300 are recruited to the TLR2 promoter upon stimulation of human monocytes followed by histone hyperacetylation. Taken together, these results define a mechanism whereby histone modification and increased promoter access induce expression of human TLR2 following infection.	Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL 61801 USA; Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tapping, RI (corresponding author), Univ Illinois, Dept Microbiol, B103 Chem & Life Sci Bldg,C 110,601 Goodwin Ave, Urbana, IL 61801 USA.	tapping@life.uiuc.edu			NIAID NIH HHS [AI052344] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344, R21AI052344] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1999, J ALLERGY CLIN IMMUN, V103, P990, DOI 10.1016/S0091-6749(99)70168-5; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Goodman RH, 2000, GENE DEV, V14, P1553; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; JEONG S, 1994, J BIOL CHEM, V269, P2197; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Magner WJ, 2000, J REPROD IMMUNOL, V48, P1, DOI 10.1016/S0165-0378(00)00066-8; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Marsik C, 2003, BRIT J HAEMATOL, V121, P653, DOI 10.1046/j.1365-2141.2003.04350.x; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Orihara K, 2007, CLIN EXP IMMUNOL, V148, P260, DOI 10.1111/j.1365-2249.2007.03352.x; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Siedlar M, 2004, J IMMUNOL, V173, P2736, DOI 10.4049/jimmunol.173.4.2736; Sumegi A, 2007, INT ARCH ALLERGY IMM, V143, P177, DOI 10.1159/000099309; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Viemann D, 2005, PEDIATR RES, V58, P654, DOI 10.1203/01.PDR.0000180544.02537.FD; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wang TY, 2000, J IMMUNOL, V165, P6308, DOI 10.4049/jimmunol.165.11.6308; Wang TY, 2002, J IMMUNOL, V169, P795, DOI 10.4049/jimmunol.169.2.795; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Wetzler LM, 2003, VACCINE, V21, pS55, DOI 10.1016/S0264-410X(03)00201-9; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; ZIEGLERHEITBROCK HWL, 1993, J IMMUNOL, V151, P6986	44	37	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31197	31205		10.1074/jbc.M705151200	http://dx.doi.org/10.1074/jbc.M705151200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728249	hybrid			2022-12-25	WOS:000250309200009
J	Weaver, AK; Olsen, ML; McFerrin, MB; Sontheimer, H				Weaver, Amy K.; Olsen, Michelle L.; McFerrin, Michael B.; Sontheimer, Harald			BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts - A novel mechanism for coupling [Ca2+](i) to ion channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLIOMA-CELLS; CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; SMOOTH-MUSCLE; MUSCARINIC RECEPTORS; RYANODINE RECEPTORS; CHOLESTEROL CONTENT; SIGNALING COMPLEX; MEMBRANE DOMAINS; CA2+ CHANNELS	Glioma cells prominently express a unique splice variant of a large conductance, calcium-activated potassium channel (BK channel). These channels transduce changes in intracellular calcium to changes of K+ conductance in the cells and have been implicated in growth control of normal and malignant cells. The Ca2+ increase that facilitates channel activation is thought to occur via activation of intracellular calcium release pathways or influx of calcium through Ca2+-permeable ion channels. We show here that BK channel activation involves the activation of inositol 1,4,5-triphosphate receptors (IP3R), which localize near BK channels in specialized membrane domains called lipid rafts. Disruption of lipid rafts with methyl-beta-cyclodextrin disrupts the functional association of BK channel and calcium source resulting in a > 50% reduction in K+ conductance mediated by BK channels. The reduction of BK current by lipid raft disruption was overcome by the global elevation of intracellular calcium through inclusion of 750 nM Ca2+ in the pipette solution, indicating that neither the calcium sensitivity of the channel nor their overall number was altered. Additionally, pretreatment of glioma cells with 2-aminoethoxydiphenyl borate to inhibit IP(3)Rs negated the effect of methyl-beta-cyclodextrin, providing further support that IP(3)Rs are the calcium source for BK channels. Taken together, these data suggest a privileged association of BK channels in lipid raft domains and provide evidence for a novel coupling of these Ca2+-sensitive channels to their second messenger source.	Univ Alabama, Ctr Glial Biol Med, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), 1719 6th Ave, CIRC 425, Birmingham, AL 35294 USA.	hws@uab.edu		Sontheimer, Harald/0000-0002-5843-9871; Olsen, Michelle/0000-0003-1394-664X	NCI NIH HHS [P50 CA097247-05, P50 CA097247] Funding Source: Medline; NINDS NIH HHS [R01-NS31234, R01 NS036692, R01 NS031234-14A1, R01-NS36692, R01 NS031234, R01 NS036692-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA097247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031234, R01NS036692] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; BOMBEN VC, 2007, IN PRESS CELL PROLIF; Bordey A, 2000, J MEMBRANE BIOL, V176, P31, DOI 10.1007/s002320001073; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Catlin MC, 2000, CYTOMETRY, V41, P123; CHANG HM, 1995, J MEMBRANE BIOL, V145, P13; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Christian AE, 1997, J LIPID RES, V38, P2264; Delling M, 2002, J NEUROSCI, V22, P7154; Doheny HC, 2005, J CLIN ENDOCR METAB, V90, P5786, DOI 10.1210/jc.2005-0574; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Grunnet M, 2004, J BIOL CHEM, V279, P36445, DOI 10.1074/jbc.M402254200; Guizzetti M, 1998, EUR J PHARMACOL, V359, P223, DOI 10.1016/S0014-2999(98)00620-7; Guizzetti M, 2001, NEUROREPORT, V12, P1639, DOI 10.1097/00001756-200106130-00025; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartel S, 1998, ANAL BIOCHEM, V258, P277, DOI 10.1006/abio.1998.2594; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; KUNERTRADEK J, 1989, ACTA NEUROL SCAND, V79, P166, DOI 10.1111/j.1600-0404.1989.tb03731.x; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Ningaraj NS, 2002, J PHARMACOL EXP THER, V301, P838, DOI 10.1124/jpet.301.3.838; OHI Y, 2001, J PHYSIOL-LONDON, V534, P2; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; PATTERSON RL, 2004, ANNU REV BIOCHEM, V73, P18; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Ransom CB, 2002, GLIA, V38, P281, DOI 10.1002/glia.10064; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rujoi M, 2003, INVEST OPHTH VIS SCI, V44, P1634, DOI 10.1167/iovs.02-0786; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Wellman GC, 2003, CELL CALCIUM, V34, P211, DOI 10.1016/S0143-4160(03)00124-6; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177	50	77	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31558	31568		10.1074/jbc.M702866200	http://dx.doi.org/10.1074/jbc.M702866200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17711864	Green Accepted, hybrid			2022-12-25	WOS:000250309200048
J	Aris-Brosou, S				Aris-Brosou, Stephane			Dating Phylogenies with Hybrid Local Molecular Clocks	PLOS ONE			English	Article								Background. Because rates of evolution and species divergence times cannot be estimated directly from molecular data, all current dating methods require that specific assumptions be made before inferring any divergence time. These assumptions typically bear either on rates of molecular evolution (molecular clock hypothesis, local clocks models) or on both rates and times (penalized likelihood, Bayesian methods). However, most of these assumptions can affect estimated dates, oftentimes because they underestimate large amounts of rate change. Principal Findings. A significant modification to a recently proposed ad hoc rate-smoothing algorithm is described, in which local molecular clocks are automatically placed on a phylogeny. This modification makes use of hybrid approaches that borrow from recent theoretical developments in microarray data analysis. An ad hoc integration of phylogenetic uncertainty under these local clock models is also described. The performance and accuracy of the new methods are evaluated by reanalyzing three published data sets. Conclusions. It is shown that the new maximum likelihood hybrid methods can perform better than penalized likelihood and almost as well as uncorrelated Bayesian models. However, the new methods still tend to underestimate the actual amount of rate change. This work demonstrates the difficulty of estimating divergence times using local molecular clocks.	[Aris-Brosou, Stephane] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Aris-Brosou, S (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	sarisbro@uottawa.ca		Aris-Brosou, Stephane/0000-0003-4987-0296				Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; Aris-Brosou S, 2006, GENOME, V49, P767, DOI 10.1139/G06-038; Aris-Brosou S, 2006, GENE, V378, P58, DOI 10.1016/j.gene.2006.04.024; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards AWF, 1992, LIKELIHOOD; Felsenstein J., 2004, INFERRING PHYLOGENIE; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Ho SYW, 2005, MOL BIOL EVOL, V22, P1355, DOI 10.1093/molbev/msi125; Huelsenbeck JP, 2000, GENETICS, V154, P1879; KAUFMAN L, 1990, FINDING GROUPS DATA, pR14; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pollard KS, 2002, MATH BIOSCI, V176, P99, DOI 10.1016/S0025-5564(01)00116-X; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rannala B, 2002, SYST BIOL, V51, P754, DOI 10.1080/10635150290102429; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Welch JJ, 2005, SYST BIOL, V54, P672, DOI 10.1080/10635150590947212; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Yang Z., 2006, COMPUTATIONAL MOL EV, p[xvi, 357], DOI DOI 10.1093/NAR/GKP952; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang Ziheng, 2004, Acta Zoologica Sinica, V50, P645; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; ZUCKERKANDL EMILE, 1965, P97; [No title captured]	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e879	10.1371/journal.pone.0000879	http://dx.doi.org/10.1371/journal.pone.0000879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849008	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455600025
J	Brownstein, JS; Sordo, M; Kohane, IS; Mandl, KD				Brownstein, John S.; Sordo, Margarita; Kohane, Isaac S.; Mandl, Kenneth D.			The Tell-Tale Heart: Population-Based Surveillance Reveals an Association of Rofecoxib and Celecoxib with Myocardial Infarction	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; UPPER GASTROINTESTINAL TOXICITY; CONFLICT-OF-INTEREST; CARDIOVASCULAR EVENTS; COX-2 INHIBITORS; CYCLO-OXYGENASE-2 INHIBITORS; CYCLOOXYGENASE-2 INHIBITORS; PUBLIC-HEALTH; RISK; SAFETY	Background. COX-2 selective inhibitors are associated with myocardial infarction (MI). We sought to determine whether population health monitoring would have revealed the effect of COX-2 inhibitors on population-level patterns of MI. Methodology/Principal Findings. We conducted a retrospective study of inpatients at two Boston hospitals, from January 1997 to March 2006. There was a population-level rise in the rate of MI that reached 52.0 MI-related hospitalizations per 100,000 (a two standard deviation exceedence) in January of 2000, eight months after the introduction of rofecoxib and one year after celecoxib. The exceedence vanished within one month of the withdrawal of rofecoxib. Trends in inpatient stay due to MI were tightly coupled to the rise and fall of prescriptions of COX-2 inhibitors, with an 18.5% increase in inpatient stays for MI when both rofecoxib and celecoxib were on the market (P<0.001). For every million prescriptions of rofecoxib and celecoxib, there was a 0.5% increase in MI (95% CI 0.1 to 0.9) explaining 50.3% of the deviance in yearly variation of MI-related hospitalizations. There was a negative association between mean age at MI and volume of prescriptions for celecoxib and rofecoxib (Spearman correlation, -0.67, P<0.05). Conclusions/Significance. The strong relationship between prescribing and outcome time series supports a population-level impact of COX-2 inhibitors on MI incidence. Further, mean age at MI appears to have been lowered by use of these medications. Use of a population monitoring approach as an adjunct to pharmacovigilence methods might have helped confirm the suspected association, providing earlier support for the market withdrawal of rofecoxib.	[Brownstein, John S.; Sordo, Margarita; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Mit Div Hlth Sci & Technol, Informat Program, Childrens Hosp, Boston, MA USA; [Brownstein, John S.; Mandl, Kenneth D.] Childrens Hosp Boston, Div Emergency Med, Boston, MA USA; [Brownstein, John S.; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Sordo, Margarita] Brigham & Womens Hosp, Decis Syst Grp, Boston, MA 02115 USA; [Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Med Sch, Ctr Biomed Informat, Boston, MA USA; [Kohane, Isaac S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Brownstein, JS (corresponding author), Harvard Mit Div Hlth Sci & Technol, Informat Program, Childrens Hosp, Boston, MA USA.	john_brownstein@harvard.edu	Kohane, Isaac Kohane/K-3716-2012; Brownstein, John S/A-1438-2011	Kohane, Isaac Kohane/0000-0003-2192-5160; 	National Library of Medicine, National Institutes of Health [R01 LM007677-01, 5U54LM008748-02.20]; Canadian Institutes of Health Research [200510MFE-154492]; Massachusetts Institute of Technology Center for Biomedical Innovation; NATIONAL LIBRARY OF MEDICINE [U54LM008748, R01LM007677] Funding Source: NIH RePORTER	National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Massachusetts Institute of Technology Center for Biomedical Innovation; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported grant numbers R01 LM007677-01 and 5U54LM008748-02.20 from the National Library of Medicine, National Institutes of Health, grant number 200510MFE-154492 from the Canadian Institutes of Health Research and a grant from the Massachusetts Institute of Technology Center for Biomedical Innovation. The funders had no role in the design or conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	American Heart Association, 2005, HEART DIS STROKE STA; Avorn J, 2006, CIRCULATION, V113, P2173, DOI 10.1161/CIRCULATIONAHA.106.625749; Baune B, 2006, PLOS MED, V3, P734, DOI 10.1371/journal.pmed.0030220; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; BORER JS, 2007, EUR HEART J; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Campion EW, 2000, NEW ENGL J MED, V343, P1485, DOI 10.1056/NEJM200011163432009; Crawford LM, 2005, FOOD DRUG LAW J, V60, P99; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Davis RL, 2005, EPIDEMIOLOGY, V16, P336, DOI 10.1097/01.ede.0000155506.05636.a4; Drazen JM, 2005, NEW ENGL J MED, V352, P1131, DOI 10.1056/NEJMe058038; *FOOD DRUG ADM, 2003, MEDWATCH REP CONS; Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Hauben M, 2003, DRUG SAFETY, V26, P159, DOI 10.2165/00002018-200326030-00003; Heeley E, 2001, LANCET, V358, P1872, DOI 10.1016/S0140-6736(01)06898-2; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; *IMS HLTH, 2006, COMM REQ THER CLASS; *IOM, 2006, FUT DRUG SAF PROM PR; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; Mann RD, 2004, PHARMACOEPIDEM DR S, V13, P501, DOI 10.1002/pds.994; McCullagh P, 1989, GEN LINEAR MODELS; Milane MS, 2006, PLOS MED, V3, P816, DOI 10.1371/journal.pmed.0030190; Moore N, 2003, PHARMACOEPIDEM DR S, V12, P271, DOI 10.1002/pds.848; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2007, NEW ENGL J MED, V356, P2522, DOI 10.1056/NEJMe078099; Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404; Ray WA, 2006, NEW ENGL J MED, V354, P194, DOI 10.1056/NEJMsb053432; Reis BY, 2003, P NATL ACAD SCI USA, V100, P1961, DOI 10.1073/pnas.0335026100; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Strom BL, 2004, JAMA-J AM MED ASSOC, V292, P2643, DOI 10.1001/jama.292.21.2643; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Tsui FC, 2003, J AM MED INFORM ASSN, V10, P399, DOI 10.1197/jamia.M1345; Waxman HA, 2005, NEW ENGL J MED, V352, P2576, DOI 10.1056/NEJMp058136; WILLIAMS SM, 1992, BRIT MED J, V304, P1359, DOI 10.1136/bmj.304.6838.1359; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Wysowski DK, 2001, AM J GASTROENTEROL, V96, P1698, DOI 10.1016/S0002-9270(01)02490-X; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998; 1998, MMWR MORB MORTAL WKL, V50, P90	53	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e840	10.1371/journal.pone.0000840	http://dx.doi.org/10.1371/journal.pone.0000840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786211	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500023
J	Lee, SJ				Lee, Se-Jin			Quadrupling Muscle Mass in Mice by Targeting TGF-beta Signaling Pathways	PLOS ONE			English	Article							MYOSTATIN PROPEPTIDE; GENE; MUTATIONS; GROWTH	Myostatin is a transforming growth factor-beta family member that normally acts to limit skeletal muscle growth. Mice genetically engineered to lack myostatin activity have about twice the amount of muscle mass throughout the body, and similar effects are seen in cattle, sheep, dogs, and a human with naturally occurring loss-of-function mutations in the myostatin gene. Hence, there is considerable interest in developing agents capable of inhibiting myostatin activity for both agricultural and human therapeutic applications. We previously showed that the myostatin binding protein, follistatin, can induce dramatic increases in muscle mass when overexpressed as a transgene in mice. In order to determine whether this effect of follistatin results solely from inhibition of myostatin activity, I analyzed the effect of this transgene in myostatin-null mice. Mstn(-/-) mice carrying a follistatin transgene had about four times the muscle mass of wild type mice, demonstrating the existence of other regulators of muscle mass with similar activity to myostatin. The greatest effect on muscle mass was observed in offspring of mothers homozygous for the Mstn mutation, raising the possibility that either myostatin itself or a downstream regulator may normally be transferred from the maternal to fetal circulations. These findings demonstrate that the capacity for increasing muscle growth by manipulating TGF-beta signaling pathways is much more extensive than previously appreciated and suggest that muscle mass may be controlled at least in part by a systemic mode of action of myostatin.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Lee, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sjlee@jhmi.edu			National Institutes of Health [R01HD35887, U54AR052646]; Muscular Dystrophy Association [MDA3765]; Merck Research Laboratories; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Merck Research Laboratories(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health ( R01HD35887 and U54AR052646), a grant from the Muscular Dystrophy Association ( MDA3765), and a gift from Merck Research Laboratories.	Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; BULLOUGH WS, 1962, BIOL REV, V37, P307, DOI 10.1111/j.1469-185X.1962.tb01615.x; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Ji SQ, 1998, AM J PHYSIOL-REG I, V275, pR1265, DOI 10.1152/ajpregu.1998.275.4.R1265; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Thies RS, 2001, GROWTH FACTORS, V18, P251; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	26	233	249	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e789	10.1371/journal.pone.0000789	http://dx.doi.org/10.1371/journal.pone.0000789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726519	Green Published, gold			2022-12-25	WOS:000207455400006
J	Slotman, MA; Parmakelis, A; Marshall, JC; Awono-Ambene, PH; Antonio-Nkondjo, C; Simard, F; Caccone, A; Powell, JR				Slotman, Michel A.; Parmakelis, Aristeidis; Marshall, Jonathon C.; Awono-Ambene, Parfait H.; Antonio-Nkondjo, Christophe; Simard, Frederic; Caccone, Adalgisa; Powell, Jeffrey R.			Patterns of Selection in Anti-Malarial Immune Genes in Malaria Vectors: Evidence for Adaptive Evolution in LRIM1 in Anopheles arabiensis	PLOS ONE			English	Article							GAMBIAE COMPLEX; PLASMODIUM; RESPONSES; IDENTIFICATION; INTROGRESSION; INFERENCE; SEQUENCE; PCR	Background. Co-evolution between Plasmodium species and its vectors may result in adaptive changes in genes that are crucial components of the vector's defense against the pathogen. By analyzing which genes show evidence of positive selection in malaria vectors, but not in closely related non-vectors, we can identify genes that are crucial for the mosquito's resistance against Plasmodium. Methodology/Principle Findings. We investigated genetic variation of three anti-malarial genes; CEC1, GNBP-B1 and LRIM1, in both vector and non-vector species of the Anopheles gambiae complex. Whereas little protein differentiation was observed between species in CEC1 and GNBP-B1, McDonald-Kreitman and maximum likelihood tests of positive selection show that LRIM1 underwent adaptive evolution in a primary malaria vector; An. arabiensis. In particular, two adjacent codons show clear signs of adaptation by having accumulated three out of four replacement substitutions. Furthermore, our data indicate that this LRIM1 allele has introgressed from An. arabiensis into the other main malaria vector An. gambiae. Conclusions/Significance. Although no evidence exists to link the adaptation of LRIM1 to P. falciparum infection, an adaptive response of a known anti-malarial gene in a primary malaria vector is intriguing, and may suggest that this gene could play a role in Plasmodium resistance in An. arabiensis. If so, our data also predicts that LRIM1 alleles in An. gambiae vary in their level of resistance against P. falciparum.	[Slotman, Michel A.; Parmakelis, Aristeidis; Marshall, Jonathon C.; Caccone, Adalgisa; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Awono-Ambene, Parfait H.; Antonio-Nkondjo, Christophe; Simard, Frederic] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Simard, Frederic] Inst Rech Dev, Yaounde, Cameroon	Yale University; Institut de Recherche pour le Developpement (IRD)	Slotman, MA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	michel.slotman@yale.edu	Frederic, SIMARD/AFV-5001-2022; Parmakelis, Aristeidis/AAD-1162-2020; Marshall, Jonathon C./AGG-8101-2022; SIMARD, Frederic/J-9489-2016; Caccone, Adalgisa/AAE-4238-2021	Frederic, SIMARD/0000-0002-2871-5329; Parmakelis, Aristeidis/0000-0003-3092-4194; SIMARD, Frederic/0000-0002-2871-5329; Caccone, Adalgisa/0000-0002-8949-9260; Antonio Nkondjio, Christophe/0000-0003-0073-1578	National Institutes of Health [RO1 A1 046018]; Marie Curie Outgoing International Fellowship [MOIF-CT-2006-021357]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Outgoing International Fellowship(European Commission)	This research was supported by National Institutes of Health grant RO1 A1 046018 to JRP. Additionally, AP was supported by a Marie Curie Outgoing International Fellowship ( Contract No. MOIF-CT-2006-021357).	Besansky NJ, 2006, ANN TROP MED PARASIT, V100, P277, DOI 10.1179/136485906X105624; BESANSKY NJ, 1994, P NATL ACAD SCI USA, V91, P6885, DOI 10.1073/pnas.91.15.6885; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1984, AM J TROP MED HYG, V33, P538, DOI 10.4269/ajtmh.1984.33.538; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Onyabe DY, 2001, MOL ECOL, V10, P2577, DOI 10.1046/j.0962-1083.2001.01387.x; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlenke TA, 2003, GENETICS, V164, P1471; Simard F, 2007, INFECT GENET EVOL, V7, P285, DOI 10.1016/j.meegid.2006.11.004; Slotman MA, 2005, AM J TROP MED HYG, V73, P326, DOI 10.4269/ajtmh.2005.73.326; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Vizioli J, 2000, INSECT MOL BIOL, V9, P75, DOI 10.1046/j.1365-2583.2000.00164.x; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006; White BJ, 2007, AM J TROP MED HYG, V76, P334; Yang, 2006, COMPUTATIONAL MOL EV, P357; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	38	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e793	10.1371/journal.pone.0000793	http://dx.doi.org/10.1371/journal.pone.0000793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726523	Green Published, gold			2022-12-25	WOS:000207455400010
J	Mattei, E; Corbi, N; Di Certo, MG; Strimpakos, G; Severini, C; Onori, A; Desantis, A; Libri, V; Buontempo, S; Floridi, A; Fanciulli, M; Baban, D; Davies, KE; Passananti, C				Mattei, Elisabetta; Corbi, Nicoletta; Di Certo, Maria Grazia; Strimpakos, Georgios; Severini, Cinzia; Onori, Annalisa; Desantis, Agata; Libri, Valentina; Buontempo, Serena; Floridi, Aristide; Fanciulli, Maurizio; Baban, Dilair; Davies, Kay E.; Passananti, Claudio			Utrophin Up-Regulation by an Artificial Transcription Factor in Transgenic Mice	PLOS ONE			English	Article								Duchenne Muscular Dystrophy (DMD) is a severe muscle degenerative disease, due to absence of dystrophin. There is currently no effective treatment for DMD. Our aim is to up-regulate the expression level of the dystrophin related gene utrophin in DMD, complementing in this way the lack of dystrophin functions. To this end we designed and engineered several synthetic zinc finger based transcription factors. In particular, we have previously shown that the artificial three zinc finger protein named Jazz, fused with the appropriate effector domain, is able to drive the transcription of a test gene from the utrophin promoter "A''. Here we report on the characterization of Vp16-Jazz-transgenic mice that specifically over-express the utrophin gene at the muscular level. A Chromatin Immunoprecipitation assay (ChIP) demonstrated the effective access/binding of the Jazz protein to active chromatin in mouse muscle and Vp16-Jazz was shown to be able to up-regulate endogenous utrophin gene expression by immunohistochemistry, western blot analyses and real-time PCR. To our knowledge, this is the first example of a transgenic mouse expressing an artificial gene coding for a zinc finger based transcription factor. The achievement of Vp16-Jazz transgenic mice validates the strategy of transcriptional targeting of endogenous genes and could represent an exclusive animal model for use in drug discovery and therapeutics.	[Mattei, Elisabetta; Fanciulli, Maurizio; Passananti, Claudio] Roman Oncogenom Ctr, Italian Assoc Canc Res, Rome, Italy; [Mattei, Elisabetta; Di Certo, Maria Grazia; Strimpakos, Georgios; Severini, Cinzia] European Brain Res Inst, Consiglio Nazl Ric, Ist Neurobiol & Med Mol, Rome, Italy; [Corbi, Nicoletta; Onori, Annalisa; Desantis, Agata; Libri, Valentina; Buontempo, Serena; Passananti, Claudio] Regina Elena Inst Canc Res, Consiglio Nazl Ric, Ist Biol & Patol Mol, Rome, Italy; [Di Certo, Maria Grazia; Desantis, Agata; Floridi, Aristide] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Floridi, Aristide; Fanciulli, Maurizio] Regina Elena Inst Canc Res, Lab B, Rome, Italy; [Baban, Dilair; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genet Unit, Oxford, England	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of L'Aquila; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Oxford	Passananti, C (corresponding author), Roman Oncogenom Ctr, Italian Assoc Canc Res, Rome, Italy.	passananti@ifo.it	Severini, Cinzia/AAX-3569-2020; Passananti, Claudio/K-9593-2016; Maria Grazia, Di Certo/AAW-8769-2020; Corbi, Nicoletta/K-2313-2014; Corbi, Nicoletta/AAW-8835-2020; fanciulli, maurizio/ABH-6745-2020	Severini, Cinzia/0000-0002-6932-704X; STRIMPAKOS, GEORGIOS/0000-0002-6021-9704; PASSANANTI, CLAUDIO/0000-0002-9288-5736; Libri, Valentina/0000-0002-2080-1089; CORBI, NICOLETTA/0000-0002-4505-1632	Telethon A160, Regional Grant-Lazio; FIRB; Regione Lazio; Medical Research Council UK; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI	Telethon A160, Regional Grant-Lazio(Fondazione Telethon); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Regione Lazio(Regione Lazio); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Telethon A160, Regional Grant-Lazio ( AIRC), FIRB project "Epigenetica e Cromatina'' and M. I. U. R. ex 60%. Dr. Maria Grazia Di Certo is a recipient of a fellowship supported by Regione Lazio fundings for "Sviluppo della Ricerca sul Cervello''. Dr. Dilair Baban and Prof. Kay E. Davies are supported by the Medical Research Council UK.	Beltran A, 2006, ASSAY DRUG DEV TECHN, V4, P317, DOI 10.1089/adt.2006.4.317; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campbell KP, 1996, NATURE, V384, P308, DOI 10.1038/384308a0; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Corbi N, 2000, GENE THER, V7, P1076, DOI 10.1038/sj.gt.3301204; Corbi N, 1997, FEBS LETT, V417, P71, DOI 10.1016/S0014-5793(97)01257-X; Corbi N, 2004, BIOCHEM CELL BIOL, V82, P428, DOI 10.1139/O04-047; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Dreier B, 2000, J MOL BIOL, V303, P489, DOI 10.1006/jmbi.2000.4133; Gramolini AO, 1999, J NEUROPATH EXP NEUR, V58, P235, DOI 10.1097/00005072-199903000-00003; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Lee DK, 2003, CURR TOP MED CHEM, V3, P645, DOI 10.2174/1568026033452384; Libri V, 2004, FEBS LETT, V560, P75, DOI 10.1016/S0014-5793(04)00075-4; Matecki S, 2004, AM J PHYSIOL-LUNG C, V287, pL569, DOI 10.1152/ajplung.00117.2004; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagy A., 2003, MANIPULATING MOUSE E; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Odom GL, 2007, BBA-MOL BASIS DIS, V1772, P243, DOI 10.1016/j.bbadis.2006.09.007; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Onori A, 2007, BIOCHEM CELL BIOL, V85, P358, DOI 10.1139/O07-015; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pandolfi PP, 2001, ONCOGENE, V20, P3116, DOI 10.1038/sj.onc.1204299; Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Stocksley MA, 2005, NEUROMUSCULAR DISORD, V15, P437, DOI 10.1016/j.nmd.2005.03.008; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Voisin V, 2004, INT REV CYTOL, V240, P1, DOI 10.1016/S0074-7696(04)40001-1; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Weir AP, 2004, NEUROMUSCULAR DISORD, V14, P19, DOI 10.1016/j.nmd.2003.09.004	50	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e774	10.1371/journal.pone.0000774	http://dx.doi.org/10.1371/journal.pone.0000774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712422	Green Published, gold			2022-12-25	WOS:000207455300022
J	Crook, MF; Olive, M; Xue, HH; Langenickel, TH; Boehm, M; Leonard, WJ; Nabel, EG				Crook, Martin F.; Olive, Michelle; Xue, Hai-Hui; Langenickel, Thomas H.; Boehm, Manfred; Leonard, Warren J.; Nabel, Elizabeth G.			GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression	FASEB JOURNAL			English	Article						kinase interacting strathmin; p27(Kip1); vascular smooth muscle cells; vascular biology	TRANSCRIPTION FACTOR GABP; DEPENDENT KINASE INHIBITORS; ETS-DOMAIN; COOPERATIVE INTERACTIONS; VASCULAR-DISEASE; FACTOR FAMILY; RB GENE; P27(KIP1); PROMOTER; DNA	The cyclin-dependent kinase inhibitor p27(Kip1) arrests cell cycle progression through G1/S phases and is regulated by phosphorylation of serine/threonine residues. Recently, we identified the serine/threonine kinase, KIS, which phosphorylates p27(Kip1) on serine 10 leading to nuclear export of p27(Kip1) and protein degradation. However, the molecular mechanisms of transcriptional activation of the human KIS gene and its biological activity are not known. We mapped the transcription initiation site similar to 116 bp 5' to the translation start site, and sequences extending to -141 were sufficient for maximal promoter activity. Mutation in either of two Ets-binding sites in this region resulted in an approximately 75-80% decrease in promoter activity. These sites form at least 3 specific complexes, which contained GA-binding protein (GABP). Knocking down GABP alpha by siRNA in vascular smooth muscle cells (VSMCs) diminished KIS gene expression and reduced cell migration. Correspondingly, in serum stimulated GABP alpha-deficient mouse embryonic fibroblasts (MEFs), KIS gene expression was also significantly reduced, which was associated with an increase in p27(Kip1) protein levels and a decreased percentage of cells in S-phase. Consistent with these findings, following vascular injury in vivo, GABP alpha-heterozygous mice demonstrated reduced KIS gene expression within arterial lesions and these lesions were significantly smaller compared to GABP(+/+) mice. In summary, serum-responsive GABP binding to Ets-binding sites activates the KIS promoter, leading to KIS gene expression, cell migration, and cell cycle progression. -Crook, M. F., Olive, M., Xue, H.-H., Langenickel, T. H., Boehm, M., Leonard, W. J., Nabel, E. G. GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression.	[Crook, Martin F.; Olive, Michelle; Langenickel, Thomas H.; Boehm, Manfred; Nabel, Elizabeth G.] NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; [Xue, Hai-Hui; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Nabel, EG (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 31-Rm 5A48,31 Ctr Dr, Bethesda, MD 20892 USA.	nabele@nih.gov	Leonard, Warren/AAA-1397-2022	Xue, Hai-Hui/0000-0002-9163-7669	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005066, Z01HL005410, Z01HL005066] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200334, Z01HG200334] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Avots A, 1997, MOL CELL BIOL, V17, P4381, DOI 10.1128/MCB.17.8.4381; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Boehm M, 2004, J CLIN INVEST, V114, P419, DOI 10.1172/jci200420176; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Carlini LE, 2002, J BIOL CHEM, V277, P8682, DOI 10.1074/jbc.M109754200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chinenov Y, 2000, J BIOL CHEM, V275, P7749, DOI 10.1074/jbc.275.11.7749; DELABROUSSE FC, 1994, GENE DEV, V8, P1853, DOI 10.1101/gad.8.15.1853; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Flory E, 1996, J VIROL, V70, P2260, DOI 10.1128/JVI.70.4.2260-2268.1996; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Imaki H, 2003, CANCER RES, V63, P4607; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Izumi M, 2000, BBA-GENE STRUCT EXPR, V1492, P341, DOI 10.1016/S0167-4781(00)00117-2; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Lie-Venema H, 2003, CIRC RES, V92, P749, DOI 10.1161/01.RES.0000066662.70010.DB; Maucuer A, 2000, EUR J BIOCHEM, V267, P4456, DOI 10.1046/j.1432-1327.2000.01493.x; Nabel EG, 2002, NAT REV DRUG DISCOV, V1, P587, DOI 10.1038/nrd869; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rudge TL, 2002, EXP CELL RES, V274, P45, DOI 10.1006/excr.2001.5451; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; SAVOYSKY E, 1994, ONCOGENE, V9, P1839; Schweppe RE, 2003, J BIOL CHEM, V278, P16863, DOI 10.1074/jbc.M213063200; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sowa Y, 1997, CANCER RES, V57, P3145; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; WATANABE H, 1993, MOL CELL BIOL, V13, P1385, DOI 10.1128/MCB.13.3.1385; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	44	17	17	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2008	22	1					225	235		10.1096/fj.07-8573com	http://dx.doi.org/10.1096/fj.07-8573com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17726090				2022-12-25	WOS:000252309900025
J	Hall, JP; Kurdi, Y; Hsu, S; Cuozzo, J; Liu, J; Telliez, JB; Seidl, KJ; Winkler, A; Hu, Y; Green, N; Askew, GR; Tam, S; Clark, JD; Lin, LL				Hall, J. Perry; Kurdi, Yahya; Hsu, Sang; Cuozzo, John; Liu, Julie; Telliez, Jean-Baptiste; Seidl, Katherine J.; Winkler, Aaron; Hu, Yonghan; Green, Neal; Askew, G. Roger; Tam, Steve; Clark, James D.; Lin, Lih-Ling			Pharmacologic inhibition of Tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; EARLY RHEUMATOID-ARTHRITIS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CYCLOOXYGENASE-2 EXPRESSION; ACTIVATE ERK; KINASE; PROGRESSION; INDUCTION; PROTEIN	Tumor necrosis factor alpha(TNF alpha) is a pro-inflammatory cytokine that controls the initiation and progression of inflammatory diseases such as rheumatoid arthritis. Tpl2 is a MAPKKK in the MAPK (i. e. ERK) pathway, and the Tpl2-MEK-ERK signaling pathway is activated by the pro-inflammatory mediators TNF alpha, interleukin (IL)-1 beta, and bacterial endotoxin (lipopolysaccharide (LPS)). Moreover, Tpl2 is required for TNF alpha expression. Thus, pharmacologic inhibition of Tpl2 should be a valid approach to therapeutic intervention in the pathogenesis of rheumatoid arthritis and other inflammatory diseases in humans. We have developed a series of highly selective and potent Tpl2 inhibitors, and in the present study we have used these inhibitors to demonstrate that the catalytic activity of Tpl2 is required for the LPS-induced activation of MEK and ERK in primary human monocytes. These inhibitors selectively target Tpl2 in these cells, and they block LPS- and IL-1 beta-induced TNF alpha production in both primary human monocytes and human blood. In rheumatoid arthritis fibroblast-like synoviocytes these inhibitors block ERK activation, cyclooxygenase-2 expression, and the production of IL-6, IL-8, and prostaglandin E-2, and the matrix metalloproteinases MMP-1 and MMP-3. Taken together, our results show that inhibition of Tpl2 in primary human cell types can decrease the production of TNF alpha and other pro-inflammatory mediators during inflammatory events, and they further support the notion that Tpl2 is an appropriate therapeutic target for rheumatoid arthritis and other human inflammatory diseases.	Wyeth Ayerst Res, Dept Inflammat, Cambridge, MA 02140 USA; Wyeth Ayerst Res, Dept Chem & Screening Sci, Cambridge, MA 02140 USA	Pfizer; Pfizer	Hall, JP (corresponding author), 200 CambridgePkDr,T4017N, Cambridge, MA 02140 USA.	jphall@wyeth.com; llin@wyeth.com		Cuozzo, John/0000-0002-6229-0395; Clark, James D./0000-0002-4801-0123				AGGARWAL BB, 2001, CYTOKINE REFERENCE, P413; Caivano M, 2003, J BIOL CHEM, V278, P52124, DOI 10.1074/jbc.M306583200; Channavajhala PL, 2003, J BIOL CHEM, V278, P47089, DOI 10.1074/jbc.M306002200; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; CLOSE DR, 2001, ANN RHEUM DIS     S3, V60, P62; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Doran MF, 2002, ARTHRITIS RHEUM-US, V46, P625, DOI 10.1002/art.509; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; Hu YH, 2006, BIOORG MED CHEM LETT, V16, P6067, DOI 10.1016/j.bmcl.2006.08.102; Jia Y, 2006, ANAL BIOCHEM, V350, P268, DOI 10.1016/j.ab.2005.11.010; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Posthumus MD, 2000, J RHEUMATOL, V27, P2761; Rodriguez C, 2006, CELL SIGNAL, V18, P1376, DOI 10.1016/j.cellsig.2005.10.016; Roux-Lombard P, 2001, RHEUMATOLOGY, V40, P544, DOI 10.1093/rheumatology/40.5.544; Schottelius AJG, 2004, EXP DERMATOL, V13, P193, DOI 10.1111/j.0906-6705.2004.00205.x; Simmons DL, 2006, DRUG DISCOV TODAY, V11, P210, DOI 10.1016/S1359-6446(05)03721-9; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; WOOLLEY DE, 1977, ARTHRITIS RHEUM, V20, P1231, DOI 10.1002/art.1780200612	33	67	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33295	33304		10.1074/jbc.M703694200	http://dx.doi.org/10.1074/jbc.M703694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848581	hybrid			2022-12-25	WOS:000250840200009
J	Caglic, D; Pungercar, JR; Pejler, G; Turk, V; Turk, B				Caglic, Dejan; Pungercar, Jerica Rozman; Pejler, Gunnar; Turk, Vito; Turk, Boris			Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATHEPSIN-B; LYSOSOMAL CYSTEINE PROTEASES; MAST-CELL TRYPTASE; CONFORMATIONAL-CHANGE; HEPARAN-SULFATE; IN-VITRO; CRYSTAL-STRUCTURE; OCCLUDING LOOP; BINDING; PH	Lysosomal cysteine cathepsin B participates in numerous diverse cellular processes. In acquiring its activity, the proregion, which blocks the substrate-binding site in the proenzyme, needs to be cleaved off. Here we demonstrate that polyanionic polysaccharides, glycosaminoglycans ( GAGs), can accelerate the autocatalytic removal of the propeptide and subsequent activation of cathepsin B. We show that naturally occurring GAGs such as chondroitin sulfates and heparin, as well as the synthetic analog dextran sulfate, accelerate the processing in a concentration-dependent manner. Heparin oligosaccharides down to the size of tetrasaccharides were efficient in accelerating the procathepsin B processing, whereas disaccharides were without effect. Further, the ability of the GAGs to accelerate procathepsin B processing was sensitive to increasing NaCl concentrations, indicating that electrostatic interaction between the GAGs and procathepsin B are operative in the accelerating effect. Also the processing of the catalytic procathepsin B mutant by wild type cathepsin B was enhanced in the presence of GAGs, suggesting that GAGs induce a conformational change in procathepsin B, converting it into a better substrate. Site-directed mutagenesis showed that His(28), Lys(39), and Arg(40), located within the procathepsin B propeptide, have significant roles in the acceleration of procathepsin B activation induced by short GAGs. Because procathepsin B and GAGs often co-localize in vivo, we propose that GAGs may play a physiological role in the activation of procathepsin B.	Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; Swedish Univ Agr Sci, Dept Mol Biosci, S-75123 Uppsala, Sweden	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Swedish University of Agricultural Sciences	Turk, B (corresponding author), Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Jamova 39, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si	Caglic, Dejan/A-1868-2009	Turk, Boris/0000-0002-9007-5764				Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; BAICI A, 1995, ANN RHEUM DIS, V54, P289, DOI 10.1136/ard.54.4.289; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; Cunnane G, 1999, RHEUMATOLOGY, V38, P34, DOI 10.1093/rheumatology/38.1.34; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Edavettal SC, 2004, BIOCHEMISTRY-US, V43, P4680, DOI 10.1021/bi0499112; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Ishidoh K, 1995, BIOCHEM BIOPH RES CO, V217, P624, DOI 10.1006/bbrc.1995.2820; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; MACH L, 1994, J BIOL CHEM, V269, P13030; MASON RW, 1992, BIOCHEM BIOPH RES CO, V189, P1659, DOI 10.1016/0006-291X(92)90268-P; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; MICHAEL SF, 1994, BIOTECHNIQUES, V16, P410; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1994, SEMIN THROMB HEMOST, V20, P373, DOI 10.1055/s-2007-1001928; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pejler G, 1996, BIOCHEM J, V320, P897, DOI 10.1042/bj3200897; PEJLER G, 1994, J BIOL CHEM, V269, P14451; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; RECKLIES AD, 1982, BIOCHEM J, V207, P633, DOI 10.1042/bj2070633; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; Rozman J, 1999, FEBS LETT, V459, P358, DOI 10.1016/S0014-5793(99)01302-2; Schedin-Weiss S, 2004, BIOCHEMISTRY-US, V43, P675, DOI 10.1021/bi030173b; Serveau C, 2003, BIOL CHEM, V384, P921, DOI 10.1515/BC.2003.103; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; TURK B, 1993, J BIOL CHEM, V268, P7323; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vanwildemeersch M, 2006, J BIOL CHEM, V281, P10298, DOI 10.1074/jbc.M508483200; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Winchester B G, 1996, Subcell Biochem, V27, P191	46	71	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33076	33085		10.1074/jbc.M705761200	http://dx.doi.org/10.1074/jbc.M705761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17726009	hybrid			2022-12-25	WOS:000250625400056
J	Gonzalez-Gronow, M; Kaczowka, SJ; Payne, S; Wang, F; Gawdi, G; Pizzo, SV				Gonzalez-Gronow, Mario; Kaczowka, Steven J.; Payne, Sturgis; Wang, Fang; Gawdi, Govind; Pizzo, Salvatore V.			Plasminogen structural domains exhibit different functions when associated with cell surface GRP78 or the voltage-dependent anion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-REACTIVE ANTIBODIES; DENGUE VIRUS-INFECTION; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ACTIVATION SYSTEM; TUMOR INVASION; CA2+ CHANNELS; PROTEIN GRP78; BINDING-SITE	Both the voltage-dependent anion channel and the glucose-regulated protein 78 have been identified as plasminogen kringle 5 receptors on endothelial cells. In this study, we demonstrate that kringle 5 binds to a region localized in the N-terminal domain of the glucose-regulated protein 78, whereas microplasminogen does so through the C-terminal domain of the glucose-regulated protein 78. Both plasminogen fragments induce Ca2+ signaling cascades; however, kringle 5 acts through voltage-dependent anion channel and microplasminogen does so via the glucose-regulated protein 78. Because trafficking of voltage-dependent anion channel to the cell surface is associated with heat shock proteins, we investigated a possible association between voltage-dependent anion channel and glucose-regulated protein 78 on the surface of 1-LN human prostate tumor cells. We demonstrate that these proteins co-localize, and changes in the expression of the glucose-regulated protein 78 affect the expression of voltage-dependent anion channel. To differentiate the functions of these receptor proteins, either when acting singly or as a complex, we employed human hexokinase I as a specific ligand for voltage-dependent anion channel, in addition to kringle 5. We show that kringle 5 inhibits 1-LN cell proliferation and promotes caspase-7 activity by a mechanism that requires binding to cell surface voltage-dependent anion channel and is inhibited by human hexokinase I.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Gonzalez-Gronow, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	gonza002@mc.duke.edu			NCI NIH HHS [CA 86344] Funding Source: Medline; NHLBI NIH HHS [HL 24066] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086344] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL024066, R01HL024066] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anastasiadis Aristotelis G, 2002, Curr Urol Rep, V3, P222, DOI 10.1007/s11934-002-0068-6; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Botto L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-7; Cao RH, 1999, P NATL ACAD SCI USA, V96, P5728, DOI 10.1073/pnas.96.10.5728; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cao YH, 1996, J BIOL CHEM, V271, P29461, DOI 10.1074/jbc.271.46.29461; Chen GD, 2007, HEARING RES, V226, P14, DOI 10.1016/j.heares.2006.06.007; CHUNGUE E, 1994, J INFECT DIS, V170, P1304, DOI 10.1093/infdis/170.5.1304; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dudani AK, 2007, MOL CELL BIOCHEM, V300, P197, DOI 10.1007/s11010-006-9384-3; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FORSGREN M, 1987, FEBS LETT, V213, P254, DOI 10.1016/0014-5793(87)81501-6; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Gonzalez-Gronow M, 2005, EXP CELL RES, V303, P22, DOI 10.1016/j.yexcr.2004.09.008; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Gonzalez-Gronow M, 2001, BIOCHEM J, V355, P397, DOI 10.1042/0264-6021:3550397; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hooft L, 2005, J CLIN ENDOCR METAB, V90, P328, DOI 10.1210/jc.2004-0779; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; KNUDSEN BS, 1986, J BIOL CHEM, V261, P765; Lee ATC, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-16; LINDEN M, 1982, FEBS LETT, V141, P189, DOI 10.1016/0014-5793(82)80044-6; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; MARKOFF LJ, 1991, J INFECT DIS, V164, P294, DOI 10.1093/infdis/164.2.294; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1982; Misra UK, 2005, J LEUKOCYTE BIOL, V78, P187, DOI 10.1189/jlb.1104685; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reuning U, 1998, INT J ONCOL, V13, P893; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; SHI GY, 1988, J BIOL CHEM, V263, P17071; Shimoda LA, 2006, MICROCIRCULATION, V13, P657, DOI 10.1080/10739680600930305; SILVERSTEIN RL, 1988, J CLIN INVEST, V82, P1948, DOI 10.1172/JCI113814; Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Stockwin LH, 2006, J PROTEOME RES, V5, P2996, DOI 10.1021/pr0601739; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; THEWES T, 1987, BIOCHIM BIOPHYS ACTA, V912, P254, DOI 10.1016/0167-4838(87)90096-3; THORSEN S, 1981, BIOCHIM BIOPHYS ACTA, V668, P377, DOI 10.1016/0005-2795(81)90171-9; Tohma T, 2005, HEPATO-GASTROENTEROL, V52, P486; Triantafilou K, 2003, VIROLOGY, V317, P128, DOI 10.1016/j.virol.2003.08.036; VARADY A, 1981, BIOCHEM BIOPH RES CO, V103, P91; WALLEN P, 1970, BIOCHIM BIOPHYS ACTA, V221, P20, DOI 10.1016/0005-2795(70)90194-7; Wouters BG, 2003, SEMIN RADIAT ONCOL, V13, P31, DOI 10.1053/srao.2003.50004; WU HL, 1990, J BIOL CHEM, V265, P19658; XIE GC, 1988, ARCH BIOCHEM BIOPHYS, V267, P803, DOI 10.1016/0003-9861(88)90090-2	59	44	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32811	32820		10.1074/jbc.M703342200	http://dx.doi.org/10.1074/jbc.M703342200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848573	hybrid			2022-12-25	WOS:000250625400030
J	Oh, E; Heise, CJ; English, JM; Cobb, MH; Thurmond, DC				Oh, Eunjin; Heise, Charles J.; English, Jessie M.; Cobb, Melanie H.; Thurmond, Debbie C.			WNK1 is a novel regulator of Munc18c-syntaxin 4 complex formation in soluble NSF attachment protein receptor (SNARE)-mediated vesicle exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; PANCREATIC BETA-CELLS; TYROSINE PHOSPHORYLATION; GLUT4 TRANSLOCATION; PLASMA-MEMBRANE; ACTIVATES SGK1; BLOOD-PRESSURE; T-SNARE; KINASE; MUNC18C	Defects in soluble NSF attachment protein receptor ( SNARE)mediated granule exocytosis occur in islet beta cells, adipocytes, and/ or skeletal muscle cells correlate with increased susceptibility to insulin resistance and diabetes. The serine/ threonine kinase WNK1 ( with no K ( lysine)) has recently been implicated in exocytosis and is expressed in all three of these cell types. To search for WNK1 substrates related to exocytosis, we conducted a WNK1 two- hybrid screen, which yielded Munc18c. Munc18c is known to be a key regulator of accessibility of the target membrane (t-SNARE) protein syntaxin 4 to participate in SNARE core complex assembly, although a paucity of Munc18c- binding factors has precluded discovery of its precise functions. To validate WNK1 as a new Munc18c- interacting partner, the direct interaction between WNK1 and Munc18c was confirmed using in vitro binding analysis, and endogenous WNK1- Munc18c complexes were detected in the cytosolic and plasma membrane compartments of the islet beta cell line MIN6. This binding interaction is mediated through the N- terminal 172 residues of Munc18c and the kinase domain residues of WNK1 ( residues 159 - 491). Expression of either of these two minimal interaction domains resulted in inhibition of glucose- stimulated insulin secretion, consistent with a functional importance for the endogenous WNK1- Munc18c complex in exocytosis. Interestingly, Munc18c failed to serve as a WNK1 substrate in kinase activity assays, suggesting that WNK1 functions in SNARE complex assembly outside its role as a kinase. Taken together, these data support a novel role for WNK1 and a new mechanism for the regulation of SNARE complex assembly by WNK1- Munc18c complexes.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Diabet Res Ctr, Indianapolis, IN 46202 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Pfizer Res Technol Ctr, Cambridge, MA 02139 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University; Pfizer; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Thurmond, DC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Diabet Res Ctr, 635 Barnhill Dr,MS4053, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu		Cobb, Melanie/0000-0003-0833-5473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053032] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK067912-04, DK 067912, R01 DK067912] Funding Source: Medline; NIGMS NIH HHS [R01 GM053032, GM 53032] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Chan CB, 1999, DIABETES, V48, P997, DOI 10.2337/diabetes.48.5.997; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Macaulay SL, 2002, FEBS LETT, V528, P154, DOI 10.1016/S0014-5793(02)03279-9; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Perez-Branguli F, 2002, MOL CELL NEUROSCI, V20, P169, DOI 10.1006/mcne.2002.1122; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 2000, EMBO J, V19, P3565, DOI 10.1093/emboj/19.14.3565; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Wang ZH, 2004, BIOCHEM BIOPH RES CO, V317, P939, DOI 10.1016/j.bbrc.2004.03.132; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2005, CELL RES, V15, P6, DOI 10.1038/sj.cr.7290256; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	48	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32613	32622		10.1074/jbc.M706591200	http://dx.doi.org/10.1074/jbc.M706591200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848561	hybrid, Green Accepted			2022-12-25	WOS:000250625400010
J	Pinnola, A; Naumova, N; Shah, M; Tulin, AV				Pinnola, Aaron; Naumova, Natasha; Shah, Meera; Tulin, Alexei V.			Nucleosomal core Histones mediate dynamic regulation of Poly(ADP-ribose) polymerase 1 protein binding to chromatin and induction of its enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOBILITY; DNA-BINDING; PARP; GENE; SEQUENCE; DOMAIN	Poly(ADP-ribose) polymerase 1 protein (PARP1) mediates chromatin loosening and activates the transcription of inducible genes, but the mechanism of PARP1 regulation in chromatin is poorly understood. We have found that PARP1 interaction with chromatin is dynamic and that PARP1 is exchanged continuously between chromatin and nucleoplasm, as well as between chromatin domains. Specifically, the PARP1 protein preferentially interacts with nucleosomal particles, and although the nucleosomal linker DNA is not necessary for this interaction, we have shown that the core histones, H3 and H4, are critical for PARP1 binding. We have also demonstrated that the histones H3 and H4 interact preferentially with the C-terminal portion of PARP1 protein and that the N-terminal domain of PARP1 negatively regulates these interactions. Finally, we have found that interaction with the N-terminal tail of the H4 histone triggers PARP1 enzymatic activity. Therefore, our data collectively suggests a model in which both the regulation of PARP1 protein binding to chromatin and the enzymatic activation of PARP1 protein depend on the dynamics of nucleosomal core histone mediation.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Tulin, AV (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Alexei.Tulin@fccc.edu			NIGMS NIH HHS [GM27875, R01 GM077452] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027875, R01GM027875] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Aoufouchi S, 1997, BIOCHEM J, V325, P543, DOI 10.1042/bj3250543; AUBIN RJ, 1983, EMBO J, V2, P1685, DOI 10.1002/j.1460-2075.1983.tb01643.x; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; Casso D, 2000, MECH DEVELOP, V91, P449; Chandler S, 1999, METH MOL B, V119, P103; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 1998, NUCLEIC ACIDS RES, V26, P1891, DOI 10.1093/nar/26.8.1891; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Ellen TP, 2004, BIOCHEMISTRY-US, V43, P7867, DOI 10.1021/bi0497704; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Hanai S, 1998, J BIOL CHEM, V273, P11881, DOI 10.1074/jbc.273.19.11881; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; KRUPITZA G, 1989, BIOCHEMISTRY-US, V28, P4054, DOI 10.1021/bi00435a063; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; Luger K, 1999, METHOD ENZYMOL, V304, P3; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pirrotta V, 2003, SCIENCE, V299, P528, DOI 10.1126/science.1081520; POIRIER GG, 1982, EUR J BIOCHEM, V127, P437; PROKHOROVA AV, 1994, GENETIKA+, V30, P874; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; Wolffe AP, 2001, ESSAYS BIOCHEM, V37, P45, DOI 10.1042/bse0370045; YAMANAKA H, 1988, J BIOL CHEM, V263, P3879	41	88	88	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32511	32519		10.1074/jbc.M705989200	http://dx.doi.org/10.1074/jbc.M705989200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827147	hybrid			2022-12-25	WOS:000250480300074
J	Wang, L; Dai, W; Lu, L				Wang, Ling; Dai, Wei; Lu, Luo			Stress-induced c-Jun activation mediated by polo-like kinase 3 in corneal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-3; UV-LIGHT; SERINE/THREONINE KINASE; CYCLE ARREST; APOPTOSIS; PHOSPHORYLATION; PATHWAYS; GENE; IDENTIFICATION; IRRADIATION	Polo-like kinase 3 (Plk3) activation occurs after exposure to environmental or genotoxic stresses. Plk3 regulates cell fate through regulating cell cycle progression. UV irradiation is one of the major environmental stresses that affect corneal epithelial wound healing. In the present study, we report that UV irradiation activated Plk3 and that Plk3 interacts with AP-1 and c-Jun, which appears to be important to mediate corneal epithelial cell apoptosis after UV irradiation. Recombinant Plk3, as well as Plk3 immunoprecipitated from UV-irradiated cells, phosphorylated c-Jun in vitro. The phosphorylation of c-Jun by Plk3 immunoprecipitates was not altered by the pre-removal of JNK from the cell lysates. In addition, the effect of UV irradiation-induced phosphorylation of c-Jun and apoptosis were not significantly affected by knockdown of JNK mRNA. Co-immunoprecipitation reveals that Plk3 and c-Jun directly interacted with each other. Consistently, Plk3 co-localized with c-Jun to the nucleus after UV irradiation. Further, modulating Plk3 activities by overexpressing Plk3 or its mutants significantly affected UV irradiation-induced c-Jun activity and subsequent apoptosis. Our results thus provide for the first time that Plk3 mediates UV irradiation-induced c-Jun activation by phosphorylating c-Jun, suggesting that Plk3 plays an important role in mediating programmed cell death of corneal epithelial cells after UV irradiation.	Univ Calif Los Angeles, Harbor UCLA Med Ctr, Dept Med, David Geffen Sc, Torrance, CA 90502 USA; NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, Harbor UCLA Med Ctr, Dept Med, David Geffen Sc, 1124 W Carson St,C-2, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	NATIONAL CANCER INSTITUTE [R01CA074229] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012953] Funding Source: NIH RePORTER; NCI NIH HHS [CA074229] Funding Source: Medline; NEI NIH HHS [EY12953] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler V, 1996, CARCINOGENESIS, V17, P2073, DOI 10.1093/carcin/17.9.2073; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Bodero AJ, 2003, BIOCHEM BIOPH RES CO, V301, P923, DOI 10.1016/S0006-291X(03)00063-9; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; BUSCHER M, 1988, ONCOGENE, V3, P301; Conn CW, 2000, CANCER RES, V60, P6826; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Frisch SM, 1996, J CELL BIOL, V135, P1377, DOI 10.1083/jcb.135.5.1377; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; Holbrook N J, 1996, EXS, V77, P273; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; Lu L, 2006, PROG RETIN EYE RES, V25, P515, DOI 10.1016/j.preteyeres.2006.07.004; Merienne K, 2000, ONCOGENE, V19, P4221, DOI 10.1038/sj.onc.1203712; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Ruan Q, 2004, EXP CELL RES, V294, P51, DOI 10.1016/j.yexcr.2003.10.022; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Wang L, 2004, INVEST OPHTH VIS SCI, V45, P1796, DOI 10.1167/iovs.03-1056; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P5095, DOI 10.1167/iovs.03-0590; Wang L, 2007, INVEST OPHTH VIS SCI, V48, P652, DOI 10.1167/iovs.06-1007; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271	31	22	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32121	32127		10.1074/jbc.M702791200	http://dx.doi.org/10.1074/jbc.M702791200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804415	hybrid			2022-12-25	WOS:000250480300033
J	Halasz, K; Kassner, A; Morgelin, M; Heinegard, D				Halasz, Krisztina; Kassner, Anja; Morgelin, Matthias; Heinegard, Dick			COMP acts as a catalyst in collagen fibrillogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; ARTICULAR-CARTILAGE; NATIVE COLLAGEN; POLYACRYLAMIDE GELS; ELECTRON-MICROSCOPY; FIBRIL FORMATION; CORE PROTEINS; IX COLLAGEN; TENDON; FIBROMODULIN	We have previously reported that COMP (cartilage oligomeric matrix protein) is prominent in cartilage but is also present in tendon and binds to collagens I and II with high affinity. Here we show that COMP influences the fibril formation of these collagens. Fibril formation in the presence of pentameric COMP was much faster, and the amount of collagen in fibrillar form was markedly increased. Monomeric COMP, lacking the N-terminal coiled-coil linker domain, decelerated fibrillogenesis. The data show that stimulation of collagen fibrillogenesis depends on the pentameric nature of COMP and not only on collagen binding. COMP interacts primarily with free collagen I and II molecules, bringing several molecules to close proximity, apparently promoting further assembly. These assemblies further join in discrete steps to a narrow distribution of completed fibril diameters of 149 +/- 16 nm with a banding pattern of 67 nm. COMP is not found associated with the mature fibril and dissociates from the collagen molecules or their early assemblies. However, a few COMP molecules are found bound to more loosely associated molecules at the tip/end of the growing fibril. Thus, COMP appears to catalyze the fibril formation by promoting early association of collagen molecules leading to increased rate of fibrillogenesis and more distinct organization of the fibrils.	Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Heinegard, D (corresponding author), Biomed Ctr, Dept Expt Med Sci, BMC C 12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se						BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; Birk DE, 1997, EUR J CELL BIOL, V72, P352; BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231; BIRK DE, 1990, ANN NY ACAD SCI, V580, P176, DOI 10.1111/j.1749-6632.1990.tb17928.x; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BOEDTKER H, 1956, J AM CHEM SOC, V78, P4267, DOI 10.1021/ja01598a024; CHAPMAN JA, 1989, BIOPOLYMERS, V28, P1367, DOI 10.1002/bip.360280803; COOPER A, 1970, BIOCHEM J, V118, P355, DOI 10.1042/bj1180355; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; ENGEL J, 1987, STRUCTURAL CONTRACTI, P3; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HEDLUND H, 1993, APMIS, V101, P133, DOI 10.1111/j.1699-0463.1993.tb00092.x; HEINEGARD D, 1985, BIOCHEM J, V230, P181, DOI 10.1042/bj2300181; Heinegard D., 2002, CONNECTIVE TISSUE IT, P271; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; KUHN K, 1987, STRUCTURE FUNCTION C, P1; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE JM, 1975, ARTHRITIS RHEUM-US, V18, P553, DOI 10.1002/art.1780180605; Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; MILLER EJ, 1984, EXTRACELLULAR MATRIX, P67; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Narouz-Ott L, 2000, J BIOL CHEM, V275, P37110, DOI 10.1074/jbc.M007223200; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; PARRY DAD, 1979, NATURE, V282, P213, DOI 10.1038/282213a0; PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Shen ZX, 1995, MATRIX BIOL, V14, P773, DOI 10.1016/S0945-053X(05)80020-4; SMITH JW, 1968, NATURE, V219, P157, DOI 10.1038/219157a0; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; STENBERG M, 1991, BIOPHYS CHEM, V41, P131, DOI 10.1016/0301-4622(91)80013-H; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUS BL, 1980, NATURE, V286, P300, DOI 10.1038/286300a0; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WOTTON SF, 1988, FEBS LETT, V234, P79, DOI 10.1016/0014-5793(88)81307-3; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Zaia J, 1997, J BIOL CHEM, V272, P14120, DOI 10.1074/jbc.272.22.14120	54	220	228	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31166	31173		10.1074/jbc.M705735200	http://dx.doi.org/10.1074/jbc.M705735200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716974	hybrid			2022-12-25	WOS:000250309200006
J	Gao, Z; Tian, Y; Wang, J; Yin, Q; Wu, H; Li, YM; Jiang, X				Gao, Zhonghua; Tian, Yuan; Wang, Junru; Yin, Qian; Wu, Hao; Li, Yue-Ming; Jiang, Xuejun			A dimeric Smac/Diablo peptide directly relieves caspase-3 inhibition by XIAP - Dynamic and cooperative regulation of xiap by Smac/Diablo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE OMI/HTRA2; CYTOCHROME-C; STRUCTURAL BASIS; BCL-2 FAMILY; CELL-DEATH; BIR DOMAIN; APOPTOSIS; ACTIVATION; PROTEINS; BINDING	Caspase activation, the executing event of apoptosis, is under deliberate regulation. IAP proteins inhibit caspase activity, whereas Smac/Diablo antagonizes IAP. XIAP, a ubiquitous IAP, can inhibit both caspase-9, the initiator caspase of the mitochondrial apoptotic pathway, and the downstream effector caspases, caspase-3 and caspase-7. Smac neutralizes XIAP inhibition of caspase-9 by competing for binding of the BIR3 domain of XIAP with caspase-9, whereas how Smac liberates effector caspases from XIAP inhibition is not clear. It is generally believed that binding of Smac with IAP generates a steric hindrance that prevents XIAP from inhibiting effector caspases, and therefore small molecule mimics of Smac are not able to reverse inhibition of the effector caspases. Surprisingly, we show here that binding of a dimeric Smac N-terminal peptide with the BIR2 domain of XIAP effectively antagonizes inhibition of caspase-3 by XIAP. Further, we defined the dynamic and cooperative interaction of Smac with XIAP: binding of Smac with the BIR3 domain anchors the subsequent binding of Smac with the BIR2 domain, which in turn attenuates the caspase-3 inhibitory function of XIAP. We also show that XIAP homotrimerizes via its C-terminal Ring domain, making its inhibitory activity toward caspase-3 more susceptible to Smac.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Sch Biomed Sci, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Jiang, X (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	jiangx@mskcc.org	LI, Yue/GRS-8071-2022		NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937, R01AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113890] Funding Source: Medline; NIAID NIH HHS [R01 AI050872, R01 AI045937] Funding Source: Medline; NIA NIH HHS [R01 AG026660] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Huang YH, 2004, CANCER CELL, V5, P1, DOI 10.1016/S1535-6108(03)00340-4; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; SCHIMMER AD, 2005, AM SOC HEMATOLOGY ED, P215; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Silke J, 2002, J CELL BIOL, V157, P115, DOI 10.1083/jcb.200108085; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Verhagen AM, 2001, GENOME BIOL, V2; Wang ZL, 2004, J BIOL CHEM, V279, P48168, DOI 10.1074/jbc.M405022200; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	47	82	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30718	30727		10.1074/jbc.M705258200	http://dx.doi.org/10.1074/jbc.M705258200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724022	Green Accepted, hybrid			2022-12-25	WOS:000250136300040
J	Goytia, M; Chamond, N; Cosson, A; Coatnoan, N; Hermant, D; Berneman, A; Minoprio, P				Goytia, Maira; Chamond, Nathalie; Cosson, Alain; Coatnoan, Nicolas; Hermant, Daniel; Berneman, Armand; Minoprio, Paola			Molecular and Structural Discrimination of Proline Racemase and Hydroxyproline-2-Epimerase from Nosocomial and Bacterial Pathogens	PLOS ONE			English	Article								The first eukaryotic proline racemase (PRAC), isolated from the human Trypanosoma cruzi pathogen, is a validated therapeutic target against Chagas' disease. This essential enzyme is implicated in parasite life cycle and infectivity and its ability to trigger host B-cell nonspecific hypergammaglobulinemia contributes to parasite evasion and persistence. Using previously identified PRAC signatures and data mining we present the identification and characterization of a novel PRAC and five hydroxyproline epimerases (HyPRE) from pathogenic bacteria. Single-mutation of key HyPRE catalytic cysteine abrogates enzymatic activity supporting the presence of two reaction centers per homodimer. Furthermore, evidences are provided that Brucella abortus PrpA [for 'proline racemase' virulence factor A] and homologous proteins from two Brucella spp are bona fide HyPREs and not 'one way' directional PRACs as described elsewhere. Although the mechanisms of aminoacid racemization and epimerization are conserved between PRAC and HyPRE, our studies demonstrate that substrate accessibility and specificity partly rely on contraints imposed by aromatic or aliphatic residues distinctively belonging to the catalytic pockets. Analysis of PRAC and HyPRE sequences along with reaction center structural data disclose additional valuable elements for in silico discrimination of the enzymes. Furthermore, similarly to PRAC, the lymphocyte mitogenicity displayed by HyPREs is discussed in the context of bacterial metabolism and pathogenesis. Considering tissue specificity and tropism of infectious pathogens, it would not be surprising if upon infection PRAC and HyPRE play important roles in the regulation of the intracellular and extracellular amino acid pool profiting the microrganism with precursors and enzymatic pathways of the host.	[Goytia, Maira; Chamond, Nathalie; Cosson, Alain; Coatnoan, Nicolas; Hermant, Daniel; Berneman, Armand; Minoprio, Paola] Inst Pasteur, Dept Immunol, Lab Immunobiol Infect Trypanosoma, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Minoprio, P (corresponding author), Inst Pasteur, Dept Immunol, Lab Immunobiol Infect Trypanosoma, F-75724 Paris, France.	pmm@pasteur.fr	Chamond, Nathalie/C-5907-2018	Chamond, Nathalie/0000-0002-0518-2929; Minoprio, Paola/0000-0002-1659-833X; COATNOAN, Nicolas/0000-0003-4129-0019	Institut Pasteur and Fonds Dedies (Sanofi/Aventis/Ministere de la Recherche) [17]; Fondation pour la Recherche Medicale (FRM)	Institut Pasteur and Fonds Dedies (Sanofi/Aventis/Ministere de la Recherche)(Sanofi-AventisMinistry of Research, France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Funding: This work was supported by grants of Institut Pasteur and Fonds Dedies n degrees 17 (Sanofi/Aventis/Ministere de la Recherche). MG is a fellow from Fondation pour la Recherche Medicale (FRM).	Adams E, 1970, Int Rev Connect Tissue Res, V5, P1; ADAMS E, 1959, J BIOL CHEM, V234, P2073; ADAMS E, 1964, J BIOL CHEM, V239, P1525; BEJARANO PA, 1989, INFECT IMMUN, V57, P3783, DOI 10.1128/IAI.57.12.3783-3787.1989; BELASCO JG, 1986, BIOCHEMISTRY-US, V25, P2552, DOI 10.1021/bi00357a040; Bouza E, 2005, CLIN MICROBIOL INFEC, V11, P57, DOI 10.1111/j.1469-0691.2005.01165.x; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; CARDINALE GJ, 1968, BIOCHEMISTRY-US, V7, P3970, DOI 10.1021/bi00851a026; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chamond N., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P247, DOI 10.2174/1568008023340604; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; de Bentzmann S, 2000, LAB INVEST, V80, P209, DOI 10.1038/labinvest.3780024; FISHER LM, 1986, BIOCHEMISTRY-US, V25, P2529, DOI 10.1021/bi00357a037; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; GRYDER RM, 1969, J BACTERIOL, V97, P292, DOI 10.1128/JB.97.1.292-306.1969; Gryder RM, 1970, J BACTERIOL, V101, P948, DOI 10.1128/JB.101.3.948-958.1970; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; MACFARLANE L, 1991, J INFECTION, V23, P346, DOI 10.1016/0163-4453(91)93620-R; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RADHAKRISHNAN AN, 1957, J BIOL CHEM, V226, P559; RAMASWAMY SG, 1984, J BIOL CHEM, V259, P249; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Reina-San-Martin B, 2000, PARASITOL TODAY, V16, P62, DOI 10.1016/S0169-4758(99)01591-4; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; STADTMAN TC, 1957, J BIOL CHEM, V228, P983; Stoddart B, 2002, CURR OPIN INFECT DIS, V15, P513, DOI 10.1097/00001432-200210000-00010; VALLE D, 1973, BIOCHEM BIOPH RES CO, V54, P1418, DOI 10.1016/0006-291X(73)91144-3; VALLE D, 1975, NATURE, V253, P214, DOI 10.1038/253214a0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3	34	38	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e885	10.1371/journal.pone.0000885	http://dx.doi.org/10.1371/journal.pone.0000885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849014	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455600031
J	Purves, DW; Lichstein, JW; Pacala, SW				Purves, Drew W.; Lichstein, Jeremy W.; Pacala, Stephen W.			Crown Plasticity and Competition for Canopy Space: A New Spatially Implicit Model Parameterized for 250 North American Tree Species	PLOS ONE			English	Article							JAPONICA DON,D. PLANTATIONS; PREDICTION MODELS; FOREST INVENTORY; TROPICAL FOREST; GROWTH; DYNAMICS; SURVIVORSHIP; DISPLACEMENT; ARCHITECTURE; DIAMETER	Background. Canopy structure, which can be defined as the sum of the sizes, shapes and relative placements of the tree crowns in a forest stand, is central to all aspects of forest ecology. But there is no accepted method for deriving canopy structure from the sizes, species and biomechanical properties of the individual trees in a stand. Any such method must capture the fact that trees are highly plastic in their growth, forming tessellating crown shapes that fill all or most of the canopy space. Methodology/Principal Findings. We introduce a new, simple and rapidly-implemented model-the Ideal Tree Distribution, ITD-with tree form (height allometry and crown shape), growth plasticity, and space-filling, at its core. The ITD predicts the canopy status (in or out of canopy), crown depth, and total and exposed crown area of the trees in a stand, given their species, sizes and potential crown shapes. We use maximum likelihood methods, in conjunction with data from over 100,000 trees taken from forests across the coterminous US, to estimate ITD model parameters for 250 North American tree species. With only two free parameters per species-one aggregate parameter to describe crown shape, and one parameter to set the so-called depth bias-the model captures between-species patterns in average canopy status, crown radius, and crown depth, and within-species means of these metrics vs stem diameter. The model also predicts much of the variation in these metrics for a tree of a given species and size, resulting solely from deterministic responses to variation in stand structure. Conclusions/Significance. This new model, with parameters for US tree species, opens up new possibilities for understanding and modeling forest dynamics at local and regional scales, and may provide a new way to interpret remote sensing data of forest canopies, including LIDAR and aerial photography.	[Purves, Drew W.; Lichstein, Jeremy W.; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Purves, Drew W.] Microsoft Res, External Res Off, Cambridge, England	Princeton University; Microsoft	Purves, DW (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	dpurves@microsoft.com	Lichstein, Jeremy/GMW-6555-2022					Barnes B. V., 1998, FOREST ECOLOGY, V4th; Bechtold WA, 2004, WEST J APPL FOR, V19, P245, DOI 10.1093/wjaf/19.4.245; Bechtold WA, 2003, SOUTH J APPL FOR, V27, P269, DOI 10.1093/sjaf/27.4.269; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; Brisson J, 1997, ECOLOGY, V78, P2378; Brown S, 2005, ECOL APPL, V15, P1083, DOI 10.1890/04-0829; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; CASPERSEN JP, 2004, FOREST ECOL MANAG, V200, P540; Coates KD, 2003, FOREST ECOL MANAG, V186, P297, DOI 10.1016/S0378-1127(03)00301-3; DELEUZE C, 1993, CANADIAN J FOREST RE, V26, P1957; Di Lucca CM, 1999, STAND DENSITY MANAGEMENT: USING THE PLANNING TOOLS, PROCEEDING, P7; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fujita T, 2003, J ECOL, V91, P686, DOI 10.1046/j.1365-2745.2003.00796.x; Herwitz SR, 2000, ECOLOGY, V81, P585, DOI 10.1890/0012-9658(2000)081[0585:LTSACA]2.0.CO;2; HILBORN R, 1997, ECOLOGICAL DETECTIVE, pR17; HORN H S, 1971, P144; Jensen JLR, 2006, CAN J FOREST RES, V36, P1129, DOI 10.1139/X06-007; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; MacFarlane DW, 2003, FOREST ECOL MANAG, V173, P145, DOI 10.1016/S0378-1127(02)00011-7; McRoberts RE, 2005, J FOREST, V103, P304; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; MITCHELL KJ, 1969, YALE U SCH FORESTRY, V75; Moorcroft PR, 2003, P ROY SOC B-BIOL SCI, V270, P1215, DOI 10.1098/rspb.2002.2251; Muth CC, 2003, CAN J FOREST RES, V33, P1323, DOI 10.1139/X03-045; Muth CC, 2002, CAN J FOREST RES, V32, P247, DOI [10.1139/x01-196, 10.1139/X01-196]; Naesset E, 2002, REMOTE SENS ENVIRON, V79, P105, DOI 10.1016/S0034-4257(01)00243-7; Nelson R, 1997, REMOTE SENS ENVIRON, V60, P327, DOI 10.1016/S0034-4257(96)00214-3; Olesen T, 2001, ECOLOGY, V82, P2719, DOI 10.1890/0012-9658(2001)082[2719:AOACTR]2.0.CO;2; Oliver Chadwick D., 1996; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Piboule A, 2005, ANN FOREST SCI, V62, P645, DOI 10.1051/forest:2005071; PINKER RT, 1988, BOUND-LAY METEOROL, V43, P43, DOI 10.1007/BF00153968; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; Purves DW, 2004, GLOBAL CHANGE BIOL, V10, P1737, DOI 10.1111/j.1365-2486.2004.00844.x; Roberts SD, 2005, FOREST ECOL MANAG, V213, P54, DOI 10.1016/j.foreco.2005.03.025; Roelandt C, 2001, ECOL MODEL, V143, P191, DOI 10.1016/S0304-3800(01)00331-3; Shugart H. H., 1984, A theory of forest dynamics. The ecological implications of forest succession models.; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; SORRENSENCOTHERN KA, 1993, ECOL MONOGR, V63, P277, DOI 10.2307/2937102; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; Takahashi T, 2005, J FOREST RES-JPN, V10, P305, DOI 10.1007/s10310-005-0150-2; Takahashi T, 2005, J FOREST RES-JPN, V10, P135, DOI 10.1007/s10310-004-0125-8; UMEKI K, 1995, ECOL MODEL, V82, P11, DOI 10.1016/0304-3800(94)00081-R; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; WELLER DE, 1987, ECOL MONOGR, V57, P23, DOI 10.2307/1942637; Wyckoff PH, 2005, CAN J FOREST RES, V35, P13, DOI 10.1139/x04-142; YOUNG TP, 1991, ECOLOGY, V72, P1464, DOI 10.2307/1941119; [No title captured]	49	118	124	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e870	10.1371/journal.pone.0000870	http://dx.doi.org/10.1371/journal.pone.0000870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849000	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455600017
J	Staiger, H; Machicao, F; Stefan, N; Tschritter, O; Thamer, C; Kantartzis, K; Schafer, SA; Kirchhoff, K; Fritsche, A; Haring, HU				Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Tschritter, Otto; Thamer, Claus; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Fritsche, Andreas; Haering, Hans-Ulrich			Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine beta-Cell Function	PLOS ONE			English	Article								Background. Type 2 diabetes arises when insulin resistance-induced compensatory insulin secretion exhausts. Insulin resistance and/or beta-cell dysfunction result from the interaction of environmental factors (high-caloric diet and reduced physical activity) with a predisposing polygenic background. Very recently, genetic variations within four novel genetic loci (SLC30A8, HHEX, EXT2, and LOC387761) were reported to be more frequent in subjects with type 2 diabetes than in healthy controls. However, associations of these variations with insulin resistance and/or beta-cell dysfunction were not assessed. Methodology/Principal Findings. By genotyping of 921 metabolically characterized German subjects for the reported candidate single nucleotide polymorphisms (SNPs), we show that the major alleles of the SLC30A8 SNP rs13266634 and the HHEX SNP rs7923837 associate with reduced insulin secretion stimulated by orally or intravenously administered glucose, but not with insulin resistance. In contrast, the other reported type 2 diabetes candidate SNPs within the EXT2 and LOC387761 loci did not associate with insulin resistance or beta-cell dysfunction, respectively. Conclusions/Significance. The HHEX and SLC30A8 genes encode for proteins that were shown to be required for organogenesis of the ventral pancreas and for insulin maturation/storage, respectively. Therefore, the major alleles of type 2 diabetes candidate SNPs within these genetic loci represent crucial alleles for beta-cell dysfunction and, thus, might confer increased susceptibility of beta-cells towards adverse environmental factors.	[Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Tschritter, Otto; Thamer, Claus; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Kantartzis, Konstantinos/AAC-3999-2019; Staiger, Harald/N-5871-2014	Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595; Kantartzis, Konstantinos/0000-0002-0584-1138	German Research Foundation [KFO 114/2]	German Research Foundation(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation (KFO 114/2).	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Freeman H, 2006, HUM MOL GENET, V15, pR202, DOI 10.1093/hmg/ddl191; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Koch M, 1999, DIABETOLOGIA, V42, P758, DOI 10.1007/s001250051225; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	24	138	141	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e832	10.1371/journal.pone.0000832	http://dx.doi.org/10.1371/journal.pone.0000832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786204	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500016
J	Kleps, RA; Myers, TC; Lipcius, RN; Henderson, TO				Kleps, Robert A.; Myers, Terrell C.; Lipcius, Romuald N.; Henderson, Thomas O.			A Sex-Specific Metabolite Identified in a Marine Invertebrate Utilizing Phosphorus-31 Nuclear Magnetic Resonance	PLOS ONE			English	Article								Hormone level differences are generally accepted as the primary cause for sexual dimorphism in animal and human development. Levels of low molecular weight metabolites also differ between men and women in circulating amino acids, lipids and carbohydrates and within brain tissue. While investigating the metabolism of blue crab tissues using Phosphorus-31 Nuclear Magnetic Resonance, we discovered that only the male blue crab (Callinectes sapidus) contained a phosphorus compound with a chemical shift well separated from the expected phosphate compounds. Spectra obtained from male gills were readily differentiated from female gill spectra. Analysis from six years of data from male and female crabs documented that the sex-specificity of this metabolite was normal for this species. Microscopic analysis of male and female gills found no differences in their gill anatomy or the presence of parasites or bacteria that might produce this phosphorus compound. Analysis of a rare gynandromorph blue crab (laterally, half male and half female) proved that this sex-specificity was an intrinsic biochemical process and was not caused by any variations in the diet or habitat of male versus female crabs. The existence of a sex-specific metabolite is a previously unrecognized, but potentially significant biochemical phenomenon. An entire enzyme system has been synthesized and activated only in one sex. Unless blue crabs are a unique species, sex-specific metabolites are likely to be present in other animals. Would the presence or absence of a sex-specific metabolite affect an animal's development, anatomy and biochemistry?	[Kleps, Robert A.] Univ Illinois, Res Resources Ctr, Chicago, IL 60680 USA; [Myers, Terrell C.; Henderson, Thomas O.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Lipcius, Romuald N.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; William & Mary; Virginia Institute of Marine Science	Kleps, RA (corresponding author), Univ Illinois, Res Resources Ctr, Chicago, IL 60680 USA.	kleps@uic.edu						BUCKLEY PF, 1994, BIOL PSYCHIAT, V36, P792, DOI 10.1016/0006-3223(94)90591-6; BURT CT, 1992, COMP BIOCHEM PHYS A, V103, P715, DOI 10.1016/0300-9629(92)90171-L; CLARIDGE TDW, 2004, TETRAHEDRON ORGANIC, V19, P15; Crews D, 2005, HORM BEHAV, V48, P384, DOI 10.1016/j.yhbeh.2005.04.003; Curry BB, 2001, INT J TOXICOL, V20, P153, DOI 10.1080/109158101317097737; FOGARTY MJ, 2006, BLUE CRAB C IN PRESS; Glickman SE, 2005, HORM BEHAV, V48, P403, DOI 10.1016/j.yhbeh.2005.07.013; GLONEK T, 1970, SCIENCE, V169, P192, DOI 10.1126/science.169.3941.192; HENDERSO.TO, 1972, ARCH BIOCHEM BIOPHYS, V149, P484, DOI 10.1016/0003-9861(72)90348-7; HINES AH, 2007, BLUE CRAB C IN PRESS; HORIGUCHI M, 1959, NATURE, V184, P901, DOI 10.1038/184901b0; Johnston CM, 1995, PHILOS T R SOC B, V350, P297, DOI 10.1098/rstb.1995.0165; Kariotoglou DM, 2003, COMP BIOCHEM PHYS B, V136, P27, DOI 10.1016/S1096-4959(03)00168-4; Kawachi T, 2002, J NEUROL SCI, V199, P79, DOI 10.1016/S0022-510X(02)00112-0; KITTREDGE JS, 1969, SCIENCE, V164, P37, DOI 10.1126/science.164.3875.37; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Koning A. J. de, 1970, Biochimica et Biophysica Acta, V202, P187; KONING AJ, 2003, S AFR J SCI, V99, P521; Lamont LS, 2003, J APPL PHYSIOL, V95, P1259, DOI 10.1152/japplphysiol.01028.2002; Laz EV, 2004, MOL CELL PROTEOMICS, V3, P1170, DOI 10.1074/mcp.M400102-MCP200; Lipcius RN, 2002, MAR ECOL PROG SER, V226, P45, DOI 10.3354/meps226045; LIPCIUS RN, 2000, SPINY LOBSTERS FISHE, P1, DOI DOI 10.1002/9780470698808.CH; Lipcius Romuald N., 2007, BLUE CRAB CALLINECTE, P535; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Miller T.J., 2005, TECHNICAL REPORT SER; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Mukhamedova KS, 2000, CHEM NAT COMPD+, V36, P329, DOI 10.1023/A:1002804409503; OHLSSON A, 1971, CANNABINOID CONSTITU, P29; Oliveira RF, 2005, HORM BEHAV, V48, P430, DOI 10.1016/j.yhbeh.2005.06.002; Quin LD, 2001, COMP BIOCHEM PHYS B, V128, P173, DOI 10.1016/S1096-4959(00)00310-9; Ren J, 2004, ENDOCRINE, V25, P73, DOI 10.1385/ENDO:25:2:073; Riehemann S, 1999, NMR BIOMED, V12, P483, DOI 10.1002/(SICI)1099-1492(199912)12:8<483::AID-NBM589>3.0.CO;2-D; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Stanley EG, 2005, ANAL BIOCHEM, V343, P195, DOI 10.1016/j.ab.2005.01.024; Tarnopolsky MA, 2001, CURR OPIN CLIN NUTR, V4, P521, DOI 10.1097/00075197-200111000-00010; Tipton KD, 2001, CURR OPIN CLIN NUTR, V4, P493, DOI 10.1097/00075197-200111000-00005; Towle DW, 2001, J EXP BIOL, V204, P4005; Tweedie EP, 2004, J EXP BIOL, V207, P2589, DOI 10.1242/jeb.01070; van den Broek HHLP, 2005, MULT SCLER J, V11, P349, DOI 10.1191/1352458505ms1174rr; Van ENGEL W. A., 1958, COMMERCIAL FISH REV, V20, P6; Volkow ND, 1997, AM J PSYCHIAT, V154, P119; WASEF SZY, 2004, GENDER MED, V1, P12, DOI DOI 10.1016/S1550-8579(04)80006-8; WHITNEY JO, 1974, COMP BIOCHEM PHYSIOL, V49, P433, DOI 10.1016/0300-9629(74)90559-3; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e780	10.1371/journal.pone.0000780	http://dx.doi.org/10.1371/journal.pone.0000780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712428	Green Published, gold			2022-12-25	WOS:000207455300028
J	Gal, A; Sjoblom, T; Fedorova, L; Imreh, S; Beug, H; Moustakas, A				Gal, A.; Sjoeblom, T.; Fedorova, L.; Imreh, S.; Beug, H.; Moustakas, A.			Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis	ONCOGENE			English	Article						epithelial-mesenchymal transition; metastasis; Smad; signal transduction; TGF beta; tumour suppression	TRANSFORMING GROWTH-FACTOR-BETA-1; TUMOR PROGRESSION; HUMAN CANCER; HA-RAS; METASTASIS; PLASTICITY; PATHWAY; TRANSDIFFERENTIATION; PROLIFERATION; INVASIVENESS	To better understand the dual, tumour-suppressive and tumour-promoting function of transforming growth factor-beta (TGF beta), we analysed mammary epithelial NMuMG cells in response to short and long-term TGFb exposure. NMuMG cells became proliferation-arrested and apoptotic after exposure to TGFb for 2-5 days, whereas surviving cells underwent epithelial-mesenchymal transition (EMT). After chronic TGFb exposure (2-3 weeks), however, NMuMG cells became resistant to proliferation arrest and apoptosis, showing sustained EMT instead (TD cells). EMT was fully reversed by a pharmacologic TGF beta-receptor-I kinase inhibitor or withdrawal of TGFb for 6-12 days. Interestingly, both cell cycle arresting/proapoptotic (Smads, p38 kinase) and antiapoptotic, proliferation and EMT-promoting signalling pathways (PI3K-PKB/Akt, ERK) were co-suppressed to low, but significant levels. Except for PI3K-Akt, TGF beta-dependent downregulation of these signalling pathways in transdifferentiated (TD) cells was fully reversed upon TGFb withdrawal, together with partial re-induction of proliferation arrest and apoptosis. Co-injection of non-tumorigenic NMuMG cells with tumour-forming CHO cells oversecreting exogenous TGF beta 1 (CHO-TGF beta 1) allowed outgrowth of epithelioid cells in CHO-TGF beta 1 cell-induced tumours. These epithelial islands enhanced CHO-TGF beta 1 tumour cell proliferation, possibly due to chemokines (for example, JE/MCP-1) secreted by NMuMG/TD cells. We conclude that suppression of antiproliferative, proapoptotic TGF beta signalling in TD cells may permit TGF beta-dependent proliferation, survival and EMT-enhancing signalling pathways to act at low levels. Thus, TGF beta may modulate its own signalling to facilitate switching from tumour suppression to tumour progression.	[Gal, A.; Beug, H.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Gal, A.; Sjoeblom, T.; Moustakas, A.] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; [Sjoeblom, T.; Fedorova, L.] Karolinska Inst, Microbiol & Tumor Biol Ctr, Stockholm, Sweden	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Ludwig Institute for Cancer Research; Karolinska Institutet	Beug, H (corresponding author), Inst Mol Pathol, Dr A Moustakas, A-1030 Vienna, Austria.	beug@imp.univie.ac.at; aris.moustakas@LICR.uu.se		Gal, Annamaria/0000-0001-8171-1389	Austrian Science Fund (FWF) [F 2802] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; DALAL BI, 1993, AM J PATHOL, V143, P381; Dooley S, 2001, FEBS LETT, V502, P4, DOI 10.1016/S0014-5793(01)02656-4; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gotzmann J, 2002, J CELL SCI, V115, P1189; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; IVANOVIC V, 1995, NAT MED, V1, P282, DOI 10.1038/nm0495-282; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Janda E, 2002, ONCOGENE, V21, P5148, DOI 10.1038/sj.onc.1205661; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Piek E, 1999, J CELL SCI, V112, P4557; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Shim KS, 1999, CANCER-AM CANCER SOC, V85, P554, DOI 10.1002/(SICI)1097-0142(19990201)85:3<554::AID-CNCR6>3.0.CO;2-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sjoblom T, 2001, CANCER RES, V61, P5778; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020	26	174	181	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 21	2008	27	9					1218	1230		10.1038/sj.onc.1210741	http://dx.doi.org/10.1038/sj.onc.1210741			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17724470				2022-12-25	WOS:000253407000004
J	Baden, KN; Murray, J; Capaldi, RA; Guillemin, K				Baden, Katrina N.; Murray, James; Capaldi, Roderick A.; Guillemin, Karen			Early developmental pathology due to cytochrome c oxidase deficiency is revealed by a new zebrafish model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEIGH-SYNDROME PATIENTS; PERIPHERAL NEUROPATHY; MITOCHONDRIAL DISEASE; OXIDATIVE-PHOSPHORYLATION; CELL-DEATH; IDENTIFIED MOTONEURONS; BRAIN MITOCHONDRIA; PRENATAL-DIAGNOSIS; RESPIRATORY-CHAIN; ASSEMBLY GENE	Deficiency of cytochrome c oxidase (COX) is associated with significant pathology in humans. However, the consequences for organogenesis and early development are not well understood. We have investigated these issues using a zebrafish model. COX deficiency was induced using morpholinos to reduce expression of CoxVa, a structural subunit, and Surf1, an assembly factor, both of which impaired COX assembly. Reduction of COX activity to 50% resulted in developmental defects in endodermal tissue, cardiac function, and swimming behavior. Cellular investigations revealed different underlying mechanisms. Apoptosis was dramatically increased in the hindbrain and neural tube, and secondary motor neurons were absent or abnormal, explaining the motility defect. In contrast, the heart lacked apoptotic cells but showed increasingly poor performance over time, consistent with energy deficiency. The zebrafish model has revealed tissue-specific responses to COX deficiency and holds promise for discovery of new therapies to treat mitochondrial diseases in humans.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Mitosci Inc, Eugene, OR 97403 USA	University of Oregon	Guillemin, K (corresponding author), Univ Oregon, Inst Mol Biol, 1370 Franklin Blvd, Eugene, OR 97403 USA.	guillemin@molbio.uoregon.edu		Guillemin, Karen/0000-0001-6004-9955	NICHD NIH HHS [HD22486] Funding Source: Medline; NIDDK NIH HHS [R01 DK075549-01, R21 DK067065-01] Funding Source: Medline; NIGMS NIH HHS [T32 GM007759] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067065, R01DK075549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; BARAK Y, 1995, ISRAEL J MED SCI, V31, P224; Beattie CE, 1997, DEV BIOL, V187, P171, DOI 10.1006/dbio.1997.8604; Capaldi RA, 2004, MITOCHONDRION, V4, P417, DOI 10.1016/j.mito.2004.07.006; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Davey GP, 1997, J NEUROCHEM, V69, P2564; Davey GP, 1996, J NEUROCHEM, V66, P1617; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DIMAURO S, 1991, REV NEUROL, V147, P443; DiMauro S, 2000, NEUROL SCI, V21, pS901; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239; Gogvadze V, 2006, CHEM-BIOL INTERACT, V163, P4, DOI 10.1016/j.cbi.2006.04.010; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; HANNEMAN E, 1989, J COMP NEUROL, V284, P350, DOI 10.1002/cne.902840303; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1; Houstek J, 1999, PRENATAL DIAG, V19, P552, DOI 10.1002/(SICI)1097-0223(199906)19:6<552::AID-PD588>3.0.CO;2-C; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; JOHNS DR, 1994, J NEURO-OPHTHALMOL, V14, P135; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1; Melberg A, 1996, MUSCLE NERVE, V19, P751; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; MIZUSAWA H, 1988, J NEUROL SCI, V86, P171, DOI 10.1016/0022-510X(88)90096-2; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Papadopoulou LC, 1999, NAT GENET, V23, P333; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; PEZESHKPOUR G, 1987, J NEUROL SCI, V77, P285, DOI 10.1016/0022-510X(87)90129-8; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028; RANMAN S, 1996, ANN NEUROL, V39, P343; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862; Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Stickler DE, 2006, PEDIATR NEUROL, V34, P127, DOI 10.1016/j.pediatrneurol.2005.08.006; SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0; Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P950, DOI 10.1001/archneur.61.6.950; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P84, DOI 10.1007/BF01800349; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	80	44	45	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34839	34849		10.1074/jbc.M703528200	http://dx.doi.org/10.1074/jbc.M703528200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17761683	hybrid			2022-12-25	WOS:000251155200026
J	Uzunova, K; Gottsche, K; Miteva, M; Weisshaar, SR; Glanemann, C; Schnellhardt, M; Niessen, M; Scheel, H; Hofmann, K; Johnson, ES; Praefcke, GJK; Dohmen, RJ				Uzunova, Kristina; Goettsche, Kerstin; Miteva, Maria; Weisshaar, Stefan R.; Glanemann, Christoph; Schnellhardt, Marion; Niessen, Michaela; Scheel, Hartmut; Hofmann, Kay; Johnson, Erica S.; Praefcke, Gerrit J. K.; Dohmen, R. Juergen			Ubiquitin-dependent proteolytic control of SUMO conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE DEGRADATION; BINDING MOTIF; DNA-REPAIR; SNURF RNF4; PROTEIN; NUCLEAR; COMPLEX; LIGASE; IDENTIFICATION; PCNA	Posttranslational protein modification with small ubiquitin-related modifier (SUMO) is an important regulatory mechanism implicated in many cellular processes, including several of biomedical relevance. We report that inhibition of the proteasome leads to accumulation of proteins that are simultaneously conjugated to both SUMO and ubiquitin in yeast and in human cells. A similar accumulation of such conjugates was detected in Saccharomyces cerevisiae ubc4 ubc5 cells as well as in mutants lacking two RING finger proteins, Ris1 and Hex3/Slx5-Slx8, that bind to SUMO as well as to the ubiquitin-conjugating enzyme Ubc4. In vitro, Hex3-Slx8 complexes promote Ubc4-dependent ubiquitylation. Together these data identify a previously unrecognized pathway that mediates the proteolytic down-regulation of sumoylated proteins. Formation of substrate-linked SUMO chains promotes targeting of SUMO-modified substrates for ubiquitin-mediated proteolysis. Genetic and biochemical evidence indicates that SUMO conjugation can ultimately lead to inactivation of sumoylated substrates by polysumoylation and/or ubiquitin-dependent degradation. Simultaneous inhibition of both mechanisms leads to severe phenotypic defects.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50674 Cologne, Germany; Miltenyi Biotec GmbH, Bioinformat Dept, MACSmol Business Unit, D-50829 Cologne, Germany; Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Cologne; University of Cologne; Miltenyi Biotec; Jefferson University	Dohmen, RJ (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	j.dohmen@uni-koeln.de	Hofmann, Kay/D-6714-2011; Dohmen, R. Jürgen/AAD-6649-2022	Hofmann, Kay/0000-0002-2289-9083; Dohmen, R. Jürgen/0000-0002-5756-6780; Praefcke, Gerrit/0000-0001-8818-1499	NIGMS NIH HHS [GM 62268] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062268] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bai C, 1997, METHOD ENZYMOL, V283, P141; Biggins S, 2001, GENETICS, V159, P453; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Flood F, 2005, BIOCHEM J, V385, P545, DOI 10.1042/BJ20041145; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Isik S, 2003, FEBS LETT, V546, P374, DOI 10.1016/S0014-5793(03)00637-9; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Iwase M, 2001, GENES GENET SYST, V76, P335, DOI 10.1266/ggs.76.335; James P, 1996, GENETICS, V144, P1425; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mullen JR, 2001, GENETICS, V157, P103; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhang Z, 1997, MOL CELL BIOL, V17, P6147, DOI 10.1128/MCB.17.10.6147; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	63	246	255	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34167	34175		10.1074/jbc.M706505200	http://dx.doi.org/10.1074/jbc.M706505200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17728242	hybrid			2022-12-25	WOS:000251145700031
J	Willoughby, D; Baillie, GS; Lynch, MJ; Ciruela, A; Houslay, MD; Cooper, DMF				Willoughby, Debbie; Baillie, George S.; Lynch, Martin J.; Ciruela, Antonio; Houslay, Miles D.; Cooper, Dermot M. F.			Dynamic regulation, desensitization, and cross-talk in discrete subcellular microdomains during beta(2)-adrenoceptor and prostanoid receptor cAMP signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; AIRWAY SMOOTH-MUSCLE; NUCLEOTIDE-GATED CHANNELS; RESONANCE ENERGY-TRANSFER; CARDIAC MYOCYTES; BETA-ARRESTIN; COUPLED RECEPTORS; IN-VIVO; COMPARTMENTALIZED PHOSPHODIESTERASES; VENTRICULAR MYOCYTES	Dynamic and localized actions of cAMP are central to the generation of discrete cellular events in response to a range of G(s)-coupled receptor agonists. In the present study we have employed a cyclic nucleotide-gated channel sensor to report acute changes in cAMP in the restricted cellular microdomains adjacent to two different G(s)-coupled receptor pathways, beta(2)-adrenoceptors and prostanoid receptors that are expressed endogenously in HEK293 cells. We probed by either selective small interference RNA-mediated knockdown or dominant negative overexpression the contribution of key signaling components in the rapid attenuation of the local cAMP signaling and subsequent desensitization of each of these G-protein-coupled receptor signaling pathways immediately following receptor activation. Direct measurements of cAMP changes just beneath the plasma membrane of single HEK293 cells reveal novel insights into key regulatory roles provided by protein kinase A-RII, beta-arrestin2, cAMP phosphodiesterase-4D3, and cAMP phosphodiesterase-4D5. We provide new evidence for distinct modes of cAMP down-regulation in these two Gs-linked pathways and show that these distinct G-protein-coupled receptor signaling systems are subject to unidirectional, heterologous desensitization that allows for limited cross-talk between distinct, dynamically regulated pools of cAMP.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Cambridge; University of Glasgow	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk	Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020	Houslay, Miles/0000-0002-3826-8091	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028389] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 28389] Funding Source: Medline; Wellcome Trust [RG 31760] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bastepe M, 1999, BRIT J PHARMACOL, V126, P365, DOI 10.1038/sj.bjp.0702291; Billington CK, 2003, RESP RES, V4; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; HSIA JA, 1985, J BIOL CHEM, V260, P4922; Jurevicius J, 2003, J PHYSIOL-LONDON, V551, P239, DOI 10.1113/jphysiol.2003.045211; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Mundell SJ, 1999, BIOCHEMISTRY-US, V38, P8723, DOI 10.1021/bi990361v; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Rochais F, 2004, J BIOL CHEM, V279, P52095, DOI 10.1074/jbc.M405697200; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113	44	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34235	34249		10.1074/jbc.M706765200	http://dx.doi.org/10.1074/jbc.M706765200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855344	hybrid			2022-12-25	WOS:000251145700039
J	Campbell, DR; Chapman, KE; Waldron, KJ; Tottey, S; Kendall, S; Cavallaro, G; Andreini, C; Hinds, J; Stoker, NG; Robinson, NJ; Cavet, JS				Campbell, Duncan R.; Chapman, Kaye E.; Waldron, Kevin J.; Tottey, Stephen; Kendall, Sharon; Cavallaro, Gabriele; Andreini, Claudia; Hinds, Jason; Stoker, Neil G.; Robinson, Nigel J.; Cavet, Jennifer S.			Mycobacterial cells have dual nickel-cobalt sensors - Sequence relationships and metal sites of metal-responsive repressors are not congruent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PI258 CADC; STAPHYLOCOCCUS-AUREUS; MACROPHAGE PROTEIN-1; NATURAL-RESISTANCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; METALLOREGULATORY PROTEIN; SMTB/ARSR FAMILY; BINDING SITES; ZINC SENSOR	A novel ArsR-SmtB family transcriptional repressor, KmtR, has been characterized from mycobacteria. Mutants of Mycobacterium tuberculosis lacking kmtR show elevated expression of Rv2025c encoding a deduced CDF-family metal exporter. KmtR-dependent repression of the cdf and kmtR operator-promoters was alleviated by nickel and cobalt in minimal medium. Electrophoretic mobility shift assays and fluorescence anisotropy show binding of purified KmtR to nucleotide sequences containing a region of dyad symmetry from the cdf and kmtR operator-promoters. Incubation of KmtR with cobalt inhibits DNA complex assembly and metal-protein binding was confirmed. KmtR is the second, to NmtR, characterized ArsR-SmtB sensor of nickel and cobalt from M. tuberculosis suggesting special significance for these ions in this pathogen. KmtR-dependent expression is elevated in complete medium with no increase in response to metals, whereas NmtR retains a response to nickel and cobalt under these conditions. KmtR has tighter affinities for nickel and cobalt than NmtR consistent with basal levels of these metals being sensed by KmtR but not NmtR in complete medium. More than a thousand genes encoding ArsR-SmtB-related proteins are listed in databases. KmtR has none of the previously defined metal-sensing sites. Substitution of His(88), Glu(101), His(102), His(110), or His(111) with Gln generated KmtR variants that repress the cdf and kmtR operator-promoters even in elevated nickel and cobalt, revealing a new sensory site. Importantly, ArsR-SmtB sequence groupings do not correspond with the different sensory motifs revealing that only the latter should be used to predict metal sensing.	Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Manchester, Manchester M13 9PT, Lancs, England; Univ London Royal Vet Coll, London NW1 0TU, England; Univ Florence, Magnet Resonance Ctr, Florence, Italy; Consorzio Interuniv Risonanze Magnet Metalloprote, Florence, Italy; St George Hosp, Bacterial Microarray Grp, London SW17 0RE, England	Newcastle University - UK; University of Manchester; University of London; University of London Royal Veterinary College; University of Florence; St Georges University London	Cavet, JS (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jennifer.s.cavet@manchester.ac.uk	Stoker, Neil G/L-8812-2016; Waldron, Kevin/J-2368-2016; Robinson, Nigel J/J-6363-2012; Waldron, Kevin John/HHM-8983-2022; Andreini, Claudia/D-5614-2014; Cavallaro, Gabriele/GRE-9439-2022; Cavallaro, Gabriele/C-6991-2008	Stoker, Neil G/0000-0001-7055-6184; Waldron, Kevin/0000-0002-5577-7357; Robinson, Nigel J/0000-0001-5586-1092; Waldron, Kevin John/0000-0002-5577-7357; Andreini, Claudia/0000-0003-4329-8225; Cavet, Jennifer/0000-0001-5913-7157; Kendall, Sharon/0000-0003-3277-3035; Hinds, Jason/0000-0002-2739-1908	Biotechnology and Biological Sciences Research Council [P18581, D19920] Funding Source: Medline; Wellcome Trust [080039] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Agranoff D, 2004, FRONT BIOSCI-LANDMRK, V9, P2996, DOI 10.2741/1454; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Busenlehner LS, 2002, J MOL BIOL, V319, P685, DOI 10.1016/S0022-2836(02)00299-1; Canneva F, 2005, J BACTERIOL, V187, P5837, DOI 10.1128/JB.187.16.5837-5840.2005; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; CLEMENS DL, 1995, J BACTERIOL, V177, P5644, DOI 10.1128/jb.177.19.5644-5652.1995; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; Eicken C, 2003, J MOL BIOL, V333, P683, DOI 10.1016/j.jmb.2003.09.007; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Harvie DR, 2006, MOL MICROBIOL, V59, P1341, DOI 10.1111/j.1365-2958.2006.05029.x; Hoal EG, 2004, INT J TUBERC LUNG D, V8, P1464; Hotter GS, 2001, FEMS MICROBIOL LETT, V200, P151, DOI 10.1016/S0378-1097(01)00214-2; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; KARASSEVA V, 1977, ZBL BAKT-INT J MED M, V239, P514; Kuroda M, 1999, MICROBIOL IMMUNOL, V43, P115, DOI 10.1111/j.1348-0421.1999.tb02382.x; Liu T, 2005, BIOCHEMISTRY-US, V44, P8673, DOI 10.1021/bi050450+; Liu T, 2004, J BIOL CHEM, V279, P17810, DOI 10.1074/jbc.M310560200; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Manabe YC, 1999, P NATL ACAD SCI USA, V96, P12844, DOI 10.1073/pnas.96.22.12844; Mandal S, 2007, MICROBIOL-SGM, V153, P80, DOI 10.1099/mic.0.29197-0; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Milano A, 2004, RES MICROBIOL, V155, P192, DOI 10.1016/j.resmic.2003.11.009; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pennella MA, 2003, P NATL ACAD SCI USA, V100, P3713, DOI 10.1073/pnas.0636943100; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; VanZile ML, 2002, BIOCHEMISTRY-US, V41, P9776, DOI 10.1021/bi020178t; Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Xu C, 1996, J BIOL CHEM, V271, P2427, DOI 10.1074/jbc.271.5.2427; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang WH, 2005, CLIN INFECT DIS, V40, P1232, DOI 10.1086/428726	51	83	87	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32298	32310		10.1074/jbc.M703451200	http://dx.doi.org/10.1074/jbc.M703451200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726022	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000250480300053
J	Manna, D; Albanese, A; Park, WS; Cho, W				Manna, Debasis; Albanese, Alexandra; Park, Wei Sun; Cho, Wonhwa			Mechanistic basis of differential cellular responses of phosphatidylinositol 3,4-bisphosphate- and phosphatidylinositol 3,4,5-trisphosphate-binding pleckstrin homology domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; MEMBRANE-PROTEIN INTERACTIONS; PHOSPHOINOSITIDE-BINDING; C2 DOMAINS; PH-DOMAIN; INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; STRUCTURAL BASIS; MOLECULAR-BASIS; PX DOMAINS; ACTIVATION	Phosphatidylinositol 3,4-bisphosphate ( PtdIns( 3,4) P-2) and phosphatidylinositol 3,4,5-trisphosphate ( PtdIns( 3,4,5) P-3) are lipid second messengers that regulate various cellular processes by recruiting a wide range of downstream effector proteins to membranes. Several pleckstrin homology ( PH) domains have been reported to interact with PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P-3. To understand how these PH domains differentially respond to PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P-3 signals, we quantitatively determined the PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P3 binding properties of several PH domains, including Akt, ARNO, Btk, DAPP1, Grp1, and C-terminal TAPP1 PH domains by surface plasmon resonance and monolayer penetration analyses. The measurements revealed that these PH domains have significant different phosphoinositide specificities and affinities. Btk-PH and TAPP1-PH showed genuine PtdIns( 3,4,5) P-3 and PtdIns( 3,4) P2 specificities, respectively, whereas other PH domains exhibited less pronounced specificities. Also, the PH domains showed different degrees of membrane penetration, which greatly affected the kinetics of their membrane dissociation. Mutational studies showed that the presence of two proximal hydrophobic residues on the membrane-binding surface of the PH domain is important for membrane penetration and sustained membrane residence. When NIH 3T3 cells were stimulated with platelet-derived growth factor to generate PtdIns( 3,4,5) P-3, reversible translocation of Btk-PH, Grp1-PH, ARNO-PH, DAPP1-PH, and its L177A mutant to the plasma membrane was consistent with their in vitro membrane binding properties. Collectively, these studies provide new insight into how various PH domains would differentially respond to cellular PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P-3 signals.	Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Stanford Univ, Med Ctr, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University	Cho, W (corresponding author), Univ Illinois, Dept Chem, MC 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu		Manna, Debasis/0000-0002-6920-9000	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68849] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Banfic H, 1998, J BIOL CHEM, V273, P13, DOI 10.1074/jbc.273.1.13; Banfic H, 1998, J BIOL CHEM, V273, P11630, DOI 10.1074/jbc.273.19.11630; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Flesch FM, 2005, BIOCHEM J, V389, P435, DOI 10.1042/BJ20041721; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Malkova S, 2006, BIOCHEMISTRY-US, V45, P13566, DOI 10.1021/bi061133l; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Singh SM, 2003, PROTEIN SCI, V12, P1934, DOI 10.1110/ps.0358803; Stahelin RV, 2006, J BIOL CHEM, V281, P39396, DOI 10.1074/jbc.M607079200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Thomas CC, 2001, BIOCHEM J, V358, P287, DOI 10.1042/0264-6021:3580287; Tuzi S, 2003, J BIOL CHEM, V278, P28019, DOI 10.1074/jbc.M300101200; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8	75	111	111	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32093	32105		10.1074/jbc.M703517200	http://dx.doi.org/10.1074/jbc.M703517200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823121	hybrid			2022-12-25	WOS:000250480300030
J	Takeda, AN; Gautschi, I; van Bemmelen, MX; Schild, L				Takeda, Armelle-Natsuo; Gautschi, Ivan; van Bemmelen, Miguel X.; Schild, Laurent			Cadmium trapping in an epithelial sodium channel pore mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVITY FILTER; AMILORIDE BLOCK; REGION; RESIDUES; SUBUNIT	The putative selectivity filter of the epithelial sodium channel (ENaC) comprises a three- residue sequence G/ SXS, but it remains uncertain whether the backbone atoms of this sequence or whether their side chains are lining the pore. It has been reported that the S589C mutation in the selectivity filter of alpha ENaC renders the channel sensitive to block by externally applied Cd2+; this was interpreted as evidence for Cd2+ coordination with the thiol group of the side chain of alpha 589C, pointing toward the pore lumen. Because the alpha S589C mutation alters the monovalent to divalent cation selectivity ratio of ENaC and because internally applied Cd2+ blocks wild-type ENaC with high affinity, we hypothesized that the inhibition of alpha S589C ENaC by Cd2+ results rather from the coordination of this cation with native cysteine residues located in the internal pore of ENaC. We show here that Cd2+ inhibits not only ENaC alpha S589C and alpha S589D but also alpha S589N mutants and that Ca2+ weakly interacts with the S589D mutant. The block of alpha S589C, - D, and - N mutants is characterized by a slow on- rate, is nearly irreversible, is voltage- dependent, and can be prevented by amiloride. The C546S mutation in the second transmembrane helix of gamma subunit in the background of the ENaC alpha S589C, - D, or - N mutants reduces the sensitivity to block by Cd2+ and renders the block rapidly reversible. We conclude therefore that the block by Cd2+ of the alpha S589C, - D, and - N mutants results from the trapping of Cd2+ ions in the internal pore of the channel and involves Cys-546 in the second transmembrane helix of the gamma ENaC subunit.	Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, CH-1005 Lausanne, Switzerland	University of Lausanne	Schild, L (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, Bugnon 27, CH-1005 Lausanne, Switzerland.	Schild@unil.ch	TAKEDA, Armelle-Natsuo/B-6031-2009; van Bemmelen, Miguel Xavier/A-8660-2014; van Bemmelen, Miguel/B-5971-2009	van Bemmelen, Miguel Xavier/0000-0003-2762-6153; 				Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kellenberger S, 2003, MOL PHARMACOL, V64, P848, DOI 10.1124/mol.64.4.848; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; PALMER LG, 1990, RENAL PHYSIOL BIOCH, V13, P51; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; RAVINDRAN A, 1991, J GEN PHYSIOL, V97, P89, DOI 10.1085/jgp.97.1.89; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2005, J BIOL CHEM, V280, P8513, DOI 10.1074/jbc.M413880200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484	20	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31928	31936		10.1074/jbc.M700733200	http://dx.doi.org/10.1074/jbc.M700733200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804416	hybrid			2022-12-25	WOS:000250480300013
J	Wang, Y; Rosen, H; Madtes, DK; Shao, B; Martin, TR; Heinecke, JW; Fu, X				Wang, Yi; Rosen, Henry; Madtes, David K.; Shao, Baohai; Martin, Thomas R.; Heinecke, Jay W.; Fu, Xiaoyun			Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue - An oxidative mechanism for regulating proteolysis during inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; HYPOCHLOROUS ACID; METHIONINE RESIDUES; HYDROGEN-PEROXIDE; OXIDANTS; PEPTIDE; DOMAIN; NEUTROPHILS; GENERATION	An imbalance between the proteolytic activity of matrix metalloproteinases (MMPs) and the activity of tissue inhibitors of metalloproteinases (TIMPs) is implicated in tissue injury during inflammation. The N-terminal cysteine of TIMP-1 plays a key role in the inhibitory activity of the protein because it coordinates the essential catalytic Zn2+ of the MMP, preventing the metal ion from functioning. An important mechanism for controlling the interaction of TIMPs with MMPs might involve hypochlorous acid (HOCl), a potent oxidant produced by the myeloperoxidase (MPO) system of phagocytes. Here, we show that HOCl generated by the MPO-H2O2-chloride system inactivates TIMP-1 by oxidizing its N-terminal cysteine. The product is a novel 2-oxo acid. Liquid chromatography-mass spectrometry and tandem mass spectrometry analyses demonstrated that methionine and N-terminal cysteine residues were rapidly oxidized by MPO-derived HOCl but only oxidation of the N-terminal cysteine of TIMP-1 correlated well with loss of inhibitory activity. Importantly, we detected the signature 2-oxo-acid N-terminal peptide in tryptic digests of bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome, demonstrating that TIMP-1 oxidation occurs in vivo. Loss of the N-terminal amino group and disulfide structure are crucial for preventing TIMP-1 from inhibiting MMPs. Our findings suggest that pericellular production of HOCl by phagocytes is a pathogenic mechanism for impairing TIMP-1 activity during inflammation.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Vet Affairs Puget Sound Hlth Care Syst, Med Res Serv, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Fu, X (corresponding author), Univ Washington, Dept Med, Box 356426, Seattle, WA 98195 USA.	xyfu@u.washington.edu	Wang, Yi/C-2871-2013	Shao, Baohai/0000-0001-8832-2845	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086, R01HL078527, P50HL073996, R01HL075381, R01HL063994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL030086, R01 HL075381, HL075381, P50HL073996, HL063994, R01 HL078527, HL078527, P50 HL073996, R01 HL063994] Funding Source: Medline; NIEHS NIH HHS [P30 ES007033, P30ES07033] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; BODDEN MK, 1994, ANN NY ACAD SCI, V732, P403, DOI 10.1111/j.1749-6632.1994.tb24767.x; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Drapeau G R, 1977, Methods Enzymol, V47, P189; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; Frears ER, 1996, FEBS LETT, V381, P21, DOI 10.1016/0014-5793(96)00065-8; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grenier D, 2001, FEMS MICROBIOL LETT, V203, P161, DOI 10.1016/S0378-1097(01)00351-2; Haji R, 2007, J PATHOL, V211, P340, DOI 10.1002/path.2118; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; KALYANARAMAN B, 1985, J CLIN INVEST, V75, P1618, DOI 10.1172/JCI111868; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kobayashi T, 2004, METH MOL B, V289, P201; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Lee Y, 2001, STAT MODEL, V1, P3, DOI 10.1177/1471082X0100100102; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Melnyk O, 2001, J ORG CHEM, V66, P4153, DOI 10.1021/jo001509f; Melnyk O, 2000, BIOPOLYMERS, V55, P165, DOI 10.1002/1097-0282(2000)55:2<165::AID-BIP50>3.0.CO;2-#; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Okarvi SM, 2002, J LABELLED COMPD RAD, V45, P407, DOI 10.1002/jlcr.568; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; RAY JM, 1994, EUR RESPIR J, V7, P2062; Ricou B, 1996, AM J RESP CRIT CARE, V154, P346, DOI 10.1164/ajrccm.154.2.8756805; Shabani F, 1998, FREE RADICAL RES, V28, P115, DOI 10.3109/10715769809065797; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Woessner J.F., 2000, PROTEIN PROFILE SER	51	96	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31826	31834		10.1074/jbc.M704894200	http://dx.doi.org/10.1074/jbc.M704894200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726014	hybrid, Green Accepted			2022-12-25	WOS:000250480300002
J	Baltzis, D; Pluquet, O; Papadakis, AI; Kazemi, S; Qu, LK; Koromilas, AE				Baltzis, Dionissios; Pluquet, Olivier; Papadakis, Andreas I.; Kazemi, Shirin; Qu, Li-Ke; Koromilas, Antonis E.			The elF2 alpha kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-SYNTHASE KINASE-3; RIBOSOME ENTRY SITES; TRANSLATIONAL CONTROL; MUTANT P53; P53-DEPENDENT APOPTOSIS; GENE-EXPRESSION; TUMOR-CELLS; IN-VIVO; KAPPA-B	Phosphorylation of eukaryotic initiation factor 2 alpha(eIF2 alpha) is mediated by a family of kinases that respond to various forms of environmental stress. The eIF2 alpha kinases are critical for mRNA translation, cell proliferation, and apoptosis. Activation of the tumor suppressor p53 results in cell cycle arrest and apoptosis in response to various types of stress. We previously showed that, unlike the majority of stress responses that stabilize and activate p53, induction of endoplasmic reticulum stress leads to p53 degradation through an Mdm2-dependent mechanism. Here, we demonstrate that the endoplasmic reticulum-resident eIF2 alpha kinase PERK mediates the proteasomal degradation of p53 independently of translational control. This role is not specific for PERK, because the eIF2 alpha kinase PKR also promotes p53 degradation in response to double-stranded RNA. We further establish that the eIF2 alpha kinases induce glycogen synthase kinase 3 to promote the nuclear export and proteasomal degradation of p53. Our findings reveal a novel cross- talk between the eIF2 alpha kinases and p53 with implications in cell proliferation and tumorigenesis.	INSERM, Bordeaux 33076, France; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pennsylvania; Pennsylvania Medicine; Lady Davis Institute; McGill University	Koromilas, AE (corresponding author), 3755 Cote-Ste-Catherine St, Montreal, PQ H3T 1E2, Canada.	antonis.koromilas@mcgill.ca						Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Arava Yoav, 2003, Methods Mol Biol, V224, P79; Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Bell John C., 2003, Cancer Cell, V4, P7, DOI 10.1016/S1535-6108(03)00170-3; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Corcoran CA, 2004, CANCER BIOL THER, V3, P721, DOI 10.4161/cbt.3.8.1068; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; GANNON JV, 1991, NATURE, V349, P802; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huang S, 2004, CELL CYCLE, V3, P1043; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jonkers J, 1997, EMBO J, V16, P441, DOI 10.1093/emboj/16.3.441; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kimball Sr, 2000, COLD SPRING HARBOR M, V39, P561; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005; Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477; Norman KL, 2001, CYTOKINE GROWTH F R, V12, P271, DOI 10.1016/S1359-6101(00)00024-1; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Qu L, 2004, CELL CYCLE, V3, P567, DOI 10.4161/cc.3.5.872; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Roh MS, 2005, BIOL PSYCHIAT, V57, P278, DOI 10.1016/j.biopsych.2004.10.039; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; van Amerongen R, 2005, CELL CYCLE, V4, pE89; van Amerongen R, 2005, GENE DEV, V19, P425, DOI 10.1101/gad.326705; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wenger RH, 1998, CANCER RES, V58, P5678; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200	79	90	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31675	31687		10.1074/jbc.M704491200	http://dx.doi.org/10.1074/jbc.M704491200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785458	hybrid			2022-12-25	WOS:000250309200059
J	Jonsson, SR; LaRue, RS; Stenglein, MD; Fahrenkrug, SC; Andresdottir, V; Harris, RS				Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Fahrenkrug, Scott C.; Andresdottir, Valgerdur; Harris, Reuben S.			The Restriction of Zoonotic PERV Transmission by Human APOBEC3G	PLOS ONE			English	Article								The human APOBEC3G protein is an innate anti-viral factor that can dominantly inhibit the replication of some endogenous and exogenous retroviruses. The prospects of purposefully harnessing such an anti-viral defense are under investigation. Here, long-term co-culture experiments were used to show that porcine endogenous retrovirus (PERV) transmission from pig to human cells is reduced to nearly undetectable levels by expressing human APOBEC3G in virus-producing pig kidney cells. Inhibition occurred by a deamination-independent mechanism, likely after particle production but before the virus could immortalize by integration into human genomic DNA. PERV inhibition did not require the DNA cytosine deaminase activity of APOBEC3G and, correspondingly, APOBEC3G-attributable hypermutations were not detected. In contrast, over-expression of the sole endogenous APOBEC3 protein of pigs failed to interfere significantly with PERV transmission. Together, these data constitute the first proof-of-principle demonstration that APOBEC3 proteins can be used to fortify the innate anti-viral defenses of cells to prevent the zoonotic transmission of an endogenous retrovirus. These studies suggest that human APOBEC3G-transgenic pigs will provide safer, PERV-less xenotransplantation resources and that analogous cross-species APOBEC3-dependent restriction strategies may be useful for thwarting other endogenous as well as exogenous retrovirus infections.	[Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN USA; [Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Fahrenkrug, Scott C.; Harris, Reuben S.] Univ Minnesota, Arnold & Mabel Beckman Ctr Transposon Res, Minneapolis, MN USA; [Jonsson, Stefan R.; Andresdottir, Valgerdur] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Fahrenkrug, Scott C.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Iceland; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu	Stenglein, Mark/E-3541-2017	Stenglein, Mark/0000-0002-0993-813X; Fahrenkrug, Scott/0000-0002-7176-6551	NIH; Spring Point Project; Icelandic Research Fund; Val Bjornson Icelandic Exchange Scholarship; 3M Science and Technology Graduate Fellowship; Searle Scholarship; University of Minnesota	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spring Point Project; Icelandic Research Fund; Val Bjornson Icelandic Exchange Scholarship; 3M Science and Technology Graduate Fellowship(3M); Searle Scholarship; University of Minnesota(University of Minnesota System)	Funding: These studies were funded in part by grants from the NIH to RSH and from Spring Point Project to SCF. SRJ was supported in part by the Icelandic Research Fund for Graduate Students and a 2004-2005 Val Bjornson Icelandic Exchange Scholarship. MDS was supported in part by a 3M Science and Technology Graduate Fellowship. RSH was supported in part by a Searle Scholarship and a University of Minnesota McKnight Land Grant Professorship. Sponsors did not contribute to the study design, to the collection, analysis and interpretation of data, to writing the paper or to the decision to submit it for publication.	AbuBakar S, 2004, EMERG INFECT DIS, V10, P2228, DOI 10.3201/eid1012.040452; Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055; Agarwal S, 2006, MOL THER, V14, P555, DOI 10.1016/j.ymthe.2006.03.025; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cooper DKC, 2002, ANNU REV MED, V53, P133, DOI 10.1146/annurev.med.53.082901.103900; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Dieckhoff B, 2007, ARCH VIROL, V152, P629, DOI 10.1007/s00705-006-0868-y; Dorak M.T., 2006, REAL TIME PCR, P89; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Specke V, 2001, VIROLOGY, V285, P177, DOI 10.1006/viro.2001.0934; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Takeuchi Y, 2005, REV SCI TECH OIE, V24, P323, DOI 10.20506/rst.24.1.1575; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Weiss RA, 1999, SCIENCE, V285, P1221, DOI 10.1126/science.285.5431.1221; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	57	49	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e893	10.1371/journal.pone.0000893	http://dx.doi.org/10.1371/journal.pone.0000893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849022	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455600039
J	Kachhap, SK; Faith, D; Qian, DZ; Shabbeer, S; Galloway, NL; Pili, R; Denmeade, SR; DeMarzo, AM; Carducci, MA				Kachhap, Sushant K.; Faith, Dennis; Qian, David Z.; Shabbeer, Shabana; Galloway, Nathan L.; Pili, Roberto; Denmeade, Samuel R.; DeMarzo, Angelo M.; Carducci, Michael A.			The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved in Vesicular Recycling of E-Cadherin	PLOS ONE			English	Article								Cell to cell adhesion is mediated by adhesion molecules present on the cell surface. Downregulation of molecules that form the adhesion complex is a characteristic of metastatic cancer cells. Downregulation of the N-myc down regulated gene1 (NDRG1) increases prostate and breast metastasis. The exact function of NDRG1 is not known. Here by using live cell confocal microscopy and in vitro reconstitution, we report that NDRG1 is involved in recycling the adhesion molecule E-cadherin thereby stabilizing it. Evidence is provided that NDRG1 recruits on recycling endosomes in the Trans Golgi network by binding to phosphotidylinositol 4-phosphate and interacts with membrane bound Rab4aGTPase. NDRG1 specifically interacts with constitutively active Rab4aQ67L mutant protein and not with GDP-bound Rab4aS22N mutant proving NDRG1 as a novel Rab4a effector. Transferrin recycling experiments reveals NDRG1 colocalizes with transferrin during the recycling phase. NDRG1 alters the kinetics of transferrin recycling in cells. NDRG1 knockdown cells show a delay in recycling transferrin, conversely NDRG1 overexpressing cells reveal an increase in rate of transferrin recycling. This novel finding of NDRG1 as a recycling protein involved with recycling of E-cadherin will aid in understanding NDRG1 role as a metastasis suppressor protein.	[Kachhap, Sushant K.; Faith, Dennis; Qian, David Z.; Shabbeer, Shabana; Galloway, Nathan L.; Pili, Roberto; Denmeade, Samuel R.; DeMarzo, Angelo M.; Carducci, Michael A.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Prostate Canc Program, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Kachhap, SK (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Prostate Canc Program, Baltimore, MD 21218 USA.	kachhsu@jhmi.edu	Galloway, Nathan/K-4843-2012; Qian, David Z/AAL-3441-2021; Carducci, Michael/R-8164-2019		Prostate Cancer Foundation; NCI SPORE [P50CA58236]; AEGON International Fellowship; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER	Prostate Cancer Foundation; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AEGON International Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by the David Koch Fund which was provided by the Prostate Cancer Foundation, the Prostate Cancer Foundation and the NCI SPORE Grant P50CA58236. SKK is supported by the AEGON International Fellowship.	Agnantis NJ, 2004, IN VIVO, V18, P481; Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Anitei M, 2006, CURR BIOL, V16, pR418, DOI 10.1016/j.cub.2006.05.010; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; CHOI SY, 2006, CELL DEATH DIFFER; Choudhury RR, 2005, BIOCHEM SOC SYMP, V72, P31, DOI 10.1042/bss0720031; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Elferink LA, 2005, METHOD ENZYMOL, V403, P732, DOI 10.1016/S0076-6879(05)03064-8; Faith D, 2005, PROSTATE, V65, P73, DOI 10.1002/pros.20258; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Guang RJ, 2000, CANCER RES, V60, P749; Hunter M, 2005, BIOCHEM BIOPH RES CO, V332, P982, DOI 10.1016/j.bbrc.2005.05.050; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; KOHN EC, 1991, PHARMACOL THERAPEUT, V52, P235, DOI 10.1016/0163-7258(91)90011-A; Kyuno J, 2003, BIOCHEM BIOPH RES CO, V309, P52, DOI 10.1016/S0006-291X(03)01522-5; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Lazarescu E, 2006, GENE, V374, P77, DOI 10.1016/j.gene.2006.01.025; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LIOTTA LA, 1988, BREAST CANCER RES TR, V11, P113, DOI 10.1007/BF01805835; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Nishie A, 2001, CLIN CANCER RES, V7, P2145; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Piquemal D, 1999, BBA-MOL CELL RES, V1450, P364, DOI 10.1016/S0167-4889(99)00056-7; Polishchuk RS, 2006, TRAFFIC, V7, P1092, DOI 10.1111/j.1600-0854.2006.00453.x; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RINKERSCHAEFFER CW, 1993, CANCER METAST REV, V12, P3, DOI 10.1007/BF00689785; Sakai T, 1998, BIOCHEM BIOPH RES CO, V242, P151, DOI 10.1006/bbrc.1997.7577; Salnikow K, 1999, TOXICOL APPL PHARM, V160, P127, DOI 10.1006/taap.1999.8759; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Taketomi Y, 2003, BIOCHEM BIOPH RES CO, V306, P339, DOI 10.1016/S0006-291X(03)00942-2; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Utleg AG, 2003, PROSTATE, V56, P150, DOI 10.1002/pros.10255; Wang XD, 2002, J IMMUNOL, V168, P4612, DOI 10.4049/jimmunol.168.9.4612; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	90	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e844	10.1371/journal.pone.0000844	http://dx.doi.org/10.1371/journal.pone.0000844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786215	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455500027
J	Wei, JN; Wang, LZ; Zhu, JW; Zhang, SF; Nandi, OI; Kang, L				Wei, Jianing; Wang, Lizhong; Zhu, Junwei; Zhang, Sufang; Nandi, Owi I.; Kang, Le			Plants Attract Parasitic Wasps to Defend Themselves against Insect Pests by Releasing Hexenol	PLOS ONE			English	Article							LIRIOMYZA-SATIVAE DIPTERA; INDUCED VOLATILES; NATURAL ENEMIES; ZEA-MAYS; ODORS; LEAFMINER; RESPONSES; LOCATION; INDUCE; RBCL	Background. Plant volatiles play an important role in defending plants against insect attacks by attracting their natural enemies. For example, green leaf volatiles (GLVs) and terpenoids emitted from herbivore-damaged plants were found to be important in the host location of parasitic wasps. However, evidence of the functional roles and mechanisms of these semiochemicals from a system of multiple plants in prey location by the parasitoid is limited. Little is known about the potential evolutionary trends between herbivore-induced host plant volatiles and the host location of their parasitoids. Methodology/Principal Findings. The present study includes hierarchical cluster analyses of plant volatile profiles from seven families of host and non-host plants of pea leafminer, Liriomyza huidobrensis, and behavioral responses of a naive parasitic wasp, Opius dissitus, to some principal volatile compounds. Here we show that plants can effectively pull wasps, O. dissitus, towards them by releasing a universally induced compound, (Z)-3-hexenol, and potentially keep these plants safe from parasitic assaults by leafminer pests, L. huidobrensis. Specifically, we found that volatile profiles from healthy plants revealed a partly phylogenetic signal, while the inducible compounds of the infested-plants did not result from the fact that the induced plant volatiles dominate most of the volatile blends of the host and non-host plants of the leafminer pests. We further show that the parasitoids are capable of distinguishing the damaged host plant from the non-host plant of the leafminers. Conclusions/Significance. Our results suggest that, as the most passive scenario of plant involvement, leafminers and mechanical damages evoke similar semio-chemicals. Using ubiquitous compounds, such as hexenol, for host location by general parasitoids could be an adaptation of the most conservative evolution of tritrophic interaction. Although for this, other compounds may be used to improve the precision of the host location by the parasitoids.	[Wei, Jianing; Wang, Lizhong; Zhang, Sufang; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhu, Junwei] Iowa State Univ, Dept Entomol, Iowa City, IA USA; [Nandi, Owi I.] Inst Systemat Bot, Zurich, Switzerland	Chinese Academy of Sciences; Institute of Zoology, CAS; Iowa State University	Kang, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022; Wei, Jianing/L-7575-2019	Kang, Le/0000-0003-4262-2329; Wei, Jianing/0000-0002-8517-2164; Zhu, Junwei/0000-0001-9846-9656	National Basic Research Program of China [2006CB102006]; Chinese Academy of Sciences; National Nature Science Foundation of China [30670356, 30621003]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Basic Research Program of China (973 Program) (No. 2006CB102006), the Chinese Academy of Sciences (Project No: KSCX2-YW-N-006), and the National Nature Science Foundation of China (30670356 and 30621003).	*AM CHEM SOC, 2007, CHEM ABSTR DAT; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; D'Alessandro M, 2005, CHEM SENSES, V30, P739, DOI 10.1093/chemse/bji066; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Dicke M, 1999, ENTOMOL EXP APPL, V91, P131, DOI 10.1023/A:1003608019062; Dicke M, 1999, J CHEM ECOL, V25, P1907, DOI 10.1023/A:1020942102181; Dicke Marcel, 1999, P62; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Gouinguene S, 2005, J CHEM ECOL, V31, P1023, DOI 10.1007/s10886-005-4245-1; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; HEGNAUER R, 1966, CHEMOTAXONOMIE PFLAN, V1; Hoballah ME, 2005, J CHEM ECOL, V31, P2003, DOI 10.1007/s10886-005-6074-7; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; HOPKE J, 1994, FEBS LETT, V352, P146, DOI 10.1016/0014-5793(94)00948-1; KANG L, 1996, ECOLOGY SUSTAINABLE; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; LEWIS WJ, 1990, J CHEM ECOL, V16, P3067, DOI 10.1007/BF00979613; Liscombe DK, 2005, PHYTOCHEMISTRY, V66, P1374, DOI 10.1016/j.phytochem.2005.04.029; Mumm R, 2005, CHEM SENSES, V30, P337, DOI 10.1093/chemse/bji028; Nandi OI, 1998, ANN MO BOT GARD, V85, P137, DOI 10.2307/2992003; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Shiojiri K, 2006, PLOS BIOL, V4, P1044, DOI 10.1371/journal.pbio.0040164; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Spencer K. A., 1990, SERIES ENTOMOLOGICA, V45, DOI 10.2307/4110790; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN, P62; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Wei JN, 2006, CHEM SENSES, V31, P467, DOI 10.1093/chemse/bjj051; Wei JN, 2006, PLANTA, V224, P279, DOI 10.1007/s00425-005-0212-x; Zhao YX, 2002, EUR J ENTOMOL, V99, P445, DOI 10.14411/eje.2002.056; Zhao YX, 2002, PHYSIOL ENTOMOL, V27, P103, DOI 10.1046/j.1365-3032.2002.00275.x; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8	42	67	77	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e852	10.1371/journal.pone.0000852	http://dx.doi.org/10.1371/journal.pone.0000852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786223	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455500035
J	Miguel, RN; Wong, J; Westoll, JF; Brooks, HJ; O'Neill, LAJ; Gay, NJ; Bryant, CE; Monie, TP				Miguel, Ricardo Nunez; Wong, Joyce; Westoll, Julian F.; Brooks, Heather J.; O'Neill, Luke A. J.; Gay, Nicholas J.; Bryant, Clare E.; Monie, Tom P.			A Dimer of the Toll-Like Receptor 4 Cytoplasmic Domain Provides a Specific Scaffold for the Recruitment of Signalling Adaptor Proteins	PLOS ONE			English	Article								The Toll-like receptor 4 (TLR4) is a class I transmembrane receptor expressed on the surface of immune system cells. TLR4 is activated by exposure to lipopolysaccharides derived from the outer membrane of Gram negative bacteria and forms part of the innate immune response in mammals. Like other class 1 receptors, TLR4 is activated by ligand induced dimerization, and recent studies suggest that this causes concerted conformational changes in the receptor leading to self association of the cytoplasmic Toll/Interleukin 1 receptor (TIR) signalling domain. This homodimerization event is proposed to provide a new scaffold that is able to bind downstream signalling adaptor proteins. TLR4 uses two different sets of adaptors; TRAM and TRIF, and Mal and MyD88. These adaptor pairs couple two distinct signalling pathways leading to the activation of interferon response factor 3 (IRF-3) and nuclear factor kappa B (NF kappa B) respectively. In this paper we have generated a structural model of the TLR4 TIR dimer and used molecular docking to probe for potential sites of interaction between the receptor homodimer and the adaptor molecules. Remarkably, both the Mal and TRAM adaptors are strongly predicted to bind at two symmetry-related sites at the homodimer interface. This model of TLR4 activation is supported by extensive functional studies involving site directed mutagenesis, inhibition by cell permeable peptides and stable protein phosphorylation of receptor and adaptor TIR domains. Our results also suggest a molecular mechanism for two recent findings, the caspase 1 dependence of Mal signalling and the protective effects conferred by the Mal polymorphism Ser180Leu.	[Miguel, Ricardo Nunez; Wong, Joyce; Westoll, Julian F.; Gay, Nicholas J.; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Brooks, Heather J.; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	University of Cambridge; University of Cambridge; Trinity College Dublin	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	njg11@cam.ac.uk; ceb27@cam.ac.uk; tpm22@cam.ac.uk	Miguel, Ricardo Nunez/F-4412-2010; Monie, Tom/H-4662-2019	Monie, Tom/0000-0003-4097-1680; O'Neill, Luke/0000-0002-4333-2748	UK Medical Research Council and Biotechnology; Biological Sciences Research Council; MRC [G0400007] Funding Source: UKRI; Medical Research Council [G0400007] Funding Source: researchfish	UK Medical Research Council and Biotechnology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants to NJG from the UK Medical Research Council and Biotechnology and Biological Sciences Research Council.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; de Bakker PIW, 2001, BIOINFORMATICS, V17, P748, DOI 10.1093/bioinformatics/17.8.748; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hunter P, 2006, EMBO REP, V7, P667, DOI 10.1038/sj.embor.7400742; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lin RT, 1999, MOL CELL BIOL, V19, P959; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2004, BIOINFORMATICS, V20, P2380, DOI 10.1093/bioinformatics/bth255; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Vakser IA, 1997, PROTEINS, P226; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	45	154	156	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e788	10.1371/journal.pone.0000788	http://dx.doi.org/10.1371/journal.pone.0000788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726518	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455400005
J	Pinz, I; Robbins, J; Rajasekaran, NS; Benjamin, IJ; Ingwall, JS				Pinz, Ilka; Robbins, Jeffrey; Rajasekaran, Namakkal S.; Benjamin, Ivor J.; Ingwall, Joanne S.			Unmasking different mechanical and energetic roles for the small heat shock proteins CryAB and HSPB2 using genetically modified mouse hearts	FASEB JOURNAL			English	Article						transgenesis; cardiac function	ALPHA-B-CRYSTALLIN; CARDIAC TITIN; ISCHEMIA; MUSCLE; ASSOCIATION; MYOCARDIUM; FAMILY; MEMBER; DAMAGE; GENE	CryAB and HSPB2 are small heat shock proteins constitutively expressed in the heart. CryAB protects cytoskeletal organization and intermediate filament assembly; the functions of HSPB2 are unknown. The promoters of CryAB and HSPB2 share regulatory elements, making identifying their separate functions difficult. Here, using a genetic approach, we report distinct roles for these sHSPs, with CryAB protecting mechanical properties and HSPB2 protecting energy reserve. Isolated hearts of wild type mice (WT), mice lacking both sHSPs (DKO), WT mice overexpressing mouse CryAB protein (mCryAB(Tg)), and mice with no HSPB2 made by crossing DKO with mCryABTg (DKO/ mCryAB(Tg)) were stressed with either ischemia/reperfusion or inotropic stimulation. Contractile performance and energetics were measured using P-31 NMR spectroscopy. Ischemia/reperfusion caused severe diastolic dysfunction in DKO hearts. Recovery of [ATP] and [PCr] during reperfusion was impaired only in DKO/ mCryAB(Tg). During inotropic stimulation, DKO/ mCryABTg showed blunted systolic and diastolic function and revealed massive energy wasting on acute stress: vertical bar Delta G(similar to ATP)vertical bar similar to decreased in DKO by 6.4 +/- 0.7 and in DKO/mCryAB(Tg) by 5.5 +/- 0.8 kJ/mol compared with only similar to 3.3 kJ/mol in WT and mCryAB(Tg). Thus, CryAB and HSPB2 proteins play nonredundant roles in the heart, CryAB in structural remodeling and HSPB2 in maintaining energetic balance.-Pinz, I., Robbins, J., Rajasekaran, N. S., Benjamin, I. J., Ingwall, J. S. Unmasking different mechanical and energetic roles for the small heat shock proteins CryAB and HSPB2 using genetically modified mouse hearts.	[Pinz, Ilka; Ingwall, Joanne S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Physiol Chem Lab, Boston, MA 02115 USA; [Rajasekaran, Namakkal S.; Benjamin, Ivor J.] Univ Utah, Hlth Sci Ctr, Ctr Cardiovasc Translat Biomed, Div Cardiol, Salt Lake City, UT 84132 USA; [Robbins, Jeffrey] Childrens Hosp, Cincinnati, OH 45229 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Cincinnati Children's Hospital Medical Center	Ingwall, JS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Physiol Chem Lab, 221 Longwood Ave,Rm 247, Boston, MA 02115 USA.	ivor.benjamin@hsc.utah.edu; jingwall@rics.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052320, R01HL063834, R01HL063985] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL63834, R01-HL63985, HL52320] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barbato R, 1996, CIRC RES, V78, P821, DOI 10.1161/01.RES.78.5.821; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; CHU G, 1996, CIRC RES, V9, P1064; Golenhofen N, 2006, PFLUG ARCH EUR J PHY, V451, P518, DOI 10.1007/s00424-005-1488-1; Golenhofen N, 1999, J MOL CELL CARDIOL, V31, P569, DOI 10.1006/jmcc.1998.0892; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; Golenhofen N, 1998, AM J PHYSIOL-HEART C, V274, pH1457, DOI 10.1152/ajpheart.1998.274.5.H1457; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; Kadono T, 2006, J MOL CELL CARDIOL, V40, P783, DOI 10.1016/j.yjmcc.2006.03.003; KAMMERME.H, 1973, ANAL BIOCHEM, V56, P341, DOI 10.1016/0003-2697(73)90199-1; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; Lutsch G, 1997, CIRCULATION, V96, P3466; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Saupe KW, 1998, CIRC RES, V82, P898; SHAMA KM, 1999, CELL STRUCT FUNCT, V1, P1; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528	26	36	37	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2008	22	1					84	92		10.1096/fj.07-8130com	http://dx.doi.org/10.1096/fj.07-8130com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17846079				2022-12-25	WOS:000252309900012
J	Ballar, P; Zhong, Y; Nagahama, M; Tagaya, M; Shen, Y; Fang, S				Ballar, Petek; Zhong, Yongwang; Nagahama, Masami; Tagaya, Mitsuo; Shen, Yuxian; Fang, Shengyun			Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; UBIQUITIN-LIGASE; RETRO-TRANSLOCATION; QUALITY-CONTROL; RING FINGER; GP78; COMPLEX; PROTEASOME; E3; ATPASE	Misfolded proteins in the endoplasmic reticulum (ER) are eliminated by a process known as ER- associated degradation (ERAD), which starts with misfolded protein recognition, followed by ubiquitination, retrotranslocation to the cytosol, deglycosylation, and targeting to the proteasome for degradation. Actions of multisubunit protein machineries in the ER membrane integrate these steps. We hypothesized that regulation of the multisubunit machinery assembly is a mechanism by which ERAD activity is regulated. To test this hypothesis, we investigated the potential regulatory role of the small p97/VCP-interacting protein (SVIP) on the formation of the ERAD machinery that includes ubiquitin ligase gp78, AAA ATPase p97/VCP, and the putative channel Derlin1. We found that SVIP is anchored to microsomal membrane via myristoylation and co-fractionated with gp78, Derlin1, p97/VCP, and calnexin to the ER. Like gp78, SVIP also physically interacts with p97/VCP and Derlin1. Overexpression of SVIP blocks unassembled CD3 delta from association with gp78 and p97/VCP, which is accompanied by decreases in CD3 delta ubiquitination and degradation. Silencing SVIP expression markedly enhances the formation of gp78-p97/VCP-Derlin1 complex, which correlates with increased degradation of CD3 delta and misfolded Z variant of alpha-1-antitrypsin, established substrates of gp78. These results suggest that SVIP is an endogenous inhibitor of ERAD that acts through regulating the assembly of the gp78-p97/VCP-Derlin1 complex.	Univ Maryland, Maryland Biotechnol Inst, Ctr Med Biotechnol, Baltimore, MD 21201 USA; Univ Tokushima, Tokushima 7708506, Japan; Tokyo Univ Pharm & Life Sci, Tokyo 1920392, Japan; Univ Maryland, Sch Med, Grad Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Tokushima University; Tokyo University of Pharmacy & Life Sciences; University System of Maryland; University of Maryland Baltimore	Fang, S (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Med Biotechnol, UMBI Bldg,N359,725 W Lombard St, Baltimore, MD 21201 USA.	fangs@umbi.umd.edu	Zhong, Yongwang/A-2527-2012; Fang, Shengyun/H-3802-2011; Kirmizibayrak, Petek Ballar/Y-6869-2018	Kirmizibayrak, Petek Ballar/0000-0002-6189-1818; Fang, Shengyun/0000-0001-7280-5463; Shen, Yuxian/0000-0002-0916-0743	NIGMS NIH HHS [R01 GM069967, R01 GM 69967] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069967] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NADLER MJS, 1993, BIOCHEMISTRY-US, V32, P9250, DOI 10.1021/bi00086a034; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shen YX, 2007, BIOCHEM BIOPH RES CO, V352, P919, DOI 10.1016/j.bbrc.2006.11.121; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	37	61	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33908	33914		10.1074/jbc.M704446200	http://dx.doi.org/10.1074/jbc.M704446200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17872946	hybrid			2022-12-25	WOS:000251145700003
J	Renda, M; Baglivo, I; Burgess-Beusse, B; Esposito, S; Fattorusso, R; Felsenfeld, G; Pedone, PV				Renda, Mario; Baglivo, Ilaria; Burgess-Beusse, Bonnie; Esposito, Sabrina; Fattorusso, Roberto; Felsenfeld, Gary; Pedone, Paolo V.			Critical DNA binding interactions of the insulator protein CTCF - A small number of zinc fingers mediate strong binding, and a single finger-DNA interaction controls binding at imprinted loci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BLOCKING ACTIVITY; PROMOTER; TRANSCRIPTION; METHYLATION; BOUNDARIES; REPRESSOR; UPSTREAM; SEQUENCE; SILENCER; ELEMENT	The DNA-binding protein CTCF (CCCTC binding factor) mediates enhancer blocking insulation at sites throughout the genome and plays an important role in regulating allele-specific expression at the Igf2/H19 locus and at other imprinted loci. Evidence is also accumulating that CTCF is involved in large scale organization of genomic chromatin. Although CTCF has 11 zinc fingers, we show here that only 4 of these are essential to strong binding and that they recognize a core 12-bp DNA sequence common to most CTCF sites. By deleting individual fingers and mutating individual sites, we determined the orientation of binding. Furthermore, we were able to identify the specific finger and its point of DNA interaction that are responsible for the loss of CTCF binding when CpG residues are methylated in the imprinted Igf2/H19 locus. This single interaction appears to be critical for allele-specific binding and insulation by CTCF.	NIDDK, NIH, Mol Biol Lab, Bethesda, MD 20892 USA; Univ Naples 2, Dipartimento Sci Ambientali, I-81100 Caserta, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Universita della Campania Vanvitelli	Felsenfeld, G (corresponding author), NIDDK, NIH, Mol Biol Lab, Bldg 5 Rm 212, Bethesda, MD 20892 USA.	gary.felsenfeld@nih.gov; paolov.pedone@unina2.it	Baglivo, Ilaria/U-2444-2017	Fattorusso, Roberto/0000-0002-3539-5343; Pedone, Paolo Vincenzo/0000-0002-0828-5843; Baglivo, Ilaria/0000-0002-3746-3880; ESPOSITO, Sabrina/0000-0001-6750-7365	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036148, ZIADK036148] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Chernukhin IV, 2000, J BIOL CHEM, V275, P29915, DOI 10.1074/jbc.M001538200; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fitzpatrick GV, 2007, MOL CELL BIOL, V27, P2636, DOI 10.1128/MCB.02036-06; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; ISERNIA C, 2006, RECENT DEV BIOINORGA; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Sambrook J, 2007, MOL CLONING LAB MANU, V3 rd; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Vostrov AA, 2002, J BIOL CHEM, V277, P1619, DOI 10.1074/jbc.M109748200; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	32	115	120	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33336	33345		10.1074/jbc.M706213200	http://dx.doi.org/10.1074/jbc.M706213200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827499	hybrid			2022-12-25	WOS:000250840200013
J	Harikumar, KG; Lam, PCH; Dong, M; Sexton, PM; Abagyan, R; Miller, LJ				Harikumar, Kaleeckal G.; Lam, Polo C. -H.; Dong, Maoqing; Sexton, Patrick M.; Abagyan, Ruben; Miller, Laurence J.			Fluorescence resonance energy transfer analysis of secretin docking to its receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AMINO-TERMINUS; PEPTIDE AGONIST; CHOLECYSTOKININ RECEPTOR; SPATIAL APPROXIMATION; CALCITONIN RECEPTOR; RESIDUES; BINDING; REGION; DOMAIN	Full structural characterization of G protein-coupled receptors has been limited to rhodopsin, with its uniquely stable structure and ability to be crystallized. For other members of this important superfamily, direct structural insights have been limited to NMR structures of soluble domains. Two members of the Class II family have recently had the structures of their isolated amino-terminal regions solved by NMR, yet it remains unclear how that domain is aligned with the heptahelical transmembrane bundle domain of those receptors. Indeed, three distinct orientations have been suggested for different members of this family. In the current work, we have utilized fluorescence resonance energy transfer to establish the distances between four residues distributed throughout fully biologically active, high affinity analogues of secretin and distinct residues in each of four extracellular regions of the intact secretin receptor. These 16 distance constraints were utilized along with nine photoaffinity labeling spatial approximation constraints to study the three proposed orientations of the peptide-binding amino terminus and helical bundle domains of this receptor. In the best model, the carboxyl terminus of secretin was found to bind in a groove above the beta-hairpin region of the receptor amino terminus, with its amino-terminal end adjacent to the third extracellular loop and top of transmembrane segment VI. This refined model of the intact receptor was also fully consistent with the spatial approximation of the Trp(48)-Asp(49)-Asn(50) endogenous agonist segment with the third extracellular loop region that it has been shown to photolabel. This provides strong evidence for the orientation of peptide-binding and signaling domains of a prototypic Class II G protein-coupled receptor.	Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Molsoft LLC, La Jolla, CA 92037 USA	Mayo Clinic; Mayo Clinic Phoenix; Monash University; Scripps Research Institute	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 46577] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Asmann YW, 2000, MOL PHARMACOL, V58, P911, DOI 10.1124/mol.58.5.911; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CLORE GM, 1988, EUR J BIOCHEM, V171, P479, DOI 10.1111/j.1432-1033.1988.tb13814.x; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2006, MOL PHARMACOL, V70, P206, DOI 10.1124/mol.105.021840; Dong MQ, 2000, J BIOL CHEM, V275, P26032, DOI 10.1074/jbc.M000612200; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Dong MQ, 2002, MOL ENDOCRINOL, V16, P2490, DOI 10.1210/me.2002-0111; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Harikumar KG, 2006, J BIOL CHEM, V281, P2543, DOI 10.1074/jbc.M509197200; Harikumar KG, 2005, J BIOL CHEM, V280, P18631, DOI 10.1074/jbc.M410834200; Harikumar KG, 2004, MOL PHARMACOL, V65, P28, DOI 10.1124/mol.65.1.28; Hooft RWW, 1996, COMPUT APPL BIOSCI, V12, P525; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lisenbee CS, 2005, J BIOL CHEM, V280, P12330, DOI 10.1074/jbc.M414016200; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200	28	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32834	32843		10.1074/jbc.M704563200	http://dx.doi.org/10.1074/jbc.M704563200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827151	hybrid			2022-12-25	WOS:000250625400033
J	Hoshino, T; Nakaya, T; Homan, T; Tanaka, KI; Sugimoto, Y; Araki, W; Narita, M; Narumiya, S; Suzuki, T; Mizushima, T				Hoshino, Tatsuya; Nakaya, Tadashi; Homan, Takashi; Tanaka, Ken-Ichiro; Sugimoto, Yukihiko; Araki, Wataru; Narita, Masami; Narumiya, Shuh; Suzuki, Toshiharu; Mizushima, Tohru			Involvement of prostaglandin E-2 in production of amyloid-beta peptides both in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; E-RECEPTOR SUBTYPES; GAMMA-SECRETASE ACTIVITY; PRECURSOR PROTEIN APP; ALZHEIMERS-DISEASE; TRANSGENIC MICE; CYCLOOXYGENASE (COX)-2; SELECTIVE INHIBITOR; EP2 RECEPTOR; HUMAN BRAIN	Amyloid-beta peptides (A beta), generated by proteolysis of the beta- amyloid precursor protein ( APP) by beta- and gamma-secretases, play an important role in the pathogenesis of Alzheimer disease ( AD). Inflammation is also believed to be integral to the pathogenesis of AD. Here we show that prostaglandin E-2 (PGE(2)), a strong inducer of inflammation, stimulates the production of A beta in cultured human embryonic kidney ( HEK) 293 or human neuroblastoma ( SH- SY5Y) cells, both of which express a mutant type of APP. We have demonstrated using subtype- specific agonists that, of the four main subtypes of PGE(2) receptors (EP1-4), EP4 receptors alone or EP2 and EP4 receptors together are responsible for this PGE(2)- stimulated production of A beta in HEK293 or SH-SY5Y cells, respectively. An EP4 receptor antagonist suppressed the PGE2- stimulated production of A beta in HEK293 cells. This stimulation was accompanied by an increase in cellular cAMP levels, and an analogue of cAMP stimulated the production of A beta, demonstrating that increases in the cellular level of cAMP are responsible for the PGE2- stimulated production of A beta. Immunoblotting experiments and direct measurement of gamma-secretase activity suggested that PGE2- stimulated production of A beta is mediated by activation of gamma-secretase but not of beta-secretase. Transgenic mice expressing the mutant type of APP showed lower levels of A beta in the brain, when they were crossed with mice lacking either EP2 or EP4 receptors, suggesting that PGE2- mediated activation of EP2 and EP4 receptors is involved in the production of A beta in vivo and in the pathogenesis of AD.	Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Kyoto 6068501, Japan; Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan	Kumamoto University; Hokkaido University; Kyoto University; Kyoto University; National Center for Neurology & Psychiatry - Japan; Ono Pharmaceutical Co Ltd	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Sugimoto, Yukihiko/AAV-6470-2021; Tanaka, Ken-ichiro/J-8557-2013; Narita, Masami/AAF-1079-2019; Araki, Wataru/G-7913-2014; Suzuki, Toshiharu/B-5342-2013	Sugimoto, Yukihiko/0000-0001-6973-932X; Araki, Wataru/0000-0001-8467-6937; 				Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; Andreasson KI, 2001, J NEUROSCI, V21, P8198; Araki H, 2000, ALIMENT PHARM THERAP, V14, P116, DOI 10.1046/j.1365-2036.2000.014s1116.x; Belton O, 2000, CIRCULATION, V102, P840; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Crider JY, 2000, PROSTAG LEUKOTR ESS, V62, P21, DOI 10.1054/plef.1999.0120; Echeverria V, 2005, EUR J NEUROSCI, V22, P2199, DOI 10.1111/j.1460-9568.2005.04427.x; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; IWAMOTO N, 1989, J NEUROL, V236, P80, DOI 10.1007/BF00314401; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kitamura Y, 1999, BIOCHEM BIOPH RES CO, V254, P582, DOI 10.1006/bbrc.1998.9981; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Ma H, 2001, CIRCULATION, V104, P1176, DOI 10.1161/hc3601.094003; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; MILLER TA, 1983, AM J PHYSIOL, V245, pG601, DOI 10.1152/ajpgi.1983.245.5.G601; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Qin WP, 2003, J BIOL CHEM, V278, P50970, DOI 10.1074/jbc.M307699200; Quadros A, 2003, NEUROSCI LETT, V353, P66, DOI 10.1016/j.neulet.2003.08.076; Ray WA, 2004, NEW ENGL J MED, V351, P2767, DOI 10.1056/NEJMc045711; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Singh D, 2004, BRIT MED J, V329, P816, DOI 10.1136/bmj.329.7470.816-a; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Srinivasan B D, 1989, Prog Clin Biol Res, V312, P229; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Takeuchi K, 1997, GASTROENTEROLOGY, V113, P1553, DOI 10.1053/gast.1997.v113.pm9352857; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; Vane JR, 1996, SCAND J RHEUMATOL, P9; VELD BA, 2001, NEW ENGL J MED, V348, P1515; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watanabe K, 2000, CANCER LETT, V156, P57, DOI 10.1016/S0304-3835(00)00440-7; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Yan Q, 2003, J NEUROSCI, V23, P7504; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	75	62	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32676	32688		10.1074/jbc.M703087200	http://dx.doi.org/10.1074/jbc.M703087200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17767011	hybrid			2022-12-25	WOS:000250625400016
J	Nakajima, M; Kizawa, H; Saitoh, M; Kou, I; Miyazono, K; Ikegawa, S				Nakajima, Masahiro; Kizawa, Hideki; Saitoh, Masao; Kou, Ikuyo; Miyazono, Kohei; Ikegawa, Shiro			Mechanisms for asporin function and regulation in articular cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MATRIX PROTEOGLYCAN SYNTHESIS; ACID REPEAT POLYMORPHISM; ATDC5 IN-VITRO; TGF-BETA; EXPERIMENTAL OSTEOARTHRITIS; PROTEIN FAMILY; II RECEPTOR; DECORIN; CELLS	Osteoarthritis ( OA), the most prevalent form of skeletal disease, represents a leading cause of disability following middle age. OA is characterized by the loss of articular cartilage; however, the details of its etiology and pathogenesis remain unclear. Recently, we demonstrated a genetic association between the cartilage extracellular matrix protein asporin and OA ( Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A., Mabuchi, A., Kotani, A., Kawakami, A., Yamamoto, S., Uchida, A., Nakamura, K., Notoya, K., Nakamura, Y., and Ikegawa, S. ( 2005) Nat. Genet. 37, 138-144). Furthermore, we showed that asporin binds to transforming growth factor-beta (TGF-beta), a key cytokine in OA pathogenesis, and inhibits TGF-beta-induced chondrogenesis. To date, functional data for asporin have come primarily from mouse cell culture models of developing cartilage rather than from human articular cartilage cells, in which OA occurs. Here, we describe mechanisms for asporin function and regulation in human articular cartilage. Asporin blocks chondrogenesis and inhibits TGF-beta 1-induced expression of matrix genes and the resulting chondrocyte phenotypes. Small interfering RNA-mediated knockdown of asporin increases the expression of cartilage marker genes and TGF-beta 1; in turn, TGF-beta 1 stimulates asporin expression in articular cartilage cells, suggesting that asporin and TGF-beta 1 form a regulatory feedback loop. Asporin inhibits TGF-beta/Smad signaling upstream of TGF-beta type I receptor activation in vivo by co-localizing with TGF-beta 1 on the cell surface and blocking its interaction with the TGF-beta type II receptor. Our results provide a basis for elucidating the role of asporin in the molecular pathogenesis of OA.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Ikegawa, S (corresponding author), RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147				Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Comalada M, 2003, J IMMUNOL, V170, P4450, DOI 10.4049/jimmunol.170.9.4450; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; INOUE H, 1989, J CELL PHYSIOL, V138, P329, DOI 10.1002/jcp.1041380216; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kawai J, 1999, EUR J CELL BIOL, V78, P707, DOI 10.1016/S0171-9335(99)80039-9; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Lafeber FPJG, 1997, J RHEUMATOL, V24, P536; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Mustafa Z, 2005, ARTHRITIS RHEUM-US, V52, P3502, DOI 10.1002/art.21399; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Noble Nancy A., 1992, Progress in Growth Factor Research, V4, P369, DOI 10.1016/0955-2235(92)90017-C; Peach CA, 2005, TRENDS MOL MED, V11, P186, DOI 10.1016/j.molmed.2005.02.005; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Sokol JP, 2004, MOL CANCER RES, V2, P183; Spector T. D., 2004, Osteoarthritis and Cartilage, V12, P39, DOI 10.1016/j.joca.2003.09.005; Spector TD, 1996, BRIT MED J, V312, P940; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; YAN WQ, 1990, J BIOL CHEM, V265, P10125; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	40	114	125	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32185	32192		10.1074/jbc.M700522200	http://dx.doi.org/10.1074/jbc.M700522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827158	hybrid			2022-12-25	WOS:000250480300041
J	Venugopal, SK; Chen, J; Zhang, Y; Clemens, D; Follenzi, A; Zern, MA				Venugopal, Senthil K.; Chen, Jenny; Zhang, Yanhong; Clemens, Dahn; Follenzi, Antonia; Zern, Mark A.			Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; STRESS-INDUCED APOPTOSIS; INNATE IMMUNE-RESPONSES; OXIDATIVE STRESS; RAT HEPATOCYTES; TNF-ALPHA; TRANSGENE EXPRESSION; SIGNAL-TRANSDUCTION; PROTEASOME ACTIVITY; LENTIVIRAL VECTOR	Ethanol metabolism plays a central role in activating the mitogen- activated protein kinase (MAPK) cascade leading to inflammation and apoptosis. Sustained activation of c- Jun N-terminal kinase (JNK), one of the MAPKs, has been shown to induce apoptosis in hepatocytes. MAPK phosphatase-1 (MKP-1) has been shown to dephosphorylate MAPKs in several cells. The aim of the study is to evaluate the role of MKP-1 in sustained JNK activation as a mechanism to explain ethanol-induced hepatocyte apoptosis. VL-17A cells (HepG2 cells overexpressing alcohol dehydrogenase and cytochrome P450-2E1) were exposed to ethanol for different time periods. Western blots were performed for MKP-1, phospho-JNK, phosphotyrosine, and protein kinase C delta(PKC delta). Electrophoretic mobility shift assays for AP-1 were performed. Apoptosis was measured by caspase-3 activity assay, TUNEL, and 4',6-diamidino-2-phenylindole staining. Reactive oxygen species were neutralized by overexpressing both superoxide dismutase-3 and catalase genes using lentiviral vectors in VL-17A cells. Ethanol incubation markedly decreased the MKP-1 protein levels to 15% of control levels and was associated with sustained phosphorylation of p46 JNK and p54 JNK, as well as increased apoptosis. VL-17A cells overexpressing superoxide dismutase-3 and catalase, treatment with a tyrosine kinase inhibitor, or incubation of the cells with PKC delta small interference RNAs significantly inhibited the ethanol-induced MKP-1 degradation and apoptosis. Ethanol-induced oxidative stress enhanced the tyrosine phosphorylation of PKC delta, which in turn caused the proteasomal degradation of MKP-1, leading to sustained JNK activation and increased apoptosis in VL-17A cells.	Univ Calif Davis, Med Ctr, Dept Internal Med, Transplant Res Program, Sacramento, CA 95817 USA; Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA	University of California System; University of California Davis; University of Nebraska System; University of Nebraska Medical Center; Yeshiva University; Albert Einstein College of Medicine	Zern, MA (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Transplant Res Program, 4635 2nd Ave,Rm 1001, Sacramento, CA 95817 USA.	mazern@ucdavis.edu		Follenzi, Antonia/0000-0001-9780-300X	NIAAA NIH HHS [R01 AA006386] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006386] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/j.lfs.2003.11.001; Auer KL, 1998, MOL BIOL CELL, V9, P561, DOI 10.1091/mbc.9.3.561; Bardag-Gorce F, 2000, BIOCHEM BIOPH RES CO, V279, P23, DOI 10.1006/bbrc.2000.3889; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cardin R, 2002, ALCOHOL ALCOHOLISM, V37, P43, DOI 10.1093/alcalc/37.1.43; Cederbaum AI, 2006, J GASTROEN HEPATOL, V21, pS22, DOI 10.1111/j.1440-1746.2006.04595.x; Chen JP, 1998, BIOCHEM J, V334, P669, DOI 10.1042/bj3340669; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Condiotti R, 2004, BIOCHEM BIOPH RES CO, V320, P998, DOI 10.1016/j.bbrc.2004.06.044; Czaja MJ, 2003, AM J PHYSIOL-GASTR L, V284, pG875, DOI 10.1152/ajpgi.00549.2002; Devaraj S, 2005, DIABETES, V54, P85, DOI 10.2337/diabetes.54.1.85; Donohue TM, 2006, INT J BIOCHEM CELL B, V38, P92, DOI 10.1016/j.biocel.2005.07.010; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; Hoek JB, 2004, SEMIN LIVER DIS, V24, P257, DOI 10.1055/s-2004-832939; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jarvis WD, 1997, FEBS LETT, V412, P9, DOI 10.1016/S0014-5793(97)00705-9; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lee YJ, 2005, EUR J PHARMACOL, V508, P31, DOI 10.1016/j.ejphar.2004.12.006; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu HL, 2002, AM J PHYSIOL-GASTR L, V282, pG257, DOI 10.1152/ajpgi.00304.2001; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Luo J, 1999, J NEUROSCI, V19, P10014, DOI 10.1523/jneurosci.19-22-10014.1999; Maher P, 2001, J NEUROSCI, V21, P2929, DOI 10.1523/JNEUROSCI.21-09-02929.2001; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Osna NA, 2005, HEPATOLOGY, V42, P1109, DOI 10.1002/hep.20909; Osna NA, 2003, BIOCHEM PHARMACOL, V66, P697, DOI 10.1016/S0006-2952(03)00252-1; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Venugopal SK, 2002, DIABETES, V51, P3049, DOI 10.2337/diabetes.51.10.3049; Whelan RDH, 1998, ONCOGENE, V16, P1939, DOI 10.1038/sj.onc.1201725; Wu J, 2004, HEPATOLOGY, V40, P195, DOI 10.1002/hep.20288; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	53	44	48	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31900	31908		10.1074/jbc.M703729200	http://dx.doi.org/10.1074/jbc.M703729200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848570	hybrid			2022-12-25	WOS:000250480300010
J	Carvalho, AF; Pinto, MP; Grou, CP; Alencastre, IS; Fransen, M; Sa-Miranda, C; Azevedo, JE				Carvalho, Andreia F.; Pinto, Manuel P.; Grou, Claudia P.; Alencastre, Ines S.; Fransen, Marc; Sa-Miranda, Clara; Azevedo, Jorge E.			Ubiquitination of mammalian pex5p, the peroxisomal import receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TYPE-1 RECEPTOR; FUNCTIONAL-CHARACTERIZATION; CONSERVED CYSTEINE; CYCLING RECEPTOR; PROTEIN IMPORT; PTS1 RECEPTOR; IDENTIFICATION; BIOGENESIS; MECHANISM; MEMBRANE	Protein translocation across the peroxisomal membrane requires the concerted action of numerous peroxins. One central component of this machinery is Pex5p, the cycling receptor for matrix proteins. Pex5p recognizes newly synthesized proteins in the cytosol and promotes their translocation across the peroxisomal membrane. After this translocation step, Pex5p is recycled back into the cytosol to start a new protein transport cycle. Here, we show that mammalian Pex5p is ubiquitinated at the peroxisomal membrane. Two different types of ubiquitination were detected, one of which is thoil-sensitive, involves Cys(11) of Pex5p, and is necessary for the export of the receptor back into the cytosol. Together with mechanistic data recently described for yeast Pex5p, these findings provide strong evidence for the existence of Pex4p- and Pex22p-like proteins in mammals.	Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4009003 Oporto, Portugal; Katholieke Univ Leuven, Fac Geneeskunde, Dept Mol Celbiol, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Fransen, Marc/C-6262-2008; Pinto, Manuel/K-6425-2013; Carvalho, Andreia/J-9013-2015; Fransen, Marc/ADL-0723-2022; Azevedo, Jorge E/A-4113-2008; sá Miranda, Maria Clara/K-3920-2013; Grou, Claudia P/K-5472-2013	Fransen, Marc/0000-0001-9284-1197; Pinto, Manuel/0000-0001-9778-2093; Carvalho, Andreia/0000-0001-8781-5680; Azevedo, Jorge E/0000-0001-7714-5302; sá Miranda, Maria Clara/0000-0003-0123-5525; Grou, Claudia P/0000-0001-5197-2270; Alencastre, Ines/0000-0002-5591-5596				Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; Baker A, 2005, CURR OPIN PLANT BIOL, V8, P640, DOI 10.1016/j.pbi.2005.09.009; Born LJ, 1996, HEPATOLOGY, V23, P1556, DOI 10.1002/hep.510230636; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; FERRO A, 2007, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/J.BBARNCR.2007.07.012; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HAAS AL, 1987, J BIOL CHEM, V262, P345; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; KIEL JA, 2006, J CELL BIOL, V7, P1291; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; SCHEFFNER M, 1992, EMBO J, V11, P2425, DOI 10.1002/j.1460-2075.1992.tb05307.x; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; WALKER J, 1993, MOL BIOCHEM PARASIT, V61, P255, DOI 10.1016/0166-6851(93)90071-5; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	40	134	137	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31267	31272		10.1074/jbc.M706325200	http://dx.doi.org/10.1074/jbc.M706325200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726030	hybrid			2022-12-25	WOS:000250309200016
J	Walker, D; Moshbahi, K; Vankemmelbeke, M; James, R; Kleanthous, C				Walker, Daniel; Moshbahi, Khedidja; Vankemmelbeke, Mireille; James, Richard; Kleanthous, Colin			The role of electrostatics in colicin nuclease domain translocation into bacterial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PROTEASE FTSH; NEGATIVELY CHARGED PHOSPHOLIPIDS; ESCHERICHIA-COLI; OUTER-MEMBRANE; CHOLERA-TOXIN; RIBONUCLEASE COLICIN-E3; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; IMMUNITY PROTEIN; RECEPTOR-BINDING	The mechanism(s) by which nuclease colicins translocate distinct cytotoxic enzymes (DNases, rRNases, and tRNases) to the cytoplasm of Escherichia coli is unknown. Previous in vitro investigations on isolated colicin nuclease domains have shown that they have a strong propensity to associate with anionic phospholipid vesicles, implying that electrostatic interactions with biological membranes play a role in their import. In the present work we set out to test this hypothesis in vivo. We show that cell killing by the DNase toxin colicin E9 of E. coli HDL11, a strain in which the level of anionic phospholipid and hence inner membrane charge is regulated by isopropyl beta-D-thiogalactopyranoside induction, is critically dependent on the level of inducer, whereas this is not the case for pore-forming colicins that take the same basic route into the periplasm. Moreover, there is a strong correlation between the level and rate of HDL11 cell killing and the net positive charge on a colicin DNase, with similar effects seen for wild type E. coli cells, data that are consistent with a direct, electrostatically mediated interaction between colicin nucleases and the bacterial inner membrane. We next sought to identify how membrane-associated colicin nucleases might be translocated into the cell. We show that neither the Sec or Tat systems are involved in nuclease colicin uptake but that nuclease colicin toxicity is instead dependent on functional FtsH, an inner membrane AAA(+) ATPase and protease that dislocates misfolded membrane proteins to the cytoplasm for destruction.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Nottingham, Ctr Biomol Sci, Inst Infect, Nottingham NG7 2RD, England	University of York - UK; University of Nottingham	Kleanthous, C (corresponding author), Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England.	ck11@york.ac.uk	James, Richard/B-2252-2009	Walker, Daniel/0000-0002-4206-2942; Vankemmelbeke, Mireille/0000-0002-8100-813X	Biotechnology and Biological Sciences Research Council [BB/C516236/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BENEDETTI H, 1992, EMBO J, V11, P441, DOI 10.1002/j.1460-2075.1992.tb05073.x; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; JAKES KS, 1988, J BACTERIOL, V170, P4231, DOI 10.1128/jb.170.9.4231-4238.1988; James R, 2002, BIOCHIMIE, V84, P381, DOI 10.1016/S0300-9084(02)01450-5; Kadner R. J., 1996, ESCHERICHIA COLI SAL, P58; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Karata K, 2001, MOL MICROBIOL, V39, P890, DOI 10.1046/j.1365-2958.2001.02301.x; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; KUSTERS R, 1991, J BIOL CHEM, V266, P8659; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; Matsumoto G, 2000, GENES CELLS, V5, P991, DOI 10.1046/j.1365-2443.2000.00388.x; MATSUZAWA H, 1984, J BACTERIOL, V160, P733, DOI 10.1128/JB.160.2.733-739.1984; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Penfold CN, 2004, J BACTERIOL, V186, P4520, DOI 10.1128/JB.186.14.4520-4527.2004; POGLIANO KJ, 1993, GENETICS, V133, P763; Pommer AJ, 1999, J BIOL CHEM, V274, P27153, DOI 10.1074/jbc.274.38.27153; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P369; Qu JN, 1996, J BACTERIOL, V178, P3457, DOI 10.1128/jb.178.12.3457-3461.1996; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; SHIBUYA I, 1985, J BACTERIOL, V161, P1086, DOI 10.1128/JB.161.3.1086-1092.1985; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; van den Bremer ETJ, 2004, PROTEIN SCI, V13, P1391, DOI 10.1110/ps.03508204; Vankemmelbeke M, 2005, J BACTERIOL, V187, P4900, DOI 10.1128/JB.187.14.4900-4907.2005; Walker D, 2003, BIOCHEMISTRY-US, V42, P4161, DOI 10.1021/bi0273720; Walker D, 2004, J BACTERIOL, V186, P866, DOI 10.1128/JB.186.3.866-869.2004; WALLIS R, 1992, EUR J BIOCHEM, V207, P687, DOI 10.1111/j.1432-1033.1992.tb17096.x; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Zakharov SD, 2002, BIOCHIMIE, V84, P465, DOI 10.1016/S0300-9084(02)01453-0	54	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31389	31397		10.1074/jbc.M705883200	http://dx.doi.org/10.1074/jbc.M705883200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17720814	hybrid			2022-12-25	WOS:000250309200029
J	Isgandarova, S; Jones, L; Forsberg, D; Loncar, A; Dawson, J; Tedrick, K; Eitzen, G				Isgandarova, Sabina; Jones, Lynden; Forsberg, Daniel; Loncar, Ana; Dawson, John; Tedrick, Kelly; Eitzen, Gary			Stimulation of actin polymerization by vacuoles via Cdc42p-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEX RING DOMAIN; MEMBRANE-FUSION; BINDING SITE; YEAST ACTIN; PROTEIN; DOCKING; CYTOSKELETON; ACTIVATION; CDC42; ATP	We have previously shown that actin ligands inhibit the fusion of yeast vacuoles in vitro, which suggests that actin remodeling is a subreaction of membrane fusion. Here, we demonstrate the presence of vacuole-associated actin polymerization activity, and its dependence on Cdc42p and Vrp1p. Using a sensitive in vitro pyrene-actin polymerization assay, we found that vacuole membranes stimulated polymerization, and this activity increased when vacuoles were preincubated under conditions that support membrane fusion. Vacuoles purified from a VRP1-gene deletion strain showed reduced polymerization activity, which could be recovered when reconstituted with excess Vrp1p. Cdc42p regulates this activity because overexpression of dominant-negative Cdc42p significantly reduced vacuole-associated polymerization activity, while dominant-active Cdc42p increased activity. We also used size-exclusion chromatography to directly examine changes in yeast actin induced by vacuole fusion. This assay confirmed that actin undergoes polymerization in a process requiring ATP. To further confirm the need for actin polymerization during vacuole fusion, an actin polymerization-deficient mutant strain was examined. This strain showed in vivo defects in vacuole fusion, and actin purified from this strain inhibited in vitro vacuole fusion. Affinity isolation of vacuole-associated actin and in vitro binding assays revealed a polymerization-dependent interaction between actin and the SNARE Ykt6p. Our results suggest that actin polymerization is a subreaction of vacuole membrane fusion governed by Cdc42p signal transduction.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Alberta; University of Guelph	Eitzen, G (corresponding author), Univ Alberta, Dept Cell Biol, 5-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	gary.eitzen@ualberta.ca	Eitzen, Gary/D-3682-2009					Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; AUNIS D, 1988, J EXP BIOL, V139, P253; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Bittner MA, 2005, MOL PHARMACOL, V67, P1089, DOI 10.1124/mol.104.008474; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; JANSEN G, 2004, GENE, V344, P43; Jeremic A, 2003, BIOPHYS J, V85, P2035, DOI 10.1016/S0006-3495(03)74631-1; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lejen T, 2001, J NEUROCHEM, V76, P768, DOI 10.1046/j.1471-4159.2001.00024.x; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Marcu MG, 1998, J BIOL CHEM, V273, P3661, DOI 10.1074/jbc.273.6.3661; May RC, 2001, J CELL SCI, V114, P1061; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; RURKEVICH LA, 2006, CAN J PHYSL PHARM, V84, P111; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Teal DJ, 2007, BIOCHEM CELL BIOL, V85, P319, DOI 10.1139/O07-047; Tedrick K, 2004, MOL BIOL CELL, V15, P4609, DOI 10.1091/mbc.E04-03-0194; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; Vaduva G, 1999, J BIOL CHEM, V274, P17103, DOI 10.1074/jbc.274.24.17103; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Weber A, 1999, MOL CELL BIOCHEM, V190, P67, DOI 10.1023/A:1006984010267; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yu HYE, 2007, NAT CELL BIOL, V9, P149, DOI 10.1038/ncb1527; Zhang L, 1996, NEURON, V17, P287, DOI 10.1016/S0896-6273(00)80160-9	57	29	29	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30466	30475		10.1074/jbc.M704117200	http://dx.doi.org/10.1074/jbc.M704117200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726018	hybrid			2022-12-25	WOS:000250136300014
J	Lin, JJ; Dutta, A				Lin, Jie Jessie; Dutta, Anindya			ATR pathway is the primary pathway for activating G(2)/m checkpoint induction after re-replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FANCONI-ANEMIA PATHWAY; DNA-DAMAGE; CELL-CYCLE; GEMININ; COMPLEXES; PROTEIN; CLAMP; PHOSPHORYLATION; REREPLICATION; KINASE	DNA replication is tightly controlled to ensure accurate chromosome duplication and segregation in each cell cycle. Inactivation of Geminin, an inhibitor of origin licensing, leads to re-replication in human tumor cells within the same cell cycle and triggers a G(2)/M checkpoint. We find that the primary pathway to signal that re-replication has been detected is the ATR kinase and the Rad9-Rad1-Hus1 (9-1-1) clamp complex together with Rad17-RFC clamp loader. ATM kinase and the Mre11-Rad50-Nbs1 complex do not appear to play significant roles in the checkpoint. Chk1 activation occurs at early stages, whereas Chk2 activation occurs much later. Overall we conclude that ATR/Chk1 pathway is activated at an early time point after the loss of Geminin and contributes to checkpoint arrest essential for the accumulation of re-replicated cells, whereas activation of the ATM/Chk2 pathway is a by-product of DNA re-replication at a later period.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Dutta, A (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Box 800733,1300 Jefferson Pk Ave,Jordan 1240, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073	NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA060499, R01 CA060499-14, R01 CA60499] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lei M, 2001, J CELL SCI, V114, P1447; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu QH, 2000, GENE DEV, V14, P1448; Lygerou Z, 2000, SCIENCE, V290, P2271; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Shiomi Y, 2002, GENES CELLS, V7, P861, DOI 10.1046/j.1365-2443.2002.00566.x; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zhou JQ, 2006, CANCER LETT, V243, P9, DOI 10.1016/j.canlet.2006.01.026; Zhu WG, 2006, CELL CYCLE, V5, P2306, DOI 10.4161/cc.5.20.3364; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	44	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30357	30362		10.1074/jbc.M705178200	http://dx.doi.org/10.1074/jbc.M705178200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17716975	hybrid			2022-12-25	WOS:000250136300003
J	Copeland, SJ; Green, BJ; Burchat, S; Papalia, GA; Banner, D; Copeland, JW				Copeland, Sarah J.; Green, Brenda J.; Burchat, Sarah; Papalia, Giuseppe A.; Banner, David; Copeland, John W.			The diaphanous inhibitory domain/diaphanous autoregulatory domain interaction is able to mediate heterodimerization between mDia1 and mDia2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; FORMIN HOMOLOGY PROTEIN; ACTIN DYNAMICS; FISSION YEAST; CELL-MIGRATION; SRF ACTIVITY; RHO-GTPASE; C-ELEGANS; PROFILIN; NUCLEATION	Formins are multidomain proteins that regulate numerous cytoskeleton-dependent cellular processes. These effects are mediated by the presence of two regions of homology, formin homology 1 and FH2. The diaphanous-related formins (DRFs) are distinguished by the presence of interacting N- and C-terminal regulatory domains. The GTPase binding domain and diaphanous inhibitory domain ( DID) are found in the N terminus and bind to the diaphanous autoregulatory domain ( DAD) found in the C terminus. Adjacent to the DID is an N- terminal dimerization motif ( DD) and coiled-coil region ( CC). The N terminus of Dia1 is also proposed to contain a Rho-independent membrane-targeting motif. We undertook an extensive structure/function analysis of the mDia1 N terminus to further our understanding of its role in vivo. We show here that both DID and DD are required for efficient autoinhibition in the context of full-length mDia1 and that the DD of mDia1 and mDia2, like formin homology 2, mediates homo- but not heterodimerization with other DRF family members. In contrast, our results suggest that the DID/DAD interaction mediates heterodimerization of full-length mDia1 and mDia2 and that the auto-inhibited conformation of DRFs is oligomeric. In addition, we also show that the DD/CC region is required for the Rho-independent membrane targeting of the isolated N terminus.	Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84312 USA	University of Ottawa; Utah System of Higher Education; University of Utah	Copeland, JW (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	john.copeland@uottawa.ca		Green, Brenda/0000-0002-4274-0969				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Chan DC, 1996, J BIOL CHEM, V271, P23472, DOI 10.1074/jbc.271.38.23472; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Menard I, 2006, APOPTOSIS, V11, P1863, DOI 10.1007/s10495-006-0087-8; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; O'Rourke DA, 2000, J AM SOC NEPHROL, V11, P2212, DOI 10.1681/ASN.V11122212; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452	47	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30120	30130		10.1074/jbc.M703834200	http://dx.doi.org/10.1074/jbc.M703834200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716977				2022-12-25	WOS:000249981200042
J	Norian, LA; Allen, PM				Norian, Lyse A.; Allen, Paul M.			Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor Regression	PLOS ONE			English	Article							CHEMICALLY-INDUCED SARCOMAS; IN-VIVO; ANTITUMOR IMMUNITY; LINEAGE RELATIONSHIP; ESTABLISHED TUMORS; CUTTING EDGE; MEMORY CTL; IFN-GAMMA; ANTIGEN; LYMPHOCYTES	Increasing the efficacy of adoptively transferred, tumor antigen specific T cells is a major goal of immunotherapy. Clearly, a more thorough understanding of the effector phase of T cell responses, within the tumor site itself, would be beneficial. To examine this issue, we adoptively transferred tumor antigen-specific effector T cells into tumor-bearing mice, then performed kinetic evaluations of their phenotype, function, and survival in tumors, draining lymph nodes (dLNs), and spleens during regression of murine fibrosarcomas. Effector function in tumors was quantitated through the use of a novel intratumoral cytolytic assay. This approach revealed dynamic changes in the phenotype, cytolytic capacity, and viability of tumor infiltrating effector T cells during the course of tumor regression. Over a period of days, T cells within tumors rapidly transitioned from a CD25(hi)/CD27(hi) to a CD25(low)/CD27(low) phenotype and displayed an increase in cytolytic capacity, indicative of effector maturation. Simultaneously, however, the viability of maturing T cells within tumors diminished. In contrast, transferred T cells trafficking through lymphoid organs were much more static, as they maintained a stable phenotype, robust cytolytic activity, and high viability. Therefore, there exists a marked phenotypic and functional divergence between tumor-infiltrating effector T cells and their counterparts in lymphoid organs. Our results indicate that the population of tumor-infiltrating T cells is unique in experiencing rapid effector maturation post-transfer, and suggest that strategies aimed at prolonging the survival of CD25(low)/CD27(low) full effectors, which displayed the highest levels of intratumoral cytolytic activity, should enhance the efficacy of T cell based tumor immunotherapies.	[Norian, Lyse A.; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Norian, LA (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	lnorian@wustl.edu		Norian, Lyse/0000-0003-1016-313X	NIH [P50CA94056]; Cancer Research Institute Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH grant P50CA94056 (PMA) Cancer Research Institute Samuel and Ruth Engelberg Fellowship (LAN)	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Harlin H, 2006, CANCER IMMUNOL IMMUN, V55, P1185, DOI 10.1007/s00262-005-0118-2; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hollenbaugh JA, 2004, J IMMUNOL, V173, P1738, DOI 10.4049/jimmunol.173.3.1738; Ikeda H, 1997, P NATL ACAD SCI USA, V94, P6375, DOI 10.1073/pnas.94.12.6375; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Kang SS, 2005, J IMMUNOL, V174, P5382, DOI 10.4049/jimmunol.174.9.5382; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Koneru M, 2006, J IMMUNOL, V176, P6103, DOI 10.4049/jimmunol.176.10.6103; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lyman MA, 2004, J IMMUNOL, V172, P6558, DOI 10.4049/jimmunol.172.11.6558; Matsui K, 2003, INT IMMUNOL, V15, P797, DOI 10.1093/intimm/dxg078; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mortarini R, 2003, CANCER RES, V63, P2535; Norian LA, 2004, J IMMUNOL, V173, P835, DOI 10.4049/jimmunol.173.2.835; O'Mara LA, 2005, J IMMUNOL, V174, P4662, DOI 10.4049/jimmunol.174.8.4662; Oehen S, 1998, J IMMUNOL, V161, P5338; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Palmer DC, 2004, J IMMUNOL, V173, P7209, DOI 10.4049/jimmunol.173.12.7209; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Powell DJ, 2004, J IMMUNOTHER, V27, P36, DOI 10.1097/00002371-200401000-00004; Radoja S, 2001, J IMMUNOL, V166, P6074, DOI 10.4049/jimmunol.166.10.6074; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Stumbles PA, 2004, J IMMUNOL, V173, P5923, DOI 10.4049/jimmunol.173.10.5923; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Ye SW, 2006, J CLIN IMMUNOL, V26, P447, DOI 10.1007/s10875-006-9040-4; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e821	10.1371/journal.pone.0000821	http://dx.doi.org/10.1371/journal.pone.0000821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786193	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500005
J	Pedersen, BR; Kamwendo, D; Blood, M; Mwapasa, V; Molyneux, M; North, K; Rogerson, SJ; Zimmerman, P; Meshnick, SR				Pedersen, Bonnie R.; Kamwendo, Deborah; Blood, Melinda; Mwapasa, Victor; Molyneux, Malcolm; North, Kari; Rogerson, Stephen J.; Zimmerman, Peter; Meshnick, Steven R.			CCR5 Haplotypes and Mother-to-Child HIV Transmission in Malawi	PLOS ONE			English	Article								Background. CCR5 and CCR2 gene polymorphisms (SNPs) have been associated with protection against HIV transmission in adults and with delayed progression to AIDS. The CCR5 Delta 32 deletion and SNP -2459G are associated with reduced expression of the CCR5 protein. Methodology/Principal Findings. We investigated the association between infant CCR2/CCR5 diplotype and HIV mother to child transmission (MTCT) in Malawi. Blood samples from infants (n = 552) of HIV positive women who received nevirapine were genotyped using a post-PCR multiplex ligase detection reaction and haplotypes were identified based on 8 CCR2/CCR5 SNPs and the open reading frame 32 base pair deletion. Following verification of Hardy-Weinberg equilibrium, log linear regression was performed to examine the association between mutations and MTCT. Overall, protection against MTCT was weakly associated with two CCR5 SNPs, -2459G (Risk ratio [RR], 0.78; confidence interval [CI], 0.54-1.12), and the linked CCR5 -2135T (RR, 0.78; CI, 0.54-1.13). No child carried the CCR5 D32 SNP. Maternal Viral Load (MVL) was found to be an effect measure modifier. Among mothers with low MVL, statistically significant protection against MTCT was observed for -2459G (RR, 0.50; CI, 0.27-0.91), and -2135T (RR, 0.51; CI, 0.28-0.92). Statistically significant protection was not found at high MVL. Conclusions/Significance. Results from this study suggest that CCR5 SNPs -2459G and -2135T associated with reduced receptor expression protect against MTCT of HIV at low MVLs, whereas high MVLs may over-ride differences in coreceptor availability.	[Pedersen, Bonnie R.; Kamwendo, Deborah; North, Kari; Meshnick, Steven R.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Blood, Melinda; Zimmerman, Peter] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Mwapasa, Victor; Molyneux, Malcolm] Univ Malawi, Coll Med, Blantyre, Malawi; [Rogerson, Stephen J.] Univ Melbourne, Melbourne, Vic, Australia	University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; University of Malawi; University of Melbourne	Zimmerman, P (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	paz@case.edu; meshnick@unc.edu		Joubert, Bonnie/0000-0001-7952-1180; Rogerson, Stephen/0000-0003-4287-1982; Mwapasa, Victor/0000-0002-2748-8902	NIH [AI 49084, 5P01AI051649-05]; NIH-FIC [5 D43 TW00908]; Center for AIDS Research at the University of North Carolina; FOGARTY INTERNATIONAL CENTER [D43TW000908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051649, R01AI049084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research at the University of North Carolina; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant # AI 49084 (SM), 5P01AI051649-05 (PZ), the NIH-FIC grant # 5 D43 TW00908 and the Center for AIDS Research at the University of North Carolina. SJR is a Wellcome Trust Senior Overseas Fellow in Biomedical Sciences. Pregnant women in this study were given nevirapine provided by Global Strategies for HIV Prevention. None of the sponsors had any input in the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Anzala AO, 1998, LANCET, V351, P1632, DOI 10.1016/S0140-6736(05)77688-1; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; BRUSE S, 2006, MULTIPLEX LIGASE DET; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Clegg AO, 2000, AIDS, V14, P103, DOI 10.1097/00002030-200001280-00004; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Easterbrook PJ, 1999, J INFECT DIS, V180, P1096, DOI 10.1086/314997; Eugen-Olsen J, 1998, J ACQ IMMUN DEF SYND, V18, P110, DOI 10.1097/00042560-199806010-00002; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Heitjan DF, 1997, AM J PUBLIC HEALTH, V87, P548, DOI 10.2105/AJPH.87.4.548; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; HUANG RD, 1996, FINANCIAL MARKETS I, V5, P1; John GC, 2001, J INFECT DIS, V184, P89, DOI 10.1086/321006; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Knudsen TB, 2001, J MED VIROL, V65, P441, DOI 10.1002/jmv.2054.abs; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Little R. J. A., 1987, STAT ANAL MISSING DA; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Ometto L, 2000, AIDS, V14, P1721, DOI 10.1097/00002030-200008180-00006; Princen K, 2005, CYTOKINE GROWTH F R, V16, P659, DOI 10.1016/j.cytogfr.2005.05.009; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; Rubin DB, 2004, MULTIPLE IMPUTATION; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schinkel J, 1999, J INFECT DIS, V179, P825, DOI 10.1086/314658; Tang JM, 2002, J VIROL, V76, P662, DOI 10.1128/JVI.76.2.662-672.2002; Thomas SM, 2006, AIDS, V20, P1879, DOI 10.1097/01.aids.0000244207.49123.ff; *UNAIDS, 2004, AIDS EP UPD; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e838	10.1371/journal.pone.0000838	http://dx.doi.org/10.1371/journal.pone.0000838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786209	Green Published, gold			2022-12-25	WOS:000207455500021
J	Yokota, Y; Ghashghaei, HT; Han, C; Watson, H; Campbell, KJ; Anton, ES				Yokota, Yukako; Ghashghaei, H. T.; Han, Christine; Watson, Hannah; Campbell, Kenneth J.; Anton, E. S.			Radial Glial Dependent and Independent Dynamics of Interneuronal Migration in the Developing Cerebral Cortex	PLOS ONE			English	Article							LATERAL GANGLIONIC EMINENCE; GABAERGIC INTERNEURONS; CORTICAL INTERNEURONS; NEURONAL MIGRATION; TANGENTIAL MIGRATION; INHIBITORY NEURONS; BASEMENT-MEMBRANE; CELL-MIGRATION; NUCLEOKINESIS; ADULT	Interneurons originating from the ganglionic eminence migrate tangentially into the developing cerebral wall as they navigate to their distinct positions in the cerebral cortex. Compromised connectivity and differentiation of interneurons are thought to be an underlying cause in the emergence of neurodevelopmental disorders such as schizophrenia. Previously, it was suggested that tangential migration of interneurons occurs in a radial glia independent manner. Here, using simultaneous imaging of genetically defined populations of interneurons and radial glia, we demonstrate that dynamic interactions with radial glia can potentially influence the trajectory of interneuronal migration and thus the positioning of interneurons in cerebral cortex. Furthermore, there is extensive local interneuronal migration in tangential direction opposite to that of pallial orientation (i.e., in a medial to lateral direction from cortex to ganglionic eminence) all across the cerebral wall. This counter migration of interneurons may be essential to locally position interneurons once they invade the developing cerebral wall from the ganglionic eminence. Together, these observations suggest that interactions with radial glial scaffold and localized migration within the expanding cerebral wall may play essential roles in the guidance and placement of interneurons in the developing cerebral cortex.	[Yokota, Yukako; Ghashghaei, H. T.; Han, Christine; Watson, Hannah; Anton, E. S.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA; [Yokota, Yukako; Ghashghaei, H. T.; Han, Christine; Watson, Hannah; Anton, E. S.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Campbell, Kenneth J.] Cincinnati Childrens Hosp, Dev Biol Program, Cincinnati, OH USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cincinnati Children's Hospital Medical Center	Anton, ES (corresponding author), Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	anton@med.unc.edu	Campbell, Kenneth/ABC-3570-2021		NIH [MH060929]; Staglin Award (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Staglin Award (NARSAD)(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grant MH060929 and Staglin Award (NARSAD) to EA.	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Denaxa M, 2001, DEVELOPMENT, V128, P4635; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Higginbotham H, 2006, MOL CELL NEUROSCI, V32, P118, DOI 10.1016/j.mcn.2006.03.003; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Metin C, 1996, J NEUROSCI, V16, P3219; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Moya F, 2004, CEREB CORTEX, V14, P610, DOI 10.1093/cercor/bhh022; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; ORourke NA, 1997, DEVELOPMENT, V124, P997; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Parnavelas JG, 2001, NEURON, V31, P881, DOI 10.1016/S0896-6273(01)00437-8; Polleux F, 2002, DEVELOPMENT, V129, P3147; Poluch S, 2007, GLIA, V55, P822, DOI 10.1002/glia.20488; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmid RS, 2006, GLIA, V53, P345, DOI 10.1002/glia.20274; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Stenman J, 2003, J NEUROSCI, V23, P167; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yabut O, 2007, BRAIN RES, V1140, P75, DOI 10.1016/j.brainres.2005.09.070; Yun K, 2002, DEVELOPMENT, V129, P5029; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685	50	81	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e794	10.1371/journal.pone.0000794	http://dx.doi.org/10.1371/journal.pone.0000794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726524	gold, Green Published			2022-12-25	WOS:000207455400011
J	Frye, M; Fisher, AG; Watt, FM				Frye, Michaela; Fisher, Amanda G.; Watt, Fiona M.			Epidermal Stem Cells Are Defined by Global Histone Modifications that Are Altered by Myc-Induced Differentiation	PLOS ONE			English	Article								Activation of Myc induces epidermal stem cells to exit their niche and differentiate into sebocytes and interfollicular epidermis, a process that is associated with widespread changes in gene transcription. We have identified chromatin modifications that are characteristic of epidermal stem cells and investigated the effects of Myc activation. Quiescent stem cells in the interfollicular epidermis and the hair follicle bulge had high levels of tri-methylated histone H3 at lysine 9 and H4 at lysine 20. Chromatin in both stem cell populations was hypoacteylated at histone H4 and lacked mono-methylation of histone H4 at lysine 20. Myc-induced exit from the stem cell niche correlated with increased acetylation at histone H4 and transiently increased mono-methylation at lysine 20. The latter was replaced by epigenetic modifications that are largely associated with chromatin silencing: di-methylation at histone H3 lysine 9 and histone H4 lysine 20. These modifications correlated with changes in the specific histone methyltransferases Set8 and Ash-1. The Myc-induced switch from mono-to di-methylated H4K20 required HDAC activity and was blocked by the HDAC inhibitor trichostatin A (TSA). TSA treatment induced a similar epidermal phenotype to activation of Myc, and activation of Myc in the presence of TSA resulted in massive stimulation of terminal differentiation. We conclude that Myc-induced chromatin modifications play a major role in Myc-induced exit from the stem cell compartment.	[Frye, Michaela; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England; [Fisher, Amanda G.] Imperial Coll Sch Med, Lymphocyte Dev Grp, London, England; [Watt, Fiona M.] Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England	University of Cambridge; Imperial College London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Watt, FM (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	fiona.watt@cancer.org.uk	Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154; Frye, Michaela/0000-0002-5636-6840	Cancer Research UK; EuroStemCell; Medical Research Council; Wellcome Trust; MRC [MC_U120027516] Funding Source: UKRI; Medical Research Council [G0300723B, MC_U120027516] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EuroStemCell(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds from Cancer Research UK (FMW and MF), EuroStemCell (FMW), the Medical Research Council (AF) and the Wellcome Trust (FMW).	Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DITTEL BN, 1993, BLOOD, V81, P2272; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; KONDO T, 2006, CURR OPIN GENET DEV; Konstantinopoulos PA, 2006, DRUG DISCOV TODAY, V11, P91, DOI 10.1016/S1359-6446(05)03713-X; Kubicek S, 2006, E SCHERING RES FDN W, V57, P1; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Markova NG, 2007, J INVEST DERMATOL, V127, P1126, DOI 10.1038/sj.jid.5700684; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; ONEILL LP, 1995, EMBO J, V14, P3946, DOI 10.1002/j.1460-2075.1995.tb00066.x; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	44	83	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e763	10.1371/journal.pone.0000763	http://dx.doi.org/10.1371/journal.pone.0000763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712411	Green Published, gold			2022-12-25	WOS:000207455300011
J	Mukherjee, S; Abd-El-Latif, M; Bronstein, M; Ben-nun-Shaul, O; Kler, S; Oppenheim, A				Mukherjee, Santanu; Abd-El-Latif, Mahmoud; Bronstein, Michal; Ben-nun-Shaul, Orly; Kler, Stanislav; Oppenheim, Ariella			High Cooperativity of the SV40 Major Capsid Protein VP1 in Virus Assembly	PLOS ONE			English	Article								SV40 is a small, non enveloped DNA virus with an icosahedral capsid of 45 nm. The outer shell is composed of pentamers of the major capsid protein, VP1, linked via their flexible carboxy-terminal arms. Its morphogenesis occurs by assembly of capsomers around the viral minichromosome. However the steps leading to the formation of mature virus are poorly understood. Intermediates of the assembly reaction could not be isolated from cells infected with wt SV40. Here we have used recombinant VP1 produced in insect cells for in vitro assembly studies around supercoiled heterologous plasmid DNA carrying a reporter gene. This strategy yields infective nanoparticles, affording a simple quantitative transduction assay. We show that VP1 assembles under physiological conditions into uniform nanoparticles of the same shape, size and CsCl density as the wild type virus. The stoichiometry is one DNA molecule per capsid. VP1 deleted in the C-arm, which is unable to assemble but can bind DNA, was inactive indicating genuine assembly rather than non-specific DNA-binding. The reaction requires host enzymatic activities, consistent with the participation of chaperones, as recently shown. Our results demonstrate dramatic cooperativity of VP1, with a Hill coefficient of similar to 6. These findings suggest that assembly may be a concerted reaction. We propose that concerted assembly is facilitated by simultaneous binding of multiple capsomers to a single DNA molecule, as we have recently reported, thus increasing their local concentration. Emerging principles of SV40 assembly may help understanding assembly of other complex systems. In addition, the SV40-based nanoparticles described here are potential gene therapy vectors that combine efficient gene delivery with safety and flexibility.	[Mukherjee, Santanu; Abd-El-Latif, Mahmoud; Bronstein, Michal; Ben-nun-Shaul, Orly; Kler, Stanislav; Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Mukherjee, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	ariella@cc.huji.ac.il	Mukherjee, Santanu/AAF-1684-2020	Mukherjee, Santanu/0000-0001-8344-7200	ISRAEL SCIENCE FOUNDATION [240/04]; NIH [R21 EB002982]; Herman Poley endowment fund through The Friends of the Hebrew University; Israeli Ministry of Absorption; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB002982] Funding Source: NIH RePORTER	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman Poley endowment fund through The Friends of the Hebrew University; Israeli Ministry of Absorption; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The research was supported by the ISRAEL SCIENCE FOUNDATION ( grant No. 240/04) and by NIH grant # R21 EB002982. SM was a recipient of a PhD Fellowship from the Herman Poley endowment fund through The Friends of the Hebrew University. SK is a recipient of a PhD Fellowship of Israeli Ministry of Absorption.	AMBROSE C, 1986, P NATL ACAD SCI USA, V83, P3287, DOI 10.1073/pnas.83.10.3287; Arad U, 2005, HUM GENE THER, V16, P361, DOI 10.1089/hum.2005.16.361; BAKER TS, 1988, P NATL ACAD SCI USA, V85, P422, DOI 10.1073/pnas.85.2.422; BAUMGARTNER I, 1979, VIROLOGY, V96, P54, DOI 10.1016/0042-6822(79)90172-7; Bina M, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P565; BLACK PH, 1964, VIROLOGY, V24, P381, DOI 10.1016/0042-6822(64)90175-8; BLASQUEZ V, 1986, J MOL BIOL, V191, P97, DOI 10.1016/0022-2836(86)90425-0; BLASQUEZ V, 1983, J BIOL CHEM, V258, P8477; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; CLEVER J, 1993, J BIOL CHEM, V268, P20877; COCAPRADOS M, 1979, J VIROL, V31, P199, DOI 10.1128/JVI.31.1.199-208.1979; COLOMAR MC, 1993, J VIROL, V67, P2779, DOI 10.1128/JVI.67.5.2779-2786.1993; DalyotHerman N, 1996, J MOL BIOL, V259, P69, DOI 10.1006/jmbi.1996.0302; Daniels R, 2006, MOL CELL, V24, P955, DOI 10.1016/j.molcel.2006.11.001; Daniels R, 2006, J VIROL, V80, P6575, DOI 10.1128/JVI.00347-06; Endres D, 2002, BIOPHYS J, V83, P1217, DOI 10.1016/S0006-3495(02)75245-4; FANNING E, 1980, VIROLOGY, V102, P1, DOI 10.1016/0042-6822(80)90064-1; FERNANDEZMUNOZ R, 1979, J VIROL, V29, P612, DOI 10.1128/JVI.29.2.612-623.1979; FORSTOVA J, 1993, J VIROL, V67, P1405; FREIFELDER D, 1982, PHYS BIOCH, P663; GARBER EA, 1980, VIROLOGY, V107, P389, DOI 10.1016/0042-6822(80)90306-2; GARBER EA, 1978, VIROLOGY, V90, P305, DOI 10.1016/0042-6822(78)90315-X; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; Gillock ET, 1997, J VIROL, V71, P2857, DOI 10.1128/JVI.71.4.2857-2865.1997; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goldmann C, 1999, J VIROL, V73, P4465, DOI 10.1128/JVI.73.5.4465-4469.1999; Gordon-Shaag A, 1998, J MOL BIOL, V275, P187, DOI 10.1006/jmbi.1997.1461; Gordon-Shaag A, 2002, J VIROL, V76, P5915, DOI 10.1128/JVI.76.12.5915-5924.2002; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Ishizu KI, 2001, J VIROL, V75, P61, DOI 10.1128/JVI.75.1.61-72.2001; Kimchi-Sarfaty C, 2006, CANCER GENE THER, V13, P648, DOI 10.1038/sj.cgt.7700943; Kimchi-Sarfaty C, 2004, CURR PHARM BIOTECHNO, V5, P451, DOI 10.2174/1389201043376670; Kimchi-Sarfaty C, 2003, HUM GENE THER, V14, P167, DOI 10.1089/104303403321070865; Kondo R, 1998, GENE THER, V5, P575, DOI 10.1038/sj.gt.3300623; Kosukegawa A, 1996, BBA-GEN SUBJECTS, V1290, P37; Li PP, 2003, J VIROL, V77, P7527, DOI 10.1128/JVI.77.13.7527-7538.2003; Li PP, 2002, P NATL ACAD SCI USA, V99, P1353, DOI 10.1073/pnas.032668699; Li PP, 2001, J VIROL, V75, P7321, DOI 10.1128/JVI.75.16.7321-7329.2001; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Mannova P, 2002, J GEN VIROL, V83, P2309, DOI 10.1099/0022-1317-83-9-2309; MARTIN RG, 1977, VIROLOGY, V83, P433, DOI 10.1016/0042-6822(77)90190-8; Mukherjee S, 2006, J AM CHEM SOC, V128, P2538, DOI 10.1021/ja056656f; Nakanishi A, 2007, J VIROL, V81, P3778, DOI 10.1128/JVI.02664-06; NG SC, 1984, J VIROL, V50, P471, DOI 10.1128/JVI.50.2.471-477.1984; OPPENHEIM A, 1992, J VIROL, V66, P5320, DOI 10.1128/JVI.66.9.5320-5328.1992; OPPENHEIM A, 1994, J MOL BIOL, V238, P501, DOI 10.1006/jmbi.1994.1310; Ou WC, 1999, J GEN VIROL, V80, P39, DOI 10.1099/0022-1317-80-1-39; Pawlita M, 1996, J VIROL, V70, P7517, DOI 10.1128/JVI.70.11.7517-7526.1996; ROITMAN V, 2005, THESIS HEBREW U JERU; Roitman-Shemer V, 2007, BIOCHEM BIOPH RES CO, V353, P424, DOI 10.1016/j.bbrc.2006.12.038; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; Sandalon Z, 1997, HUM GENE THER, V8, P843, DOI 10.1089/hum.1997.8.7-843; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SPENCE SL, 1994, J VIROL, V68, P4227, DOI 10.1128/JVI.68.7.4227-4240.1994; SPENCE SL, 1994, VIROLOGY, V204, P200, DOI 10.1006/viro.1994.1524; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Stokrova J, 1999, FEBS LETT, V445, P119, DOI 10.1016/S0014-5793(99)00003-4; Touze A, 2001, J GEN VIROL, V82, P3005, DOI 10.1099/0022-1317-82-12-3005; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	63	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e765	10.1371/journal.pone.0000765	http://dx.doi.org/10.1371/journal.pone.0000765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712413	Green Published, gold			2022-12-25	WOS:000207455300013
J	Collet, C; Schiltz, C; Geoffroy, V; Maroteaux, L; Launay, JM; de Vernejoul, MC				Collet, C.; Schiltz, C.; Geoffroy, V.; Maroteaux, L.; Launay, J. -M.; de Vernejoul, M. -C.			The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation	FASEB JOURNAL			English	Article						osteoporosis; aging; neurotransmitter	NECROSIS-FACTOR-ALPHA; ACCELERATED SENESCENCE; RETINOIC ACID; CELL-FUNCTION; MURINE MODEL; 2B RECEPTOR; IN-VIVO; DIFFERENTIATION; 5-HYDROXYTRYPTAMINE; OSTEOPOROSIS	The monoamine serotonin (5-HT), a well-known neurotransmitter, is also important in peripheral tissues. Several studies have suggested that 5-HT is involved in bone metabolism. Starting from our original observation of increased 5-HT2B receptor (5HT(2B)R) expression during in vitro osteoblast differentiation, we investigated a putative bone phenotype in vivo in 5-HT2BR knockout mice. Of interest, 5-HT2BR mutant female mice displayed reduced bone density that was significant from age 4 months and had intensified by 12 and 18 months. This histomorphometrically confirmed osteopenia seems to be due to reduced bone formation because 1) the alkaline phosphatase-positive colony-forming unit capacity of bone marrow precursors was markedly reduced in the 5-HT2BR mutant mice from 4 to 12 months of age, 2) ex vivo primary osteoblasts from mutant mice exhibited reduced proliferation and delayed differentiation, and 3) calcium incorporation was markedly reduced in osteoblasts after 5-HT2BR depletion (produced genetically or by pharmacological inactivation). These findings support the hypothesis that the 5-HT2BR receptor facilitates osteoblast recruitment and proliferation and that its absence leads to osteopenia that worsens with age. We show here, for the first time, that the 5-HT2BR receptor is a physiological mediator of 5-HT in bone formation and, potentially, in the onset of osteoporosis in aging women.	[Schiltz, C.; Geoffroy, V.; de Vernejoul, M. -C.] Hop Lariboisiere, INSERM, U606, F-75475 Paris 10, France; [Collet, C.; Launay, J. -M.] Hop Lariboisiere, Serv Biochim, F-75475 Paris, France; [Maroteaux, L.] Inst Fer Moulin, INSERM, U839, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	de Vernejoul, MC (corresponding author), Hop Lariboisiere, INSERM, U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	christine.devernejoul@lrb.aphp.fr	Geoffroy, Valerie/P-1521-2014; Maroteaux, Luc/H-4585-2019	Geoffroy, Valerie/0000-0003-3920-7482; Maroteaux, Luc/0000-0002-9499-8603; collet, corinne/0000-0001-6990-863X				Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Bhasin N, 2004, ANAT EMBRYOL, V208, P135, DOI 10.1007/s00429-004-0380-7; Bhasin N, 2004, DEV DYNAM, V230, P201, DOI 10.1002/dvdy.20038; Bliziotes M, 2006, BONE, V39, P1313, DOI 10.1016/j.bone.2006.06.009; Bliziotes MM, 2001, BONE, V29, P477, DOI 10.1016/S8756-3282(01)00593-2; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Callebert J, 2006, J PHARMACOL EXP THER, V317, P724, DOI 10.1124/jpet.105.098269; Chen TL, 2004, BONE, V35, P83, DOI 10.1016/j.bone.2004.03.019; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; Choi DS, 1997, DEVELOPMENT, V124, P1745; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Geoffroy V, 2004, J BONE MINER RES, V19, P811, DOI 10.1359/JBMR.040119; Gustafsson BI, 2006, J CELL BIOCHEM, V98, P139, DOI 10.1002/jcb.20734; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Jaffre F, 2004, CIRCULATION, V110, P969, DOI 10.1161/01.CIR.0000139856.20505.57; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kellermann O, 1996, BRIT J PHARMACOL, V118, P1161, DOI 10.1111/j.1476-5381.1996.tb15519.x; Kubera M, 2005, PSYCHIAT RES, V134, P251, DOI 10.1016/j.psychres.2004.01.014; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Lerner U. H., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P87; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Locker M, 2006, CELL SIGNAL, V18, P628, DOI 10.1016/j.cellsig.2005.06.006; Lundberg P, 2001, ENDOCRINOLOGY, V142, P339, DOI 10.1210/en.142.1.339; Merciris D, 2007, AM J PATHOL, V170, P1676, DOI 10.2353/ajpath.2007.061069; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Moiseiwitsch JRD, 2000, CRIT REV ORAL BIOL M, V11, P230, DOI 10.1177/10454411000110020601; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P2591, DOI 10.1073/pnas.050282397; PARFITT AM, 1995, J BONE MINER RES, V10, P466; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767; SANDERSBUSH E, 2007, GOODMAN GILMANS PHAR, P297; Shin CS, 2000, J CELL BIOCHEM, V78, P566, DOI 10.1002/1097-4644(20000915)78:4<566::AID-JCB6>3.0.CO;2-K; SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Suzuki A, 1998, BONE, V23, P197, DOI 10.1016/S8756-3282(98)00099-4; Taylor A. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P285; Warden SJ, 2005, MOL CELL ENDOCRINOL, V242, P1, DOI 10.1016/j.mce.2005.06.005; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Watts SW, 2004, J PHARMACOL EXP THER, V309, P165, DOI 10.1124/jpet.103.062562; Westbroek I, 2001, J BIOL CHEM, V276, P28961, DOI 10.1074/jbc.M101824200	46	85	98	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2008	22	2					418	427		10.1096/fj.07-9209com	http://dx.doi.org/10.1096/fj.07-9209com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17846081	Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000252822600012
J	Healy-Fried, ML; Funke, T; Priestman, MA; Han, H; Schonbrunn, E				Healy-Fried, Martha L.; Funke, Todd; Priestman, Melanie A.; Han, Huijong; Schoenbrunn, Ernst			Structural basis of glyphosate tolerance resulting from mutations of Pro(101) in Escherichia coli 5-enolpyruvylshikimate-3-phosphate synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; CONFERS RESISTANCE; SHIKIMATE PATHWAY; LOLIUM-RIGIDUM; PROTEIN MODELS; SUBSTITUTION; GENE; INHIBITION; PNEUMONIAE	Glyphosate, the world's most used herbicide, is a massive success because it enables efficient weed control with minimal animal and environmental toxicity. The molecular target of glyphosate is 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), which catalyzes the sixth step of the shikimate pathway in plants and microorganisms. Glyphosate-tolerant variants of EPSPS constitute the basis of genetically engineered herbicide-tolerant crops. A single-site mutation of Pro(101) in EPSPS (numbering according to the enzyme from Escherichia coli) has been implicated in glyphosate-resistant weeds, but this residue is not directly involved in glyphosate binding, and the basis for this phenomenon has remained unclear in the absence of further kinetic and structural characterization. To probe the effects of mutations at this site, E. coli EPSPS enzymes were produced with glycine, alanine, serine, or leucine substituted for Pro(101). These mutant enzymes were analyzed by steady-state kinetics, and the crystal structures of the substrate binary and substrate . glyphosate ternary complexes of P101S and P101L EPSPS were determined to between 1.5- and 1.6-angstrom resolution. It appears that residues smaller than leucine may be substituted for Pro(101) without decreasing catalytic efficiency. Any mutation at this site results in a structural change in the glyphosate-binding site, shifting Thr(97) and Gly(96) toward the inhibitor molecule. We conclude that the decreased inhibitory potency observed for glyphosate is a result of these mutation-induced long-range structural changes. The implications of our findings concerning the development and spread of glyphosate-resistant weeds are discussed.	Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Schonbrunn, E (corresponding author), H Lee Moffitt Canc Res Inst, Drug Discovery Program, Tampa, FL 33612 USA.	ernst.schonbrunn@moffitt.org		Han, Huijong/0000-0002-1197-3014	NIGMS NIH HHS [1R01 GM 70633-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070633] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMRHEIN N, 1983, FEBS LETT, V157, P191, DOI 10.1016/0014-5793(83)81143-0; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; BOOCOCK MR, 1983, FEBS LETT, V154, P127, DOI 10.1016/0014-5793(83)80888-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; Eichholtz D.A., 2001, U.S. Patent, Patent No. 6225114; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRANZ JE, 1997, GLYPHOSATE UNIQUE GL, P441; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; HASLAM E, 1993, SHIKIMIC ACIDS METAB; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Ng CH, 2003, WEED RES, V43, P108, DOI 10.1046/j.1365-3180.2003.00322.x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Park H, 2004, MOL MICROBIOL, V51, P963, DOI 10.1046/j.1365-2958.2003.03885.x; Perez-Jones A, 2007, PLANTA, V226, P395, DOI 10.1007/s00425-007-0490-6; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; Priestman MA, 2005, FEBS LETT, V579, P728, DOI 10.1016/j.febslet.2004.12.057; Reddy KN, 2004, WEED TECHNOL, V18, P131, DOI 10.1614/WT-03-059R; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Service RF, 2007, SCIENCE, V316, P1114, DOI 10.1126/science.316.5828.1114; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1984, EUR J BIOCHEM, V143, P351, DOI 10.1111/j.1432-1033.1984.tb08379.x; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Wakelin AM, 2004, WEED RES, V44, P453, DOI 10.1111/j.1365-3180.2004.00421.x; Yu Q, 2007, PLANTA, V225, P499, DOI 10.1007/s00425-006-0364-3; [No title captured], Patent No. 6040497	37	67	75	5	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32949	32955		10.1074/jbc.M705624200	http://dx.doi.org/10.1074/jbc.M705624200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855366	hybrid			2022-12-25	WOS:000250625400043
J	Molday, LL; Wu, WWH; Molday, RS				Molday, Laurie L.; Wu, Winco W. H.; Molday, Robert S.			Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE RETINOSCHISIS; ADHESION MOLECULE; FACTOR-VIII; C2 DOMAIN; FACTOR-VA; DISCOIDIN; EXPRESSION; FAMILY; MUTATIONS; MOUSE	Retinoschisin or RS1 is a discoidin domain-containing protein encoded by the gene responsible for X-linked retinoschisis (XLRS), an early onset macular degeneration characterized by a splitting of the retina. Retinoschisin, expressed and secreted from photoreceptors and bipolar cells as a homo-octameric complex, associates with the surface of these cells where it serves to maintain the cellular organization of the retina and the photoreceptor-bipolar synaptic structure. To gain insight into the role of retinoschisin in retinal cell adhesion and the pathogenesis of XLRS, we have investigated membrane components in retinal extracts that interact with retinoschisin. Unlike the discoidin domain-containing blood coagulation proteins Factor V and Factor VIII, retinoschisin did not bind to phospholipids or retinal lipids reconstituted into unilamellar vesicles or immobilized on microtiter plates. Instead, co-immunoprecipitation studies together with mass spectrometric-based proteomics and Western blotting showed that retinoschisin is associated with a complex consisting of Na/K ATPase (alpha 3, beta 2 isoforms) and the sterile alpha and TIR motif-containing protein SARM1. Double labeling studies for immunofluorescence microscopy confirmed the co-localization of retinoschisin with Na/K ATPase and SARM1 in photoreceptors and bipolar cells of retina tissue. We conclude that retinoschisin binds to Na/K ATPase on photoreceptor and bipolar cells. This interaction may be part of a novel SARM1-mediated cell signaling pathway required for the maintenance of retinal cell organization and photoreceptor-bipolar synaptic structure.	Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, LL (corresponding author), Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca			NEI NIH HHS [EY 02422] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; CONSORTIUM R, 1998, HUM MOL GENET, V7, P1185; Dyka FM, 2007, INVEST OPHTH VIS SCI, V48, P2491, DOI 10.1167/iovs.06-1465; Fraternali F, 2003, FEBS LETT, V544, P21, DOI 10.1016/S0014-5793(03)00433-2; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; GEORGE NDL, 1995, BRIT J OPHTHALMOL, V79, P697, DOI 10.1136/bjo.79.7.697; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Hiriyanna KT, 1999, HUM MUTAT, V14, P423, DOI 10.1002/(SICI)1098-1004(199911)14:5<423::AID-HUMU8>3.0.CO;2-D; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Lee CC, 2003, STRUCTURE, V11, P99, DOI 10.1016/S0969-2126(02)00941-3; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Molday RS, 2007, EXP EYE RES, V84, P227, DOI 10.1016/j.exer.2005.12.013; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; ORTEL TL, 1992, J BIOL CHEM, V267, P4189; POOLE S, 1981, J MOL BIOL, V153, P273, DOI 10.1016/0022-2836(81)90278-3; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Reid SNM, 2003, J NEUROSCI, V23, P6030, DOI 10.1523/JNEUROSCI.23-14-06030.2003; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Sikkink SK, 2007, J MED GENET, V44, P225, DOI 10.1136/jmg.2006.047340; SIMPSON DL, 1974, BIOCHEMISTRY-US, V13, P3487, DOI 10.1021/bi00714a011; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; Tantri A, 2004, SURV OPHTHALMOL, V49, P214, DOI 10.1016/j.survophthal.2003.12.007; VANDEWAART P, 1983, BIOCHEMISTRY-US, V22, P2427, DOI 10.1021/bi00279a019; Vijayasarathy C, 2007, INVEST OPHTH VIS SCI, V48, P991, DOI 10.1167/iovs.06-0915; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang T, 2006, BRIT J OPHTHALMOL, V90, P81, DOI 10.1136/bjo.2005.078048; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Weinberg DV, 2001, ARCH OPHTHALMOL-CHIC, V119, P1719; Wetzel RK, 1999, J NEUROSCI, V19, P9878; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Zeibdawi AR, 2001, J BIOL CHEM, V276, P19929, DOI 10.1074/jbc.M004711200	41	90	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32792	32801		10.1074/jbc.M706321200	http://dx.doi.org/10.1074/jbc.M706321200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804407	hybrid			2022-12-25	WOS:000250625400028
J	Coster, G; Hayouka, Z; Argaman, L; Strauss, C; Friedler, A; Brandeis, M; Goldberg, M				Coster, Gideon; Hayouka, Zvi; Argaman, Liron; Strauss, Carmit; Friedler, Assaf; Brandeis, Michael; Goldberg, Michal			The DNA damage response mediator MDC1 directly interacts with the anaphase-promoting complex/cyclosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; DEPENDENT PROTEOLYSIS; GENOMIC INSTABILITY; MASS-SPECTROMETRY; BRCT DOMAIN; FHA DOMAIN; CHECKPOINT; PROTEIN; COMPLEX; PHOSPHORYLATION	MDC1 (NFBD1), a mediator of the cellular response to DNA damage, plays an important role in checkpoint activation and DNA repair. Here we identified a cross-talk between the DNA damage response and cell cycle regulation. We discovered that MDC1 binds the anaphase-promoting complex/cyclosome ( APC/C), an E3 ubiquitin ligase that controls the cell cycle. The interaction is direct and is mediated by the tandem BRCA1 C-terminal domains of MDC1 and the C terminus of the Cdc27 ( APC3) subunit of the APC/C. It requires the phosphorylation of Cdc27 and is enhanced after induction of DNA damage. We show that the tandem BRCA1 C-terminal domains of MDC1, known to directly bind the phosphorylated form of histone H2AX (gamma-H2AX), also bind the APC/C by the same mechanism, as phosphopeptides that correspond to the C termini of gamma-H2AX and Cdc27 competed with each other for the binding to MDC1. Our results reveal a link between the cellular response to DNA damage and cell cycle regulation, suggesting that MDC1, known to have a role in checkpoint regulation, executes part of this role by binding the APC/C.	Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Organ Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	goldbergm@vms.huji.ac.il	Coster, Gideon/L-6319-2019; Coster, Gideon/B-2781-2009	Coster, Gideon/0000-0002-1449-6655; Goldberg, Michal/0000-0001-9397-2383				Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Malavazi I, 2005, MOL MICROBIOL, V57, P222, DOI 10.1111/j.1365-2958.2005.04671.x; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Mochan TA, 2003, CANCER RES, V63, P8586; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	41	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32053	32064		10.1074/jbc.M705890200	http://dx.doi.org/10.1074/jbc.M705890200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827148	hybrid			2022-12-25	WOS:000250480300026
J	Huang, CH; Lin, TY; Pan, RL; Juang, JL				Huang, Chiu-Hui; Lin, Tzu-Yang; Pan, Rong-Long; Juang, Jyh-Lyh			The involvement of Abl and PTP61F in the regulation of Abi protein localization and stability and lamella formation in Drosophila S2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAVE2 SIGNALING COMPLEX; C-ABL; TYROSINE KINASE; ACTIN POLYMERIZATION; ENDOPLASMIC-RETICULUM; TRANSFORMING ACTIVITY; BOUND PTP1B; PHOSPHORYLATION; ACTIVATION; ADAPTER	Most aspects of cellular events are regulated by a series of protein phosphorylation and dephosphorylation processes. Abi (Abl interactor protein) functions as a substrate adaptor protein for Abl and a core member of the WAVE complex, relaying signals from Rac to Arp2/3 complex and regulating actin dynamics. It is known that the recruitment of Abi into the lamella promotes polymerization of actin, although how it does this is unclear. In this study, we found PTP61F, a Drosophila homolog of mammalian PTP1B, can reverse the Abl phosphorylation of Abi and colocalizes with Abi in Drosophila S2 cells. Abi can be translocalized from the cytosol to the cell membrane by either increasing Abl or reducing endogenous PTP61F. This reciprocal regulation of Abi phosphorylation is also involved in modulating Abi protein level, which is thought to affect the stability of the WAVE complex. Using mass spectrometry, we identified several important tyrosine phosphorylation sites in Abi. We compared the translocalization and protein half-life of wild type (wt) and phosphomutant Abi and their abilities to restore the lamellipodia structure of the Abi-reduced cells. We found the phosphomutant to have reduced ability to translocalize and to have a protein half-life shorter than that of wt Abi. We also found that although the wt Abi could fully restore the lamellipodia structure, the phosphomutant could not. Together, these findings suggest that the reciprocal regulation of Abi phosphorylation by Abl and PTP61F may regulate the localization and stability of Abi and may regulate the formation of lamella.	Natl Inst Res Inst, Div Mol & Genom Med, Zhunan Town 35053, Miaoli County, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30043, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan	National Tsing Hua University; National Defense Medical Center	Juang, JL (corresponding author), Natl Inst Res Inst, Div Mol & Genom Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	juang@nhri.org.tw	Lin, Tzu-Yang/U-6553-2018; Juang, Jyh-Lyh/E-3944-2010; Huang, Chiu-Hui/O-1061-2018; Lin, Tzu-Yang/D-8300-2013	Lin, Tzu-Yang/0000-0002-1968-177X; Huang, Chiu-Hui/0000-0003-1485-5731; 				Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Cherezova L, 2002, FRONT BIOSCI-LANDMRK, V7, pD164, DOI 10.2741/cherezov; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cohen P, 1999, CURR OPIN CHEM BIOL, V3, P459, DOI 10.1016/S1367-5931(99)80067-2; Courtney KD, 2000, MOL CELL NEUROSCI, V16, P244, DOI 10.1006/mcne.2000.0865; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dai ZH, 1998, GENE DEV, V12, P1415, DOI 10.1101/gad.12.10.1415; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Echarri A, 2004, MOL CELL BIOL, V24, P4979, DOI 10.1128/MCB.24.11.4979-4993.2004; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Hernandez MV, 2006, J CELL SCI, V119, P1233, DOI 10.1242/jcs.02846; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Lin TY, 2004, J BIOMED SCI, V11, P902, DOI 10.1159/000081837; Maruoka M, 2005, FEBS LETT, V579, P2986, DOI 10.1016/j.febslet.2005.04.052; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Ptacek J, 2006, TRENDS GENET, V22, P545, DOI 10.1016/j.tig.2006.08.005; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Suetsugu S, 2006, J CELL BIOL, V173, P571, DOI 10.1083/jcb.200509067; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038	49	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32442	32452		10.1074/jbc.M702583200	http://dx.doi.org/10.1074/jbc.M702583200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804420	hybrid			2022-12-25	WOS:000250480300067
J	Smith, TK; Kimmel, J; Azzouz, N; Shams-Eldin, H; Schwarz, RT				Smith, Terry K.; Kimmel, Juergen; Azzouz, Nahid; Shams-Eldin, Hosam; Schwarz, Ralph T.			The role of inositol acylation and inositol deacylation in the Toxoplasma gondii glycosylphosphatidylinositol Biosynthetic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; VARIANT SURFACE GLYCOPROTEIN; MOLECULAR-WEIGHT ANTIGEN; TRYPANOSOMA-BRUCEI; PLASMODIUM-FALCIPARUM; AFRICAN TRYPANOSOMES; SUBSTRATE-SPECIFICITY; STRUCTURAL-ANALYSIS; PROTEIN ANCHORS; PRECURSORS	Toxoplasma gondii is a ubiquitous parasitic protozoan that invades nucleated cells in a process thought to be in part due to several surface glycosylphosphatidylinositol (GPI)-anchored proteins, like the major surface antigenSAG1(P30), which dominates the plasma membrane. The serine protease inhibitors phenylmethylsulfonyl fluoride and diisopropyl fluoride were found to have a profound effect on the T. gondii GPI biosynthetic pathway, leading to the observation and characterization of novel inositol-acylated mannosylated GPI intermediates. This inositol acylation is acyl-CoA-dependent and takes place before mannosylation, but uniquely for this class of inositol-acyltransferase, it is inhibited by phenylmethylsulfonyl fluoride. The subsequent inositol deacylation of fully mannosylated GPI intermediates is inhibited by both phenylmethylsulfonyl fluoride and diisopropyl fluoride. The use of these serine protease inhibitors allows observations as to the timing of inositol acylation and subsequent inositol deacylation of the GPI intermediates. Inositol acylation of the non-mannosylated GPI intermediate D-GlcN alpha 1-6-D-myo-inositol-1HPO4-sn-lipid precedes mannosylation. Inositol deacylation of the fully mannosylated GPI intermediate allows further processing, i. e. addition of GalNAc side chain to the first mannose. Characterization of the phosphatidylinositol moieties present on both free GPIs and GPI-anchored proteins shows the presence of a diacylglycerol lipid, whose sn-2 position contains almost exclusively an C18: 1 acyl chain. The data presented here identify key novel inositol-acylated mannosylated intermediates, allowing the formulation of an updated T. gondii GPI biosynthetic pathway along with identification of the putative genes involved.	Univ Dundee, Coll Life Sci, BCDD, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; Univ Marburg, Med Zentrum Hyg & Med Mikrobiol, D-35043 Marburg, Germany; Univ Sci & Tech Lille Flandres Artois, Unite Glycobiol Struct & Fonct UMR CNRS USTL 8576, IFR 147, F-59655 Villeneuve Dascq, France	University of Dundee; Philipps University Marburg; Universite de Lille - ISITE; Universite de Lille	Smith, TK (corresponding author), Univ Dundee, Coll Life Sci, BCDD, Div Biol Chem & Drug Discovery, Dow St, Dundee DD1 5EH, Scotland.	k.smith@dundee.ac.uk			Wellcome Trust [067441] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Azzouz N, 2005, ANAL BIOCHEM, V343, P152, DOI 10.1016/j.ab.2005.04.030; Azzouz N, 2006, INT J BIOCHEM CELL B, V38, P1914, DOI 10.1016/j.biocel.2006.05.006; Boska MD, 2004, CURR HIV RES, V2, P61, DOI 10.2174/1570162043485095; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; DOERING TL, 1989, J BIOL CHEM, V264, P11168; ECKERT V, 1996, GLYCOSCIENCES STATUS, P223; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Ferguson MAJ, 1999, BBA-MOL BASIS DIS, V1455, P327, DOI 10.1016/S0925-4439(99)00058-7; Flury I, 2000, J BIOL CHEM, V275, P24458, DOI 10.1074/jbc.M003844200; Gerold P, 1999, BIOCHEM J, V344, P731, DOI 10.1042/0264-6021:3440731; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Guther MLS, 2003, BIOCHEMISTRY-US, V42, P14532, DOI 10.1021/bi034869g; GUTHER MLS, 1995, EMBO J, V14, P3080, DOI 10.1002/j.1460-2075.1995.tb07311.x; Heise N, 1996, J BIOL CHEM, V271, P16877, DOI 10.1074/jbc.271.28.16877; HIROSE S, 1992, J BIOL CHEM, V267, P16968; Hong Y, 2006, J BIOL CHEM, V281, P11595, DOI 10.1074/jbc.M513061200; Jones JL, 2001, OBSTET GYNECOL SURV, V56, P296, DOI 10.1097/00006254-200105000-00025; Kimmel J, 2006, EUKARYOT CELL, V5, P1420, DOI 10.1128/EC.00078-06; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Kravetz JD, 2005, AM J MED, V118, P212, DOI 10.1016/j.amjmed.2004.08.023; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; McConville MJ, 2000, MOL MEMBR BIOL, V17, P1; MCDOWELL W, 1988, POSTTRANSLATIONAL MO, P99; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; MENON AK, 1990, J BIOL CHEM, V265, P9033; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; MENON AK, 2004, ENCY BIOL CHEM, V2, P308; MILNE KG, 1992, EUR J BIOCHEM, V208, P309, DOI 10.1111/j.1432-1033.1992.tb17188.x; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Morita YS, 2000, J BIOL CHEM, V275, P14147, DOI 10.1074/jbc.275.19.14147; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; PUOTI A, 1993, J BIOL CHEM, V268, P7215; Ralton JE, 1998, J BIOL CHEM, V273, P4245, DOI 10.1074/jbc.273.7.4245; Robinson SA, 2004, PARASITOLOGY, V128, P391, DOI 10.1017/S0031182003004736; SHARMA SD, 1983, J IMMUNOL, V131, P977; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Smith TK, 1997, BIOCHEM J, V326, P393, DOI 10.1042/bj3260393; Smith TK, 1997, EMBO J, V16, P6667, DOI 10.1093/emboj/16.22.6667; Smith TK, 1996, J BIOL CHEM, V271, P6476, DOI 10.1074/jbc.271.11.6476; Smith TK, 2002, BIOCHEMISTRY-US, V41, P12395, DOI 10.1021/bi020351l; Smith TK, 1999, EMBO J, V18, P5922, DOI 10.1093/emboj/18.21.5922; Striepen B, 1999, BIOCHEMISTRY-US, V38, P1478, DOI 10.1021/bi981884q; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Sutterlin C, 1998, BIOCHEM J, V332, P153; TOMAVO S, 1992, J BIOL CHEM, V267, P21446; TOMAVO S, 1992, J BIOL CHEM, V267, P11721; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; TOMAVO S, 1993, BIOL CELL, V78, P155, DOI 10.1016/0248-4900(93)90126-Y; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Watanabe R, 1999, BIOCHEM J, V339, P185, DOI 10.1042/0264-6021:3390185	56	17	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32032	32042		10.1074/jbc.M703784200	http://dx.doi.org/10.1074/jbc.M703784200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804418	hybrid			2022-12-25	WOS:000250480300024
J	Leclerc, E; Fritz, G; Weibel, M; Heizmann, CW; Galichet, A				Leclerc, Estelle; Fritz, Gunter; Weibel, Mirjam; Heizmann, Claus W.; Galichet, Arnaud			S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; NF-KAPPA-B; NEURITE OUTGROWTH; TRANSGENIC MICE; ALZHEIMERS-DISEASE; SURFACE RECEPTOR; SPLICE VARIANTS; GROWTH-FACTOR; EXPRESSION; ACTIVATION	S100 proteins are EF-hand calcium-binding proteins with various intracellular functions including cell proliferation, differentiation, migration, and apoptosis. Some S100 proteins are also secreted and exert extracellular paracrine and autocrine functions. Experimental results suggest that the receptor for advanced glycation end products (RAGE) plays important roles in mediating S100 protein-induced cellular signaling. Here we compared the interaction of two S100 proteins, S100B and S100A6, with RAGE by in vitro assay and in culture of human SH-SY5Y neuroblastoma cells. Our in vitro binding data showed that S100B and S100A6, although structurally very similar, interact with different RAGE extracellular domains. Our cell assay data demonstrated that S100B and S100A6 differentially modulate cell survival. At micromolar concentration, S100B increased cellular proliferation, whereas at the same concentration, S100A6 triggered apoptosis. Although both S100 proteins induced the formation of reactive oxygen species, S100B recruited phosphatidylinositol 3-kinase/AKT and NF-kappa B, whereas S100A6 activated JNK. More importantly, we showed that S100B and S100A6 modulate cell survival in a RAGE-dependent manner; S100B specifically interacted with the RAGE V and C-1 domains and S100A6 specifically interacted with the C1 and C-2 RAGE domains. Altogether these results highlight the complexity of S100/RAGE cellular signaling.	Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Zurich; State University System of Florida; Florida Atlantic University; University of Konstanz	Galichet, A (corresponding author), Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	arnaud.galichet@kispi.uzh.ch	Fritz, Guenter/E-2933-2013	Fritz, Guenter/0000-0002-4571-8812				Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; BRETT J, 1993, AM J PATHOL, V143, P1699; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Ciccarelli R, 1999, GLIA, V27, P275, DOI 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Duarte WR, 1999, BIOCHEM BIOPH RES CO, V255, P416, DOI 10.1006/bbrc.1999.0214; FRIEND WC, 1992, J NEUROSCI, V12, P4337; FRITZ G, 2004, HDB METALLOPROTEINS, V3, P529; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Heizmann C. W., 2007, V45, P93; Heizmann CW, 2005, J PEDIATR-US, V147, P731, DOI 10.1016/j.jpeds.2005.08.046; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hoyaux D, 2002, J NEUROPATH EXP NEUR, V61, P736, DOI 10.1093/jnen/61.8.736; Hoyaux D, 2000, BBA-MOL CELL RES, V1498, P264, DOI 10.1016/S0167-4889(00)00101-4; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2002, J BIOL CHEM, V277, P38635, DOI 10.1074/jbc.M202515200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iiyama M, 2006, CELL SIGNAL, V18, P174, DOI 10.1016/j.cellsig.2005.04.002; Kiewitz R, 2000, BIOCHEM BIOPH RES CO, V274, P865, DOI 10.1006/bbrc.2000.3229; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mbeunkui F, 2007, J PROTEOME RES, V6, P2993, DOI 10.1021/pr060629m; Mikkelsen SE, 2001, J NEUROCHEM, V79, P767, DOI 10.1046/j.1471-4159.2001.00605.x; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ostendorp T, 2006, BIOCHEM BIOPH RES CO, V347, P4, DOI 10.1016/j.bbrc.2006.04.077; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Roden LD, 1996, BIOCHEM BIOPH RES CO, V225, P1073, DOI 10.1006/bbrc.1996.1297; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sajithlal G, 2002, J BIOL CHEM, V277, P6888, DOI 10.1074/jbc.M107627200; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tiu SC, 2000, DEV BRAIN RES, V119, P159, DOI 10.1016/S0165-3806(99)00151-0; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; VANELDIK LJ, 1984, P NATL ACAD SCI-BIOL, V81, P6034; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wainwright MS, 2004, ANN NEUROL, V56, P61, DOI 10.1002/ana.20142; Whitaker-Azmitia PM, 1997, BRAIN RES, V776, P51, DOI 10.1016/S0006-8993(97)01002-0; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yamashita N, 1997, BRAIN RES, V778, P388, DOI 10.1016/S0006-8993(97)01025-1; Yamashita N, 1999, J COMP NEUROL, V404, P235; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang Z, 2001, J LEUKOCYTE BIOL, V69, P986; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	67	207	218	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31317	31331		10.1074/jbc.M703951200	http://dx.doi.org/10.1074/jbc.M703951200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726019	hybrid			2022-12-25	WOS:000250309200021
J	Repetto, E; Yoon, IS; Zheng, H; Kang, DE				Repetto, Emanuela; Yoon, Il-Sang; Zheng, Hui; Kang, David E.			Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; TRANSGENIC MOUSE MODELS; BETA-CATENIN; EGF RECEPTOR; TYROSINE PHOSPHORYLATION; MISSENSE MUTATIONS; CELL-SURFACE; MICE LACKING	Mutations in the gene encoding presenilin 1 (PS1) cause the most aggressive form of early-onset familial Alzheimer disease. In addition to its well established role in A beta production and Notch proteolysis, PS1 has been shown to mediate other physiological activities, such as regulation of the Wnt/beta-catenin signaling pathway, modulation of phosphatidylinositol 3-kinase/Akt and MEK/ERK signaling, and trafficking of select membrane proteins and/or intracellular vesicles. In this study, we present evidence that PS1 is a critical regulator of a key signaling receptor tyrosine kinase, epidermal growth factor receptor (EGFR). Specifically, EGFR levels were robustly increased in fibroblasts deficient in both PS1 and PS2 (PS-/-) due to delayed turnover of EGFR protein. Stable transfection of wild-type PS1 but not PS2 corrected EGFR to levels comparable to PS+/+ cells, while FAD PS1 mutations showed partial loss of activity. The C-terminal fragment of PS1 was sufficient to fully reduce EGFR levels. In addition, the rapid ligand-induced degradation of EGFR was markedly delayed in PS+/+ cells, resulting in prolonged signal activation. Despite the defective turnover of EGFR, ligand-induced autophosphorylation, ubiquitination, and endocytosis of EGFR were not affected by the lack of PS1. Instead, the trafficking of EGFR from early endosomes to lysosomes was severely delayed by PS1 deficiency. Elevation of EGFR was also seen in brains of adult mice conditionally ablated in PS1 and in skin tumors associated with the loss of PS1. These findings demonstrate a critical role of PS1 in the trafficking and turnover of EGFR and suggest potential pathogenic effects of elevated EGFR as well as perturbed endosomal-lysosomal trafficking in cell cycle control and Alzheimer disease.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	University of California System; University of California San Diego; Baylor College of Medicine	Kang, DE (corresponding author), Univ Calif San Diego, Dept Neurosci, Leichtag Biomed Res 380,9500 Gilman Dr, La Jolla, CA 92093 USA.	dekang@ucsd.edu	Kang, David E./E-5234-2012	REPETTO, EMANUELA/0000-0002-6270-3540; Kang, David E./0000-0002-7132-821X				Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; BIRECREE E, 1988, J NEUROPATH EXP NEUR, V47, P549, DOI 10.1097/00005072-198809000-00006; Burke PM, 1999, J CELL PHYSIOL, V180, P448, DOI 10.1002/(SICI)1097-4652(199909)180:3<448::AID-JCP16>3.0.CO;2-8; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; CASPER D, 1995, J NEUROCHEM, V65, P1016; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Cha YK, 2000, J NEUROCHEM, V75, P298, DOI 10.1046/j.1471-4159.2000.0750298.x; Chevallier NL, 2005, AM J PATHOL, V167, P151, DOI 10.1016/S0002-9440(10)62962-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ghanevati M, 2005, J MOL NEUROSCI, V25, P79, DOI 10.1385/JMN:25:1:079; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kang DE, 1999, J NEUROSCI, V19, P4229; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kil SJ, 1999, J BIOL CHEM, V274, P3141, DOI 10.1074/jbc.274.5.3141; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; MAIESE K, 1995, J CEREBR BLOOD F MET, V15, P440, DOI 10.1038/jcbfm.1995.55; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Park KHJ, 2007, J NEUROSCI, V27, P2969, DOI 10.1523/JNEUROSCI.0186-07.2007; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Pigino G, 2003, J NEUROSCI, V23, P4499; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Takahashi K, 1997, ONCOGENE, V15, P71, DOI 10.1038/sj.onc.1201160; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Uemura K, 2003, J NEUROSCI RES, V74, P184, DOI 10.1002/jnr.10753; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	60	64	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31504	31516		10.1074/jbc.M704273200	http://dx.doi.org/10.1074/jbc.M704273200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716970	hybrid			2022-12-25	WOS:000250309200042
J	Casi, G; Hilvert, D				Casi, Giulio; Hilvert, Donald			Reinvestigation of a selenopeptide with purportedly high glutathione peroxidase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATIVE CHEMICAL LIGATION; SYNTHETIC ORGANOSELENIUM COMPOUNDS; CYCLIC-PEPTIDES; SELENOCYSTEINE; CHEMISTRY; CHYMOTRYPSIN; SPECIFICITY; RESOLUTION; ENZYMES; TRYPSIN	A 15-amino acid long selenopeptide (15SeP) was recently reported to possess nearly the same catalytic activity as glutathione peroxidase (Gpx) for the reduction of hydrogen peroxide by glutathione (Sun, Y., Li, T. Y., Chen, H., Zhang, K., Zheng, K. Y., Mu, Y., Yan, G. L., Li, W., Shen, J. C., and Luo, G. M. (2004) J. Biol. Chem. 279, 37235-37240). Such a finding is startling considering the high efficiency of the natural enzyme and the modest catalytic properties of most short peptides. As 15SeP had been subjected only to limited chemical characterization, we prepared it by a new route involving selenocysteine-mediated native chemical ligation. High resolution matrix-assisted laser desorption ionization mass spectrometry confirmed the identity of the reaction product, whereas circular dichroism spectroscopy showed that 15SeP assumes a random coil conformation in solution. Although low levels of peroxidase activity were detectable under standard assay conditions, the peptide is >5 orders of magnitude less active than native Gpx. Our observations are incompatible with claims ascribing remarkable catalytic properties to 15SeP and suggest that the efficiency of Gpx derives from its well defined three-dimensional structure.	ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Organ Chem Lab, Honggerberg HCI F 339, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch						[Anonymous], 1980, ENZYMATIC BASIS DETO; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; ATASSI MZ, 1993, P NATL ACAD SCI USA, V90, P8282, DOI 10.1073/pnas.90.17.8282; Boschi-Muller S, 1998, FEBS LETT, V439, P241, DOI 10.1016/S0014-5793(98)01377-5; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; COREY DR, 1994, P NATL ACAD SCI USA, V91, P4106, DOI 10.1073/pnas.91.10.4106; Corey MJ, 1996, P NATL ACAD SCI USA, V93, P11428, DOI 10.1073/pnas.93.21.11428; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; FLOHE L, 1972, H-S Z PHYSIOL CHEM, V353, P987, DOI 10.1515/bchm2.1972.353.1.987; FLOHE L, 1969, BIOCHIM BIOPHYS ACTA, V191, P541, DOI 10.1016/0005-2744(69)90347-7; GANTHER HE, 1984, METHOD ENZYMOL, V107, P593; Gieselman MD, 2001, ORG LETT, V3, P1331, DOI 10.1021/ol015712o; HAHN KW, 1990, SCIENCE, V248, P1544, DOI 10.1126/science.2360048; HANCOCK WS, 1976, ANAL BIOCHEM, V71, P260, DOI 10.1016/0003-2697(76)90034-8; Hondal RJ, 2001, J AM CHEM SOC, V123, P5140, DOI 10.1021/ja005885t; KNORR R, 1989, TETRAHEDRON LETT, V30, P1927, DOI 10.1016/S0040-4039(00)99616-3; MATTHEWS BW, 1994, P NATL ACAD SCI USA, V91, P4103, DOI 10.1073/pnas.91.10.4103; Miller SJ, 2004, ACCOUNTS CHEM RES, V37, P601, DOI 10.1021/ar030061c; Mugesh G, 2000, CHEM SOC REV, V29, P347, DOI 10.1039/a908114c; Mugesh G, 2001, CHEM REV, V101, P2125, DOI 10.1021/cr000426w; Quaderer R, 2001, HELV CHIM ACTA, V84, P1197, DOI 10.1002/1522-2675(20010516)84:5<1197::AID-HLCA1197>3.0.CO;2-#; Ren B, 1997, J MOL BIOL, V268, P869, DOI 10.1006/jmbi.1997.1005; Sies H, 1997, Adv Pharmacol, V38, P229; Sun Y, 2004, J BIOL CHEM, V279, P37235, DOI 10.1074/jbc.M403032200; URSINI F, 1995, METHOD ENZYMOL, V252, P38; von Eggelkraut-Gottanka R, 2003, TETRAHEDRON LETT, V44, P3551, DOI 10.1016/S0040-4039(03)00582-3; WELLS JA, 1994, P NATL ACAD SCI USA, V91, P4110, DOI 10.1073/pnas.91.10.4110; Wendel A, 1981, Methods Enzymol, V77, P325; WU ZP, 1990, J AM CHEM SOC, V112, P5647, DOI 10.1021/ja00170a043; Yu HJ, 2005, J BIOL CHEM, V280, P11930, DOI 10.1074/jbc.M408574200	30	11	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30518	30522		10.1074/jbc.M705528200	http://dx.doi.org/10.1074/jbc.M705528200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724019	hybrid			2022-12-25	WOS:000250136300019
J	Marron, MB; Singh, H; Tahir, TA; Kavumkal, J; Kim, HZ; Koh, GY; Brindle, NPJ				Marron, Marie B.; Singh, Harprit; Tahir, Tariq A.; Kavumkal, Jais; Kim, Hak-Zoo; Koh, Gou Young; Brindle, Nicholas P. J.			Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE CLEAVAGE; GAMMA-SECRETASE; INTRACELLULAR DOMAIN; CONVERTING-ENZYME; DISINTEGRIN-METALLOPROTEASE; SOLUBLE TIE; NOTCH; ANGIOPOIETIN-1	Regulated ectodomain shedding followed by intramembrane proteolysis has recently been recognized as important in cell signaling and for degradation of several type I transmembrane proteins. The receptor-tyrosine kinase Tie1 is known to undergo ectodomain cleavage generating a membrane-tethered endodomain. Here we show Tie1 is a substrate for regulated intramembrane proteolysis. After Tie1 ectodomain cleavage the newly formed 45-kDa endodomain undergoes additional proteolytic processing mediated by gamma-secretase to generate an amino-terminal-truncated 42-kDa fragment that is subsequently degraded by proteasomal activity. This sequential processing occurs constitutively and is stimulated by phorbol ester and vascular endothelial growth factor. To assess the biological significance of regulated Tie1 processing, we analyzed its effects on angiopoietin signaling. Activation of ectodomain cleavage causes loss of phosphorylated Tie1 holoreceptor and generation of phosphorylated receptor fragments in the presence of cartilage oligomeric protein angiopoietin 1. A key function of gamma-secretase is in preventing accumulation of these phosphorylated fragments. We also find that regulated Tie1 processing modulates ligand responsiveness of the Tie-1-associated receptor Tie2. Activation of Tie1 ectodomain cleavage increases cartilage oligomeric protein angiopoietin 1 activation of Tie2. This correlates with increased ability of Tie2 to bind ligand after shedding of the Tie1 extracellular domain. A similar enhancement of ligand activation of Tie2 is seen when Tie1 expression is suppressed by RNA interference. Together these data indicate that Tie1, via its extracellular domain, limits the ability of ligand to bind and activate Tie2. Furthermore the data suggest that regulated processing of Tie1 may be an important mechanism for controlling signaling by Tie2.	Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England; Korea Adv Inst Sci & Technol, Biomed Ctr, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	University of Leicester; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Brindle, NPJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, POB 65, Leicester LE2 7LX, Leics, England.	npjb1@le.ac.uk	Koh, Gou Young/C-1615-2011	Tahir, Tariq/0000-0002-3992-6877; Brindle, Nicholas/0000-0002-4221-677X; Singh, Harprit/0000-0003-2337-3523	British Heart Foundation [PG/03/094/15787, PG/05/028/18599] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chen-Konak L, 2003, FASEB J, V17, P2121, DOI 10.1096/fj.02-1151fje; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Heaney ML, 1998, J LEUKOCYTE BIOL, V64, P135, DOI 10.1002/jlb.64.2.135; Hooper NM, 2000, BIOCHEM SOC T, V28, P441, DOI 10.1042/0300-5127:0280441; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; MATTHEWS JA, 1985, ANAL BIOCHEM, V151, P205, DOI 10.1016/0003-2697(85)90073-9; McCarthy MJ, 1999, LAB INVEST, V79, P889; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Partanen J, 1996, DEVELOPMENT, V122, P3013; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Porat RM, 2004, CIRC RES, V94, P394, DOI 10.1161/01.RES.0000111803.92923.D6; Price CJ, 2000, ARTERIOSCL THROM VAS, V20, P2051, DOI 10.1161/01.ATV.20.9.2051; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Wajih N, 2002, CIRC RES, V90, P46, DOI 10.1161/hh0102.102756; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yabkowitz R, 1999, BLOOD, V93, P1969, DOI 10.1182/blood.V93.6.1969.406k14_1969_1979; Yabkowitz R, 1997, BLOOD, V90, P706, DOI 10.1182/blood.V90.2.706.706_706_715; Yang XH, 2003, TUMOR BIOL, V24, P61, DOI 10.1159/000071078; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966	56	86	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30509	30517		10.1074/jbc.M702535200	http://dx.doi.org/10.1074/jbc.M702535200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728252	Green Accepted, hybrid			2022-12-25	WOS:000250136300018
J	Teuscher, F; Lowther, J; Skinner-Adams, TS; Spielmann, T; Dixon, MWA; Stack, CM; Donnelly, S; Mucha, A; Kafarski, P; Vassiliou, S; Gardiner, DL; Dalton, JP; Trenholme, KR				Teuscher, Franka; Lowther, Jonathan; Skinner-Adams, Tina S.; Spielmann, Tobias; Dixon, Matthew W. A.; Stack, Colin M.; Donnelly, Sheila; Mucha, Artur; Kafarski, Pawel; Vassiliou, Stamatia; Gardiner, Donald L.; Dalton, John P.; Trenholme, Katharine R.			The m18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEASES; INHIBITION; IDENTIFICATION; DIGESTION; ACID; GENE	A member of the M18 family of aspartyl aminopeptidases is expressed by all intra-erythrocytic stages of the human malaria parasite Plasmodium falciparum ( PfM18AAP), with highest expression levels in rings. Functionally active recombinant enzyme, rPfM18AAP, and native enzyme in cytosolic extracts of malaria parasites are 560-kDa octomers that exhibit optimal activity at neutral pH and require the presence of metal ions to maintain enzymatic activity and stability. Like the human aspartyl aminopeptidase, the exopeptidase activity of PfM18AAP is exclusive to N-terminal acidic amino acids, glutamate and aspartate, making this enzyme of particular interest and suggesting that it may function alongside the malaria cytosolic neutral aminopeptidases in the release of amino acids from host hemoglobin-derived peptides. Whereas immunocytochemical studies using transgenic P. falciparum parasites show that PfM18AAP is expressed in the cytosol, immunoblotting experiments revealed that the enzyme is also trafficked out of the parasite into the surrounding parasitophorous vacuole. Antisense-mediated knockdown of PfM18AAP results in a lethal phenotype as a result of significant intracellular damage and validates this enzyme as a target at which novel antimalarial drugs could be directed. Novel phosphinic derivatives of aspartate and glutamate showed modest inhibition of rPfM18AAP but did not inhibit malaria growth in culture. However, we were able to draw valuable observations concerning the structure-activity relationship of these inhibitors that can be employed in future inhibitor optimization studies.	Queensland Inst Med Res, Malaria Biol Lab, Brisbane, Qld 4006, Australia; Univ Technol Sydney, IBID, Sydney, NSW 2007, Australia; Univ Queensland, Dept Med, Cent Clin Div, Brisbane, Qld 4072, Australia; Wroclaw Univ Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland; Univ Athens, Dept Chem, Organ Chem Lab, GR-15771 Athens, Greece	QIMR Berghofer Medical Research Institute; University of Technology Sydney; University of Queensland; Wroclaw University of Science & Technology; National & Kapodistrian University of Athens	Vassiliou, S (corresponding author), Queensland Inst Med Res, Malaria Biol Lab, 300 Herston Rd, Brisbane, Qld 4006, Australia.	Katharine.Trenholme@qimr.edu.au	Dixon, Matthew/N-4503-2019; Gardiner, Don/G-4717-2010; Donnelly, Sheila/H-7733-2014; Dalton, John/K-4457-2014; Stack, Colin M/D-4601-2009; Dixon, Matthew/A-2412-2009; Skinner-Adams, Tina S/A-9798-2012; Kafarski, Paweł/AAA-9112-2019; Trenholme, Katharine/C-9244-2013; Vassiliou, Stamatia/AAD-5048-2020	Dixon, Matthew/0000-0001-9732-9686; Skinner-Adams, Tina S/0000-0001-7011-3850; Mucha, Artur/0000-0002-6421-1371; Spielmann, Tobias/0000-0002-3968-4601; Donnelly, Sheila/0000-0003-2005-3698; Vassiliou, Stamatia/0000-0002-0734-6579; Stack, Colin/0000-0002-7539-7677				Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Becker K, 2004, TRENDS PARASITOL, V20, P590, DOI 10.1016/j.pt.2004.09.004; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Chen XC, 2006, P NATL ACAD SCI USA, V103, P14548, DOI 10.1073/pnas.0604101103; CHULAY JD, 1987, J IMMUNOL, V139, P2768; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Gardiner DL, 2000, MOL BIOCHEM PARASIT, V110, P33, DOI 10.1016/S0166-6851(00)00254-1; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gardiner DL, 2004, PARASITOL RES, V93, P590, DOI 10.1007/s00436-004-1098-4; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; Georgiadis D, 1999, TETRAHEDRON, V55, P14635, DOI 10.1016/S0040-4020(99)00910-2; GLAUERT AM, 1974, PRACTICAL METHODS EL, V3, P1; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Grembecka J, 2003, J MED CHEM, V46, P2641, DOI 10.1021/jm030795v; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; KAFARSKI P, 2000, AMINOPHOSPHONIC AMIN, P33; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lauterbach SB, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-47; Lew VL, 2004, BLOOD CELL MOL DIS, V32, P353, DOI 10.1016/j.bcmd.2004.01.006; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Nankya-Kitaka MF, 1998, PARASITOL RES, V84, P552, DOI 10.1007/s004360050447; NWAGWU M, 1992, EXP PARASITOL, V75, P399, DOI 10.1016/0014-4894(92)90253-7; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2006, INT J PARASITOL, V36, P1245, DOI 10.1016/j.ijpara.2006.06.017; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uttamchandani M, 2007, J AM CHEM SOC, V129, P7848, DOI 10.1021/ja070870h; Vartak DG, 2007, J DRUG TARGET, V15, P1, DOI 10.1080/10611860600968967; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Wilk S, 2002, ARCH BIOCHEM BIOPHYS, V407, P176, DOI 10.1016/S0003-9861(02)00494-0; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Wright JW, 1997, BRAIN RES REV, V25, P96, DOI 10.1016/S0165-0173(97)00019-2; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x	36	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30817	30826		10.1074/jbc.M704938200	http://dx.doi.org/10.1074/jbc.M704938200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720817	hybrid			2022-12-25	WOS:000250136300050
J	Pankow, S; Bamberger, C				Pankow, Sandra; Bamberger, Casimir			The p53 Tumor Suppressor-Like Protein nvp63 Mediates Selective Germ Cell Death in the Sea Anemone Nematostella vectensis	PLOS ONE			English	Article							DNA-DAMAGE; CLIMATE-CHANGE; ELEGANS P53; P63; APOPTOSIS; HOMOLOG; HYDRA; DROSOPHILA-P53; IDENTIFICATION; MUTATIONS	Here we report the identification and molecular function of the p53 tumor suppressor-like protein nvp63 in a non-bilaterian animal, the starlet sea anemone Nematostella vectensis. So far, p53-like proteins had been found in bilaterians only. The evolutionary origin of p53-like proteins is highly disputed and primordial p53-like proteins are variably thought to protect somatic cells from genotoxic stress. Here we show that ultraviolet (UV) irradiation at low levels selectively induces programmed cell death in early gametes but not somatic cells of adult N. vectensis polyps. We demonstrate with RNA interference that nvp63 mediates this cell death in vivo. Nvp63 is the most archaic member of three p53-like proteins found in N. vectensis and in congruence with all known p53-like proteins, nvp63 binds to the vertebrate p53 DNA recognition sequence and activates target gene transcription in vitro. A transactivation inhibitory domain at its C-terminus with high homology to the vertebrate p63 may regulate nvp63 on a molecular level. The genotoxic stress induced and nvp63 mediated apoptosis in N. vectensis gametes reveals an evolutionary ancient germ cell protective pathway which relies on p63-like proteins and is conserved from cnidarians to vertebrates.	[Pankow, Sandra] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Bamberger, C (corresponding author), Sundgauallee 64, Freiburg, Germany.	casimir.bamberger@bluewin.ch	Bamberger, Casimir/E-7356-2011; Bamberger, Tom Casimir/D-1292-2014	Bamberger, Tom Casimir/0000-0002-3830-4486; Pankow, Sandra/0000-0003-3213-9886				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bamberger C, 2001, FEBS LETT, V501, P121, DOI 10.1016/S0014-5793(01)02643-6; Baum JS, 2005, SEMIN CELL DEV BIOL, V16, P245, DOI 10.1016/j.semcdb.2004.12.008; Bottger A, 2007, SEMIN CANCER BIOL, V17, P134, DOI 10.1016/j.semcancer.2006.11.008; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brusca RC, 2002, INVERTEBRATES; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chang CC, 2002, DEV BIOL, V252, P100, DOI 10.1006/dbio.2002.0840; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Extavour CG, 2005, EVOL DEV, V7, P201, DOI 10.1111/j.1525-142X.2005.05023.x; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Kuznetsov SG, 2003, ZOOLOGY, V106, P109, DOI 10.1078/0944-2006-00105; Kuznetsov SG, 2002, J EXP BIOL, V205, P3809; LARKMAN A, 1980, ULTRASTRUCTURAL ASPE, P61; Lesser MP, 2007, P NATL ACAD SCI USA, V104, P5259, DOI 10.1073/pnas.0700910104; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; METZ B, 2001, SPECIAL REPORT SAFEG; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nordstrom W, 2000, CELL DEATH DIFFER, V7, P1035, DOI 10.1038/sj.cdd.4400766; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rentzsch F, 2005, DEV BIOL, V278, P1, DOI 10.1016/j.ydbio.2004.10.007; Saccone C, 2003, J MOL EVOL, V57, pS277, DOI 10.1007/s00239-003-0037-9; Schroder HC, 2005, PROG MOLEC, V39, P111; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; STEPHENSON TA, 1935, BRIT SEA ANEMONES, P415; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Technau U, 2003, DEV BIOL, V260, P191, DOI 10.1016/S0012-1606(03)00241-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Wilhelm SW, 2002, PHOTOCHEM PHOTOBIOL, V76, P268, DOI 10.1562/0031-8655(2002)076<0268:EOBDUL>2.0.CO;2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	51	52	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e782	10.1371/journal.pone.0000782	http://dx.doi.org/10.1371/journal.pone.0000782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848985	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455600001
J	Wang, WH; Liu, XY; Gelinas, D; Ciruna, B; Sun, Y				Wang, Wenhui; Liu, Xinyu; Gelinas, Danielle; Ciruna, Brian; Sun, Yu			A Fully Automated Robotic System for Microinjection of Zebrafish Embryos	PLOS ONE			English	Article								As an important embodiment of biomanipulation, injection of foreign materials (e.g., DNA, RNAi, sperm, protein, and drug compounds) into individual cells has significant implications in genetics, transgenics, assisted reproduction, and drug discovery. This paper presents a microrobotic system for fully automated zebrafish embryo injection, which overcomes the problems inherent in manual operation, such as human fatigue and large variations in success rates due to poor reproducibility. Based on computer vision and motion control, the microrobotic system performs injection at a speed of 15 zebrafish embryos (chorion unremoved) per minute, with a survival rate of 98% (n = 350 embryos), a success rate of 99% (n = 350 embryos), and a phenotypic rate of 98.5% (n = 210 embryos). The sample immobilization technique and microrobotic control method are applicable to other biological injection applications such as the injection of mouse oocytes/embryos and Drosophila embryos to enable high-throughput biological and pharmaceutical research.	[Wang, Wenhui; Liu, Xinyu; Sun, Yu] Univ Toronto, Adv Micro & Nanosyst Lab, Toronto, ON, Canada; [Gelinas, Danielle; Ciruna, Brian] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ciruna, B (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ciruna@sickkids.ca; sun@mie.utoronto.ca	Liu, Xinyu/B-5529-2009; Wang, Wenhui/H-7514-2018	Liu, Xinyu/0000-0001-5705-9765; Wang, Wenhui/0000-0002-5884-6098; Sun, Yu/0000-0001-7895-0741				Chun K, 1999, PROC IEEE MICR ELECT, P406, DOI 10.1109/MEMSYS.1999.746863; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; HASHMI S, 1995, BIOTECHNIQUES, V19, P766; Kim DH, 2006, IEEE T NANOBIOSCI, V5, P89, DOI 10.1109/TNB.2006.875054; KOBAYASHI K, 1992, MOL REPROD DEV, V33, P81, DOI 10.1002/mrd.1080330112; Kumar R, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P3186; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lin MTS, 2000, INT J DERMATOL, V39, P161, DOI 10.1046/j.1365-4362.2000.00925.x; Matsuoka H, 2005, J BIOTECHNOL, V116, P185, DOI 10.1016/j.jbiotec.2004.10.010; Mattos L., 2007, P IEEE INT C ROB AUT; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; PILLARISETTI A, 2006, P S HAPT INT VIRT EN; Rols MP, 2006, BBA-BIOMEMBRANES, V1758, P423, DOI 10.1016/j.bbamem.2006.01.005; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Sun Y, 2002, INT J ROBOT RES, V21, P861, DOI 10.1177/0278364902021010833; Sundaram J., 2004, BIOPHYS J, V87, P1013; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002; Wang WH, 2007, INT J ROBOT RES, V26, P821, DOI 10.1177/0278364907080254; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zappe S, 2006, LAB CHIP, V6, P1012, DOI 10.1039/b600238b	23	178	186	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e862	10.1371/journal.pone.0000862	http://dx.doi.org/10.1371/journal.pone.0000862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848993	Green Published, gold			2022-12-25	WOS:000207455600009
J	Liu, TL; Papagiannakopoulos, T; Puskar, K; Qi, SP; Santiago, F; Clay, W; Lao, KQ; Lee, YH; Nelson, SF; Kornblum, HI; Doyle, F; Petzold, L; Shraiman, B; Kosik, KS				Liu, Tsunglin; Papagiannakopoulos, Thales; Puskar, Kathy; Qi, Shuping; Santiago, Fernando; Clay, William; Lao, Kaiqin; Lee, Yohan; Nelson, Stanley F.; Kornblum, Harley I.; Doyle, Frank; Petzold, Linda; Shraiman, Boris; Kosik, Kenneth S.			Detection of a MicroRNA Signal in an In Vivo Expression Set of mRNAs	PLOS ONE			English	Article								Background. microRNAs (miRNAs) are approximately 21 nucleotide non-coding transcripts capable of regulating gene expression. The most widely studied mechanism of regulation involves binding of a miRNA to the target mRNA. As a result, translation of the target mRNA is inhibited and the mRNA may be destabilized. The inhibitory effects of miRNAs have been linked to diverse cellular processes including malignant proliferation, apoptosis, development, differentiation, and metabolic processes. We asked whether endogenous fluctuations in a set of mRNA and miRNA profiles contain correlated changes that are statistically distinguishable from the many other fluctuations in the data set. Methodology/Principal Findings. RNA was extracted from 12 human primary brain tumor biopsies. These samples were used to determine genome-wide mRNA expression levels by microarray analysis and a miRNA profile by real-time reverse transcription PCR. Correlation coefficients were determined for all possible mRNA-miRNA pairs and the distribution of these correlations compared to the random distribution. An excess of high positive and negative correlation pairs were observed at the tails of these distributions. Most of these highest correlation pairs do not contain sufficiently complementary sequences to predict a target relationship; nor do they lie in physical proximity to each other. However, by examining pairs in which the significance of the correlation coefficients is modestly relaxed, negative correlations do tend to predict targets and positive correlations tend to predict physically proximate pairs. A subset of high correlation pairs were experimentally validated by over-expressing or suppressing a miRNA and measuring the correlated mRNAs. Conclusions/Significance. Sufficient information exists within a set of tumor samples to detect endogenous correlations between miRNA and mRNA levels. Based on the validations the causal arrow for these correlations is likely to be directed from the miRNAs to the mRNAs. From these data sets, we inferred and validated a tumor suppression pathway linked to miR-181c.	[Liu, Tsunglin; Papagiannakopoulos, Thales; Santiago, Fernando; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Liu, Tsunglin; Papagiannakopoulos, Thales; Santiago, Fernando; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Shraiman, Boris] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Puskar, Kathy; Petzold, Linda] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Doyle, Frank] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Lee, Yohan; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Psychiat Mol, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Med Pharmacol, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Clay, William] Jackson State Univ, Dept Math, Jackson, MS USA; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA 94404 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jackson State University; Thermo Fisher Scientific; Applied Biosystems	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	Nelson, Stanley F/D-4771-2009; Santiago, Fernando Enrique/GLS-9127-2022	Nelson, Stanley F/0000-0002-2082-3114; Santiago, Fernando/0000-0001-9514-3722	W.M. Keck Foundation; NIH Neuroscience Microarray Consortium [U24NSNS052108, NS052563]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS052563, R01NS052563] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); NIH Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the W.M. Keck Foundation, the NIH Neuroscience Microarray Consortium U24NSNS052108, and NS052563.	Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Fisher R.A., 1922, PHILOS T ROYAL SOC A, V222, P309, DOI [10.1098/rsta.1922.0009, DOI 10.1098/RSTA.1922.0009]; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Lao Kaiqin, 2007, Biotechnology Journal, V2, P33, DOI 10.1002/biot.200600119; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; NILSEN TW, 2007, MECH MICRORNA MEDIAT; Nutt CL, 2003, CANCER RES, V63, P1602; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Watts GS, 2004, NEOPLASIA, V6, P187, DOI 10.1593/neo.03292; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	26	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e804	10.1371/journal.pone.0000804	http://dx.doi.org/10.1371/journal.pone.0000804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726534	gold, Green Published			2022-12-25	WOS:000207455400021
J	Nassanian, H; Sanchez, AM; Lo, A; Bradley, KA; Lee, B				Nassanian, Hoorig; Sanchez, Ana M.; Lo, Alice; Bradley, Kenneth A.; Lee, Benhur			Efficient Construction of an Inverted Minimal H1 Promoter Driven siRNA Expression Cassette: Facilitation of Promoter and siRNA Sequence Exchange	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE; MAMMALIAN-CELLS; MESSENGER-RNA; DC-SIGN; TRANSCRIPTION; LIBRARIES; SCREENS; SYSTEM	Background. RNA interference (RNAi), mediated by small interfering RNA (siRNA), is an effective method used to silence gene expression at the post-transcriptional level. Upon introduction into target cells, siRNAs incorporate into the RNA-induced silencing complex (RISC). The antisense strand of the siRNA duplex then "guides'' the RISC to the homologous mRNA, leading to target degradation and gene silencing. In recent years, various vector-based siRNA expression systems have been developed which utilize opposing polymerase III promoters to independently drive expression of the sense and antisense strands of the siRNA duplex from the same template. Principal Findings. We show here the use of a ligase chain reaction (LCR) to develop a new vector system called pinv-H1 in which a DNA sequence encoding a specific siRNA is placed between two inverted minimal human H1 promoters (similar to 100 bp each). Expression of functional siRNAs from this construct has led to efficient silencing of both reporter and endogenous genes. Furthermore, the inverted H1 promoter-siRNA expression cassette was used to generate a retrovirus vector capable of transducing and silencing expression of the targeted protein by>80% in target cells. Conclusions. The unique design of this construct allows for the efficient exchange of siRNA sequences by the directional cloning of short oligonucleotides via asymmetric restriction sites. This provides a convenient way to test the functionality of different siRNA sequences. Delivery of the siRNA cassette by retroviral transduction suggests that a single copy of the siRNA expression cassette efficiently knocks down gene expression at the protein level. We note that this vector system can potentially be used to generate a random siRNA library. The flexibility of the ligase chain reaction suggests that additional control elements can easily be introduced into this siRNA expression cassette.	[Nassanian, Hoorig; Sanchez, Ana M.; Lo, Alice; Bradley, Kenneth A.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lee, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	bleebhl@microbio.ucla.edu	Lee, Benhur/A-8554-2016	Lee, Benhur/0000-0003-0760-1709	Burroughs Wellcome Fund Career Development Award; UCLA AIDS Institute; NIH National Research Service Award [1 F31 AI 61847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052021, F31AI061847] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Development Award(Burroughs Wellcome Fund); UCLA AIDS Institute; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BL is a Charles E. Culpepper Medical Scholar and is a recipient of the Burroughs Wellcome Fund Career Development Award. Support from the UCLA AIDS Institute is acknowledged. AMS is a recipient of an NIH National Research Service Award (grant 1 F31 AI 61847).	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chalmers FM, 2001, BIOTECHNIQUES, V30, P249, DOI 10.2144/01302bm02; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Devroe Eric, 2002, BMC Biotechnol, V2, P15, DOI 10.1186/1472-6750-2-15; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Kaykas A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-16; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shen HL, 2007, LEUKEMIA RES, V31, P515, DOI 10.1016/j.leukres.2006.09.011; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Tran N, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-21; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zecherle GN, 1996, MOL CELL BIOL, V16, P5801; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	31	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e767	10.1371/journal.pone.0000767	http://dx.doi.org/10.1371/journal.pone.0000767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712415	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455300015
J	Bottley, G; Watherston, OG; Hiew, YL; Norrild, B; Cook, GP; Blair, GE				Bottley, G.; Watherston, O. G.; Hiew, Y-L; Norrild, B.; Cook, G. P.; Blair, G. E.			High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells	ONCOGENE			English	Article						HPV; E7; MHC class I; cervical cancer; NK cells	CERVICAL KERATINOCYTES; CHROMATIN REPRESSION; DOWN-REGULATION; HLA-E; COMPLEX; GENES; E6	High-risk human papillomavirus (HPV) is a major causative agent of cervical cancer and the E6 and E7 genes encode the major HPV oncoproteins. The E7 protein from high-risk HPV types alters cell cycle progression and represses genes encoding components of the antigen-presentation pathway, suggesting a role for E7 in tumour immune evasion. We show that knockdown of E7 expression in HPV16- and HPV18-transformed cervical carcinoma cells by RNA interference increased expression of major histocompatibility complex (MHC) class I at the cell surface and reduced susceptibility of these cells to natural killer (NK) cells. Tetracycline-regulated induction of HPV16 E7 resulted in reduced expression of cell surface MHC class I molecules and increased NK cell killing. Our results suggest that, for HPV-associated malignancies, reduced MHC class I expression is the result of an active immune evasion strategy that has evolved to assist viral replication.	[Bottley, G.; Watherston, O. G.; Hiew, Y-L; Blair, G. E.] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Norrild, B.] Univ Copenhagen, Panum Inst, Inst Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Cook, G. P.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Copenhagen; Saint James's University Hospital; University of Leeds	Blair, GE (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Garstang Bldg Room, Leeds LS2 9JT, W Yorkshire, England.	g.e.blair@leeds.ac.uk	Blair, George Eric/A-5906-2008; Norrild, Bodil/C-1115-2009	Blair, George Eric/0000-0003-0440-1795; Cook, Graham/0000-0003-0223-3652	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Berger AJ, 2002, AM J PATHOL, V161, P603, DOI 10.1016/S0002-9440(10)64215-0; Bottley G, 2005, VIROLOGY, V338, P297, DOI 10.1016/j.virol.2005.05.017; Bottley Graham, 2007, Methods Mol Med, V131, P221; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CROMME FV, 1993, ONCOGENE, V8, P2969; CROMME FV, 1994, J EXP MED, V179, P335, DOI 10.1084/jem.179.1.335; Garcia-Lora A, 2003, EUR J IMMUNOGENET, V30, P177, DOI 10.1046/j.1365-2370.2003.00384.x; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; HOWLEY PM, 2007, FIELDS VIROLOGY, P2299; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kaznelson DW, 2004, VIROLOGY, V320, P301, DOI 10.1016/j.virol.2003.12.018; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Li H, 2006, BIOCHEM BIOPH RES CO, V349, P1315, DOI 10.1016/j.bbrc.2006.08.182; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; Pett MR, 2006, P NATL ACAD SCI USA, V103, P3822, DOI 10.1073/pnas.0600078103; PROFFITT JL, 1994, NUCLEIC ACIDS RES, V22, P4779, DOI 10.1093/nar/22.22.4779; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhao BW, 2006, VIROLOGY, V352, P338, DOI 10.1016/j.virol.2006.04.036	27	46	49	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2008	27	12					1794	1799		10.1038/sj.onc.1210798	http://dx.doi.org/10.1038/sj.onc.1210798			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17828295				2022-12-25	WOS:000253962100015
J	Phillips, A; Blaydes, JP				Phillips, A.; Blaydes, J. P.			MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA	ONCOGENE			English	Article						p53; MDM2; mRNA export; breast cancer; eIF4E	SINGLE NUCLEOTIDE POLYMORPHISM; INITIATION-FACTOR EIF4E; TRANSLATION INITIATION; NEGATIVE REGULATION; GENE-EXPRESSION; P53 PATHWAY; MDM2; PROTEIN; ACTIVATION; TRANSPORT	Regulation of the synthesis, function and degradation of HDM2 (Mdm2 in mouse) plays a key role in controlling the abundance and activity of the transcription factor p53, with consequent implications for the proliferation and survival of normal and cancer cells. We have previously identified the regulation of export of HDM2 mRNA from the nucleus as a novel point of control of HDM2 synthesis. This process is dependent on the activity of the growth factor-regulated MAP-kinase kinases ( MEKs). Here, we provide evidence that the eIF4E kinase MNK1 is a key downstream effector of MEKs in this regulatory pathway. We show that HDM2 mRNA export in breast cancer cells is promoted by overexpressed eIF4E in a MEK- and MNK1-dependent manner, and inhibition of MNK1 suppresses endogenous HDM2 mRNA export pathways. This MNK1- and eIF4E-dependent HDM2 regulation occurs through sequences in the 30 untranslated region of HDM2 mRNA, and consequently HDM2 mRNA transcripts from both the constitutive P1 and inducible P2 promoters are regulated by this pathway. eIF4E is a known oncogene that is overexpressed in human tumours, including the majority of breast cancers. This pathway, therefore, may play an important role in the dysregulation of HDM2 oncoprotein expression that occurs in many human tumours.	[Phillips, A.; Blaydes, J. P.] Univ Southampton, Southampton Gen Hosp, Canc Sci Div, Southampton SO16 6YD, Hants, England	University of Southampton	Blaydes, JP (corresponding author), Univ Southampton, Southampton Gen Hosp, Canc Sci Div, Somers Res Bldg,MP824, Southampton SO16 6YD, Hants, England.	jpb1@soton.ac.uk	Blaydes, Jeremy/AAC-6939-2019	Blaydes, Jeremy/0000-0001-8525-0209				Blaydes JP, 1997, ONCOGENE, V14, P1859, DOI 10.1038/sj.onc.1201018; Blaydes JP, 1998, ONCOGENE, V16, P3317, DOI 10.1038/sj.onc.1201880; Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Culjkovic B, 2005, J CELL BIOL, V169, P245, DOI 10.1083/jcb.200501019; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Culjkovic B, 2007, CELL CYCLE, V6, P65, DOI 10.4161/cc.6.1.3688; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; Erkmann JA, 2004, EXP CELL RES, V296, P12, DOI 10.1016/j.yexcr.2004.03.015; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; HARVEY M, 1993, ONCOGENE, V8, P2457; Keene JD, 2003, NAT GENET, V33, P111, DOI 10.1038/ng0203-111; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Onel K, 2004, MOL CANCER RES, V2, P1; Phelps M, 2005, J BIOL CHEM, V280, P16651, DOI 10.1074/jbc.M412334200; Phelps M, 2003, CANCER RES, V63, P2616; Phillips A, 2006, ONCOGENE, V25, P4183, DOI 10.1038/sj.onc.1209451; Phillips A, 2006, FEBS LETT, V580, P300, DOI 10.1016/j.febslet.2005.12.026; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Shaulian E, 1997, ONCOGENE, V15, P2717, DOI 10.1038/sj.onc.1201453; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584	36	35	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2008	27	11					1645	1649		10.1038/sj.onc.1210785	http://dx.doi.org/10.1038/sj.onc.1210785			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17828301	Green Accepted			2022-12-25	WOS:000253815800017
J	Ganguly, S; Grodzki, C; Sugden, D; Moller, M; Odom, S; Gaildrat, P; Gery, I; Siraganian, RP; Rivera, J; Klein, DC				Ganguly, Surajit; Grodzki, Cristina; Sugden, David; Moller, Morten; Odom, Sandra; Gaildrat, Pascaline; Gery, Igal; Siraganian, Reuben P.; Rivera, Juan; Klein, David C.			Neural adrenergic/cyclic AMP regulation of the immunoglobulin e receptor alpha-subunit expression in the mammalian pinealocyte a - Neuroendocrine/immune response link?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; ISOFORM MESSENGER-RNAS; AFFINITY IGE RECEPTOR; REAL-TIME PCR; N-ACETYLTRANSFERASE; CIRCADIAN EXPRESSION; GLAND; RAT; CELL; MELATONIN	The high affinity immunoglobulin E receptor (Fc epsilon RI) complex is dedicated to immunoglobulin E- mediated allergic responses. Expression of the Fc epsilon RI receptor is thought to be relatively stable and limited to mast cells, basophils, eosinophils, monocytes, Langerhans cells, platelets, and neutrophils. We now report that the Fc epsilon RI alpha and Fc epsilon RI gamma polypeptides are expressed in the pinealocyte, the melatonin- secreting cell of the pineal gland. Moreover, Fcer1a mRNA levels increased similar to 100-fold at night to levels that were higher than in other tissues examined. Pineal Fc epsilon RI alpha protein also increased markedly at night from nearly undetectable daytime levels. Our studies indicate that pineal Fcer1a mRNA levels are controlled by a well described neural pathway that controls pineal function. This pathway includes the master circadian oscillator in the suprachiasmatic nucleus and passes through central and peripheral structures. The circadian expression of Fc epsilon RI alpha in the pineal gland is driven by this neural circuit via an adrenergic/ cyclic AMP mechanism. Pineal Fc epsilon RI alpha and Fc epsilon RI gamma may represent a previously unrealized molecular link between the neuroendocrine and immune systems.	NICHD, Sect Neuroendocrinol, Off Sci Director, Natl Inst Hlth, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; NIDCR, Oral Infect & Immun Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; Kings Coll London, Sch Biomed & Hlth Sci, Div Reprod & Endocrinol, London SE1 1UL, England; Univ Copenhagen, Panum Inst, Dept Neurobiol & Pharmacol, DK-2200 Copenhagen, Denmark; NIAMS, Mol Inflammat Sect, Mol Immunol & Inflammat Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; NEI, Immunol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of London; King's College London; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Klein, DC (corresponding author), NICHD, Sect Neuroendocrinol, Off Sci Director, Natl Inst Hlth, Bldg 49,Rm 6A82, Bethesda, MD 20892 USA.	kleind@mail.nih.gov		Ganguly, Surajit/0000-0002-1876-9147; Klein, David/0000-0002-1792-5806	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000095, ZIAHD000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041101, ZIAAR041101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696, Z01DE000696] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ajpru S, 2002, MOL BRAIN RES, V105, P29, DOI 10.1016/S0169-328X(02)00387-X; Albrecht B, 2000, J IMMUNOL, V165, P5686, DOI 10.4049/jimmunol.165.10.5686; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; CAROLEO MC, 1992, AUTOIMMUNITY, V13, P303; Cauvi DM, 2006, J BIOL CHEM, V281, P10448, DOI 10.1074/jbc.M510751200; Fedyk ER, 1996, CLIN IMMUNOL IMMUNOP, V81, P101, DOI 10.1006/clin.1996.0165; Fiebiger E, 2005, J EXP MED, V201, P267, DOI 10.1084/jem.20041384; Gaildrat P, 2005, J BIOL CHEM, V280, P16851, DOI 10.1074/jbc.M414587200; Ganguly S, 2002, CELL TISSUE RES, V309, P127, DOI 10.1007/s00441-002-0579-y; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335; Kim JS, 2005, J BIOL CHEM, V280, P677, DOI 10.1074/jbc.M408438200; Kinet JP, 1999, CURR OPIN IMMUNOL, V11, P603, DOI 10.1016/S0952-7915(99)00023-0; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KLEIN DC, 1985, CIBA F SYMP, V117, P38; Kuhlwein E, 2001, J NEUROIMMUNOL, V117, P51, DOI 10.1016/S0165-5728(01)00325-3; Larche M, 2006, CURR OPIN IMMUNOL, V18, P745, DOI 10.1016/j.coi.2006.09.013; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; MEFFORD IN, 1983, ENDOCRINOLOGY, V113, P1582, DOI 10.1210/endo-113-5-1582; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Moller M, 2006, CHRONOBIOL INT, V23, P393, DOI 10.1080/07420520500521855; MOLLER M, 1978, CELL TISSUE RES, V195, P1; Moller M, 1997, CELL TISSUE RES, V288, P279, DOI 10.1007/s004410050813; Mosenson JA, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-1; Nadler M J, 2000, Adv Immunol, V76, P325; Novak N, 2004, CURR ALLERGY ASTHM R, V4, P263, DOI 10.1007/s11882-004-0069-2; PARFITT A, 1976, NEUROPHARMACOLOGY, V15, P353, DOI 10.1016/0028-3908(76)90083-6; Pongratz G, 2006, J IMMUNOL, V177, P2926, DOI 10.4049/jimmunol.177.5.2926; REDECKER P, 1993, J NEUROSCI RES, V34, P79, DOI 10.1002/jnr.490340109; Redecker P, 1999, INT REV CYTOL, V191, P201, DOI 10.1016/S0074-7696(08)60160-6; Reiter RJ, 2000, ANN NY ACAD SCI, V917, P376; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; SCHAAD NC, 1993, BRAIN RES, V614, P251, DOI 10.1016/0006-8993(93)91042-Q; Seminario MC, 1999, J IMMUNOL, V162, P6893; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; Silva SO, 2004, J NEUROIMMUNOL, V156, P146, DOI 10.1016/j.jneuroim.2004.07.015; Sugden D, 2003, J NEUROCHEM, V86, P1308, DOI 10.1046/j.1471-4159.2003.01959.x; TAMOTSU S, 1995, CELL TISSUE RES, V282, P219, DOI 10.1007/s004410050474; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0	45	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32758	32764		10.1074/jbc.M705950200	http://dx.doi.org/10.1074/jbc.M705950200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17728245	hybrid			2022-12-25	WOS:000250625400024
J	Belotserkovskii, BP; De Silva, E; Tornaletti, S; Wang, G; Vasquez, KM; Hanawalt, PC				Belotserkovskii, Boris P.; De Silva, Erandi; Tornaletti, Silvia; Wang, Guliang; Vasquez, Karen M.; Hanawalt, Philip C.			A triplex-forming sequence from the human c-MYC promoter interferes with DNA transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; CLASS SWITCH RECOMBINATION; H-DNA; MAMMALIAN-CELLS; HELIX FORMATION; COUPLED REPAIR; REPEAT; ELONGATION; TEMPLATE; REGIONS	Naturally occurring DNA sequences that are able to form unusual DNA structures have been shown to be mutagenic, and in some cases the mutagenesis induced by these sequences is enhanced by their transcription. It is possible that transcription-coupled DNA repair induced at sites of transcription arrest might be involved in this mutagenesis. Thus, it is of interest to determine whether there are correlations between the mutagenic effects of such noncanonical DNA structures and their ability to arrest transcription. We have studied T7 RNA polymerase transcription through the sequence from the nuclease-sensitive element of the human c-MYC promoter, which is mutagenic in mammalian cells (Wang, G., and Vasquez, K. M. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 13448 -13453). This element has two mirror-symmetric homopurine-homopyrimidine blocks that potentially can form either DNA triplex (H-DNA) or quadruplex structures. We detected truncated transcription products indicating partial transcription arrest within and closely downstream of the element. The arrest required negative supercoiling and was much more pronounced when the pyrimidine-rich strand of the element served as the template. The exact positions of arrest sites downstream from the element depended upon the downstream flanking sequences. We made various nucleotide substitutions in the wild-type sequence from the c-MYC nuclease-sensitive element that specifically destabilize either the triplex or the quadruplex structure. When these substitutions were ranked for their effects on transcription, the results implicated the triplex structure in the transcription arrest. We suggest that transcription induced triplex formation enhances pre-existing weak transcription pause sites within the flanking sequences by creating ;steric obstacles for the transcription machinery.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, Smithville, TX 78957 USA	Stanford University; University of Texas System; UTMD Anderson Cancer Center	Hanawalt, PC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	hanawalt@stanford.edu		Belotserkovskii, Boris/0000-0002-1570-9923	NCI NIH HHS [CA93729, CA77712, R01 CA077712] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093729, R56CA077712, R01CA077712] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; ALUNNIFABBRONI M, 1994, EUR J BIOCHEM, V226, P831, DOI 10.1111/j.1432-1033.1994.00831.x; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; BELOTSERKOVSKII BP, 1992, NUCLEIC ACIDS RES, V20, P1903, DOI 10.1093/nar/20.8.1903; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; EICK D, 1990, ONCOGENE, V5, P1397; FIRULLI AB, 1992, BIOCHEM BIOPH RES CO, V185, P264, DOI 10.1016/S0006-291X(05)80985-4; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; GRABCZYK E, 1995, J BIOL CHEM, V270, P1791, DOI 10.1074/jbc.270.4.1791; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; Gyi JI, 1996, BIOCHEMISTRY-US, V35, P12538, DOI 10.1021/bi960948z; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; He B, 1998, J BIOL CHEM, V273, P18802, DOI 10.1074/jbc.273.30.18802; Hoover R G, 1995, Curr Top Microbiol Immunol, V194, P257; Huang FT, 2006, P NATL ACAD SCI USA, V103, P5030, DOI 10.1073/pnas.0506548103; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Kuzmine I, 2001, NUCLEIC ACIDS RES, V29, P2601, DOI 10.1093/nar/29.12.2601; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; MIRKIN SM, 1987, NATURE, V330, P495, DOI 10.1038/330495a0; Nelson P, 1999, P NATL ACAD SCI USA, V96, P14342, DOI 10.1073/pnas.96.25.14342; Praseuth D, 1999, BBA-GENE STRUCT EXPR, V1489, P181, DOI 10.1016/S0167-4781(99)00149-9; RANDO RF, 1994, NUCLEIC ACIDS RES, V22, P678, DOI 10.1093/nar/22.4.678; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; SAXOWSKY TT, 2006, TRENDS GENET, V106, P474; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Tornaletti S, 2003, J BIOL CHEM, V278, P35791, DOI 10.1074/jbc.M305394200; VESELKOV AG, 1993, NATURE, V364, P496, DOI 10.1038/364496a0; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	46	113	116	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32433	32441		10.1074/jbc.M704618200	http://dx.doi.org/10.1074/jbc.M704618200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785457	hybrid			2022-12-25	WOS:000250480300066
J	Dicker, IB; Samanta, HK; Li, ZF; Hong, Y; Tian, Y; Banville, J; Remillard, RR; Walker, MA; Langley, DR; Krystal, M				Dicker, Ira B.; Samanta, Himadri K.; Li, Zhufang; Hong, Yang; Tian, Yuan; Banville, Jacques; Remillard, Roger R.; Walker, Michael A.; Langley, David R.; Krystal, Mark			Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL DNA INTEGRATION; PROTEIN IN-VITRO; VIRAL-DNA; CATALYTIC DOMAIN; MOLECULAR-DYNAMICS; CORE DOMAIN; CONCERTED INTEGRATION; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURES	Human immunodeficiency virus (HIV) integrase enzyme is required for the integration of viral DNA into the host cell chromosome. Integrase complex assembly and subsequent strand transfer catalysis are mediated by specific interactions between integrase and bases at the end of the viral long terminal repeat (LTR). The strand transfer reaction can be blocked by the action of small molecule inhibitors, thought to bind in the vicinity of the viral LTR termini. This study examines the contributions of the terminal four bases of the nonprocessed strand (G(2)T(1)C(-1)A(-2)) of the HIV LTR on complex assembly, specific strand transfer activity, and inhibitor binding. Base substitutions and abasic replacements at the LTR terminus provided a means to probe the importance of each nucleotide on the different functions. An approach is described wherein the specific strand transfer activity for each integrase/LTR variant is derived by normalizing strand transfer activity to the concentration of active sites. The key findings of this study are as follows. 1) The G(2):C-2 base pair is necessary for efficient assembly of the complex and for maintenance of an active site architecture, which has high affinity for strand transfer inhibitors. 2) Inhibitor-resistant enzymes exhibit greatly increased sensitivity to LTR changes. 3) The strand transfer and inhibitor binding defects of a Q148R mutant are due to a decreased affinity of the complex for magnesium. 4) Gln(148) interacts with G(2), T-1, and C-1 at the 5(') end of the viral LTR, with these four determinants playing important and overlapping roles in assembly, strand transfer catalysis and high affinity inhibitor binding.	Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Virol, Wallingford, CT 06492 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Med Chem, Wallingford, CT 06492 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Comp Assisted Drug Design, Wallingford, CT 06492 USA; Pharmaceut Res Inst, Dept Synthet Chem, Radiochem Grp, Princeton, NJ 08540 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Dicker, IB (corresponding author), Bristol Myers Squibb Co, 5 Res Pkwy, Wallingford, CT 06492 USA.	Ira.Dicker@BMS.com		Langley, David/0000-0002-0820-3190				Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Agapkina J, 2004, EUR J BIOCHEM, V271, P205, DOI 10.1046/j.1432-1033.2003.03921.x; ASSANTEAPPIAH E, 1999, ADV VIRUS RES, P351; Barreca ML, 2003, BIOPHYS J, V84, P1450, DOI 10.1016/S0006-3495(03)74958-3; Brigo A, 2005, PROTEINS, V59, P723, DOI 10.1002/prot.20447; BUSHMAN FD, 1992, P NATL ACAD SCI USA, V89, P3458, DOI 10.1073/pnas.89.8.3458; BUSHMAN FD, 1990, SCIENCE, V249, P1555, DOI 10.1126/science.2171144; BUSHMAN FD, 1994, J VIROL, V68, P2215, DOI 10.1128/JVI.68.4.2215-2223.1994; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; COOPER D, 2007, 14 C RETR OPP INF FE; Cox Arthur G., 2006, Antiviral Chemistry & Chemotherapy, V17, P343; DELESUS E, 2006, J ACQ IMMUN DEF SYND, V43, P1; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fikkert V, 2004, AIDS, V18, P2019, DOI 10.1097/00002030-200410210-00006; Fikkert V, 2003, J VIROL, V77, P11459, DOI 10.1128/JVI.77.21.11459-11470.2003; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gerton JL, 1998, J VIROL, V72, P5046, DOI 10.1128/JVI.72.6.5046-5055.1998; Gerton JL, 1999, J BIOL CHEM, V274, P33480, DOI 10.1074/jbc.274.47.33480; Gerton JL, 1997, J BIOL CHEM, V272, P25809, DOI 10.1074/jbc.272.41.25809; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Hindmarsh P, 1999, ADV VIRUS RES, V52, P397, DOI 10.1016/S0065-3527(08)60308-5; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Kehlenbeck S, 2006, J VIROL, V80, P6883, DOI 10.1128/JVI.00306-06; King PJ, 2003, VIROLOGY, V306, P147, DOI 10.1016/S0042-6822(02)00042-9; KULKOSKY J, 1994, PHARMACOL THERAPEUT, V61, P185, DOI 10.1016/0163-7258(94)90062-0; LAFEMINA RL, 1992, J VIROL, V66, P7414, DOI 10.1128/JVI.66.12.7414-7419.1992; LAFEMINA RL, 1991, J VIROL, V65, P5624, DOI 10.1128/JVI.65.10.5624-5630.1991; LEAVITT AD, 1992, J VIROL, V66, P2359, DOI 10.1128/JVI.66.4.2359-2368.1992; Lee DJ, 2006, ANTIMICROB AGENTS CH, V50, P134, DOI 10.1128/AAC.50.1.134-142.2006; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lins RD, 1999, BIOPHYS J, V76, P2999, DOI 10.1016/S0006-3495(99)77453-9; Lins RD, 2000, PHARMACOL THERAPEUT, V85, P123, DOI 10.1016/S0163-7258(99)00059-5; Lins RD, 2000, BIOPOLYMERS, V53, P308, DOI 10.1002/(SICI)1097-0282(20000405)53:4<308::AID-BIP3>3.0.CO;2-H; Lovell S, 2002, NAT STRUCT BIOL, V9, P278, DOI 10.1038/nsb778; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; MAZUMDER A, 1995, NUCLEIC ACIDS RES, V23, P2865, DOI 10.1093/nar/23.15.2865; McColl DJ, 2007, 16 INT DRUG RES WORK; Neamati N, 2002, EXPERT OPIN THER PAT, V12, P709, DOI 10.1517/13543776.12.5.709; Pais GCG, 2002, J MED CHEM, V45, P3184, DOI 10.1021/jm020037p; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Renisio JG, 2005, NUCLEIC ACIDS RES, V33, P1970, DOI 10.1093/nar/gki346; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; SHERMAN PA, 1992, J VIROL, V66, P3593, DOI 10.1128/JVI.66.6.3593-3601.1992; Sinha S, 2002, J VIROL, V76, P3105, DOI 10.1128/JVI.76.7.3105-3113.2002; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; VANDENENT FMI, 1994, J VIROL, V68, P7825, DOI 10.1128/JVI.68.12.7825-7832.1994; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; WAI J, 2007, 12 C RETR OPP INF FE; Wang T, 1999, BIOCHEMISTRY-US, V38, P3624, DOI 10.1021/bi982124i; Weber W, 1998, J BIOMOL STRUCT DYN, V16, P733, DOI 10.1080/07391102.1998.10508285; Wlodawer A, 1999, ADV VIRUS RES, V52, P335, DOI 10.1016/S0065-3527(08)60305-X; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463	70	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31186	31196		10.1074/jbc.M704935200	http://dx.doi.org/10.1074/jbc.M704935200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715137	hybrid			2022-12-25	WOS:000250309200008
J	Haggie, PM; Verkman, AS				Haggie, Peter M.; Verkman, A. S.			Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL STORAGE DISEASE; CHLORIDE CHANNEL; ENDOSOMAL ACIDIFICATION; H+-ATPASE; CFTR; PHAGOCYTOSIS; MATURATION; MEMBRANE; PH; HYPERACIDIFICATION	It was reported recently that the cystic fibrosis transmembrane conductance regulator (CFTR) is required for acidification of phagosomes in alveolar macrophages (Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., Palfrey, H. C., and Nelson, D. J. (2006) Nat. Cell Biol. 8, 933-944). Here we determined whether the CFTR chloride channel is a generalized pathway for chloride entry into phagosomes in macrophages and whether mutations in CFTR could contribute to alveolar macrophage dysfunction. The pH of mature phagolysosomes in macrophages was measured by fluorescence ratio imaging using a zymosan conjugate containing Oregon Green((R)) 488 and tetramethylrhodamine. Acidification of phagolysosomes in J774A.1 macrophages (pH similar to 5.1 at 45 min), murine alveolar macrophages (pH similar to 5.3), and human alveolar macrophages (pH similar to 5.3) was insensitive to CFTR inhibition by the thiazolidinone CFTRinh-172. Acidification of phagolysosomes in alveolar macrophages isolated from mice homozygous for Delta F508-CFTR, the most common mutation in cystic fibrosis, was not different compared with that in alveolar macrophages isolated from wild-type mice. We also measured the kinetics of phagosomal acidification in J774A. 1 and murine alveolar macrophages using a zymosan conjugate containing fluorescein and tetramethylrhodamine. Phagosomal acidification began within 3 min of zymosan binding and was complete within similar to 15 min of internalization. The rate of phagosomal acidification in J774A. 1 cells was not slowed by CFTRinh-172 and was not different in alveolar macrophages from wild-type versus similar to F508-CFTR mice. Our data indicate that phagolysosomal acidification in macrophages is not dependent on CFTR channel activity and do not support a proposed mechanism for cystic fibrosis lung disease involving defective phagosomal acidification and bacterial killing in alveolar macrophages.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Canc Res Inst, 1246 Hlth Sci E Tower,PO Box 0521, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, P30DK072517, R37DK035124] Funding Source: NIH RePORTER; NEI NIH HHS [EY13574] Funding Source: Medline; NHLBI NIH HHS [HL59198, HL73856] Funding Source: Medline; NIBIB NIH HHS [EB00415] Funding Source: Medline; NIDDK NIH HHS [DK35124, DK72517] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Biwersi J, 1996, P NATL ACAD SCI USA, V93, P12484, DOI 10.1073/pnas.93.22.12484; BIWERSI J, 1994, AM J PHYSIOL, V266, pC149, DOI 10.1152/ajpcell.1994.266.1.C149; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; de Jonge HR, 2007, J PHYSIOL-LONDON, V580, P7, DOI 10.1113/jphysiol.2007.129361; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; DUNN KW, 1994, J BIOL CHEM, V269, P5336; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; LUKACS GL, 1992, J BIOL CHEM, V267, P14568; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; O'Connor N, 2007, METHOD CELL BIOL, V81, P415, DOI 10.1016/S0091-679X(06)81019-8; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Poschet JF, 2006, EMBO REP, V7, P553, DOI 10.1038/sj.embor.7400674; Poschet JF, 2002, J BIOL CHEM, V277, P13959, DOI 10.1074/jbc.M105441200; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Seksek O, 1996, J BIOL CHEM, V271, P15542, DOI 10.1074/jbc.271.26.15542; SHERRY AM, 1994, AM J PHYSIOL, V266, pC870, DOI 10.1152/ajpcell.1994.266.3.C870; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Swanson J, 2006, NAT CELL BIOL, V8, P908, DOI 10.1038/ncb0906-908; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; Thelin WR, 2007, CURR OPIN PHARMACOL, V7, P290, DOI 10.1016/j.coph.2007.01.004; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; VANDYKE RW, 1992, BIOCHEM BIOPH RES CO, V184, P300, DOI 10.1016/0006-291X(92)91192-S; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	59	97	99	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31422	31428		10.1074/jbc.M705296200	http://dx.doi.org/10.1074/jbc.M705296200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724021	hybrid			2022-12-25	WOS:000250309200032
J	Cheng, JW; Yu, DV; Zhou, JH; Shapiro, DJ				Cheng, Jingwei; Yu, David V.; Zhou, Jian-Hua; Shapiro, David J.			Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HUMAN ESTROGEN-RECEPTOR; C/EBP-ALPHA; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; DOWN-REGULATION; PROLIFERATION; INHIBITION; EXPRESSION; DOMAINS	Low concentrations of tamoxifen or its active metabolite 4-hydroxytamoxifen (OHT) induce estrogen receptor alpha(ER alpha)-dependent apoptosis. To analyze the pathway of OHT-ER alpha-induced apoptosis, we developed stably transfected lines of HeLa cells expressing wild-type ER and an inactive mutant ER alpha unable to bind estrogen response elements. HeLa cells expressing the mutant ER alpha and HeLa cells expressing wild-type ER alpha in which the ER was knocked down with an ER-specific small interfering RNA were not killed by Tam or OHT, suggesting that estrogen response element-mediated transcription is required for Tam- and OHT-induced apoptosis. Microarray analysis to identify a gene(s) whose expression is important in OHT-ER-mediated apoptosis identified 19 mRNAs that OHT up-regulated by > 1.6-fold and 15 down-regulated mRNAs. Gene function and the time course of induction by OHT-ER alpha led us to further investigate CCAAT enhancer-binding protein alpha (C/EBP alpha), which has roles in cell cycle progression and apoptosis, and p21. Quantitative reverse transcription-PCR, Western blot analysis, and RNA interference knockdown suggest that cell cycle arrest resulting from OHT-ER alpha induction of p21 may facilitate apoptosis. OHT-ER alpha, but not E-2-ER alpha, induced C/EBP alpha mRNA and protein. RNA interference knockdown of C/EBP alpha nearly abolished OHT-ER alpha-induced apoptosis. We isolated stable cell lines that were resistant to OHT-induced apoptosis, contain full-length functional ER alpha, and undergo apoptosis in response to etoposide. In these OHT-resistant cell lines both before and after OHT treatment, C/EBP alpha levels are much lower than in OHT-sensitive cells. These studies establish a novel molecular site responsible for Tam- and OHT-ER alpha-induced apoptosis of cancer cells.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, 413 RAL,Box B4,600 S Mathews, Urbana, IL 61801 USA.	djshapir@uiuc.edu			NCI NIH HHS [CA90371] Funding Source: Medline; NICHD NIH HHS [HD16720] Funding Source: Medline; NIDDK NIH HHS [DK071909] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; Bjornstrom L, 2002, J BIOL CHEM, V277, P48479, DOI 10.1074/jbc.C200570200; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Calkhoven CF, 2000, GENE DEV, V14, P1920; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; D'Alo F, 2003, BLOOD, V102, P3163, DOI 10.1182/blood-2003-02-0479; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; Ferlini C, 1999, BRIT J CANCER, V79, P257, DOI 10.1038/sj.bjc.6690042; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Halmos B, 2002, CANCER RES, V62, P528; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Kim JA, 1999, CANCER LETT, V147, P115, DOI 10.1016/S0304-3835(99)00284-0; Klinge CM, 1997, J STEROID BIOCHEM, V63, P283, DOI 10.1016/S0960-0760(97)00091-5; KOSZEWSKI NJ, 1991, MOL ENDOCRINOL, V5, P1129, DOI 10.1210/mend-5-8-1129; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; Linford N, 2000, J NEUROCYTOL, V29, P367, DOI 10.1023/A:1007113323582; Mandlekar S, 2000, CANCER RES, V60, P6601; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; McEwen B, 2001, P NATL ACAD SCI USA, V98, P7093, DOI 10.1073/pnas.121146898; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; Otto AM, 1996, J CANCER RES CLIN, V122, P603, DOI 10.1007/BF01221192; PERRY RR, 1995, BRIT J CANCER, V72, P1441, DOI 10.1038/bjc.1995.527; Petz LN, 2000, MOL ENDOCRINOL, V14, P972, DOI 10.1210/me.14.7.972; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Toran-Allerand C D, 2000, Novartis Found Symp, V230, P56, DOI 10.1002/0470870818.ch6; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wang F, 1997, BIOCHEMISTRY-US, V36, P7793, DOI 10.1021/bi963100j; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WEBSTER NJG, 1989, EMBO J, V8, P1441, DOI 10.1002/j.1460-2075.1989.tb03526.x; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; Williams SC, 1997, GENE EXPRESSION, V6, P371; XU LX, 1994, CHINESE MED J-PEKING, V107, P596; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632; Zhang GJ, 1999, CLIN CANCER RES, V5, P2971	59	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30535	30543		10.1074/jbc.M704829200	http://dx.doi.org/10.1074/jbc.M704829200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17716978	hybrid			2022-12-25	WOS:000250136300021
J	Pagan, I; Alonso-Blanco, C; Garcia-Arenal, F				Pagan, Israel; Alonso-Blanco, Carlos; Garcia-Arenal, Fernando			The Relationship of Within-Host Multiplication and Virulence in a Plant-Virus System	PLOS ONE			English	Article								Background. Virulence does not represent any obvious advantage to parasites. Most models of virulence evolution assume that virulence is an unavoidable consequence of within-host multiplication of parasites, resulting in trade-offs between within-host multiplication and between-host transmission fitness components. Experimental support for the central assumption of this hypothesis, i.e., for a positive correlation between within-host multiplication rates and virulence, is limited for plant-parasite systems. Methodology/Principal Findings. We have addressed this issue in the system Arabidopsis thaliana-Cucumber mosaic virus (CMV). Virus multiplication and the effect of infection on plant growth and on viable seed production were quantified for 21 Arabidopsis wild genotypes infected by 3 CMV isolates. The effect of infection on plant growth and seed production depended of plant architecture and length of postembryonic life cycle, two genetically-determined traits, as well as on the time of infection in the plant's life cycle. A relationship between virus multiplication and virulence was not a general feature of this host-parasite system. This could be explained by tolerance mechanisms determined by the host genotype and operating differently on two components of plant fitness, biomass production and resource allocation to seeds. However, a positive relationship between virus multiplication and virulence was detected for some accessions with short life cycle and high seed weight to biomass ratio, which show lower levels of tolerance to infection. Conclusions/Significance. These results show that genotype-specific tolerance mechanisms may lead to the absence of a clear relationship between parasite multiplication and virulence. Furthermore, a positive correlation between parasite multiplication and virulence may occur only in some genotypes and/or environmental conditions for a given host-parasite system. Thus, our results challenge the general validity of the trade-off hypothesis for virulence evolution, and stress the need of considering the effect of both the host and parasite genotypes in analyses of host-parasite interactions.	[Pagan, Israel; Garcia-Arenal, Fernando] Univ Politecn Madrid, Dept Biotecnol, Madrid, Spain; [Pagan, Israel; Garcia-Arenal, Fernando] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Alonso-Blanco, Carlos] Univ Autonoma, CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Garcia-Arenal, F (corresponding author), Univ Politecn Madrid, Dept Biotecnol, Madrid, Spain.	fernando.garciaar-enal@upm.es	Pagán, Israel/H-1843-2015; Garcia-Arenal, Fernando/H-1603-2015; Alonso-Blanco, Carlos/F-8864-2016	Pagán, Israel/0000-0001-8876-1194; Alonso-Blanco, Carlos/0000-0002-4738-5556; GARCIA-ARENAL RODRIGUEZ, FERNANDO/0000-0002-5327-3200	Plan Nacional de I+D, Spain [AGL2005-01122]; Ministerio de Educacion y Ciencia, Spain	Plan Nacional de I+D, Spain; Ministerio de Educacion y Ciencia, Spain(Spanish Government)	This work was partly supported by grant AGL2005-01122 from Plan Nacional de I+D, Spain, to FGA. IP was supported by a Formacion de Personal Investigador fellowship from Ministerio de Educacion y Ciencia, Spain.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Bonnet J, 2005, VIROLOGY, V332, P359, DOI 10.1016/j.virol.2004.11.017; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BULL JJ, 1992, EVOLUTION, V46, P882, DOI 10.1111/j.1558-5646.1992.tb00606.x; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Carr DE, 2006, HEREDITY, V96, P29, DOI 10.1038/sj.hdy.6800743; Carr DE, 2003, EVOL ECOL, V17, P85, DOI 10.1023/A:1022439432213; Clarke D. D., 1986, Advances in Plant Pathology Volume 5., P161; Davies CM, 2001, P ROY SOC B-BIOL SCI, V268, P251, DOI 10.1098/rspb.2000.1367; Day T, 2002, P ROY SOC B-BIOL SCI, V269, P1317, DOI 10.1098/rspb.2002.2021; Ding XS, 2004, MOL PLANT MICROBE IN, V17, P583, DOI 10.1094/MPMI.2004.17.6.583; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Ebert D, 1996, TRENDS ECOL EVOL, V11, pA79; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Ebert D, 1997, EVOLUTION, V51, P1828, DOI [10.2307/2411005, 10.1111/j.1558-5646.1997.tb05106.x]; Escriu F, 2000, PHYTOPATHOLOGY, V90, P1068, DOI 10.1094/PHYTO.2000.90.10.1068; Escriu F, 2000, PHYTOPATHOLOGY, V90, P480, DOI 10.1094/PHYTO.2000.90.5.480; Escriu F, 2003, EVOLUTION, V57, P755, DOI 10.1111/j.0014-3820.2003.tb00287.x; FENNER F, 1965, MIXOMATOSIS; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gal-On A, 2007, MOL PLANT PATHOL, V8, P139, DOI 10.1111/J.1364-3703.2007.00381.X; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Goss EM, 2006, EVOLUTION, V60, P1562, DOI 10.1111/j.0014-3820.2006.tb00501.x; Handford MG, 2007, J GEN VIROL, V88, P337, DOI 10.1099/vir.0.82376-0; Jaenike J, 1996, EVOLUTION, V50, P2241, DOI [10.1111/j.1558-5646.1996.tb03613.x, 10.2307/2410694]; Jakel T, 2001, INT J PARASITOL, V31, P1639, DOI 10.1016/S0020-7519(01)00289-2; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; LENSKI RE, 1994, J THEOR BIOL, V169, P253, DOI 10.1006/jtbi.1994.1146; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Little TJ, 2006, EVOLUTION, V60, P31, DOI 10.1111/j.0014-3820.2006.tb01079.x; LOT H, 1972, Annales de Phytopathologie, V4, P25; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Matthews REF., 2002, PLANT VIROLOGY; Messenger SL, 1999, P ROY SOC B-BIOL SCI, V266, P397, DOI 10.1098/rspb.1999.0651; Miller MR, 2006, EVOLUTION, V60, P945, DOI 10.1111/j.0014-3820.2006.tb01173.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Palukaitis P, 2003, DESCRIPTION PLANT VI; Paul REL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-30; Peever TL, 2000, APPL ENVIRON MICROB, V66, P4863, DOI 10.1128/AEM.66.11.4863-4869.2000; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Restif O, 2003, AM NAT, V161, P827, DOI 10.1086/375171; RIZZO TM, 1990, MOL GEN GENET, V222, P249, DOI 10.1007/BF00633825; RODRIGUEZCEREZO E, 1991, P NATL ACAD SCI USA, V88, P9863, DOI 10.1073/pnas.88.21.9863; Sacristan S, 2005, PHYTOPATHOLOGY, V95, P827, DOI 10.1094/PHYTO-95-0827; Salvaudon L, 2005, EVOLUTION, V59, P2518, DOI 10.1111/j.0014-3820.2005.tb00965.x; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Shi BJ, 2002, MOL PLANT MICROBE IN, V15, P947, DOI 10.1094/MPMI.2002.15.9.947; Sokal RR, 1995, BIOMETRY; Somerville C, 2002, NAT REV GENET, V3, P883, DOI 10.1038/nrg927; Stewart AD, 2005, EVOLUTION, V59, P730, DOI 10.1111/j.0014-3820.2005.tb01749.x; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; TAKAHASHI H, 1994, PLANT J, V6, P369, DOI 10.1046/j.1365-313X.1994.06030369.x; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Webster JP, 2004, AM NAT, V164, pS33, DOI 10.1086/424607; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Yoon JY, 2006, VIRUS RES, V118, P23, DOI 10.1016/j.virusres.2005.11.004; ZHANG L, 1994, J GEN VIROL, V75, P3185, DOI 10.1099/0022-1317-75-11-3185	69	53	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e786	10.1371/journal.pone.0000786	http://dx.doi.org/10.1371/journal.pone.0000786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726516	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455400003
J	Uys, PW; Warren, RM; van Helden, PD				Uys, Pieter W.; Warren, Robin M.; van Helden, Paul D.			A Threshold Value for the Time Delay to TB Diagnosis	PLOS ONE			English	Article								Background. In many communities where TB occurs at high incidence, the major force driving the epidemic is transmission. It is plausible that the typical long delay from the onset of infectious disease to diagnosis and commencement of treatment is almost certainly the major factor contributing to the high rate of transmission. Methodology/Principal Findings. This study is confined to communities which are epidemiologically relatively isolated and which have low HIV incidence. The consequences of delays to diagnosis are analyzed and the existence of a threshold delay value is demonstrated. It is shown that unless a sufficient number of cases are detected before this threshold, the epidemic will escalate. The method used for the analysis avoids the standard computer integration of systems of differential equations since the intention is to present a line of reasoning that reveals the essential dynamics of an epidemic in an intuitively clear way that is nevertheless quantitatively realistic. Conclusions/Significance. The analysis presented here shows that typical delays to diagnosis present a major obstacle to the control of a TB epidemic. Control can be achieved by optimizing the rapid identification of TB cases together with measures to increase the threshold value. A calculated and aggressive program is therefore necessary in order to bring about a reduction in the prevalence of TB in a community by decreasing the time to diagnosis in all its ramifications. Intervention strategies to increase the threshold value relative to the time to diagnosis and which thereby decrease disease incidence are discussed.	[Uys, Pieter W.; Warren, Robin M.; van Helden, Paul D.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol,Fac Hlth Sci, Cape Town, Western Cape, South Africa	National Research Foundation - South Africa; Stellenbosch University	van Helden, PD (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol,Fac Hlth Sci, Cape Town, Western Cape, South Africa.	pvh@sun.ac.za		Warren, Robin/0000-0001-5741-7358	EDCTP	EDCTP	Salary for PU from EDCTP. Sponsor had no role in the study.	Aparicio JP, 2000, J THEOR BIOL, V206, P327, DOI 10.1006/jtbi.2000.2129; Arias-Bouda LMP, 2000, J CLIN MICROBIOL, V38, P2278; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; DUBOS J, 1987, WHITE PLAGUE; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; LILJEROS F, 2005, CONTACT NETWORK PATI; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Phillips L, 2004, PEDIATRICS, V113, pE514, DOI 10.1542/peds.113.6.e514; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; SADA E, 1983, LANCET, V2, P651; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306; Toyota M, 1994, Kekkaku, V69, P375; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; YANEZ MA, 1986, J CLIN MICROBIOL, V23, P822	22	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e757	10.1371/journal.pone.0000757	http://dx.doi.org/10.1371/journal.pone.0000757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712405	Green Published, gold			2022-12-25	WOS:000207455300005
J	Plans, V; Guerra-Rebollo, M; Thomson, TM				Plans, V.; Guerra-Rebollo, M.; Thomson, T. M.			Regulation of mitotic exit by the RNF8 ubiquitin ligase	ONCOGENE			English	Article						RNF8; ubiquitin ligase; cell cycle; mitosis	RING FINGER PROTEIN; CELL-CYCLE; CONJUGATING ENZYMES; CYTOKINESIS FAILURE; FHA DOMAIN; CHFR; CHECKPOINT; MECHANISMS; DMA1; LOCALIZATION	RNF8 is a ubiquitin ligase with a FHA domain near its N terminus, and a RING-finger domain at its C terminus, through which it recruits several ubiquitin-conjugating enzymes. In metazoans, only the mitotic checkpoint regulator CHFR shares this domain architecture. Here we show that RNF8 is a nuclear protein that follows a cell-cycle-dependent turnover, reaching its highest levels in mitosis, followed by a strong decline in late mitotic stages. Overexpression of RNF8 caused a delay in cytokinesis and the frequent appearance of aberrant mitotic figures. These effects were dependent on the ubiquitin ligase activity of RNF8, since they were significantly attenuated when a RING-finger mutant, inactive as an E3, was over-expressed. Depletion of RNF8 also caused a delay in the exit from the mitotic arrest induced by nocodazole, associated with a reduced turnover of the APC/C substrate cyclin B1. These observations suggest that RNF8 regulates the rate of exit from mitosis and cytokinesis.	[Plans, V.; Guerra-Rebollo, M.; Thomson, T. M.] CSIC, Inst Biol Mol Barcelona, Dept Mol & Cellular Biol, ES-08034 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Thomson, TM (corresponding author), CSIC, Inst Biol Mol Barcelona, Dept Mol & Cellular Biol, C Jordi Girona 18-26, ES-08034 Barcelona, Spain.	titbmc@cid.csic.es	Guerra-Rebollo, Marta/H-3199-2015; Thomson, Timothy/Z-6271-2019	Guerra-Rebollo, Marta/0000-0002-3731-4527; Thomson, Timothy/0000-0002-4670-9440				Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Chaturvedi P, 2002, CANCER RES, V62, P1797; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fraschini R, 2004, MOL BIOL CELL, V15, P3796, DOI 10.1091/mbc.E04-02-0094; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Guertin DA, 2002, DEV CELL, V3, P779, DOI 10.1016/S1534-5807(02)00367-2; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Liao H, 1999, J MOL BIOL, V294, P1041, DOI 10.1006/jmbi.1999.3313; Mariatos G, 2003, CANCER RES, V63, P7185; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Satoh A, 2003, CANCER RES, V63, P8606; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Takano Y, 2004, J BIOL CHEM, V279, P18926, DOI 10.1074/jbc.M309148200; Trielli MO, 1996, J CELL BIOL, V135, P689, DOI 10.1083/jcb.135.3.689; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	30	34	35	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2008	27	10					1355	1365		10.1038/sj.onc.1210782	http://dx.doi.org/10.1038/sj.onc.1210782			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	267ZR	17724460				2022-12-25	WOS:000253548200002
J	Lin, DI; Lessie, M; Gladden, AB; Bassing, C; Wagner, K; Diehl, J				Lin, D. I.; Lessie, M. D.; Gladden, A. B.; Bassing, C. H.; Wagner, K. U.; Diehl, J. A.			Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis	ONCOGENE			English	Article						CDK4; cyclin D1; FBX4; mammary gland; PD0332991	GENOMIC INSTABILITY; DEPENDENT KINASE; BREAST-CANCER; TUMORIGENESIS; HYPERPLASIA; EXPRESSION; ONCOGENE; CELLS; MICE; MYC	Cyclin D1 levels are maintained at steady state by phosphorylation-dependent nuclear export and polyubiquitination by SCFFBX4-alpha B (crystallin). Inhibition of cyclin D1 proteolysis has been implicated as a causative factor leading to its overexpression in breast and esophageal carcinomas; however, the contribution of stable cyclin D1 to the genesis of such carcinomas has not been evaluated. We therefore generated transgenic mice wherein expression of either wild-type or a stable cyclin D1 allele ( D1T286A) is regulated by MMTV-LTR. MMTV-D1T286A mice developed mammary adenocarcinomas at an increased rate relative to MMTV-D1 mice. Similar to human cancers that overexpress cyclin D1, D1T286A tumors were estrogen receptor-positive and exhibited estrogen-dependent growth. Collectively, these results suggest that temporal control of cyclin D1 subcellular localization and proteolysis is critical for maintenance of homeostasis within the mammary epithelium.	[Diehl, J. A.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Lin, D. I.; Lessie, M. D.; Gladden, A. B.; Diehl, J. A.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Bassing, C. H.] Univ Penn, Childrens Hosp, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wagner, K. U.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Pathol & Microbiol, Omaha, NE 68182 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Nebraska System; University of Nebraska Medical Center	Diehl, J (corresponding author), Univ Penn, Abramson Family Canc Res Inst, 454 BRB 2 3,421 Curie Blvd, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu		Wagner, Kay-Uwe/0000-0002-5081-0226; Lin, Douglas/0000-0003-0105-9760	NCI NIH HHS [CA11360, R01 CA111360, R01 CA125195-01A1, R01 CA111360-05, R01 CA125195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111360, R01CA125195] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HENNIGHAUSEN L, 1994, CELL GROWTH DIFFER, V5, P607; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Ip M. M., 2000, METHODS MAMMARY GLAN; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lu FM, 2003, CANCER RES, V63, P7056; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; Rowse GJ, 1998, CANCER RES, V58, P2675; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Utsumi T, 2000, INT J CANCER, V89, P39, DOI 10.1002/(SICI)1097-0215(20000120)89:1<39::AID-IJC7>3.0.CO;2-T; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012	26	60	61	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 21	2008	27	9					1231	1242		10.1038/sj.onc.1210738	http://dx.doi.org/10.1038/sj.onc.1210738			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17724472	Green Accepted			2022-12-25	WOS:000253407000005
J	Liu, Y; Wang, Y; Rusinol, AE; Sinensky, MS; Liu, J; Shell, SM; Zou, Y				Liu, Yiyong; Wang, Youjie; Rusinol, Antonio E.; Sinensky, Michael S.; Liu, Ji; Shell, Steven M.; Zou, Yue			Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A	FASEB JOURNAL			English	Article						Hutchinson-Gilford progeria syndrome; lamin A; Zmpste24; DNA double strand breaks and repair; DNA damage	HUTCHINSON-GILFORD-PROGERIA; NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; MUTANT LAMIN-A; MRE11/RAD50/NBS1 COMPLEX; INHIBITING FARNESYLATION; NUCLEAR ARCHITECTURE; REPLICATION FORKS; UV-IRRADIATION	Cellular accumulation of DNA damage has been widely implicated in cellular senescence, aging, and premature aging. In Hutchinson-Gilford progeria syndrome (HGPS) and restrictive dermopathy (RD), premature aging is linked to accumulation of DNA double-strand breaks (DSBs), which results in genome instability. However, how DSBs accumulate in cells despite the presence of intact DNA repair proteins remains unknown. Here we report that the recruitment of DSB repair factors Rad50 and Rad51 to the DSB sites, as marked by gamma-H2AX, was impaired in human HGPS and Zmpste24-deficient cells. Consistently, the progeria-associated DSBs appeared to be unrepairable although DSBs induced by camptothecin were efficiently removed in the progeroid cells. We also found that these progeroid cells exhibited nuclear foci of xeroderma pigmentosum group A (XPA), a unique nucleotide excision repair protein. Strikingly, these XPA foci colocalized with the DSB sites in the progeroid cells. This XPA-DSB association was further confirmed and found to be mediated by DNA, using a modified chromatin immunoprecipitation assay and coimmunoprecipitation. RNA interference (RNAi) knockdown of XPA in HGPS cells partially restored DSB repair as evidenced by Western blot analysis, immunofluorescence and comet assays. We propose that the uncharacteristic localization of XPA to or near DSBs inhibits DSB repair, thereby contributing to the premature aging phenotypes observed in progeria arising from genetic defects in prelamin A maturation.	[Liu, Yiyong; Wang, Youjie; Rusinol, Antonio E.; Sinensky, Michael S.; Liu, Ji; Shell, Steven M.; Zou, Yue] E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA; [Liu, Ji] Sichuan Univ, Dept Biochem & Mol Biol, Chengdu 610064, Peoples R China	East Tennessee State University; Sichuan University	Zou, Y (corresponding author), E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA.	zouy@etsu.edu	Zou, Yue/ABA-8429-2020		NCI NIH HHS [R01 CA086927, R01 CA086927-05, CA-86927, R01 CA086927-04, R01 CA086927-06A2, R56 CA086927] Funding Source: Medline; NIA NIH HHS [R03 AG031503-01A1, R03 AG031503] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086927, R56CA086927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG031503] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gorbunova V, 2005, MECH AGEING DEV, V126, P621, DOI 10.1016/j.mad.2005.02.008; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lees-Miller SP, 2006, DNA REPAIR, V5, P286, DOI 10.1016/j.dnarep.2005.10.007; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mattout A, 2007, J CELL SCI, V120, P77, DOI 10.1242/jcs.03325; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Misteli T, 2005, NAT MED, V11, P718, DOI 10.1038/nm0705-718; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; SINENSKY M, 1994, CANCER RES, V54, P3229; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	46	76	78	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					603	611		10.1096/fj.07-8598com	http://dx.doi.org/10.1096/fj.07-8598com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17848622	Green Accepted			2022-12-25	WOS:000252822600030
J	Wiley, JC; Smith, EA; Hudson, MP; Ladiges, WC; Bothwell, M				Wiley, Jesse C.; Smith, Elise A.; Hudson, Mark P.; Ladiges, Warren C.; Bothwell, Mark			Fe65 stimulates proteolytic liberation of the beta-amyloid precursor protein intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRONIC BIALLELIC POLYMORPHISM; PHOSPHOTYROSINE-BINDING DOMAIN; RECEPTOR-RELATED PROTEIN; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; ADAPTER PROTEIN; NUCLEAR TRANSLOCATION; SECRETASE CLEAVAGE; TERMINAL FRAGMENT; CANDIDATE GENES	The beta-amyloid precursor protein (APP)-binding protein Fe65 is involved in APP nuclear signaling and several steps in APP proteolytic processing. In this study, we show that Fe65 stimulates gamma-secretase-mediated liberation of the APP intracellular domain (AICD). The mechanism of Fe65-mediated stimulation of AICD formation appears to be through enhanced production of the carboxyl-terminal fragment substrates of gamma-secretase and direct stimulation of processing by gamma-secretase. The stimulatory capacity of Fe65 is isoform-dependent, as the non-neuronal and a2 isoforms promote APP processing more effectively than the exon 9 inclusive neuronal form of Fe65. Intriguingly, Fe65 stimulation of AICD production appears to be inversely related to pathogenic beta-amyloid production as the Fe65 isoforms profoundly stimulate AICD production and simultaneously decreaseA beta 42 production. Despite the capacity of Fe65 to stimulate gamma-secretase-mediated APP proteolysis, it does not rescue the loss of proteolytic function associated with the presenilin-1 familial Alzheimer disease mutations. These data suggest that Fe65 regulation of APP proteolysis may be integrally associated with its nuclear signaling function, as all antecedent proteolytic steps prior to release of Fe65 from the membrane are fostered by the APP-Fe65 interaction.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bothwell, M (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	mab@u.washington.edu		Bothwell, Mark/0000-0001-5423-2702	NIA NIH HHS [AG21127, AG26476] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021127, R21AG026476] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Barbato C, 2005, NEUROBIOL DIS, V18, P399, DOI 10.1016/j.nbd.2004.10.011; Barnes NY, 1998, J NEUROSCI, V18, P5869; Bertram L, 2000, EXP GERONTOL, V35, P1353, DOI 10.1016/S0531-5565(00)00193-5; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Guenette SY, 1999, J NEUROCHEM, V73, P985, DOI 10.1046/j.1471-4159.1999.0730985.x; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hu QB, 2005, J BIOL CHEM, V280, P12548, DOI 10.1074/jbc.M411855200; Hu QB, 1998, HUM GENET, V103, P295, DOI 10.1007/s004390050820; Hu QB, 1999, J NEUROSCI RES, V58, P632, DOI 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P; Hu QB, 2000, J NEUROSCI RES, V60, P73, DOI 10.1002/(SICI)1097-4547(20000401)60:1<73::AID-JNR8>3.0.CO;2-S; Hu QB, 2002, HUM MOL GENET, V11, P465, DOI 10.1093/hmg/11.4.465; Jolly-Tornetta C, 2000, BIOCHEMISTRY-US, V39, P15282, DOI 10.1021/bi001723y; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lambert JC, 2000, NEUROSCI LETT, V293, P29, DOI 10.1016/S0304-3940(00)01477-4; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Papassotiropoulos A, 2000, INT J MOL MED, V6, P587; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Prince JA, 2001, EUR J HUM GENET, V9, P437, DOI 10.1038/sj.ejhg.5200651; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128	49	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33313	33325		10.1074/jbc.M706024200	http://dx.doi.org/10.1074/jbc.M706024200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855370	hybrid			2022-12-25	WOS:000250840200011
J	Masaki, H; Nishida, T; Kitajima, S; Asahina, K; Teraoka, H				Masaki, Hisaharu; Nishida, Tomohiro; Kitajima, Shigetaka; Asahina, Kinji; Teraoka, Hirobumi			Developmental pluripotency-associated 4 (DPPA4) localized in active chromatin inhibits mouse embryonic stem cell differentiation into a primitive ectoderm lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; ENDODERM DIFFERENTIATION; ES CELLS; PLURIPOTENCY; NANOG; EXPRESSION; GENES; SOX2; ACTIVATION	Because embryonic stem (ES) cells can proliferate indefinitely in an undifferentiated state and differentiate into various cell types, ES cells are expected to be useful for cell replacement therapy and basic research on early embryogenesis. Although molecular mechanisms of ES cell self-renewal have been studied, many uncharacterized genes expressed in ES cells remain to be clarified. Developmental pluripotency associated 4 (Dppa4) is one such gene highly expressed in both ES cells and early embryos. Here, we investigated the role of Dppa4 in mouse ES cell self-renewal and differentiation. We generated Dppa4-overexpressing ES cells under the control of tetracycline. Dppa4 overexpression suppressed cell proliferation and formation of embryoid bodies and caused massive cell death in differentiating ES cells. Quantitative reverse transcription-PCR analysis showed that Dppa4 overexpression does not support ES cell self-renewal but partially inhibits ES cell differentiation. Suppression of Dppa4 expression by short hairpin RNA induced ES cell differentiation into a primitive ectoderm lineage. DPPA4 protein was localized in the ES cell nucleus associated with chromatin. Micrococcal nuclease digestion analysis and immunocytochemistry revealed that DPPA4 is associated with transcriptionally active chromatin. These findings indicate that DPPA4 is a nuclear factor associated with active chromatin and that it regulates differentiation of ES cells into a primitive ectoderm lineage.	Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Chiyoda Ku, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Chiyoda Ku, Tokyo 1010062, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Asahina, K (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA.	asahina@usc.edu	Asahina, Kinji/X-8794-2019	Asahina, Kinji/0000-0003-0398-8395				Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lake JA, 2000, J CELL SCI, V113, P555; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Remboutsika E, 1999, J CELL SCI, V112, P1671; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROSE SM, 1984, J BIOL CHEM, V259, P8534; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	50	44	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33034	33042		10.1074/jbc.M703245200	http://dx.doi.org/10.1074/jbc.M703245200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855347	hybrid			2022-12-25	WOS:000250625400052
J	Wang, H; Gilham, D; Lehner, R				Wang, Huajin; Gilham, Dean; Lehner, Richard			Proteomic and lipid characterization of apolipoprotein B-free luminal lipid droplets from mouse liver Microsomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEIN; TRIACYLGLYCEROL HYDROLASE; ENDOPLASMIC-RETICULUM; APO-B; FATTY-ACIDS; SECRETION; CELL; GOLGI; LOCALIZATION	The assembly of very low density lipoproteins involves the formation of a primordial, poorly lipidated apoB-containing particle in the endoplasmic reticulum, followed by the addition of neutral lipid from luminal lipid droplets ( LLD). However, the lipid and protein compositions of LLD have not been determined. We have isolated LLD from mouse liver microsomes and analyzed their lipid and protein compositions. LLD are variably sized particles relatively poor in triacylglycerol ( TG) content when compared with the lipid composition of cytosolic lipid droplets ( CLD). They are devoid of apoB, adipophilin, and albumin but contain numerous proteins different from those found on CLD, including TG hydrolase ( TGH), carboxylesterase 1 ( Ces1), microsomal triglyceride transfer protein ( MTP), and apoE. Ectopic expression of TGH in McArdle RH7777 hepatoma cells resulted in decreased cellular TG levels, demonstrating a role for TGH in the mobilization of hepatic neutral lipid stores. The isolation and characterization of LLD provide new supporting evidence for the two-step assembly of very low density lipoproteins.	Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada; Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Dept Pediat, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Lehner, R (corresponding author), Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Dept Cell Biol, 328 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	richard.lehner@ualberta.ca		Lehner, Richard/0000-0002-6008-1805; Wang, Huajin/0000-0003-0121-4257				Alam M, 2002, PROTEIN EXPRES PURIF, V24, P33, DOI 10.1006/prep.2001.1553; ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Bradbury P, 1999, J BIOL CHEM, V274, P3159, DOI 10.1074/jbc.274.5.3159; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Dolinsky VW, 2004, CELL MOL LIFE SCI, V61, P1633, DOI 10.1007/s00018-004-3426-3; Ellinghaus P, 1998, BBA-GENE STRUCT EXPR, V1397, P175, DOI 10.1016/S0167-4781(98)00023-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; Gilham D, 2005, MOL BIOL CELL, V16, P984, DOI 10.1091/mbc.e04-03-0224; Gilham D, 2004, REV ENDOCR METAB DIS, V5, P303, DOI 10.1023/B:REMD.0000045101.42431.c7; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; Gordon DA, 1996, J BIOL CHEM, V271, P33047, DOI 10.1074/jbc.271.51.33047; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025; HAMILTON JA, 1981, P NATL ACAD SCI-BIOL, V78, P6878, DOI 10.1073/pnas.78.11.6878; Hamilton RL, 1998, J LIPID RES, V39, P1543; Higashi Y, 2003, J BIOL CHEM, V278, P21450, DOI 10.1074/jbc.M301376200; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Hussain MM, 1997, BIOCHEMISTRY-US, V36, P13060, DOI 10.1021/bi971395a; Jonas A., 2002, BIOCH LIPIDS LIPOPRO, P483; Kuipers F, 1996, HEPATOLOGY, V24, P241; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lankester DL, 1998, J LIPID RES, V39, P1889; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Lehner R, 1997, BIOCHEMISTRY-US, V36, P1861, DOI 10.1021/bi962186d; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Maugeais C, 2000, J LIPID RES, V41, P1673; Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; MORIMURA S, 1992, CELL GROWTH DIFFER, V3, P685; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Pease RJ, 1999, BIOCHEM J, V341, P453, DOI 10.1042/0264-6021:3410453; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; RUSTAEUS S, 1995, J BIOL CHEM, V270, P28879, DOI 10.1074/jbc.270.48.28879; Rustaeus S, 1998, J BIOL CHEM, V273, P5196, DOI 10.1074/jbc.273.9.5196; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; SPOONER PJR, 1987, BIOCHEMISTRY-US, V26, P5820, DOI 10.1021/bi00392a036; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Valyi-Nagy K, 2002, LIPIDS, V37, P879, DOI 10.1007/s11745-002-0974-3; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P4406, DOI 10.1021/bi00232a006; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Wu XJ, 1996, J BIOL CHEM, V271, P10277, DOI 10.1074/jbc.271.17.10277; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Yamamoto M, 2001, J BIOCHEM MOL TOXIC, V15, P76, DOI 10.1002/jbt.2; Yang LY, 1996, J LIPID RES, V37, P262	65	63	63	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33218	33226		10.1074/jbc.M706841200	http://dx.doi.org/10.1074/jbc.M706841200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848546	hybrid			2022-12-25	WOS:000250625400069
J	Xu, K; Kitchen, CM; Shu, HKG; Murphy, TJ				Xu, Kaiming; Kitchen, Chad M.; Shu, Hui-Kuo G.; Murphy, Thomas J.			Platelet-derived growth factor-induced stabilization of cyclooxygenase 2 mRNA in rat smooth muscle cells requires the c-Src family of protein-tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; BINDING PROTEINS; 3'-UNTRANSLATED REGION; INCREASES EXPRESSION; C/EBP-BETA; PDGF-BB; P38; STABILITY; TRISTETRAPROLIN; INVOLVEMENT	Cyclooxygenases ( COXs) are crucial rate- limiting enzymes required for the biosynthesis of prostaglandins. COX- 2 is an inducible isoform of this enzyme, which is believed to play important roles in the development of atherosclerotic vascular disease. We found that COX- 2 expression rapidly increases in response to various signaling events, including activation of the platelet- derived growth factor ( PDGF) pathway. Activation of PDGF receptor ( PDGFR) in rat aortic vascular smooth muscle cells leads to c- Src- dependent stabilization of COX- 2 mRNA requiring an AU- rich region within the 3'-untranslated region of this transcript. This regulation correlates with tyrosine phosphorylation of the RNA- associated protein, CUG- binding protein 2 ( CUGBP2), which appears to enhance its interaction with COX-2 mRNA. Site-directed mutagenesis of putative tyrosine phosphorylation sites in CUGBP2 identified tyrosine 39 as a c-Src target, and a CUGBP2 with a mutated tyrosine 39 displayed an attenuated ability to bind COX- 2 mRNA. We further show that silencing of CUGBP2 with specific small interference RNAs significantly reduces PDGF- dependent induction of COX- 2 at both mRNA and protein levels. Furthermore, forced expression of CUGBP2 or constitutively active c- Src leads to stabilization of co- expressed COX- 2 mRNA. Finally, in vitro RNA decay assay demonstrates that CUGBP2 is functionally required for the stabilization of COX- 2 mRNA. Therefore, our data suggest that tyrosine phosphorylation of CUGBP2 is an important underlying mechanism for the ability of PDGFR/ c- Src signaling to control the stability of COX- 2 mRNA.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Xu, K (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	kxu@emory.edu			NHLBI NIH HHS [HL 56107] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056107] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Bromann PA, 2005, J BIOL CHEM, V280, P10253, DOI 10.1074/jbc.M413806200; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chen CY, 2000, GENE DEV, V14, P1236; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; Chiarugi P, 1998, J BIOL CHEM, V273, P6776, DOI 10.1074/jbc.273.12.6776; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Englesbe MJ, 2004, J VASC SURG, V39, P1091, DOI 10.1016/j.jvs.2004.01.041; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Good PJ, 2000, J BIOL CHEM, V275, P28583, DOI 10.1074/jbc.M003083200; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Liang HY, 1999, J BIOL CHEM, V274, P19846, DOI 10.1074/jbc.274.28.19846; Liu B, 2006, J MOL CELL CARDIOL, V41, P160, DOI 10.1016/j.yjmcc.2006.03.426; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mifflin RC, 2004, MOL PHARMACOL, V65, P470, DOI 10.1124/mol.65.2.470; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Montero L, 1999, CANCER RES, V59, P5286; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Poon M, 1999, MOL CELL BIOL, V19, P6471; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Robida AM, 2000, MOL PHARMACOL, V58, P701, DOI 10.1124/mol.58.4.701; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Singh G, 2004, NUCLEIC ACIDS RES, V32, P1232, DOI 10.1093/nar/gkh275; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tamura M, 2003, J MOL ENDOCRINOL, V31, P95, DOI 10.1677/jme.0.0310095; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Vane JR, 1998, INFLAMM RES, V47, pS78; Wang SW, 1999, INFLAMM RES, V48, P533, DOI 10.1007/s000110050499; Wang XF, 1997, MOL PHARMACOL, V52, P781, DOI 10.1124/mol.52.5.781; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; Xu KM, 2000, J BIOL CHEM, V275, P7604, DOI 10.1074/jbc.275.11.7604; Xu KM, 2000, J BIOL CHEM, V275, P23012, DOI 10.1074/jbc.M001611200; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhang ZH, 2000, NEOPLASIA, V2, P523, DOI 10.1038/sj.neo.7900117	56	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32699	32709		10.1074/jbc.M705272200	http://dx.doi.org/10.1074/jbc.M705272200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855367	hybrid			2022-12-25	WOS:000250625400018
J	Eckermann, K; Mocanu, MM; Khlistunova, I; Biernat, J; Nissen, A; Hofmann, A; Schonig, K; Bujard, H; Haemisch, A; Mandelkow, E; Zhou, L; Rune, G; Mandelkow, EM				Eckermann, Katrin; Mocanu, Maria-Magdalena; Khlistunova, Inna; Biernat, Jacek; Nissen, Astrid; Hofmann, Anne; Schoenig, Kai; Bujard, Hermann; Haemisch, Andreas; Mandelkow, Eckhard; Zhou, Lepu; Rune, Gabriele; Mandelkow, Eva-Maria			The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; HUMAN BRAIN TAU; ALZHEIMERS-DISEASE; TRANSGENIC MICE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; REGULATED EXPRESSION; P301L TAU; A-BETA	Neurofibrillary lesions are characteristic for a group of human diseases, named tauopathies, which are characterized by prominent intracellular accumulations of abnormal filaments formed by the microtubule-associated protein Tau. The tauopathies are accompanied by abnormal changes in Tau protein, including pathological conformation, somatodendritic mislocalization, hyperphosphorylation, and aggregation, whose interdependence is not well understood. To address these issues we have created transgenic mouse lines in which different variants of full-length Tau are expressed in a regulatable fashion, allowing one to switch the expression on and off at defined time points. The Tau variants differ by small mutations in the hexapeptide motifs that control the ability of Tau to adopt a beta-structure conformation and hence to aggregate. The "pro-aggregation" mutant Delta K280, derived from one of the mutations observed in frontotemporal dementias, aggregates avidly in vitro, whereas the "anti-aggregation" mutant Delta K280/PP cannot aggregate because of two beta-breaking prolines. In the transgenic mice, the pro-aggregation Tau induces a pathological conformation and pre-tangle aggregation, even at low expression levels, the antiaggregation mutant does not. This illustrates that abnormal aggregation is primarily controlled by the molecular structure of Tau in vitro and in the organism. Both variants of Tau become mislocalized and hyperphosphorylated independently of aggregation, suggesting that localization and phosphorylation are mainly a consequence of increased concentration. These pathological changes are reversible when the expression of Tau is switched off. The pro-aggregation Tau causes a strong reduction in spine synapses.	Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; Univ Heidelberg, Ctr Mol Biol, ZMBH, Heidelberg, Germany; Univ Hamburg, Sch Med, Cent Anim Facil, Hamburg 20146, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; University of Hamburg	Mandelkow, EM (corresponding author), Max Planck Unit Struct Mol Biol, Notkestrasse 85, D-22607 Hamburg, Germany.	mandelkow@mpasmb.desy.de	Mocanu, Maria-Magdalena/B-5911-2011	Mocanu, Maria-Magdalena/0000-0002-1381-0649				Allen B, 2002, J NEUROSCI, V22, P9340; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kosik KS, 2005, BBA-MOL BASIS DIS, V1739, P298, DOI 10.1016/j.bbadis.2004.10.011; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Muyllaert D, 2006, REV NEUROL-FRANCE, V162, P903, DOI 10.1016/S0035-3787(06)75098-6; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Prange-Kiel J, 2004, EUR J NEUROSCI, V19, P309, DOI 10.1111/j.0953-816X.2003.03124.x; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	65	117	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31755	31765		10.1074/jbc.M705282200	http://dx.doi.org/10.1074/jbc.M705282200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716969	hybrid			2022-12-25	WOS:000250309200066
J	Heroux, M; Hogue, M; Lemieux, S; Bouvier, M				Heroux, Madeleine; Hogue, Mireille; Lemieux, Sebastien; Bouvier, Michel			Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION; LIVING CELLS; VISUALIZATION; COMPLEXES; CHANNELS; STOICHIOMETRY; HETERODIMERS; MICROSCOPY; TRANSPORT; FAMILY	In addition to their interactions with hetero-trimeric G proteins, seven-transmembrane domain receptors are now known to form multimeric complexes that can include receptor homoor hetero-oligomers and/or accessory proteins that modulate their activity. The calcitonin gene-related peptide ( CGRP) receptor requires the assembly of the seven-transmembrane domain calcitonin receptor-like receptor with the single-transmembrane domain receptor activity-modifying protein-1 to reach the cell surface and be active. However, the relative stoichiometric arrangement of these two proteins within a receptor complex remains unknown. Despite recent advances in the development of protein-protein interactions assays, determining the composition and stoichiometric arrangements of such signaling complexes in living cells remains a challenging task. In the present study, we combined bimolecular fluorescence complementation (BiFC) with bioluminescence resonance energy transfer (BRET) to probe the stoichiometric arrangement of the CGRP receptor complex. Together with BRET competition assays, co-immunoprecipitation experiments, and BiFC imaging, dual BRET/BiFC revealed that functional CGRP receptors result from the association of a homo-oligomer of the calcitonin receptor-like receptor with a monomer of the accessory protein receptor activity-modifying protein-1. In addition to revealing the existence of an unexpected asymmetric oligomeric organization for a G protein-coupled receptor, our study illustrates the usefulness of dual BRET/BiFC as a powerful tool for analyzing constitutive and dynamically regulated multiprotein complexes.	Univ Medicament, Dept Biochem, Grp Rech, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Inst Res Immunol & Canc, Dept Comp sci & Operat Res, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bouvier, M (corresponding author), Univ Medicament, Dept Biochem, Grp Rech, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100				Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Efron B., 1994, INTRO BOOTSTRAP; FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x; Heroux M, 2007, BIOCHEMISTRY-US, V46, P7022, DOI 10.1021/bi0622470; Hilaire S, 2001, J BIOL CHEM, V276, P42182, DOI 10.1074/jbc.M107323200; Hilairet S, 2001, J BIOL CHEM, V276, P29575, DOI 10.1074/jbc.M102722200; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Leuthauser K, 2000, BIOCHEM J, V351, P347, DOI 10.1042/0264-6021:3510347; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P441; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Michnick SW, 2001, CURR OPIN STRUC BIOL, V11, P472, DOI 10.1016/S0959-440X(00)00235-9; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Press WH., 2002, NUMERICAL RECIPES C, V2; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Sexton PM, 2001, CELL SIGNAL, V13, P73, DOI 10.1016/S0898-6568(00)00143-1; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Udawela M, 2004, SEMIN CELL DEV BIOL, V15, P299, DOI 10.1016/j.semcdb.2003.12.019; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3	29	65	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31610	31620		10.1074/jbc.M701790200	http://dx.doi.org/10.1074/jbc.M701790200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785463	hybrid			2022-12-25	WOS:000250309200053
J	Kovacheva, VP; Mellott, TJ; Davison, JM; Wagner, N; Lopez-Coviella, I; Schnitzler, AC; Blusztajn, JK				Kovacheva, Vesela P.; Mellott, Tiffany J.; Davison, Jessica M.; Wagner, Nicholas; Lopez-Coviella, Ignacio; Schnitzler, Aletta C.; Blusztajn, Jan K.			Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of dnmt1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; ADENOSYL-L-METHIONINE; CPG-BINDING-PROTEINS; S-ADENOSYLMETHIONINE; FOLATE-DEFICIENCY; HISTONE DEACETYLASE; DIETARY-FOLATE; TISSUE-LEVELS; RAT-LIVER; HYPOMETHYLATION	During gestation there is a high demand for the essential nutrient choline. Adult rats supplemented with choline during embryonic days ( E) 11-17 have improved memory performance and do not exhibit age-related memory decline, whereas prenatally choline-deficient animals have memory deficits. Choline, via betaine, provides methyl groups for the production of S-adenosylmethionine, a substrate of DNA methyltransferases (DNMTs). We describe an apparently adaptive epigenomic response to varied gestational choline supply in rat fetal liver and brain. S-Adenosylmethionine levels increased in both organs of E17 fetuses whose mothers consumed a choline-supplemented diet. Surprisingly, global DNA methylation increased in choline-deficient animals, and this was accompanied by overexpression of Dnmt1 mRNA. Previous studies showed that the prenatal choline supply affects the expression of multiple genes, including insulin-like growth factor 2 (Igf2), whose expression is regulated in aDNA methylation-dependent manner. The differentially methylated region 2 of Igf2 was hypermethylated in the liver of E17 choline-deficient fetuses, and this as well as Igf2 mRNA levels correlated with the expression of Dnmt1 and with hypomethylation of a regulatory CpG within the Dnmt1 locus. Moreover, mRNA expression of brain and liver Dnmt3a and methyl CpG-binding domain 2 (Mbd2) protein as well as cerebral Dnmt3l was inversely correlated to the intake of choline. Thus, choline deficiency modulates fetal DNA methylation machinery in a complex fashion that includes hypomethylation of the regulatory CpGs within the Dnmt1 gene, leading to its overexpression and the resultant increased global and gene- specific ( e. g. Igf2) DNA methylation. These epigenomic responses to gestational choline supply may initiate the long term developmental changes observed in rats exposed to varied choline intake in utero.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Blusztajn, JK (corresponding author), Boston Univ, Sch Med, 715 Albany St,L804, Boston, MA 02118 USA.	jbluszta@bu.edu		/0000-0001-8438-3122; Wagner, Nicholas/0000-0002-4192-4774; Mellott, Tiffany/0000-0003-3287-9374	NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER; NIA NIH HHS [AG009525, P01 AG009525] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AlonsoAperte E, 1996, INT J VITAM NUTR RES, V66, P232; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; BECK F, 1987, DEVELOPMENT, V101, P175; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BHAVE MR, 1988, CARCINOGENESIS, V9, P343, DOI 10.1093/carcin/9.3.343; BIERI JG, 1977, J NUTR, V107, P1394; Bieri JG., 1980, J NUTR, V110, P1726, DOI [10.1093/jn/110.8.1726, DOI 10.1093/JN/110.8.1726]; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BONDY CA, 1990, MOL ENDOCRINOL, V4, P1386, DOI 10.1210/mend-4-9-1386; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Detich N, 2002, J BIOL CHEM, V277, P35791, DOI 10.1074/jbc.C200408200; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Esfandiari F, 2003, CARCINOGENESIS, V24, P1935, DOI 10.1093/carcin/bgg163; FAROOQUI JZ, 1983, BIOCHIM BIOPHYS ACTA, V757, P342; FEIL R, 1994, DEVELOPMENT, V120, P2933; FINKELSTEIN JD, 1983, J NUTR, V113, P519, DOI 10.1093/jn/113.3.519; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GARNER SC, 1995, J NUTR, V125, P2851; GEHRKE CW, 1984, J CHROMATOGR, V301, P199, DOI 10.1016/S0021-9673(01)89189-5; GHARIB A, 1982, J NEUROCHEM, V38, P810, DOI 10.1111/j.1471-4159.1982.tb08702.x; Ghoshal K, 2006, J NUTR, V136, P1522, DOI 10.1093/jn/136.6.1522; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; HOFFMAN DR, 1979, CAN J BIOCHEM CELL B, V57, P56, DOI 10.1139/o79-007; HOFFMAN DR, 1981, CAN J BIOCHEM CELL B, V59, P543, DOI 10.1139/o81-075; Hsu DW, 1999, P NATL ACAD SCI USA, V96, P9751, DOI 10.1073/pnas.96.17.9751; HU JF, 1995, MOL ENDOCRINOL, V9, P628, DOI 10.1210/me.9.5.628; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KIM YI, 1995, AM J CLIN NUTR, V61, P1083, DOI 10.1093/ajcn/61.5.1083; Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Maloney CA, 2007, BRIT J NUTR, V97, P1090, DOI 10.1017/S0007114507670834; McCann JC, 2006, NEUROSCI BIOBEHAV R, V30, P696, DOI 10.1016/j.neubiorev.2005.12.003; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 1997, NEUROREPORT, V8, P2831, DOI 10.1097/00001756-199709080-00005; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mellott TJ, 2007, BRAIN RES, V1151, P1, DOI 10.1016/j.brainres.2007.03.004; Mellott TJ, 2007, FASEB J, V21, P1311, DOI 10.1096/fj.06-6597com; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 2002, J NUTR, V132, p2462S, DOI 10.1093/jn/132.8.2462S; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Pogribny IP, 2004, MUTAT RES-FUND MOL M, V548, P53, DOI 10.1016/j.mrfmmm.2003.12.014; POIRIER LA, 1977, CANCER RES, V37, P744; Pruitt K, 2005, J BIOL CHEM, V280, P23363, DOI 10.1074/jbc.M503083200; Ross SA, 2003, ANN NY ACAD SCI, V983, P197, DOI 10.1111/j.1749-6632.2003.tb05974.x; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; Singal R, 2001, BLOOD, V98, P3441, DOI 10.1182/blood.V98.12.3441; Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x; Sohn KJ, 2003, CARCINOGENESIS, V24, P81, DOI 10.1093/carcin/24.1.81; Song J, 2000, CANCER RES, V60, P3191; STYLIANOPOULOU F, 1988, DEVELOPMENT, V103, P497; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; WAINFAN E, 1989, CANCER RES, V49, P4094; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; WATERLAND RA, 2007, IN PRESS FASEB J; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; WILSON MJ, 1984, BIOCHEM J, V218, P987, DOI 10.1042/bj2180987; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; ZEISEL SH, 1995, J NUTR, V125, P3049; ZEISEL SH, 1989, BIOCHEM J, V259, P725, DOI 10.1042/bj2590725; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	88	160	167	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31777	31788		10.1074/jbc.M705539200	http://dx.doi.org/10.1074/jbc.M705539200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724018	hybrid			2022-12-25	WOS:000250309200068
J	Qi, XM; Pohl, NM; Loesch, M; Hou, SW; Li, RS; Qin, JZ; Cuenda, A; Chen, G				Qi, Xiaomei; Pohl, Nicole M.; Loesch, Mathew; Hou, Songwang; Li, Rongshan; Qin, Jian-Zhong; Cuenda, Ana; Chen, Guan			P38 alpha antagonizes p38 gamma activity through c-jun-dependent ubiquitin-proteasome pathways in regulating ras transformation and stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; VITAMIN-D-RECEPTOR; N-TERMINAL KINASE; MAP KINASE; P38 MAPK; CELL-DEATH; SUSTAINED ACTIVATION; ESTROGEN-RECEPTOR; CANCER CELLS; JNK	p38 MAPK family consists of four isoform proteins (alpha, beta, gamma, and delta) that are activated by the same stimuli, but the information about how these proteins act together to yield a biological response is missing. Here we show a feed-forward mechanism by which p38 alpha may regulate Ras transformation and stress response through depleting its family member p38 gamma protein via c-Jun-dependent ubiquitin-proteasome pathways. Analyses of MAPK kinase 6 (MKK6)-p38 fusion proteins showed that constitutively active p38 alpha (MKK6-p38 alpha) and p38 gamma (MKK6-p38 gamma) stimulates and inhibits c-Jun phosphorylation respectively, leading to a distinct AP-1 regulation. Depending on cell type and/or stimuli, p38 alpha phosphorylation results in either Rastransformation inhibition or a cell-death escalation that invariably couples with a decrease in p38 gamma protein expression. p38 gamma, on the other hand, increases Ras-dependent growth or inhibits stress induced cell-death independent of phosphorylation. In cells expressing both proteins, p38 alpha phosphorylation decreases p38 gamma protein expression, whereas its inhibition increases cellular p38 gamma concentrations, indicating an active role of p38 gamma phosphorylation in negatively regulating p38 gamma protein expression. Mechanistic analyses show that p38 alpha requires c-Jun activation to deplete p38 gamma proteins by ubiquitin-proteasome pathways. These results suggest that p38 alpha may, upon phosphorylation, act as a gatekeeper of the p38 MAPK family to yield a coordinative biological response through disrupting its antagonistic p38 gamma family protein.	Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; Loyola Univ, Ctr Canc, Dept Pathol, Maywood, IL 60153 USA; Univ Dundee, MRC, Protein Phosphorlat Unit, Dundee DD1 5EH, Scotland	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Loyola University Chicago; University of Dundee	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gchen@mcw.edu			Medical Research Council [MC_U127015387] Funding Source: Medline; NCI NIH HHS [2R01 CA91576] Funding Source: Medline; MRC [MC_U127015387] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA091576] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn KS, 2006, J BIOL CHEM, V281, P19798, DOI 10.1074/jbc.M601162200; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jehan F, 1997, P NATL ACAD SCI USA, V94, P10138, DOI 10.1073/pnas.94.19.10138; Johnson R, 1996, MOL CELL BIOL, V16, P4504; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; LAINE A, 2005, SCI STKE, P1; Li QP, 2007, J BIOL CHEM, V282, P1544, DOI 10.1074/jbc.M604052200; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Rennefahrt UEE, 2002, J BIOL CHEM, V277, P29510, DOI 10.1074/jbc.M203010200; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Shi GX, 2005, J BIOL CHEM, V280, P37599, DOI 10.1074/jbc.M507364200; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Tosti E, 2004, J BIOL CHEM, V279, P47652, DOI 10.1074/jbc.M409961200; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Whitmarsh AJ, 2000, NATURE, V403, P255, DOI 10.1038/35002220; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	55	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31398	31408		10.1074/jbc.M703857200	http://dx.doi.org/10.1074/jbc.M703857200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724032	hybrid			2022-12-25	WOS:000250309200030
J	Marques, B; Liguori, L; Paclet, MH; Villegas-Mendez, A; Rothe, R; Morel, F; Lenormand, JL				Marques, Bruno; Liguori, Lavinia; Paclet, Marie-Helene; Villegas-Mendez, Ana; Rothe, Romy; Morel, Francoise; Lenormand, Jean-Luc			Liposome-Mediated Cellular Delivery of Active gp91(phox)	PLOS ONE			English	Article								Background. Gp91(phox) is a transmembrane protein and the catalytic core of the NADPH oxidase complex of neutrophils. Lack of this protein causes chronic granulomatous disease (CGD), a rare genetic disorder characterized by severe and recurrent infections due to the incapacity of phagocytes to kill microorganisms. Methodology. Here we optimize a prokaryotic cell-free expression system to produce integral mammalian membrane proteins. Conclusions. Using this system, we over-express truncated forms of the gp91(phox) protein under soluble form in the presence of detergents or lipids resulting in active proteins with a "native-like'' conformation. All the proteins exhibit diaphorase activity in the presence of cytosolic factors (p67(phox), p47(phox), p40(phox) and Rac) and arachidonic acid. We also produce proteoliposomes containing gp91(phox) protein and demonstrate that these proteins exhibit activities similar to their cellular counterpart. The proteoliposomes induce rapid cellular delivery and relocation of recombinant gp91(phox) proteins to the plasma membrane. Our data support the concept of cell-free expression technology for producing recombinant proteoliposomes and their use for functional and structural studies or protein therapy by complementing deficient cells in gp91(phox) protein.	[Marques, Bruno; Liguori, Lavinia; Villegas-Mendez, Ana; Rothe, Romy; Lenormand, Jean-Luc] Univ Grenoble 1, Lab Enzymol DBPC, Ctr Hosp Univ Grenoble, CNRS,Ctr Hosp Univ,HumProTher,UMR 5525, Grenoble, France; [Paclet, Marie-Helene; Morel, Francoise] Univ Grenoble 1, Lab Enzymol DBPC, Ctr Hosp Univ Grenoble, CNRS,Ctr Hosp Univ,GREPI,TIMC Imag,UMR 5525, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Lenormand, JL (corresponding author), Univ Grenoble 1, Lab Enzymol DBPC, Ctr Hosp Univ Grenoble, CNRS,Ctr Hosp Univ,HumProTher,UMR 5525, BP 217, Grenoble, France.	JLLenormand@chu-grenoble.fr	Lenormand, Jean-Luc/M-6644-2014; Lenormand, Jean-Luc/ABF-3850-2021; Paclet, Marie-Hélène/AAS-5029-2020	villegas-mendez, ana/0000-0002-8363-680X; Lenormand, Jean-Luc/0000-0002-2766-9180				Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; BEDARD K, 2007, NOX FAMILY NADPH OXI; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Berthier S, 2003, J BIOL CHEM, V278, P25499, DOI 10.1074/jbc.M209755200; Boeckle S, 2006, AAPS J, V8, pE731, DOI 10.1208/aapsj080483; CAMPION Y, 2007, BIOCHIMIE; CROSS AR, 1994, J BIOL CHEM, V269, P21448; Cusi MG, 2004, VACCINE, V22, P735, DOI 10.1016/j.vaccine.2003.08.024; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Kim A, 1999, INT J PHARM, V180, P75, DOI 10.1016/S0378-5173(98)00408-6; KLAMMT C, 2007, J STRUCT BIOL; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; KOSHKIN V, 1993, FEBS LETT, V327, P57, DOI 10.1016/0014-5793(93)81039-3; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Liguori L, 2007, EXPERT REV PROTEOMIC, V4, P79, DOI 10.1586/14789450.4.1.79; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mizrahi A, 2006, J LEUKOCYTE BIOL, V79, P881, DOI 10.1189/jlb.1005553; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Niegowski D, 2006, INT J BIOL MACROMOL, V39, P83, DOI 10.1016/j.ijbiomac.2006.02.011; Nisimoto Y, 2004, BIOCHEMISTRY-US, V43, P9567, DOI 10.1021/bi0400249; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; PACLET MH, 2007, FASEB J; Park JW, 2001, J CONTROL RELEASE, V74, P95, DOI 10.1016/S0168-3659(01)00315-7; Pessach I, 2006, J LEUKOCYTE BIOL, V80, P630, DOI 10.1189/jlb.1105684; Poinas A, 2002, EUR J BIOCHEM, V269, P1243, DOI 10.1046/j.1432-1033.2002.02764.x; Rentsendorj A, 2006, GENE THER, V13, P821, DOI 10.1038/sj.gt.3302729; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; ROTROSEN D, 1993, J BIOL CHEM, V268, P14256; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Taylor RM, 2006, J BIOL CHEM, V281, P37045, DOI 10.1074/jbc.M607354200; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; WASAN KM, 2006, J PHARM SCI; ZHU Y, 2006, J BIOL CHEM	45	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e856	10.1371/journal.pone.0000856	http://dx.doi.org/10.1371/journal.pone.0000856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848987	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600003
J	Gillingham, AK; Munro, S				Gillingham, Alison K.; Munro, Sean			Identification of a Guanine Nucleotide Exchange Factor for Arf3, the Yeast Orthologue of Mammalian Arf6	PLOS ONE			English	Article								Small G proteins of the Arf and Rab families are fundamental to the organisation and activity of intracellular membranes. One of the most well characterised of these G proteins is mammalian Arf6, a protein that participates in many cellular processes including endocytosis, actin remodelling and cell adhesion. Exchange of GDP for GTP on Arf6 is performed by a variety of guanine nucleotide exchange factors (GEFs), principally of the cytohesin (PSCD) and EFA6 (PSD) families. In this paper we describe the characterisation of a GEF for the yeast orthologue of Arf6, Arf3, which we have named Yel1 (yeast EFA6-like-1) using yeast genetics, fluorescence microscopy and in vitro nucleotide exchange assays. Yel1 appears structurally related to the EFA6 family of GEFs, having an N-terminal Sec7 domain and C-terminal PH and coiled-coil domains. We find that Yel1 is constitutively targeted to regions of polarised growth in yeast, where it co-localises with Arf3. Moreover the Sec7 domain of Yel1 is required for its membrane targeting and for that of Arf3. Finally we show that the isolated Yel1 Sec7 domain strongly stimulates nucleotide exchange activity specifically on Arf3 in vitro.	[Gillingham, Alison K.; Munro, Sean] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Gillingham, AK (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ag@mrc-lmb.cam.ac.uk		Munro, Sean/0000-0001-6160-5773	U. K. Medical Research Council; MRC [MC_U105178783] Funding Source: UKRI; Medical Research Council [MC_U105178783] Funding Source: researchfish	U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the U. K. Medical Research Council.	ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Beraud-Dufour S, 2001, METHOD ENZYMOL, V329, P264; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Costa R, 2005, BIOCHEM SOC T, V33, P1273, DOI 10.1042/BST0331273; Costa R, 2005, BIOCHEM J, V387, P649, DOI 10.1042/BJ20041729; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; GILLINGHAM AK, 2007, ANN REV CEL IN PRESS; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Huang CF, 1999, J BIOL CHEM, V274, P3819, DOI 10.1074/jbc.274.6.3819; Huang CF, 2003, MOL BIOL CELL, V14, P3834, DOI 10.1091/mbc.E03-01-0013; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Jones S, 1999, GENETICS, V152, P1543; KAHN RA, 2004, ARF FAMILY GTPASES, V1; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; LAMBERT AA, 2007, FEMS YEAST RES; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Nickel W, 1998, J CELL SCI, V111, P3081; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zakrzewska E, 2003, GENETICS, V165, P985	40	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e842	10.1371/journal.pone.0000842	http://dx.doi.org/10.1371/journal.pone.0000842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786213	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500025
J	Chandriani, S; Ganem, D				Chandriani, Sanjay; Ganem, Don			Host Transcript Accumulation during Lytic KSHV Infection Reveals Several Classes of Host Responses	PLOS ONE			English	Article								Lytic infection by Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with an extensive shutoff of host gene expression, mediated chiefly by accelerated mRNA turnover due to expression of the viral SOX protein. We have previously identified a small number of host mRNAs that can escape SOX-mediated degradation. Here we present a detailed, transcriptome-wide analysis of host shutoff, with careful microarray normalization to allow rigorous determination of the magnitude and extent of transcript loss. We find that the extent of transcript reduction represents a continuum of susceptibilities of transcripts to virus-mediated shutoff. Our results affirm that the levels of over 75% of host transcripts are substantially reduced during lytic infection, but also show that another similar to 20% of cellular mRNAs declines only slightly (less than 2-fold) during the course of infection. Approximately 2% of examined cellular genes are strongly upregulated during lytic infection, most likely due to transcriptional induction of mRNAs that display intrinsic SOX-resistance.	[Chandriani, Sanjay; Ganem, Don] Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ganem, D (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu		Chandriani, Sanjay/0000-0002-8680-7424	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	All work was funded by the Howard Hughes Medical Institute.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; GANEM D, 2007, FIELDS VIROLOGY, P2847; Glaunsinger B, 2004, J EXP MED, V200, P391, DOI 10.1084/jem.20031881; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kirshner JR, 2000, J VIROL, V74, P3586, DOI 10.1128/JVI.74.8.3586-3597.2000; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Nicholas J, 2005, J INTERF CYTOK RES, V25, P373, DOI 10.1089/jir.2005.25.373; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Renne R, 1996, J VIROL, V70, P8151, DOI 10.1128/JVI.70.11.8151-8154.1996; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sarid R, 1999, J VIROL, V73, P1438, DOI 10.1128/JVI.73.2.1438-1446.1999; Schulz TF, 1999, ADV CANCER RES, V76, P121, DOI 10.1016/S0065-230X(08)60775-7; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; Sturzl M, 1997, INT J CANCER, V72, P68, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;68::AID-IJC10&gt;3.0.CO;2-6; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wang SZE, 2003, J VIROL, V77, P9590, DOI 10.1128/JVI.77.17.9590-9612.2003; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	46	37	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e811	10.1371/journal.pone.0000811	http://dx.doi.org/10.1371/journal.pone.0000811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726541	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455400028
J	Tanimura, S; Hirano, AI; Hashizume, J; Yasunaga, M; Kawabata, T; Ozaki, KI; Kohno, M				Tanimura, Susumu; Hirano, A-i; Hashizume, Junya; Yasunaga, Masahiro; Kawabata, Takumi; Ozaki, Kei-ichi; Kohno, Michiaki			Anticancer drugs up-regulate HspBP1 and thereby antagonize the prosurvival function of hsp70 in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; KINASE SIGNALING PATHWAY; MOLECULAR CHAPERONES; COCHAPERONE HSPBP1; APOPTOSIS; HEAT-SHOCK-PROTEIN-70; LYSOSOMES; STRESS; CANCER; EXPRESSION	The 70-kDa heat shock protein (Hsp70) is up-regulated in a wide variety of tumor cell types and contributes to the resistance of these cells to the induction of cell death by anticancer drugs. Hsp70 binding protein 1 (HspBP1) modulates the activity of Hsp70 but its biological significance has remained unclear. We have now examined whether HspBP1 might interfere with the prosurvival function of Hsp70, which is mediated, at least in part, by inhibition of the death-associated permeabilization of lysosomal membranes. HspBP1 was found to be expressed at a higher level than Hsp70 in all normal and tumor cell types examined. Tumor cells with a high HspBP1/Hsp70 molar ratio were more susceptible to anticancer drugs than were those with a low ratio. Ectopic expression of HspBP1 enhanced this effect of anticancer drugs in a manner that was both dependent on the ability of HspBP1 to bind to Hsp70 and sensitive to the induction of Hsp70 by mild heat shock. Furthermore, anticancer drugs up-regulated HspBP1 expression, whereas prevention of such up-regulation by RNA interference reduced the susceptibility of tumor cells to anticancer drugs. Overexpression of HspBP1 promoted the permeabilization of lysosomal membranes, the release of cathepsins from lysosomes into the cytosol, and the activation of caspase-3 induced by anticancer drugs. These results suggest that HspBP1, by antagonizing the prosurvival activity of Hsp70, sensitizes tumor cells to cathepsin-mediated cell death.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Lab Cell Regulat, Nagasaki 8528521, Japan	Nagasaki University	Kohno, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Lab Cell Regulat, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kohnom@nagasaki-u.ac.jp	Kohno, Michiaki/R-6532-2019	Kohno, Michiaki/0000-0002-7644-0059				Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fujiwara Y, 2007, MOL CANCER THER, V6, P1133, DOI 10.1158/1535-7163.MCT-06-0639; Gabai VL, 2002, MOL CELL BIOL, V22, P3415, DOI 10.1128/MCB.22.10.3415-3424.2002; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gottwald E, 2006, CELL BIOL INT, V30, P553, DOI 10.1016/j.cellbi.2006.03.005; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Gurbuxani S, 2001, ONCOGENE, V20, P7478, DOI 10.1038/sj.onc.1204948; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Hoshino R, 2001, J BIOL CHEM, V276, P2686, DOI 10.1074/jbc.M006132200; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Raynes DA, 2003, TUMOR BIOL, V24, P281, DOI 10.1159/000076459; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Tanimura S, 2002, J BIOL CHEM, V277, P28256, DOI 10.1074/jbc.M202866200; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	37	27	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35430	35439		10.1074/jbc.M707547200	http://dx.doi.org/10.1074/jbc.M707547200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17855353	hybrid			2022-12-25	WOS:000251458100002
J	Brock, C; Oueslati, N; Soler, S; Boudier, L; Rondard, P; Pin, JP				Brock, Carsten; Oueslati, Nadia; Soler, Stephan; Boudier, Laure; Rondard, Philippe; Pin, Jean-Philippe			Activation of a dimeric metabotropic glutamate receptor by intersubunit rearrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; POSITIVE ALLOSTERIC MODULATORS; GABA(B) RECEPTOR; ERYTHROPOIETIN RECEPTOR; HEPTAHELICAL DOMAIN; BINDING DOMAINS; CLASS-A; RHODOPSIN; MECHANISM; DIMERIZATION	Although many G protein-coupled receptors (GPCRs) can form dimers, a possible role of this phenomenon in their activation remains elusive. A recent and exciting proposal is that a dynamic intersubunit interplay may contribute to GPCR activation. Here, we examined this possibility using dimeric metabotropic glutamate receptors (mGluRs). We first developed a system to perfectly control their subunit composition and show that mGluR dimers do not form larger oligomers. We then examined an mGluR dimer containing one subunit in which the extracellular agonist-binding domain was uncoupled from the G protein-activating transmembrane domain. Despite this uncoupling in one protomer, agonist stimulation resulted in symmetric activation of either transmembrane domain in the dimer with the same efficiency. This, plus other data, can only be explained by an intersubunit rearrangement as the activation mechanism. Although well established for other types of receptors such as tyrosine kinase and guanylate cyclase receptors, this is the first clear demonstration that such a mechanism may also apply to GPCRs.	Univ Montpellier 1 & 2, CNRS, Inst Funct Genom, UMR5203, F-34094 Montpellier, France; CNRS, INSERM, U661, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Pin, JP (corresponding author), Univ Montpellier 1 & 2, CNRS, Inst Funct Genom, UMR5203, 141 Rue Cardonille, F-34094 Montpellier, France.	jppin@igf.cnrs.fr	Pin, Jean-Philippe/Y-6668-2019; Rondard, Philippe/N-9720-2018	Pin, Jean-Philippe/0000-0002-1423-345X; RONDARD, Philippe/0000-0003-1134-2738				Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bessis AS, 2002, P NATL ACAD SCI USA, V99, P11097, DOI 10.1073/pnas.162138699; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Calver AR, 2001, J NEUROSCI, V21, P1203; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Jeoung M, 2007, MOL CELL ENDOCRINOL, V260, P137, DOI 10.1016/j.mce.2005.09.015; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Kubo Y, 2005, CURR OPIN NEUROBIOL, V15, P289, DOI 10.1016/j.conb.2005.05.011; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Pagano A, 2001, J NEUROSCI, V21, P1189; Parnot C, 2004, NAT STRUCT MOL BIOL, V11, P691, DOI 10.1038/nsmb0804-691; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Pin JP, 1999, EUR J PHARMACOL, V375, P277, DOI 10.1016/S0014-2999(99)00258-7; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Rondard P, 2006, J BIOL CHEM, V281, P24653, DOI 10.1074/jbc.M602277200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; van den Akker F, 2001, J MOL BIOL, V311, P923, DOI 10.1006/jmbi.2001.4922; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	47	86	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33000	33008		10.1074/jbc.M702542200	http://dx.doi.org/10.1074/jbc.M702542200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855348	hybrid, Green Submitted			2022-12-25	WOS:000250625400049
J	Bussen, W; Raynard, S; Busygina, V; Singh, AK; Sung, P				Bussen, Wendy; Raynard, Steven; Busygina, Valeria; Singh, Akhilesh K.; Sung, Patrick			Holliday junction processing activity of the BLM-topo III alpha-BLAP75 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; BLOOMS-SYNDROME HELICASE; SYNDROME GENE-PRODUCT; DAMAGED REPLICATION FORKS; TOPOISOMERASE-III-ALPHA; HOMOLOGOUS RECOMBINATION; DNA HELICASE; RECQ HELICASES; CHROMOSOMAL TRANSLOCATIONS; SYNDROME PROTEINS	BLM, the protein mutated in Bloom's syndrome, possesses a helicase activity that can dissociate DNA structures, including the Holliday junction, expected to arise during homologous recombination. BLM is stably associated with topoisomerase III alpha (Topo III alpha) and the BLAP75 protein. The BLM-Topo III alpha-BLAP75 (BTB) complex can efficiently resolve a DNA substrate that harbors two Holliday junctions (the double Holliday junction) in a non-crossover manner. Here we show that the Holliday junction unwinding activity of BLM is greatly enhanced as a result of its association with Topo III alpha and BLAP75. Enhancement of this BLM activity requires both Topo III alpha and BLAP75. Importantly, Topo III alpha cannot be substituted by Escherichia coli Top3, and the Holliday junction unwinding activity of BLM-related helicases WRN and RecQ is likewise impervious to Topo III alpha and BLAP75. However, the topoisomerase activity of Topo III alpha is dispensable for the enhancement of the DNA unwinding reaction. We have also ascertained the requirement for the BLM ATPase activity in double Holliday junction dissolution and DNA unwinding by constructing, purifying, and characterizing specific mutant variants that lack this activity. These results provide valuable information concerning how the functional integrity of the BTB complex is governed by specific protein-protein interactions among the components of this complex and the enzymatic activities of BLM and Topo III alpha.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,C130 Sterling Hall Med, New Haven, CT 06520 USA.	Patrick.Sung@yale.edu			NATIONAL CANCER INSTITUTE [R01CA110415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES015252] Funding Source: NIH RePORTER; NCI NIH HHS [CA110415] Funding Source: Medline; NIEHS NIH HHS [ES015632, ES015252] Funding Source: Medline; NIGMS NIH HHS [T32 GM08735] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; GERMAN J, 1974, CHROMOSOMA, V48, P361, DOI 10.1007/BF00290993; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lo YC, 2006, MOL CELL BIOL, V26, P4086, DOI 10.1128/MCB.00136-06; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Mankouri HW, 2004, BIOCHEM SOC T, V32, P957, DOI 10.1042/BST0320957; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Miyajima A, 2000, MOL CELL BIOL, V20, P6399, DOI 10.1128/MCB.20.17.6399-6409.2000; Miyajima A, 2000, GENES GENET SYST, V75, P319, DOI 10.1266/ggs.75.319; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Mullen JR, 2000, GENETICS, V154, P1101; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Popescu NC, 2003, CANCER LETT, V192, P1, DOI 10.1016/S0304-3835(02)00596-7; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	51	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31484	31492		10.1074/jbc.M706116200	http://dx.doi.org/10.1074/jbc.M706116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728255	hybrid			2022-12-25	WOS:000250309200040
J	Choi, HS; Carman, GM				Choi, Hyeon-Son; Carman, George M.			Respiratory deficiency mediates the regulation of CHO1-encoded phosphatidylserine synthase by mRNA stability in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; DEPENDENT PROTEIN-KINASE; PHOSPHOLIPID BIOSYNTHESIS; COORDINATE REGULATION; CARDIOLIPIN BIOSYNTHESIS; ETHANOLAMINE KINASE; GENETIC-REGULATION; SHUTTLE VECTORS; GROWTH-PHASE; CYTOCHROME-C	The CHO1-encoded phosphatidylserine synthase (CDP-diacylglycerol: L-serine O-phosphatidyltransferase, EC 2.7.8.8) is one of the most highly regulated phospholipid biosynthetic enzymes in the yeast Saccharomyces cerevisiae. CHO1 expression is regulated by nutrient availability through a regulatory circuit involving a UAS(INO) cis-acting element in the CHO1 promoter, the positive transcription factors Ino2p and Ino4p, and the transcriptional repressor Opi1p. In this work, we examined the post-transcriptional regulation of CHO1 by mRNA stability. CHO1 mRNA was stabilized in mutants defective in deadenylation (ccr4 Delta), mRNA decapping (dcp1), and the 5(')-3(')-exonuclease (xrn1), indicating that the CHO1 transcript is primarily degraded through the general 5(')-3(') mRNA decay pathway. In respiratory-sufficient cells, the CHO1 transcript was moderately stable with a half-life of 12 min. However, the CHO1 transcript was stabilized to a half-life of >45 min in respiratory-deficient (rho-and rho(o)) cells, the cox4 Delta mutant defective in the cytochrome c oxidase, and wild type cells treated with KCN(acytochrome coxidase inhibitor). The increased CHO1 mRNA stability in response to respiratory deficiency caused increases in CHO1 mRNA abundance, phosphatidylserine synthase protein and activity, and the synthesis of phosphatidylserine in vivo. Respiratory deficiency also caused increases in the activities of CDP-diacylglycerol synthase, phosphatidylserine decarboxylase, and the phospholipid methyltransferases. Phosphatidylinositol synthase and choline kinase activities were not affected by respiratory deficiency. This work advances our understanding of phosphatidylserine synthase regulation and underscores the importance of mitochondrial respiration to the regulation of phospholipid synthesis in S. cerevisiae.	Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM050679, GM-50679, R01 GM050679-14] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADOLPHUS, 1983, EMBO J, V2, P1765, DOI 10.1002/j.1460-2075.1983.tb01655.x; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; AUSUBEL FM, 1993, CURRENT PROTOLS MOL; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; CARMAN GM, 1992, METHOD ENZYMOL, V209, P242; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Cause G F, 1970, Experientia, V26, P209; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Choi HS, 2004, J BIOL CHEM, V279, P12081, DOI 10.1074/jbc.M400297200; CULBERTSON MR, 1975, GENETICS, V80, P23; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Elabbadi N, 1997, BIOCHEM J, V324, P435, DOI 10.1042/bj3240435; GARETT RH, 1999, BIOCHEMISTRY; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1988, MOL CELL BIOL, V8, P4773, DOI 10.1128/MCB.8.11.4773; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Henry S. A., 1982, MOL BIOL YEAST SACCH, P101; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HROMY JM, 1986, J BIOL CHEM, V261, P5572; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; JAMIESON DJ, 1994, MICROBIOL-UK, V140, P3277, DOI 10.1099/13500872-140-12-3277; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678, DOI 10.1128/JB.174.20.6678-6681.1992; Kaiser C., 1994, METHODS YEAST GENETI; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kersting MC, 2004, J BIOL CHEM, V279, P35353, DOI 10.1074/jbc.M405704200; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KINNEY AJ, 1990, J BACTERIOL, V172, P1133, DOI 10.1128/jb.172.2.1133-1136.1990; KIYONO K, 1987, J BIOCHEM-TOKYO, V102, P1089, DOI 10.1093/oxfordjournals.jbchem.a122147; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; LAMPING E, 1994, GENETICS, V137, P55; LAMPING E, 1991, J BACTERIOL, V173, P6432, DOI 10.1128/jb.173.20.6432-6437.1991; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; MESKAUSKAS A, 1985, FEBS LETT, V182, P413, DOI 10.1016/0014-5793(85)80344-6; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; MORASH SC, 1994, J BIOL CHEM, V269, P28769; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; NIKAWA J, 1987, EUR J BIOCHEM, V167, P7, DOI 10.1111/j.1432-1033.1987.tb13297.x; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; PORTER TJ, 1992, METHOD ENZYMOL, V209, P134; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SIKORSKI RS, 1989, GENETICS, V122, P19; Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; Vemula M, 2003, J BIOL CHEM, V278, P45269, DOI 10.1074/jbc.M308812200; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Yamashita S, 1997, BBA-LIPID LIPID MET, V1348, P228, DOI 10.1016/S0005-2760(97)00102-1; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	100	6	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31217	31227		10.1074/jbc.M705098200	http://dx.doi.org/10.1074/jbc.M705098200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761681	hybrid, Green Accepted			2022-12-25	WOS:000250309200011
J	Zaccagnini, G; Martelli, F; Magenta, A; Cencioni, C; Fasanaro, P; Nicoletti, C; Biglioli, P; Pelicci, PG; Capogrossi, MC				Zaccagnini, Germana; Martelli, Fabio; Magenta, Alessandra; Cencioni, Chiara; Fasanaro, Pasquale; Nicoletti, Carmine; Biglioli, Paolo; Pelicci, Pier Giuseppe; Capogrossi, Maurizio C.			P66(ShcA) and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; SIGNALING PATHWAY; GENE PROTECTS; NITRIC-OXIDE; MOUSE MODEL; STEM-CELLS; DELETION; PROLIFERATION; ACTIVATION; EXPRESSION	Oxidative stress plays a pivotal role in ischemic injury, and p66(ShcA)ko mice exhibit both lower oxidative stress and decreased tissue damage following hind limb ischemia. Thus, it was investigated whether tissue regeneration following acute hind limb ischemia was altered in p66(ShcA)ko mice. Upon femoral artery dissection, muscle regeneration started earlier and was completed faster than in wild-type (WT) control. Moreover, faster regeneration was associated with decreased oxidative stress. Unlike ischemia, cardiotoxin injury induced similar skeletal muscle damage in both genotypes. However, p66(ShcA)ko mice regenerated faster, in agreement with the regenerative advantage upon ischemia. Since no difference between p66(ShcA)wt and knock-out (ko) mice was found in blood perfusion recovery after ischemia, satellite cells (SCs), a resident population of myogenic progenitors, were examined. Similar SCs numbers were present in WT and ko mice. However, in vitro cultured p66(ShcA)ko SCs displayed lower oxidative stress levels and higher proliferation rate and differentiated faster than WT. Furthermore, when exposed to sublethal H2O2 doses, p66(ShcA)ko SCs were resistant to H2O2-induced inhibition of differentiation. Finally, myogenic conversion induced by MyoD overexpression was more efficient in p66(ShcA)ko fibroblasts compared with WT. The present work demonstrates that oxidative stress and p66(ShcA) play a crucial role in the regenerative pathways activated by acute ischemia.	Ist Dermopatico Immacol, IRSS, Lab Patol Vasc, I-00167 Rome, Italy; Ctr Cardiol, Lab Biol Vascolare, Milan 20138, Italy; Ctr Cardiol, Inst Ricovero & Cura Carattere Sci, Dipartimento Chirurgia Vascolare, Milan 20138, Italy; Univ Roma La Sapienza, Dipartimento Istol & Embriol Med, Rome 00185, Italy; Ist Europeo Oncol, Milan 20141, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome; IRCCS European Institute of Oncology (IEO)	Martelli, F (corresponding author), Ist Dermopatico Immacol, IRSS, Lab Patol Vasc, Via dei Monti Creta 104, I-00167 Rome, Italy.	f.martelli@idi.it	Zaccagnini, Germana/J-7722-2016; Martelli, Fabio/AAL-3788-2020; Cencioni, Chiara/I-8490-2018; Pelicci, Pier Giuseppe/AAL-6572-2020; magenta, alessandra/A-9473-2017; Franzeck, Fabian C/B-5055-2011	Zaccagnini, Germana/0000-0002-9441-4735; Martelli, Fabio/0000-0002-8624-7738; Cencioni, Chiara/0000-0001-6284-539X; magenta, alessandra/0000-0002-9054-337X; NICOLETTI, Carmine/0000-0001-5896-2040				Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Graiani G, 2005, HYPERTENSION, V46, P433, DOI 10.1161/01.HYP.0000174986.73346.ba; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Martelli F, 1999, P NATL ACAD SCI USA, V96, P2858, DOI 10.1073/pnas.96.6.2858; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Natalicchio A, 2004, J BIOL CHEM, V279, P43900, DOI 10.1074/jbc.M403936200; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Turrini P, 2002, NEUROSCI LETT, V323, P109, DOI 10.1016/S0304-3940(02)00090-3; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Yagi K, 1998, Methods Mol Biol, V108, P107; Yamamori T, 2005, J MOL CELL CARDIOL, V39, P992, DOI 10.1016/j.yjmcc.2005.09.003; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046	51	62	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31453	31459		10.1074/jbc.M702511200	http://dx.doi.org/10.1074/jbc.M702511200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726026	hybrid			2022-12-25	WOS:000250309200036
J	Coulibaly, MB; Lobo, NF; Fitzpatrick, MC; Kern, M; Grushko, O; Thaner, DV; Traore, SF; Collins, FH; Besansky, NJ				Coulibaly, Mamadou B.; Lobo, Neil F.; Fitzpatrick, Meagan C.; Kern, Marcia; Grushko, Olga; Thaner, Daniel V.; Traore, Sekou F.; Collins, Frank H.; Besansky, Nora J.			Segmental Duplication Implicated in the Genesis of Inversion 2Rj of Anopheles gambiae	PLOS ONE			English	Article								The malaria vector Anopheles gambiae maintains high levels of inversion polymorphism that facilitate its exploitation of diverse ecological settings across tropical Africa. Molecular characterization of inversion breakpoints is a first step toward understanding the processes that generate and maintain inversions. Here we focused on inversion 2Rj because of its association with the assortatively mating Bamako chromosomal form of An. gambiae, whose distinctive breeding sites are rock pools beside the Niger River in Mali and Guinea. Sequence and computational analysis of 2Rj revealed the same 14.6 kb insertion between both breakpoints, which occurred near but not within predicted genes. Each insertion consists of 5.3 kb terminal inverted repeat arms separated by a 4 kb spacer. The insertions lack coding capacity, and are comprised of degraded remnants of repetitive sequences including class I and II transposable elements. Because of their large size and patchwork composition, and as no other instances of these insertions were identified in the An. gambiae genome, they do not appear to be transposable elements. The 14.6 kb modules inserted at both 2Rj breakpoint junctions represent low copy repeats (LCRs, also called segmental duplications) that are strongly implicated in the recent (similar to 0.4N(e) generations) origin of 2Rj. The LCRs contribute to further genome instability, as demonstrated by an imprecise excision event at the proximal breakpoint of 2Rj in field isolates.	[Coulibaly, Mamadou B.; Lobo, Neil F.; Fitzpatrick, Meagan C.; Kern, Marcia; Grushko, Olga; Thaner, Daniel V.; Collins, Frank H.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA; [Coulibaly, Mamadou B.; Traore, Sekou F.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali	University of Notre Dame; University of Bamako	Besansky, NJ (corresponding author), Univ Notre Dame, Dept Biol Sci, Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA.	nbesansk@nd.edu	Coulibaly, Mamadou/AAE-7006-2019; Fitzpatrick, Meagan C/K-5083-2012	Fitzpatrick, Meagan C/0000-0002-5248-2668	UNDP/World Bank/WHO [A30272]; National Institutes of Health [U01 AI48846, R01 AI48842, R01 AI63508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI048846, R01AI063508, R01AI048842] Funding Source: NIH RePORTER	UNDP/World Bank/WHO(World Health Organization); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation received financial support from the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (A30272 to NJB), and from the National Institutes of Health (U01 AI48846 to FHC). NJB was supported by NIH R01 AI48842 and R01 AI63508.	Achaz G, 2001, MOL BIOL EVOL, V18, P2280, DOI 10.1093/oxfordjournals.molbev.a003774; Andolfatto P, 1999, GENETICS, V153, P1297; Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bingham PM, 1989, MOBILE DNA, P485; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Caceres M, 2001, GENOME RES, V11, P1353, DOI 10.1101/gr.174001; CIRERA S, 1995, GENETICS, V139, P321; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Dobzhansky T., 1937; EGNER C, 1981, P NATL ACAD SCI-BIOL, V78, P459, DOI 10.1073/pnas.78.1.459; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Hong YS, 2003, MOL GENET GENOMICS, V268, P720, DOI 10.1007/s00438-003-0813-7; Hua-Van A, 2002, MOL GENET GENOMICS, V267, P79, DOI 10.1007/s00438-002-0638-9; KIDWELL MG, 2002, MOBILE DNA, V2; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Krzywinski J, 2004, GENETICS, V166, P1291, DOI 10.1534/genetics.166.3.1291; Kumar V., 1997, The molecular biology of insect disease vectors: a methods manual., P337; Lobachev KS, 1998, GENETICS, V148, P1507; Mathiopoulos KD, 1998, P NATL ACAD SCI USA, V95, P12444, DOI 10.1073/pnas.95.21.12444; Matzkin LM, 2005, GENETICS, V170, P1143, DOI 10.1534/genetics.104.038810; Mukabayire O, 1996, CHROMOSOMA, V104, P585, DOI 10.1007/BF00352298; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; POTTER S, 1980, CELL, V20, P639, DOI 10.1016/0092-8674(80)90310-4; Powell J. R., 1997, PROGR PROSPECTS EVOL; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Smit A, 1996, REPEATMASKER OPEN 30; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; Torre A. della, 1997, The molecular biology of insect disease vectors: a methods manual., P329; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Wang Y, 2006, FEBS LETT, V580, P1277, DOI 10.1016/j.febslet.2006.01.045; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; WESLEY CS, 1994, P NATL ACAD SCI USA, V91, P3132, DOI 10.1073/pnas.91.8.3132; Wessler SR, 2006, IMPLICIT GENOME, P138	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e849	10.1371/journal.pone.0000849	http://dx.doi.org/10.1371/journal.pone.0000849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786220	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500032
J	Saul, A; Fay, MP				Saul, Allan; Fay, Michael P.			Human Immunity and the Design of Multi-Component, Single Target Vaccines	PLOS ONE			English	Article								Background. Inclusion of multiple immunogens to target a single organism is a strategy being pursued for many experimental vaccines, especially where it is difficult to generate a strongly protective response from a single immunogen. Although there are many human vaccines that contain multiple defined immunogens, in almost every case each component targets a different pathogen. As a consequence, there is little practical experience for deciding where the increased complexity of vaccines with multiple defined immunogens vaccines targeting single pathogens will be justifiable. Methodology/Principal Findings. A mathematical model, with immunogenicity parameters derived from a database of human responses to established vaccines, was used to predict the increase in the efficacy and the proportion of the population protected resulting from addition of further immunogens. The gains depended on the relative protection and the range of responses in the population to each immunogen and also to the correlation of the responses between immunogens. In most scenarios modeled, the gain in overall efficacy obtained by adding more immunogens was comparable to gains obtained from a single immunogen through the use of better formulations or adjuvants. Multi-component single target vaccines were more effective at decreasing the proportion of poor responders than increasing the overall efficacy of the vaccine in a population. Conclusions/Significance. Inclusion of limited number of antigens in a vaccine aimed at targeting a single organism will increase efficacy, but the gains are relatively modest and for a practical vaccine there are constraints that are likely to limit multi-component single target vaccines to a small number of key antigens. The model predicts that this type of vaccine will be most useful where the critical issue is the reduction in proportion of poor responders.	[Saul, Allan] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Saul, A (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	ASaul@niaid.nih.gov	Saul, Allan/ABH-2091-2020; Fay, Michael P/A-2974-2008; Saul, Allan J/I-6968-2013	Saul, Allan/0000-0003-0665-4091; Fay, Michael P/0000-0002-8643-9625; Saul, Allan J/0000-0003-0665-4091	National Institute for Allergy and Infectious Diseases, National Institutes of Health	National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the Intramural Research Program of the National Institute for Allergy and Infectious Diseases, National Institutes of Health. The funder played no role in the study or preparation, review or approval of the manuscript.	[Anonymous], 1997, GUIDANCE IND EVALUAT; Bagnoli F, 2006, CURR OPIN INVESTIG D, V7, P695; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Burgess MA, 2001, VACCINE, V19, P4835, DOI 10.1016/S0264-410X(01)00221-3; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Dagan R, 2004, INFECT IMMUN, V72, P5383, DOI 10.1128/IAI.72.9.5383-5391.2004; Dickman S, 2003, PLOS BIOL, V1, P144, DOI 10.1371/journal.pbio.0000048; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Goldenthal KL, 2001, CLIN INFECT DIS, V33, pS267, DOI 10.1086/322561; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; Knuf M, 2006, VACCINE, V24, P2043, DOI 10.1016/j.vaccine.2005.11.024; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kumar S, 2002, TRENDS PARASITOL, V18, P129, DOI 10.1016/S1471-4922(01)02207-3; Li SQ, 2007, VACCINE, V25, P2567, DOI 10.1016/j.vaccine.2006.07.035; Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; REED GF, 1995, PEDIATRICS, V96, P600; Robbins JB, 2005, J INFECT DIS, V191, P81, DOI 10.1086/426454; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Siber GR, 1997, DEV BIOL STAND, V89, P283; Sturgess AW, 1999, VACCINE, V17, P1169, DOI 10.1016/S0264-410X(98)00337-5; Taranger J, 2000, J INFECT DIS, V181, P1010, DOI 10.1086/315318; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vandepapeliere P, 2005, VACCINE, V23, P2591, DOI 10.1016/j.vaccine.2004.11.034; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103	29	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e850	10.1371/journal.pone.0000850	http://dx.doi.org/10.1371/journal.pone.0000850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786221	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500033
J	Tang, CT; Nguyen, DT; Ngo, TH; Nguyen, TMP; Le, VT; To, SD; Lindsay, J; Nguyen, TD; Bach, VC; Le, QT; Le, TH; Le, DL; James, C; Nguyen, TKT; Nguyen, VVC; Cockfield, J; Le, TG; Phan, VN; Le, HS; Huynh, TS; Le, VP; Megan, C; Adwoa, BE; Richard, B; James, S; Nguyen, TC; Tran, TH; Jeremy, F; Schultsz, C				Tang Chi Thuong; Nguyen Dac Tho; Ngo Thi Hoa; Nguyen Thi Minh Phuong; Le Van Tuan; To Song Diep; Lindsay, Jodi; Nguyen The Dung; Bach Van Cam; Le Quoc Thinh; Le Thanh Hai; Le Dieu Linh; James Campbell; Nguyen Thi Kim Tien; Nguyen Van Vinh Chau; Cockfield, Joshua; Le Truong Giang; Phan Van Nghiem; Le Hoang Son; Huynh Tan Son; Le Van Phung; Megan Counahan; Adwoa Bentsi-Enchill; Richard Brown; James Simmerman; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar; Schultsz, Constance			An Outbreak of Severe Infections with Community-Acquired MRSA Carrying the Panton-Valentine Leukocidin Following Vaccination	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; SKIN INFECTIONS; STRAINS; SEQUENCE; EPIDEMIOLOGY; PNEUMONIA; PATTERNS; DISEASE	Background. Infections with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) are emerging worldwide. We investigated an outbreak of severe CA-MRSA infections in children following out-patient vaccination. Methods and Findings. We carried out a field investigation after adverse events following immunization (AEFI) were reported. We reviewed the clinical data from all cases. S. aureus recovered from skin infections and from nasal and throat swabs were analyzed by pulse-field gel electrophoresis, multi locus sequence typing, PCR and microarray. In May 2006, nine children presented with AEFI, ranging from fatal toxic shock syndrome, necrotizing soft tissue infection, purulent abscesses, to fever with rash. All had received a vaccination injection in different health centres in one District of Ho Chi Minh City. Eight children had been vaccinated by the same health care worker (HCW). Deficiencies in vaccine quality, storage practices, or preparation and delivery were not found. Infection control practices were insufficient. CA-MRSA was cultured in four children and from nasal and throat swabs from the HCW. Strains from children and HCW were indistinguishable. All carried the Panton-Valentine leukocidine (PVL), the staphylococcal enterotoxin B gene, the gene complex for staphylococcal-cassette-chromosome mec type V, and were sequence type 59. Strain HCM3A is epidemiologically unrelated to a strain of ST59 prevalent in the USA, although they belong to the same lineage. Conclusions. We describe an outbreak of infections with CA-MRSA in children, transmitted by an asymptomatic colonized HCW during immunization injection. Consistent adherence to injection practice guidelines is needed to prevent CA-MRSA transmission in both in-and outpatient settings.	[Ngo Thi Hoa; Le Dieu Linh; James Campbell; Jeremy Farrar; Schultsz, Constance] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tang Chi Thuong; Bach Van Cam; Le Quoc Thinh] Pediat Hosp No 1, Ho Chi Minh City, Vietnam; [Nguyen Dac Tho; Le Thanh Hai] Prevent Med Ctr, Ho Chi Minh City, Vietnam; [Nguyen Thi Minh Phuong; Nguyen Thi Kim Tien] Inst Pasteur, Ho Chi Minh City, Vietnam; [Le Van Tuan; Megan Counahan; Adwoa Bentsi-Enchill; Richard Brown; James Simmerman] WHO, Ho Chi Minh City, Vietnam; [To Song Diep; Nguyen Van Vinh Chau; Nguyen Tran Chinh; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Lindsay, Jodi; Cockfield, Joshua] St George Hosp, London, England; [Nguyen The Dung; Le Truong Giang; Phan Van Nghiem; Le Hoang Son; Huynh Tan Son] Hlth Serv Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Le Van Phung] Natl Inst Control Vaccines & Biol, Hanoi, Vietnam	University of Oxford; World Health Organization; St Georges University London	Schultsz, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	schultsz@gmail.com	Lindsay, Jodi/ABH-8205-2020; Farrar, Jeremy J./HGA-7610-2022; Lindsay, Jodi/B-9565-2008	Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Farrar, Jeremy/0000-0002-2700-623X; Ngo, Hoa/0000-0001-9320-4050	Health Service of Ho Chi Minh City; Ministry of Health Viet Nam; World Health Organization; Wellcome Trust UK [064874]	Health Service of Ho Chi Minh City; Ministry of Health Viet Nam; World Health Organization(World Health Organization); Wellcome Trust UK(Wellcome Trust)	This work was supported by the Health Service of Ho Chi Minh City, the Ministry of Health Viet Nam, the World Health Organization and the Wellcome Trust UK. Ngo T. Hoa is a recipient of a Wellcome Trust International Traveling Fellowship (064874).	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Bassetti S, 2005, INFECT CONT HOSP EP, V26, P196, DOI 10.1086/502526; Boubaker K, 2004, EMERG INFECT DIS, V10, P121, DOI 10.3201/eid1001.030144; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Bratu S, 2005, EMERG INFECT DIS, V11, P808, DOI 10.3201/eid1106.040885; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Clinical and Laboratory Standards Institute, 2005, PERF STAND ANT SUS S; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Edmiston CE, 2005, SURGERY, V138, P573, DOI 10.1016/j.surg.2005.06.045; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Frazee BW, 2005, ANN EMERG MED, V46, P401, DOI 10.1016/j.annemergmed.2005.05.023; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Huijsdens XW, 2006, J CLIN MICROBIOL, V44, P2994, DOI 10.1128/JCM.00846-06; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Ma XX, 2005, EMERG INFECT DIS, V11, P973; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Rutishauser J, 1999, INFECTION, V27, P259, DOI 10.1007/s150100050024; Sax H, 2006, J HOSP INFECT, V63, P93, DOI 10.1016/j.jhin.2005.11.016; SIMON PA, 1993, PEDIATR INFECT DIS J, V12, P368, DOI 10.1097/00006454-199305000-00003; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; *WHO, WHO BEST INF CONTR P; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	37	33	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e822	10.1371/journal.pone.0000822	http://dx.doi.org/10.1371/journal.pone.0000822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786194	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000207455500006
J	Brenner, JS; Dolmetsch, RE				Brenner, Jacob S.; Dolmetsch, Ricardo E.			TrpC3 Regulates Hypertrophy-Associated Gene Expression without Affecting Myocyte Beating or Cell Size	PLOS ONE			English	Article								Pathological cardiac hypertrophy is associated with an increased risk of heart failure and cardiovascular mortality. Calcium (Ca2+)-regulated gene expression is essential for the induction of hypertrophy, but it is not known how myocytes distinguish between the Ca2+ signals that regulate contraction and those that lead to cardiac hypertrophy. We used in vitro neonatal rat ventricular myocytes to perform an RNA interference (RNAi) screen for ion channels that mediate Ca2+-dependent gene expression in response to hypertrophic stimuli. We identified several ion channels that are linked to hypertrophic gene expression, including transient receptor potential C3 (TrpC3). RNAi-mediated knockdown of TrpC3 decreases expression of hypertrophy-associated genes such as the A- and B-type natriuretic peptides (ANP and BNP) in response to numerous hypertrophic stimuli, while TrpC3 overexpression increases BNP expression. Furthermore, stimuli that induce hypertrophy dramatically increase TrpC3 mRNA levels. Importantly, whereas TrpC3-knockdown strongly reduces gene expression associated with hypertrophy, it has a negligible effect on cell size and on myocyte beating. These results suggest that Ca2+ influx through TrpC3 channels increases transcription of genes associated with hypertrophy but does not regulate the signaling pathways that control cell size or contraction. Thus TrpC3 may represent an important therapeutic target for the treatment of cardiac hypertrophy and heart failure.	[Brenner, Jacob S.; Dolmetsch, Ricardo E.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Brenner, Jacob S.] Stanford Univ, Program Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu			NIH [RO1 NS048564]; Searle Scholars Program; McKnight Endowment for Neuroscience; Burroughs Wellcome Trust; Stanford Medical Scientist Training Program ( MSTP) fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; McKnight Endowment for Neuroscience; Burroughs Wellcome Trust(Wellcome Trust); Stanford Medical Scientist Training Program ( MSTP) fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH RO1 NS048564, the Searle Scholars Program, the McKnight Endowment for Neuroscience, and the Burroughs Wellcome Trust. J. S. B. is supported by a Stanford Medical Scientist Training Program ( MSTP) fellowship. These studies were designed and executed solely by J. S. B. and R. E. D., without consultation with the agents which funded this work.	Berridge MJ, 2003, BIOCHEM SOC T, V31, P930; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; GRUVER CL, 1993, ENDOCRINOLOGY, V133, P376, DOI 10.1210/en.133.1.376; Hunton DL, 2004, AM J PHYSIOL-HEART C, V286, pH1124, DOI 10.1152/ajpheart.00162.2003; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jeong MY, 2005, CIRCULATION, V111, P1645, DOI 10.1161/01.CIR.0000160367.99928.87; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Kirchhefer U, 2001, J BIOL CHEM, V276, P4142, DOI 10.1074/jbc.M006443200; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liang FQ, 2001, CAN J PHYSIOL PHARM, V79, P640, DOI 10.1139/cjpp-79-8-640; MCDONOUGH PM, 1992, J BIOL CHEM, V267, P11665; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295; Zobel C, 2002, CIRCULATION, V106, P2385, DOI 10.1161/01.CIR.0000033970.22130.93	34	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e802	10.1371/journal.pone.0000802	http://dx.doi.org/10.1371/journal.pone.0000802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726532	Green Published, gold			2022-12-25	WOS:000207455400019
J	Huang, HS; Akbarian, S				Huang, Hsien-Sung; Akbarian, Schahram			GAD1 mRNA Expression and DNA Methylation in Prefrontal Cortex of Subjects with Schizophrenia	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CHROMATIN; REELIN; INTERNEURONS; DYSFUNCTION; PROMOTER; NEURONS	Dysfunction of prefrontal cortex in schizophrenia includes changes in GABAergic mRNAs, including decreased expression of GAD1, encoding the 67 kDa glutamate decarboxylase (GAD(67)) GABA synthesis enzyme. The underlying molecular mechanisms remain unclear. Alterations in DNA methylation as an epigenetic regulator of gene expression are thought to play a role but this hypothesis is difficult to test because no techniques are available to extract DNA from GAD1 expressing neurons efficiently from human postmortem brain. Here, we present an alternative approach that is based on immunoprecipitation of mononucleosomes with anti-methyl-histone antibodies differentiating between sites of potential gene expression as opposed to repressive or silenced chromatin. Methylation patterns of CpG dinucleotides at the GAD1 proximal promoter and intron 2 were determined for each of the two chromatin fractions separately, using a case-control design for 14 schizophrenia subjects affected by a decrease in prefrontal GAD1 mRNA levels. In controls, the methylation frequencies at CpG dinucleotides, while overall higher in repressive as compared to open chromatin, did not exceed 5% at the proximal GAD1 promoter and 30% within intron 2. Subjects with schizophrenia showed a significant, on average 8-fold deficit in repressive chromatin-associated DNA methylation at the promoter. These results suggest that chromatin remodeling mechanisms are involved in dysregulated GABAergic gene expression in schizophrenia.	[Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA; [Huang, Hsien-Sung] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Akbarian, S (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA.	Schahram.akbarian@umassmed.edu		Huang, Hsien-Sung/0000-0003-2657-3635	National Institutes of Mental Health [R01 MH071476]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071476] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by a grant from the National Institutes of Mental Health (R01 MH071476).	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Huang HS, 2006, J NEUROSCI METH, V156, P284, DOI 10.1016/j.jneumeth.2006.02.018; Iwamoto K, 2005, J NEUROSCI, V25, P5376, DOI 10.1523/JNEUROSCI.0766-05.2005; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Sharma RP, 2005, J PSYCHIATR NEUROSCI, V30, P257; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Veldic M, 2005, P NATL ACAD SCI USA, V102, P2152, DOI 10.1073/pnas.0409665102	19	157	159	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e809	10.1371/journal.pone.0000809	http://dx.doi.org/10.1371/journal.pone.0000809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726539	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455400026
J	Akbari, MR; Malekzadeh, R; Nasrollahzadeh, D; Amanian, D; Islami, F; Li, S; Zandvakili, I; Shakeri, R; Sotoudeh, M; Aghceli, K; Salahi, R; Pourshams, A; Semnani, S; Boffetta, P; Dawsey, SM; Ghadirian, P; Narod, SA				Akbari, M. R.; Malekzadeh, R.; Nasrollahzadeh, D.; Amanian, D.; Islami, F.; Li, S.; Zandvakili, I.; Shakeri, R.; Sotoudeh, M.; Aghceli, K.; Salahi, R.; Pourshams, A.; Semnani, S.; Boffetta, P.; Dawsey, S. M.; Ghadirian, P.; Narod, S. A.			Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma	ONCOGENE			English	Article						esophageal squamous cell carcinoma; Turkmen population; BRCA2; K3326X; Fanconi anemia pathway	POLYMORPHIC STOP CODON; FANCONI-ANEMIA; CANCER SUSCEPTIBILITY; BREAST-CANCER; GENETIC SUSCEPTIBILITY; PANCREATIC-CANCER; ALLELIC LOSS; CROSS-LINKS; DNA-BINDING; IRAN	The incidence of esophageal squamous cell carcinoma (ESCC) is very high among the Turkmen population of Iran. Family studies suggest a genetic component to the disease. Turkmen are ethnically homogenous and are well suited for genetic studies. A previous study from China suggested that BRCA2 might play a role in the etiology of ESCC. We screened for mutations in the coding region of the BRCA2 gene in the germline DNA of 197 Turkmen patients with ESCC. A nonsense variant, K3326X, was identified in 9 of 197 cases (4.6%) vs 2 of 254 controls (0.8%) (OR = 6.0, 95% CI = 1.3-28; P = 0.01). This mutation leads to the loss of the C-terminal domain of the BRCA2 protein, a part of the region of interaction with the FANCD2 protein. We observed nine other BRCA2 variants in single cases only, including two deletions, and seven missense mutations. Six of these were judged to be pathogenic. In total, a suspicious deleterious BRCA2 variant was identified in 15 of 197 ESCC cases (7.6%).	[Akbari, M. R.; Malekzadeh, R.; Nasrollahzadeh, D.; Amanian, D.; Islami, F.; Shakeri, R.; Sotoudeh, M.; Aghceli, K.; Pourshams, A.] Univ Tehran, Shariati Hosp, Digest Dis Res Ctr, Tehran 14114, Iran; [Akbari, M. R.; Li, S.; Zandvakili, I.; Narod, S. A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Akbari, M. R.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Semnani, S.] Golestan Univ Med Sci, Res Ctr Gastroentrol, Gorgan, Iran; [Boffetta, P.] Int Agcy Res Canc, F-69372 Lyon, France; [Dawsey, S. M.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Ghadirian, P.] Univ Montreal, CHUM Hotel Dieu, Epidemiol Res Unit Res Ctr, Montreal, PQ, Canada	Tehran University of Medical Sciences; University of Tehran; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Golestan University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universite de Montreal	Narod, SA (corresponding author), Univ Tehran, Shariati Hosp, Digest Dis Res Ctr, Tehran 14114, Iran.	malek@ams.ac.ir	Boffetta, Paolo/AAI-7767-2021; Zandvakili, Inuk/P-7241-2019; Zandvakili, Inuk/C-8496-2011; Malekzadeh, Reza/U-1382-2017; Narod, Steven A/AAA-6112-2022; Semnani, Shahryar/N-2270-2016	Boffetta, Paolo/0000-0002-3811-2791; Zandvakili, Inuk/0000-0003-3409-0019; Malekzadeh, Reza/0000-0002-9820-6335; Semnani, Shahryar/0000-0002-8768-6142; Islami, Farhad/0000-0002-7357-5994; Malekzadeh, Reza/0000-0003-1043-3814; , Ramin/0000-0003-0487-3629; Pourshams, Akram/0000-0002-7950-3983	NATIONAL CANCER INSTITUTE [Z01CP000185] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akbari MR, 2006, INT J CANCER, V119, P1047, DOI 10.1002/ijc.21906; Alter BP, 2005, ARCH OTOLARYNGOL, V131, P635, DOI 10.1001/archotol.131.7.635; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Atanassov BS, 2005, GENE CHROMOSOME CANC, V44, P429, DOI 10.1002/gcc.20255; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Fuks F, 1998, ONCOGENE, V17, P2531, DOI 10.1038/sj.onc.1202475; GHADIRIAN P, 1985, CANCER-AM CANCER SOC, V56, P2112, DOI 10.1002/1097-0142(19851015)56:8<2112::AID-CNCR2820560838>3.0.CO;2-3; Houghtaling S, 2005, HUM MOL GENET, V14, P3027, DOI 10.1093/hmg/ddi334; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hu N, 2004, ONCOGENE, V23, P852, DOI 10.1038/sj.onc.1207150; Hu N, 2003, CANCER DETECT PREV, V27, P132, DOI 10.1016/S0361-090X(03)00031-X; Hu N, 2002, CLIN CANCER RES, V8, P1121; Hu N, 2000, GENE CHROMOSOME CANC, V27, P217, DOI 10.1002/(SICI)1098-2264(200003)27:3<217::AID-GCC1>3.0.CO;2-A; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; HUSSAR DA, 2003, DRUG ADVISOR, V2, P1; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Li G, 2001, GENE CHROMOSOME CANC, V31, P390, DOI 10.1002/gcc.1158; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; MAHBOUBI E, 1973, BRIT J CANCER, V28, P192, DOI 10.1038/bjc.1973.138; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Martin ST, 2005, ONCOGENE, V24, P3652, DOI 10.1038/sj.onc.1208411; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; McAllister KA, 2002, CANCER RES, V62, P990; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Morimatsu M, 1998, CANCER RES, V58, P3441; Narod SA, 2002, NAT REV CANCER, V2, P113, DOI 10.1038/nrc726; Offit K, 2003, JNCI-J NATL CANCER I, V95, P1548, DOI 10.1093/jnci/djg072; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; POUR P, 1974, CANCER-AM CANCER SOC, V33, P1649, DOI 10.1002/1097-0142(197406)33:6<1649::AID-CNCR2820330627>3.0.CO;2-0; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Saidi F, 2000, BRIT J CANCER, V83, P1249, DOI 10.1054/bjoc.2000.1414; SCHOTTENFELD D, 1984, SEMIN ONCOL, V11, P92; Simard J, 2003, ENDOCR-RELAT CANCER, V10, P225, DOI 10.1677/erc.0.0100225; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Tian XX, 2005, CANCER RES, V65, P4747, DOI 10.1158/0008-5472.CAN-05-0018; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	46	61	63	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2008	27	9					1290	1296		10.1038/sj.onc.1210739	http://dx.doi.org/10.1038/sj.onc.1210739			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17724471				2022-12-25	WOS:000253407000011
J	Gu, S; He, J; Ho, WT; Ramineni, S; Thal, DM; Natesh, R; Tesmer, JJG; Hepler, JR; Heximer, SP				Gu, Steven; He, Janet; Ho, Wing-Ting; Ramineni, Suneela; Thal, David M.; Natesh, Ramanathan; Tesmer, John J. G.; Hepler, John R.; Heximer, Scott P.			Unique hydrophobic extension of the RGS2 amphipathic helix domain imparts increased plasma membrane binding and function relative to other RGS R4/B subfamily members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; TERMINAL CYSTEINE RESIDUES; 3RD-INTRACELLULAR LOOP; ALPHA-SUBUNITS; SIGNALING RGS; RECEPTOR; PALMITOYLATION; IDENTIFICATION; DETERMINANTS; ASSOCIATION	RGS2 and RGS5 are inhibitors of G-protein signaling belonging to the R4/B subfamily of RGS proteins. We here show that RGS2 is a much more potent attenuator of M1 muscarinic receptor signaling than RGS5. We hypothesize that this difference is mediated by variation in their ability to constitutively associate with the plasma membrane ( PM). Compared with full-length RGS2, the RGS-box domains of RGS2 and RGS5 both show reduced PM association and activity. Prenylation of both RGS-box domains increases activity to RGS2 levels, demonstrating that lipid bilayer targeting increases RGS domain function. Amino-terminal domain swaps confirm that key determinants of localization and function are found within this important regulatory domain. An RGS2 amphipathic helix domain mutant deficient for phospholipid binding ( L45D) shows reduced PM association and activity despite normal binding to the M1 muscarinic receptor third intracellular loop and activated G alpha(q). Replacement of a unique dileucine motif adjacent to the RGS2 helix with corresponding RGS5 residues disrupts both PMlocalization and function. These data suggest that RGS2 contains a hydrophobic extension of its helical domain that imparts high efficiency binding to the inner leaflet of the lipid bilayer. In support of this model, disruption of membrane phospholipid composition with N-ethylmaleimide reduces PM association of RGS2, without affecting localization of the M1 receptor or G(alpha)q. Together, these data indicate that novel features within the RGS2 amphipathic alpha helix facilitate constitutive PM targeting and more efficient inhibition of M1 muscarinic receptor signaling than RGS5 and other members of the R4/B subfamily.	Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Dept Physiol, Toronto, ON M5S 1A8, Canada; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30329 USA; Univ Michigan, Inst Life Sci, Chem Biol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Toronto; Emory University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Heximer, SP (corresponding author), Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	scott.heximer@utoronto.ca	NATESH, Ramanathan/C-4488-2008; Thal, David/GXH-4911-2022	NATESH, Ramanathan/0000-0002-1145-5962; Thal, David/0000-0002-0325-2524; Tesmer, John/0000-0003-1125-3727	NHLBI NIH HHS [R01 HL 071818, HL 086865] Funding Source: Medline; NIGMS NIH HHS [R01 GM 61847] Funding Source: Medline; NINDS NIH HHS [R01 NS 37112] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Barker SA, 2001, GENOMICS, V78, P223, DOI 10.1006/geno.2001.6659; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Chen CH, 1999, J BIOL CHEM, V274, P19799, DOI 10.1074/jbc.274.28.19799; Druey KM, 1999, J BIOL CHEM, V274, P18836, DOI 10.1074/jbc.274.26.18836; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Jones TLZ, 2004, METHOD ENZYMOL, V389, P33; KOZAK M, 1994, BIOCHIMIE, V76, P815, DOI 10.1016/0300-9084(94)90182-1; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Tovey SC, 2004, MOL PHARMACOL, V66, P1453, DOI 10.1124/mol.104.005827; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549	30	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33064	33075		10.1074/jbc.M702685200	http://dx.doi.org/10.1074/jbc.M702685200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848575	hybrid			2022-12-25	WOS:000250625400055
J	Kauskot, A; Adam, F; Mazharian, A; Ajzenberg, N; Berrou, E; Bonnefoy, A; Rosa, JP; Hoylaerts, MF; Bryckaert, M				Kauskot, Alexandre; Adam, Frederic; Mazharian, Alexandra; Ajzenberg, Nadine; Berrou, Eliane; Bonnefoy, Arnaud; Rosa, Jean-Philippe; Hoylaerts, Marc F.; Bryckaert, Marijke			Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; N-TERMINAL KINASE; P38 MAP KINASE; PLATELET-ADHESION; ERK2 ACTIVATION; INTEGRIN ALPHA(IIB)BETA(3); SIGNALING PATHWAY; SHEAR-STRESS; ADP RECEPTOR; COLLAGEN	The involvement of the mitogen-activated protein kinase c- Jun NH2-terminal kinase-1 (JNK1) has never been investigated in hemostasis and thrombosis. Using two JNK inhibitors (SP600125 and 60), we have demonstrated that JNK1 is involved in collagen-induced platelet aggregation dependent on ADP. In these conditions, JNK1 activation requires the coordinated signaling pathways of collagen receptors (alpha 2 beta 1 and glycoprotein (GP)VI) and ADP. In contrast, JNK1 is not required for platelet adhesion on a collagen matrix in static or blood flow conditions (300-1500 s(-1)) involving collagen receptors (alpha 2 beta 1 and GPVI). Importantly, at 1500 s(-1), JNK1 acts on thrombus formation on a collagen matrix dependent on GPIb- von Willebrand factor (vWF) interaction but not ADP receptor activation. This is confirmed by the involvement of JNK1 in shear-induced platelet aggregation at 4000 s(-1). We also provide evidence during rolling and adhesion of platelets to vWF that platelet GPIb-vWF interaction triggers alpha IIb beta 3 activation in a JNK1-dependent manner. This was confirmed with a Glanzmann thrombastenic patient lacking alpha IIb beta 3. Finally, in vivo, JNK1 is involved in arterial but not in venular thrombosis in mice. Overall, our in vitro studies define a new role of JNK1 in thrombus formation in flowing blood that is relevant to thrombus development in vivo.	Hop Lariboisiere, INSERM, U689 E4, Ctr Rech Cardiovasc, F-75010 Paris, France; Hop X Bichat, INSERM, U698, F-75018 Paris, France; INSERM, U743, Montreal, PQ H2X 1P1, Canada; Katholieke Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium; Hop X Bichat, AP HP, F-75018 Paris, France; Univ Paris 07, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bryckaert, M (corresponding author), Hop Lariboisiere, INSERM, U689 E4, Ctr Rech Cardiovasc, 8 Rue Guy Patin, F-75010 Paris, France.	marijke.bryckaert@larib.inserm.fr	ROSA, JEAN-PHILIPPE/B-6245-2018; Kauskot, Alexandre/J-6794-2015	ROSA, JEAN-PHILIPPE/0000-0001-7342-0389; Kauskot, Alexandre/0000-0002-4064-8114; Hoylaerts, Marc/0000-0002-6474-3933; ADAM, Frederic/0000-0001-6603-2687; Bryckaert, Marijke/0000-0003-3398-0976; Mazharian, Alexandra/0000-0002-0204-3325; ajzenberg, nadine/0000-0001-8960-1766				Amagasaki K, 2006, J BIOL CHEM, V281, P22173, DOI 10.1074/jbc.M513307200; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Bugaud F, 1999, BLOOD, V94, P3800, DOI 10.1182/blood.V94.11.3800.423k25_3800_3805; Canobbio I, 2004, THROMB HAEMOSTASIS, V91, P102, DOI 10.1160/TH03-02-0083; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Cruz MA, 2005, BLOOD, V105, P1986, DOI 10.1182/blood-2004-04-1365; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Depraetere H, 1998, BLOOD, V91, P3792; Falker K, 2004, THROMB HAEMOSTASIS, V92, P114, DOI 10.1160/th03-12-0729; GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415; Greco F, 2004, J THROMB HAEMOST, V2, P2223, DOI 10.1111/j.1538-7836.2004.01018.x; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kodama H, 2003, HYPERTENSION, V41, P1372, DOI 10.1161/01.HYP.0000069698.11814.F4; Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Matsui H, 2002, BLOOD, V100, P3604, DOI 10.1182/blood-2002-02-0508; Mazharian A, 2005, J BIOL CHEM, V280, P26002, DOI 10.1074/jbc.M414083200; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; Melis E, 2004, J THROMB HAEMOST, V2, P993, DOI 10.1111/j.1538-7836.2004.00747.x; Moroi M, 1997, BLOOD, V90, P4413; Nadal F, 1997, J BIOL CHEM, V272, P22381, DOI 10.1074/jbc.272.36.22381; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; NURDEN AT, 1985, BLOOD, V65, P1021; Oury C, 2006, J THROMB HAEMOST, V4, P443, DOI 10.1111/j.1538-7836.2006.01745.x; Oury C, 2002, BLOOD, V100, P2499, DOI 10.1182/blood-2002-03-0812; Remijn JA, 2002, ARTERIOSCL THROM VAS, V22, P686, DOI 10.1161/01.ATV.0000012805.49079.23; Roger S, 2004, FEBS LETT, V556, P227, DOI 10.1016/S0014-5793(03)01430-3; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; ROUX SP, 1991, ARTERIOSCLER THROMB, V11, P1182, DOI 10.1161/01.ATV.11.5.1182; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Sakurai K, 2004, J RECEPT SIG TRANSD, V24, P283, DOI 10.1081/RRS-200040324; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Song S, 2000, BRIT J HAEMATOL, V109, P851, DOI 10.1046/j.1365-2141.2000.02126.x; STRONY J, 1993, AM J PHYSIOL, V265, pH1787; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Theilmeier G, 1999, BLOOD, V94, P2725, DOI 10.1182/blood.V94.8.2725.420k18_2725_2734; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Toth-Zsamboki E, 2003, J BIOL CHEM, V278, P46661, DOI 10.1074/jbc.M308452200; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200	50	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31990	31999		10.1074/jbc.M701596200	http://dx.doi.org/10.1074/jbc.M701596200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785464	hybrid			2022-12-25	WOS:000250480300020
J	Kligys, K; Claiborne, JN; Debiase, PJ; Hopkinson, SB; Wu, Y; Mizuno, K; Jones, JCR				Kligys, Kristina; Claiborne, Jessica N.; Debiase, Phillip J.; Hopkinson, Susan B.; Wu, Yvonne; Mizuno, Kensaku; Jones, Jonathan C. R.			The slingshot family of Phosphatases mediates rac1 regulation of cofilin phosphorylation, laminin-332 organization, and motility Behavior of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL MOTILITY; NF-KAPPA-B; LIM-KINASE; ALPHA-6-BETA-4 INTEGRIN; ACTIN REORGANIZATION; PROTEIN-KINASES; MIGRATION; HEMIDESMOSOMES; ADHESION; ACTIVATION	The motility of keratinocytes is an essential component of wound closure and the development of epidermal tumors. In vitro, the specific motile behavior of keratinocytes is dictated by the assembly of laminin-332 tracks, a process that is dependent upon alpha 6 beta 4 integrin signaling to Rac1 and the actin-severing protein cofilin. Here we have analyzed how cofilin phosphorylation is regulated by phosphatases (slingshot (SSH) or chronophin (CIN)) downstream of signaling by alpha 6 beta 4 integrin/Rac1 in human keratinocytes. Keratinocytes express all members of the SSH family (SSH1, SSH2, and SSH3) and CIN. However, expression of phosphatase-dead versions of all three SSH proteins, but not dominant inactive CIN, results in phosphorylation/ inactivation of cofilin, changes in actin cytoskeleton organization, loss of cell polarity, and assembly of aberrant arrays of laminin-332 in human keratinocytes. SSH activity is regulated by 14-3-3 protein binding, and intriguingly, 14-3-3/alpha 6 beta 4 integrin protein interaction is required for keratinocyte migration. We wondered whether 14-3-3 proteins function as regulators of Rac1-mediated keratinocyte migration patterns. In support of this hypothesis, inhibition of Rac1 results in an increase in 14-3-3 protein association with SSH. Thus, we propose a novel mechanism in which alpha 6 beta 4 integrin signaling via Rac1, 14-3-3 proteins, and SSH family members regulates cofilin activation, cell polarity, and matrix assembly, leading to specific epidermal cell migration behavior.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Northwestern University; Feinberg School of Medicine; Tohoku University	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Mizuno, Kensaku/G-8631-2015; Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	NHLBI NIH HHS [T32 HL076139] Funding Source: Medline; NIAMS NIH HHS [R01 AR054184, R01 AR054184-18] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010; Giannelli G, 2002, CLIN EXP METASTAS, V19, P217, DOI 10.1023/A:1015579204607; Gilcrease MZ, 2004, CANCER RES, V64, P7395, DOI 10.1158/0008-5472.CAN-04-1809; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jonkman MF, 2002, J INVEST DERMATOL, V119, P1275, DOI 10.1046/j.1523-1747.2002.19609.x; Jonkman MF, 1999, J DERMATOL SCI, V20, P103, DOI 10.1016/S0923-1811(99)00017-1; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Qin P, 1998, EXP EYE RES, V66, P569, DOI 10.1006/exer.1997.0455; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang K, 1996, EXP CELL RES, V227, P309, DOI 10.1006/excr.1996.0280	47	65	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32520	32528		10.1074/jbc.M707041200	http://dx.doi.org/10.1074/jbc.M707041200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848544	Green Accepted, hybrid			2022-12-25	WOS:000250480300075
J	Maliekal, P; Sokolova, T; Vertommen, D; Veiga-Da-Cunha, M; Van Schaftingen, E				Maliekal, Pushpa; Sokolova, Tatiana; Vertommen, Didier; Veiga-da-Cunha, Maria; Van Schaftingen, Emile			Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; RED-BLOOD-CELLS; FRUCTOSE 2,6-BISPHOSPHATE; MUSCLE PHOSPHOGLUCOMUTASE; GLUCOSE 1,6-BISPHOSPHATE; RIBOSE 1,5-BISPHOSPHATE; ENZYME; PURIFICATION; METABOLISM; 1,6-DIPHOSPHATE	The molecular identity of mammalian phosphopentomutase has not yet been established unequivocally. That of glucose-1,6bisphosphate synthase, the enzyme that synthesizes a cofactor for phosphomutases and putative regulator of glycolysis, is completely unknown. In the present work, we have purified phosphopentomutase from human erythrocytes and found it to copurify with a 68-kDa polypeptide that was identified by mass spectrometry as phosphoglucomutase 2 (PGM2), a protein of the alpha-D-phosphohexomutase family and sharing about 20% identity with mammalian phosphoglucomutase 1. Data base searches indicated that vertebrate genomes contained, in addition to PGM2, a homologue (PGM2L1, for PGM2-like 1) sharing about 60% sequence identity with this protein. Both PGM2 and PGM2L1 were overexpressed in Escherichia coli, purified, and their properties were studied. Using catalytic efficiency as a criterion, PGM2 acted more than 10-fold better as a phosphopentomutase (both on deoxyribose 1-phosphate and on ribose 1-phosphate) than as a phosphoglucomutase. PGM2L1 showed only low (< 5%) phosphopentomutase and phosphoglucomutase activities compared with PGM2, but was about 5-20-fold better than the latter enzyme in catalyzing the 1,3-bisphosphoglycerate-dependent synthesis of glucose 1,6-bisphosphate and other aldosebisphosphates. Furthermore, quantitative real-time PCR analysis indicated that PGM2L1 was mainly expressed in brain where glucose1,6-bisphosphate synthase activity was previously shown to be particularly high. We conclude that mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase correspond to two closely related proteins, PGM2 and PGM2L1, encoded by two genes that separated early in vertebrate evolution.	Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Duve Inst, 7539 Ave Hippocrate 75, B-1200 Brussels, Belgium.	vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282				ACCORSI A, 1989, PREP BIOCHEM, V19, P251, DOI 10.1080/10826068908544915; Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARSKY DL, 1983, BIOCHIM BIOPHYS ACTA, V743, P162, DOI 10.1016/0167-4838(83)90430-2; BEITNER R, 1979, BIOCHIM BIOPHYS ACTA, V583, P266, DOI 10.1016/0304-4165(79)90434-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRANE RK, 1954, J BIOL CHEM, V210, P597; DAI JB, 1992, J BIOL CHEM, V267, P6322; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Follens A, 1999, J BACTERIOL, V181, P2001, DOI 10.1128/JB.181.7.2001-2007.1999; Fortpied J, 2005, BIOCHEM J, V388, P795, DOI 10.1042/BJ20041976; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Gemayel R, 2007, FEBS J, V274, P4360, DOI 10.1111/j.1742-4658.2007.05948.x; GERBER G, 1974, EUR J BIOCHEM, V45, P39, DOI 10.1111/j.1432-1033.1974.tb03527.x; GIBLETT ER, 1972, LANCET, V2, P1067; GIBLETT ER, 1985, ANN NY ACAD SCI, V451, P1, DOI 10.1111/j.1749-6632.1985.tb27090.x; GUHA SK, 1982, J BIOL CHEM, V257, P6634; GUHA SK, 1986, ARCH BIOCHEM BIOPHYS, V250, P513, DOI 10.1016/0003-9861(86)90756-3; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; ISHIKAWA E, 1990, J BIOL CHEM, V265, P18875; KAMMEN HO, 1969, J BIOL CHEM, V244, P4888; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KOSTER JF, 1972, BIOCHIM BIOPHYS ACTA, V258, P763, DOI 10.1016/0005-2744(72)90177-5; MARCUS CJ, 1976, J BIOL CHEM, V251, P2963; MORINO H, 1991, J NEUROCHEM, V56, P1049, DOI 10.1111/j.1471-4159.1991.tb02028.x; PASSONNEAU JV, 1969, J BIOL CHEM, V244, P902; QUICK CB, 1972, ANN HUM GENET, V35, P445, DOI 10.1111/j.1469-1809.1957.tb01869.x; Rashid N, 2004, J BACTERIOL, V186, P4185, DOI 10.1128/JB.186.13.4185-4191.2004; RAY WJ, 1983, J BIOL CHEM, V258, P9166; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; ROSE IA, 1975, J BIOL CHEM, V250, P3466; ROSE IA, 1974, BIOCHEM BIOPH RES CO, V59, P1333, DOI 10.1016/0006-291X(74)90460-4; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; WIJNEN LMM, 1977, HUM GENET, V37, P271, DOI 10.1007/BF00393608; WONG LJ, 1976, J BIOL CHEM, V251, P5431; YIP V, 1988, J NEUROCHEM, V50, P594, DOI 10.1111/j.1471-4159.1988.tb02952.x	38	38	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31844	31851		10.1074/jbc.M706818200	http://dx.doi.org/10.1074/jbc.M706818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804405	hybrid			2022-12-25	WOS:000250480300004
J	Smith, AJ; Thompson, BR; Sanders, MA; Bernlohr, DA				Smith, Anne J.; Thompson, Brian R.; Sanders, Mark A.; Bernlohr, David A.			Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase - Regulation by fatty acids and phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BINDING; TRANSLOCATION; LIPOLYSIS; DROPLETS	Adipocyte fatty acid-binding protein (AFABP/aP2) forms a physical complex with the hormone-sensitive lipase (HSL) and AFABP/aP2-null mice exhibit reduced basal and hormone-stimulated lipolysis. To identify the determinants affecting the interaction fluorescence resonance energy transfer (FRET) imaging was used in conjunction with a mutagenesis strategy to evaluate the roles AFABP/aP2 fatty acid binding and HSL phosphorylation have in complex formation as well as determine the HSL binding site on AFABP/aP2. The nonfatty acid binding mutant of AFABP/aP2 (R126Q) failed to form a FRET-competent complex with HSL either under basal or forskolin-stimulated conditions, indicating that lipid binding is required for association. Once bound to HSL and on the surface of the lipid droplet, YFP-AFABP/aP2 (but not YFP-HSL) exhibited energy transfer between the fusion protein and BODIPY-C12-labeled triacylglycerol. Serine to alanine mutations at the two PKA phosphorylation sites of HSL (659 and 660), or at the AMPK phosphorylation sites (565), blocked FRET between HSL and AFABP/aP2. Substitution of isoleucine for lysine at position 21 of AFABP/aP2 (K21I), but not 31 (K31I), resulted in a non-HSL-binding protein indicating that residues on helix alpha I of AFABP/ aP2 define a component of the HSL binding site. These results indicate that the ligand-bound form of AFABP/aP2. interacts with the activated, phosphorylated HSL and that the association is likely to be regulatory; either delivering FA to inhibit HSL (facilitating feedback inhibition) or affecting multicomponent complex formation on the droplet surface.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Imaging Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Twin Cities 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	Bernl001@umn.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053189] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK053189] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; CLIFFORD GM, 1997, BIOCHEM SOC T, V25, P56; Coe NR, 1999, J LIPID RES, V40, P967; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kleinfeld AM, 2004, J AM SOC MASS SPECTR, V15, P1572, DOI 10.1016/j.jasms.2004.07.010; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Mittelman SD, 2002, DIABETES, V51, P755, DOI 10.2337/diabetes.51.3.755; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; SHA RS, 1993, J BIOL CHEM, V268, P7885; Shen WJ, 2000, BIOCHEMISTRY-US, V39, P2392, DOI 10.1021/bi992283h; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; XU ZH, 1991, J BIOL CHEM, V266, P14367; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200	30	85	98	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32424	32432		10.1074/jbc.M703730200	http://dx.doi.org/10.1074/jbc.M703730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785468	hybrid			2022-12-25	WOS:000250480300065
J	Kramer, A; Ludwig, Y; Shahin, V; Oberleithner, H				Kramer, Armin; Ludwig, Yvonne; Shahin, Victor; Oberleithner, Hans			A pathway separate from the central channel through the nuclear pore complex for inorganic ions and small macromolecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; FORCE MICROSCOPY; ARCHITECTURE; ENVELOPE; PERMEABILITY; KARYOPHERINS; NUCLEOPORINS; INHIBITION; DIFFUSION; MEMBRANE	Nuclear pore complexes (NPCs) are supramolecular nanomachines that mediate the exchange of macromolecules and inorganic ions between the nucleus and the cytosol. Although there is no doubt that large cargo is transported through the centrally located channel, the route of ions and small molecules remains debatable. We thus tested the hypothesis that there are two separate pathways by imaging NPCs using atomic force microscopy, NPC electrical conductivity measurements, and macromolecule permeability assays. Our data indicate a spatial separation between the active transport of macromolecules through the central channel and the passive transport of ions and small macromolecules through the pore periphery.	Univ Munster, Inst Physiol 2, D-48149 Munster, Germany	University of Munster	Kramer, A (corresponding author), Univ Munster, Inst Physiol 2, Robert-Koch Str 27b, D-48149 Munster, Germany.	kramercom@gmail.com	Kramer, Armin/C-1382-2010					AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5; BUSTAMANTE JO, 1995, J MEMBRANE BIOL, V146, P239; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Danker T, 1999, P NATL ACAD SCI USA, V96, P13530, DOI 10.1073/pnas.96.23.13530; Danker T, 1997, CELL BIOL INT, V21, P747, DOI 10.1006/cbir.1997.0219; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Enss K, 2003, J MEMBRANE BIOL, V196, P147, DOI 10.1007/s00232-003-0632-0; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Jaggi RD, 2003, BIOPHYS J, V85, P4093, DOI 10.1016/S0006-3495(03)74821-8; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Ludwig Y, 2006, CELL PHYSIOL BIOCHEM, V17, P181, DOI 10.1159/000094123; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Saitoh H, 1996, MOL BIOL CELL, V7, P1319, DOI 10.1091/mbc.7.9.1319; Santella L, 1997, FASEB J, V11, P1091, DOI 10.1096/fasebj.11.13.9367344; Shahin V, 2005, J CELL SCI, V118, P2881, DOI 10.1242/jcs.02429; Shahin V, 2001, FASEB J, V15, P1895, DOI 10.1096/fj.00-0838com; Singh S, 2006, NATURE, V442, P526, DOI 10.1038/442526a; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7	41	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31437	31443		10.1074/jbc.M703720200	http://dx.doi.org/10.1074/jbc.M703720200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726020	hybrid			2022-12-25	WOS:000250309200034
J	Rajeev, L; Segall, A; Gardner, J				Rajeev, Lara; Segall, Anca; Gardner, Jeffrey			The Bacteroides NBU1 integrase performs a homology-independent strand exchange to form a Holliday junction intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; CONJUGATIVE TRANSPOSON CTNDOT; LOXP SPACER REGION; LAMBDA-INTEGRASE; MEDIATED RECOMBINATION; INSERTION ELEMENT; SENSING HOMOLOGY; DNA; MECHANISM; SEQUENCES	The Bacteroides mobilizable transposon NBU1 uses an integrase (IntN1) that is a tyrosine recombinase for its integration and excision from the host chromosome. Previously we showed that IntN1 makes 7-bp staggered cuts within the NBU1 att sites, and certain mismatches within the crossover region of the attN1 site (G(-2)C attN1) or the chromosomal target site (C(-3) G attBT1-1) enhanced the in vivo integration efficiency. Here we describe an in vitro integration system for NBU1. We used nicked substrates and a Holliday junction trapping peptide to show that NBU1 integration proceeds via formation of a Holliday junction intermediate that is formed by exchange of bottom strands. Some mismatches next to the first strand exchange site (in reactions with C(-3) G attBT1-1 or G(-2) C attN1 with their wild-type partner site) not only allowed formation of the Holliday junction intermediate but also increased the rate of recombinant formation. The second strand exchange appears to be homology-dependent. IntN1 is the only tyrosine recombinase known to catalyze a reaction that is more efficient in the presence of mismatches and where the first strand exchange is homology-independent. The possible mechanisms by which the mismatches stimulate recombination are discussed.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; San Diego State Univ, Ctr Microbial Sci, Dept Biol, San Diego, CA 92182 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; San Diego State Univ, Ctr Microbial Sci, Dept Biol, San Diego, CA 92182 USA	University of Illinois System; University of Illinois Urbana-Champaign; California State University System; San Diego State University; University of Illinois System; University of Illinois Urbana-Champaign; California State University System; San Diego State University	Rajeev, L (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave,B322 CLSL, Urbana, IL 61801 USA.	rajeev@uiuc.edu		Segall, Anca/0000-0002-8454-5248; Rajeev, Lara/0000-0002-0106-9195	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028717, R01GM052847] Funding Source: NIH RePORTER; NIAID NIH HHS [AI58253] Funding Source: Medline; NIGMS NIH HHS [GM52847, GM28717] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS BJ, 1986, MOL CELL BIOL, V6, P2482, DOI 10.1128/MCB.6.7.2482; BAUER CE, 1985, J MOL BIOL, V181, P187, DOI 10.1016/0022-2836(85)90084-1; Blakely GW, 2000, J BIOL CHEM, V275, P9930, DOI 10.1074/jbc.275.14.9930; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Cassell GD, 2003, J MOL BIOL, V327, P413, DOI 10.1016/S0022-2836(03)00058-5; Cheng Q, 2002, J BACTERIOL, V184, P4829, DOI 10.1128/JB.184.17.4829-4837.2002; DiChiara JM, 2007, J BACTERIOL, V189, P2692, DOI 10.1128/JB.01796-06; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Kazmierczak RA, 2002, NUCLEIC ACIDS RES, V30, P5193, DOI 10.1093/nar/gkf652; Kepple KV, 2005, P NATL ACAD SCI USA, V102, P6867, DOI 10.1073/pnas.0409496102; KITTS PA, 1987, NATURE, V329, P346, DOI 10.1038/329346a0; KITTS PA, 1988, NUCLEIC ACIDS RES, V16, P6839, DOI 10.1093/nar/16.14.6839; KITTS PA, 1988, J MOL BIOL, V204, P95, DOI 10.1016/0022-2836(88)90602-X; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; LEE J, 1995, J BIOL CHEM, V270, P4042, DOI 10.1074/jbc.270.8.4042; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; NunesDuby SE, 1997, J MOL BIOL, V272, P493, DOI 10.1006/jmbi.1997.1260; Rajeev L, 2006, MOL MICROBIOL, V61, P978, DOI 10.1111/j.1365-2958.2006.05282.x; Schmidt JW, 2006, MOL MICROBIOL, V60, P152, DOI 10.1111/j.1365-2958.2006.05073.x; SENECOFF JF, 1986, J BIOL CHEM, V261, P7380; SHOEMAKER NB, 1988, J BACTERIOL, V170, P1651, DOI 10.1128/jb.170.4.1651-1657.1988; SHOEMAKER NB, 1993, J BACTERIOL, V175, P6578, DOI 10.1128/jb.175.20.6578-6587.1993; Shoemaker NB, 1996, J BACTERIOL, V178, P3594, DOI 10.1128/jb.178.12.3594-3600.1996; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; WEISBERG RA, 1983, J MOL BIOL, V170, P319, DOI 10.1016/S0022-2836(83)80151-X	29	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31228	31237		10.1074/jbc.M705370200	http://dx.doi.org/10.1074/jbc.M705370200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766246	hybrid			2022-12-25	WOS:000250309200012
J	Jain, S; Stanford, N; Bhagwat, N; Seiler, B; Costanzo, M; Boone, C; Oelkers, P				Jain, Shilpa; Stanford, NaTaza; Bhagwat, Neha; Seiler, Brian; Costanzo, Michael; Boone, Charles; Oelkers, Peter			Identification of a novel lysophospholipid acyltransferase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; FATTY-ACIDS; II CELLS; FUNCTIONAL-CHARACTERIZATION; ENZYMATIC-ACTIVITY; ARACHIDONIC-ACID; LIPID-SYNTHESIS; GENE STRUCTURE; ACYL-COA	The incorporation of unsaturated acyl chains into phospholipids during de novo synthesis is primarily mediated by the 1-acyl-sn-glycerol-3-phosphate acyltransferase reaction. In Saccharomyces cerevisiae, Slc1 has been shown to mediate this reaction, but distinct activity remains after its removal from the genome. To identify the enzyme that mediates the remaining activity, we performed synthetic genetic array analysis using a slc1 Delta strain. One of the genes identified by the screen, LPT1, was found to encode for an acyltransferase that uses a variety of lysophospholipid species, including 1-acyl-sn-glycerol-3-phosphate. Deletion of LPT1 had a minimal effect on 1-acyl-sn-glycerol-3-phosphate acyltransferase activity, but overexpression increased activity 7-fold. Deletion of LPT1 abrogated the esterification of other lysophospholipids, and overexpression increased lysophosphatidylcholine acyltransferase activity 7-fold. The majority of this activity co-purified with microsomes. To test the putative role for this enzyme in selectively incorporating unsaturated acyl chains into phospholipids in vitro, substrate concentration series experiments were performed with the four acyl-CoA species commonly found in yeast. Although the saturated palmitoyl-CoA and stearoyl-CoA showed a lower apparent Km, the monounsaturated palmitoleoyl-CoA and oleoyl-CoA showed a higher apparent V-max. Arachidonyl-CoA, although not abundant in yeast, also had a high apparent V-max. Pulse- labeling of lpt1 Delta strains showed a 30% reduction in [H-3] oleate incorporation into phosphatidylcholine only. Therefore, Lpt1p, a member of the membrane-bound o-acyltransferase gene family, seems to work in conjunction with Slc1 to mediate the incorporation of unsaturated acyl chains into the sn-2 position of phospholipids.	Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Mol Genet & Microbiol, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	Drexel University; University of Toronto; University of Toronto	Oelkers, P (corresponding author), Drexel Univ, Dept Biosci & Biotechnol, 3141 Chestnut St, Philadelphia, PA 19104 USA.	pmo24@drexel.edu		Oelkers, Peter/0000-0002-2421-472X				ADAMS A, 1997, METHODS YEAST GENETI, P148; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2007, J ENDOCRINOL, V193, P445, DOI 10.1677/JOe-07-0027; Agarwal AK, 2006, ARCH BIOCHEM BIOPHYS, V449, P64, DOI 10.1016/j.abb.2006.03.014; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CHILTON FH, 1987, BIOCHIM BIOPHYS ACTA, V917, P48, DOI 10.1016/0005-2760(87)90282-7; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; HANAHAN DJ, 1960, J BIOL CHEM, V235, P1917; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; LANDS WEM, 1963, J BIOL CHEM, V238, P898; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; PHILLIPS MC, 1972, CHEM PHYS LIPIDS, V8, P127, DOI 10.1016/0009-3084(72)90024-2; PIK JR, 1978, CAN J BIOCHEM CELL B, V56, P765, DOI 10.1139/o78-115; POST M, 1983, BIOCHIM BIOPHYS ACTA, V750, P68, DOI 10.1016/0005-2760(83)90205-9; RESNICK RJ, 1994, J BIOL CHEM, V269, P32336; Richard MG, 1998, LIPIDS, V33, P1229, DOI 10.1007/s11745-998-0328-1; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUBIN RP, 1983, BIOCHEM BIOPH RES CO, V112, P502, DOI 10.1016/0006-291X(83)91493-6; SANJANWALA M, 1989, ARCH BIOCHEM BIOPHYS, V271, P407, DOI 10.1016/0003-9861(89)90290-7; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; YAMADA K, 1977, ARCH BIOCHEM BIOPHYS, V183, P281, DOI 10.1016/0003-9861(77)90441-6; Yamashita S, 1981, Methods Enzymol, V71 Pt C, P528; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200	52	80	92	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30562	30569		10.1074/jbc.M706326200	http://dx.doi.org/10.1074/jbc.M706326200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726007	hybrid			2022-12-25	WOS:000250136300024
J	Young, JM; Waters, H; Dong, C; Fulle, HJ; Liman, ER				Young, Janet M.; Waters, Hang; Dong, Cora; Fuelle, Hans-Juergen; Liman, Emily R.			Degeneration of the Olfactory Guanylyl Cyclase D Gene during Primate Evolution	PLOS ONE			English	Article								Background. The mammalian olfactory system consists of several subsystems that detect specific sets of chemical cues and underlie a variety of behavioral responses. Within the main olfactory epithelium at least three distinct types of chemosensory neurons can be defined by their expression of unique sets of signal transduction components. In rodents, one set of neurons expresses the olfactory-specific guanylyl cyclase (GC)-D gene (Gucy2d, guanylyl cyclase 2d) and other cell-type specific molecules. GC-D-positive neurons project their axons to a small group of atypical "necklace" glomeruli in the olfactory bulb, some of which are activated in response to suckling in neonatal rodents and to atmospheric CO2 in adult mice. Because GC-D is a pseudogene in humans, signaling through this system appears to have been lost at some point in primate evolution. Principal Findings. Here we used a combination of bioinformatic analysis of trace-archive and genome-assembly data and sequencing of PCR-amplified genomic DNA to determine when during primate evolution the functional gene was lost. Our analysis reveals that GC-D is a pseudogene in a large number of primate species, including apes, Old World and New World monkeys and tarsier. In contrast, the gene appears intact and has evolved under purifying selection in mouse, rat, dog, lemur and bushbaby. Conclusions. These data suggest that signaling through GC-D-expressing cells was probably compromised more than 40 million years ago, prior to the divergence of New World monkeys from Old World monkeys and apes, and thus cannot be involved in chemosensation in most primates.	[Waters, Hang; Dong, Cora; Liman, Emily R.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Young, Janet M.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Fuelle, Hans-Juergen] Univ So Calif, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90089 USA; Univ So Calif, Dept Ophthalmol, Keck Sch Med, Los Angeles, CA 90089 USA; [Liman, Emily R.] Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; Fred Hutchinson Cancer Center; University of Southern California; University of Southern California; University of Southern California	Liman, ER (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	jayoung@fhcrc.org; Liman@usc.edu	Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496	NIH [DC004564, DC004209, DC004281]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004281, R01DC004564, R01DC004209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: Our work was funded by three NIH grants: DC004564 to Emily Liman, DC004209 to Barbara Trask and DC004281 to Hans-Jurgen Fulle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gimelbrant AA, 2004, P NATL ACAD SCI USA, V101, P9019, DOI 10.1073/pnas.0401566101; Giorgi D, 2000, GENOME RES, V10, P1979, DOI 10.1101/gr.10.12.1979; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GREER CA, 1982, J NEUROSCI, V2, P1744; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; KIMCHI T, 2007, NATURE IN PRESS; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Potter LR, 2005, FRONT BIOSCI-LANDMRK, V10, P1205, DOI 10.2741/1613; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; RISSER JM, 1987, BRAIN RES BULL, V19, P275, DOI 10.1016/0361-9230(87)90093-1; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 2002, CURR BIOL, V12, pR409, DOI 10.1016/S0960-9822(02)00909-0; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Smith TD, 2001, ANAT RECORD, V265, P176, DOI 10.1002/ar.1152; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; Tian HK, 2004, J NEUROSCI, V24, P8383, DOI 10.1523/JNEUROSCI.2222-04.2004; Yamagami S, 2005, ZOOL SCI, V22, P819, DOI 10.2108/zsj.22.819; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100	50	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e884	10.1371/journal.pone.0000884	http://dx.doi.org/10.1371/journal.pone.0000884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849013	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455600030
J	Miranda, A; Morgan, M; Jamal, L; Laserson, K; Barreira, D; Silva, G; Santos, J; Wells, C; Paine, P; Garrett, D				Miranda, Abraham; Morgan, Meade; Jamal, Leda; Laserson, Kayla; Barreira, Draurio; Silva, Guida; Santos, Joseney; Wells, Charles; Paine, Patricia; Garrett, Denise			Impact of Antiretroviral Therapy on the Incidence of Tuberculosis: The Brazilian Experience, 1995-2001	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-ASSOCIATED TUBERCULOSIS; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-1-INFECTED PATIENTS; MORTALITY; INFECTION; RISK; ERA; PROPHYLAXIS; MORBIDITY	Background. The human immunodeficiency virus (HIV) fuels tuberculosis (TB) epidemics. In controlled clinical trials, antiretroviral therapy (ART) reduces TB incidence in HIV-infected patients. In this study we determine if, under programmatic conditions, Brazil's policy of universal ART access has impacted TB incidence among HIV-infected patients. Methods. We abstracted clinical information from records of HIV-infected patients managed in the public sector in 11 Brazilian states between 1/1/1995 and 12/31/2001. Case ascertainment (TB and HIV) utilized guidelines (with added stringency) published by Brazil's Ministry of Health. We determined TB incidence and hazards ratio (HR) for ART-naive and ART-treated [including highly active ART (HAART)] patients employing Cox proportional hazards analysis. Results. Information from 463 HIV-infected patients met study criteria. The median age of the study population was 34 years, 70% were male, and mean follow-up to primary endpoints-TB, death, and last clinic visit-was 330, 1059, and 1125 days, respectively. Of the 463 patients, 76 (16%) remained ART-naive. Of the patients who never received HAART (n = 157) 81 were treated with ART non-HAART. Of the patients who received any ART (n = 387), 306 were treated with HAART (includes those patients who later switched from ART non-HAART to HAART). Tuberculosis developed in 39/463 (8%) patients. Compared to HAART- and ART non-HAART-treated patient groups, TB incidence was 10- (p<0.001) and 2.5-fold (p = 0.03) higher in ART-naive patients, respectively. The median baseline absolute CD4+ T-lymphocyte count for patients who developed TB was not significantly different from that of patients who remained TB free. In multivariate analysis, the incidence of TB was statistically significantly lower in HAART- treated [HR 0.2; 95% (CI 0.1, 0.6); p<0.01] compared to ART naive patients. A baseline CD4+ T-lymphocyte count <200 cells/mm(3) [HR 2.5; (95% CI 1.2, 5.4); p<0.01], prior hospitalization [HR 4.2; (95% CI 2.0, 8.8); p<0.001], prior incarceration [HR 4.1; 95% CI 1.6, 10.3); p<0.01], and a positive tuberculin skin test [HR 3.1; (95% CI 1.1, 9.0); p = 0.04] were independently and positively associated with incident TB. Conclusion. In this population-based study we demonstrate an 80% reduction in incident TB, under programmatic conditions, in HAART- treated HIV-infected patients compared to ART-naive patients.	[Miranda, Abraham; Morgan, Meade; Laserson, Kayla] US Ctr Dis Control & Prevent, Global AIDS Program, Atlanta, GA USA; [Miranda, Abraham; Wells, Charles] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Jamal, Leda] State Sao Paulo Dept Hlth, Ctr Referencia & Treinamento DST AIDS, STD AIDS Program State Sao Paulo, Sao Paulo, Brazil; [Laserson, Kayla] US Ctr Dis Control & Prevent, Off Director, Off Global Hlth Coordinator, Atlanta, GA USA; [Barreira, Draurio] Brazil Minist Hlth, Programa Nacl DST AIDS, Brasilia, DF, Brazil; [Silva, Guida; Santos, Joseney; Paine, Patricia; Garrett, Denise] Brazil Minist Hlth, Programa Nacl Controle TB, Brasilia, DF, Brazil; [Garrett, Denise] Int Union TB & Lung Dis, Paris, France	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Miranda, A (corresponding author), US Ctr Dis Control & Prevent, Global AIDS Program, Atlanta, GA USA.	aci5@cdc.gov; garrettdo@yahoo.com			The US Agency for International Development (USAID)	The US Agency for International Development (USAID)(United States Agency for International Development (USAID))	The US Agency for International Development (USAID) provided financial support for this project but had no role in the design or conduct of the study, in the collection, analysis, or interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Badri M, 2002, INT J TUBERC LUNG D, V6, P231; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bleed D, 2000, Curr Opin Pulm Med, V6, P174, DOI 10.1097/00063198-200005000-00002; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Carmody ER, 2003, TROP MED INT HEALTH, V8, P378, DOI 10.1046/j.1365-3156.2003.01046.x; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; DIPERRI G, 1989, LANCET, V2, P1502; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; GODREYFAUSSETT P, 2003, TUBERCULOSIS, V83, P68; Grant AD, 1997, AIDS, V11, P1357, DOI 10.1097/00002030-199711000-00010; Hopewell PC, 2000, LUNG BIOL HEALTH DIS, P525; Hung CC, 2003, AIDS, V17, P2615, DOI 10.1097/00002030-200312050-00008; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; JORDA R, 2002, BRIT MED J, V325, P757; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Levi GC, 2002, AIDS, V16, P2373, DOI 10.1097/00002030-200212060-00001; Lienhardt C, 1997, INT J TUBERC LUNG D, V1, P196; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; Maher D, 2005, INT J TUBERC LUNG D, V9, P17; *MIN SAUD BRAS PRO, 2006, REC TER ANT AD AD IN; *MIN SAUD BRAS SEC, 2002, MAN TECN CONTR TUB C; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; *WHO, 2006, TUB INF CONTR ER EXP; *WHO, 2002, WHOCDSTB2002296; *WHO, 1995, WHOHTMTB2004336, P27; *WHO, 2002, WHOHTMTB2004330; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; WHO, 2007, WHOHTMTB2007376; *WHO, 2004, 3 5 PROGR REP; WHO/UNAIDS, 1999, WEEKLY EPIDEMIOLOGIC, V74, P385; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Wolday H, 2003, INT J TUBERC LUNG D, V7, P110; World Health Organization, 2002, SCAL ANT THER RES LT	49	63	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e826	10.1371/journal.pone.0000826	http://dx.doi.org/10.1371/journal.pone.0000826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786198	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455500010
J	Willberg, CB; Ward, SM; Clayton, RF; Naoumov, NV; McCormick, C; Proto, S; Harris, M; Patel, AH; Klenerman, P				Willberg, Christian B.; Ward, Scott M.; Clayton, Reginald F.; Naoumov, Nikolai V.; McCormick, Christopher; Proto, Sandra; Harris, Mark; Patel, Arvind H.; Klenerman, Paul			Protection of Hepatocytes from Cytotoxic T Cell Mediated Killing by Interferon-Alpha	PLOS ONE			English	Article								Background. Cellular immunity plays a key role in determining the outcome of hepatitis C virus (HCV) infection, although the majority of infections become persistent. The mechanisms behind persistence are still not clear; however, the primary site of infection, the liver, may be critical. We investigated the ability of CD8+ T-cells (CTL) to recognise and kill hepatocytes under cytokine stimulation. Methods/Principle Findings. Resting hepatocytes cell lines expressed low levels of MHC Class I, but remained susceptible to CTL cytotoxicity. IFN-alpha treatment, in vitro, markedly increased hepatocyte MHC Class I expression, however, reduced sensitivity to CTL cytotoxicity. IFN-alpha stimulated hepatocyte lines were still able to present antigen and induce IFN-gamma expression in interacting CTL. Resistance to killing was not due to the inhibition of the FASL/FAS-pathway, as stimulated hepatocytes were still susceptible to FAS-mediated apoptosis. In vitro stimulation with IFN-alpha, or the introduction of a subgenomic HCV replicon into the HepG2 line, upregulated the expression of the granzyme-B inhibitor-proteinase inhibitor 9 (PI-9). PI-9 expression was also observed in liver tissue biopsies from patients with chronic HCV infection. Conclusion/Significance. IFN-alpha induces resistance in hepatocytes to perforin/granzyme mediate CTL killing pathways. One possible mechanism could be through the expression of the PI-9. Hindrance of CTL cytotoxicity could contribute to the chronicity of hepatic viral infections.	[Willberg, Christian B.; Ward, Scott M.; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford, England; [Clayton, Reginald F.; Patel, Arvind H.] MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Naoumov, Nikolai V.; Proto, Sandra] UCL, Inst Hepatol, London, England; [McCormick, Christopher; Harris, Mark] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Willberg, Christian B.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Ward, Scott M.] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [McCormick, Christopher] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England	University of Oxford; University of London; University College London; University of Leeds; University of California System; University of California San Francisco; University of Southampton	Klenerman, P (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	paul.klenerman@medawar.ox.ac.uk		McCormick, Christopher/0000-0002-6155-9161; Willberg, Christian/0000-0001-5299-9344; Phillips, Sandra/0000-0002-3720-6470; klenerman, paul/0000-0003-4307-9161; Harris, Mark/0000-0002-9821-1003	BBSRC; European Union Virgil Network; Wellcome Trust; Medical Research Council, United Kingdom; MRC [MC_U130184144] Funding Source: UKRI; Medical Research Council [MC_U130184144] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Virgil Network; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the BBSRC, European Union Virgil Network, Wellcome Trust, and Medical Research Council, United Kingdom.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Barrie MB, 2004, J IMMUNOL, V172, P6453, DOI 10.4049/jimmunol.172.10.6453; BERTOLETTI A, 1994, J EXP MED, V180, P933, DOI 10.1084/jem.180.3.933; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; CALNE RY, 1969, LANCET, V2, P940; Chisari FV, 1997, J CLIN INVEST, V99, P1472, DOI 10.1172/JCI119308; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; Ehl S, 1998, CELL IMMUNOL, V189, P67, DOI 10.1006/cimm.1998.1344; Eisenberger C F, 1994, Transpl Int, V7 Suppl 1, pS163; Gugenheim J, 1996, EUR SURG RES, V28, P256, DOI 10.1159/000129464; Guidotti LG, 2000, J EXP MED, V191, P1247, DOI 10.1084/jem.191.7.1247; Guidotti LG, 1999, J EXP MED, V189, P1555, DOI 10.1084/jem.189.10.1555; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Jensen ER, 1998, INFECT IMMUN, V66, P4143; Jin YD, 1997, J CLIN IMMUNOL, V17, P140, DOI 10.1023/A:1027326415164; Kafrouni MI, 2001, J IMMUNOL, V167, P1566, DOI 10.4049/jimmunol.167.3.1566; LAU JYN, 1993, DIGEST DIS SCI, V38, P888, DOI 10.1007/BF01295916; Lechner F, 2001, REV MED VIROL, V11, P11, DOI 10.1002/rmv.295; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Li XK, 2001, TRANSPLANTATION, V71, P503, DOI 10.1097/00007890-200102270-00004; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; McCormick CJ, 2004, J GEN VIROL, V85, P429, DOI 10.1099/vir.0.19676-0; McCormick CJ, 2002, J GEN VIROL, V83, P383, DOI 10.1099/0022-1317-83-2-383; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; Schultz UA, 1999, J VIROL, V73, P3162, DOI 10.1128/JVI.73.4.3162-3168.1999; Sheehy ME, 2001, J IMMUNOL METHODS, V249, P99, DOI 10.1016/S0022-1759(00)00329-X; SO SKS, 1987, TRANSPLANTATION, V43, P79, DOI 10.1097/00007890-198701000-00018; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Tsuzuki S, 2003, BIOCHEM J, V372, P227, DOI 10.1042/BJ20021891; UDA K, 1994, J SURG RES, V57, P563, DOI 10.1006/jsre.1994.1183; WKLY EPIDEMIOL REC, V74, P425	40	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e791	10.1371/journal.pone.0000791	http://dx.doi.org/10.1371/journal.pone.0000791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726521	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000207455400008
J	Munoz-Fontela, C; Garcia, MA; Garcia-Cao, I; Collado, M; Arroyo, J; Esteban, M; Serrano, M; Rivas, C				Munoz-Fontela, C; Garcia, MA; Garcia-Cao, I; Collado, M; Arroyo, J; Esteban, M; Serrano, M; Rivas, C			Resistance to viral infection of super p53 mice	ONCOGENE			English	Article						p53; vesicular stomatitis virus; vaccinia virus; tumor suppressor; antiviral activity; `super p53' mice	VESICULAR STOMATITIS-VIRUS; SV40-TRANSFORMED CELLS; ONCOLYTIC VIRUS; APOPTOSIS; ANTIGEN; INDUCTION; REPLICATION; ACTIVATION; CARCINOMA; PROTEINS	Induction of expression of the tumor suppressor p53 after interferon treatment has been recently demonstrated (Takaoka et al., 2003), suggesting an antiviral activity of the protein. In addition, a direct correlation between p53 levels and tumor resistance has been addressed by generating mice with an extra copy of p53 ('super p53' mice) (Garcia-Cao et al., 2002). Here, we show that vesicular stomatitis virus replication in mouse embryo fibroblasts derived from 'super p53' mice is impaired as a result of apoptosis induction via p53 activation. These findings unequivocally demonstrate an antiviral activity of p53, a process that may contribute to inhibit the spread of the virus in vivo.	Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, Madrid, Spain; CNIO, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Oncologicas (CNIO)	Rivas, C (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal SN, E-28040 Madrid, Spain.	mdcrivas@farm.ucm.es	Arroyo, Javier/E-9308-2016; Garcia, Maria Angel MA/I-5116-2016; Rivas, Carmen/AAB-6278-2019; Collado, Manuel/K-8140-2014; Serrano, Manuel/H-2634-2015; Rivas, Carmen/L-3162-2017	Arroyo, Javier/0000-0002-1971-1721; Garcia, Maria Angel MA/0000-0003-2003-3769; Rivas, Carmen/0000-0002-0518-7199; Collado, Manuel/0000-0002-0330-0880; Serrano, Manuel/0000-0001-7177-9312; Rivas, Carmen/0000-0002-0518-7199; ESTEBAN, MARIANO/0000-0003-0846-2827; Munoz-Fontela, Cesar/0000-0002-7725-2586				Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Balachandran S, 2000, IUBMB LIFE, V50, P135, DOI 10.1080/15216540050212169; Clemens MJ, 2003, J INTERF CYTOK RES, V23, P277, DOI 10.1089/107999003766628124; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; FEITELSON MA, 1993, ONCOGENE, V8, P1109; Gadaleta P, 2002, VIRUS RES, V86, P87, DOI 10.1016/S0168-1702(02)00049-7; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Giedlin MA, 2003, CANCER CELL, V4, P241, DOI 10.1016/S1535-6108(03)00251-4; GONZALO JA, 1994, EUR J IMMUNOL, V24, P48, DOI 10.1002/eji.1830240108; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; KAO CC, 1990, VIROLOGY, V179, P806, DOI 10.1016/0042-6822(90)90148-K; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Kopecky SA, 2001, J VIROL, V75, P12169, DOI 10.1128/JVI.75.24.12169-12181.2001; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; Pluquet O, 2001, CANCER LETT, V174, P1, DOI 10.1016/S0304-3835(01)00698-X; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Sur JH, 2003, VET PATHOL, V40, P512, DOI 10.1354/vp.40-5-512; SZEKELY L, 1993, P NATL ACAD SCI USA, V90, P5455, DOI 10.1073/pnas.90.12.5455; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; WAGNER RR, 1996, FIELDS VIROLOGY	28	59	64	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2005	24	18					3059	3062		10.1038/sj.onc.1208477	http://dx.doi.org/10.1038/sj.onc.1208477			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	919WY	17726827	Bronze			2022-12-25	WOS:000228649500016
J	Hafner, N; Driesch, C; Gajda, M; Jansen, L; Kirchmayr, R; Runnebaum, IB; Durst, M				Hafner, N.; Driesch, C.; Gajda, M.; Jansen, L.; Kirchmayr, R.; Runnebaum, I. B.; Duerst, M.			Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts	ONCOGENE			English	Article						cervical cancer; HPV16; oncogene expression; physical state; integration	HUMAN-PAPILLOMAVIRUS TYPE-16; RISK HUMAN-PAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; DNA-REPLICATION; E7 ONCOPROTEIN; MESSENGER-RNA; CANCER-CELLS; DIPS-PCR	Virus integration into the host genome is a characteristic step during cervical carcinogenesis. Experimental data provide evidence that integration could result in increased levels of oncogene (E6/E7) transcripts. This is the first study in which the level of viral transcripts is correlated to the physical state of the viral genome in cervical intraepithelial neoplasia (CIN) and cervical carcinomas (CxCa). Using the APOT-assayinteg rate-derived transcripts only were detected in 3/28 (11%) CIN and in 28/55 (51%) carcinomas, respectively. The remaining biopsies contained either episome-derived transcripts only or both mRNA species. SybrGreen real time reverse transcriptase-PCR assays were used to quantify viral gene expression for (i) all transcripts initiated from p97, (ii) full-length E6, (iii) E6*I and (iv) E5 transcripts (E6/E7) transcript levels showed a broad distribution but similar median values irrespective of histopathological grading and physical state of the viral genome. Biopsies with integrate-derived transcripts only generally lacked E5-specific mRNA. Our data do not support the hypothesis that HPV integration invariably results in high levels of oncogene transcripts. Instead, constitutive expression of oncogene transcripts rather than the level of expression appears to be decisive for transformation and the maintenance of the malignant phenotype.	[Hafner, N.; Driesch, C.; Jansen, L.; Runnebaum, I. B.; Duerst, M.] FSU Jena, Frauenklin, D-07743 Jena, Germany; [Gajda, M.] Klinikum Friedrich Schiller Univ, Inst Pathol, Jena, Germany; [Kirchmayr, R.] Gynakol Praxis, Ulm, Germany	Friedrich Schiller University of Jena	Durst, M (corresponding author), FSU Jena, Frauenklin, Bachstr 18, D-07743 Jena, Germany.	matthias.duerst@med.uni-jena.de	Häfner, Norman/B-6892-2012	Häfner, Norman/0000-0002-7012-483X				Alazawi W, 2002, CANCER RES, V62, P6959; Andersson S, 2006, INT J ONCOL, V29, P705; Arends MJ, 1998, J CLIN PATHOL, V51, P96, DOI 10.1136/jcp.51.2.96; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; De Marco L, 2007, J CLIN VIROL, V38, P7, DOI 10.1016/j.jcv.2006.09.008; DOEBERITZ MV, 1991, P NATL ACAD SCI USA, V88, P1411, DOI 10.1073/pnas.88.4.1411; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; DURST M, 1992, VIROLOGY, V189, P132, DOI 10.1016/0042-6822(92)90688-L; Durst M, 1995, CANCER GENET CYTOGEN, V85, P105, DOI 10.1016/0165-4608(95)00155-7; DURST M, 1987, ONCOGENE, V1, P251; FALCINELLI C, 1993, J MED VIROL, V40, P261, DOI 10.1002/jmv.1890400402; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hammerly C, 2022, LINGUIST INQ, V53, P823, DOI 10.1162/ling_a_00422; Hopman AHN, 2005, INT J CANCER, V115, P419, DOI 10.1002/ijc.20862; Itoshima T, 2000, CLIN CANCER RES, V6, P2851; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Klaes R, 1999, CANCER RES, V59, P6132; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; Molden T, 2005, CANCER EPIDEM BIOMAR, V14, P367, DOI 10.1158/1055-9965.EPI-04-0410; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munoz N, 1992, IARC Sci Publ, P251; Nakagawa S, 2000, J MED VIROL, V62, P251, DOI 10.1002/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett MR, 2004, CANCER RES, V64, P1359, DOI 10.1158/0008-5472.CAN-03-3214; Riethdorf S, 2001, INT J GYNECOL PATHOL, V20, P177, DOI 10.1097/00004347-200104000-00011; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SEDMAN SA, 1991, J VIROL, V65, P4860, DOI 10.1128/JVI.65.9.4860-4866.1991; SolinasToldo S, 1997, P NATL ACAD SCI USA, V94, P3854, DOI 10.1073/pnas.94.8.3854; Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; ZerfassThome K, 1996, ONCOGENE, V13, P2323; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	44	94	99	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2008	27	11					1610	1617		10.1038/sj.onc.1210791	http://dx.doi.org/10.1038/sj.onc.1210791			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17828299				2022-12-25	WOS:000253815800013
J	Radhakrishnan, SK; Bhat, UG; Halasi, M; Gartel, AL				Radhakrishnan, S. K.; Bhat, U. G.; Halasi, M.; Gartel, A. L.			P-TEFb inhibitors interfere with activation of p53 by DNA-damaging agents	ONCOGENE			English	Article						P-TEFb; ARC; flavopiridol; p53; phosphorylation; DNA-damaging agents	DEPENDENT PROTEIN-KINASE; TUMOR-CELLS; PHOSPHORYLATION; APOPTOSIS; DOXORUBICIN	Tumor suppressor p53 is stabilized in response to c-irradiation or treatment with DNA-damaging agents, and as a result p53 transcriptionally activates its targets leading to cell-cycle arrest or apoptosis. P-TEFb (positive transcription elongation factor b) inhibitors such as flavopiridol or 4-amino-6-hydrazino-7-b-d-ribofuranosyl-7H- pyrrolo[2,3-d]-pyrimidine-5-carboxamide (ARC) upregulate p53 protein levels, but inhibit the expression of its targets p21 and hdm2. DNA-damaging agents, doxorubicin and cisplatin are being used in combination with P-TEFb inhibitor flavopiridol in clinical trials for the treatment of some cancer patients. In this study, we found that P-TEFb inhibitors block the phosphorylation of p53 induced by doxorubicin. Furthermore, treatment of cells with P-TEFb inhibitors together with doxorubicin inhibits doxorubicin-induced binding of p53 to DNA and p53 transcriptional activity. These data suggest that P-TEFb inhibitors may antagonize the activation of p53 by DNA-damaging agents in tumors with wild-type p53.	[Radhakrishnan, S. K.; Bhat, U. G.; Halasi, M.; Gartel, A. L.] Univ Illinois, Dept Med, Coll Med, Chicago, IL 60612 USA; [Radhakrishnan, S. K.; Gartel, A. L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Halasi, M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gartel, AL (corresponding author), Univ Illinois, Dept Med, Coll Med, 840 S Wood St,Room 1041, Chicago, IL 60612 USA.	agartel@uic.edu		Radhakrishnan, Senthil/0000-0002-5211-9498				Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Bible KC, 2005, CLIN CANCER RES, V11, P5935, DOI 10.1158/1078-0432.CCR-04-2566; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Demidenko ZN, 2004, CANCER RES, V64, P3653, DOI 10.1158/0008-5472.CAN-04-0204; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guillot C, 1997, ONCOGENE, V14, P45, DOI 10.1038/sj.onc.1200803; Jack MT, 2004, J BIOL CHEM, V279, P15269, DOI 10.1074/jbc.M309917200; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Radhakrishnan SK, 2006, CANCER RES, V66, P3264, DOI 10.1158/0008-5472.CAN-05-3940; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, NAT CELL BIOL, V2, pE178, DOI 10.1038/35036427; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343	19	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 21	2008	27	9					1306	1309		10.1038/sj.onc.1210737	http://dx.doi.org/10.1038/sj.onc.1210737			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17724473				2022-12-25	WOS:000253407000013
J	Ammirante, M; Rosati, A; Gentilella, A; Festa, M; Petrella, A; Marzullo, L; Pascale, M; Belisario, MA; Leone, A; Turco, MC				Ammirante, M.; Rosati, A.; Gentilella, A.; Festa, M.; Petrella, A.; Marzullo, L.; Pascale, M.; Belisario, M. A.; Leone, A.; Turco, M. C.			The activity of hsp90 alpha promoter is regulated by NF-kappa B transcription factors	ONCOGENE			English	Article						hsp90 alpha; NF-kappa B; heat shock proteins	CELL APOPTOSIS; IKK; PROTEIN; HSP90	Heat-shock proteins ( HSP) 90 exert a relevant role in the survival and response to therapy of many neoplastic cell types. Here, we show that the promoter of hsp90 alpha gene, that encodes the inducible form of HSP90, is regulated by nuclear factor-kappa B (NF-kappa B) activity. Indeed, we found that NF-kappa B factors bound to one of the two putative consensus sequences present in the hsp90 alpha-flanking region; mutation of such motif hampered the phorbol-myristate-13-acetate-stimulated expression of a luciferase reporter gene under the control of the hsp90a promoter. Furthermore, the downmodulation of NF-kappa B ( p65) levels by a specific small interfering ( si) RNA resulted in reducing the levels of endogenous HSP90 alpha protein. These findings disclose a previously unrecognized mechanism that contributes to connect NF-kappa B factors and HSPs in cell defence machinery.	[Ammirante, M.; Rosati, A.; Gentilella, A.; Festa, M.; Petrella, A.; Marzullo, L.; Pascale, M.; Belisario, M. A.; Leone, A.; Turco, M. C.] Univ Salerno, Dept Pharmaceut Sci, I-84084 Fisciano, SA, Italy	University of Salerno	Turco, MC (corresponding author), Univ Salerno, Dept Pharmaceut Sci, Via Ponte Don Melillo, I-84084 Fisciano, SA, Italy.	mcturco@unisa.it	belisario, maria antonietta/B-4762-2012; Pascale, Maria/B-4273-2012; TURCO, Maria Caterina/AAC-5282-2022; Marzullo, Liberato/C-4408-2008; Gentilella, Antonio/AAA-9864-2020; Petrella, Antonello/E-7708-2012	TURCO, Maria Caterina/0000-0002-7835-359X; Marzullo, Liberato/0000-0001-6133-4483; PETRELLA, Antonello/0000-0002-6945-5295				Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Maiuri MC, 2004, AM J PATHOL, V165, P115, DOI 10.1016/S0002-9440(10)63280-4; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Pittet JF, 2005, J IMMUNOL, V174, P384, DOI 10.4049/jimmunol.174.1.384; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Richter K, 2007, NAT STRUCT MOL BIOL, V14, P90, DOI 10.1038/nsmb0207-90; Romano MF, 1999, BLOOD, V94, P4060, DOI 10.1182/blood.V94.12.4060.424k23_4060_4066; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	14	56	60	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2008	27	8					1175	1178		10.1038/sj.onc.1210716	http://dx.doi.org/10.1038/sj.onc.1210716			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	262GJ	17724475				2022-12-25	WOS:000253136700017
J	Radhakrishnan, SK; Halasi, M; Bhat, UG; Kurmasheva, RT; Houghton, PJ; Gartel, AL				Radhakrishnan, S. K.; Halasi, M.; Bhat, U. G.; Kurmasheva, R. T.; Houghton, P. J.; Gartel, A. L.			Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells	ONCOGENE			English	Article						ARC; neuroblastoma; survivin; Mcl-1; Akt; N-myc	HIGH-RISK NEUROBLASTOMA; APOPTOSIS; TRANSPLANTATION; CHEMOTHERAPY; INHIBITOR; SURVIVAL; PROTEIN; EXPRESSION; REPRESSION; IRINOTECAN	We have previously described the identification of a nucleoside analog transcriptional inhibitor ARC (4-amino- 6-hydrazino-7-beta-D-ribofuranosyl-7H-pyrrolo[ 2,3-d]- pyrimidine-5-carboxamide) that was able to induce apoptosis in cancer cell lines of different origin. Here, we report the characterization of ARC on a panel of neuroblastoma cell lines. We found that these cell lines were more than 10-fold sensitive to ARC than to the well-known nucleoside analog DRB (5,6-dichloro-1-beta-Dribofuranosylbenzimidazole), and that ARC-induced apoptosis proceeds through mitochondrial injury. Also, we observed that ARC-mediated cell death was accompanied by caspase-3 cleavage and repression of antiapoptotic proteins such as Mcl-1 and survivin. Conversely, we found that overexpression of Mcl-1-protected neuroblastoma cell line NB-1691 from ARC-induced apoptosis. Furthermore, we found that while ARC inhibited the phosphorylation of Akt Ser-473 in multiple cancer cell lines, forced expression of myristoylated Akt promoted resistance to ARC-induced apoptosis in neuroblastoma cells. In addition, we observed that ARC was able to downregulate the protein levels of N-myc, a commonly amplified oncogene in neuroblastomas, and Akt protected N-myc from ARC-induced downregulation. These data suggest that ARC may antagonize different antiapoptotic pathways and induce apoptosis in neuroblastoma cells via multiple mechanisms. Overall, ARC could represent an attractive candidate for anticancer drug development against neuroblastomas.	[Radhakrishnan, S. K.; Bhat, U. G.; Gartel, A. L.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Radhakrishnan, S. K.; Gartel, A. L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Halasi, M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60680 USA; [Kurmasheva, R. T.; Houghton, P. J.] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; St Jude Children's Research Hospital	Gartel, AL (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,Room 1041, Chicago, IL 60612 USA.	agartel@uic.edu	Houghton, Peter/E-3265-2011	Radhakrishnan, Senthil/0000-0002-5211-9498	NCI NIH HHS [CA96696, CA23099] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096696, P01CA023099] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Castel V, 2001, MED PEDIATR ONCOL, V37, P537, DOI 10.1002/mpo.1248; Castel V, 2000, MED PEDIATR ONCOL, V35, P724, DOI 10.1002/1096-911X(20001201)35:6<724::AID-MPO53>3.0.CO;2-U; Castillo S, 2004, ATHEROSCLEROSIS SUPP, V5, P80, DOI 10.1016/S1567-5688(04)90347-4; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Donfrancesco A, 2004, ACTA PAEDIATR, V93, P6, DOI 10.0180/08035320310021165; DuBois SG, 1999, J PEDIAT HEMATOL ONC, V21, P181, DOI 10.1097/00043426-199905000-00005; Furman WL, 1999, J CLIN ONCOL, V17, P1815, DOI 10.1200/JCO.1999.17.6.1815; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Goldsby Robert E, 2004, Paediatr Drugs, V6, P107, DOI 10.2165/00148581-200406020-00004; Houghton PJ, 2002, J PEDIAT HEMATOL ONC, V24, P84, DOI 10.1097/00043426-200202000-00002; Imaizumi M, 2001, TOHOKU J EXP MED, V195, P73, DOI 10.1620/tjem.195.73; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kaneko M, 2002, J PEDIAT HEMATOL ONC, V24, P613, DOI 10.1097/00043426-200211000-00004; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Ma YH, 2003, MOL CANCER THER, V2, P73; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Newcomb EW, 2003, CELL CYCLE, V2, P243, DOI 10.4161/cc.2.3.357; Norris MD, 1996, NEW ENGL J MED, V334, P231, DOI 10.1056/NEJM199601253340405; Peng J, 1998, COLD SPRING HARB SYM, V63, P365, DOI 10.1101/sqb.1998.63.365; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Radhakrishnan SK, 2006, CANCER RES, V66, P3264, DOI 10.1158/0008-5472.CAN-05-3940; Radhakrishnan SK, 2005, CELL CYCLE, V4, P582, DOI 10.4161/cc.4.4.1583; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Thompson J, 1999, CLIN CANCER RES, V5, P3617; Thompson J, 2001, CANCER CHEMOTH PHARM, V47, P211, DOI 10.1007/s002800000235; Valteau-Couanet D, 2000, BONE MARROW TRANSPL, V25, P937, DOI 10.1038/sj.bmt.1702376; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042	31	16	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 24	2008	27	5					694	699		10.1038/sj.onc.1210692	http://dx.doi.org/10.1038/sj.onc.1210692			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	255RK	17724478				2022-12-25	WOS:000252674900013
J	Mathew, LK; Sengupta, S; Kawakami, A; Andreasen, EA; Lohr, CV; Loynes, CA; Renshaw, SA; Peterson, RT; Tanguay, RL				Mathew, Lijoy K.; Sengupta, Sumitra; Kawakami, Atsushi; Andreasen, Eric A.; Loehr, Christiane V.; Loynes, Catherine A.; Renshaw, Stephen A.; Peterson, Randall T.; Tanguay, Robert L.			Unraveling tissue regeneration pathways using chemical genetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR ISOFORMS; CAUDAL FIN REGENERATION; APPENDAGE REGENERATION; EXPRESSION ANALYSIS; ZEBRAFISH; MECHANISMS; DISCOVERY; GROWTH; INFLAMMATION; SPECIFICITY	Identifying the molecular pathways that are required for regeneration remains one of the great challenges of regenerative medicine. Although genetic mutations have been useful for identifying some molecular pathways, small molecule probes of regenerative pathways might offer some advantages, including the ability to disrupt pathway function with precise temporal control. However, a vertebrate regeneration model amenable to rapid throughput small molecule screening is not currently available. We report here the development of a zebrafish early life stage fin regeneration model and its use in screening for small molecules that modulate tissue regeneration. By screening 2000 biologically active small molecules, we identified 17 that specifically inhibited regeneration. These compounds include a cluster of glucocorticoids, and we demonstrate that transient activation of the glucocorticoid receptor is sufficient to block regeneration, but only if activation occurs during wound healing/blastema formation. In addition, knockdown of the glucocorticoid receptor restores regenerative capability to nonregenerative, glucocorticoid-exposed zebrafish. To test whether the classical anti-inflammatory action of glucocorticoids is responsible for blocking regeneration, we prevented acute inflammation following amputation by antisense repression of the Pu.1 gene. Although loss of Pu.1 prevents the inflammatory response, regeneration is not affected. Collectively, these results indicate that signaling from exogenous glucocorticoids impairs blastema formation and limits regenerative capacity through an acute inflammation-independent mechanism. These studies also demonstrate the feasibility of exploiting chemical genetics to define the pathways that govern vertebrate regeneration.	Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; Oregon State Univ, Marine & Freshwater Biomed Sci Ctr, Corvallis, OR 97331 USA; Oregon State Univ, Dept Vet Med, Corvallis, OR 97331 USA; Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England; Massachusetts Gen Hosp, Dev Biol Lab, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Tokyo Institute of Technology; University of Sheffield; Harvard University; Massachusetts General Hospital	Tanguay, RL (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, 1007 ALS, Corvallis, OR 97331 USA.	robert.tanguay@oregonstate.edu	Sengupta, Sumitra/G-1814-2017; Renshaw, Steve/E-6192-2010; Löhr, C. V./AAU-4902-2020; Kawakami, Atsushi/D-3785-2019	Sengupta, Sumitra/0000-0003-2861-5608; Renshaw, Steve/0000-0003-1790-1641; Löhr, C. V./0000-0003-3787-5583; Kawakami, Atsushi/0000-0001-9461-6372; Peterson, Randall/0000-0003-0727-3469	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES003850, R01ES010820, P30ES000210, P30ES003850] Funding Source: NIH RePORTER; MRC [G108/595] Funding Source: UKRI; Medical Research Council [G108/595] Funding Source: Medline; NIEHS NIH HHS [R01 ES010820, ES00210, ES03850, P30 ES000210, ES10820] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; BADER D, 1978, J MORPHOL, V155, P349, DOI 10.1002/jmor.1051550307; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; CARLSTEDTDUKE J, 1987, J STEROID BIOCHEM, V27, P99, DOI 10.1016/0022-4731(87)90299-8; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Croxtall JD, 2002, BRIT J PHARMACOL, V135, P511, DOI 10.1038/sj.bjp.0704474; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Fujisawa T, 2003, DEV DYNAM, V226, P182, DOI 10.1002/dvdy.10221; Goulding NJ, 2004, CURR OPIN PHARMACOL, V4, P629, DOI 10.1016/j.coph.2004.06.009; GUSTAFSSON JA, 1987, ENDOCR REV, V8, P185, DOI 10.1210/edrv-8-2-185; Hsu K, 2004, BLOOD, V104, P1291, DOI 10.1182/blood-2003-09-3105; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Love DR, 2004, CURR OPIN BIOTECH, V15, P564, DOI 10.1016/j.copbio.2004.09.004; Lu NZ, 2006, TRENDS CELL BIOL, V16, P301, DOI 10.1016/j.tcb.2006.04.005; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oakley RH, 1999, J BIOL CHEM, V274, P27857, DOI 10.1074/jbc.274.39.27857; Oyewumi MO, 2003, BIOCONJUGATE CHEM, V14, P404, DOI 10.1021/bc0340013; Peterson RT, 2004, METHOD CELL BIOL, V76, P569; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sbafizadeh E, 2004, COMP BIOCHEM PHYS C, V138, P245, DOI 10.1016/j.cca.2004.05.003; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Schier AF, 1997, DEVELOPMENT, V124, P327; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Sekiya I, 2001, J ENDOCRINOL, V169, P573, DOI 10.1677/joe.0.1690573; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	46	140	142	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35202	35210		10.1074/jbc.M706640200	http://dx.doi.org/10.1074/jbc.M706640200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17848559	hybrid			2022-12-25	WOS:000251155200065
J	Nagai, R; Brock, JW; Blatnik, M; Baatz, JE; Bethard, J; Walla, MD; Thorpe, SR; Baynes, JW; Frizzell, N				Nagai, Ryoji; Brock, Jonathan W.; Blatnik, Matthew; Baatz, John E.; Bethard, Jennifer; Walla, Michael D.; Thorpe, Suzanne R.; Baynes, John W.; Frizzell, Norma			Succination of protein thiols during adipocyte maturation - A biomarker of mitochondrial stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-MODIFICATION; HUMAN MUSCLE; CELLS; IDENTIFICATION; METHYLGLYOXAL; GLYCATION; OXIDATION	Although obesity is a risk factor for development of type 2 diabetes and chemical modification of proteins by advanced glycoxidation and lipoxidation end products is implicated in the development of diabetic complications, little is known about the chemical modification of proteins in adipocytes or adipose tissue. In this study we show that S-(2-succinyl) cysteine (2SC), the product of chemical modification of proteins by the Krebs cycle intermediate, fumarate, is significantly increased during maturation of 3T3-L1 fibroblasts to adipocytes. Fumarate concentration increased >= 5-fold during adipogenesis in medium containing 30 mM glucose, producing a >= 10-fold increase in 2SC-proteins in adipocytes compared with undifferentiated fibroblasts grown in the same high glucose medium. The elevated glucose concentration in the medium during adipocyte maturation correlated with the increase in 2SC, whereas the concentration of the advanced glycoxidation and lipoxidation end products, N-is an element of-(carboxymethyl)lysine and N-is an element of-(carboxyethyl)lysine, was unchanged under these conditions. Adipocyte proteins were separated by one- and two-dimensional electrophoresis and similar to 60 2SC-proteins were detected using an anti-2SC polyclonal antibody. Several of the prominent and well resolved proteins were identified by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry. These include cytoskeletal proteins, enzymes, heat shock and chaperone proteins, regulatory proteins, and a fatty acid-binding protein. We propose that the increase in fumarate and 2SC is the result of mitochondrial stress in the adipocyte during adipogenesis and that 2SC may be a useful biomarker of mitochondrial stress in obesity, insulin resistance, and diabetes.	Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29243 USA; Childrens Res Hosp, Charleston, SC 29243 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Baynes, JW (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St GSRC, Columbia, SC 29208 USA.	john.baynes@sc.edu			NIDDK NIH HHS [DK 19971] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019971, R01DK019971] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Alt N, 2004, ARCH BIOCHEM BIOPHYS, V425, P200, DOI 10.1016/j.abb.2004.03.012; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Das K, 1999, BIOCHEM J, V344, P313, DOI 10.1042/0264-6021:3440313; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; GIARDINO I, 1994, J CLIN INVEST, V94, P110, DOI 10.1172/JCI117296; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Gibala MJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE239, DOI 10.1152/ajpendo.1997.272.2.E239; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; JUNG G, 1972, EUR J BIOCHEM, V24, P438, DOI 10.1111/j.1432-1033.1972.tb19704.x; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI RK, 1992, METABOLISM, V41, P545, DOI 10.1016/0026-0495(92)90216-W; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCDEVITT J, 1990, METABOLISM, V39, P1012, DOI 10.1016/0026-0495(90)90159-A; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Padival AK, 2003, FEBS LETT, V551, P113, DOI 10.1016/S0014-5793(03)00874-3; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; ROGERS KR, 1991, BIOCHEM J, V275, P789, DOI 10.1042/bj2750789; ROGERS KR, 1989, INT J TISSUE REACT, V11, P309; RUBIN AH, 1978, P NATL ACAD SCI USA, V75, P4379, DOI 10.1073/pnas.75.9.4379; Shaw J Nikki, 2002, Methods Mol Biol, V186, P129; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; TANAKA A, 1980, J CHROMATOGR, V194, P21, DOI 10.1016/S0021-9673(00)81046-8; TBARKA N, 1993, FEBS LETT, V322, P125, DOI 10.1016/0014-5793(93)81551-A; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Xiang XQ, 2002, MOL ENDOCRINOL, V16, P552, DOI 10.1210/me.16.3.552; Yu YH, 2004, AM J PHYSIOL-ENDOC M, V286, pE402, DOI 10.1152/ajpendo.00247.2003; Zeng JM, 2006, BIOCHEM J, V398, P197, DOI 10.1042/BJ20060019	35	86	87	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34219	34228		10.1074/jbc.M703551200	http://dx.doi.org/10.1074/jbc.M703551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17726021	hybrid			2022-12-25	WOS:000251145700037
J	Goransson, O; McBride, A; Hawley, SA; Ross, FA; Shpiro, N; Foretz, M; Viollet, B; Hardie, DG; Sakamoto, K				Goeransson, Olga; McBride, Andrew; Hawley, Simon A.; Ross, Fiona A.; Shpiro, Natalia; Foretz, Marc; Viollet, Benoit; Hardie, D. Grahame; Sakamoto, Kei			Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; GLUCOSE-HOMEOSTASIS; UPSTREAM KINASE; SKELETAL-MUSCLE; FATTY-ACID; RAT-LIVER; METFORMIN; PHOSPHORYLATION; INSULIN; AICAR	We have studied the mechanism of A- 769662, a new activator of AMP- activated protein kinase ( AMPK). Unlike other pharmacological activators, it directly activates native rat AMPK by mimicking both effects of AMP, i. e. allosteric activation and inhibition of dephosphorylation. We found that it has no effect on the isolated alpha subunit kinase domain, with or without the associated autoinhibitory domain, or on interaction of glycogen with the beta subunit glycogen- binding domain. Although it mimics actions of AMP, it has no effect on binding of AMP to the isolated Bateman domains of the gamma subunit. The addition of A- 769662 to mouse embryonic fibroblasts or primary mouse hepatocytes stimulates phosphorylation of acetyl- CoA carboxylase ( ACC), effects that are completely abolished in AMPK- alpha 1(-/-) alpha 2(-/-) cells but not in TAK1(-/-) mouse embryonic fibroblasts. Phosphorylation of AMPK and ACC in response to A- 769662 is also abolished in isolated mouse skeletal muscle lacking LKB1, a major upstream kinase for AMPK in this tissue. However, in HeLa cells, which lack LKB1 but express the alternate upstream kinase calmodulin- dependent protein kinase kinase-beta, phosphorylation of AMPK and ACC in response to A- 769662 still occurs. These results show that in intact cells, the effects of A- 769662 are independent of the upstream kinase utilized. We propose that this direct and specific AMPK activator will be a valuable experimental tool to understand the physiological roles of AMPK.	Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Lund Univ, Dept Expt Med Sci, Div Endocrinol Diabet & Metab, S-22184 Lund, Sweden; Univ Dundee, Coll Life Sci, Div Mol Phys, Dundee DD1 5EH, Scotland; Univ Dundee, Coll Life Sci, Div Signal Transduct Therapy, Dundee DD1 5EH, Scotland; Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; Inst Natl Sante & Rech Med, U567, F-75014 Paris, France	University of Dundee; Lund University; University of Dundee; University of Dundee; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sakamoto, K (corresponding author), Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dow St, Dundee DD1 5EH, Scotland.	k.sakamoto@dundee.ac.uk	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Hardie, David/Z-1979-2019; sakamoto, kei/C-8806-2019; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; sakamoto, kei/0000-0001-8839-5980; FORETZ, Marc/0000-0001-7017-9032; Goransson, Olga/0000-0002-7209-8022; Hardie, Grahame/0000-0002-8373-7379	Medical Research Council [MC_U127088492] Funding Source: Medline; Wellcome Trust [080982] Funding Source: Medline; MRC [MC_U127088492] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAILEY CJ, 1992, BRIT J PHARMACOL, V105, P1009, DOI 10.1111/j.1476-5381.1992.tb09093.x; BAIN J, 2007, IN PRESS BIOCH J; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Iyengar R. R., 2005, U.S. Patent, Patent No. [0,038,068 A1, 0038068]; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KOEPSELL H, 2007, PHARM RES; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Longnus SL, 2003, AM J PHYSIOL-REG I, V284, pR936, DOI 10.1152/ajpregu.00319.2002; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	60	331	343	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32549	32560		10.1074/jbc.M706536200	http://dx.doi.org/10.1074/jbc.M706536200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855357	Green Accepted, hybrid			2022-12-25	WOS:000250625400004
J	Xie, Y; Luo, J; Kennedy, S; Davidson, NO				Xie, Yan; Luo, Jianyang; Kennedy, Susan; Davidson, Nicholas O.			Conditional intestinal lipotoxicity in Apobec-1(-/-) Mttp-IKO mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL TRANSFER PROTEIN; ENDOPLASMIC-RETICULUM STRESS; APOLIPOPROTEIN-B; CELL-DEATH; APO-B; DEVELOPMENTAL REGULATION; CATALYTIC SUBUNIT; SECRETION; LIVER	Mammalian small intestinal lipid absorption requires the coordinated interactions of apolipoprotein B ( apoB) and the microsomal triglyceride transfer protein ( Mttp). The observation that apoB100 displays greater dependence on Mttp availability than does apoB48 prompted us to examine the phenotype of Mttp deletion in an Apobec-1(-/-) background ( i. e. apoB100 Mttp-IKO). 20% apoB100 Mttp-IKO mice died on a chow diet, and > 90% died following high fat feeding ( versus 0 and 11% apoB48 Mttp-IKO mice, respectively). Intestinal adaptation occurred in apoB48 Mttp-IKO mice in response to high fat feeding, evidenced by increased bromodeoxyuridine incorporation and villus lengthening, changes that did not occur in apoB100 Mttp-IKO mice. There was an exaggerated unfolded protein response ( UPR), which became more pronounced in apoB100 Mttp-IKO mice. To examine the role of endoplasmic reticulum stress and the UPR in the lipotoxic effects of Mttp deletion, we administered tauroursodeoxycholate to apoB100 Mttp-IKO mice upon initiation of high fat feeding. Tauroursodeoxycholate administration abrogated the UPR but produced an unexpected acceleration in the onset of lethality in apoB100 Mttp-IKO mice. The findings demonstrate that there is activation of the UPR with lethal lipotoxicity in conditional intestinal apoB100 Mttp-IKO mice. Together the data provide the first plausible biological evidence for a survival advantage for mammalian intestinal apoB mRNA editing.	Washington Univ, Sch Med, GI Div, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, GI Div, Dept Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, GI Div, Dept Mol Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, Sch Med, GI Div, Dept Med, 660 S Euclid, St Louis, MO 63110 USA.	nod@wustl.edu			NHLBI NIH HHS [HL 38180, R01 HL038180] Funding Source: Medline; NIDDK NIH HHS [R01 DK056260, P30 DK056341-06, P30 DK056341, P30 DK056341-07, DK 52574, DK 56260] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK056341, P30DK052574] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chen ZG, 2007, AM J PHYSIOL-GASTR L, V292, pG53, DOI 10.1152/ajpgi.00118.2006; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Di Leo E, 2005, ATHEROSCLEROSIS, V180, P311, DOI 10.1016/j.athersclerosis.2004.12.004; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FUNAHASHI T, 1995, J LIPID RES, V36, P414; GIANNONI F, 1995, J LIPID RES, V36, P1664; GLICKMAN RM, 1986, P NATL ACAD SCI USA, V83, P5296, DOI 10.1073/pnas.83.14.5296; Henderson JO, 2001, BBA-GENE STRUCT EXPR, V1522, P22, DOI 10.1016/S0167-4781(01)00295-0; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Kendrick JS, 2001, BIOCHEM J, V356, P821, DOI 10.1042/0264-6021:3560821; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Larsson SL, 2004, J BIOL CHEM, V279, P831, DOI 10.1074/jbc.M303057200; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu S, 2002, J LIPID RES, V43, P1303, DOI 10.1194/jlr.M200035-JLR200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rava P, 2006, J BIOL CHEM, V281, P11019, DOI 10.1074/jbc.M512823200; Rodrigues CMP, 2003, BIOCHEMISTRY-US, V42, P3070, DOI 10.1021/bi026979d; Rubin DC, 1998, GASTROENTEROLOGY, V115, P1291, DOI 10.1016/S0016-5085(98)70105-2; Sellers JA, 2003, J BIOL CHEM, V278, P20367, DOI 10.1074/jbc.M300271200; Shelton JM, 2000, J LIPID RES, V41, P532; Smith HC, 1997, RNA, V3, P1105; Tang YZ, 2004, GASTROENTEROLOGY, V126, P220, DOI 10.1053/j.gastro.2003.10.077; TENG BB, 1990, J BIOL CHEM, V265, P20616; TENG BB, 1990, BIOCHEM BIOPH RES CO, V173, P74, DOI 10.1016/S0006-291X(05)81023-X; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2003, AM J PHYSIOL-GASTR L, V285, pG735, DOI 10.1152/ajpgi.00202.2003; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	42	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33043	33051		10.1074/jbc.M705386200	http://dx.doi.org/10.1074/jbc.M705386200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855359	hybrid			2022-12-25	WOS:000250625400053
J	Chang, J; Sonoyama, W; Wang, Z; Jin, QM; Zhang, CF; Krebsbach, PH; Giannobile, W; Shi, ST; Wang, CY				Chang, Jia; Sonoyama, Wataru; Wang, Zhuo; Jin, Qiming; Zhang, Chengfei; Krebsbach, Paul H.; Giannobile, William; Shi, Songtao; Wang, Cun-Yu			Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES OSTEOGENIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; BETA-CATENIN; PROMOTES PROLIFERATION; PROTEIN-KINASE; MECHANISMS; EXPRESSION; DICKKOPF-1; DELIVERY; DENSITY	Mesenchymal stem cells (MSCs) are multipotent cells that can be differentiated into osteoblasts and provide an excellent cell source for bone regeneration and repair. Recently, the canonical Wnt/beta-catenin signaling pathway has been found to play a critical role in skeletal development and osteogenesis, implying that Wnts can be utilized to improve de novo bone formation mediated by MSCs. However, it is unknown whether noncanonical Wnt signaling regulates osteogenic differentiation. Here, we find that Wnt-4 enhanced in vitro osteogenic differentiation of MSCs isolated from human adult craniofacial tissues and promoted bone formation in vivo. Whereas Wnt-4 did not stabilize beta-catenin, it activated p38 MAPK in a novel noncanonical signaling pathway. The activation of p38 was dependent on Axin and was required for the enhancement of MSC differentiation by Wnt-4. Moreover, using two different models of craniofacial bone injury, we found that MSCs genetically engineered to express Wnt-4 enhanced osteogenesis and improved the repair of craniofacial defects in vivo. Taken together, our results reveal that noncanonical Wnt signaling could also play a role in osteogenic differentiation. Wnt-4 may have a potential use in improving bone regeneration and repair of craniofacial defects.	Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90095 USA; Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Peking Univ, Hlth Sci Ctr, Sch Stomatol, Beijing 100081, Peoples R China; Peking Univ, Hlth Sci Ctr, Hosp Stomatol, Beijing 100081, Peoples R China; Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Peking University; Peking University; University of Southern California	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu	Krebsbach, Paul H./AAC-4765-2021; Sonoyama, Wataru/B-2160-2011	Zhang, Chengfei/0000-0002-6016-9436; Giannobile, William/0000-0002-7102-9746	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013397, R01DE016513] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE13397, DE16513, R01 DE013397] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Canalis E, 2005, J Endocrinol Invest, V28, P3; Chien KR, 2005, CELL, V121, P153, DOI 10.1016/j.cell.2005.03.020; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gregory C. A., 2005, SCI STKE, ppe37; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jin QM, 2004, MOL THER, V9, P519, DOI 10.1016/j.ymthe.2004.01.016; Jin QM, 2003, J BIOMED MATER RES A, V67A, P54, DOI 10.1002/jbm.a.10058; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nussenbaum B, 2005, LARYNGOSCOPE, V115, P1170, DOI 10.1097/01.MLG.0000166513.74247.CC; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Ross FP, 2006, J CLIN INVEST, V116, P1140, DOI 10.1172/JCI28605; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sottile V, 2002, BONE, V30, P699, DOI 10.1016/S8756-3282(02)00674-9; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhao M, 2004, J PERIODONTOL, V75, P154, DOI 10.1902/jop.2004.75.1.154	51	180	194	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30938	30948		10.1074/jbc.M702391200	http://dx.doi.org/10.1074/jbc.M702391200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720811	hybrid			2022-12-25	WOS:000250136300062
J	Collins, QF; Liu, HY; Pi, JB; Liu, ZQ; Quon, MJ; Cao, WH				Collins, Qu Fan; Liu, Hui-Yu; Pi, Jingbo; Liu, Zhenqi; Quon, Michael J.; Cao, Wenhong			Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5 '-AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; CATECHIN-POLYPHENOLS; CELL-SURVIVAL; NITRIC-OXIDE; GALLATE; ACTIVATION; RECEPTOR; MECHANISMS; CANCER; OBESITY	Epigallocatechin-3-gallate (EGCG), a main catechin of green tea, has been suggested to inhibit hepatic gluconeogenesis. However, the exact role and related mechanism have not been established. In this study, we examined the role of EGCG in hepatic gluconeogenesis at concentrations that are reachable by ingestion of pure EGCG or green tea, and are not toxic to hepatocytes. Our results show in isolated hepatocytes that EGCG at relatively low concentrations (<= 1 mu M) inhibited glucose production via gluconeogenesis and expression of key gluconeogenic genes. EGCG was not toxic at these concentrations while demonstrating significant cytotoxicity at 10 mu M and higher concentrations. EGCG at 1 mu M or lower concentrations effective in suppressing hepatic gluconeogenesis did not activate the insulin signaling pathway, but activated 5 '-AMP-activated protein kinase (AMPK). The EGCG suppression of hepatic gluconeogenesis was prevented by blockade of AMPK activity. In defining the mechanism by which EGCG activates AMPK, we found that the EGCG activation of AMPK was mediated by the Ca2+/calmodulin-dependent protein kinase kinase ( CaMKK). Furthermore, our results show that the EGCG activation of AMPK and EGCG suppression of hepatic gluconeogenesis were both dependent on production of reactive oxygen species (ROS), which was a known activator of CaMKK. Together, our results demonstrate an inhibitory role for EGCG in hepatic gluconeogenesis and shed new light on the mechanism by which EGCG suppresses gluconeogenesis.	Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA; Univ Virginia, Hlth Sci Ctr, Dept Internal Med, Div Endocrinol, Charlottesville, VA 22908 USA; NIH, Diabet Unit, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Internal Med, Div Endocrinol, Durham, NC 27710 USA	The Hamner Institutes for Health Sciences; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Duke University	Cao, WH (corresponding author), Hamner Inst Hlth Sci, 6 Davis Dr,POB 12137, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org	Quon, Michael/B-1970-2008; PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041; QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	NIDDK NIH HHS [R01 DK076039-01A2, R01 DK076039, R01DK076039] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z01AT000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c; Anton S, 2007, CELL SIGNAL, V19, P378, DOI 10.1016/j.cellsig.2006.07.008; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chung JH, 2003, FASEB J, V17, P1913, DOI 10.1096/fj.02-0914fje; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980; Koh SH, 2004, TOXICOLOGY, V202, P213, DOI 10.1016/j.tox.2004.05.008; Koh SH, 2004, NEUROTOXICOLOGY, V25, P793, DOI 10.1016/j.neuro.2004.02.001; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koyama Y, 2004, PLANTA MED, V70, P1100, DOI 10.1055/s-2004-832659; Lambert JD, 2003, J NUTR, V133, p3262S, DOI 10.1093/jn/133.10.3262S; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115; Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200; Masamune A, 2005, WORLD J GASTROENTERO, V11, P3368, DOI 10.3748/wjg.v11.i22.3368; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Nelson-Dooley C, 2005, CURR MED CHEM, V12, P2215, DOI 10.2174/0929867054864886; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Sah JF, 2004, J BIOL CHEM, V279, P12755, DOI 10.1074/jbc.M312333200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Yang CS, 2006, MOL NUTR FOOD RES, V50, P170, DOI 10.1002/mnfr.200500105; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006	52	266	284	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30143	30149		10.1074/jbc.M702390200	http://dx.doi.org/10.1074/jbc.M702390200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17724029	hybrid, Green Accepted			2022-12-25	WOS:000249981200044
J	Greene, E				Greene, Ernest			Retinal Encoding of Ultrabrief Shape Recognition Cues	PLOS ONE			English	Article								Shape encoding mechanisms can be probed by the sequential brief display of dots that mark the boundary of the shape, and delays of less that a millisecond between successive dots can impair recognition. It is not entirely clear whether this is accomplished by preserving stimulus timing in the signal being sent to the brain, or calls for a retinal binding mechanism. Two experiments manipulated the degree of simultaneity among and within dot pairs, requiring also that the pair members be in the same half of the visual field or on opposite halves, i.e., across the midline from one another. Recognition performance was impaired the same for these two conditions. The results make it likely that simultaneity of cues is being registered within the retina. A potential mechanism is suggested, calling for linkage of stimulated sites through activation of PA1 cells. A third experiment confirmed a prior finding that the overall level of recognition deficit is partly a function of display-set size, and affirmed submillisecond resolution in binding dot pairs into effective shape-recognition cues.	[Greene, Ernest] Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA; [Greene, Ernest] Neuropsychol Fdn, Sun Valley, CA USA	University of Southern California	Greene, E (corresponding author), Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA.	egreene@usc.edu						Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AMMERMULLER J, 1988, J COMP NEUROL, V273, P137, DOI 10.1002/cne.902730202; Amthor FR, 2005, VISUAL NEUROSCI, V22, P769, DOI 10.1017/S0952523805226081; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; CHATTERJEE S, 2006, J VISION, V6, pA62; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P391, DOI 10.1002/cne.903160402; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P406, DOI 10.1002/cne.903160403; Freed MA, 1996, J COMP NEUROL, V364, P556; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; Greene Ernest, 2006, Behav Brain Funct, V2, P38, DOI 10.1186/1744-9081-2-38; Greene E, 2007, PERCEPT PSYCHOPHYS, V69, P772, DOI 10.3758/BF03193778; Greene E, 2007, PERCEPT MOTOR SKILL, V104, P1043, DOI 10.2466/PMS.104.4.1043-1059; Greene E, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-15; Greene E, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-27; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Kohler W, 1928, PSYCHOL FORSCH, V11, P188, DOI 10.1007/BF00410257; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; LONG GM, 1980, PSYCHOL BULL, V88, P785, DOI 10.1037/0033-2909.88.3.785; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MAUNSELL JHR, VIS NEUROSCI, V16, P1; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NISLY SJ, 1989, PSYCHOL BULL, V106, P483, DOI 10.1037/0033-2909.106.3.483; Reinagel P, 2002, J NEUROSCI, V22, P6837; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; RODIECK RW, 1998, COMP PRIMATE BIOL, V5, P203; Samonds JM, 2006, J NEUROPHYSIOL, V95, P2602, DOI 10.1152/jn.01070.2005; Schall R., 1991, BIOMETRIKA, V40, P917, DOI 10.1093/biomet/78.4.719; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STANFORD LR, 1987, SCIENCE, V238, P358, DOI 10.1126/science.3659918; Taylor WR, 1996, VISUAL NEUROSCI, V13, P599, DOI 10.1017/S0952523800008506; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; Volgyi B, 2001, J COMP NEUROL, V440, P109, DOI 10.1002/cne.1373; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; von der Malsburg C., 1994, MODELS NEURAL NETWOR, P95, DOI [DOI 10.1007/978-1-4612-4320-5_2, 10.1007/978-1-4612-4320-5_2]; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wright LL, 2004, VISUAL NEUROSCI, V21, P145, DOI 10.1017/S0952523804042063	52	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e871	10.1371/journal.pone.0000871	http://dx.doi.org/10.1371/journal.pone.0000871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849001	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455600018
J	Somenzi, G; Sala, G; Rossetti, S; Ren, MQ; Ghidoni, R; Sacchi, N				Somenzi, Giulia; Sala, Giusy; Rossetti, Stefano; Ren, MingQiang; Ghidoni, Riccardo; Sacchi, Nicoletta			Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid	PLOS ONE			English	Article							BREAST-CANCER CELLS; NUCLEAR RECEPTORS; VITAMIN-A; EXTRACELLULAR RELEASE; CARCINOMA-CELLS; BETA-CAROTENE; LUNG-CANCER; KINASE; ACTIVATION; EXPRESSION	Background. Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RAR alpha, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25: 10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RAR alpha, through differential regulation of the "rheostat'' comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingolipid with prosurvival activity. Methodology/Principal Findings. We found that functional inhibition of endogenous RAR alpha in breast cancer cells by using either RAR alpha specific antagonists or a dominant negative RAR alpha mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. Conclusions/Significance. In the presence of functional RAR alpha, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RAR alpha, RA-in a non-RAR-mediated fashion-promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA.	[Sala, Giusy; Ghidoni, Riccardo] Univ Milan, Sch Med, San Paolo Univ Hosp, Biochem & Mol Biol Lab, Milan, Italy; [Somenzi, Giulia; Rossetti, Stefano; Ren, MingQiang; Sacchi, Nicoletta] Roswell Pk Canc Inst, Dept Canc Biol, Canc Genet Program, Buffalo, NY 14263 USA	University of Milan; Roswell Park Cancer Institute	Ghidoni, R (corresponding author), Univ Milan, Sch Med, San Paolo Univ Hosp, Biochem & Mol Biol Lab, Milan, Italy.	riccardo.ghidoni@unimi.it; nicoletta.sacchi@roswellpark.org		GHIDONI, RICCARDO/0000-0002-6300-5867	MIUR, Italy [PRIN 20011065545]; Cariplo Foundation Award (Italy); Roswell Park Alliance Foundation Award; U. S. Army [DAMD 17-02-01-0432]; Graduate Program of Molecular Medicine, University of Milan, Italy	MIUR, Italy(Ministry of Education, Universities and Research (MIUR)); Cariplo Foundation Award (Italy); Roswell Park Alliance Foundation Award; U. S. Army; Graduate Program of Molecular Medicine, University of Milan, Italy	This work was funded by the PRIN 20011065545 grant "Lipids as effectors and mediators of growth, differentiation and apoptosis in cancer cells'' (MIUR, Italy) (RG and NS), a Cariplo Foundation Award (Italy) (RG and NS), a Roswell Park Alliance Foundation Award (NS), the U. S. Army DAMD 17-02-01-0432 (NS), the Graduate Program of Molecular Medicine, University of Milan, Italy (G. Somenzi and G. Sala).	Albright CD, 2004, J NUTR, V134, P1139, DOI 10.1093/jn/134.5.1139; Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; AMES BN, 1960, J BIOL CHEM, V235, P769; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bistulfi G, 2006, CANCER RES, V66, P10308, DOI 10.1158/0008-5472.CAN-06-1052; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Decensi A, 2007, NAT CLIN PRACT ONCOL, V4, P64, DOI 10.1038/ncponc0735; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Guo XJ, 2002, CANCER RES, V62, P1654; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; HENION PD, 1994, DEV BIOL, V161, P243, DOI 10.1006/dbio.1994.1024; Jing YK, 1996, FASEB J, V10, P1064, DOI 10.1096/fasebj.10.9.8801168; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Khuri FR, 2006, JNCI-J NATL CANCER I, V98, P441, DOI 10.1093/jnci/djj091; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kikuchi K, 2001, BIOORG MED CHEM LETT, V11, P1215, DOI 10.1016/S0960-894X(01)00177-9; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; MERRILL AH, 1992, METHOD ENZYMOL, V209, P427; Mikkelsen S, 1998, CARCINOGENESIS, V19, P663, DOI 10.1093/carcin/19.4.663; Mira-y-Lopez R, 2000, J CELL PHYSIOL, V185, P302, DOI 10.1002/1097-4652(200011)185:2<302::AID-JCP15>3.0.CO;2-#; Mollersen L, 2004, CARCINOGENESIS, V25, P149, DOI 10.1093/carcin/bgg176; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pozzi S, 2006, ONCOGENE, V25, P1400, DOI 10.1038/sj.onc.1209173; REN M, 2005, P AM ASSOC CANC RES, V46, P300; REN M, 2006, P AM ASSOC CANC RES, V47, P1625; REN M, 2007, P AM ASSOC CANC RES, V48, P1660; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; Ren MQ, 2004, ANTICANCER RES, V24, P2879; Rexer BN, 2001, CANCER RES, V61, P7065; ROMAN SD, 1992, CANCER RES, V52, P2236; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SHEIKH MS, 1993, J CELL BIOCHEM, V53, P394, DOI 10.1002/jcb.240530417; Sirchia SM, 2002, CANCER RES, V62, P2455; TSAI S, 1992, GENE DEV, V6, P2258, DOI 10.1101/gad.6.12a.2258; VANDERBURG B, 1993, MOL CELL ENDOCRINOL, V91, P149, DOI 10.1016/0303-7207(93)90267-N; VANVELDHOVEN PP, 1995, BIOCHEM MOL BIOL INT, V36, P21; Wang HT, 2003, UROLOGY, V61, P1047, DOI 10.1016/S0090-4295(02)02511-6; Wang HT, 2001, CANCER RES, V61, P5102; Zanardi S, 2006, ENDOCR-RELAT CANCER, V13, P51, DOI 10.1677/erc.1.00938; Zelent A, 2001, ONCOGENE, V20, P7186, DOI 10.1038/sj.onc.1204766	52	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e836	10.1371/journal.pone.0000836	http://dx.doi.org/10.1371/journal.pone.0000836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786207	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455500019
J	Churamani, D; Boulware, MJ; Geach, TJ; Martin, ACR; Moy, GW; Su, YH; Vacquier, VD; Marchant, JS; Dale, L; Patel, S				Churamani, Dev; Boulware, Michael J.; Geach, Timothy J.; Martin, Andrew C. R.; Moy, Gary W.; Su, Yi-Hsien; Vacquier, Victor D.; Marchant, Jonathan S.; Dale, Leslie; Patel, Sandip			Molecular Characterization of a Novel Intracellular ADP-Ribosyl Cyclase	PLOS ONE			English	Article								Background. ADP-ribosyl cyclases are remarkable enzymes capable of catalyzing multiple reactions including the synthesis of the novel and potent intracellular calcium mobilizing messengers, cyclic ADP-ribose and NAADP. Not all ADP-ribosyl cyclases however have been characterized at the molecular level. Moreover, those that have are located predominately at the outer cell surface and thus away from their cytosolic substrates. Methodology/Principal Findings. Here we report the molecular cloning of a novel expanded family of ADP-ribosyl cyclases from the sea urchin, an extensively used model organism for the study of inositol trisphosphate-independent calcium mobilization. We provide evidence that one of the isoforms (SpARC1) is a soluble protein that is targeted exclusively to the endoplasmic reticulum lumen when heterologously expressed. Catalytic activity of the recombinant protein was readily demonstrable in crude cell homogenates, even under conditions where luminal continuity was maintained. Conclusions/Significance. Our data reveal a new intracellular location for ADP-ribosyl cyclases and suggest that production of calcium mobilizing messengers may be compartmentalized.	[Churamani, Dev; Patel, Sandip] UCL, Dept Physiol, London, England; [Boulware, Michael J.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Geach, Timothy J.; Dale, Leslie] UCL, Dept Anat & Dev Biol, London, England; [Martin, Andrew C. R.] UCL, Dept Biochem & Mol Biol, London, England; [Moy, Gary W.; Su, Yi-Hsien; Vacquier, Victor D.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA	University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; University of London; University College London; University of California System; University of California San Diego; Scripps Institution of Oceanography	Patel, S (corresponding author), UCL, Dept Physiol, London, England.	patel.s@ucl.ac.uk	Marchant, Jonathan/Q-5484-2019; Su, Yi-Hsien/F-2910-2014; MARCHANT, Jonathan/B-8051-2009; Patel, Sandip/O-9591-2015	Marchant, Jonathan/0000-0001-6592-0877; MARCHANT, Jonathan/0000-0001-6592-0877; Martin, Andrew/0000-0002-2835-2572; Patel, Sandip/0000-0001-7247-2013	BBSRC [BB/D018110/1, BBS/B/0661X]; NIH [HD12986, NS046783]; NSF [0237946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012986, R01HD012986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046783] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D018110/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grants BB/D018110/1 ( DC and SP) and BBS/B/0661X ( TJG and LD), NIH grants HD12986 ( Y-HS, GWM and VDD) and NS046783 ( MJB and JSM), and NSF grant 0237946 ( MJB and JSM).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Billington RA, 2006, FERTIL STERIL, V86, P891, DOI 10.1016/j.fertnstert.2006.03.030; Boulware MJ, 2005, CURR BIOL, V15, P765, DOI 10.1016/j.cub.2005.02.065; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2001, MOL PHARMACOL, V60, P718; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Ceni C, 2003, J BIOL CHEM, V278, P40670, DOI 10.1074/jbc.M301196200; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chini EN, 1997, AM J PHYSIOL-CELL PH, V272, pC416, DOI 10.1152/ajpcell.1997.272.2.C416; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; Galione A, 2000, BIOL CELL, V92, P197, DOI 10.1016/S0248-4900(00)01070-4; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; GALIONE A, 1993, SCIENCE, V261, P348, DOI 10.1126/science.8392748; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; GLICK DL, 1991, CELL REGUL, V2, P211, DOI 10.1091/mbc.2.3.211; Goodrich SP, 2005, BIOCHEMISTRY-US, V44, P11082, DOI 10.1021/bi050704r; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee HC, 2000, CHEM IMMUNOL, V75, P39; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 1996, BIOL SIGNAL, V5, P101; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Mani RS, 1998, J BIOL CHEM, V273, P30818, DOI 10.1074/jbc.273.46.30818; Matsumura N, 1998, BIOCHEM BIOPH RES CO, V253, P246, DOI 10.1006/bbrc.1998.9752; Meszaros LG, 1997, BIOCHEM BIOPH RES CO, V234, P252, DOI 10.1006/bbrc.1997.6620; Moreno-Garcia ME, 2005, MOL IMMUNOL, V42, P703, DOI 10.1016/j.molimm.2004.09.019; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SOARES S, 2006, AM J PHYSL CELL PHYS; Sternfeld L, 2003, J BIOL CHEM, V278, P33629, DOI 10.1074/jbc.M301043200; Subramanian VS, 2001, AM J PHYSIOL-GASTR L, V281, pG1477, DOI 10.1152/ajpgi.2001.281.6.G1477; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Wilson HL, 2001, J BIOL CHEM, V276, P11180, DOI 10.1074/jbc.M004849200; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	73	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e797	10.1371/journal.pone.0000797	http://dx.doi.org/10.1371/journal.pone.0000797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726527	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455400014
J	Tabach, Y; Brosh, R; Buganim, Y; Reiner, A; Zuk, O; Yitzhaky, A; Koudritsky, M; Rotter, V; Domany, E				Tabach, Yuval; Brosh, Ran; Buganim, Yossi; Reiner, Anat; Zuk, Or; Yitzhaky, Assif; Koudritsky, Mark; Rotter, Varda; Domany, Eytan			Wide-Scale Analysis of Human Functional Transcription Factor Binding Reveals a Strong Bias towards the Transcription Start Site	PLOS ONE			English	Article							NF-KAPPA-B; DNA REGULATORY MOTIFS; FALSE DISCOVERY RATE; GENE-EXPRESSION; CELL-CYCLE; IDENTIFICATION; MYOCARDIN; ELEMENTS; CONSERVATION; SEQUENCES	Background. Transcription factors (TF) regulate expression by binding to specific DNA sequences. A binding event is functional when it affects gene expression. Functionality of a binding site is reflected in conservation of the binding sequence during evolution and in over represented binding in gene groups with coherent biological functions. Functionality is governed by several parameters such as the TF-DNA binding strength, distance of the binding site from the transcription start site (TSS), DNA packing, and more. Understanding how these parameters control functionality of different TFs in different biological contexts is a must for identifying functional TF binding sites and for understanding regulation of transcription. Methodology/Principal Findings. We introduce a novel method to screen the promoters of a set of genes with shared biological function (obtained from the functional Gene Ontology (GO) classification) against a precompiled library of motifs, and find those motifs which are statistically over-represented in the gene set. More than 8000 human (and 23,000 mouse) genes, were assigned to one of 134 GO sets. Their promoters were searched (from 200 bp downstream to 1000 bp upstream the TSS) for 414 known DNA motifs. We optimized the sequence similarity score threshold, independently for every location window, taking into account nucleotide heterogeneity along the promoters of the target genes. The method, combined with binding sequence and location conservation between human and mouse, identifies with high probability functional binding sites for groups of functionally-related genes. We found many location-sensitive functional binding events and showed that they clustered close to the TSS. Our method and findings were tested experimentally. Conclusions/Significance. We identified reliably functional TF binding sites. This is an essential step towards constructing regulatory networks. The promoter region proximal to the TSS is of central importance for regulation of transcription in human and mouse, just as it is in bacteria and yeast.	[Tabach, Yuval; Reiner, Anat; Zuk, Or; Yitzhaky, Assif; Koudritsky, Mark; Domany, Eytan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Tabach, Yuval; Brosh, Ran; Buganim, Yossi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Domany, E (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	eytan.domany@weizmann.ac.il	Tabach, Yuval/Q-8488-2019; Reiner-Benaim, Anat/HGQ-1183-2022; DOMANY, EYTAN/K-1560-2012; Brosh, Ran/H-7309-2019; Brosh, Ran/HDL-9562-2022	Reiner-Benaim, Anat/0000-0001-8709-3112; Brosh, Ran/0000-0001-9714-8623; 	Ridgefield Foundation; NIH [5 P01 CA 65930-06]; EC [FP6]; NATIONAL CANCER INSTITUTE [P01CA065930] Funding Source: NIH RePORTER	Ridgefield Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by grants from the Ridgefield Foundation, the NIH grant # 5 P01 CA 65930-06 and by EC FP6 funding.	Aerts S, 2003, NUCLEIC ACIDS RES, V31, P1753, DOI 10.1093/nar/gkg268; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ambesi-Impiombato A, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S8; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARASH Y, 2001, SIMPLE HYPER GEOMETR; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Buckland PR, 2005, HUM MUTAT, V26, P214, DOI 10.1002/humu.20207; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Frech K, 1997, TRENDS BIOCHEM SCI, V22, P103; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; Lam AL, 2005, CHROMOSOMA, V114, P242, DOI 10.1007/s00412-005-0001-0; Li H, 2002, P NATL ACAD SCI USA, V99, P11772, DOI 10.1073/pnas.112341999; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu RX, 2003, GENOME RES, V13, P654, DOI 10.1101/gr.911803; Lodish H., 2000, MOL CELL BIOL WH FRE; MacIsaac KD, 2006, PLOS COMPUT BIOL, V2, P201, DOI 10.1371/journal.pcbi.0020036; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Plessy C, 2005, TRENDS GENET, V21, P207, DOI 10.1016/j.tig.2005.02.006; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yao GQ, 2000, ENDOCRINOLOGY, V141, P2914, DOI 10.1210/en.141.8.2914; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287	65	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e807	10.1371/journal.pone.0000807	http://dx.doi.org/10.1371/journal.pone.0000807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726537	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455400024
J	Palmqvist, L; Pineault, N; Wasslavik, C; Humphries, RK				Palmqvist, Lars; Pineault, Nicolas; Wasslavik, Carina; Humphries, R. Keith			Candidate Genes for Expansion and Transformation of Hematopoietic Stem Cells by NUP98-HOX Fusion Genes	PLOS ONE			English	Article								Background. Hox genes are implicated in hematopoietic stem cell (HSC) regulation as well as in leukemia development through translocation with the nucleoporin gene NUP98. Interestingly, an engineered NUP98-HOXA10 (NA10) fusion can induce a several hundred-fold expansion of HSCs in vitro and NA10 and the AML-associated fusion gene NUP98-HOXD13 (ND13) have a virtually indistinguishable ability to transform myeloid progenitor cells in vitro and to induce leukemia in collaboration with MEIS1 in vivo. Methodology/Principal Findings. These findings provided a potentially powerful approach to identify key pathways mediating Hox-induced expansion and transformation of HSCs by identifying gene expression changes commonly induced by ND13 and NA10 but not by a NUP98-Hox fusion with a non-DNA binding homedomain mutation (N51S). The gene expression repertoire of purified murine bone marrow Sca-1+Lin-cells transduced with retroviral vectors encoding for these genes was established using the Affymetrix GeneChip MOE430A. Approximately seventy genes were differentially expressed in ND13 and NA10 cells that were significantly changed by both compared to the ND13(N51S) mutant. Intriguingly, several of these potential Hox target genes have been implicated in HSC expansion and self-renewal, including the tyrosine kinase receptor Flt3, the prion protein, Prnp, hepatic leukemia factor, Hlf and Jagged-2, Jag2. Consistent with these results, FLT3, HLF and JAG2 expression correlated with HOX A cluster gene expression in human leukemia samples. Conclusions. In conclusion this study has identified several novel Hox downstream target genes and provides important new leads to key regulators of the expansion and transformation of hematopoietic stem cells by Hox.	[Palmqvist, Lars; Pineault, Nicolas; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Palmqvist, Lars; Wasslavik, Carina] Sahlgrens Univ Hosp, Inst Biomed, Gothenburg, Sweden; [Humphries, R. Keith] Univ British Columbia, Dept Med, Vancouver, BC, Canada	British Columbia Cancer Agency; Sahlgrenska University Hospital; University of British Columbia	Humphries, RK (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	khumphri@bccrc.ca		Humphries, Richard/0000-0003-0540-7005	National Cancer Institute of Canada; Terry Fox Foundation; Canadian Stem Cell Network; Genome Canada/British Columbia; Canadian Institutes of Health; National Institutes of Health; Swedish Cancer Society; ALF/LUA at the Sahlgrenska University Hospital	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Terry Fox Foundation; Canadian Stem Cell Network; Genome Canada/British Columbia(Genome Canada); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Society(Swedish Cancer Society); ALF/LUA at the Sahlgrenska University Hospital	This work was supported in part by the National Cancer Institute of Canada, with funds from the Terry Fox Foundation and by grants from the Canadian Stem Cell Network and Genome Canada/British Columbia, the Canadian Institutes of Health and National Institutes of Health to RKH. LP held a postdoctoral fellowship funded by the Swedish Cancer Society and his work is supported by ALF/LUA at the Sahlgrenska University Hospital.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Arai Y, 1997, BLOOD, V89, P3936, DOI 10.1182/blood.V89.11.3936; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Dodelet VC, 1998, BLOOD, V91, P1556, DOI 10.1182/blood.V91.5.1556.1556_1556_1561; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; Gervais C, 2005, LEUKEMIA, V19, P145, DOI 10.1038/sj.leu.2403565; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalberer CP, 2000, P NATL ACAD SCI USA, V97, P5411, DOI 10.1073/pnas.100082597; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann I, 2002, CURR BIOL, V12, pR514, DOI 10.1016/S0960-9822(02)01025-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Moore MAS, 2005, EXP HEMATOL, V33, P719, DOI 10.1016/j.exphem.2005.04.011; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Ohta H, 2007, EXP HEMATOL, V35, P817, DOI 10.1016/j.exphem.2007.02.012; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Palmqvist L, 2006, BLOOD, V108, P1030, DOI 10.1182/blood-2005-12-007005; Panagopoulos L, 2003, GENE CHROMOSOME CANC, V36, P107, DOI 10.1002/gcc.10139; PAWLIUK R, 1994, BLOOD, V84, P2868, DOI 10.1182/blood.V84.9.2868.bloodjournal8492868; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Pineault N, 2004, MOL CELL BIOL, V24, P1907, DOI 10.1128/MCB.24.5.1907-1917.2004; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; PINEAULT N, 2005, LEUKEMIA; Quentmeier H, 2004, LEUKEMIA LYMPHOMA, V45, P567, DOI 10.1080/10428190310001609942; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Roche J, 2004, LEUKEMIA, V18, P1059, DOI 10.1038/sj.leu.2403366; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; Suzuki A, 2002, BRIT J HAEMATOL, V116, P170, DOI 10.1046/j.1365-2141.2002.03246.x; Takacs-Vellai K, 2007, DEV BIOL, V302, P661, DOI 10.1016/j.ydbio.2006.09.049; Taketani T, 2002, CANCER RES, V62, P4571; Taketani T, 2002, GENE CHROMOSOME CANC, V34, P437, DOI 10.1002/gcc.10077; Taketani T, 2002, CANCER RES, V62, P33; Thornhill S, 1997, PHYS WORLD, V10, P17; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; WANG GG, 2005, BLOOD; Wiellette EL, 1999, DEVELOPMENT, V126, P1985; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	56	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e768	10.1371/journal.pone.0000768	http://dx.doi.org/10.1371/journal.pone.0000768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712416	Green Published, gold			2022-12-25	WOS:000207455300016
J	Quach, TT; Massicotte, G; Belin, MF; Honnorat, J; Glasper, ER; Devries, AC; Jakeman, LB; Baudry, M; Duchemin, AM; Kolattukudy, PE				Quach, Tam T.; Massicotte, Guy; Belin, Marie-Francoise; Honnorat, Jerome; Glasper, Erica R.; Devries, Anne C.; Jakeman, Lyn B.; Baudry, Michel; Duchemin, Anne-Marie; Kolattukudy, Pappachan E.			CRMP3 is required for hippocampal CA1 dendritic organization and plasticity	FASEB JOURNAL			English	Article						Golgi analysis; gene targeting; neurite outgrowth; LTP	RESPONSE MEDIATOR PROTEINS; LONG-TERM POTENTIATION; COLLAPSIN; ACTIN; PHOSPHORYLATION; INVOLVEMENT; EXTENSION; SYSTEM; FAMILY; CYPIN	In vitro studies have pointed to the collapsin response mediator proteins (CRMPs) as key regulators of neurite outgrowth and axonal differentiation. CRMP3 is expressed mostly in the nervous system during development but remains at high levels in the hippocampus of adults. To explore CRMP3 function in vivo, we generated mice with targeted disruption of the CRMP3 gene. Immunohistochemistry and Golgi staining of CA1 showed abnormal dendrite and spine morphogenesis in the hippocampus of CRMP3-deficient mice. Apical dendrites displayed an increase in undulation and a reduction in length and branching points. Basal dendrites also exhibited a reduction in length with an alteration in soma stem distribution and an increased number of thick dendrites localized in stratum oriens (SO). Long-term potentiation (LTP) was impaired in this area. These data indicate an important role for CRMP3 in dendrite arborization, guide-posts navigation, and neuronal plasticity.	[Quach, Tam T.; Belin, Marie-Francoise; Honnorat, Jerome] Univ Lyon 1, Fac Med Laennec, INSERM, U842, F-69372 Lyon, France; [Massicotte, Guy] Univ Quebec Trois Rivieres, Dept Chim Biol, Neurosci Res Grp, Trois Rivieres, PQ GA9 5H7, Canada; [Glasper, Erica R.; Devries, Anne C.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Glasper, Erica R.; Devries, Anne C.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Jakeman, Lyn B.] Ohio State Univ, Dept Cell Biol & Physiol, Columbus, OH 43210 USA; [Duchemin, Anne-Marie] Ohio State Univ, Dept Psychiat, Columbus, OH 43210 USA; [Baudry, Michel] Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; [Kolattukudy, Pappachan E.] Univ Cent Florida, Burnett Coll Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Quebec; University of Quebec Trois Rivieres; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Southern California; State University System of Florida; University of Central Florida	Quach, TT (corresponding author), Univ Lyon 1, Fac Med Laennec, INSERM, U842, Rue Guillaume Paradin, F-69372 Lyon, France.	quach.1@lyon.inserm.fr	kolattukudy, pappachan e/A-1350-2012; GLASPER, ERICA/GOK-0082-2022; Honnorat, jerome/G-6394-2017; Jakeman, Lyn/A-5094-2009	GLASPER, ERICA/0000-0003-1938-2144; Honnorat, jerome/0000-0002-4721-5952; Jakeman, Lyn/0000-0002-1760-8819	NINDS NIH HHS [R01 NS043246-04, R01 NS043246] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043246] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akum BF, 2004, NAT NEUROSCI, V7, P145, DOI 10.1038/nn1179; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Honnorat J, 1999, EUR J NEUROSCI, V11, P4226, DOI 10.1046/j.1460-9568.1999.00864.x; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Knudsen A, 2007, CLIN EXP IMMUNOL, V149, P16, DOI 10.1111/j.1365-2249.2007.03379.x; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lin B, 2005, J NEUROSCI, V25, P2062, DOI 10.1523/JNEUROSCI.4283-04.2005; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Quach TT, 2000, GENE, V242, P175, DOI 10.1016/S0378-1119(99)00528-4; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Wang LH, 1996, J NEUROSCI, V16, P6197; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P95; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	26	55	56	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					401	409		10.1096/fj.07-9012com	http://dx.doi.org/10.1096/fj.07-9012com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17785607	Green Accepted			2022-12-25	WOS:000252822600010
J	Benziane, B; Demaretz, S; Defontaine, N; Zaarour, N; Cheval, L; Bourgeois, S; Klein, C; Froissart, M; Blanchard, A; Paillard, M; Gamba, G; Houillier, P; Laghmani, K				Benziane, Boubacar; Demaretz, Sylvie; Defontaine, Nadia; Zaarour, Nancy; Cheval, Lydie; Bourgeois, Soline; Klein, Christophe; Froissart, Marc; Blanchard, Anne; Paillard, Michel; Gamba, Gerardo; Houillier, Pascal; Laghmani, Kamel			NKCC2 surface expression in mammalian cells - down-regulation by novel interaction with aldolase b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; THICK ASCENDING LIMB; N-TERMINAL RESIDUE; HEREDITARY FRUCTOSE INTOLERANCE; VACUOLAR H+-ATPASE; NA+-K+-2CL(-) COTRANSPORTER; NA-K-2CL COTRANSPORTER; MOLECULAR-CLONING; RAT-KIDNEY; F-ACTIN	Apical bumetanide-sensitive Na+-K+-2Cl(+) co-transporter, termed NKCC2, is the major salt transport pathway in kidney thick ascending limb. NKCC2 surface expression is subject to regulation by intracellular protein trafficking. However, the protein partners involved in the intracellular trafficking of NKCC2 remain unknown. Moreover, studies aimed at understanding the post-translational regulation of NKCC2 have been hampered by the difficulty to express NKCC2 protein in mammalian cells. Here we were able to express NKCC2 protein in renal epithelial cells by tagging its N-terminal domain. To gain insights into the regulation of NKCC2 trafficking, we screened for interaction partners of NKCC2 with the yeast two-hybrid system, using the C-terminal tail of NKCC2 as bait. Aldolase B was identified as a dominant and novel interacting protein. Real time PCR on renal microdissected tubules demonstrated the expression of aldolase B in the thick ascending limb. Co-immunoprecipitation and co-immunolocalization experiments confirmed NKCC2-aldolase interaction in renal cells. Biotinylation assays showed that aldolase co-expression reduces NKCC2 surface expression. In the presence of aldolase substrate, fructose 1,6-bisphosphate, aldolase binding was disrupted, and aldolase co-expression had no further effect on the cell surface level of NKCC2. Finally, functional studies demonstrated that aldolase-induced down-regulation of NKCC2 at the plasma membrane was associated with a decrease in its transport activity. In summary, we identified aldolase B as a novel NKCC2 binding partner that plays a key role in the modulation of NKCC2 surface expression, thereby revealing a new regulatory mechanism governing the co-transporter intracellular trafficking. Furthermore, NKCC2 protein expression in mammalian cells and its regulation by protein-protein interactions, described here, may open new and important avenues in studying the cell biology and post-transcriptional regulation of the co-transporter.	Univ Paris 06, CNRS, UMR7134, F-75006 Paris, France; Inst Biomed Cordeliers, IFR58, F-75006 Paris, France; Univ Paris 05, F-75006 Paris, France; Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 14000, DF, Mexico; Hop Europeen Georges Pompidou, AP HP, Dept Physiol, F-75015 Paris, France; INSERM, U652, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Laghmani, K (corresponding author), INSERM, U652, 15 Rue Ecole Med, F-75270 Paris 06, France.	Kamel.Laghmani@bhdc.jussieu.fr	Froissart, Marc/L-7493-2014; Laghmani, Kamel/AIE-9621-2022; Houillier, Pascal/AAD-4903-2019; Gamba, Gerardo/P-4873-2016	Froissart, Marc/0000-0002-4010-3173; Laghmani, Kamel/0000-0002-2167-5766; Houillier, Pascal/0000-0003-4953-6917; klein, christophe/0000-0001-8015-287X; CHEVAL, LYDIE/0000-0003-2957-6487; BLANCHARD, Anne/0000-0002-0815-0586; Gamba, Gerardo/0000-0002-4378-9043				Ali M, 1998, J MED GENET, V35, P353, DOI 10.1136/jmg.35.5.353; Amlal H, 1996, AM J PHYSIOL-CELL PH, V271, pC455, DOI 10.1152/ajpcell.1996.271.2.C455; AMLAL H, 1994, J BIOL CHEM, V269, P21962; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Bourgeois S, 2003, PFLUG ARCH EUR J PHY, V446, P672, DOI 10.1007/s00424-003-1108-x; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; BRONSTEIN WW, 1981, CAN J BIOCHEM CELL B, V59, P494, DOI 10.1139/o81-069; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; CHEN JG, 1993, BIOCHIM BIOPHYS ACTA, V1149, P299, DOI 10.1016/0005-2736(93)90214-K; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Christova TY, 1996, BIOCHEM BIOPH RES CO, V228, P272, DOI 10.1006/bbrc.1996.1652; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; DOUCET A, 1979, AM J PHYSIOL, V237, pF105, DOI 10.1152/ajprenal.1979.237.2.F105; Ehringer WD, 2000, MOL CELL BIOCHEM, V210, P35, DOI 10.1023/A:1007059214754; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1998, P NATL ACAD SCI USA, V95, P7179, DOI 10.1073/pnas.95.12.7179; Juergens TM, 1996, MOL CELL BIOCHEM, V154, P83; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Kaunisto K, 2002, KIDNEY INT, V61, P2111, DOI 10.1046/j.1523-1755.2002.00371.x; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kurtz CL, 1997, J AM SOC NEPHROL, V8, P1706; Laghmani K, 2005, AM J PHYSIOL-RENAL, V288, pF732, DOI 10.1152/ajprenal.00300.2004; LAZZARINO G, 1984, CLIN BIOCHEM, V17, P42, DOI 10.1016/S0009-9120(84)90480-6; Liedtke CM, 2005, J BIOL CHEM, V280, P25491, DOI 10.1074/jbc.M504473200; Lopes A I, 1998, Acta Med Port, V11, P1121; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; McReynolds MR, 2005, AM J PHYSIOL-RENAL, V288, pF315, DOI 10.1152/ajprenal.00207.2004; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mikalsen T, 2005, INT J BIOCHEM CELL B, V37, P2513, DOI 10.1016/j.biocel.2005.06.007; MIYAUCHI A, 1990, AM J PHYSIOL, V259, pF485, DOI 10.1152/ajprenal.1990.259.3.F485; MOE OW, 1991, J CLIN INVEST, V88, P1703, DOI 10.1172/JCI115487; MORRIS RC, 1968, J CLIN INVEST, V47, P1389, DOI 10.1172/JCI105830; Mount DB, 1999, AM J PHYSIOL-RENAL, V276, pF347, DOI 10.1152/ajprenal.1999.276.3.F347; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; OREILLY G, 1993, FEBS LETT, V321, P69, DOI 10.1016/0014-5793(93)80623-3; OROSZ F, 1988, MOL PHARMACOL, V33, P678; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; PAULAIS M, 1992, J CLIN INVEST, V89, P1142, DOI 10.1172/JCI115695; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Plata C, 1999, AM J PHYSIOL-RENAL, V276, pF359, DOI 10.1152/ajprenal.1999.276.3.F359; Plata C, 2002, J BIOL CHEM, V277, P11004, DOI 10.1074/jbc.M110442200; Plata C, 2001, AM J PHYSIOL-RENAL, V280, pF574, DOI 10.1152/ajprenal.2001.280.4.F574; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; REZNICK AZ, 1985, P NATL ACAD SCI USA, V82, P6114, DOI 10.1073/pnas.82.18.6114; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Saez DE, 2000, J CELL BIOCHEM, V78, P62, DOI 10.1002/(SICI)1097-4644(20000701)78:1<62::AID-JCB6>3.3.CO;2-N; Salvatore F, 1986, Horiz Biochem Biophys, V8, P611; Simard CF, 2004, J BIOL CHEM, V279, P48449, DOI 10.1074/jbc.M407012200; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; STEWART M, 1980, BIOCHEM J, V186, P99, DOI 10.1042/bj1860099; VALLET V, 1995, EXP CELL RES, V216, P363, DOI 10.1006/excr.1995.1046; WACHSMUTH ED, 1975, HISTOCHEMISTRY, V45, P143, DOI 10.1007/BF00495158; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wheeler TJ, 2004, MOL CELL BIOCHEM, V259, P105, DOI 10.1023/B:MCBI.0000021356.89867.0d; WU MS, 1994, J MEMBRANE BIOL, V142, P323; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Yanez AJ, 2005, J CELL PHYSIOL, V202, P743, DOI 10.1002/jcp.20183	77	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33817	33830		10.1074/jbc.M700195200	http://dx.doi.org/10.1074/jbc.M700195200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848580	hybrid			2022-12-25	WOS:000250840200064
J	Liu, H; Jiravanichpaisal, P; Cerenius, L; Lee, BL; Sorderhall, I; Soderhall, K				Liu, Haipeng; Jiravanichpaisal, Pikul; Cerenius, Lage; Lee, Bok Luel; Soerderhaell, Irene; Soederhaell, Kenneth			Phenoloxidase is an important component of the Defense against Aeromonas hydrophila infection in a crustacean, Pacifastacus leniusculus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRESH-WATER CRAYFISH; PROPHENOLOXIDASE-ACTIVATING SYSTEM; IMMUNE-RESPONSIVE SERPIN; DROSOPHILA HOST-DEFENSE; CELL-ADHESION FACTOR; ANOPHELES-GAMBIAE; MELANIZATION CASCADE; ARMIGERES-SUBALBATUS; RECOGNITION PROTEIN; APHANOMYCES-ASTACI	The melanization cascade, in which phenoloxidase is the terminal enzyme, appears to play a key role in recognition of and defense against microbial infections in invertebrates. Here, we show that phenoloxidase activity and melanization are important for the immune defense toward a highly pathogenic bacterium, Aeromonas hydrophila, in the freshwater crayfish, Pacifastacus leniusculus. RNA interference-mediated depletion of crayfish prophenoloxidase leads to increased bacterial growth, lower phagocytosis, lower phenoloxidase activity, lower nodule formation, and higher mortality when infected with this bacterium. In contrast, if RNA interference of pacifastin, an inhibitor of the crayfish prophenoloxidase activation cascade, is performed, it results in lower bacterial growth, increased phagocytosis, increased nodule formation, higher phenoloxidase activity, and delayed mortality. Our data therefore suggest that phenoloxidase is required in crayfish defense against an infection by A. hydrophila, a highly virulent and pathogenic bacterium to crayfish.	Uppsala Univ, Dept Comparat Physiol, SE-75236 Uppsala, Sweden; Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Mol Aquat Biol & Genet Lab, Bangkok 10400, Thailand; Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea	Uppsala University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Pusan National University	Soderhall, K (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, SE-75236 Uppsala, Sweden.	Kenneth.Soderhall@ebc.uu.se	Liu, HP/G-4633-2010					Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Asada N, 1999, DEV COMP IMMUNOL, V23, P535, DOI 10.1016/S0145-305X(99)00035-X; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2003, CELL MICROBIOL, V5, P353, DOI 10.1046/j.1462-5822.2003.00282.x; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; CHRISTENSEN BM, 1984, J INVERTEBR PATHOL, V44, P267, DOI 10.1016/0022-2011(84)90024-7; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Hed J, 1986, Methods Enzymol, V132, P198; Hillyer JF, 2004, MICROBES INFECT, V6, P448, DOI 10.1016/j.micinf.2004.01.005; Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y; Jiravanichpaisal P, 2007, DEV COMP IMMUNOL, V31, P441, DOI 10.1016/j.dci.2006.08.002; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Johansson M.W., 1996, Progress in Molecular and Subcellular Biology, V15, P46; JOHANSSON MW, 1988, J CELL BIOL, V106, P1795, DOI 10.1083/jcb.106.5.1795; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lambrechts L, 2004, EVOLUTION, V58, P2377, DOI 10.1111/j.0014-3820.2004.tb01611.x; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Lin XH, 2007, BBA-GEN SUBJECTS, V1770, P87, DOI 10.1016/j.bbagen.2006.06.018; Mavrouli MD, 2005, BBA-MOL CELL RES, V1744, P145, DOI 10.1016/j.bbamcr.2005.04.011; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Nappi AJ, 2005, J INSECT PHYSIOL, V51, P197, DOI 10.1016/j.jinsphys.2004.10.013; PASKEWITZ SM, 1988, J PARASITOL, V74, P432, DOI 10.2307/3282053; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; SMITH VJ, 1983, BIOL BULL, V164, P299, DOI 10.2307/1541146; SODERHALL K, 1982, J INVERTEBR PATHOL, V39, P105, DOI 10.1016/0022-2011(82)90164-1; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Tamang D, 2004, INSECT MOL BIOL, V13, P595, DOI 10.1111/j.0962-1075.2004.00516.x; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; THORNQVIST PO, 1994, DEV COMP IMMUNOL, V18, P3, DOI 10.1016/0145-305X(94)90247-X; Vass E, 2000, J PARASITOL, V86, P1259, DOI 10.1645/0022-3395(2000)086[1259:DAIAOD]2.0.CO;2; VAUGHAN JA, 1994, J PARASITOL, V80, P674, DOI 10.2307/3283245; Vernick Kenneth D., 1998, P261; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang XG, 2005, MOL BIOCHEM PARASIT, V139, P65, DOI 10.1016/j.molbiopara.2004.09.009; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	48	178	186	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33593	10.1074/jbc.M706113200	http://dx.doi.org/10.1074/jbc.M706113200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855335	hybrid			2022-12-25	WOS:000250840200040
J	Inouye, S; Fujimoto, M; Nakamura, T; Takaki, E; Hayashida, N; Hai, T; Nakai, A				Inouye, Sachiye; Fujimoto, Mitsuaki; Nakamura, Tamami; Takaki, Eiichi; Hayashida, Naoki; Hai, Tsonwin; Nakai, Akira			Heat shock transcription factor 1 opens chromatin structure of interleukin-6 promoter to facilitate binding of an activator or a repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; FACTOR-I; RESPONSIVE ELEMENT; LENS DEVELOPMENT; GENE; PROTEINS; HSF1; MICE; LIPOPOLYSACCHARIDE	Heat shock transcription factor 1 ( HSF1) not only regulates expression of heat shock genes in response to elevated temperature, but is also involved in developmental processes by regulating genes such as cytokine genes. However, we did not know how HSF1 regulates non-heat shock genes. Here, we show that constitutive HSF1 binding to the interleukin ( IL)-6 promoter is necessary for its maximal induction by lipopolysaccharide ( LPS) stimulation in mouse embryo fibroblasts and peritoneal macrophages. Lack of HSF1 inhibited LPS-induced in vivo binding of an activator NF-kappa B and a repressor ATF3 to IL-6 promoter. Neither NF-kappa B nor ATF3 binds to the IL-6 promoter in unstimulated HSF1-null cells even if they were overexpressed. Treatment with histone deacetylase inhibitor or a DNA methylation inhibitor restored LPS-induced IL-6 expression in HSF1-null cells, and histone modification enzymes were recruited on the IL-6 promoter in the presence of HSF1. Consistently, chromatin structure of the IL-6 promoter in the presence of HSF1 was more open than that in its absence. These results indicate that HSF1 partially opens the chromatin structure of the IL-6 promoter for an activator or a repressor to bind to it, and provides a novel mechanism of gene regulation by HSF1.	Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 7558505, Japan; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Yamaguchi University; University System of Ohio; Ohio State University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	anakai@yamaguchi-u.ac.jp	Hayashida, Naoki/HGA-3453-2022; Hai, Tsonwin/E-3185-2011; Hai, Tsonwin/H-4480-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315; Hayashida, Naoki/0000-0002-8785-8012				Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Forshew T, 2005, HUM GENET, V117, P452, DOI 10.1007/s00439-005-1309-9; Franchimont N, 1999, J BIOL CHEM, V274, P6783, DOI 10.1074/jbc.274.10.6783; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	45	85	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33210	33217		10.1074/jbc.M704471200	http://dx.doi.org/10.1074/jbc.M704471200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17766920	hybrid			2022-12-25	WOS:000250625400068
J	Kaasik, A; Safiulina, D; Choubey, V; Kuum, M; Zharkovsky, A; Veksler, V				Kaasik, Allen; Safiulina, Dzhamilja; Choubey, Vinay; Kuum, Malle; Zharkovsky, Alexander; Veksler, Vladimir			Mitochondrial swelling impairs the transport of organelles in cerebellar granule neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AXONAL-TRANSPORT; TRANSGENIC MICE; HUMAN SOD1; DISEASE; NEUROFILAMENTS; GLUTAMATE; ACCUMULATION; DEGENERATION; DYSFUNCTION	Organelle transport in neuronal processes is central to the organization, developmental fate, and functions of neurons. Organelles must be transported through the slender, highly branched neuronal processes, making the axonal transport vulnerable to any perturbation. However, some intracellular structures like mitochondria are able to considerably modify their volume. We therefore hypothesized that swollen mitochondria could impair the traffic of other organelles in neurite shafts. To test this hypothesis, we have investigated the effects of mitochondrial swellers on the organelle traffic. Our data demonstrate that treatment of neurons with potassium ionophore valinomycin led to the fast time-dependent inhibition of organelle movement in cerebellar granule neurons. Similar inhibition was observed in neurons treated with the inhibitors of the mitochondrial respiratory chain, sodium azide and antimycin, which also induced swelling. No decrease in the motility of organelles was observed in cultures treated with inhibitors of ATP production or transport, oligomycin or bongkrekic acid, suggesting that inhibition of the ATP-generating activity itself without swelling does not affect the motility of organelles. The effect of swellers on the traffic was more important in thin processes, thus indicating the role of steric hindrance of swollen mitochondria. We propose that the size and morphology of the transported cargo is also relevant for seamless axonal transport and speculate that mitochondrial swelling could be one of the reasons for impaired organelle transport in neuronal processes.	Univ Tartu, Dept Pharmacol, Ctr Mol & Clin Med, EE-51014 Tartu, Estonia; INSERM, U 769, F-92296 Chatenay Malabry, France; Univ Paris Sud, F-92296 Chatenay Malabry, France	University of Tartu; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Kaasik, A (corresponding author), Univ Tartu, Dept Pharmacol, Ctr Mol & Clin Med, Ravila 19, EE-51014 Tartu, Estonia.	Allen.Kaasik@ut.ee	Safiulina, Dzamilja/I-7336-2015; Kaasik, Allen/I-2738-2015; Choubey, Vinay/H-3170-2015	Choubey, Vinay/0000-0002-1953-5692; Veksler, Vladimir/0000-0002-8869-9594; Safiulina, Dzhamilja/0000-0002-4188-4207; Kaasik, Allen/0000-0002-4850-3198				Benquet P, 2002, J NEUROPHYSIOL, V88, P1475, DOI 10.1152/jn.2002.88.3.1475; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Budd SL, 1996, J NEUROCHEM, V67, P2282; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Hollenbeck, 1996, FRONT BIOSCI, V1, pD91; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; MUNOZ DG, 1988, J NEUROPATH EXP NEUR, V47, P9, DOI 10.1097/00005072-198801000-00002; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Safiulina D, 2006, J CELL PHYSIOL, V206, P347, DOI 10.1002/jcp.20476; Shah SB, 2005, BIOPHYS J, V88, p400A; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Vanden Berghe P, 2004, AM J PHYSIOL-GASTR L, V286, pG671, DOI 10.1152/ajpgi.00283.2003; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	26	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32821	32826		10.1074/jbc.M702295200	http://dx.doi.org/10.1074/jbc.M702295200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17785462	hybrid			2022-12-25	WOS:000250625400031
J	von Horsten, HH; Johnson, SS; SanFrancisco, SK; Hastert, MC; Whelly, SM; Cornwall, GA				von Horsten, Hans H.; Johnson, Seethal S.; SanFrancisco, Susan K.; Hastert, Mary Catherine; Whelly, Sandra M.; Cornwall, Gail A.			Oligomerization and transglutaminase cross-linking of the cystatin CRES in the mouse epididymal lumen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; AMYLOID-BETA PROTEIN; SPERM MATURATION; COMMON MECHANISM; FIBRIL FORMATION; HUMAN-SEMEN; AGGREGATION; ANGIOPATHY; INHIBITION; PEPTIDE	CRES (cystatin-related epididymal spermatogenic), a member of the cystatin superfamily of cysteine protease inhibitors, is expressed in the epididymis and spermatozoa, suggesting specialized roles in reproduction. Several cystatin family members oligomerize, including cystatin C that forms amyloid deposits associated with cerebral amyloid angiopathy. Our studies demonstrate that CRES also forms oligomers. Size exclusion chromatography revealed the presence of multiple forms of CRES in the epididymal luminal fluid, including SDS-sensitive and SDS-resistant high molecular mass complexes. In vitro experiments demonstrated that CRES is a substrate for transglutaminase and that an endogenous transglutaminase activity in the epididymal lumen catalyzed the formation of SDS-resistant CRES complexes. The use of a conformation-dependent antibody that recognizes only the oligomeric precursors to amyloid, negative stain electron microscopy, and Congo Red staining showed that CRES adopted similar oligomeric and fibrillar structures during its aggregation as other amyloidogenic proteins, suggesting that CRES has the potential to form amyloid in the epididymal lumen. The addition of transglutaminase, however, prevented the formation of CRES oligomers recognized by the conformation antibody by cross-linking CRES into an amorphous structure. We propose that transglutaminase activity in the epididymal lumen may function as a mechanism of extracellular quality control by diverting proteins such as CRES from the amyloidogenic pathway.	Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA; Texas Tech Univ, Dept Sci Biol, Imaging Ctr, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University	Cornwall, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, 3601 4th St, Lubbock, TX 79430 USA.	gail.cornwall@ttuhsc.edu			NICHD NIH HHS [HD 44669, HD 33903] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033903, R29HD033903, K02HD044669] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACEVEDO F, 1995, ELECTROPHORESIS, V16, P1394, DOI 10.1002/elps.11501601231; Asquith KL, 2005, BIOL REPROD, V72, P328, DOI 10.1095/biolreprod.104.034470; AUERSWALD EA, 1992, EUR J BIOCHEM, V209, P837, DOI 10.1111/j.1432-1033.1992.tb17355.x; Aumuller G, 1990, Acta Histochem Suppl, V38, P209; BARSIGIAN C, 1991, J BIOL CHEM, V266, P22501; BIRCKBICHLER PJ, 1977, BIOCHEM BIOPH RES CO, V78, P1, DOI 10.1016/0006-291X(77)91213-X; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Boros S, 2004, FEBS LETT, V576, P57, DOI 10.1016/j.febslet.2004.08.062; Breci LA, 2003, ANAL CHEM, V75, P1963, DOI 10.1021/ac026359i; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; CASELLA R, 2002, UROLOGY, V59; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chae KY, 2005, J BIOCHEM, V137, P407, DOI 10.1093/jb/mvi051; CORNWALL GA, 1995, MOL REPROD DEV, V41, P37, DOI 10.1002/mrd.1080410107; Cornwall GA, 2003, MOL CELL ENDOCRINOL, V200, P1, DOI 10.1016/S0303-7207(02)00408-2; Cornwall GA, 2003, ENDOCRINOLOGY, V144, P901, DOI 10.1210/en.2002-220997; CORNWALL GA, 1992, MOL ENDOCRINOL, V6, P1653, DOI 10.1210/me.6.10.1653; Cuasnicu P. S., 2002, EPIDIDYMIS MOL CLIN, P389, DOI DOI 10.1007/978-1-4615-0679-9_; Dacheux J. -L., 2002, EPIDIDYMIS MOL CLIN, P151, DOI [10.1007/978-1-4615-0679-9_9, DOI 10.1007/978-1-4615-0679-9_9]; Dehouck Y, 2003, J MOL BIOL, V330, P1215, DOI 10.1016/S0022-2836(03)00614-4; DELAMIRANDE E, 1989, GAMETE RES, V22, P179, DOI 10.1002/mrd.1120220206; DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P6446, DOI 10.1073/pnas.0731893100; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P2391, DOI 10.1073/pnas.0335642100; FONTANA A, 1983, METHOD ENZYMOL, V91, P311; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; GRASSO P, 1987, ENDOCRINOLOGY, V121, P459, DOI 10.1210/endo-121-2-459; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jeitner TM, 2005, BIOCHEM PHARMACOL, V69, P961, DOI 10.1016/j.bcp.2004.12.011; Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Konno T, 2005, J BIOL CHEM, V280, P17520, DOI 10.1074/jbc.M413988200; Konno T, 2005, BIOCHEMISTRY-US, V44, P2072, DOI 10.1021/bi047722d; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; MACHLEIDT W, 1991, BIOMED BIOCHIM ACTA, V50, P613; Madi A, 2005, ANAL BIOCHEM, V343, P256, DOI 10.1016/j.ab.2005.05.034; Merz GS, 1997, J CELL PHYSIOL, V173, P423; MUKHERJEE DC, 1983, SCIENCE, V219, P989, DOI 10.1126/science.6130601; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Nagai A, 1998, MOL CHEM NEUROPATHOL, V33, P63, DOI 10.1007/BF02815860; NISTAL M, 1989, Applied Pathology, V7, P2; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Olofsson A, 2002, CLIN CHEM LAB MED, V40, P1266, DOI 10.1515/CCLM.2002.219; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Peter A, 1998, EUR J BIOCHEM, V252, P216, DOI 10.1046/j.1432-1327.1998.2520216.x; PORTA R, 1986, BIOL REPROD, V35, P965, DOI 10.1095/biolreprod35.4.965; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0; Sodhi R, 2003, ANAL BIOCHEM, V315, P141, DOI 10.1016/S0003-2697(02)00656-5; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; TAKAHASHI M, 1992, FEBS LETT, V308, P79, DOI 10.1016/0014-5793(92)81055-Q; von Horsten HH, 2003, ANAL BIOCHEM, V316, P139, DOI 10.1016/S0003-2697(03)00023-X; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	62	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32912	32923		10.1074/jbc.M703956200	http://dx.doi.org/10.1074/jbc.M703956200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855342	hybrid			2022-12-25	WOS:000250625400040
J	Steinberg, R; Harari, OA; Lidington, EA; Boyle, JJ; Nohadani, M; Samarel, AM; Ohba, M; Haskard, DO; Mason, JC				Steinberg, Rivka; Harari, Olivier A.; Lidington, Elaine A.; Boyle, Joseph J.; Nohadani, Mahrokh; Samarel, Allen M.; Ohba, Motoi; Haskard, Dorian O.; Mason, Justin C.			A protein kinase C epsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECAY-ACCELERATING FACTOR; GROWTH-FACTOR; PKC-EPSILON; ATHEROSCLEROTIC PLAQUES; IN-VIVO; ACTIVATION; DELTA; SURVIVAL; PATHWAY; CANCER	Endothelial cell apoptosis is associated with vascular injury and predisposes to atherogenesis. Endothelial cells express antiapoptotic genes including Bcl-2, Bcl-XL and survivin, which also contribute to angiogenesis and vascular remodeling. We report a central role for protein kinase C epsilon(PKC epsilon) in the regulation of Bcl-2 expression and cytoprotection of human vascular endothelium against apoptosis. Using myristoylated inhibitory peptides, a predominant role for PKC epsilon in vascular endothelial growth factor-mediated endothelial resistance to apoptosis was revealed. Immunoblotting of endothelial cells infected with an adenovirus expressing a constitutively active form of PKC epsilon (Adv-PKC epsilon-CA) or control Adv-beta-galactosidase demonstrated a 3-fold, PKC epsilon-dependent increase in Bcl-2 expression, with no significant change in Bcl-X-L, Bad, Bak, or Bax. The induction of Bcl-2 inhibited apoptosis induced by serum starvation or etoposide, and PKC epsilon activation attenuated etoposide-induced caspase-3 cleavage. The functional role of Bcl-2 was confirmed with Bcl-2 antagonist HA-14-1. Inhibition of phosphoinositide 3-kinase attenuated vascular endothelial growth factor-induced protection against apoptosis, and this was rescued by overexpression of constitutively active PKC epsilon, suggesting PKC epsilon acts downstream of phosphoinositide 3-kinase. Co-immunoprecipitation studies demonstrated a physical interaction between PKC epsilon and Akt, which resulted in formation of a signaling complex, leading to optimal induction of Bcl-2. This study reveals a pivotal role for PKC epsilon in endothelial cell cytoprotection against apoptosis. We demonstrate that PKC epsilon forms a signaling complex and acts co-operatively with Akt to protect human vascular endothelial cells against apoptosis through induction of the anti-apoptotic protein Bcl-2 and inhibition of caspase-3 cleavage.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Bywaters Ctr Vasc Inflammat, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Histopathol Sect, London W12 0NN, England; Loyola Univ, Chicago Stritch Sch Med, Cardiovasc Inst, Maywood, IL 60153 USA; Showa Univ, Inst Mol Oncol, Tokyo 1428555, Japan	Imperial College London; Imperial College London; Loyola University Chicago; Showa University	Mason, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Bywaters Ctr Vasc Inflammat, Cane Rd, London W12 0NN, England.	justin.mason@imperial.ac.uk	Samarel, Allen/Q-9810-2019	Harari, Olivier/0000-0001-8214-489X; Boyle, Joseph J/0000-0002-4337-3320; Samarel, Allen/0000-0001-8765-9884; Mason, Justin/0000-0001-7783-1660	British Heart Foundation [FS/13/12/30037] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; CACACE AM, 1993, ONCOGENE, V8, P2095; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dimmeler S, 2002, CURR OPIN LIPIDOL, V13, P531, DOI 10.1097/00041433-200210000-00009; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gliki G, 2001, BIOCHEM J, V353, P503, DOI 10.1042/0264-6021:3530503; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Gray MO, 2004, J BIOL CHEM, V279, P3596, DOI 10.1074/jbc.M311459200; Gubina E, 1998, BLOOD, V91, P823, DOI 10.1182/blood.V91.3.823.823_823_829; GUSTAFSSON AB, 2006, AM J PHYSIOL-CELL PH, V292, P45; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Haskard DO, 2004, SCAND J RHEUMATOL, V33, P281, DOI 10.1080/03009740410010281; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; Hurwitz H, 2006, SEMIN ONCOL, V33, pS26, DOI 10.1053/j.seminoncol.2006.08.001; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Li LW, 1999, MOL CELL BIOL, V19, P8547; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; LINDINGTON EA, 2005, AM J PHYSIOL-CELL PH, V289, P1437; Littler CM, 2005, AM J PHYSIOL-LUNG C, V289, pL1083, DOI 10.1152/ajplung.00472.2004; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Mason JC, 2001, ARTHRITIS RHEUM, V44, P138, DOI 10.1002/1529-0131(200101)44:1<138::AID-ANR18>3.0.CO;2-G; Matsumoto M, 2001, J BIOL CHEM, V276, P14400, DOI 10.1074/jbc.M011093200; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; Mirandola P, 2006, BLOOD, V107, P508, DOI 10.1182/blood-2005-07-2676; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; NEWTON AC, 2005, CHEM REV, V165, P2353; Ni CW, 2003, J CELL PHYSIOL, V195, P428, DOI 10.1002/jcp.10259; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Ramalingam R, 1999, BLOOD, V93, P2936; Saurin AT, 2002, CARDIOVASC RES, V55, P672, DOI 10.1016/S0008-6363(02)00325-5; Stoneman VEA, 2004, CLIN SCI, V107, P343, DOI 10.1042/CS20040086; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Traub O, 1997, J BIOL CHEM, V272, P31251, DOI 10.1074/jbc.272.50.31251; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Venkatesan BA, 2006, CELL SIGNAL, V18, P508, DOI 10.1016/j.cellsig.2005.05.022; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wu DQ, 2004, ONCOGENE, V23, P8659, DOI 10.1038/sj.onc.1207900; Wu DQ, 2002, CANCER RES, V62, P2423; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	71	44	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32288	32297		10.1074/jbc.M704001200	http://dx.doi.org/10.1074/jbc.M704001200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785460	hybrid			2022-12-25	WOS:000250480300052
J	Wood, KS; Dunn, SD				Wood, Kristi S.; Dunn, Stanley D.			Role of the asymmetry of the homodimeric b(2) stator stalk in the interaction with the F-1 sector of Escherichia coli ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HANDED COILED-COIL; B-SUBUNIT; DIMERIZATION DOMAIN; MONOCLONAL-ANTIBODIES; F1F0-ATP SYNTHASE; DELTA SUBUNITS; BINDING; ALPHA; PROTEINS; RESIDUES	The b subunit dimer in the peripheral stator stalk of Escherichia coli ATP synthase is essential for enzyme assembly and the rotational catalytic mechanism. Recent protein chemical evidence revealed the dimerization domain of b to contain a novel two-stranded right-handed coiled coil with offset helices. Here, the existence of this structure in more complete constructs of b containing the C-terminal domain, and therefore capable of binding to the peripheral F1-ATPase, was supported by the more efficient formation of intersubunit disulfide bonds between cysteine residues that are proximal only in the offset arrangement and by the greater thermal stabilities of crosslinked heterodimers trapped in the offset configuration as opposed to homodimers with the helices trapped in-register. F1-ATPase binding analyses revealed the offset heterodimers to bind F1 more tightly than in-register homodimers. Mutations near the C terminus of b were incorporated specifically into either the N-terminally or the C-terminally shifted polypeptide, bN or bC, respectively, to determine the contribution of each position to F1 binding. Deletion of the last four residues of bN substantially weakened F1 binding, whereas the effect of the deletion in bC was modest. Similarly, benzophenone maleimide introduced at the C terminus of bN, but not bC, mediated cross-linking to the delta subunit of F1. These results imply that the polypeptide in the bN position is more important for F1 binding than the one in the bC position and illustrate the significance of the asymmetry of the b dimer in the enzyme.	Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Dunn, SD (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada.	sdunn@uwo.ca	Dunn, Stanley/D-3418-2013					AGGELER R, 1992, ARCH BIOCHEM BIOPHYS, V296, P685, DOI 10.1016/0003-9861(92)90627-9; Bhatt D, 2005, J BIOENERG BIOMEMBR, V37, P67, DOI 10.1007/s10863-005-4129-7; Briere LAK, 2006, BIOCHEMISTRY-US, V45, P8607, DOI 10.1021/bi0606997; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; Cipriano DJ, 2006, J BIOL CHEM, V281, P12408, DOI 10.1074/jbc.M513368200; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Diez M, 2004, BIOCHEMISTRY-US, V43, P1054, DOI 10.1021/bi0357098; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Duncan T. M., 2004, ENZYMES, VXXIII, P203; Dunn S. D., 2004, HDB ATPASES, P311; Dunn SD, 2000, BBA-BIOENERGETICS, V1459, P521, DOI 10.1016/S0005-2728(00)00192-4; Dunn SD, 2000, J BIOENERG BIOMEMBR, V32, P347, DOI 10.1023/A:1005571818730; Dunn SD, 2001, BIOCHEMISTRY-US, V40, P187, DOI 10.1021/bi001821j; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; Grabar TB, 2004, J BIOL CHEM, V279, P31205, DOI 10.1074/jbc.M404420200; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McLachlin DT, 1996, PROTEIN EXPRES PURIF, V7, P275, DOI 10.1006/prep.1996.0039; McLachlin DT, 2000, BIOCHEMISTRY-US, V39, P3486, DOI 10.1021/bi992586b; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; McLachlin DT, 2000, J BIOL CHEM, V275, P17571, DOI 10.1074/jbc.M000375200; Nakanishi-Matsui M, 2006, IUBMB LIFE, V58, P318, DOI 10.1080/15216540600702255; Penefsky H S, 1979, Methods Enzymol, V56, P527; Peng GH, 2006, FEBS LETT, V580, P5934, DOI 10.1016/j.febslet.2006.09.062; Revington M, 2002, PROTEIN SCI, V11, P1227, DOI 10.1110/ps.3200102; Revington M, 1999, J BIOL CHEM, V274, P31094, DOI 10.1074/jbc.274.43.31094; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Sorgen PL, 1998, BIOCHEMISTRY-US, V37, P923, DOI 10.1021/bi972309+; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; TAKEYAMA M, 1988, J BIOL CHEM, V263, P16106; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Weber J, 2004, J BIOL CHEM, V279, P11253, DOI 10.1074/jbc.M312576200; Weber J, 2007, TRENDS BIOCHEM SCI, V32, P53, DOI 10.1016/j.tibs.2006.12.006; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8	46	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31920	31927		10.1074/jbc.M706259200	http://dx.doi.org/10.1074/jbc.M706259200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17766239	hybrid			2022-12-25	WOS:000250480300012
J	Takahashi, S; Yeo, YS; Zhao, YX; O'Maille, PE; Greenhagen, BT; Noel, JP; Coates, RM; Chappell, J				Takahashi, Shunji; Yeo, Yun-Soo; Zhao, Yuxin; O'Maille, Paul E.; Greenhagen, Bryan T.; Noel, Joseph P.; Coates, Robert M.; Chappell, Joe			Functional characterization of premnaspirodiene oxygenase, a cytochrome P450 catalyzing regio- and stereo-specific hydroxylations of diverse sesquiterpene substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUALENE SYNTHETASE; AMINO-ACID; EXPRESSION; BIOSYNTHESIS; CULTURES; ENZYMES; CLONING; CYCLASE; GENE; IDENTIFICATION	Solavetivone, a potent antifungal phytoalexin, is derived from a vetispirane-type sesquiterpene, premnaspirodiene, by a putative regio- and stereo-specific hydroxylation, followed by a second oxidation to yield the alpha, beta-unsaturated ketone. Mechanistically, these reactions could occur via a single, multifunctional cytochrome P450 or some combination of cytochrome P450s and a dehydrogenase. We report here the characterization of a single cytochrome P450 enzyme, Hyoscyamus muticus premnaspirodiene oxygenase (HPO), that catalyzes these successive reactions at carbon 2 (C-2) of the spirane substrate. HPO also catalyzes the equivalent regio- specific (C-2) hydroxylation of several eremophilane-type ( decalin ring system) sesquiterpenes, such as with 5-epi-aristolochene. Moreover, HPO displays interesting comparisons to other sesquiterpene hydroxylases. 5-Epi-aristolochene di-hydroxylase (EAH) differs catalytically from HPO by introducing hydroxyl groups first at C-1, then C-3 of 5-epi-aristolochene. HPO and EAH also differ from one another by 91-amino acid differences, with four of these differences mapping to putative substrate recognition regions 5 and 6. These four positions were mutagenized alone and in various combinations in both HPO and EAH and the mutant enzymes were characterized for changes in substrate selectivity, reaction product specificity, and kinetic properties. These mutations did not alter the regio- or stereo-specificity of either HPO or EAH, but specific combinations of the mutations did improve the catalytic efficiencies 10-15- fold. Molecular models and comparisons between HPO and EAH provide insights into the catalytic properties of these enzymes of specialized metabolism in plants.	Univ Kentucky, Dept Plant & Soil Sci, Plant Biol program, Lexington, KY 40546 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Salk Institute	Chappell, J (corresponding author), 1405 Vet Dr, Lexington, KY USA.	chappell@uky.edu	Noel, Joseph P/A-9459-2009; Takahashi, Shunji/GLT-3245-2022; Takahashi, Shunji/N-6921-2015	Takahashi, Shunji/0000-0003-1684-9298; Takahashi, Shunji/0000-0003-1684-9298	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM054029, R01 GM013956, GM54029, GM13956] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054029, R01GM013956] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AYERS AR, 1976, PLANT PHYSIOL, V57, P760, DOI 10.1104/pp.57.5.760; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Bell SG, 2003, J AM CHEM SOC, V125, P705, DOI 10.1021/ja028460a; Bellucci G, 1996, CHEM RES TOXICOL, V9, P871, DOI 10.1021/tx9600053; BIRNBAUM GI, 1974, CAN J CHEM, V52, P993, DOI 10.1139/v74-159; BUCKINGHAM J, 1994, DICT NATURAL PRODUCT; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; de Kraker JW, 2003, TETRAHEDRON, V59, P409, DOI 10.1016/S0040-4020(02)01479-5; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; Engstrom K, 1999, POTATO RES, V42, P43, DOI 10.1007/BF02358390; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; GOTOH O, 1992, J BIOL CHEM, V267, P83; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Greenhagen BT, 2003, ARCH BIOCHEM BIOPHYS, V409, P385, DOI 10.1016/S0003-9861(02)00613-6; Hansen B, 2005, PLANTA, V221, P603, DOI 10.1007/s00425-005-1553-1; He XY, 2004, ARCH BIOCHEM BIOPHYS, V427, P143, DOI 10.1016/j.abb.2004.03.016; Hilser VJ, 1998, P NATL ACAD SCI USA, V95, P9903, DOI 10.1073/pnas.95.17.9903; Kaspera R, 2005, APPL MICROBIOL BIOT, V67, P477, DOI 10.1007/s00253-004-1794-0; Kim D, 2004, BIOCHEMISTRY-US, V43, P981, DOI 10.1021/bi035593f; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Kuroyanagi M, 1998, J NAT PROD, V61, P1516, DOI 10.1021/np980214i; Lupien S, 1999, ARCH BIOCHEM BIOPHYS, V368, P181, DOI 10.1006/abbi.1999.1298; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Oksman-Caldentey KM, 2004, TRENDS PLANT SCI, V9, P433, DOI 10.1016/j.tplants.2004.07.006; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pan LP, 2004, ARCH BIOCHEM BIOPHYS, V422, P31, DOI 10.1016/j.abb.2003.09.047; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Rising KA, 2000, J AM CHEM SOC, V122, P1861, DOI 10.1021/ja993584h; Sakamaki H, 2005, J MOL CATAL B-ENZYM, V32, P103, DOI 10.1016/j.molcatb.2004.10.004; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; SHAFFER GW, 1975, J ORG CHEM, V40, P2181, DOI 10.1021/jo00903a010; Takahashi S, 2005, J BIOL CHEM, V280, P3686, DOI 10.1074/jbc.M411870200; THRELFALL DR, 1988, PHYTOCHEMISTRY, V27, P2567, DOI 10.1016/0031-9422(88)87028-6; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VOGELI U, 1988, PLANT PHYSIOL, V88, P1291, DOI 10.1104/pp.88.4.1291; Wang EM, 2001, NAT BIOTECHNOL, V19, P371, DOI 10.1038/86770; Weyerstahl P, 2000, FLAVOUR FRAG J, V15, P153, DOI 10.1002/1099-1026(200005/06)15:3&lt;153::AID-FFJ885&gt;3.0.CO;2-5; Yao MK, 2003, MYCORRHIZA, V13, P333, DOI 10.1007/s00572-003-0267-0; Yokose T, 2004, BIOSCI BIOTECH BIOCH, V68, P2640, DOI 10.1271/bbb.68.2640; Zhao YX, 2004, J ORG CHEM, V69, P7428, DOI 10.1021/jo049058c	46	78	97	1	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31744	31754		10.1074/jbc.M703378200	http://dx.doi.org/10.1074/jbc.M703378200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715131	Green Accepted, hybrid			2022-12-25	WOS:000250309200065
J	Uvarov, P; Ludwig, A; Markkanen, M; Pruunsild, P; Kaila, K; Delpire, E; Timmusk, T; Rivera, C; Airaksinen, MS				Uvarov, Pavel; Ludwig, Anastasia; Markkanen, Marika; Pruunsild, Priit; Kaila, Kai; Delpire, Eric; Timmusk, Tonis; Rivera, Claudio; Airaksinen, Matti S.			A novel N-terminal isoform of the neuron-specific K-Cl cotransporter KCC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; GENOME-WIDE ANALYSIS; ALANINE-RICH KINASE; ALTERNATIVE PROMOTERS; UP-REGULATION; RAT-BRAIN; EXPRESSION; GENE; DISRUPTION; PATTERNS	The neuronal K-Cl cotransporter KCC2 maintains the low intracellular chloride concentration required for the hyperpolarizing actions of inhibitory neurotransmitters gamma-aminobutyric acid and glycine in the central nervous system. This study shows that the mammalian KCC2 gene ( alias Slc12a5) generates two neuron-specific isoforms by using alternative promoters and first exons. The novel KCC2a isoform differs from the only previously known KCC2 isoform (now termed KCC2b) by 40 unique N-terminal amino acid residues, including a putative Ste20-related proline alanine-rich kinase-binding site. Ribonuclease protection and quantitative PCR assays indicated that KCC2a contributes 20-50% of total KCC2 mRNA expression in the neonatal mouse brain stem and spinal cord. In contrast to the marked increase in KCC2b mRNA levels in the cortex during postnatal development, the overall expression of KCC2a remains relatively constant and makes up only 5-10% of total KCC2 mRNA in the mature cortex. A rubidium uptake assay in human embryonic kidney 293 cells showed that the KCC2a isoform mediates furosemide-sensitive ion transport activity comparable with that of KCC2b. Mice that lack both KCC2 isoforms die at birth due to severe motor defects, including disrupted respiratory rhythm, whereas mice with a targeted disruption of the first exon of KCC2b survive for up to 2 weeks but eventually die due to spontaneous seizures. We show that these mice lack KCC2b but retain KCC2a mRNA. Thus, distinct populations of neurons show a differential dependence on the expression of the two isoforms: KCC2a expression in the absence of KCC2b is presumably sufficient to support vital neuronal functions in the brain stem and spinal cord but not in the cortex.	Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA	University of Helsinki; University of Helsinki; University of Helsinki; Tallinn University of Technology; Vanderbilt University	Uvarov, P (corresponding author), Univ Helsinki, Ctr Neurosci, Villkinkaari 4, FIN-00014 Helsinki, Finland.	pavel.uvarov@helsinki.fi; matti.airaksinen@helsinki.fi	Kaila, Kai K/R-8528-2016; Rivera, Claudio/ABE-2499-2021; Uvarov, Pavel/AGR-2614-2022; Ludwig, Anastasia/N-1837-2016; Timmusk, Tonis/H-4889-2015	Kaila, Kai K/0000-0003-0668-5955; Rivera, Claudio/0000-0003-2462-6561; Uvarov, Pavel/0000-0001-8439-6150; Ludwig, Anastasia/0000-0003-4849-8074; Pruunsild, Priit/0000-0001-6823-6683; Timmusk, Tonis/0000-0002-1015-3348; Airaksinen, Matti/0000-0002-7199-4984	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Delpire E, 2007, PHYSIOL GENOMICS, V28, P223, DOI 10.1152/physiolgenomics.00173.2006; Di Fulvio M, 2003, NITRIC OXIDE-BIOL CH, V9, P165, DOI 10.1016/j.niox.2003.11.004; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Karadsheh MF, 2001, J NEUROPHYSIOL, V85, P995, DOI 10.1152/jn.2001.85.2.995; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Le Rouzic P, 2006, BRAIN RES, V1110, P39, DOI 10.1016/j.brainres.2006.06.055; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Uvarov P, 2005, J NEUROCHEM, V95, P1144, DOI 10.1111/j.1471-4159.2005.03434.x; Uvarov P, 2006, J NEUROSCI, V26, P13463, DOI 10.1523/JNEUROSCI.4731-06.2006; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85	35	100	104	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30570	30576		10.1074/jbc.M705095200	http://dx.doi.org/10.1074/jbc.M705095200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17715129	hybrid			2022-12-25	WOS:000250136300025
J	Alvarez, BV; Gilmour, GS; Mema, SC; Martin, BT; Shull, GE; Casey, JR; Sauve, Y				Alvarez, Bernardo V.; Gilmour, Gregory S.; Mema, Silvina C.; Martin, Brent T.; Shull, Gary E.; Casey, Joseph R.; Sauve, Yves			Blindness Caused by Deficiency in AE3 Chloride/Bicarbonate Exchanger	PLOS ONE			English	Article								Background. Vision is initiated by phototransduction in the outer retina by photoreceptors, whose high metabolic rate generates large CO2 loads. Inner retina cells then process the visual signal and CO2. The anion exchanger 3 gene (AE3/Slc4a3) encodes full-length AE3 (AE3fl) and cardiac AE3 (AE3c) isoforms, catalyzing plasma membrane Cl-/HCO3- exchange in Muller (AE3fl) and horizontal (AE3c) cells. AE3 thus maintains acid-balance by removing photoreceptor-generated CO2 waste. Methodology/Principal Findings. We report that Slc4a3(-/-) null mice have inner retina defects (electroretinogram b-wave reduction, optic nerve and retinal vessel anomalies). These pathologic features are common to most human vitreoretinal degenerations. Immunobloting analysis revealed that Na+/HCO3- co-transporter (NBC1), and carbonic anhydrase II and CAXIV, protein expression were elevated in Slc4a3(-/-) mouse retinas, suggesting compensation for loss of AE3. TUNEL staining showed increased numbers of apoptotic nuclei from 4-6 months of age, in Slc4a3(-/-) mice, indicating late onset photoreceptor death. Conclusions/Significance. Identification of Slc4a3 as underlying a previously unrecognized cause of blindness suggests this gene as a new candidate for a subset of hereditary vitreoretinal retinal degeneration.	[Alvarez, Bernardo V.; Martin, Brent T.; Casey, Joseph R.; Sauve, Yves] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Alvarez, Bernardo V.; Casey, Joseph R.] Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB, Canada; [Gilmour, Gregory S.; Mema, Silvina C.; Sauve, Yves] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; [Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Alberta; University of Alberta; University of Alberta; University of Cincinnati	Sauve, Y (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	ysauve@ualberta.ca	Casey, Joseph/A-8888-2013; Mema, Silvina/J-5416-2019	Casey, Joseph/0000-0002-9890-5056; Mema, Silvina/0000-0001-5895-9159	Canadian Institutes of Health Research; NIH [HL61974]; Barbara Tuck/MacPhee Family Vision Research Award; Canadian Cystic Fibrosis Foundation; NSERC Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061974] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barbara Tuck/MacPhee Family Vision Research Award; Canadian Cystic Fibrosis Foundation; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Canadian Institutes of Health Research Grants to YS and JRC and NIH grant HL61974 to GES. YS is a recipient of the Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration. JRC is a Scientist of the Alberta Heritage Foundation for Medical Research. BVA was supported by a Postdoctoral Fellowship from the Canadian Cystic Fibrosis Foundation, and BTM by a NSERC Canada Graduate Scholarship (Masters level).	Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; ALVAREZ BV, 2007, ARVO; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; BROWN DM, 1995, ARCH OPHTHALMOL-CHIC, V113, P671, DOI 10.1001/archopht.1995.01100050139045; CABANTCHIK ZI, 1992, AM J PHYSIOL, V262, pC803, DOI 10.1152/ajpcell.1992.262.4.C803; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; DOERING C, 2007, NEUROSCIENC IN PRESS; EVERETT WG, 1968, AM J OPHTHALMOL, V65, P229, DOI 10.1016/0002-9394(68)93592-7; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; HIROSE T, 1980, ANN OPHTHALMOL, V12, P1135; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; IWASAKI M, 1987, GRAEF ARCH CLIN EXP, V225, P177, DOI 10.1007/BF02175446; JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7; Jiao XD, 2004, INVEST OPHTH VIS SCI, V45, P4498, DOI 10.1167/iovs.04-0722; Kellner U, 1998, BRIT J OPHTHALMOL, V82, P650, DOI 10.1136/bjo.82.6.650; Kniep EM, 2006, INVEST OPHTH VIS SCI, V47, P1185, DOI 10.1167/iovs.05-0555; KOBAYASHI S, 1994, J NEUROSCI, V14, P6266; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; MAUMENEE IH, 1979, AM J OPHTHALMOL, V88, P432, DOI 10.1016/0002-9394(79)90645-7; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; MEYERTHOLEN EP, 1986, VISION RES, V26, P521, DOI 10.1016/0042-6989(86)90001-5; Nagelhus EA, 2005, P NATL ACAD SCI USA, V102, P8030, DOI 10.1073/pnas.0503021102; OAKLEY B, 1989, J PHYSIOL-LONDON, V419, P353, DOI 10.1113/jphysiol.1989.sp017876; Ochrietor JD, 2005, EXP EYE RES, V81, P492, DOI 10.1016/j.exer.2005.03.010; OGILVIE JM, 2007, P NATL ACAD SCI US; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; Peachey NS, 1997, VISUAL NEUROSCI, V14, P627, DOI 10.1017/S0952523800012591; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; ROMERO MF, 2004, PFLUGERS ARCH, V14, P14; RUETZ S, 1993, J CELL BIOL, V121, P37, DOI 10.1083/jcb.121.1.37; Sander T, 2002, EPILEPSY RES, V51, P249, DOI 10.1016/S0920-1211(02)00152-3; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; SILLMAN AJ, 1972, VISION RES, V12, P1519, DOI 10.1016/0042-6989(72)90177-0; Snead MP, 1996, EYE, V10, P653, DOI 10.1038/eye.1996.158; Snead MP, 1996, ANN NY ACAD SCI, V785, P331, DOI 10.1111/j.1749-6632.1996.tb56300.x; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; SU YR, 1994, GENOMICS, V22, P605, DOI 10.1006/geno.1994.1433; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; TAKAHASHI KI, 1993, J GEN PHYSIOL, V101, P695, DOI 10.1085/jgp.101.5.695; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; WALLS G L, 1949, Am J Ophthalmol, V32, P1409; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667	49	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e839	10.1371/journal.pone.0000839	http://dx.doi.org/10.1371/journal.pone.0000839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786210	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500022
J	Crevel, G; Hashimoto, R; Vass, S; Sherkow, J; Yamaguchi, M; Heck, MMS; Cotterill, S				Crevel, Gilles; Hashimoto, Reina; Vass, Sharron; Sherkow, Jake; Yamaguchi, Masamitsu; Heck, Margarete M. S.; Cotterill, Sue			Differential Requirements for MCM Proteins in DNA Replication in Drosophila S2 Cells	PLOS ONE			English	Article								Background. The MCM2-7 proteins are crucial components of the pre replication complex (preRC) in eukaryotes. Since they are significantly more abundant than other preRC components, we were interested in determining whether the entire cellular content was necessary for DNA replication in vivo. Methodology/Principle Findings. We performed a systematic depletion of the MCM proteins in Drosophila S2 cells using dsRNA-interference. Reducing MCM2-6 levels by >95-99% had no significant effect on cell cycle distribution or viability. Depletion of MCM7 however caused an S-phase arrest. MCM2-7 depletion produced no change in the number of replication forks as measured by PCNA loading. We also depleted MCM8. This caused a 30% reduction in fork number, but no significant effect on cell cycle distribution or viability. No additive effects were observed by co-depleting MCM8 and MCM5. Conclusions/Significance. These studies suggest that, in agreement with what has previously been observed for Xenopus in vitro, not all of the cellular content of MCM2-6 proteins is needed for normal cell cycling. They also reveal an unexpected unique role for MCM7. Finally they suggest that MCM8 has a role in DNA replication in S2 cells.	[Crevel, Gilles; Cotterill, Sue] St Georges Univ London, London, England; [Hashimoto, Reina; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Insect Biomed Res Ctr, Kyoto 606, Japan; [Vass, Sharron; Sherkow, Jake; Heck, Margarete M. S.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	St Georges University London; Kyoto Institute of Technology; University of Edinburgh	Cotterill, S (corresponding author), St Georges Univ London, London, England.	s.cotterill@sgul.ac.uk		Sherkow, Jacob/0000-0002-9724-9261; Yamaguchi, Masamitsu/0000-0002-6321-9750; Vass, Sharron/0000-0003-4201-2002	AICR; Wellcome Trust	AICR; Wellcome Trust(Wellcome TrustEuropean Commission)	This research in the Cotterill lab was funded by the AICR. Research in the Heck laboratory is funded by a Senior Research Fellowship from the Wellcome Trust.	Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Crevel G, 2005, J CELL SCI, V118, P2451, DOI 10.1242/jcs.02361; Crevel G, 2001, NUCLEIC ACIDS RES, V29, P4834, DOI 10.1093/nar/29.23.4834; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Kelman Z, 2003, NAT STRUCT BIOL, V10, P148, DOI 10.1038/nsb0303-148; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Loupart ML, 2000, CURR BIOL, V10, P1547, DOI 10.1016/S0960-9822(00)00844-7; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Maiorano D, 2005, CELL, V120, P315, DOI 10.1016/j.cell.2004.12.010; Matsubayashi H, 2003, GENES GENET SYST, V78, P363, DOI 10.1266/ggs.78.363; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; You ZY, 1999, MOL CELL BIOL, V19, P8003	35	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e833	10.1371/journal.pone.0000833	http://dx.doi.org/10.1371/journal.pone.0000833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786205	Green Published, Green Accepted, gold			2022-12-25	WOS:000207455500017
J	Kugimiya, F; Kawaguchi, H; Ohba, S; Kawamura, N; Hirata, M; Chikuda, H; Azuma, Y; Woodgett, JR; Nakamura, K; Chung, U				Kugimiya, Fumitaka; Kawaguchi, Hiroshi; Ohba, Shinsuke; Kawamura, Naohiro; Hirata, Makoto; Chikuda, Hirotaka; Azuma, Yoshiaki; Woodgett, James R.; Nakamura, Kozo; Chung, Ung-il			GSK-3 beta Controls Osteogenesis through Regulating Runx2 Activity	PLOS ONE			English	Article								Despite accumulated knowledge of various signalings regulating bone formation, the molecular network has not been clarified sufficiently to lead to clinical application. Here we show that heterozygous glycogen synthase kinase-3 beta (GSK-3 beta)-deficient mice displayed an increased bone formation due to an enhanced transcriptional activity of Runx2 by suppressing the inhibitory phosphorylation at a specific site. The cleidocranial dysplasia in heterozygous Runx2-deficient mice was significantly rescued by the genetic insufficiency of GSK-3 beta or the oral administration of lithium chloride, a selective inhibitor of GSK-3 beta. These results establish GSK-3 beta as a key attenuator of Runx2 activity in bone formation and as a potential molecular target for clinical treatment of bone catabolic disorders like cleidocranial dysplasia.	[Kugimiya, Fumitaka; Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo, Japan; [Kugimiya, Fumitaka; Kawaguchi, Hiroshi; Kawamura, Naohiro; Hirata, Makoto; Chikuda, Hirotaka; Nakamura, Kozo] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Azuma, Yoshiaki] Teijin Inst Biomed Res, Tokyo, Japan; [Woodgett, James R.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada	University of Tokyo; University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Chung, U (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo, Japan.	uichung-tky@umin.ac.jp	Kawamura, Naohiro/J-8372-2019; Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797; Ohba, Shinsuke/0000-0002-6874-8539	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17390410]; Terumo Life Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Life Science Foundation(Terumo Life Science Foundation)	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#17390410) and Terumo Life Science Foundation. The sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; CANALIS E, 1993, BONE, V14, P273, DOI 10.1016/8756-3282(93)90151-Y; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Dixon JF, 1998, P NATL ACAD SCI USA, V95, P8363, DOI 10.1073/pnas.95.14.8363; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200	41	114	117	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e837	10.1371/journal.pone.0000837	http://dx.doi.org/10.1371/journal.pone.0000837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786208	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455500020
J	Zikopoulos, B; Barbas, H				Zikopoulos, Basilis; Barbas, Helen			Parallel Driving and Modulatory Pathways Link the Prefrontal Cortex and Thalamus	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LATERAL GENICULATE-NUCLEUS; PRIMARY AUDITORY-CORTEX; PRIMARY VISUAL-CORTEX; NEURONS-IN-VITRO; RHESUS-MONKEY; MACAQUE MONKEY; BASAL GANGLIA; CORTICOCORTICAL COMMUNICATION; CORTICOTHALAMIC PROJECTIONS	Pathways linking the thalamus and cortex mediate our daily shifts from states of attention to quiet rest, or sleep, yet little is known about their architecture in high-order neural systems associated with cognition, emotion and action. We provide novel evidence for neurochemical and synaptic specificity of two complementary circuits linking one such system, the prefrontal cortex with the ventral anterior thalamic nucleus in primates. One circuit originated from the neurochemical group of parvalbumin-positive thalamic neurons and projected focally through large terminals to the middle cortical layers, resembling 'drivers' in sensory pathways. Parvalbumin thalamic neurons, in turn, were innervated by small 'modulatory' type cortical terminals, forming asymmetric (presumed excitatory) synapses at thalamic sites enriched with the specialized metabotropic glutamate receptors. A second circuit had a complementary organization: it originated from the neurochemical group of calbindin-positive thalamic neurons and terminated through small 'modulatory' terminals over long distances in the superficial prefrontal layers. Calbindin thalamic neurons, in turn, were innervated by prefrontal axons through small and large terminals that formed asymmetric synapses preferentially at sites with ionotropic glutamate receptors, consistent with a driving pathway. The largely parallel thalamo-cortical pathways terminated among distinct and laminar-specific neurochemical classes of inhibitory neurons that differ markedly in inhibitory control. The balance of activation of these parallel circuits that link a high-order association cortex with the thalamus may allow shifts to different states of consciousness, in processes that are disrupted in psychiatric diseases.	[Zikopoulos, Basilis; Barbas, Helen] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Barbas, Helen] Boston Univ, Program Neurosci, Boston, MA 02215 USA; [Barbas, Helen] Harvard Univ, Sch Med, New England Primate Res Ctr, Boston, MA USA; [Barbas, Helen] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02215 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Boston University	Barbas, H (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	barbas@bu.edu	Zikopoulos, Basilis/K-2443-2012	Zikopoulos, Vasileios/0000-0002-8834-5104; Barbas, Helen/0000-0003-0825-0832	NIMH; NINDS	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants from NIMH and NINDS. The authors declare no financial interest in this manuscript.	Abbott LF, 2005, PROG BRAIN RES, V149, P147, DOI 10.1016/S0079-6123(05)49011-1; ABRAMSON BP, 1985, NEUROSCIENCE, V15, P81, DOI 10.1016/0306-4522(85)90125-3; BARBAS H, 1991, J COMP NEUROL, V313, P65, DOI 10.1002/cne.903130106; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barbas H, 2005, CEREB CORTEX, V15, P1356, DOI 10.1093/cercor/bhi018; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; CASAGRANDE VA, 2005, PROG BRAIN RES, V149; CIPOLLONI PB, 1989, BRAIN RES, V492, P347, DOI 10.1016/0006-8993(89)90918-9; Conn PJ, 2005, NAT REV NEUROSCI, V6, P787, DOI 10.1038/nrn1763; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dombrowski SM, 2001, CEREB CORTEX, V11, P975, DOI 10.1093/cercor/11.10.975; Eaton SA, 1996, NEUROSCIENCE, V73, P1, DOI 10.1016/0306-4522(96)00123-6; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gabbott PLA, 1996, J COMP NEUROL, V364, P609; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Germuska M, 2006, CEREB CORTEX, V16, P865, DOI 10.1093/cercor/bhj030; Godwin DW, 1996, J NEUROSCI, V16, P8181; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; Guillery RW, 2005, PROG BRAIN RES, V149, P235, DOI 10.1016/S0079-6123(05)49017-2; Guillery RW, 1995, J ANAT, V187, P583; Guillery RW, 2003, J NEUROPHYSIOL, V90, P539, DOI 10.1152/jn.00337.2003; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; HASHIKAWA T, 1995, J COMP NEUROL, V362, P195, DOI 10.1002/cne.903620204; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; Howard C, 1998, UNBIASED STEREOLOGY; ILINSKY IA, 1990, J COMP NEUROL, V294, P455, DOI 10.1002/cne.902940313; Jones E G, 1998, Adv Neurol, V77, P49; Jones EG, 1998, J COMP NEUROL, V397, P371, DOI 10.1002/(SICI)1096-9861(19980803)397:3<371::AID-CNE5>3.0.CO;2-#; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; JONES EG, 1989, EUR J NEUROSCI, V1, P222, DOI 10.1111/j.1460-9568.1989.tb00791.x; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Jones EG, 1985, THALAMUS; Kao CQ, 1997, J NEUROPHYSIOL, V77, P2661, DOI 10.1152/jn.1997.77.5.2661; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Kwegyir-Afful EE, 2005, J NEUROSCI, V25, P5926, DOI 10.1523/JNEUROSCI.1360-05.2005; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; LEE CC, 2006, 2006 NEUR M PLANN AT; LEWIS DA, 1988, BRAIN RES, V449, P225, DOI 10.1016/0006-8993(88)91040-2; Lewis DA, 2001, AM J PSYCHIAT, V158, P1411, DOI 10.1176/appi.ajp.158.9.1411; Li JL, 2003, J NEUROPHYSIOL, V90, P3429, DOI 10.1152/jn.00456.2003; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; MADARASZ M, 1981, ANAT EMBRYOL, V162, P363, DOI 10.1007/BF00299979; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; McFarland NR, 2002, J NEUROSCI, V22, P8117; MEDALLA M, 2007, CEREB CORTE IN PRESS; Melchitzky DS, 1999, J COMP NEUROL, V408, P11; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Negyessy L, 2005, EXP BRAIN RES, V164, P148, DOI 10.1007/s00221-005-2237-6; OJIMA H, 1994, CEREB CORTEX, V4, P646, DOI 10.1093/cercor/4.6.646; olszewski j, 1952, THALAMUS MACACA MULA; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Peters A., 1991, FINE STRUCTURE NERVO; PIERCE JP, 1993, J NEUROSCI, V13, P4748; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Ramcharan EJ, 2005, P NATL ACAD SCI USA, V102, P12236, DOI 10.1073/pnas.0502843102; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; RICHMOND FJR, 1994, J NEUROSCI METH, V53, P35, DOI 10.1016/0165-0270(94)90142-2; Rockland KS, 1999, J COMP NEUROL, V406, P221, DOI 10.1002/(SICI)1096-9861(19990405)406:2<221::AID-CNE7>3.0.CO;2-K; Rockland KS, 1996, J COMP NEUROL, V368, P57, DOI 10.1002/(SICI)1096-9861(19960422)368:1<57::AID-CNE5>3.0.CO;2-J; Rollenhagen A, 2006, CELL TISSUE RES, V326, P221, DOI 10.1007/s00441-006-0288-z; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; SCHWARTZ ML, 1991, J COMP NEUROL, V309, P289, DOI 10.1002/cne.903090302; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2004, NEURON, V41, P493, DOI 10.1016/S0896-6273(04)00076-5; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS ORG FUNCTIO; Thomson AM, 2000, PROG NEUROBIOL, V62, P159, DOI 10.1016/S0301-0082(00)00008-3; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Vidnyanszky Z, 1996, EUR J NEUROSCI, V8, P1061, DOI 10.1111/j.1460-9568.1996.tb01273.x; Volk DW, 2003, BIOL PSYCHIAT, V53, P385, DOI 10.1016/S0006-3223(02)01547-0; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Wang S, 2002, J COMP NEUROL, V454, P482, DOI 10.1002/cne.10453; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wurtz RH, 2005, PROG BRAIN RES, V149, P207, DOI 10.1016/S0079-6123(05)49015-9; Xiao D., 2002, Thalamus & Related Systems, V2, P33; Xiao Danqing, 2004, Thalamus & Related Systems, V2, P325, DOI 10.1016/j.tharel.2004.03.001; ZIKOPOULOS B, 2007, REV NEUROSC IN PRESS; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	105	86	86	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e848	10.1371/journal.pone.0000848	http://dx.doi.org/10.1371/journal.pone.0000848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786219	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455500031
J	Kullberg, M; Hallstrom, B; Arnason, U; Janke, A				Kullberg, Morgan; Hallstrom, Bjorn; Arnason, Ulfur; Janke, Axel			Expressed Sequence Tags as a Tool for Phylogenetic Analysis of Placental Mammal Evolution	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; POSITIVE SELECTION; LIKELIHOOD METHOD; PROTEIN FAMILIES; GENES; IDENTIFICATION; SUBFAMILIES; SYSTEMATICS; INFERENCE; PATTERNS	Background. We investigate the usefulness of expressed sequence tags, ESTs, for establishing divergences within the tree of placental mammals. This is done on the example of the established relationships among primates (human), lagomorphs (rabbit), rodents (rat and mouse), artiodactyls (cow), carnivorans (dog) and proboscideans (elephant). Methodology/Principal Findings. We have produced 2000 ESTs (1.2 mega bases) from a marsupial mouse and characterized the data for their use in phylogenetic analysis. The sequences were used to identify putative orthologous sequences from whole genome projects. Although most ESTs stem from single sequence reads, the frequency of potential sequencing errors was found to be lower than allelic variation. Most of the sequences represented slowly evolving housekeeping-type genes, with an average amino acid distance of 6.6% between human and mouse. Positive Darwinian selection was identified at only a few single sites. Phylogenetic analyses of the EST data yielded trees that were consistent with those established from whole genome projects. Conclusions. The general quality of EST sequences and the general absence of positive selection in these sequences make ESTs an attractive tool for phylogenetic analysis. The EST approach allows, at reasonable costs, a fast extension of data sampling from species outside the genome projects.	[Kullberg, Morgan; Hallstrom, Bjorn; Arnason, Ulfur; Janke, Axel] Lund Univ, Dept Cell & Organism Biol, Div Evolutionary Mol Systemat, Lund, Sweden	Lund University	Kullberg, M (corresponding author), Lund Univ, Dept Cell & Organism Biol, Div Evolutionary Mol Systemat, Lund, Sweden.	morgan.kullberg@cob.lu.se	Janke, Axel/M-2135-2013	Janke, Axel/0000-0002-9394-1904	Swedish Science Council; Jorgen Lindstrom Foundation; Royal Physiographic Society (Nilsson-Ehle)	Swedish Science Council; Jorgen Lindstrom Foundation; Royal Physiographic Society (Nilsson-Ehle)	The Swedish Science Council, the Jorgen Lindstrom Foundation, and the Royal Physiographic Society (Nilsson-Ehle) supported the study.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ADACHI J, 1993, J MOL EVOL, V36, P270, DOI 10.1007/BF00160483; Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; [Anonymous], NCBI REFSEQ DAT; Arnason U, 2002, CYTOGENET GENOME RES, V96, P20, DOI 10.1159/000063023; ARNASON U, 1992, J MOL EVOL, V34, P493, DOI 10.1007/BF00160463; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 1996, J MOL EVOL, V43, P650, DOI 10.1007/BF02202113; BAURAIN D, 2006, MOL BIOL EV IN PRESS; BENTON MJ, 2006, PALEONTOLOGICAL EVID; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Cannarozzi G, 2007, PLOS COMPUT BIOL, V3, P9, DOI 10.1371/journal.pcbi.0030002; Cao Y, 1998, MOL BIOL EVOL, V15, P1637, DOI 10.1093/oxfordjournals.molbev.a025891; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de la Torre JEB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-48; DeBry RW, 2003, SYST BIOL, V52, P604, DOI 10.1080/10635150390235403; DEJONG WW, 1981, NATURE, V292, P538, DOI 10.1038/292538a0; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; *ENSEMBL, ENSEMBL PUBL FTP; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GU X, 1995, MOL BIOL EVOL, V12, P546; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2007, MOL PHYLOGENET EVOL, V45, P81, DOI 10.1016/j.ympev.2007.04.022; Hughes J, 2006, MOL BIOL EVOL, V23, P268, DOI 10.1093/molbev/msj041; HUTTLEY GA, 2007, MOL BIOL EV IN PRESS; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; JANKE A, 1994, GENETICS, V137, P243; Jansa SA, 2006, MOL PHYLOGENET EVOL, V38, P363, DOI 10.1016/j.ympev.2005.06.007; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jorgensen FG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-2; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Kullberg M, 2006, MOL BIOL EVOL, V23, P1493, DOI 10.1093/molbev/msl027; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Parkinson J, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-31; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Pie MR, 2006, MOL BIOL EVOL, V23, P2274, DOI 10.1093/molbev/msl116; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 1996, SE ALV2 0A11 SEQUENC; Reyes A, 2004, MOL BIOL EVOL, V21, P397, DOI 10.1093/molbev/msh033; Reyes A, 2000, GENE, V259, P177, DOI 10.1016/S0378-1119(00)00438-8; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strugnell J, 2005, MOL PHYLOGENET EVOL, V37, P426, DOI 10.1016/j.ympev.2005.03.020; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Waters PD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000158; Watson J. D., 1965, MOL BIOL GENE; YANG Z, 2006, COMPUTIONAL MOL EVOL; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zheng XH, 2005, BIOINFORMATICS, V21, P703, DOI 10.1093/bioinformatics/bti045	69	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e775	10.1371/journal.pone.0000775	http://dx.doi.org/10.1371/journal.pone.0000775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712423	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455300023
J	Piontek, J; Winkler, L; Wolburg, H; Muller, SL; Zuleger, N; Piehl, C; Wiesner, B; Krause, G; Blasig, IE				Piontek, Joerg; Winkler, Lars; Wolburg, Hartwig; Mueller, Sebastian L.; Zuleger, Nikolaj; Piehl, Christian; Wiesner, Burkhard; Krause, Gerd; Blasig, Ingolf E.			Formation of tight junction: determinants of homophilic interaction between classic claudins	FASEB JOURNAL			English	Article						transmembrane protein; protein-protein interaction; cell-cell contacts; freeze-fracturing; FRET	BLOOD-BRAIN-BARRIER; PARACELLULAR CONDUCTANCE; SELECTIVE DECREASE; CHARGE SELECTIVITY; EXPRESSION; STRANDS; CATION; CONSTITUTES; MODULATION; OCCLUDIN	Claudins are the critical transmembrane proteins in tight junctions. Claudin-5, for instance, prevents paracellular permeation of small molecules. However, the molecular interaction mechanism is unknown. Hence, the claudin-claudin interaction and tight junction strand formation were investigated using systematic single mutations. Claudin-5 mutants transfected into tight junction-free cells demonstrated that the extracellular loop 2 is involved in strand formation via trans-interaction, but not via polymerization, along the plasma membrane of one cell. Three phenotypes were obtained: the tight junction type (wild-type-like trans-and cis-interaction; the disjunction type (blocked trans-interaction); the intracellular type (disturbed folding). Combining site-directed mutagenesis, live-cell imaging, electron microscopy-, and molecular modeling data led to an antiparallel homodimer homology model of the loop. These data for the first time explain how two claudins hold onto each other and constrict the paracellular space. The intermolecular interface includes aromatic (F147, Y148, Y158) and hydrophilic (Q156, E159) residues. The aromatic residues form a strong binding core between two loops from opposing cells. Since nearly all these residues are conserved in most claudins, our findings are of general relevance for all classical claudins. On the basis of the data we have established a novel molecular concept for tight junction formation. -Piontek, J., Winkler, L., Wolburg, H., Muller, S. L., Zuleger, N., Piehl, C., Wiesner, B., Krause, G., Blasig, I. E. Formation of tight junction: determinants of homophilic interaction between classic claudins.	[Piontek, Joerg; Winkler, Lars; Mueller, Sebastian L.; Zuleger, Nikolaj; Piehl, Christian; Wiesner, Burkhard; Krause, Gerd; Blasig, Ingolf E.] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Krause, G (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	gkrause@fmp-berlin.de	Horstmann, Britta/C-2154-2008; Winkler, Lars/M-6134-2014; Piontek, Joerg/K-6305-2013; Piontek, Joerg/F-8549-2011; Winkler, Lars/D-1949-2012	Winkler, Lars/0000-0003-3350-1189; Piontek, Joerg/0000-0002-0880-8915; Piehl, Christian/0000-0002-1054-0081				Ahrens T, 2002, J BIOL CHEM, V277, P19455, DOI 10.1074/jbc.M200606200; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Deschenes SM, 1997, J NEUROSCI, V17, P9077; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mack AF, 2006, BRAIN RES, V1103, P25, DOI 10.1016/j.brainres.2006.04.135; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; Waters ML, 2004, BIOPOLYMERS, V76, P435, DOI 10.1002/bip.20144; Wen HJ, 2004, MOL CELL BIOL, V24, P8408, DOI 10.1128/MCB.24.19.8408-8417.2004; WOLBURG H, 1994, J CELL SCI, V107, P1347; Wu J, 2006, PROTEINS, V65, P808, DOI 10.1002/prot.21218; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200	37	291	298	0	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					146	158		10.1096/fj.07-8319com	http://dx.doi.org/10.1096/fj.07-8319com			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17761522				2022-12-25	WOS:000252309900018
J	Jiang, XN; Borgesi, RA; McKnight, NC; Kaur, R; Carpenter, CL; Balk, SP				Jiang, Xinnong; Borgesi, Robert A.; McKnight, Nicole C.; Kaur, Ramneet; Carpenter, Christopher L.; Balk, Steven P.			Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAIN; FOCAL ADHESION KINASE; TEC FAMILY; INTRAEPITHELIAL NEOPLASIA; ANDROGEN RECEPTOR; CELL-MIGRATION; PH-DOMAIN; ETK/BMX; BMX; BTK	Pathways activated downstream of constitutively active phosphatidylinositol ( PI) 3- kinase in PTEN- deficient prostate cancer ( PCa) cells are possible therapeutic targets. We found that the nonreceptor Tec family tyrosine kinase Bmx/ Etk was activated by tyrosine phosphorylation downstream of Src and PI 3- kinase in PTEN- deficient LNCaP and PC3 PCa cells and that Bmx down- regulation by short interfering RNA markedly inhibited LNCaP cell growth. Bmx also associated with ErbB3 in LNCaP cells, and heregulin-beta 1 enhanced this interaction and further stimulated Bmx activity. Epidermal growth factor ( EGF) similarly stimulated an interaction between Bmx and EGF receptor and rapidly increased Bmx kinase activity. Bmx stimulation in response to heregulin-beta 1 and EGF was Src- dependent, and heregulin-beta 1 stimulation of Bmx was also PI 3-kinase-dependent. In contrast, the rapid tyrosine phosphorylation and activation of Bmx in response to EGF was PI3-kinase-independent. Taken together, these results demonstrate that Bmx is a critical downstream target of the constitutively active PI 3- kinase in PTEN- deficient PCa cells and further show that Bmx is recruited by the EGF receptor and ErbB3 and activated in response to their respective ligands. Therefore, Bmx may be a valuable therapeutic target in PCa and other epithelial malignancies in which PI 3- kinase or EGF receptor family pathways are activated.	Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Canc Biol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Balk, SP (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Canc Biol Program, HIM Bldg,Rm 1050,330 Brookline Ave, Boston, MA 02115 USA.	sbalk@bidmc.harvard.edu		McKnight, Nicole/0000-0003-4269-3960				Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; Afar DEH, 1996, MOL CELL BIOL, V16, P3465; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Chau CH, 2002, ONCOGENE, V21, P8817, DOI 10.1038/sj.onc.1206032; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Chott A, 1999, AM J PATHOL, V155, P1271, DOI 10.1016/S0002-9440(10)65229-7; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Deocampo N D, 2003, Minerva Endocrinol, V28, P145; Ekman N, 2000, ONCOGENE, V19, P4151, DOI 10.1038/sj.onc.1203763; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Kim O, 2004, ONCOGENE, V23, P1838, DOI 10.1038/sj.onc.1207304; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mao JH, 1998, EMBO J, V17, P5638, DOI 10.1093/emboj/17.19.5638; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Rajantie I, 2001, MOL CELL BIOL, V21, P4647, DOI 10.1128/MCB.21.14.4647-4655.2001; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Saharinen P, 1997, BLOOD, V90, P4341; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Stoletov KV, 2004, BIOCHEM BIOPH RES CO, V320, P70, DOI 10.1016/j.bbrc.2004.05.134; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Vargas L, 2002, J BIOL CHEM, V277, P9351, DOI 10.1074/jbc.M108537200; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wen X, 1999, J BIOL CHEM, V274, P38204, DOI 10.1074/jbc.274.53.38204; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200	45	28	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32689	32698		10.1074/jbc.M703412200	http://dx.doi.org/10.1074/jbc.M703412200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17823122	hybrid			2022-12-25	WOS:000250625400017
J	Dreux, M; Boson, B; Ricard-Blum, S; Molle, J; Lavillette, D; Bartosch, B; Pecheur, EI; Cosset, FL				Dreux, Marlene; Boson, Bertrand; Ricard-Blum, Sylvie; Molle, Jennifer; Lavillette, Dimitri; Bartosch, Birke; Pecheur, Eve-Isabelle; Cosset, Francois-Loic			The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HIGH-DENSITY-LIPOPROTEINS; B TYPE-I; RECEPTOR CLASS-B; CELL-SURFACE EXPRESSION; HYPERVARIABLE REGION 1; SCAVENGER-RECEPTOR; VERY-LOW; A-I; VIRAL-INFECTION; NEUTRALIZING ANTIBODIES	Cell entry of hepatitis C virus (HCV) is strikingly linked to lipoproteins and their receptors. Particularly, high density lipoprotein (HDL) enhances infectivity of HCV by involving the lipid-transfer function of the scavenger receptor BI, a receptor for both HDL and HCV. Here, we demonstrate that apoC-I, an exchangeable apolipoprotein that predominantly resides in HDL, specifically enhances HCVcc and HCVpp infectivity and increases the fusion rates between viral and target membranes via a direct interaction with the HCV surface. We identify the hypervariable region 1, located at the N terminus of the HCV E2 glycoprotein, as an essential viral component that modulates apoC-I-mediated enhancement of HCV fusion properties. The affinity of apoC-I for the HCV membrane may predispose it for fusion with a target membrane via alterations of its outer phospholipid layer. Conversely, we found that excess apoC-I provided as lipoprotein-free protein induces the disruption of the HCV membrane and subsequent loss of infectivity. Furthermore, our data indicate that HDL neither interacts nor spontaneously exchanges apoC-I with HCV virions. Because apoC-I is not present in serum as a lipoprotein-free form, our results suggest that HDL-embedded apoC-I could be released from the lipoprotein particle through a fine-tuned mechanism regulated via a triple interplay between hypervariable region 1, HDL, and scavenger receptor BI, resulting in optimal apoC-I recruitment on the viral membrane. These results provide the first description of a host serum factor helping the fusion process of an enveloped virus.	Univ Lyon, UCB Lyon 1, INSERM, IFR128,U758, F-69007 Lyon, France; Ecole Normale Super Lyon, F-69007 Lyon, France; CNRS UCB, IBCP, UMR5086, F-69007 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Cosset, FL (corresponding author), ENS Lyon, 46 Allee Italie, F-69007 Lyon, France.	flcosset@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019; Bartosch, Birke/I-7255-2018; Dreux, Marlene/M-7295-2014	Cosset, François-Loïc/0000-0001-8842-3726; Bartosch, Birke/0000-0001-6354-4660; Dreux, Marlene/0000-0002-6607-4796; RICARD-BLUM, Sylvie/0000-0001-9263-1851; Boson, Bertrand/0000-0003-1920-5172; Pecheur, Eve/0000-0002-8613-862X; Lavillette, Dimitri/0000-0002-4706-1519				Agnello V, 1997, ARTHRITIS RHEUM, V40, P2007, DOI 10.1002/art.1780401113; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; ASZTALOS BF, 1995, ARTERIOSCL THROM VAS, V15, P1419, DOI 10.1161/01.ATV.15.9.1419; Barter PJ, 1996, CURR OPIN LIPIDOL, V7, P82, DOI 10.1097/00041433-199604000-00006; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Barth H, 2006, HEPATOLOGY, V44, P527, DOI 10.1002/hep.21321; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benjwal S, 2005, BIOCHEMISTRY-US, V44, P10218, DOI 10.1021/bi050781m; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; CLAY MA, 1991, ARTERIOSCLER THROMB, V11, P415, DOI 10.1161/01.ATV.11.2.415; Cleverley DZ, 1998, P NATL ACAD SCI USA, V95, P3425, DOI 10.1073/pnas.95.7.3425; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cohn JS, 2002, J LIPID RES, V43, P1680, DOI 10.1194/jlr.M200055-JLR200; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dreux M, 2006, HEPATOLOGY, V43, P903, DOI 10.1002/hep.21202; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Gursky O, 2002, BIOCHEMISTRY-US, V41, P7373, DOI 10.1021/bi025588w; Gursky O, 2001, BIOCHEMISTRY-US, V40, P12178, DOI 10.1021/bi0111505; Heo TH, 2006, VIRUS RES, V121, P58, DOI 10.1016/j.virusres.2006.04.002; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; JACKSON RL, 1974, J BIOL CHEM, V249, P5314; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; KANTO T, 1995, J HEPATOL, V22, P440, DOI 10.1016/0168-8278(95)80107-3; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2001, J VIROL, V75, P3685, DOI 10.1128/JVI.75.8.3685-3695.2001; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; LIANG HQ, 1994, J LIPID RES, V35, P1187; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; MALMENDIER CL, 1986, ATHEROSCLEROSIS, V62, P167, DOI 10.1016/0021-9150(86)90063-8; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Mehta R, 2003, BIOCHEMISTRY-US, V42, P4751, DOI 10.1021/bi0341253; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; MOLINA S, 2007, H HEPATOL, V46, P411; Monazahian M, 2000, MED MICROBIOL IMMUN, V188, P177, DOI 10.1007/s004300000032; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Nieland TJF, 2004, J LIPID RES, V45, P1256, DOI 10.1194/jlr.M300358-JLR200; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Oram JF, 1996, J LIPID RES, V37, P2473; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prince AM, 1996, J VIRAL HEPATITIS, V3, P11, DOI 10.1111/j.1365-2893.1996.tb00075.x; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Rozek A, 1999, BIOCHEMISTRY-US, V38, P14475, DOI 10.1021/bi982966h; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; SEGREST JP, 1992, J LIPID RES, V33, P141; Shachter NS, 2001, CURR OPIN LIPIDOL, V12, P297, DOI 10.1097/00041433-200106000-00009; Shimizu YK, 1996, VIROLOGY, V223, P409, DOI 10.1006/viro.1996.0497; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; TAKEUCHI Y, 1994, J VIROL, V68, P8001, DOI 10.1128/JVI.68.12.8001-8007.1994; Tanaka M, 2005, BIOCHEMISTRY-US, V44, P10689, DOI 10.1021/bi050853+; Taylor GM, 1999, MOL BIOL CELL, V10, P2803, DOI 10.1091/mbc.10.9.2803; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Webb NR, 2002, J LIPID RES, V43, P1890, DOI 10.1194/jlr.M200173-JLR200; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	102	75	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32357	32369		10.1074/jbc.M705358200	http://dx.doi.org/10.1074/jbc.M705358200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761674	hybrid			2022-12-25	WOS:000250480300059
J	Ma, LH; Takanishi, CL; Wood, MJ				Ma, Li-Hua; Takanishi, Christina L.; Wood, Matthew J.			Molecular mechanism of oxidative stress perception by the Orp1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYR TRANSCRIPTION FACTOR; DISULFIDE BOND FORMATION; CYSTEINE-SULFENIC ACID; REDOX REGULATION; GLUTATHIONE PEROXIDASES; CHEMICAL CARCINOGENESIS; STRUCTURAL BASIS; YEAST; DAMAGE; YAP1	In this study we investigated the molecular mechanism by which the Orp1 (Gpx3) protein in Saccharomyces cerevisiae senses and reacts with hydrogen peroxide. Upon exposure to H2O2 Orp1(Cys36) forms a disulfide-bonded complex with the C-terminal domain of the Yap1 protein (Yap1-cCRD). We used 4-nitrobenzo-2-oxa-1,3-diazole to identify a cysteine sulfenic acid (Cys-SOH) modification that forms on Cys(36) of Orp1(Cys36) upon exposure to H2O2. Under similar conditions, neither Cys(82) of Orp1(Cys82) nor Cys(598) of Yap1 forms Cys-SOH. A homology-based molecular model of Orp1 suggests that the structure of the active site of Orp1 is similar to that found in mammalian selenocysteine glutathione peroxidases. Proposed active site residues Gln(70) and Trp(125) form a catalytic triad with Cys36 in the Orp1 molecular model. The remainder of the active site pocket is formed by Phe(38), Asn(126), and Phe(127), which are evolutionarily conserved residues. We made Q70A and W125A mutants and tested the ability of these mutants to form Cys-SOH in response to H2O2. Both mutants were unable to form Cys-SOH and did not form a H2O2-inducible disulfide-bonded complex with Yap1-cCRD. The pK(a) of Cys(36) was determined to be 5.1, which is 3.2 pH units lower than that of a free cysteine (8.3). In contrast, Orp1 Cys(82) (the resolving cysteine) has a pKa value of 8.3. The pKa of Cys(36) in the Q70A and W125A mutants is also 8.3, demonstrating the importance of these residues in modulating the nucleophilic character of Cys(36). Finally, we show that S. cerevisiae strains with ORP1 Q70A and W125A mutations are less tolerant to H2O2 than those containing wild-type ORP1. The results of our study suggest that attempts to identify novel redox-regulated proteins and signal transduction pathways should focus on characterization of low pKa cysteines.	Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis	Wood, MJ (corresponding author), Univ Calif Davis, Dept Environm Toxicol, One Shields Ave, Davis, CA 95616 USA.	mjwood@ucdavis.edu	Wood, Matthew/HDN-1469-2022					Avery AM, 2004, J BIOL CHEM, V279, P46652, DOI 10.1074/jbc.M408340200; CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Flohe L., 1989, GLUTATHIONE CHEM BIO, P643; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gladysheva T, 1996, J BIOL CHEM, V271, P33256, DOI 10.1074/jbc.271.52.33256; Hampton MB, 2006, REDOX PROTEOMICS, P253; Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; McEligot AJ, 2005, ANNU REV NUTR, V25, P261, DOI 10.1146/annurev.nutr.25.050304.092633; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; OESTERHELT D, 1977, EUR J BIOCHEM, V79, P173, DOI 10.1111/j.1432-1033.1977.tb11795.x; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; SLUYTERMAN LA, 1967, BIOCHIM BIOPHYS ACTA, V139, P439, DOI 10.1016/0005-2744(67)90047-2; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; TRUSH MA, 1991, FREE RADICAL BIO MED, V10, P201, DOI 10.1016/0891-5849(91)90077-G; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; WEMMIE A, 1994, J BIOL CHEM, V269, P14690; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	50	67	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31429	31436		10.1074/jbc.M705953200	http://dx.doi.org/10.1074/jbc.M705953200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17720812	hybrid			2022-12-25	WOS:000250309200033
J	Baker, LMS; Baker, PRS; Golin-Bisello, F; Schopfer, FJ; Fink, M; Woodcock, SR; Branchaud, BP; Radi, R; Freeman, BA				Baker, Laura M. S.; Baker, Paul R. S.; Golin-Bisello, Franca; Schopfer, Francisco J.; Fink, Mitchell; Woodcock, Steven R.; Branchaud, Bruce P.; Radi, Rafael; Freeman, Bruce A.			Nitro-fatty acid reaction with glutathione and cysteine - Kinetic analysis of thiol alkylation by a Michael addition reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; NITROLINOLEIC ACID; KAPPA-B; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDINS; ANTIINFLAMMATORY PROPERTIES; STRUCTURAL-CHARACTERIZATION; COVALENT MODIFICATION; NITRATION PRODUCTS; LIPID OXIDATION	Fatty acid nitration by nitric oxide-derived species yields electrophilic products that adduct protein thiols, inducing changes in protein function and distribution. Nitro-fatty acid adducts of protein and reduced glutathione (GSH) are detected in healthy human blood. Kinetic and mass spectrometric analyses reveal that nitroalkene derivatives of oleic acid (OA-NO2) and linoleic acid (LNO2) rapidly react with GSH and Cys via Michael addition reaction. Rates of OA-NO2 and LNO2 reaction with GSH, determined via stopped flow spectrophotometry, displayed second-order rate constants of 183 M-1 s(-1) and 355 M(-1)s(-1), respectively, at pH 7.4 and 37 degrees C. These reaction rates are significantly greater than those for GSH reaction with hydrogen peroxide and non-nitrated electrophilic fatty acids including 8-iso-prostaglandin A(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2). Increasing reaction pH from 7.4 to 8.9 enhanced apparent second-order rate constants for the thiol reaction with OA-NO2 and LNO2, showing dependence on the thiolate anion of GSH for reactivity. Rates of nitroalkene reaction with thiols decreased as the pK(a) of target thiols increased. Increasing concentrations of the detergent octyl-beta-D-glucopyranoside decreased rates of nitroalkene reaction with GSH, indicating that the organization of nitro-fatty acids into micellar or membrane structures can limit Michael reactivity with more polar nucleophilic targets. In aggregate, these results reveal that the reversible adduction of thiols by nitro-fatty acids is a mechanism for reversible post-translational regulation of protein function by nitro-fatty acids.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oregon; Universidad de la Republica, Uruguay	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol, Thomas E Starzl Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	freerad@pitt.edu	Schopfer, Francisco Jose/AAE-8125-2020; Schopfer, Francisco/AAW-6505-2021; Woodcock, Steven/AAE-9199-2020; Freeman, Bruce A/H-9342-2012	Schopfer, Francisco Jose/0000-0001-9526-695X; 	NHLBI NIH HHS [R01 HL064937, HL64937, R01 HL058115, R01 HL058115-10, HL58115, R01 HL064937-07, R37 HL058115] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058115, R01HL064937, R01HL058115] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BERNASCONI CF, 1988, J AM CHEM SOC, V110, P7506, DOI 10.1021/ja00230a038; Bogaards JJP, 1997, CHEM RES TOXICOL, V10, P310, DOI 10.1021/tx9601770; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; d'Ischia M, 1999, TETRAHEDRON, V55, P9297, DOI 10.1016/S0040-4020(99)00491-3; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Fink MP, 2003, CRIT CARE MED, V31, P2400, DOI 10.1097/01.CCM.0000084860.49412.10; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gong PF, 2002, ANTIOXID REDOX SIGN, V4, P249, DOI 10.1089/152308602753666307; Gorczynski MJ, 2006, ORG LETT, V8, P2305, DOI 10.1021/ol060548w; Han D, 2005, BIOCHEMISTRY-US, V44, P11986, DOI 10.1021/bi0509393; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Lee SH, 2005, J BIOL CHEM, V280, P28337, DOI 10.1074/jbc.M504178200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; LoPachin RM, 2006, TOXICOL SCI, V94, P240, DOI 10.1093/toxsci/kfl066; Lowry T. H., 1987, MECH THEORY ORGANIC; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Napolitano A, 2002, TETRAHEDRON, V58, P5061, DOI 10.1016/S0040-4020(02)00460-X; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; PEARSON RG, 1968, J AM CHEM SOC, V90, P319, DOI 10.1021/ja01004a021; Phan TB, 2006, ANGEW CHEM INT EDIT, V45, P3869, DOI 10.1002/anie.200600542; PRESTERA T, 1995, P NATL ACAD SCI USA, V92, P8965, DOI 10.1073/pnas.92.19.8965; RADI R, 1991, J BIOL CHEM, V266, P4244; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sappington PL, 2005, BIOCHEM PHARMACOL, V70, P1579, DOI 10.1016/j.bcp.2005.08.015; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Song MC, 2004, J PHARMACOL EXP THER, V308, P307, DOI 10.1124/jpet.103.056622; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Trujillo M, 2002, ARCH BIOCHEM BIOPHYS, V397, P91, DOI 10.1006/abbi.2001.2619; Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	61	153	163	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31085	31093		10.1074/jbc.M704085200	http://dx.doi.org/10.1074/jbc.M704085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720974	Green Accepted, hybrid			2022-12-25	WOS:000250136300076
J	Gonzalez, MI; Krizman-Genda, E; Robinson, MB				Gonzalez, Marco I.; Krizman-Genda, Elizabeth; Robinson, Michael B.			Caveolin-1 regulates the delivery and endocytosis of the glutamate transporter, excitatory amino acid carrier 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-SURFACE EXPRESSION; LONG-TERM POTENTIATION; LIPID RAFTS; PLASMA-MEMBRANE; VESICLE FUSION; GROWTH-FACTOR; ENDOPLASMIC-RETICULUM; SNARE PROTEINS; GLT-1 SUBTYPE	The sodium- dependent glutamate transporter, excitatory amino acid carrier 1 ( EAAC1), has been implicated in the regulation of excitatory signaling and prevention of cell death in the nervous system. There is evidence that EAAC1 constitutively cycles on and off the plasma membrane and that under steady state conditions up to 80% of the transporter is intracellular. As is observed with other neurotransmitter transporters, the activity of EAAC1 is regulated by a variety of molecules, and some of these effects are associated with redistribution ofEAAC1on and off the plasma membrane. In the present study we tested the hypothesis that a structural component of lipid rafts, caveolin- 1 ( Cav- 1), may participate in EAAC1 trafficking. Using C6 glioma cells as a model system, co- expression of Cav- 1 S80E ( a dominant negative variant) or small interfering RNA- mediated knock- down of caveolin- 1 reduced cell surface expression of myc epitope- tagged EAAC1 or endogenous EAAC1, respectively. Cav- 1 S80E slowed the constitutive delivery and endocytosis of myc- EAAC1. In primary cultures derived from caveolin-1 knock- out mice, a similar reduction in delivery and internalization of endogenous EAAC1 was observed. We also found that caveolin- 1, caveolin- 2, or Cav- 1 S80E formed immuno-precipitable complexes with EAAC1 in C6 glioma and/ or transfected HEK cells. Together, these data provide strong evidence that caveolin- 1 contributes to the trafficking of EAAC1 on and off the plasma membrane and that these effects are associated with formation of EAAC1- caveolin complexes.	Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Robinson, MB (corresponding author), 502N Abramson Pediat Res Bldg,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	Robinson@pharm.med.upenn.edu			NINDS NIH HHS [NS39011] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039011] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; BECKMAN ML, 2005, 35 ANN M SOC NEUR WA; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Cha SH, 2004, IUBMB LIFE, V56, P621, DOI 10.1080/15216540400020353; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fournier KM, 2006, NEUROCHEM INT, V48, P596, DOI 10.1016/j.neuint.2005.12.030; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; Gonzalez MI, 2004, MOL INTERV, V4, P48, DOI 10.1124/mi.4.1.48; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; GONZALEZ MI, 2004, 34 ANN M SOC NEUR SA; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; He Y, 2000, J COMP NEUROL, V418, P255; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kinoshita N, 2004, GENES CELLS, V9, P1, DOI 10.1111/j.1356-9597.2004.00696.x; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Marchand S, 2002, J NEUROSCI, V22, P8891; Marie H, 2002, MOL CELL NEUROSCI, V19, P152, DOI 10.1006/mcne.2001.1066; Miller BT, 1997, PEPTIDES, V18, P1585, DOI 10.1016/S0196-9781(97)00225-8; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Morpurgo M, 1999, J BIOCHEM BIOPH METH, V38, P17, DOI 10.1016/S0165-022X(98)00027-X; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Najimi M, 2002, FEBS LETT, V523, P224, DOI 10.1016/S0014-5793(02)02981-2; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Pita-Almenar JD, 2006, J NEUROSCI, V26, P10461, DOI 10.1523/JNEUROSCI.2579-06.2006; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Royle SJ, 2003, BIOESSAYS, V25, P39, DOI 10.1002/bies.10200; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Schlegel A, 2001, J BIOL CHEM, V276, P4398, DOI 10.1074/jbc.M005448200; Schniepp R, 2004, INVEST OPHTH VIS SCI, V45, P1442, DOI 10.1167/iovs.03-0062; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Sheldon AL, 2006, J BIOL CHEM, V281, P4876, DOI 10.1074/jbc.M504983200; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Xue MS, 2002, P NATL ACAD SCI USA, V99, P13359, DOI 10.1073/pnas.232565999; Yu YX, 2006, J CELL SCI, V119, P3776, DOI 10.1242/jcs.03151; Zhu Y, 2005, J NEUROSCI RES, V79, P503, DOI 10.1002/jnr.20385	70	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29855	29865		10.1074/jbc.M704738200	http://dx.doi.org/10.1074/jbc.M704738200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715130	hybrid			2022-12-25	WOS:000249981200014
J	Nilsson, MB; Armaiz-Pena, G; Takahashi, R; Lin, YG; Trevino, J; Li, Y; Jennings, N; Arevalo, J; Lutgendorf, SK; Gallick, GE; Sanguino, AM; Lopez-Berestein, G; Cole, SW; Sood, AK				Nilsson, Monique B.; Armaiz-Pena, Guillermo; Takahashi, Rie; Lin, Yvonne G.; Trevino, Jose; Li, Yang; Jennings, Nicholas; Arevalo, Jesusa; Lutgendorf, Susan K.; Gallick, Gary E.; Sanguino, Angela M.; Lopez-Berestein, Gabriel; Cole, Steven W.; Sood, Anil K.			Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTERFERING RNA DELIVERY; HUMAN LUNG FIBROBLASTS; TYROSINE KINASE; GENE-EXPRESSION; FAMILY KINASES; SOCIAL SUPPORT; CANCER CELLS; TUMOR-GROWTH; NOREPINEPHRINE	Recent studies have demonstrated that chronic stress promotes tumor growth, angiogenesis, and metastasis. In ovarian cancer, levels of the pro- angiogenic cytokine, interleukin 6 ( IL6), are known to be elevated in individuals experiencing chronic stress, but the mechanism( s) by which this cytokine is regulated and its role in tumor growth remain under investigation. Here we show that stress hormones such as norepinephrine lead to increased expression of IL- 6mRNAand protein levels in ovarian carcinoma cells. Furthermore, we demonstrate that norepinephrine stimulation activates Src tyrosine kinase and this activation is required for increased IL- 6 expression. These results demonstrate that stress hormones activate signaling pathways known to be critical in ovarian tumor progression.	Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; Univ Iowa, Dept Psychol, Iowa City, IA 52241 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa	Sood, AK (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, 1515 Herman Pressler,Unit 1362, Houston, TX 77030 USA.	asood@mdanderson.org		Armaiz-Pena, Guillermo N/0000-0002-9081-5339	NCI NIH HHS [P50 CA 083639, CA109298, CA110793] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083639, R01CA109298, R01CA110793] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Briest W, 2003, PFLUG ARCH EUR J PHY, V446, P437, DOI 10.1007/s00424-003-1043-x; Conze D, 2001, CANCER RES, V61, P8851; Costanzo ES, 2005, CANCER-AM CANCER SOC, V104, P305, DOI 10.1002/cncr.21147; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Fidler IJ, 2001, JNCI-J NATL CANCER I, V93, P1040, DOI 10.1093/jnci/93.14.1040; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Jee SH, 2004, J INVEST DERMATOL, V123, P1169, DOI 10.1111/j.0022-202X.2004.23497.x; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Keller P, 2004, J APPL PHYSIOL, V97, P1309, DOI 10.1152/japplphysiol.00284.2004; KEMP VH, 1989, RES NURS HEALTH, V12, P331, DOI 10.1002/nur.4770120509; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Landen CN, 2006, J NATL CANCER I, V98, P1558, DOI 10.1093/jnci/djj414; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lara HE, 2002, MICROSC RES TECHNIQ, V59, P495, DOI 10.1002/jemt.10229; Lara HE, 2001, ENDOCRINE, V15, P187, DOI 10.1385/ENDO:15:2:187; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Obata NH, 1997, ANTICANCER RES, V17, P337; Parker J, 2004, J AM ACAD DERMATOL, V51, P919, DOI 10.1016/j.jaad.2004.08.042; PLANTE M, 1994, CANCER, V73, P1882, DOI 10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R; RILEY V, 1975, SCIENCE, V189, P465, DOI 10.1126/science.168638; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; Saul AN, 2005, JNCI-J NATL CANCER I, V97, P1760, DOI 10.1093/jnci/dji401; SCAMBIA G, 1994, INT J CANCER, V57, P318, DOI 10.1002/ijc.2910570305; Schmidt C, 1996, Eur J Med Res, V1, P528; Summy JM, 2005, MOL CANCER THER, V4, P1900, DOI 10.1158/1535-7163.MCT-05-0171; Tempfer C, 1997, GYNECOL ONCOL, V66, P27, DOI 10.1006/gyno.1997.4726; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Trevino JG, 2005, CANCER RES, V65, P7214, DOI 10.1158/0008-5472.CAN-04-3858; Weiner H., 1992, PERTURBING ORGANISM; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; WU S, 1992, AM J OBSTET GYNECOL, V166, P997, DOI 10.1016/0002-9378(92)91379-O; Yan LZ, 2000, AM J PHYSIOL-CELL PH, V279, pC1665, DOI 10.1152/ajpcell.2000.279.5.C1665; YU DH, 1993, CANCER RES, V53, P891	45	114	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29919	29926		10.1074/jbc.M611539200	http://dx.doi.org/10.1074/jbc.M611539200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716980	hybrid			2022-12-25	WOS:000249981200021
J	Deagle, BE; Gales, NJ; Evans, K; Jarman, SN; Robinson, S; Trebilco, R; Hindell, MA				Deagle, Bruce E.; Gales, Nick J.; Evans, Karen; Jarman, Simon N.; Robinson, Sarah; Trebilco, Rowan; Hindell, Mark A.			Studying Seabird Diet through Genetic Analysis of Faeces: A Case Study on Macaroni Penguins (Eudyptes chrysolophus)	PLOS ONE			English	Article							SEALS PHOCA-VITULINA; CHRYSOCOME-CHRYSOCOME; SALMONID PREY; GUT CONTENTS; DNA; ISLAND; IDENTIFICATION; IDENTIFY; FOOD; SEGREGATION	Background. Determination of seabird diet usually relies on the analysis of stomach-content remains obtained through stomach flushing; this technique is both invasive and logistically difficult. We evaluate the usefulness of DNA-based faecal analysis in a dietary study on chick-rearing macaroni penguins (Eudyptes chrysolophus) at Heard Island. Conventional stomach-content data was also collected, allowing comparison of the approaches. Methodology/Principal Findings. Prey-specific PCR tests were used to detect dietary DNA in faecal samples and amplified prey DNA was cloned and sequenced. Of the 88 faecal samples collected, 39 contained detectable DNA from one or more of the prey groups targeted with PCR tests. Euphausiid DNA was most commonly detected in the early (guard) stage of chick-rearing, and detection of DNA from the myctophid fish Krefftichthys anderssoni and amphipods became more common in samples collected in the later (creche) stage. These trends followed those observed in the penguins' stomach contents. In euphausiid-specific clone libraries the proportion of sequences from the two dominant euphausiid prey species (Euphausia vallentini and Thysanoessa macrura) changed over the sampling period; again, this reflected the trend in the stomach content data. Analysis of prey sequences in universal clone libraries revealed a higher diversity of fish prey than identified in the stomachs, but non-fish prey were not well represented. Conclusions/Significance. The present study is one of the first to examine the full breadth of a predator's diet using DNA-based faecal analysis. We discuss methodological difficulties encountered and suggest possible refinements. Overall, the ability of the DNA-based approach to detect temporal variation in the diet of macaroni penguins indicates this non-invasive method will be generally useful for monitoring population-level dietary trends in seabirds.	[Deagle, Bruce E.; Evans, Karen; Trebilco, Rowan; Hindell, Mark A.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Deagle, Bruce E.; Gales, Nick J.; Jarman, Simon N.; Robinson, Sarah] Australian Govt Antarctic Div, Kingston, Tas, Australia	University of Tasmania; Australian Antarctic Division	Deagle, BE (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas, Australia.	bedeagle@utas.edu.au	Deagle, Bruce E/R-2999-2019; Hindell, Mark A/K-1131-2013; evans, karen/D-7110-2012; Deagle, Bruce E/A-9854-2008; Trebilco, Rowan/I-5311-2012; Hindell, Mark A/C-8368-2013; Jarman, Simon/H-9265-2016	Deagle, Bruce E/0000-0001-7651-3687; Trebilco, Rowan/0000-0001-9712-8016; Jarman, Simon/0000-0002-0792-9686; Evans, Karen/0000-0003-2205-4264; Hindell, Mark/0000-0002-7823-7185	Australian Government Antarctic Division	Australian Government Antarctic Division(Australian Government)	The research was funded by the Australian Government Antarctic Division.	Abraham CL, 2006, MAR ECOL PROG SER, V313, P271, DOI 10.3354/meps313271; Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barlow KE, 2002, MAR BIOL, V140, P205, DOI 10.1007/s00227-001-0691-7; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; BROWN CR, 1987, J ZOOL, V212, P7, DOI 10.1111/j.1469-7998.1987.tb05111.x; Cherel Y, 2000, OECOLOGIA, V122, P155, DOI 10.1007/PL00008843; Chiaradia A, 2003, EMU, V103, P43, DOI 10.1071/MU02020; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLARKE MR, 1985, HDB IDENTIFICATION S; COOPER J, 1990, PENGUIN BIOL; Crawford RJM, 2003, AFR J MAR SCI, V25, P475, DOI 10.2989/18142320309504036; CROXALL JP, 1985, J ZOOL, V206, P485; CROXALL JP, 1980, IBIS, V122, P245, DOI 10.1111/j.1474-919X.1980.tb02665.x; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; DEAGLE BE, 2006, FRONTIERS ZOOLOGY, pE11; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; EALEY E. H. M., 1954, EMU, V54, P204; Fischer W, 1985, SO OCEAN FISHING ARE; GALES RP, 1988, IBIS, V130, P418, DOI 10.1111/j.1474-919X.1988.tb00999.x; Gauthier-Clerc M, 2000, NATURE, V408, P928, DOI 10.1038/35050163; Green K., 1998, Marine Ornithology, V26, P27; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; HARTLEY PHT, 1948, IBIS, V90, P361, DOI 10.1111/j.1474-919X.1948.tb01700.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedd A, 2006, MAR ECOL PROG SER, V309, P263, DOI 10.3354/meps309263; HINDELL MA, 1988, EMU, V88, P219, DOI 10.1071/MU9880219; Hull CL, 1999, J ZOOL, V247, P507, DOI 10.1111/j.1469-7998.1999.tb01013.x; Jarman SN, 2006, MOL ECOL NOTES, V6, P268, DOI 10.1111/j.1471-8286.2005.01172.x; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; KLAGES NTW, 1989, AUST WILDLIFE RES, V16, P599; Kvitrud MA, 2005, MAR BIOL, V147, P1459, DOI 10.1007/s00227-005-0047-9; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Palumbi Stephen R., 1996, P205; Parsons KM, 2005, J ZOOL, V266, P275, DOI 10.1017/S0952836905006904; Purcell M, 2004, FISH B-NOAA, V102, P213; Ropert-Coudert Y, 2007, MAR ECOL PROG SER, V333, P281, DOI 10.3354/meps333281; ROSEL PE, 2002, J EXPT MARINE BIOL E, V42, P75; Scribner KT, 1998, MOL ECOL, V7, P1401, DOI 10.1046/j.1365-294x.1998.00434.x; SUTHERLAND RM, 2000, THESIS U OXFORD OXFO; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; TREBILCO R, 2004, THESIS U TASMANIA; VENCES M, 2005, FRONTIERS ZOOLOGY, pE5; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Williams R., 1990, ANARE RES NOTES, V75, P1; WILLIAMS TD, 1991, J ZOOL, V223, P189, DOI 10.1111/j.1469-7998.1991.tb04759.x; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; WOEHLER EJ, 2006, HEARD ISLAND SO OCEA, P128	56	153	157	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e831	10.1371/journal.pone.0000831	http://dx.doi.org/10.1371/journal.pone.0000831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786203	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000207455500015
J	Shaw, SD; Chakrabarti, S; Ghosh, G; Krainer, AR				Shaw, Stephanie D.; Chakrabarti, Sutapa; Ghosh, Gourisankar; Krainer, Adrian R.			Deletion of the N-terminus of SF2/ASF Permits RS-Domain-Independent Pre-mRNA Splicing	PLOS ONE			English	Article								Serine/arginine-rich (SR) proteins are essential splicing factors with one or two RNA-recognition motifs (RRMs) and a C-terminal arginine- and serine-rich (RS) domain. SR proteins bind to exonic splicing enhancers via their RRM(s), and from this position are thought to promote splicing by antagonizing splicing silencers, recruiting other components of the splicing machinery through RS-RS domain interactions, and/or promoting RNA base-pairing through their RS domains. An RS domain tethered at an exonic splicing enhancer can function as a splicing activator, and RS domains play prominent roles in current models of SR protein functions. However, we previously reported that the RS domain of the SR protein SF2/ASF is dispensable for in vitro splicing of some pre-mRNAs. We have now extended these findings via the identification of a short inhibitory domain at the SF2/ASF N-terminus; deletion of this segment permits splicing in the absence of this SR protein's RS domain of an IgM pre-mRNA substrate previously classified as RS-domain-dependent. Deletion of the N-terminal inhibitory domain increases the splicing activity of SF2/ASF lacking its RS domain, and enhances its ability to bind pre-mRNA. Splicing of the IgM pre-mRNA in S100 complementation with SF2/ASF lacking its RS domain still requires an exonic splicing enhancer, suggesting that an SR protein RS domain is not always required for ESE-dependent splicing activation. Our data provide additional evidence that the SF2/ASF RS domain is not strictly required for constitutive splicing in vitro, contrary to prevailing models for how the domains of SR proteins function to promote splicing.	[Shaw, Stephanie D.; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chakrabarti, Sutapa; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Shaw, Stephanie D.] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	krainer@cshl.edu		Krainer, Adrian/0000-0001-9024-9501	NIH [GM42699]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM42699 to ARK.	Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bouck J, 1998, J BIOL CHEM, V273, P15169, DOI 10.1074/jbc.273.24.15169; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; CAO W, 1988, J BIOL CHEM, V273, P20629; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Chew SL, 1999, P NATL ACAD SCI USA, V96, P10655, DOI 10.1073/pnas.96.19.10655; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; FU XD, 1995, RNA, V1, P663; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Graveley BR, 1998, MOL CELL, V1, P765, DOI 10.1016/S1097-2765(00)80076-3; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Guth S, 1999, MOL CELL BIOL, V19, P8263; Guth S, 2001, MOL CELL BIOL, V21, P7673, DOI 10.1128/MCB.21.22.7673-7681.2001; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; HE F, 2005, SOLUTION STRUCTURE R; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Li Y, 1999, J BIOL CHEM, V274, P35074, DOI 10.1074/jbc.274.49.35074; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; MAYEDA A, 1988, MOL CELL BIOL, V8, P4484, DOI 10.1128/MCB.8.10.4484; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; MERRILL BM, 1988, J BIOL CHEM, V263, P3307; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Philipps D, 2003, NUCLEIC ACIDS RES, V31, P6502, DOI 10.1093/nar/gkg845; Pont-Kingdon Genevieve, 2003, Methods Mol Biol, V226, P511; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Rudner DZ, 1998, GENE DEV, V12, P1010, DOI 10.1101/gad.12.7.1010; Rudner DZ, 1998, MOL CELL BIOL, V18, P4004, DOI 10.1128/MCB.18.7.4004; Sanford JR, 1999, GENE DEV, V13, P1513, DOI 10.1101/gad.13.12.1513; SCHNEIDER D, 1992, J MOL BIOL, V228, P862, DOI 10.1016/0022-2836(92)90870-P; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Shen HH, 2004, MOL CELL, V16, P363, DOI 10.1016/j.molcel.2004.10.021; Shen HH, 2004, RNA, V10, P787, DOI 10.1261/rna.5229704; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; STAKNIS D, 1994, MOL CELL BIOL, V14, P7670, DOI 10.1128/MCB.14.11.7670; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; WANG Z, 1995, RNA, V1, P21; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zhu J, 2001, NANO LETT, V1, P8, DOI 10.1021/nl005512q; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	79	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e854	10.1371/journal.pone.0000854	http://dx.doi.org/10.1371/journal.pone.0000854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786225	Green Accepted, Green Published, gold			2022-12-25	WOS:000207455500037
J	Malone, JH; Chrzanowski, TH; Michalak, P				Malone, John H.; Chrzanowski, Thomas H.; Michalak, Pawel			Sterility and Gene Expression in Hybrid Males of Xenopus laevis and X. muelleri	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; INTERSPECIFIC DROSOPHILA HYBRIDS; POLYMERASE I TRANSCRIPTION; SOMATIC-CELL HYBRIDS; GENOME-WIDE PATTERNS; HORDEUM-VULGARE-L; NUCLEOLAR DOMINANCE; SEX DETERMINATION; CLAWED FROGS; CYTOSINE METHYLATION	Background. Reproductive isolation is a defining characteristic of populations that represent unique biological species, yet we know very little about the gene expression basis for reproductive isolation. The advent of powerful molecular biology tools provides the ability to identify genes involved in reproductive isolation and focuses attention on the molecular mechanisms that separate biological species. Herein we quantify the sterility pattern of hybrid males in African Clawed Frogs (Xenopus) and apply microarray analysis of the expression pattern found in testes to identify genes that are misexpressed in hybrid males relative to their two parental species (Xenopus laevis and X. muelleri). Methodology/Principal Findings. Phenotypic characteristics of spermatogenesis in sterile male hybrids (X. laevis x X. muelleri) were examined using a novel sperm assay that allowed quantification of live, dead, and undifferentiated sperm cells, the number of motile vs. immotile sperm, and sperm morphology. Hybrids exhibited a dramatically lower abundance of mature sperm relative to the parental species. Hybrid spermatozoa were larger in size and accompanied by numerous undifferentiated sperm cells. Microarray analysis of gene expression in testes was combined with a correction for sequence divergence derived from genomic hybridizations to identify candidate genes involved in the sterility phenotype. Analysis of the transcriptome revealed a striking asymmetric pattern of misexpression. There were only about 140 genes misexpressed in hybrids compared to X. laevis but nearly 4,000 genes misexpressed in hybrids compared to X. muelleri. Conclusions/Significance. Our results provide an important correlation between phenotypic characteristics of sperm and gene expression in sterile hybrid males. The broad pattern of gene misexpression suggests intriguing mechanisms creating the dominance pattern of the X. laevis genome in hybrids. These findings significantly contribute to growing evidence for allelic dominance in hybrids and have implications for the mechanism of species differentiation at the transcriptome level.	[Malone, John H.; Chrzanowski, Thomas H.; Michalak, Pawel] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Michalak, P (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	michalak@uta.edu			National Science Foundation Dissertation Improvement [DEB-0508882]; Texas Academy of Science Student Research	National Science Foundation Dissertation Improvement(National Science Foundation (NSF)); Texas Academy of Science Student Research	Funding was provided by a National Science Foundation Dissertation Improvement Grant (DEB-0508882) and Texas Academy of Science Student Research Grant to JHM.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APPELS R, 1982, THEOR APPL GENET, V63, P337, DOI 10.1007/BF00303905; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; BARBASH DA, 2006, J EXP ZOOL MOL DEV B, V306; BAUERDANTOIN AC, 1992, ENDOCRINOLOGY, V131, P2946, DOI 10.1210/en.131.6.2946; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; BLACKLER AW, 1972, DEV BIOL, V27, P385, DOI 10.1016/0012-1606(72)90177-7; BOLSTAD B, 2005, RMAEXPRESS; BOSELEY P, 1979, CELL, V17, P19, DOI 10.1016/0092-8674(79)90291-5; BRAMWELL ME, 1971, BIOCHIM BIOPHYS ACTA, V232, P580, DOI 10.1016/0005-2787(71)90611-3; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; BROWN DD, 1977, DEV BIOL, V59, P266, DOI 10.1016/0012-1606(77)90263-9; BRUN LO, 1995, P NATL ACAD SCI USA, V92, P9861, DOI 10.1073/pnas.92.21.9861; BUSBY SJ, 1983, CELL, V34, P989, DOI 10.1016/0092-8674(83)90556-1; CASSIDY DM, 1974, DEV BIOL, V41, P84, DOI 10.1016/0012-1606(74)90285-1; Chain FJJ, 2006, PLOS GENET, V2, P478, DOI 10.1371/journal.pgen.0020056; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Christensen JR, 2004, CAN J ZOOL, V82, P555, DOI 10.1139/Z04-021; Comai L, 2003, PHILOS T R SOC B, V358, P1149, DOI 10.1098/rstb.2003.1305; CROCE CM, 1977, P NATL ACAD SCI USA, V74, P694, DOI 10.1073/pnas.74.2.694; CROSBY AR, 1957, AM J BOT, V44, P813, DOI 10.2307/2438902; CROUSE HV, 1960, GENETICS, V45, P1429; de la Casa-Esperon E, 2003, ANNU REV GENET, V37, P349, DOI 10.1146/annurev.genet.37.110801.143741; DEROBERTIS EM, 1979, DEV BIOL, V68, P334, DOI 10.1016/0012-1606(79)90267-7; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Dobson SL, 1998, GENETICS, V149, P233; Doelling JH, 1996, NUCLEIC ACIDS RES, V24, P4725, DOI 10.1093/nar/24.23.4725; DOVER GA, 1984, CELL, V38, P622, DOI 10.1016/0092-8674(84)90255-1; DURICA DS, 1978, GENETICS, V89, P37; DURICA DS, 1977, DEV BIOL, V59, P62, DOI 10.1016/0012-1606(77)90240-8; ELICEIRI GL, 1969, J MOL BIOL, V41, P253, DOI 10.1016/0022-2836(69)90390-8; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; FAN H, 1995, PLANT J, V8, P295, DOI 10.1046/j.1365-313X.1995.08020295.x; Fischer WJ, 2000, J ZOOL, V252, P99, DOI 10.1017/S0952836900009110; FLAVELL RB, 1988, J MOL BIOL, V204, P523, DOI 10.1016/0022-2836(88)90352-X; Frieman M, 1999, GENETICS, V152, P451; Galili N, 2000, DEV DYNAM, V218, P102, DOI 10.1002/(SICI)1097-0177(200005)218:1<102::AID-DVDY9>3.3.CO;2-1; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Goday C, 2001, BIOESSAYS, V23, P242, DOI 10.1002/1521-1878(200103)23:3&lt;242::AID-BIES1034&gt;3.0.CO;2-P; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; GRUMMT I, 1982, NATURE, V296, P173, DOI 10.1038/296173a0; Gye MC, 2004, REPROD DOMEST ANIM, V39, P43, DOI 10.1046/j.1439-0531.2003.00474.x; Haerty W, 2006, MOL BIOL EVOL, V23, P1707, DOI 10.1093/molbev/msl033; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Hayes TB, 1998, J EXP ZOOL, V281, P373, DOI 10.1002/(SICI)1097-010X(19980801)281:5<373::AID-JEZ4>3.0.CO;2-L; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; HENEEN WK, 1962, HEREDITAS, V48, P471; HONJO T, 1973, J MOL BIOL, V80, P217, DOI 10.1016/0022-2836(73)90168-X; Hsu LC, 2000, BBA-GENE STRUCT EXPR, V1492, P289, DOI 10.1016/S0167-4781(00)00108-1; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JIN Y, 2007, MOL REPROD DEV; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Kajiura-Kobayashi H, 2004, BIOCHEM BIOPH RES CO, V323, P288, DOI 10.1016/j.bbrc.2004.08.097; Kanzaki M, 1996, ENDOCRINOLOGY, V137, P1249, DOI 10.1210/en.137.4.1249; KASHA KJ, 1971, CHROMOSOMA, V35, P264, DOI 10.1007/BF00326278; KAULEN H, 1991, MOL CELL BIOL, V11, P412, DOI 10.1128/MCB.11.1.412; KEEP E, 1962, CAN J GENET CYTOL, V4, P206, DOI 10.1139/g62-025; KEEP E, 1960, NATURE, V188, P339, DOI 10.1038/188339a0; KNOX KL, 1995, ENDOCRINOLOGY, V136, P187, DOI 10.1210/en.136.1.187; KOBEL HR, 1981, J ZOOL, V194, P317, DOI 10.1111/j.1469-7998.1981.tb04584.x; KOBEL HR, 1985, S AFR J SCI, V81, P205; KOBEL HR, 1986, TRENDS GENET, V2, P310, DOI 10.1016/0168-9525(86)90286-6; KOBEL HR, 1975, IMMUNOGENETICS, V2, P87, DOI 10.1007/BF01572278; KOBEL HR, 1996, BIOL XENOPUS, P391; KOBEL HR, 1996, BIOL XENOPUS, P9; LABHART P, 1984, CELL, V37, P285, DOI 10.1016/0092-8674(84)90324-6; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; LANGE W, 1976, GENETICA, V46, P217, DOI 10.1007/BF00121038; Mable BK, 1995, J HERED, V86, P432, DOI 10.1093/oxfordjournals.jhered.a111617; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Michalak P, 2006, J EVOLUTION BIOL, V19, P1768, DOI 10.1111/j.1420-9101.2006.01141.x; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; MIESFELD R, 1984, MOL CELL BIOL, V4, P221, DOI 10.1128/MCB.4.2.221; MIESFELD R, 1984, MOL CELL BIOL, V4, P1306, DOI 10.1128/MCB.4.7.1306; MIKAMO K, 1964, EXPERIENTIA, V20, P622, DOI 10.1007/BF02144823; MIKAMO K, 1963, GENETICS, V48, P1411; MILLER OJ, 1976, P NATL ACAD SCI USA, V73, P4531, DOI 10.1073/pnas.73.12.4531; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Miyata S, 1999, ZOOL SCI, V16, P335, DOI 10.2108/zsj.16.335; Moehring AJ, 2007, MOL BIOL EVOL, V24, P137, DOI 10.1093/molbev/msl142; MOSS T, 1983, NATURE, V302, P223, DOI 10.1038/302223a0; NAVASHIN M., 1934, CYTOLOGIA, V5, P169, DOI 10.1508/cytologia.5.169; NICOLOFF H, 1979, THEOR APPL GENET, V55, P247, DOI 10.1007/BF00265358; Nielsen MG, 2006, EVOL DEV, V8, P23, DOI 10.1111/j.1525-142X.2006.05072.x; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; ONISHI T, 1984, P NATL ACAD SCI-BIOL, V81, P484, DOI 10.1073/pnas.81.2.484; Ortiz-Barrientos D, 2007, GENETICA, V129, P71, DOI 10.1007/s10709-006-0034-1; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Picker M. D., 1996, BIOL XENOPUS, P61; PICKER MD, 1989, BIOL CONSERV, V49, P169, DOI 10.1016/0006-3207(89)90034-7; PICKER MD, 1985, COPEIA, P574, DOI 10.2307/1444746; Pikaard CS, 2000, PLANT MOL BIOL, V43, P163, DOI 10.1023/A:1006471009225; PIKAARD CS, 1988, MOL CELL BIOL, V8, P4282, DOI 10.1128/MCB.8.10.4282; Pilder SH, 1997, J ANDROL, V18, P663; Porter AH, 2002, EVOLUTION, V56, P2103; Pozzi AG, 2006, J EXP ZOOL PART A, V305A, P96, DOI 10.1002/jez.a.254; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 1998, SCIENCE, V282, P952, DOI 10.1126/science.282.5390.952; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; REEDER RH, 1984, CELL, V38, P39, DOI 10.1016/0092-8674(84)90524-5; REEDER RH, 1985, J CELL BIOL, V101, P2013, DOI 10.1083/jcb.101.5.2013; REEDER RH, 1984, CELL, V38, P349, DOI 10.1016/0092-8674(84)90489-6; REEDER RH, 1983, CELL, V35, P449, DOI 10.1016/0092-8674(83)90178-2; Reiland J, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-16; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rosemblit C, 2006, J COMP PHYSIOL B, V176, P559, DOI 10.1007/s00360-006-0078-7; SARDANA R, 1993, MOL GEN GENET, V236, P155, DOI 10.1007/BF00277107; Scheltinga David M., 2003, P119; SCHMID M, 1991, CHROMOSOMA, V101, P123, DOI 10.1007/BF00357062; SCHNAPP A, 1991, MOL CELL BIOCHEM, V104, P137; SCHUBERT I, 1990, CHROMOSOMA, V99, P352, DOI 10.1007/BF01731723; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Smith JM, 2004, DEV DYNAM, V230, P366, DOI 10.1002/dvdy.20053; Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; SOPRANO KJ, 1979, P NATL ACAD SCI USA, V76, P3885, DOI 10.1073/pnas.76.8.3885; SOPRANO KJ, 1980, P NATL ACAD SCI-BIOL, V77, P1566, DOI 10.1073/pnas.77.3.1566; Terado M, 2006, ASIAN J ANDROL, V8, P443, DOI 10.1111/j.1745-7262.2006.00166.x; THOMPSON WF, 1988, J MOL BIOL, V204, P535, DOI 10.1016/0022-2836(88)90353-1; TYMOWSKA J, 1972, CYTOGENETICS, V11, P270, DOI 10.1159/000130197; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092; VONWYL E, 1983, COMP BIOCHEM PHYS B, V76, P17, DOI 10.1016/0305-0491(83)90164-5; WALL DA, 1974, DEV BIOL, V36, P379, DOI 10.1016/0012-1606(74)90059-1; WALLACE H, 1971, HEREDITY, V27, P1, DOI 10.1038/hdy.1971.66; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang R, 2005, J HISTOCHEM CYTOCHEM, V53, P1235, DOI 10.1369/jhc.5A6688.2005; Wassersug R., 1996, BIOL XENOPUS, P143; Wilkinson J, 1944, ANN BOT-LONDON, V8, P269, DOI 10.1093/oxfordjournals.aob.a088566; Witschi E, 1971, HORMONES DEV, P601; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; YEH BY, 1965, AM J BOT, V52, P626, DOI 10.2307/2440131	148	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e781	10.1371/journal.pone.0000781	http://dx.doi.org/10.1371/journal.pone.0000781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712429	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455300029
J	Strasburg, JL; Kearney, M; Moritz, C; Templeton, AR				Strasburg, Jared L.; Kearney, Michael; Moritz, Craig; Templeton, Alan R.			Combining Phylogeography with Distribution Modeling: Multiple Pleistocene Range Expansions in a Parthenogenetic Gecko from the Australian Arid Zone	PLOS ONE			English	Article							HETERONOTIA-BINOEI GEKKONIDAE; GEOGRAPHIC PARTHENOGENESIS; MITOCHONDRIAL-DNA; STATISTICAL PHYLOGEOGRAPHY; MOLECULAR PHYLOGENETICS; POPULATION-GROWTH; GENETIC-EVIDENCE; SPECIES GROUP; ORIGIN; EVOLUTION	Phylogenetic and geographic evidence suggest that many parthenogenetic organisms have evolved recently and have spread rapidly. These patterns play a critical role in our understanding of the relative merits of sexual versus asexual reproductive modes, yet their interpretation is often hampered by a lack of detail. Here we present a detailed phylogeographic study of a vertebrate parthenogen, the Australian gecko Heteronotia binoei, in combination with statistical and biophysical modeling of its distribution during the last glacial maximum. Parthenogenetic H. binoei occur in the Australian arid zone and have the widest range of any known vertebrate parthenogen. They are broadly sympatric with their sexual counterparts, from which they arose via hybridization. We have applied nested clade phylogeographic, effective migration, and mismatch distribution analyses to mitochondrial DNA ( mtDNA) sequences obtained for 319 individuals sampled throughout the known geographic ranges of two parthenogenetic mitochondrial lineages. These analyses provide strong evidence for past range expansion events from west to east across the arid zone, and for continuing eastward range expansion. Parthenogen formation and range expansion events date to the late Pleistocene, with one lineage expanding from the northwest of its present range around 240,000 years ago and the second lineage expanding from the far west around 70,000 years ago. Statistical and biophysical distribution models support these inferences of recent range expansion, with suitable climatic conditions during the last glacial maximum most likely limited to parts of the arid zone north and west of much of the current ranges of these lineages. Combination of phylogeographic analyses and distribution modeling allowed considerably stronger inferences of the history of this complex than either would in isolation, illustrating the power of combining complementary analytical approaches.	[Strasburg, Jared L.; Templeton, Alan R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kearney, Michael] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Kearney, Michael] Univ Melbourne, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia; [Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Washington University (WUSTL); University of Melbourne; University of Melbourne; University of California System; University of California Berkeley	Strasburg, JL (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jstrasbu@indiana.edu	Templeton, Alan R./F-5963-2011; Kearney, Michael/R-3404-2017	Kearney, Michael/0000-0002-3349-8744; Templeton, Alan/0000-0002-0167-845X	Howard Hughes Medical Institute; Ethel Mary Read Fund; Peter Rankin Trust Fund for Herpetology; Australian Research Council	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ethel Mary Read Fund; Peter Rankin Trust Fund for Herpetology; Australian Research Council(Australian Research Council)	This work was supported by a Howard Hughes Medical Institute predoctoral fellowship to JLS and by grants from the Ethel Mary Read Fund, Peter Rankin Trust Fund for Herpetology, and Australian Research Council to MK.	Adamowicz SJ, 2002, MOL ECOL, V11, P1209, DOI 10.1046/j.1365-294X.2002.01517.x; Adams M, 2003, EVOLUTION, V57, P2619; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bell G., 1982, MASTERPIECE NATURE E; BIERZYCHUDEK P, 1985, EXPERIENTIA, V41, P1255, DOI 10.1007/BF01952068; Brisson JA, 2005, EVOLUTION, V59, P1046; BROWN WM, 1979, SCIENCE, V203, P1247, DOI 10.1126/science.424751; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Chaplin JA, 1997, HEREDITY, V78, P57; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLE C J, 1988, American Museum Novitates, P1; De Gelas K, 2005, MOL ECOL, V14, P753, DOI 10.1111/j.1365-294X.2004.02434.x; De Iorio M, 2004, ADV APPL PROBAB, V36, P417, DOI 10.1239/aap/1086957579; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fu JZ, 2000, COPEIA, P432, DOI 10.1643/0045-8511(2000)000[0432:DOTCBG]2.0.CO;2; Fu YX, 1997, GENETICS, V147, P915; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; HEWITT GM, 1993, EVOLUTIONARY PATTERN, P95; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kearney M, 2005, PHYSIOL BIOCHEM ZOOL, V78, P316, DOI 10.1086/430033; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2003, EVOL ECOL RES, V5, P953; Kearney M, 2006, MOL ECOL, V15, P1743, DOI 10.1111/j.1365-294X.2006.02898.x; Kearney MR, 2003, TRENDS ECOL EVOL, V18, P605, DOI 10.1016/j.tree.2003.09.021; KIMURA M, 1970, GENET RES, V15, P131, DOI 10.1017/S0016672300001439; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Macey JR, 2001, MOL PHYLOGENET EVOL, V19, P131, DOI 10.1006/mpev.2000.0908; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; MANTEL N, 1967, CANCER RES, V27, P209; Miller GH, 1997, NATURE, V385, P241, DOI 10.1038/385241a0; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1993, GENETICA, V90, P269, DOI 10.1007/BF01435044; MORITZ C, 1993, SYST BIOL, V42, P293, DOI 10.2307/2992465; MORITZ C, 1991, GENETICS, V129, P211; MORITZ C, 1991, P ROY SOC B-BIOL SCI, V244, P145, DOI 10.1098/rspb.1991.0063; MORITZ C, 1984, CHROMOSOMA, V89, P151, DOI 10.1007/BF00292899; Moritz C., 1989, EVOLUTION ECOLOGY UN, P87; Nei M., 1987, MOL EVOLUTIONARY GEN; Paland S, 2005, EVOLUTION, V59, P800; Panchal M, 2007, EVOLUTION, V61, P1466, DOI 10.1111/j.1558-5646.2007.00124.x; Peck JR, 1998, NATURE, V391, P889, DOI 10.1038/36099; Pfenninger M, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-8; Pongratz N, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-23; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; ROGERS AR, 1995, HUM BIOL, V67, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SLATKIN M, 1991, GENETICS, V129, P555; Strasburg JL, 2005, MOL ECOL, V14, P2755, DOI 10.1111/j.1365-294X.2005.02627.X; TAJIMA F, 1989, GENETICS, V123, P585; Templeton A.R., 1982, P75; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 2003, EVOLUTIONARY THEORY, P1; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; VRIJENHOEK RC, EVOLUTION ECOLOGY UN, P19; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; White M.J.D., 1978, MODES SPECIATION	65	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e760	10.1371/journal.pone.0000760	http://dx.doi.org/10.1371/journal.pone.0000760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712408	Green Published, gold			2022-12-25	WOS:000207455300008
J	Endeward, V; Cartron, JP; Ripoche, P; Gros, G				Endeward, Volker; Cartron, Jean-Pierre; Ripoche, Pierre; Gros, Gerolf			RhAG protein of the Rhesus complex is a CO2 channel in the human red cell membrane	FASEB JOURNAL			English	Article						Rhesus-associated glycoprotein; membrane CO2; permeability; ammonia; aquaporin	CARBON-DIOXIDE PERMEABILITY; HUMAN-ERYTHROCYTES; AMMONIA TRANSPORT; GREEN-ALGA; BLOOD; AQUAPORIN-1; NULL; DIFFUSION; ANHYDRASE; NH3	We have determined CO2 permeabilities, P-CO2, of red cells of normal human blood and of blood deficient in various blood group proteins by a previously described mass spectrometric technique. While PCO2 of normal red cells is similar to 0.15 cm/s, we find in red blood cells (RBCs) lacking the Rh protein complex (Rh-null) a significantly reduced P-CO2 of 0.07 cm/s +/- 0.02 cm/s (P< 0.02). This value is similar to the value we have reported previously for RBCs lacking aquaporin-1 protein (AQP-1(null)), suggesting that each of the Rh and AQP-1 proteins is responsible for similar to 1/2 of the normal CO2 permeability of the RBC membrane. Four other blood group deficiencies tested lack diverse membrane proteins but exhibit normal CO2 permeability. The CO2 pathway constituted by Rh proteins was inhibitable at pH(e) = 7.4 by NH4Cl with an I-50 of similar to 10 mM corresponding to an I50 for NH3 of similar to 0.3 mM. The pathway independent of Rh proteins, presumably that constituted by AQP-1, was not inhibitable by NH4Cl/NH3. However, both pathways were strongly inhibited by DIDS, which accounts for the marked inhibitory effect of DIDS on normal PCO2, while in contrast another AE1 inhibitor, DiBAC, does not inhibit PCO2, although it markedly reduces PHCO3-. We conclude that Rh protein, presumably the Rh-associated glycoprotein RhAG, possesses a gas channel that allows passage of CO2 in addition to NH3.-Endeward, V., Cartron, J.-P., Ripoche, P., and Gros, G. RhAG protein of the Rhesus complex is a CO2 channel in the human red cell membrane.	[Endeward, Volker; Gros, Gerolf] Hannover Med Sch, Abt Vegetat Physiol, D-30623 Hannover, Germany; [Cartron, Jean-Pierre; Ripoche, Pierre] Inst Natl Sante & Rech Med, Paris, France; [Cartron, Jean-Pierre; Ripoche, Pierre] Inst Natl Transfus Sanguine, Hannover, Germany	Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gros, G (corresponding author), Hannover Med Sch, Abt Vegetat Physiol, D-30623 Hannover, Germany.	gros.gerolf@mh-hannover.de	Gros, Gerolf/K-8421-2012					Alberts B, 2002, MOL BIOL CELL; BALLAS SK, 1984, BLOOD, V63, P1046; BLANK M, 1960, T FARADAY SOC, V56, P1832, DOI 10.1039/tf9605601832; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; BRAHM J, 1982, J GEN PHYSIOL, V79, P791, DOI 10.1085/jgp.79.5.791; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Cartron JP, 2001, TRANSFUS CLIN BIOL, V8, P163, DOI 10.1016/S1246-7820(01)00142-2; Casey JR, 2004, J MED CHEM, V47, P2337, DOI 10.1021/jm031079w; Cho MR, 1999, BIOPHYS J, V76, P1136, DOI 10.1016/S0006-3495(99)77278-4; Cooper GJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1481, DOI 10.1152/ajpcell.1998.275.6.C1481; *CRC, 1977, CRC HDB CHEM PHYS; DENKER BM, 1988, J BIOL CHEM, V263, P15634; EDSALL JT, 1969, CO2 CHEM BIOCH PHYSL; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Endeward V, 2006, TRANSFUS CLIN BIOL, V13, P123, DOI 10.1016/j.tracli.2006.02.007; Endeward V, 2005, J PHYSIOL-LONDON, V567, P253, DOI 10.1113/jphysiol.2005.085761; Forster RE, 1998, P NATL ACAD SCI USA, V95, P15815, DOI 10.1073/pnas.95.26.15815; GROS G, 1971, PFLUG ARCH EUR J PHY, V324, P249, DOI 10.1007/BF00586422; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; Hill WG, 1999, J GEN PHYSIOL, V114, P405, DOI 10.1085/jgp.114.3.405; Hirschfelder J. O., 1954, MOL THEORY GASES LIQ; Huang CH, 2000, SEMIN HEMATOL, V37, P150, DOI 10.1016/S0037-1963(00)90040-4; ITADA N, 1977, J BIOL CHEM, V252, P3881; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KNAUF PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1073, DOI 10.1152/ajpcell.1995.269.4.C1073; KUYPERS F, 1984, BIOCHEM J, V221, P931, DOI 10.1042/bj2210931; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Mathai JC, 1996, J BIOL CHEM, V271, P1309, DOI 10.1074/jbc.271.3.1309; MOORE WJ, 1962, PHYSL CHEM; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Prasad Ramjee, 1998, IEEE Communications Surveys & Tutorials, V1, P2, DOI 10.1109/COMST.1998.5340404; Reid ME, 2004, SEMIN HEMATOL, V41, P93, DOI 10.1053/j.seminhematol.2004.01.001; REINHART WH, 1986, BLOOD, V67, P1110; Ripoche P, 2006, TRANSFUS CLIN BIOL, V13, P117, DOI 10.1016/j.tracli.2006.03.004; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; SINGH SK, 1995, P NATL ACAD SCI USA, V92, P11573, DOI 10.1073/pnas.92.25.11573; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599; Soupene E, 2001, MOL CELL BIOL, V21, P5733, DOI 10.1128/MCB.21.17.5733-5741.2001; STURGEON P, 1970, BLOOD-J HEMATOL, V36, P310, DOI 10.1182/blood.V36.3.310.310; THULBORN KR, 1977, BLOOD, V50, P964; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	52	127	131	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					64	73		10.1096/fj.07-9097com	http://dx.doi.org/10.1096/fj.07-9097com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17712059				2022-12-25	WOS:000252309900010
J	Kim, S; Yun, HM; Baik, JH; Chung, KC; Nah, SY; Rhim, H				Kim, Sunoh; Yun, Hyung-Mun; Baik, Ja-Hyun; Chung, Kwang Chul; Nah, Seung-Yeol; Rhim, Hyewhon			Functional interaction of neuronal ca(v)1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; NMDA RECEPTOR; SKELETAL-MUSCLE; GENE-EXPRESSION; DIHYDROPYRIDINE RECEPTOR; CREB PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; INSULIN-SECRETION; STRIATAL NEURONS; BETA-CELLS	Neuronal L-type Ca2+ channels do not support synaptic transmission, but they play an essential role in synaptic activity-dependent gene expression. Ca(v)1.2 and Ca(v)1.3 are the two most widely expressed L-type Ca2+ channels in neurons and have different biophysical and subcellular distributions. The function of the Ca(v)1.3 L-type Ca2+ channel and its cellular mechanisms in the central nervous system are poorly understood. In this study, using a yeast two-hybrid assay, we found that the N terminus of the rat Ca(v)1.3 alpha(1) subunit interacts with a partial N-terminal amino acid sequence of ryanodine receptor type 2 (RyR2). Reverse transcription-PCR and Western blot assays revealed high expression of both Ca(v)1.3 and RyR2 in the rat hippocampus. We also demonstrate a physical association of Ca(v)1.3 with RyR2 using co-immunoprecipitation assays. Moreover, immunocytochemistry revealed prominent co-localization between Ca(v)1.3 and RyR2 in hippocampal neurons. Depolarizing cells by an acute treatment of a high concentration of KCl (high-K, 60 mM) showed that the activation of L-type Ca2+ channels induced RyR opening and led to RyR-dependent Ca2+ release, even in the absence of extracellular Ca2+. Furthermore, we found that RyR2 mRNA itself is increased by long term treatment of high-K via activation of L-type Ca2+ channels. These acute and long term effects of high-K on RyRs were selectively blocked by small interfering RNA-mediated silencing of Ca(v)1.3. These results suggest a physical and functional interaction between Ca(v)1.3 and RyR2 and important implications of Ca(v)1.3/RyR2 clusters in translating synaptic activity into alterations in gene expression.	Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; Konkuk Univ, Coll Vet Med, Dept Physiol, Seoul 143701, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Yonsei University; Konkuk University	Rhim, H (corresponding author), Korea Inst Sci & Technol, Div Life Sci, 39-1 Hawholgok Dong, Seoul 136791, South Korea.	hrhim@kist.re.kr		Lee, Junho/0000-0003-0913-8578				ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; BEAM KG, 1989, ANN NY ACAD SCI, V560, P127, DOI 10.1111/j.1749-6632.1989.tb24090.x; Biao X, 2002, BRIT J PHARMACOL, V136, P375, DOI 10.1038/sj.bjp.0704753; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; del Valle-Rodriguez A, 2003, EMBO J, V22, P4337; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Finkbeiner S, 1997, BIOESSAYS, V19, P657, DOI 10.1002/bies.950190803; Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4; FURUICHI T, 1994, J NEUROSCI, V14, P4794; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; Hirasawa M, 2003, P NATL ACAD SCI USA, V100, P6139, DOI 10.1073/pnas.0936131100; Kim S, 2004, BIOCHEM BIOPH RES CO, V323, P416, DOI 10.1016/j.bbrc.2004.08.106; Kim S, 2004, ARCH PHARM RES, V27, P524, DOI 10.1007/BF02980126; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LarssonNyren G, 1996, BIOCHEM J, V314, P167, DOI 10.1042/bj3140167; LEBRUN P, 1985, BIOPHYS J, V48, P919, DOI 10.1016/S0006-3495(85)83855-8; Leong P, 1998, BIOCHEM CELL BIOL, V76, P681, DOI 10.1139/bcb-76-5-681; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Liu GH, 2006, J PHARMACOL EXP THER, V318, P152, DOI 10.1124/jpet.105.097477; Liu QY, 1996, J NEUROSCI, V16, P2912; LU XY, 1994, J BIOL CHEM, V269, P6511; Ludwig A, 1997, J NEUROSCI, V17, P1339; Macias W, 2001, BRAIN RES, V890, P222, DOI 10.1016/S0006-8993(00)03163-2; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Niggli E, 1999, ANNU REV PHYSIOL, V61, P311, DOI 10.1146/annurev.physiol.61.1.311; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Reyes M, 1996, J NEUROSCI, V16, P5951; SHMIGOL A, 1995, NEUROSCIENCE, V65, P1109, DOI 10.1016/0306-4522(94)00553-H; Sukhareva M, 2002, J NEUROPHYSIOL, V88, P1077, DOI 10.1152/jn.2002.88.3.1077; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Tunwell REA, 1996, BIOCHEM J, V318, P477, DOI 10.1042/bj3180477; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; Wang Y, 1996, J PHYSIOL-LONDON, V495, P755, DOI 10.1113/jphysiol.1996.sp021631; Weick JP, 2003, J NEUROSCI, V23, P3446; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x; Zhao WQ, 2000, FASEB J, V14, P290, DOI 10.1096/fasebj.14.2.290	53	64	64	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32877	32889		10.1074/jbc.M701418200	http://dx.doi.org/10.1074/jbc.M701418200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17823125	hybrid			2022-12-25	WOS:000250625400037
J	Borzok, MA; Catino, DH; Nicholson, JD; Kontrogianni-Konstantopoulos, A; Bloch, RJ				Borzok, Maegen A.; Catino, Dawn H.; Nicholson, James D.; Kontrogianni-Konstantopoulos, Aikaterini; Bloch, Robert J.			Mapping the binding site on small ankyrin 1 for obscurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; ISOFORM SPECIFICITY; DOMAIN; MEMBRANE; REPEATS; GENE; ORGANIZATION; CONTRACTION	Small ankyrin 1 (sAnk1), an integral protein of the sarcoplasmic reticulum encoded by the ANK1 gene, binds with nanomolar affinity to the C terminus of obscurin, a giant protein surrounding the contractile apparatus in striated muscle. We used site-directed mutagenesis to characterize the binding site on sAnk1, specifically addressing the role of two putative amphipathic, positively charged helices. We measured binding qualitatively by blot overlay assays and quantitatively by surface plasmon resonance and showed that both positively charged sequences are required for activity. We showed further that substitution of a lysine or arginine with an alanine or glutamate located at the same position along either of the two putative helices has similar inhibitory or stimulatory effects on binding and that the effects of a particular mutation depended on the position of the mutated amino acid in each helix. We modeled the structure of the binding region of sAnk1 by homology with ankyrin repeats of human Notch1, which have a similar pattern of charged and hydrophobic residues. Our modeling suggested that each of the two positively charged sequences forms pairs of amphipathic, anti-parallel alpha-helices flanked by beta-hairpin-like turns. Most of the residues in homologous positions along each helical unit have similar, though not identical, orientations. CD spectroscopy confirmed the alpha-helical content of sAnk1, similar to 33%, predicted by the model. Thus, structural and mutational studies of the binding region on sAnk1 for obscurin suggest that it consists of two ankyrin repeats with very similar structures.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bloch, RJ (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	rbloch@umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052768] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL64304] Funding Source: Medline; NIAMS NIH HHS [R01 AR52768] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Birkenmeier CS, 1998, GENOMICS, V50, P79, DOI 10.1006/geno.1998.5305; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Borisov AB, 2006, HISTOCHEM CELL BIOL, V125, P227, DOI 10.1007/s00418-005-0069-x; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Cammett TJ, 2003, J MOL BIOL, V327, P285, DOI 10.1016/S0022-2836(03)00043-3; Desrosiers DC, 2005, J MOL BIOL, V354, P375, DOI 10.1016/j.jmb.2005.09.045; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Franzini-Armstrong C, 1999, FASEB J, V13, pS266, DOI 10.1096/fasebj.13.9002.S266; FRANZINIARMSTRO.C, 1981, J CELL BIOL, V91, P166; Gallagher PG, 1997, J BIOL CHEM, V272, P19220, DOI 10.1074/jbc.272.31.19220; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; GAY NJ, 1993, FEBS LETT, V335, P155, DOI 10.1016/0014-5793(93)80720-F; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; KONTROGIANNIKON.A, 2006, J MUSCLE RES CELL M, V26, P419; Kordeli E, 1998, J CELL SCI, V111, P2197; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Porter NC, 2005, MOL MEMBR BIOL, V22, P421, DOI 10.1080/09687860500244262; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; SEGAWA S, 1991, BIOPOLYMERS, V31, P497, DOI 10.1002/bip.360310505; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TAKEKURA H, 1994, J MUSCLE RES CELL M, V15, P102, DOI 10.1007/BF00130422; Tani S, 2001, NUCLEIC ACIDS RES, V29, P1373, DOI 10.1093/nar/29.6.1373; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14344, DOI 10.1021/bi011435h	46	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32384	32396		10.1074/jbc.M704089200	http://dx.doi.org/10.1074/jbc.M704089200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17720975	hybrid			2022-12-25	WOS:000250480300061
J	Kou, I; Nakajima, M; Ikegawa, S				Kou, Ikuyo; Nakajima, Masahiro; Ikegawa, Shiro			Expression and regulation of the osteoarthritis-associated protein asporin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LEUCINE-RICH PROTEOGLYCANS; ACID REPEAT POLYMORPHISM; BIGLYCAN GENE-EXPRESSION; TGF-BETA; TRANSCRIPTIONAL REGULATION; EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; LINK PROTEIN; CELL-LINES	Asporin ( ASPN) is a small leucine-rich proteoglycan that is involved in pathological processes of osteoarthritis. Previously, we showed that asporin can inhibit transforming growth factor-beta 1 ( TGF-beta 1)-mediated expression of cartilage matrix genes and chondrogenesis in vitro (Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A., Mabuchi, A., Kotani, A., Kawakami, A., Yamamoto, S., Uchida, A., Nakamura, K., Notoya, K., Nakamura, Y., and Ikegawa, S. ( 2005) Nat. Genet. 37, 138 -144). However, details about regulation of asporin itself are not yet known. Here, we examined ASPN expression in skeletal tissue and potential regulation of ASPN by TGF-beta. In situ hybridization revealed the presence of ASPN mRNA in the perichondrium/periosteum of long bones, but its absence in articular cartilage and growth plates. Immunohistochemical analysis also showed ASPN protein expression predominantly in the perichondrium/periosteum. TGF-beta 1 induced endogenous ASPN mRNA expression over time in vitro, and this induction was suppressed by the TGF-beta type I receptor kinase inhibitor SB431542. Inhibition of Smad3 significantly reduced TGF-beta 1induced ASPN expression, whereas overexpression of Smad3 augmented the induction. Characterization of the human ASPN promoter region revealed a region from -126 to -82 that is sufficient for full promoter activity; however, TGF-beta 1 failed to increase activity through the ASPN promoter. Our findings indicate that TGF-beta 1 induces ASPN through Smad3 but that this induction is indirect.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan	RIKEN	Ikegawa, S (corresponding author), RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147				BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; Chen WB, 2002, J BIOL CHEM, V277, P36118, DOI 10.1074/jbc.M203709200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Demoor-Fossard M, 2001, J BIOL CHEM, V276, P36983, DOI 10.1074/jbc.M011442200; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kobayashi H, 2000, J BIOL CHEM, V275, P21185, DOI 10.1074/jbc.M907862199; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Major MB, 2004, J BIOL CHEM, V279, P5278, DOI 10.1074/jbc.M311517200; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MAUVIEL A, 1995, J BIOL CHEM, V270, P11692, DOI 10.1074/jbc.270.19.11692; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; ROMARIS M, 1991, BIOCHIM BIOPHYS ACTA, V1093, P229, DOI 10.1016/0167-4889(91)90127-J; ROUGHLEY PJ, 1994, MATRIX BIOL, V14, P51, DOI 10.1016/0945-053X(94)90029-9; SANTRA M, 1994, J BIOL CHEM, V269, P579; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; Ungefroren H, 1996, J BIOL CHEM, V271, P15787, DOI 10.1074/jbc.271.26.15787; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; WESTERGRENTHORSSON G, 1991, MATRIX, V11, P177, DOI 10.1016/S0934-8832(11)80156-3; Wilda M, 2000, J BONE MINER RES, V15, P2187, DOI 10.1359/jbmr.2000.15.11.2187; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	39	41	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32193	32199		10.1074/jbc.M706262200	http://dx.doi.org/10.1074/jbc.M706262200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804408	hybrid			2022-12-25	WOS:000250480300042
J	Li, T; Wen, H; Brayton, C; Das, P; Smithson, LA; Fauq, A; Fan, X; Crain, BJ; Price, DL; Golde, TE; Eberhart, CG; Wong, PC				Li, Tong; Wen, Hongjin; Brayton, Cory; Das, Pritam; Smithson, Lisa A.; Fauq, Abdul; Fan, Xing; Crain, Barbara J.; Price, Donald L.; Golde, Todd E.; Eberhart, Charles G.; Wong, Philip C.			Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-CATENIN; CYCLIN D2; C-ELEGANS; CANCER; PRESENILIN-1; SKIN; OVEREXPRESSION; PROLIFERATION; EXPRESSION	gamma-Secretase, a unique aspartyl protease, is required for the regulated intramembrane proteolysis of Notch and APP, pathways that are implicated, respectively, in the pathogenesis of cancer and Alzheimer disease. However, the mechanism whereby reduction of gamma-secretase causes tumors such as squamous cell carcinoma ( SCC) remains poorly understood. Here, we demonstrate that gamma-secretase functions in epithelia as a tumor suppressor in an enzyme activity-dependent manner. Notch signaling is down-regulated and epidermal growth factor receptor ( EGFR) is activated in SCC caused by genetic reduction of gamma-secretase. Moreover, the level of EGFR is inversely correlated with the level of gamma-secretase in fibroblasts, suggesting that the up-regulation of EGFR stimulates hyperproliferation in epithelia of mice with genetic reduction of gamma-secretase. Supporting this notion is our finding that the proliferative response of fibroblasts lacking gamma-secretase activity is more sensitive when challenged by either EGF or an inhibitor of EGFR as compared with wild type cells. Interestingly, the up-regulation of EGFR is independent of Notch signaling, suggesting that the EGFR pathway functions in parallel with Notch in the tumorigenesis of SCC. Collectively, our results establish a novel mechanism linking the EGFR pathway to the tumor suppressor role of gamma-secretase and that mice with genetic reduction of gamma-secretase represent an excellent rodent model for clarifying pathogenesis of SCC and for testing therapeutic strategy to ameliorate this type of human cancer.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic	Golde, TE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	tli1@jhmi.edu; wong@jhmi.edu	Brayton, Cory/AAW-4681-2021	Brayton, Cory/0000-0002-6666-6548	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG05146] Funding Source: Medline; NINDS NIH HHS [P01 NS047308, R01 NS45150] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Brayton C, 2001, VET PATHOL, V38, P1, DOI 10.1354/vp.38-1-1; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; DASSONVILLE O, 1993, J CLIN ONCOL, V11, P1873, DOI 10.1200/JCO.1993.11.10.1873; DE SB, 1999, NATURE, V398, P518; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2003, AM J PATHOL, V162, P1763, DOI 10.1016/S0002-9440(10)64311-8; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Lewis SJ, 2005, BIOORG MED CHEM LETT, V15, P373, DOI 10.1016/j.bmcl.2004.10.062; Li T, 2003, J NEUROSCI, V23, P3272; LI T, 2007, IN PRESS J NEUROSCI; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Rogers SJ, 2005, CANCER METAST REV, V24, P47, DOI 10.1007/s10555-005-5047-1; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Takano Y, 1999, J PATHOL, V189, P194; Takano Y, 2000, AM J PATHOL, V156, P585, DOI 10.1016/S0002-9440(10)64763-3; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; WONG PC, 2005, NEUROBIOLOGY ALZHEIM; WONG WT, 1994, ONCOGENE, V9, P3057; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Yu ZW, 2005, CLIN CANCER RES, V11, P2471, DOI 10.1158/1078-0432.CCR-04-2199; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	38	73	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32264	32273		10.1074/jbc.M703649200	http://dx.doi.org/10.1074/jbc.M703649200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827153	hybrid			2022-12-25	WOS:000250480300049
J	Parlitz, R; Eitan, A; Stjepanovic, G; Bahari, L; Bange, G; Bibi, E; Sinning, I				Parlitz, Richard; Eitan, Asa; Stjepanovic, Goran; Bahari, Liat; Bange, Gert; Bibi, Eitan; Sinning, Irmgard			Escherichia coli signal recognition particle receptor FtsY contains an essential and autonomous membrane-binding amphipathic helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; TARGETING PATHWAY; SRP RECEPTOR; NG DOMAIN; PROTEIN; ASSOCIATION; RIBOSOME; SEQUENCE; PHOSPHOLIPIDS; BIOGENESIS	Escherichia coli membrane protein biogenesis is mediated by a signal recognition particle and its membrane-associated receptor ( FtsY). Although crucial for its function, it is still not clear how FtsY interacts with the membrane. Analysis of the structure/function differences between severely truncated active ( NG + 1) and inactive ( NG) mutants of FtsY enabled us to identify an essential membrane-interacting determinant. Comparison of the three-dimensional structures of the mutants, combined with site-directed mutagenesis, modeling, and liposome-binding assays, revealed that FtsY contains a conserved autonomous lipid-binding amphipathic alpha-helix at the N-terminal end of the N domain. Deletion experiments showed that this helix is essential for FtsY function in vivo, thus offering, for the first time, clear evidence for the functionally important, physiologically relevant interaction of FtsY with lipids.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Ruprecht Karls University Heidelberg	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, POB 26, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Bange, Gert/AAB-3734-2021; Stjepanovic, Goran/A-7902-2010; Sinning, Irmgard/A-2982-2010	Stjepanovic, Goran/0000-0002-4841-9949; Bange, Gert/0000-0002-7826-0932; Bibi, Eitan/0000-0003-3700-2707				Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bibi E, 2001, TRENDS BIOCHEM SCI, V26, P15, DOI 10.1016/S0968-0004(00)01711-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; deLeeuw E, 1997, FEBS LETT, V416, P225, DOI 10.1016/S0014-5793(97)01238-6; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gariani T, 2006, J STRUCT BIOL, V153, P85, DOI 10.1016/j.jsb.2005.10.003; Gawronski-Salerno J, 2007, PROTEINS, V66, P984, DOI 10.1002/prot.21200; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; Mandon EC, 2003, J CELL BIOL, V162, P575, DOI 10.1083/jcb.200303143; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Millman JS, 1999, J BIOL CHEM, V274, P33227, DOI 10.1074/jbc.274.47.33227; Millman JS, 2001, J BIOL CHEM, V276, P25982, DOI 10.1074/jbc.M011331200; Montoya G, 1997, PROTEINS, V28, P285, DOI 10.1002/(SICI)1097-0134(199706)28:2<285::AID-PROT15>3.0.CO;2-E; Montoya G, 2000, STRUCTURE, V8, P515, DOI 10.1016/S0969-2126(00)00131-3; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Reyes CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000607; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Snapp EL, 2004, J CELL BIOL, V164, P997, DOI 10.1083/jcb.200312079; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	45	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32176	32184		10.1074/jbc.M705430200	http://dx.doi.org/10.1074/jbc.M705430200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726012	hybrid			2022-12-25	WOS:000250480300040
J	Sha, Z; Yen, HCS; Scheel, H; Suo, JF; Hofmann, K; Chang, EC				Sha, Zhe; Yen, Hsueh-Chi S.; Scheel, Hartmut; Suo, Jinfeng; Hofmann, Kay; Chang, Eric C.			Isolation of the Schizosaccharomyces pombe proteasome subunit rpn7 and a structure-function study of the Proteasome-COP9-Initiation factor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR VIRUS; 26S PROTEASOME; INT6; HOMOLOGS; GENE; LOCALIZATION; COMPLEXES; PROTEINS; SEQUENCE; MOE1	Proper assembly of the 26 S proteasome is required to efficiently degrade polyubiquitinated proteins. Many proteasome subunits contain the proteasome-COP9-initiation factor (PCI) domain, thus raising the possibility that the PCI domain may play a role in mediating proteasome assembly. We have previously characterized the PCI protein Yin6, a fission yeast ortholog of the mammalian Int6 that has been implicated in breast oncogenesis, and demonstrated that it binds and regulates the assembly of the proteasome. In this study, we isolated another PCI proteasome subunit, Rpn7, as a high copy suppressor that rescued the proteasome defects in yin6 null cells. To better define the function of the PCI domain, we aligned protein sequences to identify a conserved leucine residue that is present in nearly all known PCI domains. Replacing it with aspartate in yeast Rpn7, Yin6, and Rpn5 inactivated these proteins, and mutant human Int6 mislocalized in HeLa cells. Rpn7 and Rpn5 bind Rpn9 with high affinity, but their mutant versions do not. Our data suggest that this leucine may interact with several hydrophobic amino acid residues to influence the spatial arrangement either within the N-terminal tandem alpha-helical repeats or between these repeats and the more C-terminal winged helix subdomain. Disruption of such an arrangement in the PCI domain may substantially inactivate many PCI proteins and block their binding to other proteins.	Baylor Coll Med, Dept Mol & Cell Biol, Lester & Sue Smith Brest Ctr, Houston, TX 77030 USA; Miltenyi Biotec GmbH, MACSmol Business Unit, Bioinformat Dept, D-50829 Cologne, Germany	Baylor College of Medicine; Miltenyi Biotec	Chang, EC (corresponding author), Baylor Coll Med, Dept Mol & Cell Biol, Lester & Sue Smith Brest Ctr, 1 Baylor Plaza,BCM 600, Houston, TX 77030 USA.	echang1@bcm.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021; Hofmann, Kay/D-6714-2011	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414; Hofmann, Kay/0000-0002-2289-9083	NCI NIH HHS [R01 CA090464-06, R01 CA107187-04, R01 CA107187, CA107187, CA90464, R01 CA090464-05, R01 CA090464, R01 CA090464-07] Funding Source: Medline; NCRR NIH HHS [P41 RR001081, P41 RR-01081] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090464, R01CA107187] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alfa C., 1993, EXPT FISSION YEAST; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107790200; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chang Eric C, 2004, EMBO Rep, V5, P1041, DOI 10.1038/sj.embor.7400275; Guo JJ, 2000, J VIROL, V74, P1892, DOI 10.1128/JVI.74.4.1892-1899.2000; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Isono E, 2004, J BIOL CHEM, V279, P27168, DOI 10.1074/jbc.M314231200; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Leggett David S., 2005, V301, P57; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Norbury C, 1997, METHOD ENZYMOL, V283, P44; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; SAP J, 2005, AFCS NATURE MOL PAGE, DOI DOI 10.1038/MP.A003493.01; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Watkins SJ, 2004, CELL PROLIFERAT, V37, P149, DOI 10.1111/j.1365-2184.2004.00305.x; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yen HCS, 2003, J BIOL CHEM, V278, P30669, DOI 10.1074/jbc.M302093200; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Yen HCS, 2000, P NATL ACAD SCI USA, V97, P14370, DOI 10.1073/pnas.97.26.14370; Yen HCS, 2003, CELL CYCLE, V2, P81, DOI 10.4161/cc.2.2.340	32	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32414	32423		10.1074/jbc.M706276200	http://dx.doi.org/10.1074/jbc.M706276200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761670	hybrid, Green Accepted			2022-12-25	WOS:000250480300064
J	Siddiqui, K; Stillman, B				Siddiqui, Khalid; Stillman, Bruce			ATP-dependent assembly of the human origin recognition complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; WALKER-A MOTIF; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; CELL-CYCLE; IN-VITRO; HEXAMERIC HELICASE; T-ANTIGEN; CHROMATIN; PROTEINS	The origin recognition complex (ORC) was initially discovered in budding yeast extracts as a protein complex that binds with high affinity to autonomously replicating sequences in an ATP-dependent manner. We have cloned and expressed the human homologs of the ORC subunits as recombinant proteins. In contrast to other eukaryotic initiators examined thus far, assembly of human ORC in vitro is dependent on ATP binding. Mutations in the ATP-binding sites of Orc4 or Orc5 impair complex assembly, whereas Orc1 ATP binding is not required. Immunofluorescence staining of human cells with anti-Orc3 antibodies demonstrate cell cycle-dependent association with a nuclear structure. Immunoprecipitation experiments show that ORC disassembles as cells progress through S phase. The Orc6 protein binds directly to the Orc3 subunit and interacts as part of ORC in vivo. These data suggest that the assembly and disassembly of ORC in human cells is uniquely regulated and may contribute to restricting DNA replication to once in every cell division cycle.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091; /0000-0001-6448-0902	NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA013106, P01 CA013106-38S10025, CA13106, P30 CA045508] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; DEAN FB, 1992, J BIOL CHEM, V267, P14129; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; HARLOW E, 1988, ANTIBODIES LAB MANUA, P138; Harvey KJ, 2003, J BIOL CHEM, V278, P48524, DOI 10.1074/jbc.M307661200; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Neuwald AF, 1999, GENOME RES, V9, P27; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Podobnik M, 2003, STRUCTURE, V11, P253, DOI 10.1016/S0969-2126(03)00027-3; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rowles A, 1999, J CELL SCI, V112, P2011; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1991, J BIOL CHEM, V266, P12041; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Stefanovic D, 2003, J BIOL CHEM, V278, P42737, DOI 10.1074/jbc.M307058200; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Takahashi N, 2004, J BIOL CHEM, V279, P8469, DOI 10.1074/jbc.M305531200; Takenaka H, 2002, BIOL PHARM BULL, V25, P652, DOI 10.1248/bpb.25.652; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Waga S, 2006, J BIOL CHEM, V281, P10926, DOI 10.1074/jbc.M600299200; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0	65	69	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32370	32383		10.1074/jbc.M705905200	http://dx.doi.org/10.1074/jbc.M705905200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17716973	Green Accepted, hybrid			2022-12-25	WOS:000250480300060
J	Schwartz, A; Margeat, E; Rahmouni, AR; Boudvillain, M				Schwartz, Annie; Margeat, Emmanuel; Rahmouni, A. Rachid; Boudvillain, Marc			Transcription termination factor rho can displace streptavidin from biotinylated RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA HELICASE ACTIVITY; ESCHERICHIA-COLI RHO; DEPENDENT TERMINATION; SECONDARY STRUCTURE; ELONGATION COMPLEX; DELETION ANALYSIS; MESSENGER-RNA; BINDING-SITE; NASCENT RNA; IN-VIVO	In Escherichia coli, binding of the hexameric Rho protein to naked C-rich Rut (Rho utilization) regions of nascent RNA transcripts initiates Rho-dependent termination of transcription. Although the ring-shaped Rho factor exhibits in vitro RNA-dependent ATPase and directional RNA-DNA helicase activities, the actual molecular mechanisms used by Rho to disrupt the intricate network of interactions that cement the ternary transcription complex remain elusive. Here, we show that Rho is a molecular motor that can apply significant disruptive forces on heterologous nucleoprotein assemblies such as streptavidin bound to biotinylated RNA molecules. ATP-dependent disruption of the biotin-streptavidin interaction demonstrates that Rho is not mechanistically limited to the melting of nucleic acid base pairs within molecular complexes and confirms that specific interactions with the roadblock target are not required for Rho to operate properly. We also show that Rho-induced streptavidin displacement depends significantly on the identity of the biotinylated transcript as well as on the position, nature, and length of the biotin link to the RNA chain. Altogether, our data are consistent with a "snow plough" type of mechanism of action whereby an early rearrangement of the Rho-substrate complex (activation) is rate-limiting, physical force (pulling) is exerted on the RNA chain by residues of the central Rho channel, and removal of structural obstacles from the RNA track stems from their nonspecific steric exclusion from the hexamer central hole. In this context, a simple model for the regulation of Rho-dependent termination based on the modulation of disruptive dynamic loading by secondary factors is proposed.	CNRS, Ctr Biophys Mol, UPR4301, F-45071 Orleans, France; CNRS, Ctr Biochim Struct, UMR5048, F-34090 Montpellier, France; INSERM, F-34090 Montpellier, France; Univ Montpellier I, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Boudvillain, M (corresponding author), CNRS, Ctr Biophys Mol, UPR4301, F-45071 Orleans, France.	marc.boudvillain@cnrs-orleans.fr	Margeat, Emmanuel/AAY-9167-2021	Margeat, Emmanuel/0000-0001-6063-6420; Boudvillain, Marc/0000-0002-6398-9122				Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; ALIFANO P, 1991, CELL, V64, P553; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; Burns CM, 1999, J BIOL CHEM, V274, P5245, DOI 10.1074/jbc.274.8.5245; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; CERUZZI MAF, 1985, J BIOL CHEM, V260, P9412; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Guerin M, 1998, NUCLEIC ACIDS RES, V26, P4895, DOI 10.1093/nar/26.21.4895; HART CM, 1994, J MOL BIOL, V237, P255, DOI 10.1006/jmbi.1994.1229; HART CM, 1991, J BIOL CHEM, V266, P24140; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Hyeon C, 2007, BIOPHYS J, V92, P731, DOI 10.1529/biophysj.106.093062; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; JANKOWSKY PH, 2006, NAT STRUCT MOL BIOL, V34, P4181; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Kainz M, 1998, J MOL BIOL, V284, P1379, DOI 10.1006/jmbi.1998.2272; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Knowlton JR, 2003, BIOCHEMISTRY-US, V42, P2275, DOI 10.1021/bi0272508; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; LOWERYGO.C, 1974, P NATL ACAD SCI USA, V71, P2003, DOI 10.1073/pnas.71.5.2003; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Nowatzke W, 1996, METHOD ENZYMOL, V274, P353; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; Persson T, 2005, HDB RNA BIOCH, P53; Qin PZF, 1999, METHODS, V18, P60, DOI 10.1006/meth.1999.0757; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Richardson JP, 2006, MOL CELL, V22, P711, DOI 10.1016/j.molcel.2006.06.002; Richardson JP, 2003, CELL, V114, P157, DOI 10.1016/S0092-8674(03)00554-3; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Richardson LV, 1996, J BIOL CHEM, V271, P21597, DOI 10.1074/jbc.271.35.21597; SCHMIDT MC, 1984, J BIOL CHEM, V259, P5000; Schwartz A, 2003, EMBO J, V22, P3385, DOI 10.1093/emboj/cdg310; Schwartz A, 2007, BIOCHEMISTRY-US, V46, P9366, DOI 10.1021/bi700493m; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; STEINMETZ EJ, 1990, J BIOL CHEM, V265, P18408; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vieu E, 2004, J MOL BIOL, V339, P1077, DOI 10.1016/j.jmb.2004.04.022; von Hippel PH, 2004, NAT STRUCT MOL BIOL, V11, P494, DOI 10.1038/nsmb0604-494; Walmacq C, 2004, J MOL BIOL, V342, P403, DOI 10.1016/j.jmb.2004.07.026; Walmacq C, 2006, BIOCHEMISTRY-US, V45, P5885, DOI 10.1021/bi0600648; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7980, DOI 10.1021/bi963179s; Walstrom KM, 1998, J MOL BIOL, V279, P713, DOI 10.1006/jmbi.1998.1814; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; ZALATAN F, 1992, J BIOL CHEM, V267, P19082; ZALATAN F, 1993, J BIOL CHEM, V268, P17051	67	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31469	31476		10.1074/jbc.M706935200	http://dx.doi.org/10.1074/jbc.M706935200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724015	hybrid, Green Published			2022-12-25	WOS:000250309200038
J	Llarrull, LI; Tioni, MF; Kowalski, J; Bennett, B; Vila, AJ				Llarrull, Leticia I.; Tioni, Mariana F.; Kowalski, Jason; Bennett, Brian; Vila, Alejandro J.			Evidence for a dinuclear active site in the metallo-ss-lactamase BcII with substoichiometric Co(II) - A new model for metal uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COBALT-BETA-LACTAMASE; BACILLUS-CEREUS; COORDINATION GEOMETRY; PARAMAGNETIC H-1-NMR; CATALYTIC EFFICIENCY; COPPER SITES; SHIFTED NMR; BINDING; HYDROLYSIS; IMIS	Metallo-beta-lactamases are zinc-dependent enzymes that constitute one of the main resistance mechanisms to beta-lactam antibiotics. Metallo-beta-lactamases have been characterized both in mono- and dimetallic forms. Despite many studies, the role of each metal binding site in substrate binding and catalysis is still unclear. This is mostly due to the difficulties in assessing the metal content and site occupancy in solution. For this reason, Co( II) has been utilized as a useful probe of the active site structure. We have employed UV-visible, EPR, and NMR spectroscopy to study Co( II) binding to the metallo-beta-lactamase BcII from Bacillus cereus. The spectroscopic features were attributed to the two canonical metal binding sites, the 3H ( His(116), His(118), and His(196)) and DCH ( Asp(120), Cys(221), and His(263)) sites. These data clearly reveal the coexistence of mononuclear and dinuclear Co( II)-loaded forms at Co( II)/enzyme ratios as low as 0.6. This picture is consistent with the macroscopic dissociation constants here determined from competition binding experiments. A spectral feature previously assigned to the DCH site in the dinuclear species corresponds to a third, weakly bound Co( II) site. The present work emphasizes the importance of using different spectroscopic techniques to follow the metal content and localization during metallo-beta-lactamase turnover.	Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol Celular Rosario,Mol Biol Div, RA-2000 Rosario, Argentina; Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Biophys Sect, RA-2000 Rosario, Argentina; Med Coll Wisconsin, Dept Biophys, Natl Biomed EPR Ctr, Milwaukee, WI 53226 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Medical College of Wisconsin	Vila, AJ (corresponding author), Supacha 531,S2002LRK, Rosario, Argentina.	vila@ibr.gov.ar		Vila, Alejandro/0000-0002-7978-3233	NIAID NIH HHS [AI056231] Funding Source: Medline; NIBIB NIH HHS [EB001980] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Badarau A, 2007, BIOCHEM J, V401, P197, DOI 10.1042/BJ20061002; Badarau A, 2006, BIOCHEMISTRY-US, V45, P10654, DOI 10.1021/bi060934l; Badarau A, 2006, BIOCHEMISTRY-US, V45, P11012, DOI 10.1021/bi0610146; BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; BERTINI I, 1983, ACCOUNTS CHEM RES, V16, P272, DOI 10.1021/ar00092a002; BICKNELL R, 1986, BIOCHEMISTRY-US, V25, P7208, DOI 10.1021/bi00370a066; BICKNELL R, 1985, BIOCHEMISTRY-US, V24, P6876, DOI 10.1021/bi00345a021; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Crawford PA, 2005, BIOCHEMISTRY-US, V44, P5168, DOI 10.1021/bi047463s; Crawford PA, 2004, PROTEIN EXPRES PURIF, V36, P272, DOI 10.1016/j.pep.2004.04.017; Dal Peraro M, 2004, J AM CHEM SOC, V126, P12661, DOI 10.1021/ja048071b; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; DAVIES RB, 1974, BIOCHEM J, V143, P129, DOI 10.1042/bj1430129; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Donaire A, 1998, BIOCHEMISTRY-US, V37, P8659, DOI 10.1021/bi971974f; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fernandez CO, 2003, J BIOL INORG CHEM, V8, P75, DOI 10.1007/s00775-002-0390-y; Fernandez CO, 2001, J AM CHEM SOC, V123, P11678, DOI 10.1021/ja0162515; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; GROWDER MW, 2006, ACCOUNTS CHEM RES, V39, P721; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; INUBUSHI T, 1983, J MAGN RESON, V51, P128, DOI 10.1016/0022-2364(83)90109-9; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; Periyannan G, 2004, PROTEIN SCI, V13, P2236, DOI 10.1110/ps.04742704; Periyannan GR, 2006, BIOCHEMISTRY-US, V45, P1313, DOI 10.1021/bi051105n; Rasia RM, 2002, BIOCHEMISTRY-US, V41, P1853, DOI 10.1021/bi010933n; Riley EA, 2006, INORG CHEM, V45, P10016, DOI 10.1021/ic061207h; SALGADO J, 1995, EUR J BIOCHEM, V231, P358, DOI 10.1111/j.1432-1033.1995.tb20708.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; VILA AJ, 1994, FEBS LETT, V355, P15, DOI 10.1016/0014-5793(94)01141-9; Vila AJ, 1996, J AM CHEM SOC, V118, P7291, DOI 10.1021/ja9601346; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200	45	54	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30586	30595		10.1074/jbc.M704613200	http://dx.doi.org/10.1074/jbc.M704613200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17715135	hybrid			2022-12-25	WOS:000250136300027
J	Harkonen, T; Harding, K; Rasmussen, TD; Teilmann, J; Dietz, R				Harkonen, Tero; Harding, Karin; Rasmussen, Thomas Dau; Teilmann, Jonas; Dietz, Rune			Age- and Sex-Specific Mortality Patterns in an Emerging Wildlife Epidemic: The Phocine Distemper in European Harbour Seals	PLOS ONE			English	Article							SCOTTISH GREY SEALS; VITULINA; VIRUS; IDENTIFICATION; ANTIBODIES	Analyses of the dynamics of diseases in wild populations typically assume all individuals to be identical. However, profound effects on the long-term impact on the host population can be expected if the disease has age and sex dependent dynamics. The Phocine Distemper Virus (PDV) caused two mass mortalities in European harbour seals in 1988 and in 2002. We show the mortality patterns were highly age specific on both occasions, where young of the year and adult (>4 yrs) animals suffered extremely high mortality, and sub-adult seals (1-3 yrs) of both sexes experienced low mortality. Consequently, genetic differences cannot have played a main role explaining why some seals survived and some did not in the study region, since parents had higher mortality levels than their progeny. Furthermore, there was a conspicuous absence of animals older than 14 years among the victims in 2002, which strongly indicates that the survivors from the previous disease outbreak in 1988 had acquired and maintained immunity to PDV. These specific mortality patterns imply that contact rates and susceptibility to the disease are strongly age and sex dependent variables, underlining the need for structured epidemic models for wildlife diseases. Detailed data can thus provide crucial information about a number of vital parameters such as functional herd immunity. One of many future challenges in understanding the epidemiology of the PDV and other wildlife diseases is to reveal how immune system responses differ among animals in different stages during their life cycle. The influence of such underlying mechanisms may also explain the limited evidence for abrupt disease thresholds in wild populations.	[Harkonen, Tero] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; [Harding, Karin] Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden; [Rasmussen, Thomas Dau; Teilmann, Jonas; Dietz, Rune] Natl Environm Res Inst, Roskilde, Denmark	Swedish Museum of Natural History; University of Gothenburg; Aarhus University	Harkonen, T (corresponding author), Swedish Museum Nat Hist, S-10405 Stockholm, Sweden.	tero.harkonen@swipnet.se	Teilmann, Jonas/J-7828-2013; Dietz, Rune/F-9154-2015; Harding, Karin/F-9957-2013; Dietz, Rune/L-4640-2013	Teilmann, Jonas/0000-0002-4376-4700; Dietz, Rune/0000-0001-9652-317X; Harding, Karin/0000-0003-1527-0903	Swedish Environmental Protection Agency; The Danish Ministry of Environment	Swedish Environmental Protection Agency; The Danish Ministry of Environment	Funding: This study was financed by the Swedish Environmental Protection Agency and The Danish Ministry of Environment.	Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; COHEN JE, 1979, SIAM J APPL MATH, V36, P169, DOI 10.1137/0136015; DIETZ R, 1989, AMBIO, V18, P258; DIETZ R, 1991, SARSIA, V76, P17, DOI 10.1080/00364827.1991.10413461; Duignan PJ, 1997, J WILDLIFE DIS, V33, P7, DOI 10.7589/0090-3558-33.1.7; GALVANI AP, 2003, P ROY SOC LOND B BIO, V271, P171; Hammond JA, 2005, J GEN VIROL, V86, P2563, DOI 10.1099/vir.0.80962-0; Harding KC, 2003, ECOL LETT, V6, P894, DOI 10.1046/j.1461-0248.2003.00507.x; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harding KC, 2005, AM NAT, V166, P722, DOI 10.1086/497580; Harkonen T, 2002, CAN J ZOOL, V80, P1498, DOI 10.1139/Z02-141; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; HARKONEN T, 1990, OPHELIA, V32, P211; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; HEIDEJORGENSEN MP, 1992, AMBIO, V21, P511; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; KENNEDY S, 1990, VET REC, V127, P563; KEYFITZ N, 1971, DEMOGRAPHY, V8, P71, DOI 10.2307/2060339; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; Lonergan M, 2003, ECOL LETT, V6, P889, DOI 10.1046/j.1461-0248.2003.00510.x; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; Pomeroy PP, 2005, MAR ECOL PROG SER, V287, P241, DOI 10.3354/meps287241; Thompson D, 2005, J APPL ECOL, V42, P638, DOI 10.1111/j.1365-2664.2005.01025.x; Thompson PM, 2002, VET REC, V151, P609, DOI 10.1136/vr.151.20.609; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009	25	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e887	10.1371/journal.pone.0000887	http://dx.doi.org/10.1371/journal.pone.0000887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849016	Green Published, gold			2022-12-25	WOS:000207455600033
J	Marinescu, V; Loomis, PA; Ehmann, S; Beales, M; Potashkin, JA				Marinescu, Victor; Loomis, Patricia A.; Ehmann, Svetlana; Beales, Mitchell; Potashkin, Judith A.			Regulation of Retention of FosB Intron 4 by PTB	PLOS ONE			English	Article								One effect of stressors such as chronic drug administration is that sequence within the terminal exon of the transcription factor FosB is recognized as intronic and removed by alternative splicing. This results in an open-reading-frame shift that produces a translation stop codon and ultimately a truncated protein, termed Delta FosB. In vitro splicing assays with control and mutated transcripts generated from a fosB mini-gene construct indicated a CU-rich sequence at the 39 end of intron 4 (I4) plays an important role in regulating fosB pre-mRNA splicing due to its binding of polypyrimidine tract binding protein (PTB). PTB binding to this sequence is dependent upon phosphorylation by protein kinase A and is blocked if the CU-rich sequence is mutated to a U-rich region. When this mutated fosB minigene is expressed in HeLa cells, the splicing efficiency of its product is increased compared to wild type. Moreover, transient transfection of PTB-1 in HeLa cells decreased the splicing efficiency of a wild type fosB minigene transcript. Depletion of PTB from nuclear extracts facilitated U2AF(65) binding to wild type sequence in vitro, suggesting these proteins function in a dynamic equilibrium to modulate fosB pre-mRNA alternative splicing. These results demonstrate for the first time that phosphorylated PTB promotes intron retention and thereby silences the splicing of fosB I4.	[Marinescu, Victor; Loomis, Patricia A.; Ehmann, Svetlana; Beales, Mitchell; Potashkin, Judith A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL USA.	judy.potashkin@rosalindfranklin.edu			National Institutes of Health [DA-13703, DA-15367]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA013703, R01DA015367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA-13703 and DA-15367 to JP.	Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; Alibhai IN, 2007, BRAIN RES, V1143, P22, DOI 10.1016/j.brainres.2007.01.069; Ashiya M, 1997, RNA, V3, P996; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Chen JS, 1997, J NEUROSCI, V17, P4933; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; HAMPSON RK, 1987, P NATL ACAD SCI USA, V84, P2673, DOI 10.1073/pnas.84.9.2673; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hiroi N, 1998, J NEUROSCI, V18, P6952; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kikuchi T, 2000, J BIOCHEM, V128, P811, DOI 10.1093/oxfordjournals.jbchem.a022819; Ladd AN, 2002, GENOME BIOL, V3; LIN CH, 1995, RNA, V1, P234; Lou H, 1999, MOL CELL BIOL, V19, P78; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; MATLIN AJ, 2007, RNA; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; Miyata S, 2001, MOL BRAIN RES, V90, P39, DOI 10.1016/S0169-328X(01)00072-9; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; MUMBERG D, 1991, GENE DEV, V5, P1212, DOI 10.1101/gad.5.7.1212; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1999, BRAIN RES, V835, P10, DOI 10.1016/S0006-8993(98)01191-3; PARADIS C, 2007, RNA; Perez-Otano I, 1998, MOL BRAIN RES, V53, P41, DOI 10.1016/S0169-328X(97)00269-6; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Southby J, 1999, MOL CELL BIOL, V19, P2699; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; Ulery PG, 2007, EUR J NEUROSCI, V25, P224, DOI 10.1111/j.1460-9568.2006.05262.x; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Zavolan M, 2006, CURR OPIN STRUC BIOL, V16, P362, DOI 10.1016/j.sbi.2006.05.002; Zhang L, 1999, RNA, V5, P117, DOI 10.1017/S1355838299981530; Zhang L, 1996, RNA, V2, P682	53	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e828	10.1371/journal.pone.0000828	http://dx.doi.org/10.1371/journal.pone.0000828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786200	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500012
J	Sobo, K; Le Blanc, I; Luyet, PP; Fivaz, M; Ferguson, C; Parton, RG; Gruenberg, J; van der Goot, FG				Sobo, Komla; Le Blanc, Isabelle; Luyet, Pierre-Philippe; Fivaz, Marc; Ferguson, Charles; Parton, Robert G.; Gruenberg, Jean; van der Goot, F. Gisou			Late Endosomal Cholesterol Accumulation Leads to Impaired Intra-Endosomal Trafficking	PLOS ONE			English	Article								Background. Pathological accumulation of cholesterol in late endosomes is observed in lysosomal storage diseases such as Niemann-Pick type C. We here analyzed the effects of cholesterol accumulation in NPC cells, or as phenocopied by the drug U18666A, on late endosomes membrane organization and dynamics. Methodology/Principal Findings. Cholesterol accumulation did not lead to an increase in the raft to non-raft membrane ratio as anticipated. Strikingly, we observed a 23 fold increase in the size of the compartment. Most importantly, properties and dynamics of late endosomal intralumenal vesicles were altered as revealed by reduced late endosomal vacuolation induced by the mutant pore-forming toxin ASSP, reduced intoxication by the anthrax lethal toxin and inhibition of infection by the Vesicular Stomatitis Virus. Conclusions/Significance. These results suggest that back fusion of intralumenal vesicles with the limiting membrane of late endosomes is dramatically perturbed upon cholesterol accumulation.	[Sobo, Komla; Fivaz, Marc; van der Goot, F. Gisou] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Le Blanc, Isabelle; Luyet, Pierre-Philippe; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Ferguson, Charles; Parton, Robert G.] Univ Queensland, Sch Biomed Sci, Ctr Microscopy & Microanal, Inst Mol Biosci, Brisbane, Qld, Australia; [van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Queensland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland.	gisou.vandergoot@epfl.ch	Parton, Robert G/C-5673-2009; van der Goot, Gisou G/B-2279-2012	Parton, Robert G/0000-0002-7494-5248; van der Goot, Gisou G/0000-0002-8522-274X; Fivaz, Marc/0000-0003-1003-7934	Swiss National Science Foundation; National Health and Medical Research Council of Australia; Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Roche Research Foundation	This work was supported by a grant from the Swiss National Science Foundation to JG and to GvdG and a grant from the National Health and Medical Research Council of Australia to RP. ILB was a recipient of a fellowship from the Roche Research Foundation. GvdG is an international Fellow of the Howard Hughes Medical Institute.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; GRUENBERG J, 2006, NAT REV MOL CELL BIO; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kopitz J, 1996, AM J MED GENET, V63, P198; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	46	108	109	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e851	10.1371/journal.pone.0000851	http://dx.doi.org/10.1371/journal.pone.0000851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786222	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455500034
J	Zeller, SL; Brandl, H; Schmid, B				Zeller, Simon L.; Brandl, Helmut; Schmid, Bernhard			Host-Plant Selectivity of Rhizobacteria in a Crop/Weed Model System	PLOS ONE			English	Article							RHIZOSPHERE BACTERIA; CYANIDE PRODUCTION; SP NOV.; SOIL	Belowground microorganisms are known to influence plants' performance by altering the soil environment. Plant pathogens such as cyanide-producing strains of the rhizobacterium Pseudomonas may show strong host-plant selectivity. We analyzed interactions between different host plants and Pseudomonas strains and tested if these can be linked to the cyanide sensitivity of host plants, the cyanide production of bacterial strains or the plant identity from which strains had been isolated. Eight strains (four cyanide producing) were isolated from roots of four weed species and then re-inoculated on the four weed and two additional crop species. Bacterial strain composition varied strongly among the four weed species. Although all six plant species showed different reductions in root growth when cyanide was artificially applied to seedlings, they were generally not negatively affected by inoculation with cyanide-producing bacterial strains. We found a highly significant plant species x bacterial strain interaction. Partitioning this interaction into contrasts showed that it was entirely due to a strongly negative effect of a bacterial strain (Pseudomonas kilonensis/brassicacearum, isolated from Galium mollugo) on Echinochloa crus-galli. This exotic weed may not have become adapted to the bacterial strain isolated from a native weed. Our findings suggest that host-specific rhizobacteria hold some promise as biological weed-control agents.	[Zeller, Simon L.; Brandl, Helmut; Schmid, Bernhard] Univ Zurich, Inst Environm Sci, Zurich, Switzerland	University of Zurich	Zeller, SL (corresponding author), Univ Zurich, Inst Environm Sci, Zurich, Switzerland.	zellsim@uwinst.uzh.ch	Schmid, Bernhard/C-8625-2009; Zeller, Simon/A-7396-2010	Schmid, Bernhard/0000-0002-8430-3214; 				Achouak W, 2000, INT J SYST EVOL MICR, V50, P9, DOI 10.1099/00207713-50-1-9; ALSTROM S, 1989, BIOL FERT SOILS, V7, P232, DOI 10.1007/BF00709654; ASTROM B, 1988, PLANT SOIL, V109, P263, DOI 10.1007/BF02202093; BAKKER AW, 1987, SOIL BIOL BIOCHEM, V19, P451, DOI 10.1016/0038-0717(87)90037-X; BEGONIA MFT, 1994, FEMS MICROBIOL ECOL, V15, P227, DOI 10.1111/j.1574-6941.1994.tb00246.x; Brandl H, 2005, J APPL MICROBIOL, V99, P1099, DOI 10.1111/j.1365-2672.2005.02700.x; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CASTRIC KF, 1983, APPL ENVIRON MICROB, V45, P701, DOI 10.1128/AEM.45.2.701-702.1983; Faramarzi MA, 2004, J BIOTECHNOL, V113, P321, DOI 10.1016/j.jbiotec.2004.03.031; Flores-Vargas RD, 2006, J APPL MICROBIOL, V100, P946, DOI 10.1111/j.1365-2672.2006.02851.x; FREDRICKSON JK, 1985, PLANT SOIL, V83, P399, DOI 10.1007/BF02184452; HETRICK BAD, 1988, SOIL BIOL BIOCH, V20; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; KENNEDY AC, 1991, SOIL SCI SOC AM J, V55, P722, DOI 10.2136/sssaj1991.03615995005500030014x; Kremer RJ, 2001, CURR MICROBIOL, V43, P182, DOI 10.1007/s002840010284; KREMER RJ, 1990, APPL ENVIRON MICROB, V56, P1649, DOI 10.1128/AEM.56.6.1649-1655.1990; Li SH, 2005, ENVIRON GEOL, V47, P1150, DOI 10.1007/s00254-005-1253-y; McCrady MH, 1915, J INFECT DIS, V17, P183, DOI 10.1093/infdis/17.1.183; Nehl DB, 1997, APPL SOIL ECOL, V5, P1, DOI 10.1016/S0929-1393(96)00124-2; SANDS DC, 1970, APPL MICROBIOL, V20, P513, DOI 10.1128/AEM.20.3.513-514.1970; SCHIPPERS B, 1987, ANNU REV PHYTOPATHOL, V25, P339, DOI 10.1146/annurev.py.25.090187.002011; SCHROTH MN, 1982, SCIENCE, V216, P1376, DOI 10.1126/science.216.4553.1376; Sikorski J, 2001, INT J SYST EVOL MICR, V51, P1549, DOI 10.1099/00207713-51-4-1549; Westover KM, 1997, J ECOL, V85, P863, DOI 10.2307/2960607; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; WOLTZ SS, 1978, ANNU REV PHYTOPATHOL, V16, P403, DOI 10.1146/annurev.py.16.090178.002155	26	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e846	10.1371/journal.pone.0000846	http://dx.doi.org/10.1371/journal.pone.0000846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786217	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500029
J	Hotta, K; Ogura, T; Nishii, K; Kodani, T; Onishi, M; Shimizu, Y; Kanehiro, A; Kiura, K; Tanimoto, M; Tobe, K				Hotta, Katsuyuki; Ogura, Toshio; Nishii, Kenji; Kodani, Tsuyoshi; Onishi, Masaru; Shimizu, Yukito; Kanehiro, Arihiko; Kiura, Katsuyuki; Tanimoto, Mitsune; Tobe, Kazuo			Whole Blood Interferon-Gamma Assay for Baseline Tuberculosis Screening among Japanese Healthcare Students	PLOS ONE			English	Article								Background. The whole blood interferon-gamma assay (QuantiFERON-TB-2G; QFT) has not been fully evaluated as a baseline tuberculosis screening test in Japanese healthcare students commencing clinical contact. The aim of this study was to compare the results from the QFT with those from the tuberculin skin test (TST) in a population deemed to be at a low risk for infection with Mycobacterium tuberculosis. Methodology/Principal Findings. Healthcare students recruited at Okayama University received both the TST and the QFT to assess the level of agreement between these two tests. The interleukin-10 levels before and after exposure to M tuberculosis-specific antigens (early-secreted antigenic target 6-kDa protein [ESAT-6] and culture filtrate protein 10 [CFP-10]) were also measured. Of the 536 healthcare students, most of whom had been vaccinated with bacillus-Calmette-Guerin (BCG), 207 (56%) were enrolled in this study. The agreement between the QFT and the TST results was poor, with positive result rates of 1.4% vs. 27.5%, respectively. A multivariate analysis also revealed that the induration diameter of the TST was not affected by the interferon-gamma concentration after exposure to either of the antigens but was influenced by the number of BCG needle scars (p = 0.046). The whole blood interleukin-10 assay revealed that after antigen exposure, the median increases in interleukin-10 concentration was higher in the subgroup with the small increase in interferon-gamma concentration than in the subgroup with the large increase in interferon-gamma concentration (0.3 vs. 0 pg/mL; p = 0.004). Conclusions/Significance. As a baseline screening test for low-risk Japanese healthcare students at their course entry, QFT yielded quite discordant results, compared with the TST, probably because of the low specificity of the TST results in the BCG-vaccinated population. We also found, for the first time, that the change in the interleukin-10 level after exposure to specific antigens was inversely associated with that in the interferon-gamma level in a low-risk population.	[Hotta, Katsuyuki; Ogura, Toshio; Onishi, Masaru; Shimizu, Yukito; Tobe, Kazuo] Okayama Univ, Hlth & Environm Ctr, Okayama, Japan; [Nishii, Kenji; Kodani, Tsuyoshi] Okayama Inst Hlth & Prevent, Dept Resp Med, Okayama, Japan; [Kanehiro, Arihiko; Kiura, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Resp Med, Okayama, Japan	Okayama University; Okayama University	Hotta, K (corresponding author), Okayama Univ, Hlth & Environm Ctr, Okayama, Japan.	khotta@md.okayama-u.ac.jp	KANEHIRO, Arihiko/B-1926-2011; KIURA, Katsuyuki/B-1991-2011	Kiura, Katsuyuki/0000-0002-9172-9379	Ministry of Education, Culture, Sports, Science and Technology of Japan [18790397]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a Grant-in-Aid for Young Scientists ( B) ( No. 18790397) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aliberti J, 2005, PROSTAG LEUKOTR ESS, V73, P283, DOI 10.1016/j.plefa.2005.05.018; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Graham M, 2006, MED J AUSTRALIA, V185, P324, DOI 10.5694/j.1326-5377.2006.tb00587.x; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Johnson PDR, 1999, CLIN DIAGN LAB IMMUN, V6, P934, DOI 10.1128/CDLI.6.6.934-937.1999; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Minion FC, 2003, INFECT IMMUN, V71, P2239, DOI 10.1128/IAI.71.4.2239-2243.2003; Mori T, 2000, EMERG INFECT DIS, V6, P566, DOI 10.3201/eid0606.000602; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Trajkovic V, 2002, INFECT IMMUN, V70, P6558, DOI 10.1128/IAI.70.12.6558-6566.2002; *WHO, WHO GLOB TB CONTR 20; YAMAUCHI Y, 1994, KEKKAKU, V74, P819	20	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e803	10.1371/journal.pone.0000803	http://dx.doi.org/10.1371/journal.pone.0000803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726533	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455400020
J	Joshi, R; Patil, S; Kalantri, S; Schwartzman, K; Menzies, D; Pai, M				Joshi, Rajnish; Patil, Samir; Kalantri, Shriprakash; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar			Prevalence of Abnormal Radiological Findings in Health Care Workers with Latent Tuberculosis Infection and Correlations with T Cell Immune Response	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; PULMONARY TUBERCULOSIS; SCREENING-PROGRAMS; IMMIGRANTS; DIAGNOSIS; MANIFESTATIONS; CHILDHOOD; REFUGEES; DISEASE; INDIA	Background. More than half of all health care workers (HCWs) in high TB-incidence, low and middle income countries are latently infected with tuberculosis (TB). We determined radiological lesions in a cohort of HCWs with latent TB infection (LTBI) in India, and determined their association with demographic, occupational and T-cell immune response variables. Methodology. We obtained chest radiographs of HCWs who had undergone tuberculin skin test (TST) and QuantiFERON-TB Gold In Tube (QFT), an interferon-gamma release assay, in a previous cross-sectional study, and were diagnosed to have LTBI because they were positive by either TST or QFT, but had no evidence of clinical disease. Two observers independently interpreted these radiographs using a standardized data form and any discordance between them resolved by a third observer. The radiological diagnostic categories (normal, suggestive of inactive TB, and suggestive of active TB) were compared with results of TST, QFT assay, demographic, and occupational covariates. Results. A total of 330 HCWs with positive TST or QFT underwent standard chest radiography. Of these 330, 113 radiographs (34.2%) were finally classified as normal, 206 (62.4%) had lesions suggestive of inactive TB, and 11 (3.4%) had features suggestive of active TB. The mean TST indurations and interferon-gamma levels in the HCWs in these three categories were not significantly different. None of the demographic or occupational covariates was associated with prevalence of inactive TB lesions on chest radiography. Conclusion/Significance. In a high TB incidence setting, nearly two-thirds of HCWs with latent TB infection had abnormal radiographic findings, and these findings had no clear correlation with T cell immune responses. Further studies are needed to verify these findings and to identify the causes and prognosis of radiologic abnormalities in health care workers.	[Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Patil, Samir] Parmanand D Hinduja Hosp, Bombay, Maharashtra, India; [Patil, Samir] Med Res Ctr, Bombay, Maharashtra, India; [Joshi, Rajnish; Kalantri, Shriprakash] Mahatma Gandhi Inst Med Sci, Dept Med, Sevagram, Maharashtra, India; [Joshi, Rajnish] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	McGill University; McGill University; Mahatma Gandhi Institute of Medical Sciences, Sevagram; University of California System; University of California Berkeley	Pai, M (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Kalantri, Shriprakash/ABG-9318-2021; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	Kalantri, Shriprakash/0000-0002-1633-1029; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Patil, Samir/0000-0003-3898-3594; Joshi, Rajnish/0000-0002-4702-0522	Canadian Institutes of Health Research (CIHR) [MOP-81362]; Fogarty AIDS International Training Program [AITRP] [1-D43-TW00003-17]; Fonds de la Recherche en Sante du Quebec (FRSQ); CIHR New Investigator Career Award; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fogarty AIDS International Training Program [AITRP](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR New Investigator Career Award(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported in part by a grant from the Canadian Institutes of Health Research (CIHR), grant MOP-81362. RJ is a recipient of a training fellowship from the Fogarty AIDS International Training Program [AITRP] (grant 1-D43-TW00003-17), USA. KS is the recipient of a Chercheur-Boursier Clinicien career award from the Fonds de la Recherche en Sante du Quebec (FRSQ). DM is the recipient of a Chercheur National career award from the FRSQ. MP is a recipient of a CIHR New Investigator Career Award. The CIHR, Fogarty AITRP and FRSQ had no role in the design, conduct or review of this manuscript.	Al Zahrani K, 2000, AM J RESP CRIT CARE, V162, P1419, DOI 10.1164/ajrccm.162.4.9912048; Andreu J, 2004, EUR J RADIOL, V51, P139, DOI 10.1016/j.ejrad.2004.03.009; Balabanova Y, 2005, BMJ-BRIT MED J, V331, P379, DOI 10.1136/bmj.331.7513.379; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; DALEY CL, 2003, RADIOGRAPHIC MANIFES; DANNENBERG AM, 1982, AM REV RESPIR DIS, V125, P25; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; DeRiemer K, 1998, ARCH INTERN MED, V158, P753, DOI 10.1001/archinte.158.7.753; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; GOTHI G. D., 1982, Indian Journal of Tuberculosis, V29, P134; Graham S, 2002, INT J TUBERC LUNG D, V6, P137; HAQUE AK, 1990, J THORAC IMAG, V5, P8, DOI 10.1097/00005382-199004000-00004; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; HORWITZ O, 1976, PUBLIC HEALTH REP, V91, P146; *ILO, 2002, OCC SAF HLTH SER, V22; Jenssen HK, 2005, INDIANA U MATH J, V54, P1, DOI 10.1512/iumj.2005.54.2685; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; LoBue PA, 2004, CHEST, V126, P1777, DOI 10.1378/chest.126.6.1777; Magkanas E, 2005, INT J TUBERC LUNG D, V9, P865; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; MCADAMS HP, 1995, RADIOL CLIN N AM, V33, P655; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, EMERG INFECT DIS, V12, P1311, DOI 10.3201/eid1209.051663; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pang SC, 2000, INT J TUBERC LUNG D, V4, P232; REICHMAN LB, 1974, HEALTH SERV REP, V89, P177, DOI 10.2307/4595006; REIDER HI, 1999, EPIDEMIOLOGICAL BASI; Richards B, 2005, INT J TUBERC LUNG D, V9, P858; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; STEINBRUCK P, 1972, B INT UNION TUBERC, V47; Wilcke JTR, 1998, INT J TUBERC LUNG D, V2, P219; Zellweger JP, 2006, INT J TUBERC LUNG D, V10, P1123	45	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e805	10.1371/journal.pone.0000805	http://dx.doi.org/10.1371/journal.pone.0000805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726535	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455400022
J	Meulemans, D; Bronner-Fraser, M				Meulemans, Daniel; Bronner-Fraser, Marianne			Insights from Amphioxus into the Evolution of Vertebrate Cartilage	PLOS ONE			English	Article								Central to the story of vertebrate evolution is the origin of the vertebrate head, a problem difficult to approach using paleontology and comparative morphology due to a lack of unambiguous intermediate forms. Embryologically, much of the vertebrate head is derived from two ectodermal tissues, the neural crest and cranial placodes. Recent work in protochordates suggests the first chordates possessed migratory neural tube cells with some features of neural crest cells. However, it is unclear how and when these cells acquired the ability to form cellular cartilage, a cell type unique to vertebrates. It has been variously proposed that the neural crest acquired chondrogenic ability by recruiting proto-chondrogenic gene programs deployed in the neural tube, pharynx, and notochord. To test these hypotheses we examined the expression of 11 amphioxus orthologs of genes involved in neural crest chondrogenesis. Consistent with cellular cartilage as a vertebrate novelty, we find that no single amphioxus tissue co-expresses all or most of these genes. However, most are variously co-expressed in mesodermal derivatives. Our results suggest that neural crest-derived cartilage evolved by serial cooption of genes which functioned primitively in mesoderm.	[Meulemans, Daniel; Bronner-Fraser, Marianne] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Meulemans, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dm@caltech.edu		MEDEIROS, DANIEL/0000-0002-8182-6028; Bronner, Marianne/0000-0003-4274-1862	NIH [DE017911]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this work was provided by NIH grant DE017911 to MBF.	Amore G, 2006, DEV BIOL, V293, P555, DOI 10.1016/j.ydbio.2006.02.024; AZARIAH J, 1973, ACTA HISTOCHEM, V46, P10; Baker CVH, 1997, MECH DEVELOP, V69, P13, DOI 10.1016/S0925-4773(97)00129-9; Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bruneau S, 1997, MECH DEVELOP, V65, P163, DOI 10.1016/S0925-4773(97)00072-5; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; COULY GF, 1993, DEVELOPMENT, V117, P409; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Kang JS, 2004, MECH DEVELOP, V121, P301, DOI 10.1016/j.mod.2004.01.007; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Martinez-Morales JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r36; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; Meulemans D, 2005, J EXP ZOOL PART B, V304B, P298, DOI 10.1002/jez.b.21047; Meulemans D, 2003, DEV BIOL, V264, P430, DOI 10.1016/j.ydbio.2003.09.006; Meulemans D, 2002, DEVELOPMENT, V129, P4953; Miller CT, 2000, DEVELOPMENT, V127, P3815; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; NORTHCUTT RG, 1983, Q REV BIOL, V58, P1, DOI 10.1086/413055; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; RAHR H, 1982, ZOOMORPHOLOGY, V99, P167, DOI 10.1007/BF00310308; Rodrigo I, 2003, DEVELOPMENT, V130, P473, DOI 10.1242/dev.00240; RYCHEL AL, 2005, MOL BIOL EVOL; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Spokony RF, 2002, DEVELOPMENT, V129, P421; STOKES MD, 1995, ACTA ZOOL-STOCKHOLM, V76, P105, DOI 10.1111/j.1463-6395.1995.tb00986.x; Stone JR, 2004, EVOL DEV, V6, P123, DOI 10.1111/j.1525-142X.2004.04014.x; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Wada H, 2006, EVOL DEV, V8, P370, DOI 10.1111/j.1525-142X.2006.00109.x; Walshe J, 2003, DEV BIOL, V264, P522, DOI 10.1016/j.ydbio.2003.08.010; Wenke AK, 2006, BIOCHEM BIOPH RES CO, V345, P495, DOI 10.1016/j.bbrc.2006.04.123; Wilson J, 2004, DEV BIOL, V266, P138, DOI 10.1016/j.ydbio.2003.10.012; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yasui K, 1998, DEV BIOL, V195, P49, DOI 10.1006/dbio.1997.8834; Yoshida CA, 2005, CRIT REV EUKAR GENE, V15, P243, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.60; Yu JK, 2002, DEV DYNAM, V225, P289, DOI 10.1002/dvdy.10173; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P16829, DOI 10.1073/pnas.0605630103; Zhao Q, 1996, NAT GENET, V13, P275, DOI 10.1038/ng0796-275	55	97	101	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e787	10.1371/journal.pone.0000787	http://dx.doi.org/10.1371/journal.pone.0000787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726517	Green Published, gold, Green Accepted			2022-12-25	WOS:000207455400004
J	Regales, L; Balak, MN; Gong, YX; Politi, K; Sawai, A; Le, C; Koutcher, JA; Solit, DB; Rosen, N; Zakowski, MF; Pao, W				Regales, Lucia; Balak, Marissa N.; Gong, Yixuan; Politi, Katerina; Sawai, Ayana; Le, Carl; Koutcher, Jason A.; Solit, David B.; Rosen, Neal; Zakowski, Maureen F.; Pao, William			Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors	PLOS ONE			English	Article								Background. The EGFR T790M mutation confers acquired resistance to kinase inhibitors in human EGFR mutant lung adenocarcinoma, is occasionally detected before treatment, and may confer genetic susceptibility to lung cancer. Methodology/Principal Findings. To study further its role in lung tumorigenesis, we developed mice with inducible expression in type II pneumocytes of EGFR(T790M) alone or together with a drug-sensitive L858R mutation. Both transgenic lines develop lung adenocarcinomas that require mutant EGFR for tumor maintenance but are resistant to an EGFR kinase inhibitor. EGFR(L858R+T790M)-driven tumors are transiently targeted by hsp90 inhibition. Notably, EGFR(T790M)-expressing animals develop tumors with longer latency than EGFR(L858R+T790M)-bearing mice and in the absence of additional kinase domain mutations. Conclusions/Significance. These new mouse models of mutant EGFR-dependent lung adenocarcinomas provide insight into clinical observations. The models should also be useful for developing improved therapies for patients with lung cancers harboring EGFR(T790M) alone or in conjunction with drug-sensitive EGFR kinase domain mutations.	[Regales, Lucia; Balak, Marissa N.; Gong, Yixuan; Pao, William] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Pao Lab, New York, NY 10021 USA; [Politi, Katerina] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Varmus Lab, New York, NY 10021 USA; [Sawai, Ayana; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Rosen Lab, New York, NY 10021 USA; [Le, Carl; Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, Imaging & Spectroscop Phys Serv, New York, NY 10021 USA; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Solit Lab, New York, NY 10021 USA; [Zakowski, Maureen F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Pao, William] Cornell Univ, Weill Med Coll, Dept Med 7, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Pao, W (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Pao Lab, 1275 York Ave, New York, NY 10021 USA.	paow@mskcc.org	Le, Hongbiao/H-4735-2011; Rosen, Neal/ABF-2677-2020; Solit, David B./AAC-5309-2019		American Cancer Society-Davidson Sinai Research Foundation [PF-05-078-01-MGO]; Labrecque Foundation; NIH [R24CA83084, P30 CA08748]; Byrne Fund; The Joan Scarangello Foundation [K08-CA097980, R01-CA121210, R01-CA120247]; MSKCC TIMRF fund; Carmel Hill Fund; NATIONAL CANCER INSTITUTE [P30CA008748, R24CA083084] Funding Source: NIH RePORTER	American Cancer Society-Davidson Sinai Research Foundation; Labrecque Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Byrne Fund; The Joan Scarangello Foundation; MSKCC TIMRF fund; Carmel Hill Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society-Davidson Sinai Research Foundation (PF-05-078-01-MGO) (KP), the Labrecque Foundation (KP); NIH grants R24CA83084 and P30 CA08748 (JAK); The Byrne Fund (DBS); Joan's Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer (WP), K08-CA097980 (WP), R01-CA121210 (WP), R01-CA120247 (KP, awarded to HV); the MSKCC TIMRF fund (WP), and The Carmel Hill Fund (KP, awarded to HV; WP). KP and WP are part of a pending application on EGFR T790M mutations. WP is the incumbent of the Miner Family Chair for Intrathoracic Cancers.	Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; JI H, 2006, CANC CELL; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; Solit DB, 2006, CURR TOP MED CHEM, V6, P1205, DOI 10.2174/156802606777812068; Solit DB, 2003, CANCER RES, V63, P2139; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Vikis H, 2007, CANCER RES, V67, P4665, DOI 10.1158/0008-5472.CAN-07-0217; Yang SC, 2006, CANCER RES, V66, P6990, DOI 10.1158/0008-5472.CAN-06-1042	24	96	101	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e810	10.1371/journal.pone.0000810	http://dx.doi.org/10.1371/journal.pone.0000810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726540	Green Published, gold			2022-12-25	WOS:000207455400027
J	Chen, N; Napoli, JL				Chen, Na; Napoli, Joseph L.			All-trans- retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RAR alpha	FASEB JOURNAL			English	Article						vitamin A; cytoskeleton remodeling; GluR; dendritic protein synthesis	LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT REGULATION; LOCAL PROTEIN-SYNTHESIS; PHOSPHOINOSITIDE 3-KINASE-AKT-MAMMALIAN TARGET; RAPAMYCIN SIGNALING PATHWAY; RELATIONAL MEMORY DEFICIT; ESTROGEN-RECEPTOR-ALPHA; CENTRAL-NERVOUS-SYSTEM; VITAMIN-A-DEFICIENCY; SYNAPTIC PLASTICITY	Differentiation and patterning in the developing nervous system require the vitamin A metabolite all-trans-retinoic acid (atRA). Recent data suggest that higher cognitive functions, such as creation of hippocampal memory, also require atRA and its receptors, RAR, through affecting synaptic plasticity. Here we show that within 30 min atRA increased dendritic growth similar to 2- fold, and PSD-95 and synaptophysin puncta intensity similar to 3- fold, in cultured mouse hippocampal neurons, suggesting increased synapse formation. atRA (10 nM) increased ERK1/2 phosphorylation within 10 min. In synaptoneurosomes, atRA rapidly increased phosphorylation of ERK1/2, its target 4E-BP, and p70S6K, and its substrate, ribosome protein S6, indicating activation of MAPK and mammalian target of rapamycin (mTOR). Immunofluoresence revealed intense dendritic expression of RAR alpha in the mouse hippocampus and localization of RAR alpha on the surfaces of primary cultures of hippocampal neurons, with bright puncta along soma and neurites. Surface biotinylation confirmed the locus of RAR alpha expression. Knockdown of RAR alpha by shRNA impaired atRA-induced spine formation and abolished dendritic growth. Prolonged atRA stimulation reduced surface/total RAR alpha by 43%, suggesting internalization, whereas brain-derived nerve growth factor or bicuculline increased the ratio by similar to 1.8fold. atRA increased translation in the somatodendritic compartment, similar to brain-derived nerve growth factor. atRA specifically increased dendritic translation and surface expression of the alpha-amino-3-hydroxyl-5methyl-4-isoxazole propionate receptor (AMPAR) subunit 1 (GluR1), without affecting GluR2. These data provide mechanistic insight into atRA function in the hippocampus and identify a unique membrane-associated RAR alpha that mediates rapid induction of neuronal translation by atRA.	[Chen, Na; Napoli, Joseph L.] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Chen, N (corresponding author), Univ Calif Berkeley, 119 Morgan Hall,MC 3104, Berkeley, CA 94720 USA.	jna@berkeley.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013566] Funding Source: NIH RePORTER; NIA NIH HHS [AG13566] Funding Source: Medline; NIDDK NIH HHS [DK36870] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Akama KT, 2003, J NEUROSCI, V23, P2333; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chandrasekaran V, 2000, J NEUROBIOL, V42, P383, DOI 10.1002/(SICI)1097-4695(200003)42:4<383::AID-NEU1>3.0.CO;2-9; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Chytil F, 2003, ANNU REV NUTR, V23, P1, DOI 10.1146/annurev.nutr.23.011702.073155; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Evans TRJ, 1999, BRIT J CANCER, V80, P1, DOI 10.1038/sj.bjc.6690312; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Goldin M, 2001, J NEUROSCI, V21, P186, DOI 10.1523/JNEUROSCI.21-01-00186.2001; GRAY EG, 1959, J ANAT, V93, P420; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ivanova T, 2001, BRAIN RES, V889, P264, DOI 10.1016/S0006-8993(00)03149-8; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kauer JA, 2006, NAT NEUROSCI, V9, P593, DOI 10.1038/nn0506-593; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly MJ, 1999, STEROIDS, V64, P64, DOI 10.1016/S0039-128X(98)00095-6; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mark M, 1999, P NUTR SOC, V58, P609, DOI 10.1017/S0029665199000798; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; SCHEIBE RJ, 1991, J CELL BIOL, V113, P1173, DOI 10.1083/jcb.113.5.1173; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simoncini T, 2002, STEROIDS, V67, P935, DOI 10.1016/S0039-128X(02)00040-5; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Volterra A, 2004, GLIA, V47, P249, DOI 10.1002/glia.20080; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	81	129	135	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					236	245		10.1096/fj.07-8739com	http://dx.doi.org/10.1096/fj.07-8739com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17712061				2022-12-25	WOS:000252309900026
J	Eirin-Lopez, JM; Ishibashi, T; Ausio, J				Eirin-Lopez, Jose Maria; Ishibashi, Toyotaka; Ausio, Juan			H2A.Bbd: a quickly evolving hypervariable mammalian histone that destabilizes nucleosomes in an acetylation-independent way	FASEB JOURNAL			English	Article						chromatin; evolution; sedimentation velocity	RAPID EVOLUTION; CORE PARTICLES; CHROMATIN; PROTEIN; H2A; TRANSCRIPTION; VARIANTS; VERTEBRATE; INCREASES; SELECTION	Molecular evolutionary analyses revealed that histone H2A.Bbd is a highly variable quickly evolving mammalian replacement histone variant, in striking contrast to all other histones. At the nucleotide level, this variability appears to be the result of a larger amount of nonsynonymous variation, which affects to a lesser extent, the structural domain of the protein comprising the histone fold. The resulting amino acid sequence diversity can be predicted to affect the internucleosomal and intranucleosomal histone interactions. Our phylogenetic analysis has allowed us to identify several of the residues involved. The biophysical characterization of nucleosomes reconstituted with recombinant mouse H2A.Bbd and their comparison to similar data obtained with human H2A.Bbd clearly support this notion. Despite the high interspecific amino acid sequence variability, all of the H2A.Bbd variants exert similar structural effects at the nucleosome level, which result in an unfolded highly unstable nucleoprotein complex. Such structure resembles that previously described for the highly dynamically acetylated nucleosomes associated with transcriptionally active regions of the genome. Nevertheless, the structure of nucleosome core particles reconstituted from H2A.Bbd is not affected by the presence of a hyperacetylated histone complement. This suggests that replacement by H2A.Bbd provides an alternative mechanism to unfold chromatin structure, possibly in euchromatic regions, in a way that is not dependent on acetylation.	[Eirin-Lopez, Jose Maria; Ishibashi, Toyotaka; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Eirin-Lopez, Jose Maria] Univ A Coruna, Dept Biol Celular & Mol, Galicia, Spain	University of Victoria; Universidade da Coruna	Ausio, J (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Petch Bldg 258A, Victoria, BC V8W 3P6, Canada.	jausio@uvic.ca	Ishibashi, Toyotaka/AAW-2687-2020; Eirin-Lopez, Jose Maria/A-5618-2008	Ishibashi, Toyotaka/0000-0001-8015-2319; Eirin-Lopez, Jose Maria/0000-0002-8041-9770				Angelov D, 2004, EMBO J, V23, P3815, DOI 10.1038/sj.emboj.7600400; ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Ausio J, 1998, METHODS, V15, P333, DOI 10.1006/meth.1998.0637; AUSIO J, 2004, CHROMATIN STRUCTURE, P241; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Calestagne-Morelli A, 2006, BIOCHEM CELL BIOL, V84, P518, DOI 10.1139/O06-067; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chadwick BP, 2001, J CELL BIOL, V152, P375, DOI 10.1083/jcb.152.2.375; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Doyen CM, 2006, EMBO J, V25, P4234, DOI 10.1038/sj.emboj.7601310; Eirin-Lopez JM, 2004, MOL BIOL EVOL, V21, P1992, DOI 10.1093/molbev/msh213; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frehlick LJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-99; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Gautier T, 2004, EMBO REP, V5, P715, DOI 10.1038/sj.embor.7400182; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Imhof Axel, 2006, Briefings in Functional Genomics & Proteomics, V5, P222, DOI 10.1093/bfgp/ell030; ISENBERG I, 1978, HISTONES, V4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levchenko V, 2004, BIOCHEMISTRY-US, V43, P2359, DOI 10.1021/bi035737q; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; Li A, 2005, BIOCHEM CELL BIOL, V83, P505, DOI 10.1139/O05-114; Li A, 2005, BIOCHEMISTRY-US, V44, P2529, DOI 10.1021/bi048061n; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Marino-Ramirez L, 2005, EXPERT REV PROTEOMIC, V2, P719, DOI 10.1586/14789450.2.5.719; Nei M., 2000, MOL EVOLUTION PHYLOG; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Okuwaki M, 2005, MOL CELL BIOL, V25, P10639, DOI 10.1128/MCB.25.23.10639-10651.2005; PEHRSON JR, 1992, SCIENCE, V257, P1398; Perez-Bercoff A, 2006, BIOINFORMATICS, V22, P112, DOI 10.1093/bioinformatics/bti761; PERRY M, 1982, J BIOL CHEM, V257, P7336; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; RETIEF JD, 1993, EUR J BIOCHEM, V218, P1095; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saperas N, 2006, FEBS J, V273, P4548, DOI 10.1111/j.1742-4658.2006.05461.x; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SITNIKOVA T, 1995, MOL BIOL EVOL, V12, P319; Sitnikova T, 1996, MOL BIOL EVOL, V13, P605, DOI 10.1093/oxfordjournals.molbev.a025620; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TATCHELL K, 1979, BIOCHEMISTRY-US, V18, P2870, DOI 10.1021/bi00580a031; van Holde K.E., 1988, CHROMATIN; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; YAGER TD, 1984, J BIOL CHEM, V259, P4212; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	57	35	38	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					316	326		10.1096/fj.07-9255com	http://dx.doi.org/10.1096/fj.07-9255com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17726088				2022-12-25	WOS:000252309900033
J	Magzoub, M; Jin, S; Verkman, AS				Magzoub, Mazin; Jin, Songwan; Verkman, A. S.			Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin	FASEB JOURNAL			English	Article						FRAP; ECS; hyluronan	IN-VIVO; VOLUME FRACTION; FIBRILLAR COLLAGEN; SKIN FRAGILITY; SOLID TUMORS; TRANSPORT; INTERSTITIUM; MODULATION; EXPRESSION; MICROSCOPY	Drug access to tumors is limited by diffusion through the tumor interstitium. We used a micro-fiberoptic epifluorescence photobleaching method to determine the role of extracellular matrix (ECM) components in macromolecule diffusion deep in tumor tissue. In subcutaneous B16 tumors in living mice, translational diffusion of 10 kDa FITC-dextran was slowed 2- to 3- fold (compared with its diffusion in water) within a depth of 0.2 mm from the tumor surface, but >10-fold beyond a depth of 1 mm. Diffusion of larger macromolecules, FITC-albumin and 500 kDa FITC-dextran, was slowed by up to 40-fold at 0.5 mm and 300-fold at 2 mm. Intratumoral collagenase (to digest collagen) or cathespin C (to digest decorin) each increased diffusion of 10 kDa FITC-dextran by similar to 2-fold. However, these treatments dramatically increased diffusion (> 10-fold) of larger macromolecules, such as 500 kDa dextran, in deep tumor (2 mm depth). Intratumoral hyaluronidase, in contrast, slowed diffusion throughout the tumor. In vitro measurements in defined gel-like mixtures of collagen, hyaluronan, and decorin closely recapitulated results in tumors in vivo. Mathematical modeling quantified the roles of extracellular space volume fraction and dimensions, and indicated a substantial effect of cell density on diffusion in deep tumor. Our data define the determinants of diffusion in deep tumor and suggest collagen and decorin digestion to greatly facilitate macromolecule delivery.	[Magzoub, Mazin; Jin, Songwan; Verkman, A. S.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Magzoub, Mazin; Jin, Songwan; Verkman, A. S.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			NEI NIH HHS [EY13574] Funding Source: Medline; NHLBI NIH HHS [HL73856, HL59198] Funding Source: Medline; NIBIB NIH HHS [EB00415] Funding Source: Medline; NIDDK NIH HHS [DK35124, DK72517] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R37DK035124, R01DK035124] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberts B., 1994, MOL BIOL CELL, P971; Alexandrakis G, 2004, NAT MED, V10, P203, DOI 10.1038/nm981; Banerjee RK, 2002, ANN BIOMED ENG, V30, P828, DOI 10.1114/1.1496087; BECKENLEHNER K, 1992, J CANCER RES CLIN, V118, P591, DOI 10.1007/BF01211802; Bittner K, 1996, BIOCHEM J, V314, P159, DOI 10.1042/bj3140159; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Brown EB, 2004, MICROVASC RES, V67, P231, DOI 10.1016/j.mvr.2004.02.001; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Buhling F, 2004, EUR RESPIR J, V23, P620, DOI 10.1183/09031936.04.00105304; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DiResta GR, 2000, ANN BIOMED ENG, V28, P543, DOI 10.1114/1.295; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; ELKAREH AW, 1993, BIOPHYS J, V64, P1638, DOI 10.1016/S0006-3495(93)81532-7; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Graff BA, 2000, EUR J CANCER, V36, P1433, DOI 10.1016/S0959-8049(00)00120-9; Gribbon PM, 1998, WENN GR INT, V71, P95; HAHN RA, 1992, DEVELOPMENT, V115, P383; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JAIN RK, 1987, CANCER RES, V47, P3039; JAKOBSEN I, 1995, MAGN RESON IMAGING, V2, P97; Koninger J, 2004, CLIN CANCER RES, V10, P4776, DOI 10.1158/1078-0432.CCR-1190-03; Krol A, 1999, CANCER RES, V59, P4136; Kuc IM, 1997, CONNECT TISSUE RES, V36, P287, DOI 10.3109/03008209709160228; Kuriyama N, 2001, CANCER RES, V61, P1805; Kyle AH, 1999, CANCER CHEMOTH PHARM, V43, P213, DOI 10.1007/s002800050886; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Masuda A, 2001, J AM CHEM SOC, V123, P11468, DOI 10.1021/ja016401b; McKee TD, 2006, CANCER RES, V66, P2509, DOI 10.1158/0008-5472.CAN-05-2242; Nash MA, 2002, CLIN CANCER RES, V8, P1754; Netti PA, 2000, CANCER RES, V60, P2497; Netti PA, 1999, P NATL ACAD SCI USA, V96, P3137, DOI 10.1073/pnas.96.6.3137; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; POGANY G, 1994, ARCH BIOCHEM BIOPHYS, V313, P102, DOI 10.1006/abbi.1994.1365; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Ribatti D, 2007, CANCER LETT, V248, P18, DOI 10.1016/j.canlet.2006.06.007; Schomburg D, 1991, ENZYME HDB; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Scott JE, 1998, EXP CELL RES, V243, P59, DOI 10.1006/excr.1998.4089; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shenoy V, 1995, MACROMOLECULES, V28, P8751, DOI 10.1021/ma00130a007; Smith KJ, 1997, J AM ACAD DERMATOL, V36, P239, DOI 10.1016/S0190-9622(97)70288-3; StCroix B, 1996, JNCI-J NATL CANCER I, V88, P1285, DOI 10.1093/jnci/88.18.1285; Stroh M, 2005, NAT MED, V11, P678, DOI 10.1038/nm1247; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; TANNOCK IF, 1989, CANCER RES, V49, P4373; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; Thiagarajah JR, 2006, NAT METHODS, V3, P275, DOI 10.1038/NMETH863; Yuan F, 2001, ANN BIOMED ENG, V29, P1150, DOI 10.1114/1.1424915	51	102	109	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					276	284		10.1096/fj.07-9150com	http://dx.doi.org/10.1096/fj.07-9150com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17761521				2022-12-25	WOS:000252309900029
J	Garcia-Saez, AJ; Chiantia, S; Schwille, P				Garcia-Saez, Ana J.; Chiantia, Salvatore; Schwille, Petra			Effect of line tension on the lateral organization of lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-SEPARATION; DOMAIN MICROSTRUCTURE; PORE FORMATION; RAFTS; MODEL; CHOLESTEROL; DYNAMICS; BAX; SPHINGOMYELIN; UNSATURATION	The principles of organization and functioning of cellular membranes are currently not well understood. The raft hypothesis suggests the existence of domains or rafts in cell membranes, which behave as protein and lipid platforms. They have a functional role in important cellular processes, like protein sorting or cell signaling, among others. Theoretical work suggests that the interfacial energy at the domain edge, also known as line tension, is a key parameter determining the distribution of domain sizes, but there is little evidence of how line tension affects membrane organization. We have investigated the effects of the line tension on the formation and stability of liquid ordered domains in model lipid bilayers with raft-like composition by means of time-lapse confocal microscopy coupled to atomic force microscopy. We varied the hydrophobic mismatch between the two phases, and consequently the line tension, by modifying the thickness of the disordered phase with phosphatidylcholines of different acyl chain length. The temperature of domain formation, the dynamics of domain growth, and the distribution of domain sizes depend strongly on the thickness difference between the domains and the surrounding membrane, which is related to line tension. When considering line tension calculated from a theoretical model, our results revealed a linear increase of the temperature of domain formation and domain growth rate with line tension. Domain budding was also shown to depend on height mismatch. Our experiments contribute significantly to our knowledge of the physical-chemical parameters that control membrane organization. Importantly, the general trends observed can be extended to cellular membranes.	Tech Univ Dresden, Biotechnol Zentrum, D-1307 Dresden, Germany	Technische Universitat Dresden	Schwille, P (corresponding author), Tatzberg 47-51, D-1307 Dresden, Germany.	petra.schwille@biotec.tu-dresden.de	Saez, Ana J. Garcia/U-1611-2019; Chiantia, Salvatore/A-4546-2010; Schwille, Petra/A-4983-2010; Chiantia, Salvatore/U-6363-2019	Chiantia, Salvatore/0000-0003-0791-967X				Akimov SA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011919; Ayton GS, 2005, BIOPHYS J, V88, P3855, DOI 10.1529/biophysj.105.059436; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Baumgart T, 2005, BIOPHYS J, V89, P1067, DOI 10.1529/biophysj.104.049692; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Blanchette CD, 2007, LANGMUIR, V23, P5875, DOI 10.1021/la7004584; Blanchette CD, 2006, BIOPHYS J, V90, P4466, DOI 10.1529/biophysj.105.072744; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chiantia S, 2006, CHEMPHYSCHEM, V7, P2409, DOI 10.1002/cphc.200600464; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Frolov VAJ, 2006, BIOPHYS J, V91, P189, DOI 10.1529/biophysj.105.068502; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; GARCIASAEZ AJ, 2007, APPL MICROBIOL BIOTE; Hamm M, 1998, EUR PHYS J B, V6, P519, DOI 10.1007/s100510050579; Hamm M, 2000, EUR PHYS J E, V3, P323, DOI 10.1007/s101890070003; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hu YF, 2006, BIOPHYS J, V91, P444, DOI 10.1529/biophysj.106.081000; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; JORGENSEN K, 1995, BIOPHYS J, V69, P942, DOI 10.1016/S0006-3495(95)79968-4; Julicher F, 1996, PHYS REV E, V53, P2670, DOI 10.1103/PhysRevE.53.2670; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kohyama T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061905; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; Laradji M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198105; Laradji M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.040901; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lin WC, 2007, BIOPHYS J, V92, P2831, DOI 10.1529/biophysj.106.095422; Maulik PR, 1996, BIOPHYS J, V70, P2256, DOI 10.1016/S0006-3495(96)79791-6; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; MOURITSEN OG, 1990, INT J MOD PHYS B, V4, P1925, DOI 10.1142/S0217979290000954; Nicolini C, 2006, J AM CHEM SOC, V128, P192, DOI 10.1021/ja055779x; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Staneva G, 2004, CHEM PHYS LIPIDS, V129, P53, DOI 10.1016/j.chemphyslip.2003.11.005; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Wallace EJ, 2006, BIOPHYS J, V90, P4104, DOI 10.1529/biophysj.105.062778; Yanagisawa M, 2007, BIOPHYS J, V92, P115, DOI 10.1529/biophysj.106.087494	50	293	294	4	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33537	10.1074/jbc.M706162200	http://dx.doi.org/10.1074/jbc.M706162200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848582	hybrid			2022-12-25	WOS:000250840200034
J	Goehring, AS; Pedroja, BS; Hinke, SA; Langeberg, LK; Scott, JD				Goehring, April S.; Pedroja, Benjamin S.; Hinke, Simon A.; Langeberg, Lorene K.; Scott, John D.			MyRIP anchors protein kinase a to the exocyst complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT RII; HIGH-AFFINITY BINDING; AKAP SIGNALING COMPLEXES; SLP HOMOLOGY DOMAIN; MOLECULAR CHARACTERIZATION; INSULIN-SECRETION; LINKER PROTEIN; RAB EFFECTOR; MYOSIN VIIA; CAMP	The movement of signal transduction enzymes in and out of multi-protein complexes coordinates the spatial and temporal resolution of cellular events. Anchoring and scaffolding proteins are key to this process because they sequester protein kinases and phosphatases with a subset of their preferred substrates. The protein kinase A-anchoring family of proteins ( AKAPs), which target the cAMP-dependent protein kinase ( PKA) and other enzymes to defined subcellular microenvironments, represent a well studied group of these signal-organizing molecules. In this report we demonstrate that the Rab27a GTPase effector protein MyRIP is a member of the AKAP family. The zebrafish homolog of MyRIP ( Ze-AKAP2) was initially detected in a two-hybrid screen for AKAPs. A combination of biochemical, cell-based, and immunofluorescence approaches demonstrate that the mouse MyRIP ortholog targets the type II PKA holoenzyme via an atypical mechanism to a specific perinuclear region of insulin-secreting cells. Similar approaches show that MyRIP interacts with the Sec6 and Sec8 components of the exocyst complex, an evolutionarily conserved protein unit that controls protein trafficking and exocytosis. These data indicate that MyRIP functions as a scaffolding protein that links PKA to components of the exocytosis machinery.	Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, Portland, OR 97239 USA	Howard Hughes Medical Institute; Oregon Health & Science University	Scott, JD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	scott@ohsu.edu	Hinke, Simon/R-7120-2019		NHLBI NIH HHS [5F32 HL 074647, F32 HL074647] Funding Source: Medline; NIGMS NIH HHS [GM 48231, R01 GM048231, R37 GM048231] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL074647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Bajjalieh S, 2004, NAT GENET, V36, P216, DOI 10.1038/ng0304-216; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; COGHLAN VM, 1995, BIOCHEM SOC T, V23, P591; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Corbin J D, 1974, Methods Enzymol, V38, P287; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; Fukuyama T, 2001, ONCOGENE, V20, P6225, DOI 10.1038/sj.onc.1204794; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Goldfine ID, 1997, NAT BIOTECHNOL, V15, P1378, DOI 10.1038/nbt1297-1378; Han JD, 1997, J BIOL CHEM, V272, P26611, DOI 10.1074/jbc.272.42.26611; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Hisatomi M, 1996, ENDOCRINOLOGY, V137, P4644, DOI 10.1210/en.137.11.4644; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; INAGAKI N, 1994, TRENDS BIOCHEM SCI, V19, P448, DOI 10.1016/0968-0004(94)90128-7; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kuroda TS, 2005, J BIOL CHEM, V280, P28015, DOI 10.1074/jbc.M501465200; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lester LB, 1997, RECENT PROG HORM RES, V52, P409; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Morrison DK, 2001, J CELL SCI, V114, P1609; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 1997, J BIOL CHEM, V272, P23637, DOI 10.1074/jbc.272.38.23637; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; Scott JD., 1985, PROC NATLACAD SCI US, V84, P703; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Tegge WJ, 1998, METH MOL B, V87, P99; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Vega IE, 2003, NEUROREPORT, V14, P31, DOI 10.1097/00001756-200301200-00006; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088	84	37	49	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33155	33167		10.1074/jbc.M705167200	http://dx.doi.org/10.1074/jbc.M705167200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827149	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000250625400063
J	Hacisalihoglu, A; Panizzi, P; Bock, PE; Camire, RM; Krishnaswamy, S				Hacisalihoglu, Ayse; Panizzi, Peter; Bock, Paul E.; Camire, Rodney M.; Krishnaswamy, Sriram			Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-XA; MACROMOLECULAR SUBSTRATE; BLOOD-COAGULATION; BINDING-SITE; FACTOR-VA; ACTIVATION; COMPLEX; RECOGNITION; SPECIFICITY; PROTEINASE	The preferred pathway for prothrombin activation by prothrombinase involves initial cleavage at Arg(320) to produce meizothrombin, which is then cleaved at Arg(271) to liberate thrombin. Exosite binding drives substrate affinity and is independent of the bond being cleaved. The pathway for cleavage is determined by large differences in V-max for cleavage at the two sites within intact prothrombin. By fluorescence binding studies in the absence of catalysis, we have assessed the ability of the individual cleavage sites to engage the active site of Xa within prothrombinase at equilibrium. Using a panel of recombinant cleavage site mutants, we show that in intact prothrombin, the Arg(320) site effectively engages the active site in a 1: 1 interaction between substrate and enzyme. In contrast, the Arg(271) site binds to the active site poorly in an interaction that is similar to 600-fold weaker. Perceived substrate affinity is independent of active site engagement by either cleavage site. We further show that prior cleavage at the 320 site or the stabilization of the uncleaved zymogen in a proteinase-like state facilitates efficient docking of Arg(271) at the active site of prothrombinase. Therefore, we establish direct relationships between docking of either cleavage site at the active site of the catalyst, the V-max for cleavage at that site, substrate conformation, and the resulting pathway for prothrombin cleavage. Exosite tethering of the substrate in either the zymogen or proteinase conformation dictates which cleavage site can engage the active site of the catalyst and enforces the sequential cleavage of prothrombin by prothrombinase.	Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA	Vanderbilt University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Krishnaswamy, S (corresponding author), 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Panizzi, Peter/A-6072-2019; Krishnaswamy, Sriram/Z-4380-2019	Panizzi, Peter/0000-0003-0141-8807; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047465, R01HL071544, R37HL071544, R29HL038779, R01HL038779, R00HL094533, P01HL074124] Funding Source: NIH RePORTER; NHLBI NIH HHS [R00 HL094533, P01 HL074124, HL 47465, R01 HL047465, HL 038779, R01 HL038779-21, HL 071544, HL 74124, R01 HL038779, R01 HL071544, R37 HL071544] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKO H, 1974, BIOCHEMISTRY-US, V13, P132, DOI 10.1021/bi00698a021; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; Bevington P. R., 1992, DATA REDUCTION ERROR, P161; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Camire R.M., 2006, HEMOSTASIS THROMBOSI, P59; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FERSHT A, 1977, ENZYME STRUCTURE MEC, P109; Furie B.C., 1976, Methods Enzymol, V45, P191; Hosokawa K, 2001, BIOCHEM J, V354, P309, DOI 10.1042/0264-6021:3540309; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENCKS WP, 1989, METHOD ENZYMOL, V171, P145; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; VINCENT JP, 1974, BIOCHEMISTRY-US, V13, P4205, DOI 10.1021/bi00717a023; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Warshel A, 1998, P NATL ACAD SCI USA, V95, P5950, DOI 10.1073/pnas.95.11.5950; Warshel A, 2001, CHEMBIOCHEM, V2, P109, DOI 10.1002/1439-7633(20010202)2:2<109::AID-CBIC109>3.0.CO;2-9	44	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32974	32982		10.1074/jbc.M706529200	http://dx.doi.org/10.1074/jbc.M706529200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848548	Green Accepted, hybrid			2022-12-25	WOS:000250625400046
J	Chen, X; Molino, C; Liu, L; Gumbiner, BM				Chen, Xuejun; Molino, Caitlyn; Liu, Li; Gumbiner, Barry M.			Structural elements necessary for oligomerization, trafficking, and cell sorting function of paraxial protocadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN SUPERFAMILY; NF-PROTOCADHERIN; C-CADHERIN; TISSUE MORPHOGENESIS; ADHESION ACTIVITY; XENOPUS; DIVERSITY; DIMERIZATION; TAF1/SET; DOMAIN	Protocadherins have been shown to regulate cell adhesion, cell migration, cell survival, and tissue morphogenesis in the embryo and the central nervous system, but little is known about the mechanism of protocadherin function. We previously showed that Xenopus paraxial protocadherin ( PAPC) mediates cell sorting and morphogenesis by down-regulating the adhesion activity of a classical cadherin, C-cadherin. Classical cadherins function by forming lateral dimers that are necessary for their adhesive function. However, it is not known whether oligomerization also plays a role in protocadherin function. We show here that PAPC forms oligomers that are stabilized by disulfide bonds formed between conserved Cys residues in the extracellular domain. Disruption of these disulfide bonds by dithiothreitol or mutation of the conserved cysteines results in defects in oligomerization, post-translational modification, trafficking to the cell surface and cell sorting function of PAPC. Furthermore, none of the residues in the cytoplasmic domain of PAPC is required for its cell sorting activity, whereas both the transmembrane domain and the extracellular domain are necessary. Therefore, protein oligomerization and/or protein interactions via the extracellular and transmembrane domains of PAPC are required for its cell sorting function.	Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia	Gumbiner, BM (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, POB 800732, Charlottesville, VA 22908 USA.	Gumbiner@virginia.edu	Liu, Li/C-3130-2012		NIGMS NIH HHS [R01-GM052717, F32-GM67752] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067752, R01GM052717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angst BD, 2001, J CELL SCI, V114, P629; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bradley RS, 1998, CURR BIOL, V8, P325, DOI 10.1016/S0960-9822(98)70132-0; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; FREEZE HH, 2006, CURRENT PROTOCOLS PR; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Heggem MA, 2003, DEV CELL, V4, P419, DOI 10.1016/S1534-5807(03)00036-4; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Rashid D, 2006, DEV BIOL, V291, P170, DOI 10.1016/j.ydbio.2005.12.027; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Suzuki ST, 1996, J CELL SCI, V109, P2609; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5	23	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32128	32137		10.1074/jbc.M705337200	http://dx.doi.org/10.1074/jbc.M705337200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823115	hybrid			2022-12-25	WOS:000250480300034
J	Fang, JM; Ruiz, FA; Docampo, M; Luo, SH; Rodrigues, JCF; Motta, LS; Rohloff, P; Docampo, R				Fang, Jianmin; Ruiz, Felix A.; Docampo, Melissa; Luo, Shuhong; Rodrigues, Juliany C. F.; Motta, Lucimar S.; Rohloff, Peter; Docampo, Roberto			Overexpression of a Zn2+-sensitive soluble exopolyphosphatase from Trypanosoma cruzi depletes polyphosphate and affects osmoregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE COMPLEX; ALGA DUNALIELLA-SALINA; SACCHAROMYCES-CEREVISIAE; INORGANIC POLYPHOSPHATE; CYTOSOLIC EXOPOLYPHOSPHATASE; H+-PYROPHOSPHATASE; ESCHERICHIA-COLI; ACIDIC VACUOLES; P-31 NMR; ACIDOCALCISOMES	We report the cloning, expression, purification, and characterization of the Trypanosoma cruzi exopolyphosphatase (TcPPX). The product of this gene (TcPPX), has 383 amino acids and a molecular mass of 43.1 kDa. TcPPX differs from most exopolyphosphatases in its preference for short-chain polyphosphate (poly P). Heterologous expression of TcPPX in Escherichia coli produced a functional enzyme that had a neutral optimum pH and was dramatically inhibited by low concentrations of Zn2+, high concentrations of basic amino acids (lysine and arginine), and heparin. TcPPX is a processive enzyme and does not hydrolyze ATP, pyrophosphate, or p-nitrophenyl phosphate, although it hydrolyzes guanosine 5 '-tetraphosphate very efficiently. Overexpression of TcPPX resulted in a dramatic decrease in total short-chain poly P and partial decrease in long-chain poly P. This was accompanied by a delayed regulatory volume decrease after hyposmotic stress. These results support the role of poly P in T. cruzi osmoregulation.	Univ Georgia, Paul D Coverdell Biomed & Hlth Sci Ctr, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Paul D Coverdell Biomed & Hlth Sci Ctr, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Paul D Coverdell Ctr, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@cb.uga.edu	Rodrigues, Juliany Cola Fernandes/X-4977-2019; Ruiz, Felix A./B-1032-2008; Rodrigues, Juliany Cola Fernandes/H-2836-2012; Rohloff, Peter/P-8722-2017	Rodrigues, Juliany Cola Fernandes/0000-0001-6807-8101; Ruiz, Felix A./0000-0003-0748-5015; Rohloff, Peter/0000-0001-7274-8315	NIAID NIH HHS [R01 AI068647, R01 AI068647-02, AI68647] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKIYAMA M, 1993, J BIOL CHEM, V268, P633; ALLAN RA, 1980, CAN J MICROBIOL, V26, P912, DOI 10.1139/m80-158; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; Andreeva N, 1998, YEAST, V14, P383, DOI 10.1002/(SICI)1097-0061(19980315)14:4<383::AID-YEA232>3.0.CO;2-S; Andreeva NA, 2000, MICROBIOLOGY+, V69, P411, DOI 10.1007/BF02756765; ANDREEVA NA, 1993, YEAST, V9, P127, DOI 10.1002/yea.320090204; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BENTAL M, 1990, EUR J BIOCHEM, V188, P111, DOI 10.1111/j.1432-1033.1990.tb15377.x; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; CASTRO CD, 1995, APPL ENVIRON MICROB, V61, P4448, DOI 10.1128/AEM.61.12.4448-4453.1995; Castrol CD, 1999, BIOTECHNOL PROGR, V15, P65, DOI 10.1021/bp9800743; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Hernandez-Ruiz L, 2006, HAEMATOLOGICA, V91, P1180; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709; Kulaev IS, 1997, MICROBIOL RES, V152, P221; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lemercier G, 2003, J CHROMATOGR B, V786, P305, DOI 10.1016/S1570-0232(02)00745-6; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lichko LP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P355; Lichko LP, 2003, FEMS YEAST RES, V3, P233, DOI 10.1016/S1567-1356(02)00205-2; LORENZ B, 1994, J BIOL CHEM, V269, P22198; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; PICK U, 1991, PLANT PHYSIOL, V97, P1226, DOI 10.1104/pp.97.3.1226; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rodrigues CO, 2002, J BIOL CHEM, V277, P50899, DOI 10.1074/jbc.M208940200; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2006, MOL BIOCHEM PARASIT, V150, P249, DOI 10.1016/j.molbiopara.2006.08.010; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Sambrook F., 1989, MOL CLONING LAB MANU; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Seufferheld M, 2004, J BIOL CHEM, V279, P51193, DOI 10.1074/jbc.M406099200; SHATTON JB, 1983, ANAL BIOCHEM, V130, P114, DOI 10.1016/0003-2697(83)90657-7; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Tammenkoski M, 2007, J BIOL CHEM, V282, P9302, DOI 10.1074/jbc.M609423200; TIJSSEN JPF, 1982, BIOCHIM BIOPHYS ACTA, V721, P394, DOI 10.1016/0167-4889(82)90094-5; Ugochukwu E, 2007, J MOL BIOL, V371, P1007, DOI 10.1016/j.jmb.2007.05.066; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; WEISS M, 1991, PLANT PHYSIOL, V97, P1241, DOI 10.1104/pp.97.3.1241; WURST H, 1994, J BIOL CHEM, V269, P10996; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; YANG YC, 1993, BIOCHIM BIOPHYS ACTA, V1179, P141, DOI 10.1016/0167-4889(93)90135-C	59	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32501	32510		10.1074/jbc.M704841200	http://dx.doi.org/10.1074/jbc.M704841200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827150	hybrid			2022-12-25	WOS:000250480300073
J	Kimura, N; Ohmori, K; Miyazaki, K; Izawa, M; Matsuzaki, Y; Yasuda, Y; Takematsu, H; Kozutsumi, Y; Moriyama, A; Kannagi, R				Kimura, Naoko; Ohmori, Katsuyuki; Miyazaki, Keiko; Izawa, Mineko; Matsuzaki, Yuji; Yasuda, Yosuke; Takematsu, Hiromu; Kozutsumi, Yasunori; Moriyama, Akihiko; Kannagi, Reiji			Human B-lymphocytes express alpha 2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGANDS; SIALYL-LEWIS-X; ADHESION MOLECULE CD22-BETA; N-GLYCOLYLNEURAMINIC ACID; HIGH ENDOTHELIAL VENULES; CELL ACTIVATION; INHIBITORY RECEPTOR; GLYCOSYL FLUORIDES; ANTIGEN RECEPTOR; NATURAL LIGANDS	CD22/Siglec-2, an important inhibitory co-receptor on B-lymphocytes, is known to recognize alpha 2-6-sialylated glycan as a specific ligand. Here we propose that the alpha 2-6-sialylated and 6-GlcNAc-sulfated determinant serves as a preferred ligand for CD22 because the binding of a human B-cell line to CD22 was almost completely abrogated after incubating the cells with NaClO3, an inhibitor of cellular sulfate metabolism, and was also significantly inhibited by a newly generated monoclonal antibody specific to the alpha 2-6-sialylated 6-sulfo-N-acetyllactosamine ( LacNAc) determinant ( KN343, murine IgM). The alpha 2-6-sialylated 6-sulfo-LacNAc determinant defined by the antibody was significantly expressed on a majority of normal human peripheral B-lymphocytes as well as follicular B-lymphocytes in peripheral lymph nodes. The determinant was also expressed in endothelial cells of high endothelial venules of secondary lymphoid tissues, including lymph nodes, tonsils, and intestine-associated lymphoid tissues, more strongly than on B-lymphocytes, suggesting a role for CD22 in B-cell interaction with blood vessels and trafficking. These results indicate that the alpha 2-6-sialylated 6-sulfo-LacNAc determinant serves as an endogenous ligand for human CD22 and suggest the possibility that 6-GlcNAc sulfation as well as alpha 2-6-sialylation may regulate CD22/Siglec-2 functions in humans.	Aichi Canc Ctr, Res Inst, Dept Mol Pathol, Nagoya, Aichi 4648681, Japan; Kyoto Univ, Sch Med, Dept Clin Pathol, Kyoto 6068501, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan; Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan; Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Kyoto 6068501, Japan; Nagoya City Univ, Grad Sch Nat Sci, Div Biomol Sci, Nagoya, Aichi 4678601, Japan	Aichi Cancer Center; Kyoto University; Japan Science & Technology Agency (JST); Seikagaku Corporation; Kyoto University; Nagoya City University	Kannagi, R (corresponding author), Aichi Canc Ctr, Res Inst, Dept Mol Pathol, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	rkannagi@aichi-cc.jp	Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921; Ohmori, Katsuyuki/0000-0002-3794-6970				Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; HELFERICH B, 1952, ADV CARBOHYD CHEM, V7, P209; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Kannagi R, 2000, METHOD ENZYMOL, V312, P160; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KUHN R, 1966, CHEM BER-RECL, V99, P611, DOI 10.1002/cber.19660990235; LASZLO G, 1993, J IMMUNOL, V150, P5252; Le Marer N, 1999, J CELL PHYSIOL, V179, P315, DOI 10.1002/(SICI)1097-4652(199906)179:3<315::AID-JCP9>3.0.CO;2-U; MATSUMOTO T, 1988, TETRAHEDRON LETT, V29, P3567, DOI 10.1016/0040-4039(88)85294-8; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Nitschke L, 2004, TRENDS IMMUNOL, V25, P543, DOI 10.1016/j.it.2004.08.002; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; Ohmori K, 2000, BIOCHEM BIOPH RES CO, V278, P90, DOI 10.1006/bbrc.2000.3768; Ohmori K, 2006, BLOOD, V107, P3197, DOI 10.1182/blood-2005-05-2185; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; ROSENBROOK W, 1985, TETRAHEDRON LETT, V26, P3, DOI 10.1016/S0040-4039(00)98450-8; Sato M, 2007, J IMMUNOL, V178, P2901, DOI 10.4049/jimmunol.178.5.2901; SATO S, 1988, TETRAHEDRON LETT, V29, P4097, DOI 10.1016/S0040-4039(00)80426-8; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; TAKADA A, 1993, CANCER RES, V53, P354; Tjew SL, 2005, GLYCOBIOLOGY, V15, p7C, DOI 10.1093/glycob/cwi050; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Uchimura K, 1998, J BIOCHEM-TOKYO, V124, P670, DOI 10.1093/oxfordjournals.jbchem.a022164; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963	44	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32200	32207		10.1074/jbc.M702341200	http://dx.doi.org/10.1074/jbc.M702341200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728258	hybrid			2022-12-25	WOS:000250480300043
J	Joseph, JW; Odegaard, ML; Ronnebaum, SM; Burgess, SC; Muehlbauer, J; Sherry, AD; Newgard, CB				Joseph, Jamie W.; Odegaard, Matthew L.; Ronnebaum, Sarah M.; Burgess, Shawn C.; Muehlbauer, Jeffrey; Sherry, A. Dean; Newgard, Christopher B.			Normal flux through ATP-citrate lyase or fatty acid synthase is not required for glucose-stimulated insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; METABOLIC COUPLING FACTORS; NMR ISOTOPOMER ANALYSIS; COENZYME-A ESTERS; MALONYL-COA; PROTEIN ACYLATION; REGULATED ANAPLEROSIS; MAMMALIAN-CELLS; PYRUVATE; ISLETS	It has been proposed that de novo synthesis of long-chain acyl-CoA (LC-CoA) is a signal for glucose-stimulated insulin secretion (GSIS). Key enzymes involved in synthesis of fatty acids from glucose include ATP-citrate lyase ( CL) and fatty acid synthase (FAS). An inhibitor of CL, hydroxycitrate (HC), has been reported to inhibit insulin secretion in some laboratories but not in others. Here we show that high concentrations of NaCl created during preparation of HC by standard methods explain the inhibition of GSIS, and that removal of the excess NaCl prevents the effect. To further investigate the role of CL, two small interfering RNA adenoviruses (Ad-siCL2 and Ad-siCL3) were generated. Ad-siCL3 reduced CLmRNA levels by 92 +/- 6% and CL protein levels by 75 +/- 4% but did not affect GSIS in 832/13 cells compared with cells treated with a control adenovirus (Ad-siControl). Similar results were obtained with Ad-siCL2. Ad-siCL3-treated cells also exhibited a 52 +/- 7% reduction in cytosolic oxaloacetate, an 83 +/- 4% reduction in malonyl-CoA levels, and inhibition of [U-C-14] glucose incorporation into lipid by 43 +/- 4%, all expected metabolic outcomes of CL suppression. Similarly, treatment of 832/ 13 cells with a recombinant adenovirus specific to FAS(Ad-siFAS) reduced FAS mRNA levels by 81 +/- 2% in 832/13 cells, resulting in a 59 +/- 4% decreasein[U-C-14] glucose incorporation intolipid, without affecting GSIS. Finally, treatment of primary rat islets with Ad-siCL3 or Ad-siFAS reduced CL and FAS mRNA levels by 65 +/- 4% and 52 +/- 3%, respectively, but had no effect on GSIS relative to Ad-siControl-treated islets. These findings demonstrate that a normal rate of flux of glucose carbons through CL and FAS is not required for GSIS in insulinoma cell lines or rat islets.	Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; Univ Texas, SW Med Ctr, Ralph & Mary Nell Rogers NMR Ctr, Dept Radiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Adv Imaging Res Ctr, Dept Internal Med, Dallas, TX 75235 USA	Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Newgard, CB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA.	newga002@mc.duke.edu	Muehlbauer, Jeffrey/G-3607-2011; Sherry, Dean/P-2348-2018	Muehlbauer, Jeffrey/0000-0003-1808-580X; Ronnebaum, Sarah/0000-0003-4787-754X; Sherry, Dean/0000-0001-7150-8301	NIDDK NIH HHS [DK42583, DK58398] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHEN SY, 1994, DIABETES, V43, P878, DOI 10.2337/diabetes.43.7.878; Cheng HY, 2003, AM J PHYSIOL-ENDOC M, V285, pE287, DOI 10.1152/ajpendo.00535.2002; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Fox JEM, 2004, MOL ENDOCRINOL, V18, P679, DOI 10.1210/me.2003-0431; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lawrence DS, 1999, J MED CHEM, V42, P4932, DOI 10.1021/jm980591s; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Matschinsky F.M., 2001, HDB PHYSL 7, P125; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PARVIN R, 1980, ANAL BIOCHEM, V104, P296, DOI 10.1016/0003-2697(80)90078-0; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1991, BIOCHIMIE, V73, P1287, DOI 10.1016/0300-9084(91)90090-N; SRERE PA, 1959, J BIOL CHEM, V234, P2544; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Straub SG, 2002, DIABETES, V51, pS91, DOI 10.2337/diabetes.51.2007.S91; Straub SG, 2007, DIABETES-METAB RES, V23, P146, DOI 10.1002/dmrr.649; Zhao Y, 2007, BIOCHEM PHARMACOL, V74, P273, DOI 10.1016/j.bcp.2007.04.012	53	57	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31592	31600		10.1074/jbc.M706080200	http://dx.doi.org/10.1074/jbc.M706080200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17823126	hybrid			2022-12-25	WOS:000250309200051
J	Ling, Y; Li, ZH; Miranda, K; Oldfield, E; Moreno, SNJ				Ling, Yan; Li, Zhu-Hong; Miranda, Kildare; Oldfield, Eric; Moreno, Silvia N. J.			The Farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-LENGTH DETERMINATION; T-CELL-ACTIVATION; IN-VIVO; PYROPHOSPHATE SYNTHASE; ARABIDOPSIS-THALIANA; TRYPANOSOMA-CRUZI; LEISHMANIA-DONOVANI; POTENTIAL ROUTE; BONE-RESORPTION; EXPRESSION	Farnesyl-diphosphate synthase ( FPPS) catalyzes the synthesis of farnesyl diphosphate, an important precursor of sterols, dolichols, ubiquinones, and prenylated proteins. We report the cloning and characterization of two Toxoplasma gondii farnesyldiphosphate synthase ( TgFPPS) homologs. A single genetic locus produces two transcripts, TgFPPS and TgFPPSi, by alternative splicing. Both isoforms were heterologously expressed in Escherichia coli, but only TgFPPS was active. The protein products predicted from the nucleotide sequences have 646 and 605 amino acids and apparent molecular masses of 69.5 and 64.5 kDa, respectively. Several conserved sequence motifs found in other prenyl-diphosphate synthases are present in both TgFPPSs. TgFPPS was also expressed in the baculovirus system and was biochemically characterized. In contrast to the FPPS of other eukaryotic organisms, TgFPPS is bifunctional, catalyzing the formation of both farnesyl diphosphate and geranylgeranyl diphosphate. TgFPPS localizes to the mitochondria, as determined by the co-localisation of the affinity-purified antibodies against the protein with MitoTracker, and in accord with the presence of an N-terminal mitochondria-targeting signal in the protein. This enzyme is an attractive target for drug development, because the order of inhibition of the enzyme by a number of bisphosphonates is the same as that for inhibition of parasite growth. In summary, we report the first bifunctional farnesyl-diphosphate/geranylgeranyl-diphosphate synthase identified in eukaryotes, which, together with previous results, establishes this enzyme as a valid target for the chemotherapy of toxoplasmosis.	Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Moreno, SNJ (corresponding author), Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	smoreno@cb.uga.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045806, Z01AI005093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065307] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR16515-01] Funding Source: Medline; NIAID NIH HHS [AI1968467, 1R01AI045806, AI05093] Funding Source: Medline; NIGMS NIH HHS [GM65307] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON MS, 1989, J BIOL CHEM, V264, P19176; APPELKVIST EL, 1989, EUR J BIOCHEM, V185, P503, DOI 10.1111/j.1432-1033.1989.tb15142.x; Biardi L, 1996, J BIOL CHEM, V271, P1784, DOI 10.1074/jbc.271.3.1784; BLANCHARD L, 1993, GENE, V125, P185, DOI 10.1016/0378-1119(93)90326-X; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Chaudhary K, 2005, J BIOL CHEM, V280, P22053, DOI 10.1074/jbc.M503178200; CHEN AJ, 1993, J BIOL CHEM, V268, P11002; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; Delbac F, 2001, J CELL BIOL, V155, P613, DOI 10.1083/jcb.200012116; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Fujiwara S, 2004, BIOCHEM BIOPH RES CO, V325, P1066, DOI 10.1016/j.bbrc.2004.10.129; Gossman W, 2002, J MED CHEM, V45, P4868, DOI 10.1021/jm020224n; Grunler J, 1999, FEBS LETT, V455, P233, DOI 10.1016/S0014-5793(99)00892-3; Hemmi H, 2003, EUR J BIOCHEM, V270, P2186, DOI 10.1046/j.1432-1033.2003.03583.x; Hugueney P, 1996, PLANT PHYSIOL, V111, P619, DOI 10.1104/pp.111.2.619; Ibrahim M, 2001, INT J PARASITOL, V31, P1489, DOI 10.1016/S0020-7519(01)00268-5; Kuzuguchi T, 1999, J BIOL CHEM, V274, P5888, DOI 10.1074/jbc.274.9.5888; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERICHE MA, 1991, MOL BIOCHEM PARASIT, V45, P249, DOI 10.1016/0166-6851(91)90092-K; Ling Y, 2005, J MED CHEM, V48, P3130, DOI 10.1021/jm040132t; Luo SH, 2001, EMBO J, V20, P55, DOI 10.1093/emboj/20.1.55; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; Montalvetti A, 2001, J BIOL CHEM, V276, P33930, DOI 10.1074/jbc.M103950200; Montalvetti A, 2003, J BIOL CHEM, V278, P17075, DOI 10.1074/jbc.M210467200; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Ortiz-Gomez A, 2006, EUKARYOT CELL, V5, P1057, DOI 10.1128/EC.00034-06; Parmryd I, 1999, ARCH BIOCHEM BIOPHYS, V364, P153, DOI 10.1006/abbi.1999.1134; Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375; Rogers MJ, 1999, BONE, V24, p73S, DOI 10.1016/S8756-3282(99)00070-8; Roullet E, 1999, J NEUROL, V246, P237, DOI 10.1007/s004150050341; Sanders JM, 2004, J MED CHEM, V47, P375, DOI 10.1021/jm0303709; Sanmiya K, 1999, PLANT CELL PHYSIOL, V40, P348, DOI 10.1093/oxfordjournals.pcp.a029549; SHEARES BT, 1989, BIOCHEMISTRY-US, V28, P8129, DOI 10.1021/bi00446a025; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Szabo CM, 2002, J MED CHEM, V45, P2894, DOI 10.1021/jm010279+; Szabo CM, 2002, J MED CHEM, V45, P2185, DOI 10.1021/jm010412y; THOMPSON SL, 1987, J BIOL CHEM, V262, P17420; Toursel C, 2000, MOL BIOCHEM PARASIT, V111, P319, DOI 10.1016/S0166-6851(00)00324-8; Urbina JA, 1999, J BIOL CHEM, V274, P33609, DOI 10.1074/jbc.274.47.33609; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang K, 1999, TRENDS BIOCHEM SCI, V24, P445, DOI 10.1016/S0968-0004(99)01464-4; Yardley V, 2002, ANTIMICROB AGENTS CH, V46, P929, DOI 10.1128/AAC.46.3.929-931.2002; Zhu XF, 1997, PLANT MOL BIOL, V35, P331, DOI 10.1023/A:1005898805326	51	72	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30804	30816		10.1074/jbc.M703178200	http://dx.doi.org/10.1074/jbc.M703178200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724033	hybrid			2022-12-25	WOS:000250136300049
J	Chen, LT; Ko, TP; Chang, YW; Lin, KA; Wang, AHJ; Wang, TF				Chen, Li-Tzu; Ko, Tzu-Ping; Chang, Yu-Wei; Lin, Kuei-An; Wang, Andrew H. -J.; Wang, Ting-Fang			Structural and Functional Analyses of Five Conserved Positively Charged Residues in the L1 and N-Terminal DNA Binding Motifs of Archaeal RadA Protein	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RECA PROTEIN; METHANOCOCCUS-VOLTAE; RECOMBINATION; COMPLEXES; HOMOLOG; DOMAIN; DMC1; GLYCOSYLASE; INSIGHTS	RecA family proteins engage in an ATP-dependent DNA strand exchange reaction that includes a ssDNA nucleoprotein helical filament and a homologous dsDNA sequence. In spite of more than 20 years of efforts, the molecular mechanism of homology pairing and strand exchange is still not fully understood. Here we report a crystal structure of Sulfolobus solfataricus RadA overwound right-handed filament with three monomers per helical pitch. This structure reveals conformational details of the first ssDNA binding disordered loop (denoted L1 motif) and the dsDNA binding N-terminal domain (NTD). L1 and NTD together form an outwardly open palm structure on the outer surface of the helical filament. Inside this palm structure, five conserved basic amino acid residues (K27, K60, R117, R223 and R229) surround a 25 A pocket that is wide enough to accommodate anionic ssDNA, dsDNA or both. Biochemical analyses demonstrate that these five positively charged residues are essential for DNA binding and for RadA-catalyzed D-loop formation. We suggest that the overwound right-handed RadA filament represents a functional conformation in the homology search and pairing reaction. A new structural model is proposed for the homologous interactions between a RadA-ssDNA nucleoprotein filament and its dsDNA target.	[Chen, Li-Tzu; Chang, Yu-Wei; Wang, Andrew H. -J.; Wang, Ting-Fang] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Wang, Andrew H. -J.] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Chen, Li-Tzu; Ko, Tzu-Ping; Chang, Yu-Wei; Lin, Kuei-An; Wang, Andrew H. -J.; Wang, Ting-Fang] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Wang, Andrew H. -J.] Acad Sinica, Natl Core Facil High Throughput Prot Crystallog, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Wang, AHJ (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; tfwang@gate.sinica.edu.tw	Wang, Ting-Fang/ABI-3818-2020	Wang, Ting-Fang/0000-0001-6306-9505				Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; De Zutter SK, 1999, J MOL BIOL, V293, P769, DOI 10.1006/jmbi.1999.3200; Henning W, 2003, TOXICOLOGY, V193, P91, DOI 10.1016/S0300-483X(03)00291-9; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinebuchi T, 2005, J BIOL CHEM, V280, P28382, DOI 10.1074/jbc.M503372200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Lee MH, 2004, BIOCHEM BIOPH RES CO, V323, P845, DOI 10.1016/j.bbrc.2004.08.163; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Shi WX, 2005, NANO LETT, V5, P2476, DOI 10.1021/nl051783v; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; YU X, 1990, BIOPHYS J, V57, P555, DOI 10.1016/S0006-3495(90)82571-6; Zhang XP, 2005, J BIOL CHEM, V280, P26303, DOI 10.1074/jbc.M503244200	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e858	10.1371/journal.pone.0000858	http://dx.doi.org/10.1371/journal.pone.0000858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848989	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455600005
J	Muller, J; Tsuji, LA				Mueller, Johannes; Tsuji, Linda A.			Impedance-Matching Hearing in Paleozoic Reptiles: Evidence of Advanced Sensory Perception at an Early Stage of Amniote Evolution	PLOS ONE			English	Article								Background. Insights into the onset of evolutionary novelties are key to the understanding of amniote origins and diversification. The possession of an impedance-matching tympanic middle ear is characteristic of all terrestrial vertebrates with a sophisticated hearing sense and an adaptively important feature of many modern terrestrial vertebrates. Whereas tympanic ears seem to have evolved multiple times within tetrapods, especially among crown-group members such as frogs, mammals, squamates, turtles, crocodiles, and birds, the presence of true tympanic ears has never been recorded in a Paleozoic amniote, suggesting they evolved fairly recently in amniote history. Methodology/Principal Findings. In the present study, we performed a morphological examination and a phylogenetic analysis of poorly known parareptiles from the Middle Permian of the Mezen River Basin in Russia. We recovered a well-supported clade that is characterized by a unique cheek morphology indicative of a tympanum stretching across large parts of the temporal region to an extent not seen in other amniotes, fossil or extant, and a braincase specialized in showing modifications clearly related to an increase in auditory function, unlike the braincase of any other Paleozoic tetrapod. In addition, we estimated the ratio of the tympanum area relative to the stapedial footplate for the basalmost taxon of the clade, which, at 23:1, is in close correspondence to that of modern amniotes capable of efficient impedance-matching hearing. Conclusions/Significance. Using modern amniotes as analogues, the possession of an impedance-matching middle ear in these parareptiles suggests unique ecological adaptations potentially related to living in dim-light environments. More importantly, our results demonstrate that already at an early stage of amniote diversification, and prior to the Permo-Triassic extinction event, the complexity of terrestrial vertebrate ecosystems had reached a level that proved advanced sensory perception to be of notable adaptive significance.	[Mueller, Johannes; Tsuji, Linda A.] Humboldt Univ, Museum Naturkunde, Berlin, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Muller, J (corresponding author), Humboldt Univ, Museum Naturkunde, Berlin, Germany.	johannes.mueller@museum.hu-berlin.de	Müller, Johannes/A-6293-2017	Müller, Johannes/0000-0001-5801-856X	Deutsche Forschungsgemeinschaft (DFG) [Mu 1760/2-3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: The study was funded by a grant of the Deutsche Forschungsgemeinschaft (DFG Mu 1760/2-3).	[Anonymous], 1987, T PALEONTOLOGICHESKO; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Carroll R.L., 1988, VERTEBRAE PALEONTOLO, P698; CARROLL RL, 1985, CAN J EARTH SCI, V22, P1571, DOI 10.1139/e85-166; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; CLACK JA, 1993, ACTA BIOTHEOR, V41, P391, DOI 10.1007/BF00709373; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; Clack JA., 2002, GAINING GROUND ORIGI, P369; Clark JA, 1997, BRAIN BEHAV EVOLUT, V50, P198, DOI 10.1159/000113334; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; deBraga M, 2003, CAN J EARTH SCI, V40, P527, DOI 10.1139/E02-082; EFREMOV IA, 1938, DOKL AKAD NAUK SSSR, V19, P771; Frey E, 1997, SCIENCE, V275, P1450, DOI 10.1126/science.275.5305.1450; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; Ivakhnenko MF, 1997, PALEONTOL J, V31, P552; Iwaniuk AN, 2006, BEHAV BRAIN RES, V167, P305, DOI 10.1016/j.bbr.2005.09.015; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; Laurin M, 1998, ANN SCI NAT ZOOL, V19, P1, DOI 10.1016/S0003-4339(98)80132-9; Lombard R. Eric, 1993, P241; Maddison W., 2003, MACCLADE 4 06; MANLEY GA, 1972, J COMP PHYSIOL, V81, P239, DOI 10.1007/BF00693629; Mason MJ, 2001, J ZOOL, V255, P467; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Modesto S, 2001, P ROY SOC B-BIOL SCI, V268, P2047, DOI 10.1098/rspb.2001.1766; Modesto SP, 2006, ZOOL J LINN SOC-LOND, V146, P345, DOI 10.1111/j.1096-3642.2006.00205.x; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Narins PM, 1997, BRAIN RES BULL, V44, P641, DOI 10.1016/S0361-9230(97)00286-4; NORBERG RA, 1978, PHILOS T R SOC B, V282, P325, DOI 10.1098/rstb.1978.0014; Nummela S, 2006, J ZOOL, V270, P256, DOI 10.1111/j.1469-7998.2006.00126.x; Reisz RR, 2007, ZOOL J LINN SOC-LOND, V151, P191, DOI 10.1111/j.1096-3642.2007.00312.x; Reisz RR, 1997, TRENDS ECOL EVOL, V12, P218, DOI 10.1016/S0169-5347(97)01060-4; Reisz RR, 2001, GEOL SOC AM BULL, V113, P1229, DOI 10.1130/0016-7606(2001)113<1229:TRMFVE>2.0.CO;2; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Robinson J, 2005, ZOOL J LINN SOC-LOND, V143, P577, DOI 10.1111/j.1096-3642.2005.00156.x; Rybczynski N, 2001, NATURE, V411, P684, DOI 10.1038/35079567; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tsuji LA, 2006, J VERTEBR PALEONTOL, V26, P849, DOI 10.1671/0272-4634(2006)26[849:CAAPAO]2.0.CO;2; Werner YL, 2005, ANAT REC PART A, V283A, P212, DOI 10.1002/ar.a.20142; WEVER EG, 1970, J EXP ZOOL, V175, P327, DOI 10.1002/jez.1401750307; WEVER EG, 1978, REPTILE EAR ITS STRU, P1025	41	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e889	10.1371/journal.pone.0000889	http://dx.doi.org/10.1371/journal.pone.0000889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849018	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600035
J	Tuljapurkar, SD; Puleston, CO; Gurven, MD				Tuljapurkar, Shripad D.; Puleston, Cedric O.; Gurven, Michael D.			Why Men Matter: Mating Patterns Drive Evolution of Human Lifespan	PLOS ONE			English	Article							FERTILITY	Evolutionary theory predicts that senescence, a decline in survival rates with age, is the consequence of stronger selection on alleles that affect fertility or mortality earlier rather than later in life. Hamilton quantified this argument by showing that a rare mutation reducing survival is opposed by a selective force that declines with age over reproductive life. He used a female-only demographic model, predicting that female menopause at age ca. 50 yrs should be followed by a sharp increase in mortality, a "wall of death.'' Human lives obviously do not display such a wall. Explanations of the evolution of lifespan beyond the age of female menopause have proven difficult to describe as explicit genetic models. Here we argue that the inclusion of males and mating patterns extends Hamilton's theory and predicts the pattern of human senescence. We analyze a general two-sex model to show that selection favors survival for as long as men reproduce. Male fertility can only result from matings with fertile females, and we present a range of data showing that males much older than 50 yrs have substantial realized fertility through matings with younger females, a pattern that was likely typical among early humans. Thus old-age male fertility provides a selective force against autosomal deleterious mutations at ages far past female menopause with no sharp upper age limit, eliminating the wall of death. Our findings illustrate the evolutionary importance of males and mating preferences, and show that one-sex demographic models are insufficient to describe the forces that shape human senescence.	[Tuljapurkar, Shripad D.; Puleston, Cedric O.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Gurven, Michael D.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Stanford University; University of California System; University of California Santa Barbara	Tuljapurkar, SD (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	tulja@stanford.edu		Tuljapurkar, Shripad/0000-0001-5549-4245; Gurven, Michael/0000-0002-5661-527X	U.S. National Institute [1 PO1 AG22500-01]; NIA [R01 AG024119-01]; NATIONAL INSTITUTE ON AGING [R01AG024119, P01AG022500] Funding Source: NIH RePORTER	U.S. National Institute; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by U.S. National Institute on Aging grant 1 PO1 AG22500-01 and NIA grant R01 AG024119-01.	[Anonymous], 1997, ZEUS SALMON BIODEMOG; CASTERLINE JB, 1986, POP STUD-J DEMOG, V40, P353, DOI 10.1080/0032472031000142296; Charlesworth B, 1997, CURR BIOL, V7, pR440, DOI 10.1016/S0960-9822(06)00213-2; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; CHARLESWORTH B, 2004, EVOLUTION AGE STRUCT; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; FELDMAN MW, 1983, GENETICS, V105, P1003; *GOV PAK, 1984, CAM DEM HLTH SURV PA; GURVEN M, 2007, HUNTER GATHERER LONG; GURVEN M, 2007, AM J HUM BI IN PRESS; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; HOWELL N, 1979, DEMOGRAPHY DOBE 1KUN; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Kuhnert B, 2004, HUM REPROD UPDATE, V10, P327, DOI 10.1093/humupd/dmh030; Lardoux S, 2003, POPULATION, V58, P807, DOI 10.2307/3271283; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Marlowe FW, 2000, HUM NATURE-INT BIOS, V11, P27, DOI 10.1007/s12110-000-1001-7; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Medawar P., 1952, UNSOLVED PROBLEM BIO; Melancon T., 1982, THESIS PENNSYLVANIA; MULDER MB, 1988, REPROD SUCCESS, pCH26; *NAT I STAT, CAM DEM HLTH SURV; PAGET WJ, 1994, POP STUD-J DEMOG, V48, P333, DOI 10.1080/0032472031000147826; POLLAK RA, 1987, THEOR POPUL BIOL, V32, P176, DOI 10.1016/0040-5809(87)90046-3; POLLAK RA, 1990, J POLIT ECON, V98, P399, DOI 10.1086/261683; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; RAVANERA ZR, 2003, ANN M POP ASS AM MIN; ROGERS AR, 1993, EVOL ECOL, V7, P406, DOI 10.1007/BF01237872; ROGERS AR, 1994, HUMAN REPROD DECISIO, P76; SCHOEN R, 1981, DEMOGRAPHY, V18, P201, DOI 10.2307/2061093; Shanley DP, 2001, BIOESSAYS, V23, P282, DOI 10.1002/1521-1878(200103)23:3<282::AID-BIES1038>3.0.CO;2-9; *UN STAT DIV, 2006, SOC IND IND HLTH; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	36	83	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e785	10.1371/journal.pone.0000785	http://dx.doi.org/10.1371/journal.pone.0000785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726515	Green Published, gold			2022-12-25	WOS:000207455400002
J	Towner, JS; Pourrut, X; Albarino, CG; Nkogue, CN; Bird, BH; Grard, G; Ksiazek, TG; Gonzalez, JP; Nichol, ST; Leroy, EM				Towner, Jonathan S.; Pourrut, Xavier; Albarino, Cesar G.; Nkogue, Chimene Nze; Bird, Brian H.; Grard, Gilda; Ksiazek, Thomas G.; Gonzalez, Jean-Paul; Nichol, Stuart T.; Leroy, Eric M.			Marburg Virus Infection Detected in a Common African Bat	PLOS ONE			English	Article							HEMORRHAGIC-FEVER	Marburg and Ebola viruses can cause large hemorrhagic fever (HF) outbreaks with high case fatality (80-90%) in human and great apes. Identification of the natural reservoir of these viruses is one of the most important topics in this field and a fundamental key to understanding their natural history. Despite the discovery of this virus family almost 40 years ago, the search for the natural reservoir of these lethal pathogens remains an enigma despite numerous ecological studies. Here, we report the discovery of Marburg virus in a common species of fruit bat (Rousettus aegyptiacus) in Gabon as shown by finding virus-specific RNA and IgG antibody in individual bats. These Marburg virus positive bats represent the first naturally infected non-primate animals identified. Furthermore, this is the first report of Marburg virus being present in this area of Africa, thus extending the known range of the virus. These data imply that more areas are at risk for MHF outbreaks than previously realized and correspond well with a recently published report in which three species of fruit bats were demonstrated to be likely reservoirs for Ebola virus.	[Pourrut, Xavier; Nkogue, Chimene Nze; Grard, Gilda; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Towner, Jonathan S.; Albarino, Cesar G.; Bird, Brian H.; Ksiazek, Thomas G.; Nichol, Stuart T.] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA USA; [Pourrut, Xavier; Leroy, Eric M.] Inst Rech Dev, UR178, Franceville, Gabon; [Bird, Brian H.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Gonzalez, Jean-Paul] Inst Rech Dev, UR178, Nakhon Pathom, Thailand	Centers for Disease Control & Prevention - USA; Institut de Recherche pour le Developpement (IRD); University of California System; University of California Davis; Institut de Recherche pour le Developpement (IRD)	Leroy, EM (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	eric.leroy@ird.fr	Gonzalez, J-P/C-3077-2013; Towner, Jonathan/ABC-3780-2020; LEROY, Eric M/I-4347-2016	Gonzalez, J-P/0000-0003-3063-1770; LEROY, Eric M/0000-0003-0022-0890	Government of the United States of America; Government of Gabon, Total-Fina-Elf Gabon; Ministere de la Cooperation Francaise; Ministere des Affaires Etrangeres de la France [FSP ndegrees 2002005700]	Government of the United States of America; Government of Gabon, Total-Fina-Elf Gabon; Ministere de la Cooperation Francaise; Ministere des Affaires Etrangeres de la France	CDC is supported by the Government of the United States of America. CIRMF is supported by the Government of Gabon, Total-Fina-Elf Gabon, and the Ministere de la Cooperation Francaise. This work was also supported by a Fonds de Solidarite Prioritaire grant from the Ministere des Affaires Etrangeres de la France (FSP n degrees 2002005700).	Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; BERGMANS W, 1989, Beaufortia, V39, P89; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P308; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Johnson ED, 1996, ARCH VIROL, P101; KINGDON J, 1974, E AFRICAN MAMMALS, P341; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; TOWNER JS, 2007, J INFECT DI IN PRESS; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P115	14	255	268	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e764	10.1371/journal.pone.0000764	http://dx.doi.org/10.1371/journal.pone.0000764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712412	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455300012
J	Vasilcanu, R; Vasilcanu, D; Rosengren, L; Natalishvili, N; Sehat, B; Yin, S; Girnita, A; Axelson, M; Girnita, L; Larsson, O				Vasilcanu, R.; Vasilcanu, D.; Rosengren, L.; Natalishvili, N.; Sehat, B.; Yin, S.; Girnita, A.; Axelson, M.; Girnita, L.; Larsson, O.			Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1	ONCOGENE			English	Article						PPP; IGF-1R; MDM2; beta-arrestin1; cancer	GROWTH-FACTOR-I; IGF-1 RECEPTOR; CYCLOLIGNAN PPP; BETA-ARRESTIN; CELL-GROWTH; MULTIPLE-MYELOMA; TYROSINE KINASE; UVEAL MELANOMA; TUMOR-GROWTH; MOUSE MODEL	The insulin-like growth factor 1 receptor (IGF-1R) is crucial for growth and survival of malignant cells. Experience in targeting IGF-1R in cancer models has shown that strategies promoting downregulation of the receptor are much more efficient in inducing apoptosis than those inhibiting the IGF-1R activity. Recently, we found that the cyclolignan picropodophyllin (PPP) inhibits phosphorylation of IGF-1R and activation of downstream signaling without interfering with the highly homologous insulin receptor (IR). Furthermore, PPP treatment caused strong regression of tumor grafts and prolonged survival of animals with systemic tumor disease. Here we demonstrate that PPP also downregulates the IGF-1R, whereas the IR and several other receptors were not affected. PPP-induced IGF-1R downregulation required expression of the MDM2 E3 ligase, which recently was found to ubiquitinate and cause degradation of the IGF-1R. In addition knockdown of beta-arrestin1, the adaptor molecule known to bridges MDM2 and IGF-1R, prevented downregulation of the receptor and significantly decreased PPP-induced cell death. All together these data suggest that PPP downregulates IGF-1R by interfering with the action of beta-arrestin1/MDM2 as well as the achieved receptor downregulation contributes to the apoptotic effect of PPP.	[Vasilcanu, R.; Vasilcanu, D.; Rosengren, L.; Natalishvili, N.; Sehat, B.; Yin, S.; Girnita, A.; Girnita, L.; Larsson, O.] Karolinska Inst, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden; [Vasilcanu, R.; Vasilcanu, D.; Rosengren, L.; Natalishvili, N.; Sehat, B.; Yin, S.; Girnita, A.; Girnita, L.; Larsson, O.] Karolinska Univ Hosp, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden; [Axelson, M.] Karolinska Univ Hosp, Dept Clin Chem, SE-17176 Stockholm, Sweden; [Axelson, M.] Karolinska Inst, Dept Clin Chem, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Larsson, O (corresponding author), Karolinska Inst, Dept Pathol & Oncol, CCK R8 04, SE-17176 Stockholm, Sweden.	Olle.Larsson@ki.se	Girnita, Leonard/A-4168-2008; Girnita, Ada/AAC-4518-2020	Girnita, Leonard/0000-0003-0280-9500; 				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Baserga R, 2004, EUR J CANCER, V40, P2013, DOI 10.1016/j.ejca.2004.06.015; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; BUCHARDT O, 1986, J PHARM SCI, V75, P1076, DOI 10.1002/jps.2600751111; Catrina SB, 2005, BRIT J CANCER, V92, P1467, DOI 10.1038/sj.bjc.6602408; Colon E, 2007, ENDOCRINOLOGY, V148, P128, DOI 10.1210/en.2006-0835; Conti L, 2007, BLOOD, V109, P2496, DOI 10.1182/blood-2006-07-034231; GHOSH RN, 1994, J CELL SCI, V107, P2177; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Girnita A, 2006, CLIN CANCER RES, V12, P1383, DOI 10.1158/1078-0432.CCR-05-1106; Girnita L, 2000, CANCER RES, V60, P5278; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Girnita L, 2000, ANTI-CANCER DRUG DES, V15, P67; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee CT, 1996, CANCER RES, V56, P3038; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Loughran G, 2005, ONCOGENE, V24, P6185, DOI 10.1038/sj.onc.1208772; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Menu E, 2007, INT J CANCER, V121, P1857, DOI 10.1002/ijc.22845; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Razuvaev A, 2007, J VASC SURG, V46, P108, DOI 10.1016/j.jvs.2007.02.066; RESNICOFF M, 1994, CANCER RES, V54, P4848; Rubini M, 1997, EXP CELL RES, V230, P284, DOI 10.1006/excr.1996.3430; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; SHAPIRO DN, 1994, J CLIN INVEST, V94, P1235, DOI 10.1172/JCI117441; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stromberg T, 2006, BLOOD, V107, P669, DOI 10.1182/blood-2005-01-0306; Tomizawa M, 2006, WORLD J GASTROENTERO, V12, P6531, DOI 10.3748/wjg.v12.i40.6531; Ulfarsson E, 2005, CLIN CANCER RES, V11, P4674, DOI 10.1158/1078-0432.CCR-05-0129; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Xie YT, 1999, CANCER RES, V59, P3588; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	42	64	68	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1629	1638		10.1038/sj.onc.1210797	http://dx.doi.org/10.1038/sj.onc.1210797			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17828296				2022-12-25	WOS:000253815800015
J	Grochova, D; Vankova, J; Damborsky, J; Ravcukova, B; Smarda, J; Vojtesek, B; Smardova, J				Grochova, D.; Vankova, J.; Damborsky, J.; Ravcukova, B.; Smarda, J.; Vojtesek, B.; Smardova, J.			Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast	ONCOGENE			English	Article						p53; FASAY; transactivation; conformation; temperature-dependent mutants; discriminating mutants	CYTOPROTECTIVE AMINOTHIOL WR1065; WILD-TYPE P53; TUMOR-SUPPRESSOR; FUNCTIONAL ASSAY; TRANSCRIPTION FACTOR; MONOCLONAL-ANTIBODY; MUTATION ANALYSIS; SENSITIVE MUTANT; HUMAN CANCERS; DNA-BINDING	The p53 gene is often mutated during cancer development. Frequency and functional consequences of these mutations vary in different tumor types. We analysed conformation and temperature dependency of 23 partially inactivating temperature-dependent (td) p53 mutants derived from various human tumors in yeast. We found considerable differences in transactivation capabilities and discriminative character of various p53 mutants. No correlations in transactivation rates and conformations of the td p53 proteins were detected. Amifostine-induced p53 reactivation occurred only in 13 of 23 td mutants, and this effect was temperature dependent and responsive element specific. The most of the p53 mutations (10/13) reactivated by amifostine were located in the part of the p53 gene coding for hydrophobic b-sandwich structure of the DNA-binding domain.	[Grochova, D.; Vankova, J.; Ravcukova, B.; Smardova, J.] Univ Hosp, Dept Pathol, Brno 62500, Czech Republic; [Grochova, D.; Vankova, J.; Damborsky, J.; Smardova, J.] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic; [Vojtesek, B.] Masaryk Memory Canc Inst, Dept Expt Oncol, Brno, Czech Republic	University Hospital Brno; Masaryk University Brno; Masaryk Memorial Cancer Institute	Smardova, J (corresponding author), Univ Hosp, Dept Pathol, Jihlavska 20, Brno 62500, Czech Republic.	janasmarda@seznam.cz	Damborsky, Jiri/H-3799-2012	Damborsky, Jiri/0000-0002-7848-8216				Acosta JC, 2003, MOL CANCER THER, V2, P893; Campomenosi P, 2001, ONCOGENE, V20, P3573, DOI 10.1038/sj.onc.1204468; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Di Como CJ, 1998, ONCOGENE, V16, P2527; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Flaman JM, 1998, ONCOGENE, V16, P1369, DOI 10.1038/sj.onc.1201889; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Gaitonde SV, 2000, ONCOGENE, V19, P4042, DOI 10.1038/sj.onc.1203756; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Hansen S, 1996, J BIOL CHEM, V271, P3917; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Lane DR, 2003, DRUG DISCOV TODAY, V8, P347, DOI 10.1016/S1359-6446(03)02669-2; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Maurici D, 2001, ONCOGENE, V20, P3533, DOI 10.1038/sj.onc.1204428; McLure KG, 1999, EMBO J, V18, P763, DOI 10.1093/emboj/18.3.763; MILNER J, 1987, ONCOGENE, V1, P453; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; North S, 2000, ONCOGENE, V19, P1206, DOI 10.1038/sj.onc.1203413; North S, 2002, MOL CARCINOGEN, V33, P181, DOI 10.1002/mc.10038; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; Pataer A, 2006, CANCER GENE THER, V13, P806, DOI 10.1038/sj.cgt.7700960; Pavlova S, 2003, INT J ONCOL, V23, P121; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Resnick MA, 2003, P NATL ACAD SCI USA, V100, P9934, DOI 10.1073/pnas.1633803100; SCHATZBERG AF, 1992, J CLIN PSYCHIAT, V53, P20; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Shiraishi K, 2004, J BIOL CHEM, V279, P348, DOI 10.1074/jbc.M310815200; Smardova J, 2005, DIFFERENTIATION, V73, P261, DOI 10.1111/j.1432-0436.2005.00028.x; Smardova J, 2004, ONCOL REP, V11, P923; Smardova J, 2001, TUMOR BIOL, V22, P59; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; Xirodimas DP, 1999, J BIOL CHEM, V274, P28042, DOI 10.1074/jbc.274.39.28042; ZHANG W, 1994, EMBO J, V13, P2535, DOI 10.1002/j.1460-2075.1994.tb06543.x	40	21	21	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2008	27	9					1243	1252		10.1038/sj.onc.1210748	http://dx.doi.org/10.1038/sj.onc.1210748			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17724467				2022-12-25	WOS:000253407000006
J	Richter, S; Lindenstrauss, U; Lucke, C; Bayliss, R; Bruser, T				Richter, Silke; Lindenstrauss, Ute; Luecke, Christian; Bayliss, Richard; Brueser, Thomas			Functional tat transport of unstructured, small, hydrophilic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE TRANSLOCATION PATHWAY; GREEN FLUORESCENT PROTEIN; FXFG NUCLEOPORIN REPEATS; FOLDING QUALITY-CONTROL; ESCHERICHIA-COLI; SIGNAL PEPTIDE; ALPHA-SYNUCLEIN; SYSTEM; EXPORT; MEMBRANE	The twin-arginine translocation ( Tat) system is a protein translocation system that is adapted to the translocation of folded proteins across biological membranes. An understanding of the folding requirements for Tat substrates is of fundamental importance for the elucidation of the transport mechanism. We now demonstrate for the first time Tat transport for fully unstructured proteins, using signal sequence fusions to naturally unfolded FG repeats from the yeast Nsp1p nuclear pore protein. The transport of unfolded proteins becomes less efficient with increasing size, consistent with only a single interaction between the system and the substrate. Strikingly, the introduction of six residues from the hydrophobic core of a globular protein completely blocked translocation. Physiological data suggest that hydrophobic surface patches abort transport at a late stage, most likely by membrane interactions during transport. This study thus explains the observed restriction of the Tat system to folded globular proteins on a molecular level.	Univ Halle Wittenberg, Inst Biol Microbiol, D-06120 Halle, Germany; Max Planck Res Unit Enzmol Protein Folding, D-06120 Halle, Germany; Inst Canc Res, London SW3 6JB, England	Martin Luther University Halle Wittenberg; Max Planck Society; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bruser, T (corresponding author), Univ Halle Wittenberg, Inst Biol Microbiol, Kurt Mothes Str 3, D-06120 Halle, Germany.	brueser@mikrobiologie.uni-halle.de		Bruser, Thomas/0000-0002-5889-8306; Bayliss, Richard/0000-0003-0604-2773				Bayliss R, 2000, J STRUCT BIOL, V131, P240, DOI 10.1006/jsbi.2000.4297; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bentrop D, 1999, BIOCHEMISTRY-US, V38, P4669, DOI 10.1021/bi982647q; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2001, ARCH MICROBIOL, V177, P107, DOI 10.1007/s00203-001-0366-2; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; HURT EC, 1989, J CELL SCI, P243; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; Natarajan K, 1997, J AM CHEM SOC, V119, P4082, DOI 10.1021/ja9639729; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; Sargent F, 2002, ARCH MICROBIOL, V178, P77, DOI 10.1007/s00203-002-0434-2; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	43	54	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33257	33264		10.1074/jbc.M703303200	http://dx.doi.org/10.1074/jbc.M703303200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848553	hybrid			2022-12-25	WOS:000250840200005
J	Goulet, I; Gauvin, G; Boisvenue, S; Cote, J				Goulet, Isabelle; Gauvin, Gabrielle; Boisvenue, Sophie; Cote, Jocelyn			Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR DAL-1/4.1B; NUCLEAR-EXPORT SIGNALS; BREAST-CANCER CELLS; MESSENGER-RNA; IN-VIVO; N-METHYLTRANSFERASE; SM PROTEINS; ANDROGEN RECEPTOR; METHYLATION SITES; MAMMALIAN-CELLS	PRMT1 is the predominant member of a family of protein arginine methyltransferases (PRMTs) that have been implicated in various cellular processes, including transcription, RNA processing, and signal transduction. It was previously reported that the human PRMT1 pre-mRNA was alternatively spliced to yield three isoforms with distinct N-terminal sequences. Close inspection of the genomic organization in the 5'-end of the PRMT1 gene revealed that it can produce up to seven protein isoforms, all varying in their N-terminal domain. A detailed biochemical characterization of these variants revealed that unique N-terminal sequences can influence catalytic activity as well as substrate specificity. In addition, our results uncovered the presence of a functional nuclear export sequence in PRMT1v2. Finally, we find that the relative balance of PRMT1 isoforms is altered in breast cancer.	Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Cote, J (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	jcote@uottawa.ca	Cote, Jocelyn/O-2351-2018	Cote, Jocelyn/0000-0001-9551-2284				Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Altschuler L, 1999, J INTERF CYTOK RES, V19, P189, DOI 10.1089/107999099314333; ANCZUKOW O, 2007, IN PRESS HUM MUTAT, V22, P119; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Duriez C., 2004, B CANC, V91, P242; Edberg DD, 2004, BIOCHEMISTRY-US, V43, P11500, DOI 10.1021/bi049833i; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Fackelmayer FO, 2005, TRENDS BIOCHEM SCI, V30, P666, DOI 10.1016/j.tibs.2005.10.002; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Hong H, 2004, CANCER-AM CANCER SOC, V101, P83, DOI 10.1002/cncr.20327; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Ikenaka K, 2006, NEUROSCIENCE, V141, P1971, DOI 10.1016/j.neuroscience.2006.05.022; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jiang W, 2005, BIOCHEM BIOPH RES CO, V329, P522, DOI 10.1016/j.bbrc.2005.01.153; Jiang W, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-4; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lim IK, 1998, BIOCHEM MOL BIOL INT, V45, P871; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pawlak MR, 2002, J CELL BIOCHEM, V87, P394, DOI 10.1002/jcb.10307; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Scorilas A, 2000, BIOCHEM BIOPH RES CO, V278, P349, DOI 10.1006/bbrc.2000.3807; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	78	131	135	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33009	33021		10.1074/jbc.M704349200	http://dx.doi.org/10.1074/jbc.M704349200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848568	hybrid			2022-12-25	WOS:000250625400050
J	Hakimi, P; Yang, J; Casadesus, G; Massillon, D; Tolentino-Silva, F; Nye, CK; Cabrera, ME; Hagen, DR; Utter, CB; Baghdy, Y; Johnson, DH; Wilson, DL; Kirwan, JP; Kalhan, SC; Hanson, RW				Hakimi, Parvin; Yang, Jianqi; Casadesus, Gemma; Massillon, Duna; Tolentino-Silva, Fatima; Nye, Colleen K.; Cabrera, Marco E.; Hagen, David R.; Utter, Christopher B.; Baghdy, Yacoub; Johnson, David H.; Wilson, David L.; Kirwan, John P.; Kalhan, Satish C.; Hanson, Richard W.			Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE GENE; MITOCHONDRIAL BIOGENESIS; ACID CYCLE; TRANSGENIC MICE; ADIPOSE-TISSUE; PGC-1-ALPHA TRANSCRIPTION; CALORIE RESTRICTION; PROLONGED EXERCISE; INSULIN-RESISTANCE; EXPRESSION	Transgenic mice, containing a chimeric gene in which the cDNA for phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C) (EC 4.1.1.32) was linked to the alpha-skeletal actin gene promoter, express PEPCK-C in skeletal muscle (1-3 units/g). Breeding two founder lines together produced mice with an activity of PEPCK-C of 9 units/g of muscle (PEPCK-C-mus mice). These mice were seven times more active in their cages than controls. On a mouse treadmill, PEPCK-C-mus mice ran up to 6 km at a speed of 20 m/min, whereas controls stopped at 0.2 km. PEPCK-C-mus mice had an enhanced exercise capacity, with a VO2max of 156 +/- 8.0 ml/kg/min, a maximal respiratory exchange ratio of 0.91 +/- 0.03, and a blood lactate concentration of 3.7 +/- 1.0 mM after running for 32 min at a 25 degrees grade; the values for control animals were 112 +/- 21 ml/kg/min, 0.99 +/- 0.08, and 8.1 +/- 5.0 mM respectively. The PEPCK-C-mus mice ate 60% more than controls but had half the body weight and 10% the body fat as determined by magnetic resonance imaging. In addition, the number of mitochondria and the content of triglyceride in the skeletal muscle of PEPCK-C-mus mice were greatly increased as compared with controls. PEPCK-C-mus mice had an extended life span relative to control animals; mice up to an age of 2.5 years ran twice as fast as 6-12-month-old control animals. We conclude that overexpression of PEPCK-C repatterns energy metabolism and leads to greater longevity.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biomed Engn, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Dept Gastroenterol Hepatol & Pathobiol, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Hanson, RW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	rwh@case.edu	Kirwan, John P/G-6942-2012; Johnson, David/AHI-8369-2022; Hakimi, Parvin/AAB-1643-2021; Hagen, David R/B-3911-2013	Hagen, David R/0000-0003-0992-8465; Casadesus, Gemma/0000-0002-5206-5637; Wilson, David/0000-0001-9763-1463; Kalhan, Satish/0000-0002-8012-4171	NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509, R01EB004070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058620, R01DK025541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM066309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG012834, R01AG012834] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA043703, CA 43703] Funding Source: Medline; NIA NIH HHS [R01 AG012834, AG 12834, R29 AG012834] Funding Source: Medline; NIBIB NIH HHS [EB 004070, T32 EB007509, R01 EB004070] Funding Source: Medline; NIDDK NIH HHS [R01 DK025541, DK 058620, DK 025541, R01 DK058620] Funding Source: Medline; NIGMS NIH HHS [GM 66309, P50 GM066309] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; ARAGON JJ, 1980, EUR J BIOCHEM, V110, P371, DOI 10.1111/j.1432-1033.1980.tb04877.x; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; Boffi FM, 2002, EQUINE VET J, V34, P275; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; CANNON JG, 1990, AM J PHYSIOL, V259, pR1214, DOI 10.1152/ajpregu.1990.259.6.R1214; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; CRABTREE B, 1972, BIOCHEM J, V126, P49, DOI 10.1042/bj1260049; Cresci S, 1996, AM J PHYSIOL-CELL PH, V270, pC1413, DOI 10.1152/ajpcell.1996.270.5.C1413; DOHM GL, 1986, BIOCHEM MED METAB B, V35, P260, DOI 10.1016/0885-4505(86)90081-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gibala MJ, 1997, J PHYSIOL-LONDON, V502, P703, DOI 10.1111/j.1469-7793.1997.703bj.x; HAHN P, 1975, J LIPID RES, V16, P79; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hanson RW, 1994, P ENOLPYRUVATE CARBO, P203; HOLLOSZY JO, 1993, J GERONTOL, V48, pB97, DOI 10.1093/geronj/48.3.B97; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; KIRWAN JP, 1986, EUR J APPL PHYSIOL O, V55, P330, DOI 10.1007/BF02343808; KIRWAN JP, 1992, J APPL PHYSIOL, V72, P2197, DOI 10.1152/jappl.1992.72.6.2197; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; LEE SH, 1979, J BIOL CHEM, V254, P420; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; MCGRANE MM, 1990, J BIOL CHEM, V265, P22371; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; McKee EE, 2000, AM J PHYSIOL-CELL PH, V279, pC1870, DOI 10.1152/ajpcell.2000.279.6.C1870; NEWSHOLME EA, 1978, BIOCHEM J, V176, P623, DOI 10.1042/bj1760623; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; OPIE LH, 1967, BIOCHEM J, V103, P391, DOI 10.1042/bj1030391; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; SAHLIN K, 1990, AM J PHYSIOL, V259, pC834, DOI 10.1152/ajpcell.1990.259.5.C834; SNELL K, 1977, BIOCHEM J, V162, P399, DOI 10.1042/bj1620399; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wieland O., 1965, METHODS ENZYMATIC AN, P211; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; YOOWARREN H, 1981, J BIOL CHEM, V256, P224; ZIMMER DB, 1990, J HISTOCHEM CYTOCHEM, V38, P171, DOI 10.1177/38.2.1688895	53	146	156	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32844	32855		10.1074/jbc.M706127200	http://dx.doi.org/10.1074/jbc.M706127200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17716967	Green Accepted, hybrid			2022-12-25	WOS:000250625400034
J	Germain, M; Duronio, V				Germain, Marc; Duronio, Vincent			The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BH3-ONLY PROTEINS; CELL-DEATH; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; SURVIVAL; BAK; PERMEABILIZATION; PHOSPHORYLATION; DEGRADATION	The BCL-2 homologue MCL-1 plays an important role in the regulation of cell fate by blocking apoptosis as well as regulating cell cycle. MCL-1 has an unusual N-terminal extension, which contains a PEST domain and several phosphorylation sites that have been suggested to regulate its turnover. Here we report that the first 79 amino acids of MCL-1 regulate its subcellular localization. Deletion of this domain impairs both its mitochondrial localization and its anti-apoptotic activity. Conversely, expression of the N terminus of MCL-1 promotes both the association of MCL-1 with mitochondria and cell survival in a fashion that is dependent on the presence of endogenous MCL-1. In addition, the N terminus of MCL-1 has an antagonistic effect on proliferation. Although MCL-1 decreases proliferation through binding to proliferating cell nuclear antigen and cyclin-dependent kinase 1 in the nucleus, the N terminus of MCL-1 accelerates cell division. On the other hand, deletion of this region further increases the anti-proliferative activity of MCL-1. These results suggest that the N terminus of MCL-1 plays a major regulatory role, regulating coordinately the mitochondrial ( anti-apoptotic) and nuclear ( anti-proliferative) functions of MCL-1.	Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada; Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Germain, M (corresponding author), Univ British Columbia, Dept Med, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	mgermain@interchange.ubc.ca						Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; GERMAIN M, 2003, SCI STKE; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Jamil S, 2005, BIOCHEM J, V387, P659, DOI 10.1042/BJ20041596; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Rinkenberger JL, 2000, GENE DEV, V14, P23; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou P, 1998, BLOOD, V92, P3226, DOI 10.1182/blood.V92.9.3226.421k49_3226_3239; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	34	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32233	32242		10.1074/jbc.M706408200	http://dx.doi.org/10.1074/jbc.M706408200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823113	hybrid			2022-12-25	WOS:000250480300046
J	Liu, XS; Patterson, LD; Miller, MJ; Theil, EC				Liu, Xiaofeng S.; Patterson, Leslie D.; Miller, Marvin J.; Theil, Elizabeth C.			Peptides selected for the protein nanocage pores change the rate of iron recovery from the ferritin mineral	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATING MODIFIER TOXINS; DESFERRIOXAMINE-B; H-CHAIN; RELEASE; KINETICS; CHANNELS; MOBILIZATION; ANTIOXIDANT; FERROPORTIN; DERIVATIVES	Pores regulate access between ferric-oxy biomineral inside and reductants/chelators outside the ferritin protein nanocage to control iron demineralization rates. The pore helix/loop/helix motifs that are contributed by three subunits unfold independently of the protein cage, as observed by crystallography, Fe removal rates, and CD spectroscopy. Pore unfolding is induced in wild type ferritin by increased temperature or urea (1-10 mM), a physiological urea range, 0.1 mM guanidine, or mutation of conserved pore amino acids. A peptide selected for ferritin pore binding from a combinatorial, heptapeptide library increased the rate of Fe demineralization 3-fold (p < 0.001), similarly to a mutation that unfolded the pores. Conjugating the peptide to Desferal (R) (desferrioxamine B mesylate), a chelator in therapeutic use, increased the rates to 8-fold (p < 0.001). A second pore binding peptide had the opposite effect and decreased the rate of Fe demineralization 60% (p < 0.001). The peptides could have pharmacological uses and may model regulators of ferritin demineralization rates in vivo or peptide regulators of gated pores in membranes. The results emphasize that small peptides can exploit the structural plasticity of protein pores to modulate function.	CHORI, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Oakland, CA 94609 USA; Univ Notre Dame, Dept Chem, Notre Dame, IN 46556 USA	Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley; University of Notre Dame	Theil, EC (corresponding author), CHORI, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	etheil@chori.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020251, R56DK020251, R01DK020251] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 054193] Funding Source: Medline; NIDDK NIH HHS [DK20251] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAPA S, 1982, HELV CHIM ACTA, V65, P1818, DOI 10.1002/hlca.19820650617; Bertola F., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P93, DOI 10.2174/1568008043339893; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; CRICHTON RR, 1980, J MOL CATAL, V7, P267, DOI 10.1016/0304-5102(80)85024-3; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; De Domenico I, 2007, BLOOD, V109, P2205, DOI 10.1182/blood-2006-06-032516; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; DIONIS JB, 1989, J ORG CHEM, V54, P5623, DOI 10.1021/jo00284a044; Duong-Ly KC, 2005, PROTEIN SCI, V14, P856, DOI 10.1110/ps.041185805; Farkas E, 2001, J INORG BIOCHEM, V83, P107, DOI 10.1016/S0162-0134(00)00197-5; HERSCHEID JDM, 1984, EUR J NUCL MED, V9, P508, DOI 10.1007/BF00263255; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; JALAL MAF, 1985, J ORG CHEM, V50, P5642, DOI 10.1021/jo00350a043; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; LYNCH SR, 1974, IRON BIOCH MED, P563; McDonough SI, 2007, TOXICON, V49, P202, DOI 10.1016/j.toxicon.2006.09.018; Meersman F, 2006, CHEM SOC REV, V35, P908, DOI 10.1039/b517761h; Michael DJ, 2006, TRENDS ENDOCRIN MET, V17, P408, DOI 10.1016/j.tem.2006.10.011; MUETTERTIES KA, 1991, MAGNET RESON MED, V22, P88, DOI 10.1002/mrm.1910220110; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; PETO TEA, 1983, BRIT J HAEMATOL, V54, P623, DOI 10.1111/j.1365-2141.1983.tb02142.x; RODGERS SJ, 1983, J MED CHEM, V26, P439, DOI 10.1021/jm00357a022; Rodi DJ, 2002, CURR OPIN CHEM BIOL, V6, P92, DOI 10.1016/S1367-5931(01)00287-3; Sachs JN, 2006, ANNU REV BIOCHEM, V75, P707, DOI 10.1146/annurev.biochem.75.110105.142336; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil E. C., 2001, HDB METALLOPROTEINS, P771; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Vichinsky E, 2001, SEMIN HEMATOL, V38, P1, DOI 10.1016/S0037-1963(01)90053-8; Wiedenheft B, 2005, P NATL ACAD SCI USA, V102, P10551, DOI 10.1073/pnas.0501497102; WUSTEFELD C, 1982, FEBS LETT, V150, P43, DOI 10.1016/0014-5793(82)81301-X	43	55	57	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31821	31825		10.1074/jbc.C700153200	http://dx.doi.org/10.1074/jbc.C700153200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785467	hybrid			2022-12-25	WOS:000250480300001
J	Neiers, F; Sonkaria, S; Olry, A; Boschi-Muller, S; Branlant, G				Neiers, Fabrice; Sonkaria, Sanjiv; Olry, Alexandre; Boschi-Muller, Sandrine; Branlant, Guy			Characterization of the amino acids from Neisseria meningitidis methionine sulfoxide reductase B involved in the chemical catalysis and substrate specificity of the reductase step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; KINETIC CHARACTERIZATION; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; MECHANISM; PROTEINS; REPAIR; SURVIVAL; RESIDUES; DAMAGE	Methionine sulfoxide reductases (Msrs) are antioxidant repair enzymes that catalyze the thioredoxin-dependent reduction of methionine sulfoxide back to methionine. The Msr family is composed of two structurally unrelated classes of enzymes named MsrA and MsrB, which display opposite stereoselectivities toward the S and R isomers of the sulfoxide function, respectively. Both classes of Msr share a similar three-step chemical mechanism involving first a reductase step that leads to the formation of a sulfenic acid intermediate. In this study, the invariant amino acids of Neisseria meningitidis MsrB involved in the reductase step catalysis and in substrate binding have been characterized by the structure-function relationship approach. Altogether the results show the following: 1) formation of the MsrB-substrate complex leads to an activation of the catalytic Cys-117 characterized by a decreased pK(app) of similar to 2.7 pH units; 2) the catalytic active MsrB form is the Cys-117(-)/His-103(+) species with a pKapp of 6.6 and 8.3, respectively; 3) His-103 and to a lesser extent His-100, Asn-119, and Thr-26 (via a water molecule) participate in the stabilization of the polarized form of the sulfoxide function and of the transition state; and 4) Trp-65 is essential for the catalytic efficiency of the reductase step by optimizing the position of the substrate in the active site. A scenario for the reductase step is proposed and discussed in comparison with that of MsrA.	Nancy Univ, CNRS, Fac Sci & Tech, UMR UHP 7567,Maturat ARN & Enzymol Mol, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Branlant, G (corresponding author), Nancy Univ, CNRS, Fac Sci & Tech, UMR UHP 7567,Maturat ARN & Enzymol Mol, Blvd Aiguillettes,BP 239, F-54506 Vandoeuvre Les Nancy, France.	Guy.Branlant@maem.uhp-nancy.fr	Neiers, Fabrice/AAM-1637-2021	Neiers, Fabrice/0000-0002-8965-4929; Boschi, Sandrine/0000-0001-8962-4749				Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; EJIRI SI, 1979, J BACTERIOL, V139, P161, DOI 10.1128/JB.139.1.161-164.1979; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gand A, 2007, J BIOL CHEM, V282, P20484, DOI 10.1074/jbc.M702350200; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Kauffmann B, 2005, BBA-PROTEINS PROTEOM, V1703, P249, DOI 10.1016/j.bbapap.2004.09.008; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Neiers F, 2004, J BIOL CHEM, V279, P42462, DOI 10.1074/jbc.M407464200; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Petropoulos I, 2006, FREE RADICAL RES, V40, P1269, DOI 10.1080/10715760600917144; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	26	24	25	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32397	32405		10.1074/jbc.M704730200	http://dx.doi.org/10.1074/jbc.M704730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17766244	hybrid, Green Published			2022-12-25	WOS:000250480300062
J	Zhang, YK; Brovkovych, V; Brovkovych, S; Tan, FL; Lee, BS; Sharma, T; Skidgel, RA				Zhang, Yongkang; Brovkovych, Viktor; Brovkovych, Svitlana; Tan, Fulong; Lee, Bao-Shiang; Sharma, Tiffany; Skidgel, Randal A.			Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of ser(745)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTING-ENZYME INHIBITORS; BRADYKININ B-1 RECEPTOR; ENDOTHELIAL-CELLS; NADPH-CYTOCHROME-P450 OXIDOREDUCTASE; BINDING DOMAIN; PROTEIN; MECHANISMS; PHARMACOLOGY; PREDICTION; DIMERIZATION	Nitric oxide (NO) is a pleiotropic regulator of vascular function, and its overproduction by inducible nitric-oxide synthase (iNOS) in inflammatory conditions plays an important role in the pathogenesis of vascular diseases. iNOS activity is thought to be regulated primarily at the level of expression to generate "high output" NO compared with constitutive NO synthases. Here we show iNOS activity is acutely up-regulated by activation of the B-1-kinin receptor (B1R) in human endothelial cells or transfected HEK293 cells to generate 2.5-5-fold higher NO than that stimulated by Arg alone. Increased iNOS activity was dependent on B1R activation of the MAPK ERK. In HEK293 cells transfected with human iNOS and B1R, ERK phosphorylated iNOS on Ser(745) as determined by Western analysis using phospho-Ser antibody, in vitro kinase assays with activated ERK, and MALDI-TOF mass spectrometry. Mutation of Ser(745) to Ala did not affect basal iNOS activity but eliminated iNOS phosphorylation and activation in response to B1R agonist. Mutation of Ser(745) to Asp resulted in a basally hyperactive iNOS whose activity was not further increased by B1R agonist. ERK and phospho-ERK (after B1R activation) were co-localized with iNOS as determined by confocal fluorescence microscopy. Furthermore, ERK co-immunoprecipitated with iNOS. The discovery that iNOS can be phosphorylated by ERK and acutely activated by receptor-mediated signaling reveals a new level of regulation for this isoform. These findings provide a novel therapeutic target to explore in the treatment of vascular inflammatory diseases.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Prot Res Lab, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol M C 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu			NHLBI NIH HHS [P01 HL 60678] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreeva AV, 2006, MOL PHARMACOL, V69, P975, DOI 10.1124/mol.105.018846; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Hadkar V, 2004, AM J PHYSIOL-LUNG C, V287, pL35, DOI 10.1152/ajplung.00346.2003; Hausel P, 2006, ONCOGENE, V25, P198, DOI 10.1038/sj.onc.1209030; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Ignjatovic T, 2004, MOL PHARMACOL, V66, P1310, DOI 10.1124/mol.104.001990; Ignjatovic T, 2002, J BIOL CHEM, V277, P16847, DOI 10.1074/jbc.M200355200; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P451; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Kolodziejski PJ, 2004, P NATL ACAD SCI USA, V101, P18141, DOI 10.1073/pnas.0406711102; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Kubes Pal, 1995, Microcirculation (New York), V2, P235, DOI 10.3109/10739689509146769; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lee BS, 2004, ANAL BIOCHEM, V334, P106, DOI 10.1016/j.ab.2004.06.041; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MALINSKI T, 1992, NATURE, V358, P676, DOI 10.1038/358676a0; Masters BSS, 2005, BIOCHEM BIOPH RES CO, V338, P507, DOI 10.1016/j.bbrc.2005.09.165; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitchell DA, 2005, BIOCHEMISTRY-US, V44, P4636, DOI 10.1021/bi0474463; MONCADA S, 1991, PHARMACOL REV, V43, P109; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pan JM, 1996, BIOCHEM J, V314, P889, DOI 10.1042/bj3140889; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Skidgel RA, 2006, BIOL CHEM, V387, P159, DOI 10.1515/BC.2006.021; Skidgel RA, 2002, AM J PHYSIOL-LUNG C, V282, pL1179, DOI 10.1152/ajplung.00045.2002; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tsutsui M, 2000, AM J PHYSIOL-HEART C, V278, pH367, DOI 10.1152/ajpheart.2000.278.2.H367; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; Zhang YK, 1999, J BIOL CHEM, V274, P34657, DOI 10.1074/jbc.274.49.34657	50	49	50	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32453	32461		10.1074/jbc.M706242200	http://dx.doi.org/10.1074/jbc.M706242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804409	hybrid			2022-12-25	WOS:000250480300068
J	Koivunen, P; Tiainen, P; Hyvarinen, J; Williams, KE; Sormunen, R; Klaus, SJ; Kivirikko, KI; Myllyharju, J				Koivunen, Peppi; Tiainen, Paeivi; Hyvarinen, Jaana; Williams, Kim E.; Sormunen, Raija; Klaus, Stephen J.; Kivirikko, Kari I.; Myllyharju, Johanna			An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; PROLINE HYDROXYLATION; GENE-EXPRESSION; HIF-ALPHA; COLLAGEN; HIF-1-ALPHA; SUBUNIT; PATHWAY; ENZYMES; PHD2	Prolyl 4-hydroxylases (P4Hs) act on collagens (C-P4Hs) and the oxygen-dependent degradation domains (ODDDs) of hypoxia-inducible factor alpha subunits (HIF-P4Hs) leading to degradation of the latter. We report data on a human P4H possessing a transmembrane domain (P4H-TM). Its gene is also found in zebrafish but not in flies and nematodes. Its sequence more closely resembles those of the C-P4Hs than the HIF-P4Hs, but it lacks the peptide substrate-binding domain of the C-P4Hs. P4H-TM levels in cultured cells are increased by hypoxia, and P4H-TMisN-glycosylated and is located in endoplasmic reticulum membranes with its catalytic site inside the lumen, a location differing from those of the HIF-P4Hs. Despite this, P4H-TM overexpression in cultured neuroblastoma cells reduced HIF-alpha ODDD reporter construct levels, and its small interfering RNA increased HIF-1 alpha protein level, in the same way as those of HIF-P4Hs. Furthermore, recombinant P4H-TM hydroxylated the two critical prolines in HIF-1 alpha ODDD in vitro, with a preference for the C-terminal proline, whereas it did not hydroxylate any prolines in recombinant type I procollagen chains.	Univ Oulu, Collagen Res Unit, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Collagen Res Unit, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; Univ Oulu, Collagen Res Unit, Dept Pathol, FIN-90014 Oulu, Finland; FibroGen Inc, San Francisco, CA 94080 USA	University of Oulu; University of Oulu; University of Oulu; FibroGen	Myllyharju, J (corresponding author), Univ Oulu, Collagen Res Unit, Bioctr Oulu, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi						Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dann CE, 2005, BIOCHEM BIOPH RES CO, V338, P639, DOI 10.1016/j.bbrc.2005.08.140; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang LE, 2002, J BIOL CHEM, V277, P41750, DOI 10.1074/jbc.M207280200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Khan Z, 2006, AM J PATHOL, V169, P1251, DOI 10.2353/ajpath.2006.060360; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KODITZ J, 2007, IN PRESS BLOOD; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Metzen E, 2004, BIOL CHEM, V385, P223, DOI 10.1515/BC.2004.016; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C	41	109	115	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30544	30552		10.1074/jbc.M704988200	http://dx.doi.org/10.1074/jbc.M704988200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726031	hybrid			2022-12-25	WOS:000250136300022
J	Hansen, T; Olsen, L; Lindow, M; Jakobsen, KD; Ullum, H; Jonsson, E; Andreassen, OA; Djurovic, S; Melle, I; Agartz, I; Hall, H; Timm, S; Wang, AG; Werge, T				Hansen, Thomas; Olsen, Line; Lindow, Morten; Jakobsen, Klaus D.; Ullum, Henrik; Jonsson, Erik; Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid; Agartz, Ingrid; Hall, Hakan; Timm, Sally; Wang, August G.; Werge, Thomas			Brain Expressed microRNAs Implicated in Schizophrenia Etiology	PLOS ONE			English	Article								Background. Protein encoding genes have long been the major targets for research in schizophrenia genetics. However, with the identification of regulatory microRNAs ( miRNAs) as important in brain development and function, miRNAs genes have emerged as candidates for schizophrenia-associated genetic factors. Indeed, the growing understanding of the regulatory properties and pleiotropic effects that miRNA have on molecular and cellular mechanisms, suggests that alterations in the interactions between miRNAs and their mRNA targets may contribute to phenotypic variation. Methodology/Principal Findings. We have studied the association between schizophrenia and genetic variants of miRNA genes associated with brain-expression using a case-control study design on three Scandinavian samples. Eighteen known SNPs within or near brain-expressed miRNAs in three samples (Danish, Swedish and Norwegian: 420/163/257 schizophrenia patients and 1006/177/293 control subjects), were analyzed. Subsequently, joint analysis of the three samples was performed on SNPs showing marginal association. Two SNPs rs17578796 and rs1700 in hsa-mir-206 (mir-206) and hsa-mit-198 (mir-198) showed nominal significant allelic association to schizophrenia in the Danish and Norwegian sample respectively (P = 0.0021 & p = 0.038), of which only rs17578796 was significant in the joint sample. In-silico analysis revealed that 8 of the 15 genes predicted to be regulated by both mir-206 and mir-198, are transcriptional targets or interaction partners of the JUN, ATF2 and TAF1 connected in a tight network. JUN and two of the miRNA targets (CCND2 and PTPN1) in the network have previously been associated with schizophrenia. Conclusions/Significance. We found nominal association between brain-expressed miRNAs and schizophrenia for rs17578796 and rs1700 located in mir-206 and mir-198 respectively. These two miRNAs have a surprising large number (15) of targets in common, eight of which are also connected by the same transcription factors.	[Hansen, Thomas; Olsen, Line; Jakobsen, Klaus D.; Werge, Thomas] SCT Hans Mental Hosp, Res Inst Biol Psychiat, Roskilde, Denmark; [Lindow, Morten] Univ Copenhagen, Bioinformat Ctr, Inst Mol Biol, Copenhagen, Denmark; [Ullum, Henrik] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Jonsson, Erik; Agartz, Ingrid; Hall, Hakan] Karolinska Hosp & Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid] Ullevaal Univ Hosp, TOP Project, Dept Psychiat, Oslo, Norway; [Timm, Sally] Univ Dept Psychiat, Psychiat Ctr Frederiksberg, Frederiksberg, Denmark; [Wang, August G.] Univ Dept Psychiat, Psychiat Ctr Amager, Copenhagen, Denmark; [Hansen, Thomas] Univ Copenhagen, Ctr Pharmacogenom, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; University of Oslo; University of Copenhagen	Werge, T (corresponding author), SCT Hans Mental Hosp, Res Inst Biol Psychiat, Roskilde, Denmark.	thomas.werge@shh.regionh.dk	Melle, Ingrid S/B-4858-2011; Hansen, Thomas/GWZ-2858-2022; Andreassen, Ole A./AAY-7531-2020; Hall, Hakan/A-5197-2009; Hansen, Thomas Folkmann/O-5965-2014; Werge, Thomas/G-7263-2012	Melle, Ingrid S/0000-0002-9783-548X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Andreassen, Ole A./0000-0002-4461-3568; Wang, August G./0000-0003-4518-0466; Agartz, Ingrid/0000-0002-9839-5391; Ullum, Henrik/0000-0001-7306-9058; Djurovic, Srdjan/0000-0002-8140-8061				Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Davidsson P, 1999, SCHIZOPHR RES, V40, P23, DOI 10.1016/S0920-9964(99)00037-7; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Falush D, 2003, GENETICS, V164, P1567; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Freedman R, 2001, AM J MED GENET, V105, P794, DOI 10.1002/ajmg.10100; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Jakobsen KD, 2006, PSYCHOPATHOLOGY, V39, P269, DOI 10.1159/000095731; Jakobsen KD, 2005, NORD J PSYCHIAT, V59, P209, DOI 10.1080/08039480510027698; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jonsson EG, 2006, PROG NEURO-PSYCHOPH, V30, P924, DOI 10.1016/j.pnpbp.2006.02.008; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; MCGUFFIN P, 1994, SEMINARS PSYCHIAT GE, P100; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogaev EI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1404, DOI 10.1007/s10541-005-0276-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tamminga CA, 2005, MOL PSYCHIATR, V10, P27, DOI 10.1038/sj.mp.4001563; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vares M, 2006, PSYCHOPATHOLOGY, V39, P286, DOI 10.1159/000095733; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; [No title captured]	44	212	228	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e873	10.1371/journal.pone.0000873	http://dx.doi.org/10.1371/journal.pone.0000873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849003	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455600020
J	Buskila, Y; Abu-Ghanem, Y; Levi, Y; Moran, A; Grauer, E; Amitai, Y				Buskila, Yossi; Abu-Ghanem, Yasmin; Levi, Yifat; Moran, Arie; Grauer, Ettie; Amitai, Yael			Enhanced Astrocytic Nitric Oxide Production and Neuronal Modifications in the Neocortex of a NOS2 Mutant Mouse	PLOS ONE			English	Article							SYNTHASE MESSENGER-RNA; EXPRESSION; RECEPTOR; ACTIVATION; STRESS; MODEL; ROLES; MICE; POTENTIATION; INHIBITORS	Background. It has been well accepted that glial cells in the central nervous system (CNS) produce nitric oxide (NO) through the induction of a nitric oxide synthase isoform (NOS2) only in response to various insults. Recently we described rapid astroglial, NOS2-dependent, NO production in the neocortex of healthy mice on a time scale relevant to neuronal activity. To explore a possible role for astroglial NOS2 in normal brain function we investigated a NOS2 knockout mouse (B6; 129P2-Nos2(tm1Lau)/J, Jackson Laboratory). Previous studies of this mouse strain revealed mainly altered immune responses, but no compensatory pathways and no CNS abnormalities have been reported. Methodology/Principal Findings. To our surprise, using NO imaging in brain slices in combination with biochemical methods we uncovered robust NO production by neocortical astrocytes of the NOS2 mutant. These findings indicate the existence of an alternative pathway that increases basal NOS activity. In addition, the astroglial mutation instigated modifications of neuronal attributes, shown by changes in the membrane properties of pyramidal neurons, and revealed in distinct behavioral abnormalities characterized by an increase in stress-related parameters. Conclusions/Significance. The results strongly indicate the involvement of astrocytic-derived NO in modifying the activity of neuronal networks. In addition, the findings corroborate data linking NO signaling with stress-related behavior, and highlight the potential use of this genetic model for studies of stress-susceptibility. Lastly, our results beg re-examination of previous studies that used this mouse strain to examine the pathophysiology of brain insults, assuming lack of astrocytic nitrosative reaction.	[Buskila, Yossi; Abu-Ghanem, Yasmin; Levi, Yifat; Moran, Arie; Amitai, Yael] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Grauer, Ettie] Israel Inst Biol Res, Dept Pharmacol, IL-70450 Ness Ziona, Israel	Ben Gurion University	Amitai, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel.	yaela@bgu.ac.il	Amitai, Yael/G-2791-2013; MORAN, ARIE/F-1210-2012; Buskila, Yossi/Y-1041-2019	Buskila, Yossi/0000-0001-8500-469X; Amitai, Yael/0000-0001-6664-8705; Abu-Ghanem, Yasmin/0000-0003-3682-5963	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	The study was supported by a grant from the Israel Science Foundation to Yael Amitai.	Aguado F, 2002, J NEUROSCI, V22, P9430; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broillet MC, 2001, FEBS LETT, V491, P227, DOI 10.1016/S0014-5793(01)02206-2; Brown LA, 1999, J NEUROSCI METH, V92, P101, DOI 10.1016/S0165-0270(99)00098-9; Burette A, 2002, J NEUROSCI, V22, P8961; Buskila Y, 2005, GLIA, V52, P169, DOI 10.1002/glia.20217; Chen LC, 2003, BRAIN RES, V973, P214, DOI 10.1016/S0006-8993(03)02484-3; CHIANG LW, 1994, MOL BRAIN RES, V27, P183, DOI 10.1016/0169-328X(94)90202-X; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; de Oliveira RMW, 2000, NEUROSCI LETT, V289, P123, DOI 10.1016/S0304-3940(00)01287-8; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Demas GE, 1999, J NEUROSCI, V19; Demas GE, 1997, MOL MED, V3, P610, DOI 10.1007/BF03401818; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gil Z, 1996, J NEUROSCI, V16, P6567; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Guimaraes FS, 2005, NEUROSCI BIOBEHAV R, V29, P1313, DOI 10.1016/j.neubiorev.2005.03.026; GUIMARAES FS, 1994, NEUROREPORT, V5, P1929, DOI 10.1097/00001756-199410000-00022; Ikeda H, 2004, J NEUROSCI, V24, P9888, DOI 10.1523/JNEUROSCI.2608-04.2004; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Kara P, 1999, J NEUROSCI, V19, P5528; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Liberatore GT, 1999, NAT MED, V5, P1403; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; Lopez-Figueroa MO, 2000, BRAIN RES, V852, P239, DOI 10.1016/S0006-8993(99)02241-6; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Mashimo H, 1999, AM J PHYSIOL-GASTR L, V277, pG745, DOI 10.1152/ajpgi.1999.277.4.G745; Moreira FD, 2003, PHARMACOL BIOCHEM BE, V76, P35, DOI 10.1016/S0091-3057(03)00186-2; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Mungrue IN, 2003, ACTA PHYSIOL SCAND, V179, P123, DOI 10.1046/j.1365-201X.2003.01182.x; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Olivenza R, 2000, J NEUROCHEM, V74, P785, DOI 10.1046/j.1471-4159.2000.740785.x; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Pokk P, 2002, PROG NEURO-PSYCHOPH, V26, P241, DOI 10.1016/S0278-5846(01)00261-5; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Roychowdhury S, 2002, GLIA, V38, P103, DOI 10.1002/glia.10024; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002	55	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e843	10.1371/journal.pone.0000843	http://dx.doi.org/10.1371/journal.pone.0000843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786214	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455500026
J	Phillips, KA; Sherwood, CC; Lilak, AL				Phillips, Kimberley A.; Sherwood, Chet C.; Lilak, Alayna L.			Corpus Callosum Morphology in Capuchin Monkeys Is Influenced by Sex and Handedness	PLOS ONE			English	Article								Sex differences have been reported in both overall corpus callosum area and its regional subdivisions in humans. Some have suggested this reflects a unique adaptation in humans, as similar sex differences in corpus callosum morphology have not been reported in any other species of primate examined to date. Furthermore, an association between various measurements of corpus callosum morphology and handedness has been found in humans and chimpanzees. In the current study, we report measurements of corpus callosum cross-sectional area from midsagittal MR images collected in vivo from 14 adult capuchin monkeys, 9 of which were also characterized for hand preference on a coordinated bimanual task. Adult females were found to have a significantly larger corpus callosum: brain volume ratio, rostral body, posterior midbody, isthmus, and splenium than adult males. Left-handed individuals had a larger relative overall corpus callosum area than did right-handed individuals. Additionally, a significant sex and handedness interaction was found for anterior midbody, with right-handed males having a significantly smaller area than right-handed females. These results suggest that sex and handedness influences on corpus callosum morphology are not restricted to Homo sapiens.	[Phillips, Kimberley A.; Lilak, Alayna L.] Hiram Coll, Dept Psychol, Hiram, OH USA; [Sherwood, Chet C.] George Washington Univ, Dept Anthropol, Washington, DC USA	Hiram College; George Washington University	Phillips, KA (corresponding author), Hiram Coll, Dept Psychol, Hiram, OH USA.	phillipsk@hiram.edu	Phillips, Kimberley/P-1212-2016	Phillips, Kimberley/0000-0002-5517-3596	Howard Hughes Medical Institute, NIH [NS42867, NS24328, MH56661]; NSF [BCS-0515484, BCS0549117]; Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024328, R01NS042867] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the Howard Hughes Medical Institute, NIH ( NS42867, NS24328, MH56661), NSF ( BCS-0515484, BCS0549117) and the Wenner-Gren Foundation.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Bishop KM, 1997, NEUROSCI BIOBEHAV R, V21, P581, DOI 10.1016/S0149-7634(96)00049-8; BROADFIELD DC, 2001, THESIS COLUMBIA U; Dadda M, 2006, NEUROPSYCHOLOGIA, V44, P2582, DOI 10.1016/j.neuropsychologia.2006.03.037; Davatzikos C, 1998, CEREB CORTEX, V8, P635, DOI 10.1093/cercor/8.7.635; DELACOSTE MC, 1988, BRAIN BEHAV EVOLUT, V31, P318, DOI 10.1159/000116598; DELACOSTE MC, 1986, HUM NEUROBIOL, V5, P93; DRIESEN NR, 1995, PSYCHOBIOLOGY, V23, P240; Dunham LA, 2006, BEHAV NEUROSCI, V120, P1025, DOI 10.1037/0735-7044.120.5.1025; Fragaszy D. M., 2004, COMPLETE CAPUCHIN; Fragaszy DM, 1990, J COMP PSYCHOL, V104, P272; HABIB M, 1991, BRAIN COGNITION, V16, P41, DOI 10.1016/0278-2626(91)90084-L; HOLLOWAY RL, 1992, AM J PHYS ANTHROPOL, V87, P349, DOI 10.1002/ajpa.1330870309; HOLLOWAY RL, 1993, AM J PHYS ANTHROPOL, V92, P481, DOI 10.1002/ajpa.1330920407; HOLLOWAY RL, 1986, HUM NEUROBIOL, V5, P87; HOLLOWAY RL, 1990, APES ANGELS ESSAYS A, P221; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P659, DOI 10.1037/0735-7044.118.3.659; Hopkins WD, 2003, J COMP PSYCHOL, V117, P302, DOI 10.1037/0735-7036.117.3.302; HOPKINS WD, 1995, J COMP PSYCHOL, V109, P291, DOI 10.1037/0735-7036.109.3.291; Hopkins WD, 2000, BEHAV NEUROSCI, V114, P739, DOI 10.1037//0735-7044.114.4.739; Jack K., 2007, PRIMATES PERSPECTIVE, P107; JOHNSON SC, 1994, BRAIN RES BULL, V35, P373, DOI 10.1016/0361-9230(94)90116-3; LACOSTEUTAMSING C, 1982, SCIENCE, V216, P1431; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Limongelli L., 1994, P9; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2333, DOI 10.1016/j.neuropsychologia.2007.02.010; Schoenemann PT, 2006, ANNU REV ANTHROPOL, V35, P379, DOI 10.1146/annurev.anthro.35.081705.123210; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Smith RJ, 2005, CURR ANTHROPOL, V46, P249, DOI 10.1086/427117; Spinozzi G, 1998, J COMP PSYCHOL, V112, P183, DOI 10.1037/0735-7036.112.2.183; Sussman RW, 2000, NEW WORLD MONKEYS, V2; Vauclair J, 2005, COGNITIVE BRAIN RES, V25, P210, DOI 10.1016/j.cogbrainres.2005.05.012; WESTERGAARD GC, 1993, PRIMATES, V34, P295, DOI 10.1007/BF02382624; WESTERGAARD GC, 1993, FOLIA PRIMATOL, V61, P38, DOI 10.1159/000156726; Westergaard GC, 1996, J COMP PSYCHOL, V110, P406, DOI 10.1037/0735-7036.110.4.406; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wundrum I. J., 1986, HUMAN EVOLUTION, V1, P183, DOI [10.1007/BF02437494, DOI 10.1007/BF02437494]	43	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e792	10.1371/journal.pone.0000792	http://dx.doi.org/10.1371/journal.pone.0000792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726522	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455400009
J	Bolzoni, L; Real, L; De Leo, G				Bolzoni, Luca; Real, Leslie; De Leo, Giulio			Transmission Heterogeneity and Control Strategies for Infectious Disease Emergence	PLOS ONE			English	Article								Background. The control of emergence and spread of infectious diseases depends critically on the details of the genetic makeup of pathogens and hosts, their immunological, behavioral and ecological traits, and the pattern of temporal and spatial contacts among the age/stage-classes of susceptible and infectious host individuals. Methods and Findings. We show that failing to acknowledge the existence of heterogeneities in the transmission rate among age/stage-classes can make traditional eradication and control strategies ineffective, and in some cases, policies aimed at controlling pathogen emergence can even increase disease incidence in the host. When control strategies target for reduction in numbers those subsets of the population that effectively limit the production of new susceptible individuals, then control can produce a flush of new susceptibles entering the population. The availability of a new cohort of susceptibles may actually increase disease incidence. We illustrate these general points using Classical Swine Fever as a reference disease. Conclusion. Negative effects of culling are robust to alternative formulations of epidemiological processes and underline the importance of better assessing transmission structure in the design of wildlife disease control strategies.	[Bolzoni, Luca; De Leo, Giulio] Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy; [Real, Leslie] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Parma; Emory University	Bolzoni, L (corresponding author), Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy.	luca.bolzoni@nemo.unipr.it	De Leo, Giulio/AAC-5098-2019; Bolzoni, Luca/F-5061-2011	De Leo, Giulio/0000-0002-4186-3369; Bolzoni, Luca/0000-0001-8523-4460	Italian Minister of Research [II04CE49G8]; US National Institutes of Health [RO1 AI1047498]; Emory University	Italian Minister of Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University	This work was supported in part by the Italian Minister of Research prot. II04CE49G8 (LB and GDL) and by a US National Institutes of Health RO1 AI1047498 and an International and Comparative Studies grant from Emory University ( to LAR).	ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; CASTILLOCHAVEZ C, 1989, MATH STAT APPROACHES; Choisy M, 2006, P ROY SOC B-BIOL SCI, V273, P2025, DOI 10.1098/rspb.2006.3554; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; COYNE MJ, 1989, AM J VET RES, V50, P2148; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Heesterbeek J. A. P., 1995, P90, DOI 10.1017/CBO9780511629396.004; Hethcote HW, 1992, MODELING HIV TRANSMI; Kaden V, 2005, EUR J WILDLIFE RES, V51, P101, DOI 10.1007/s10344-005-0083-2; Laddomada A, 2000, VET MICROBIOL, V73, P121, DOI 10.1016/S0378-1135(00)00139-5; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Oliver JH, 2003, P NATL ACAD SCI USA, V100, P11642, DOI 10.1073/pnas.1434553100; Pluimers FH, 1999, PREV VET MED, V42, P139, DOI 10.1016/S0167-5877(99)00085-9; REAL LA, 2005, J HEREDITY, V96; Saatkamp HW, 1997, PREV VET MED, V30, P121, DOI 10.1016/S0167-5877(96)01104-X; Shirley MDF, 2005, EPIDEMIOL INFECT, V133, P1023, DOI 10.1017/S095026880500453X; Sidwa TJ, 2005, JAVMA-J AM VET MED A, V227, P785, DOI 10.2460/javma.2005.227.785; Woodroffe R, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P123	27	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e747	10.1371/journal.pone.0000747	http://dx.doi.org/10.1371/journal.pone.0000747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712403	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455300003
J	Mirambeau, G; Lyonnais, S; Coulaud, D; Hameau, L; Lafosse, S; Jeusset, J; Borde, I; Reboud-Ravaux, M; Restle, T; Gorelick, RJ; Le Cam, E				Mirambeau, Gilles; Lyonnais, Sebastien; Coulaud, Dominique; Hameau, Laurence; Lafosse, Sophie; Jeusset, Josette; Borde, Isabelle; Reboud-Ravaux, Michele; Restle, Tobias; Gorelick, Robert J.; Le Cam, Eric			HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner	PLOS ONE			English	Article								The HIV-1 nucleocapsid is formed during protease (PR)-directed viral maturation, and is transformed into pre-integration complexes following reverse transcription in the cytoplasm of the infected cell. Here, we report a detailed transmission electron microscopy analysis of the impact of HIV-1 PR and reverse transcriptase (RT) on nucleocapsid plasticity, using in vitro reconstitutions. After binding to nucleic acids, NCp15, a proteolytic intermediate of nucleocapsid protein (NC), was processed at its C-terminus by PR, yielding premature NC (NCp9) followed by mature NC (NCp7), through the consecutive removal of p6 and p1. This allowed NC co-aggregation with its single-stranded nucleic-acid substrate. Examination of these co-aggregates for the ability of RT to catalyse reverse transcription showed an effective synthesis of double-stranded DNA that, remarkably, escaped from the aggregates more efficiently with NCp7 than with NCp9. These data offer a compelling explanation for results from previous virological studies that focused on i) Gag processing leading to nucleocapsid condensation, and ii) the disappearance of NCp7 from the HIV-1 pre-integration complexes. We propose that HIV-1 PR and RT, by controlling the nucleocapsid architecture during the steps of condensation and dismantling, engage in a successive nucleoprotein-remodelling process that spatiotemporally coordinates the pre-integration steps of HIV-1. Finally we suggest that nucleoprotein remodelling mechanisms are common features developed by mobile genetic elements to ensure successful replication.	[Mirambeau, Gilles; Lyonnais, Sebastien; Coulaud, Dominique; Hameau, Laurence; Lafosse, Sophie; Jeusset, Josette; Le Cam, Eric] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR Interact Mol & Canc 8126,Lab Microscopie Mol, Villejuif, France; [Mirambeau, Gilles] Univ Paris 06, Div Biochim, UFR Sci Vie, Paris, France; [Borde, Isabelle] Univ Paris 06, Lab Biol & Multimedia, Paris, France; [Reboud-Ravaux, Michele] Univ Paris 06, CNRS, Inst Jacques Monod, Lab Enzymol Mol & Fonct,FRE 2852, Paris, France; [Restle, Tobias] Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany; [Restle, Tobias] ZMSB, Lubeck, Germany; [Gorelick, Robert J.] NCI, AIDS Vaccine Program, Basic Res Program, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Kiel; Schleswig Holstein University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Mirambeau, G (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR Interact Mol & Canc 8126,Lab Microscopie Mol, Villejuif, France.	gilles.mirambeau@free.fr; elecam@igr.fr		Mirambeau, Gilles/0000-0001-8308-4948; Le cam, Eric/0000-0002-6832-6117; Lyonnais, Sebastien/0000-0002-3154-8568	ANRS; EC [LSHG-CT-2003-503480]; National Cancer Institute, National Institutes of Health [N01-CO-12400]	ANRS(ANRSFrench National Research Agency (ANR)); EC(European CommissionEuropean Commission Joint Research Centre); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SL and LH were supported by fellowships from Agence Nationale de Recherches sur le SIDA (ANRS). This work was supported by grants from ANRS (GM and EL), by EC-grant LSHG-CT-2003-503480 (TR) and with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400 (RG). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government.	AlGhusein H, 1996, BIOCHEM BIOPH RES CO, V224, P191, DOI 10.1006/bbrc.1996.1006; Anthony RM, 2007, J MOL BIOL, V365, P310, DOI 10.1016/j.jmb.2006.10.007; Apolloni A, 2003, J VIROL, V77, P9912, DOI 10.1128/JVI.77.18.9912-9921.2003; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Bannwarth L, 2006, J MED CHEM, V49, P4657, DOI 10.1021/jm060576k; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; BILLICH A, 1990, BIOL CHEM H-S, V371, P265, DOI 10.1515/bchm3.1990.371.1.265; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Cruceanu M, 2006, NUCLEIC ACIDS RES, V34, P593, DOI 10.1093/nar/gkj458; de Rocquigny H, 1997, J BIOL CHEM, V272, P30753, DOI 10.1074/jbc.272.49.30753; Dettenhofer M, 1999, J VIROL, V73, P4696, DOI 10.1128/JVI.73.6.4696-4704.1999; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; DUBOCHET J, 1971, J ULTRA MOL STRUCT R, V35, P147, DOI 10.1016/S0022-5320(71)80148-X; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fisher RJ, 2006, NUCLEIC ACIDS RES, V34, P472, DOI 10.1093/nar/gkj442; Forshey BM, 2003, J VIROL, V77, P4409, DOI 10.1128/JVI.77.7.4409-4414.2003; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Fu W, 2006, J VIROL, V80, P1242, DOI 10.1128/JVI.80.3.1242-1249.2006; Gao K, 2003, J VIROL, V77, P1598, DOI 10.1128/JVI.77.2.1598-1603.2003; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Hameau L, 2001, J VIROL, V75, P3301, DOI 10.1128/JVI.75.7.3301-3313.2001; Henriet S, 2005, J MOL BIOL, V354, P55, DOI 10.1016/j.jmb.2005.09.025; Hill MK, 2002, J VIROL, V76, P11245, DOI 10.1128/JVI.76.22.11245-11253.2002; Hsu M, 2000, J HUMAN VIROL, V3, P16; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Jenkins Y, 2001, J VIROL, V75, P10537, DOI 10.1128/JVI.75.21.10537-10542.2001; JOANICOT M, 1987, BIOPOLYMERS, V26, P315, DOI 10.1002/bip.360260211; KHAN R, 1994, J BIOL CHEM, V269, P22538; Kleiman L, 2004, CURR HIV RES, V2, P163, DOI 10.2174/1570162043484988; Kotov A, 1999, J VIROL, V73, P8824, DOI 10.1128/JVI.73.10.8824-8830.1999; Krishnamoorthy G, 2003, NUCLEIC ACIDS RES, V31, P5425, DOI 10.1093/nar/gkg738; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Le Cam E, 1998, BIOPOLYMERS, V45, P217, DOI 10.1002/(SICI)1097-0282(199803)45:3&lt;217::AID-BIP4&gt;3.0.CO;2-U; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Lehmann-Che J, 2004, AIDS REV, V6, P199; Lener D, 1998, J BIOL CHEM, V273, P33781, DOI 10.1074/jbc.273.50.33781; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Lyonnais S, 2003, NUCLEIC ACIDS RES, V31, P5754, DOI 10.1093/nar/gkg716; Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644; Mirambeau G, 2006, J MOL BIOL, V364, P496, DOI 10.1016/j.jmb.2006.08.065; MULLER B, 1989, J BIOL CHEM, V264, P13975; Nermut MV, 2003, J VIROL, V77, P8196, DOI 10.1128/JVI.77.15.8196-8206.2003; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Pettit SC, 1998, ADV EXP MED BIOL, V436, P15; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; Prabu-Jeyabalan M, 2004, J VIROL, V78, P12446, DOI 10.1128/JVI.78.22.12446-12454.2004; Schultz SJ, 2006, J BIOL CHEM, V281, P1943, DOI 10.1074/jbc.M510504200; Shehu-Xhilaga M, 2002, J VIROL, V76, P4331, DOI 10.1128/JVI.76.9.4331-4340.2002; Shehu-Xhilaga M, 2001, J VIROL, V75, P9156, DOI 10.1128/JVI.75.19.9156-9164.2001; Sheng NJ, 1997, J VIROL, V71, P5723, DOI 10.1128/JVI.71.8.5723-5732.1997; SHENG NJ, 1994, J VIROL, V68, P6207, DOI 10.1128/JVI.68.10.6207-6214.1994; Shi J, 2006, VIROLOGY, V350, P493, DOI 10.1016/j.virol.2006.03.013; THOMAS JA, 2006, VIROLOGY; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	67	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e669	10.1371/journal.pone.0000669	http://dx.doi.org/10.1371/journal.pone.0000669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712401	Green Published, gold			2022-12-25	WOS:000207455300001
J	Tang, J; Park, JG; Millard, CB; Schmidt, JJ; Pang, YP				Tang, Jing; Park, Jewn Giew; Millard, Charles B.; Schmidt, James J.; Pang, Yuan-Ping			Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A	PLOS ONE			English	Article							PROTON DISSOCIATION-ENERGIES; SUBSTRATE-SPECIFICITY; DYNAMICS SIMULATIONS; COUPLING REACTION; ARYL; IDENTIFICATION; IMIDAZOLE; MECHANISM; POTENT; IMP-1	Optimization of a serotype-selective, small-molecule inhibitor of botulinum neurotoxin serotype A (BoNTA) endopeptidase is a formidable challenge because the enzyme-substrate interface is unusually large and the endopeptidase itself is a large, zinc-binding protein with a complex fold that is difficult to simulate computationally. We conducted multiple molecular dynamics simulations of the endopeptidase in complex with a previously described inhibitor (K-i(app) of 7+/-2.4 mu M) using the cationic dummy atom approach. Based on our computational results, we hypothesized that introducing a hydroxyl group to the inhibitor could improve its potency. Synthesis and testing of the hydroxyl-containing analog as a BoNTA endopeptidase inhibitor showed a twofold improvement in inhibitory potency (K-i(app) of 3.8+/-0.8 mu M) with a relatively small increase in molecular weight (16 Da). The results offer an improved template for further optimization of BoNTA endopeptidase inhibitors and demonstrate the effectiveness of the cationic dummy atom approach in the design and optimization of zinc protease inhibitors.	[Schmidt, James J.] USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Frederick, MD USA; [Tang, Jing; Park, Jewn Giew; Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN USA; [Millard, Charles B.] Walter Reed Army Inst Res, Div Biochem, Silver Spring, MD USA	Mayo Clinic; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Schmidt, JJ (corresponding author), USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Frederick, MD USA.	james.schmidt@det.amedd.army.mil; pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	Advanced Research Projects Agency [DAAD19-01-10322]; U.S. Army Medical Research Acquisition Activity [W81XWH-04-2-0001]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [5R01AI054574-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054574] Funding Source: NIH RePORTER	Advanced Research Projects Agency; U.S. Army Medical Research Acquisition Activity; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Advanced Research Projects Agency (DAAD19-01-10322), the U.S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), and the National Institutes of Health/National Institute of Allergy and Infectious Diseases (5R01AI054574-03).	Ariffin A, 2004, SYNTHETIC COMMUN, V34, P4439, DOI 10.1081/SCC-200043164; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boldt GE, 2006, ORG LETT, V8, P1729, DOI 10.1021/ol0603211; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Boldt GE, 2006, CHEM COMMUN, P3063, DOI 10.1039/b603099h; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2003, BIOCHEM BIOPH RES CO, V310, P84, DOI 10.1016/j.bbrc.2003.08.112; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickerson TJ, 2006, ACS CHEM BIOL, V1, P359, DOI 10.1021/cb600179d; DIECK HA, 1975, J ORGANOMET CHEM, V93, P259, DOI 10.1016/S0022-328X(00)94049-X; El Yazal J, 2000, J PHYS CHEM B, V104, P6662, DOI 10.1021/jp994283x; El Yazal J, 1999, J PHYS CHEM B, V103, P8773, DOI 10.1021/jp991787m; El Yazal J, 2001, J MOL STRUC-THEOCHEM, V545, P271, DOI 10.1016/S0166-1280(01)00405-5; EUBANKS LM, 2007, P NATL ACAD SCI US; Frisch M J, 1999, GAUSSIAN 98 REVISION; GUPTA RR, 1999, HETEROCYCLIC CHEM, V2, P145; Ho CY, 2005, J ORG CHEM, V70, P4873, DOI 10.1021/jo050036f; Johnson SL, 2006, CURR TOP MED CHEM, V6, P317, DOI 10.2174/156802606776287072; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JOULE JA, 1998, HETEROCYCLIC CHEM, P261; Kessler KR, 1997, NEUROTOXICOLOGY, V18, P761; Meegalla SK, 2004, BIOORG MED CHEM LETT, V14, P4949, DOI 10.1016/j.bmcl.2004.07.033; Merino I, 2006, BIOORGAN MED CHEM, V14, P3583, DOI 10.1016/j.bmc.2006.01.015; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866; MOOTOO DR, 1989, TETRAHEDRON LETT, V30, P2363, DOI 10.1016/S0040-4039(01)80399-3; Oelschlaeger P, 2003, BIOCHEMISTRY-US, V42, P8945, DOI 10.1021/bi0300332; Oelschlaeger P, 2003, PROTEIN ENG, V16, P341, DOI 10.1093/protein/gzg049; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Pang YP, 2004, BIOORGAN MED CHEM, V12, P3063, DOI 10.1016/j.bmc.2004.02.026; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Pang YP, 1996, J BIOL CHEM, V271, P23646, DOI 10.1074/jbc.271.39.23646; Pang YP, 1999, J AM CHEM SOC, V121, P1717, DOI 10.1021/ja9828410; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Roe RR, 1999, J MOL MODEL, V5, P134, DOI 10.1007/s008940050113; Sakai N, 2004, ORG LETT, V6, P1527, DOI 10.1021/ol036499u; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; SHAPIRO R, 1984, BIOCHEMISTRY-US, V23, P5225, DOI 10.1021/bi00317a021; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; SHONE CC, 1994, EUR J BIOCHEM, V225, P263, DOI 10.1111/j.1432-1033.1994.00263.x; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; SPRINGEN K, 2002, BOTOX BOOM NEWSWEEK, P50; SUZUKI A, 1991, PURE APPL CHEM, V63, P419, DOI 10.1351/pac199163030419; Todhunter J A, 1979, Methods Enzymol, V63, P383	52	44	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e761	10.1371/journal.pone.0000761	http://dx.doi.org/10.1371/journal.pone.0000761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712409	Green Published, gold			2022-12-25	WOS:000207455300009
J	Yokota, SI; Okabayashi, T; Yokosawa, N; Fujii, N				Yokota, Shin-ichi; Okabayashi, Tamaki; Yokosawa, Noriko; Fujii, Nobuhiro			Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20	FASEB JOURNAL			English	Article						viral infection; immunosuppression; TLR; monocyte; NF-kappa beta	NF-KAPPA-B; NEGATIVE REGULATION; NUCLEOCAPSID PROTEIN; DENDRITIC CELLS; MUMPS-VIRUS; V PROTEIN; A20; EXPRESSION; PHOSPHOPROTEIN; INFECTION	We recently reported that the activation of NF-kappa beta and AP-1 was suppressed in monocytes infected with measles virus, but not in infected epithelial cells. This cell-type-specific suppression of the inflammatory response represents a potential for measles virus to evade host immune system. In the current study, we examined the suppression mechanism of lipopolysaccharide (LPS)induced, namely Toll-like receptor 4 (TLR4)-mediated, activation of NF-kappa beta and AP-1 in measles virus-infected monocytic cells. In the infected cells, LPS treatment failed to induce the formation of active protein kinase complex containing TAK1, TAB2 and tumor necrosis factor receptor-associated factor 6 (TRAF6), dissociate from TLR complexes containing Interleukin-1 receptor-associated kinase 1 (IRAK1). Ubiquitin-modifying enzyme A20, which is a host negative feedback regulator of NF-kappa beta, was dramatically up-regulated in infected monocytic cells, but not in infected epithelial cells. Suppression of A20 expression by siRNA restored LPS-induced signaling in infected cells. Measles virus phosphoprotein ( P protein) expression was necessary and sufficient for the induction of A20. P protein interacted indirectly with a negative regulatory motif in the A20 gene promoter, and released the suppression of A20 transcription, independent of the activation of NF-kappa beta.-Yokota, S., Okabayashi, T., Yokosawa, N., Fujii, N. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20.	[Yokota, Shin-ichi; Okabayashi, Tamaki; Yokosawa, Noriko; Fujii, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Microbiol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University	Fujii, N (corresponding author), Sapporo Med Univ, Sch Med, Dept Microbiol, Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	fujii@sapmed.ac.jp	Yokota, Shin-ichi/K-8139-2019	Yokota, Shin-ichi/0000-0002-0831-3429				Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Chen A, 2003, VIRUS RES, V98, P123, DOI 10.1016/j.virusres.2003.09.003; Chen MZ, 2006, VIRAL IMMUNOL, V19, P349, DOI 10.1089/vim.2006.19.349; Chen MZ, 2005, J VIROL, V79, P11824, DOI 10.1128/JVI.79.18.11824-11836.2005; FUJII N, 1988, J GEN VIROL, V69, P2085, DOI 10.1099/0022-1317-69-8-2085; Fujii N, 1999, VIRUS RES, V65, P175, DOI 10.1016/S0168-1702(99)00114-8; Gon Y, 2004, AM J RESP CELL MOL, V31, P330, DOI 10.1165/rcmb.2003-0438OC; Griffin D., 2001, FIELDS VIROLOGY, P1401; Hahm B, 2004, VIROLOGY, V323, P292, DOI 10.1016/j.virol.2004.03.011; HARTY RN, 1995, J GEN VIROL, V76, P2863, DOI 10.1099/0022-1317-76-11-2863; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; HORIKAMI SM, 1994, VIROLOGY, V205, P540, DOI 10.1006/viro.1994.1676; HUBER M, 1991, VIROLOGY, V185, P299, DOI 10.1016/0042-6822(91)90777-9; Indoh T, 2007, VIROLOGY, V361, P294, DOI 10.1016/j.virol.2006.11.002; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Naniche D, 1999, J VIROL, V73, P1894, DOI 10.1128/JVI.73.3.1894-1901.1999; Nguyen H, 2006, VIROLOGY, V354, P58, DOI 10.1016/j.virol.2006.04.028; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; Onose A, 2006, EUR J PHARMACOL, V541, P198, DOI 10.1016/j.ejphar.2006.03.073; Oxman Michael N., 2002, P791; Ravanel K, 1997, J EXP MED, V186, P269, DOI 10.1084/jem.186.2.269; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Schneider-Schaulies S, 2003, CURR TOP MICROBIOL, V276, P77; Servet-Delprat C, 2003, CURR TOP MICROBIOL, V276, P103; Spehner D, 1997, VIROLOGY, V232, P260, DOI 10.1006/viro.1997.8568; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; Tober C, 1998, J VIROL, V72, P8124, DOI 10.1128/JVI.72.10.8124-8132.1998; Wang M, 2003, VIRAL IMMUNOL, V16, P45, DOI 10.1089/088282403763635447; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0; Yokota S, 2001, EUR J BIOCHEM, V268, P4664, DOI 10.1046/j.1432-1327.2001.02393.x; Yonekura N, 2003, CELL DEATH DIFFER, V10, P313, DOI 10.1038/sj.cdd.4401169	37	45	51	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2008	22	1					74	83		10.1096/fj.07-8976com	http://dx.doi.org/10.1096/fj.07-8976com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17720800				2022-12-25	WOS:000252309900011
J	Das, AV; James, J; Bhattacharya, S; Imbalzano, AN; Antony, ML; Hegde, G; Zhao, X; Mallya, K; Ahmad, F; Knudsen, E; Ahmad, I				Das, Ani V.; James, Jackson; Bhattacharya, Sumitra; Imbalzano, Anthony N.; Antony, Marie Lue; Hegde, Ganapati; Zhao, Xing; Mallya, Kavita; Ahmad, Faraz; Knudsen, Eric; Ahmad, Iqbal			SWI/SNF chromatin remodeling ATPase Brm regulates the differentiation of early retinal stem cells/progenitors by influencing Brn3b expression and notch signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL FATE DETERMINATION; GANGLION-CELL; PROGENITOR CELLS; TRANSCRIPTION FACTORS; CYCLIN D1; IN-VITRO; MUSCLE DIFFERENTIATION; NEURAL DIFFERENTIATION; MAMMALIAN RETINA; GENE-EXPRESSION	Based on a variety of approaches, evidence suggests that different cell types in the vertebrate retina are generated by multipotential progenitors in response to interactions between cell intrinsic and cell extrinsic factors. The identity of some of the cellular determinants that mediate such interactions has emerged, shedding light on mechanisms underlying cell differentiation. For example, we know now that Notch signaling mediates the influence of the microenvironment on states of commitment of the progenitors by activating transcriptional repressors. Cell intrinsic factors such as the proneural basic helix-loop-helix and homeodomain transcription factors regulate a network of genes necessary for cell differentiation and maturation. What is missing from this picture is the role of developmental chromatin remodeling in coordinating the expression of disparate classes of genes for the differentiation of retinal progenitors. Here we describe the role of Brm, an ATPase in the SWI/SNF chromatin remodeling complex, in the differentiation of retinal progenitors into retinal ganglion cells. Using the perturbation of expression and function analyses, we demonstrate that Brm promotes retinal ganglion cell differentiation by facilitating the expression and function of a key regulator of retinal ganglion cells, Brn3b, and the inhibition of Notch signaling. In addition, we demonstrate that Brm promotes cell cycle exit during retinal ganglion cell differentiation. Together, our results suggest that Brm represents one of the nexus where diverse information of cell differentiation is integrated during cell differentiation.	Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Cincinnati, Dept Cell & Canc Biol, Cincinnati, OH 45267 USA	University of Nebraska System; University of Nebraska Medical Center; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Cincinnati	Ahmad, I (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, 4044 Durham Res Ctr, Omaha, NE 68198 USA.	iahmad@unmc.edu	Antony, Marie Lue/AAB-3952-2019	James, Jackson/0000-0002-7038-2687				Ahmad I, 1999, BRAIN RES, V831, P1, DOI 10.1016/S0006-8993(99)01376-1; Ahmad I, 1997, DEV BIOL, V185, P92, DOI 10.1006/dbio.1997.8546; Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brown RC, 2002, MOL CELL BIOL, V22, P161, DOI 10.1128/MCB.22.1.161-170.2002; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; CHRISTIE GA, 1964, J MORPHOL, V114, P263, DOI 10.1002/jmor.1051140207; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; DAS AV, 2005, STEM CELLS CNS DEV, P235; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Dooley CM, 2003, J NEUROBIOL, V54, P313, DOI 10.1002/neu.10176; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gregg RG, 2003, P NATL ACAD SCI USA, V100, P6535, DOI 10.1073/pnas.0631813100; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hegde GV, 2007, EXP EYE RES, V84, P577, DOI 10.1016/j.exer.2006.11.012; Hempel William M, 2004, Methods Mol Biol, V287, P53; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Imbalzano AN, 2004, ADV PROTEIN CHEM, V67, P157; James J, 2003, J NEUROSCI, V23, P8193; James J, 2004, J NEUROBIOL, V61, P359, DOI 10.1002/neu.20064; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; LeGouy E, 1998, DEV DYNAM, V212, P38, DOI 10.1002/(SICI)1097-0177(199805)212:1<38::AID-AJA4>3.0.CO;2-3; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Machida Y, 2001, J BIOCHEM, V129, P43, DOI 10.1093/oxfordjournals.jbchem.a002834; Marenda DR, 2004, DEV BIOL, V267, P279, DOI 10.1016/j.ydbio.2003.10.040; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; RANDAZZO FM, 1994, DEV BIOL, V161, P229, DOI 10.1006/dbio.1994.1023; Rapaport DH, 1998, SEMIN CELL DEV BIOL, V9, P241, DOI 10.1006/scdb.1998.0232; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Schofield J, 1999, MECH DEVELOP, V80, P115, DOI 10.1016/S0925-4773(98)00207-X; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Sherr CJ, 2000, CANCER RES, V60, P3689; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sidman RL, 1961, STRUCTURE EYE, P487; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Wagner KD, 2003, GENE, V305, P217, DOI 10.1016/S0378-1119(02)01231-3; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang DY, 2001, EXP HEMATOL, V29, P1278, DOI 10.1016/S0301-472X(01)00725-1; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002; Zhou H, 1996, J NEUROSCI, V16, P2261, DOI 10.1523/jneurosci.16-07-02261.1996; Zraly CB, 2004, GENETICS, V168, P199, DOI 10.1534/genetics.104.029439	88	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35187	35201		10.1074/jbc.M706742200	http://dx.doi.org/10.1074/jbc.M706742200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855369	hybrid			2022-12-25	WOS:000251155200064
J	Chon, SH; Zhou, YX; Dixon, JL; Storch, J				Chon, Su-Hyoun; Zhou, Yin Xiu; Dixon, Joseph L.; Storch, Judith			Intestinal monoacylglycerol metabolism - Developmental and nutritional regulation of monoacylglycerol lipase and monoacylglycerol acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; CARBOXYL ESTER LIPASE; FATTY-ACID; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DIETARY DIACYLGLYCEROL; RAT-LIVER; ACYL-COA; TISSUE DISTRIBUTION; CACO-2 CELLS; TRIACYLGLYCEROL	Intestinal monoacylglycerol (MG) metabolism is well known to involve its anabolic reesterification to triacylglycerol (TG). We recently provided evidence for enterocyte MG hydrolysis and demonstrated expression of the monoacylglycerol lipase (MGL) gene in human intestinal Caco-2 cells and rodent small intestinal mucosa. Despite the large quantities of MG derived from dietary TG, the regulation of MG metabolism in the intestine has not been previously explored. In the present studies, we examined the mRNA expression, protein expression, and activities of the two known MG-metabolizing enzymes, MGL and MGAT2, in C57BL/6 mouse small intestine, as well as liver and adipose tissues, during development and under nutritional modifications. Results demonstrate that MG metabolism undergoes tissue-specific changes during development. Marked induction of small intestinal MGAT2 protein expression and activity were found during suckling. Moreover, while substantial levels of MGL protein and activity were detected in adult intestine, its regulation during ontogeny was complex, suggesting post-transcriptional regulation of expression. In addition, during the suckling period MG hydrolytic activity is likely to derive from carboxyl ester lipase rather than MGL. In contrast to intestinal MGL, liver MGL mRNA, protein and activity all increased 5-10-fold during development, suggesting that transcriptional regulation is the primary mechanism for hepatic MGL expression. Three weeks of high fat feeding (40% kcal) significantly induced MGL expression and activity in small intestine relative to low fat feeding (10% kcal), but little change was observed upon starvation, suggesting a role for MGL in dietary lipid assimilation following a high fat intake.	Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, 96 Lipman Dr, New Brunswick, NJ 08901 USA.	storch@aesop.rutgers.edu		Storch, Judith/0000-0001-5482-1777	NIDDK NIH HHS [R01 DK038389, DK38389] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruneau N, 2001, EXP CELL RES, V271, P94, DOI 10.1006/excr.2001.5361; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; COLEMAN RA, 1984, J BIOL CHEM, V259, P8934; COLEMAN RA, 1983, J BIOL CHEM, V258, P450; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; DEJONG BJ, 1978, BIOCHIM BIOPHYS ACTA, V1393, P119; Di Carlo G, 2003, EXPERT OPIN INV DRUG, V12, P39, DOI 10.1517/eoid.12.1.39.21246; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Douglas DN, 2001, J BIOL CHEM, V276, P25621, DOI 10.1074/jbc.M103874200; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; GALLO LL, 1980, J LIPID RES, V21, P537; Ho SP, 2001, AM J PHYSIOL-CELL PH, V281, pC1106, DOI 10.1152/ajpcell.2001.281.4.C1106; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; JAMDAR SC, 1978, J LIPID RES, V19, P763; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JOHNSTON JM, 1967, BIOCHIM BIOPHYS ACTA, V137, P578, DOI 10.1016/0005-2760(67)90140-3; KAMHPUIS M, 2002, AM J CLIN NUTR, V77, P1133; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Kim TS, 1996, J NUTR, V126, P611, DOI 10.1093/jn/126.3.611; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Lewin TM, 2001, ARCH BIOCHEM BIOPHYS, V396, P119, DOI 10.1006/abbi.2001.2604; LIDMER AS, 1995, GENOMICS, V29, P115, DOI 10.1006/geno.1995.1221; LIN MCM, 1994, J BIOL CHEM, V269, P29138; MANOWITZ NR, 1986, J LIPID RES, V27, P196; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Murase T, 2001, J LIPID RES, V42, P372; Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626; Nagao T, 2000, J NUTR, V130, P792, DOI 10.1093/jn/130.4.792; Onorato TM, 2005, J BIOL CHEM, V280, P19527, DOI 10.1074/jbc.M410422200; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Pinto L, 2002, PROSTAG LEUKOTR ESS, V66, P333, DOI 10.1054/plef.2001.0345; Poirier H, 1997, AM J PHYSIOL-GASTR L, V273, pG289, DOI 10.1152/ajpgi.1997.273.2.G289; POPE JL, 1966, J BIOL CHEM, V241, P2306; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; SZTALRYD C, 1994, AM J PHYSIOL, V266, pE179, DOI 10.1152/ajpendo.1994.266.2.E179; Tso P, 2002, BIOCH PHYSL ASPECTS, P125; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WANG CS, 1983, J BIOL CHEM, V258, P9197; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; XIA T, 1993, AM J PHYSIOL, V265, pR414, DOI 10.1152/ajpregu.1993.265.2.R414; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	53	45	48	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33346	33357		10.1074/jbc.M706994200	http://dx.doi.org/10.1074/jbc.M706994200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848545	hybrid			2022-12-25	WOS:000250840200014
J	Shin, M; Chetkovich, DM				Shin, Minyoung; Chetkovich, Dane M.			Activity-dependent regulation of h channel distribution in hippocampal CA1 pyramidal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING RAT HIPPOCAMPUS; ACTIVATED PACEMAKER CHANNELS; PROTEIN-KINASE-II; ANATOMICAL DATA; AMPA RECEPTORS; UP-REGULATION; ION CHANNELS; HCN CHANNELS; EXPRESSION; BRAIN	The hyperpolarization-activated cation current, I-h, plays an important role in regulating intrinsic neuronal excitability in the brain. In hippocampal pyramidal neurons, Ih is mediated by h channels comprised primarily of the hyperpolarization-activated cyclic nucleotide-gated ( HCN) channel subunits, HCN1 and HCN2. Pyramidal neuron h channels within hippocampal area CA1 are remarkably enriched in distal apical dendrites, and this unique distribution pattern is critical for regulating dendritic excitability. We utilized biochemical and immunohistochemical approaches in organotypic slice cultures to explore factors that control h channel localization in dendrites. We found that distal dendritic enrichment of HCN1 is first detectable at postnatal day 13, reaching maximal enrichment by the 3rd postnatal week. Interestingly we found that an intact entorhinal cortex, which projects to distal dendrites of CA1 but not area CA3, is critical for the establishment and maintenance of distal dendritic enrichment of HCN1. Moreover blockade of excitatory neurotransmission using tetrodotoxin, 6-cyano-7-nitroquinoxaline- 2,3-dione, or 2-aminophosphonovalerate redistributed HCN1 evenly throughout the dendrite without significant changes in protein expression levels. Inhibition of calcium/calmodulin-dependent protein kinase II activity, but not p38 MAPK, also redistributed HCN1 in CA1 pyramidal neurons. We conclude that activation of ionotropic glutamate receptors by excitatory temporoammonic pathway projections from the entorhinal cortex establishes and maintains the distribution pattern of HCN1 in CA1 pyramidal neuron dendrites by activating calcium/calmodulin-dependent protein kinase II-mediated downstream signals.	Northwestern Univ, Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Chetkovich, DM (corresponding author), Northwestern Univ, Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA.	d-chetkovich@northwestern.edu	Chetkovich, Dane/AAV-5457-2021		NINDS NIH HHS [K02 NS055995-02, K02 NS055995, R21 NS052595, R21 NS 052595, R21 NS052595-02, K02 NS055995-01, R21 NS052595-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052595, K02NS055995] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bender RA, 2005, EUR J NEUROSCI, V22, P2669, DOI 10.1111/j.1460-9568.2005.04407.x; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Cai X, 2007, J NEUROSCI, V27, P59, DOI 10.1523/JNEUROSCI.4502-06.2007; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Dailey ME, 1996, J NEUROSCI, V16, P2983; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Niesen CE, 1999, DEV NEUROSCI-BASEL, V21, P328, DOI 10.1159/000017382; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; WITTER MP, 1993, HIPPOCAMPUS, V3, P33	42	65	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33168	33180		10.1074/jbc.M703736200	http://dx.doi.org/10.1074/jbc.M703736200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848552	hybrid, Green Accepted			2022-12-25	WOS:000250625400064
J	Devaraj, SG; Wang, N; Chen, Z; Chen, Z; Tseng, M; Barretto, N; Lin, R; Peters, CJ; Tseng, CTK; Baker, SC; Li, K				Devaraj, Santhana G.; Wang, Nan; Chen, Zhongbin; Chen, Zihong; Tseng, Monica; Barretto, Naina; Lin, Rongtuan; Peters, Clarence J.; Tseng, Chien-Te K.; Baker, Susan C.; Li, Kui			Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; MOUSE HEPATITIS-VIRUS; RIG-I; ADAPTER PROTEIN; INTERFERON INDUCTION; ANTIVIRAL RESPONSES; CELLULAR-RESPONSE; IKK-EPSILON; ACTIVATION	Severe acute respiratory syndrome coronavirus ( SARS-CoV) is a novel coronavirus that causes a highly contagious respiratory disease, SARS, with significant mortality. Although factors contributing to the highly pathogenic nature of SARS-CoV remain poorly understood, it has been reported that SARS-CoV infection does not induce type I interferons ( IFNs) in cell culture. However, it is uncertain whether SARS-CoV evades host detection or has evolved mechanisms to counteract innate host defenses. We show here that infection of SARS-CoV triggers a weak IFN response in cultured human lung/bronchial epithelial cells without inducing the phosphorylation of IFN-regulatory factor 3 ( IRF-3), a latent cellular transcription factor that is pivotal for type I IFN synthesis. Furthermore, SARS-CoV infection blocked the induction of IFN antiviral activity and the up-regulation of protein expression of a subset of IFN-stimulated genes triggered by double-stranded RNA or an unrelated paramyxovirus. In searching for a SARS-CoV protein capable of counteracting innate immunity, we identified the papain-like protease ( PLpro) domain as a potent IFN antagonist. The inhibition of the IFN response does not require the protease activity of PLpro. Rather, PLpro interacts with IRF-3 and inhibits the phosphorylation and nuclear translocation of IRF-3, thereby disrupting the activation of type I IFN responses through either Toll-like receptor 3 or retinoic acid-inducible gene I/melanoma differentiation-associated gene 5 pathways. Our data suggest that regulation of IRF-3-dependent innate antiviral defenses by PLpro may contribute to the establishment of SARS-CoV infection.	Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA; Loyola Univ, Dept Microbiol & Immunol, Maywood, IL 60153 USA; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Loyola University Chicago; Lady Davis Institute; McGill University	Li, K (corresponding author), Univ Texas, Med Branch, Dept Microbiol & Immunol, 4-142G Blocker Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	kuli@utmb.edu	Lin, Rongtuan/A-1442-2008; Chen, Zhongbin/C-5259-2009	Lin, Rongtuan/0000-0002-2238-3503; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060915, N01AI30039, R01AI069285, U54AI057156, N01AI030039, R01AI045798, R56AI069285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA018054] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045798, N01 AI030039-009, AI45798, P01 AI060915-030001, R01 AI045798-01A2, AI069285, AI30039, U54 AI057156, R01 AI069285-01A2, AI060915, R01 AI069285, U54 AI057156-05S10038, AI057156, P01 AI060915] Funding Source: Medline; NIDA NIH HHS [R21 DA018054-01, R21 DA018054, DA018054] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fries KL, 1999, VIROLOGY, V264, P159, DOI 10.1006/viro.1999.9980; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Goldsmith CS, 2004, EMERG INFECT DIS, V10, P320, DOI 10.3201/eid1002.030913; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Goutagny N, 2006, NAT IMMUNOL, V7, P555, DOI 10.1038/ni0606-555; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Langford M P, 1981, Methods Enzymol, V78, P339; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li K, 2002, HEPATOLOGY, V35, P1237, DOI 10.1053/jhep.2002.32968; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; MCKIMMBRESCHKIN JL, 1982, INFECT IMMUN, V36, P857, DOI 10.1128/IAI.36.3.857-863.1982; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Mossel EC, 2005, J VIROL, V79, P3846, DOI 10.1128/JVI.79.6.3846-3850.2005; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Ziebuhr J, 2006, ADV EXP MED BIOL, V581, P3	80	290	313	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32208	32221		10.1074/jbc.M704870200	http://dx.doi.org/10.1074/jbc.M704870200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761676	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000250480300044
J	Hanington, PC; Wang, T; Secombes, CJ; Belosevic, M				Hanington, Patrick C.; Wang, Tiehui; Secombes, Christopher J.; Belosevic, Miodrag			Growth factors of lower vertebrates - Characterization of goldfish (Carassius auratus L.) macrophage colony-stimulating factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-RECEPTOR; M-CSF; LANGSDORFII KIDNEY; CELLS; PROLIFERATION; CULTURES; VITRO	Colony-stimulating factor-1 (CSF-1) regulates mononuclear cell proliferation, differentiation, and survival. The functions of CSF-1 are well documented in mammals; however, little is known about CSF-1 biology in lower vertebrates. This is the first report on the identification and functional characterization of a fish CSF-1 molecule expressed highly in the spleen and in phorbol 12-myristate 13-acetate-stimulated monocytes. Goldfish CSF-1 is a 199-amino acid protein that possesses the required cysteine residues to form important intra-chain and inter-chain disulfide bonds that allow CSF-1 to form a functional homodimer and to interact with its high affinity receptor, CSF-1R. Recombinant goldfish CSF-1 formed a homodimer and bound to the soluble goldfish CSF-1R. The addition of the recombinant CSF-1 to sorted goldfish progenitor cells, monocytes, and macrophages induced the differentiation of monocytes into macrophages and the proliferation of monocyte-like cells. The proliferation of these cells was abrogated by addition of an anti-CSF-1R antibody as well as the soluble CSF1R. The ability of the soluble CSF-1R to inhibit CSF-1-induced proliferation represents a novel mechanism for the regulation of CSF-1 function.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2E9, Canada; Univ Aberdeen, Scottish Fish Immunol Res Ctr, Aberdeen AB24 2TZ, Scotland	University of Alberta; University of Alberta; University of Aberdeen	Belosevic, M (corresponding author), Univ Alberta, Dept Biol Sci, CW-405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mike.belosevic@ualberta.ca	Belosevic, Mike/A-2617-2014; Belosevic, Miodrag/G-9396-2018; Belosevic, Miodrag/C-6729-2008	Belosevic, Mike/0000-0001-6512-3587; Belosevic, Miodrag/0000-0002-6412-8236; Belosevic, Miodrag/0000-0002-6412-8236; Wang, Tiehui/0000-0002-1148-8959; Hanington, Patrick/0000-0002-3964-5012				Barreda DR, 2005, DEV COMP IMMUNOL, V29, P879, DOI 10.1016/j.dci.2005.02.006; Barreda DR, 2001, FISH SHELLFISH IMMUN, V11, P169, DOI 10.1006/fsim.2000.0305; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; BECKER S, 1987, J IMMUNOL, V139, P3703; Belosevic M, 2006, FISH SHELLFISH IMMUN, V20, P152, DOI 10.1016/j.fsi.2004.10.010; GUILBERT LJ, 1980, J CELL BIOL, V85, P153, DOI 10.1083/jcb.85.1.153; Hanington PC, 2006, J BIOL CHEM, V281, P9963, DOI 10.1074/jbc.M600631200; Hanington PC, 2005, FISH SHELLFISH IMMUN, V18, P359, DOI 10.1016/j.fsi.2004.09.003; Honda T, 2005, MOL IMMUNOL, V42, P1, DOI 10.1016/j.molimm.2004.07.002; Kobayashi I, 2007, DEV COMP IMMUNOL, V31, P696, DOI 10.1016/j.dci.2006.10.003; Kobayashi I, 2006, DEV COMP IMMUNOL, V30, P1034, DOI 10.1016/j.dci.2006.01.005; Koths K, 1997, MOL REPROD DEV, V46, P31; Motoyoshi K, 1998, INT J HEMATOL, V67, P109; Neumann NF, 2000, FISH SHELLFISH IMMUN, V10, P1, DOI 10.1006/fsim.1999.0221; Neumann NF, 1998, DEV COMP IMMUNOL, V22, P417, DOI 10.1016/S0145-305X(98)00023-8; Oshibe T, 1999, J VET MED B, V46, P389, DOI 10.1046/j.1439-0450.1999.00245.x; PAMPFER S, 1991, BIOESSAYS, V13, P535, DOI 10.1002/bies.950131007; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Roca FJ, 2006, MOL IMMUNOL, V43, P1418, DOI 10.1016/j.molimm.2005.07.028; SHADLE PJ, 1989, J CELL BIOCHEM, V40, P91, DOI 10.1002/jcb.240400110; Shao XG, 1996, REPROD FERT DEVELOP, V8, P103, DOI 10.1071/RD9960103; SHERR CJ, 1989, BLOOD, V73, P1786; SHERR CJ, 1988, COLD SPRING HARB SYM, V53, P521, DOI 10.1101/SQB.1988.053.01.060; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Williams H, 2002, GENE, V295, P255, DOI 10.1016/S0378-1119(02)00736-9; ZE W, 1993, MOL CELL BIOL, V13, P5348, DOI 10.1128/MCB.13.9.5348	28	41	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31865	31872		10.1074/jbc.M706278200	http://dx.doi.org/10.1074/jbc.M706278200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827160	hybrid			2022-12-25	WOS:000250480300006
J	Jacobs, A; Quraishi, O; Huang, XC; Bousquet-Gagnon, N; Nault, G; Francella, N; Alvord, WG; Pham, N; Soucy, C; Robitaille, M; Bridon, D; Blumenthal, R				Jacobs, Amy; Quraishi, Omar; Huang, Xicai; Bousquet-Gagnon, Nathalie; Nault, Genevieve; Francella, Nicholas; Alvord, W. Gregory; Pham, Nga; Soucy, Chantal; Robitaille, Martin; Bridon, Dominique; Blumenthal, Robert			A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CELL FUSION; 6-HELIX BUNDLE; PEPTIDE INHIBITOR; POTENT INHIBITORS; SYNTHETIC PEPTIDE; ATOMIC-STRUCTURE; MEMBRANE-FUSION; COILED-COIL; SOLUBLE CD4	Peptide inhibitors corresponding to sequences in the six helix bundle structure of the fusogenic portion (gp41) of the HIV envelope glycoprotein have been successfully implemented in preventing HIV entry. These peptides bind to regions in HIV gp41 transiently exposed during the fusion reaction. In an effort to improve upon these entry inhibitors, we have successfully designed and tested peptide analogs composed of chemical spacers and reactive moieties positioned strategically to facilitate covalent attachment. Using a temperature-arrested state prime wash in vitro assay we show evidence for the trapping of a pre-six helix bundle fusion intermediate by a covalent reaction with the specific anti-HIV-1 peptide. This is the first demonstration of the trapping of an intermediate conformation of a viral envelope glycoprotein during the fusion process that occurs in live cells. The permanent specific attachment of the covalent inhibitor is projected to improve the pharmacokinetics of administration in vivo and thereby improve the long-term sustainability of peptide entry inhibitor therapy and help to expand its applicability beyond salvage therapy.	Conjuchem Biotechnol Inc, Montreal, PQ H2X 3Y8, Canada; NCI, Ctr Canc Res Nanobiol Program, NIH, Frederick, MD 21702 USA; Data Management Serv Inc, NCI, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumenthal, R (corresponding author), Conjuchem Biotechnol Inc, 225 President Kennedy Ave,Ste PK-3950, Montreal, PQ H2X 3Y8, Canada.	blumenthalr@mail.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC008303, ZIABC008303] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CIMINALE V, 1990, AIDS RES HUM RETROV, V6, P1281, DOI 10.1089/aid.1990.6.1281; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELEAN A, 1979, MOL PHARMACOL, V15, P60; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DOMS RW, 1990, J VIROL, V64, P3537, DOI 10.1128/JVI.64.7.3537-3540.1990; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; DUBAY JW, 1991, ADV EXP MED BIOL, V303, P39; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; FREY S, 1995, J VIROL, V69, P1462, DOI 10.1128/JVI.69.3.1462-1472.1995; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gallo SA, 2004, J MOL BIOL, V340, P9, DOI 10.1016/j.jmb.2004.04.027; Gallo SA, 2004, BIOCHEMISTRY-US, V43, P8230, DOI 10.1021/bi049957v; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Hart TK, 1996, AIDS RES HUM RETROV, V12, P1305, DOI 10.1089/aid.1996.12.1305; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; JIANG SB, 1993, BIOCHEM BIOPH RES CO, V195, P533, DOI 10.1006/bbrc.1993.2078; Leger R, 2004, BIOORG MED CHEM LETT, V14, P4395, DOI 10.1016/j.bmcl.2004.06.066; Leger R, 2004, BIOORG MED CHEM LETT, V14, P841, DOI 10.1016/j.bmcl.2003.12.025; Leger R, 2003, BIOORG MED CHEM LETT, V13, P3571, DOI 10.1016/S0960-894X(03)00790-X; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; MCKEATING JA, 1991, J VIROL, V65, P852, DOI 10.1128/JVI.65.2.852-860.1991; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Patel IH, 2005, CLIN PHARMACOKINET, V44, P175, DOI 10.2165/00003088-200544020-00003; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SATTENTAU QJ, 1986, SCIENCE, V234, P1120, DOI 10.1126/science.2430333; Shai Y, 2000, BIOSCIENCE REP, V20, P535, DOI 10.1023/A:1010411021326; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Thibaudeau K, 2005, BIOCONJUGATE CHEM, V16, P1000, DOI 10.1021/bc050102k; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; [No title captured]	50	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32406	32413		10.1074/jbc.M705577200	http://dx.doi.org/10.1074/jbc.M705577200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726011	hybrid			2022-12-25	WOS:000250480300063
J	Li, XY; Guo, F; Zhang, L; Kleiman, L; Cen, S				Li, Xiao-Yu; Guo, Fei; Zhang, Li; Kleiman, Lawrence; Cen, Shan			APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEOCAPSID PROTEIN; VIRAL-RNA; ANTIVIRAL ACTIVITY; VIF PROTEIN; SOR GENE; TYPE-1; MECHANISM; GAG; REPLICATION	Human APOBEC3G ( hA3G) has been identified as an anti-HIV-1 host factor. The presence of hA3G in HIV-1 strongly inhibits the ability of the virus to produce new viral DNA upon infection. In this report, we demonstrate that the reduction of late viral DNA synthesis is due to the inhibition by hA3G of the strand transfer steps that occur during reverse transcription. Analysis of viral cDNA intermediates in vivo reveals that hA3G causes an inhibition of the minus and plus strand transfers, without having a significant impact on DNA elongation. Using an in vitro system to measure minus strand transfer similarly shows a dose-dependent reduction of strand transfer by hA3G. This inhibition of strand transfer occurs independently the editing activity of hA3G and is correlated with its ability to prevent RNaseH degradation of the template RNA.	McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; Chinese Acad Med Sci, Dept Virol, Inst Med Biotechnol, Beijing 100050, Peoples R China	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS	Kleiman, L (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	lawrence.kleiman@mcgill.ca; shan.cen@mcgill.ca		Guo, Fei/0000-0003-3500-1006				Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bampi C, 2004, INT J BIOCHEM CELL B, V36, P1668, DOI 10.1016/j.biocel.2004.02.024; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Gabor J, 2002, J VIROL, V76, P9096, DOI 10.1128/JVI.76.18.9096-9102.2002; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Guo XF, 2003, VIROLOGY, V307, P154, DOI 10.1016/S0042-6822(02)00068-5; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Larocque Daniel, 2005, RNA Biol, V2, P37, DOI 10.4161/rna.2.2.1603; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Li JL, 2004, J CELL BIOCHEM, V92, P560, DOI 10.1002/jcb.20082; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Willetts KE, 1999, J VIROL, V73, P1682, DOI 10.1128/JVI.73.2.1682-1688.1999; WOHRL BM, 1993, J BIOL CHEM, V268, P13617; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	52	128	131	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32065	32074		10.1074/jbc.M703423200	http://dx.doi.org/10.1074/jbc.M703423200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17855362				2022-12-25	WOS:000250480300027
J	Burton, RL; Chen, SW; Xu, XL; Grant, GA				Burton, Rodney L.; Chen, Shawei; Xu, Xiao Lan; Grant, Gregory A.			A novel mechanism for substrate inhibition in mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACT DOMAIN	Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase undergoes significant inhibition of activity with increasing concentrations of its substrate, hydroxypyruvic acid phosphate. The enzyme also displays an unusual dual pH optimum. A significant decrease in the K-i for substrate inhibition at pH values corresponding to the valley between these optima is responsible for this phenomena. The change in Ki has an average pK of similar to 5.8 and involves two functional groups that are protonated and two functional groups that are unprotonated for optimal substrate inhibition to occur. Mutagenesis of positively charged amino acid residues at a putative anion binding site previously revealed by the x-ray structure, produces significant changes in the pH-dependent profile of substrate inhibition. Several single residue mutations eliminate the dual pH optima by reducing substrate inhibition between pH 5 and 7 and a triple mutation was identified that eliminates the substrate inhibition altogether. The mutagenesis data support the conclusion that the anion binding site represents a new allosteric site for the control of enzyme activity and functions in a novel mechanism for substrate inhibition.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Grant, GA (corresponding author), Washington Univ, Sch Med, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	ggrant@wustl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56676] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Cleland W W, 1979, Methods Enzymol, V63, P500; CORMACK B, 1991, CURRENT PROTOCOLS MO; Dey S, 2005, J BIOL CHEM, V280, P14892, DOI 10.1074/jbc.M414489200; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHUDSON M, 1995, FORBES MEDIA CRITIC, V2, P76; Segel I, 1975, ENZYME KINETICS; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081	15	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31517	31524		10.1074/jbc.M704032200	http://dx.doi.org/10.1074/jbc.M704032200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761677	hybrid			2022-12-25	WOS:000250309200043
J	Gouttenoire, J; Valcourt, U; Bougault, C; Aubert-Foucher, E; Arnaud, E; Giraud, L; Mallein-Gerin, F				Gouttenoire, Jerome; Valcourt, Ulrich; Bougault, Carole; Aubert-Foucher, Elisabeth; Arnaud, Estelle; Giraud, Lionel; Mallein-Gerin, Frederic			Knockdown of the intraflagellar transport protein IFT46 stimulates selective gene expression in mouse chondrocytes and affects early development in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSOVENTRAL PATTERN-FORMATION; ENDOCHONDRAL BONE-DEVELOPMENT; POLYCYSTIC KIDNEY-DISEASE; DIFFERENTIATION IN-VITRO; BARDET-BIEDL-SYNDROME; II COLLAGEN GENE; PRIMARY CILIUM; GROWTH-PLATE; LIMB DEVELOPMENT; MORPHOGENETIC PROTEIN-2	Bone morphogenetic proteins (BMPs) act as multifunctional regulators in morphogenesis during development. In particular they play a determinant role in the formation of cartilage molds and their replacement by bone during endochondral ossification. In cell culture, BMP-2 favors chondrogenic expression and promotes hypertrophic maturation of chondrocytes. In mouse chondrocytes we have identified a BMP-2-sensitive gene encoding a protein of 301 amino acids. This protein, named mIFT46, is the mouse ortholog of recently identified Caenorhabditis elegans and Chlamydomonas reinhardtii intraflagellar transport (IFT) proteins. After generation of a polyclonal antibody against mIFT46, we showed for the first time that the endogenous protein is located in the primary cilium of chondrocytes. We also found that mIFT46 is preferentially expressed in early hypertrophic chondrocytes located in the growth plate. Additionally, mIFT46 knockdown by small interfering RNA oligonucleotides in cultured chondrocytes specifically stimulated the expression of several genes related to skeletogenesis. Furthermore, Northern blotting analysis indicated that mIFT46 is also expressed before chondrogenesis in embryonic mouse development, suggesting that the role of mIFT46 might not be restricted to cartilage. To explore the role of IFT46 during early development, we injected antisense morpholino oligonucleotides in Danio rerio embryos to reduce zebrafish IFT46 protein (zIFT46) synthesis. Dramatic defects in embryonic development such as a dorsalization and a tail duplication were observed. Thus our results taken together indicate that the ciliary protein IFT46 has a specific function in chondrocytes and is also essential for normal development of vertebrates.	Univ Lyon, F-69003 Lyon, France; Univ Lyon 1, CNRS UMR 5086, Inst Biol & Chim Prot, IFR Biosci Gerland Lyon Sud 128, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Mallein-Gerin, F (corresponding author), Univ Lyon, F-69003 Lyon, France.	f.mallein-gerin@ibcp.fr	Gouttenoire, Jérôme/G-7947-2017; Gouttenoire, Jérôme/AAQ-8353-2020; VALCOURT, Ulrich/ABB-3943-2021	Gouttenoire, Jérôme/0000-0002-7715-1494; Gouttenoire, Jérôme/0000-0002-7715-1494; VALCOURT, Ulrich/0000-0002-1727-4409				Alieva I B, 1999, Membr Cell Biol, V12, P895; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnaud E, 2006, CELL DEATH DIFFER, V13, P1128, DOI 10.1038/sj.cdd.4401797; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P3244, DOI 10.1002/art.22167; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Bluteau G, 2002, BIORHEOLOGY, V39, P247; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Deng CX, 1997, DEV BIOL, V185, P42, DOI 10.1006/dbio.1997.8553; Dick A, 2000, DEVELOPMENT, V127, P343; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Evans MJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1263, DOI 10.1152/ajplung.00180.2002; GITELMAN SE, 1994, J CELL BIOL, V126, P1595, DOI 10.1083/jcb.126.6.1595; Gregory KE, 2001, J BONE MINER RES, V16, P2005, DOI 10.1359/jbmr.2001.16.11.2005; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149; Hay E, 1999, J CELL BIOCHEM, V72, P81, DOI 10.1002/(SICI)1097-4644(19990101)72:1<81::AID-JCB9>3.0.CO;2-N; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hild M, 1999, DEVELOPMENT, V126, P2149; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; JOLY JS, 1993, DEVELOPMENT, V119, P1261; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leboy PS, 1997, J CELL BIOCHEM, V66, P394, DOI 10.1002/(SICI)1097-4644(19970901)66:3<394::AID-JCB11>3.0.CO;2-F; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LEGUELLEC D, 1994, HISTOCHEM J, V26, P695, DOI 10.1007/BF00158202; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Loones MT, 1998, CELL STRESS CHAPERON, V3, P237, DOI 10.1379/1466-1268(1998)003<0237:HACDDE>2.3.CO;2; Mallein-Gerin F, 2004, METH MOLEC MED, V100, P105; MALLEINGERIN F, 1990, ROUX ARCH DEV BIOL, V198, P363, DOI 10.1007/BF00383774; MALLEINGERIN F, 1988, DEV BIOL, V126, P337, DOI 10.1016/0012-1606(88)90144-3; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; McGlashan SR, 2007, MATRIX BIOL, V26, P234, DOI 10.1016/j.matbio.2006.12.003; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Mullins MC, 1996, DEVELOPMENT, V123, P81; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Mykytyn K, 2004, TRENDS MOL MED, V10, P106, DOI 10.1016/j.molmed.2004.01.003; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; O'Brien KP, 2000, BIOCHEM BIOPH RES CO, V273, P90, DOI 10.1006/bbrc.2000.2910; Olsen B, 2005, MATRIX BIOL, V24, P449, DOI 10.1016/j.matbio.2005.09.003; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Poole CA, 2001, J ANAT, V199, P393, DOI 10.1046/j.1469-7580.2001.19940393.x; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Rutherford R B, 1992, Int J Oral Maxillofac Implants, V7, P297; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; SOKOLOV BP, 1994, NUCLEIC ACIDS RES, V22, P4009, DOI 10.1093/nar/22.19.4009; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Takagi M, 2000, HISTOCHEM J, V32, P175, DOI 10.1023/A:1004099324169; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tiffee JC, 2000, TISSUE CELL, V32, P141, DOI 10.1054/tice.2000.0097; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Valcourt U, 1999, EXP CELL RES, V251, P264, DOI 10.1006/excr.1999.4584; Valcourt U, 2003, FEBS LETT, V545, P115, DOI 10.1016/S0014-5793(03)00510-6; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; VUKICEVIC S, 1989, P NATL ACAD SCI USA, V86, P8793, DOI 10.1073/pnas.86.22.8793; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wang O, 2001, DEVELOPMENT, V128, P3867; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; WILSMAN NJ, 1980, ANAT REC, V197, P355, DOI 10.1002/ar.1091970309; WILSMAN NJ, 1978, J ULTRA MOL STRUCT R, V64, P270, DOI 10.1016/S0022-5320(78)90036-9; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yeh LCC, 2002, J CELL PHYSIOL, V191, P298, DOI 10.1002/jcp.10094; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang L, 2003, J PHYSIOL-LONDON, V551, P765, DOI 10.1113/jphysiol.2003.041707; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	89	22	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30960	30973		10.1074/jbc.M705730200	http://dx.doi.org/10.1074/jbc.M705730200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720815	hybrid			2022-12-25	WOS:000250136300064
J	Jang, SW; Yang, SJ; Srinivasan, S; Ye, KQ				Jang, Sung-Wuk; Yang, Seung-Ju; Srinivasan, Shanthi; Ye, Keqiang			Akt phosphorylates Mstl and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; CASPASE; APOPTOSIS; CLEAVAGE; INDUCTION; SURVIVAL	Oxidative stress can induce apoptosis through activation of MstI, subsequent phosphorylation of FOXO and nuclear translocation. MstI is a common component of apoptosis initiated by various stresses. MstI kinase activation requires autophosphorylation and proteolytic degradation by caspases. The role of Akt in regulating MstI activity has not been previously examined. Here, we show that MstI is a physiological substrate of Akt. Akt phosphorylation of MstI diminishes its apoptotic cleavage by caspases and prevents its kinase activity on FOXO3. MstI directly binds to Akt, which is regulated Akt kinase activity. Akt phosphorylates MstI on the Thr(387) residue and protects MstI from apoptotic cleavage in vitro and in apoptotic cells. Interestingly, Akt phosphorylation of MstI strongly inhibits its kinase activity on FOXO3. The phosphorylation mimetic mutant MST1 T387E blocks H2O2-triggered FOXO3 nuclear translocation and apoptosis. Thus, our findings support that Akt blocks MstI-triggered FOXO3 nuclear translocation by phosphorylating MstI, promoting cell survival.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University; Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Srinivasan, Shanthi/A-6133-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER; NINDS NIH HHS [R01, NS045627] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Blois JT, 2004, J BIOL CHEM, V279, P30123, DOI 10.1074/jbc.M402793200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; DEL PL, 1997, SCIENCE, V278, P687; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Renner O, 2007, CARCINOGENESIS, V28, P1418, DOI 10.1093/carcin/bgm059; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601	28	113	116	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30836	30844		10.1074/jbc.M704542200	http://dx.doi.org/10.1074/jbc.M704542200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726016	hybrid			2022-12-25	WOS:000250136300052
J	Lee, IH; Dinudom, A; Sanchez-Perez, A; Kumar, S; Cook, DI				Lee, Il-Ha; Dinudom, Anuwat; Sanchez-Perez, Angeles; Kumar, Sharad; Cook, David I.			Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; HORMONAL-REGULATION; A6 CELLS; ENAC; ALDOSTERONE; SGK1; EXPRESSION; TRANSPORT	The epithelial sodium channel (ENaC) plays an important role in transepithelial Na+ absorption; hence its function is essential for maintaining Na (+) and fluid homeostasis and regulating blood pressure. Insulin is one of the hormones that regulates activity of ENaC. In this study, we investigated the contribution of two related protein kinases, Akt (also known as protein kinase B) and the serum-and glucocorticoid-dependent kinase (Sgk), on insulin-induced ENaC activity in Fisher rat thyroid cells expressing ENaC. Overexpression of Akt1 or Sgk1 significantly increased ENaC activity, whereas expression of a dominantnegative construct of Akt1, Akt1K179M, decreased basal activity of ENaC. Inhibition of the endogenous expression of Akt1 and Sgk1 by short interfering RNA not only inhibited ENaC but also disrupted the stimulatory effect on ENaC of insulin and of the downstream effectors of insulin, phosphatidylinositol 3-kinase and PDK1. Conversely, overexpression of Akt1 or Sgk1 increased expression of ENaC at the cell membrane and overcame the inhibitory effect of Nedd4-2 on ENaC. Furthermore, mutation of consensus phosphorylation sites on Nedd4-2 for Akt1 and Sgk1, Ser342 and Ser428, completely abolished the inhibitory effect of Sgk1 and Akt1 on Nedd4-2 action. Together these data suggest that both Akt and Sgk are components of an insulin signaling pathway that increases Na (+)absorption by upregulating membrane expression of ENaC via a regulatory system that involves inhibition of Nedd4-2.	Univ Sydney, Fac Med, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; Hanson Ctr Canc Res, Inst Med & Vet Sci, Adelaide, SA 500, Australia	University of Sydney; Institute Medical & Veterinary Science Australia	Cook, DI (corresponding author), Med Fdn Bldg,92-94 Parramatta Rd, Sydney, NSW 2050, Australia.	davidc@physiol.usyd.edu.au	Kumar, Sharad/AAX-7787-2020	Kumar, Sharad/0000-0001-7126-9814				Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Arteaga MF, 2005, AM J PHYSIOL-RENAL, V289, pF90, DOI 10.1152/ajprenal.00390.2004; Blazer-Yost BL, 2003, AM J PHYSIOL-CELL PH, V284, pC1645, DOI 10.1152/ajpcell.00372.2002; Blazer-Yost BL, 1998, AM J PHYSIOL-CELL PH, V274, pC1373, DOI 10.1152/ajpcell.1998.274.5.C1373; BLAZERYOST BL, 1989, AM J PHYSIOL, V257, pC612, DOI 10.1152/ajpcell.1989.257.4.C612; Boehmer C, 2003, BIOCHEM BIOPH RES CO, V306, P156, DOI 10.1016/S0006-291X(03)00921-5; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Fuster DG, 2007, AM J PHYSIOL-RENAL, V292, pF577, DOI 10.1152/ajprenal.00240.2006; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; HERRERA FRANCISCO C., 1965, AMER J PHYSIOL, V209, P819; Kim IS, 2000, BBA-MOL CELL RES, V1496, P333, DOI 10.1016/S0167-4889(00)00029-X; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; MARUNAKA Y, 1992, AM J PHYSIOL, V263, pF392, DOI 10.1152/ajprenal.1992.263.3.F392; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Nizet A, 1976, Curr Probl Clin Biochem, V6, P262; NIZET A, 1971, PFLUG ARCH EUR J PHY, V323, P11, DOI 10.1007/BF00586561; Palmada M, 2006, DIABETES, V55, P421, DOI 10.2337/diabetes.55.02.06.db05-0720; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; Record RD, 1998, AM J PHYSIOL-ENDOC M, V274, pE611, DOI 10.1152/ajpendo.1998.274.4.E611; Record RD, 1996, AM J PHYSIOL-CELL PH, V271, pC1079, DOI 10.1152/ajpcell.1996.271.4.C1079; Shane MA, 2006, GEN COMP ENDOCR, V147, P85, DOI 10.1016/j.ygcen.2005.11.010; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	36	112	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29866	29873		10.1074/jbc.M701923200	http://dx.doi.org/10.1074/jbc.M701923200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715136	hybrid			2022-12-25	WOS:000249981200015
J	Sohy, D; Parmentier, M; Springael, JY				Sohy, Denis; Parmentier, Marc; Springael, Jean-Yves			Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; CHEMOKINE RECEPTOR; NEGATIVE COOPERATIVITY; BREAST-CANCER; FACTOR-I; CXCR4; DIMERIZATION; EXPRESSION; CCR5; HOMODIMERIZATION	Chemokine receptors are presently used as targets for candidate drugs in the frame of inflammatory diseases and human immunodeficiency virus infection. They were shown to dimerize, but the functional relevance of dimerization in terms of drug action remains poorly understood. We reported previously the existence of negative binding cooperativity between the subunits of CCR2/CCR5 heterodimers. In the present study, we extend these observations to heterodimers formed by CCR2 and CXCR4, which are more distantly related. We also show that specific antagonists of one receptor inhibit the binding of chemokines to the other receptor as a consequence of their heterodimerization, both in recombinant cell lines and primary leukocytes. This resulted in a significant functional cross-inhibition in terms of calcium mobilization and chemotaxis. These data demonstrate that chemokine receptor antagonists regulate allosterically the functional properties of receptors on which they do not bind directly, with important implications on the effects of these potential therapeutic agents.	Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium	Universite Libre de Bruxelles	Parmentier, M (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	mparment@ulb.ac.be		Parmentier, Marc/0000-0001-8081-4685				Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blanpain C, 1999, BLOOD, V94, P1899; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Dar WA, 2007, IMMUNOLOGY, V120, P467, DOI 10.1111/j.1365-2567.2006.02534.x; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Frade JMR, 1997, J IMMUNOL, V159, P5576; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gao P, 2003, J LEUKOCYTE BIOL, V73, P273, DOI 10.1189/jlb.0602269; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; JIANG YL, 1992, J IMMUNOL, V148, P2423; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; LEVITZKI A, 1974, J THEOR BIOL, V44, P367, DOI 10.1016/0022-5193(74)90167-2; Majka M, 2006, FOLIA HISTOCHEM CYTO, V44, P155; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Muller A, 2006, INT J CANCER, V118, P2147, DOI 10.1002/ijc.21514; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Peacock JW, 1999, J IMMUNOL, V162, P215; Pease JE, 2006, BRIT J PHARMACOL, V147, pS212, DOI 10.1038/sj.bjp.0706475; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Rabin RL, 1999, J IMMUNOL, V162, P3840; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001	37	127	133	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30062	30069		10.1074/jbc.M705302200	http://dx.doi.org/10.1074/jbc.M705302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715128	hybrid			2022-12-25	WOS:000249981200036
J	de Napoles, M; Nesterova, T; Brockdorff, N				de Napoles, Mariana; Nesterova, Tatyana; Brockdorff, Neil			Early Loss of Xist RNA Expression and Inactive X Chromosome Associated Chromatin Modification in Developing Primordial Germ Cells	PLOS ONE			English	Article								Background. The inactive X chromosome characteristic of female somatic lineages is reactivated during development of the female germ cell lineage. In mouse, analysis of protein products of X-linked genes and/or transgenes located on the X chromosome has indicated that reactivation occurs after primordial germ cells reach the genital ridges. Principal Findings/Methodology. We present evidence that the epigenetic reprogramming of the inactive X-chromosome is initiated earlier than was previously thought, around the time that primordial germ cells (PGCs) migrate through the hindgut. Specifically, we find that Xist RNA expression, the primary signal for establishment of chromosome silencing, is extinguished in migrating PGCs. This is accompanied by displacement of Polycomb-group repressor proteins Eed and Suz(12), and loss of the inactive X associated histone modification, methylation of histone H3 lysine 27. Conclusions/Significance. We conclude that X reactivation in primordial germ cells occurs progressively, initiated by extinction of Xist RNA around the time that germ cells migrate through the hindgut to the genital ridges. The events that we observe are reminiscent of X reactivation of the paternal X chromosome in inner cell mass cells of mouse pre-implantation embryos and suggest a unified model in which execution of the pluripotency program represses Xist RNA thereby triggering progressive reversal of epigenetic silencing of the X chromosome.	[de Napoles, Mariana; Nesterova, Tatyana; Brockdorff, Neil] Hammersmith Hosp, MRC, Ctr Clin Sci, Imperial Coll,Fac Med, London, England	Imperial College London	Brockdorff, N (corresponding author), Hammersmith Hosp, MRC, Ctr Clin Sci, Imperial Coll,Fac Med, London, England.	neil.brockdorff@csc.mrc.ac.uk		Brockdorff, Neil/0000-0003-4838-2653; Nesterova, Tatyana/0000-0001-7740-4386	MRC [MC_U120031757] Funding Source: UKRI; Medical Research Council [MC_U120031757] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; EPSTEIN CJ, 1969, SCIENCE, V163, P1078, DOI 10.1126/science.163.3871.1078; GRANT M, 1992, NAT GENET, V2, P161, DOI 10.1038/ng1092-161; JOHNSTON PG, 1981, GENET RES, V37, P317, DOI 10.1017/S0016672300020322; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Nesterova TB, 2002, DIFFERENTIATION, V69, P216, DOI 10.1046/j.1432-0436.2002.690415.x; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saitou M, 2003, PHILOS T R SOC B, V358, P1363, DOI 10.1098/rstb.2003.1324; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P1413, DOI 10.1073/pnas.89.4.1413; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; TAM PPL, 1994, DEVELOPMENT, V120, P2925; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	35	75	75	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e860	10.1371/journal.pone.0000860	http://dx.doi.org/10.1371/journal.pone.0000860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848991	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600007
J	Gururajan, M; Jacob, J; Pulendran, B				Gururajan, Murali; Jacob, Joshy; Pulendran, Bali			Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets	PLOS ONE			English	Article								Background. Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogen associated molecular patterns and trigger innate immunity leading to initiation of adaptive immunity. TLR-mediated activation of dendritic cells (DCs) is known to be a critical event in the initiation of cellular and humoral immune responses. Recent work however suggests that B cells also express TLRs, and that they can be activated via TLR ligands. However, whether such B cell activation occurs only on memory B cells, or whether it can also occur on truly naive B cells remains controversial. Furthermore, the expression and functional relevance of TLRs on distinct subsets of B cells, which are known to play differential roles in humoral responses is not known. Methodology/Principal Findings. In this study, we investigated the expression pattern of different TLRs in distinct subsets of murine B cells (naive, memory, follicular, marginal zone, B-1 and peyer's patch). In contrast to the reported restricted expression pattern of TLRs in human peripheral blood naive B cells, murine splenic naive B cells express a variety of TLRs with the exception of TLR5 and 8. Consistent with this relatively broad expression pattern, murine naive B cells proliferate and secrete antibody to a variety of TLR agonists in vitro, in the absence of B-cell receptor cross-linking. In addition, we observed subtle differences in the antibody secretion pattern of follicular, marginal zone, B-1 and peyer's patch B-cell subsets. Conclusions/Significance. Thus various B cell subsets, including truly naive B cells, express multiple TLRs, and signaling via such TLRs results in their robust proliferation and antibody secretion, even in the absence of dendritic cell activation, or T-cell help.	[Gururajan, Murali; Jacob, Joshy; Pulendran, Bali] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Jacob, Joshy] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Pulendran, B (corresponding author), Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA.	bpulend@rmy.emory.edu	Pulendran, Bali/AAW-9550-2021		NIAID NIH HHS [U19AI057266, R01 AI056499, R01 AI048638, R01 AI48638-01, R01 AI056499-01, U19 AI057266] Funding Source: Medline; NIDDK NIH HHS [R01 DK57665-01, R01 DK057665] Funding Source: Medline; PHS HHS [N01 A150025, N01-A1-50019] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R01AI056499, R01AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Chappell CP, 2006, J IMMUNOL, V176, P4706, DOI 10.4049/jimmunol.176.8.4706; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fink K, 2006, EUR J IMMUNOL, V36, P2094, DOI 10.1002/eji.200635993; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; Ito T, 2005, INT J HEMATOL, V81, P188, DOI 10.1532/IJH97.05012; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Mansson A, 2006, IMMUNOLOGY, V118, P539, DOI 10.1111/j.1365-2567.2006.02392.x; Martin D, 2002, BRILLS TIBET STU LIB, V2, P335; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; VITETTA ES, 1975, J IMMUNOL, V115, P603; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; WHITLOCK CA, 1979, J EXP MED, V150, P1483, DOI 10.1084/jem.150.6.1483	29	147	154	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e863	10.1371/journal.pone.0000863	http://dx.doi.org/10.1371/journal.pone.0000863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848994	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455600010
J	Horibe, T; Hoogenraad, NJ				Horibe, Tomohisa; Hoogenraad, Nicholas J.			The Chop Gene Contains an Element for the Positive Regulation of the Mitochondrial Unfolded Protein Response	PLOS ONE			English	Article							STRESS-RESPONSE; IDENTIFICATION; ACTIVATION; EXPRESSION; INDUCTION; ATF6	We have previously reported on the discovery of a mitochondrial specific unfolded protein response (mtUPR) in mammalian cells, in which the accumulation of unfolded protein within the mitochondrial matrix results in the transcriptional activation of nuclear genes encoding mitochondrial stress proteins such as chaperonin 60, chaperonin 10, mtDnaJ, and ClpP, but not those encoding stress proteins of the endoplasmic reticulum (ER) or the cytosol. Analysis of the chaperonin 60/10 bidirectional promoter showed that the CHOP element was required for the mtUPR and that the transcription of the chop gene is activated by mtUPR. In order to investigate the role of CHOP in the mtUPR, we carried out a deletion analysis of the chop promoter. This revealed that the transcriptional activation of the chop gene by mtUPR is through an AP-1 (activator protein-1) element. This site lies alongside an ERSE element through which chop transcription is activated in response to the ER stress response (erUPR). Thus CHOP can be induced separately in response to 2 different stress response pathways. We also discuss the potential signal pathway between mitochondria and the nucleus for the mtUPR.	[Horibe, Tomohisa; Hoogenraad, Nicholas J.] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia	La Trobe University	Hoogenraad, NJ (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia.	n.hoogenraad@latrobe.edu.au	Hoogenraad, Nicholas J/C-7505-2011					ALDRIDGE J, 2007, PLOS ONE UNPUB; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Dietrich AJ, 2004, ANN FAM MED, V2, P301, DOI 10.1370/afm.102; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; RYAN MT, 2007, ANN REV BIO IN PRESS; Schroder M, 2006, MOL BIOTECHNOL, V34, P279, DOI 10.1385/MB:34:2:279; SRERE PA, 1980, TRENDS BIOCHEM SCI, V5, P120, DOI 10.1016/0968-0004(80)90051-1; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	32	149	151	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e835	10.1371/journal.pone.0000835	http://dx.doi.org/10.1371/journal.pone.0000835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848986	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600002
J	Ligios, C; Cancedda, GM; Margalith, I; Santucciu, C; Madau, L; Maestrale, C; Basagni, M; Saba, M; Heikenwalder, M				Ligios, Ciriaco; Cancedda, Giovanna Maria; Margalith, Ilan; Santucciu, Cinzia; Madau, Laura; Maestrale, Caterina; Basagni, Massimo; Saba, Mariangela; Heikenwalder, Mathias			Intraepithelial and Interstitial Deposition of Pathological Prion Protein in Kidneys of Scrapie-Affected Sheep	PLOS ONE			English	Article								Prions have been documented in extra-neuronal and extra-lymphatic tissues of humans and various ruminants affected by Transmissible Spongiform Encephalopathy (TSE). The presence of prion infectivity detected in cervid and ovine blood tempted us to reason that kidney, the organ filtrating blood derived proteins, may accumulate disease associated PrP(Sc). We collected and screened kidneys of experimentally, naturally scrapie-affected and control sheep for renal deposition of PrP(Sc) from distinct, geographically separated flocks. By performing Western blot, PET blot analysis and immunohistochemistry we found intraepithelial (cortex, medulla and papilla) and occasional interstitial (papilla) deposition of PrP(Sc) in kidneys of scrapie-affected sheep. Interestingly, glomerula lacked detectable signals indicative of PrP(Sc). PrP(Sc) was also detected in kidneys of subclinical sheep, but to significantly lower degree. Depending on the stage of the disease the incidence of PrP(Sc) in kidney varied from approximately 27% (subclinical) to 73.6% (clinical) in naturally scrapie-affected sheep. Kidneys from flocks without scrapie outbreak were devoid of PrP(Sc). Here we demonstrate unexpectedly frequent deposition of high levels of PrP(Sc) in ovine kidneys of various flocks. Renal deposition of PrP(Sc) is likely to be a pre-requisite enabling prionuria, a possible co-factor of horizontal prion-transmission in sheep.	[Ligios, Ciriaco; Cancedda, Giovanna Maria; Santucciu, Cinzia; Madau, Laura; Maestrale, Caterina; Saba, Mariangela] Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy; [Margalith, Ilan; Heikenwalder, Mathias] Univ Spital Zurich, Inst Neuropathol, Dept Pathol, Zurich, Switzerland	IZS Della Sardegna; University of Zurich; University Zurich Hospital	Ligios, C (corresponding author), Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy.	ciriaco.ligios@izs-sardegna.it; mathias.heikenwalder@usz.ch	Santucciu, Cinzia/D-1229-2012; Heikenwalder, Mathias/AAA-2269-2020	Santucciu, Cinzia/0000-0001-9699-3745; 				Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Andreoletti O, 2002, J HISTOCHEM CYTOCHEM, V50, P1357, DOI 10.1177/002215540205001009; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Kovacs GG, 2004, ANN NEUROL, V55, P121, DOI 10.1002/ana.10813; Lezmi S, 2003, HISTOCHEM CELL BIOL, V119, P415, DOI 10.1007/s00418-003-0524-5; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Lupi O, 2005, MED HYPOTHESES, V65, P47, DOI 10.1016/j.mehy.2005.01.039; MAESTRALE C, 2004, P 16 C NAZ SOC IT PA, P178; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ryder SJ, 2001, VET REC, V148, P437, DOI 10.1136/vr.148.14.437; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Siso S, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327-b; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Wisniewski HM, 1996, LANCET, V347, P1114, DOI 10.1016/S0140-6736(96)90310-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	35	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e859	10.1371/journal.pone.0000859	http://dx.doi.org/10.1371/journal.pone.0000859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848990	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455600006
J	Gingras, S; Pelletier, S; Boyd, K; Ihle, JN				Gingras, Sebastien; Pelletier, Stephane; Boyd, Kelli; Ihle, James N.			Characterization of a Family of Novel Cysteine- Serine-Rich Nuclear Proteins (CSRNP)	PLOS ONE			English	Article								Gene array analysis has been widely used to identify genes induced during T cell activation. Our studies identified an immediate early gene that is strongly induced in response to IL-2 in mouse T cells which we named cysteine- serine-rich nuclear protein-1 (CSRNP-1). The human ortholog was previously identified as an AXIN1 induced gene (AXUD1). The protein does not contain sequence defined domains or motifs annotated in public databases, however the gene is a member of a family of three mammalian genes that share conserved regions, including cysteine- and serine-rich regions and a basic domain, they encode nuclear proteins, possess transcriptional activation domain and bind the sequence AGAGTG. Consequently we propose the nomenclature of CSRNP-1, -2 and -3 for the family. To elucidate the physiological functions of CSRNP-1, -2 and -3, we generated mice deficient for each of these genes by homologous recombination in embryonic stem cells. Although the CSRNP proteins have the hallmark of transcription factors and CSRNP-1 expression is highly induced by IL-2, deletion of the individual genes had no obvious consequences on normal mouse development, hematopoiesis or T cell functions. However, combined deficiencies cause partial neonatal lethality suggesting that the genes have redundant functions.	[Gingras, Sebastien; Pelletier, Stephane; Ihle, James N.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Boyd, Kelli] St Jude Childrens Res Hosp, Anim Resource Ctr, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.ihle@stjude.org		Pelletier, Stephane/0000-0002-1127-0212	Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities ( ALSAC);  [RO1 DK42932];  [PO1 HL53740]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER	Cancer Center CORE; American Lebanese Syrian Associated Charities ( ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cancer Center CORE grant CA21765, by grants RO1 DK42932 and PO1 HL53740 to J. N. I., and by the American Lebanese Syrian Associated Charities ( ALSAC).	Beadling Carol, 2002, Med Immunol, V1, P2, DOI 10.1186/1476-9433-1-2; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Gatzka M, 2006, CYTOKINE, V34, P143, DOI 10.1016/j.cyto.2006.04.003; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Hoffmeyer A, 2001, MOL CELL BIOL, V21, P3137, DOI 10.1128/MCB.21.9.3137-3143.2001; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; LAHTI JM, 1994, NAT GENET, V7, P370, DOI 10.1038/ng0794-370; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nishidate T, 2004, INT J ONCOL, V25, P797; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yi XM, 2006, AM J PHYSIOL-HEART C, V290, pH1098, DOI 10.1152/ajpheart.00832.2005; Zamorano J, 1998, J IMMUNOL, V160, P3502	34	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e808	10.1371/journal.pone.0000808	http://dx.doi.org/10.1371/journal.pone.0000808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726538	Green Published, gold			2022-12-25	WOS:000207455400025
J	Kelter, G; Steinbach, D; Konkimalla, VB; Tahara, T; Taketani, S; Fiebig, HH; Efferth, T				Kelter, Gerhard; Steinbach, Daniel; Konkimalla, Venkata Badireenath; Tahara, Tsuyoshi; Taketani, Shigeru; Fiebig, Heinz-Herbert; Efferth, Thomas			Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate	PLOS ONE			English	Article								The anti-malarial artesunate also exerts profound anti-cancer activity. The susceptibility of tumor cells to artesunate can be enhanced by ferrous iron. The transferrin receptor (TfR) is involved in iron uptake by internalization of transferrin and is over-expressed in rapidly growing tumors. The ATP-binding cassette (ABC) transporters ABCB6 and ABCB7 are also involved in iron homeostasis. To investigate whether these proteins play a role for sensitivity towards artesunate, Oncotest's 36 cell line panel was treated with artesunate or artesunate plus iron(II) glycine sulfate (Ferrosanol (R)). The majority of cell lines showed increased inhibition rates, for the combination of artesunate plus iron(II) glycine sulfate compared to artesunate alone. However, in 11 out of the 36 cell lines the combination treatment was not superior. Cell lines with high TfR expression significantly correlated with high degrees of modulation indicating that high TfR expressing tumor cells would be more efficiently inhibited by this combination treatment than low TfR expressing ones. Furthermore, we found a significant relationship between cellular response to artesunate and TfR expression in 55 cell lines of the National Cancer Institute (NCI), USA. A significant correlation was also found for ABCB6, but not for ABCB7 in the NCI panel. Artesunate treatment of human CCRF-CEM leukemia and MCF7 breast cancer cells induced ABCB6 expression but repressed ABCB7 expression. Finally, artesunate inhibited proliferation and differentiation of mouse erythroleukemia (MEL) cells. Down-regulation of ABCB6 by antisense oligonucleotides inhibited differentiation of MEL cells indicating that artesunate and ABCB6 may cooperate. In conclusion, our results indicate that ferrous iron improves the activity of artesunate in some but not all tumor cell lines. Several factors involved in iron homeostasis such as TfR and ABCB6 may contribute to this effect.	[Konkimalla, Venkata Badireenath; Efferth, Thomas] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Kelter, Gerhard; Fiebig, Heinz-Herbert] Oncotest GmbH, Inst Expt Oncol, Freiburg, Germany; [Steinbach, Daniel] Univ Ulm, Dept Pediat, D-7900 Ulm, Germany; [Tahara, Tsuyoshi; Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Kyoto 606, Japan	Helmholtz Association; German Cancer Research Center (DKFZ); Oncotest GmbH; Ulm University; Kyoto Institute of Technology	Efferth, T (corresponding author), German Canc Res Ctr, Pharmaceut Biol C015, D-6900 Heidelberg, Germany.	t.efferth@dkfz.de	Konkimalla, Badireenath/A-7473-2011; Konkimalla, VB/K-7496-2019; Tahara, Tsuyoshi/E-4024-2010	Efferth, Thomas/0000-0002-3096-3292; Konkimalla, Badireenath/0000-0003-3699-7490	intramural grants	intramural grants	This work was funded by intramural grants.	ALLEY MC, 1988, CANCER RES, V48, P589; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; Berger TG, 2005, ONCOL REP, V14, P1599; Boonstra R, 2004, BRIT J CANCER, V90, P2411, DOI 10.1038/sj.bjc.6601863; BOUSTOS MD, 1994, B WORLD HEALTH ORGAN, V72, P729; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DENGLER WA, 1995, ANTI-CANCER DRUG, V6, P522, DOI 10.1097/00001813-199508000-00005; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 1996, ARZNEIMITTEL-FORSCH, V46, P196; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2007, PLANTA MED, V73, P299, DOI 10.1055/s-2007-967138; Efferth T, 2006, MOL CANCER THER, V5, P1986, DOI 10.1158/1535-7163.MCT-06-0086; Efferth Thomas, 2001, Current Molecular Medicine (Hilversum), V1, P45, DOI 10.2174/1566524013364194; FIEBIG HH, 1992, IMMUNODEFICIENT MICE, V42, P321; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; Gillet Jean-Pierre, 2006, Cancer Genomics & Proteomics, V3, P97; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Meshnick S R, 1998, Med Trop (Mars), V58, P13; Moore JC, 1995, CANCER LETT, V98, P83, DOI 10.1016/0304-3835(95)90207-4; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; POSNER GH, 1995, J AM CHEM SOC, V117, P5885, DOI 10.1021/ja00126a042; POSNER GH, 2000, CARBON CTR RADICALS, P289; Robert A, 2002, ACCOUNTS CHEM RES, V35, P167, DOI 10.1021/ar990164o; ROTH T, 1999, CONTRIB ONCOL, V54, P145; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; SHTERMAN N, 1991, PATHOBIOLOGY, V59, P19, DOI 10.1159/000163611; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Steinbach D, 2003, BLOOD, V102, P4493, DOI 10.1182/blood-2002-11-3461; Steinbach D, 2006, CLIN CANCER RES, V12, P4357, DOI 10.1158/1078-0432.CCR-05-2587; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Ucar T, 2003, BRIT J NEUROSURG, V17, P525, DOI 10.1080/02688690310001627759; Volm Manfred, 2004, Cancer Genomics & Proteomics, V1, P157; WHITNEY JF, 1995, CANCER, V76, P20, DOI 10.1002/1097-0142(19950701)76:1<20::AID-CNCR2820760104>3.0.CO;2-3; Wirth GJ, 2006, ONCOLOGY-BASEL, V71, P86, DOI 10.1159/000100476; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Yang DC, 2001, ANTICANCER RES, V21, P541; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; ZHANG F, 1992, BIOCHEM PHARMACOL, V43, P1805, DOI 10.1016/0006-2952(92)90713-S	46	81	90	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e798	10.1371/journal.pone.0000798	http://dx.doi.org/10.1371/journal.pone.0000798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726528	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455400015
J	Matsuura, K; Tamura, T; Kobayashi, N; Yashiro, T; Tatsumi, S				Matsuura, Kenji; Tamura, Takashi; Kobayashi, Norimasa; Yashiro, Toshihisa; Tatsumi, Shingo			The Antibacterial Protein Lysozyme Identified as the Termite Egg Recognition Pheromone	PLOS ONE			English	Article							ISOPTERA; SEQUENCE; FUNGUS; ANTS	Social insects rely heavily on pheromone communication to maintain their sociality. Egg protection is one of the most fundamental social behaviours in social insects. The recent discovery of the termite-egg mimicking fungus 'termite-ball' and subsequent studies on termite egg protection behaviour have shown that termites can be manipulated by using the termite egg recognition pheromone (TERP), which strongly evokes the egg-carrying and -grooming behaviours of workers. Despite the great scientific and economic importance, TERP has not been identified because of practical difficulties. Herein we identified the antibacterial protein lysozyme as the TERP. We isolated the target protein using ion-exchange and hydrophobic interaction chromatography, and the MALDI-TOF MS analysis showed a molecular size of 14.5 kDa. We found that the TERP provided antibacterial activity against a gram-positive bacterium. Among the currently known antimicrobial proteins, the molecular size of 14.5 kDa limits the target to lysozyme. Termite lysozymes obtained from eggs and salivary glands, and even hen egg lysozyme, showed a strong termite egg recognition activity. Besides eggs themselves, workers also supply lysozyme to eggs through frequent egg-grooming, by which egg surfaces are coated with saliva containing lysozyme. Reverse transcript PCR analysis showed that mRNA of termite lysozyme was expressed in both salivary glands and eggs. Western blot analysis confirmed that lysozyme production begins in immature eggs in queen ovaries. This is the first identification of proteinaceous pheromone in social insects. Researchers have focused almost exclusively on hydrocarbons when searching for recognition pheromones in social insects. The present finding of a proteinaceous pheromone represents a major step forward in, and result in the broadening of, the search for recognition pheromones. This novel function of lysozyme as a termite pheromone illuminates the profound influence of pathogenic microbes on the evolution of social behaviour in termites.	[Matsuura, Kenji; Kobayashi, Norimasa; Yashiro, Toshihisa; Tatsumi, Shingo] Okayama Univ, Grad Sch Environm Sci, Okayama, Japan; [Matsuura, Kenji] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Tamura, Takashi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan	Okayama University; Harvard University; Okayama University	Matsuura, K (corresponding author), Okayama Univ, Grad Sch Environm Sci, Okayama, Japan.	kenjijpn@cc.okayama-u.ac.jp	Tamura, Takashi/B-2097-2011; Matsuura, Kenji/B-1573-2011; Yashiro, Toshihisa/J-3120-2015; Matsuura, Kenji/H-8364-2019	Yashiro, Toshihisa/0000-0002-9582-4605; Matsuura, Kenji/0000-0002-9099-6694	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was funded by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). PROBRAIN provides full financial support for this research and publication of the achievement.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; D'Ettorre P, 2006, NATURWISSENSCHAFTEN, V93, P136, DOI 10.1007/s00114-005-0075-9; de Bruijn PJA, 2006, J CHEM ECOL, V32, P1599, DOI 10.1007/s10886-006-9092-1; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Fujita A, 2002, INSECT BIOCHEM MOLEC, V32, P1615, DOI 10.1016/S0965-1748(02)00100-5; Gorman MJ, 2004, INSECT MOL BIOL, V13, P19, DOI 10.1111/j.1365-2583.2004.00454.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Holldobler B., 1990, pi; Hultmark D., 1996, Experientia Supplementum (Basel), V75, P87; JOLLES P, 1996, MODEL ENZYMES BIOCH; Koganesawa N, 2001, PROTEIN ENG, V14, P705, DOI 10.1093/protein/14.9.705; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; MATSUMURA F, 1968, NATURE, V219, P963, DOI 10.1038/219963a0; Matsuura K, 2005, APPL ENTOMOL ZOOL, V40, P53, DOI 10.1303/aez.2005.53; Matsuura K, 2003, CONT T ENT, P131; Matsuura K, 2002, ANIM BEHAV, V64, P167, DOI 10.1006/anbe.2002.3062; Matsuura K, 2000, ECOL RES, V15, P405, DOI 10.1046/j.1440-1703.2000.00361.x; MATSUURA K, 2002, THESIS KYOTO U KYOTO; MATSUURA K, 2000, Patent No. 2000342149; Matsuura K, 2007, POPUL ECOL, V49, P179, DOI 10.1007/s10144-006-0030-4; Matsuura K, 2006, NATURWISSENSCHAFTEN, V93, P506, DOI 10.1007/s00114-006-0136-8; Matsuura K, 2006, P ROY SOC B-BIOL SCI, V273, P1203, DOI 10.1098/rspb.2005.3434; Pankewitz F, 2006, J CHEM ECOL, V32, P2067, DOI 10.1007/s10886-006-9129-5; Rosengaus RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P546, DOI 10.1007/s002650100394; Shellman-Reeve Janet S., 1997, P52; Singer TL, 1998, AM ZOOL, V38, P394; Su NY, 2002, SOCIOBIOLOGY, V40, P95; Tallamy DW, 2005, ANNU REV ENTOMOL, V50, P347, DOI 10.1146/annurev.ento.50.071803.130424; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vander Meer RK., 1998, PHEROMONE COMMUNICAT, P159; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	33	55	61	2	527	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e813	10.1371/journal.pone.0000813	http://dx.doi.org/10.1371/journal.pone.0000813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726543	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455400030
J	Lee, SU; Grigorian, A; Pawling, J; Chen, IJ; Gao, G; Mozaffar, T; McKerlie, C; Demetriou, M				Lee, Sung-Uk; Grigorian, Ani; Pawling, Judy; Chen, I-Ju; Gao, Guoyan; Mozaffar, Tahseen; McKerlie, Colin; Demetriou, Michael			N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; ACETYLGLUCOSAMINYLTRANSFERASE-V; DISEASE; SUSCEPTIBILITY; GLYCOSYLATION	Multiple sclerosis ( MS) is characterized by inflammatory demyelination of axons and neurodegeneration, the latter inadequately modeled in experimental autoimmune encephalomyelitis (EAE). Susceptibility of inbred mouse strains to EAE is in part determined by major histocompatibility complex haplotype; however, other molecular mechanisms remain elusive. Galectins bind GlcNAc-branched N-glycans attached to surface glycoproteins, forming a molecular lattice that restricts lateral movement and endocytosis of glycoproteins. GlcNAc branching negatively regulates T cell activity and autoimmunity, and when absent in neurons, induces apoptosis in vivo in young adult mice. We find that EAE susceptible mouse strains PL/J, SJL, and NOD have reduced GlcNAc branching. PL/J mice display the lowest levels, partial deficiencies in N-acetylglucosaminyltransferase I, II, and V (i. e. Mgat1, -2, and -5), T cell hyperactivity and spontaneous late onset inflammatory demyelination and neurodegeneration; phenotypes markedly enhanced by Mgat5(+/-) and Mgat5(+/-) backgrounds in a gene dose-dependent manner. Spontaneous disease is transferable and characterized by progressive paralysis, tremor, dystonia, neuronophagia, and axonal damage in both demyelinated lesions and normal white matter, phenocopying progressive MS. Our data identify hypomorphic Golgi processing as an inherited trait that determines susceptibility to EAE, provides a unique spontaneous model of MS, and suggests GlcNAc-branching deficiency may promote T cell-mediated demyelination and neurodegeneration in MS.	Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, 250 Sprague Hall, Irvine, CA 92697 USA.	mdemetri@uci.edu	Mozaffar, Tahseen/AAE-6971-2020	McKerlie, Colin/0000-0002-2232-0967; Demetriou, Michael/0000-0002-2224-7798				Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BENNUN A, 1982, J IMMUNOL, V129, P303; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dyment DA, 2004, HUM MOL GENET, V13, P1005, DOI 10.1093/hmg/ddh123; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Encinas JA, 1996, J IMMUNOL, V157, P2186; Filippi M, 2005, J NEUROL, V252, pV16, DOI 10.1007/s00415-005-5004-5; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Granovsky M, 2000, NAT MED, V6, P306; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Jabs C, 2002, EUR J IMMUNOL, V32, P2687, DOI 10.1002/1521-4141(200209)32:9<2687::AID-IMMU2687>3.0.CO;2-1; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nakagawa H, 1996, EUR J BIOCHEM, V237, P76, DOI 10.1111/j.1432-1033.1996.0076n.x; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; Pace KE, 1999, J IMMUNOL, V163, P3801; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; TRANCHANT C, 1995, MOVEMENT DISORD, V10, P418, DOI 10.1002/mds.870100403; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	44	72	75	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33725	33734		10.1074/jbc.M704839200	http://dx.doi.org/10.1074/jbc.M704839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855338	Green Published, hybrid			2022-12-25	WOS:000250840200054
J	Cordray, P; Doyle, K; Edes, K; Moos, PJ; Fitzpatrick, FA				Cordray, Pauline; Doyle, Kelly; Edes, Kornelia; Moos, Philip J.; Fitzpatrick, Frank A.			Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ALKYL HYDROPEROXIDE REDUCTASE; POLYUNSATURATED FATTY-ACIDS; THIOL-SPECIFIC ANTIOXIDANT; HYDROGEN-PEROXIDE; PLATELET 12-LIPOXYGENASE; REVERSIBLE OXIDATION; HUMAN-NEUTROPHILS; ESCHERICHIA-COLI; PEROXIREDOXIN-II	Human peroxiredoxins serve dual roles as anti- oxidants and regulators of H2O2- mediated cell signaling. The functional versatility of peroxiredoxins depends on progressive oxidation of key cysteine residues. The sulfinic or sulfonic forms of peroxiredoxin lose their peroxidase activity, which allows cells to accumulate H2O2 for signaling or pathogenesis in inflammation, cancer, and other disorders. We report that arachidonic acid lipid hydroperoxide metabolites of 5-, 12-, 15- lipoxygenase- 1, and cyclooxygenase- 2 oxidize the 2- Cysperoxiredoxins 1, 2, and 3 to their sulfinic and sulfonic forms. When added exogenously to cells, 5-, 12- and 15- hydroperoxyeicosatetraenoic acids also over- oxidized peroxiredoxins. Our results suggest that lipoxygenases and cyclooxygenases may affect 2- Cys peroxiredoxin signaling, analogous to NADPH oxidases in the " floodgate" model ( Wood, Z. A., Poole, L. B, and Karplus P. A. ( 2003) Science 300, 600 - 653). Peroxiredoxin- dependent mechanisms may modulate the receptor- dependent actions of autocoids derived from cellular lipoxygenase and cyclooxygenase catalysis.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Fitzpatrick, FA (corresponding author), Univ Utah, Huntsman Canc Inst, 200 Circle Hoope, Salt Lake City, UT 84112 USA.	frank.fitzpatrick@hci.utah.edu		Moos, Philip/0000-0002-8223-442X	NATIONAL CANCER INSTITUTE [R01CA115616, P01CA073992] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA 73992, R01 CA 115616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BABA A, 1989, J BIOL CHEM, V264, P15790; BADWEY JA, 1981, J BIOL CHEM, V256, P2640; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BRASH AR, 1985, CIRCULATION, V72, P702, DOI 10.1161/01.CIR.72.4.702; CHA MK, 1995, J BIOL CHEM, V270, P28635, DOI 10.1074/jbc.270.48.28635; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHEN XS, 1993, EUR J BIOCHEM, V214, P845, DOI 10.1111/j.1432-1033.1993.tb17988.x; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Christmas P, 1999, J BIOL CHEM, V274, P25594, DOI 10.1074/jbc.274.36.25594; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Lepley RA, 1998, ARCH BIOCHEM BIOPHYS, V356, P71, DOI 10.1006/abbi.1998.0744; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; Lepley RA, 1996, J BIOL CHEM, V271, P6179, DOI 10.1074/jbc.271.11.6179; Lepley RA, 1996, ARCH BIOCHEM BIOPHYS, V331, P141, DOI 10.1006/abbi.1996.0292; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Poole LB, 1996, BIOCHEMISTRY-US, V35, P65, DOI 10.1021/bi951888k; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Smith WL, 2005, CURR OPIN CELL BIOL, V17, P174, DOI 10.1016/j.ceb.2005.02.005; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yu MK, 2004, J BIOL CHEM, V279, P28028, DOI 10.1074/jbc.M313939200	42	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32623	32629		10.1074/jbc.M704369200	http://dx.doi.org/10.1074/jbc.M704369200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855346	hybrid			2022-12-25	WOS:000250625400011
J	Maki, Y; Hashimoto, T; Zhou, M; Naganuma, T; Ohta, J; Nomura, T; Robinson, CV; Uchiumi, T				Maki, Yasushi; Hashimoto, Tetsuo; Zhou, Min; Naganuma, Takao; Ohta, Jun; Nomura, Takaomi; Robinson, Carol V.; Uchiumi, Toshio			Three binding sites for stalk protein dimers are generally present in ribosomes from archaeal organism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; ESCHERICHIA-COLI RIBOSOME; GTPASE-ASSOCIATED CENTER; C-TERMINAL DOMAIN; ANGSTROM RESOLUTION; INTACT RIBOSOMES; P2 PROTEINS; RNA; ELONGATION; DYNAMICS	Ribosomes have a characteristic protuberance termed the stalk, which is indispensable for ribosomal function. The ribosomal stalk has long been believed to be a pentameric protein complex composed of two sets of protein dimers, L12-L12, bound to a single anchor protein, although ribosomes carrying three L12 dimers were recently discovered in a few thermophilic bacteria. Here we have characterized the stalk complex from Pyrococcus horikoshii, a thermophilic species of Archaea. This complex is known to be composed of proteins homologous to eukaryotic counterparts rather than bacterial ones. In truncation experiments of the C-terminal regions of the anchor protein Ph-P0, we surprisingly observed three Ph-L12 dimers bound to the C-terminal half of Ph-P0, and the binding site for the third dimer was unique to the archaeal homologs. The stoichiometry of the heptameric complex Ph-P0(Ph-L12)(2)(PhL12)(2)(Ph-L12)(2) was confirmed by mass spectrometry of the intact complex. In functional tests, ribosomes carrying a single Ph-L12 dimer had significant activity, but the addition of the second and third dimers increased the activity. A bioinformatics analysis revealed the evidence that ribosomes from all archaeal and also from many bacterial organisms may contain a heptameric complex at the stalk, whereas eukaryotic ribosomes seem to contain exclusively a pentameric stalk complex, thus modifying our view of the stalk structure significantly.	Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan	Niigata University; University of Tsukuba; University of Cambridge; Shinshu University	Uchiumi, T (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Ikarashi 2-8050, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp		robinson, carol/0000-0001-7829-5505				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; CASIANO C, 1991, J BIOL CHEM, V266, P21578; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; COWGILL CA, 1984, J BIOL CHEM, V259, P5257; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Griaznova O, 2000, BIOCHEMISTRY-US, V39, P4075, DOI 10.1021/bi992621e; Guarinos E, 2001, J BIOL CHEM, V276, P32474, DOI 10.1074/jbc.M103229200; GUDKOV AT, 1978, FEBS LETT, V93, P215, DOI 10.1016/0014-5793(78)81106-5; GUDKOV AT, 1982, FEBS LETT, V138, P229, DOI 10.1016/0014-5793(82)80448-1; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Hamman BD, 1996, BIOCHEMISTRY-US, V35, P16672, DOI 10.1021/bi9615001; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Iwasaki K, 1979, Methods Enzymol, V60, P657; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Lalioti VS, 2002, MOL MICROBIOL, V46, P719, DOI 10.1046/j.1365-2958.2002.03179.x; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; MAASSEN JA, 1985, EUR J BIOCHEM, V149, P609, DOI 10.1111/j.1432-1033.1985.tb08968.x; Mckay AR, 2006, J AM CHEM SOC, V128, P11433, DOI 10.1021/ja061468q; Moller W., 1986, STRUCTURE FUNCTION G, P309; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; Nomura T, 2006, BIOCHEM J, V396, P565, DOI 10.1042/BJ20060038; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; ROSENDAHL G, 1993, J MOL BIOL, V234, P1013, DOI 10.1006/jmbi.1993.1655; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Uchiumi T, 2002, J BIOL CHEM, V277, P41401, DOI 10.1074/jbc.M207424200; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	43	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32827	32833		10.1074/jbc.M705412200	http://dx.doi.org/10.1074/jbc.M705412200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804412	hybrid			2022-12-25	WOS:000250625400032
J	Sanders, MJ; Ali, ZS; Hegarty, BD; Heath, R; Snowden, MA; Carling, D				Sanders, Matthew J.; Ali, Zahabia S.; Hegarty, Bronwyn D.; Heath, Richard; Snowden, Michael A.; Carling, David			Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; FOOD-INTAKE; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; CELLULAR-LOCALIZATION; CATALYTIC SUBUNIT; UPSTREAM KINASE; GAMMA-SUBUNITS; GLUCOSE-UPTAKE; BETA	AMP- activated protein kinase ( AMPK) plays a key role in maintaining energy homeostasis. Activation of AMPK in peripheral tissues has been shown to alleviate the symptoms of metabolic diseases, such as type 2 diabetes, and consequently AMPK is a target for treatment of these diseases. Recently, a small molecule activator ( A- 769662) of AMPK was identified that had beneficial effects on metabolism in ob/ ob mice. Here we show that A- 769662 activates AMPK both allosterically and by inhibiting dephosphorylation of AMPK on Thr- 172, similar to the effects of AMP. A- 769662 activates AMPK harboring a mutation in the gamma subunit that abolishes activation by AMP. An AMPK complex lacking the glycogen binding domain of the beta subunit abolishes the allosteric effect of A- 769662 but not the allosteric activation by AMP. Moreover, mutation of serine 108 to alanine, an autophosphorylation site within the glycogen binding domain of the 1 subunit, almost completely abolishes activation of AMPK by A-769662 in cells and in vitro, while only partially reducing activation by AMP. Based on our results we propose a model for activation of AMPK by A- 769662. Importantly, this model may provide clues for understanding the mechanism by which AMP leads to activation of AMPK, which in turn may help in the identification of other AMPK activators.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci,Cellular Stress Grp, London W12 0NN, England; GlaxoSmithKline Inc, Screenign & Cpds Profling, Harlow CM19 5AW, Essex, England	Imperial College London; GlaxoSmithKline	Carling, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci,Cellular Stress Grp, DuCane Rd, London W12 0NN, England.	dcarling@csc.mrc.ac.uk	Sanders, Matthew J/B-4077-2009; Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830; Sanders, Matthew James/0000-0001-6185-6337	Medical Research Council [MC_U120027537] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	48	259	264	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32539	32548		10.1074/jbc.M706543200	http://dx.doi.org/10.1074/jbc.M706543200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17728241	hybrid			2022-12-25	WOS:000250625400003
J	Criswell, TL; Arteaga, CL				Criswell, Tracy L.; Arteaga, Carlos L.			Modulation of NF kappa B activity and e-cadherin by the type III transforming growth factor ss receptor regulates cell growth and motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; SNAIL TRANSCRIPTION; CYTOPLASMIC DOMAIN; MAMMARY-TUMOR; EXPRESSION; METASTASIS; TARGET; ACTIVATION; INHIBITION	Transforming growth factor beta is growth-inhibitory in non-transformed epithelial cells but becomes growth-promoting during tumorigenesis. The role of the type I and II receptors in tumorigenesis has been extensively studied, but the role of the ubiquitously expressed type III receptor (T beta RIII) remains elusive. We developed short hairpin RNAs directed against T beta RIII to investigate the role of this receptor in breast cancer tumorigenesis. Nontumorigenic NMuMG mouse cells stably expressing short hairpin RNA specific to mouse T beta RIII (NM-kd) demonstrated increased cell growth, motility, and invasion as compared with control cells expressing shRNA to human T beta RIII (NM-con). Reconstitution of T beta RIII expression with rat T beta RIII abrogated the increased growth and motility seen in the NM-kd cells. In addition, the NM-kd cells exhibited marked reduction in the expression of the adherens junction protein, E-cadherin. This loss of E-cadherin was due to increased NF kappa B activity that, in turn, resulted in increased expression of the transcriptional repressors of E-cadherin such as Snail, Slug, Twist, and Sip1. Finally, NMuMG cells in which T beta RIII had been knocked down formed invasive tumors in athymic nude mice, whereas the control cells did not. These data indicate that T beta RIII acts as a tumor suppressor in nontumorigenic mammary epithelial cells at least in part by inhibiting NF kappa B-mediated repression of E-cadherin.	Vanderbilt Univ, Ctr Med, Div Oncol, Sch Med,Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Breast Canc Res Program, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Arteaga, CL (corresponding author), Vanderbilt Univ, Ctr Med, Div Oncol, Sch Med,Dept Canc Biol, 2220 Pierce Ave,777 PRB, Nashville, TN 37232 USA.	carlos.arteaga@vanderbilt.edu			NCI NIH HHS [R01 CA62212, P30 CA68485, T32 CA 09592, P50 CA98131, T32 CA009592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA062212, P50CA098131, P30CA068485, T32CA009592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Bristow RE, 1999, CANCER, V85, P658, DOI 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Iolascon A, 2000, BRIT J CANCER, V82, P1171; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kaltschmidt B, 2001, MECH DEVELOP, V101, P11, DOI 10.1016/S0925-4773(00)00542-6; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lu T, 2004, P NATL ACAD SCI USA, V101, P7112, DOI 10.1073/pnas.0402048101; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Santander C, 2006, CELL SIGNAL, V18, P1482, DOI 10.1016/j.cellsig.2005.11.011; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sharifi N, 2007, PROSTATE, V67, P301, DOI 10.1002/pros.20526; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Sun LZ, 1997, J BIOL CHEM, V272, P25367, DOI 10.1074/jbc.272.40.25367; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Woszczyk D, 2004, MED SCI MONITOR, V10, pCR33; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	49	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32491	32500		10.1074/jbc.M704434200	http://dx.doi.org/10.1074/jbc.M704434200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823118	hybrid			2022-12-25	WOS:000250480300072
J	Wang, L; Zhang, ZG; Gregg, SR; Zhang, RL; Jiao, ZX; LeTourneau, Y; Liu, XS; Feng, YF; Gerwien, J; Torup, L; Leist, M; Noguchi, CT; Chen, ZY; Chopp, M				Wang, Lei; Zhang, Zheng Gang; Gregg, Sara R.; Zhang, Rui Lan; Jiao, Zhongxian; LeTourneau, Yvonne; Liu, Xianshuang; Feng, Yifan; Gerwien, Jens; Torup, Lars; Leist, Marcel; Noguchi, Constance Tom; Chen, Zhi-Yong; Chopp, Michael			The sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; MAMMALIAN FOREBRAIN; SUBVENTRICULAR ZONE; IN-VIVO; SUBEPENDYMAL CELLS; PRECURSOR CELLS; CREST CELLS; NEUROGENESIS; STROKE; RAT	Carbamylated erythropoietin (CEPO), a well characterized erythropoietin (EPO) derivative, does not bind to the classical EPO receptor and does not stimulate erythropoiesis. Using neural progenitor cells derived from the subventricular zone of the adult mouse, we investigated the effect of CEPO on neurogenesis and the associated signaling pathways in vitro. We found that CEPO significantly increased neural progenitor cell proliferation and promoted neural progenitor cell differentiation into neurons, which was associated with up-regulation of Sonic hedgehog (Shh), its receptor ptc, and mammalian achaete-scute homolog 1 (Mash1), a pro-neuron basic helix-loop-helix protein transcription factor. Blockage of the Shh signaling pathway with a pharmacological inhibitor, cyclopamine, abolished the CEPO-induced neurogenesis. Attenuation of endogenous Mash1 expression by short-interfering RNA blocked CEPO-promoted neuronal differentiation. In addition, recombinant mouse Shh up-regulated Mash1 expression in neural progenitor cells. These results demonstrate that the Shh signaling pathway mediates CEPO-enhanced neurogenesis and Mash1 is a downstream target of the Shh signaling pathway that regulates CEPO-enhanced neuronal differentiation.	Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Sci Ctr, Detroit, MI 48202 USA; Oakland Univ, Dept Phys, Rochester, MI 48309 USA; H Lundbeck & Co AS, Drug Metab, DK-2500 Valby, Denmark; H Lundbeck & Co AS, Neurophamacol, DK-2500 Valby, Denmark; Univ Konstanz, Dept Biol, D-78457 Constance, Germany; NIDDK, Mol Cell Biol Sect, Biol Chem Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Lundbeck Corporation; Lundbeck Corporation; University of Konstanz; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Sci Ctr, 2799 W Grand Blvd, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	Mordwinkin, Nicholas M/A-4347-2010; Leist, Marcel/D-2133-2010; zhang, zheng/HCH-9684-2022	Leist, Marcel/0000-0002-3778-8693; 	NHLBI NIH HHS [R01HL64766] Funding Source: Medline; NINDS NIH HHS [P01 NS23393, R01NS43324, P01 NS42345] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK025061, ZIADK025061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043324, P01NS023393, P01NS042345] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Charytoniuk D, 2002, EUR J NEUROSCI, V16, P2351, DOI 10.1046/j.1460-9568.2002.02412.x; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Gassmann M, 2003, ADV EXP MED BIOL, V543, P323; Goetz JA, 2002, BIOESSAYS, V24, P157, DOI 10.1002/bies.10056; Gutierrez-Frias C, 2004, J IMMUNOL, V173, P5046, DOI 10.4049/jimmunol.173.8.5046; IALTABA AR, 2002, NAT REV CANCER, V2, P361; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Ma QF, 1997, J NEUROSCI, V17, P3644; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Tanaka R, 2004, STROKE, V35, P1454, DOI 10.1161/01.STR.0000126480.40967.b3; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zhang L, 2005, ARTIF INTELL MED, V33, P41, DOI 10.1016/j.artmed.2004.06.002; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhu GF, 1999, DEV BIOL, V215, P118, DOI 10.1006/dbio.1999.9431	44	95	102	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32462	32470		10.1074/jbc.M706880200	http://dx.doi.org/10.1074/jbc.M706880200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804404	hybrid, Green Submitted			2022-12-25	WOS:000250480300069
J	Lee, JA; Pallas, DC				Lee, Jocelyn A.; Pallas, David C.			Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; ADENOVIRUS E4ORF4 PROTEIN; PP2A CATALYTIC SUBUNIT; POLYOMAVIRUS MIDDLE-T; MAP KINASE PATHWAY; B-ALPHA-SUBUNIT; METHYL ESTERIFICATION; SACCHAROMYCES-CEREVISIAE; REGULATORY SUBUNIT; OKADAIC ACID	Protein phosphatase 2A (PP2A) is a multifunctional phosphatase that plays important roles in many cellular processes including regulation of cell cycle and apoptosis. Because PP2A is involved in so many diverse processes, it is highly regulated by both non-covalent and covalent mechanisms that are still being defined. In this study we have investigated the importance of leucine carboxyl methyltransferase-1 (LCMT-1) for PP2A methylation and cell function. We show that reduction of LCMT-1 protein levels by small hairpin RNAs causes up to a 70% reduction in PP2A methylation in HeLa cells, indicating that LCMT-1 is the major mammalian PP2A methyltransferase. In addition, LCMT-1 knockdown reduced the formation of PP2A heterotrimers containing the B alpha regulatory subunit and, in a subset of the cells, induced apoptosis, characterized by caspase activation, nuclear condensation/fragmentation, and membrane blebbing. Knockdown of the PP2A B alpha regulatory subunit induced a similar amount of apoptosis, suggesting that LCMT-1 induces apoptosis in part by disrupting the formation of PP2A(B alpha AC) heterotrimers. Treatment with a pan-caspase inhibitor partially rescued cells from apoptosis induced by LCMT-1 or B alpha knockdown. LCMT-1 knockdown cells and B alpha knockdown cells were more sensitive to the spindle-targeting drug nocodazole, suggesting that LCMT-1 and B alpha are important for spindle checkpoint. Treatment of LCMT-1 and B alpha knockdown cells with thymidine dramatically reduced cell death, presumably by blocking progression through mitosis. Consistent with these results, homozygous gene trap knock-out of LCMT-1 in mice resulted in embryonic lethality. Collectively, our results indicate that LCMT-1 is important for normal progression through mitosis and cell survival and is essential for embryonic development in mice.	Emory Univ, Sch Med, Dept Biochem, Winship Canc Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA	Emory University; Emory University	Pallas, DC (corresponding author), Emory Univ, Sch Med, Dept Biochem, Winship Canc Ctr, 1510 Clifton Rd, Atlanta, GA 30322 USA.	dpallas@emory.edu			NATIONAL CANCER INSTITUTE [R01CA057327] Funding Source: NIH RePORTER; NCI NIH HHS [CA57327, R01 CA057327, CA1236402] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonness K, 2006, MOL CANCER THER, V5, P2727, DOI 10.1158/1535-7163.MCT-06-0273; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; CAYLA X, 1993, EUR J BIOCHEM, V214, P281, DOI 10.1111/j.1432-1033.1993.tb17922.x; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Evans DRH, 2000, MOL GEN GENET, V264, P425; FAVRE B, 1994, J BIOL CHEM, V269, P16311; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; GLENN GM, 1995, J VIROL, V69, P3729, DOI 10.1128/JVI.69.6.3729-3736.1995; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kalhor HR, 2001, ARCH BIOCHEM BIOPHYS, V395, P239, DOI 10.1006/abbi.2001.2558; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; LEE TH, 1994, MOL BIOL CELL, V5, P323, DOI 10.1091/mbc.5.3.323; LI M, 1994, BIOCHEM BIOPH RES CO, V202, P1023, DOI 10.1006/bbrc.1994.2031; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Wang YC, 1997, MOL CELL BIOL, V17, P620, DOI 10.1128/MCB.17.2.620; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu T, 1997, ARCH BIOCHEM BIOPHYS, V339, P210, DOI 10.1006/abbi.1996.9835	54	47	53	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30974	30984		10.1074/jbc.M704861200	http://dx.doi.org/10.1074/jbc.M704861200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724024	Green Accepted, hybrid			2022-12-25	WOS:000250136300065
J	MacDonald, MJ; Smith, AD; Hasan, NM; Sabat, G; Fahien, LA				MacDonald, Michael J.; Smith, Andrew D., III; Hasan, Noaman M.; Sabat, Grzegorz; Fahien, Leonard A.			Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; NMR ISOTOPOMER ANALYSIS; METHYL SUCCINATE; RAT-LIVER; GLYCERALDEHYDE PHOSPHATE; METABOLISM; PYRUVATE; RELEASE; ISLETS; CITRATE	The mitochondria of pancreatic beta cells are believed to convert insulin secretagogues into products that are translocated to the cytosol where they participate in insulin secretion. We studied the hypothesis that short chain acyl-CoA ( SC-CoAs) might be some of these products by discerning the pathways of SC-CoA formation in beta cells. Insulin secretagogues acutely stimulated 1.5-5-fold increases in acetoacetyl-CoA, succinyl-CoA, malonyl-CoA, hydroxymethylglutaryl-CoA ( HMG-CoA), and acetyl-CoA in INS-1832/13 cells as judged from liquid chromatography-tandem mass spectrometry measurements. Studies of 12 relevant enzymes in rat and human pancreatic islets and INS-1832/13 cells showed the feasibility of at least two redundant pathways, one involving acetoacetate and the other citrate, for the synthesis SC-CoAs from secretagogue carbon in mitochondria and the transfer of their acyl groups to the cytosol where the acyl groups are converted to SC-CoAs. Knockdown of two key cytosolic enzymes in INS-1832/13 cells with short hairpin RNA supported the proposed scheme. Lowering ATP citrate lyase 88% did not inhibit glucose-induced insulin release indicating citrate is not the only carrier of acyl groups to the cytosol. However, lowering acetoacetyl-CoA synthetase 80% partially inhibited glucose-induced insulin release indicating formation of SC-CoAs from acetoacetate in the cytosol is important for insulin secretion. The results indicate beta cells possess enzyme pathways that can incorporate carbon from glucose into acetylCoA, acetoacetyl-CoA, and succinyl-CoA and carbon from leucine into these three SC-CoAs plus HMG-CoA in their mitochondria and enzymes that can form acetyl-CoA, acetoacetyl-CoA, malonyl-CoA, and HMG-CoA in their cytosol.	Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabetes Ctr, Madison, WI 53706 USA; Univ Wisconsin, Ctr Biotechnol, Mass Spectrometry Facil, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	MacDonald, MJ (corresponding author), Rm 3459 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	mjmacdon@wisc.edu		Sabat, Grzegorz/0000-0001-7668-7767	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK28348, R01 DK028348] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHMARINA LI, 1994, J BIOL CHEM, V269, P31929; BERGSTROM JD, 1985, METHOD ENZYMOL, V110, P3; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Cheng HY, 2003, AM J PHYSIOL-ENDOC M, V285, pE287, DOI 10.1152/ajpendo.00535.2002; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; ENDEMANN G, 1982, J BIOL CHEM, V257, P3434; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Gunawardana SC, 2004, AM J PHYSIOL-ENDOC M, V287, pE828, DOI 10.1152/ajpendo.00381.2003; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; ITO M, 1986, BIOCHIM BIOPHYS ACTA, V876, P280, DOI 10.1016/0005-2760(86)90285-7; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Ki SW, 2000, J BIOL CHEM, V275, P39231, DOI 10.1074/jbc.M006192200; Kowluru A, 2001, DIABETOLOGIA, V44, P89, DOI 10.1007/s001250051584; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MACDONALD MJ, 1991, J BIOL CHEM, V266, P1335; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P201, DOI 10.1006/abbi.1993.1028; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2004, MOL CELL BIOCHEM, V258, P201, DOI 10.1023/B:MCBI.0000012856.31929.91; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; MACDONALD MJ, 1990, ARCH BIOCHEM BIOPHYS, V279, P104, DOI 10.1016/0003-9861(90)90468-E; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MACDONALD MJ, 1988, DIABETES, V37, P997, DOI 10.2337/diabetes.37.7.997; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MALAISSE WJ, 1982, J BIOL CHEM, V257, P8731; MIDDLETON B, 1974, BIOCHEM J, V139, P109, DOI 10.1042/bj1390109; Montague W, 1980, Horm Metab Res Suppl, VSuppl 10, P153; Poitout V, 2003, TRENDS ENDOCRIN MET, V14, P201, DOI 10.1016/S1043-2760(03)00086-9; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Veluthakal R, 2007, DIABETES, V56, P204, DOI 10.2337/db06-0668; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Yamada S, 2003, ENDOCRINOLOGY, V144, P5232, DOI 10.1210/en.2003-0719; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4	50	63	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30596	30606		10.1074/jbc.M702732200	http://dx.doi.org/10.1074/jbc.M702732200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724028	hybrid			2022-12-25	WOS:000250136300028
J	Mattison, CP; Old, WM; Steiner, E; Huneycutt, BJ; Resing, KA; Ahn, NG; Winey, M				Mattison, Christopher P.; Old, William M.; Steiner, Estelle; Huneycutt, Brenda J.; Resing, Katheryn A.; Ahn, Natalie G.; Winey, Mark			Mps1 activation loop autophosphorylation enhances kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; DUPLICATION GENE MPS1; PROTEIN-KINASE; KINETOCHORE LOCALIZATION; ASSEMBLY CHECKPOINT; CATALYTIC DOMAIN; MITOTIC ARREST; MAP KINASE; PHOSPHORYLATION; EXPRESSION	The Mps1 protein kinase is required for proper assembly of the mitotic spindle, checkpoint signaling, and several other aspects of cell growth and differentiation. Mps1 regulation is mediated by cell cycle-dependent changes in transcription and protein level. There is also a strong correlation between hyper-phosphorylated mitotic forms of Mps1 and increased kinase activity. We investigated the role that autophosphorylation plays in regulating human Mps1 (hMps1) protein kinase activity. Here we report that hyperphosphorylated hMps1 forms are not the only active forms of the kinase. However, autophosphorylation of hMps1 within the activation loop is required for full activity in vitro. Mass spectrometry analysis of de novo synthesized enzyme in Escherichia coli identified autophosphorylation sites at residues Thr(675), Thr(676), and Thr(686), but phosphatase-treated and reactivated enzyme was only phosphorylated on Thr(676). Mutation of Thr(676) in hMps1 or the corresponding Thr(591) residue within yeast Mps1 reduces kinase activity in vitro. We find that overexpression of an hMps1-T676A mutation inhibits centrosome duplication in RPE1 cells. Likewise, yeast cells harboring mps1-T591A as the sole MPS1 allele are not viable. Our data strongly support the conclusion that site-specific Mps1 autophosphorylation within the activation loop is required for full activity in vitro and function in vivo.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Winey, M (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	mark.winey@colorado.edu		OLD, WILLIAM/0000-0002-9499-8478	NCI NIH HHS [R01 CA87648] Funding Source: Medline; NIGMS NIH HHS [GM07135, GM51312] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312, T32GM007135] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Carr SA, 2005, METHOD ENZYMOL, V405, P82, DOI 10.1016/S0076-6879(05)05005-6; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; FERNANDEZPATRON C, 1992, BIOTECHNIQUES, V12, P564; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Gilliland WD, 2005, CURR BIOL, V15, P672; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; He XW, 1998, J CELL SCI, V111, P1635; HOGG D, 1994, ONCOGENE, V9, P89; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LINDBERG RA, 1993, ONCOGENE, V8, P351; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; POCH O, 1994, MOL GEN GENET, V243, P641, DOI 10.1007/BF00279573; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Poss KD, 2002, DEVELOPMENT, V129, P5141; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Straight PD, 2000, MOL BIOL CELL, V11, P3525, DOI 10.1091/mbc.11.10.3525; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Szczepanowska J, 1998, P NATL ACAD SCI USA, V95, P4146, DOI 10.1073/pnas.95.8.4146; TRAFNY EAM, 2006, PROTEIN SCI, V3, P176; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Zappacosta F, 2006, MOL CELL PROTEOMICS, V5, P2019, DOI 10.1074/mcp.M600238-MCP200; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	45	68	75	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30553	30561		10.1074/jbc.M707063200	http://dx.doi.org/10.1074/jbc.M707063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728254	hybrid			2022-12-25	WOS:000250136300023
J	Adhikari, S; Uren, A; Roy, R				Adhikari, Sanjay; Uren, Aykut; Roy, Rabindra			N-terminal extension of N-methylpurine DNA glycosylase is required for turnover in hypoxanthine excision reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; ENDONUCLEASE-III; REPAIR; SPECIFICITY; MECHANISM; RESIDUES; SITES; BASES	N-Methylpurine DNA glycosylase (MPG) initiates base excision repair in DNA by removing a wide variety of alkylated, deaminated, and lipid peroxidation-induced purine adducts. In this study we tested the role of N-terminal extension on MPG hypoxanthine (Hx) cleavage activity. Our results showed that MPG lacking N-terminal extension excises hypoxanthine with significantly reduced efficiency, one-third of that exhibited by full-length MPG under similar conditions. Steady-state kinetics showed full-length MPG has higher V-max and lower K-m than N Delta 100 MPG. Real time binding experiments by surface plasmon resonance spectroscopy suggested that truncation can substantially increase the equilibrium binding constant of MPG toward Hx, but under single-turnover conditions there is apparently no effect on catalytic chemistry; however, the truncation of the N-terminal tail affected the turnover of the enzyme significantly under multiple turnover conditions. Real time binding experiments by surface plasmon resonance spectroscopy further showed that N Delta 100 MPG binds approximately six times more tightly toward its product apurinic/apyrimidinic site than the substrate, whereas full-length MPG similarly binds to both the substrate and the product. We thereby conclude that the N-terminal tail in MPG plays a critical role in overcoming the product inhibition, which is achieved by reducing the differences of MPG binding affinity toward Hx and apurinic/apyrimidinic sites and thus is essential for the Hx cleavage reaction of MPG. The results from this study also affirm the need for reinvestigation of full-length MPG for its enzymatic and structural properties, which are currently available mostly for the truncated protein.	Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Roy, R (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, LL Level,S-122,3800 Reservoir Rd NW, Washington, DC 20057 USA.	rr228@georgetown.edu			NCI NIH HHS [R01 CA92306, R01 CA092306, R01CA108641] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092306, R01CA108641] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; BREIMER LH, 1984, J BIOL CHEM, V259, P5543; DOSANJH MK, 1994, BIOCHEMISTRY-US, V33, P1624, DOI 10.1021/bi00173a002; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P59; HATCHET Z, 1994, J BIOL CHEM, V269, P18814; HILLPERKINS M, 1986, MUTAT RES, V162, P153, DOI 10.1016/0027-5107(86)90081-3; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; LARSON K, 1985, MUTAT RES, V233, P211; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Mattes WB, 1996, CARCINOGENESIS, V17, P643, DOI 10.1093/carcin/17.4.643; Miao F, 1998, NUCLEIC ACIDS RES, V26, P4034, DOI 10.1093/nar/26.17.4034; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Roy R, 1996, J BIOL CHEM, V271, P23690, DOI 10.1074/jbc.271.39.23690; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Roy R, 1996, CARCINOGENESIS, V17, P2177, DOI 10.1093/carcin/17.10.2177; Saparbaev M, 2002, J BIOL CHEM, V277, P26987, DOI 10.1074/jbc.M111100200; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; Singer B, 1997, CHEM RES TOXICOL, V10, P713, DOI 10.1021/tx970011e; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302	25	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30078	30084		10.1074/jbc.M704051200	http://dx.doi.org/10.1074/jbc.M704051200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716976	hybrid			2022-12-25	WOS:000249981200038
J	Zayed, A; Constantin, SA; Packer, L				Zayed, Amro; Constantin, Serban A.; Packer, Laurence			Successful Biological Invasion despite a Severe Genetic Load	PLOS ONE			English	Article							POPULATION BIOLOGY; SEX DETERMINATION; GEOGRAPHIC DISTANCE; PROPAGULE PRESSURE; COLONY STRUCTURE; ARGENTINE ANTS; FIRE ANT; HYMENOPTERA; BEE; EVOLUTION	Understanding the factors that influence the success of ecologically and economically damaging biological invasions is of prime importance. Recent studies have shown that invasive populations typically exhibit minimal, if any, reductions in genetic diversity, suggesting that large founding populations and/or multiple introductions are required for the success of biological invasions, consistent with predictions of the propagule pressure hypothesis. Through population genetic analysis of neutral microsatellite markers and a gene experiencing balancing selection, we demonstrate that the solitary bee Lasioglossum leucozonium experienced a single and severe bottleneck during its introduction from Europe. Paradoxically, the success of L. leucozonium in its introduced range occurred despite the severe genetic load caused by single-locus complementary sex-determination that still turns 30% of female-destined eggs into sterile diploid males, thereby substantially limiting the growth potential of the introduced population. Using stochastic modeling, we show that L. leucozonium invaded North America through the introduction of a very small number of propagules, most likely a singly-mated female. Our results suggest that chance events and ecological traits of invaders are more important than propagule pressure in determining invasion success, and that the vigilance required to prevent invasions may be considerably greater than has been previously considered.	[Zayed, Amro; Constantin, Serban A.; Packer, Laurence] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Zayed, A (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	azayed@life.uiuc.edu	Zayed, Amro/G-6405-2011	Zayed, Amro/0000-0003-3233-4585; packer, laurence/0000-0002-1711-8203	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Graduate Scholarship (CGS); Ontario Genomics Institute; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Graduate Scholarship (CGS)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Genomics Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to LP and a Canada Graduate Scholarship (CGS) to AZ. Support for sequencing was obtained through funding to the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC, and other sponsors listed at www.BOLNET.ca. The funding sources played no role in the design, analysis, and interpretation of the data or in the preparation of the manuscript.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; ATWOOD C. E., 1933, CANADIAN JOUR RES, V9, P443; Beveridge M, 2006, MOL ECOL, V15, P951, DOI 10.1111/j.1365-294X.2006.02846.x; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Brohede J, 1999, P ROY SOC B-BIOL SCI, V266, P825, DOI 10.1098/rspb.1999.0712; Buczkowski G, 2004, MOL ECOL, V13, P2235, DOI 10.1111/j.1365-294X.2004.02261.x; CANC JH, 2003, NONNATIVE CROPS WHEN, P113; Clausen C.P., 1978, INTRO PARASITES PRED; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cornuet JM, 1996, GENETICS, V144, P2001; Crawley M.J., 1989, BIOL INVASIONS GLOBA, P407; Danforth BN, 1999, SYST ENTOMOL, V24, P377, DOI 10.1046/j.1365-3113.1999.00087.x; Danforth BN, 2003, J KANSAS ENTOMOL SOC, V76, P221; EICKWORT GC, 1980, ANNU REV ENTOMOL, V25, P421, DOI 10.1146/annurev.en.25.010180.002225; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Giles V, 2006, J HYMENOPT RES, V15, P208; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Goodisman MAD, 2001, MOL ECOL, V10, P1423, DOI 10.1046/j.1365-294X.2001.01291.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grevstad Fritzi S., 1999, Biological Invasions, V1, P313, DOI 10.1023/A:1010037912369; Grixti JC, 2006, CAN ENTOMOL, V138, P147; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick PW, 2006, TRENDS ECOL EVOL, V21, P55, DOI 10.1016/j.tree.2005.11.014; Henshaw MT, 2005, AUST J ENTOMOL, V44, P37, DOI 10.1111/j.1440-6055.2005.00421.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Johnson RN, 2004, ANN ENTOMOL SOC AM, V97, P732, DOI 10.1603/0013-8746(2004)097[0732:ASLOGD]2.0.CO;2; KNERER G, 1969, Entomological News, V80, P141; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LINDROTH CH, 1957, FAUNAL CONNECTIONS E, P135; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; MCGINLEY RJ, 1986, SMITHSONIAN CONTRIBU, V429, P1, DOI DOI 10.5479/SI.00810282.429; Memmott J, 2005, J ANIM ECOL, V74, P50, DOI 10.1111/j.1365-2656.2004.00896.x; Neumann K, 2006, APIDOLOGIE, V37, P75, DOI 10.1051/apido:2005060; OWEN RE, 1994, HEREDITY, V72, P219, DOI 10.1038/hdy.1994.31; Packer L, 2001, CONSERV ECOL, V5; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROSS KG, 1993, GENETICS, V135, P843; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; SIMBERLOFF D, 1989, BIOL INVASIONS, P00061; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Suarez AV, 2005, P NATL ACAD SCI USA, V102, P17032, DOI 10.1073/pnas.0506119102; Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; Tsutsui ND, 2001, EVOLUTION, V55, P976, DOI 10.1554/0014-3820(2001)055[0976:PGACSO]2.0.CO;2; VANWILGENBURG E, 2006, FRONT ZOOL, V3; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; YOKOYAMA S, 1979, GENETICS, V91, P609; Zar JH, 1999, BIOSTATISTICAL ANAL; Zayed A, 2007, HEREDITY, V99, P397, DOI 10.1038/sj.hdy.6801013; Zayed A, 2005, CONSERV GENET, V6, P1017, DOI 10.1007/s10592-005-9094-5; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2004, HEREDITY, V93, P627, DOI 10.1038/sj.hdy.6800588; Zayed A, 2006, MOL ECOL NOTES, V6, P1154, DOI 10.1111/j.1471-8286.2006.01469.x	61	81	83	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e868	10.1371/journal.pone.0000868	http://dx.doi.org/10.1371/journal.pone.0000868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848999	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600015
J	Mizrahi, S; Markel, G; Porgador, A; Bushkin, Y; Mandelboim, O				Mizrahi, Sa'ar; Markel, Gal; Porgador, Angel; Bushkin, Yuri; Mandelboim, Ofer			CD100 on NK Cells Enhance IFN gamma Secretion and Killing of Target Cells Expressing CD72	PLOS ONE			English	Article								Background. NK cells are able to kill tumor and virus-infected cells without the need of prior antigen stimulation. The killing of these target cells is regulated by inhibitory, lysis and co-stimulatory receptors that are expressed on the surface of NK cells. Principal Findings. CD100 (Semaphorin 4D), a 150kD transmembrane protein, is expressed on the surface of activated NK cells as a homodimer, mediates the killing of target cells by binding to CD72. CD100 is not involved directly in the killing process but is rather increases NK cytotoxicity by enhancing the adhesion between NK cells and their targets. This increased adhesion leads to a more efficient killing and enhanced IFN gamma secretion. Significance. Since CD72 is expressed on antigen presenting cells (APC) and the CD100-CD72 interaction lead to the shading of CD100, we suggest that NK interacting with APC cells could be the early source of soluble CD100 which is crucial for the formation of antigen specific immune response. CD100-CD72 interaction can be the mechanism by which NK cell communicate with B cells.	[Mizrahi, Sa'ar; Markel, Gal; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel; [Porgador, Angel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, Canc Res Ctr, IL-84105 Beer Sheva, Israel; [Bushkin, Yuri] NJMS UMDNJ, Publ Hlth Res Inst, Newark, NJ USA	Hebrew University of Jerusalem; Ben Gurion University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel.	oferm@ekmd.huji.ac.il		Mandelboim, Ofer/0000-0002-9354-1855; Porgador, Angel/0000-0003-1540-4449	US-Israel Bi-national Science Foundation; The Israeli Cancer Research Foundation; Israel Science Foundation; AICR; European consortium [MRTN-CT-2005, LSCH-CT-2005-518178]; NIH [AI 045761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045761] Funding Source: NIH RePORTER	US-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); The Israeli Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); AICR; European consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the US-Israel Bi-national Science Foundation, by a grant from The Israeli Cancer Research Foundation, by a grant from the Israel Science Foundation, by a grant from the AICR, by grants from the European consortium MRTN-CT-2005 and LSCH-CT-2005-518178, and by NIH AI 045761 for Yuri Bushkin.	Arnold D, 2001, COMMUN ACM, V44, P30, DOI 10.1145/379300.379306; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Billard C, 2000, BLOOD, V95, P965, DOI 10.1182/blood.V95.3.965.003k39_965_972; BISMUTH G, 2002, SCI STKE, pRE4; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BOUGERET C, 1992, J IMMUNOL, V148, P318; Braud VM, 1999, CURR TOP MICROBIOL, V244, P85; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DANDREA A, 1995, J IMMUNOL, V155, P2306; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; GARAND R, 1994, LEUKEMIA RES, V18, P651, DOI 10.1016/0145-2126(94)90050-7; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; HAUSER WE, 1982, CELL IMMUNOL, V69, P330, DOI 10.1016/0008-8749(82)90076-4; Herold C, 1996, J IMMUNOL, V157, P5262; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kumanogoh A, 2005, INT IMMUNOL, V17, P1277, DOI 10.1093/intimm/dxh307; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li M, 2006, J IMMUNOL, V177, P3406, DOI 10.4049/jimmunol.177.5.3406; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MYERS DE, 1995, LEUKEMIA LYMPHOMA, V18, P119, DOI 10.3109/10428199509064931; PESANDO JM, 1990, HUM IMMUNOL, V27, P193, DOI 10.1016/0198-8859(90)90050-Y; ROBERTSON MJ, 1992, J EXP MED, V175, P779, DOI 10.1084/jem.175.3.779; SCHWARTING R, 1992, AM J HEMATOL, V41, P151, DOI 10.1002/ajh.2830410303; SHAH PD, 1985, J EXP MED, V162, P625, DOI 10.1084/jem.162.2.625; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Watanabe C, 2001, J IMMUNOL, V167, P4321, DOI 10.4049/jimmunol.167.8.4321	51	21	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e818	10.1371/journal.pone.0000818	http://dx.doi.org/10.1371/journal.pone.0000818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786190	Green Published, gold			2022-12-25	WOS:000207455500002
J	Burki, F; Shalchian-Tabrizi, K; Minge, M; Skjaeveland, A; Nikolaev, SI; Jakobsen, KS; Pawlowski, J				Burki, Fabien; Shalchian-Tabrizi, Kamran; Minge, Marianne; Skjaeveland, Asmund; Nikolaev, Sergey I.; Jakobsen, Kjetill S.; Pawlowski, Jan			Phylogenomics Reshuffles the Eukaryotic Supergroups	PLOS ONE			English	Article							COMMON ORIGIN; MISSING DATA; SEQUENCES; CERCOZOA; GENE; TREE; CLASSIFICATION; DINOFLAGELLATE; DIVERSITY; SELECTION	Background. Resolving the phylogenetic relationships between eukaryotes is an ongoing challenge of evolutionary biology. In recent years, the accumulation of molecular data led to a new evolutionary understanding, in which all eukaryotic diversity has been classified into five or six supergroups. Yet, the composition of these large assemblages and their relationships remain controversial. Methodology/Principle Findings. Here, we report the sequencing of expressed sequence tags (ESTs) for two species belonging to the supergroup Rhizaria and present the analysis of a unique dataset combining 29908 amino acid positions and an extensive taxa sampling made of 49 mainly unicellular species representative of all supergroups. Our results show a very robust relationship between Rhizaria and two main clades of the supergroup chromalveolates: stramenopiles and alveolates. We confirm the existence of consistent affinities between assemblages that were thought to belong to different supergroups of eukaryotes, thus not sharing a close evolutionary history. Conclusions. This well supported phylogeny has important consequences for our understanding of the evolutionary history of eukaryotes. In particular, it questions a single red algal origin of the chlorophyll-c containing plastids among the chromalveolates. We propose the abbreviated name 'SAR' (Stramenopiles+Alveolates+Rhizaria) to accommodate this new super assemblage of eukaryotes, which comprises the largest diversity of unicellular eukaryotes.	[Burki, Fabien; Pawlowski, Jan] Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland; [Nikolaev, Sergey I.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Shalchian-Tabrizi, Kamran; Minge, Marianne; Skjaeveland, Asmund; Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, Oslo, Norway	University of Geneva; University of Geneva; University of Oslo	Burki, F (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.	Fabien.Burki@zoo.unige.ch	Nikolaev, Sergey/F-3148-2012; Burki, Fabien/F-4818-2010	Skjaeveland, Asmund Steen/0000-0002-2375-381X	Swiss National Science Foundation [3100A0-100415, 3100A0-112645]; Norwegian Research Council [118894/431]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was supported by the Swiss National Science Foundation grant 3100A0-100415 and 3100A0-112645 ( JP); and by research grant ( grant no 118894/431) from the Norwegian Research Council ( KSJ).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Bachvaroff TR, 2005, MOL BIOL EVOL, V22, P1772, DOI 10.1093/molbev/msi172; BHATTACHARYA D, 1995, J EUKARYOT MICROBIOL, V42, P65, DOI 10.1111/j.1550-7408.1995.tb01541.x; Bodyl A, 2005, J PHYCOL, V41, P712, DOI 10.1111/j.1529-8817.2005.00091.x; Burki F, 2002, PROTIST, V153, P251, DOI 10.1078/1434-4610-00102; Burki F, 2006, GENOME, V49, P882, DOI 10.1139/G06-048; Burki F, 2006, MOL BIOL EVOL, V23, P1922, DOI 10.1093/molbev/msl055; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; CAVALIERSMITH T, 2004, ORGANELLES GENOMES E, P32; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HACKETT JD, 2007, MOL BIOL EVOL, pSM89; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Keeling PJ, 2001, P NATL ACAD SCI USA, V98, P10745, DOI 10.1073/pnas.191337098; Keeling PJ, 2001, MOL BIOL EVOL, V18, P1551, DOI 10.1093/oxfordjournals.molbev.a003941; Li SL, 2006, MOL BIOL EVOL, V23, P663, DOI 10.1093/molbev/msj075; Longet D, 2003, INT J SYST EVOL MICR, V53, P1735, DOI 10.1099/ijs.0.02597-0; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Nikolaev SI, 2003, ACTA PROTOZOOL, V42, P183; NOZAKI H, 2007, MOL BIOL EVOL; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Shalchian-Tabrizi K, 2006, P ROY SOC B-BIOL SCI, V273, P1833, DOI 10.1098/rspb.2006.3515; Shalchian-Tabrizi K, 2007, PROTIST, V158, P173, DOI 10.1016/j.protis.2006.10.003; Shalchian-Tabrizi K, 2006, MOL BIOL EVOL, V23, P1504, DOI 10.1093/molbev/msl011; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583	50	279	289	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e790	10.1371/journal.pone.0000790	http://dx.doi.org/10.1371/journal.pone.0000790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726520	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455400007
J	Michael, TP; Park, S; Kim, TS; Booth, J; Byer, A; Sun, Q; Chory, J; Lee, K				Michael, Todd P.; Park, Sohyun; Kim, Tae-Sung; Booth, Jim; Byer, Amanda; Sun, Qi; Chory, Joanne; Lee, Kwangwon			Simple Sequence Repeats Provide a Substrate for Phenotypic Variation in the Neurospora crassa Circadian Clock	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; WHITE COLLAR-1; AERIAL DISPERSAL; GENETIC-ANALYSIS; TRANSCRIPTION; ENTRAINMENT; BINDING; CONIDIATION; ARABIDOPSIS; MECHANISMS	Background. WHITE COLLAR-1 (WC-1) mediates interactions between the circadian clock and the environment by acting as both a core clock component and as a blue light photoreceptor in Neurospora crassa. Loss of the amino-terminal polyglutamine (NpolyQ) domain in WC-1 results in an arrhythmic circadian clock; this data is consistent with this simple sequence repeat (SSR) being essential for clock function. Methodology/Principal Findings. Since SSRs are often polymorphic in length across natural populations, we reasoned that investigating natural variation of the WC-1 NpolyQ may provide insight into its role in the circadian clock. We observed significant phenotypic variation in the period, phase and temperature compensation of circadian regulated asexual conidiation across 143 N. crassa accessions. In addition to the NpolyQ, we identified two other simple sequence repeats in WC-1. The sizes of all three WC-1 SSRs correlated with polymorphisms in other clock genes, latitude and circadian period length. Furthermore, in a cross between two N. crassa accessions, the WC-1 NpolyQ co-segregated with period length. Conclusions/Significance. Natural variation of the WC-1 NpolyQ suggests a mechanism by which period length can be varied and selected for by the local environment that does not deleteriously affect WC-1 activity. Understanding natural variation in the N. crassa circadian clock will facilitate an understanding of how fungi exploit their environments.	[Michael, Todd P.; Park, Sohyun; Kim, Tae-Sung; Lee, Kwangwon] Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA; [Michael, Todd P.; Byer, Amanda; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA USA; [Booth, Jim] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Sun, Qi] Cornell Univ, Cornell Theory Ctr, Ithaca, NY USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Cornell University; Salk Institute; Cornell University; Cornell University; Howard Hughes Medical Institute; Salk Institute	Lee, K (corresponding author), Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA.	kl272@cornell.edu	Lee, Kwangwon/AAC-8060-2021	Lee, Kwangwon/0000-0001-8225-4220; Michael, Todd/0000-0001-6272-2875	NIH [5 F32 GM068381, R01GM062932, R01GM052413]; College of Agriculture and Life Science, Cornell University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932, R01GM052413, F32GM068381] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Agriculture and Life Science, Cornell University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TPM is supported by a NIH fellowship 5 F32 GM068381 and NIH grant R01GM062932 to JC. AB is supported by NIH grant R01GM052413 to JC. JC is an investigator of the Howard Hughes Medical Institute. KL is supported by the College of Agriculture and Life Science, Cornell University.	AYLOR DE, 1982, P NATL ACAD SCI USA, V79, P697, DOI 10.1073/pnas.79.2.697; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Bhat A, 2003, GENETICS, V164, P947; Borstnik B, 2002, GENOME RES, V12, P909, DOI 10.1101/gr.138802; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Cheng P, 2003, J BIOL CHEM, V278, P3801, DOI 10.1074/jbc.M209592200; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Edwards KD, 2005, GENETICS, V170, P387, DOI 10.1534/genetics.104.035238; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Jacobson DJ, 2006, MYCOLOGIA, V98, P550, DOI 10.3852/mycologia.98.4.550; Jacobson DJ, 2004, MYCOLOGIA, V96, P66, DOI 10.2307/3761989; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; KIM C K, 1990, Annals of the Phytopathological Society of Japan, V56, P315, DOI 10.3186/jjphytopath.56.315; Kurosawa G, 2006, J THEOR BIOL, V242, P478, DOI 10.1016/j.jtbi.2006.03.016; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; Lee K, 2003, GENETICS, V163, P103; Lee K, 2004, FUNGAL GENETICS NEWS, V51, P12; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Liu Y, 2003, J BIOL RHYTHM, V18, P195, DOI 10.1177/0748730403018003002; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Merrow M, 2006, CHRONOBIOL INT, V23, P71, DOI 10.1080/07420520500545888; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Nadkarni NA, 2005, J BIOL RHYTHM, V20, P490, DOI 10.1177/0748730405281332; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Rozen S., 1998, PRIMER3; Ruoff P., 2000, COMMENTS THEOR BIOL, V5, P361; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; SARGENT ML, 1972, PLANT PHYSIOL, V50, P171, DOI 10.1104/pp.50.1.171; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schmale DG, 2006, CAN J PLANT PATHOL, V28, P100, DOI 10.1080/07060660609507276; SPRINGER ML, 1993, BIOESSAYS, V15, P365, DOI 10.1002/bies.950150602; SPRINGER ML, 1989, GENE DEV, V3, P559, DOI 10.1101/gad.3.4.559; TAJIMA F, 1989, GENETICS, V123, P585; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Toyota K, 2002, MOL GENET GENOMICS, V268, P56, DOI 10.1007/s00438-002-0722-1; Turner BC, 2001, FUNGAL GENET BIOL, V32, P67, DOI 10.1006/fgbi.2001.1247; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	54	52	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e795	10.1371/journal.pone.0000795	http://dx.doi.org/10.1371/journal.pone.0000795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726525	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455400012
J	Clark, JL; Caceres, CF; Lescano, AG; Konda, KA; Leon, SR; Jones, FR; Kegeles, SM; Klausner, JD; Coates, TJ				Clark, Jesse L.; Caceres, Carlos F.; Lescano, Andres G.; Konda, Kelika A.; Leon, Segundo R.; Jones, Franca R.; Kegeles, Susan M.; Klausner, Jeffrey D.; Coates, Thomas J.		NIMH STD HIV Collaborative Prevent	Prevalence of Same-Sex Sexual Behavior and Associated Characteristics among Low-Income Urban Males in Peru	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; TYPE-2 INFECTION; LATIN-AMERICA; HIV-INFECTION; MEN; GAY; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS	Background. Peru has a concentrated HIV epidemic in which men who have sex with men are particularly vulnerable. We describe the lifetime prevalence of same-sex sexual contact and associated risk behaviors of men in Peru's general population, regardless of their sexual identity. Methods and Results. A probability sample of males from low-income households in three Peruvian cities completed an epidemiologic survey addressing their sexual risk behavior, including sex with other men. Serum was tested for HSV-2, HIV, and syphilis. Urine was tested for chlamydia and gonorrhea. A total of 2,271 18-30 year old men and women were contacted, of whom 1,645 (72.4%) agreed to participate in the study. Among the sexually experienced men surveyed, 15.2% (85/558, 95% CI: 12.2%-18.2%) reported a history of sex with other men. Men ever reporting sex with men (MESM) had a lower educational level, had greater numbers of sex partners, and were more likely to engage in risk behaviors including unprotected sex with casual partners, paying for or providing compensated sex, and using illegal drugs. MESM were also more likely to have had previous STI symptoms or a prior STI diagnosis, and had a greater prevalence of HSV-2 seropositivity. Conclusions. Many low-income Peruvian men have engaged in same-sex sexual contact and maintain greater behavioral and biological risk factors for HIV/STI transmission than non-MESM. Improved surveillance strategies for HIV and STIs among MESM are necessary to better understand the epidemiology of HIV in Latin America and to prevent its further spread.	[Clark, Jesse L.; Konda, Kelika A.; Coates, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Caceres, Carlos F.; Leon, Segundo R.] Univ Peruana Cayetano Heredia, Unidad Salud Sexualidad & Desarrollo Humano, Lima, Peru; [Lescano, Andres G.] USN, Med Ctr Res Detachment, Lima, Peru; [Jones, Franca R.] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA; [Kegeles, Susan M.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [NIMH STD HIV Collaborative Prevent] NIMH, Multisite Int Grp, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Peruana Cayetano Heredia; United States Department of Defense; United States Navy; University of California System; University of California San Francisco; San Francisco Department of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Clark, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA.	jlclark@mednet.ucla.edu	Lescano, Andres G./M-9849-2019; Leon, Segundo Ramos/J-3058-2019; Oliveira, Claudia DL/G-8618-2011; Lescano, Andres G/B-8479-2008	Lescano, Andres G./0000-0001-9779-633X; Leon, Segundo Ramos/0000-0002-5630-5714; Lescano, Andres G/0000-0001-9779-633X; Clark, Jesse/0000-0001-5862-6530; Caceres, Carlos F./0000-0002-8101-0790	NIH/NIMH [U10 MH61536]; LP-CRADA [NM-04-1787]; FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U10MH061536] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); LP-CRADA; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by NIH/NIMH grant number U10 MH61536 which is a five-country Cooperative Agreement being conducted in China, India, Peru, Russia, and Zimbabwe. Each site has selected a different venue and population with which to implement the prevention program entitled Community Public Opinion Leader (C-POL) Intervention. This article is based on a pre-baseline study conducted in all the sites to prepare for initiation of the intervention. This study was partially supported by LP-CRADA NM-04-1787. The supporting institutions supervised design and execution of the study, including data collection, and approved the final version of the manuscript.	Agronick G, 2004, AIDS BEHAV, V8, P185, DOI 10.1023/B:AIBE.0000030249.11679.d0; Almaguer T, 1991, DIFFERENCES, V3, P75; Bautista CT, 2004, SEX TRANSM INFECT, V80, P498, DOI 10.1136/sti.2004.013094; BEYRER C, 1995, AIDS, V9, P171, DOI 10.1097/00002030-199509020-00009; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; CACERES C, 2004, NEEDS ARE IDENTIFYIN; Caceres C F, 1999, Cult Health Sex, V1, P261, DOI 10.1080/136910599301012; Caceres CF, 2003, INT J EPIDEMIOL, V32, P740, DOI 10.1093/ije/dyg214; Caceres CF, 2002, AIDS, V16, pS23, DOI 10.1097/00002030-200212003-00005; CACERES CF, 1999, RECONFIGURACION UNIV; Carballo-Dieguez A., 1994, J PSYCHOL HUMAN SEXU, V6, P41; CARBALLODIEGUEZ A, 2000, J PSYCHOL HUMAN SEXU, V12, P49; CARCAMO C, 2003, SEXUALLY TRANSMITTED; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Chng CL, 2000, AIDS EDUC PREV, V12, P326; *COM EC AM LAT CAR, 1993, CENS POBL VIV 1993; Dodds JP, 2006, SEX TRANSM INFECT, V82, P86, DOI 10.1136/sti.2005.015248; Dûíaz RM., 1998, LATINO GAY MEN HIV C; Finlinson HA, 2006, AIDS BEHAV, V10, P531, DOI 10.1007/s10461-006-9107-5; Goodreau SM, 2005, J INFECT DIS, V191, pS147, DOI 10.1086/425268; Gutierrez JP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-152; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heimer R, 2005, AIDS BEHAV, V9, P403, DOI 10.1007/s10461-005-9030-1; *I NAC EST INF, 1994, PER MAP NEC BAS INS; Jarama SL, 2005, AIDS BEHAV, V9, P513, DOI 10.1007/s10461-005-9022-1; Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) Working Group on Global HIV/AIDS and STI Surveillance, 2004, UNAIDS WHO EP FACT S; Konda KA, 2005, SEX TRANSM DIS, V32, P534, DOI 10.1097/01.olq.0000175413.89733.ae; KONDA KA, 2007, AIDS BEHAV IN PRESS; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; McFarland W, 2001, AIDS, V15, pS23, DOI 10.1097/00002030-200104003-00004; MILLER M, 2005, J URBAN HLTH S1, V82, P26; Montano SM, 2005, JAIDS-J ACQ IMM DEF, V40, P57, DOI 10.1097/01.qai.0000159667.72584.8b; O'Donnell L, 2002, AIDS EDUC PREV, V14, P457, DOI 10.1521/aeap.14.8.457.24109; Pando MA, 2006, SEX TRANSM DIS, V33, P307, DOI 10.1097/01.olq.0000194578.06795.2d; Ramirez-Valles J, 2005, AIDS BEHAV, V9, P387, DOI 10.1007/s10461-005-9012-3; Salazar X, 2005, CULT HEALTH SEX, V7, P375, DOI 10.1080/13691050500100849; Salazar Ximena, 2006, Cad. Saúde Pública, V22, P2097, DOI 10.1590/S0102-311X2006001000015; SANCHEZ J, 2007, J ACQUIR IMMUNE DEFI; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Sutmoller Frits, 2002, International Journal of Infectious Diseases, V6, P259, DOI 10.1016/S1201-9712(02)90158-X; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; Tabet SR, 1996, AIDS, V10, P201, DOI 10.1097/00002030-199602000-00011	44	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e778	10.1371/journal.pone.0000778	http://dx.doi.org/10.1371/journal.pone.0000778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712426	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455300026
J	Iyer, J; Reich, NC				Iyer, Janaki; Reich, Nancy C.			Constitutive nuclear import of latent and activated STAT5a by its coiled coil domain	FASEB JOURNAL			English	Article						transcription factor; nuclear trafficking; tyrosine phosphorylation; live cell imaging	DNA-BINDING DOMAIN; GENE-EXPRESSION; TRANSCRIPTION FACTOR; NUCLEOCYTOPLASMIC TRANSPORT; UNPHOSPHORYLATED STAT1; LYMPHOID DEVELOPMENT; MAMMARY EPITHELIUM; CELL-PROLIFERATION; GROWTH; ALPHA	Signal transducer and activator of transcription 5a (STAT5a) is a critical transcription factor for a number of physiological processes including hematopoiesis and mammary gland development. Cytokines such as growth hormone, prolactin, erythropoietin, and interleukin-2 stimulate the activation of STAT5a by tyrosine phosphorylation. Tyrosine phosphorylation confers a conformational change and the ability to bind specific target DNA. To execute its function as a signaling molecule and transcription factor, accurate cellular localization of STAT5a is essential. This study explores the nuclear trafficking of STAT5a both before phosphorylation and after tyrosine phosphorylation. With the use of live cell imaging we demonstrate the continuous shuttling of STAT5a in and out of the nucleus. Evaluation of a series of mutations and deletions identifies a region within the coiled coil domain of STAT5a that is critical for nuclear import of both unphosphorylated and tyrosine-phosphorylated forms. The mechanism that regulates transport of STAT5a through nuclear pore complexes into the nucleus is therefore independent of tyrosine phosphorylation. However, after tyrosine phosphorylation, STAT5a accumulates in the nucleus because of its retention by DNA binding. These findings should provide a foundation for further studies that involve targeting the activity of STAT5a.	[Iyer, Janaki; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reich, NC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	nreich@notes.cc.sunysb.edu			NCI NIH HHS [P01CA2814, R01CA122910] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA122910] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Constantino S, 2001, ONCOGENE, V20, P2080, DOI 10.1038/sj.onc.1204308; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; Gatzka M, 2006, CYTOKINE, V34, P143, DOI 10.1016/j.cyto.2006.04.003; Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Groner B, 2000, BREAST CANCER RES, V2, P149, DOI 10.1186/bcr47; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Melen K, 2001, J BIOL CHEM, V276, P16447, DOI 10.1074/jbc.M008821200; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; NISHI K, 1994, J BIOL CHEM, V269, P6320; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peters Reiner, 2006, V322, P235; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; Pranada AL, 2004, J BIOL CHEM, V279, P15114, DOI 10.1074/jbc.M312530200; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Smit LS, 1997, ENDOCRINOLOGY, V138, P3426, DOI 10.1210/en.138.8.3426; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Yang J, 2005, CANCER RES, V65, P939; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110; Zeng R, 2002, J IMMUNOL, V168, P4567, DOI 10.4049/jimmunol.168.9.4567	52	32	33	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2008	22	2					391	400		10.1096/fj.07-8965com	http://dx.doi.org/10.1096/fj.07-8965com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17846080				2022-12-25	WOS:000252822600009
J	Baker, AM; Sauliere, A; Gaibelet, G; Lagane, B; Mazeres, S; Fourage, M; Bachelerie, F; Salome, L; Lopez, A; Dumas, F				Baker, Aurelie-Marie; Sauliere, Aude; Gaibelet, Gerald; Lagane, Bernard; Mazeres, Serge; Fourage, Marie; Bachelerie, Francoise; Salome, Laurence; Lopez, Andre; Dumas, Fabrice			CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells - A fluorescence recovery after photobleaching at variable radii approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FRAP EXPERIMENTS; T-CELLS; RECEPTOR; DOMAINS; SURFACE; ENTRY; DIMERIZATION; ASSOCIATION; MICROVILLI	The entry of human immunodeficiency virus into target cells requires successive interactions of the viral envelope glycoprotein gp120 with CD4 and the chemokine receptors CCR5 or CXCR4. We previously demonstrated, by Forster resonance energy transfer experiments, the constitutive association of CD4 and CCR5 at the surface of living cells. We therefore speculated that this interaction may correlate with compartmentalization of CD4 and CCR5 within the plasma membrane. Here, we characterize the lateral distribution, the dynamics, and the stoichiometry of these receptors in living cells stably expressing CD4 and/or CCR5 by means of fluorescence recovery after photobleaching at variable radii experiments. We found that (i) these receptors expressed alone are confined into 1-mu m-sized domains, (ii) CD4-CCR5 associations occur outside and inside smaller domains, and (iii) these interactions involve multiple CCR5 molecules per CD4.	Univ Toulouse 3, Inst Pharmacol & Biol Struct, CNRS, UMR 5089, F-31062 Toulouse, France; Inst Pasteur, Unite Pathogenie Virale Mol, INSERM, U819, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dumas, F (corresponding author), Univ Toulouse 3, Inst Pharmacol & Biol Struct, CNRS, UMR 5089, 205 Route Narbonne, F-31062 Toulouse, France.	Fabrice.Dumas@ipbs.fr	BACHELERIE, FRANCOISE/F-8823-2013; Lagane, Bernard/K-8446-2016; Fourage, Marie/AAA-5163-2021; Lagane, Bernard/AAA-2205-2019	BACHELERIE, FRANCOISE/0000-0002-0399-3277; Lagane, Bernard/0000-0002-3459-7867; SALOME, Laurence/0000-0001-9667-4154; Dumas, Fabrice/0000-0002-9164-4527				Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chang MI, 2005, J VIROL, V79, P14748, DOI 10.1128/JVI.79.23.14748-14755.2005; Desmetz C, 2006, IMMUNOLOGY, V119, P551, DOI 10.1111/j.1365-2567.2006.02470.x; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doranz BJ, 1999, J VIROL, V73, P10346, DOI 10.1128/JVI.73.12.10346-10358.1999; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Foti M, 2002, P NATL ACAD SCI USA, V99, P2008, DOI 10.1073/pnas.042689099; Gaibelet G, 2006, J BIOL CHEM, V281, P37921, DOI 10.1074/jbc.M607103200; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; LAYNE SP, 1990, NATURE, V346, P277, DOI 10.1038/346277a0; Li S, 1998, IMMUNOL TODAY, V19, P455, DOI 10.1016/S0167-5699(98)01325-5; LOPEZ A, 1988, BIOPHYS J, V53, P963, DOI 10.1016/S0006-3495(88)83177-1; Lynch GW, 1999, EUR J IMMUNOL, V29, P2590, DOI 10.1002/(SICI)1521-4141(199908)29:08<2590::AID-IMMU2590>3.0.CO;2-R; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; MONTI JA, 1978, J LIPID RES, V19, P222; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Platt EJ, 2001, J VIROL, V75, P12266, DOI 10.1128/JVI.75.24.12266-12278.2001; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Sauliere A, 2006, FEBS LETT, V580, P5227, DOI 10.1016/j.febslet.2006.08.056; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496	26	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35163	35168		10.1074/jbc.M705617200	http://dx.doi.org/10.1074/jbc.M705617200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855336	hybrid			2022-12-25	WOS:000251155200061
J	Ahuja, N; Schwer, B; Carobbio, S; Waltregny, D; North, BJ; Castronovo, V; Maechler, P; Verdin, E				Ahuja, Nidhi; Schwer, Bjoern; Carobbio, Stefania; Waltregny, David; North, Brian J.; Castronovo, Vincenzo; Maechler, Pierre; Verdin, Eric			Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADING ENZYME; INCREASED DOSAGE; CELL-SURVIVAL; NAD; HOMOLOG; PROTEIN; P53; TRANSCRIPTION; RIBOSYLATION; DEACETYLASE	Sirtuins are homologues of the yeast transcriptional repressor Sir2p and are conserved from bacteria to humans. We report that human SIRT4 is localized to the mitochondria. SIRT4 is a matrix protein and becomes cleaved at amino acid 28 after import into mitochondria. Mass spectrometry analysis of proteins that coimmunoprecipitate with SIRT4 identified insulin degrading enzyme and the ADP/ATP carrier proteins, ANT2 and ANT3. SIRT4 exhibits no histone deacetylase activity but functions as an efficient ADP-ribosyltransferase on histones and bovine serum albumin. SIRT4 is expressed in islets of Langerhans and colocalizes with insulin-expressing beta cells. Depletion of SIRT4 from insulin-producing INS-1E cells results in increased insulin secretion in response to glucose. These observations define a new role for mitochondrial SIRT4 in the regulation of insulin secretion.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; Univ Geneva, Univ Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; Univ Liege, Metastasis Res Lab, B-4000 Liege, Belgium	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Geneva; University of Liege	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	carobbio, stefania/E-7095-2018; Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183; Maechler, Pierre/0000-0002-2005-1433				ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chacinska A, 2002, TRENDS CELL BIOL, V12, P299, DOI 10.1016/S0962-8924(02)02310-3; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Guarente L, 2000, GENE DEV, V14, P1021; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HARDY DL, 1992, BIOCHEM J, V283, P849, DOI 10.1042/bj2830849; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luciano P, 1996, EXPERIENTIA, V52, P1077, DOI 10.1007/BF01952105; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Maechler Pierre, 2003, Curr Opin Investig Drugs, V4, P1166; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mowbray J, 1996, FEBS LETT, V394, P61, DOI 10.1016/0014-5793(96)00921-0; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pebay-Peyroula E, 2004, CURR OPIN STRUC BIOL, V14, P420, DOI 10.1016/j.sbi.2004.06.009; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	50	307	323	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33583	10.1074/jbc.M705488200	http://dx.doi.org/10.1074/jbc.M705488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17715127	hybrid			2022-12-25	WOS:000250840200039
J	Coulon, V; L'Honore, A; Ouimette, JF; Dumontier, E; van den Munckhof, P; Drouin, J				Coulon, Vincent; L'Honore, Aurore; Ouimette, Jean-Francois; Dumontier, Emilie; van den Munckhof, Pepijn; Drouin, Jacques			A muscle-specific promoter directs Pitx3 gene expression in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; HOMEOBOX GENE; APHAKIA MICE; PITUITARY DEVELOPMENT; LENS DEVELOPMENT; PTX1; TRANSCRIPTION; HINDLIMB; DIFFERENTIATION; ISOFORMS	The Pitx homeobox transcription factor genes have been implicated in different developmental processes, including determination of hind limb identity for Pitx1, left-right asymmetry for Pitx2, and eye development and survival of midbrain dopaminergic neurons for Pitx3. Pitx1 and Pitx2 have partly redundant activities in craniofacial development, including in pituitary organogenesis, as indicated by their names. These genes also exhibit redundant activities in the control of hind limb bud growth. Recent studies have shown expression of the three Pitx genes in muscle, with Pitx3 being the most widely expressed in all skeletal muscles. We now report the identification of a muscle-specific promoter within the Pitx3 gene that is situated between the first exon for eye and brain expression and exon 2 that contains the initiator ATG codon. Sequences proximal to this muscle-specific exon 1 are essential and sufficient to confer muscle-specific expression in transgenic mice, they are responsive to myogenic basic helix-loop-helix regulatory factors, and they recruit these factors in vivo. In agreement with exclusive use of the muscle-specific promoter in aphakia mice that are deleted of the brain promoter, the trimethyl-lysine 4 histone H3 promoter signature shifts to this promoter in embryonic day 13 ak limb bud muscle cells. Myogenic basic helix-loop-helix regulatory factor activation of Pitx3 transcription may be part of a positive feedback loop contributing to establishment of the myogenic program.	Inst Rech Clin Montreal, Lab Genet Mol, Montreal, PQ H2W 1R7, Canada; Inst Mol Genet, CNRS, UMR 5535, F-34293 Montpellier 05, France; Univ Amsterdam, Acad Med Centrum, NL-1100 DD Amsterdam, Netherlands	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Amsterdam; Academic Medical Center Amsterdam	Drouin, J (corresponding author), Inst Rech Clin Montreal, Lab Genet Mol, 110 Ave Pins Quest, Montreal, PQ H2W 1R7, Canada.	jacques.drouin@ircm.qc.ca	Coulon, Vincent/B-2437-2009; Coulon, Vincent/AFF-7934-2022; van den Munckhof, Pepijn/AAY-9259-2020	Coulon, Vincent/0000-0002-3168-8755; Coulon, Vincent/0000-0002-3168-8755; Drouin, Jacques/0000-0001-8226-5691; L'honore, Aurore/0000-0001-6371-4455				Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Forrester WC, 1999, GENE DEV, V13, P3003, DOI 10.1101/gad.13.22.3003; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; KENDALL SK, 1994, MOL ENDOCRINOL, V8, P1420, DOI 10.1210/me.8.10.1420; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1999, ENDOCRINOLOGY, V140, P1416, DOI 10.1210/en.140.3.1416; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Liu CY, 2002, DEVELOPMENT, V129, P5081; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rieger DK, 2001, GENOMICS, V72, P61, DOI 10.1006/geno.2000.6464; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; van den Munckhof P, 2006, J NEUROCHEM, V96, P160, DOI 10.1111/j.1471-4159.2005.03522.x; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	39	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33192	33200		10.1074/jbc.M706119200	http://dx.doi.org/10.1074/jbc.M706119200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848564	hybrid			2022-12-25	WOS:000250625400066
J	Walden, CM; Sandhoff, R; Chuang, CC; Yildiz, Y; Butters, TD; Dwek, RA; Platt, FM; van der Spoel, AC				Walden, Charlotte M.; Sandhoff, Roger; Chuang, Chia-Chen; Yildiz, Yildiz; Butters, Terry D.; Dwek, Raymond A.; Platt, Frances M.; van der Spoel, Aarnoud C.			Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2 - Implications for spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYLATED IMINO SUGARS; ACID BETA-GLUCOSIDASE; N-BUTYLDEOXYNOJIRIMYCIN; NONLYSOSOMAL GLUCOSYLCERAMIDASE; GANGLIOSIDE BIOSYNTHESIS; MALE CONTRACEPTION; STORAGE DISEASE; MALE-FERTILITY; HUMAN LIVER; GERM-CELLS	One of the hallmarks of male germ cell development is the formation of a specialized secretory organelle, the acrosome. This process can be pharmacologically disturbed in C57BL/ 6 mice, and thus infertility can be induced, by small molecular sugar- like compounds ( alkylated imino sugars). Here the biochemical basis of this effect has been investigated. Our findings suggest that in vivo alkylated imino sugars primarily interact with the non- lysosomal glucosylceramidase. This enzyme cleaves glucosylceramide into glucose and ceramide, is sensitive to imino sugars in vitro, and has been characterized as beta- glucosidase 2 ( GBA2). Imino sugars raised the level of glucosylceramide in brain, spleen, and testis, in a dose- dependent fashion. In testis, multiple species of glucosylceramide were similarly elevated, those having long acyl chains ( C16 - 24), as well as those with very long polyunsaturated acyl chains ( C28 - 30: 5). Both of these GlcCer species were also increased in the testes from GBA2- deficient mice. When considering that the very long polyunsaturated sphingolipids are restricted to germ cells, these results indicate that in the testis GBA2 is present in both somatic and germ cells. Furthermore, in all mouse strains tested imino sugar treatment caused a rise in testicular glucosylceramide, even in a number of strains, of which the males remain fertile after drug administration. Therefore, it appears that acrosome formation can be derailed by accumulation of glucosylceramide in an extralysosomal localization, and that the sensitivity of male germ cells to glucosylceramide is genetically determined.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QU, England; German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany; Univ Hosp Bonn, Dept Internal Med 1, D-53105 Bonn, Germany	University of Oxford; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn	van der Spoel, AC (corresponding author), Mansfield Rd, Oxford OX1 3QT, England.	aarnoud.vanderspoel@pharm.ox.ac.uk	Platt, Frances/G-1004-2010	Platt, Frances/0000-0001-7614-0403	NICHD NIH HHS [1U01 HD 45861] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045861] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; CONZELMANN E, 1991, DEV NEUROSCI-BASEL, V13, P197, DOI 10.1159/000112160; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; Furland NE, 2007, J BIOL CHEM, V282, P18141, DOI 10.1074/jbc.M700708200; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gunzer F, 2002, AM J CLIN PATHOL, V118, P364; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jeyakumar M, 2002, NEUROBIOL DIS, V10, P201, DOI 10.1006/nbdi.2002.0511; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; MATERN H, 1992, FEBS LETT, V314, P183, DOI 10.1016/0014-5793(92)80970-R; Matern H, 2001, J BIOL CHEM, V276, P37929; Matern H, 1997, J BIOL CHEM, V272, P11261; Mellor HR, 2000, ANAL BIOCHEM, V284, P136, DOI 10.1006/abio.2000.4678; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Roy A, 2006, J CLIN INVEST, V116, P2860, DOI 10.1172/JCI30221; Sandhoff R, 2005, J BIOL CHEM, V280, P27310, DOI 10.1074/jbc.M502775200; Suganuma R, 2005, BIOL REPROD, V72, P805, DOI 10.1095/biolreprod.104.036053; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; van Meer G, 2003, PHILOS T ROY SOC B, V358, P869, DOI 10.1098/rstb.2003.1266; VANECHTEN G, 1989, J NEUROCHEM, V52, P207; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Walden CM, 2006, HUM REPROD, V21, P1309, DOI 10.1093/humrep/dei463; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	41	60	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32655	32664		10.1074/jbc.M702387200	http://dx.doi.org/10.1074/jbc.M702387200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848577	hybrid			2022-12-25	WOS:000250625400014
J	Keller, DM; McWeeney, S; Arsenlis, A; Drouin, J; Wright, CVE; Wang, H; Wollheim, CB; White, P; Kaestner, KH; Goodman, RH				Keller, David M.; McWeeney, Shannon; Arsenlis, Athanasios; Drouin, Jacques; Wright, Christopher V. E.; Wang, Haiyan; Wollheim, Claes B.; White, Peter; Kaestner, Klaus H.; Goodman, Richard H.			Characterization of pancreatic transcription factor pdx-1 binding sites using promoter Microarray and serial analysis of chromatin occupancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-PRODUCING CELLS; NUCLEAR FACTOR 3-BETA; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; REGULATORY REGION; BETA-CELLS; IN-VIVO; LIVER; DIFFERENTIATION; PROTEIN	The homeobox transcription factor Pdx-1 is necessary for pancreas organogenesis and beta cell function, however, most Pdx-1-regulated genes are unknown. To further the understanding of Pdx-1 in beta cell biology, we have characterized its genomic targets in NIT-1 cells, a mouse insulinoma cell line. To identify novel targets, we developed a microarray that includes traditional promoters as well as non-coding conserved elements, micro-RNAs, and elements identified through an unbiased approach termed serial analysis of chromatin occupancy. In total, 583 new Pdx-1 target genes were identified, many of which contribute to energy sensing and insulin release in pancreatic beta cells. By analyzing 31 of the protein-coding Pdx-1 target genes, we show that 29 are expressed in beta cells and, of these, 68% are down-or up-regulated in cells expressing a dominant negative mutant of Pdx-1. We additionally show that many Pdx-1 targets also interact with NeuroD1/BETA2, including the micro-RNA miR-375, a known regulator of insulin secretion.	Oregon Hlth & Sci Univ, Vollum Inst, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Div Biostat, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland; Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Oregon Health & Science University; Oregon Health & Science University; University of Pennsylvania; University of Pennsylvania; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Vanderbilt University; Roche Holding; University of Geneva	Keller, DM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Dept Publ Hlth & Prevent Med, 3181 S W Sam Jackson Pk Rd, Portland, OR 97239 USA.	kellerd@ohsu.edu	White, Peter/E-4301-2011	White, Peter/0000-0002-5218-5903; Drouin, Jacques/0000-0001-8226-5691	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK056947, U01DK072477] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01-DK072477, U01-DK056947] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chae JH, 2004, MOL CELLS, V18, P271; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Friedman JR, 2004, P NATL ACAD SCI USA, V101, P12986, DOI 10.1073/pnas.0402875101; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kemp DM, 2003, REV ENDOCR METAB DIS, V4, P5, DOI 10.1023/A:1021809917576; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Marshak S, 2000, MOL CELL BIOL, V20, P7583, DOI 10.1128/MCB.20.20.7583-7590.2000; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Miyatsuka T, 2003, BIOCHEM BIOPH RES CO, V310, P1017, DOI 10.1016/j.bbrc.2003.09.108; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Nakajima-Nagata N, 2004, BIOCHEM BIOPH RES CO, V318, P631, DOI 10.1016/j.bbrc.2004.04.071; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rozen S, 2000, Methods Mol Biol, V132, P365; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Smith SB, 2000, J BIOL CHEM, V275, P36910, DOI 10.1074/jbc.M005202200; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wang XL, 1999, ENDOCRINOLOGY, V140, P4904, DOI 10.1210/en.140.10.4904; Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100	64	85	90	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32084	32092		10.1074/jbc.M700899200	http://dx.doi.org/10.1074/jbc.M700899200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761679	hybrid, Green Published			2022-12-25	WOS:000250480300029
J	Shen, G; Balasubramanian, R; Wang, T; Wu, Y; Hoffart, LM; Krebs, C; Bryant, DA; Golbeck, JH				Shen, Gaozhong; Balasubramanian, Ramakrishnan; Wang, Tao; Wu, Yingxian; Hoffart, Lee M.; Krebs, Carsten; Bryant, Donald A.; Golbeck, John H.			SufR coordinates two [4Fe-4S](2+,1+) clusters and functions as a transcriptional repressor of the sufBCDS operon and an autoregulator of sufR in cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; LIGAND 4FE-4S CLUSTER; SP STRAIN PCC-6803; FE-S PROTEINS; PHOTOSYSTEM-I; AZOTOBACTER-VINELANDII; SPECTROSCOPIC CHARACTERIZATION; DESULFOVIBRIO-AFRICANUS; ELECTRON-TRANSFER; 2FE-2S CLUSTERS	The sufR gene encodes a protein that functions as a transcriptional repressor of the suf regulon in cyanobacteria. It is predicted to contain an N- terminal helix loop helix DNA binding motif and a C- terminal Fe/S binding domain. Through immunoblotting assays of cell extracts, the sufR product in Synechocystis sp. PCC 6803 was shown to have a mass of similar to 25 kDa. This indicates that the second ATG in the open reading frame is the correct start codon and that sufR encodes a protein of 216 amino acids (SufR(216)) rather than the originally predicted 240 amino acids. Recombinant SufR(216) harbored [4Fe-4S](2+,1+) clusters, which were present in a mixture of S = 1/2 and 3/2 ground spin states, and the holoprotein was a homodimer, containing 3.7 of non- heme irons and 3.5 labile sulfides per monomer. Thus, two [4Fe-4S](2+,1+) clusters are coordinated by each SufR(216) homodimer. SufR(216) bound to two DNA sequences in the regulatory region between the divergently transcribed sufR gene and the sufBCDS operon, and its binding affinity depended on the presence and redox state of the [4Fe- 4S](2+,1+) clusters. A high affinity binding site, which controls sufBCDS expression, and a low affinity binding site, which controls sufR expression, were identified. The SufR binding sites, which are separated by 26 base pairs, each contain a perfect inverted repeat, CAAC- N6GTTG, and are highly conserved in cyanobacteria. The Fe/S protein SufR thus functions both as a transcriptional repressor of the sufBCDS operon and as an autoregulator of sufR.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Golbeck, JH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, 3105 Frear Bldg, University Pk, PA 16802 USA.	jhg5@psu.edu	Balasubramanian, Ramakrishnan/C-7620-2011; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053				Antonkine ML, 2007, BBA-BIOENERGETICS, V1767, P712, DOI 10.1016/j.bbabio.2007.02.003; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1999, CURR OPIN CHEM BIOL, V3, P152, DOI 10.1016/S1367-5931(99)80027-1; Beinert H, 1978, Methods Enzymol, V54, P435; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busch JLH, 1997, BIOCHEM J, V323, P95, DOI 10.1042/bj3230095; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Ellis KES, 2001, MOL MICROBIOL, V41, P973, DOI 10.1046/j.1365-2958.2001.02588.x; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Frazzon J, 2002, MET IONS BIOL SYST, V39, P163; Frazzon J, 2001, P NATL ACAD SCI USA, V98, P14751, DOI 10.1073/pnas.011579098; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; GOLBECK JH, 1978, ARCH BIOCHEM BIOPHYS, V188, P233, DOI 10.1016/S0003-9861(78)80005-8; Golbeck JH, 1999, PHOTOSYNTH RES, V61, P107, DOI 10.1023/A:1006281802710; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; KENNEDY MC, 1987, P NATL ACAD SCI USA, V84, P8854, DOI 10.1073/pnas.84.24.8854; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; LI N, 1991, BIOCHIM BIOPHYS ACTA, V1059, P215, DOI 10.1016/S0005-2728(05)80206-3; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; MEHARI T, 1995, J BIOL CHEM, V270, P28108; Moore LJ, 2006, J BIOL CHEM, V281, P33268, DOI 10.1074/jbc.M608331200; Morimoto K, 2002, FEBS LETT, V519, P123, DOI 10.1016/S0014-5793(02)02736-9; NAKAI M, 2002, RECENT RES DEV PROTE, V1, P1; Reents H, 2006, MOL MICROBIOL, V60, P1432, DOI 10.1111/j.1365-2958.2006.05198.x; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Schreiter ER, 2003, NAT STRUCT BIOL, V10, P794, DOI 10.1038/nsb985; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seki A, 2006, FEBS LETT, V580, P5044, DOI 10.1016/j.febslet.2006.08.027; SHEN G, 2005, OXIDOREDUCTASE PHOTO, P529; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; VASSILIEV IR, 1995, BIOPHYS J, V69, P1544, DOI 10.1016/S0006-3495(95)80026-3; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Wollenberg M, 2003, EUR J BIOCHEM, V270, P1662, DOI 10.1046/j.1432-1033.2003.03522.x; Yu JP, 2003, J BACTERIOL, V185, P3878, DOI 10.1128/JB.185.13.3878-3887.2003; YU L, 1995, BIOCHEMISTRY-US, V34, P7861, DOI 10.1021/bi00024a010; YU LA, 1995, J BIOL CHEM, V270, P28118	44	62	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31909	31919		10.1074/jbc.M705554200	http://dx.doi.org/10.1074/jbc.M705554200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827500	hybrid			2022-12-25	WOS:000250480300011
J	Chandra, D; Choy, G; Tang, DG				Chandra, Dhyan; Choy, Grace; Tang, Dean G.			Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release - Evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; MEDIATED APOPTOSIS; HYDROXAMIC ACID; HEAT-SHOCK-PROTEIN-60; EXPRESSION; STRESS; DEATH; ACTIVATION	Most heat shock proteins (HSPs) have pro-survival functions. However, the role of HSP60, a mitochondrial matrix protein, is somewhat controversial with both pro-survival and pro-apoptotic functions reported. Here we show that in numerous apoptotic systems HSP60 protein accumulates in the cytosol. In BMD188-induced cell death, HSP60 accumulates in the cytosol with significant mitochondrial release. In contrast, in apoptosis induced by multiple other inducers, the cytosolic HSP60 accumulates without an apparent mitochondrial release. The short interfering RNA-mediated knockdown experiments revealed that in BMD188-induced apoptosis, HSP60 has a pro-death function and that the pro-death role of HSP60 seems to involve caspase-3 maturation and activation in the cytosol. In contrast, HSP60 appears to play a pro-survival role in other apoptotic systems where there is no apparent mitochondrial release as its knockdown promotes cell death. In these latter apoptotic systems HSP60 does not associate with active caspase-3. In both cases, HSP60 does not appreciably interact with Bax. Taken together, our results suggest the following: 1) cytosolic accumulation of HSP60 represents a common phenomenon during apoptosis induction; 2) cytosolic HSP60 accumulation during apoptosis occurs either with or without apparent mitochondrial release; and 3) the cytosolically accumulated HSP60 possesses either pro-survival or pro-death functions, which involves differential interactions with caspase-3.	Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, Smithville, TX 78957 USA; Grad Sch Biomed Sci, PRogram Environm & Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Tang, DG (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, PO Box 389,1808 Pk Rd 1-C, Smithville, TX 78957 USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Chandra, Dhyan/0000-0001-7272-9384	NATIONAL CANCER INSTITUTE [K01CA123142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015888, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER; NCI NIH HHS [K012 CA123142] Funding Source: Medline; NIA NIH HHS [AG023374] Funding Source: Medline; NIEHS NIH HHS [ES15888, ES07784] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahn JH, 1999, MOL CELLS, V9, P200; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Castle PE, 2005, CANCER LETT, V229, P245, DOI 10.1016/j.canlet.2005.06.045; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Chang AYW, 2006, J PHYSIOL-LONDON, V574, P547, DOI 10.1113/jphysiol.2006.110890; Clemons NJ, 2005, J BIOL CHEM, V280, P9005, DOI 10.1074/jbc.M414165200; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cornford PA, 2000, CANCER RES, V60, P7099; Faried A, 2004, EUR J CANCER, V40, P2804, DOI 10.1016/j.ejca.2004.08.013; Hsu PL, 1998, CANCER RES, V58, P5507; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; Joshi B, 1999, CANCER RES, V59, P4343; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Lebret T, 2003, CANCER, V98, P970, DOI 10.1002/cncr.11594; Li L, 1999, ANTICANCER RES, V19, P51; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; MAILHOS C, 1993, NEUROSCIENCE, V55, P621, DOI 10.1016/0306-4522(93)90428-I; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nadin SB, 2003, CELL STRESS CHAPERON, V8, P361, DOI 10.1379/1466-1268(2003)008<0361:DADIBD>2.0.CO;2; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Schneider J, 1999, ANTICANCER RES, V19, P2141; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Thomas X, 2005, LEUKEMIA RES, V29, P1049, DOI 10.1016/j.leukres.2005.02.010; Twiddy D, 2004, J BIOL CHEM, V279, P19665, DOI 10.1074/jbc.M311388200; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Zhang LX, 2004, EXP CELL RES, V292, P231, DOI 10.1016/j.yexcr.2003.08.012	40	181	190	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31289	31301		10.1074/jbc.M702777200	http://dx.doi.org/10.1074/jbc.M702777200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17823127	hybrid			2022-12-25	WOS:000250309200018
J	Cho, MH; Corea, ORA; Yang, H; Bedgar, DL; Laskar, DD; Anterola, AM; Moog-Anterola, FA; Hood, RL; Kohalmi, SE; Bernards, MA; Kang, C; Davin, LB; Lewis, NG				Cho, Man-Ho; Corea, Oliver R. A.; Yang, Hong; Bedgar, Diana L.; Laskar, Dhrubojyoti D.; Anterola, Aldwin M.; Moog-Anterola, Frances Anne; Hood, Rebecca L.; Kohalmi, Susanne E.; Bernards, Mark A.; Kang, ChulHee; Davin, Laurence B.; Lewis, Norman G.			Phenylalanine biosynthesis in Arabidopsis thaliana - Identification and characterization of arogenate dehydratases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID BIOSYNTHESIS; COLI P-PROTEIN; PREPHENATE DEHYDRATASE; ESCHERICHIA-COLI; SHIKIMATE PATHWAY; CYCLOHEXADIENYL DEHYDRATASE; CORYNEBACTERIUM-GLUTAMICUM; PHENYLPROPANOID METABOLISM; PSEUDOMONAS-AERUGINOSA; FEEDBACK INHIBITION	There is much uncertainty as to whether plants use arogenate, phenylpyruvate, or both as obligatory intermediates in Phe biosynthesis, an essential dietary amino acid for humans. This is because both prephenate and arogenate have been reported to undergo decarboxylative dehydration in plants via the action of either arogenate (ADT) or prephenate (PDT) dehydratases; however, neither enzyme(s) nor encoding gene(s) have been isolated and/or functionally characterized. An in silico data mining approach was thus undertaken to attempt to identify the dehydratase(s) involved in Phe formation in Arabidopsis, based on sequence similarity of PDT-like and ACT-like domains in bacteria. This data mining approach suggested that there are six PDT-like homologues in Arabidopsis, whose phylogenetic analyses separated them into three distinct subgroups. All six genes were cloned and subsequently established to be expressed in all tissues examined. Each was then expressed as a Nus fusion recombinant protein in Escherichia coli, with their substrate specificities measured in vitro. Three of the resulting recombinant proteins, encoded by ADT1 ( At1g11790), ADT2 (At3g07630), and ADT6 (At1g08250), more efficiently utilized arogenate than prephenate, whereas the remaining three, ADT3 (At2g27820), ADT4 (At3g44720), and ADT5 (At5g22630) essentially only employed arogenate. ADT1, ADT2, and ADT6 had k(cat)/K-m values of 1050, 7650, and 1560 M-1 s(-1) for arogenate versus 38, 240, and 16 M-1 s(-1) for prephenate, respectively. By contrast, the remaining three, ADT3, ADT4, and ADT5, had kcat/Km values of 1140, 490, and 620 M-1 s(-1), with prephenate not serving as a substrate unless excess recombinant protein (> 150 mu g/assay) was used. All six genes, and their corresponding proteins, are thus provisionally classified as arogenate dehydratases and designated ADT1-ADT6.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University; Western University (University of Western Ontario); Washington State University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu	Yang, Hong/C-2333-2012	Kang, ChulHee/0000-0002-0693-7860; Lewis, Norman/0000-0001-5742-032X; Davin, Laurence/0000-0002-3248-6485	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066173] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66173] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; BERRY A, 1987, J GEN MICROBIOL, V133, P2147; BONNER CA, 1985, ARCH BIOCHEM BIOPHYS, V238, P237, DOI 10.1016/0003-9861(85)90161-4; BONNER CA, 1995, PLANT CELL PHYSIOL, V36, P1013, DOI 10.1093/oxfordjournals.pcp.a078843; BYNG GS, 1983, ARCH MICROBIOL, V136, P163, DOI 10.1007/BF00409838; BYNG GS, 1981, MOL CELL BIOL, V1, P426, DOI 10.1128/MCB.1.5.426; Chan MS, 1996, BIOCHEM BIOPH RES CO, V219, P537, DOI 10.1006/bbrc.1996.0269; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Cochrane FC, 2004, PHYTOCHEMISTRY, V65, P1557, DOI 10.1016/j.phytochem.2004.05.006; COTTON R. G. H., 1968, BIOCHIM BIOPHYS ACTA, V156, P187, DOI 10.1016/0304-4165(68)90118-9; DAVIN LB, 2008, LIGNOCELLULOSE RECAL; DIXON RA, 1999, COMPREHENSIVE NATURA, V1, P713; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Ermolova NV, 2003, PROTEIN EXPRES PURIF, V29, P123, DOI 10.1016/S1046-5928(03)00014-7; FISCHER RS, 1993, ARCH MICROBIOL, V160, P440, DOI 10.1007/BF00245304; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Griesbach RJ, 2005, PL BRED RE, V25, P89; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HERRMANN KM, 1995, PLANT CELL, V7, P907; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hsu SK, 2004, ARCH MICROBIOL, V181, P237, DOI 10.1007/s00203-004-0649-5; HUDSON GS, 1984, J MOL BIOL, V180, P1023, DOI 10.1016/0022-2836(84)90269-9; JENSEN RA, 1977, J BACTERIOL, V132, P896, DOI 10.1128/JB.132.3.896-903.1977; JUNG E, 1986, P NATL ACAD SCI USA, V83, P7231, DOI 10.1073/pnas.83.19.7231; Kleeb AC, 2006, BIOCHEMISTRY-US, V45, P14101, DOI 10.1021/bi061274n; Lack G, 2006, J BIOL CHEM, V281, P9538, DOI 10.1074/jbc.M509119200; Lewis N. G., 1999, COMPREHENSIVE NATURA, V1, P639, DOI DOI 10.1016/B978-0-08-091283-7.00027-8; Lewis N.G., 1999, COMPR NAT PROD CHEM, V3, P617, DOI [10.1016/B978-0-08-091283-7.00085-0, DOI 10.1016/B978-0-08-091283-7.00085-0]; Li MC, 2006, J BIOTECHNOL, V122, P334, DOI 10.1016/j.jbiotec.2005.11.019; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; LUDWIG SR, 1987, P NATL ACAD SCI USA, V84, P5833, DOI 10.1073/pnas.84.16.5833; PATEL N, 1977, J BIOL CHEM, V252, P5839; Pohnert G, 1999, BIOCHEMISTRY-US, V38, P12212, DOI 10.1021/bi991134w; Prakash P, 2005, J BIOL CHEM, V280, P20666, DOI 10.1074/jbc.M502107200; RAZAL RA, 1994, PHYTOCHEM ANALYSIS, V5, P98, DOI 10.1002/pca.2800050303; Razal RA, 1996, PHYTOCHEMISTRY, V41, P31, DOI 10.1016/0031-9422(95)00628-1; SCHMID J, 1995, PHYTOCHEMISTRY, V39, P737, DOI 10.1016/0031-9422(94)00962-S; SIEHL DL, 1986, Z NATURFORSCH C, V41, P79; SIEHL DL, 1988, ARCH BIOCHEM BIOPHYS, V260, P822, DOI 10.1016/0003-9861(88)90513-9; Singh S, 1998, J PLANT PHYSIOL, V153, P316, DOI 10.1016/S0176-1617(98)80157-0; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Turner P, 2005, PROTEIN EXPRES PURIF, V39, P54, DOI 10.1016/j.pep.2004.09.012; Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5; vanHeerden PS, 1996, J BIOL CHEM, V271, P12350, DOI 10.1074/jbc.271.21.12350; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WHITAKER RJ, 1981, J BACTERIOL, V147, P526, DOI 10.1128/JB.147.2.526-534.1981; XIA TH, 1991, ARCH BIOCHEM BIOPHYS, V286, P461, DOI 10.1016/0003-9861(91)90066-R; ZAMIR LO, 1983, TETRAHEDRON LETT, V24, P2815, DOI 10.1016/S0040-4039(00)88031-4; ZAMIR LO, 1980, J AM CHEM SOC, V102, P4499, DOI 10.1021/ja00533a032; Zhang S, 1998, J BIOL CHEM, V273, P6248, DOI 10.1074/jbc.273.11.6248; Zhang S, 2000, BIOCHEMISTRY-US, V39, P4722, DOI 10.1021/bi9926680; ZHAO GS, 1992, J BIOL CHEM, V267, P2487	53	83	96	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30827	30835		10.1074/jbc.M702662200	http://dx.doi.org/10.1074/jbc.M702662200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726025	hybrid			2022-12-25	WOS:000250136300051
J	Lipson, RS; Clarke, SG				Lipson, Rebecca S.; Clarke, Steven G.			S-adenosylmethionine-dependent protein methylation in mammalian cytosol via tyrphostin modification by catechol-O-methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITORS; RAT-LIVER MICROSOMES; HUMAN CYTOCHROME-P450; IRREVERSIBLE BINDING; SIGNAL-TRANSDUCTION; ADDUCT FORMATION; IN-VITRO; CELLS; METABOLISM; MECHANISM	It has previously been shown that incubation of mammalian cell cytosolic extracts with the protein kinase inhibitor tyrphostin A25 results in enhanced transfer of methyl groups from S-adenosyl-[methyl-H-3] methionine to proteins. These findings were interpreted as demonstrating tyrphostin stimulation of a novel type of protein carboxyl methyltransferase. We find here, however, that tyrphostin A25 addition to mouse heart cytosol incubated with S-adenosyl-[methyl-H-3] methionine or S-adenosyl-[methyl-C-14] methionine stimulates the labeling of small molecules in addition to proteins. Base treatment of both protein and small molecule fractions releases volatile radioactivity, suggesting labile ester-like linkages of the labeled methyl group. Production of both the base-volatile product and labeled protein occurs with tyrphostins A25, A47, and A51, but not with thirteen other tyrphostin family members. These active tyrphostins all contain a catechol moiety and are good substrates for recombinant and endogenous catechol-O-methyltransferase. Inhibition of catechol-O-methyltransferase activity with tyrphostin AG1288 prevents both base-volatile product formation and protein labeling from methyl-labeled S-adenosylmethionine in heart, kidney, and liver, but not in testes or brain extracts. These results suggest that the incorporation of methyl groups into protein follows a complex pathway initiated by the methylation of select tyrphostins by endogenous catechol-O-methyltransferase. We suggest that the methylated tyrphostins are further modified in the cell extract and covalently attached to cellular proteins. The presence of endogenous catechols in cells suggests that similar reactions can also occur in vivo.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E,Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM026020, GM07185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bilodeau D, 1999, CELL SIGNAL, V11, P45, DOI 10.1016/S0898-6568(98)00030-8; BINDOLI A, 1992, FREE RADICAL BIO MED, V13, P391, DOI 10.1016/0891-5849(92)90182-G; Blackledge G, 2003, J UROLOGY, V170, pS77, DOI 10.1097/01.ju.0000095022.80033.d3; Blum G, 2003, J BIOL CHEM, V278, P40442, DOI 10.1074/jbc.M305490200; BOLT HM, 1974, J STEROID BIOCHEM, V5, P179, DOI 10.1016/0022-4731(74)90126-5; CADET JL, 1994, NEUROSCI BIOBEHAV R, V18, P457, DOI 10.1016/0149-7634(94)90001-9; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; Cuttle L, 2000, DRUG METAB DISPOS, V28, P945; GOTTLIEB AJ, 1974, BLOOD, V43, P85, DOI 10.1182/blood.V43.1.85.85; GRAHAM DG, 1978, MOL PHARMACOL, V14, P644; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; Jaleel M, 2004, BIOCHEMISTRY-US, V43, P8247, DOI 10.1021/bi036234n; Lautala P, 2001, MOL PHARMACOL, V59, P393, DOI 10.1124/mol.59.2.393; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Levitzki A, 2003, ACCOUNTS CHEM RES, V36, P462, DOI 10.1021/ar0201207; LEVITZKI A, 1992, FASEB J, V6, P3275, DOI 10.1096/fasebj.6.14.1426765; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; LIBERATO DJ, 1981, J MED CHEM, V24, P28, DOI 10.1021/jm00133a007; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; MAYER W, 1960, CHEM BER-RECL, V93, P2761, DOI 10.1002/cber.19600931203; Miranda TB, 2004, FEBS LETT, V577, P181, DOI 10.1016/j.febslet.2004.09.080; MONTINE TJ, 1995, J NEUROPATH EXP NEUR, V54, P311, DOI 10.1097/00005072-199505000-00004; Munns AJ, 1997, CHEM RES TOXICOL, V10, P1049, DOI 10.1021/tx9700836; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; RAMDAS L, 1995, ARCH BIOCHEM BIOPHYS, V323, P237, DOI 10.1006/abbi.1995.9969; Sagara Y, 2002, J BIOL CHEM, V277, P36204, DOI 10.1074/jbc.M203895200; SCHEULEN M, 1975, BIOCHEM BIOPH RES CO, V66, P1396, DOI 10.1016/0006-291X(75)90514-8; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Smythies J, 1998, BBA-GEN SUBJECTS, V1380, P159, DOI 10.1016/S0304-4165(97)00131-1; STOCK JB, 1992, J BIOL CHEM, V267, P19753; Svensson AW, 2006, METHOD ENZYMOL, V407, P144, DOI 10.1016/S0076-6879(05)07013-8; TENHUNEN J, 1993, BIOCHEM J, V296, P595, DOI 10.1042/bj2960595; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; TSE DCS, 1976, J MED CHEM, V19, P37, DOI 10.1021/jm00223a008; WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P121; Werner P, 2001, BRAIN RES, V893, P278, DOI 10.1016/S0006-8993(00)03298-4; WOLBRING G, 1994, J BIOL CHEM, V269, P22470; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu BT, 2004, INT J MOL MED, V13, P343; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	47	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31094	31102		10.1074/jbc.M705456200	http://dx.doi.org/10.1074/jbc.M705456200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724020	hybrid			2022-12-25	WOS:000250136300077
J	Ben-Shachar, D; Karry, R				Ben-Shachar, Dorit; Karry, Rachel			Sp1 Expression Is Disrupted in Schizophrenia; A Possible Mechanism for the Abnormal Expression of Mitochondrial Complex I Genes, NDUFV1 and NDUFV2	PLOS ONE			English	Article							PHOSPHORYLATION; ACTIVATION; PROMOTER; BRAIN; SUBUNIT; INVOLVEMENT; DYSFUNCTION; PLATELETS; DOPAMINE; REVEALS	Background. The prevailing hypothesis regards schizophrenia as a polygenic disease, in which multiple genes combine with each other and with environmental stimuli to produce the variance of its clinical symptoms. We investigated whether the ubiquitous transcription factor Sp1 is abnormally expressed in schizophrenia, and consequently can affect the expression of genes implicated in this disorder. Methodology/Principal Findings. mRNA of Sp1 and of mitochondrial complex I subunits (NDUFV1, NDUFV2) was analyzed in three postmortem brain regions obtained from the Stanley Foundation Brain Collection, and in lymphocytes of schizophrenic patients and controls. Sp1 role in the transcription of these genes was studied as well. Sp1 was abnormally expressed in schizophrenia in both brain and periphery. Its mRNA alteration pattern paralleled that of NDUFV1 and NDUFV2, decreasing in the prefrontal cortex and the striatum, while increasing in the parieto-occipital cortex and in lymphocytes of schizophrenic patients as compared with controls. Moreover, a high and significant correlation between these genes existed in normal subjects, but was distorted in patients. Sp1 role in the regulation of complex I subunits, was demonstrated by the ability of the Sp1/DNA binding inhibitor, mithramycin, to inhibit the transcription of NDUFV1 and NDUFV2, in neuroblastoma cells. In addition, Sp1 activated NDUFV2 promoter by binding to its three GC-boxes. Both activation and binding were inhibited by mithramycin. Conclusions/Significance. These findings suggest that abnormality in Sp1, which can be the main activator/repressor or act in combination with additional transcription factors and is subjected to environmental stimuli, can contribute to the polygenic and clinically heterogeneous nature of schizophrenia.	[Ben-Shachar, Dorit; Karry, Rachel] Technion Israel Inst Technol, Rambam Med Ctr, Ruth & Bruce Rappaport Fac Med, Psychobiol Lab,Dept Psychiat, Haifa, Israel; [Ben-Shachar, Dorit; Karry, Rachel] Technion Israel Inst Technol, Rambam Med Ctr, Ruth & Bruce Rappaport Fac Med, Mol Med Lab, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ben-Shachar, D (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Ruth & Bruce Rappaport Fac Med, Psychobiol Lab,Dept Psychiat, Haifa, Israel.	shachar@tx.technion.ac.il	Ben-Shachar, Dorit/D-4703-2015	Ben-Shachar, Dorit/0000-0003-2317-1489	Israel Chief Scientist Ministry of Health; The Stanley Medical Research Institute	Israel Chief Scientist Ministry of Health; The Stanley Medical Research Institute	This work was supported in part by a grant from Israel Chief Scientist Ministry of Health, and in part by a grant from The Stanley Medical Research Institute.	Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Bahn S, 2001, J CHEM NEUROANAT, V22, P79, DOI 10.1016/S0891-0618(01)00099-0; Banchio C, 2004, J BIOL CHEM, V279, P40220, DOI 10.1074/jbc.M406468200; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Caruncho Hector J., 2004, Critical Reviews in Neurobiology, V16, P25, DOI 10.1615/CritRevNeurobiol.v16.i12.20; CHEN ML, 2005, J PSYCHIAT RES; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Daniel S, 1996, J BIOL CHEM, V271, P1385, DOI 10.1074/jbc.271.3.1385; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dror N, 2002, MOL PSYCHIATR, V7, P995, DOI 10.1038/sj.mp.4001116; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Eastwood SL, 2001, BRAIN RES BULL, V55, P569, DOI 10.1016/S0361-9230(01)00530-5; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Glantz LA, 1997, ARCH GEN PSYCHIAT, V54, P943; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Goldberg HJ, 2000, DIABETES, V49, P863, DOI 10.2337/diabetes.49.5.863; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012; Knable MB, 2002, MOL PSYCHIATR, V7, P392, DOI 10.1038/sj.mp.4001034; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Liu AG, 2003, J BIOL CHEM, V278, P26423, DOI 10.1074/jbc.M211165200; Ma LM, 2004, J BIOL CHEM, V279, P40451, DOI 10.1074/jbc.M406827200; Mancama D, 2003, CURR OPIN MOL THER, V5, P642; Matsumoto N, 1998, J BIOL CHEM, V273, P28229, DOI 10.1074/jbc.273.43.28229; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; MCGLASHAN TH, 1988, SCHIZOPHRENIA BULL, V14, P515, DOI 10.1093/schbul/14.4.515; MCGLASHAN TH, 1992, ARCH GEN PSYCHIAT, V49, P63; MEHLERWEX C, 2004, MITROCHONDRIAL COMPL; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Okamoto S, 2002, MOL BRAIN RES, V107, P89, DOI 10.1016/S0169-328X(02)00440-0; Pearlson GD, 2000, ANN NEUROL, V48, P556, DOI 10.1002/1531-8249(200010)48:4<556::AID-ANA2>3.3.CO;2-U; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; SAFFER JD, 1990, GENE DEV, V4, P659, DOI 10.1101/gad.4.4.659; SHIH JC, 1993, J PSYCHIATR NEUROSCI, V18, P25; Stefansson H, 2004, ANN MED, V36, P62, DOI 10.1080/07853890310017585; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Szabo G, 1996, DNA CELL BIOL, V15, P1081, DOI 10.1089/dna.1996.15.1081; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Trisciuoglio D, 2004, J BIOL CHEM, V279, P6737, DOI 10.1074/jbc.M308938200; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Zaid A, 1999, J BIOENERG BIOMEMBR, V31, P129, DOI 10.1023/A:1005499727732; Zornoza T, 2005, NEUROPHARMACOLOGY, V49, P1067, DOI 10.1016/j.neuropharm.2005.06.005	55	61	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e817	10.1371/journal.pone.0000817	http://dx.doi.org/10.1371/journal.pone.0000817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786189	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455500001
J	Wang, Q; Pang, YP				Wang, Qi; Pang, Yuan-Ping			Preference of Small Molecules for Local Minimum Conformations when Binding to Proteins	PLOS ONE			English	Article								It is well known that small molecules (ligands) do not necessarily adopt their lowest potential energy conformations when binding to proteins. Analyses of protein-bound ligand crystal structures have reportedly shown that many of them do not even adopt the conformations at local minima of their potential energy surfaces (local minimum conformations). The results of these analyses raise a concern regarding the validity of virtual screening methods that use ligands in local minimum conformations. Here we report a normal-mode-analysis (NMA) study of 100 crystal structures of protein-bound ligands. Our data show that the energy minimization of a ligand alone does not automatically stop at a local minimum conformation if the minimum of the potential energy surface is shallow, thus leading to the folding of the ligand. Furthermore, our data show that all 100 ligand conformations in their protein-bound ligand crystal structures are nearly identical to their local minimum conformations obtained from NMA-monitored energy minimization, suggesting that ligands prefer to adopt local minimum conformations when binding to proteins. These results both support virtual screening methods that use ligands in local minimum conformations and caution about possible adverse effect of excessive energy minimization when generating a database of ligand conformations for virtual screening.	[Wang, Qi; Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MI USA	Mayo Clinic	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MI USA.	pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	U. S. Army Medical Research Acquisition Activity [W81XWH-04-2-0001]; National Institutes of Health [5R01AI054574-03, 5R01GM061300-06]; Mayo Graduate School; Mayo Foundation for Medical Education and Research	U. S. Army Medical Research Acquisition Activity; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation for Medical Education and Research	This work was supported by the U. S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), the National Institutes of Health (5R01AI054574-03 and 5R01GM061300-06), Mayo Graduate School, and the Mayo Foundation for Medical Education and Research.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Bruns RF, 1996, TRENDS PHARMACOL SCI, V17, P189, DOI 10.1016/0165-6147(96)20027-6; BURGEN ASV, 1981, FED PROC, V40, P2723; Case D.A, 1999, MOL BIOL+, V18, P329, DOI [10.1007/0-306-47089-6, DOI 10.1007/0-306-47089-6]; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Dooley AJ, 2006, BIOORG MED CHEM LETT, V16, P830, DOI 10.1016/j.bmcl.2005.11.018; Frisch M J, 1999, GAUSSIAN 98 REVISION; Hinsen Konrad, 2006, P1; JENSEN F, 1998, INTRO COMPUTATIONAL, P312; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; Kenakin T, 1996, TRENDS PHARMACOL SCI, V17, P190, DOI 10.1016/0165-6147(96)20026-4; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; NICKLAUS MC, 1995, BIOORGAN MED CHEM, V3, P411, DOI 10.1016/0968-0896(95)00031-B; Pang YP, 2007, CLIN PHARMACOL THER, V81, P30, DOI 10.1038/sj.clpt.6100030; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Pang YP, 1997, J MOL MODEL, V3, P240, DOI 10.1007/s008940050036; PANG YP, 2007, IBM J RES D IN PRESS; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perola E, 2004, J MED CHEM, V47, P2499, DOI 10.1021/jm030563w; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Vieth M, 1998, J COMPUT AID MOL DES, V12, P563, DOI 10.1023/A:1008055202136; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531	27	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e820	10.1371/journal.pone.0000820	http://dx.doi.org/10.1371/journal.pone.0000820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786192	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455500004
J	Beres, SB; Musser, JM				Beres, Stephen B.; Musser, James M.			Contribution of Exogenous Genetic Elements to the Group A Streptococcus Metagenome	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ERYTHROMYCIN RESISTANCE GENES; POPULATION-BASED SURVEILLANCE; MATRIX-BINDING PROTEINS; GRAM-POSITIVE BACTERIA; ACUTE RHEUMATIC-FEVER; PILUS-LIKE STRUCTURES; STAPHYLOCOCCUS-AUREUS; MACROLIDE-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS	Variation in gene content among strains of a bacterial species contributes to biomedically relevant differences in phenotypes such as virulence and antimicrobial resistance. Group A Streptococcus (GAS) causes a diverse array of human infections and sequelae, and exhibits a complex pathogenic behavior. To enhance our understanding of genotype-phenotype relationships in this important pathogen, we determined the complete genome sequences of four GAS strains expressing M protein serotypes (M2, M4, and 2 M12) that commonly cause noninvasive and invasive infections. These sequences were compared with eight previously determined GAS genomes and regions of variably present gene content were assessed. Consistent with the previously determined genomes, each of the new genomes is similar to 1.9 Mb in size, with similar to 10% of the gene content of each encoded on variably present exogenous genetic elements. Like the other GAS genomes, these four genomes are polylysogenic and prophage encode the majority of the variably present gene content of each. In contrast to most of the previously determined genomes, multiple exogenous integrated conjugative elements (ICEs) with characteristics of conjugative transposons and plasmids are present in these new genomes. Cumulatively, 242 new GAS metagenome genes were identified that were not present in the previously sequenced genomes. Importantly, ICEs accounted for 41% of the new GAS metagenome gene content identified in these four genomes. Two large ICEs, designated 2096-RD.2 (63 kb) and 10750-RD.2 (49 kb), have multiple genes encoding resistance to antimicrobial agents, including tetracycline and erythromycin, respectively. Also resident on these ICEs are three genes encoding inferred extracellular proteins of unknown function, including a predicted cell surface protein that is only present in the genome of the serotype M12 strain cultured from a patient with acute poststreptococcal glomerulonephritis. The data provide new information about the GAS metagenome and will assist studies of pathogenesis, antimicrobial resistance, and population genomics.	[Beres, Stephen B.; Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston	Musser, JM (corresponding author), Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmh.tmc.edu		Beres, Stephen/0000-0003-3041-0185	National Institute of Allergy and Infectious Diseases [UO1-60595]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by grant UO1-60595 from the National Institute of Allergy and Infectious Diseases ( to JMM).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Alberti S, 2003, J CLIN MICROBIOL, V41, P2385, DOI 10.1128/JCM.41.6.2385-2390.2003; ALLIGNET J, 1995, ANTIMICROB AGENTS CH, V39, P2027, DOI 10.1128/AAC.39.9.2027; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aracil B, 2001, J ANTIMICROB CHEMOTH, V48, P592, DOI 10.1093/jac/48.4.592; Areschoug T, 2004, VACCINE, V22, pS9, DOI 10.1016/j.vaccine.2004.08.010; Arpin C, 1999, ANTIMICROB AGENTS CH, V43, P2335, DOI 10.1128/AAC.43.9.2335; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Banks DJ, 2003, J INFECT DIS, V188, P1898, DOI 10.1086/379897; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; BERRIOS X, 1986, J LAB CLIN MED, V108, P535; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bingen E, 2002, ANTIMICROB AGENTS CH, V46, P1199, DOI 10.1128/AAC.46.5.1199-1203.2002; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brandt CM, 2001, MICROB DRUG RESIST, V7, P165, DOI 10.1089/10766290152045039; Brenciani A, 2004, J ANTIMICROB CHEMOTH, V54, P991, DOI 10.1093/jac/dkh481; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chuang I, 2002, CLIN INFECT DIS, V35, P665, DOI 10.1086/342062; Clancy J, 1996, MOL MICROBIOL, V22, P867, DOI 10.1046/j.1365-2958.1996.01521.x; CLEWELL DB, 1974, ANTIMICROB AGENTS CH, V5, P534, DOI 10.1128/AAC.5.5.534; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; De Azavedo JCS, 1999, ANTIMICROB AGENTS CH, V43, P2144, DOI 10.1128/AAC.43.9.2144; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Bouri KW, 1998, EPIDEMIOL INFECT, V121, P515, DOI 10.1017/S095026889800168X; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Eriksson BKG, 2003, CLIN INFECT DIS, V37, P1189, DOI 10.1086/379013; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fitzgerald JR, 2001, TRENDS MICROBIOL, V9, P547, DOI 10.1016/S0966-842X(01)02228-4; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Giovanetti E, 2002, J ANTIMICROB CHEMOTH, V50, P249, DOI 10.1093/jac/dkf122; Giovanetti E, 2003, ANTIMICROB AGENTS CH, V47, P2844, DOI 10.1128/AAC.47.9.2844-2849.2003; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Green NM, 2005, J CLIN MICROBIOL, V43, P4083, DOI 10.1128/JCM.43.8.4083-4091.2005; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hammerum AM, 2004, J ANTIMICROB CHEMOTH, V53, P118, DOI 10.1093/jac/dkh043; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; HYDER SL, 1978, J INFECT DIS, V138, P281, DOI 10.1093/infdis/138.3.281; JOHNSTON KH, 1986, J EXP MED, V163, P697, DOI 10.1084/jem.163.3.697; Kataja J, 2000, J ANTIMICROB CHEMOTH, V46, P789, DOI 10.1093/jac/46.5.789; Kataja J, 1999, ANTIMICROB AGENTS CH, V43, P48, DOI 10.1128/AAC.43.1.48; Kataja J, 2002, EUR J CLIN MICROBIOL, V21, P589, DOI 10.1007/s10096-002-0771-8; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; LINTON KJ, 1994, MOL MICROBIOL, V11, P777, DOI 10.1111/j.1365-2958.1994.tb00355.x; Luna VA, 1999, J ANTIMICROB CHEMOTH, V44, P19, DOI 10.1093/jac/44.1.19; Luna VA, 2002, ANTIMICROB AGENTS CH, V46, P2513, DOI 10.1128/AAC.46.8.2513-2517.2002; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; MALKE H, 1974, MOL GEN GENET, V135, P349, DOI 10.1007/BF00271149; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; Molinari G, 2001, MOL MICROBIOL, V40, P99, DOI 10.1046/j.1365-2958.2001.02373.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; MURPHY E, 1985, J BACTERIOL, V162, P633, DOI 10.1128/JB.162.2.633-640.1985; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Musser JM, 1998, BIOMED RES REP, P185; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Nielsen HUK, 2004, MICROB DRUG RESIST, V10, P231, DOI 10.1089/mdr.2004.10.231; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Palavecino EL, 2001, ANTIMICROB AGENTS CH, V45, P339, DOI 10.1128/AAC.45.1.339-341.2001; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Perez-Trallero E, 2001, J ANTIMICROB CHEMOTH, V48, P225, DOI 10.1093/jac/48.2.225; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; POONKING R, 1993, J EXP MED, V178, P759, DOI 10.1084/jem.178.2.759; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Santagati M, 2003, MICROB DRUG RESIST, V9, P243, DOI 10.1089/107662903322286445; Schmitz FJ, 2003, J INFECT DIS, V188, P1578, DOI 10.1086/379230; SCOTT RJD, 1989, EPIDEMIOL INFECT, V102, P85, DOI 10.1017/S095026880002971X; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Sharkawy A, 2002, CLIN INFECT DIS, V34, P454, DOI 10.1086/338466; Shulman ST, 2004, CLIN INFECT DIS, V39, P325, DOI 10.1086/421949; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Snodgrass JL, 1999, INFECT IMMUN, V67, P3952, DOI 10.1128/IAI.67.8.3952-3959.1999; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; STOLLERMAN GH, 1971, CIRCULATION, V43, P915, DOI 10.1161/01.CIR.43.6.915; Subtil A, 2004, CURR OPIN MICROBIOL, V7, P85, DOI 10.1016/j.mib.2003.12.012; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Suter TM, 1997, ANTIMICROB AGENTS CH, V41, P1385, DOI 10.1128/AAC.41.6.1385; Syrogiannopoulos GA, 2001, PEDIATR INFECT DIS J, V20, P863, DOI 10.1097/00006454-200109000-00008; Tanz RR, 2004, CLIN INFECT DIS, V39, P1794, DOI 10.1086/426025; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Thompson PR, 1998, J BIOL CHEM, V273, P14788, DOI 10.1074/jbc.273.24.14788; Tyrrell GJ, 2002, J CLIN MICROBIOL, V40, P4466, DOI 10.1128/JCM.40.12.4466-4471.2002; UBUKATA K, 1975, J ANTIBIOT, V28, P681, DOI 10.7164/antibiotics.28.681; VILLARREAL H, 1979, J EXP MED, V149, P459, DOI 10.1084/jem.149.2.459; Vlaminckx B, 2004, EUR J CLIN MICROBIOL, V23, P434, DOI 10.1007/s10096-004-1147-z; Vlaminckx BJM, 2003, J CLIN MICROBIOL, V41, P4941, DOI 10.1128/JCM.41.11.4941-4949.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe PA, 2003, APPL ENVIRON MICROB, V69, P2737, DOI 10.1128/AEM.69.5.2737-2747.2003; WIDDOWSON JP, 1971, J GEN MICROBIOL, V65, P69, DOI 10.1099/00221287-65-1-69; WIDDOWSON JP, 1970, J GEN MICROBIOL, V61, P343, DOI 10.1099/00221287-61-3-343; Yan JJ, 2000, J CLIN MICROBIOL, V38, P2475, DOI 10.1128/JCM.38.7.2475-2479.2000; Zampaloni C, 2003, J CLIN MICROBIOL, V41, P1307, DOI 10.1128/JCM.41.3.1307-1310.2003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	130	128	136	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e800	10.1371/journal.pone.0000800	http://dx.doi.org/10.1371/journal.pone.0000800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726530	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455400017
J	Konig, O; Ruttiger, L; Muller, M; Zimmermann, U; Erdmann, B; Kalbacher, H; Gross, M; Knipper, M				Koenig, Ovidiu; Ruettiger, Lukas; Mueller, Marcus; Zimmermann, Ulrike; Erdmann, Bettina; Kalbacher, Hubert; Gross, Manfred; Knipper, Marlies			Estrogen and the inner ear: megalin knockout mice suffer progressive hearing loss	FASEB JOURNAL			English	Article						cochlea; stria vascularis; LDL-receptor; sex hormone; presbycusis	HORMONE-BINDING GLOBULIN; DENSITY-LIPOPROTEIN RECEPTOR; SCANNING ELECTRON-MICROSCOPY; BRAIN-STEM RESPONSE; GUINEA-PIG COCHLEA; STRIA VASCULARIS; HEYMANN NEPHRITIS; AUDITORY FUNCTION; THYROID-HORMONE; MARGINAL CELLS	Megalin, the largest member of the low-density lipoprotein receptor-related protein family, functions as an endocytic receptor for a variety of essential lipophilic metabolites, including the steroid hormone estrogen. In the cochlea, megalin is strongly expressed within the marginal cells of the stria vascularis, and previous studies demonstrated that beta-estrogen receptors are also expressed in megalin-expressing marginal cells. In the present study, we demonstrate that homozygous megalin mutant mice exhibit profound hearing loss at 3 months of age associated with features of presbycusis, enrichment of lipofuscin granules, and a reduced number of microvilli in marginal cells of the stria vascularis. FITC-labeled beta-estrogen is taken up into the strial marginal cells; however, in megalin-deficient mice the uptake of FITC-labeled beta-estrogen is reduced. This highlights beta-estrogen as a possible carrier-bound candidate ligand for megalin and supports the concept that estrogen may function via megalin within the inner ear. A crucial role of megalin in hearing should be considered and the megalin/estrogen interaction needs to be discussed in the context of early presbycusis in estrogen-deficient humans and mice.	[Koenig, Ovidiu; Gross, Manfred] Charite Univ Clin Berlin, Berlin, Germany; [Mueller, Marcus] Univ Tubingen, Dept Otorhinolaryngol, Hearing Res Ctr Tubingen, Tubingen, Germany; [Kalbacher, Hubert] Univ Tubingen, Med Nat Sci Res Ctr, Tubingen, Germany; [Erdmann, Bettina] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Knipper, M (corresponding author), Univ HNO Klin, Elfriede Aulhorn Str 5, D-72076 Tubingen, Germany.	marlies.knipper@uni-tuebingen.de	Müller, Marcus/B-3877-2016	Müller, Marcus/0000-0001-5881-7708				ANNIKO M, 1976, ACTA OTO-LARYNGOL, V82, P343, DOI 10.3109/00016487609120918; BOHNE BA, 1990, HEARING RES, V48, P79, DOI 10.1016/0378-5955(90)90200-9; BROOKES GB, 1983, J LARYNGOL OTOL, V97, P405, DOI 10.1017/S0022215100094330; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHRISTENSEN EI, 1992, J HISTOCHEM CYTOCHEM, V40, P1481, DOI 10.1177/40.10.1382088; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; COLEMAN JR, 1994, HEARING RES, V80, P209, DOI 10.1016/0378-5955(94)90112-0; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; Dickersin RG., 2000, DIAGNOSTIC ELECT MIC; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; FORGE A, 1980, CLIN OTOLARYNGOL, V5, P87, DOI 10.1111/j.1365-2273.1980.tb01633.x; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; Geneser F, 1990, HISTOLOGIE; Guitton MJ, 2005, EUR J NEUROSCI, V22, P2675, DOI 10.1111/j.1460-9568.2005.04436.x; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; HAMMOND GL, 1995, J STEROID BIOCHEM, V53, P543, DOI 10.1016/0960-0760(95)00110-L; Hammond TG, 1997, AM J PHYSIOL-RENAL, V272, pF117, DOI 10.1152/ajprenal.1997.272.1.F117; Hilpert J, 2001, BIOCHEM J, V360, P609, DOI 10.1042/0264-6021:3600609; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Hultcrantz M, 2000, HEARING RES, V143, P182, DOI 10.1016/S0378-5955(00)00042-3; ISHII T, 1977, ARCH OTO-RHINO-LARYN, V215, P213, DOI 10.1007/BF00463059; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; Jonsson R, 1998, SCAND AUDIOL, V27, P81, DOI 10.1080/010503998420324; KANEKO Y, 1978, ACTA OTO-LARYNGOL, V86, P375; Kim SH, 2002, OBSTET GYNECOL, V99, P726, DOI 10.1016/S0029-7844(02)01963-4; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Knipper M, 2006, J PHYSIOL-LONDON, V576, P73, DOI 10.1113/jphysiol.2006.116889; KONISHI T, 1978, ACTA OTO-LARYNGOL, V86, P22, DOI 10.3109/00016487809124717; KRSTIC RV, 1997, HUMAN MICROSCOPIC AN; MASON DY, 1978, J CLIN PATHOL, V31, P454, DOI 10.1136/jcp.31.5.454; MAUNSBACH AB, 1999, BIOMED ELECT MICROSC; Mizuta K, 1999, HEARING RES, V129, P83, DOI 10.1016/S0378-5955(98)00221-4; MOESTRUP SK, 1995, J CLIN INVEST, V96, P1404, DOI 10.1172/JCI118176; Muller M, 1997, HEARING RES, V114, P259, DOI 10.1016/S0378-5955(97)00175-5; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Oliver D, 2003, J NEUROSCI, V23, P2141; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Rink Timothy L, 2004, Occup Health Saf, V73, P179; Romeo G, 1985, Acta Vitaminol Enzymol, V7 Suppl, P85; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Schimmang T, 2003, DEVELOPMENT, V130, P4741, DOI 10.1242/dev.00676; Scholtz AW, 2001, HEARING RES, V157, P77, DOI 10.1016/S0378-5955(01)00279-9; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P903, DOI 10.1210/en.132.2.903; Stenberg AE, 2001, HEARING RES, V157, P87, DOI 10.1016/S0378-5955(01)00280-5; Stenberg AE, 1999, HEARING RES, V136, P29, DOI 10.1016/S0378-5955(99)00098-2; SUGA F, 1976, ANN OTO RHINOL LARYN, V85, P169, DOI 10.1177/000348947608500201; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; WANGEMANN P, 1995, HEARING RES, V90, P149, DOI 10.1016/0378-5955(95)00157-2; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Weber T, 2002, P NATL ACAD SCI USA, V99, P2901, DOI 10.1073/pnas.052609899; WHARTON JA, 1990, AUDIOLOGY, V29, P196; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; WRIGHT A, 1980, ARCH OTO-RHINO-LARYN, V229, P39, DOI 10.1007/BF00453750; Zeginiadou T, 1997, EUR J DRUG METAB PH, V22, P229, DOI 10.1007/BF03189812	60	27	29	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2008	22	2					410	417		10.1096/fj.07-9171com	http://dx.doi.org/10.1096/fj.07-9171com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17846082				2022-12-25	WOS:000252822600011
J	Ambasta, RK; Ai, XB; Emerson, CP				Ambasta, Rashmi K.; Ai, Xingbin; Emerson, Charles P., Jr.			Quail sulf1 function requires asparagine-linked glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSYLATION; BREAST-CANCER; TUNICAMYCIN; EXPRESSION; PROTEIN; CELLS	The heparan sulfate endosulfatases Sulf1 and Sulf2 are cellsurface enzymes that control growth factor signaling through regulation of the 6-O-sulfation states of cell-surface and matrix heparan sulfate proteoglycans. Here, we report that quail Sulf1 (QSulf1) is an asparagine-linked glycosylated protein. Domain mapping studies in combination with a protein glycosylation prediction program identified multiple asparagine-linked glycosylation sites in the enzymatic and C-terminal domains. Glycosylation inhibitor studies revealed that glycosylation of QSulf1 is essential for its enzymatic activity, membrane targeting, and secretion. Furthermore, N-glycanase cleavage of asparagine-linked sites in native QSulf1 provided direct evidence that these N-linked glycosylation sites are specifically required for QSulf1 heparin binding and its 6-O-desulfation activity, revealing that N-linked glycosylation has a key role in the control of sulfatase enzymatic function.	Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Emerson, CP (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	emersonc@bbri.org	Ambasta, Rashmi/K-8611-2019	Ai, Xingbin/0000-0002-2178-0080				Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Berger SB, 2006, IMMUNOLOGY, V119, P178, DOI 10.1111/j.1365-2567.2006.02419.x; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Branza-Nichita N, 2004, BIOCHEM BIOPH RES CO, V319, P655, DOI 10.1016/j.bbrc.2004.05.039; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; GIRAUD A, 1989, EUR J CELL BIOL, V48, P128; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; KATZ FN, 1977, P NATL ACAD SCI USA, V74, P3278, DOI 10.1073/pnas.74.8.3278; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Trombetta ES, 2002, ADV PROTEIN CHEM, V59, P303	20	22	22	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34492	34499		10.1074/jbc.M706744200	http://dx.doi.org/10.1074/jbc.M706744200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855356	hybrid			2022-12-25	WOS:000251145700064
J	Cooper, WC; Jin, Y; Penning, TM				Cooper, William C.; Jin, Yi; Penning, Trevor M.			Elucidation of a complete kinetic mechanism for a mammalian hydroxysteroid dehydrogenase (HSD) and identification of all enzyme forms on the reaction coordinate - The example of rat liver 3 alpha-HSD (AKR1C9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-3 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; NICOTINAMIDE-ADENINE DINUCLEOTIDE; KETO REDUCTASE SUPERFAMILY; PRE-RECEPTOR REGULATION; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; BINDING-SITE; CRYSTAL-STRUCTURE; REDOX STATE; INTERCONVERSION; METABOLISM	Hydroxysteroid dehydrogenases (HSDs) are essential for the biosynthesis and mechanism of action of all steroid hormones. We report the complete kinetic mechanism of a mammalian HSD using rat 3 alpha-HSD of the aldo-keto reductase superfamily (AKR1C9) with the substrate pairs androstane-3,17-dione and NADPH( reduction) and androsterone and NADP(+) ( oxidation). Steady-state, transient state kinetics, and kinetic isotope effects reconciled the ordered bi-bi mechanism, which contained 9 enzyme forms and permitted the estimation of 16 kinetic constants. In both reactions, loose association of the NADP( H) was followed by two conformational changes, which increased cofactor affinity by>86-fold. For androstane-3,17-dione reduction, the release of NADP(+) controlled k(cat), whereas the chemical event also contributed to this term. kcat was insensitive to [H-2]NADPH, whereas (D)k(cat)/K-m and the (D)k(lim) (ratio of the maximum rates of single turnover) were 1.06 and 2.06, respectively. Under multiple turnover conditions partial burst kinetics were observed. For androsterone oxidation, the rate of NADPH release dominated kcat, whereas the rates of the chemical event and the release of androstane-3,17-dione were 50-fold greater. Under multiple turnover conditions full burst kinetics were observed. Although the internal equilibrium constant favored oxidation, the overall K-eq favored reduction. The kinetic Haldane and free energy diagram confirmed that Keq was governed by ligand binding terms that favored the reduction reactants. Thus, HSDs in the aldo-keto reductase superfamily thermodynamically favor ketosteroid reduction.	Univ Penn, Dept Pharmacol, Ctr Excellence Environm Toxicol, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Ctr Excellence Environm Toxicol, Sch Med, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@pharm.med.upenn.edu		Penning, Trevor/0000-0002-3937-1066	NIDDK NIH HHS [R01-DK47015, R01 DK047015] Funding Source: Medline; NIEHS NIH HHS [P30 ES013508] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ASKONAS LJ, 1991, BIOCHEM J, V278, P835, DOI 10.1042/bj2780835; Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GRIMSHAW CE, 1995, BIOCHEMISTRY-US, V34, P14356, DOI 10.1021/bi00044a012; Heredia VV, 2004, BIOCHEMISTRY-US, V43, P12028, DOI 10.1021/bi0489762; Heredia VV, 2004, BIOCHEMISTRY-US, V43, P5832, DOI 10.1021/bi0499563; HERMES JD, 1984, BIOCHEMISTRY-US, V23, P5479, DOI 10.1021/bi00318a016; HOOG SS, 1994, P NATL ACAD SCI USA, V91, P2517, DOI 10.1073/pnas.91.7.2517; Hosfield DJ, 2005, J BIOL CHEM, V280, P4639, DOI 10.1074/jbc.M411104200; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1996, J BIOL CHEM, V271, P30190, DOI 10.1074/jbc.271.47.30190; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Khan N, 2004, ARCH BIOCHEM BIOPHYS, V429, P50, DOI 10.1016/j.abb.2004.05.023; Liden M, 2003, MOL ASPECTS MED, V24, P403, DOI 10.1016/S0098-2997(03)00036-0; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Ogg D, 2005, J BIOL CHEM, V280, P3789, DOI 10.1074/jbc.M412463200; Papari-Zareei M, 2006, ENDOCRINOLOGY, V147, P1591, DOI 10.1210/en.2005-1141; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Penning TM, 2007, MOL CELL ENDOCRINOL, V265, P77, DOI 10.1016/j.mce.2006.12.007; Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t; RICIGLIANO JW, 1990, BIOCHEM J, V269, P749, DOI 10.1042/bj2690749; Rizner TL, 2003, ENDOCRINOLOGY, V144, P2922, DOI 10.1210/en.2002-0032; SEGEL IH, 1993, ENZYME KINETICS BEHA, P574; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Stone SR, 1997, J MOL BIOL, V265, P344, DOI 10.1006/jmbi.1996.0727; TALALAY P, 1959, CIBA FDN STUDY GROUP, P64; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514	40	45	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33484	10.1074/jbc.M703414200	http://dx.doi.org/10.1074/jbc.M703414200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848571	hybrid			2022-12-25	WOS:000250840200029
J	Corbett, D; Bennett, HJ; Askar, H; Green, J; Roberts, IS				Corbett, David; Bennett, Hayley J.; Askar, Hamdia; Green, Jeffrey; Roberts, Ian S.			SlyA and H-NS regulate transcription of the Escherichia coli K5 capsule gene cluster, and expression of slyA in Escherichia coli is temperature-dependent, positively autoregulated, and independent of H-NS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA-PSEUDOTUBERCULOSIS; SALMONELLA-TYPHIMURIUM; GLOBAL REGULATOR; STPA PROTEINS; DNA; VIRULENCE; ROVA; ORGANIZATION; RESISTANCE; BINDING	In this paper, we present the first evidence of a role for the transcriptional regulator SlyA in the regulation of transcription of the Escherichia coli K5 capsule gene cluster and demonstrate, using a combination of reporter gene fusions, DNase I footprinting, and electrophoretic mobility shift assays, the dependence of transcription on the functional interplay between H-NS and SlyA. Both SlyA and H-NS bind to multiple overlapping sites within the promoter in vitro, but their binding is not mutually exclusive, resulting in a remodeled nucleoprotein complex. In addition, we show that expression of the E. coli slyA gene is temperature-regulated, positively autoregulated, and independent of H-NS.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Mansoura, Fac Med, Dept Med Microbiol & Immunol, Mansoura, Egypt; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Manchester; Egyptian Knowledge Bank (EKB); Mansoura University; University of Sheffield	Roberts, IS (corresponding author), Univ Manchester, Fac Life Sci, Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	i.s.roberts@manchester.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Afflerbach H, 1999, J MOL BIOL, V286, P339, DOI 10.1006/jmbi.1998.2494; Badaut C, 2002, J BIOL CHEM, V277, P41657, DOI 10.1074/jbc.M206037200; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Donato GM, 1998, J BIOL CHEM, V273, P24030, DOI 10.1074/jbc.273.37.24030; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorman CJ, 1999, TRENDS MICROBIOL, V7, P124, DOI 10.1016/S0966-842X(99)01455-9; Ellison DW, 2006, J BACTERIOL, V188, P5101, DOI 10.1128/JB.00862-05; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; HOBBS M, 1994, MOL MICROBIOL, V12, P855, DOI 10.1111/j.1365-2958.1994.tb01071.x; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Johansson J, 1998, J BACTERIOL, V180, P6117; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; LUCHT JM, 1994, J BIOL CHEM, V269, P6578; Ludwig A, 1995, MOL GEN GENET, V249, P474, DOI 10.1007/BF00290573; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Maxam A M, 1980, Methods Enzymol, V65, P499; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; Miller JH., 1972, EXPT MOL GENETICS; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Owens RM, 2004, EMBO J, V23, P3375, DOI 10.1038/sj.emboj.7600343; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Pul U, 2005, MOL MICROBIOL, V58, P864, DOI 10.1111/j.1365-2958.2005.04873.x; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Schroder O, 2002, BIOL CHEM, V383, P945, DOI 10.1515/BC.2002.101; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Simpson DA, 1996, J BACTERIOL, V178, P6466, DOI 10.1128/jb.178.22.6466-6474.1996; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Starcic-Erjavec M, 2003, MOL GENET GENOMICS, V270, P94, DOI 10.1007/s00438-003-0908-1; Stevens MP, 1997, MOL MICROBIOL, V24, P1001, DOI 10.1046/j.1365-2958.1997.4241780.x; STEVENS MP, 1994, FEMS MICROBIOL LETT, V124, P93, DOI 10.1111/j.1574-6968.1994.tb07267.x; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Williams RM, 1996, J BACTERIOL, V178, P4335, DOI 10.1128/jb.178.15.4335-4343.1996; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004	49	46	49	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33326	33335		10.1074/jbc.M703465200	http://dx.doi.org/10.1074/jbc.M703465200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827501	hybrid			2022-12-25	WOS:000250840200012
J	Min, L; Leung, YM; Tomas, A; Watson, RT; Gaisano, HY; Halban, PA; Pessin, JE; Hou, JC				Min, Le; Leung, Yuk M.; Tomas, Alejandra; Watson, Robert T.; Gaisano, Herbert Y.; Halban, Philippe A.; Pessin, Jeffrey E.; Hou, June Chunqiu			Dynamin is functionally coupled to insulin granule exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TRANS-GOLGI NETWORK; SECRETORY GRANULES; COMPOUND EXOCYTOSIS; FLUORESCENT PROTEIN; SYNAPTOTAGMIN III; CA2+ CHANNELS; MEMBRANE; FUSION; SINGLE	The insulin granule integral membrane protein marker phogrin-green fluorescent protein was co-localized with insulin in Min6B1 beta-cell secretory granules but did not undergo plasma membrane translocation following glucose stimulation. Surprisingly, although expression of a dominant-interfering dynamin mutant (Dyn/K44A) inhibited transferrin receptor endocytosis, it had no effect on phogrin-green fluorescent protein localization in the basal or secretagogue-stimulated state. By contrast, co-expression of Dyn/ K44A with human growth hormone as an insulin secretory marker resulted in a marked inhibition of human growth hormone release by glucose, KCl, and a combination of multiple secretagogues. Moreover, serial pulse depolarization stimulated an increase in cell surface capacitance that was also blocked in cells expressing Dyn/ K44A. Similarly, small interference RNA-mediated knockdown of dynamin resulted in marked inhibition of glucose-stimulated insulin secretion. Together, these data suggest the presence of a selective kiss and run mechanism of insulin release. Moreover, these data indicate a coupling between endocytosis and exocytosis in the regulation of beta-cell insulin secretion.	SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; W China Univ Med Sci, Dept Physiol, Taichung 404, Taiwan; Ctr Med Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University of Toronto; University of Geneva	Hou, JC (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, BST8-140, Stony Brook, NY 11794 USA.	Hou@pharm.stonybrook.edu		Tomas, Alejandra/0000-0002-2290-8453	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033823, R01DK055811, R37DK033823] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33823, DK55811] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barg S, 2003, PHARMACOL TOXICOL, V92, P3, DOI 10.1034/j.1600-0773.2003.920102.x; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Bokvist K, 2000, PFLUG ARCH EUR J PHY, V439, P634, DOI 10.1007/s004240050987; Brown H, 2000, DIABETES, V49, P383, DOI 10.2337/diabetes.49.3.383; Cheviet S, 2004, MOL ENDOCRINOL, V18, P117, DOI 10.1210/me.2003-0300; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Kwan EP, 2005, DIABETES, V54, P2734, DOI 10.2337/diabetes.54.9.2734; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Leung YM, 2002, BIOCHEM BIOPH RES CO, V292, P980, DOI 10.1006/bbrc.2002.6712; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Ma L, 2004, P NATL ACAD SCI USA, V101, P9266, DOI 10.1073/pnas.0403201101; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mizuta M, 1997, DIABETES, V46, P2002, DOI 10.2337/diabetes.46.12.2002; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Ohara-Imaizumi M, 2004, DIABETOLOGIA, V47, P2200, DOI 10.1007/s00125-004-1579-0; Ohara-Imaizumi M, 2002, BIOCHEM J, V363, P73, DOI 10.1042/0264-6021:3630073; ORCI L, 1980, DIABETES, V29, P943, DOI 10.2337/diab.29.11.943; ORCI L, 1973, SCIENCE, V179, P82, DOI 10.1126/science.179.4068.82; PROCINO G, 2005, AM J PHYSIOL, V290, pF985; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Tsuboi T, 2002, J BIOL CHEM, V277, P15957, DOI 10.1074/jbc.C200051200; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	41	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33530	33536		10.1074/jbc.M703402200	http://dx.doi.org/10.1074/jbc.M703402200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848579	hybrid, Green Published			2022-12-25	WOS:000250840200033
J	Townsend, M; Mehta, T; Selkoe, DJ				Townsend, Matthew; Mehta, Tapan; Selkoe, Dennis J.			Soluble A beta inhibits specific signal transduction cascades common to the insulin receptor pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; AMP RESPONSE ELEMENT; ALZHEIMERS-DISEASE; CALMODULIN-BINDING; NATURAL OLIGOMERS; NMDA RECEPTORS; MOUSE MODEL	Numerous studies have now shown that the amyloid beta-protein (A beta),the principal component of cerebral plaques in Alzheimer disease, rapidly and potently inhibits certain forms of synaptic plasticity. The amyloid (or A beta) hypothesis proposes that the continuous disruption of normal synaptic physiology by A beta contributes to the development of Alzheimer disease. However, there is little consensus about how A beta mediates this inhibition at the molecular level. Using mouse primary hippocampal neurons, we observed that a brief treatment with cell-derived, soluble, human A beta disrupted the activation of three kinases (Erk/MAPK, CaMKII, and the phosphatidylinositol 3-kinase-activated protein Akt/protein kinase B) that are required for long term potentiation, whereas two other kinases (protein kinase A and protein kinase C) were stimulated normally. An antagonist of the insulin receptor family of tyrosine kinases was found to mimic the pattern of A beta-mediated kinase inhibition. We then found that soluble A beta binds to the insulin receptor and interferes with its insulin-induced autophosphorylation. Taken together, these data demonstrate that physiologically relevant levels of naturally secreted A beta interfere with insulin receptor function in hippocampal neurons and prevent the rapid activation of specific kinases required for long term potentiation.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027443] Funding Source: NIH RePORTER; NIA NIH HHS [AG027443] Funding Source: Medline; NINDS NIH HHS [T32 NS07484-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balazs R, 2006, CURR TOP MED CHEM, V6, P961, DOI 10.2174/156802606777323700; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; Daniels WMU, 2001, METAB BRAIN DIS, V16, P175, DOI 10.1023/A:1012541011123; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; HEIDENREICH KA, 1988, J NEUROCHEM, V51, P878, DOI 10.1111/j.1471-4159.1988.tb01824.x; Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; HUANG HM, 1993, J BIOL CHEM, V268, P14616; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nelson TJ, 2005, BIOCHEM SOC T, V33, P1033, DOI 10.1042/BST0331033; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2; Zhao DY, 2004, J NEUROPHYSIOL, V92, P2853, DOI 10.1152/jn.00485.2004	53	264	274	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33305	33312		10.1074/jbc.M610390200	http://dx.doi.org/10.1074/jbc.M610390200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855343	hybrid			2022-12-25	WOS:000250840200010
J	Kovaleski, BJ; Kennedy, R; Khorchid, A; Kleiman, L; Matsuo, H; Musier-Forsyth, K				Kovaleski, Brandie J.; Kennedy, Robert; Khorchid, Ahmad; Kleiman, Lawrence; Matsuo, Hiroshi; Musier-Forsyth, Karin			Critical role of Helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MAJOR HOMOLOGY REGION; ESCHERICHIA-COLI; TRNA(LYS) INCORPORATION; DIMERIZATION DOMAIN; WILD-TYPE; PROTEIN; MUTANT; GAG; RECOGNITION	Human tRNA(Lys3) is used as the primer for human immunodeficiency virus type 1 ( HIV-1) reverse transcription. HIV-1 Gag and GagPol, as well as host cell factor lysyl-tRNA synthetase ( LysRS), are required for specific packaging of tRNALys into virions. Gag alone is sufficient for packaging of LysRS, and these two proteins have been shown to interact in vitro with an equilibrium binding constant of similar to 310 nM. The capsid ( CA) domain of Gag binds to LysRS with a similar affinity as full-length Gag. In this work, we report further characterization of the interaction between HIV-1 CA and human LysRS using truncation constructs and point mutations in the putative interaction helices. Fluorescence anisotropy binding measurements reveal that a LysRS variant lacking the N-terminal 219 residues still displays high affinity binding to CA. The CA C-terminal domain ( CTD) is also sufficient for binding to LysRS. Nuclear magnetic resonance spectroscopy studies using N-15-labeled CA-CTD reveal chemical shift perturbations of residues in and proximal to helix 4 of CA-CTD upon LysRS binding. A synthetic peptide that includes helix 4 binds to LysRS with high affinity, whereas peptides derived from the other three helical domains of CA-CTD do not. Alanine-scanning mutagenesis studies targeting residues in the helix 4 region support a direct interaction between this domain of CA-CTD and LysRS. The high resolution mapping studies reported here will facilitate future work aimed at disrupting the Gag-LysRS interaction, which represents a novel anti-viral strategy.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lady Davis Institute; McGill University; McGill University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu	Kennedy, Robert T/G-9095-2016	Kennedy, Robert T/0000-0003-2447-7471	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008700, F32GM069339] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054145] Funding Source: Medline; NIGMS NIH HHS [GM069339, T32-GM08700] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cen S, 2004, J VIROL, V78, P1595, DOI 10.1128/JVI.78.3.1595-1601.2004; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; GOODMAN M, 1962, J AM CHEM SOC, V84, P3770, DOI 10.1021/ja00878a036; Guo F, 2003, J VIROL, V77, P9817, DOI 10.1128/JVI.77.18.9817-9822.2003; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Javanbakht H, 2003, J BIOL CHEM, V278, P27644, DOI 10.1074/jbc.M301840200; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; Kleiman L, 2004, INT J BIOCHEM CELL B, V36, P1776, DOI 10.1016/j.biocel.2004.02.022; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Matsuo H, 1996, J MAGN RESON SER B, V111, P194, DOI 10.1006/jmrb.1996.0082; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; PARK J, 1992, J VIROL, V66, P6304, DOI 10.1128/JVI.66.11.6304-6313.1992; POWERS R, 1992, BIOCHEMISTRY-US, V31, P4334, DOI 10.1021/bi00132a026; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Shiba K, 1997, J BIOL CHEM, V272, P22809, DOI 10.1074/jbc.272.36.22809; STRAMBIODECASTILLIA C, 1992, J VIROL, V66, P7021, DOI 10.1128/JVI.66.12.7021-7032.1992; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051	26	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32274	32279		10.1074/jbc.M706256200	http://dx.doi.org/10.1074/jbc.M706256200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17724017	hybrid			2022-12-25	WOS:000250480300050
J	Lee, AYL; Liu, E; Wu, X				Lee, Alan Yueh-Luen; Liu, Enbo; Wu, Xiaohua			The mre11/Rad50/Nbs1 complex plays an important role in the prevention of DNA rereplication in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; REPLICATION PROTEIN-A; S-PHASE CHECKPOINT; ATM-DEPENDENT PHOSPHORYLATION; TELANGIECTASIA-LIKE DISORDER; ATAXIA-TELANGIECTASIA; DAMAGE RESPONSE; MRE11 COMPLEX; MRE11-RAD50-NBS1 COMPLEX; G(2)/M CHECKPOINT	The Mre11/Nbs1/Rad50 complex ( MRN) plays multiple roles in the maintenance of genome stability, including repair of double-stranded breaks ( DSBs) and activation of the S-phase checkpoint. Here we demonstrate that MRN is required for the prevention of DNA rereplication in mammalian cells. DNA replication is strictly regulated by licensing control so that the genome is replicated once and only once per cell cycle. Inactivation of Nbs1 or Mre11 leads to a substantial increase of DNA rereplication induced by overexpression of the licensing factor Cdt1. Our studies reveal that multiple mechanisms are likely involved in the MRN-mediated suppression of rereplication. First, both Mre11 and Nbs1 are required for facilitating ATR activation when Cdt1 is overexpressed, which in turn suppresses rereplication. Second, Cdt1 overexpression induces ATR-mediated phosphorylation of Nbs1 at Ser(343) and this phosphorylation depends on the FHA and BRCT domains of Nbs1. Mutations at Ser343 or in the FHA and BRCT domains lead to more severe rereplication when Cdt1 is overexpressed. Third, the interaction of the Mre11 complex with RPA is important for the suppression of rereplication. This suggests that modulating RPA activity via a direct interaction of MRN is likely one of the effector mechanisms to suppress rereplication. Moreover, we demonstrate that MRN is also required for preventing the accumulation of DSBs when rereplication is induced. Therefore, our studies suggest new roles of MRN in the maintenance of genome stability through preventing rereplication and rereplication-associated DSBs when licensing control is compromised.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Wu, X (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	Lee, Alan Yueh-Luen/A-9141-2010; Lee, Alan Yueh-Luen/B-1097-2010	Lee, Alan Yueh-Luen/0000-0003-0252-0571	NATIONAL CANCER INSTITUTE [R01CA102361] Funding Source: NIH RePORTER; NCI NIH HHS [CA102361] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Green BM, 2005, MOL BIOL CELL, V16, P421, DOI 10.1091/mbc.e04-09-0833; Guo WY, 2004, J RADIAT RES, V45, P269, DOI 10.1269/jrr.45.269; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Ikui AE, 2007, GENETICS, V175, P1011, DOI 10.1534/genetics.106.068213; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; LIU E, IN PRESS J CELL BIOL; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	75	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32243	32255		10.1074/jbc.M705486200	http://dx.doi.org/10.1074/jbc.M705486200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17715134	hybrid			2022-12-25	WOS:000250480300047
J	Roy, A; Liu, X; Pahan, K				Roy, Avik; Liu, Xiaojuan; Pahan, Kalipada			Myelin basic protein-primed T cells induce Neurotrophins in glial cells via alpha 5 beta 3 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; PROINFLAMMATORY CYTOKINES; MICROGLIAL CELLS; ADOPTIVE TRANSFER; GENE-EXPRESSION; GROWTH-FACTOR; BRAIN; MICE	Increasing the level of neurotrophins within the central nervous system may have therapeutic efficacy in patients with various neurological diseases. Earlier we have demonstrated that myelin basic protein ( MBP)-primed T cells induce the expression of various proinflammatory molecules in glial cells via cell-to-cell contact. Here we describe that after Th2 polarization by gemfibrozil or other drugs, MBP-primed T cells induced the expression of neurotrophic molecules such as brain-derived neurotrophic factor ( BDNF) and neurotrophin-3 ( NT-3), but not proinflammatory molecules in microglia and astroglia via cell-to-cell contact. MBP-primed Th2 cells expressed alpha 5 and beta 3 integrins and functional blocking antibodies against both alpha 5 and beta 3 integrins inhibited the ability of MBP-primed Th2 cells to induce glial neurotrophins. On the other hand, glial cells expressed PDGF-R beta and neutralization of this glial receptor abrogated the ability of Th2 cells to induce neurotrophins in glia. Activation of glial cAMP response element-binding protein ( CREB) by MBP-primed Th2 cell contact and inhibition of contact-mediated expression of neurotrophins by antisense knockdown of glial CREB suggest that MBP-primed Th2 cell-glia contact induces the expression of neurotrophins through glial activation of CREB. Accordingly, blocking of either alpha 5 beta 3 integrins on T cells or PDGF-R beta on glial cells impaired the ability of MBP-primed Th2 cells to induce glial activation of CREB. Furthermore, we demonstrate that these MBP-primed Th2 cells entered into the central nervous system and increased the expression of neurotrophins in vivo in the brain. This study illuminates the importance of alpha 5 beta 3 and PDGF-R beta in guiding the novel neurotrophic property of neuroantigen-primed T cells via activation of CREB that may be of therapeutic importance in various neurological disorders.	Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Univ Nebraska, Coll Dent, Med Ctr, Dept Oral Biol,Sect Neurosci, Lincoln, NE 68583 USA	Rush University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Cohn Res Bldg,Suite 320,1735 W Harrison St, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			NINDS NIH HHS [R21 NS048923-03, R01 NS039940, NS48923, NS39940, R01 NS039940-08, R21 NS048923] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048923, R01NS039940] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aharoni R, 2003, P NATL ACAD SCI USA, V100, P14157, DOI 10.1073/pnas.2336171100; Althaus HH, 2004, PROG BRAIN RES, V146, P415; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; Chabot S, 1997, J CLIN INVEST, V100, P604, DOI 10.1172/JCI119571; Dasgupta S, 2005, J BIOL CHEM, V280, P32609, DOI 10.1074/jbc.M500299200; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Dasgupta S, 2002, J BIOL CHEM, V277, P39327, DOI 10.1074/jbc.M111841200; DATE I, 1993, BRAIN RES, V621, P150, DOI 10.1016/0006-8993(93)90312-B; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hohlfeld R, 2000, J NEUROIMMUNOL, V107, P161, DOI 10.1016/S0165-5728(00)00233-2; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Mellstrom Britt, 2004, Critical Reviews in Neurobiology, V16, P43, DOI 10.1615/CritRevNeurobiol.v16.i12.40; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Wolinsky Jerry S, 2006, Adv Neurol, V98, P273; Ziemssen T, 2002, BRAIN, V125, P2381, DOI 10.1093/brain/awf252	30	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32222	32232		10.1074/jbc.M702899200	http://dx.doi.org/10.1074/jbc.M702899200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823123	Green Accepted, hybrid			2022-12-25	WOS:000250480300045
J	Saito, T; Jones, CC; Huang, S; Czech, MP; Pilch, PF				Saito, Tsugumichi; Jones, Christine C.; Huang, Shaohui; Czech, Michael P.; Pilch, Paul F.			The interaction of akt with APPL1 is required for insulin-stimulated glut4 translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; GLUCOSE-TRANSPORT; PLASMA-MEMBRANE; FUSION; PHOSPHORYLATES; VESICLES; RECEPTOR; GENE; ENDOCYTOSIS; ACTIVATION	APPL1 (adaptor protein containing PHdomain, PTB domain, and leucine zipper motif 1) is an Akt/protein kinase B-binding protein involved in signal transduction and membrane trafficking pathways for various receptors, including receptor tyrosine kinases. Here, we establish a role for APPL1 in insulin signaling in which we demonstrate its interaction with Akt2 by co-immunoprecipitation and pulldown assays. In primary rat adipocytes and skeletal muscle, APPL1 and Akt2 formed a complex that was dissociated upon insulin stimulation in both tissues. To investigate possible APPL1 function in adipocytes, we analyzed Akt phosphorylation, 2-deoxyglucose uptake, and Glut4 translocation by immunofluorescence following APPL1 knockdown by small interfering and short hairpin RNAs. We show that APPL1 knockdown suppressed Akt phosphorylation, glucose uptake, and Glut4 translocation. We also tested the effect in 3T3-L1 adipocytes of expressing full-length APPL1 or an N-or a C-terminal APPL1 construct. Interestingly, expression of full-length APPL1 and its N terminus suppressed insulin-stimulated 2-deoxyglucose uptake and Glut4 translocation to roughly the same extent (40-60%). We confirmed by cellular fractionation that Glut4 translocation was substantially blocked in 3T3-L1 adipocytes transfected with full-length APPL1. By cellular fractionation, APPL1 was localized mainly in the cytosol, and it showed a small degree of re-localization to the light microsomes and nucleus in response to insulin. By immunofluorescence, we also show that APPL1 partially co-localized with Glut4. These data suggest that APPL1 plays an important role in insulin-stimulated Glut4 translocation in muscle and adipose tissues and that its N-terminal portion may be critical for APPL1 function.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01507 USA	Boston University; University of Massachusetts System; University of Massachusetts Worcester	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,K-402, Boston, MA 02118 USA.	ppilch@bu.edu		Pilch, Paul/0000-0003-1997-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK060564, R01DK056935, R01DK030425] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-30425, DK-60564, DK-56935] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Coffer PJ, 1998, BIOCHEM J, V335, P1; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Kupriyanova TA, 1999, J BIOL CHEM, V274, P1458, DOI 10.1074/jbc.274.3.1458; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Simpson JC, 2005, BIOCHEM SOC SYMP, V72, P99, DOI 10.1042/bss0720099; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Zhang LB, 2004, J BIOL CHEM, V279, P2053, DOI 10.1074/jbc.M310357200	53	99	110	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32280	32287		10.1074/jbc.M704150200	http://dx.doi.org/10.1074/jbc.M704150200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848569	hybrid			2022-12-25	WOS:000250480300051
J	Fujinaka, Y; Takane, K; Yamashita, H; Vasavada, RC				Fujinaka, Yuichi; Takane, Karen; Yamashita, Hiroko; Vasavada, Rupangi C.			Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-X-L upregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; PLACENTAL-LACTOGEN; PANCREATIC-ISLETS; INSULIN-SECRETION; PROLACTIN RECEPTORS; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; GENE-EXPRESSION; RAT; GROWTH	One of the goals in the treatment for diabetes is to enhance pancreatic beta cell function, proliferation, and survival. This study explores the role of lactogenic hormones, prolactin ( PRL) and placental lactogen ( PL), in beta cell survival. We have previously shown that transgenic mice expressing mouse placental lactogen-1 ( mPL1) in beta cells under the rat insulin II promoter ( RIP) are resistant to the diabetogenic and cytotoxic effects of streptozotocin ( STZ) in vivo. The current study demonstrates that lactogens protect rat insulinoma ( INS-1) cells and primary mouse beta cells against two distinct beta cell death inducers, STZ and dexamethasone ( DEX), in vitro. Further, we identify the mechanism through which lactogens protect beta cells against DEX-induced death. The signaling pathway mediating this protective effect is the janus-activated-kinase-2/signal transducer and activator of transcription-5 ( JAK2/STAT5) pathway. This is demonstrated in INS-1 cells and primary mouse beta cells using three separate approaches, pharmacological inhibitors, JAK2-specific siRNAs and a dominant-negative STAT5 mutant. Furthermore, lactogens specifically and significantly increase the anti-apoptotic protein Bcl-X-L in insulinoma cells and mouse islets. Bcl-X-L-specific siRNA significantly inhibits lactogen-mediated protection against DEX-induced beta cell death. We believe this is the first direct demonstration of lactogens mediating their protective effect through the JAK2/STAT5 pathway in the beta cell and through Bcl-X-L in any cell type.	Univ Pittsburgh, Div Endocrinol, Pittsburgh, PA 15261 USA; Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagoya City University	Vasavada, RC (corresponding author), Univ Pittsburgh, Div Endocrinol, 200 Lothrop St BST E1140, Pittsburgh, PA 15261 USA.	vasavada@dom.pitt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072264] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-072264] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahonen TJ, 2002, ENDOCRINOLOGY, V143, P228, DOI 10.1210/en.143.1.228; Ali S, 2003, J BIOL CHEM, V278, P52021, DOI 10.1074/jbc.M306758200; Amaral MEC, 2003, HORM METAB RES, V35, P282; BISWAS R, 1987, CANCER RES, V47, P3509; Bordin S, 2004, MOL CELL ENDOCRINOL, V220, P41, DOI 10.1016/j.mce.2004.04.001; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201; Brelje TC, 2002, J HISTOCHEM CYTOCHEM, V50, P365, DOI 10.1177/002215540205000308; Buckley AR, 2000, ANN NY ACAD SCI, V917, P522; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cebrian A, 2002, DIABETES, V51, P3003, DOI 10.2337/diabetes.51.10.3003; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Druilhe A, 2003, APOPTOSIS, V8, P481, DOI 10.1023/A:1025590308147; Fernandez ML, 2003, ARCH BIOCHEM BIOPHYS, V416, P249, DOI 10.1016/S0003-9861(03)00292-3; Fleenor D, 2000, PEDIATR RES, V47, P136, DOI 10.1203/00006450-200001000-00023; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Fujinaka Y, 2004, DIABETES, V53, P3120, DOI 10.2337/diabetes.53.12.3120; Goffin V, 1999, GENET ANAL-BIOMOL E, V15, P189, DOI 10.1016/S1050-3862(99)00025-X; Hoogwerf B, 1999, RHEUM DIS CLIN N AM, V25, P489, DOI 10.1016/S0889-857X(05)70083-1; Jensen J, 2005, J ENDOCRINOL, V187, P25, DOI 10.1677/joe.1.06086; Kay TWH, 2000, TRENDS ENDOCRIN MET, V11, P11, DOI 10.1016/S1043-2760(99)00210-6; Krishnan N, 2001, ENDOCRINE, V15, P177, DOI 10.1385/ENDO:15:2:177; Leff MA, 1996, ENDOCRINOLOGY, V137, P5456, DOI 10.1210/en.137.12.5456; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; Matthews SG, 2002, ENDOCR RES, V28, P709, DOI 10.1081/ERC-120016991; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Ploszaj T, 1998, APOPTOSIS, V3, P295, DOI 10.1023/A:1009669427662; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Reichardt Holger M, 2006, Expert Rev Neurother, V6, P1657, DOI 10.1586/14737175.6.11.1657; ROYSTER M, 1995, ENDOCRINOLOGY, V136, P3892, DOI 10.1210/en.136.9.3892; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SORENSON RL, 1995, ENDOCRINOLOGY, V136, P4092, DOI 10.1210/en.136.9.4092; Sorenson RL, 2001, ENDOCRIN UPDAT, V12, P297; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; TALAMANTES F, 1990, PROG CLIN BIOL RES, V342, P81; Tessier C, 2001, ENDOCRINOLOGY, V142, P4086, DOI 10.1210/en.142.9.4086; Tian YR, 2003, MOL CELL ENDOCRINOL, V204, P75, DOI 10.1016/S0303-7207(03)00126-6; Tonner E, 2000, ADV EXP MED BIOL, V480, P45; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; VASAVADA RC, 2007, IN PRESS DIABETES; Wang LH, 1999, J IMMUNOL, V162, P3897; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277	45	59	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30707	30717		10.1074/jbc.M702607200	http://dx.doi.org/10.1074/jbc.M702607200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728251	hybrid			2022-12-25	WOS:000250136300039
J	Troein, C; Ahren, D; Krogh, M; Peterson, C				Troein, Carl; Ahren, Dag; Krogh, Morten; Peterson, Carsten			Is Transcriptional Regulation of Metabolic Pathways an Optimal Strategy for Fitness?	PLOS ONE			English	Article							GENE-REGULATION; DEMAND THEORY; BISTABILITY; EXPRESSION; EVOLUTION; LACTOSE; OPERONS	Background. Transcriptional regulation of the genes in metabolic pathways is a highly successful strategy, which is virtually universal in microorganisms. The lac operon of E. coli is but one example of how enzyme and transporter production can be made conditional on the presence of a nutrient to catabolize. Methodology. With a minimalist model of metabolism, cell growth and transcriptional regulation in a microorganism, we explore how the interaction between environmental conditions and gene regulation set the growth rate of cells in the phase of exponential growth. This in silico model, which is based on biochemical rate equations, does not describe a specific organism, but the magnitudes of its parameters are chosen to match realistic values. Optimizing the parameters of the regulatory system allows us to quantify the fitness benefit of regulation. When a second nutrient and its metabolic pathway are introduced, the system must further decide whether and how to activate both pathways. Conclusions. Even the crudest transcriptional network is shown to substantially increase the fitness of the organism, and this effect persists even when the range of nutrient levels is kept very narrow. We show that maximal growth is achieved when pathway activation is a more or less steeply graded function of the nutrient concentration. Furthermore, we predict that bistability of the system is a rare phenomenon in this context, but outline a situation where it may be selected for.	[Troein, Carl; Krogh, Morten; Peterson, Carsten] Lund Univ, Dept Theoret Phys, S-22362 Lund, Sweden; [Ahren, Dag] Lund Univ, Dept Ecol, S-22362 Lund, Sweden	Lund University; Lund University	Troein, C (corresponding author), Lund Univ, Dept Theoret Phys, Solvegatan 14A, S-22362 Lund, Sweden.	carl@thep.lu.se			Swedish National Research School in Genomics and Bioinformatics; Knut and Alice Wallenberg foundation; Swedish Foundation for Strategic Research	Swedish National Research School in Genomics and Bioinformatics; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	CT acknowledges support from the Swedish National Research School in Genomics and Bioinformatics. DA was supported by the Knut and Alice Wallenberg foundation. CP and MK were supported by the Swedish Foundation for Strategic Research (Senior Individual Grant). MK was also supported by the Knut and Alice Wallenberg Foundation through the Swegene consortium and the Strategic Science Foundation (Lund Strategic Center for Clinical Cancer Research).	BARFORD JP, 1992, BIOPROCESS ENG, V7, P297, DOI 10.1007/BF00705158; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Nelson P., 2004, BIOL PHYS; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Savageau MA, 1998, GENETICS, V149, P1677; Savageau MA, 1998, GENETICS, V149, P1665; Shoemaker J, 2003, J THEOR BIOL, V222, P307, DOI 10.1016/S0022-5193(03)00036-5; Soyer OS, 2006, P NATL ACAD SCI USA, V103, P16337, DOI 10.1073/pnas.0604449103; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thattai M, 2003, BIOPHYS J, V85, P744, DOI 10.1016/S0006-3495(03)74517-2; van Hoek MJA, 2006, BIOPHYS J, V91, P2833, DOI [10.1529/biophysj.105.077420, 10.1529/biophysj.106.077420]; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	26	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e855	10.1371/journal.pone.0000855	http://dx.doi.org/10.1371/journal.pone.0000855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786226	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455500038
J	Safina, A; Ren, MQ; Vandette, E; Bakin, AV				Safina, A.; Ren, M-Q; Vandette, E.; Bakin, A. V.			TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis	ONCOGENE			English	Article						angiogenesis; invasion; metastasis; MMP-9; TAK1; TGF-beta	GROWTH-FACTOR-BETA; NF-KAPPA-B; BREAST-CANCER CELLS; ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR SMAD4; GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; MESENCHYMAL TRANSITION; TRANSIENT ACTIVATION; SIGNAL-TRANSDUCTION	Transforming growth factor-beta 1 (TGF-beta 1) signaling in tumor cells has been implicated in tumor angiogenesis and metastasis by regulating matrix proteolysis. Although MMP-9/gelatinase-B is an important component of these TGF-b1 responses, the mechanism of its regulation is not well understood. Here, we present evidence that TGF-beta-activated protein kinase 1 (TAK1) is critical for TGF-beta regulation of MMP-9 and the metastatic potential of breast cancer cell line MDA-MB-231. We found that suppression of TAK1 signaling by dominant-negative (dn) TAK1 or RNA interference (siRNA) reduces expression of MMP-9 and tumor cell invasion, without growth inhibition in cell culture. The orthotopic xenograft studies in SCID mice showed that suppression of TAK1 signaling by Dn-TAK1 reduces tumor growth and formation of lung metastases. QJ; Dn-TAK1 reduced the proliferation Ki-67 index and neovasculature of orthotopic xenografts. TAK1-mediated regulation of MMP-9 involves NF-kappa B signaling. Dn-TAK1 reduces NF-kappa B transcriptional response and inhibition of NF-kappa B reduces expression of MMP-9 and activity of the MMP-9 promoter reporter. Together, these findings suggest that TAK1 contributes to TGF-beta 1-mediated tumor angiogenesis and metastasis via a mechanism involving the TAK1-NF-kappa B-MMP-9 pathway.	[Safina, A.; Ren, M-Q; Vandette, E.; Bakin, A. V.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Bakin, AV (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	andrei.bakin@roswellpark.org		Bakin, Andrei/0000-0002-7728-1969	NCI NIH HHS [R01 CA095263, CA 16056, R01 CA95263, P30 CA016056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA095263] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Azuma M, 1999, EXP CELL RES, V250, P213, DOI 10.1006/excr.1999.4503; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Bakin AV, 2002, J CELL SCI, V115, P3193; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bitzer M, 2000, GENE DEV, V14, P187; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; deWinter JP, 1997, ONCOGENE, V14, P1891, DOI 10.1038/sj.onc.1201017; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x; Farina AR, 1998, INT J CANCER, V75, P721; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang FY, 2000, INT J ENG SCI, V38, P275, DOI 10.1016/S0020-7225(99)00041-5; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; Janji B, 1999, INT J CANCER, V83, P255, DOI 10.1002/(SICI)1097-0215(19991008)83:2<255::AID-IJC18>3.3.CO;2-O; Johansson N, 2000, J CELL SCI, V113, P227; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Ogata H, 2001, CANCER LETT, V172, P159, DOI 10.1016/S0304-3835(01)00648-6; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Safina A, 2007, ONCOGENE, V26, P2407, DOI 10.1038/sj.onc.1210046; Saha D, 2001, J BIOL CHEM, V276, P29531, DOI 10.1074/jbc.M100069200; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; SATO H, 1993, ONCOGENE, V8, P395; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Suarez-Cuervo C, 2004, CLIN EXP METASTAS, V21, P525, DOI 10.1007/s10585-004-3503-x; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Verrecchia F, 2003, J BIOL CHEM, V278, P1585, DOI 10.1074/jbc.M206927200; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEXLER H, 1966, JNCI-J NATL CANCER I, V36, P641, DOI 10.1093/jnci/36.4.641; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	50	72	77	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 21	2008	27	9					1198	1207		10.1038/sj.onc.1210768	http://dx.doi.org/10.1038/sj.onc.1210768			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17828308				2022-12-25	WOS:000253407000002
J	Kibaly, C; Meyer, L; Patte-Mensah, C; Mensah-Nyagan, AG				Kibaly, Cherkaouia; Meyer, Laurence; Patte-Mensah, Christine; Mensah-Nyagan, Ayikoe G.			Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord	FASEB JOURNAL			English	Article						biochemistry of steroidogenic enzymes; cytochrome P450c17; HPLC; neurosteroids; real-time PCR	CENTRAL-NERVOUS-SYSTEM; SUPERFICIAL DORSAL-HORN; METHYL-D-ASPARTATE; NEUROPATHIC PAIN; ADULT-RAT; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; IMMUNOCYTOCHEMICAL LOCALIZATION; STEROIDOGENIC ENZYME; BIOLOGICAL-ACTIVITY; SIGMA-RECEPTORS	We investigated the role and mechanism of action of dehydroepiandrosterone (DHEA) produced by the spinal cord (SC) in pain modulation in sciatic-neuropathic and control rats. Real-time polymerase chain reaction (PCR) after reverse transcription revealed cytochrome P450c17 (DHEA-synthesizing enzyme) gene repression in neuropathic rat SC. A combination of pulse-chase experiments, high performance liquid chromatography (HPLC), and flow-scintillation detection showed decreased DHEA biosynthesis from pregnenolone in neuropathic SC slices. Radioimmunoassays demonstrated endogenous DHEA level drop in neuropathic SC. Behavioral analysis showed a rapid pronociceptive and a delayed antinociceptive action of acute DHEA treatment. Inhibition of DHEA biosynthesis in the SC by intrathecally administered ketoconazole (P450c17 inhibitor) induced analgesia in neuropathic rats. BD1047 (sigma-1 receptor antagonist) blocked the transient pronociceptive effect evoked by acute DHEA administration. Chronic DHEA treatment increased and maintained elevated the basal nociceptive thresholds in neuropathic and control rats, suggesting that androgenic metabolites generated from daily administered DHEA exerted analgesic effects while DHEA itself (before being metabolized) induced a rapid pronociceptive action. Indeed, intrathecal administration of testosterone, an androgen deriving from DHEA, caused analgesia in neuropathic rats. Together, these molecular, biochemical, and functional results demonstrate that DHEA synthesized in the SC controls pain mechanisms. Possibilities are opened for pain modulation by drugs regulating P450c17 in nerve cells.-Kibaly, C., Meyer, L., Patte-Mensah, C., Mensah-Nyagan, A. G. Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord.	[Kibaly, Cherkaouia; Meyer, Laurence; Patte-Mensah, Christine; Mensah-Nyagan, Ayikoe G.] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, LC2,Ctr Natl Rech Sci,Dept Nocept & Douleur, Unite Mixte Rech 7168,Equipe Steroides & Syst Noc, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mensah-Nyagan, AG (corresponding author), Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, LC2,Ctr Natl Rech Sci,Dept Nocept & Douleur, Unite Mixte Rech 7168,Equipe Steroides & Syst Noc, 21 Rue Rene Descartes, F-67084 Strasbourg, France.	gmensah@neurochem.u-strasbg.fr	Mensah-Nyagan, Ayikoe G/D-5951-2011; Meyer, Laurence/D-5967-2011; Patte-Mensah, Christine/D-5961-2011	Mensah-Nyagan, Ayikoe G/0000-0003-4454-511X; Meyer, Laurence/0000-0002-6113-936X; Patte-Mensah, Christine/0000-0002-9970-8214				Aicher SA, 1997, BRAIN RES, V772, P71, DOI 10.1016/S0006-8993(97)00637-9; Aloisi AM, 2006, HORM BEHAV, V50, P1, DOI 10.1016/j.yhbeh.2005.12.002; Alonso G, 2000, NEUROSCIENCE, V97, P155, DOI 10.1016/S0306-4522(00)00014-2; ARNER S, 1988, PAIN, V33, P11, DOI 10.1016/0304-3959(88)90198-4; AYUB M, 1987, J STEROID BIOCHEM, V28, P521, DOI 10.1016/0022-4731(87)90511-5; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; BAULIEU EE, 1999, CONTEMPORARY ENDOCRI, V16; BELLINO FL, 1995, DEHYDROEPIANDROSTERO, V774; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bergeron R, 1996, J NEUROSCI, V16, P1193; Collo G, 1996, J NEUROSCI, V16, P2495; CORPECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P4704, DOI 10.1073/pnas.78.8.4704; De Roo M, 2003, J PHYSIOL-LONDON, V552, P59, DOI 10.1113/jphysiol.2003.046078; Edinger KL, 2005, PSYCHONEUROENDOCRINO, V30, P418, DOI 10.1016/j.psyneuen.2004.11.001; Gambhir Mridula, 2002, Indian Journal of Physiology and Pharmacology, V46, P202; Goodchild CS, 2001, BRIT J ANAESTH, V86, P528, DOI 10.1093/bja/86.4.528; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kibaly C, 2005, J NEUROCHEM, V93, P1220, DOI 10.1111/j.1471-4159.2005.03113.x; Kingery WS, 1997, PAIN, V73, P123, DOI 10.1016/S0304-3959(97)00049-3; Koltzenburg M, 1998, CURR OPIN NEUROL, V11, P515, DOI 10.1097/00019052-199810000-00014; LACROIX C, 1987, J STEROID BIOCHEM, V28, P317, DOI 10.1016/0022-4731(87)91025-9; Lu CR, 2005, J COMP NEUROL, V486, P169, DOI 10.1002/cne.20525; MATHUR C, 1993, P NATL ACAD SCI USA, V90, P85, DOI 10.1073/pnas.90.1.85; MATSUMOTO RR, 1995, EUR J PHARMACOL, V280, P301, DOI 10.1016/0014-2999(95)00208-3; Maurice T, 2006, PHARMACOL BIOCHEM BE, V84, P581, DOI 10.1016/j.pbb.2006.07.009; Mensah-Nyagan AG, 1999, PHARMACOL REV, V51, P63; MENSAHNYAGAN AG, 1994, J NEUROSCI, V14, P7306; MensahNyagan AG, 1996, P NATL ACAD SCI USA, V93, P1423, DOI 10.1073/pnas.93.4.1423; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Monnet FP, 2003, J PHARMACOL EXP THER, V307, P705, DOI 10.1124/jpet.103.053447; Morales AJ, 1998, CLIN ENDOCRINOL, V49, P421, DOI 10.1046/j.1365-2265.1998.00507.x; Patte-Mensah C, 2006, J MOL NEUROSCI, V28, P17, DOI 10.1385/JMN:28:1:17; Patte-Mensah C, 2005, P NATL ACAD SCI USA, V102, P9044, DOI 10.1073/pnas.0502968102; Patte-Mensah C, 2004, J COMP NEUROL, V477, P286, DOI 10.1002/cne.20251; Patte-Mensah C, 2004, CELL MOL LIFE SCI, V61, P2274, DOI 10.1007/s00018-004-4235-4; Patte-Mensah C, 2003, J NEUROCHEM, V86, P1233, DOI 10.1046/j.1471-4159.2003.01935.x; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RAIGORODSKY G, 1990, EUR J PHARMACOL, V182, P37, DOI 10.1016/0014-2999(90)90491-N; Sakaue M, 2002, J VET MED SCI, V64, P107, DOI 10.1292/jvms.64.107; Saredi S, 2005, NEUROSCIENCE, V135, P869, DOI 10.1016/j.neuroscience.2005.06.033; Shirayama Y, 2002, SCHIZOPHR RES, V58, P69, DOI 10.1016/S0920-9964(01)00367-X; Strous Rael D, 2005, Essent Psychopharmacol, V6, P141; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; TRACHTENBERG J, 1988, CLIN INVEST MED, V11, P1; VANWEERDEN WM, 1992, LIFE SCI, V50, P857, DOI 10.1016/0024-3205(92)90204-3; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	65	67	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					93	104		10.1096/fj.07-8930com	http://dx.doi.org/10.1096/fj.07-8930com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17720801				2022-12-25	WOS:000252309900013
J	Pecqueur, C; Bui, T; Gelly, C; Hauchard, J; Barbot, C; Bouillaud, F; Ricquier, D; Miroux, B; Thompson, CB				Pecqueur, Claire; Bui, Thi; Gelly, Chantal; Hauchard, Julie; Barbot, Celine; Bouillaud, Frederic; Ricquier, Daniel; Miroux, Bruno; Thompson, Craig B.			Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization	FASEB JOURNAL			English	Article						carrier; mitochondria; metabolism	BETA-CELL DYSFUNCTION; KAPPA-B ACTIVATION; HYDROGEN-PEROXIDE; INSULIN-SECRETION; EXPRESSION; SUPEROXIDE; MITOCHONDRIA; MICE; APOPTOSIS; STRESS	Uncoupling protein-2 (UCP2) belongs to the mitochondrial carrier family and has been thought to be involved in suppressing mitochondrial ROS production through uncoupling mitochondrial respiration from ATP synthesis. However, we show here that loss of function of UCP2 does not result in a significant increase in ROS production or an increased propensity for cells to undergo senescence in culture. Instead, Ucp2-/- cells display enhanced proliferation associated with a metabolic switch from fatty acid oxidation to glucose metabolism. This metabolic switch requires the unrestricted availability of glucose, and Ucp2-/- cells more readily activate autophagy than wild- type cells when deprived of glucose. Altogether, these results suggest that UCP2 promotes mitochondrial fatty acid oxidation while limiting mitochondrial catabolism of pyruvate. The persistence of fatty acid catabolism in Ucp2-/- cells during a proliferative response correlates with reduced cell proliferation and enhances resistance to glucose starvation-induced autophagy. Pecqueur, C., Bui, T., Gelly, C., Hauchard, J., Barbot, C., Bouillaud, F., Ricquier, D., Miroux, B., Thompson, C. B. Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization.	[Pecqueur, Claire; Gelly, Chantal; Hauchard, Julie; Barbot, Celine; Bouillaud, Frederic; Ricquier, Daniel; Miroux, Bruno] Univ Paris 05, CNRS, UPR9078, Fac Med Necker, F-75730 Paris 15, France; [Pecqueur, Claire; Bui, Thi] Biomed Res, Philadelphia, PA USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Pecqueur, C (corresponding author), Univ Paris 05, CNRS, UPR9078, Fac Med Necker, 156 Rue Vaugrard, F-75730 Paris 15, France.	pecqueuc@necker.fr	Miroux, Bruno/E-9267-2017; Pecqueur, Claire/L-3073-2015; Bouillaud, Frédéric R/L-3238-2017	Pecqueur, Claire/0000-0002-7612-1672; Bouillaud, Frédéric R/0000-0002-7518-9237; Miroux, Bruno/0000-0002-3066-4700				Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Aubert J, 1997, BIOCHEM BIOPH RES CO, V238, P606, DOI 10.1006/bbrc.1997.7348; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; BURDON RH, 1990, FREE RADICAL RES COM, V11, P65, DOI 10.3109/10715769009109669; Burdon RH, 1996, FREE RADICAL RES, V24, P81, DOI 10.3109/10715769609088004; CASTEILLA L, 1990, P NATL ACAD SCI USA, V87, P5124, DOI 10.1073/pnas.87.13.5124; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Derdak Z, 2006, CARCINOGENESIS, V27, P956, DOI 10.1093/carcin/bgi335; Dulloo AG, 2001, BIOCHEM SOC T, V29, P785, DOI 10.1042/BST0290785; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mozo J, 2006, BIOCHEM J, V393, P431, DOI 10.1042/BJ20050494; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Newell MK, 1999, ANN NY ACAD SCI, V887, P77, DOI 10.1111/j.1749-6632.1999.tb07923.x; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Reilly JM, 2000, BIOCHEM BIOPH RES CO, V277, P541, DOI 10.1006/bbrc.2000.3705; Ryu JW, 2004, ARTERIOSCL THROM VAS, V24, P864, DOI 10.1161/01.ATV.0000125705.28058.eb; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Stuart JA, 2001, J BIOL CHEM, V276, P18633, DOI 10.1074/jbc.M011566200; Van der Lee KAJM, 2000, FASEB J, V14, P495, DOI 10.1096/fasebj.14.3.495; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	41	152	153	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2008	22	1					9	18		10.1096/fj.07-8945com	http://dx.doi.org/10.1096/fj.07-8945com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17855623				2022-12-25	WOS:000252309900004
J	Chouinard, S; Barbier, O; Belanger, A				Chouinard, Sarah; Barbier, Olivier; Belanger, Alain			UDP-glucuronosyltransferase 2B15 ( UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; HOMEOBOX GENE NKX3.1; HUMAN LIVER; RECEPTOR; EXPRESSION; CDNA; LOCALIZATION; POLYMORPHISM; TISSUE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE	Uridine diphosphate-glucuronosyltransferase 2 ( UGT2) B15 and B17 enzymes conjugate dihydrotestosterone ( DHT) and its metabolites androstane-3 alpha,17 beta-diol ( 3 alpha-DIOL) and androsterone (ADT). The presence of UGT2B15/B17 in the epithelial cells of the human prostate has been clearly demonstrated, and significant 3 alpha-DIOL glucuronide and ADT-glucuronide concentrations have been detected in this tissue. The human androgen-dependent cancer cell line, LNCaP, expresses UGT2B15 and -B17 and is also capable of conjugating androgens. To assess the impact of these two genes in the inactivation of androgens in LNCaP cells, their expression was inhibited using RNA interference. The efficient inhibitory effects of a UGT2B15/B17 small interfering RNA ( siRNA) probe was established by the 70% reduction of these UGT mRNA levels, which was further confirmed at the protein levels. The glucuronidation of dihydrotestosterone (DHT), 3 alpha-DIOL, and ADT by LNCaP cell homogenates was reduced by more than 75% in UGT2B15/B17 siRNA-transfected LNCaP cells when compared with cells transfected with a nontarget probe. In UGT2B15/B17-deficient LNCaP cells, we observe a stronger response to DHT than in control cells, as determined by cell proliferation and expression of eight known androgen-sensitive genes. As expected, the amounts of DHT in cell culture media from control cells were significantly lower than that from UGT2B15/B17 siRNA-treated cells, which was caused by a higher conversion to its corresponding glucuronide derivative. Taken together these data support the idea that UGT2B15 and -B17 are critical enzymes for the local inactivation of androgens and that glucuronidation is a major determinant of androgen action in prostate cells.	CHU Laval, Res Ctr, Oncol & Mol Endocrinol Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Belanger, A (corresponding author), CHU Laval, Res Ctr, Oncol & Mol Endocrinol Res Ctr, 2705 Laurier Blvd,Bloc T-3, Quebec City, PQ G1V 4G2, Canada.	alain.belanger@ap.ulaval.ca		Barbier, Olivier/0000-0002-3067-1134				Arnold JT, 2005, AM J PHYSIOL-ENDOC M, V288, pE573, DOI 10.1152/ajpendo.00454.2004; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Barbier O, 2000, J CLIN ENDOCR METAB, V85, P4819, DOI 10.1210/jc.85.12.4819; Beaulieu M, 1996, J BIOL CHEM, V271, P22855, DOI 10.1074/jbc.271.37.22855; Beaulieu M, 1998, BIOCHEM BIOPH RES CO, V248, P44, DOI 10.1006/bbrc.1998.8908; Belanger A, 2003, TRENDS ENDOCRIN MET, V14, P473, DOI 10.1016/j.tem.2003.10.005; BELANGER A, 1990, ANN NY ACAD SCI, V595, P251, DOI 10.1111/j.1749-6632.1990.tb34299.x; BELANGER B, 1989, J STEROID BIOCHEM, V32, P695, DOI 10.1016/0022-4731(89)90514-1; BERNS EMJJ, 1986, PROSTATE, V9, P247, DOI 10.1002/pros.2990090305; CHEN S, 2007, IN PRESS J ANDROL; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Chouinard S, 2004, ENDOCR RES, V30, P717, DOI 10.1081/ERC-200044014; Chouinard S, 2006, ENDOCRINOLOGY, V147, P5431, DOI 10.1210/en.2006-0229; Couture JF, 2005, PROTEIN SCI, V14, P1485, DOI 10.1110/ps.051353205; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Dutton G.F., 1980, GLUCURONIDATION DRUG; El-Alfy M, 1999, ENDOCRINOLOGY, V140, P1481, DOI 10.1210/en.140.3.1481; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; FARNSWORTH WE, 1976, ENDOCR RES COMMUN, V3, P105, DOI 10.3109/07435807609052926; GELLER J, 1987, UROL RES, V15, P151; GREEN MD, 1994, DRUG METAB DISPOS, V22, P799; Guillemette C, 1997, ENDOCRINOLOGY, V138, P2998, DOI 10.1210/en.138.7.2998; Guillemette C, 1996, ENDOCRINOLOGY, V137, P2872, DOI 10.1210/en.137.7.2872; GUILLEMETTE C, 1995, MOL CELL ENDOCRINOL, V107, P131, DOI 10.1016/0303-7207(94)03434-U; Hajdinjak T, 2004, PROSTATE, V59, P436, DOI 10.1002/pros.20024; HAMMOND GL, 1978, J ENDOCRINOL, V78, P7, DOI 10.1677/joe.0.0780007; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Kanaya J, 2003, ASIAN J ANDROL, V5, P9; Kazmin D, 2006, MOL ENDOCRINOL, V20, P1201, DOI 10.1210/me.2005-0309; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Korkmaz KS, 2000, GENE, V260, P25, DOI 10.1016/S0378-1119(00)00453-4; Korkmaz KS, 2001, DNA CELL BIOL, V20, P435, DOI 10.1089/104454901750361497; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034; Levesque E, 1998, ENDOCRINOLOGY, V139, P2375, DOI 10.1210/en.139.5.2375; Levesque E, 1997, PHARMACOGENETICS, V7, P317, DOI 10.1097/00008571-199708000-00007; Lin BY, 1999, CANCER RES, V59, P4180; Liu H, 2005, J STEROID BIOCHEM, V94, P173, DOI 10.1016/j.jsbmb.2005.01.023; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; MacLeod SL, 2000, ANN SURG ONCOL, V7, P777, DOI 10.1007/s10434-000-0777-3; Okugi H, 2006, CANCER DETECT PREV, V30, P262, DOI 10.1016/j.cdp.2006.04.004; Page ST, 2006, J CLIN ENDOCR METAB, V91, P4374, DOI 10.1210/jc.2006-1411; Park J, 2004, J UROLOGY, V171, P2484, DOI 10.1097/01.ju.0000117748.44313.43; Prescott J, 2007, PROSTATE, V67, P1371, DOI 10.1002/pros.20623; RITTMASTER RS, 1993, J CLIN ENDOCR METAB, V76, P977, DOI 10.1210/jc.76.4.977; SONNENSCHEIN C, 1989, CANCER RES, V49, P3474; Turgeon D, 2003, J LIPID RES, V44, P1182, DOI 10.1194/jlr.M300010-JLR200; Turgeon D, 2001, ENDOCRINOLOGY, V142, P778, DOI 10.1210/en.142.2.778; Vandenput L, 2007, J BONE MINER RES, V22, P220, DOI 10.1359/JBMR.061018; Xu LL, 2000, J UROLOGY, V163, P972, DOI 10.1016/S0022-5347(05)67867-6; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	56	85	86	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33466	10.1074/jbc.M703370200	http://dx.doi.org/10.1074/jbc.M703370200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848572	hybrid			2022-12-25	WOS:000250840200027
J	Arpin-Andre, C; Mesnard, JM				Arpin-Andre, Charlotte; Mesnard, Jean-Michel			The PDZ domain-binding motif of the human T cell leukemia virus type 1 tax protein induces mislocalization of the tumor suppressor hScrib in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HOMOLOG; SIGNALING PATHWAYS; HPV E6; SCRIBBLE; PROLIFERATION; ONCOPROTEIN; EXPRESSION; POLARITY; COMPLEX; GROWTH	Interactions with cellular PDZ domain-containing proteins obviously contribute to the tumorigenic potential of several viral oncoproteins. In this regard, the oncogenic potential of the human T cell leukemia virus type 1 Tax protein correlates with its binding capacity to the tumor suppressor hDlg. Recent results show that hDlg in T cells is associated to a network of scaffolding proteins including another PDZ domain-containing protein termed hScrib. Interestingly, previous studies have revealed complementary activities of both proteins in the control of epithelial cell polarity. Here, we demonstrate that Tax can bind to hScrib and that the resulting Tax/hScrib complex is present in human T cell leukemia virus type 1-infected T cells. By confocal microscopy, we show that Tax modifies the localization of hScrib in transfected COS cells as well as in infected T cell lines and targets hScrib to particular spots exhibiting a granular distribution, mainly distributed in the cytoplasm. Given that Tax sequesters hScrib to these particular structures, we postulate that Tax might inhibit hScrib activity. Providing further support to this idea, we find that transient overexpression of hScrib attenuates T cell receptor-induced NFAT activity but that the presence of Tax counteracts this negative effect on the NFAT pathway. The fact that hDlg and hScrib are both targeted by Tax underlies their importance in T cell function.	Inst Biol, Ctr Etudes Agents Pathogenes & Biotechnol Sante, CNRS, UM 1,UM 2,UMR 5236,IFR 122, F-34965 Montpellier 2, France	Centre National de la Recherche Scientifique (CNRS)	Mesnard, JM (corresponding author), Inst Biol, Ctr Etudes Agents Pathogenes & Biotechnol Sante, CNRS, UM 1,UM 2,UMR 5236,IFR 122, CS 69033,4 BD Henri IV, F-34965 Montpellier 2, France.	jean-michel.mesnard@univ-montp1.fr		Mesnard, Jean-Michel/0000-0003-3344-5367				Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Basbous J, 2003, J VIROL, V77, P13028, DOI 10.1128/JVI.77.24.13028-13035.2003; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hirata A, 2004, VIROLOGY, V318, P327, DOI 10.1016/j.virol.2003.10.006; Hivin P, 2005, J CELL SCI, V118, P1355, DOI 10.1242/jcs.01727; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Lemasson I, 1997, J VIROL, V71, P1975, DOI 10.1128/JVI.71.3.1975-1983.1997; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; MALEFYT RD, 1990, J IMMUNOL, V145, P2297; Massimi P, 2004, ONCOGENE, V23, P8033, DOI 10.1038/sj.onc.1207977; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Mesnard JM, 2006, PROGRESS IN VIRUS RESEARCH, P1; Mesnard JM, 1999, VIROLOGY, V257, P277, DOI 10.1006/viro.1999.9685; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; NOURRY C, 2003, SCI STKE, V179, P1; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Takizawa S, 2006, GENES CELLS, V11, P453, DOI 10.1111/j.1365-2443.2006.00954.x; Tsubata C, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-46; Weil R, 1999, J VIROL, V73, P3709, DOI 10.1128/JVI.73.5.3709-3717.1999; Wilkinson B, 2004, IMMUNOLOGY, V111, P368, DOI 10.1111/j.0019-2805.2004.01832.x; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333	51	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33132	33141		10.1074/jbc.M702279200	http://dx.doi.org/10.1074/jbc.M702279200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855372	hybrid, Green Published			2022-12-25	WOS:000250625400061
J	Hinz, M; Broemer, M; Arslan, SC; Otto, A; Mueller, EC; Dettmer, R; Scheidereit, C				Hinz, Michael; Broemer, Meike; Arslan, Seda Coel; Otto, Albrecht; Mueller, Eva-Christina; Dettmer, Rudolf; Scheidereit, Claus			Signal responsiveness of I kappa B kinases is determined by Cdc37-assisted transient interaction with Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-GAMMA; MOLECULAR CHAPERONE; COMPLEX ACTIVITY; VIVO FUNCTION; ATP BINDING; ACTIVATION; CDC37; ALPHA; PATHWAYS; TRANSCRIPTION	The I kappa B kinase (IKK) holocomplex, containing the kinases IKK alpha, IKK beta, and the scaffold NEMO (NF-kappa B essential modifier), mediates activation of NF-kappa B by numerous physiological stimuli. Heat shock protein 90 (Hsp90) and the co-chaperone Cdc37 have been indicated as additional subunits, but their specific functions in signal transduction are indistinct. Using an RNA interference approach, we demonstrate that Cdc37 recruits Hsp90 to the IKK complex in a transitory manner, preferentially via IKK alpha. Binding is conferred by N-terminal as well as C-terminal residues of Cdc37. Cdc37 is essential for the maturation of de novo synthesized IKKs into enzymatically competent kinases but not for assembly of an IKK holocomplex. Mature IKKs, T-loop-phosphorylated after stimulation either by receptor-mediated signaling or upon DNA damage, further require Hsp90-Cdc37 to generate an activated state. Thus, the present data denote Hsp90-Cdc37 as a transiently acting essential regulatory component of IKK signaling.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Scheidereit, C (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	scheidereit@mdc-berlin.de	Hinz, Michael/HCI-0550-2022	Hinz, Michael/0000-0003-2611-4121				Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pittet JF, 2005, J IMMUNOL, V174, P384, DOI 10.4049/jimmunol.174.1.384; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Santel A, 2006, GENE THER, V13, P1222, DOI 10.1038/sj.gt.3302777; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Sugita T, 1999, BIOCHEM MOL BIOL INT, V47, P587; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terasawa K, 2005, FEBS J, V272, P4684, DOI 10.1111/j.1742-4658.2005.04884.x; Voss AK, 2000, DEVELOPMENT, V127, P1; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	48	65	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32311	32319		10.1074/jbc.M705785200	http://dx.doi.org/10.1074/jbc.M705785200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728246	hybrid			2022-12-25	WOS:000250480300054
J	Abell, AN; Granger, DA; Johnson, GL				Abell, Amy N.; Granger, Deborah A.; Johnson, Gary L.			MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; KINASE KINASE KINASE; NEURAL-TUBE CLOSURE; INDUCED ACTIVATION; TERMINAL KINASE; AXIN; JUN; APOPTOSIS; GSK3; GSK-3-BETA	The MAPK kinase kinase MEKK4 is required for neurulation and skeletal patterning during mouse development. MEKK4 phosphorylates and activates MKK4/MKK7 and MKK3/MKK6 leading to the activation of JNK and p38, respectively. MEKK4 is believed to be auto-inhibited, and its interaction with other proteins controls its dimerization and activation. TRAF4, GADD45, and Axin each bind and activate MEKK4, with TRAF4 and Axin binding to the kinase domain and GADD45 binding within the N-terminal regulatory domain. Here we show that similar to the interaction with TRAF4 and Axin, the kinase domain of MEKK4 interacts with the multifunctional serine/threonine kinase GSK3 beta. GSK3 beta binding to MEKK4 blocks MEKK4 dimerization that is required for MEKK4 activation, effectively inhibiting MEKK4 stimulation of the JNK and p38 MAPK pathways. Inhibition of GSK3 beta kinase activity with SB216763 results in enhanced MEKK4 kinase activity and increased JNK and p38 activation, indicating that an active state of GSK3 beta is required for binding and inhibition of MEKK4 dimerization. Furthermore, GSK3 beta phosphorylates specific serines and threonines in the N terminus of MEKK4. Together, these findings demonstrate that GSK3 beta binds to the kinase domain of MEKK4 and regulates MEKK4 dimerization. However, unlike TRAF4, Axin, and GADD45, GSK3 beta inhibits MEKK4 activity and prevents its activation of JNK and p38. Thus, control of MEKK4 dimerization is regulated both positively and negatively by its interaction with specific proteins.	Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Abell, AN (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, 1012 Mary Ellen Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.	amy_abell@med.unc.edu			NIGMS NIH HHS [GM30324] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030324, R37GM030324] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Abell AN, 2005, J BIOL CHEM, V280, P35793, DOI 10.1074/jbc.C500260200; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Chan-Hui PY, 1998, BIOCHEM J, V336, P599, DOI 10.1042/bj3360599; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Liu SY, 2004, J BIOL CHEM, V279, P51075, DOI 10.1074/jbc.M408607200; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; MIYAKE Z, 2007, J BIOL, V27, P2765; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	27	45	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30476	30484		10.1074/jbc.M705783200	http://dx.doi.org/10.1074/jbc.M705783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726008	hybrid			2022-12-25	WOS:000250136300015
J	Liang, J; Fu, MG; Ciociola, E; Chandalia, M; Abate, N				Liang, Jian; Fu, Mingui; Ciociola, Ester; Chandalia, Manisha; Abate, Nicola			Role of ENPP1 on Adipocyte Maturation	PLOS ONE			English	Article								Background. It is recognized that the ability of adipose tissue to expand in response to energy excess, i.e. adipocyte maturation, is important in determining systemic abnormalities in glucose and lipid metabolism. Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1, also known as PC-1) has been recently reported to be involved in the pathogenesis of insulin resistance and related diseases. However, its role on adipose tissue physiology as a mechanism of systemic insulin resistance is not understood. This study was performed to evaluate whether ENPP1 is regulated during adipogenesis and whether over-expression in adipocytes can affect adipocyte maturation, a potential novel mechanism of ENPP1-related insulin resistance. Methodology/Principal Findings. ENPP1 expression was found down-regulated during 3T3-L1 maturation, and over-expression of human ENPP1 in 3T3-L1 (pQCXIP-ENPP1 vector) resulted in adipocyte insulin resistance and in defective adipocyte maturation. Adipocyte maturation was more efficient in mesenchymal embryonal cells from ENPP1 knockout mice than from wild-type. Conclusions. We identify ENPP1 as a novel mechanism of defective adipocyte maturation. This mechanism could contribute to the pathogenesis of insulin resistance in absence of obesity.	[Chandalia, Manisha; Abate, Nicola] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Ciociola, Ester; Chandalia, Manisha; Abate, Nicola] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Liang, Jian; Fu, Mingui] Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Central Florida	Chandalia, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA.	Manisha.Chandalia@utsouthwestern.edu; Nicola.Abate@UTSouthwestern.edu			NIDDK [RO1 DK072158-01]; ADA [7-03-JF-18]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072158] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ADA(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: NIDDK RO1 DK072158-01 (NA and MC); ADA 7-03-JF-18 (MF)	Abate N, 2005, DIABETES, V54, P1207, DOI 10.2337/diabetes.54.4.1207; Abate N, 2003, J CLIN ENDOCR METAB, V88, P5927, DOI 10.1210/jc.2003-030453; Belfiore A, 1996, MOL ENDOCRINOL, V10, P1318, DOI 10.1210/me.10.11.1318; CHANEY B, 2007, US NEWS WORLD REP, V143, P8; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Costanzo BV, 2001, DIABETES, V50, P831, DOI 10.2337/diabetes.50.4.831; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Garg A, 2004, ENDOCRIN METAB CLIN, V33, P305, DOI 10.1016/j.ecl.2004.03.003; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; KOUTSARI C, 2006, J LIPID RES     0510; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; MATSUOKA N, 2005, INT J OBESITY, V11, P1; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Miles JM, 2004, DIABETES, V53, P521, DOI 10.2337/diabetes.53.3.521; Prudente S, 2007, OBESITY, V15, P1, DOI 10.1038/oby.2007.636; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rosen ED, 2000, GENE DEV, V14, P1293; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Sakoda H, 1999, DIABETES, V48, P1365, DOI 10.2337/diabetes.48.7.1365; Zhang Weidong, 2004, Genet Vaccines Ther, V2, P8, DOI 10.1186/1479-0556-2-8	30	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e882	10.1371/journal.pone.0000882	http://dx.doi.org/10.1371/journal.pone.0000882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849011	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455600028
J	Mahfooz, N; Turchyn, N; Mihajlovic, M; Hrycaj, S; Popadic, A				Mahfooz, Najmus; Turchyn, Nataliya; Mihajlovic, Michelle; Hrycaj, Steven; Popadic, Aleksandar			Ubx Regulates Differential Enlargement and Diversification of Insect Hind Legs	PLOS ONE			English	Article								Differential enlargement of hind (T3) legs represents one of the hallmarks of insect evolution. However, the actual mechanism(s) responsible are yet to be determined. To address this issue, we have now studied the molecular basis of T3 leg enlargement in Oncopeltus fasciatus (milkweed bug) and Acheta domesticus (house cricket). In Oncopeltus, the T3 tibia displays a moderate increase in size, whereas in Acheta, the T3 femur, tibia, and tarsus are all greatly enlarged. Here, we show that the hox gene Ultrabithorax (Ubx) is expressed in the enlarged segments of hind legs. Furthermore, we demonstrate that depletion of Ubx during embryogenesis has a primary effect in T3 legs and causes shortening of leg segments that are enlarged in a wild type. This result shows that Ubx is regulating the differential growth and enlargement of T3 legs in both Oncopeltus and Acheta. The emerging view suggests that Ubx was co-opted for a novel role in regulating leg growth and that the transcriptional modification of its expression may be a universal mechanism for the evolutionary diversification of insect hind legs.	[Mahfooz, Najmus; Turchyn, Nataliya; Mihajlovic, Michelle; Hrycaj, Steven; Popadic, Aleksandar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Popadic, A (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	apopadic@biology.biosci.wayne.edu			NIGMS NIH HHS [GM071927, R01 GM071927] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071927] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abzhanov A, 1999, EVOL DEV, V1, P77, DOI 10.1046/j.1525-142x.1999.99014.x; Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6; Angelini DR, 2005, DEV BIOL, V287, P440, DOI 10.1016/j.ydbio.2005.08.010; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Bennett RL, 1999, DEV GENES EVOL, V209, P608, DOI 10.1007/s004270050295; Brodu V, 2002, DEVELOPMENT, V129, P2957; Carroll S.B., 2001, DNA DIVERSITY; CASTELLIGAIR J, 1995, DEVELOPMENT, V121, P2973; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Heming BS., 2003, INSECT DEV EVOLUTION; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Hughes CL, 2002, DEVELOPMENT, V129, P1225; Hughes CL, 2000, DEVELOPMENT, V127, P3683; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; Lewis DL, 2000, P NATL ACAD SCI USA, V97, P4504, DOI 10.1073/pnas.97.9.4504; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li H, 2004, EVOL DEV, V6, P310, DOI 10.1111/j.1525-142X.2004.04039.x; Liu PZ, 2004, DEVELOPMENT, V131, P1515, DOI 10.1242/dev.01046; Lohmann I, 2002, CURR BIOL, V12, pR514, DOI 10.1016/S0960-9822(02)01025-4; Mahfooz NS, 2004, P NATL ACAD SCI USA, V101, P4877, DOI 10.1073/pnas.0401216101; MIHAJLOVIC M, 2005, UTILIZING MOL PROBES; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peterson MD, 1999, DEV GENES EVOL, V209, P77, DOI 10.1007/s004270050230; Popadic A, 2001, EVOL DEV, V3, P391, DOI 10.1046/j.1525-142X.2001.01049.x; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Rozowski M, 2002, GENE DEV, V16, P1150, DOI 10.1101/gad.219302; Snodgrass R.E., 1952, TXB ARTHROPOD ANATOM; Stern DL, 1999, DEVELOPMENT, V126, P1091; Stern DL, 2003, DEV BIOL, V256, P355, DOI 10.1016/S0012-1606(03)00035-6; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Zhang HJ, 2005, GENE EXPR PATTERNS, V5, P491, DOI 10.1016/j.modgep.2004.12.006; Zheng Z, 1999, DEV GENES EVOL, V209, P460, DOI 10.1007/s004270050279	37	38	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e866	10.1371/journal.pone.0000866	http://dx.doi.org/10.1371/journal.pone.0000866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848997	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455600013
J	Hartmannsgruber, V; Heyken, WT; Kacik, M; Kaistha, A; Grgic, I; Harteneck, C; Liedtke, W; Hoyer, J; Kohler, R				Hartmannsgruber, Veronika; Heyken, Willm-Thomas; Kacik, Michael; Kaistha, Anuradha; Grgic, Ivica; Harteneck, Christian; Liedtke, Wolfgang; Hoyer, Joachim; Koehler, Ralf			Arterial Response to Shear Stress Critically Depends on Endothelial TRPV4 Expression	PLOS ONE			English	Article								Background. In blood vessels, the endothelium is a crucial signal transduction interface in control of vascular tone and blood pressure to ensure energy and oxygen supply according to the organs' needs. In response to vasoactive factors and to shear stress elicited by blood flow, the endothelium secretes vasodilating or vasocontracting autacoids, which adjust the contractile state of the smooth muscle. In endothelial sensing of shear stress, the osmo- and mechanosensitive Ca2+-permeable TRPV4 channel has been proposed to be candidate mechanosensor. Using TRPV4(-/-) mice, we now investigated whether the absence of endothelial TRPV4 alters shear-stress-induced arterial vasodilation. Methodology/Principal Findings. In TRPV4(-/-) mice, loss of the TRPV4 protein was confirmed by Western blot, immunohistochemistry and by in situ-patch-clamp techniques in carotid artery endothelial cells (CAEC). Endothelium-dependent vasodilation was determined by pressure myography in carotid arteries (CA) from TRPV4(-/-) mice and wild-type littermates (WT). In WT CAEC, TRPV4 currents could be elicited by TRPV4 activators 4 alpha-phorbol-12,13-didecanoate (4 alpha PDD), arachidonic acid ( AA), and by hypotonic cell swelling (HTS). In striking contrast, in TRPV4(-/-) mice, 4 alpha PDD did not produce currents and currents elicited by AA and HTS were significantly reduced. 4 alpha PDD caused a robust and endothelium-dependent vasodilation in WT mice, again conspicuously absent in TRPV4(-/-) mice. Shear stress-induced vasodilation could readily be evoked in WT, but was completely eliminated in TRPV4(-/-) mice. In addition, flow/reperfusion-induced vasodilation was significantly reduced in TRPV4(-/-) vs. WT mice. Vasodilation in response to acetylcholine, vasoconstriction in response to phenylephrine, and passive mechanical compliance did not differ between genotypes, greatly underscoring the specificity of the above trpv4-dependent phenotype for physiologically relevant shear stress. Conclusions/Significance. Genetically encoded loss-of-function of trpv4 results in a loss of shear stress-induced vasodilation, a response pattern critically dependent on endothelial TRPV4 expression. Thus, Ca2+-influx through endothelial TRPV4 channels is a molecular mechanism contributing significantly to endothelial mechanotransduction.	[Hartmannsgruber, Veronika; Heyken, Willm-Thomas; Kacik, Michael; Kaistha, Anuradha; Grgic, Ivica; Hoyer, Joachim; Koehler, Ralf] Univ Marburg, Dept Internal Med Nephrol, Marburg, Germany; [Harteneck, Christian] Charite Campus Benjamin Franklin, Inst Pharmakol, Berlin, Germany; [Liedtke, Wolfgang] Duke Univ, Ctr Translat Neurosci, Durham, NC USA	Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Duke University	Kohler, R (corresponding author), Univ Marburg, Dept Internal Med Nephrol, Marburg, Germany.	rkoehler@med.uni-marburg.de	Liedtke, Wolfgang B/G-4633-2011; Liedtke, Wolfgang/GNH-1878-2022; Hoyer, Joachim/GQB-1090-2022	Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft [SFB593, FOR 667]; National Institute of Mental Health (Bethesda, MD, USA); Whitehall Foundation; Klingenstein Fund; Duke University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Mental Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Whitehall Foundation; Klingenstein Fund(Klingenstein Philanthropies); Duke University	RK, JH and CH were supported by the Deutsche Forschungsgemeinschaft (P A11 of the SFB593 (JH, RK) and P4 of the FOR 667; CH); WL was supported by a K08 Career Development Award of the National Institute of Mental Health (Bethesda, MD, USA), by funding from the Whitehall Foundation (Palm Springs, FL, USA), the Klingenstein Fund (New York, NY, USA) and by the Duke University (Durham, NC, USA). All funders had no influence in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; FALCONE JC, 1993, AM J PHYSIOL, V264, pH653, DOI 10.1152/ajpheart.1993.264.2.H653; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Flockerzi V., 2007, V179, P1; Fukunaga R, 2006, AM J PHYSIOL-HEART C, V291, pH2388, DOI 10.1152/ajpheart.01313.2005; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gudermann T, 2005, N-S ARCH PHARMACOL, V371, P241, DOI 10.1007/s00210-005-1029-7; Guler AD, 2002, J NEUROSCI, V22, P6408; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Kohler R, 2007, KIDNEY INT, V72, P145, DOI 10.1038/sj.ki.5002303; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Kohler R, 2001, CIRC RES, V89, P174, DOI 10.1161/hh1401.093460; Liedtke W., 2007, V179, P473; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liedtke Wolfgang B., 2007, P303; Maier T, 2005, DEUT MED WOCHENSCHR, V130, P2637, DOI 10.1055/s-2005-922047; Marrelli SP, 2007, AM J PHYSIOL-HEART C, V292, pH1390, DOI 10.1152/ajpheart.01006.2006; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Muller JM, 1999, AM J PHYSIOL-HEART C, V276, pH1706, DOI 10.1152/ajpheart.1999.276.5.H1706; Mutai H, 2003, CELL CALCIUM, V33, P471, DOI 10.1016/S0143-4160(03)00062-9; Nilius B, 2003, ENDOTHELIUM-J ENDOTH, V10, P5, DOI 10.1080/10623320303356; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Trebak M., 2007, V179, P593; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2004, BIOL CELL, V96, P47, DOI 10.1016/j.biolcel.2003.12.003; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151	53	195	199	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e827	10.1371/journal.pone.0000827	http://dx.doi.org/10.1371/journal.pone.0000827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786199	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455500011
J	North, BJ; Verdin, E				North, Brian J.; Verdin, Eric			Interphase Nucleo-Cytoplasmic Shuttling and Localization of SIRT2 during Mitosis	PLOS ONE			English	Article								The human NAD+-dependent protein deacetylase SIRT2 resides predominantly in the cytoplasm where it functions as a tubulin deacetylase. Here we report that SIRT2 maintains a largely cytoplasmic localization during interphase by active nuclear export in a Crm1-dependent manner. We identified a functional, leptomycin B-sensitive, nuclear export signal sequence within SIRT2. During the cell cycle, SIRT2 becomes enriched in the nucleus and is associated with mitotic structures, beginning with the centrosome during prophase, the mitotic spindle during metaphase, and the midbody during cytokinesis. Cells overexpressing wild-type or a catalytically inactive SIRT2 exhibit an increase in multinucleated cells. The findings suggest a novel mechanism of regulating SIRT2 function by nucleo-cytoplasmic shuttling, as well as a role for SIRT2 in the nucleus during interphase and throughout mitosis.	[North, Brian J.; Verdin, Eric] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183	The J. David Gladstone Institutes	The J. David Gladstone Institutes	We thank John C. W. Carroll, Jack Hull and Chris Goodfellow for graphics, Amanda Bradford for administrative assistance, and Stephen Ordway and Gary Howard for editorial assistance. This work was supported by The J. David Gladstone Institutes ( E. V.). Eric Verdin is a senior scholar of the Larry Ellison Medical Foundation.	Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; Bae NS, 2004, J BIOCHEM, V135, P695, DOI 10.1093/jb/mvh084; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2000, GENE DEV, V14, P1021; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Michishita E, 2005, MOL BIOL CELL; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Monzo P, 2005, MOL BIOL CELL, V16, P2891, DOI 10.1091/mbc.E04-09-0773; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; NISHI K, 1994, J BIOL CHEM, V269, P6320; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shindo M, 1998, BIOCHEM BIOPH RES CO, V244, P285, DOI 10.1006/bbrc.1998.8250; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Wilson JM, 2006, EMBO REP, V7, P1247, DOI 10.1038/sj.embor.7400829; Yamaga M, 1999, J BIOL CHEM, V274, P28537, DOI 10.1074/jbc.274.40.28537; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425	42	206	216	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e784	10.1371/journal.pone.0000784	http://dx.doi.org/10.1371/journal.pone.0000784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726514	Green Published, gold			2022-12-25	WOS:000207455400001
J	Huang, JTJ; Leweke, FM; Tsang, TM; Koethe, D; Kranaster, L; Gerth, CW; Gross, S; Schreiber, D; Ruhrmann, S; Schultze-Lutter, F; Klosterkotter, J; Holmes, E; Bahn, S				Huang, Jeffrey T. -J.; Leweke, F. Markus; Tsang, Tsz M.; Koethe, Dagmar; Kranaster, Laura; Gerth, Christoph W.; Gross, Sonja; Schreiber, Daniela; Ruhrmann, Stephan; Schultze-Lutter, Frauke; Klosterkoetter, Joachim; Holmes, Elaine; Bahn, Sabine			CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis	PLOS ONE			English	Article								Background. The initial prodromal state of psychosis (IPS) is defined as an early disease stage prior to the onset of overt psychosis characterized by sub-threshold or more unspecific psychiatric symptoms. Little is known regarding the biochemical changes during this period. Methodology/Principal Findings. We investigated the metabolic/proteomic profiles of cerebrospinal fluid (CSF) of first-onset drug naive paranoid schizophrenia patients (n=54) and individuals presenting with initial prodromal symptoms (n=24), alongside healthy volunteers (n=70) using proton nuclear magnetic resonance (H-1-NMR) spectroscopy and surface enhanced laser desorption ionization (SELDI) mass spectrometry, respectively. Partial least square discriminant analysis (PLS-DA) showed that 36%/29% of IPS patients displayed proteomic/metabolic profiles characteristic of first-onset, drug naive schizophrenia, i.e., changes in levels of glucose and lactate as well as changes in a VGF-derived peptide (VGF23-62) and transthyretin protein concentrations. However, only 29% (n=7) of the investigated IPS patients (who to date have been followed up for up to three years) have so far received a diagnosis of schizophrenia. The presence of biochemical alterations in the IPS group did not correlate with the risk to develop schizophrenia. Conclusions/Significance. Our results imply that schizophrenia-related biochemical disease processes can be traced in CSF of prodromal patients. However, the biochemical disturbances identified in IPS patients, at least when measured at a single time point, may not be sufficient to predict clinical outcome.	[Huang, Jeffrey T. -J.; Bahn, Sabine] Univ Cambridge, Inst Biotechnol, Cambridge, England; [Leweke, F. Markus; Koethe, Dagmar; Kranaster, Laura; Gerth, Christoph W.; Gross, Sonja; Schreiber, Daniela; Ruhrmann, Stephan; Schultze-Lutter, Frauke; Klosterkoetter, Joachim] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Tsang, Tsz M.; Holmes, Elaine] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Biomol Med, Div SORA, London, England	University of Cambridge; University of Cologne; Imperial College London	Bahn, S (corresponding author), Univ Cambridge, Inst Biotechnol, Cambridge, England.	sb209@cam.ac.uk	Leweke, F. Markus/D-5435-2009; Schultze-Lutter, Frauke/AAU-1724-2021; Leweke, Markus/GVS-7897-2022; Ruhrmann, Stephan/AAG-9470-2020; Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Koethe, Dagmar/G-2462-2014	Leweke, F. Markus/0000-0002-8163-195X; Ruhrmann, Stephan/0000-0002-6022-2364; Holmes, Elaine/0000-0002-0556-8389; Koethe, Dagmar/0000-0002-8324-6756; Huang, Jeffrey/0000-0001-9982-2298	Stanley Medical Research Institute (SMRI); Koeln Fortune Program; Henry Smith Charity; BBSRC; NARSAD Essel Independent Investigator Fellowship	Stanley Medical Research Institute (SMRI); Koeln Fortune Program; Henry Smith Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NARSAD Essel Independent Investigator Fellowship(NARSAD)	This research was supported by the Stanley Medical Research Institute (SMRI) and the Koeln Fortune Program. Further thanks to The Henry Smith Charity and the BBSRC for financial support. S. B. holds a NARSAD Essel Independent Investigator Fellowship.	FERNANDES J, 1982, LANCET, V1, P113; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; HAWKINS RA, 1986, AM J PHYSIOL, V250, pE169, DOI 10.1152/ajpendo.1986.250.2.E169; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Huang JTJ, 2006, PLOS MED, V3, P2145, DOI 10.1371/journal.pmed.0030428; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klosterkotter J, 2001, ARCH GEN PSYCHIAT, V58, P158, DOI 10.1001/archpsyc.58.2.158; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Lencz T, 2003, SCHIZOPHRENIA BULL, V29, P717, DOI 10.1093/oxfordjournals.schbul.a007041; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Miller TJ, 1999, PSYCHIAT QUART, V70, P273, DOI 10.1023/A:1022034115078; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Miller TJ, 2002, AM J PSYCHIAT, V159, P863, DOI 10.1176/appi.ajp.159.5.863; Morrison AP, 2004, BRIT J PSYCHIAT, V185, P291, DOI 10.1192/bjp.185.4.291; Phillips LJ, 2000, AUST NZ J PSYCHIAT, V34, pS164, DOI 10.1046/j.1440-1614.2000.00798.x; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Ruhrmann S, 2003, PHARMACOPSYCHIATRY, V36, pS162; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Schreiber G, 2002, J ENDOCRINOL, V175, P61, DOI 10.1677/joe.0.1750061; SCHULTZELUTTER F, 2006, EUROPEAN PSYCHIAT, V21, pS27; Seidman LJ, 2003, SCHIZOPHRENIA BULL, V29, P803, DOI 10.1093/oxfordjournals.schbul.a007048; Strupp M, 2001, NEUROLOGY, V57, P2310, DOI 10.1212/WNL.57.12.2310; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Yung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6	29	86	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e756	10.1371/journal.pone.0000756	http://dx.doi.org/10.1371/journal.pone.0000756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712404	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455300004
J	Viera, A; Gomez, R; Parra, MT; Schmiesing, JA; Yokomori, K; Rufas, JS; Suja, JA				Viera, Alberto; Gomez, Rocio; Parra, Maria T.; Schmiesing, John A.; Yokomori, Kyoko; Rufas, Julio S.; Suja, Jose A.			Condensin I Reveals New Insights on Mouse Meiotic Chromosome Structure and Dynamics	PLOS ONE			English	Article							MITOTIC CHROMOSOME; XCAP-E; CHROMATID SEGREGATION; SYNAPTONEMAL COMPLEX; DOSAGE COMPENSATION; HISTONE H3; PROTEIN; CENTROMERE; PROPHASE; COHESIN	Chromosome shaping and individualization are necessary requisites to warrant the correct segregation of genomes in either mitotic or meiotic cell divisions. These processes are mainly prompted in vertebrates by three multiprotein complexes termed cohesin and condensin I and II. In the present study we have analyzed by immunostaining the appearance and subcellular distribution of condensin I in mouse mitotic and meiotic chromosomes. Our results demonstrate that in either mitotically or meiotically dividing cells, condensin I is loaded onto chromosomes by prometaphase. Condensin I is detectable as a fuzzy axial structure running inside chromatids of condensed chromosomes. The distribution of condensin I along the chromosome length is not uniform, since it preferentially accumulates close to the chromosome ends. Interestingly, these round accumulations found at the condensin I axes termini colocalized with telomere complexes. Additionally, we present the relative distribution of the condensin I and cohesin complexes in metaphase I bivalents. All these new data have allowed us to propose a comprehensive model for meiotic chromosome structure.	[Viera, Alberto; Gomez, Rocio; Parra, Maria T.; Rufas, Julio S.; Suja, Jose A.] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Schmiesing, John A.; Yokomori, Kyoko] Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92717 USA	Autonomous University of Madrid; University of California System; University of California Irvine	Viera, A (corresponding author), Univ Autonoma Madrid, Dept Biol, Edificio Biol, Madrid, Spain.	alberto.viera@uam.es	Suja, José A/L-4548-2014; Parra, María Teresa/AAA-1873-2019; gomez lencero, rocio/B-2171-2013; Rufas, Julio S/L-5174-2014; Viera, Alberto/J-2929-2013	Suja, José A/0000-0002-4266-795X; Parra, María Teresa/0000-0002-1158-6903; gomez lencero, rocio/0000-0003-4408-9812; Rufas, Julio S/0000-0002-7516-809X; Viera, Alberto/0000-0002-3602-4130	Ministerio de Educacion y Ciencia [BFU2006-06655/BCM, BFU20050-05668-C03-01/BCM]; Universidad Autonoma de Madrid [CCG06-UAM/SAL-0260]; Comunidad de Madrid; Fundacion Francisco Cobos	Ministerio de Educacion y Ciencia(Spanish Government); Universidad Autonoma de Madrid; Comunidad de Madrid(Comunidad de Madrid); Fundacion Francisco Cobos	This work was supported by grants BFU2006-06655/BCM and BFU20050-05668-C03-01/BCM from Ministerio de Educacion y Ciencia, and grant CCG06-UAM/SAL-0260 from Universidad Autonoma de Madrid and Comunidad de Madrid. Rocio Gomez is supported by a Fundacion Francisco Cobos and Ministerio de Educacion y Ciencia predoctoral fellowships.	Beenders B, 2003, CHROMOSOME RES, V11, P549, DOI 10.1023/A:1024999316867; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Cabello OA, 2001, MOL BIOL CELL, V12, P3527, DOI 10.1091/mbc.12.11.3527; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; EARNSHAW WC, 1989, GENOME, V31, P541, DOI 10.1139/g89-103; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Fujimoto S, 2005, PLANTA, V222, P293, DOI 10.1007/s00425-005-1546-0; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Gomez R, 2007, EMBO REP, V8, P173, DOI 10.1038/sj.embor.7400877; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Heng HHQ, 1996, P NATL ACAD SCI USA, V93, P2795, DOI 10.1073/pnas.93.7.2795; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Kalitsis P, 2006, P NATL ACAD SCI USA, V103, P8786, DOI 10.1073/pnas.0600250103; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kuznetsova I, 2006, CYTOGENET GENOME RES, V112, P248, DOI 10.1159/000089878; Kuznetsova IS, 2005, CHROMOSOME RES, V13, P9, DOI 10.1007/s10577-005-2346-x; LAEMMLI UK, 1977, COLD SPRING HARB SYM, V42, P351; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MOENS PB, 1990, CHROMOSOMA, V100, P8, DOI 10.1007/BF00337598; MOENS PB, 1989, CHROMOSOMA, V98, P317, DOI 10.1007/BF00292383; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Page J, 2003, J CELL SCI, V116, P551, DOI 10.1242/jcs.00252; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Parra MT, 2003, J CELL SCI, V116, P961, DOI 10.1242/jcs.00330; Parra MT, 2002, CHROMOSOMA, V111, P53, DOI 10.1007/s00412-002-0185-5; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Revenkova E, 2006, CHROMOSOMA, V115, P235, DOI 10.1007/s00412-006-0060-x; Rodriguez EM, 2001, CHROMOSOMA, V110, P478, DOI 10.1007/s004120100162; RUFAS JS, 1987, GENOME, V29, P706, DOI 10.1139/g87-121; RUFAS JS, 1992, GENOME, V35, P1054, DOI 10.1139/g92-162; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Siddiqui NU, 2003, DEVELOPMENT, V130, P3283, DOI 10.1242/dev.00542; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; SUJA JA, 1992, CHROMOSOMA, V101, P493, DOI 10.1007/BF00352472; Suja JA, 1999, J CELL SCI, V112, P2957; SUJA JA, 1991, GENOME, V34, P19, DOI 10.1139/g91-004; Suja Jose A., 2008, V2, P31, DOI 10.1007/7050_2006_023; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Tres LL, 2005, MOL REPROD DEV, V72, P1, DOI 10.1002/mrd.20334; Uzbekov R, 2003, J CELL SCI, V116, P1667, DOI 10.1242/jcs.00311; Viera A, 2003, CHROMOSOME RES, V11, P797, DOI 10.1023/B:CHRO.0000005781.71466.da; Viera A, 2002, CYTOGENET GENOME RES, V98, P221, DOI 10.1159/000069851; Watrin E, 2003, J BIOL CHEM, V278, P25708, DOI 10.1074/jbc.M300192200; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014; Yu HG, 2003, J CELL BIOL, V163, P937, DOI 10.1083/jcb.200308027; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	77	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e783	10.1371/journal.pone.0000783	http://dx.doi.org/10.1371/journal.pone.0000783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712430	Green Published, gold, Green Accepted			2022-12-25	WOS:000207455300030
J	Liu, X; Mazanek, P; Dam, V; Wang, Q; Zhao, H; Guo, R; Jagannathan, J; Cnaan, A; Maris, JM; Hogarty, MD				Liu, X.; Mazanek, P.; Dam, V.; Wang, Q.; Zhao, H.; Guo, R.; Jagannathan, J.; Cnaan, A.; Maris, J. M.; Hogarty, M. D.			Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification	ONCOGENE			English	Article						neuroblastoma; CTNNB1/beta-catenin; MYC; MYCN; embryonal cancer	BETA-CATENIN; C-MYC; WNT; EXPRESSION; GENE; TARGET; ACTIVATION; MUTATIONS; MECHANISM; PATHWAY	Neuroblastoma (NB) is a frequently lethal tumor of childhood. MYCN amplification accounts for the aggressive phenotype in a subset while the majority have no consistently identified molecular aberration but frequently express MYC at high levels. We hypothesized that activated Wnt/beta-catenin (CTNNB1) signaling might account for this as MYC is a beta-catenin transcriptional target and multiple embryonal and neural crest malignancies have oncogenic alterations in this pathway. NB cell lines without MYCN amplification express higher levels of MYC and beta-catenin (with aberrant nuclear localization) than MYCN amplified cell lines. Evidence for aberrant beta-catenin-TCF transcriptional activity was demonstrated using expression profiles from 73 primary NBs. Findings included increased WNT ligands (WNT1, WNT6, WNT7A, WNT10B), DVL1 and TCF7 expression in high-risk NBs without MYCN amplification, consistent with canonical beta-catenin signaling. More directly, Patterns of Gene Expression and Gene Set Enrichment Analyses demonstrated beta-catenin target genes (for example, MYC, PPARD, NRCAM, CD44, TCF7) as coordinately upregulated in high-risk NBs without MYCN amplification in comparison to high-risk MYCN-amplified or intermediate-risk NBs, supporting pathway activation in this subset. Thus, high-risk NBs without MYCN amplification may deregulate MYC and other oncogenic genes via altered beta-catenin signaling providing a potential candidate pathway for therapeutic inhibition.	[Liu, X.; Mazanek, P.; Dam, V.; Wang, Q.; Jagannathan, J.; Cnaan, A.; Maris, J. M.; Hogarty, M. D.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Zhao, H.; Guo, R.; Cnaan, A.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Maris, J. M.; Hogarty, M. D.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Hogarty, MD (corresponding author), Childrens Hosp Philadelphia, Div Oncol, 9 N ARC 902C,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	hogartym@email.chop.edu			NCI NIH HHS [P01-CA97323] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097323] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; COHN SL, 1990, ONCOGENE, V5, P1821; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Eggert A, 2000, BIOTECHNIQUES, V28, P681, DOI 10.2144/00284st04; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Manduchi E, 2000, BIOINFORMATICS, V16, P685, DOI 10.1093/bioinformatics/16.8.685; Maris JM, 2002, CANCER CELL, V2, P447, DOI 10.1016/S1535-6108(02)00206-4; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SADEE W, 1987, CANCER RES, V47, P5207; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thompson PM, 2001, CANCER RES, V61, P679; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	34	86	89	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2008	27	10					1478	1488		10.1038/sj.onc.1210769	http://dx.doi.org/10.1038/sj.onc.1210769			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	267ZR	17724465				2022-12-25	WOS:000253548200015
J	Tan, M; Gu, Q; He, H; Pamarthy, D; Semenza, GL; Sun, Y				Tan, M.; Gu, Q.; He, H.; Pamarthy, D.; Semenza, G. L.; Sun, Y.			SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation	ONCOGENE			English	Article						E3 ligase; HIF-1; hypoxia; SAG; transcription; ubiquitination	HYPOXIA-INDUCIBLE FACTOR-1; TUMOR-SUPPRESSOR COMPLEX; PROTEIN; LIGASE; SAG; HYDROXYLATION; GROWTH; ACTIVATION; EXPRESSION; COMPONENT	SAG (sensitive to apoptosis gene) or ROC2/RBX2 is the second family member of ROC1/RBX1, a component of SCF (Skp1, Cullin, F-box protein) and VCB (von Hippel-Lindau (VHL), Cullin and Elongin B/C) E3 ubiquitin ligases. SAG protected cells from hypoxia-induced apoptosis when overexpressed. We report here that SAG was subjected to hypoxia induction at the levels of mRNA and protein. Hypoxia induction of SAG was largely HIF-1 alpha dependent. A consensus HIF-1-binding site, GCGTG was identified in the first intron of the SAG gene. In response to hypoxia, HIF-1 bound to this site and transactivated SAG expression. SAG transactivation required both the intact binding site in cis and HIF-1 alpha in trans. On the other hand, like its family member, ROC1, SAG promoted VHL-mediated HIF-1 alpha ubiquitination and degradation, which was significantly inhibited upon small interfering RNA silencing of SAG or ROC1. Furthermore, the endogenous HIF-1 alpha at both basal and hypoxia-induced levels was significantly increased upon SAG silencing. Finally, SAG forms in vivo complex with Cul-5 and VHL under hypoxia condition. These results suggest an HIF-1-SAG feedback loop in response to hypoxia, as follows: hypoxia induces HIF-1 to transactivate SAG. Induced SAG then promotes HIF-1 alpha ubiquitination and degradation. This feedback loop may serve as a cellular defensive mechanism to reduce potential cytotoxic effects of prolonged HIF-1 activation under hypoxia.	[Tan, M.; Gu, Q.; He, H.; Pamarthy, D.; Sun, Y.] Univ Michigan, Ctr Comprehens Canc, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Semenza, G. L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med,Dept Pediat, Inst Cell Engn,Vasc Biol Program, Baltimore, MD USA; [Semenza, G. L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med,Dept Med, Inst Cell Engn,Vasc Biol Program, Baltimore, MD USA; [Semenza, G. L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med,Dept Oncol, Inst Cell Engn,Vasc Biol Program, Baltimore, MD USA; [Semenza, G. L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med,Dept Radiat Oncol, Inst Cell Engn,Vasc Biol Program, Baltimore, MD USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sun, Y (corresponding author), Univ Michigan, Ctr Comprehens Canc, Dept Radiat Oncol, 4304 CCGC,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	sunyi@umich.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287; Pamarthy, Deepika/0000-0003-2486-7437	NATIONAL CANCER INSTITUTE [R01CA111554, R01CA118762, R21CA116982] Funding Source: NIH RePORTER; NCI NIH HHS [CA111554, CA116982, CA118762] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chanalaris A, 2003, J MOL CELL CARDIOL, V35, P257, DOI 10.1016/S0022-2828(03)00003-8; Corn PG, 2003, NAT GENET, V35, P229, DOI 10.1038/ng1254; Duan HJ, 1999, MOL CELL BIOL, V19, P3145; Felder CB, 1999, AAPS PHARMSCI, V1; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gu QY, 2007, CANCER RES, V67, P3616, DOI 10.1158/0008-5472.CAN-06-4020; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim SY, 2003, BIOCHEM BIOPH RES CO, V301, P671, DOI 10.1016/S0006-291X(03)00018-4; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989; Swaroop M, 1999, FREE RADICAL BIO MED, V27, P193, DOI 10.1016/S0891-5849(99)00078-7; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yang GY, 2001, J CEREBR BLOOD F MET, V21, P722, DOI 10.1097/00004647-200106000-00010; Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231	25	61	63	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2008	27	10					1404	1411		10.1038/sj.onc.1210780	http://dx.doi.org/10.1038/sj.onc.1210780			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	267ZR	17828303				2022-12-25	WOS:000253548200007
J	Allende, ML; Zhou, D; Kalkofen, DN; Benhamed, S; Tuymetova, G; Borowski, C; Bendelac, A; Proia, RL				Allende, Maria L.; Zhou, Dapeng; Kalkofen, Danielle N.; Benhamed, Sonia; Tuymetova, Galina; Borowski, Christine; Bendelac, Albert; Proia, Richard L.			S1P(1) receptor expression regulates emergence of NKT cells in peripheral tissues	FASEB JOURNAL			English	Article						lipid signaling; G-protein coupled receptors; lymphocyte trafficking; conditional knockout mice	KILLER T-CELLS; SPHINGOSINE 1-PHOSPHATE RECEPTOR; SELECTIN-DEFICIENT MICE; SECONDARY LYMPHOID ORGANS; PROTEIN-COUPLED RECEPTOR; IMMUNE MODULATOR FTY720; IMMUNOSUPPRESSANT FTY720; VASCULAR MATURATION; THYMIC EMIGRATION; SPHINGOSINE-1-PHOSPHATE	The S1P(1) receptor, on the surface of lymphocytes and endothelial cells, regulates the unique trafficking behavior of certain lymphocyte populations. We have examined whether the S1P(1) receptor also dictates the distinctive tissue distribution of V alpha 14-J alpha 18 natural killer T (NKT) cells, whose trafficking pattern is not well understood. Mice (TCS1P(1)KO) were established with a conditional deletion of the S1P(1) receptor in thymocytes that included precursors of NKT cells. Within the thymus, NKT cells were found at normal or increased levels, indicating that S1P(1) receptor expression was dispensable for NKT cell development. However, substantially reduced numbers of NKT cells were detected in the peripheral tissues of the TCS1P(1)KO mice. Short-term S1P(1) deletion after NKT cells had established residence in the periphery did not substantially alter their distribution in tissues, except for a partial decrease in the spleen. FTY720, a S1P(1) receptor ligand that has potent effects on the trafficking of conventional T cells, did not alter the preexisting distribution of NKT cells within peripheral tissues of wild-type mice. Our results indicate that the S1P(1) receptor expression on NKT cells is dispensable for development within thymus but is essential for the establishment of their tissue residency in the periphery.	[Allende, Maria L.; Kalkofen, Danielle N.; Benhamed, Sonia; Tuymetova, Galina; Proia, Richard L.] NIDDK, Natl Inst Hlth, Genet Dev & Dis Branch, Bethesda, MD 20892 USA; [Zhou, Dapeng] Univ Texas Houston, MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Borowski, Christine; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Borowski, Christine; Bendelac, Albert] Howard Hughes Med Inst, Chicago, IL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Chicago; Howard Hughes Medical Institute	Allende, ML (corresponding author), NIDDK, Natl Inst Hlth, Genet Dev & Dis Branch, Bldg 10,Room 9D-06,10 Ctr DR MSC 1821, Bethesda, MD 20892 USA.	mariaa@intra.niddk.nih.gov; proia@nih.gov	Zhou, Dapeng/A-6446-2019; zhou, dapeng/GXG-9715-2022; Proia, Richard L/A-7908-2012	Zhou, Dapeng/0000-0003-1347-3811; Proia, Richard/0000-0003-0456-1270	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056015] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI038338] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfonso C, 2006, EUR J IMMUNOL, V36, P149, DOI 10.1002/eji.200535127; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2000, TRENDS PHARMACOL SCI, V21, P49, DOI 10.1016/S0165-6147(99)01419-4; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Chiba K, 1998, J IMMUNOL, V160, P5037; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Eger KA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000050; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Franki AS, 2006, P NATL ACAD SCI USA, V103, P9160, DOI 10.1073/pnas.0508892103; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hale JJ, 2004, BIOORG MED CHEM LETT, V14, P3351, DOI 10.1016/j.bmcl.2004.02.106; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hashimoto D, 2007, EUR J IMMUNOL, V37, P271, DOI 10.1002/eji.200636123; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laloux W, 2002, J IMMUNOL, V168, P3251, DOI 10.4049/jimmunol.168.7.3251; Lee A, 2002, MED TEACH, V24, P637, DOI 10.1080/0142159021000063970; Ley K, 2005, NAT IMMUNOL, V6, P1215, DOI 10.1038/ni1205-1215; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mempel M, 2002, J IMMUNOL, V168, P365, DOI 10.4049/jimmunol.168.1.365; Nagahara Y, 2000, IMMUNOPHARMACOLOGY, V48, P75, DOI 10.1016/S0162-3109(00)00181-8; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sawicka E, 2005, J IMMUNOL, V175, P7973, DOI 10.4049/jimmunol.175.12.7973; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sugito K, 2006, TRANSPLANT P, V38, P3058, DOI 10.1016/j.transproceed.2006.08.147; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Xu JC, 1996, J EXP MED, V183, P589, DOI 10.1084/jem.183.2.589; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	72	49	53	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					307	315		10.1096/fj.07-9087com	http://dx.doi.org/10.1096/fj.07-9087com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17785606				2022-12-25	WOS:000252309900032
J	Choi, HS; Kang, BS; Shim, JH; Cho, YY; Choi, BY; Bode, AM; Dong, ZG				Choi, Hong Seok; Kang, Bong Seok; Shim, Jung-Hyun; Cho, Yong-Yeon; Choi, Bu Young; Bode, Ann M.; Dong, Zigang			Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity	FASEB JOURNAL			English	Article						c-fos promoter; AP-1	IMMEDIATE-EARLY GENE; ACTIVATED T-CELLS; GROWTH-FACTORS; MAP KINASE; SER-10 PHOSPHORYLATION; SIGNALING PATHWAYS; NUCLEAR FACTOR; TPL-2; EXPRESSION; JUN	Post-translational modification of histones is critical for gene expression, mitosis, cell growth, apoptosis, and cancer development. Thus, finding protein kinases that are responsible for the phosphorylation of histones at critical sites is considered an important step in understanding the process of histone modification. The serine/threonine kinase Cot is a member of the mitogen-activated protein kinase (MAPK) kinase kinase family. We show here that Cot can phosphorylate histone H3 at Ser-10 in vivo and in vitro, and that the phosphorylation of histone H3 at Ser-10 is required for Cot-induced cell transformation. We found that activated Cot is recruited to the c-fos promoter resulting in increased activator protein-1 (AP-1) transactivation. The formation of the Cot-c-fos promoter complex was also apparent when histone H3 was phosphorylated at Ser-10. Furthermore, the use of dominant negative mutants of histone H3 revealed that Cot was required for phosphorylation of histone H3 at Ser-10 to induce neoplastic cell transformation. These results revealed an important function of Cot as a newly discovered histone H3 kinase. Moreover, the transforming ability of Cot results from the coordinated activation of histone H3, which ultimately converges on the regulation of the transcriptional activity of the c-fos promoter, followed by AP-1 transactivation activity. -Choi, H. S., Kang, B. S., Shim, J. H., Cho, Y. Y., Choi, B. Y., Bode, A. M., Dong, Z. Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity.	[Choi, Hong Seok; Kang, Bong Seok; Shim, Jung-Hyun; Cho, Yong-Yeon; Choi, Bu Young; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Choi, Hong Seok] Chosun Univ, Coll Pharm, Kwangju, South Korea	University of Minnesota System; Chosun University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651; Shim, Jung-Hyun/0000-0002-4062-4016	NATIONAL CANCER INSTITUTE [R01CA081064, R01CA077646, R01CA120388, R01CA111356, R37CA081064] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA111356-03, R01 CA077646, R01 CA111356, CA120388, R01 CA077646-09, R01 CA120388, R01 CA120388-04, R01 CA081064-03, R01 CA081064, CA111356, R37 CA081064, CA77646, CA81064] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AOKI M, 1991, ONCOGENE, V6, P1515; BALL AR, 1988, COLD SPRING HARB SYM, V53, P687, DOI 10.1101/SQB.1988.053.01.078; Ballester A, 1998, J BIOL CHEM, V273, P14099, DOI 10.1074/jbc.273.23.14099; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; BENBROOK DM, 1990, ONCOGENE, V5, P295; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; CHAN AML, 1993, ONCOGENE, V8, P1329; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Davie JR, 1999, BIOCHEM CELL BIOL, V77, P265, DOI 10.1139/bcb-77-4-265; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DIMARCO E, 1990, NAT IMMUN CELL GROW, V9, P209; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Erny KM, 1996, ONCOGENE, V13, P2015; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MAKRIS A, 1993, J VIROL, V67, P4283, DOI 10.1128/JVI.67.7.4283-4289.1993; MATSUI M, 1990, ONCOGENE, V5, P249; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OHARA R, 1993, JPN J CANCER RES, V84, P518, DOI 10.1111/j.1349-7006.1993.tb00170.x; OKUNO H, 1991, ONCOGENE, V6, P1491; Ota T, 2002, CANCER RES, V62, P5168; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Royds JA, 1998, J CLIN PATHOL-MOL PA, V51, P55; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Strelkov IS, 2002, CANCER RES, V62, P75; SUZUKI T, 1994, J VIROL, V68, P3527, DOI 10.1128/JVI.68.6.3527-3535.1994; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199	58	26	27	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2008	22	1					113	126		10.1096/fj.07-9078com	http://dx.doi.org/10.1096/fj.07-9078com			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	250OM	17724252	Green Accepted			2022-12-25	WOS:000252309900015
J	Laufer, M; Nandula, SV; Modi, AP; Wang, S; Jasin, M; Murty, VVVS; Ludwig, T; Baer, R				Laufer, Marsha; Nandula, Subhadra V.; Modi, Ami P.; Wang, Shuang; Jasin, Maria; Murty, Vundavalli V. V. S.; Ludwig, Thomas; Baer, Richard			Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; CANCER-PREDISPOSING MUTATIONS; STRAND BREAK REPAIR; RING DOMAIN; BRCT DOMAINS; OVARIAN-CANCER; PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; CYS557SER ALLELE; MAMMALIAN-CELLS	The BRCA1 tumor suppressor exists as a heterodimeric complex with BARD1, and this complex is thought to mediate many of the functions ascribed to BRCA1, including its role in tumor suppression. The two proteins share a common structural organization that features an N-terminal RING domain and two C-terminal BRCT motifs, whereas BARD1 alone also contains three tandem ankyrin repeats. In normal cells, the BRCA1/BARD1 heterodimer is believed to enhance chromosome stability by promoting homology-directed repair (HDR) of double strand DNA breaks. Here we have investigated the structural requirements for BARD1 in this process by complementation of Bard1-null mouse mammary carcinoma cells. Our results demonstrate that the ankyrin and BRCT motifs of BARD1 are each essential for both chromosome stability and HDR. Tandem BRCT motifs, including those found at the C terminus of BARD1, are known to form a phosphoprotein recognition module. Nonetheless, the HDR function of BARD1 was not perturbed by synthetic mutations predicted to ablate the phosphorecognition activity of its BRCT sequences, suggesting that some functions of the BRCT domains are not dependent on their ability to bind phosphorylated ligands. Also, cancer-associated missense mutations in the BRCT domains of BARD1 (e.g. C557S, Q564H, V695L, and S761N) have been observed in patients with breast, ovarian, and endometrial tumors. However, none of these was found to affect the HDR activity of BARD1, suggesting that any increased cancer risk conferred by these mutations is not because of defects in this repair mechanism.	Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pathol & Cell Biol,Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA	Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center	Baer, R (corresponding author), Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pathol & Cell Biol,Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	rb670@columbia.edu	Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585	NATIONAL CANCER INSTITUTE [T32CA009503, P01CA097403, P01CA094060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA 009503, P01 CA 94060, P01 CA094060, P01 CA097403, P01 CA 97403] Funding Source: Medline; NIGMS NIH HHS [R01 GM054668] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Ghimenti C, 2002, GENE CHROMOSOME CANC, V33, P235, DOI 10.1002/gcc.1223; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Karppinen SM, 2006, J MED GENET, V43, P856, DOI 10.1136/jmg.2006.041731; Karppinen SM, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.020669; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; McCarthy EE, 2003, MOL CELL BIOL, V23, P5056, DOI 10.1128/MCB.23.14.5056-5063.2003; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2001, CANCER RES, V61, P4842; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Reidt W, 2006, EMBO J, V25, P4326, DOI 10.1038/sj.emboj.7601313; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sauer MK, 2005, J MED GENET, V42, P633, DOI 10.1136/jmg.2004.030049; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Vahteristo P, 2006, EUR J HUM GENET, V14, P167, DOI 10.1038/sj.ejhg.5201542; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	50	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34325	34333		10.1074/jbc.M705198200	http://dx.doi.org/10.1074/jbc.M705198200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17848578	Green Published, hybrid			2022-12-25	WOS:000251145700048
J	Voss, M; Vitavska, O; Walz, B; Wieczorek, H; Baumann, O				Voss, Martin; Vitavska, Olga; Walz, Bernd; Wieczorek, Helmut; Baumann, Otto			Stimulus-induced phosphorylation of vacuolar H+-ATPase by protein kinase a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOWFLY CALLIPHORA-VICINA; V-ATPASE; SUBUNIT-C; PLASMA-MEMBRANE; SALIVARY-GLANDS; CYCLIC-AMP; MALPIGHIAN TUBULES; PROTON PUMP; DROSOPHILA-MELANOGASTER; BONE-RESORPTION	Eukaryotic vacuolar-type H+-ATPases (V-ATPases) are regulated by the reversible disassembly of the active V1V0 holoenzyme into a cytosolic V-1 complex and a membrane-bound V-0 complex. The signaling cascades that trigger these events in response to changing cellular conditions are largely unknown. We report that the V-1 subunit C of the tobacco hornworm Manduca sexta interacts with protein kinase A and is the only V-ATPase subunit that is phosphorylated by protein kinase A. Subunit C can be phosphorylated as single polypeptide as well as a part of the V-1 complex but not as a part of the V1V0 holoenzyme. Both the phosphorylated and the unphosphorylated form of subunit C are able to reassociate with the V-1 complex from which subunit C had been removed before. Using salivary glands of the blowfly Calliphora vicina in which V-ATPase reassembly and activity is regulated by the neurohormone serotonin via protein kinase A, we show that the membrane-permeable cAMP analog 8-(4-chlorophenylthio) adenosine-3', 5'-cyclic monophosphate (8-CPT-cAMP) causes phosphorylation of subunit C in a tissue homogenate and that phosphorylation is reduced by incubation with antibodies against subunit C. Similarly, incubation of intact salivary glands with 8-CPT-cAMP or serotonin leads to the phosphorylation of subunit C, but this is abolished by H-89, an inhibitor of protein kinase A. These data suggest that subunit C binds to and serves as a substrate for protein kinase A and that this phosphorylation may be a regulatory switch for the formation of the active V1V0 holoenzyme.	Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; Univ Osnabruck, Fachbereich Biol & Chem, D-49076 Osnabruck, Germany	University of Potsdam; University Osnabruck	Baumann, O (corresponding author), Univ Potsdam, Inst Biochem & Biol, Karl Liebknech Str 24-25, D-14476 Potsdam, Germany.	obaumann@uni-potsdam.de						BERRIDGE MJ, 1971, PHILOS T ROY SOC B, V262, P111, DOI 10.1098/rstb.1971.0082; Beyenbach KW, 2001, NEWS PHYSIOL SCI, V16, P145; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Coast GM, 2001, J EXP BIOL, V204, P1795; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Drory O, 2006, BBA-BIOENERGETICS, V1757, P297, DOI 10.1016/j.bbabio.2006.03.011; Ehrenfeld J, 1997, J EXP BIOL, V200, P247; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; GOGARTEN JP, 1992, J EXP BIOL, V172, P137; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Karas K, 2005, J INSECT PHYSIOL, V51, P1041, DOI 10.1016/j.jinsphys.2005.05.002; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kirschner LB, 2004, J EXP BIOL, V207, P1439, DOI 10.1242/jeb.00907; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Onken H, 2000, J EXP BIOL, V203, P1373; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Rein J, 2006, J EXP BIOL, V209, P1716, DOI 10.1242/jeb.02187; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schlesinger PH, 1997, J BIOL CHEM, V272, P18636, DOI 10.1074/jbc.272.30.18636; Schoonderwoert VTG, 2001, J MEMBRANE BIOL, V182, P159, DOI 10.1007/s00232-001-0040-2; SCHWEIKL H, 1989, J BIOL CHEM, V264, P11136; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2003, GENE, V302, P147, DOI 10.1016/S0378-1119(02)01099-5; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wilson JM, 2000, J EXP BIOL, V203, P2279; ZHANG Z, 2006, FEBS LETT, V580; Zimmermann B, 2003, J EXP BIOL, V206, P1867, DOI 10.1242/jeb.00376	53	98	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33735	33742		10.1074/jbc.M703368200	http://dx.doi.org/10.1074/jbc.M703368200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17872947	hybrid			2022-12-25	WOS:000250840200055
J	Jomain, JB; Tallet, E; Broutin, I; Hoos, S; van Agthoven, J; Ducruix, A; Kelly, PA; Kragelund, BB; England, P; Goffin, V				Jomain, Jean-Baptiste; Tallet, Estelle; Broutin, Isabelle; Hoos, Sylviane; van Agthoven, Jan; Ducruix, Arnaud; Kelly, Paul A.; Kragelund, Birthe B.; England, Patrick; Goffin, Vincent			Structural and thermodynamic bases for the design of pure prolactin receptor antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; PLACENTAL-LACTOGEN; CRYSTAL-STRUCTURE; MACROMOLECULAR STRUCTURES; BIOLOGICAL-PROPERTIES; EXTRACELLULAR DOMAIN; AUTOCRINE PROLACTIN; BINDING ENERGETICS; REGULATORY STEP; ANALOGS	Competitive antagonists of the human prolactin ( hPRL) receptor are a novel class of molecules of potential therapeutic interest in the context of cancer. We recently developed the pure antagonist Del1-9-G129R-hPRL by deleting the nine N-terminal residues of G129R-hPRL, a first generation partial antagonist. We determined the crystallographic structure of Del1-9-G129R-hPRL, which revealed no major change compared with wild type hPRL, indicating that its pure antagonistic properties are intrinsically due to the mutations. To decipher the molecular bases of pure antagonism, we compared the biological, physicochemical, and structural properties of numerous hPRL variants harboring N-terminal or Gly(129) mutations, alone or combined. The pure versus partial antagonistic properties of the multiple hPRL variants could not be correlated to differences in their affinities toward the hPRL receptor, especially at site 2 as determined by surface plasmon resonance. On the contrary, residual agonism of the hPRL variants was found to be inversely correlated to their thermodynamic stability, which was altered by all the Gly(129) mutations but not by those involving the N terminus. We therefore propose that residual agonism can be abolished either by further disrupting hormone site 2-receptor contacts by N-terminal deletion, as in Del1-9-G129R-hPRL, or by stabilizing hPRL and constraining its intrinsic flexibility, as in G129V-hPRL.	Equipe PRL GH & Tumeurs, Ctr Rech Croissance & Signalisat, INSERM, U845, F-75015 Paris, France; Univ Paris 05, Fac Med, F-75015 Paris, France; Univ Paris 05, Lab Cristallo & RMN Biol, CNRS, UMR 8015, F-75006 Paris, France; Dept Biol Struct & Chim, Inst Pasteur Plateforme Biophys Macromol & Leurs, F-75015 Paris, France; Univ Copenhagen, Dept Mol Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen, Denmark	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen	Goffin, V (corresponding author), Fac Med Necker Enfants Malad, Ctr Rech Croissance & Signalisat, INSERM, U845, 156 Rue Vaguirard, F-75730 Paris 15, France.	goffin@necker.fr	Broutin, Isabelle/A-2003-2017; GOFFIN, Vincent/G-3322-2013; Kragelund, Birthe/M-3927-2014	GOFFIN, Vincent/0000-0002-8021-3086; Kragelund, Birthe/0000-0002-7454-1761; Broutin, isabelle/0000-0001-9862-1232; ENGLAND, Patrick/0000-0001-6410-5918				Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; Bernichtein S, 2003, MOL CELL ENDOCRINOL, V208, P11, DOI 10.1016/S0303-7207(03)00264-8; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bernichtein S, 2003, ENDOCRINE, V20, P177, DOI 10.1385/ENDO:20:1-2:177; Bernichtein S, 2001, ENDOCRINOLOGY, V142, P3950, DOI 10.1210/en.142.9.3950; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; BOUTIN JM, 1989, MOL ENDOCRINOL, V3, P1455, DOI 10.1210/mend-3-9-1455; CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Dagvadorj A, 2007, ENDOCRINOLOGY, V148, P3089, DOI 10.1210/en.2006-1761; DATTANI MT, 1995, J BIOL CHEM, V270, P9222, DOI 10.1074/jbc.270.16.9222; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; Elkins PA, 2000, NAT STRUCT BIOL, V7, P808, DOI 10.1038/79047; Eyal O, 2007, BIOL REPROD, V76, P777, DOI 10.1095/biolreprod.106.053058; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; FUH G, 1993, J BIOL CHEM, V268, P5376; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Glezer A, 2006, J CLIN ENDOCR METAB, V91, P1048, DOI 10.1210/jc.2005-1831; GOFFIN V, 1994, J BIOL CHEM, V269, P32598; Goffin V, 2005, ENDOCR REV, V26, P400, DOI 10.1210/er.2004-0016; Goffin V, 1999, ENDOCRINOLOGY, V140, P3853, DOI 10.1210/en.140.8.3853; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Goffin V, 2007, RECENT PATENTS ENDOC, V1, P41, DOI 10.2174/187221407779814552; Goffin V, 2006, NAT CLIN PRACT ENDOC, V2, P571, DOI 10.1038/ncpendmet0270; Helman D, 1998, J BIOL CHEM, V273, P16067, DOI 10.1074/jbc.273.26.16067; Horn JR, 2006, BIOCHEMISTRY-US, V45, P8488, DOI 10.1021/bi0604328; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; Keeler C, 2003, J MOL BIOL, V328, P1105, DOI 10.1016/S0022-2836(03)00367-X; Keeler C, 2007, BIOCHEMISTRY-US, V46, P2398, DOI 10.1021/bi061958v; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; KINET S, 2001, RRD ENDOCRINOL 1, V2, P1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P273; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Ma FY, 2005, ENDOCRINOLOGY, V146, P93, DOI 10.1210/en.2004-0800; Ma FY, 2005, ENDOCRINOLOGY, V146, P5112, DOI 10.1210/en.2005-0770; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLIVEBERG M, 1994, BIOCHEMISTRY-US, V33, P8826, DOI 10.1021/bi00195a026; Osslund TD, 1998, PROTEIN SCI, V7, P1681, DOI 10.1002/pro.5560070803; PARIS N, 1990, BIOTECHNOL APPL BIOC, V12, P436; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Qazi AM, 2006, MOL ENDOCRINOL, V20, P1912, DOI 10.1210/me.2005-0291; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sivaprasad U, 2004, BIOCHEMISTRY-US, V43, P13755, DOI 10.1021/bi049333p; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; Walsh STR, 2006, J MOL BIOL, V358, P773, DOI 10.1016/j.jmb.2006.02.038; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Willard FS, 2006, ANAL BIOCHEM, V353, P147, DOI 10.1016/j.ab.2006.02.004; Zakrzewska M, 2006, BIOCHEMISTRY-US, V45, P15338, DOI 10.1021/bi0618114	55	54	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33118	33131		10.1074/jbc.M704364200	http://dx.doi.org/10.1074/jbc.M704364200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17785459	hybrid			2022-12-25	WOS:000250625400060
J	Bates, PD; Ohlrogge, JB; Pollard, M				Bates, Philip D.; Ohlrogge, John B.; Pollard, Mike			Incorporation of newly synthesized fatty acids into cytosolic glycerolipids in pea leaves occurs via acyl editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-SYNTHESIS; CHLOROPLAST ENVELOPE; IN-VIVO; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; PHOSPHATIDIC-ACID; COA THIOESTERASE; INNER MEMBRANE; METABOLISM; PHOSPHATIDYLCHOLINE; MICROSOMES	In expanding pea leaves, over 95% of fatty acids (FA) synthesized in the plastid are exported for assembly of eukaryotic glycerolipids. It is often assumed that the major products of plastid FA synthesis (18:1 and 16:0) are first incorporated into 16:0/18:1 and 18:1/18:1 molecular species of phosphatidic acid (PA), which are then converted to phosphatidylcholine (PC), the major eukaryotic phospholipid and site of acyl desaturation. However, by labeling lipids of pea leaves with [C-14] acetate, [C-14] glycerol, and [C-14] carbon dioxide, we demonstrate that acyl editing is an integral component of eukaryotic glycerolipid synthesis. First, no precursor-product relationship between PA and PC [C-14] acyl chains was observed at very early time points. Second, analysis of PC molecular species at these early time points showed that > 90% of newly synthesized [C-14] 18:1 and [C-14] 16:0 acyl groups were incorporated into PC alongside a previously synthesized unlabeled acyl group (18:2, 18:3, or 16:0). And third, [C-14] glycerol labeling produced PC molecular species highly enriched with 18:2, 18:3, and 16:0 FA, and not 18:1, the major product of plastid fatty acid synthesis. In conclusion, we propose that most newly synthesized acyl groups are not immediately utilized for PA synthesis, but instead are incorporated directly into PC through an acyl editing mechanism that operates at both sn-1 and sn-2 positions. Additionally, the acyl groups removed by acyl editing are largely used for the net synthesis of PC through glycerol 3-phosphate acylation.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Pollard, M (corresponding author), Michigan State Univ, Dept Plant Pathol, Wilson Rd, E Lansing, MI 48824 USA.	pollard9@msu.edu	Bates, Philip D/I-7550-2013; Bates, Philip David/O-9980-2019	Bates, Philip D/0000-0002-1291-3363; Bates, Philip David/0000-0002-1291-3363				ANDREWS J, 1983, PLANT PHYSIOL, V72, P735, DOI 10.1104/pp.72.3.735; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; BERTRAMS M, 1981, Z NATURFORSCH C, V36, P62; BESSOULE JJ, 1995, EUR J BIOCHEM, V228, P490, DOI 10.1111/j.1432-1033.1995.tb20288.x; BLOCK MA, 1983, FEBS LETT, V153, P377, DOI 10.1016/0014-5793(83)80647-4; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Christie W.W, 2003, LIPID ANAL ISOLATION, V3rd; DEMANDRE C, 1994, PHYTOCHEMISTRY, V35, P1171, DOI 10.1016/S0031-9422(00)94816-7; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Ichihara K, 1996, LIPIDS, V31, P535, DOI 10.1007/BF02522648; KHAN MU, 1977, J CHROMATOGR, V140, P179, DOI 10.1016/S0021-9673(00)88412-5; Kjellberg JM, 2000, BBA-MOL CELL BIOL L, V1485, P100, DOI 10.1016/S1388-1981(00)00040-8; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Mongrand S, 1997, BIOCHEM J, V327, P853, DOI 10.1042/bj3270853; Mongrand S, 1998, PHYTOCHEMISTRY, V49, P1049, DOI 10.1016/S0031-9422(98)00243-X; Mongrand S, 2000, PLANT PHYSIOL, V122, P845, DOI 10.1104/pp.122.3.845; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; Pollard M, 1999, PLANT PHYSIOL, V121, P1217, DOI 10.1104/pp.121.4.1217; ROCHESTER CP, 1984, ARCH BIOCHEM BIOPHYS, V232, P249, DOI 10.1016/0003-9861(84)90541-1; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; Schwender J, 2002, PLANT PHYSIOL, V130, P347, DOI 10.1104/pp.004275; SERGHINICAID H, 1988, PLANT SCI, V54, P93, DOI 10.1016/0168-9452(88)90086-6; SLACK CR, 1977, BIOCHEM J, V162, P289, DOI 10.1042/bj1620289; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; SPERLING P, 1993, EUR J BIOCHEM, V213, P965, DOI 10.1111/j.1432-1033.1993.tb17841.x; STYMNE S, 1983, BIOCHIM BIOPHYS ACTA, V752, P198, DOI 10.1016/0005-2760(83)90113-3; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Williams JP, 2000, BIOCHEM J, V349, P127, DOI 10.1042/0264-6021:3490127	35	159	174	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31206	31216		10.1074/jbc.M705447200	http://dx.doi.org/10.1074/jbc.M705447200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728247	hybrid			2022-12-25	WOS:000250309200010
J	Maher, RL; Bloom, LB				Maher, Robyn L.; Bloom, Linda B.			Pre-steady-state kinetic characterization of the AP endonuclease activity of human AP endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC ENDONUCLEASE; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; ALKYLADENINE DNA GLYCOSYLASE; HUMAN ABASIC ENDONUCLEASE; BASE EXCISION-REPAIR; EXONUCLEASE-III; APYRIMIDINIC ENDONUCLEASE; SINGLE-TURNOVER; SITE ANALOGS; CELLS	Human AP endonuclease 1 ( APE1, REF1) functions within the base excision repair pathway by catalyzing the hydrolysis of the phosphodiester bond 5' to a baseless sugar ( apurinic or apyrimidinic site). The AP endonuclease activity of this enzyme and two active site mutants were characterized using equilibrium binding and pre-steady-state kinetic techniques. Wild-typeAPE1 is a remarkably potent endonuclease and highly efficient enzyme. Incision 5' to AP sites is so fast that a maximal single-turnover rate could not be measured using rapid mixing/quench techniques and is at least 850 s(-1). The entire catalytic cycle is limited by a slow step that follows chemistry and generates a steady-state incision rate of about 2 s(-1). Site-directed mutation of His-309 to Asn and Asp-210 to Ala reduced the single turnover rate of incision 5' to AP sites by at least 5 orders of magnitude such that chemistry ( or a step following DNA binding and preceding chemistry) and not a step following chemistry became rate-limiting. Our results suggest that the efficiency with which APE1 can process an AP site in vivo is limited by the rate at which it diffuses to the site and that a slow step after chemistry may prevent APE1 from leaving the site of damage before the next enzyme arrives to continue the repair process.	Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055596] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM055596, R01 GM055596] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abner CW, 2001, J BIOL CHEM, V276, P13379, DOI 10.1074/jbc.M010641200; Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P60, DOI 10.1080/00913847.1992.11947449; KANE CM, 1981, J BIOL CHEM, V256, P3405; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kuninger DT, 2002, NUCLEIC ACIDS RES, V30, P823, DOI 10.1093/nar/30.3.823; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lowry DF, 2003, J MOL BIOL, V329, P311, DOI 10.1016/S0022-2836(03)00382-6; Lucas JA, 1999, BIOCHEMISTRY-US, V38, P4958, DOI 10.1021/bi982052v; Maher RL, 2007, DNA REPAIR, V6, P71, DOI 10.1016/j.dnarep.2006.09.001; Masuda Y, 1998, J BIOL CHEM, V273, P30360, DOI 10.1074/jbc.273.46.30360; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mundle ST, 2004, DNA REPAIR, V3, P1447, DOI 10.1016/j.dnarep.2004.06.009; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Pope MA, 2005, DNA REPAIR, V4, P91, DOI 10.1016/j.dnarep.2004.08.004; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; SEKI S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P287, DOI 10.1016/0167-4781(92)90027-W; Shaw RW, 2004, DNA REPAIR, V3, P1273, DOI 10.1016/j.dnarep.2004.05.003; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yoshida A, 2003, J BIOL CHEM, V278, P37768, DOI 10.1074/jbc.M304914200; Yoshida A, 2006, INT J HEMATOL, V84, P31, DOI 10.1007/BF03342699; Zou GM, 2007, BLOOD, V109, P1917, DOI 10.1182/blood-2006-08-044172	41	74	76	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30577	30585		10.1074/jbc.M704341200	http://dx.doi.org/10.1074/jbc.M704341200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724035	hybrid			2022-12-25	WOS:000250136300026
J	Hockings, KJ; Humle, T; Anderson, JR; Biro, D; Sousa, C; Ohashi, G; Matsuzawa, T				Hockings, Kimberley J.; Humle, Tatyana; Anderson, James R.; Biro, Dora; Sousa, Claudia; Ohashi, Gaku; Matsuzawa, Tetsuro			Chimpanzees Share Forbidden Fruit	PLOS ONE			English	Article							HUNTING BEHAVIOR; WILD CHIMPANZEES; SOCIAL-BEHAVIOR	The sharing of wild plant foods is infrequent in chimpanzees, but in chimpanzee communities that engage in hunting, meat is frequently used as a 'social tool' for nurturing alliances and social bonds. Here we report the only recorded example of regular sharing of plant foods by unrelated, non-provisioned wild chimpanzees, and the contexts in which these sharing behaviours occur. From direct observations, adult chimpanzees at Bossou (Republic of Guinea, West Africa) very rarely transferred wild plant foods. In contrast, they shared cultivated plant foods much more frequently (58 out of 59 food sharing events). Sharing primarily consists of adult males allowing reproductively cycling females to take food that they possess. We propose that hypotheses focussing on 'food-for-sex and -grooming' and 'showing-off' strategies plausibly account for observed sharing behaviours. A changing human-dominated landscape presents chimpanzees with fresh challenges, and our observations suggest that crop-raiding provides adult male chimpanzees at Bossou with highly desirable food commodities that may be traded for other currencies.	[Hockings, Kimberley J.; Anderson, James R.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Humle, Tatyana] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Biro, Dora] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Sousa, Claudia] Univ Lisbon, Dept Anthropol, P-1699 Lisbon, Portugal; [Ohashi, Gaku; Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Kyoto, Japan	University of Stirling; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; Universidade de Lisboa; Kyoto University	Hockings, KJ (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	k.j.hockings@stir.ac.uk	Anderson, James/H-8471-2019; Matsuzawa, Tetsuro/ABE-9654-2021	Matsuzawa, Tetsuro/0000-0002-8147-2725; Biro, Dora/0000-0002-3408-6274; Sousa, Claudia/0000-0003-1008-5952; Hockings, Kimberley/0000-0002-6187-644X	Stirling University studentship, MEXT [16002001]; JSPS-HOPE	Stirling University studentship, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS-HOPE	Funding: This work was supported by a Stirling University studentship, MEXT grant # 16002001 and JSPS-HOPE.	Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#; Bethell E., 2000, Primate Report, V56, P67; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2000, CHIMPANZEES TAI FORE; De Waal F., 2000, CHIMPANZEE POLITICS; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; Feistner A.T.C., 1989, P21; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hill, ADAPTIVE RESPONSES N, P139; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; McGrew WC, 1996, FOOD STATUS QUEST IN, P39; Mitani JC, 1999, AM J PHYS ANTHROPOL, V109, P439, DOI 10.1002/(SICI)1096-8644(199908)109:4<439::AID-AJPA2>3.0.CO;2-3; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Nakamura M., 2001, PAN AFR NEWS, V8, P28, DOI [10.5134/143398, DOI 10.5134/143398]; Nishida Toshisada, 1992, P159; Ohashi Gaku, 2007, Pan Africa News, V14, P14; Slocombe KE, 2005, AM J PRIMATOL, V65, P385, DOI 10.1002/ajp.20123; Stanford C.B., 1998, CHIMPANZEE RED COLOB; Stanford CB, 1998, CURR ANTHROPOL, V39, P399, DOI 10.1086/204757; Stanford CB, 2001, TREE OF ORIGIN, P95; Stevens JR, 2004, ANIM BEHAV, V67, P603, DOI 10.1016/j.anbehav.2003.04.012; SUGIYAMA Y, 1989, BEHAVIORAL STUDIES W, P43; TELEKI G, 1973, PREDATORY BEHAV WILD; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; van Lawick-Goodall J., 1972, P25	28	84	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e886	10.1371/journal.pone.0000886	http://dx.doi.org/10.1371/journal.pone.0000886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849015	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455600032
J	Nielsen, M; Lundegaard, C; Blicher, T; Lamberth, K; Harndahl, M; Justesen, S; Roder, G; Peters, B; Sette, A; Lund, O; Buus, S				Nielsen, Morten; Lundegaard, Claus; Blicher, Thomas; Lamberth, Kasper; Harndahl, Mikkel; Justesen, Sune; Roder, Gustav; Peters, Bjoern; Sette, Alessandro; Lund, Ole; Buus, Soren			NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence	PLOS ONE			English	Article								Background. Binding of peptides to Major Histocompatibility Complex (MHC) molecules is the single most selective step in the recognition of pathogens by the cellular immune system. The human MHC class I system (HLA-I) is extremely polymorphic. The number of registered HLA-I molecules has now surpassed 1500. Characterizing the specificity of each separately would be a major undertaking. Principal Findings. Here, we have drawn on a large database of known peptide-HLA-I interactions to develop a bioinformatics method, which takes both peptide and HLA sequence information into account, and generates quantitative predictions of the affinity of any peptide-HLA-I interaction. Prospective experimental validation of peptides predicted to bind to previously untested HLA-I molecules, cross-validation, and retrospective prediction of known HIV immune epitopes and endogenous presented peptides, all successfully validate this method. We further demonstrate that the method can be applied to perform a clustering analysis of MHC specificities and suggest using this clustering to select particularly informative novel MHC molecules for future biochemical and functional analysis. Conclusions. Encompassing all HLA molecules, this high-throughput computational method lends itself to epitope searches that are not only genome- and pathogen-wide, but also HLA-wide. Thus, it offers a truly global analysis of immune responses supporting rational development of vaccines and immunotherapy. It also promises to provide new basic insights into HLA structure-function relationships. The method is available at http://www.cbs.dtu.dk/services/NetMHCpan.	[Nielsen, Morten; Lundegaard, Claus; Blicher, Thomas; Lund, Ole] Tech Univ Denmark, BioCtr DTU, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lamberth, Kasper; Harndahl, Mikkel; Justesen, Sune; Roder, Gustav; Buus, Soren] Univ Copenhagen, Dept Expt Immunol, Inst Med Microbiol & Immunol, Copenhagen, Denmark; [Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, San Diego, CA USA	Technical University of Denmark; University of Copenhagen; La Jolla Institute for Immunology	Nielsen, M (corresponding author), Tech Univ Denmark, BioCtr DTU, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	mniel@cbs.dtu.dk	Lundegaard, Claus/B-3938-2012; Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Sette, Alessandro/AFO-8916-2022; Lund, Ole/F-4437-2014; Nielsen, Morten/E-7754-2011	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Buus, Soren/0000-0001-8363-1999	NIH [HHSN266200400025C, HHSN266200400083C, HHSN26620040006C]; European commission [LSHB-CT-2003-503231]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the NIH ( contracts HHSN266200400025C, HHSN266200400083C, and HHSN26620040006C) and sixth Framework program of the European commission ( grant LSHB-CT-2003-503231).	ADAMS HP, 1995, J IMMUNOL METHODS, V185, P181, DOI 10.1016/0022-1759(95)00111-M; Antes I, 2006, BIOINFORMATICS, V22, pE16, DOI 10.1093/bioinformatics/btl216; BALDI P, 2001, BIOINFORMATICS MACHI; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; BRUSIC V, 1994, COMPLEX SYSTEMS MECH, P253; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; Donnes P, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-25; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Doytchinova IA, 2001, J MED CHEM, V44, P3572, DOI 10.1021/jm010021j; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOBOHM U, 1992, PROTEIN SCI, V1, P409; JANOWITZ M, 2003, BIOCONSENSUS, V61, P163; KORBER BTM, 2001, HIV MOL IMMUNOLOGY 2; Lauemoller S L, 2000, Rev Immunogenet, V2, P477; Lefranc Marie-Paule, 2005, Immunome Res, V1, P3, DOI 10.1186/1745-7580-1-3; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Mamitsuka H, 1998, PROTEINS, V33, P460, DOI 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-M; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; PARKER KC, 1994, J IMMUNOL, V152, P163; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Press WH., 1992, NUMERICAL RECIPIES C, V2nd edn; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Segal MR, 2001, BIOMETRICS, V57, P632, DOI 10.1111/j.0006-341X.2001.00632.x; SETTE A, 1989, P NATL ACAD SCI USA, V86, P3296, DOI 10.1073/pnas.86.9.3296; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; Sette A, 2007, CURR OPIN IMMUNOL, V19, P106, DOI 10.1016/j.coi.2006.11.002; Sette Alessandro, 2005, Immunity, V22, P155, DOI 10.1016/j.immuni.2005.01.009; Sidney J, 2006, IMMUNOGENETICS, V58, P559, DOI 10.1007/s00251-006-0131-4; Srinivasan KN, 2004, BIOINFORMATICS, V20, P297, DOI 10.1093/bioinformatics/bth943; STEVEN GE, 2000, HLA FACTS BOOK; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zhu SF, 2006, BIOINFORMATICS, V22, P1648, DOI 10.1093/bioinformatics/btl141; [No title captured]	51	398	428	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e796	10.1371/journal.pone.0000796	http://dx.doi.org/10.1371/journal.pone.0000796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726526	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455400013
